<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36847376</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-6612</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Australasian journal on ageing</Title><ISOAbbreviation>Australas J Ageing</ISOAbbreviation></Journal><ArticleTitle>The experience of hospital care for older surgical patients and their carers: A mixed-methods study.</ArticleTitle><Pagination><StartPage>535</StartPage><EndPage>544</EndPage><MedlinePgn>535-544</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ajag.13176</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">A growing proportion of older adults are undergoing surgery, but there is a paucity of patient and carer experience research in this group. This study investigated the experience of hospital care in an older vascular surgery population for patients and their carers.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a mixed-methods convergent design, including simultaneous collection of quantitative and qualitative research strands by combining open-ended questions with rating scales in a questionnaire. Recently hospitalised vascular surgery patients aged &#x2265;65&#x2009;years at a major teaching hospital were recruited. Carers were also approached to participate.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Forty-seven patients (mean age 77&#x2009;years, 77% male, 20% with a Clinical Frailty Scale score &gt;4) and nine carers participated. The majority of patients reported that their views were listened to (n&#xa0;=&#x2009;42, 89%), they were kept informed (n&#xa0;=&#x2009;39, 83%), and were asked about their pain (n&#xa0;=&#x2009;37, 79%). Among carers, seven reported their views were listened to and that they were kept informed. Thematic analysis of patients' and carers' responses to open-ended questions about their experience of hospital care revealed four themes in terms of what mattered to them: fundamental care including hygiene and nutrition, comfort of the hospital environment such as sleep and meals, being informed and involved in health-care decision-making, and treating pain and deconditioning to help recovery.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Older adults admitted to hospital for vascular surgery and their carers, valued highly the care that met both their fundamental needs and facilitated shared decisions for care and recovery. These priorities can be addressed through Age-Friendly Health System initiatives.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Australasian Journal on Ageing published by John Wiley &amp; Sons Australia, Ltd on behalf of AJA Inc&#x2019;.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thillainadesan</LastName><ForeName>Janani</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5287-7483</Identifier><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Concord Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Health, The University of Sydney, Camperdown, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Education and Research on Ageing, Concord Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sydney Health Economics Collaborative, Sydney Local Health District, Camperdown, Sydney, New&#xa0;South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Box</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre for Education and Research on Ageing, Concord Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kearney</LastName><ForeName>Leanne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Education and Research on Ageing, Concord Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naganathan</LastName><ForeName>Vasi</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-7243-0796</Identifier><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Concord Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Health, The University of Sydney, Camperdown, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Education and Research on Ageing, Concord Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cunich</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health, The University of Sydney, Camperdown, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sydney Health Economics Collaborative, Sydney Local Health District, Camperdown, Sydney, New&#xa0;South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aitken</LastName><ForeName>Sarah J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health, The University of Sydney, Camperdown, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Concord Institute of Academic Surgery, Concord Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Vascular Surgery, Concord Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monaro</LastName><ForeName>Sue R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Concord Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Susan Wakil School of Nursing, The University of Sydney, Sydney, New&#xa0;South Wales, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Ageing and Alzheimers Institute</Agency><Country/></Grant><Grant><Agency>Medical Insurance Group of Australia</Agency><Country/></Grant><Grant><Agency>National Health and Medical Research Council</Agency><Country/></Grant><Grant><Agency>Sydney Local Health District</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Australas J Ageing</MedlineTA><NlmUniqueID>9808874</NlmUniqueID><ISSNLinking>1440-6381</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="Y">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aged</Keyword><Keyword MajorTopicYN="N">caregiversfrailty</Keyword><Keyword MajorTopicYN="N">geriatrics</Keyword><Keyword MajorTopicYN="N">health services</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList><CoiStatement>Janani Thillainadesan and Vasi Naganathan are Associate Editors of the Australasian Journal on Ageing.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>27</Day><Hour>8</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36847376</ArticleId><ArticleId IdType="pmc">PMC10946774</ArticleId><ArticleId IdType="doi">10.1111/ajag.13176</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ridda I, Lindley R, MacIntyre RC. The challenges of clinical trials in the exclusion zone: the case of the frail elderly. Australas J Ageing. 2008;27:61&#x2010;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">18713194</ArticleId></ArticleIdList></Reference><Reference><Citation>Peden CJ, Grocott MP. National research strategies: what outcomes are important in peri&#x2010;operative elderly care? Anaesthesia. 2014;69(Suppl 1):61&#x2010;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">24303862</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centre for Perioperative Care and British Geriatrics Society
. Guideline for Perioperative Care for People Living with Frailty Undergoing Elective and Emergency Surgery. 2021. https://cpoc.org.uk/guidelines&#x2010;resources&#x2010;guidelines/perioperative&#x2010;care&#x2010;people&#x2010;living&#x2010;frailty. Accessed 12 December 2022</Citation></Reference><Reference><Citation>Thillainadesan J, Hilmer SN, Fleury AM, Naganathan V. New horizons in the perioperative care of older adults. Age Ageing. 2022;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">35134849</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung C, Meissner MA, Garg T. Incorporating outcomes that matter to older adults into surgical research. J Am Geriatr Soc. 2021;69:618&#x2010;620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8323990</ArticleId><ArticleId IdType="pubmed">33462830</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingsley C, Patel S. Patient&#x2010;reported outcome measures and patient&#x2010;reported experience measures. BJA Educ. 2017;17:137&#x2010;144.</Citation></Reference><Reference><Citation>Aitken SJ, Naganathan V, Blyth FM. Aortic aneurysm trials in octogenarians: are we really measuring the outcomes that matter? Vascular. 2016;24:435&#x2010;445.</Citation><ArticleIdList><ArticleId IdType="pubmed">26223531</ArticleId></ArticleIdList></Reference><Reference><Citation>Aitken SJ, Choy OS, Monaro S. A qualitative study exploring patient concerns and values in chronic limb&#x2010;threatening ischemia. J Surg Res. 2019;243:289&#x2010;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">31254902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitson A. Why do we need to study the fundamentals of care? Nurs Leadersh (Tor Ont). 2016;29:10&#x2010;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">27309637</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas&#x2010;Dunbar M, Gardiner P. Support for carers of people with dementia during hospital admission. Nurs Older People. 2007;19:27&#x2010;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">17972782</ArticleId></ArticleIdList></Reference><Reference><Citation>Fetters MD, Curry LA, Creswell JW. Achieving integration in mixed methods designs&#x2010;principles and practices. Health Serv Res. 2013;48:2134&#x2010;2156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4097839</ArticleId><ArticleId IdType="pubmed">24279835</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew S, Salamonson Y, Everett B, Halcomb EJ, Davidson PM. Beyond the ceiling effect: using a mixed methods approach to measure patient satisfaction. Intl J Multiple Res Approaches. 2011;5:52&#x2010;63.</Citation></Reference><Reference><Citation>Iversen HH, Bjertn&#xe6;s OA, Skudal KE. Patient evaluation of hospital outcomes: an analysis of open&#x2010;ended comments from extreme clusters in a national survey. BMJ Open. 2014;4:e004848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4039827</ArticleId><ArticleId IdType="pubmed">24879826</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew S, Halcomb EJ. Mixed methods research is an effective method of enquiry for community health research. Contemp Nurse. 2006;23:145&#x2010;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">17343517</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark VLP. Meaningful integration within mixed methods studies: identifying why, what, when, and how. Contemp Educ Psychol. 2019;57:106&#x2010;111.</Citation></Reference><Reference><Citation>Agency for clinical innovation, leading better value care (lbvc) inpatient patient&#x2010;reported experiences measure (prem) survey. 2018.</Citation></Reference><Reference><Citation>Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173:489&#x2010;495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1188185</ArticleId><ArticleId IdType="pubmed">16129869</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing. 1972;1:233&#x2010;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">4669880</ArticleId></ArticleIdList></Reference><Reference><Citation>Jitapunkul S, Pillay I, Ebrahim S. The abbreviated mental test: its use and validity. Age Ageing. 1991;20:332&#x2010;336.</Citation><ArticleIdList><ArticleId IdType="pubmed">1755388</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi&#x2010;disciplinary health research. BMC Med Res Methodol. 2013;13:117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3848812</ArticleId><ArticleId IdType="pubmed">24047204</ArticleId></ArticleIdList></Reference><Reference><Citation>Dibley L. Analysing narrative data using mccormack's lenses. Nurse Res. 2011;18:13&#x2010;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">21560921</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuper A, Lingard L, Levinson W. Critically appraising qualitative research. BMJ. 2008;337:a1035.</Citation><ArticleIdList><ArticleId IdType="pubmed">18687726</ArticleId></ArticleIdList></Reference><Reference><Citation>Miles MB, Huberman AM, Salda&#xf1;a J. Qualitative Data Analysis: A Methods Sourcebook. 3rd ed. SAGE Publications, Inc.; 2014.</Citation></Reference><Reference><Citation>Fulmer T, Mate KS, Berman A. The age&#x2010;friendly health system imperative. J Am Geriatr Soc. 2018;66:22&#x2010;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">28876455</ArticleId></ArticleIdList></Reference><Reference><Citation>van Oppen JD, Thompson D, Tite M, Griffiths S, Martin FC, Conroy S. The acute frailty network: experiences from a whole&#x2010;systems quality improvement collaborative for acutely ill older patients in the english nhs. Euro Geriatric Med. 2019;10:559&#x2010;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">34652726</ArticleId></ArticleIdList></Reference><Reference><Citation>
Safer Care Victoria
. Become Part of an Age&#x2010;Friendly Health System. State of Victoria; 2022. https://www.safercare.vic.gov.au/news&#x2010;and&#x2010;media/become&#x2010;part&#x2010;of&#x2010;an&#x2010;age&#x2010;friendly&#x2010;health&#x2010;system. Accessed 12 December 2022</Citation></Reference><Reference><Citation>Bridges J, Collins P, Flatley M, Hope J, Young A. Older people's experiences in acute care settings: systematic review and synthesis of qualitative studies. Int J Nurs Stud. 2020;102:103469.</Citation><ArticleIdList><ArticleId IdType="pubmed">31862528</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsey Z, Marcus E, Marcia MR. New standards for age&#x2010;friendly surgical care. Health Prog. 2021;102:73&#x2010;75.</Citation></Reference><Reference><Citation>Greenhalgh T, Taylor R. Papers that go beyond numbers (qualitative research). BMJ. 1997;315:740&#x2010;743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127518</ArticleId><ArticleId IdType="pubmed">9314762</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36847007</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-8908</ISSN><JournalIssue CitedMedium="Internet"><Volume>92</Volume><Issue>3</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Involvement of Informal Caregivers in Preventing Falls in Older Adults with Cognitive Impairment: A Rapid Review.</ArticleTitle><Pagination><StartPage>741</StartPage><EndPage>750</EndPage><MedlinePgn>741-750</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-221142</ELocationID><Abstract><AbstractText Label="BACKGROUND">The prevalence of falls and related injuries is double in older adults with cognitive impairment compared with cognitively healthy older adults. A growing body of literature shows that falls prevention interventions in the cognitively impaired are difficult to implement and that the feasibility and adherence to interventions depend on a number of factors including informal caregiver involvement. However, no systematic review exists on the topic.</AbstractText><AbstractText Label="OBJECTIVE">Our objective is to determine whether involvement of informal caregivers can reduce falls in older adults with cognitive impairment.</AbstractText><AbstractText Label="METHODS">Rapid review following Cochrane collaboration guidelines.</AbstractText><AbstractText Label="RESULTS">Seven randomized controlled trials were identified involving 2,202 participants. We identified the following areas where informal caregiving may have an important role in fall prevention in older adults with cognitive impairment: 1) enhancing adherence to the exercise program; 2) identifying and recording falls incidents and circumstances; 3) identifying and modifying possible environmental falls risk factors inside patient's home; and 4) playing an active role in modifying lifestyle in terms of diet/nutrition, limiting antipsychotics, and avoiding movements risking falls. However, informal caregiver involvement was identified as an incidental finding in these studies and the level of evidence ranged from low to moderate.</AbstractText><AbstractText Label="CONCLUSION">Informal caregiver involvement in planning and delivering interventions to reduce falls has been found to increase the adherence of individuals with cognitive impairment in falls prevention programs. Future research should address whether involvement of informal caregivers may improve efficacy of prevention programs by reducing the number of falls as a primary outcome.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sultana</LastName><ForeName>Munira</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gait and Brain Laboratory, Parkwood Hospital, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexander</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University of Michigan, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierucini-Faria</LastName><ForeName>Frederico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Gait and Brain Laboratory, Parkwood Hospital, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hunter</LastName><ForeName>Susan W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamkar</LastName><ForeName>Nellie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Gait and Brain Laboratory, Parkwood Hospital, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Speechley</LastName><ForeName>Mark R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Son</LastName><ForeName>Surim</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Gait and Brain Laboratory, Parkwood Hospital, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verghese</LastName><ForeName>Joe</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Albert Einstein College of Medicine, Bronx, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montero-Odasso</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gait and Brain Laboratory, Parkwood Hospital, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Task Force on Global Guidelines for Falls in Older Adults</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aged</Keyword><Keyword MajorTopicYN="N">caregivers</Keyword><Keyword MajorTopicYN="N">cognitive dysfunction</Keyword><Keyword MajorTopicYN="N">falls</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36847007</ArticleId><ArticleId IdType="doi">10.3233/JAD-221142</ArticleId><ArticleId IdType="pii">JAD221142</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36840849</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1573-689X</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>25</Day></PubDate></JournalIssue><Title>Journal of medical systems</Title><ISOAbbreviation>J Med Syst</ISOAbbreviation></Journal><ArticleTitle>Design and Evaluation of a Technological Platform for Monitoring Patients with Dementia: Unifying Requirements from Mexican Day Centers.</ArticleTitle><Pagination><StartPage>30</StartPage><MedlinePgn>30</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">30</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10916-023-01917-4</ELocationID><Abstract><AbstractText>The monitoring of patients with dementia who receive comprehensive care in day centers allows formal caregivers to make better decisions and provide better care to patients. For instance, cognitive and physical therapies can be tailored based on the current stage of disease progression. In the context of day centers of the Mexican Federation of Alzheimer, this work aims to design and evaluate Alzaid, a technological platform for assisting formal caregivers in monitoring patients with dementia. Alzaid was devised using a participatory design methodology that consisted in eliciting and validating requirements from 22 and 9 participants, respectively, which were unified to guide the construction of a high-fidelity prototype evaluated by 14 participants. The participants were formal caregivers, medical staff, and management. This work contributes a high-fidelity prototype of a technological platform for assisting formal caregivers in monitoring patients with dementia considering restrictions and requirements of four Mexican day centers. In general, the participants perceived the prototype as quite likely to be useful, usable, and relevant in the job of monitoring patients with dementia (p-value &lt; 0.05). By evaluating and designing Alzaid that unifies requirements for monitoring patients of four day centers, this work is the first effort towards a standard monitoring process of patients with dementia in the context of the Mexican Federation of Alzheimer.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barreras Diaz</LastName><ForeName>Tania-Arisdelci</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Computing and Design, Instituto Tecnol&#xf3;gico de Sonora, 5 de Febrero 818-Sur, Ciudad Obreg&#xf3;n, 85000, Sonora, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esquer-Rochin</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Computing and Design, Instituto Tecnol&#xf3;gico de Sonora, 5 de Febrero 818-Sur, Ciudad Obreg&#xf3;n, 85000, Sonora, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutierrez-Garcia</LastName><ForeName>J Octavio</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Department of Computer Science, ITAM, R&#xed;o Hondo 1, Ciudad de M&#xe9;xico, 01080, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Luis-Felipe</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Department of Computing and Design, Instituto Tecnol&#xf3;gico de Sonora, 5 de Febrero 818-Sur, Ciudad Obreg&#xf3;n, 85000, Sonora, Mexico. luis.rodriguez@itson.edu.mx.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Syst</MedlineTA><NlmUniqueID>7806056</NlmUniqueID><ISSNLinking>0148-5598</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008991" MajorTopicYN="N">Monitoring, Physiologic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">day centers</Keyword><Keyword MajorTopicYN="N">mobile applications</Keyword><Keyword MajorTopicYN="N">patient monitoring</Keyword><Keyword MajorTopicYN="N">patients with dementia</Keyword><Keyword MajorTopicYN="N">software design</Keyword></KeywordList><CoiStatement>The authors declare that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>11</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36840849</ArticleId><ArticleId IdType="pmc">PMC9959949</ArticleId><ArticleId IdType="doi">10.1007/s10916-023-01917-4</ArticleId><ArticleId IdType="pii">10.1007/s10916-023-01917-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bari&#xa0;Antor, M., Jamil, A., Mamtaz, M., Monirujjaman Khan, M., Aljahdali, S., Kaur, M., Singh, P., Masud, M.: A comparative analysis of machine learning algorithms to predict alzheimer&#x2019;s disease. Journal of Healthcare Engineering 2021, 9917919 (2021). 10.1155/2021/9917919</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8289609</ArticleId><ArticleId IdType="pubmed">34336171</ArticleId></ArticleIdList></Reference><Reference><Citation>Maki, Y., Sakurai, T., Okochi, J., Yamaguchi, H., Toba, K.: Rehabilitation to live better with dementia. Geriatrics &amp; gerontology international 18(11), 1529&#x2013;1536 (2018). 10.1111/ggi.13517</Citation><ArticleIdList><ArticleId IdType="pubmed">30318671</ArticleId></ArticleIdList></Reference><Reference><Citation>Rokstad, A.M.M., Engedal, K., Kirkevold, &#xd8;., Benth, J.&#x160;., Selb&#xe6;k, G.: The impact of attending day care designed for home-dwelling people with dementia on nursing home admission: a 24-month controlled study. BMC health services research 18(1), 1&#x2013;11 (2018). 10.1186/s12913-018-3686-5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6240251</ArticleId><ArticleId IdType="pubmed">30445937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ch&#xe1;vez, A., Borrego, G., Gutierrez-Garcia, J.O., Rodr&#xed;guez, L.-F.: Design and evaluation of a mobile application for monitoring patients with alzheimer&#x2019;s disease: A day center case study. International journal of medical informatics 131, 103972 (2019). 10.1016/j.ijmedinf.2019.103972</Citation><ArticleIdList><ArticleId IdType="pubmed">31563010</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, C.-F., Wu, J.-J., Huang, Y.-H., Ju, L.-Y., Lin, S.-Y., Chou, Y.-C., Lin, C.-S.: Impact of day care services on physical and cognitive functions in old people with dementia in a medical center in central Taiwan. Health and Quality of Life Outcomes 19(1), 1&#x2013;8 (2021). 10.1186/s12955-021-01806-9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8223263</ArticleId><ArticleId IdType="pubmed">34167529</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, D.: The effects of a recollection-based occupational therapy program of alzheimer&#x2019;s disease: a randomized controlled trial. Occupational Therapy International 2020, 6305727 (2020). 10.1155/2020/6305727</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7416254</ArticleId><ArticleId IdType="pubmed">32821251</ArticleId></ArticleIdList></Reference><Reference><Citation>Park, E., Park, H., Kim, E.K.: The effect of a comprehensive mobile application program (cmap) for family caregivers of home-dwelling patients with dementia: a preliminary research. Japan Journal of Nursing Science 17(4), 12343 (2020). 10.1111/jjns.12343</Citation><ArticleIdList><ArticleId IdType="pubmed">32363664</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichold, M., He&#xdf;, M., Kolominsky-Rabas, P., Gr&#xe4;&#xdf;el, E., Prokosch, H.-U., et al.: Usability evaluation of an offline electronic data capture app in a prospective multicenter dementia registry (digidem bayern): Mixed method study. JMIR formative research 5(11), 31649 (2021). 10.2196/31649</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8600440</ArticleId><ArticleId IdType="pubmed">34730543</ArticleId></ArticleIdList></Reference><Reference><Citation>Moshnyaga, V., Koyanagi, M., Hirayama, F., Takahama, A., Hashimoto, K.: A medication adherence monitoring system for people with dementia. In: (2016 IEEE International Conference on Systems, Man, and Cybernetics (SMC), pp. 194&#x2013;199 (2016). 10.1109/SMC.2016.7844240. IEEE</Citation></Reference><Reference><Citation>Malmgren&#xa0;F&#xe4;nge, A., Schmidt, S.M., Nilsson, M.H., Carlsson, G., Liwander, A., Dahlgren&#xa0;Bergstr&#xf6;m, C., Olivetti, P., Johansson, P., Chiatti, C.: The tech@ home study, a technological intervention to reduce caregiver burden for informal caregivers of people with dementia: study protocol for a randomized controlled trial. Trials 18(1), 1&#x2013;10 (2017). 10.1186/s13063-017-1796-8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5301412</ArticleId><ArticleId IdType="pubmed">28183323</ArticleId></ArticleIdList></Reference><Reference><Citation>Malmgren&#xa0;F&#xe4;nge, A., Carlsson, G., Chiatti, C., Lethin, C.: Using sensor-based technology for safety and independence&#x2013;the experiences of people with dementia and their families. Scandinavian Journal of Caring Sciences 34(3), 648&#x2013;657 (2020). 10.1111/scs.12766</Citation><ArticleIdList><ArticleId IdType="pubmed">31614031</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnanger&#xa0;Garshol, B., Ellingsen-Dalskau, L.H., Pedersen, I.: Physical activity in people with dementia attending farm-based dementia day care&#x2013;a comparative actigraphy study. BMC geriatrics 20(1), 1&#x2013;10 (2020). 10.1186/s12877-020-01618-4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7310071</ArticleId><ArticleId IdType="pubmed">32571238</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassandra, M., Galanis, E., Hatzigeorgiadis, A., Goudas, M., Mouzakidis, C., Karathanasi, E.M., Petridou, N., Tsolaki, M., Zikas, P., Evangelou, G., : A virtual reality app for physical and cognitive training of older people with mild cognitive impairment: mixed methods feasibility study. JMIR serious games 9(1), 24170 (2021). 10.2196/24170</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8294639</ArticleId><ArticleId IdType="pubmed">33759797</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, G., Albayrak, A., Kortuem, G., van&#xa0;der Cammen, T.J., et al., : A digital platform for facilitating personalized dementia care in nursing homes: formative evaluation study. JMIR Formative Research 5(5), 25705 (2021). 10.2196/25705</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8196358</ArticleId><ArticleId IdType="pubmed">34047703</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiotani, M., Yamaguchi, K.: Research on an anomaly detection method for physical condition change of elderly people in care facilities. Advanced Biomedical Engineering 11, 10&#x2013;15 (2022). 10.14326/abe.11.10</Citation></Reference><Reference><Citation>Atee, M., Hoti, K., Hughes, J.D.: A technical note on the painchek&#x2122; system: a web portal and mobile medical device for assessing pain in people with dementia. Frontiers in aging neuroscience 10, 117 (2018). 10.3389/fnagi.2018.00117</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6006917</ArticleId><ArticleId IdType="pubmed">29946251</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochin, M.A.E., Gutierrez-Garcia, J.O., Rosales, J.-H., Rodriguez, L.-F.: Design and evaluation of a dashboard to support the comprehension of the progression of patients with dementia in day centers. International Journal of Medical Informatics 156, 104617 (2021). 10.1016/j.ijmedinf.2021.104617</Citation><ArticleIdList><ArticleId IdType="pubmed">34710725</ArticleId></ArticleIdList></Reference><Reference><Citation>Leante-Castellanos, J.L., Ma&#xf1;as-Ux&#xf3;, M.I., Garnica-Mart&#xed;nez, B., Tom&#xe1;s-Lizcano, A., Mu&#xf1;oz-Soto, A.: Implementation of a regional standardised model for perinatal electronic medical records 46, 103 (2022)</Citation><ArticleIdList><ArticleId IdType="pubmed">36446948</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh, V., Bala, H.: Technology acceptance model 3 and a research agenda on interventions. Decision sciences 39(2), 273&#x2013;315 (2008). 10.1111/j.1540-5915.2008.00192.x</Citation></Reference><Reference><Citation>Davis, F.D.: A technology acceptance model for empirically testing new end-user information systems: Theory and results. PhD thesis, Massachusetts Institute of Technology (1985)</Citation></Reference><Reference><Citation>Chun&#xa0;Tie, Y., Birks, M., Francis, K.: Grounded theory research: A design framework for novice researchers. SAGE open medicine 7 (2019). 10.1177/2050312118822927</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6318722</ArticleId><ArticleId IdType="pubmed">30637106</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker, D., Myrick, F.: Grounded theory: An exploration of process and procedure. Qualitative Health Research 16(4), 547&#x2013;559 (2006)</Citation><ArticleIdList><ArticleId IdType="pubmed">16513996</ArticleId></ArticleIdList></Reference><Reference><Citation>Chitchyan, R., Bird, C.: Theory as a source of software requirements. In: (2020 IEEE 28th International Requirements Engineering Conference (RE), pp. 227&#x2013;237 (2020). 10.1109/RE48521.2020.00033. IEEE</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36840665</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-5279</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</Title><ISOAbbreviation>Alzheimers Dement</ISOAbbreviation></Journal><ArticleTitle>Racial and ethnic differences in neuropsychiatric symptoms and progression to incident cognitive impairment among community-dwelling participants.</ArticleTitle><Pagination><StartPage>3635</StartPage><EndPage>3643</EndPage><MedlinePgn>3635-3643</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/alz.12988</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Neuropsychiatric symptoms (NPS) are a risk factor for dementia; however, their prevalence and severity among ethnoracial groups are poorly understood.</AbstractText><AbstractText Label="METHODS">We used data from the National Alzheimer's Coordinating Center (NACC) (n&#xa0;=&#xa0;6958; &#x2265;50 years old). Cognitively normal participants at baseline, without any NPS or dementia diagnosis, had at least one follow-up. Survival analyses assessed the hazard ratio for 12 NPS models and progression to cognitive impairment. Propensity score weighting (PSW) matched participants on age, sex, education, and race/ethnicity.</AbstractText><AbstractText Label="RESULTS">All 12 NPS were significantly associated with progression to cognitive impairment. In the PSW models, compared&#xa0;to&#xa0;whites,&#xa0;Black/African Americans were more likely to progress to cognitive impairment across all 12 NPS models, followed by Hispanic, and then Asian participants.</AbstractText><AbstractText Label="DISCUSSION">PSW minimized selection bias to provide robust risk estimates. There is a higher risk of progressing to cognitive impairment for ethnoracial groups with NPS. Tailored screening of NPS and cognitive impairment should incorporate patient and caregiver reports.</AbstractText><CopyrightInformation>&#xa9; 2023 the Alzheimer's Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Babulal</LastName><ForeName>Ganesh M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychology, Faculty of Humanities, University of Johannesburg, Johannesburg, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Research and Leadership, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Public Health, Washington University in St. Louis, St. Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yiqi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Social Work, Adelphi University, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brown School, Washington University in St. Louis, St. Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trani</LastName><ForeName>Jean-Francois</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department of Psychology, Faculty of Humanities, University of Johannesburg, Johannesburg, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Public Health, Washington University in St. Louis, St. Louis, Missouri, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brown School, Washington University in St. Louis, St. Louis, Missouri, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Arts and Crafts, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG068183</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG005142</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01AG067428</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG016573</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG047266</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG010161</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG025688</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG005133</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG005138</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG047366</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG010129</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG028383</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG033514</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG056466</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG013854</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG053760</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG010124</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG023501</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG005131</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG010133</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG016574</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG005146</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG035982</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG008702</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG008051</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG005681</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG013846</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG047270</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG005136</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG049638</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG012300</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG005134</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG008017</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072977</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG074302</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG019610</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072947</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG067428</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Alzheimers Dement</MedlineTA><NlmUniqueID>101231978</NlmUniqueID><ISSNLinking>1552-5260</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057187" MajorTopicYN="N">Independent Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">cognitive impairment</Keyword><Keyword MajorTopicYN="N">ethnicity</Keyword><Keyword MajorTopicYN="N">neuropsychiatric symptoms</Keyword><Keyword MajorTopicYN="N">propensity score</Keyword><Keyword MajorTopicYN="N">race</Keyword></KeywordList><CoiStatement>CONFLICT OF INTEREST. All authors certify they have no conflicts of interest or disclosures. Author disclosures are available in the supporting information.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>8</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36840665</ArticleId><ArticleId IdType="mid">NIHMS1870970</ArticleId><ArticleId IdType="pmc">PMC10440214</ArticleId><ArticleId IdType="doi">10.1002/alz.12988</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nichols E, Steinmetz JD, Vollset SE, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. The Lancet Public Health. 2022;7:e105&#x2013;e125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8810394</ArticleId><ArticleId IdType="pubmed">34998485</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JCS. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry. 2000;157:708&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pubmed">10784462</ArticleId></ArticleIdList></Reference><Reference><Citation>Naasan G, Shdo SM, Rodriguez EM, et al. Psychosis in neurodegenerative disease: differential patterns of hallucination and delusion symptoms. Brain. 2021;144:999&#x2013;1012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8041322</ArticleId><ArticleId IdType="pubmed">33501939</ArticleId></ArticleIdList></Reference><Reference><Citation>Radue R, Walaszek A, Asthana S. Neuropsychiatric symptoms in dementia. Handb Clin Neurol. 2019;167:437&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">31753148</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. J Am Med Assoc. 2002;288:1475&#x2013;1483.</Citation><ArticleIdList><ArticleId IdType="pubmed">12243634</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q-F, Tan L, Wang H-F, et al. The prevalence of neuropsychiatric symptoms in Alzheimer&#x2019;s disease: systematic review and meta-analysis. J Affect Disord. 2016;100:264&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pubmed">26540080</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyketsos CG, Carrillo MC, Ryan JM, et al. Neuropsychiatric Symptoms in Alzheimer&#x2019;s disease. Elsevier; 2011:532&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3299979</ArticleId><ArticleId IdType="pubmed">21889116</ArticleId></ArticleIdList></Reference><Reference><Citation>Beekly DL, Ramos EM, Lee WW, et al. The National Alzheimer&#x2019;s Coordinating Center (NACC) database: the uniform data set. Alzheimer Dis Assoc Disord. 2007;21:249&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">17804958</ArticleId></ArticleIdList></Reference><Reference><Citation>Leoutsakos J-MS, Forrester SN, Lyketsos C, Smith GS. Latent classes of neuropsychiatric symptoms in NACC controls and conversion to mild cognitive impairment or dementia. J Alzheimers Dis. 2015;48:483&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4635658</ArticleId><ArticleId IdType="pubmed">26402012</ArticleId></ArticleIdList></Reference><Reference><Citation>Masters MC, Morris JC, Roe CM. &#x201c;Noncognitive&#x201d; symptoms of early Alzheimer disease: a longitudinal analysis. Neurology. 2015;84:617&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4335988</ArticleId><ArticleId IdType="pubmed">25589671</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise EA, Rosenberg PB, Lyketsos CG, Leoutsakos J-M. Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer&#x2019;s Coordinating Centers volunteers. Alzheimers Dement (Amst). 2019;11:333&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6476801</ArticleId><ArticleId IdType="pubmed">31024987</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrester SN, Gallo JJ, Smith GS, Leoutsakos J-MS. Patterns of neuropsychiatric symptoms in mild cognitive impairment and risk of dementia. Am J Geriatr Psychiatry. 2016;24:117&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4646727</ArticleId><ArticleId IdType="pubmed">26209222</ArticleId></ArticleIdList></Reference><Reference><Citation>Colby SL, Ortman JM. Projections of the size and composition of the US population: 2014 to 2060. Population Estimates and Projections. Current Population Reports. US Census Bureau. 2015;9:25&#x2013;1143.</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Association. 2021 Alzheimer&#x2019;s disease facts and figures. Alzheimers Dementia. 2021;17(3):327&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">33756057</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur B, Alvarado L, Dodoo C, Salazar R, Espay AJ, Dwivedi AK. Ethnic differences between Hispanics and non-Hispanic whites in neuropsychiatric symptoms predict conversion to mild cognitive impairment. J Geriatr Psychiatry Neurol. 2021;34:622&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">32909879</ArticleId></ArticleIdList></Reference><Reference><Citation>Babulal GM, Quiroz YT, Albensi BC, et al. Perspectives on ethnic and racial disparities in Alzheimer&#x2019;s disease and related dementias: update and areas of immediate need. Alzheimers Dementia. 2019;15:292&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6368893</ArticleId><ArticleId IdType="pubmed">30555031</ArticleId></ArticleIdList></Reference><Reference><Citation>Ag&#xfc;era-Ortiz L, Babulal GM, Bruneau MA, et al. Psychosis as a treatment target in dementia: a roadmap for designing interventions. J Alzheimers Dis. 2022;88:1203&#x2013;1228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9484097</ArticleId><ArticleId IdType="pubmed">35786651</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin E, Velayudhan L. Neuropsychiatric symptoms in mild cognitive impairment: a literature review. Dement Geriatr Cogn Disord. 2020;49:146&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pubmed">32289790</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412&#x2013;2414.</Citation><ArticleIdList><ArticleId IdType="pubmed">8232972</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufer DI, Cummings JL, Ketchel P, et al. Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. J Neuropsychiatry Clin Neurosci. 2000;12:233.</Citation><ArticleIdList><ArticleId IdType="pubmed">11001602</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41&#x2013;55.</Citation></Reference><Reference><Citation>Rosenbaum PR. Model-based direct adjustment. J Am Statist Assoc. 1987;82:387&#x2013;394.</Citation></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. Assessing sensitivity to an unobserved binary covariate in an observational study with binary outcome. J R Stat Soc Ser B Methodol. 1983;45:212&#x2013;218.</Citation></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Statist Assoc. 1984;79:516&#x2013;524.</Citation></Reference><Reference><Citation>Olmos A, Govindasamy P. Propensity scores: a practical introduction using R. J Multidiscip Eval. 2015;11:68&#x2013;88.</Citation></Reference><Reference><Citation>Ho D, Imai K, King G, Stuart EA. MatchIt: nonparametric preprocessing for parametric causal inference. J Statist Soft. 2011;42:1&#x2013;28.</Citation></Reference><Reference><Citation>Ismail Z, Smith EE, Geda Y, et al. Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dementia. 2016;12:195&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4684483</ArticleId><ArticleId IdType="pubmed">26096665</ArticleId></ArticleIdList></Reference><Reference><Citation>Babulal GM, Zhu Y, Roe CM, et al. The complex relationship between depression and progression to incident cognitive impairment across race and ethnicity. Alzheimers Dementia. 2022;18:2593&#x2013;2602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9402798</ArticleId><ArticleId IdType="pubmed">35213795</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayeda ER, Glymour MM, Quesenberry CP, Whitmer RA. Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Alzheimers Dementia. 2016;12:216&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4969071</ArticleId><ArticleId IdType="pubmed">26874595</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornblith E, Bahorik A, Boscardin WJ, Xia F, Barnes DE, Yaffe K. Association of race and ethnicity with incidence of dementia among older adults. JAMA. 2022;327:1488&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9020215</ArticleId><ArticleId IdType="pubmed">35438728</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow TW, Liu CK, Fuh JL, et al. Neuropsychiatric symptoms of Alzheimer&#x2019;s disease differ in Chinese and American patients. Int J Geriatr Psychiatry. 2002;17:22&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">11802226</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen CI, Magai C. Racial differences in neuropsychiatric symptoms among dementia outpatients. Am J Geriatr Psychiatry. 1999;7:57&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">9919321</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen CI, McKenzie SE, Rahmani M, Singh J, Prospere E. Historical changes in the severity of dementia and accompanying neuropsychiatric symptoms in persons presenting for evaluation in a multiracial urban dementia center. Alzheimer Dis Assoc Disord. 2012;26:352&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">22089639</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry. 2013;21:685&#x2013;695.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3428504</ArticleId><ArticleId IdType="pubmed">23567400</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail Z, Elbayoumi H, Fischer CE, et al. Prevalence of depression in patients with mild cognitive impairment: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74:58&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">27893026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail Z, Gatchel J, Bateman DR, et al. Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria. Int Psychogeriatr. 2018;30:185&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">28899446</ArticleId></ArticleIdList></Reference><Reference><Citation>Coe NB, Lee C. Racial and ethnic disparities in dementia care: next steps. JAMA Netw Open. 2022;5:e2216267.</Citation><ArticleIdList><ArticleId IdType="pubmed">35679050</ArticleId></ArticleIdList></Reference><Reference><Citation>Salazar R, Dwivedi AK, Royall DR. Cross-ethnic differences in the severity of neuropsychiatric symptoms in persons with mild cognitive impairment and Alzheimer&#x2019;s disease. J Neuropsychiatry Clin Neurosci. 2017;29:13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">27417070</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennon JC, Aita SL, Bene VAD, et al. Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation. Alzheimers Dementia. 2022;18:1461&#x2013;1471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9160212</ArticleId><ArticleId IdType="pubmed">34854531</ArticleId></ArticleIdList></Reference><Reference><Citation>Chui HC, Gatz M. Cultural diversity in Alzheimer disease: the interface between biology, belief, and behavior. Alzheimer Dis Assoc Disord. 2005;19:250&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">16327354</ArticleId></ArticleIdList></Reference><Reference><Citation>Saadi A, Himmelstein DU, Woolhandler S, Mejia NI. Racial disparities in neurologic health care access and utilization in the United States. Neurology. 2017;88:2268&#x2013;2275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5567325</ArticleId><ArticleId IdType="pubmed">28515272</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC, Stuart EA. Optimal full matching for survival outcomes: a method that merits more widespread use. Stat Med. 2015;34:3949&#x2013;3967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4715723</ArticleId><ArticleId IdType="pubmed">26250611</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. The performance of different propensity score methods for estimating marginal hazard ratios. Stat Med. 2013;32:2837.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3747460</ArticleId><ArticleId IdType="pubmed">23239115</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleason CE, Norton D, Zuelsdorff M, et al. Association between enrollment factors and incident cognitive impairment in Blacks and Whites: data from the Alzheimer&#x2019;s Disease Center. Alzheimers Dementia. 2019;15:1533&#x2013;1545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6925619</ArticleId><ArticleId IdType="pubmed">31601516</ArticleId></ArticleIdList></Reference><Reference><Citation>Devanand DP, Lee S, Huey ED, Goldberg TE. Associations between neuropsychiatric symptoms and neuropathological diagnoses of Alzheimer disease and related dementias. JAMA Psychiatry. 2022;79:359&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8851371</ArticleId><ArticleId IdType="pubmed">35171235</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36833870</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>11</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Dementia Care Competency Model for Higher Education: A Pilot Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3173</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph20043173</ELocationID><Abstract><AbstractText>A statewide landscape analysis was initiated to identify workforce development and educational needs concerning the support of persons with Alzheimer's Disease and Related Dementias (ADRD). Educational programs preparing healthcare professionals were targeted since people with ADRD, and their families/caregivers, often have frequent, ongoing contact with healthcare providers. A literature review and thematic analysis discovered a dearth of research and a lack of consistent competency identification for healthcare education. A crosswalk comparison of various competency models led to the development of a five factor model. A survey based on this model was sent to educators statewide evaluating confidence in ADRD-specific competency attainment in graduates. Descriptive statistics and factor analysis led to a revision of the original five factor model to a three factor model, including competencies in Global Dementia knowledge, Communication, and Safety, each with various sub-competencies. Identifying ADRD-specific competencies for graduating healthcare students is essential. This three factor competency framework will support educational programs in examining curricular offerings and increasing awareness concerning the needs of the ADRD population. Furthermore, using a robust competency model for healthcare education can assist in preparing graduates to address the needs of those with ADRD as well as the needs of the family/caregiving system and environment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Josephsen</LastName><ForeName>Jayne</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0872-9747</Identifier><AffiliationInfo><Affiliation>School of Nursing, Boise State University, 1910 W University Drive, Boise, ID 83725, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ketelsen</LastName><ForeName>Kirk</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Public and Population Health, Boise State University, 1910 W University Drive, Boise, ID 83725, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weaver</LastName><ForeName>Melody</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1451-8874</Identifier><AffiliationInfo><Affiliation>School of Nursing, Graduate Studies, Idaho State University, 921 S 8th Ave, Pocatello, ID 83209, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheuffele</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Idaho Caregiver Alliance, Center for The Study of Aging, Boise State University, 1910 W University Drive, Boise, ID 83725, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease and related dementias (ADRD)</Keyword><Keyword MajorTopicYN="N">competency model</Keyword><Keyword MajorTopicYN="N">dementia care</Keyword><Keyword MajorTopicYN="N">higher education</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The sponsors had no role in the design, execution, interpretation, or writing of the study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>2</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36833870</ArticleId><ArticleId IdType="pmc">PMC9967098</ArticleId><ArticleId IdType="doi">10.3390/ijerph20043173</ArticleId><ArticleId IdType="pii">ijerph20043173</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Healthy Brain Initiative  State and Local Public Health Partnerships to Address Dementia: The 2018&#x2013;2023 Road Map.  [(accessed on 10 May 2022)];2018  Available online:  https://www.cdc.gov/aging/pdf/2018-2023-Road-Map-508.pdf.</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Association  2022 Alzheimer&#x2019;s Disease Facts and Figures. 2022.  [(accessed on 10 May 2022)].  Available online:  https://www.alz.org/media/documents/alzheimers-facts-and-figures.pdf.</Citation></Reference><Reference><Citation>Garrod L., Fossey J., Henshall C., Williamson S., Coates A., Green H. Evaluating dementia training for healthcare staff. J. Ment. Health Train. Educ. Pract. 2019;14:277&#x2013;288. doi: 10.1108/JMHTEP-10-2018-0062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/JMHTEP-10-2018-0062</ArticleId></ArticleIdList></Reference><Reference><Citation>Handley M., Bunn F., Goodman C. Supporting general hospital staff to provide dementia sensitive care: A realist evaluation. Int. J. Nurs. Stud. 2019;96:61&#x2013;71. doi: 10.1016/j.ijnurstu.2018.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2018.10.004</ArticleId><ArticleId IdType="pubmed">30545567</ArticleId></ArticleIdList></Reference><Reference><Citation>Justice in Aging (August, 2015). Training to Serve People with Dementia: Is Our Health Care System Ready? Paper 3: A Review of Dementia Training Standards Across Professional Licensure [Issue Brief]  [(accessed on 11 January 2022)].  Available online:  http://justiceinaging.org/wp-content/uploads/2015/08/Training-to-serve-people-with-dementia-Alz3_FINAL.pdf.</Citation></Reference><Reference><Citation>Foster S., Blamer D., Gott M., Frey R., Robinson J., Boyd M. Patient-centered care training needs of health care assistants who provide care for people with dementia. Health Soc. Care Community. 2018;27:917&#x2013;925. doi: 10.1111/hsc.12709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hsc.12709</ArticleId><ArticleId IdType="pubmed">30729629</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa G.D., Spineli V.M.C.D., Oliveria M.A.C. Professional education on dementia in primary health care: An integrative review. Rev. Bras. Enferm. 2019;72:1086&#x2013;1093. doi: 10.1590/0034-7167-2018-0652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0034-7167-2018-0652</ArticleId><ArticleId IdType="pubmed">31432969</ArticleId></ArticleIdList></Reference><Reference><Citation>Surr C.A., Sass C., Burnley N., Drury M., Smith S.J., Parveen S., Burden S., Oyebode J. Components of impactful dementia training for general hospital staff: A collective case study. Aging Ment. Health. 2020;24:511&#x2013;521. doi: 10.1080/13607863.2018.1531382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2018.1531382</ArticleId><ArticleId IdType="pubmed">30596270</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S.J., Parveen S., Sass C., Drury M., Oyebode J.R., Surr C.A. An audit of dementia education and training in UK health and social care: A comparison with national benchmark standards. BMC Health Serv. Res. 2019;19:711. doi: 10.1186/s12913-019-4510-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-019-4510-6</ArticleId><ArticleId IdType="pmc">PMC6802111</ArticleId><ArticleId IdType="pubmed">31638974</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazio S., Pace D., Maslow K., Zimmerman S., Kallmyer B. Alzheimer&#x2019;s Association dementia care practice recommendations. Gerontologist. 2018;58((Suppl. S1)):S1&#x2013;S9. doi: 10.1093/geront/gnx182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnx182</ArticleId><ArticleId IdType="pubmed">29361074</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan C.M., Sachs G.A., LaMantiia M.A., Unroe K.T., Arling G.A., Boustani M.A. Redesigning systems of care for older adults with Alzheimer&#x2019;s disease. Health Aff. 2014;33:626&#x2013;632. doi: 10.1377/hlthaff.2013.1260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2013.1260</ArticleId><ArticleId IdType="pmc">PMC5337406</ArticleId><ArticleId IdType="pubmed">24711324</ArticleId></ArticleIdList></Reference><Reference><Citation>Warshaw G.A., Bragg E.J. Preparing the health care workforce to care for adults with Alzheimer&#x2019;s disease and related dementias. Health Aff. 2014;33:633&#x2013;641. doi: 10.1377/hlthaff.2013.1232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2013.1232</ArticleId><ArticleId IdType="pubmed">24711325</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar L., Roberts S., Yaghmour N.A., Hunderfund A.L., Hamstra S.J., Conforti L., Holmboe E.S. Competency crosswalk: A multispecialty review of the accreditation council for graduate medical education milestones across four competency domains. Acad. Med. 2018;93:1035&#x2013;1041. doi: 10.1097/ACM.0000000000002059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACM.0000000000002059</ArticleId><ArticleId IdType="pubmed">29166350</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V., Clarke V. Using thematic analysis in psychology. Qual. Res. Psychol. 2006;3:77&#x2013;101. doi: 10.1191/1478088706qp063oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/1478088706qp063oa</ArticleId></ArticleIdList></Reference><Reference><Citation>Tucker C.R., Moreno K., Jafari M. Shifting from alignment to transformation: Crosswalk to graduation core competency development.  [(accessed on 19 February 2022)];Res. Pract. Assess. 2021 16:1&#x2013;10. Available online:  https://files.eric.ed.gov/fulltext/EJ1307017.pdf.</Citation></Reference><Reference><Citation>Bandalos D.L. Relative performance of categorical diagonally weighted least squares and robust maximum likelihood. Struct. Equ. Model. 2014;21:102&#x2013;116. doi: 10.1080/10705511.2014.859510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10705511.2014.859510</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudeck R., Henly S.J. Model selection in covariance structures analysis and the&#x201c;problem&#x201d; of sample size: A clarification. Psychol. Bull. 1991;109:512&#x2013;519. doi: 10.1037/0033-2909.109.3.512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0033-2909.109.3.512</ArticleId><ArticleId IdType="pubmed">2062982</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne M.W., Cudeck R. Alternative ways of assessing model fit. Sociol. Methods Res. 1992;21:230&#x2013;258. doi: 10.1177/0049124192021002005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0049124192021002005</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiger J.H., Lind J.C. Statistically based tests for the number of common factors; Proceedings of the Annual Meeting of the Psychometric Society; Iowa City, IA, USA. 30 May 1980.</Citation></Reference><Reference><Citation>Cudeck R., Henly S.J. A realistic perspective on pattern representation in growth data: Comment on Bauer and Curran. Psychol. Methods. 2003;8:378&#x2013;383. doi: 10.1037/1082-989X.8.3.378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/1082-989X.8.3.378</ArticleId><ArticleId IdType="pubmed">14596498</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu L., Bentler P.M. Cutoff criteria in fix indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct. Equ. Model. 1999;6:1&#x2013;55. doi: 10.1080/10705519909540118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10705519909540118</ArticleId></ArticleIdList></Reference><Reference><Citation>Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov B.N., Csaki F., editors. Second International Symposium on Information Theory. Akademia Kiado; Budapest, Hungary: 1973. pp. 267&#x2013;281.</Citation></Reference><Reference><Citation>Annear M.J. Knowledge of dementia among the Australian health workforce: A national online survey. J. Appl. Gerontol. 2020;39:62&#x2013;73. doi: 10.1177/0733464817752085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464817752085</ArticleId><ArticleId IdType="pubmed">29313420</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36833560</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>The Level of Burden among Caregivers of Patients with Alzheimer's Disease in Saudi Arabia.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2864</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph20042864</ELocationID><Abstract><AbstractText Label="BACKGROUND">Caregiver burden is a serious global issue associated with the growing number of older adult patients with Alzheimer's disease (AD). AD patients become more dependent on their caregivers and require assistance with basic daily life activities. This study aims to measure the caregiver burden of informal caregivers of AD patients and to determine their characteristics. In addition, it intends to understand caregiver coping techniques and assess their medication knowledge.</AbstractText><AbstractText Label="METHODS">This was a cross-sectional study including 148 informal caregivers mainly recruited by the Saudi Alzheimer's Disease Association (SADA). A four-part study questionnaire was used for data collection in the Arabic Language and included the following: socio-demographic characteristics of AD patients and their caregivers, the 12-item version of the Zarit Burden Interview (ZBI), and adapted questions on coping techniques and medication knowledge.</AbstractText><AbstractText Label="RESULTS">A total of 148 caregivers (62% were female) participated in this study, and 79.06% were between 30 and 60 years old. The ZBI average score was 27, indicating a moderate to high burden. Caregivers reported their need for services to improve their quality of life. The medication knowledge was insufficient in most aspects except that more than half were aware of medications' side effects.</AbstractText><AbstractText Label="CONCLUSION">Our study revealed that the average burden among informal caregivers of AD patients was moderate-high.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Badawoud</LastName><ForeName>Amal Mohammad</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlQadheeb</LastName><ForeName>Yasmin K</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlZahrani</LastName><ForeName>Shahad S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlGhamdi</LastName><ForeName>Razan A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alanazi</LastName><ForeName>Elaf A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>College of Clinical Pharmacy, Imam Abdulrahman bin Faisal University, Dammam 31441, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlFozan</LastName><ForeName>Sarah M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>College of Clinical Pharmacy, Imam Abdulrahman bin Faisal University, Dammam 31441, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlJafer</LastName><ForeName>Norah S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>College of Clinical Pharmacy, Imam Abdulrahman bin Faisal University, Dammam 31441, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asiri</LastName><ForeName>Ibrahim M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Pharmacy Practice Department, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alotaibi</LastName><ForeName>Fawaz M</ForeName><Initials>FM</Initials><Identifier Source="ORCID">0000-0002-4247-6846</Identifier><AffiliationInfo><Affiliation>Pharmacy Practice Department, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012529" MajorTopicYN="N" Type="Geographic">Saudi Arabia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">caregiver burden</Keyword><Keyword MajorTopicYN="N">coping techniques</Keyword><Keyword MajorTopicYN="N">medication knowledge</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>2</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36833560</ArticleId><ArticleId IdType="pmc">PMC9957410</ArticleId><ArticleId IdType="doi">10.3390/ijerph20042864</ArticleId><ArticleId IdType="pii">ijerph20042864</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bloom D.E., Luca D.L. Handbook of the Economics of Population Aging. North-Holland; Bonn, Germany: 2016. The global demography of aging; pp. 3&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.hespa.2016.06.002</ArticleId></ArticleIdList></Reference><Reference><Citation>United Nations  World Population Ageing 2020 Highlights: Living Arrangements of Older Persons. 2020.  [(accessed on 26 August 2021)].  Available online:  https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/undesa_pd-2020_world_population_ageing_highlights.pdf.</Citation></Reference><Reference><Citation>United Nations  Department of Economic and Social Affairs, Population Division (2019) 2019.  [(accessed on 30 August 2021)].  Available online:  https://population.un.org/wpp/Download/Files/1_Indicators%20.</Citation></Reference><Reference><Citation>Ministry of Health  Health Days 2020, World Alzheimer&#x2019;s Day. Ministry of Health.  [(accessed on 28 August 2021)];2020 September 21; Available online:  https://www.moh.gov.sa/en/HealthAwareness/healthDay/2020/Pages/HealthDay-2020-09-21.aspx.</Citation></Reference><Reference><Citation>Guerchet M., Prince M., Prina M. Numbers of People with Dementia around the World. 2020.  [(accessed on 28 August 2021)].  Available online:  https://www.alzint.org/resource/numbers-of-people-with-dementia-worldwide/</Citation></Reference><Reference><Citation>World Health Organization  . Dementia a Public Health Priority. World Health Organization; Geneva, Switzerland: 2012.  [(accessed on 28 August 2021)].  Available online:  https://apps.who.int/iris/handle/10665/75263.</Citation></Reference><Reference><Citation>Ministry of Health  Elderly Health: Alzheimer&#x2019;s Disease: Definition, Treatment and Guidelines. Ministry of Health.  [(accessed on 28 August 2021)];2017  Available online:  https://www.moh.gov.sa/en/HealthAwareness/EducationalContent/Health-of-Older-Persons/Pages/What-Is-Aging.aspx.</Citation></Reference><Reference><Citation>Albugami M. The demographic characteristics and the risk factors of dementia in Saudi elderly. Am. J. Psychiatry Neurosci. 2018;6:1. doi: 10.11648/j.ajpn.20180601.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.11648/j.ajpn.20180601.11</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins L.G., Swartz K. Caregiver care.  [(accessed on 31 August 2021)];Am. Fam. Physician. 2011 83:1309&#x2013;1317. Available online:  www.aafp.org/afpAmericanFamilyPhysician1309.</Citation><ArticleIdList><ArticleId IdType="pubmed">21661713</ArticleId></ArticleIdList></Reference><Reference><Citation>Alasmee N., Hasan A.A. Primary caregivers experience of anti-psychotic medication: A qualitative study. Arch. Psychiatr. Nurs. 2020;34:520&#x2013;528. doi: 10.1016/j.apnu.2020.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apnu.2020.09.002</ArticleId><ArticleId IdType="pubmed">33280675</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Xiao L.D., He G.P., de Bellis A. Family caregiver challenges in dementia care in a country with undeveloped dementia services. J. Adv. Nurs. 2014;70:1369&#x2013;1380. doi: 10.1111/jan.12299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jan.12299</ArticleId><ArticleId IdType="pubmed">24192338</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health  Healthcare Transformation Strategy.  [(accessed on 12 April 2022)];2017  Available online:  https://www.moh.gov.sa/en/Ministry/vro/Documents/Healthcare-Transformation-Strategy.pdf.</Citation></Reference><Reference><Citation>Bramboeck V., Moeller K., Marksteiner J., Kaufmann L. Loneliness and burden perceived by family caregivers of patients with Alzheimer disease. Am. J. Alzheimer&#x2019;s Dis. Other Dement. 2020;35:1533317520917788. doi: 10.1177/1533317520917788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317520917788</ArticleId><ArticleId IdType="pmc">PMC10624003</ArticleId><ArticleId IdType="pubmed">32281389</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshammari S.A., Alzahrani A.A., Alabduljabbar K.A., Aldaghri A.A., Alhusainy Y.A., Khan M.A., Alshuwaier R.A., Kariz I.N. The burden perceived by informal caregivers of the elderly in Saudi Arabia. J. Fam. Community Med. 2017;24:145. doi: 10.4103/jfcm.JFCM_117_16.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfcm.JFCM_117_16</ArticleId><ArticleId IdType="pmc">PMC5596626</ArticleId><ArticleId IdType="pubmed">28932158</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghazwani E.Y., Al-Shehri A.A., Alghamdi F.A. Assessment of burden and stress among caregivers of terminally Ill patients in a Saudi University Hospital: A cross-sectional study. Cureus. 2021;13:e14215. doi: 10.7759/cureus.14215.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.14215</ArticleId><ArticleId IdType="pmc">PMC8086738</ArticleId><ArticleId IdType="pubmed">33948405</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil A., Aladwani N., Aljehani S. Relationship between knowledge, attitude, and burden among Alzheimer&#x2019;s family care givers in Jeddah, Saudi Arabia. Saudi J. Nurs. Health Care. 2020;3:167&#x2013;174. doi: 10.36348/sjnhc.2020.v03i06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.36348/sjnhc.2020.v03i06.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon P., Jeffrey W. Coping among family members of persons with serious mental illness. Psychiatr. Serv. 1995;46:1156&#x2013;1160.</Citation><ArticleIdList><ArticleId IdType="pubmed">8564505</ArticleId></ArticleIdList></Reference><Reference><Citation>Okasha A. The impact of Arab culture on psychiatric ethics. Arab J. Psych. 2008;19:81&#x2013;99.</Citation></Reference><Reference><Citation>Abolfotouh M.A., Almutairi A.F., Almutairi Z., Salam M., Alhashem A., Adlan A.A., Modayfer O. Attitudes toward mental illness, mentally ill persons, and help-seeking among the Saudi public and sociodemographic correlates. Psychol. Res. Behav. Manag. 2019;12:45&#x2013;54. doi: 10.2147/PRBM.S191676.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/PRBM.S191676</ArticleId><ArticleId IdType="pmc">PMC6338115</ArticleId><ArticleId IdType="pubmed">30679929</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodaty H., Brodaty A.H., Donkin M. Who Are Informal Caregivers? Family Caregivers of People with Dementia. 2009.  [(accessed on 31 August 2021)].  Available online:  www.dialogues-cns.org.</Citation></Reference><Reference><Citation>Schulz R., Beach S.R., Friedman E.M., Martsolf G.R., Rodakowski J., James A.E. Changing structures and processes to support family caregivers of seriously Ill patients. J. Palliat. Med. 2018;21:S36&#x2013;S42. doi: 10.1089/jpm.2017.0437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jpm.2017.0437</ArticleId><ArticleId IdType="pmc">PMC5756457</ArticleId><ArticleId IdType="pubmed">29091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Algahtani H., Shirah B., Alhazmi A., Alshareef A., Bajunaid M., Samman A. Perception and attitude of the general population towards Alzheimer&#x2019;s disease in Jeddah, Saudi Arabia. Acta Neurol. Belg. 2020;120:313&#x2013;320. doi: 10.1007/s13760-018-1040-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-018-1040-7</ArticleId><ArticleId IdType="pubmed">30421351</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;dard M., Molloy D.W., Squire L., Dubois S., Lever J.A. The Zarit Burden Interview: A New Short Version and Screening Version. 2001.  [(accessed on 31 August 2021)].  Available online:  https://academic.oup.com/gerontologist/article/41/5/652/596578.</Citation><ArticleIdList><ArticleId IdType="pubmed">11574710</ArticleId></ArticleIdList></Reference><Reference><Citation>IBM SPSS Statistics for Windows. IBM Corp; Armonk, NY, USA: 2010.  [(accessed on 12 April 2022)].  Available online:  https://www.ibm.com/support/pages/spss-statistics-190-fix-pack-1.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36831557</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2072-6694</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>14</Day></PubDate></JournalIssue><Title>Cancers</Title><ISOAbbreviation>Cancers (Basel)</ISOAbbreviation></Journal><ArticleTitle>A Systematic Review on the Potential Acceleration of Neurocognitive Aging in Older Cancer Survivors.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1215</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cancers15041215</ELocationID><Abstract><AbstractText>As survival rates increase, more emphasis has gone to possible cognitive sequelae in older cancer patients, which could be explained by accelerated brain aging. In this review, we provide a complete overview of studies investigating neuroimaging, neurocognitive, and neurodegenerative disorders in older cancer survivors (&gt;65 years), based on three databases (Pubmed, Web of Science and Medline). Ninety-six studies were included. Evidence was found for functional and structural brain changes (frontal regions, basal ganglia, gray and white matter), compared to healthy controls. Cognitive decline was mainly found in memory functioning. Anti-hormonal treatments were repeatedly associated with cognitive decline (tamoxifen) and sometimes with an increased risk of Alzheimer's disease (androgen deprivation therapy). Chemotherapy was inconsistently associated with later development of cognitive changes or dementia. Radiotherapy was not associated with cognition in patients with non-central nervous system cancer but can play a role in patients with central nervous system cancer, while neurosurgery seemed to improve their cognition in the short-term. Individual risk factors included cancer subtypes (e.g., brain cancer, hormone-related cancers), treatment (e.g., anti-hormonal therapy, chemotherapy, cranial radiation), genetic predisposition (e.g., APOE, COMT, BDNF), age, comorbidities (e.g., frailty, cognitive reserve), and psychological (e.g., depression, (post-traumatic) distress, sleep, fatigue) and social factors (e.g., loneliness, limited caregiver support, low SES). More research on accelerated aging is required to guide intervention studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kerstens</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Oncology, University Hospital Ghent, 9000 Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wildiers</LastName><ForeName>Hans P M W</ForeName><Initials>HPMW</Initials><Identifier Source="ORCID">0000-0001-8990-7837</Identifier><AffiliationInfo><Affiliation>Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Medical Oncology and Multidisciplinary Breast Centre, University Hospitals Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schroyen</LastName><ForeName>Gwen</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-9646-5106</Identifier><AffiliationInfo><Affiliation>Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Imaging and Pathology, Translational MRI, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almela</LastName><ForeName>Mercedes</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cognitive Neuropsychology, Tilburg University, 5030AB Tilburg, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mark</LastName><ForeName>Ruth E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Cognitive Neuropsychology, Tilburg University, 5030AB Tilburg, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambrecht</LastName><ForeName>Maarten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Experimental Radiotherapy, Department of Oncology, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiotherapy, University Hospitals Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deprez</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7451-5355</Identifier><AffiliationInfo><Affiliation>Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Imaging and Pathology, Translational MRI, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sleurs</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cognitive Neuropsychology, Tilburg University, 5030AB Tilburg, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cancers (Basel)</MedlineTA><NlmUniqueID>101526829</NlmUniqueID><ISSNLinking>2072-6694</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aging</Keyword><Keyword MajorTopicYN="N">cancer survivors</Keyword><Keyword MajorTopicYN="N">cognition</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">older</Keyword></KeywordList><CoiStatement>The authors have declared no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>1</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36831557</ArticleId><ArticleId IdType="pmc">PMC9954467</ArticleId><ArticleId IdType="doi">10.3390/cancers15041215</ArticleId><ArticleId IdType="pii">cancers15041215</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209&#x2013;249. doi: 10.3322/caac.21660.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21660</ArticleId><ArticleId IdType="pubmed">33538338</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson T.O., Ness K.K., Cohen H.J. Accelerated Aging among Cancer Survivors: From Pediatrics to Geriatrics. Am. Soc. Clin. Oncol. Educ. Book. 2014;34:e423&#x2013;e430. doi: 10.14694/EdBook_AM.2014.34.e423.</Citation><ArticleIdList><ArticleId IdType="doi">10.14694/EdBook_AM.2014.34.e423</ArticleId><ArticleId IdType="pubmed">24857133</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange M., Rigal O., Clarisse B., Giffard B., Sevin E., Barillet M., Eustache F., Joly F. Cognitive Dysfunctions in Elderly Cancer Patients: A New Challenge for Oncologists. Cancer Treat. Rev. 2014;40:810&#x2013;817. doi: 10.1016/j.ctrv.2014.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctrv.2014.03.003</ArticleId><ArticleId IdType="pubmed">24713425</ArticleId></ArticleIdList></Reference><Reference><Citation>Small B.J., Scott S.B., Jim H.S.L., Jacobsen P.B. Is Cancer a Risk Factor for Cognitive Decline in Late Life? Gerontology. 2015;61:561&#x2013;566. doi: 10.1159/000381022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000381022</ArticleId><ArticleId IdType="pubmed">25833334</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange M., Heutte N., Noal S., Rigal O., Kurtz J.-E., L&#xe9;vy C., Allouache D., Rieux C., Lefel J., Clarisse B., et al. Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer. Oncologist. 2019;24:62&#x2013;68. doi: 10.1634/theoncologist.2017-0570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2017-0570</ArticleId><ArticleId IdType="pmc">PMC6324624</ArticleId><ArticleId IdType="pubmed">29934409</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelsins M.C., Kesler S.R., Ahles T.A., Morrow G.R. Prevalence, Mechanisms, and Management of Cancer-Related Cognitive Impairment. Int. Rev. Psychiatry. 2014;26:102&#x2013;113. doi: 10.3109/09540261.2013.864260.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09540261.2013.864260</ArticleId><ArticleId IdType="pmc">PMC4084673</ArticleId><ArticleId IdType="pubmed">24716504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahles T.A., Saykin A.J. Candidate Mechanisms for Chemotherapy-Induced Cognitive Changes. Nat. Rev. Cancer. 2007;7:192&#x2013;201. doi: 10.1038/nrc2073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc2073</ArticleId><ArticleId IdType="pmc">PMC3329763</ArticleId><ArticleId IdType="pubmed">17318212</ArticleId></ArticleIdList></Reference><Reference><Citation>Makale M.T., McDonald C.R., Hattangadi-Gluth J.A., Kesari S. Mechanisms of Radiotherapy-Associated Cognitive Disability in Patients with Brain Tumours. Nat. Rev. Neurol. 2017;13:52&#x2013;64. doi: 10.1038/nrneurol.2016.185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.185</ArticleId><ArticleId IdType="pmc">PMC5805381</ArticleId><ArticleId IdType="pubmed">27982041</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogiers A., Boekhout A., Schwarze J.K., Awada G., Blank C.U., Neyns B., Gupta S.C. Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors. J. Oncol. 2019;2019:9062. doi: 10.1155/2019/5269062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/5269062</ArticleId><ArticleId IdType="pmc">PMC6512024</ArticleId><ArticleId IdType="pubmed">31182961</ArticleId></ArticleIdList></Reference><Reference><Citation>Joly F., Castel H., Tron L., Lange M., Vardy J. Potential Effect of Immunotherapy Agents on Cognitive Function in Cancer Patients. J. Natl. Cancer Inst. 2020;112:123&#x2013;127. doi: 10.1093/jnci/djz168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djz168</ArticleId><ArticleId IdType="pmc">PMC7019093</ArticleId><ArticleId IdType="pubmed">31504664</ArticleId></ArticleIdList></Reference><Reference><Citation>Vannorsdall T.D. Cognitive Changes Related to Cancer Therapy. Med. Clin. N. Am. 2017;101:1115&#x2013;1134. doi: 10.1016/j.mcna.2017.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcna.2017.06.006</ArticleId><ArticleId IdType="pubmed">28992858</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahles T.A., Hurria A. New Challenges in Psycho-Oncology Research IV: Cognition and cancer: Conceptual and methodological issues and future directions. Psycho-Oncology. 2018;27:3&#x2013;9. doi: 10.1002/pon.4564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pon.4564</ArticleId><ArticleId IdType="pubmed">29044730</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahles T.A., Root J.C. Cognitive Effects of Cancer and Cancer Treatments. Annu. Rev. Clin. Psychol. 2018;14:425&#x2013;451. doi: 10.1146/annurev-clinpsy-050817-084903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-clinpsy-050817-084903</ArticleId><ArticleId IdType="pmc">PMC9118140</ArticleId><ArticleId IdType="pubmed">29345974</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy S.J., Krull K.R., Wefel J.S., Janelsins M. Cognitive Changes in Cancer Survivors. Am. Soc. Clin. Oncol. Educ. Book. 2018;38:795&#x2013;806. doi: 10.1200/EDBK_201179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/EDBK_201179</ArticleId><ArticleId IdType="pubmed">30231372</ArticleId></ArticleIdList></Reference><Reference><Citation>M Steverson Ageing and Health.  [(accessed on 3 May 2022)].  Available online:  https://www.who.int/news-room/fact-sheets/detail/ageing-and-health#:~:text=At%20the%20biological%20level%2C%20ageing,of%20disease%20and%20ultimately%20death.</Citation></Reference><Reference><Citation>Muhandiramge J., Orchard S., Haydon A., Zalcberg J. The Acceleration of Ageing in Older Patients with Cancer. J. Geriatr. Oncol. 2021;12:343&#x2013;351. doi: 10.1016/j.jgo.2020.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgo.2020.09.010</ArticleId><ArticleId IdType="pubmed">32933870</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandelblatt J.S., Jacobsen P.B., Ahles T. Cognitive Effects of Cancer Systemic Therapy: Implications for the Care of Older Patients and Survivors. J. Clin. Oncol. 2014;32:2617&#x2013;2626. doi: 10.1200/JCO.2014.55.1259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2014.55.1259</ArticleId><ArticleId IdType="pmc">PMC4129505</ArticleId><ArticleId IdType="pubmed">25071135</ArticleId></ArticleIdList></Reference><Reference><Citation>Nudelman K.N.H., Risacher S.L., West J.D., McDonald B.C., Gao S., Saykin A.J. Association of Cancer History with Alzheimer&#x2019;s Disease Onset and Structural Brain Changes. Front. Physiol. 2014;5:423. doi: 10.3389/fphys.2014.00423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2014.00423</ArticleId><ArticleId IdType="pmc">PMC4215790</ArticleId><ArticleId IdType="pubmed">25400589</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma M.B., Jensen K., Urbak S.F., Funding M., Johansen J., Bechtold D., Amidi A., Eskildsen S.F., J&#xf8;rgensen J.O.L., Grau C. A Multidimensional Cohort Study of Late Toxicity after Intensity Modulated Radiotherapy for Sinonasal Cancer. Radiother. Oncol. 2020;151:58&#x2013;65. doi: 10.1016/j.radonc.2020.07.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.radonc.2020.07.029</ArticleId><ArticleId IdType="pubmed">32697945</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim&#xf3; M., Vaquero L., Ripoll&#xe9;s P., Jov&#xe9; J., Fuentes R., Cardenal F., Rodr&#xed;guez-Fornells A., Bruna J. Brain Damage Following Prophylactic Cranial Irradiation in Lung Cancer Survivors. Brain Imaging Behav. 2016;10:283&#x2013;295. doi: 10.1007/s11682-015-9393-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-015-9393-5</ArticleId><ArticleId IdType="pubmed">26015269</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponto L.L.B., Menda Y., Magnotta V.A., Yamada T.H., Denburg N.L., Schultz S.K. Frontal Hypometabolism in Elderly Breast Cancer Survivors Determined by [18F]Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET): A Pilot Study. Int. J. Geriatr. Psychiatry. 2015;30:587&#x2013;594. doi: 10.1002/gps.4189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4189</ArticleId><ArticleId IdType="pmc">PMC4345151</ArticleId><ArticleId IdType="pubmed">25176562</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandelblatt J.S., Hurria A., McDonald B.C., Saykin A.J., Stern R.A., Vanmeter J.W., McGuckin M., Traina T., Denduluri N., Turner S., et al. Cognitive Effects of Cancer and Its Treatments at the Intersection of Aging: What Do We Know; What Do We Need to Know? Semin. Oncol. 2013;40:709&#x2013;725. doi: 10.1053/j.seminoncol.2013.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.seminoncol.2013.09.006</ArticleId><ArticleId IdType="pmc">PMC3880205</ArticleId><ArticleId IdType="pubmed">24331192</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst T., Chang L., Cooray D., Salvador C., Jovicich J., Walot I., Boone K., Chlebowski R. The Effects of Tamoxifen and Estrogen on Brain Metabolism in Elderly Women. J. Natl. Cancer Inst. 2002;94:592&#x2013;597. doi: 10.1093/jnci/94.8.592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/94.8.592</ArticleId><ArticleId IdType="pubmed">11959892</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada T.H., Denburg N.L., Beglinger L.J., Schultz S.K. Neuropsychological Outcomes of Older Breast Cancer Survivors: Cognitive Features Ten or More Years after Chemotherapy. J. Neuropsychiatry Clin. Neurosci. 2010;22:48&#x2013;54. doi: 10.1176/jnp.2010.22.1.48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/jnp.2010.22.1.48</ArticleId><ArticleId IdType="pmc">PMC3641161</ArticleId><ArticleId IdType="pubmed">20160209</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Cristofori A., Zarino B., Bertani G., Locatelli M., Rampini P., Carrabba G., Caroli M. Surgery in Elderly Patients with Intracranial Meningioma: Neuropsychological Functioning during a Long Term Follow-Up. J. Neurooncol. 2018;137:611&#x2013;619. doi: 10.1007/s11060-018-2754-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11060-018-2754-3</ArticleId><ArticleId IdType="pubmed">29330748</ArticleId></ArticleIdList></Reference><Reference><Citation>Konglund A., Rogne S.G., Lund-Johansen M., Scheie D., Helseth E., Meling T.R. Outcome Following Surgery for Intracranial Meningiomas in the Aging. Acta Neurol. Scand. 2013;127:161&#x2013;169. doi: 10.1111/j.1600-0404.2012.01692.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2012.01692.x</ArticleId><ArticleId IdType="pubmed">22725678</ArticleId></ArticleIdList></Reference><Reference><Citation>Minniti G., Esposito V., Clarke E., Scaringi C., Bozzao A., Lanzetta G., de Sanctis V., Valeriani M., Osti M., Enrici R.M. Stereotactic Radiosurgery in Elderly Patients with Brain Metastases. J. Neurooncol. 2013;111:319&#x2013;325. doi: 10.1007/s11060-012-1016-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11060-012-1016-z</ArticleId><ArticleId IdType="pubmed">23187817</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi G., Bergo E., Bianco P.D., Bellu L., Pambuku A., Caccese M., Trentin L., Zagonel V. Quality of Life Perception, Cognitive Function, and Psychological Status in a Real-World Population of Glioblastoma Patients Treated with Radiotherapy and Temozolomide: A Single-Center Prospective Study. Am. J. Clin. Oncol. 2018;41:1263&#x2013;1271. doi: 10.1097/COC.0000000000000459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/COC.0000000000000459</ArticleId><ArticleId IdType="pubmed">29750673</ArticleId></ArticleIdList></Reference><Reference><Citation>Deschler B., Ihorst G., H&#xfc;ll M., Baier P. Regeneration of Older Patients after Oncologic Surgery. A Temporal Trajectory of Geriatric Assessment and Quality of Life Parameters. J. Geriatr. Oncol. 2019;10:112&#x2013;119. doi: 10.1016/j.jgo.2018.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgo.2018.09.010</ArticleId><ArticleId IdType="pubmed">30314954</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez B.D., Jim H.S.L., Booth-Jones M., Small B.J., Sutton S.K., Lin H.Y., Park J.Y., Spiess P.E., Fishman M.N., Jacobsen P.B. Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison. J. Clin. Oncol. 2015;33:2021&#x2013;2027. doi: 10.1200/JCO.2014.60.1963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2014.60.1963</ArticleId><ArticleId IdType="pmc">PMC4461804</ArticleId><ArticleId IdType="pubmed">25964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter K.E. &#x201c;Chemo Brain&#x201d;-Is Cancer Survivorship Related to Later-Life Cognition? Findings from the Health and Retirement Study. J. Aging Health. 2013;25:960&#x2013;981. doi: 10.1177/0898264313498417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0898264313498417</ArticleId><ArticleId IdType="pubmed">23965309</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin R.T., Midlarsky E. Treatment with Chemotherapy and Cognitive Functioning in Older Adult Cancer Survivors. Arch. Phys. Med. Rehabil. 2018;99:257&#x2013;263. doi: 10.1016/j.apmr.2017.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2017.06.016</ArticleId><ArticleId IdType="pubmed">28735719</ArticleId></ArticleIdList></Reference><Reference><Citation>Regier N.G., Naik A.D., Mulligan E.A., Nasreddine Z.S., Driver J.A., Sada Y.H.F., Moye J. Cancer-Related Cognitive Impairment and Associated Factors in a Sample of Older Male Oral-Digestive Cancer Survivors. Psychooncology. 2019;28:1551&#x2013;1558. doi: 10.1002/pon.5131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pon.5131</ArticleId><ArticleId IdType="pmc">PMC6666305</ArticleId><ArticleId IdType="pubmed">31134710</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Willik K.D., J&#xf3;&#x17a;wiak K., Hauptmann M., van de Velde E.E.D., Compter A., Ruiter R., Stricker B.H., Ikram M.A., Schagen S.B. Change in Cognition before and after Non-Central Nervous System Cancer Diagnosis: A Population-Based Cohort Study. Psychooncology. 2021;30:1699&#x2013;1710. doi: 10.1002/pon.5734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pon.5734</ArticleId><ArticleId IdType="pubmed">34004035</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurita K., Meyerowitz B.E., Hall P., Gatz M. Long-Term Cognitive Impairment in Older Adult Twins Discordant for Gynecologic Cancer Treatment. J. Gerontol. A Biol. Sci. Med. Sci. 2011;66:1343&#x2013;1349. doi: 10.1093/gerona/glr140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glr140</ArticleId><ArticleId IdType="pmc">PMC3210958</ArticleId><ArticleId IdType="pubmed">21860015</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandelblatt J.S., Small B.J., Luta G., Hurria A., Jim H., McDonald B.C., Graham D., Zhou X., Clapp J., Zhai W., et al. Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living with Cancer Study. J. Clin. Oncol. 2018;36:3211&#x2013;3222. doi: 10.1200/JCO.18.00140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.18.00140</ArticleId><ArticleId IdType="pmc">PMC7237199</ArticleId><ArticleId IdType="pubmed">30281396</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilder C.M., Seynaeve C., Beex L.V., Boogerd W., Linn S.C., Gundy C.M., Huizenga H.M., Nortier J.W., van de Velde C.J., van Dam F.S., et al. Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients with Breast Cancer: Results from the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial. J. Clin. Oncol. 2010;28:1294&#x2013;1300. doi: 10.1200/JCO.2008.21.3553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2008.21.3553</ArticleId><ArticleId IdType="pubmed">20142601</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganini-Hill A., Clark L.J. Preliminary Assessment of Cognitive Function in Breast Cancer Patients Treated with Tamoxifen. Breast Cancer Res. Treat. 2000;64:165&#x2013;176. doi: 10.1023/A:1006426132338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1006426132338</ArticleId><ArticleId IdType="pubmed">11194452</ArticleId></ArticleIdList></Reference><Reference><Citation>Underwood E.A., Jerzak K.J., Lebovic G., Rochon P.A., Elser C., Pritchard K.I., Tierney M.C. Cognitive Effects of Adjuvant Endocrine Therapy in Older Women Treated for Early-Stage Breast Cancer: A 1-Year Longitudinal Study. Support. Care Cancer. 2019;27:3035&#x2013;3043. doi: 10.1007/s00520-018-4603-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-018-4603-5</ArticleId><ArticleId IdType="pubmed">30610433</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida O.P., Waterreus A., Spry N., Flicker L., Martins R.N. One Year Follow-up Study of the Association between Chemical Castration, Sex Hormones, Beta-Amyloid, Memory and Depression in Men. Psychoneuroendocrinology. 2004;29:1071&#x2013;1081. doi: 10.1016/j.psyneuen.2003.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2003.11.002</ArticleId><ArticleId IdType="pubmed">15219659</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoogland A.I., Jim H.S.L., Gonzalez B.D., Small B.J., Gilvary D., Breen E.C., Bower J.E., Fishman M., Zachariah B., Jacobsen P.B. Systemic Inflammation and Symptomatology in Patients with Prostate Cancer Treated with Androgen Deprivation Therapy: Preliminary Findings. Cancer. 2021;127:1476&#x2013;1482. doi: 10.1002/cncr.33397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.33397</ArticleId><ArticleId IdType="pmc">PMC8084887</ArticleId><ArticleId IdType="pubmed">33378113</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins V.A., Bloomfield D.J., Shilling V.M., Edginton T.L. Does Neoadjuvant Hormone Therapy for Early Prostate Cancer Affect Cognition? Results from a Pilot Study. BJU Int. 2005;96:48&#x2013;53. doi: 10.1111/j.1464-410X.2005.05565.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1464-410X.2005.05565.x</ArticleId><ArticleId IdType="pubmed">15963119</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Zhong F., Qiu J., Cheng H., Wang K. Dissociation of Event-Based Prospective Memory and Time-Based Prospective Memory in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy: A Neuropsychological Study. Eur. J. Cancer Care. 2015;24:198&#x2013;204. doi: 10.1111/ecc.12299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ecc.12299</ArticleId><ArticleId IdType="pubmed">25711542</ArticleId></ArticleIdList></Reference><Reference><Citation>Alibhai S.M.H., Breunis H., Timilshina N., Marzouk S., Stewart D., Tannock I., Naglie G., Tomlinson G., Fleshner N., Krahn M., et al. Impact of Androgen-Deprivation Therapy on Cognitive Function in Men with Nonmetastatic Prostate Cancer. J. Clin. Oncol. 2010;28:5030&#x2013;5037. doi: 10.1200/JCO.2010.30.8742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2010.30.8742</ArticleId><ArticleId IdType="pubmed">21041708</ArticleId></ArticleIdList></Reference><Reference><Citation>Alibhai S.M.H., Timilshina N., Duff-Canning S., Breunis H., Tannock I.F., Naglie G., Fleshner N.E., Krahn M.D., Warde P., Marzouk S., et al. Effects of Long-Term Androgen Deprivation Therapy on Cognitive Function over 36 Months in Men with Prostate Cancer. Cancer. 2017;123:237&#x2013;244. doi: 10.1002/cncr.30320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.30320</ArticleId><ArticleId IdType="pubmed">27583806</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso-Qui&#xf1;ones H., Stish B.J., Aakre J.A., Hagen C.E., Petersen R.C., Mielke M.M. Androgen Deprivation Therapy Use and Risk of Mild Cognitive Impairment in Prostate Cancer Patients. Alzheimer Dis. Assoc. Disord. 2021;35:44&#x2013;47. doi: 10.1097/WAD.0000000000000415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0000000000000415</ArticleId><ArticleId IdType="pmc">PMC7904573</ArticleId><ArticleId IdType="pubmed">32960856</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso Qui&#xf1;ones H.J., Stish B.J., Hagen C., Petersen R.C., Mielke M.M. Prostate Cancer, Use of Androgen Deprivation Therapy, and Cognitive Impairment: A Population-Based Study. Alzheimer Dis. Assoc. Disord. 2020;34:118. doi: 10.1097/WAD.0000000000000366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0000000000000366</ArticleId><ArticleId IdType="pmc">PMC7242115</ArticleId><ArticleId IdType="pubmed">31821185</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan W.W., Heckman M.G., Vishnu P., Crook J.E., Younkin L.H., Covil E.G., Ferman T.J., Graff-Radford N.R., Younkin S.G., Smallridge R.C., et al. Effect of Leuprolide on Serum Amyloid-&#x3b2; Peptide Levels and Memory in Patients with Prostate Cancer with Biochemical Recurrence. Urology. 2013;81:150&#x2013;154. doi: 10.1016/j.urology.2012.08.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urology.2012.08.066</ArticleId><ArticleId IdType="pubmed">23273081</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon J.H., Ahn S., Seo J., Han J.W., Kim K.M., Choi S.H., Lim S., Park Y.J., Park D.J., Kim K.W., et al. The Effect of Long-Term Thyroid-Stimulating Hormone Suppressive Therapy on the Cognitive Function of Elderly Patients with Differentiated Thyroid Carcinoma. J. Clin. Endocrinol. Metab. 2014;99:3782&#x2013;3789. doi: 10.1210/jc.2013-4454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2013-4454</ArticleId><ArticleId IdType="pubmed">25029415</ArticleId></ArticleIdList></Reference><Reference><Citation>Anstey K.J., Sargent-Cox K., Cherbuin N., Sachdev P.S. Self-Reported History of Chemotherapy and Cognitive Decline in Adults Aged 60 and Older: The PATH Through Life Project. Med. Sci. 2015;70:729&#x2013;735. doi: 10.1093/gerona/glt195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glt195</ArticleId><ArticleId IdType="pubmed">24368774</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruzado J.A., L&#xf3;pez-Santiago S., Mart&#xed;nez-Mar&#xed;n V., Jos&#xe9;-Moreno G., Custodio A.B., Feliu J. Longitudinal Study of Cognitive Dysfunctions Induced by Adjuvant Chemotherapy in Colon Cancer Patients. Support Care Cancer. 2014;22:1815&#x2013;1823. doi: 10.1007/s00520-014-2147-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-014-2147-x</ArticleId><ArticleId IdType="pubmed">24535240</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurria A., Rosen C., Hudis C., Zuckerman E., Panageas K.S., Lachs M.S., Witmer M., van Gorp W.G., Fornier M., D&#x2019;Andrea G., et al. Cognitive Function of Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer: A Pilot Prospective Longitudinal Study. J. Am. Geriatr. Soc. 2006;54:925&#x2013;931. doi: 10.1111/j.1532-5415.2006.00732.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2006.00732.x</ArticleId><ArticleId IdType="pubmed">16776787</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvale E.A., Clay O.J., Ross-Meadows L.A., McGee J.S., Edwards J.D., Unverzagt F.W., Ritchie C.S., Ball K.K. Cognitive Speed of Processing and Functional Declines in Older Cancer Survivors: An Analysis of Data from the ACTIVE Trial. Eur. J. Cancer Care. 2010;19:110&#x2013;117. doi: 10.1111/j.1365-2354.2008.01018.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2354.2008.01018.x</ArticleId><ArticleId IdType="pmc">PMC2835340</ArticleId><ArticleId IdType="pubmed">19709169</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaffer V.A., Merkle E.C., Fagerlin A., Griggs J.J., Langa K.M., Iwashyna T.J. Chemotherapy Was Not Associated with Cognitive Decline in Older Adults with Breast and Colorectal Cancer: Findings from a Prospective Cohort Study. Med. Care. 2012;50:849&#x2013;855. doi: 10.1097/MLR.0b013e31825a8bb0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31825a8bb0</ArticleId><ArticleId IdType="pmc">PMC3444668</ArticleId><ArticleId IdType="pubmed">22683591</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckwalter J.G., Crooks V.C., Petitti D.B. Cognitive Performance of Older Women Who Have Survived Cancer. Int. J. Neurosci. 2005;115:1307&#x2013;1314. doi: 10.1080/00207450590934534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207450590934534</ArticleId><ArticleId IdType="pubmed">16048807</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin R.T., Midlarsky E. Depressive Symptoms and Cognitive Functioning among Older Adults with Cancer. Aging Ment. Health. 2018;22:1465&#x2013;1470. doi: 10.1080/13607863.2017.1363868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2017.1363868</ArticleId><ArticleId IdType="pubmed">28786290</ArticleId></ArticleIdList></Reference><Reference><Citation>La Carpia D., Liperoti R., Guglielmo M., di Capua B., Devizzi L.F., Matteucci P., Farina L., Fusco D., Colloca G., di Pede P., et al. Cognitive Decline in Older Long-Term Survivors from Non-Hodgkin Lymphoma: A Multicenter Cross-Sectional Study. J. Geriatr. Oncol. 2020;11:790&#x2013;795. doi: 10.1016/j.jgo.2020.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgo.2020.01.007</ArticleId><ArticleId IdType="pubmed">32008957</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams A.M., Janelsins M.C., van Wijngaarden E. Cognitive Function in Cancer Survivors: Analysis of the 1999-2002 National Health and Nutrition Examination Survey. Support Care Cancer. 2016;24:2155&#x2013;2162. doi: 10.1007/s00520-015-2992-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-015-2992-2</ArticleId><ArticleId IdType="pmc">PMC4933958</ArticleId><ArticleId IdType="pubmed">26559193</ArticleId></ArticleIdList></Reference><Reference><Citation>Ospina-Romero M., Abdiwahab E., Kobayashi L., Filshtein T., Brenowitz W.D., Mayeda E.R., Glymour M.M. Rate of Memory Change Before and After Cancer Diagnosis. JAMA Netw. Open. 2019;2:6160. doi: 10.1001/jamanetworkopen.2019.6160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.6160</ArticleId><ArticleId IdType="pmc">PMC6593639</ArticleId><ArticleId IdType="pubmed">31225893</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilder C.M.T., Seynaeve C., Linn S.C., Boogerd W., Beex L.V.A.M., Gundy C.M., Nortier J.W.R., van de Velde C.J.H., van Dam F.S.A.M., Schagen S.B. Self-Reported Cognitive Functioning in Postmenopausal Breast Cancer Patients before and during Endocrine Treatment: Findings from the Neuropsychological TEAM Side-Study. Psychooncology. 2012;21:479&#x2013;487. doi: 10.1002/pon.1928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pon.1928</ArticleId><ArticleId IdType="pubmed">21351188</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman R.A., Pitcher B., Keating N.L., Ballman K.V., Mandelblatt J., Kornblith A.B., Kimmick G.G., Hurria A., Winer E.P., Hudis C.A., et al. Cognitive Function in Older Women with Breast Cancer Treated with Standard Chemotherapy and Capecitabine on Cancer and Leukemia Group B 49907. Breast Cancer Res. Treat. 2013;139:607&#x2013;616. doi: 10.1007/s10549-013-2562-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10549-013-2562-6</ArticleId><ArticleId IdType="pmc">PMC3920483</ArticleId><ArticleId IdType="pubmed">23681403</ArticleId></ArticleIdList></Reference><Reference><Citation>Keating N.L., N&#xf8;rredam M., Landrum M.B., Huskamp H.A., Meara E. Physical and Mental Health Status of Older Long-Term Cancer Survivors. J. Am. Geriatr. Soc. 2005;53:2145&#x2013;2152. doi: 10.1111/j.1532-5415.2005.00507.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.00507.x</ArticleId><ArticleId IdType="pubmed">16398900</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandelblatt J.S., Clapp J.D., Luta G., Faul L.A., Tallarico M.D., McClendon T.D., Whitley J.A., Cai L., Ahles T.A., Stern R.A., et al. Long-Term Trajectories of Self-Reported Cognitive Function in a Cohort of Older Survivors of Breast Cancer: CALGB 369901 (Alliance) Cancer. 2016;122:3555&#x2013;3563. doi: 10.1002/cncr.30208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.30208</ArticleId><ArticleId IdType="pmc">PMC5113662</ArticleId><ArticleId IdType="pubmed">27447359</ArticleId></ArticleIdList></Reference><Reference><Citation>Heflin L.H., Meyerowitz B.E., Hall P., Lichtenstein P., Johansson B., Pedersen N.L., Gatz M. Cancer as a Risk Factor for Long-Term Cognitive Deficits and Dementia. J. Natl. Cancer Inst. 2005;97:854&#x2013;856. doi: 10.1093/jnci/dji137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/dji137</ArticleId><ArticleId IdType="pubmed">15928306</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurria A., Goldfarb S., Rosen C., Holland J., Zuckerman E., Lachs M.S., Witmer M., van Gorp W.G., Fornier M., D&#x2019;Andrea G., et al. Effect of Adjuvant Breast Cancer Chemotherapy on Cognitive Function from the Older Patient&#x2019;s Perspective. Breast Cancer Res. Treat. 2006;98:343&#x2013;348. doi: 10.1007/s10549-006-9171-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10549-006-9171-6</ArticleId><ArticleId IdType="pubmed">16541322</ArticleId></ArticleIdList></Reference><Reference><Citation>Stava C., Weiss L.T., Vassilopoulou-Sellin R. Health Profiles of 814 Very Long-Term Breast Cancer Survivors. Clin. Breast Cancer. 2006;7:228&#x2013;236. doi: 10.3816/CBC.2006.n.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.3816/CBC.2006.n.034</ArticleId><ArticleId IdType="pubmed">16942639</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibler E., Tran G., Orrell K.A., Serrano L., Majewski S., Sable K.A., Thiede R., Laumann A.E., West D.P., Nardone B. Inverse Association for Diagnosis of Alzheimer&#x2019;s Disease Subsequent to Both Melanoma and Non-Melanoma Skin Cancers in a Large, Urban, Single-Centre, Midwestern US Patient Population. J. Eur. Acad. Dermatol. Venereol. 2018;32:1893&#x2013;1896. doi: 10.1111/jdv.14952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.14952</ArticleId><ArticleId IdType="pmc">PMC6153078</ArticleId><ArticleId IdType="pubmed">29573497</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan A., Chirra M., Dwivedi A.K., Sturchio A., Keeling E.G., Marsili L., Espay A.J. Skin Cancer May Delay Onset but Not Progression of Parkinson&#x2019;s Disease: A Nested Case-Control Study. Front. Neurol. 2020;11:406. doi: 10.3389/fneur.2020.00406.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00406</ArticleId><ArticleId IdType="pmc">PMC7270344</ArticleId><ArticleId IdType="pubmed">32547471</ArticleId></ArticleIdList></Reference><Reference><Citation>White R.S., Lipton R.B., Hall C.B., Steinerman J.R. Nonmelanoma Skin Cancer Is Associated with Reduced Alzheimer Disease Risk. Neurology. 2013;80:1966&#x2013;1972. doi: 10.1212/WNL.0b013e3182941990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182941990</ArticleId><ArticleId IdType="pmc">PMC3716346</ArticleId><ArticleId IdType="pubmed">23677746</ArticleId></ArticleIdList></Reference><Reference><Citation>Frain L., Swanson D., Cho K., Gagnon D., Lu K.P., Betensky R.A., Driver J. Association of Cancer and Alzheimer&#x2019;s Disease Risk in a National Cohort of Veterans. Alzheimers Dement. 2017;13:1364&#x2013;1370. doi: 10.1016/j.jalz.2017.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2017.04.012</ArticleId><ArticleId IdType="pmc">PMC5743228</ArticleId><ArticleId IdType="pubmed">28711346</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen J.H., Friis S., Frederiksen K. Malignant Melanoma and Other Types of Cancer Preceding Parkinson Disease. Epidemiology. 2006;17:582&#x2013;587. doi: 10.1097/01.ede.0000229445.90471.5e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ede.0000229445.90471.5e</ArticleId><ArticleId IdType="pubmed">16837822</ArticleId></ArticleIdList></Reference><Reference><Citation>Driver J.A., Beiser A., Au R., Kreger B.E., Splansky G.L., Kurth T., Kiel D.P., Lu K.P., Seshadri S., Wolf P.A. Inverse Association between Cancer and Alzheimer&#x2019;s Disease: Results from the Framingham Heart Study. BMJ. 2012;344:19. doi: 10.1136/bmj.e1442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.e1442</ArticleId><ArticleId IdType="pmc">PMC3647385</ArticleId><ArticleId IdType="pubmed">22411920</ArticleId></ArticleIdList></Reference><Reference><Citation>Klinger D., Hill B.L., Barda N., Halperin E., Gofrit O.N., Greenblatt C.L., Rappoport N., Linial M., Bercovier H. Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer&#x2019;s Disease and Parkinson&#x2019;s Disease. Vaccines. 2021;9:50491. doi: 10.3390/vaccines9050491.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9050491</ArticleId><ArticleId IdType="pmc">PMC8151667</ArticleId><ArticleId IdType="pubmed">34064775</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M., Wang Y., Sundquist J., Sundquist K., Ji J. The Association Between Cancer and Dementia: A National Cohort Study in Sweden. Front. Oncol. 2020;10:73. doi: 10.3389/fonc.2020.00073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2020.00073</ArticleId><ArticleId IdType="pmc">PMC7010720</ArticleId><ArticleId IdType="pubmed">32117730</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P.C., Muo C.H., Lee Y.T., Yu Y.H., Sung F.C. Lung Cancer and Incidence of Stroke: A Population-Based Cohort Study. Stroke. 2011;42:3034&#x2013;3039. doi: 10.1161/STROKEAHA.111.615534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.111.615534</ArticleId><ArticleId IdType="pubmed">21903961</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbaz A., Peterson B.J., Yang P., van Gerpen J.A., Bower J.H., Maraganore D.M., McDonnell S.K., Ahlskog J.E., Rocca W.A. Nonfatal Cancer Preceding Parkinson&#x2019;s Disease: A Case-Control Study. Epidemiology. 2002;13:157&#x2013;164. doi: 10.1097/00001648-200203000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001648-200203000-00010</ArticleId><ArticleId IdType="pubmed">11880756</ArticleId></ArticleIdList></Reference><Reference><Citation>Roderburg C., Loosen S.H., Kunstein A., Mohr R., J&#xf6;rdens M.S., Luedde M., Kostev K., Luedde T. Cancer Patients Have an Increased Incidence of Dementia: A Retrospective Cohort Study of 185,736 Outpatients in Germany. Cancers. 2021;13:2027. doi: 10.3390/cancers13092027.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13092027</ArticleId><ArticleId IdType="pmc">PMC8122712</ArticleId><ArticleId IdType="pubmed">33922235</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman D.M., Wu J., Chen H., Kuncl R.W., Enewold L.R., Engels E.A., Freedman N.D., Pfeiffer R.M. Associations between Cancer and Alzheimer&#x2019;s Disease in a U.S. Medicare Population. Cancer Med. 2016;5:2965&#x2013;2976. doi: 10.1002/cam4.850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cam4.850</ArticleId><ArticleId IdType="pmc">PMC5083750</ArticleId><ArticleId IdType="pubmed">27628596</ArticleId></ArticleIdList></Reference><Reference><Citation>Realmuto S., Cinturino A., Arnao V., Mazzola M.A., Cupidi C., Aridon P., Ragonese P., Savettieri G., D&#x2019;Amelio M. Tumor Diagnosis Preceding Alzheimer&#x2019;s Disease Onset: Is There a Link between Cancer and Alzheimer&#x2019;s Disease? J. Alzheimers Dis. 2012;31:177&#x2013;182. doi: 10.3233/JAD-2012-120184.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2012-120184</ArticleId><ArticleId IdType="pubmed">22531415</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello Bowles E.J., Walker R.L., Anderson M.L., Dublin S., Crane P.K., Larson E.B. Risk of Alzheimer&#x2019;s Disease or Dementia Following a Cancer Diagnosis. PLoS ONE. 2017;12:e179857. doi: 10.1371/journal.pone.0179857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179857</ArticleId><ArticleId IdType="pmc">PMC5478144</ArticleId><ArticleId IdType="pubmed">28632787</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan N.F., Mant D., Carpenter L., Forman D., Rose P.W. Long-Term Health Outcomes in a British Cohort of Breast, Colorectal and Prostate Cancer Survivors: A Database Study. Br. J. Cancer. 2011;105((Suppl. 1)):420. doi: 10.1038/bjc.2011.420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjc.2011.420</ArticleId><ArticleId IdType="pmc">PMC3251947</ArticleId><ArticleId IdType="pubmed">22048030</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong J.H., Huang C.Y., Chang C.H., Muo C.H., Jaw F.S., Lu Y.C., Chung C.J. Different Androgen Deprivation Therapies Might Have a Differential Impact on Cognition&#x2014;An Analysis from a Population-Based Study Using Time-Dependent Exposure Model. Cancer Epidemiol. 2020;64:101657. doi: 10.1016/j.canep.2019.101657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canep.2019.101657</ArticleId><ArticleId IdType="pubmed">31918180</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W.K., Liu C.H., Pang S.T., Liu J.R., Chang J.W.C., Liaw C.C., Hsu C.L., Lin Y.C., See L.C. Type of Androgen Deprivation Therapy and Risk of Dementia Among Patients with Prostate Cancer in Taiwan. JAMA Netw. Open. 2020;3:e2015189. doi: 10.1001/jamanetworkopen.2020.15189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.15189</ArticleId><ArticleId IdType="pmc">PMC7489824</ArticleId><ArticleId IdType="pubmed">32865575</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayadevappa R., Chhatre S., Malkowicz S.B., Parikh R.B., Guzzo T., Wein A.J. Association Between Androgen Deprivation Therapy Use and Diagnosis of Dementia in Men with Prostate Cancer. JAMA Netw. Open. 2019;2:1271782. doi: 10.1001/jamanetworkopen.2019.6562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.6562</ArticleId><ArticleId IdType="pmc">PMC6613289</ArticleId><ArticleId IdType="pubmed">31268539</ArticleId></ArticleIdList></Reference><Reference><Citation>Jhan J.H., Yang Y.H., Chang Y.H., Guu S.J., Tsai C.C. Hormone Therapy for Prostate Cancer Increases the Risk of Alzheimer&#x2019;s Disease: A Nationwide 4-Year Longitudinal Cohort Study. Aging Male. 2017;20:33&#x2013;38. doi: 10.1080/13685538.2016.1271782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13685538.2016.1271782</ArticleId><ArticleId IdType="pubmed">28067607</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasnova A., Epstein M., Marchese M., Dickerman B.A., Cole A.P., Lipsitz S.R., Nguyen P.L., Kibel A.S., Choueiri T.K., Basaria S., et al. Risk of Dementia Following Androgen Deprivation Therapy for Treatment of Prostate Cancer. Prostate Cancer Prostatic Dis. 2020;23:410&#x2013;418. doi: 10.1038/s41391-019-0189-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41391-019-0189-3</ArticleId><ArticleId IdType="pubmed">31784699</ArticleId></ArticleIdList></Reference><Reference><Citation>Nead K.T., Gaskin G., Chester C., Swisher-McClure S., Dudley J.T., Leeper N.J., Shah N.H. Androgen Deprivation Therapy and Future Alzheimer&#x2019;s Disease Risk. J. Clin. Oncol. 2016;34:566&#x2013;571. doi: 10.1200/JCO.2015.63.6266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2015.63.6266</ArticleId><ArticleId IdType="pmc">PMC5070576</ArticleId><ArticleId IdType="pubmed">26644522</ArticleId></ArticleIdList></Reference><Reference><Citation>Nead K.T., Gaskin G., Chester C., Swisher-McClure S., Leeper N.J., Shah N.H. Association Between Androgen Deprivation Therapy and Risk of Dementia. JAMA Oncol. 2017;3:49&#x2013;55. doi: 10.1001/jamaoncol.2016.3662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2016.3662</ArticleId><ArticleId IdType="pubmed">27737437</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahinian V.B., Kuo Y.-F., Freeman J.L., Goodwin J.S. Risk of the &#x201c;Androgen Deprivation Syndrome&#x201d; in Men Receiving Androgen Deprivation for Prostate Cancer. Arch. Intern. Med. 2006;166:465. doi: 10.1001/ARCHINTE.166.4.465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/ARCHINTE.166.4.465</ArticleId><ArticleId IdType="pmc">PMC2222554</ArticleId><ArticleId IdType="pubmed">16505268</ArticleId></ArticleIdList></Reference><Reference><Citation>Tae B.S., Jeon B.J., Shin S.H., Choi H., Bae J.H., Park J.Y. Correlation of Androgen Deprivation Therapy with Cognitive Dysfunction in Patients with Prostate Cancer: A Nationwide Population-Based Study Using the National Health Insurance Service Database. Cancer Res. Treat. 2019;51:593&#x2013;602. doi: 10.4143/crt.2018.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.4143/crt.2018.119</ArticleId><ArticleId IdType="pmc">PMC6473290</ArticleId><ArticleId IdType="pubmed">30025445</ArticleId></ArticleIdList></Reference><Reference><Citation>Baik S.H., Kury F., McDonald C.J. Risk of Alzheimer&#x2019;s Disease Among Senior Medicare Beneficiaries Treated With Androgen Deprivation Therapy for Prostate Cancer. J. Clin. Oncol. 2017;35:3401&#x2013;3409. doi: 10.1200/JCO.2017.72.6109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2017.72.6109</ArticleId><ArticleId IdType="pmc">PMC5648173</ArticleId><ArticleId IdType="pubmed">28841388</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung S.D., Lin H.C., Tsai M.C., Kao L.T., Huang C.Y., Chen K.C. Androgen Deprivation Therapy Did Not Increase the Risk of Alzheimer&#x2019;s and Parkinson&#x2019;s Disease in Patients with Prostate Cancer. Andrology. 2016;4:481&#x2013;485. doi: 10.1111/andr.12187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.12187</ArticleId><ArticleId IdType="pubmed">27062333</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao L.T., Lin H.C., Chung S.D., Huang C.Y. No Increased Risk of Dementia in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer: A 5-Year Follow-up Study. Asian J. Androl. 2017;19:179528. doi: 10.4103/1008-682X.179528.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1008-682X.179528</ArticleId><ArticleId IdType="pmc">PMC5507085</ArticleId><ArticleId IdType="pubmed">27232853</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosrow-Khavar F., Rej S., Yin H., Aprikian A., Azoulay L. Androgen Deprivation Therapy and the Risk of Dementia in Patients with Prostate Cancer. J. Clin. Oncol. 2017;35:201&#x2013;207. doi: 10.1200/JCO.2016.69.6203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2016.69.6203</ArticleId><ArticleId IdType="pubmed">27870566</ArticleId></ArticleIdList></Reference><Reference><Citation>Tae B.S., Jeon B.J., Choi H., Bae J.H., Park J.Y. Is Androgen Deprivation Therapy Associated with Cerebral Infarction in Patients with Prostate Cancer? A Korean Nationwide Population-Based Propensity Score Matching Study. Cancer Med. 2019;8:4475&#x2013;4483. doi: 10.1002/cam4.2325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cam4.2325</ArticleId><ArticleId IdType="pmc">PMC6675721</ArticleId><ArticleId IdType="pubmed">31183968</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanchette P.S., Lam M., Le B., Richard L., Shariff S.Z., Pritchard K.I., Raphael J., Vandenberg T., Fernandes R., Desautels D., et al. The Association between Endocrine Therapy Use and Dementia among Post-Menopausal Women Treated for Early-Stage Breast Cancer in Ontario, Canada. J. Geriatr. Oncol. 2020;11:1132&#x2013;1137. doi: 10.1016/j.jgo.2020.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgo.2020.05.009</ArticleId><ArticleId IdType="pubmed">32611495</ArticleId></ArticleIdList></Reference><Reference><Citation>Bromley S.E., Matthews A., Smeeth L., Stanway S., Bhaskaran K. Risk of Dementia among Postmenopausal Breast Cancer Survivors Treated with Aromatase Inhibitors versus Tamoxifen: A Cohort Study Using Primary Care Data from the UK. J. Cancer Surviv. 2019;13:632&#x2013;640. doi: 10.1007/s11764-019-00782-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11764-019-00782-w</ArticleId><ArticleId IdType="pmc">PMC6776493</ArticleId><ArticleId IdType="pubmed">31321612</ArticleId></ArticleIdList></Reference><Reference><Citation>Branigan G.L., Soto M., Neumayer L., Rodgers K., Diaz Brinton R. Association Between Hormone-Modulating Breast Cancer Therapies and Incidence of Neurodegenerative Outcomes for Women with Breast Cancer Key Points. JAMA Netw. Open. 2020;3:201541. doi: 10.1001/jamanetworkopen.2020.1541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.1541</ArticleId><ArticleId IdType="pmc">PMC7093781</ArticleId><ArticleId IdType="pubmed">32207833</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong J.C., Kruser T.J., Gondi V., Mohindra P., Cannon D.M., Harari P.M., Bentzen S.M. Risk of Cerebrovascular Events in Elderly Patients after Radiation Therapy versus Surgery for Early-Stage Glottic Cancer. Int. J. Radiat. Oncol. Biol. Phys. 2013;87:290&#x2013;296. doi: 10.1016/j.ijrobp.2013.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijrobp.2013.06.009</ArticleId><ArticleId IdType="pubmed">23906930</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith G.L., Smith B.D., Buchholz T.A., Giordano S.H., Garden A.S., Woodward W.A., Krumholz H.M., Weber R.S., Ang K.K., Rosenthal D.I. Cerebrovascular Disease Risk in Older Head and Neck Cancer Patients after Radiotherapy. J. Clin. Oncol. 2008;26:5119&#x2013;5125. doi: 10.1200/JCO.2008.16.6546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2008.16.6546</ArticleId><ArticleId IdType="pmc">PMC4879715</ArticleId><ArticleId IdType="pubmed">18725647</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulet J., Pe&#xf1;a J., Hulten E.A., Neilan T.G., Dragomir A., Freeman C., Lambert C., Hijal T., Nadeau L., Brophy J.M., et al. Statin Use and Risk of Vascular Events Among Cancer Patients After Radiotherapy to the Thorax, Head, and Neck. J. Am. Heart Assoc. 2019;8:5996. doi: 10.1161/JAHA.117.005996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.117.005996</ArticleId><ArticleId IdType="pmc">PMC6662340</ArticleId><ArticleId IdType="pubmed">31213106</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X.L., Cai Y., Symanski E. Association between Chemotherapy and Cognitive Impairments in a Large Cohort of Patients with Colorectal Cancer. Int. J. Oncol. 2013;42:2123&#x2013;2133. doi: 10.3892/ijo.2013.1882.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2013.1882</ArticleId><ArticleId IdType="pubmed">23563930</ArticleId></ArticleIdList></Reference><Reference><Citation>Heck J.E., Albert S.M., Franco R., Gorin S.S. Patterns of Dementia Diagnosis in Surveillance, Epidemiology, and End Results Breast Cancer Survivors Who Use Chemotherapy. J. Am. Geriatr. Soc. 2008;56:1687&#x2013;1692. doi: 10.1111/j.1532-5415.2008.01848.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2008.01848.x</ArticleId><ArticleId IdType="pubmed">18691280</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter N.N., Durham S.B., Phillips K.A., Habermann E.B., Virning B.A. Risk of Dementia in Older Breast Cancer Survivors: A Population-Based Cohort Study of the Association with Adjuvant Chemotherapy. J. Am. Geriatr. Soc. 2009;57:403&#x2013;411. doi: 10.1111/j.1532-5415.2008.02130.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2008.02130.x</ArticleId><ArticleId IdType="pubmed">19278395</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X.L., Xia R., Hardy D. Relationship between Chemotherapy Use and Cognitive Impairments in Older Women with Breast Cancer: Findings from a Large Population-Based Cohort. Am. J. Clin. Oncol. 2010;33:533&#x2013;543. doi: 10.1097/COC.0b013e3181b9cf1b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/COC.0b013e3181b9cf1b</ArticleId><ArticleId IdType="pubmed">20023570</ArticleId></ArticleIdList></Reference><Reference><Citation>Jazzar U., Shan Y., Klaassen Z., Freedland S.J., Kamat A.M., Raji M.A., Masel T., Tyler D.S., Baillargeon J., Kuo Y.F., et al. Impact of Alzheimer&#x2019;s Disease and Related Dementia Diagnosis Following Treatment for Bladder Cancer. J. Geriatr. Oncol. 2020;11:1118&#x2013;1124. doi: 10.1016/j.jgo.2020.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgo.2020.04.009</ArticleId><ArticleId IdType="pubmed">32354675</ArticleId></ArticleIdList></Reference><Reference><Citation>Raji M.A., Tamborello L.P., Kuo Y.F., Ju H., Freeman J.L., Zhang D.D., Giordano S.H., Goodwin J.S. Risk of Subsequent Dementia Diagnoses Does Not Vary by Types of Adjuvant Chemotherapy in Older Women with Breast Cancer. Med. Oncol. 2009;26:452&#x2013;459. doi: 10.1007/s12032-008-9145-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12032-008-9145-0</ArticleId><ArticleId IdType="pmc">PMC3079442</ArticleId><ArticleId IdType="pubmed">19067255</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler M.E., Triebel K.L., Cutter G.R., Schneider L.S., Kennedy R.E. Progression of Alzheimer&#x2019;s Disease by Self-Reported Cancer History in the Alzheimer&#x2019;s Disease Neuroimaging Initiative. J. Alzheimers Dis. 2020;76:691&#x2013;701. doi: 10.3233/JAD-200108.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200108</ArticleId><ArticleId IdType="pmc">PMC7928167</ArticleId><ArticleId IdType="pubmed">32538844</ArticleId></ArticleIdList></Reference><Reference><Citation>Musicco M., Adorni F., di Santo S., Prinelli F., Pettenati C., Caltagirone C., Palmer K., Russo A. Inverse Occurrence of Cancer and Alzheimer Disease: A Population-Based Incidence Study. Neurology. 2013;81:322&#x2013;328. doi: 10.1212/WNL.0b013e31829c5ec1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31829c5ec1</ArticleId><ArticleId IdType="pubmed">23843468</ArticleId></ArticleIdList></Reference><Reference><Citation>Roe C.M., Fitzpatrick A.L., Xiong C., Sieh W., Kuller L., Miller J.P., Williams M.M., Kopan R., Behrens M.I., Morris J.C. Cancer Linked to Alzheimer Disease but Not Vascular Dementia. Neurology. 2010;74:106&#x2013;112. doi: 10.1212/WNL.0b013e3181c91873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181c91873</ArticleId><ArticleId IdType="pmc">PMC2809029</ArticleId><ArticleId IdType="pubmed">20032288</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson H.A., Horn K.P., Rasmussen K.M., Hoffman J.M., Smith K.R. Is Cancer Protective for Subsequent Alzheimer&#x2019;s Disease Risk? Evidence From the Utah Population Database. J. Gerontol. B Psychol. Sci. Soc. Sci. 2017;72:1032&#x2013;1043. doi: 10.1093/geronb/gbw040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbw040</ArticleId><ArticleId IdType="pmc">PMC5926998</ArticleId><ArticleId IdType="pubmed">27101831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ording A.G., Horv&#xe1;th-Puh&#xf3; E., Veres K., Glymour M.M., R&#xf8;rth M., S&#xf8;rensen H.T., Henderson V.W. Cancer and Risk of Alzheimer&#x2019;s Disease: Small Association in a Nationwide Cohort Study. Alzheimers Dement. 2020;16:953&#x2013;964. doi: 10.1002/alz.12090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12090</ArticleId><ArticleId IdType="pmc">PMC7351601</ArticleId><ArticleId IdType="pubmed">32432415</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Lu D., Sveinsson O., Wirdefeldt K., Fall K., Piehl F., Valdimarsd&#xf3;ttir U., Fang F. Is a Cancer Diagnosis Associated with Subsequent Risk of Transient Global Amnesia? PLoS ONE. 2015;10:e122960. doi: 10.1371/journal.pone.0122960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0122960</ArticleId><ArticleId IdType="pmc">PMC4388478</ArticleId><ArticleId IdType="pubmed">25849383</ArticleId></ArticleIdList></Reference><Reference><Citation>Orsz&#xe1;ghov&#xe1; Z., Mego M., Chovanec M. Long-Term Cognitive Dysfunction in Cancer Survivors. Front. Mol. Biosci. 2021;8:770413. doi: 10.3389/fmolb.2021.770413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.770413</ArticleId><ArticleId IdType="pmc">PMC8713760</ArticleId><ArticleId IdType="pubmed">34970595</ArticleId></ArticleIdList></Reference><Reference><Citation>Joly F., Giffard B., Rigal O., de Ruiter M.B., Small B.J., Dubois M., Lefel J., Schagen S.B., Ahles T.A., Wefel J.S., et al. Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research from the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012. J. Pain Symptom Manag. 2015;50:830&#x2013;841. doi: 10.1016/j.jpainsymman.2015.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2015.06.019</ArticleId><ArticleId IdType="pubmed">26344551</ArticleId></ArticleIdList></Reference><Reference><Citation>Castel H., Denouel A., Lange M., Tonon M.C., Dubois M., Joly F. Biomarkers Associated with Cognitive Impairment in Treated Cancer Patients: Potential Predisposition and Risk Factors. Front. Pharmacol. 2017;8:138. doi: 10.3389/fphar.2017.00138.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2017.00138</ArticleId><ArticleId IdType="pmc">PMC5359273</ArticleId><ArticleId IdType="pubmed">28377717</ArticleId></ArticleIdList></Reference><Reference><Citation>Handforth C., Clegg A., Young C., Simpkins S., Seymour M.T., Selby P.J., Young J. The Prevalence and Outcomes of Frailty in Older Cancer Patients: A Systematic Review. Ann. Oncol. 2015;26:1091&#x2013;1101. doi: 10.1093/annonc/mdu540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annonc/mdu540</ArticleId><ArticleId IdType="pubmed">25403592</ArticleId></ArticleIdList></Reference><Reference><Citation>Bluethmann S.M., Mariotto A.B., Rowland J.H. Anticipating the &#x201c;Silver Tsunami&#x201d;: Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States. Cancer Epidemiol. Biomark. Prev. 2016;25:1029&#x2013;1036. doi: 10.1158/1055-9965.EPI-16-0133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-16-0133</ArticleId><ArticleId IdType="pmc">PMC4933329</ArticleId><ArticleId IdType="pubmed">27371756</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto-Perez-De-Celis E., Li D., Yuan Y., Lau M., Hurria A. Functional versus Chronological Age: Geriatric Assessments to Guide Decision Making in Older Patients with Cancer. Lancet Oncol. 2018;19:e305&#x2013;e316. doi: 10.1016/S1470-2045(18)30348-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(18)30348-6</ArticleId><ArticleId IdType="pubmed">29893262</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurria A., Patel S.K., Mortimer J., Luu T., Somlo G., Katheria V., Ramani R., Hansen K., Feng T., Chuang C., et al. The Effect of Aromatase Inhibition on the Cognitive Function of Older Patients with Breast Cancer. Clin. Breast Cancer. 2014;14:132&#x2013;140. doi: 10.1016/j.clbc.2013.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clbc.2013.10.010</ArticleId><ArticleId IdType="pmc">PMC4103787</ArticleId><ArticleId IdType="pubmed">24291380</ArticleId></ArticleIdList></Reference><Reference><Citation>Berben L., Floris G., Wildiers H., Hatse S. Cancer and Aging: Two Tightly Interconnected Biological Processes. Cancers. 2021;13:1400. doi: 10.3390/cancers13061400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13061400</ArticleId><ArticleId IdType="pmc">PMC8003441</ArticleId><ArticleId IdType="pubmed">33808654</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahles T.A. Brain Vulnerability to Chemotherapy Toxicities. Psychooncology. 2012;21:1141&#x2013;1148. doi: 10.1002/pon.3196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pon.3196</ArticleId><ArticleId IdType="pmc">PMC3788849</ArticleId><ArticleId IdType="pubmed">23023994</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36831398</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2072-6694</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>07</Day></PubDate></JournalIssue><Title>Cancers</Title><ISOAbbreviation>Cancers (Basel)</ISOAbbreviation></Journal><ArticleTitle>Distinguishing Curable from Progressive Dementias for Defining Cancer Care Options.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1055</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cancers15041055</ELocationID><Abstract><AbstractText>The likelihood of a diagnosis of dementia increases with a person's age, as is also the case for many cancers, including melanoma and multiple myeloma, where the median age of diagnosis is above 60 years. However, patients diagnosed with dementia are less likely to be offered invasive curative therapies for cancer. Together with analysis of diet and medication history, advanced imaging methods and genetic profiling can now indicate more about syndromes causing the neurological symptoms. Cachexia, malnutrition, dehydration, alcohol consumption, and even loneliness can all accentuate or cause the "3Ds" of dementia, delirium and depression. Many common drugs, especially in the context of polypharmacy, can cause cognitive difficulties resembling neurodegenerative disease. These syndromes may be reversed by diet, social and caregiver changes, and stopping potentially inappropriate medications (PIMs). More insidious are immune reactions to many different autoantigens, some of which are related to cancers and tumors. These can induce movement and cognitive difficulties that mimic Alzheimer's and Parkinson's diseases and other ataxias associated with aging. Paraneoplastic neurological syndromes may be reversed by directed immunotherapies if detected in their early stages but are best treated by removal of the causative tumor. A full genetic workup should be done for all individuals as soon as possible after diagnosis, to guide less invasive treatments suitable for frail individuals. While surgical interventions may be contraindicated, genetic profile guided immunotherapies, oral treatments, and radiation may be equally curative in a significant number of cancers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schein</LastName><ForeName>Catherine H</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0002-8290-2109</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Institute for Human Infections and Immunity, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cancers (Basel)</MedlineTA><NlmUniqueID>101526829</NlmUniqueID><ISSNLinking>2072-6694</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer &amp; Parkinson diseases</Keyword><Keyword MajorTopicYN="N">PIMs (potentially inappropriate medications)</Keyword><Keyword MajorTopicYN="N">autoimmune encephalitis</Keyword><Keyword MajorTopicYN="N">cancer care team</Keyword><Keyword MajorTopicYN="N">cancer genetic profiling</Keyword><Keyword MajorTopicYN="N">conditions causing altered mental state</Keyword><Keyword MajorTopicYN="N">de-prescribing</Keyword><Keyword MajorTopicYN="N">dementia, delirium, depression (3Ds)</Keyword><Keyword MajorTopicYN="N">immunotherapy in CRC</Keyword><Keyword MajorTopicYN="N">microsatellite instability (MSI/DNA mismatch repair (dMMR)</Keyword><Keyword MajorTopicYN="N">neurological syndromes</Keyword><Keyword MajorTopicYN="N">non-surgical intervention in frail patients</Keyword><Keyword MajorTopicYN="N">polypharmacy</Keyword></KeywordList><CoiStatement>The author declares no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>1</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36831398</ArticleId><ArticleId IdType="pmc">PMC9954275</ArticleId><ArticleId IdType="doi">10.3390/cancers15041055</ArticleId><ArticleId IdType="pii">cancers15041055</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Cancer Institute Age and Cancer Risk.  [(accessed on 3 February 2023)]; Available online:  https://seer.cancer.gov/statfacts/html/all.html.</Citation></Reference><Reference><Citation>Ashley L., Kelley R., Griffiths A., Cowdell F., Henry A., Inman H., Hennell J., Ogden M., Walsh M., Jones L., et al. Understanding and identifying ways to improve hospital-based cancer care and treatment for people with dementia: An ethnographic study. Age Ageing. 2021;50:233&#x2013;241. doi: 10.1093/ageing/afaa210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afaa210</ArticleId><ArticleId IdType="pmc">PMC7793597</ArticleId><ArticleId IdType="pubmed">33156901</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballard C., Kales H.C., Lyketsos C., Aarsland D., Creese B., Mills R., Williams H., Sweet R.A. Psychosis in Alzheimer&#x2019;s Disease. Curr. Neurol. Neurosci. Rep. 2020;20:57. doi: 10.1007/s11910-020-01074-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-020-01074-y</ArticleId><ArticleId IdType="pmc">PMC7554014</ArticleId><ArticleId IdType="pubmed">33048274</ArticleId></ArticleIdList></Reference><Reference><Citation>Jicha G.A., Nelson P.T. Hippocampal Sclerosis, Argyrophilic Grain Disease, and Primary Age-Related Tauopathy. Continuum. 2019;25:208&#x2013;233. doi: 10.1212/CON.0000000000000697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CON.0000000000000697</ArticleId><ArticleId IdType="pmc">PMC6548534</ArticleId><ArticleId IdType="pubmed">30707194</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez H., Adrien L., Wolin A., Eun J., Chang E.H., Burstein E.S., Gomar J., Davies P., Koppel J. The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT- and rTg(P301L)4510 mouse models of Alzheimer&#x2019;s disease. Alzheimers Dement. 2022;8:e12247. doi: 10.1002/trc2.12247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12247</ArticleId><ArticleId IdType="pmc">PMC8804623</ArticleId><ArticleId IdType="pubmed">35128032</ArticleId></ArticleIdList></Reference><Reference><Citation>Geschwind M.D. Rapidly Progressive Dementia. Continuum. 2016;22:510&#x2013;537. doi: 10.1212/CON.0000000000000319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CON.0000000000000319</ArticleId><ArticleId IdType="pmc">PMC4879977</ArticleId><ArticleId IdType="pubmed">27042906</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Willik K.D., Schagen S.B., Ikram M.A. Cancer and dementia: Two sides of the same coin? Eur. J. Clin. Investig. 2018;48:e13019. doi: 10.1111/eci.13019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13019</ArticleId><ArticleId IdType="pmc">PMC6220770</ArticleId><ArticleId IdType="pubmed">30112764</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill T.M., Vander Wyk B., Leo-Summers L., Murphy T.E., Becher R.D. Population-Based Estimates of 1-Year Mortality After Major Surgery among Community-Living Older US Adults. JAMA Surg. 2022;157:e225155. doi: 10.1001/jamasurg.2022.5155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2022.5155</ArticleId><ArticleId IdType="pmc">PMC9582971</ArticleId><ArticleId IdType="pubmed">36260323</ArticleId></ArticleIdList></Reference><Reference><Citation>Caba Y., Dharmarajan K., Gillezeau C., Ornstein K.A., Mazumdar M., Alpert N., Schwartz R.M., Taioli E., Liu B. The Impact of Dementia on Cancer Treatment Decision-Making, Cancer Treatment, and Mortality: A Mixed Studies Review. JNCI Cancer Spectr. 2021;5:pkab002. doi: 10.1093/jncics/pkab002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jncics/pkab002</ArticleId><ArticleId IdType="pmc">PMC8152697</ArticleId><ArticleId IdType="pubmed">34056540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kales H.C., Gitlin L.N., Lyketsos C.G. Assessment and management of behavioral and psychological symptoms of dementia. BMJ. 2015;350:h369. doi: 10.1136/bmj.h369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h369</ArticleId><ArticleId IdType="pmc">PMC4707529</ArticleId><ArticleId IdType="pubmed">25731881</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch C.A., Fulop T. Clinical aspects of changes in water and sodium homeostasis in the elderly. Rev. Endocr. Metab. Disord. 2017;18:49&#x2013;66. doi: 10.1007/s11154-017-9420-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-017-9420-5</ArticleId><ArticleId IdType="pubmed">28303369</ArticleId></ArticleIdList></Reference><Reference><Citation>Preskin S.M. A Molecule Away from Madness: Tales of the Hijacked Brain. W. W. Norton &amp; Company; New York, NY, USA: 2022. p. 240.</Citation></Reference><Reference><Citation>Haber P.S., Riordan B.C., Winter D.T., Barrett L., Saunders J., Hides L., Gullo M., Manning V., Day C.A., Bonomo Y., et al. New Australian guidelines for the treatment of alcohol problems: An overview of recommendations. Med. J. Aust. 2021;215((Suppl. S7)):S3&#x2013;S32. doi: 10.5694/mja2.51254.</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/mja2.51254</ArticleId><ArticleId IdType="pubmed">34601742</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller H.H., Syed S., Dakkak H., Wu S.A., Volkert D. Reimagining Nutrition Care and Mealtimes in Long-Term Care. J. Am. Med. Dir. Assoc. 2022;23:253&#x2013;260.e1. doi: 10.1016/j.jamda.2021.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2021.12.021</ArticleId><ArticleId IdType="pubmed">34986411</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine A.M.P., Emonds E.E., Smith M.A., Rickles N.M., Kuchel G.A., Steffens D.C., Ohlheiser A., Fortinsky R.H. Pharmacist Identification of Medication Therapy Problems Involving Cognition Among Older Adults Followed by a Home-Based Care Team. Drugs Aging. 2021;38:157&#x2013;168. doi: 10.1007/s40266-020-00821-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40266-020-00821-7</ArticleId><ArticleId IdType="pubmed">33354755</ArticleId></ArticleIdList></Reference><Reference><Citation>Chyou T.Y., Nishtala P.S. Identifying frequent drug combinations associated with delirium in older adults: Application of association rules method to a case-time-control design. Pharm. Drug Saf. 2021;30:1402&#x2013;1410. doi: 10.1002/pds.5292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.5292</ArticleId><ArticleId IdType="pubmed">33991132</ArticleId></ArticleIdList></Reference><Reference><Citation>By the 2019 American Geriatrics Society Beers Criteria&#xae; Update Expert Panel American Geriatrics Society 2019 Updated AGS Beers Criteria&#xae; for Potentially Inappropriate Medication Use in Older Adults. J. Am. Geriatr. Soc. 2019;67:674&#x2013;694. doi: 10.1111/jgs.15767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.15767</ArticleId><ArticleId IdType="pubmed">30693946</ArticleId></ArticleIdList></Reference><Reference><Citation>Atjo N.M., Soraya G.V., Natzir R., Kasyim H., Rasyid H., Chana G., Erlichster M., Skafidas E., Hardjo M. Point-of-Care Saliva Osmolarity Testing for the Screening of Hydration in Older Adults With Hypertension. J. Am. Med. Dir. Assoc. 2022;23:1984.e9&#x2013;1984.e14. doi: 10.1016/j.jamda.2022.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2022.08.015</ArticleId><ArticleId IdType="pubmed">36174654</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen L.L., Romsing J., Dalhoff K. A Danish Survey of Antihistamine Use and Poisoning Patterns. Basic Clin. Pharm. Toxicol. 2017;120:64&#x2013;70. doi: 10.1111/bcpt.12632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcpt.12632</ArticleId><ArticleId IdType="pubmed">27288889</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali D.G., Bahrani A.A., Barber J.M., El Khouli R.H., Gold B.T., Harp J.P., Jiang Y., Wilcock D.M., Jicha G.A. Amyloid-PET Levels in the Precuneus and Posterior Cingulate Cortices Are Associated with Executive Function Scores in Preclinical Alzheimer&#x2019;s Disease Prior to Overt Global Amyloid Positivity. J. Alzheimers Dis. 2022;88:1127&#x2013;1135. doi: 10.3233/JAD-220294.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220294</ArticleId><ArticleId IdType="pmc">PMC10349398</ArticleId><ArticleId IdType="pubmed">35754276</ArticleId></ArticleIdList></Reference><Reference><Citation>Staffaroni A.M., Elahi F.M., McDermott D., Marton K., Karageorgiou E., Sacco S., Paoletti M., Caverzasi E., Hess C.P., Rosen H.J., et al. Neuroimaging in Dementia. Semin. Neurol. 2017;37:510&#x2013;537. doi: 10.1055/s-0037-1608808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1608808</ArticleId><ArticleId IdType="pmc">PMC5823524</ArticleId><ArticleId IdType="pubmed">29207412</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson P.T., Smith C.D., Abner E.L., Wilfred B.J., Wang W.X., Neltner J.H., Baker M., Fardo D.W., Kryscio R.J., Scheff S.W., et al. Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol. 2013;126:161&#x2013;177. doi: 10.1007/s00401-013-1154-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1154-1</ArticleId><ArticleId IdType="pmc">PMC3889169</ArticleId><ArticleId IdType="pubmed">23864344</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson P.T., Alafuzoff I., Bigio E.H., Bouras C., Braak H., Cairns N.J., Castellani R.J., Crain B.J., Davies P., Del Tredici K., et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature. J. Neuropathol. Exp. Neurol. 2012;71:362&#x2013;381. doi: 10.1097/NEN.0b013e31825018f7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31825018f7</ArticleId><ArticleId IdType="pmc">PMC3560290</ArticleId><ArticleId IdType="pubmed">22487856</ArticleId></ArticleIdList></Reference><Reference><Citation>Clancy U., Gilmartin D., Jochems A.C.C., Knox L., Doubal F.N., Wardlaw J.M. Neuropsychiatric symptoms associated with cerebral small vessel disease: A systematic review and meta-analysis. Lancet Psychiatry. 2021;8:225&#x2013;236. doi: 10.1016/S2215-0366(20)30431-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30431-4</ArticleId><ArticleId IdType="pubmed">33539776</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu W.T., Ozturk T., Kollhoff A., Wharton W., Christina Howell J., Alzheimer&#x2019;s Disease Neuroimaging I. Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer&#x2019;s disease. Nat. Commun. 2021;12:4001. doi: 10.1038/s41467-021-24220-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24220-7</ArticleId><ArticleId IdType="pmc">PMC8238986</ArticleId><ArticleId IdType="pubmed">34183654</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Janabi O.M., Bauer C.E., Goldstein L.B., Murphy R.R., Bahrani A.A., Smith C.D., Wilcock D.M., Gold B.T., Jicha G.A. White Matter Hyperintensity Regression: Comparison of Brain Atrophy and Cognitive Profiles with Progression and Stable Groups. Brain Sci. 2019;9:170. doi: 10.3390/brainsci9070170.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci9070170</ArticleId><ArticleId IdType="pmc">PMC6680735</ArticleId><ArticleId IdType="pubmed">31330933</ArticleId></ArticleIdList></Reference><Reference><Citation>Saieva S., Taglialatela G. Near-infrared light reduces glia activation and modulates neuroinflammation in the brains of diet-induced obese mice. Sci. Rep. 2022;12:10848. doi: 10.1038/s41598-022-14812-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-14812-8</ArticleId><ArticleId IdType="pmc">PMC9237037</ArticleId><ArticleId IdType="pubmed">35761012</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacabelos R., Naidoo V., Martinez-Iglesias O., Corzo L., Cacabelos N., Pego R., Carril J.C. Pharmacogenomics of Alzheimer&#x2019;s Disease: Novel Strategies for Drug Utilization and Development. Methods Mol. Biol. 2022;2547:275&#x2013;387. doi: 10.1007/978-1-0716-2573-6_13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-2573-6_13</ArticleId><ArticleId IdType="pubmed">36068470</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A., Cuanalo-Contreras K., Sood A., Soto C. Development of a novel pharmacophore model to screen specific inhibitors for the serine-threonine protein phosphatase calcineurin. Biochem. Biophys. Rep. 2022;31:101311. doi: 10.1016/j.bbrep.2022.101311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrep.2022.101311</ArticleId><ArticleId IdType="pmc">PMC9398911</ArticleId><ArticleId IdType="pubmed">36032402</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcatti M., Fracassi A., Montalbano M., Natarajan C., Krishnan B., Kayed R., Taglialatela G. Abeta/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer&#x2019;s disease. Cell Mol. Life. Sci. 2022;79:222. doi: 10.1007/s00018-022-04255-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-022-04255-9</ArticleId><ArticleId IdType="pmc">PMC8979934</ArticleId><ArticleId IdType="pubmed">35377002</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowitzki S., Bittner T., Sink K.M., Mackey H., Rabe C., Honig L.S., Cassetta E., Woodward M., Boada M., van Dyck C.H., et al. Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials. JAMA Neurol. 2022;79:1113. doi: 10.1001/jamaneurol.2022.2909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.2909</ArticleId><ArticleId IdType="pmc">PMC9486635</ArticleId><ArticleId IdType="pubmed">36121669</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayato S., Takenaka O., Sreerama Reddy S.H., Landry I., Reyderman L., Koyama A., Swanson C., Yasuda S., Hussein Z. Population pharmacokinetic-pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer&#x2019;s disease. CPT Pharmacomet. Syst. Pharm. 2022;11:1578&#x2013;1591. doi: 10.1002/psp4.12862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/psp4.12862</ArticleId><ArticleId IdType="pmc">PMC9755918</ArticleId><ArticleId IdType="pubmed">36165093</ArticleId></ArticleIdList></Reference><Reference><Citation>Schein C.H. Repurposing approved drugs on the pathway to novel therapies. Med. Res. Rev. 2020;40:586&#x2013;605. doi: 10.1002/med.21627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21627</ArticleId><ArticleId IdType="pmc">PMC7018532</ArticleId><ArticleId IdType="pubmed">31432544</ArticleId></ArticleIdList></Reference><Reference><Citation>Radhakrishnan H., Ubele M.F., Krumholz S.M., Boaz K., Mefford J.L., Jones E.D., Meacham B., Smiley J., Puskas L.G., Powell D.K., et al. Tacrolimus Protects against Age-Associated Microstructural Changes in the Beagle Brain. J. Neurosci. 2021;41:5124&#x2013;5133. doi: 10.1523/JNEUROSCI.0361-21.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0361-21.2021</ArticleId><ArticleId IdType="pmc">PMC8197636</ArticleId><ArticleId IdType="pubmed">33952632</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D., Martin Z.S., Soto C., Schein C.H. Computational selection of inhibitors of Abeta aggregation and neuronal toxicity. Bioorg. Med. Chem. 2009;17:5189&#x2013;5197. doi: 10.1016/j.bmc.2009.05.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2009.05.047</ArticleId><ArticleId IdType="pmc">PMC2743868</ArticleId><ArticleId IdType="pubmed">19540126</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra S., Pahan K. Gemfibrozil, a Lipid-Lowering Drug, Lowers Amyloid Plaque Pathology and Enhances Memory in a Mouse Model of Alzheimer&#x2019;s Disease via Peroxisome Proliferator-Activated Receptor alpha. J. Alzheimers. Dis. Rep. 2019;3:149&#x2013;168. doi: 10.3233/ADR-190104.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/ADR-190104</ArticleId><ArticleId IdType="pmc">PMC6597963</ArticleId><ArticleId IdType="pubmed">31259309</ArticleId></ArticleIdList></Reference><Reference><Citation>Raha S., Ghosh A., Dutta D., Patel D.R., Pahan K. Activation of PPARalpha enhances astroglial uptake and degradation of beta-amyloid. Sci. Signal. 2021;14:eabg4747. doi: 10.1126/scisignal.abg4747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.abg4747</ArticleId><ArticleId IdType="pmc">PMC8793854</ArticleId><ArticleId IdType="pubmed">34699252</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Xu J., Hou Y., Bekris L., Leverenz J.B., Pieper A.A., Cummings J., Cheng F. The Alzheimer&#x2019;s Cell Atlas (TACA): A single-cell molecular map for translational therapeutics accelerator in Alzheimer&#x2019;s disease. Alzheimers Dement. 2022;8:e12350. doi: 10.1002/trc2.12350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12350</ArticleId><ArticleId IdType="pmc">PMC9558163</ArticleId><ArticleId IdType="pubmed">36254161</ArticleId></ArticleIdList></Reference><Reference><Citation>Tucker Edmister S., Del Rosario Hernandez T., Ibrahim R., Brown C.A., Gore S.V., Kakodkar R., Kreiling J.A., Creton R. Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles. Sci. Rep. 2022;12:6120. doi: 10.1038/s41598-022-10133-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10133-y</ArticleId><ArticleId IdType="pmc">PMC9023506</ArticleId><ArticleId IdType="pubmed">35449173</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallabh S.M., Minikel E.V. Implications of new genetic risk factors in prion disease. Nat. Rev. Neurol. 2021;17:5&#x2013;6. doi: 10.1038/s41582-020-00433-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00433-0</ArticleId><ArticleId IdType="pubmed">33173159</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalmau J., Tuzun E., Wu H.Y., Masjuan J., Rossi J.E., Voloschin A., Baehring J.M., Shimazaki H., Koide R., King D., et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann. Neurol. 2007;61:25&#x2013;36. doi: 10.1002/ana.21050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21050</ArticleId><ArticleId IdType="pmc">PMC2430743</ArticleId><ArticleId IdType="pubmed">17262855</ArticleId></ArticleIdList></Reference><Reference><Citation>Irani S.R., Vincent A., Schott J.M. Autoimmune encephalitis. BMJ. 2011;342:d1918. doi: 10.1136/bmj.d1918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d1918</ArticleId><ArticleId IdType="pubmed">21511782</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrman S., Lennox B. Autoimmune encephalitis in the elderly: Who to test and what to test for. Evid. Based Ment. Health. 2019;22:172&#x2013;176. doi: 10.1136/ebmental-2019-300110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ebmental-2019-300110</ArticleId><ArticleId IdType="pmc">PMC10231602</ArticleId><ArticleId IdType="pubmed">31537612</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalvo M., Iorio R., O&#x2019;Toole O., Pittock S.J. Chapter 31&#x2014;Autoimmune and paraneoplastic neurological disorders&#x2217;&#x2217;Thoughts on teaching about the neurobiology of diseases section available at the beginning of the book and Index terms are available at the end of the book. In: Zigmond M.J., Wiley C.A., Chesselet M.-F., editors. Neurobiology of Brain Disorders. 2nd ed. Academic Press; Cambridge, MA, USA: 2023. pp. 525&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-323-85654-6.00047-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen P.B., Gregersen H., Almasi C. Anti-Tr/DNER antibody paraneoplastic cerebellar degeneration preceding a very late relapse of Hodgkin Lymphoma after 12 years. Cerebellum Ataxias. 2021;8:14. doi: 10.1186/s40673-021-00137-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40673-021-00137-1</ArticleId><ArticleId IdType="pmc">PMC8180073</ArticleId><ArticleId IdType="pubmed">34090521</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayne D., Walsh M., Merkel P.A., Peh C.A., Szpirt W., Puechal X., Fujimoto S., Hawley C., Khalidi N., Jones R., et al. Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT. Health Technol. Assess. 2022;26:1&#x2013;60. doi: 10.3310/PNXB5040.</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/PNXB5040</ArticleId><ArticleId IdType="pubmed">36155131</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M., Merkel P.A., Peh C.A., Szpirt W.M., Puechal X., Fujimoto S., Hawley C.M., Khalidi N., Flossmann O., Wald R., et al. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. N. Engl. J. Med. 2020;382:622&#x2013;631. doi: 10.1056/NEJMoa1803537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1803537</ArticleId><ArticleId IdType="pmc">PMC7325726</ArticleId><ArticleId IdType="pubmed">32053298</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra M., Modi M.E., Dies K.A., Chamberlin N.L., Buttermore E.D., Brewster S.J., Prock L., Sahin M. GENE TARGET: A framework for evaluating Mendelian neurodevelopmental disorders for gene therapy. Mol. Methods Clin. Dev. 2022;27:32&#x2013;46. doi: 10.1016/j.omtm.2022.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2022.08.007</ArticleId><ArticleId IdType="pmc">PMC9478871</ArticleId><ArticleId IdType="pubmed">36156879</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergstrom E.N., Kundu M., Tbeileh N., Alexandrov L.B. Examining clustered somatic mutations with SigProfilerClusters. Bioinformatics. 2022;38:3470&#x2013;3473. doi: 10.1093/bioinformatics/btac335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btac335</ArticleId><ArticleId IdType="pmc">PMC9237733</ArticleId><ArticleId IdType="pubmed">35595234</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergstrom E.N., Luebeck J., Petljak M., Khandekar A., Barnes M., Zhang T., Steele C.D., Pillay N., Landi M.T., Bafna V., et al. Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA. Nature. 2022;602:510&#x2013;517. doi: 10.1038/s41586-022-04398-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04398-6</ArticleId><ArticleId IdType="pmc">PMC8850194</ArticleId><ArticleId IdType="pubmed">35140399</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Cutsem E., Hoff P.M., Harper P., Bukowski R.M., Cunningham D., Dufour P., Graeven U., Lokich J., Madajewicz S., Maroun J.A., et al. Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: Integrated efficacy data and novel analyses from two large, randomised, phase III trials. Br. J. Cancer. 2004;90:1190&#x2013;1197. doi: 10.1038/sj.bjc.6601676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjc.6601676</ArticleId><ArticleId IdType="pmc">PMC2409640</ArticleId><ArticleId IdType="pubmed">15026800</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin C., Shrestha A., Morgan J., Bradburn M., Herbert E., Burton M., Todd A., Walters S., Ward S., Holmes G., et al. Treatment choices for older women with primary operable breast cancer and cognitive impairment: Results from a prospective, multicentre cohort study. J. Geriatr. Oncol. 2021;12:705&#x2013;713. doi: 10.1016/j.jgo.2020.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgo.2020.12.006</ArticleId><ArticleId IdType="pubmed">33353856</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman P.B., Einhorn L.H., Meyers M.L., Saxman S., Destro A.N., Panageas K.S., Begg C.B., Agarwala S.S., Schuchter L.M., Ernstoff M.S., et al. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 1999;17:2745&#x2013;2751. doi: 10.1200/JCO.1999.17.9.2745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.1999.17.9.2745</ArticleId><ArticleId IdType="pubmed">10561349</ArticleId></ArticleIdList></Reference><Reference><Citation>Smylie M.G. Use of immuno-oncology in melanoma. Curr. Oncol. 2020;27:S51&#x2013;S58. doi: 10.3747/co.27.5135.</Citation><ArticleIdList><ArticleId IdType="doi">10.3747/co.27.5135</ArticleId><ArticleId IdType="pmc">PMC7194004</ArticleId><ArticleId IdType="pubmed">32368174</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward J.P., Gubin M.M., Schreiber R.D. The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer. Adv. Immunol. 2016;130:25&#x2013;74. doi: 10.1016/bs.ai.2016.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.ai.2016.01.001</ArticleId><ArticleId IdType="pmc">PMC6087548</ArticleId><ArticleId IdType="pubmed">26922999</ArticleId></ArticleIdList></Reference><Reference><Citation>Sena L.A., Fountain J., Isaacsson Velho P., Lim S.J., Wang H., Nizialek E., Rathi N., Nussenzveig R., Maughan B.L., Velez M.G., et al. Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer. Oncologist. 2021;26:e270&#x2013;e278. doi: 10.1002/onco.13601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/onco.13601</ArticleId><ArticleId IdType="pmc">PMC7873327</ArticleId><ArticleId IdType="pubmed">33215787</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalabi M., Fanchi L.F., Dijkstra K.K., Van den Berg J.G., Aalbers A.G., Sikorska K., Lopez-Yurda M., Grootscholten C., Beets G.L., Snaebjornsson P., et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat. Med. 2020;26:566&#x2013;576. doi: 10.1038/s41591-020-0805-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0805-8</ArticleId><ArticleId IdType="pubmed">32251400</ArticleId></ArticleIdList></Reference><Reference><Citation>Cercek A., Lumish M., Sinopoli J., Weiss J., Shia J., Lamendola-Essel M., El Dika I.H., Segal N., Shcherba M., Sugarman R., et al. PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer. N. Engl. J. Med. 2022;386:2363&#x2013;2376. doi: 10.1056/NEJMoa2201445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2201445</ArticleId><ArticleId IdType="pmc">PMC9492301</ArticleId><ArticleId IdType="pubmed">35660797</ArticleId></ArticleIdList></Reference><Reference><Citation>Dostarlimab: An Answer for Rectal Cancer? Cancer Discov. 2022;12:1828&#x2013;1829. doi: 10.1158/2159-8290.CD-NB2022-0047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-NB2022-0047</ArticleId><ArticleId IdType="pubmed">35771084</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalabi M.e.a. LBA7&#x2014;Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 study. Ann. Oncol. 2022;33:S808&#x2013;S869. doi: 10.1016/j.annonc.2022.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annonc.2022.08.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Quandt Z., Young A., Anderson M. Immune checkpoint inhibitor diabetes mellitus: A novel form of autoimmune diabetes. Clin. Exp. Immunol. 2020;200:131&#x2013;140. doi: 10.1111/cei.13424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13424</ArticleId><ArticleId IdType="pmc">PMC7160652</ArticleId><ArticleId IdType="pubmed">32027018</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato T., Kodama S., Kaneko K., Imai J., Katagiri H. Type 1 Diabetes Mellitus Associated with Nivolumab after Second SARS-CoV-2 Vaccination, Japan. Emerg. Infect. Dis. 2022;28:1518&#x2013;1520. doi: 10.3201/eid2807.220127.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2807.220127</ArticleId><ArticleId IdType="pmc">PMC9239866</ArticleId><ArticleId IdType="pubmed">35468049</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacharakis N., Chinnasamy H., Black M., Xu H., Lu Y.C., Zheng Z., Pasetto A., Langhan M., Shelton T., Prickett T., et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat. Med. 2018;24:724&#x2013;730. doi: 10.1038/s41591-018-0040-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0040-8</ArticleId><ArticleId IdType="pmc">PMC6348479</ArticleId><ArticleId IdType="pubmed">29867227</ArticleId></ArticleIdList></Reference><Reference><Citation>Rommer P.S., Berger K., Ellenberger D., Fneish F., Simbrich A., Stahmann A., Zettl U.K. Management of MS Patients Treated With Daclizumab&#x2014;A Case Series of 267 Patients. Front Neurol. 2020;11:996. doi: 10.3389/fneur.2020.00996.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00996</ArticleId><ArticleId IdType="pmc">PMC7506133</ArticleId><ArticleId IdType="pubmed">33013658</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore J.W., Torres N., Superdock M., Mendler J.H., Loh K.P. How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia. Curr. Treat. Options. Oncol. 2022;23:1086&#x2013;1103. doi: 10.1007/s11864-022-00991-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11864-022-00991-z</ArticleId><ArticleId IdType="pmc">PMC9898635</ArticleId><ArticleId IdType="pubmed">35687257</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallman D.A., DeZern A.E., Garcia-Manero G., Steensma D.P., Roboz G.J., Sekeres M.A., Cluzeau T., Sweet K.L., McLemore A., McGraw K.L., et al. Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes. J. Clin. Oncol. 2021;39:1584&#x2013;1594. doi: 10.1200/JCO.20.02341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.20.02341</ArticleId><ArticleId IdType="pmc">PMC8099410</ArticleId><ArticleId IdType="pubmed">33449813</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujihara K.M., Corrales Benitez M., Cabalag C.S., Zhang B.Z., Ko H.S., Liu D.S., Simpson K.J., Haupt Y., Lipton L., Haupt S., et al. SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than TP53 Mutation Status. Mol. Cancer. 2021;20:1858&#x2013;1867. doi: 10.1158/1535-7163.MCT-21-0067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1535-7163.MCT-21-0067</ArticleId><ArticleId IdType="pubmed">34315763</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagasaka M., Li Y., Sukari A., Ou S.I., Al-Hallak M.N., Azmi A.S. KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne? Cancer Treat. Rev. 2020;84:101974. doi: 10.1016/j.ctrv.2020.101974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctrv.2020.101974</ArticleId><ArticleId IdType="pmc">PMC7041424</ArticleId><ArticleId IdType="pubmed">32014824</ArticleId></ArticleIdList></Reference><Reference><Citation>Schein C.H. The shape of the messenger: Using protein structure information to design novel cytokine-based therapeutics. Curr. Pharm. Des. 2002;8:2113&#x2013;2129. doi: 10.2174/1381612023393161.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612023393161</ArticleId><ArticleId IdType="pubmed">12369857</ArticleId></ArticleIdList></Reference><Reference><Citation>Weissmann C., Nagata S., Boll W., Fountoulakis M., Fujisawa A., Fujisawa J.-I., Haynes J., Henco K., Mantei N., Ragg H., et al. Interferons. Elsevier; Amsterdam, The Netherlands: 1982. Structure and expression of human alpha-interferon genes; pp. 295&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pubmed">6187725</ArticleId></ArticleIdList></Reference><Reference><Citation>Winer E.S., DeAngelo D.J. A Review of Omacetaxine: A Chronic Myeloid Leukemia Treatment Resurrected. Oncol. Ther. 2018;6:9&#x2013;20. doi: 10.1007/s40487-018-0058-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40487-018-0058-6</ArticleId><ArticleId IdType="pmc">PMC7359993</ArticleId><ArticleId IdType="pubmed">32700137</ArticleId></ArticleIdList></Reference><Reference><Citation>Heibl S., Buxhofer-Ausch V., Schmidt S., Webersinke G., Lion T., Piringer G., Kuehr T., Wolf D., Melchardt T., Greil R., et al. A Phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha 2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia not achieving a deep molecular response (MR 4.5)&#x2014;AGMT_CML 1. Hematol. Oncol. 2020;38:792&#x2013;798. doi: 10.1002/hon.2786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hon.2786</ArticleId><ArticleId IdType="pubmed">32757230</ArticleId></ArticleIdList></Reference><Reference><Citation>Schein C.H. Repurposing approved drugs for cancer therapy. Br. Med. Bull. 2021;137:13&#x2013;27. doi: 10.1093/bmb/ldaa045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldaa045</ArticleId><ArticleId IdType="pmc">PMC7929227</ArticleId><ArticleId IdType="pubmed">33517358</ArticleId></ArticleIdList></Reference><Reference><Citation>Mima A., Nagahara D., Tansho K. Successful treatment of nephrotic syndrome induced by lambda light chain deposition disease using lenalidomide: A case report and review of the literature. Clin. Nephrol. 2018;89:461&#x2013;468. doi: 10.5414/CN109342.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/CN109342</ArticleId><ArticleId IdType="pubmed">29393843</ArticleId></ArticleIdList></Reference><Reference><Citation>Brune M.M., Stussi G., Lundberg P., Vela V., Heim D., Manz M.G., Haralambieva E., Pabst T., Banz Y., Bargetzi M., et al. Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort. Ann. Hematol. 2021;100:1169&#x2013;1179. doi: 10.1007/s00277-021-04467-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-021-04467-2</ArticleId><ArticleId IdType="pmc">PMC8043896</ArticleId><ArticleId IdType="pubmed">33704530</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36827539</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-2684</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Dementia (London, England)</Title><ISOAbbreviation>Dementia (London)</ISOAbbreviation></Journal><ArticleTitle>Navigating the coronavirus pandemic 2&#xa0;years on: Experiences of people with dementia from the British IDEAL cohort.</ArticleTitle><Pagination><StartPage>760</StartPage><EndPage>782</EndPage><MedlinePgn>760-782</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/14713012231158215</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">People with dementia have been affected in unique ways during the COVID-19 pandemic. It is not known whether the impact of the pandemic has changed with time or with the changes in social restrictions. This study explored how experiences of coping with the effects of the pandemic in the UK changed over time.</AbstractText><AbstractText Label="RESEARCH DESIGN AND METHODS" NlmCategory="METHODS">We conducted semi-structured interviews with people with dementia living in the community in England and Wales who had taken part in a qualitative interview at an earlier stage of the pandemic. We applied framework analysis to identify themes and compared these with interviewees' previous accounts.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">Nine people aged between 51 and 89&#xa0;years were interviewed; four were female and five had early onset dementia. We identified three themes: 1. Navigating a changing world: Living with coronavirus; 2. A 'downward spiral': Managing advancing dementia; and 3. Availability, accessibility, and suitability of support. Findings reflect participants' ongoing caution about re-emerging from social restrictions to resume valued activities, and how this led to coping behaviours to minimise the impact on wellbeing in the absence of formal support and services.</AbstractText><AbstractText Label="DISCUSSION AND IMPLICATIONS" NlmCategory="CONCLUSIONS">Despite easing of restrictions across the UK, the negative impact of the coronavirus pandemic on people with dementia continues. Whilst individuals and services have adapted to some of the challenges, there is now an opportunity to rebuild support networks and services to ensure people with dementia are suitably advised, supported and socially engaged to allow them to live as well as possible.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dawson</LastName><ForeName>Eleanor</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-4883-7307</Identifier><AffiliationInfo><Affiliation>University of Exeter Medical School, 3286University of Exeter, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3405-7932</Identifier><AffiliationInfo><Affiliation>University of Exeter Medical School, 3286University of Exeter, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pentecost</LastName><ForeName>Claire</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2048-5538</Identifier><AffiliationInfo><Affiliation>University of Exeter Medical School, 3286University of Exeter, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stapley</LastName><ForeName>Sally</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5538-8717</Identifier><AffiliationInfo><Affiliation>University of Exeter Medical School, 3286University of Exeter, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9553-853X</Identifier><AffiliationInfo><Affiliation>Centre for Applied Dementia Studies, 1905University of Bradford, Bradford, UK; Wolfson Centre for Applied Health Research, Bradford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charlwood</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-3522-8457</Identifier><AffiliationInfo><Affiliation>University of Exeter Medical School, 3286University of Exeter, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Victor</LastName><ForeName>Christina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4213-3974</Identifier><AffiliationInfo><Affiliation>College of Health, Medicine and Life Sciences, 3890Brunel University London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clare</LastName><ForeName>Linda</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3989-5318</Identifier><AffiliationInfo><Affiliation>University of Exeter Medical School, 3286University of Exeter, Exeter, UK; NIHR Applied Research Collaboration South-West Peninsula, Exeter, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Dementia (London)</MedlineTA><NlmUniqueID>101128698</NlmUniqueID><ISSNLinking>1471-3012</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000223" MajorTopicYN="N">Adaptation, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s</Keyword><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">coping</Keyword><Keyword MajorTopicYN="N">isolation</Keyword><Keyword MajorTopicYN="N">qualitative</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>24</Day><Hour>15</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36827539</ArticleId><ArticleId IdType="pmc">PMC9969185</ArticleId><ArticleId IdType="doi">10.1177/14713012231158215</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alzheimer&#x2019;s Society . (2022, March 28). Person-centred care. https://www.alzheimers.org.uk/about-dementia/treatments/person-centred-care</Citation></Reference><Reference><Citation>Bamford C., Wheatley A., Brunskill G., Booi L., Allan L., Banerjee S, Harrison Dening K., Manthorpe J., Robinson L., PriDem study team. on behalf of the PriDem Study Team (2021). Harrison DeningK.ManthorpeJ.RobinsonL.Key components of post-diagnostic support for people with dementia and their carers: A qualitative study. Plos One, 16(12), Articlee0260506. 10.1371/journal.pone.0260506</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260506</ArticleId><ArticleId IdType="pmc">PMC8687564</ArticleId><ArticleId IdType="pubmed">34928972</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee D., Rai M. (2020). Social isolation in Covid-19: The impact of loneliness. The International journal of social psychiatry, 66(6), 525&#x2013;527. 10.1177/0020764020922269</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0020764020922269</ArticleId><ArticleId IdType="pmc">PMC7405628</ArticleId><ArticleId IdType="pubmed">32349580</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannon S. M., Wang K. E., Grunberg V. A., Dickerson B. C., Vranceanu A.-M. (2022). Couples&#x2019; experiences managing young-onset dementia early in the Covid-19 pandemic. The Gerontologist, 62(8), 1173&#x2013;1184. 10.1093/geront/gnab162</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnab162</ArticleId><ArticleId IdType="pmc">PMC9451019</ArticleId><ArticleId IdType="pubmed">34739072</ArticleId></ArticleIdList></Reference><Reference><Citation>Borelli W. V., Augustin M. C., de Oliveira P. B. F., Reggiani L. C., Bandeira-de-Mello R. G., Schumacher-Schuh A. F., Chaves M. L. F., Castilhos R. M. (2021). Neuropsychiatric symptoms in patients with dementia associated with increased psychological distress in caregivers during the Covid-19 pandemic. Journal of Alzheimer's disease: JAD, 80(4), 1705&#x2013;1712. 10.3233/jad-201513</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-201513</ArticleId><ArticleId IdType="pubmed">33646168</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutoleau-Bretonni&#xe8;re C., Pouclet-Courtemanche H., Gillet A., Bernard A., Deruet A. L., Gouraud I., Mazoue A., Lamy E., Rocher L., Kapogiannis D., El Haj M. (2020). The effects of confinement on neuropsychiatric symptoms in alzheimer's disease during the Covid-19 crisis. Journal of Alzheimer's disease: JAD, 76(1), 41&#x2013;47. 10.3233/jad-200604</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-200604</ArticleId><ArticleId IdType="pmc">PMC9988367</ArticleId><ArticleId IdType="pubmed">32568211</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown E. E., Kumar S., Rajji T. K., Pollock B. G., Mulsant B. H. (2020). Anticipating and mitigating the impact of the Covid-19 pandemic on alzheimer's disease and related dementias. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 28(7), 712&#x2013;721. 10.1016/j.jagp.2020.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2020.04.010</ArticleId><ArticleId IdType="pmc">PMC7165101</ArticleId><ArticleId IdType="pubmed">32331845</ArticleId></ArticleIdList></Reference><Reference><Citation>Canevelli M., Valletta M., Toccaceli Blasi M., Remoli G., Sarti G., Nuti F., Sciancalepore F., Ruberti E., Cesari M., Bruno G. (2020). Facing dementia during the Covid-19 outbreak. Journal of the American Geriatrics Society, 68(8), 1673&#x2013;1676. 10.1111/jgs.16644</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16644</ArticleId><ArticleId IdType="pmc">PMC7300919</ArticleId><ArticleId IdType="pubmed">32516441</ArticleId></ArticleIdList></Reference><Reference><Citation>Clare L., Martyr A., Gamble L. D., Pentecost C., Collins R., Dawson E., Hunt A., Parker S., Allan L., Burns A., Hillman A., Litherland R., Quinn C., Matthews F. E., Victor C. (2022). Impact of COVID-19 on 'living well' with mild-to-moderate dementia in the community: Findings from the IDEAL cohort. Journal of Alzheimer's disease: JAD, 85(2), 925&#x2013;940. 10.3233/jad-215095</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-215095</ArticleId><ArticleId IdType="pubmed">34776448</ArticleId></ArticleIdList></Reference><Reference><Citation>Clare L., Nelis S. M., Quinn C., Martyr A., Henderson C., Hindle J. V., Jones I. R., Jones R. W., Knapp M., Kopelman M. D., Morris R. G., Pickett J. A., Rusted J. M., Savitch N. M., Thom J. M., Victor C. R. (2014). Improving the experience of dementia and enhancing active life&#x2013;living well with dementia: Study protocol for the IDEAL study. Health and quality of life outcomes, 12(164), 164. 10.1186/s12955-014-0164-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-014-0164-6</ArticleId><ArticleId IdType="pmc">PMC4260182</ArticleId><ArticleId IdType="pubmed">25433373</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke C., Keyes S., Wilkinson H., Alexjuk J., Wilcockson J., Robinson L., Reynolds J., McClelland S., Hodgson P., Corner L., Cattan M. (2013, October 9). Healthbridge: The national evaluation of peer support networks and dementia advisers in implementation of the national dementia strategy for England. https://www.gov.uk/government/publications/peer-support-networks-and-dementia-advisers-evaluation</Citation></Reference><Reference><Citation>Cousins E., de Vries K., Harrison Dening K. (2022). &#x2018;Four walls and a garden': Exploring the experiences of families affected by dementia during the COVID-19 pandemic. Dementia, 21(3), 810&#x2013;829. DOI: 10.1177/14713012211059021</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14713012211059021</ArticleId><ArticleId IdType="pmc">PMC8995930</ArticleId><ArticleId IdType="pubmed">34918956</ArticleId></ArticleIdList></Reference><Reference><Citation>Dementia UK . (2022, June 30). Young onset dementia. https://www.dementiauk.org/about-dementia/young-onset-dementia/</Citation></Reference><Reference><Citation>Di Lorito C., Masud T., Gladman J., Godfrey M., Dunlop M., Bosco A., Harwood R. H. (2021). Deconditioning in people living with dementia during the COVID-19 pandemic: Qualitative study from the promoting activity, independence and stability in early dementia (PrAISED) process evaluation. BMC geriatrics, 21(1), 529. 10.1186/s12877-021-02451-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02451-z</ArticleId><ArticleId IdType="pmc">PMC8495442</ArticleId><ArticleId IdType="pubmed">34620129</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale N. K., Heath G., Cameron E., Rashid S., Redwood S. (2013). Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Medical Research Methodology, 13(1), 117. 10.1186/1471-2288-13-117</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-13-117</ArticleId><ArticleId IdType="pmc">PMC3848812</ArticleId><ArticleId IdType="pubmed">24047204</ArticleId></ArticleIdList></Reference><Reference><Citation>Giebel C., Cannon J., Hanna K., Butchard S., Eley R., Gaughan A., Komuravelli A., Shenton J., Callaghan S., Tetlow H., Limbert S., Whittington R., Rogers C., Rajagopal M., Ward K., Shaw L., Corcoran R., Bennett K., Gabbay M. (2021). Impact of COVID-19 related social support service closures on people with dementia and unpaid carers: A qualitative study. Aging &amp; Mental Health, 25(7), 1281&#x2013;1288. 10.1080/13607863.2020.1822292</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2020.1822292</ArticleId><ArticleId IdType="pubmed">32954794</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;rska S., Forsyth K., Maciver D. (2018). Living with dementia: A meta-synthesis of qualitative research on the lived experience. The Gerontologist, 58(3), e180&#x2013;e196. 10.1093/geront/gnw195</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnw195</ArticleId><ArticleId IdType="pmc">PMC5946830</ArticleId><ArticleId IdType="pubmed">28069886</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna K., Giebel C., Tetlow H., Ward K., Shenton J., Cannon J., Komuravelli A., Gaughan A., Eley R., Rogers C., Rajagopal M., Limbert S., Callaghan S., Whittington R., Butchard S., Shaw L., Gabbay M. (2022). Emotional and mental wellbeing following Covid-19 public health measures on people living with dementia and carers. Journal of Geriatric Psychiatry and Neurology, 35(3), 344&#x2013;352. 10.1177/0891988721996816</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988721996816</ArticleId><ArticleId IdType="pmc">PMC8996307</ArticleId><ArticleId IdType="pubmed">33626977</ArticleId></ArticleIdList></Reference><Reference><Citation>Horik J. O., Collins R., Martyr A., Henderson C., Jones R. W., Knapp M., Quinn C., Thom J. M., Victor C., Clare L., IDEAL Programme Team (2022). Limited receipt of support services among people with mild-to-moderate dementia: Findings from the IDEAL cohort. International Journal of Geriatric Psychiatry, 37(3), 1&#x2013;8. 10.1002/gps.5688</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5688</ArticleId><ArticleId IdType="pmc">PMC9306706</ArticleId><ArticleId IdType="pubmed">35128725</ArticleId></ArticleIdList></Reference><Reference><Citation>Masoud S. S., Meyer K. N., Martin Sweet L., Prado P. J., White C. L. (2021). &#x201c;We don't feel so alone&#x201d;: A qualitative study of virtual memory caf&#xe9;s to support social connectedness among individuals living with dementia and care partners during COVID-19. Frontiers in Public Health, 9: 660144. 10.3389/fpubh.2021.660144</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.660144</ArticleId><ArticleId IdType="pmc">PMC8155306</ArticleId><ArticleId IdType="pubmed">34055724</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics . (2022, July 1). Coronavirus (COVID-19): Latest data and analysis on coronavirus (COVID-19) in the UK and its effect on the economy and society. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases</Citation></Reference><Reference><Citation>O'Rourke G., Pentecost C., van den Heuvel E., Victor C., Quinn C., Hillman A., Litherland R., Clare L. (2021). Living with dementia under COVID-19 restrictions: Coping and support needs among people with dementia and carers from the IDEAL cohort. Ageing and Society, 1&#x2013;23. 10.1017/S0144686X21001719</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0144686X21001719</ArticleId></ArticleIdList></Reference><Reference><Citation>Pentecost C., Collins R., Stapley S., Victor C., Quinn C., Hillman A., Litherland R., Allan L., Clare L. (2022). Effects of social restrictions on people with dementia and carers during the pre-vaccine phase of the COVID-19 pandemic: Experiences of IDEAL cohort participants. Health &amp; social care in the community, 30(6), Article e4594&#x2013;e4604. 10.1111/hsc.13863</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hsc.13863</ArticleId><ArticleId IdType="pmc">PMC9349761</ArticleId><ArticleId IdType="pubmed">35695217</ArticleId></ArticleIdList></Reference><Reference><Citation>Portacolone E., Chodos A., Halpern J., Covinsky K. E., Keiser S., Fung J., Rivera E., Tran T., Bykhovsky C., Johnson J. K. (2021). The effects of the Covid-19 pandemic on the lived experience of diverse older adults living alone with cognitive impairment. The Gerontologist, 61(2), 251&#x2013;261. 10.1093/geront/gnaa201</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnaa201</ArticleId><ArticleId IdType="pmc">PMC7901518</ArticleId><ArticleId IdType="pubmed">33404634</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn C., Gamble L. D., Parker S., Martyr A., Collins R., Victor C., Dawson E., Hunt A., Pentecost C., Allan L., Clare L. (2022). Impact of COVID-19 on carers of people with dementia in the community: Findings from the British IDEAL cohort. International Journal of Geriatric Psychiatry, 37(5), 1&#x2013;11. 10.1002/gps.5708</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5708</ArticleId><ArticleId IdType="pmc">PMC9087398</ArticleId><ArticleId IdType="pubmed">35394090</ArticleId></ArticleIdList></Reference><Reference><Citation>Rising K. L., Salcedo V. J., Amadio G., Casten R., Chang A., Gentsch A., O'Hayer C. V., Sarpoulaki N., Worster B., Gerolamo A. M. (2022). Living through the pandemic: The voices of persons with dementia and their caregivers. Journal of applied gerontology: the official journal of the Southern Gerontological Society, 41(1), 30&#x2013;35. 10.1177/07334648211036399</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/07334648211036399</ArticleId><ArticleId IdType="pubmed">34344205</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatini S., Bennett H. Q., Martyr A., Collins R., Gamble L. D., Matthews F. E., Pentecost C., Dawson E., Hunt A., Parker S., Allan L., Burns A., Litherland R., Quinn C., Clare L. (2022). Minimal impact of COVID-19 pandemic on the mental health and wellbeing of people living with dementia: Analysis of matched longitudinal data from the IDEAL study. Frontiers in Psychiatry, 13: 849808. 10.3389/fpsyt.2022.849808</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.849808</ArticleId><ArticleId IdType="pmc">PMC8965515</ArticleId><ArticleId IdType="pubmed">35370851</ArticleId></ArticleIdList></Reference><Reference><Citation>Silarova B., Nelis S. M., Ashworth R. M., Ballard C., Bie&#x144;kiewicz M., Henderson C., Hillman A., Hindle J. V., Hughes J. C., Lamont R. A., Litherland R., Jones I. R., Jones R. W., Knapp M., Kotting P., Martyr A., Matthews F. E., Morris R. G., Quinn C., Clare L. (2018). Protocol for the IDEAL-2 longitudinal study: Following the experiences of people with dementia and their primary carers to understand what contributes to living well with dementia and enhances active life. BMC public health, 18(1), 1214. 10.1186/s12889-018-6129-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-018-6129-7</ArticleId><ArticleId IdType="pmc">PMC6208177</ArticleId><ArticleId IdType="pubmed">30376832</ArticleId></ArticleIdList></Reference><Reference><Citation>Smaling H. J. A., Tilburgs B., Achterberg W. P., Visser M. (2022). The impact of social distancing due to the Covid-19 pandemic on people with dementia, family carers and healthcare professionals: A qualitative study. International Journal of Environmental Research and Public Health, 19(1), 519. DOI: 10.3390/ijerph19010519</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19010519</ArticleId><ArticleId IdType="pmc">PMC8744737</ArticleId><ArticleId IdType="pubmed">35010779</ArticleId></ArticleIdList></Reference><Reference><Citation>Stapley S., Pentecost C., Collins R., Quinn C., Dawson E., Morris R. G., Sabatini S., Thom J., Clare L. (2022). Living with dementia during the COVID-19 pandemic: Insights into identity from the IDEAL cohort. Aging and Society, 1&#x2013;25. 10.1017/S0144686X2200135010.21203/rs.3.rs-1401908/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0144686X22001350</ArticleId><ArticleId IdType="doi">10.21203/rs.3.rs-1401908/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez-Gonz&#xe1;lez A., Rajagopalan J., Livingston G., Alladi S. (2021). The effect of COVID-19 isolation measures on the cognition and mental health of people living with dementia: A rapid systematic review of one year of quantitative evidence. EClinicalMedicine, 39(101047), 101047. 10.1016/j.eclinm.2021.101047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101047</ArticleId><ArticleId IdType="pmc">PMC8342894</ArticleId><ArticleId IdType="pubmed">34386758</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbot C. V., Briggs P. (2021). 'Getting back to normality seems as big of a step as going into lockdown': The impact of the COVID-19 pandemic on people with early to middle stage dementia. Age and Ageing, 50(3), 657&#x2013;663. 10.1093/ageing/afab012</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afab012</ArticleId><ArticleId IdType="pmc">PMC7929391</ArticleId><ArticleId IdType="pubmed">33481988</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuijt R., Rait G., Frost R., Wilcock J., Manthorpe J., Walters K. (2021). Remote primary care consultations for people living with dementia during the COVID-19 pandemic: Experiences of people living with dementia and their carers. The British journal of general practice: the journal of the Royal College of General Practitioners, 71(709), Article e574&#x2013;e582. 10.3399/BJGP.2020.1094</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2020.1094</ArticleId><ArticleId IdType="pmc">PMC8136581</ArticleId><ArticleId IdType="pubmed">33630749</ArticleId></ArticleIdList></Reference><Reference><Citation>Weetch J., O&#x2019;Dwyer S., Clare L. (2021). The involvement of people with dementia in advocacy: A systematic narrative review. Aging &amp; Mental Health, 25(9), 1595&#x2013;1604. 10.1080/13607863.2020.1783512</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2020.1783512</ArticleId><ArticleId IdType="pubmed">32578451</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation . (2020, March 11). WHO Director-General's opening remarks at the media briefing on COVID-19-11 March 2020. WHO. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19&#x2013;11-march-2020</Citation></Reference><Reference><Citation>World Health Organisation . (2021, September 2). Dementia: Key facts. WHO. https://www.who.int/news-room/fact-sheets/detail/dementia</Citation></Reference><Reference><Citation>Yates L., Csipke E., Moniz-Cook E., Leung P., Walton H., Charlesworth G., Spector A., Hogervorst E., Mountain G., Orrell M. (2019). The development of the Promoting Independence in Dementia (PRIDE) intervention to enhance independence in dementia. Clinical Interventions in Aging, 14(14), 1615&#x2013;1630. 10.2147/CIA.S214367</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S214367</ArticleId><ArticleId IdType="pmc">PMC6748161</ArticleId><ArticleId IdType="pubmed">31571842</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36827032</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Importance of telemedicine in mild cognitive impairment and Alzheimer disease patients population during admission to emergency departments with COVID-19.</ArticleTitle><Pagination><StartPage>e32934</StartPage><MedlinePgn>e32934</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e32934</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000032934</ELocationID><Abstract><AbstractText>In March 2020, the World Health Organization declared a global pandemic due to the new coronavirus SARS-CoV-2, and several governments have planned a national quarantine to control the spread of the virus. Acute psychological effects during hospitalization in frail elderly individuals with special needs, such as patients with dementia, have been little studied. The greatest distress manifested by these kinds of patients was isolation from their families during hospitalization. Thus, structured video call interventions were carried out to family caregivers of patients diagnosed with dementia during their hospitalization in the COVID-19 ward. The purpose of this quasi-experimental study was to assess changes in cognitive and behavioral symptoms in both patients and caregivers. All study participants underwent psychological assessments. Specifically, the psychological well-being states of patients and their caregivers were measured at admission (T0) and discharge (T1) using psychometric tests and clinical scales. Each participant received an electronic device to access video calls in addition meetings were scheduled with the psychologist and medical team to keep caregivers updated on the health status of their relatives. A psychological support and cognitive rehabilitation service was also provided. Significant differences were found in all clinical variables of the caregiver group. Results showed a significant relationship in the quality of life score between the patient and caregiver groups. The results of this study has highlighted the importance of maintaining significantly effective relationships during the hospitalization period of patients admitted to COVID wards.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Corallo</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>IRCCS Centro Neurolesi Bonino-Pulejo, Messina, Sicily, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maresca</LastName><ForeName>Giuseppa</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8247-3546</Identifier></Author><Author ValidYN="Y"><LastName>Bonanno</LastName><ForeName>Lilla</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Lo Buono</LastName><ForeName>Viviana</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>De Caro</LastName><ForeName>Jolanda</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Bonanno</LastName><ForeName>Carmen</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Formica</LastName><ForeName>Caterina</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Quartarone</LastName><ForeName>Angelo</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>De Cola</LastName><ForeName>Maria Cristina</ForeName><Initials>MC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>24</Day><Hour>12</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36827032</ArticleId><ArticleId IdType="pmc">PMC9949366</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000032934</ArticleId><ArticleId IdType="pii">00005792-202302220-00032</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kuroda Y, Sugimoto T, Matsumoto N, et al. . Prevalence of behavioral and psychological symptoms in patients with cognitive decline before and during the COVID-19 pandemic. Front Psychiatry. 2022;13:839683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8934776</ArticleId><ArticleId IdType="pubmed">35321225</ArticleId></ArticleIdList></Reference><Reference><Citation>Keng A, Brown EE, Rostas A, et al. . Effectively caring for individuals with behavioral and psychological symptoms of dementia during the COVID-19 pandemic. Front Psychiatry. 2020;11:573367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7574608</ArticleId><ArticleId IdType="pubmed">33132936</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting D, Atee M, Morris T, et al. . Effect of COVID-19 on BPSD severity and caregiver distress: trend data from national dementia-specific behavior support programs in Australia. Alzheimers Dement. 2021;17 Suppl 12(Suppl 12):e058454.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9011483</ArticleId><ArticleId IdType="pubmed">34971088</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonetti A, Pais C, Jones M, et al. . Neuropsychiatric symptoms in elderly with dementia during COVID-19 pandemic: definition, treatment, and future directions. Front Psychiatry. 2020;11:579842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550649</ArticleId><ArticleId IdType="pubmed">33132939</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. Behavioral and psychological symptoms of dementia. Front Neurol. 2012;3:73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3345875</ArticleId><ArticleId IdType="pubmed">22586419</ArticleId></ArticleIdList></Reference><Reference><Citation>Devita M, Bordignon A, Sergi G, et al. . The psychological and cognitive impact of COVID-19 on individuals with neurocognitive impairments: research topics and remote intervention proposals. Aging Clin Exp Res. 2021;33:733&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314284</ArticleId><ArticleId IdType="pubmed">32583375</ArticleId></ArticleIdList></Reference><Reference><Citation>Snider BJ, Holtzman DM. Effects of COVID-19 on preclinical and clinical research in neurology: examples from research on neurodegeneration and Alzheimer&#x2019;s disease. Neuron. 2021;109:3199&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">34525328</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunn F, Burn AM, Robinson L, et al. . Healthcare organisation and delivery for people with dementia and comorbidity: a qualitative study exploring the views of patients, carers and profes-sionals. BMJ Open. 2017;7:e013067.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5253574</ArticleId><ArticleId IdType="pubmed">28100562</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitnick S, Leffler C, Hood VL. Family caregivers, patients and physicians: ethical guidance to optimize rela-tionships. J Gen Intern Med. 2010;25:255&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2839338</ArticleId><ArticleId IdType="pubmed">20063128</ArticleId></ArticleIdList></Reference><Reference><Citation>Prince MJ, Comas-Herrera A, Knapp M, et al. . World Alzheimer report 2016-improving healthcare for people living with dementia: coverage, quality and costs now and in the future. 2016.</Citation></Reference><Reference><Citation>Bateson C, Allen A, Cunningham T, et al. . Review of mental health crisis services in Northern Ireland. 2021.</Citation></Reference><Reference><Citation>Jager F. The Effect of Community Treatment Orders on Identity (Doctoral dissertation. Universit&#xe9; d&#x2019;Ottawa/University of Ottawa. 2021.</Citation></Reference><Reference><Citation>Joyce M, Pilcher T, Ramm D. Health needs assessment: caring for the individual and the population. Nurs Public Health. 2011;101.</Citation></Reference><Reference><Citation>Morris SE, Moment A, Thomas JD. Caring for bereaved family members during the COVID-19 pandemic: before and after the death of a patient. J Pain Symptom Manage. 2020;60:e70&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204689</ArticleId><ArticleId IdType="pubmed">32387574</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace CL, Wladkowski SP, Gibson A, et al. . Grief during the COVID-19 pandemic: considerations for palliative care providers. J Pain Symptom Manage. 2020;60:e70&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153515</ArticleId><ArticleId IdType="pubmed">32298748</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroebe M, Schut H. Bereavement in times of COVID-19: a review and theoretical framework. OMEGA-J Death Dying. 2021;82:500&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7756059</ArticleId><ArticleId IdType="pubmed">33086903</ArticleId></ArticleIdList></Reference><Reference><Citation>Rando TA. Clinical Dimensions of Anticipatory Mourning: Theory and Practice in Working with the Dying, their Loved ones, and their Caregivers. Research Press. 2000.</Citation></Reference><Reference><Citation>Keyes KM, Pratt C, Galea S, et al. . The burden of loss: unexpected death of a loved one and psychiatric disorders across the life course in a national study. Am J Psychiatry. 2014;171:864&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4119479</ArticleId><ArticleId IdType="pubmed">24832609</ArticleId></ArticleIdList></Reference><Reference><Citation>Iverach L, Menzies RG, Menzies RE. Death anxiety and its role in psychopathology: Reviewing the status of a transdiagnostic construct. Clin Psychol Rev. 2014;34:580&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">25306232</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibberd R. Meaning reconstruction in bereavement: sense and significance. Death Stud. 2013;37:670&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">24520967</ArticleId></ArticleIdList></Reference><Reference><Citation>Talevi D, Socci V, Carai M, et al. . Mental health outcomes of the COVID-19 pandemic. Rivista di psichiatria 2020;55:137&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">32489190</ArticleId></ArticleIdList></Reference><Reference><Citation>Salameh P, Aline HAJJ, Badro DA, et al. . Mental health outcomes of the COVID-19 pandemic and a collapsing economy: perspectives from a developing country. Psychiatry Res. 2020;294:113520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577886</ArticleId><ArticleId IdType="pubmed">33142145</ArticleId></ArticleIdList></Reference><Reference><Citation>Spoorthy MS, Pratapa SK, Mahant S. Mental health problems faced by healthcare workers due to the COVID-19 pandemic&#x2013;A review. Asian J Psychiatr. 2020;51:102119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7175897</ArticleId><ArticleId IdType="pubmed">32339895</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugelius K, Harada N, Marutani M. Consequences of visiting restrictions during the COVID-19 pandemic: an integrative review. Int J Nurs Stud. 2021;121:104000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8196532</ArticleId><ArticleId IdType="pubmed">34242976</ArticleId></ArticleIdList></Reference><Reference><Citation>Canevelli M, Palmieri L, Raparelli V, et al. . Prevalence and clinical correlates of dementia among COVID-19-related deaths in Italy. Alzheimer&#x2019;s Dementia. 2020;12:e12114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7666428</ArticleId><ArticleId IdType="pubmed">33225041</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanfelici M. The Italian response to the COVID-19 crisis: lessons learned and future direction in social development. Int J Commun Social Develop. 2020;2:191&#x2013;210.</Citation></Reference><Reference><Citation>Invernizzi M, Carda S, Milani P, et al. . Development and validation of the Italian version of the Spinal Cord Independence Measure III. Disabil Rehabil. 2010;32:1194&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">20131944</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang HC, Tseng YM, Chen YC, et al. . Diagnostic accuracy of the Clinical Dementia Rating Scale for detecting mild cognitive impairment and dementia: a bivariate meta-analysis. Int J Geriatr Psychiatry. 2021;36:239&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">32955146</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufer DI, Cummings JL, Ketchel P, et al. . Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12:233&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11001602</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol.1959;32:50&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">13638508</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg SA. The geriatric depression scale (GDS). Best Pract Nurs Care Older Adults. 2012;4:1&#x2013;2.</Citation></Reference><Reference><Citation>Balestroni G, Bertolotti G. L&#x2019;EuroQol-5D (EQ-5D): uno strumento per la misura della qualit&#xe0; della vita [EuroQol-5D (EQ-5D): an instrument for measuring quality of life] [in Italian]. Monaldi Arch Chest Dis. 2012;78:155&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23614330</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein MF, Folstein SE, McHugh PR. &#x201c;Mini-mental state&#x201d;: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap P. Validity and reliability of the Zarit Burden Interview in assessing caregiving burden. Ann Acad Med Singapore. 2010;39:758&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">21063635</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck AT, Steer RA, Brown GK. Beck Depression Inventory. New York: Harcourt Brace Jovanovich. 1987.</Citation></Reference><Reference><Citation>Angelopoulou E, Papachristou N, Bougea A, et al. . How telemedicine can improve the quality of care for patients with Alzheimer&#x2019;s disease and related dementias? A narrative review. Medicina (Kaunas). 2022;58:1705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9783876</ArticleId><ArticleId IdType="pubmed">36556907</ArticleId></ArticleIdList></Reference><Reference><Citation>Maresca G, Latella D, Carnazza L, et al. . Neuropsychological effects of COVID-19: a review. Brain Behav. 2022;12:e2602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9353421</ArticleId><ArticleId IdType="pubmed">35903894</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Zhang H, Zhang M, et al. . Prevalence and risk factors of anxiety, depression, and sleep problems among caregivers of people living with neurocognitive disorders during the COVID-19 pandemic. Front Psychiatry. 2021;1516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820074</ArticleId><ArticleId IdType="pubmed">33488423</ArticleId></ArticleIdList></Reference><Reference><Citation>De Fazio P, Ciambrone P, Cerminara G, et al. . Depressive symptoms in caregivers of patients with dementia: demographic variables and burden. Clin Interv Aging. 2015;10:1085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4494176</ArticleId><ArticleId IdType="pubmed">26170648</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmann M, Wagner M. Impact of COVID-19 on informal caregiving and care receiving across Europe during the first phase of the pandemic. Front Public Health. 2021;9:590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242257</ArticleId><ArticleId IdType="pubmed">34222177</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeter ML, Kynast J, Villringer A, et al. . Face masks protect from infection but may impair social cognition in older adults and people with dementia. Front Psychol. 2021;12:640548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8418138</ArticleId><ArticleId IdType="pubmed">34489776</ArticleId></ArticleIdList></Reference><Reference><Citation>Leo M, Carcagn&#xec; P, Mazzeo PL, et al. . Analysis of facial information for healthcare applications: a survey on computer vision-based approaches. Information. 2020;11:128.</Citation></Reference><Reference><Citation>Maresca G, Formica C, De Cola MC, et al. . Care models for mental health in a population of patients affected by COVID-19. J Int Med Res. 2022;50:0300060522109743000605221097478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9092593</ArticleId><ArticleId IdType="pubmed">35531918</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai FH-Y, Yan EW-H, Chan DT-H. The protective impact oftelemedicine on persons with dementia and their caregivers during the COVID-19 pandemic. Am J Geriatric Psychiatr. 2020;28:1175&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7413846</ArticleId><ArticleId IdType="pubmed">32873496</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai FH, Yan EW, Yu KK, et al. . L&#x2019;impatto protettivo della telemedicina sulle persone con demenza e sui loro caregiver durante la pandemia di COVID-19. L&#x2019;American J Geriatric Psychiatry. 2020;28:1175&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7413846</ArticleId><ArticleId IdType="pubmed">32873496</ArticleId></ArticleIdList></Reference><Reference><Citation>Toh N, Pawlovich J, Grzybowski S. Telehealth and patient-doctor relationships in rural and remote communi-ties. Can Fam Physician. 2016;62:961&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5154642</ArticleId><ArticleId IdType="pubmed">27965327</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa IDA, Silva KCDCDD, Silva VAD, et al. . The communication process in Telenursing: integrative review. Rev Bras Enferm. 2016;69:765&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">27508484</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah YB, Kjelstrom S, Martinez D, et al. . Risk factors for heightened COVID-19-Related anxiety among breast cancer patients. Cancer Med. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9538212</ArticleId><ArticleId IdType="pubmed">36057956</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36821951</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-491X</ISSN><JournalIssue CitedMedium="Internet"><Volume>140</Volume><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>International journal of nursing studies</Title><ISOAbbreviation>Int J Nurs Stud</ISOAbbreviation></Journal><ArticleTitle>Digital healthcare for dementia and cognitive impairment: A scoping review.</ArticleTitle><Pagination><StartPage>104413</StartPage><MedlinePgn>104413</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijnurstu.2022.104413</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0020-7489(22)00242-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cognitive disorders, such as Alzheimer's disease, are a global health problem. Digital healthcare technology is an innovative management tool for delaying the progression of dementia and mild cognitive impairment. Thanks to digital technology, the possibility of safe and effective care for patients at home and in the community is increasing, even in situations that threaten the continuity of care, such as the COVID-19 pandemic. However, it is difficult to select appropriate technology and alternatives due to the lack of comprehensive reviews on the types and characteristics of digital technology for cognitive impairment, including their effects and limitations.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aims to identify the types of digital healthcare technology for dementia and mild cognitive impairment and comprehensively examine how its outcome measures were constructed in line with each technology's purpose.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">According to the Preferred Reporting Items for Systematic reviews and Meta-Analysis extension for Scoping Reviews guidelines, a literature search was conducted in August 2021 using Medline (Ovid), EMBASE, and Cochrane library. The search terms were constructed based on Population-Concept-Context mnemonic: 'dementia', 'cognitive impairment', and 'cognitive decline'; digital healthcare technology, such as big data, artificial intelligence, virtual reality, robots, applications, and so on; and the outcomes of digital technology, such as accuracy of diagnosis and physical, mental, and social health. After grasping overall research trends, the literature was classified and analysed in terms of the type of service users and technology.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 135 articles were selected. Since 2015, an increase in literature has been observed, and various digital healthcare technologies were identified. For people with mild cognitive impairment, technology for predicting and diagnosing the onset of dementia was studied, and for people with dementia, intervention technology to prevent the deterioration of health and induce significant improvement was considered. Regarding caregivers, many studies were conducted on monitoring and daily living assistive technologies that reduce the burden of care. However, problems such as data collection, storage, safety, and the digital divide persisted at different intensities for each technology type.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study revealed that appropriate technology options and considerations may differ depending on the characteristics of users. It also emphasises the role of humans in designing and managing technology to apply digital healthcare technology more effectively.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sohn</LastName><ForeName>Minsung</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Health and Medical Sciences, The Cyber University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>JungYeon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Transdisciplinary Major in Learning Health Systems, Department of Public Health Science, Graduate School, Korea University, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sohn</LastName><ForeName>Junyoung</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Artificial Intelligence, Korea University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jun-Hyup</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Health Policy and Management, College of Health Sciences, Korea University, Republic of Korea. Electronic address: junhlee@korea.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Nurs Stud</MedlineTA><NlmUniqueID>0400675</NlmUniqueID><ISSNLinking>0020-7489</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Big data</Keyword><Keyword MajorTopicYN="N">Caregiver</Keyword><Keyword MajorTopicYN="N">Cognitive decline</Keyword><Keyword MajorTopicYN="N">Cognitive impairment</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Information and communication technology</Keyword><Keyword MajorTopicYN="N">Scoping review</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: No conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>17</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>18</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36821951</ArticleId><ArticleId IdType="doi">10.1016/j.ijnurstu.2022.104413</ArticleId><ArticleId IdType="pii">S0020-7489(22)00242-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36821178</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-4156</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>1</Issue><PubDate><MedlineDate>2023 Jan-Mar 01</MedlineDate></PubDate></JournalIssue><Title>Alzheimer disease and associated disorders</Title><ISOAbbreviation>Alzheimer Dis Assoc Disord</ISOAbbreviation></Journal><ArticleTitle>Physical Exercise as a Nonpharmacological Intervention for the Treatment of Neuropsychiatric Symptoms in Persons With Dementia: A Meta-analysis of Randomized Controlled Trials.</ArticleTitle><Pagination><StartPage>73</StartPage><EndPage>81</EndPage><MedlinePgn>73-81</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/WAD.0000000000000544</ELocationID><Abstract><AbstractText Label="BACKGROUND">Neuropsychiatric symptoms (NPS) are prevalent in dementia and affect both patients and caregivers in multiple ways. Because of the complications of drug treatments, nonpharmacological interventions, such as exercise, are of particular value. This study aimed to investigate the effect of exercise on the NPS of dementia and draw recommendations for the disease management.</AbstractText><AbstractText Label="METHODS">Meta-analyses were conducted on the findings of randomized controlled trials identified during an initial systematic review of the literature, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The included studies examined the effect of exercise interventions on patients with dementia or mild cognitive impairment using valid assessment tools. The quality of evidence was assessed using Grading of Recommendations, Assessment, Development, and Evaluation analysis.</AbstractText><AbstractText Label="RESULTS">The meta-analyses revealed that exercise significantly limits NPS [mean difference: -5.28, (95% CI, -9.46, -1.11), P = 0.01] and symptoms of depression [standardized mean difference: -0.16, (95% CI, -0.29, -0.02), P = 0.02], and has a beneficial effect on agitation symptoms. The Grading of Recommendations, Assessment, Development, and Evaluation analysis results showed that exercise has a moderate and high confidence positive effect on NPS and depression, respectively.</AbstractText><AbstractText Label="CONCLUSIONS">Exercise could be an alternative approach for nonpharmacological treatment of NPS in dementia. Therefore, exercise could be utilized as a treatment of choice or to support existing treatment regimens.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kouloutbani</LastName><ForeName>Komanthi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Physical Education and Sport Science, National and Kapodistrian University of Athens, Dafni.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venetsanou</LastName><ForeName>Fotini</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Physical Education and Sport Science, National and Kapodistrian University of Athens, Dafni.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karteroliotis</LastName><ForeName>Konstantinos E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>School of Physical Education and Sport Science, National and Kapodistrian University of Athens, Dafni.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Politis</LastName><ForeName>Antonios</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0261-7517</Identifier><AffiliationInfo><Affiliation>First Department of Psychiatry, National and Kapodistrian University of Athens, Eginition Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Alzheimer Dis Assoc Disord</MedlineTA><NlmUniqueID>8704771</NlmUniqueID><ISSNLinking>0893-0341</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005081" MajorTopicYN="N">Exercise Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>11</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36821178</ArticleId><ArticleId IdType="doi">10.1097/WAD.0000000000000544</ArticleId><ArticleId IdType="pii">00002093-202301000-00011</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ballard C, Cream J. Drugs used to relieve behavioral symptoms in people with dementia or an unacceptable chemical cosh? Int Psychogeriatr. 2005;17:4&#x2013;12.</Citation></Reference><Reference><Citation>Ballard C, Day S, Sharp S, et al. Neuropsychiatric symptoms in dementia: Importance and treatment considerations. Int Rev Psychiatry. 2008;20:396&#x2013;404.</Citation></Reference><Reference><Citation>Lyketsos CG, Carrillo MC, Ryan JM, et al. Neuropsychiatric symptoms in Alzheimer&#x2019;s disease. Alzheimers Dement. 2011;7:532&#x2013;539.</Citation></Reference><Reference><Citation>Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294:1934&#x2013;1943.</Citation></Reference><Reference><Citation>Christofoletti G, Oliani MM, Bucken-Gobbi LT, et al. Physical activity attenuates neuropsychiatric disturbances and caregiver burden in patients with dementia. Clinics. 2011;66:613&#x2013;618.</Citation></Reference><Reference><Citation>Fleiner T, Dauth H, Gersie M, et al. Structured physical exercise improves neuropsychiatric symptoms in acute dementia care: a hospital-based RCT. Alzheimer&#x2019;s Res &amp; Ther. 2017;9:68.</Citation></Reference><Reference><Citation>Hulme C, Wright J, Crocker T, et al. Non-pharmacological approaches for dementia that informal carers might try or access: a systematic review. Int J Geriatr Psychiatry. 2010;25:756&#x2013;763.</Citation></Reference><Reference><Citation>Kouloutbani K, Karteroliotis K. Politis. The effect of physical activity on dementia. Psychiatriki. 2019;30:142&#x2013;155.</Citation></Reference><Reference><Citation>Leng M, Liang B, Zhou H, et al. Effects of physical exercise on depressive symptoms in patients with cognitive impairment: a systematic review and meta-analysis. J Nerv Ment Dis. 2018;206:809&#x2013;823.</Citation></Reference><Reference><Citation>Woodhead EL, Zarit SH, Braungart ER, et al. Behavioral and psychological symptoms of dementia: the effects of physical activity at adult day service centres. Am J Alzheimers Dis Other Demen. 2005;20:171&#x2013;179.</Citation></Reference><Reference><Citation>Mendon&#xe7;a DCB, Fernandes DR, Hernandez SS, et al. Physical exercise is effective for neuropsychiatric symptoms in Alzheimer&#x2019;s disease: a systematic review. Arq Neuro-Psiquiatr. 2021;79:447&#x2013;456.</Citation></Reference><Reference><Citation>Barreto PDS, Demougeot L, Pillard F, et al. Exercise training for managing behavioral and psychological symptoms in people with dementia: a systematic review and meta-analysis. Ageing Res Rev. 2015;24:274&#x2013;285.</Citation></Reference><Reference><Citation>Forbes D, Forbes SC, Blake CM, et al. Exercise programs for people with dementia. Cochrane Database Syst Rev. 2015;4:CD006489.</Citation></Reference><Reference><Citation>Oliveira AMD, Radanovic M, Mello PCHD, et al. Nonpharmacological interventions to reduce behavioral and psychological symptoms of dementia: a systematic review. BioMed Res Int. 2015;2015:1&#x2013;9.</Citation></Reference><Reference><Citation>Theleritis C, Siarkos K, Politis AA, et al. A systematic review of non-pharmacological treatment for apathy in dementia. Int J Geriatr Psychiatry. 2018;33:e177&#x2013;e192.</Citation></Reference><Reference><Citation>Kouloutbani K, Venetsanou F, Markati A, et al. The effectiveness of physical exercise interventions in the management of neuropsychiatric symptoms in dementia patients: a systematic review. Int Psychogeriatr. 2021;34:177&#x2013;190.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006&#x2013;1012.</Citation></Reference><Reference><Citation>Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308&#x2013;2314.</Citation></Reference><Reference><Citation>Higgins JPT, Altman DG, G&#xf8;tzsche PC, et al. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.</Citation></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, et al. . Cochrane handbook for systematic reviews of interventions version 6.3. Cochrane, 2022. Accessed April 10, 2022. https://training.cochrane.org/handbook</Citation></Reference><Reference><Citation>Sch&#xfc;nemann H, Bro&#x17c;ek J, Guyatt G, et al. GRADE handbook for grading quality of evidence and strength of recommendations using the GRADE approach. 2013. The GRADE Working Group. Accessed January 18, 2022. https://gdt.gradepro.org/app/handbook/handbook.html</Citation></Reference><Reference><Citation>Abd El-Kader SM, Al-Jiffri OH. Aerobic exercise improves quality of life, psychological well-being, and systemic inflammation in subjects with Alzheimer&#x2019;s disease. Afr Health Sci. 2016;16:1045&#x2013;1055.</Citation></Reference><Reference><Citation>Cancela JM, Ay&#xe1;n C, Varela S. Effects of a long-term aerobic exercise intervention on institutionalised patients with dementia. J Sci Med Sport. 2016;19:293&#x2013;298.</Citation></Reference><Reference><Citation>Chen K-M, Kuo C-C, Chang Y-H. Resistance band exercises reduce depression and behavioral problems of wheelchair-bound older adults with dementia: a cluster-randomized controlled trial. J Am Geriatr Soc. 2017;65:356&#x2013;363.</Citation></Reference><Reference><Citation>D&#x2019;Amico F, Rehill A, Knapp M, et al. Cost-effectiveness of exercise as a therapy for behavioural and psychological symptoms of dementia within the EVIDEM-E randomised controlled trial. Int J Geriatr Psychiatry. 2016;31:656&#x2013;665.</Citation></Reference><Reference><Citation>Hoffmann K, Sobol NA, Frederiksen KS, et al. Moderate-to-high intensity physical exercise in patients with Alzheimer&#x2019;s disease: a randomized controlled trial. J Alzheimer&#x2019;s Dis. 2016;50:443&#x2013;453.</Citation></Reference><Reference><Citation>Lamb SE, Sheehan B, Atherton N, et al. Dementia and physical activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial. BMJ. 2018;361:k1675.</Citation></Reference><Reference><Citation>Langoni CDS, Resende TDL, Barcellos AB, et al. The effect of group exercises on balance, mobility, and depressive symptoms in older adults with mild cognitive impairment: a randomized controlled trial. Clin Rehabil. 2019;33:439&#x2013;449.</Citation></Reference><Reference><Citation>Lowery D, Cerga-Pashoja A, Iliffe S, et al. The effect of exercise on behavioural and psychological symptoms of dementia: the EVIDEM-E randomised controlled clinical trial. Int J Geriatr Psychiatry. 2014;29:819&#x2013;827.</Citation></Reference><Reference><Citation>&#xd6;hman H, Savikko NRN, Strandberg TE, et al. Effects of frequent and long-term exercise on neuropsychiatric symptoms in patients with Alzheimer&#x2019;s disease&#x2014;secondary analyses of a randomized controlled trial (FINALEX). Eur Geriatr Med. 2017;8:153&#x2013;157.</Citation></Reference><Reference><Citation>Rolland Y, Pillard F, Klapouszczak A, et al. Exercise program for nursing home residents with Alzheimer&#x2019;s disease: a 1-year randomized, controlled trial. J Am Geriatr Soc. 2007;55:158&#x2013;165.</Citation></Reference><Reference><Citation>Sobol NA, Dall CH, Hogh P, et al. Change in fitness and the relation to change in cognition and neuropsychiatric symptoms after aerobic exercise in patients with mild Alzheimer&#x2019;s disease. J Alzheimer&#x2019;s Dis. 2018;65:137&#x2013;145.</Citation></Reference><Reference><Citation>Stella F, Canonici AP, Gobbi S, et al. Attenuation of neuropsychiatric symptoms and caregiver burden in Alzheimer&#x2019;s disease by motor intervention: a controlled trial. Clinics. 2011;66:1353&#x2013;1360.</Citation></Reference><Reference><Citation>Venturelli M, Sollima A, C&#xe8; E, et al. Effectiveness of exercise-and cognitive-based treatments on salivary cortisol levels and sundowning syndrome symptoms in patients with Alzheimer&#x2019;s disease. J Alzheimer&#x2019;s Dis. 2016;53:1631&#x2013;1640.</Citation></Reference><Reference><Citation>Matura S, Carvalho AF, Alves GS, et al. Physical exercise for the treatment of neuropsychiatric disturbances in Alzheimer&#x2019;s dementia: possible mechanisms, current evidence and future directions. Curr Alzheimer Res. 2016;13:1112&#x2013;1123.</Citation></Reference><Reference><Citation>Mellion MB. Exercise therapy for anxiety and depression. Postgrad Med. 1985;77:59&#x2013;66.</Citation></Reference><Reference><Citation>Paluska SA, Schwenk TL. Physical activity and mental health. Sports Med. 2000;29:167&#x2013;180.</Citation></Reference><Reference><Citation>Lin TW, Kuo YM. Exercise benefits brain function: the monoamine connection. Brain Sci. 2013;3:39&#x2013;53.</Citation></Reference><Reference><Citation>Chaouloff F. Effects of acute physical exercise on central serotonergic systems. Med Sci Sports Exerc. 1997;29:58&#x2013;62.</Citation></Reference><Reference><Citation>Str&#xfc;der HK, Weicker H. Physiology and pathophysiology of the serotonergic system and its implications on mental and physical performance. Part I Int J Sports Med. 2001;22:467&#x2013;481.</Citation></Reference><Reference><Citation>Ma Q. Beneficial effects of moderate voluntary physical exercise and its biological mechanisms on brain health. Neurosci Bull. 2008;24:265&#x2013;270.</Citation></Reference><Reference><Citation>Soysal P, Isik AT, Carvalho AF, et al. Oxidative stress and frailty: a systematic review and synthesis of the best evidence. Maturitas. 2017;99:66&#x2013;72.</Citation></Reference><Reference><Citation>Soysal P, Stubbs B, Lucato P, et al. Inflammation and frailty in the elderly: a systematic review and meta-analysis. Ageing Res Rev. 2016;31:1&#x2013;8.</Citation></Reference><Reference><Citation>Veronese N, Solmi M, Basso C, et al. Role of physical activity in ameliorating neuropsychiatric symptoms in Alzheimer disease: a narrative review. Int J Geriatr Psychiatry. 2019;34:1316&#x2013;1325.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36821177</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-4156</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>1</Issue><PubDate><MedlineDate>2023 Jan-Mar 01</MedlineDate></PubDate></JournalIssue><Title>Alzheimer disease and associated disorders</Title><ISOAbbreviation>Alzheimer Dis Assoc Disord</ISOAbbreviation></Journal><ArticleTitle>Research Priorities of Individuals and Caregivers With Lewy Body Dementia: A Web-based Survey.</ArticleTitle><Pagination><StartPage>50</StartPage><EndPage>58</EndPage><MedlinePgn>50-58</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/WAD.0000000000000545</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Lewy body dementia (LBD) is common, yet under-recognized and under-researched. To plan studies with the highest impact, engagement of the community personally affected by these conditions is essential.</AbstractText><AbstractText Label="METHODS">A web-based survey of people living with LBD and current and former caregivers of people with LBD queried research priorities through forced ranking and exploration of burden of LBD symptoms. Specific caregiving needs in LBD and perceptions of research participation were also investigated.</AbstractText><AbstractText Label="RESULTS">Between April 7, 2021 and July 1, 2021, 984 responses were recorded. Top research priorities included disease-modifying therapies and improved disease detection and staging. People with LBD were interested in pathophysiology and more bothered by motor symptoms; caregivers were interested in risk factors and symptomatic therapies and more bothered by neuropsychiatric symptoms. Few available LBD treatments and resources were rated as helpful, and many valuable services were never received. Previous participation in LBD research was infrequent, but interest was high.</AbstractText><AbstractText Label="DISCUSSION">People with LBD and caregivers highlighted the need for research across all aspects of LBD, from pathophysiology and disease modification to prognosis, education, symptomatic treatments, and caregiver support. Funders should increase support for all aspects of LBD research to target the many needs identified by individuals and families living with LBD.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Holden</LastName><ForeName>Samantha K</ForeName><Initials>SK</Initials><Identifier Source="ORCID">0000-0001-6494-0606</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Colorado School of Medicine, Aurora, CO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bedenfield</LastName><ForeName>Noheli</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Florida, Dorothy Mangurian Clinical-Research Headquarters for Lewy Body Dementia, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Angela S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Lewy Body Dementia Association, Liliburn, GA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayram</LastName><ForeName>Ece</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of California San Diego, San Diego.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwilk</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Lewy Body Dementia Association, Liliburn, GA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Jori</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurological Sciences, Rush University Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duda</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shill</LastName><ForeName>Holly</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Barrow Neurological Institute, Phoenix, AZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paulson</LastName><ForeName>Henry L</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stacy</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>College of Nursing, University of Cincinnati, Cincinnati, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Lewy Body Dementia Association, Liliburn, GA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corsentino</LastName><ForeName>Pamela</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Lewy Body Dementia Association, Liliburn, GA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sha</LastName><ForeName>Sharon J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Oregon Health and Science University, Portland, OR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Litvan</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of California San Diego, San Diego.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irwin</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>Joseph F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department of Neurology, Oregon Health and Science University, Portland, OR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldman</LastName><ForeName>Jennifer G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Shirley Ryan AbilityLab, Parkinson's Disease and Movement Disorders Program, Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amodeo</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Westchester Medical Center- MidHudson Regional Hospital, Poughkeepsie, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>John-Paul</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Institute of Neuroscience, Newcastle University, Newcastle Upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boeve</LastName><ForeName>Bradley F</ForeName><Initials>BF</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armstrong</LastName><ForeName>Melissa J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Florida, Dorothy Mangurian Clinical-Research Headquarters for Lewy Body Dementia, Gainesville, FL.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 NS100610</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG038791</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 NS080818</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG047266</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG066597</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG062418</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS109260</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072931</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R25 NS098999</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K99 AG073453</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG068128</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG017266</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS114764</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG063911</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Alzheimer Dis Assoc Disord</MedlineTA><NlmUniqueID>8704771</NlmUniqueID><ISSNLinking>0893-0341</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020961" MajorTopicYN="Y">Lewy Body Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>S.K.H. has received research support from the Michael J. Fox Foundation for Parkinson&#x2019;s Research and NIH and has received honoraria from the American Academy of Neurology. H.L.P. has received research support from NIH/NIA (P30AG 072931). J.G.G. has received research support from Acadia, Michael J. Fox Foundation, and Parkinson&#x2019;s Foundation, serves as a consultant for Worldwide Med, and has received honoraria from the American Academy of Neurology, Davis Phinney Foundation, International Parkinson and Movement Disorders Society, Medscape, and Parkinson&#x2019;s Foundation. I.L. has received research support from NIH (2R01AG038791-06A, U01NS100610, U01NS80818, R25NS098999; U19 AG063911-1, 1R21NS114764-01A1) the Michael J Fox Foundation, Parkinson Foundation, Lewy Body Association, CurePSP, Roche, Abbvie, Biogen, Centogene. EIP-Pharma, Biohaven Pharmaceuticals, Novartis, Brain Neurotherapy Bio, and United Biopharma SRL-UCB. I.L. was a member of the Scientific Advisory Board of Lundbeck and is a Scientific Advisor for Amydis and Rossy Center for the Progressive Supranuclear Palsy University of Toronto. I.L. receives her salary from the University of California San Diego and as Chief Editor of Frontiers in Neurology. D.J.I. receives research funding from NIH (R01-NS109260, P01-AG066597, U19-AG062418, U01-NS100610), Penn Institute on Aging. D.J.I. is a member of the scientific advisory board of Denali Therapeutics. J.-P.T. reports grants from the UK National Institute of Health Research (NIHR), non-financial support from Axovant and personal fees from GE Healthcare. B.F.B. reports personal fees for scientific advisory board membership from the Tau Consortium, grants from GE Healthcare, National Institutes of Health, Mangurian Foundation, and Axovant. M.J.A. receives research support from the NIA (R01AG068128, P30AG047266), the Florida Department of Health (Grant 20A08). M.J.A. serves on the data safety monitoring boards (DSMBs) for ACTC/ATRI and ADCS. M.J.A. receives royalties from the publication of the book Parkinson&#x2019;s Disease: Improving Patient Care. M.J.A. serves on the level of evidence editorial board for Neurology and related publications (uncompensated). The remaining authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>11</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36821177</ArticleId><ArticleId IdType="mid">NIHMS1865525</ArticleId><ArticleId IdType="pmc">PMC9971616</ArticleId><ArticleId IdType="doi">10.1097/WAD.0000000000000545</ArticleId><ArticleId IdType="pii">00002093-202301000-00008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Galvin JE, Duda JE, Kaufer DI, Lippa CF, Taylor A, Zarit SH. Lewy body dementia: the caregiver experience of clinical care. Parkinsonism Relat Disord. Jul 2010;16(6):388&#x2013;92. doi:10.1016/j.parkreldis.2010.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2010.03.007</ArticleId><ArticleId IdType="pmc">PMC2916037</ArticleId><ArticleId IdType="pubmed">20434939</ArticleId></ArticleIdList></Reference><Reference><Citation>Surendranathan A, Kane JPM, Bentley A, et al. Clinical diagnosis of Lewy body dementia. BJPsych Open. Jun 16 2020;6(4):e61. doi:10.1192/bjo.2020.44</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjo.2020.44</ArticleId><ArticleId IdType="pmc">PMC7345593</ArticleId><ArticleId IdType="pubmed">32539875</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Wilson L, Kornak J, et al. The costs of dementia subtypes to California Medicare fee-for-service, 2015. Alzheimers Dement. July 2019;15(7):899&#x2013;906. doi:10.1016/j.jalz.2019.03.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.03.015</ArticleId><ArticleId IdType="pmc">PMC7183386</ArticleId><ArticleId IdType="pubmed">31175026</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker WW, Luis CA, Kashuba A, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord. 2002 Oct-Dec 2002;16(4):203&#x2013;12. doi:10.1097/00002093-200210000-00001</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002093-200210000-00001</ArticleId><ArticleId IdType="pubmed">12468894</ArticleId></ArticleIdList></Reference><Reference><Citation>PUBLIC MEMBERS OF THE ADVISORY COUNCIL ON ALZHEIMER&#x2019;S RESEARCH, CARE AND SERVICES: 2020 Recommendations Executive Summary. https://aspe.hhs.gov/sites/default/files/private/pdf/259591/2018PubMemRec.pdf</Citation></Reference><Reference><Citation>Gitlin LN, Maslow K, Khillan R. Research Summit on Dementia Care Building Evidence for Services and Supports: Main Summit Recommendations. 2017:</Citation></Reference><Reference><Citation>Rukes K, Fowler NR. Engaging Persons Living With Dementia in the Research Process: Best Practice Considerations From a National Dementia Meeting. Am J Geriatr Psychiatry. April 2020;28(4):431&#x2013;433. doi:10.1016/j.jagp.2019.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2019.11.008</ArticleId><ArticleId IdType="pubmed">31839462</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuben DB, Wolff JL. The future of dementia care, caregiving, and services research. J Am Geriatr Soc. 07 2021;69(7):1752&#x2013;1754. doi:10.1111/jgs.17268</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17268</ArticleId><ArticleId IdType="pubmed">34245587</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowe S, Fenton M, Hall M, Cowan K, Chalmers I. Patients&#x2019;, clinicians&#x2019; and the research communities&#x2019; priorities for treatment research: there is an important mismatch. Res Involv Engagem. 2015;1:2. doi:10.1186/s40900-015-0003-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40900-015-0003-x</ArticleId><ArticleId IdType="pmc">PMC5598091</ArticleId><ArticleId IdType="pubmed">29062491</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel NK, Masoud SS, Meyer K, et al. Engaging multi-stakeholder perspectives to identify dementia care research priorities. J Patient Rep Outcomes. Jun 22 2021;5(1):46. doi:10.1186/s41687-021-00325-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41687-021-00325-x</ArticleId><ArticleId IdType="pmc">PMC8218276</ArticleId><ArticleId IdType="pubmed">34156561</ArticleId></ArticleIdList></Reference><Reference><Citation>Bethell J, Commisso E, Rostad HM, et al. Patient engagement in research related to dementia: A scoping review. Dementia (London). Nov 2018;17(8):944&#x2013;975. doi:10.1177/1471301218789292</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301218789292</ArticleId><ArticleId IdType="pubmed">30373460</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong MJ, Gamez N, Alliance S, et al. Research priorities of caregivers and individuals with dementia with Lewy bodies: An interview study. PLoS One. 2020;15(10):e0239279. doi:10.1371/journal.pone.0239279</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239279</ArticleId><ArticleId IdType="pmc">PMC7540843</ArticleId><ArticleId IdType="pubmed">33027276</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson B, Armstrong M, Galasko D, et al. Lewy Body Dementia Association&#x2019;s Research Centers of Excellence Program: Inaugural Meeting Proceedings. Alzheimers Res Ther. March 13 2019;11(1):23. doi:10.1186/s13195-019-0476-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-019-0476-1</ArticleId><ArticleId IdType="pmc">PMC6417280</ArticleId><ArticleId IdType="pubmed">30867052</ArticleId></ArticleIdList></Reference><Reference><Citation>Eysenbach G Improving the Quality of Web Surveys: The Checklist for Reporting Results of Internet E-Surveys (CHERRIES). Journal of Medical Internet Research. 2004-September-29 2004;6(3):e34. doi:10.2196/jmir.6.3.e34</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.6.3.e34</ArticleId><ArticleId IdType="pmc">PMC1550605</ArticleId><ArticleId IdType="pubmed">15471760</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. Apr 2009;42(2):377&#x2013;81. doi:10.1016/j.jbi.2008.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. July 2019;95:103208. doi:10.1016/j.jbi.2019.103208</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider J, Jeon S, Gladman JT, Corriveau RA. ADRD Summit 2019 Report to the National Advisory Neurological Disorders and Stroke Council. https://www.ninds.nih.gov/sites/default/files/2019_adrd_summit_recommendations_508c.pdf</Citation></Reference><Reference><Citation>Lewy Body Dementia: Information for Patients, Families, and Professionals. National Institutes on Health. 2022. https://order.nia.nih.gov/publication/lewy-body-dementia-information-for-patients-families-and-professionals</Citation></Reference><Reference><Citation>Armstrong MJ, Gamez N, Alliance S, et al. Clinical Care and Unmet Needs of Individuals With Dementia With Lewy Bodies and Caregivers: An Interview Study. Alzheimer Dis Assoc Disord. 2021 Oct-Dec 01 2021;35(4):327&#x2013;334. doi:10.1097/WAD.0000000000000459</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0000000000000459</ArticleId><ArticleId IdType="pmc">PMC8605983</ArticleId><ArticleId IdType="pubmed">34034295</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeith IG, Ferman TJ, Thomas AJ, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. April 2020;94(17):743&#x2013;755. doi:10.1212/WNL.0000000000009323</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009323</ArticleId><ArticleId IdType="pmc">PMC7274845</ArticleId><ArticleId IdType="pubmed">32241955</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolf SH, Zimmerman E, Haley A, Krist AH. Authentic Engagement Of Patients And Communities Can Transform Research, Practice, And Policy. Health Aff (Millwood). Apr 2016;35(4):590&#x2013;4. doi:10.1377/hlthaff.2015.1512</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2015.1512</ArticleId><ArticleId IdType="pmc">PMC4868544</ArticleId><ArticleId IdType="pubmed">27044956</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank L, Shubeck E, Schicker M, et al. The Experiences of Persons Living with Dementia Planning for a Dementia Research Meeting. Lessons Learned From the National Research Summit on Care, Services, and Supports for Persons With Dementia and Their Caregivers. Am J Geriatr Psychiatry. April 2020;28(4):434&#x2013;442. doi:10.1016/j.jagp.2019.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2019.10.015</ArticleId><ArticleId IdType="pubmed">31767451</ArticleId></ArticleIdList></Reference><Reference><Citation>Keogh F, Carney P, O&#x2019;Shea E. Innovative methods for involving people with dementia and carers in the policymaking process. Health Expect. June 2021;24(3):800&#x2013;809. doi:10.1111/hex.13213</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hex.13213</ArticleId><ArticleId IdType="pmc">PMC8235887</ArticleId><ArticleId IdType="pubmed">33650760</ArticleId></ArticleIdList></Reference><Reference><Citation>Nygaard A, Halvorsrud L, Bye A, Bergland A. It takes two to tango: carers&#x2019; reflections on their participation and the participation of people with dementia in the James Lind Alliance process. BMC Geriatr. May 14 2020;20(1):175. doi:10.1186/s12877-020-01570-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-020-01570-3</ArticleId><ArticleId IdType="pmc">PMC7227228</ArticleId><ArticleId IdType="pubmed">32408893</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank L, Jennings LA, Petersen RC, et al. Participation of persons with dementia and their caregivers in research. J Am Geriatr Soc. July 2021;69(7):1784&#x2013;1792. doi:10.1111/jgs.17340</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17340</ArticleId><ArticleId IdType="pmc">PMC8369513</ArticleId><ArticleId IdType="pubmed">34245586</ArticleId></ArticleIdList></Reference><Reference><Citation>Babulal GM, Quiroz YT, Albensi BC, et al. Perspectives on ethnic and racial disparities in Alzheimer&#x2019;s disease and related dementias: Update and areas of immediate need. Alzheimers Dement. February 2019;15(2):292&#x2013;312. doi:10.1016/j.jalz.2018.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.09.009</ArticleId><ArticleId IdType="pmc">PMC6368893</ArticleId><ArticleId IdType="pubmed">30555031</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurasz AM, Smith GE, McFarland MG, Armstrong MJ. Ethnoracial Differences in Lewy Body Diseases with Cognitive Impairment. J Alzheimers Dis. 2020;77(1):165&#x2013;174. doi:10.3233/JAD-200395</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200395</ArticleId><ArticleId IdType="pmc">PMC7553012</ArticleId><ArticleId IdType="pubmed">32804137</ArticleId></ArticleIdList></Reference><Reference><Citation>Damron L, Litvan I, Bayram E, Berk S, Siddiqi B, Shill H. Hispanic Perspectives on Parkinson&#x2019;s Disease Care and Research Participation. J Alzheimers Dis. 2021;81(2):809&#x2013;819. doi:10.3233/JAD-210231</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-210231</ArticleId><ArticleId IdType="pmc">PMC8203231</ArticleId><ArticleId IdType="pubmed">33843687</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellinger KA, Korczyn AD. Are dementia with Lewy bodies and Parkinson&#x2019;s disease dementia the same disease? BMC Med. March 06 2018;16(1):34. doi:10.1186/s12916-018-1016-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-018-1016-8</ArticleId><ArticleId IdType="pmc">PMC5840831</ArticleId><ArticleId IdType="pubmed">29510692</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36819614</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1568-4156</ISSN><JournalIssue CitedMedium="Print"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Season>Jan-Mar</Season></PubDate></JournalIssue><Title>International journal of integrated care</Title><ISOAbbreviation>Int J Integr Care</ISOAbbreviation></Journal><ArticleTitle>Nursing Care Coordination in Primary Healthcare for Patients with Complex Needs: A Comparative Case Study.</ArticleTitle><Pagination><StartPage>5</StartPage><MedlinePgn>5</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5334/ijic.6729</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Despite nurses' substantial role in care coordination, few education programs exist to better support them in this role. Identification of a set of core care coordination activities across heterogeneous care coordination programs would facilitate the development of a standard of practice. We sought to examine care coordination activities across two care coordination programs in Family Medicine Groups in Quebec, and their relationship to the program design.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We performed a comparative case study of two care coordination programs in primary care targeting frequent users of healthcare services and people with Alzheimer's disease and related disorders. Data collection included documents and semi-structured interviews with key informants.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Several activities were common to both programs, such as patient identification; assessment, development of an individualized service plan; and linking patients and caregivers with professionals and services. However, their components were different due to the impact of the integrated care program design, policy environment, and the target patient populations' complex needs.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">The homogeneity or heterogeneity of patients' complex needs shapes their care trajectory and the intensity of their care coordination needs. As the complexity of these needs grows, so does the necessity to build the care coordinators' capacity for integrated care.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karam</LastName><ForeName>Marl&#xe8;ne</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5277-2000</Identifier><AffiliationInfo><Affiliation>Faculty of Nursing, Universit&#xe9; de Montr&#xe9;al, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chouinard</LastName><ForeName>Maud-Christine</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0001-8114-9146</Identifier><AffiliationInfo><Affiliation>Faculty of Nursing, Universit&#xe9; de Montr&#xe9;al, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couturier</LastName><ForeName>Yves</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-6848-8354</Identifier><AffiliationInfo><Affiliation>Department of Social Work, Universit&#xe9; de Sherbrooke, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vedel</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-6873-1681</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, McGill University, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hudon</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6140-9916</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine and Emergency Medicine, Universit&#xe9; de Sherbrooke, Quebec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Integr Care</MedlineTA><NlmUniqueID>101214424</NlmUniqueID></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="fre"><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Malgr&#xe9; le r&#xf4;le important des infirmi&#xe8;res dans la coordination des soins et des services, peu de programmes de formation existent pour mieux les soutenir dans l&#x2019;exercice de celui-ci. L&#x2019;identification d&#x2019;un tronc commun d&#x2019;activit&#xe9;s de coordination des soins et services effectu&#xe9;es par les infirmi&#xe8;res &#xe0; travers diff&#xe9;rents programmes de coordination faciliterait l&#x2019;&#xe9;laboration d&#x2019;une norme de pratique en vue de rehausser leur formation &#xe0; cet &#xe9;gard. Cette &#xe9;tude examine les activit&#xe9;s de coordination des soins et services effectu&#xe9;es par les infirmi&#xe8;res dans deux programmes de coordination h&#xe9;t&#xe9;rog&#xe8;nes d&#xe9;ploy&#xe9;s dans les groupes de m&#xe9;decine de famille au Qu&#xe9;bec, et la fa&#xe7;on dont la conception du programme impacte celles-ci.</AbstractText><AbstractText Label="M&#xc9;THODES" NlmCategory="UNASSIGNED">Nous avons r&#xe9;alis&#xe9; une &#xe9;tude de cas comparative de deux programmes de coordination des soins et services en premi&#xe8;re ligne ciblant les usagers fr&#xe9;quents des services de sant&#xe9; et les personnes atteintes de la maladie d&#x2019;Alzheimer et des troubles apparent&#xe9;s. La collecte de donn&#xe9;es comprenait une analyse documentaire et des entretiens semi-dirig&#xe9;s avec des informateurs cl&#xe9;s.</AbstractText><AbstractText Label="R&#xc9;SULTATS" NlmCategory="UNASSIGNED">Plusieurs activit&#xe9;s &#xe9;taient communes aux deux programmes, telles que l&#x2019;identification des patients ; &#xe9;valuation, &#xe9;laboration d&#x2019;un plan de services individualis&#xe9; ; et la mise en relation des patients et des soignants avec des professionnels et des services. Cependant, leurs composantes &#xe9;taient diff&#xe9;rentes en raison de l&#x2019;impact de la conception du programme de soins int&#xe9;gr&#xe9;s, de l&#x2019;environnement politique et des besoins complexes des populations de patients cibles.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">L&#x2019;homog&#xe9;n&#xe9;it&#xe9; ou l&#x2019;h&#xe9;t&#xe9;rog&#xe9;n&#xe9;it&#xe9; des besoins complexes des patients fa&#xe7;onne leur trajectoire de soins et l&#x2019;intensit&#xe9; de leurs besoins de coordination des soins. &#xc0; mesure que la complexit&#xe9; de ces besoins augmente, la n&#xe9;cessit&#xe9; de renforcer la capacit&#xe9; des coordonnateurs de soins en mati&#xe8;re de soins int&#xe9;gr&#xe9;s augmente &#xe9;galement.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 The Author(s).</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">care coordination</Keyword><Keyword MajorTopicYN="N">case study</Keyword><Keyword MajorTopicYN="N">complex needs</Keyword><Keyword MajorTopicYN="N">continuing education</Keyword><Keyword MajorTopicYN="N">integrated care</Keyword><Keyword MajorTopicYN="N">nurses</Keyword></KeywordList><CoiStatement>The authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>10</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36819614</ArticleId><ArticleId IdType="pmc">PMC9912854</ArticleId><ArticleId IdType="doi">10.5334/ijic.6729</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Allen D, Griffiths L, Lyne P. Understanding complex trajectories in health and social care provision. Sociology of health &amp; illness. 2004; 26(7): 1008&#x2013;30. DOI: 10.1111/j.0141-9889.2004.00426.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0141-9889.2004.00426.x</ArticleId><ArticleId IdType="pubmed">15610476</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine Committee on Identifying Priority Areas for Quality I. Priority Areas for National Action: Transforming Health Care Quality. In: Adams K, Corrigan JM (eds.). Washington (DC): National Academies Press (US); 2003.</Citation><ArticleIdList><ArticleId IdType="pubmed">25057643</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell Davies G, Williams AM, Larsen K, Perkins D, Roland M, Harris MF. Coordinating primary health care: an analysis of the outcomes of a systematic review. The Medical journal of Australia. 2008; 188(8 Suppl): S65&#x2013;8. DOI: 10.5694/j.1326-5377.2008.tb01748.x</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/j.1326-5377.2008.tb01748.x</ArticleId><ArticleId IdType="pubmed">18429740</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrlich C, Kendall E, Muenchberger H, Armstrong K. Coordinated care: what does that really mean? Health &amp; social care in the community. 2009; 17(6): 619&#x2013;27. DOI: 10.1111/j.1365-2524.2009.00863.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2524.2009.00863.x</ArticleId><ArticleId IdType="pubmed">19469914</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudon C, Chouinard MC, Dubois MF, Roberge P, Loignon C, Tchouaket E, et al. Case Management in Primary Care for Frequent Users of Health Care Services: A Mixed Methods Study. Annals of family medicine. 2018; 16(3): 232&#x2013;9. DOI: 10.1370/afm.2233</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.2233</ArticleId><ArticleId IdType="pmc">PMC5951252</ArticleId><ArticleId IdType="pubmed">29760027</ArticleId></ArticleIdList></Reference><Reference><Citation>Penm J, MacKinnon NJ, Strakowski SM, Ying J, Doty MM. Minding the Gap: Factors Associated With Primary Care Coordination of Adults in 11 Countries. Annals of family medicine. 2017; 15(2): 113&#x2013;9. DOI: 10.1370/afm.2028</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.2028</ArticleId><ArticleId IdType="pmc">PMC5348227</ArticleId><ArticleId IdType="pubmed">28289109</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald KM, Sundaram V, Bravata DM, Lewis R, Lin N, Kraft SA, et al. AHRQ Technical Reviews. Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies (Vol 7: Care Coordination). Rockville, MD: Agency for Healthcare Research and Quality (US); 2007.</Citation><ArticleIdList><ArticleId IdType="pubmed">20734531</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell Davies G, Harris M, Perkins D, Roland M, Williams A, Larsen K, et al. Coordination of care within primary health care and with other sectors: A systematic review. Research Centre for Primary Health Care and Equity, School of Public Health and Community Medicine, UNSW; 2006.</Citation></Reference><Reference><Citation>Commission d&#x2019;&#xe9;tude sur les services de sant&#xe9; et les services sociaux. Les solutions &#xe9;mergentes: Rapport et recommandations. [Emerging Solutions: Report and Recommendations]. Qu&#xe9;bec; 2000. [cited 2022 12 Feb]. Available from: https://publications.msss.gouv.qc.ca/msss/fichiers/2000/00-109.pdf [in French].</Citation></Reference><Reference><Citation>Bergman H. Meeting the Challenge of Alzheimer&#x2019;s Disease and Related Disorders: A Vision Focused on the Individual, Humanism, and Excellence Qu&#xe9;bec; 2009.</Citation></Reference><Reference><Citation>Tremblay D, Prady C, Bilodeau K, Touati N, Chouinard MC, Fortin M, et al. Optimizing clinical and organizational practice in cancer survivor transitions between specialized oncology and primary care teams: a realist evaluation of multiple case studies. BMC health services research. 2017; 17(1): 834. DOI: 10.1186/s12913-017-2785-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-017-2785-z</ArticleId><ArticleId IdType="pmc">PMC5732430</ArticleId><ArticleId IdType="pubmed">29246224</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross S, Curry N, Goodwin N. Case management what it is and how it can be best implemented. UK; 2011. [cited 2021 10 Nov]. Available from: https://www.kingsfund.org.uk/sites/default/files/Case-Management-paper-The-Kings-Fund-Paper-November-2011_0.pdf.</Citation></Reference><Reference><Citation>Lamb G. Care coordination: the game changer. U.S.A: American Nurses Association; 2014.</Citation></Reference><Reference><Citation>Institute of Medicine Committee on the Health Professions Education S. In: Greiner AC, Knebel E (eds.), Health Professions Education: A Bridge to Quality. Washington, DC: National Academies Press (US); 2003.</Citation><ArticleIdList><ArticleId IdType="pubmed">25057657</ArticleId></ArticleIdList></Reference><Reference><Citation>Poitras M-E, Chouinard M-C, Fortin M, Girard A, Crossman S, Gallagher F. Nursing activities for patients with chronic disease in family medicine groups: A multiple-case study. 2018; 25(4): e12250. DOI: 10.1111/nin.12250</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nin.12250</ArticleId><ArticleId IdType="pubmed">29984533</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald KM, Schultz E, Albin L, Pineda N, Lonhart J, Sundaram V, Smith-Spangler C, Brustrom J, Malcolm E. Care Coordination Atlas Version 3 (Prepared by Stanford University under subcontract to Battelle on Contract No. 290-04-0020). AHRQ Publication No. 11-0023-EF. Rockville, MD: Agency for Healthcare Research and Quality; November
2010. [cited 2022 12 Feb]. Available from: https://www.tnaap.org/documents/ahrq-care-coordination-measures-atlas.pdf.</Citation></Reference><Reference><Citation>Steele Gray C, Zonneveld N, Breton M, Wankah P, Shaw J, Anderson GM, et al. Comparing International Models of Integrated Care: How Can We Learn Across Borders? International Journal of Integrated Care. 2020; 20(1): 14. DOI: 10.5334/ijic.5413</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/ijic.5413</ArticleId><ArticleId IdType="pmc">PMC7147684</ArticleId><ArticleId IdType="pubmed">32292312</ArticleId></ArticleIdList></Reference><Reference><Citation>Karam M, Chouinard MC, Poitras ME, Couturier Y, Vedel I, Grgurevic N, et al. Nursing Care Coordination for Patients with Complex Needs in Primary Healthcare: A Scoping Review. International Journal of Integrated Care. 2021; 21(1): 16. DOI: 10.5334/ijic.5518</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/ijic.5518</ArticleId><ArticleId IdType="pmc">PMC7977020</ArticleId><ArticleId IdType="pubmed">33776605</ArticleId></ArticleIdList></Reference><Reference><Citation>Merriam S-B. Qualitative research: A guide to design and implementation. 2nd edition. Jossey-Bass, editor. San Francisco: Jossey-Bass; 2009.</Citation></Reference><Reference><Citation>Fereday J, Muir-Cochrane E. Demonstrating Rigor Using Thematic Analysis: A Hybrid Approach of Inductive and Deductive Coding and Theme Development. International Journal of Qualitative Methods. 2006; 5(1): 80&#x2013;92. DOI: 10.1177/160940690600500107</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/160940690600500107</ArticleId></ArticleIdList></Reference><Reference><Citation>Minist&#xe8;re de la Sant&#xe9; et des Services sociaux. Evaluation de l&#x2019;implantation et des effets des premiers groupes de m&#xe9;decine de famille au Qu&#xe9;bec. [Evaluation of the implementation and effects of the first family medicine groups in Quebec]. Qu&#xe9;bec; 2008. [cited 2022 10 Jan]. Available from: https://publications.msss.gouv.qc.ca/msss/fichiers/2008/08-920-02.pdf [in French].</Citation></Reference><Reference><Citation>Chouinard MC, Hudon C, Dubois MF, Roberge P, Loignon C, Tchouaket E, et al. Case management and self-management support for frequent users with chronic disease in primary care: A pragmatic randomized controlled trial. BMC Health Services Research. 2013; 13(1). DOI: 10.1186/1472-6963-13-49</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6963-13-49</ArticleId><ArticleId IdType="pmc">PMC3601974</ArticleId><ArticleId IdType="pubmed">23391214</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudon C, Chouinard MC, Aubrey-Bassler K, Burge F, Doucet S, Ramsden VR, et al. Case management in primary care for frequent users of healthcare services with chronic diseases and complex care needs: an implementation and realist evaluation protocol. BMJ open. 2018; 8(11): e026433. DOI: 10.1136/bmjopen-2018-026433</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-026433</ArticleId><ArticleId IdType="pmc">PMC6254422</ArticleId><ArticleId IdType="pubmed">30478129</ArticleId></ArticleIdList></Reference><Reference><Citation>Chouinard MC, Fortin M. Table ronde sur les maladies chroniques au Saguenay Lac Saint Jean: Constats et recommandations. Chicoutimi; 2011.</Citation></Reference><Reference><Citation>Schraeder C, Fraser CW, Clark I, Long B, Shelton P, Waldschmidt V, et al. Evaluation of a primary care nurse case management intervention for chronically ill community dwelling older people. Journal of Clinical Nursing. 2008; 17(11C): 407&#x2013;17. DOI: 10.1111/j.1365-2702.2008.02578.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2702.2008.02578.x</ArticleId><ArticleId IdType="pubmed">26327423</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutherland D, Hayter M. Structured review: evaluating the effectiveness of nurse case managers in improving health outcomes in three major chronic diseases. Journal of clinical nursing. 2009; 18(21): 2978&#x2013;92. DOI: 10.1111/j.1365-2702.2009.02900.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2702.2009.02900.x</ArticleId><ArticleId IdType="pubmed">19747197</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey PW, Petkov JN, Misan G, Fuller J, Battersby MW, Cayetano TN, et al. Self-management support and training for patients with chronic and complex conditions improves health-related behaviour and health outcomes. Aust Health Rev. 2008; 32(2): 330&#x2013;8. DOI: 10.1071/AH080330</Citation><ArticleIdList><ArticleId IdType="doi">10.1071/AH080330</ArticleId><ArticleId IdType="pubmed">18447824</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudon C, Chouinard MC, Diadiou F, Lambert M, Bouliane D. Case management in primary care for frequent users of health care services with chronic diseases: A qualitative study of patient and family experience. Annals of family medicine. 2015; 13(6): 523&#x2013;8. DOI: 10.1370/afm.1867</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.1867</ArticleId><ArticleId IdType="pmc">PMC4639377</ArticleId><ArticleId IdType="pubmed">26553891</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudon C, Chouinard MC, Aubrey-Bassler K, Muhajarine N, Burge F, Bush PL, et al. Case Management in Primary Care for Frequent Users of Health Care Services: A Realist Synthesis. Annals of family medicine. 2020; 18(3): 218&#x2013;26. DOI: 10.1370/afm.2499</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.2499</ArticleId><ArticleId IdType="pmc">PMC7213991</ArticleId><ArticleId IdType="pubmed">32393557</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudon C, Chouinard MC, Brousselle A, Bisson M, Danish A. Evaluating complex interventions in real context: Logic analysis of a case management program for frequent users of healthcare services. Eval Program Plann. 2020; 79: 101753. DOI: 10.1016/j.evalprogplan.2019.101753</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.evalprogplan.2019.101753</ArticleId><ArticleId IdType="pubmed">31835149</ArticleId></ArticleIdList></Reference><Reference><Citation>Danish A, Chouinard MC, Aubrey-Bassler K, Burge F, Doucet S, Ramsden VR, et al. Protocol for a mixed-method analysis of implementation of case management in primary care for frequent users of healthcare services with chronic diseases and complex care needs. BMJ open. 2020; 10(6): e038241. DOI: 10.1136/bmjopen-2020-038241</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-038241</ArticleId><ArticleId IdType="pmc">PMC7265033</ArticleId><ArticleId IdType="pubmed">32487584</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudon C, Chouinard MC, Aubrey-Bassler K, Muhajarine N, Burge F, Pluye P, et al. Case management in primary care among frequent users of healthcare services with chronic conditions: protocol of a realist synthesis. BMJ open. 2017; 7(9): e017701. DOI: 10.1136/bmjopen-2017-017701</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-017701</ArticleId><ArticleId IdType="pmc">PMC5589014</ArticleId><ArticleId IdType="pubmed">28871027</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudon C, Bisson M, Dubois MF, Chiu Y, Chouinard MC, Dubuc N, et al. CONECT-6: a case-finding tool to identify patients with complex health needs. BMC health services research. 2021; 21(1): 157. DOI: 10.1186/s12913-021-06154-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-021-06154-4</ArticleId><ArticleId IdType="pmc">PMC7891167</ArticleId><ArticleId IdType="pubmed">33596929</ArticleId></ArticleIdList></Reference><Reference><Citation>Soci&#xe9;t&#xe9; Alzheimer. Raz-de-mar&#xe9;e: impact de la maladie d&#x2019;Alzheimer et des affections connexes au Canada. [Tidal wave: impact of Alzheimer&#x2019;s disease and related conditions in Canada]. Canada; 2010. [cited 2021 15 Dec]. Available from: https://alzheimer.ca/sites/default/files/documents/Raz-de-mar%C3%A9e_Soci%C3%A9t%C3%A9-Alzheimer.pdf#:~:text=Le%20Canada%20fait%20face%20%C3%A0,une%20d%C3%A9mence%20apparent%C3%A9e%20au%20Canada [in French].</Citation></Reference><Reference><Citation>Schubert CC, Boustani M, Callahan CM, Perkins AJ, Carney CP, Fox C, et al. Comorbidity profile of dementia patients in primary care: are they sicker? J Am Geriatr Soc. 2006; 54(1): 104&#x2013;9. DOI: 10.1111/j.1532-5415.2005.00543.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.00543.x</ArticleId><ArticleId IdType="pubmed">16420205</ArticleId></ArticleIdList></Reference><Reference><Citation>Minist&#xe8;re de la Sant&#xe9; et des Services sociaux. Cadre g&#xe9;n&#xe9;ral de projet: Projets d&#x2019;implantation cibl&#xe9;e en GMF pour rehausser l&#x2019;acc&#xe8;s aux services de sant&#xe9; et services sociaux avec le soutien des 2e et 3e lignes de services. [General project framework: Targeted implementation projects in Family Medicine Groups to improve access to health and social services with the support of secondary and tertiary care services]. Qu&#xe9;bec; 2014. [cited 2021 15 Dec]. Available from: https://publications.msss.gouv.qc.ca/msss/fichiers/2014/14-829-01W.pdf [in French].</Citation></Reference><Reference><Citation>Vedel I, Monette M, Lapointe L. Portrait des interventions mises en place au sein des groupes de m&#xe9;decine de famille pour les patients avec des troubles cognitifs li&#xe9;s au vieillissement (TCV) (la maladie d&#x2019;Alzheimer et les maladies apparent&#xe9;es). [Portrait of the interventions implemented within the family medicine groups for patients with cognitive disorders related to aging (Alzheimer&#x2019;s disease and related diseases)]. Montreal; 2012. [cited 2021 15 Dec]. Available from: https://numerique.banq.qc.ca/patrimoine/details/52327/2166719?docref=16o6k_da0lNsmuy8yKyX_A [in French].</Citation></Reference><Reference><Citation>Arsenault-Lapierre G, Sourial N, Pakzad S, Hardouin M, Couturier Y, Bergman H, et al. Validation of a Questionnaire for Family Physicians: Knowledge, Attitude, Practice on Dementia Care. Canadian journal on aging = La revue canadienne du vieillissement. 2020; 1&#x2013;10. DOI: 10.1017/S0714980820000069</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0714980820000069</ArticleId><ArticleId IdType="pubmed">32366352</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins C, McKay A. A collaborative approach to health promotion in early stage dementia. Nursing standard (Royal College of Nursing (Great Britain): 1987). 2013; 27(36): 49&#x2013;57; quiz 8. DOI: 10.7748/ns2013.05.27.36.49.e7304</Citation><ArticleIdList><ArticleId IdType="doi">10.7748/ns2013.05.27.36.49.e7304</ArticleId><ArticleId IdType="pubmed">23821990</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillette M. De la politique aux changements de pratiques: la traduction du Plan Alzheimer du Qu&#xe9;bec dans ses formes locales. [From policy to changes in practice: the translation of the Quebec Alzheimer&#x2019;s Plan into its local forms]. [Master&#x2019;s thesis]. Sherbrooke: Universit&#xe9; de Sherbrooke; 2016. [cited 2021 10 Nov]. Available from: http://hdl.handle.net/11143/9734 [in French].</Citation></Reference><Reference><Citation>Guillette M, Couturier Y, Moreau O, Gagnon D, Bergman H, Vedel I. Gouvernance et accompagnement du changement: le cas de la phase exp&#xe9;rimentale du Plan Alzheimer du Qu&#xe9;bec. [Governance and support for change: the case of the experimental phase of the Quebec Alzheimer&#x2019;s Plan]. Innovations. 2019; 60(3): 145&#x2013;68. [in French]. DOI: 10.3917/inno.060.0145</Citation><ArticleIdList><ArticleId IdType="doi">10.3917/inno.060.0145</ArticleId></ArticleIdList></Reference><Reference><Citation>Minist&#xe8;re de la Sant&#xe9; et des Services sociaux. Alzheimer et autres troubles neurocognitifs majeurs-Formation et mentorat. [Alzheimer&#x2019;s and other major neurocognitive disorders-Training and mentoring]. [webpage on the internet]. [cited 2021 15 Dec]; updated [updated 2018 Nov 05]. Available from: https://www.msss.gouv.qc.ca/professionnels/maladies-chroniques/alzheimer-et-autres-troubles-neurocognitifs-majeurs/formation-et-mentorat/ [in French].</Citation></Reference><Reference><Citation>Ordre des infirmi&#xe8;res et infirmiers du Qu&#xe9;bec, F&#xe9;d&#xe9;ration des m&#xe9;decins omnipraticiens du Qu&#xe9;bec. Rapport du groupe de travail OIIQ/FMOQ sur les r&#xf4;les de l&#x2019;infirmi&#xe8;re et du m&#xe9;decin omnipraticien de premi&#xe8;re ligne et les activit&#xe9;s partageables. [Report of the Order of nurses of Quebec/Federation of General Practitioners of Quebec working group on the roles of the front-line nurse and general practitioner and shared activities]. Qu&#xe9;bec; 2005. [cited 2021 Nov 3]. Available from: https://www.oiiq.org/uploads/publications/autres_publications/OIIQ_FMOQ.pdf [in French].</Citation></Reference><Reference><Citation>Minist&#xe8;re de la Sant&#xe9; et des Services sociaux. Approche non pharmacologique visant le traitement des sympt&#xf4;mes comportementaux et psychologiques de la d&#xe9;mence. [Non-pharmacological approach to the treatment of behavioral and psychological symptoms of dementia]. Qu&#xe9;bec; 2014. [cited 2021 Nov 3]. Available from: https://publications.msss.gouv.qc.ca/msss/fichiers/2014/14-829-06W.pdf [in French].</Citation></Reference><Reference><Citation>Minist&#xe8;re de la Sant&#xe9; et des Services sociaux. Cahier des exigences structurelles et de contenu &#x2013; Projets d&#x2019;implantation cibl&#xe9;e en GMF pour rehausser l&#x2019;acc&#xe8;s aux services de sant&#xe9; et services sociaux avec le soutien des 2e et 3e lignes de services. [Book of structural and content requirements &#x2013; Targeted implementation projects in Family Medicine Groups to improve access to health and social services with the support of secondary and tertiary care services]. Qu&#xe9;bec; 2012. [cited 2021 Nov 3]. Available from: https://publications.msss.gouv.qc.ca/msss/fichiers/2014/14-829-02W.pdf [in French].</Citation></Reference><Reference><Citation>Minist&#xe8;re de la Sant&#xe9; et des Services sociaux. Alzheimer et autres troubles neurocognitifs majeurs. Projet d&#x2019;implantation cibl&#xe9;e (2013&#x2013;2016). [Alzheimer&#x2019;s and other major neurocognitive disorders. Targeted implementation project (2013&#x2013;2016)]. [webpage on the internet]. [cited 2021 15 Dec]; updated [updated 2018 Nov 05]. Available from: https://www.msss.gouv.qc.ca/professionnels/maladies-chroniques/alzheimer-et-autres-troubles-neurocognitifs-majeurs/projet-d-implantation-ciblee/ [in French].</Citation></Reference><Reference><Citation>Guillette M, Moreau O, Couturier Y, Lanneville D. L&#x2019;&#xe9;thique dans une politique publique: Le cas du Plan Alzheimer du Qu&#xe9;bec. [Ethics in public policy: The case of the Quebec Alzheimer&#x2019;s Plan]. Banque Pol&#xc9;thica. 2018; 1&#x2013;14. [cited 2022 10 Jan]. Available from: https://gepps.ca/wp-content/uploads/Manuscrit_Alzheimer_MGuillette_25-09-2018_final.pdf. [in French].</Citation></Reference><Reference><Citation>Bergman H, Bouchard P. Le plan Alzheimer du Qu&#xe9;bec. Paris: Lavoisier; 2013.</Citation></Reference><Reference><Citation>Vedel I, Le Berre M, Sourial N, Arsenault-Lapierre G, Bergman H, Lapointe L. Shedding light on conditions for the successful passive dissemination of recommendations in primary care: a mixed methods study. Implementation Science. 2018; 13(1): 129. DOI: 10.1186/s13012-018-0822-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13012-018-0822-x</ArticleId><ArticleId IdType="pmc">PMC6192363</ArticleId><ArticleId IdType="pubmed">30326969</ArticleId></ArticleIdList></Reference><Reference><Citation>Vedel I, Sourial N, Arsenault-Lapierre G, Godard-Sebillotte C, Bergman H. Impact of the Quebec Alzheimer Plan on the detection and management of Alzheimer disease and other neurocognitive disorders in primary health care: a retrospective study. CMAJ open. 2019; 7(2): E391&#x2013;e8. DOI: 10.9778/cmajo.20190053</Citation><ArticleIdList><ArticleId IdType="doi">10.9778/cmajo.20190053</ArticleId><ArticleId IdType="pmc">PMC6579653</ArticleId><ArticleId IdType="pubmed">31201175</ArticleId></ArticleIdList></Reference><Reference><Citation>Minist&#xe8;re de la Sant&#xe9; et des Services sociaux. Guide de mise en &#x153;uvre pour le d&#xe9;ploiement des meilleures pratiques cliniques et organisationnelles dans les CISSS et les CIUSSS &#x2013; Seconde phase des travaux 2016 &#xe0; 2019. [Implementation guide for the deployment of clinical and organizational best practices in regional authorities (IHSSS and IUHSSS)- Second phase of work 2016 to 2019]. Qu&#xe9;bec; 2017. [cited 2021 Nov 2]. Available from: https://publications.msss.gouv.qc.ca/msss/fichiers/2016/16-829-01W_Guide_pratiques_cliniques_complet_BR.pdf [in French].</Citation></Reference><Reference><Citation>Minist&#xe8;re de la Sant&#xe9; et des Services sociaux. Processus clinique interdisciplinaire en 1&#xe8;re ligne. Processus clinique interdisciplinaire en premi&#xe8;re ligne. [Interdisciplinary clinical process in primary care]. [webpage on the internet]. [cited 2021 15 Dec]; updated [updated 2019 Nov 05]. Available from: https://publications.msss.gouv.qc.ca/msss/document-001071/#:~:text=Le%20Processus%20clinique%20interdisciplinaire%20en,dont%20la%20maladie%20d&#x2019;Alzheimer.&amp;text=Cette%20publication%20est%20disponible%20en%20version%20%C3%A9lectronique%20seulement [in French].</Citation></Reference><Reference><Citation>Minist&#xe8;re de la Sant&#xe9; et des Services sociaux. Protocole de soins &#x2013; Processus clinique interdisciplinaire en premi&#xe8;re ligne -Maladie Alzheimer et les maladies apparent&#xe9;es. [Protocol of care &#x2013; Interdisciplinary clinical process in primary care &#x2013; Alzheimer&#x2019;s disease and related disorders]. Qu&#xe9;bec; 2014. [cited 2021 15 Dec]. Available from: https://www.mcgill.ca/familymed/files/familymed/rd_protocole_de_soins_alzheimer_1e_ligne-20150127.pdf [in French].</Citation></Reference><Reference><Citation>Nicol-Clavet N. La pratique infirmi&#xe8;re en groupe de m&#xe9;decine de famille dans le cadre du Plan Alzheimer Qu&#xe9;bec. [Nursing practice in a family medicine group within the framework of the Plan Alzheimer Qu&#xe9;bec]. [Master&#x2019;s thesis]. Sherbrooke: Universit&#xe9; de Sherbrooke; 2016. [cited 2021 10 Nov]. Available from: http://hdl.handle.net/11143/11567 [in French].</Citation></Reference><Reference><Citation>Miller R, Weir C, Gulati S. Transforming primary care: scoping review of research and practice. Journal of integrated care (Brighton, England). 2018; 26(3): 176&#x2013;88. DOI: 10.1108/JICA-03-2018-0023</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/JICA-03-2018-0023</ArticleId><ArticleId IdType="pmc">PMC6091658</ArticleId><ArticleId IdType="pubmed">30166943</ArticleId></ArticleIdList></Reference><Reference><Citation>Wodchis WP, Shaw J, Sinha S, Bhattacharyya O, Shahid S, Anderson G. Innovative Policy Supports For Integrated Health And Social Care Programs In High-Income Countries. Health affairs (Project Hope). 2020; 39(4): 697&#x2013;703. DOI: 10.1377/hlthaff.2019.01587</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2019.01587</ArticleId><ArticleId IdType="pubmed">32250663</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu YM, Vanasse A, Courteau J, Chouinard MC, Dubois MF, Dubuc N, et al. Persistent frequent emergency department users with chronic conditions: A population-based cohort study. PloS one. 2020; 15(2): e0229022. DOI: 10.1371/journal.pone.0229022</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0229022</ArticleId><ArticleId IdType="pmc">PMC7015381</ArticleId><ArticleId IdType="pubmed">32050010</ArticleId></ArticleIdList></Reference><Reference><Citation>Wodchis WP, Ashton T, Baker GR, et al. A Research Program on Implementing Integrated Care for Older Adults with Complex Health Needs (iCOACH): An International Collaboration. International Journal of Integrated Care. 2018; 18(2): 11. DOI: 10.5334/ijic.4160</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/ijic.4160</ArticleId><ArticleId IdType="pmc">PMC6095069</ArticleId><ArticleId IdType="pubmed">30127695</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodwin N. Understanding and Evaluating the Implementation of Integrated Care: A &#x2018;Three Pipe&#x2019; Problem. International Journal of Integrated Care. 2016; 16(4): 19. DOI: 10.5334/ijic.2609</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/ijic.2609</ArticleId><ArticleId IdType="pmc">PMC5354212</ArticleId><ArticleId IdType="pubmed">28316558</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavrnik &#x10c;, Danhieux K, Monarres MH, Stojni&#x107; N, Lukan&#x10d;i&#x10d;, MM, Martens M, Klemenc-Keti&#x161; Z, Wouters E, van Olmen J, Poplas-Susi&#x10d; A. Scaling-up an Integrated Care for Patients with Non-communicable Diseases: An Analysis of Healthcare Barriers and Facilitators in Slovenia and Belgium. Zdravstveno varstvo. 2021; 60(3): 158&#x2013;166. DOI: 10.2478/sjph-2021-0023</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/sjph-2021-0023</ArticleId><ArticleId IdType="pmc">PMC8256765</ArticleId><ArticleId IdType="pubmed">34249162</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron A, Lart R, Bostock L, Coomber C. Factors that promote and hinder joint and integrated working between health and social care services: a review of research literature. Health &amp; Social Care in the Community. 2014. May; 22(3): 225&#x2013;33. DOI: 10.1111/hsc.12057</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hsc.12057</ArticleId><ArticleId IdType="pubmed">23750908</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R, Stein KV. The Odyssey of Integration: Is Management its Achilles&#x2019; Heel? International Journal of Integrated Care. 2020; 20(1): 7. DOI: 10.5334/ijic.5440</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/ijic.5440</ArticleId><ArticleId IdType="pmc">PMC7047758</ArticleId><ArticleId IdType="pubmed">32140091</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodwin N, Sonola L, Thiel V, Kodner D. Co-ordinated care for people with complex chronic conditions. Key lessons and markers for success; 2013. [cited 2022 11 Nov]. Available from: https://www.basw.co.uk/system/files/resources/basw_115147-3_0.pdf.</Citation></Reference><Reference><Citation>Godwin M, Gadag V, Pike A, Pitcher H, Parsons K, McCrate F, Parsons W, Buehler S, Sclater A, Miller R. A randomized controlled trial of the effect of an intensive 1-year care management program on measures of health status in independent, community-living old elderly: the Eldercare project. Family practice, 33(1): 37&#x2013;41. DOI: 10.1093/fampra/cmv089</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmv089</ArticleId><ArticleId IdType="pubmed">26560094</ArticleId></ArticleIdList></Reference><Reference><Citation>Karam M, Brault I, Van Durme T, Macq J. Comparing interprofessional and interorganizational collaboration in healthcare: A systematic review of the qualitative research. International journal of nursing studies. 2018; 79: 70&#x2013;83. DOI: 10.1016/j.ijnurstu.2017.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2017.11.002</ArticleId><ArticleId IdType="pubmed">29202313</ArticleId></ArticleIdList></Reference><Reference><Citation>Heeringa J, Mutti A, Furukawa MF, Lechner A, Maurer KA, Rich E. Horizontal and Vertical Integration of Health Care Providers: A Framework for Understanding Various Provider Organizational Structures. International Journal of Integrated Care. 2020; 20(1): 2. DOI: 10.5334/ijic.4635</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/ijic.4635</ArticleId><ArticleId IdType="pmc">PMC6978994</ArticleId><ArticleId IdType="pubmed">31997980</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozlowska O, Lumb A, Tan GD, Rea R. Barriers and facilitators to integrating primary and specialist healthcare in the United Kingdom: a narrative literature review. Future healthcare journal, 5(1): 64&#x2013;80. DOI: 10.7861/futurehosp.5-1-64</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/futurehosp.5-1-64</ArticleId><ArticleId IdType="pmc">PMC6510038</ArticleId><ArticleId IdType="pubmed">31098535</ArticleId></ArticleIdList></Reference><Reference><Citation>Leutz WN. Five laws for integrating medical and social services: lessons from the United States and the United Kingdom. The Milbank quarterly. 1999; 77(1): 77&#x2013;110, iv&#x2013;v. DOI: 10.1111/1468-0009.00125</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1468-0009.00125</ArticleId><ArticleId IdType="pmc">PMC2751110</ArticleId><ArticleId IdType="pubmed">10197028</ArticleId></ArticleIdList></Reference><Reference><Citation>Nies H, Stekelenburg D, Minkman M, Huijsman R. A Decade of Lessons Learned from Integration Strategies in the Netherlands. International Journal of Integrated Care. 2021; 21(S2): 15. DOI: 10.5334/ijic.5703</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/ijic.5703</ArticleId><ArticleId IdType="pmc">PMC8588908</ArticleId><ArticleId IdType="pubmed">34824564</ArticleId></ArticleIdList></Reference><Reference><Citation>de Bruin SR, Billings J, Stoop A, Lette M, Ambugo EA, Gadsby E, et al. Different Contexts, Similar Challenges. SUSTAIN&#x2019;s Experiences with Improving Integrated Care in Europe. International Journal of Integrated Care. 2020; 20(2): 17. DOI: 10.5334/ijic.5492</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/ijic.5492</ArticleId><ArticleId IdType="pmc">PMC7319084</ArticleId><ArticleId IdType="pubmed">32607104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuluski K, Ho JW, Hans PK, Nelson M. Community Care for People with Complex Care Needs: Bridging the Gap between Health and Social Care. International Journal of Integrated Care. 2017; 17(4): 2. DOI: 10.5334/ijic.2944</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/ijic.2944</ArticleId><ArticleId IdType="pmc">PMC5624113</ArticleId><ArticleId IdType="pubmed">28970760</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein KV. Developing a Competent Workforce for Integrated Health and Social Care: What Does It Take? International Journal of Integrated Care. 2016; 16(4): 9. DOI: 10.5334/ijic.2533</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/ijic.2533</ArticleId><ArticleId IdType="pmc">PMC5354207</ArticleId><ArticleId IdType="pubmed">28316549</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Regional office for Europe. Integrated care models: an overview. Copenhagen; 2016. [cited 2021 Dec 13]. Available from: https://www.euro.who.int/__data/assets/pdf_file/0005/322475/Integrated-care-models-overview.pdf.</Citation></Reference><Reference><Citation>Schrijvers G, van Hoorn A, Huiskes N. The care pathway: concepts and theories: an introduction. International Journal of Integrated Care. 2012; 12(Spec Ed Integrated Care Pathways): e192. DOI: 10.5334/ijic.812</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/ijic.812</ArticleId><ArticleId IdType="pmc">PMC3602959</ArticleId><ArticleId IdType="pubmed">23593066</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumlin M, Berg GV, Kvigne K, Helles&#xf8; R. Elderly patients with complex health problems in the care trajectory: a qualitative case study. BMC Health Services Research. 2020; 20(1): 595. DOI: 10.1186/s12913-020-05437-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-05437-6</ArticleId><ArticleId IdType="pmc">PMC7325247</ArticleId><ArticleId IdType="pubmed">32600322</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen D, Gillen E, Rixson L. Systematic review of the effectiveness of integrated care pathways: what works, for whom, in which circumstances? Int J Evid Based Healthc. 2009; 7(2): 61&#x2013;74. DOI: 10.1111/j.1744-1609.2009.00127.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1744-1609.2009.00127.x</ArticleId><ArticleId IdType="pubmed">21631848</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunderji N, Jokic R. Integrated Care Training in Canada: Challenges and Future Directions. Acad Psychiatry. 2015; 39(6): 740&#x2013;1. DOI: 10.1007/s40596-015-0436-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40596-015-0436-4</ArticleId><ArticleId IdType="pubmed">26443029</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36811680</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>270</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Addition of the FTD Module to the Neuropsychiatric Inventory improves classification of frontotemporal dementia spectrum disorders.</ArticleTitle><Pagination><StartPage>2674</StartPage><EndPage>2687</EndPage><MedlinePgn>2674-2687</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-023-11596-3</ELocationID><Abstract><AbstractText>Most neuropsychiatric symptoms (NPS) common in frontotemporal dementia (FTD) are currently not part of the Neuropsychiatric Inventory (NPI). We piloted an FTD Module that included eight extra items to be used in conjunction with the NPI. Caregivers of patients with behavioural variant FTD (n&#x2009;=&#x2009;49), primary progressive aphasia (PPA; n&#x2009;=&#x2009;52), Alzheimer's dementia (AD; n&#x2009;=&#x2009;41), psychiatric disorders (n&#x2009;=&#x2009;18), presymptomatic mutation carriers (n&#x2009;=&#x2009;58) and controls (n&#x2009;=&#x2009;58) completed the NPI and FTD Module. We investigated (concurrent and construct) validity, factor structure and internal consistency of the NPI and FTD Module. We performed group comparisons on item prevalence, mean item and total NPI and NPI with FTD Module scores, and multinomial logistic regression to determine its classification abilities. We extracted four components, together explaining 64.1% of the total variance, of which the largest indicated the underlying dimension 'frontal-behavioural symptoms'. Whilst apathy (original NPI) occurred most frequently in AD, logopenic and non-fluent variant PPA, the most common NPS in behavioural variant FTD and semantic variant PPA were loss of sympathy/empathy and poor response to social/emotional cues (part of FTD Module). Patients with primary psychiatric disorders and behavioural variant FTD showed the most severe behavioural problems on both the NPI as well as the NPI with FTD Module. The NPI with FTD Module correctly classified more FTD patients than the NPI alone. By quantifying common NPS in FTD the NPI with FTD Module has large diagnostic potential. Future studies should investigate whether it can also prove a useful addition to the NPI in therapeutic trials.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiskoot</LastName><ForeName>Lize C</ForeName><Initials>LC</Initials><Identifier Source="ORCID">0000-0002-1120-1858</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Room NF-331, Dr. Molenwaterplein 40, 3015 CE, Rotterdam, The Netherlands. l.c.jiskoot@erasmusmc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dementia Research Centre, Department of Neurodegenerative Disease, University College London Queen Square Institute of Neurology, London, UK. l.c.jiskoot@erasmusmc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dementia Research Centre (DRC), National Hospital for Neurology and Neurosurgery, University College London (UCL), 8-11 Queen Square, Box 16, London, WC1N 3BG, UK. l.c.jiskoot@erasmusmc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>Lucy L</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Dementia Research Centre, Department of Neurodegenerative Disease, University College London Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greaves</LastName><ForeName>Caroline V</ForeName><Initials>CV</Initials><AffiliationInfo><Affiliation>Dementia Research Centre, Department of Neurodegenerative Disease, University College London Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Schaik</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Room NF-331, Dr. Molenwaterplein 40, 3015 CE, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Berg</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Room NF-331, Dr. Molenwaterplein 40, 3015 CE, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poos</LastName><ForeName>Jackie M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Room NF-331, Dr. Molenwaterplein 40, 3015 CE, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Boer</LastName><ForeName>Liset</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Room NF-331, Dr. Molenwaterplein 40, 3015 CE, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donker Kaat</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Room NF-331, Dr. Molenwaterplein 40, 3015 CE, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seelaar</LastName><ForeName>Harro</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Room NF-331, Dr. Molenwaterplein 40, 3015 CE, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pijnenburg</LastName><ForeName>Yolande A L</ForeName><Initials>YAL</Initials><AffiliationInfo><Affiliation>Department of Neurology, Amsterdam University Medical Centre, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Swieten</LastName><ForeName>John C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Room NF-331, Dr. Molenwaterplein 40, 3015 CE, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohrer</LastName><ForeName>Jonathan D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Dementia Research Centre, Department of Neurodegenerative Disease, University College London Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HCMI 056-13-018</GrantID><Agency>NWO</Agency><Country/></Grant><Grant><GrantID>MR/M023664/1</GrantID><Agency>MRC UK GENFI grant</Agency><Country/></Grant><Grant><GrantID>MR/M008525/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>2009</GrantID><Agency>the Association for Frontotemporal Dementias Research</Agency><Country/></Grant><Grant><GrantID>733050813</GrantID><Agency>ZonMw Memorabel</Agency><Country/></Grant><Grant><GrantID>MR/M023664/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>WE.15-2019.02</GrantID><Agency>Alzheimer Nederland</Agency><Country/></Grant><Grant><GrantID>MR/M008525/1</GrantID><Agency>MRC Clinician Scientist Fellowship</Agency><Country/></Grant><Grant><GrantID>MR/T046015/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>733050103</GrantID><Agency>ZonMw Memorabel</Agency><Country/></Grant><Grant><GrantID>733051042</GrantID><Agency>JPND PreFrontAls Consortium</Agency><Country/></Grant><Grant><GrantID>BRC149/NS/MH</GrantID><Agency>NIHR Rare Disease Translational Research Collaboration</Agency><Country/></Grant><Grant><GrantID>2019-02248</GrantID><Agency>JPND GENFI-PROX grant</Agency><Country/></Grant><Grant><GrantID>09-02-00</GrantID><Agency>the Dioraphte Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001526" MajorTopicYN="N">Behavioral Symptoms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Classification</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">FTD</Keyword><Keyword MajorTopicYN="N">Neuropsychiatric inventory</Keyword><Keyword MajorTopicYN="N">Neuropsychiatric symptoms</Keyword></KeywordList><CoiStatement>The authors have no competing interests to declare that are relevant to the content of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>15</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36811680</ArticleId><ArticleId IdType="pmc">PMC10129920</ArticleId><ArticleId IdType="doi">10.1007/s00415-023-11596-3</ArticleId><ArticleId IdType="pii">10.1007/s00415-023-11596-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rohrer JD, Rosen HJ. Neuroimaging in frontotemporal dementia. Int Rev Psychiatry. 2013;25:221&#x2013;229. doi: 10.3109/09540261.2013.778822.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09540261.2013.778822</ArticleId><ArticleId IdType="pubmed">23611351</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Scola E, Canu E, Marcone A, Magnani G, Sarro L, et al. White matter damage in frontotemporal lobar degeneration spectrum. Cereb Cortex. 2012;22(12):2705&#x2013;2714. doi: 10.1093/cercor/bhr28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhr28</ArticleId><ArticleId IdType="pubmed">21988828</ArticleId></ArticleIdList></Reference><Reference><Citation>Frings L, Yew B, Flanagan E, Lam BY, H&#xfc;ll M, Huppertz HJ, Hodges JR, Hornberger MJ. Longitudinal grey and white matter changes in frontotemporal dementia and Alzheimer&#x2019;s disease. PLoS&#xa0;One. 2014;9(3):e90814. doi: 10.1371/journal.pone.0090814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0090814</ArticleId><ArticleId IdType="pmc">PMC3940927</ArticleId><ArticleId IdType="pubmed">24595028</ArticleId></ArticleIdList></Reference><Reference><Citation>Riedl L, Mackenzie IR, F&#xf6;rstl H, Kurz A, Diehl-Schmid J. Frontotemporal lobar degeneration: current perspectives. Neuropsychiatr Dis Treat. 2014;10:297&#x2013;310. doi: 10.2147/NDT.S38706.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S38706</ArticleId><ArticleId IdType="pmc">PMC3928059</ArticleId><ArticleId IdType="pubmed">24600223</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuheus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456&#x2013;2477. doi: 10.1093/brain/awr179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006&#x2013;1014. doi: 10.1212/WNL.0b013e31821103e6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31821103e6</ArticleId><ArticleId IdType="pmc">PMC3059138</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranasinghe KG, Rankin KP, Pressman PS, Perry DC, Lobach IV, Seeley WW, et al. Distinct subtypes of behavioral variant frontotemporal dementia based on patterns of network degeneration. JAMA Neurol. 2016;73(9):1078&#x2013;1088. doi: 10.1001/jamaneurol.2016.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.2016</ArticleId><ArticleId IdType="pmc">PMC5024785</ArticleId><ArticleId IdType="pubmed">27429218</ArticleId></ArticleIdList></Reference><Reference><Citation>Grishina DA, Yakhno NN, Zakharov VV. Emotional, affective and behavioral disorders in a behavioral variant of frontotemporal dementia. Zhurnal Nevrologii i Psikhiatrii Imeni S S Korsakova. 2017;117(11):13&#x2013;17. doi: 10.17116/jnevro201711711113-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.17116/jnevro201711711113-17</ArticleId><ArticleId IdType="pubmed">29265081</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda M, Brown J, Holland AJ, Fukuhara R, Hodges JR. Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002;73:371&#x2013;376. doi: 10.1136/jnnp.73.4.371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.73.4.371</ArticleId><ArticleId IdType="pmc">PMC1738075</ArticleId><ArticleId IdType="pubmed">12235302</ArticleId></ArticleIdList></Reference><Reference><Citation>Piguet O, Petersen A, Lam BYK, Gabery S, Murphy K, Hodges JR, Halliday G. Eating and hypothalamus changes in behavioral-variant frontotemporal dementia. Ann Neurol. 2011;69(2):312&#x2013;319. doi: 10.1002/ana.22244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22244</ArticleId><ArticleId IdType="pmc">PMC3084499</ArticleId><ArticleId IdType="pubmed">21387376</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MH, Kim EJ, Park KW, Kwon JC, Ku BD, Han SH, et al. Behavioural and neuropsychiatric disturbance in three clinical subtypes of frontotemporal dementia: a clinical research center for dementia of South Korea FTD study. Aust J Ageing. 2017;36(1):46&#x2013;51. doi: 10.1111/ajag.12374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajag.12374</ArticleId><ArticleId IdType="pubmed">28326689</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks SJ, Weintraub S. Neuropsychiatric symptoms in behavioral variant frontotemporal dementia and primary progressive aphasia. J Geriatr Psychiatry Neurol. 2008;21(2):133&#x2013;141. doi: 10.1177/0891988708316856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988708316856</ArticleId><ArticleId IdType="pmc">PMC2892801</ArticleId><ArticleId IdType="pubmed">18474722</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosseddu M, Benussi A, Gazzina S, Alberici A, Dell&#x2019;Era V, Manes M, et al. Progression of behavioural disturbances in frontotemporal dementia. Eur J Neurol. 2020;27(2):265&#x2013;272. doi: 10.1111/ene.14071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14071</ArticleId><ArticleId IdType="pubmed">31448481</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima-Silva TB, Bahia VS, Carvalho VA, Guimaraes HC, Caramelli P, Balthazar ML, et al. Neuropsychiatric symptoms, caregiver burden and distress in behavioral-variant frontotemporal dementia and Alzheimer&#x2019;s disease. Dementia Geriatric Cogn Disord. 2015;40:268&#x2013;275. doi: 10.1159/000437351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000437351</ArticleId><ArticleId IdType="pubmed">26302667</ArticleId></ArticleIdList></Reference><Reference><Citation>Kales HC, Gitlin LN, Lyketsos C. For the detroit expert panel on the assessment and management of the neuropsychiatic symptoms of dementia. J Am Geriatric Soc. 2014;62(4):762&#x2013;769. doi: 10.1111/jgs.12730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.12730</ArticleId><ArticleId IdType="pmc">PMC4146407</ArticleId><ArticleId IdType="pubmed">24635665</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller JB, Banks SJ, L&#xe9;ger GC, Cummings JL. Randomized controlled trials in frontotemporal dementia: cognitive and behavioral outcomes. Transl Neurodegener. 2014;3:12. doi: 10.1186/2047-9158-3-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2047-9158-3-12</ArticleId><ArticleId IdType="pmc">PMC4052335</ArticleId><ArticleId IdType="pubmed">24921043</ArticleId></ArticleIdList></Reference><Reference><Citation>Wear HJ, Wedderburn CJ, Mioshi E, Williams-Gray CH, Mason SL, Barker RA, Hodges JR. The Cambridge behavioural inventory revised. Dement Neuropsychol. 2008;2(2):102&#x2013;107. doi: 10.1590/S1980-57642009DN20200005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1980-57642009DN20200005</ArticleId><ArticleId IdType="pmc">PMC5619578</ArticleId><ArticleId IdType="pubmed">29213551</ArticleId></ArticleIdList></Reference><Reference><Citation>Kertesz, A., Davidson, W., Fox, H. Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. The Canadian Journal of Neurological Sciences, 24(1), 29&#x2013;36. doi: 10.1017/s0317167100021053</Citation><ArticleIdList><ArticleId IdType="pubmed">9043744</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E, Hsieh S, Savage S, Hornberger M, Hodges JR. Clinical staging and disease progression in frontotemporal dementia. Neurology. 2010;75(20):1591&#x2013;1597. doi: 10.1212/WNL.0b013e3181e04070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181e04070</ArticleId><ArticleId IdType="pubmed">20479357</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL. The Neuropsychiatric Inventory&#x2014;assessing psychopathology in dementia patients. Neurology. 1997;48(5):S10&#x2013;S16. doi: 10.1212/wnl.48.5_suppl_6.10s.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.48.5_suppl_6.10s</ArticleId><ArticleId IdType="pubmed">9153155</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL. The Neuropsychiatric Inventory: development and applications. J Geriatr Psychiatry Neurol. 2020;33(2):73&#x2013;84. doi: 10.1177/0891988719882102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988719882102</ArticleId><ArticleId IdType="pmc">PMC8505128</ArticleId><ArticleId IdType="pubmed">32013737</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory&#x2014;comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308&#x2013;2314. doi: 10.1212/wnl.44.12.2308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.44.12.2308</ArticleId><ArticleId IdType="pubmed">7991117</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CKY. The merits and problems of Neuropsychiatric Inventory as an assessment tool in people with dementia and other neurological disorders. Clin Interv Aging. 2014;9:1051&#x2013;1061. doi: 10.2147/CIA.S63504.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S63504</ArticleId><ArticleId IdType="pmc">PMC4099101</ArticleId><ArticleId IdType="pubmed">25031530</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiannopoulou KG, Papatriantafyllou JD, Ghika A, Tsinia N, Lykou E, Hatziantoniou E, et al. Defining Neuropsychiatric Inventory scale differences across frontotemporal dementia syndromes. Psychogeriatrics. 2019;19:32&#x2013;37. doi: 10.1111/psyg.12358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/psyg.12358</ArticleId><ArticleId IdType="pubmed">30073726</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dementia. 2011;7(3):263&#x2013;269. doi: 10.1016/j.jalz.2011.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.03.005</ArticleId><ArticleId IdType="pmc">PMC3312024</ArticleId><ArticleId IdType="pubmed">21514250</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyagawa T, Brushaber D, Syrjanen J, Kremers W, Fields J, Forsberg LK, et al. Utility of the global CDR&#xae; plus NACC FTLD rating and development of scoring rules: data from the ARTFL/LEFFTDS consortium. Alzheimer&#x2019;s Dementia. 2020;16(1):106&#x2013;117. doi: 10.1002/alz.12033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12033</ArticleId><ArticleId IdType="pmc">PMC7202045</ArticleId><ArticleId IdType="pubmed">31914218</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res. 1975;12(3):189&#x2013;198. doi: 10.1016/0022-3956(75)90026-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3956(75)90026-6</ArticleId><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Bickart KC, Brickhouse M, Negreira A, Sapolsky D, Feldman Barrett L, Dickerson BC. Atrophy in distinct corticolimbic networks in frontotemporal dementia relates to social impairments measured using the Social Impairment Rating Scale. J Neurol Neurosurg Psychiatry. 2014;85(4):438&#x2013;448. doi: 10.1136/jnnp-2012-304656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304656</ArticleId><ArticleId IdType="pmc">PMC4315506</ArticleId><ArticleId IdType="pubmed">24133285</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan D, Anderson V, Pijnenburg Y, Whitwell J, Barnes J, Scahill R, et al. The clinical profile of right temporal lobe atrophy. Brain. 2009;132:1287&#x2013;1298. doi: 10.1093/brain/awp037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp037</ArticleId><ArticleId IdType="pubmed">19297506</ArticleId></ArticleIdList></Reference><Reference><Citation>Veronelli L, Makaretz SJ, Quimby M, Dickerson BC, Collins JA. Geschwind Syndrome in frontotemporal lobar degeneration: neuroanatomical and neuropsychological features over 9 years. Cortex. 2017;94:27&#x2013;38. doi: 10.1016/j.cortex.2017.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2017.06.003</ArticleId><ArticleId IdType="pmc">PMC5565695</ArticleId><ArticleId IdType="pubmed">28711815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Goldberg ZL, Kaizik C, Kiernan MC, Hodges JR, Piguet O, Irish M. Neural correlates of changes in sexual function in frontotemporal dementia: implications for reward and physiological functioning. J Neurol. 2018;265(11):2562&#x2013;2572. doi: 10.1007/s00415-018-9024-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-9024-3</ArticleId><ArticleId IdType="pubmed">30167881</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark CN, Nicolas JM, Gordon E, Golden HL, Cohen MH, Woodward FJ, et al. Altered sense of humor in dementia. J Alzheimer&#x2019;s Disease. 2016;49(1):111&#x2013;119. doi: 10.3233/JAD-150413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-150413</ArticleId><ArticleId IdType="pmc">PMC4820649</ArticleId><ArticleId IdType="pubmed">26444779</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher PD, Downey LE, Golden HL, Clark CN, Slattery CF, Paterson RW, et al. Pain and temperature processing in dementia: a clinical and neuroanatomical analysis. Brain. 2015;138(Pt 11):3360&#x2013;3372. doi: 10.1093/brain/awv276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv276</ArticleId><ArticleId IdType="pmc">PMC4620514</ArticleId><ArticleId IdType="pubmed">26463677</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVellis RF. Scale development: theory and applications. 2. Thousand Oaks: Sage Publications; 2003.</Citation></Reference><Reference><Citation>Cerny BA, Kaiser HF. A study of a measure of sampling adequacy for factor-analytic correlation matrices. Multivariate Behav Res. 1977;12(1):43&#x2013;47. doi: 10.1207/s15327906mbr1201_3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1207/s15327906mbr1201_3</ArticleId><ArticleId IdType="pubmed">26804143</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartlett MS. Tests of significance in factor analysis. Br J Stat Psychol. 1950;3(2):77&#x2013;85. doi: 10.1111/j.2044-8317.1950.tb00285.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2044-8317.1950.tb00285.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Aalten P, de Vugt ME, Lousberg R, Korten E, Jaspers N, Senden B, Jolles J, Verhey FRJ. Behavioral problems in dementia: a factor analysis of the neuropsychiatric inventory. Dement Geriatr Cogn Disord. 2003;15:99&#x2013;105. doi: 10.1159/000067972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000067972</ArticleId><ArticleId IdType="pubmed">12566599</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang HS, Ahn IS, Kim JH, Kim DK. Neuropsychiatric symptoms in Korean patients with Alzheimer&#x2019;s Disease: exploratory factor analysis and confirmatory factor analysis of the Neuropsychiatric Inventory. Dement Geriatr Cogn Disord. 2010;29:82&#x2013;87. doi: 10.1159/000264629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000264629</ArticleId><ArticleId IdType="pubmed">20130406</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinagawa S, Nakajima S, Plitman E, Graff-Guerrero A, Mimura M, Nakayama K, Miller BL. Psychosis in frontotemporal dementia. J Alzheimer&#x2019;s Disease. 2014;42:485&#x2013;499. doi: 10.3233/JAD-140312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-140312</ArticleId><ArticleId IdType="pubmed">24898651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducharme S, Bajestan S, Dickerson BC, Voon V. Psychiatric presentations of C9orf72 mutation: what are the diagnostic implications for clinicians? J Neuropsychiatry Clin Neurosci. 2017;29(3):195&#x2013;205. doi: 10.1176/appi.neuropsych.16090168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.neuropsych.16090168</ArticleId><ArticleId IdType="pubmed">28238272</ArticleId></ArticleIdList></Reference><Reference><Citation>Karatzikou M, Afrantou T, Parissis D, Ioannidis P. Hyper-religiosity in frontotemporal dementia with predominant atrophy of the right temporal lobe. Pract Neurol. 2021;21(2):173&#x2013;174. doi: 10.1136/practneurol-2020-002755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/practneurol-2020-002755</ArticleId><ArticleId IdType="pubmed">33323358</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirono N, More E, Tanimukai S, Kazui H, Hashimoto M, Hanihara T, Imamura T. Distinctive neurobehavioral features among neurodegenerative diseases. J Neuropsychiatry Clin Neurosci. 1999;11(4):498&#x2013;503. doi: 10.1176/jnp.11.4.498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/jnp.11.4.498</ArticleId><ArticleId IdType="pubmed">10570764</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozeat S, Gregory CA, Ralph MA, Hodges JR. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer&#x2019;s disease? J Neurol Neurosurg Psychiatry. 2000;69:178&#x2013;186. doi: 10.1136/jnnp.69.2.178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.69.2.178</ArticleId><ArticleId IdType="pmc">PMC1737062</ArticleId><ArticleId IdType="pubmed">10896690</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahia VS, Viana R. Accuracy of neuropsychological tests and the Neuropsychiatric Inventory in differential diagnosis between Frontotemporal dementia and Alzheimer&#x2019;s disease. Dementia Neuropsychologia. 2009;3(4):332&#x2013;336. doi: 10.1590/S1980-57642009DN30400012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1980-57642009DN30400012</ArticleId><ArticleId IdType="pmc">PMC5619421</ArticleId><ArticleId IdType="pubmed">29213649</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Silva TBL, Ordonez TN, Bregola AG, Bahia VS, Cecchini MA, Guimaraes HC, et al. Neuropsychiatric symptoms in behavioral variant frontotemporal dementia and Alzheimer's disease: a 12-month follow-up study. Front Neurol. 2021;12:728108. doi: 10.3389/fneur.2021.728108.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.728108</ArticleId><ArticleId IdType="pmc">PMC8515178</ArticleId><ArticleId IdType="pubmed">34659093</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossenkoppele R, Pijnenburg YAL, Perry DC, Cohn-Sheehy BI, Scheltens NME, Vogel JW, et al. The behavioural/dysexecutive variant of Alzheimer&#x2019;s disease: clinical, neuroimaging and pathological features. Brain. 2015;138(9):2732&#x2013;2749. doi: 10.1093/brain/awv191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv191</ArticleId><ArticleId IdType="pmc">PMC4623840</ArticleId><ArticleId IdType="pubmed">26141491</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen HJ, Allison SC, Ogar JM, Amici S, Rose K, Dronkers N, Miller BL, Gorno-Tempini ML. Behavioral features in semantic dementia vs other forms of progressive aphasias. Neurology. 2006;67(10):1752&#x2013;1756. doi: 10.1212/01.wnl.0000247630.29222.34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000247630.29222.34</ArticleId><ArticleId IdType="pubmed">17130406</ArticleId></ArticleIdList></Reference><Reference><Citation>Malpetti M, Simon Jones P, Tsvetanov KA, Rittman T, van Swieten JC, Borroni B, et al. Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes. Alzheimer&#x2019;s Dementia. 2021;17(6):969&#x2013;983. doi: 10.1002/alz.12252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12252</ArticleId><ArticleId IdType="pmc">PMC8247340</ArticleId><ArticleId IdType="pubmed">33316852</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheran G, Silverman H, Manoochehri M, Goldman J, Lee S, Wu L, et al. Psychiatric symptoms in preclinical behavioural-variant frontotemporal dementia in MAPT mutation carriers. J Neurol Neurosurg Psychiatry. 2018;89(5):449&#x2013;455. doi: 10.1136/jnnp-2017-317263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317263</ArticleId><ArticleId IdType="pmc">PMC6317727</ArticleId><ArticleId IdType="pubmed">29353234</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer JD, Nicolas JM, Cash DM, van Swieten JC, Dopper EGP, Jiskoot LC, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol. 2015;14:253&#x2013;262. doi: 10.1016/S1474-4422(14)70324-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70324-2</ArticleId><ArticleId IdType="pmc">PMC6742501</ArticleId><ArticleId IdType="pubmed">25662776</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546&#x2013;1554. doi: 10.1212/wnl.51.6.1546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.51.6.1546</ArticleId><ArticleId IdType="pubmed">9855500</ArticleId></ArticleIdList></Reference><Reference><Citation>Eikelboom WS, den Teuling A, Pol DE, Coesmans M, Franzen S, Jiskoot LC, et al. Biweekly fluctuations of neuropsychiatric symptoms according to the neuropsychiatric inventory: erratic symptoms or scores? Int J Geriatric Psychiatry. 2022;37(7):1&#x2013;7. doi: 10.1002/gps.5770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5770</ArticleId><ArticleId IdType="pmc">PMC9327507</ArticleId><ArticleId IdType="pubmed">35702994</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutoleau-Bretonniere C, Lebouvier T, Volteau C, Jaulin P, Lacomblez L, Damier P, Thomas-Anterion C, Vercelletto M. Prospective evaluation of behavioral scales in the behavioral variant of frontotemporal dementia. Dement Geriatr Cogn Disord. 2012;34(2):75&#x2013;82. doi: 10.1159/000341784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000341784</ArticleId><ArticleId IdType="pubmed">22922703</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36803101</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1473-4877</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Current medical research and opinion</Title><ISOAbbreviation>Curr Med Res Opin</ISOAbbreviation></Journal><ArticleTitle>Extemporaneous combination of donepezil and memantine to treat dementia in Alzheimer disease: evidence from Italian real-world data.</ArticleTitle><Pagination><StartPage>567</StartPage><EndPage>577</EndPage><MedlinePgn>567-577</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/03007995.2023.2182530</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Providing evidence on donepezil and memantine administration as extemporaneous combination (DM-EXT) to treat Alzheimer Disease (AD) in Italy, and describing demographic and clinical features of AD patients prescribed DM-EXT.</AbstractText><AbstractText Label="METHODS">Retrospective observational study using IQVIA Italian LifeLink Treatment Dynamics (LRx) and Longitudinal Patient Database (LPD). Prevalent users of DM-EXT were identified on the databases (cohorts DMp<sub>LRx</sub> and DMp<sub>LPD</sub>) including patients with donepezil and memantine overlapping prescriptions during the selection period (DMp<sub>LRx</sub>: "July 2018-June 2021"; DMp<sub>LPD</sub>: "July 2012-June 2021"). Demographic and clinical profiles of patients were provided. Starting from cohort DMp<sub>LPD</sub>, new users of DM-EXT were selected to calculate treatment adherence. Three additional cohorts of prevalent users of DM-EXT were identified on IQVIA LRx over subsequent 12-month periods, from July 2018 to June 2021, to get national-level yearly estimates accounting for database representativeness.</AbstractText><AbstractText Label="RESULTS">Cohorts DMp<sub>LRx</sub> and DMp<sub>LPD</sub> included 9862 and 708 patients, respectively. For both cohorts, two-third of patients were female, and more than half were aged 80+. Concomitant conditions and co-treatments prevalence was very high; most frequent comorbidities included psychiatric and cardiovascular diseases. An intermediate-to-high adherence was observed in 57% of DM-EXT new users. National-level yearly estimates showed an increasing trend (+4%) in DM-EXT prescription, which led to estimate about 10,000 patients being treated during the period "July 2020-June 2021".</AbstractText><AbstractText Label="CONCLUSIONS">Prescription of DM-EXT is a common practice in Italy. Because the administration of fixed-dose (FDCs) instead of extemporaneous combinations improves treatment adherence, the introduction of an FDC containing donepezil and memantine might enhance AD patients' management and reduce caregiver burden.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Padovani</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falato</LastName><ForeName>Serena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>RWS Department, IQVIA Solutions Italy S.r.l, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pegoraro</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>RWS Department, IQVIA Solutions Italy S.r.l, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Med Res Opin</MedlineTA><NlmUniqueID>0351014</NlmUniqueID><ISSNLinking>0300-7995</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8SSC91326P</RegistryNumber><NameOfSubstance UI="D000077265">Donepezil</NameOfSubstance></Chemical><Chemical><RegistryNumber>W8O17SJF3T</RegistryNumber><NameOfSubstance UI="D008559">Memantine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077265" MajorTopicYN="N">Donepezil</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008559" MajorTopicYN="N">Memantine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AChEIs</Keyword><Keyword MajorTopicYN="N">Alzheimer disease</Keyword><Keyword MajorTopicYN="N">Donepezil</Keyword><Keyword MajorTopicYN="N">adherence</Keyword><Keyword MajorTopicYN="N">extemporaneous combination</Keyword><Keyword MajorTopicYN="N">fixed-dose combination</Keyword><Keyword MajorTopicYN="N">memantine</Keyword><Keyword MajorTopicYN="N">real-world evidence</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>21</Day><Hour>17</Hour><Minute>45</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36803101</ArticleId><ArticleId IdType="doi">10.1080/03007995.2023.2182530</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36802704</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1445-6354</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Rural and remote health</Title><ISOAbbreviation>Rural Remote Health</ISOAbbreviation></Journal><ArticleTitle>Reducing rural isolation through music: telehealth music therapy for community dwelling people living with dementia and their family caregivers in rural Ireland.</ArticleTitle><Pagination><StartPage>8162</StartPage><MedlinePgn>8162</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.22605/RRH8162</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Since the outset of COVID-19, we have become more reliant on technology to stay connected to others. Notable benefits of telehealth have been observed, including increased access to health and community support services for community dwelling people living with dementia and their family caregivers and diminishing barriers such as geographical location, mobility issues and increased cognitive decline. Music therapy is an evidence-based intervention for people living with dementia and has been proven to promote improved quality of life, increase social interaction and provide a form of meaningful communication and expression when language becomes difficult. This project is one of the first internationally to pilot telehealth music therapy for this population.</AbstractText><AbstractText Label="METHODS">This mixed methods action research project has six iterative phases of planning, research, action, evaluation, and monitoring. Public and Patient Involvement (PPI) has been sought from members of The Dementia Research Advisory Team at the Alzheimer Society of Ireland at all stages of the research process to ensure the research remains relevant and applicable to those with dementia. The presentation will briefly outline the phases of the project.</AbstractText><AbstractText Label="RESULTS">Preliminary results from this ongoing research suggest that there is feasibility for telehealth music therapy to provide psychosocial support to this population. Collaboration with PPI contributors resulted in the following research priorities: (1) ensuring a person-centered approach; (2) advanced care planning using music; and (3) the signposting of music related supports for community dwelling people living with dementia. Music therapy is being piloted currently and preliminary results will be outlined.</AbstractText><AbstractText Label="DISCUSSION">Telehealth music therapy has the potential to complement existing rural health and community services for people living with dementia, in particular addressing social isolation. Recommendations regarding the relevance of cultural and leisure pursuits on health and well-being of people living with dementia will be discussed, particularly the development of online access.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University Of Limerick, Castletroy, Limerick, Ireland; Health Research Institute (HRI), University of Limerick, Castletroy, Limerick, Ireland; Lero - The Science Foundation Ireland Research Centre for Software, University of Limerick, Castletroy, Limerick, Ireland; and Ageing Research Centre, University of Limerick, Castletroy, Limerick, Ireland lisa.kelly@ul.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richardson</LastName><ForeName>Ita</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>University Of Limerick, Castletroy, Limerick, Ireland; Health Research Institute (HRI), University of Limerick, Castletroy, Limerick, Ireland; Lero - The Science Foundation Ireland Research Centre for Software, University of Limerick, Castletroy, Limerick, Ireland; and Ageing Research Centre, University of Limerick, Castletroy, Limerick, Ireland ita.richardson@ul.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moss</LastName><ForeName>Hilary</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University Of Limerick, Castletroy, Limerick, Ireland; Health Research Institute (HRI), University of Limerick, Castletroy, Limerick, Ireland; and Ageing Research Centre, University of Limerick, Castletroy, Limerick, Ireland hilary.moss@ul.ie.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Rural Remote Health</MedlineTA><NlmUniqueID>101174860</NlmUniqueID><ISSNLinking>1445-6354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057187" MajorTopicYN="N">Independent Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009147" MajorTopicYN="Y">Music Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009146" MajorTopicYN="Y">Music</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007494" MajorTopicYN="N" Type="Geographic">Ireland</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>21</Day><Hour>17</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36802704</ArticleId><ArticleId IdType="doi">10.22605/RRH8162</ArticleId><ArticleId IdType="pii">8162</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36790638</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2193-8253</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Neurology and therapy</Title><ISOAbbreviation>Neurol Ther</ISOAbbreviation></Journal><ArticleTitle>Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease.</ArticleTitle><Pagination><StartPage>571</StartPage><EndPage>595</EndPage><MedlinePgn>571-595</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40120-023-00443-2</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Insight into the relationship between concepts that matter to the people affected by Alzheimer's disease (AD) and the clinical outcome assessments (COAs) commonly used in AD clinical studies is limited. Phases 1 and 2 of the What Matters Most (WMM) study series identified and quantitatively confirmed 42 treatment-related outcomes that are important to people affected by AD.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We compared WMM concepts rated as "very important" or higher to items included in COAs used commonly in AD studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty COAs designed to assess signs, symptoms, and impacts across the spectrum of AD were selected for review. Among these 20 COAs, only 5 reflected 12 or more WMM concepts [Integrated Alzheimer's Disease Rating Scale (iADRS), Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory (ADCS-ADL), Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory-Mild Cognitive Impairment (ADCS-ADL-MCI), Alzheimer's Disease Composite Scores (ADCOMS), and Clinical Dementia Rating; Clinical Dementia Rating-Sum of Boxes (CDR/CDR-SB)]. Multiple symptoms and impacts of AD identified as important and meaningful in the WMM studies map only indirectly at best to 7 of the 20 most widely used COAs.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">While many frequently used COAs in AD capture some concepts identified as important to AD populations and their care partners, overlap between any single measure and the concepts that matter to people affected by AD is limited. The highest singly matched COA reflects fewer than half (45%) of WMM concepts. Use of multiple COAs expands coverage of meaningful concepts. Future research should explore the content validity of AD COAs planned for AD trials based on further confirmation of the ecological validity of the WMM items. This research should inform development and use of core outcome sets that capture WMM items and selection or development of new companion tools to fully demonstrate clinically meaningful outcomes spanning WMM.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>DiBenedetti</LastName><ForeName>Dana B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Patient-Centered Outcomes Assessment, RTI Health Solutions, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC, 27709-2194, USA. ddibenedetti@rti.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menne</LastName><ForeName>Heather</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>RTI International, Research Triangle Park, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paulsen</LastName><ForeName>Russ</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UsAgainstAlzheimer's, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krasa</LastName><ForeName>Holly B</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Blue Persimmon Group LLC, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vradenburg</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>UsAgainstAlzheimer's, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Comer</LastName><ForeName>Meryl</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>UsAgainstAlzheimer's, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Leigh F</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Winfield</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Potashman</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biogen, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heithoff</LastName><ForeName>Kim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Biogen, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartry</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lundbeck LLC, Deerfield, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oberdhan</LastName><ForeName>Dorothee</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Otsuka Pharmaceutical Development &amp; Commercialization Inc., Rockville, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Hilary</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Boehringer Ingelheim, Burlington, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffman</LastName><ForeName>Deborah L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Takeda Pharmaceuticals, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wieberg</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Home Instead Inc., Omaha, NE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kremer</LastName><ForeName>Ian N</ForeName><Initials>IN</Initials><AffiliationInfo><Affiliation>LEAD Coalition (Leaders Engaged On Alzheimer's Disease), Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Geraldine A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Living with AD, Co-Founder of Memory Advocate Peers (MAP), New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>James M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Care Partner, CEO of Memory Advocates Peers (MAP), New York, NY, 10023, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lappin</LastName><ForeName>Debra</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Faegre Drinker Consulting, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Allison D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Faegre Drinker Consulting, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hauber</LastName><ForeName>Brett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Pfizer, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romano</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Patient-Centered Outcomes Assessment, RTI Health Solutions, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC, 27709-2194, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Neurol Ther</MedlineTA><NlmUniqueID>101637818</NlmUniqueID><ISSNLinking>2193-6536</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Care partner</Keyword><Keyword MajorTopicYN="N">Caregiver</Keyword><Keyword MajorTopicYN="N">Clinical outcome assessment</Keyword><Keyword MajorTopicYN="N">Clinically meaningful</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Patient</Keyword><Keyword MajorTopicYN="N">Value</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>11</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36790638</ArticleId><ArticleId IdType="pmc">PMC10043075</ArticleId><ArticleId IdType="doi">10.1007/s40120-023-00443-2</ArticleId><ArticleId IdType="pii">10.1007/s40120-023-00443-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DiBenedetti D, Slota C, Wronski SL, Vradenburg G, Comer M, Callahan LF, et al. Assessing what matters most to patients with or at risk for Alzheimer's and care partners: a qualitative study evaluating symptoms, impacts, and outcomes. Alzheimers Res Ther. 2020;12(1):90. doi: 10.1186/s13195-020-00659-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00659-6</ArticleId><ArticleId IdType="pmc">PMC7393916</ArticleId><ArticleId IdType="pubmed">32731886</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauber et al. Assessing what matters to people affected by alzheimer&#x2019;s disease: a quantitative analysis (forthcoming).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10043143</ArticleId><ArticleId IdType="pubmed">36763306</ArticleId></ArticleIdList></Reference><Reference><Citation>Jutten RJ, Papp KV, Hendrix S, Ellison N, Langbaum JB, Donohue MC, et al. Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's disease. Alzheimers Dement. 2022 doi: 10.1002/alz.12773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12773</ArticleId><ArticleId IdType="pmc">PMC9931632</ArticleId><ArticleId IdType="pubmed">36086926</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food and Drug Administration. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. 2009. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. Accessed 31 Mar 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1629006</ArticleId><ArticleId IdType="pubmed">17034633</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food and Drug Administration. Patient-focused drug development guidance public workshop: Methods to identify what is important to patients &amp; select, develop or modify fit for purpose clinical outcomes assessments. 2018. https://www.fda.gov/media/116281/download. Accessed 31 Mar 2022.</Citation></Reference><Reference><Citation>US Food and Drug Administration. Patient-focused drug development guidance series for enhancing the incorporation of the patient&#x2019;s voice in medical product development and regulatory decision making. https://www.fda.gov/drugs/development-approval-process-drugs/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical. Accessed 31 Mar 2022.</Citation></Reference><Reference><Citation>Abushakra S, Sadowsky CH, Porsteinsson AP, Gauthier S, Vellas B, Power A, et al. Clinical effects of tramiprosate in APOE4 homozygotes with mild to moderate Alzheimer's disease (ad) are sustained over 130 weeks: Results of a phase 3 extension study. Alzheimers Dement. 2017;13(7):P256.</Citation></Reference><Reference><Citation>Bago Rozankovic P, Badzak J. Impact of donepezil and memantine on behavioral and psychological symptoms in patients with Alzheimer's disease. Eur J Neurol. 2015;22:579.</Citation><ArticleIdList><ArticleId IdType="pubmed">34851866</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen RL, Perry G, Xiong C, Smith MA, Atwood CS. A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks. J Alzheimers Dis. 2015;44(2):549&#x2013;560. doi: 10.3233/JAD-141626.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-141626</ArticleId><ArticleId IdType="pubmed">25310993</ArticleId></ArticleIdList></Reference><Reference><Citation>Claxton A, Baker LD, Hanson A, Trittschuh EH, Cholerton B, Morgan A, et al. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. J Alzheimers Dis. 2015;44(3):897&#x2013;906. doi: 10.3233/JAD-141791.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-141791</ArticleId><ArticleId IdType="pubmed">25374101</ArticleId></ArticleIdList></Reference><Reference><Citation>Cloutier M, Gauthier-Loiselle M, Gagnon-Sanschagrin P, Guerin A, Sanon M. Level of care dependency and functional status among patients with Alzheimer's disease and agitation/aggression symptoms. Am J Geriatr Psychiatry. 2019;27(3):S151&#x2013;S152. doi: 10.1016/j.jagp.2019.01.106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2019.01.106</ArticleId></ArticleIdList></Reference><Reference><Citation>Craft S, Claxton A, Baker LD, Hanson AJ, Cholerton B, Trittschuh EH, et al. Effects of regular and long-acting insulin on cognition and Alzheimer's disease biomarkers: a pilot clinical trial. J Alzheimers Dis. 2017;57(4):1325&#x2013;1334. doi: 10.3233/JAD-161256.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-161256</ArticleId><ArticleId IdType="pmc">PMC5409050</ArticleId><ArticleId IdType="pubmed">28372335</ArticleId></ArticleIdList></Reference><Reference><Citation>Cumbo E, Cumbo S, Torregrossa S, Migliore D. Effects of vortioxetine on cognitive functions in patients with Alzheimer's disease and depressive symptoms: Interim results of an observational study. J Prev Alzheimer's Dis. 2018;5(1):S58&#x2013;S59.</Citation><ArticleIdList><ArticleId IdType="pubmed">31062834</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL, Cohen S, van Dyck CH, Brody M, Curtis C, Cho W, et al. ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease. Neurology. 2018;90(21):e1889&#x2013;e1897. doi: 10.1212/WNL.0000000000005550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005550</ArticleId><ArticleId IdType="pmc">PMC5962917</ArticleId><ArticleId IdType="pubmed">29695589</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL, Lyketsos CG, Peskind ER, Porsteinsson AP, Mintzer JE, Scharre DW, et al. Effect of dextromethorphan-quinidine on agitation in patients with Alzheimer disease dementia: a randomized clinical trial. JAMA. 2015;314(12):1242&#x2013;1254. doi: 10.1001/jama.2015.10214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.10214</ArticleId><ArticleId IdType="pubmed">26393847</ArticleId></ArticleIdList></Reference><Reference><Citation>Fullerton T, Binneman B, David W, Delnomdedieu M, Kupiec J, Lockwood P, et al. A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer's disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil. Alzheimers Res Ther. 2018;10(1):38. doi: 10.1186/s13195-018-0368-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-018-0368-9</ArticleId><ArticleId IdType="pmc">PMC5887246</ArticleId><ArticleId IdType="pubmed">29622037</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauthier S, Rountree S, Finn B, LaPlante B, Weber E, Oltersdorf T. Effects of the acetylcholine release agent ST101 with donepezil in Alzheimer's disease: a randomized phase 2 study. J Alzheimers Dis. 2015;48(2):473&#x2013;481. doi: 10.3233/JAD-150414.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-150414</ArticleId><ArticleId IdType="pubmed">26402011</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson VW, Ala T, Sainani KL, Bernstein AL, Stephenson BS, Rosen AC, et al. Raloxifene for women with Alzheimer disease: a randomized controlled pilot trial. Neurology. 2015;85(22):1937&#x2013;1944. doi: 10.1212/WNL.0000000000002171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002171</ArticleId><ArticleId IdType="pmc">PMC4664126</ArticleId><ArticleId IdType="pubmed">26537053</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann N, O'Regan J, Ruthirakuhan M, Kiss A, Eryavec G, Williams E, et al. A randomized placebo-controlled discontinuation study of cholinesterase inhibitors in institutionalized patients with moderate to severe Alzheimer disease. J Am Med Dir Assoc. 2016;17(2):142&#x2013;147. doi: 10.1016/j.jamda.2015.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2015.08.019</ArticleId><ArticleId IdType="pubmed">26482056</ArticleId></ArticleIdList></Reference><Reference><Citation>Kile S, Au W, Parise C, Rose K, Donnel T, Hankins A, et al. IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia. J Neurol Neurosurg Psychiatry. 2017;88(2):106&#x2013;112. doi: 10.1136/jnnp-2015-311486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-311486</ArticleId><ArticleId IdType="pubmed">26420886</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanct&#xf4;t KL, Ruthirakuhan M, O'Regan JN, Eryavec G, Williams E, Black SE, et al. Cholinesterase inhibitor discontinuation in institutionalized persons with moderate to severe AD: Results of a double-blind, placebo controlled trial. Am J Geriatr Psychiatry. 2015;23(3):S172&#x2013;S173. doi: 10.1016/j.jagp.2014.12.181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2014.12.181</ArticleId></ArticleIdList></Reference><Reference><Citation>Nosheny RL, Flennkiken D, Insel PS, Finley S, Mackin S, Camacho M, et al. Internet-based recruitment of subjects for prodromal and secondary prevention Alzheimer's disease trials using the brain health registry. Alzheimers Dement. 2015;11(7):P156.</Citation></Reference><Reference><Citation>Olsson T, Alexander R, Budd Haeberlein S, Hannesdottir K, Andrews T, Curry L, et al. Use of a telephone interview methodology to identify subjects with cognitive impairment among those reporting subjective memory complaints. Neurodegener Dis. 2015;15:836.</Citation></Reference><Reference><Citation>Salloway SP, Sperling R, Fox NC, Sabbagh MN, Honig LS, Porsteinsson AP, et al. Long-Term follow up of patients with mild-to-moderate Alzheimer's disease treated with bapineuzumab in a phase III, open-label, extension study. J Alzheimers Dis. 2018;64(3):689&#x2013;707. doi: 10.3233/JAD-171157.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-171157</ArticleId><ArticleId IdType="pubmed">29914022</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinberg MI, Leoutsakos JMS. The association between general medical health and course of cognition, function, and neuropsychiatric symptoms in the cache county dementia progression study. Alzheimers Dement. 2015;11(7):P261.</Citation></Reference><Reference><Citation>Vandenberghe R, Rinne JO, Boada M, Katayama S, Scheltens P, Vellas B, et al. Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials. Alzheimers Res Ther. 2016;8(1):18. doi: 10.1186/s13195-016-0189-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-016-0189-7</ArticleId><ArticleId IdType="pmc">PMC4866415</ArticleId><ArticleId IdType="pubmed">27176461</ArticleId></ArticleIdList></Reference><Reference><Citation>Wharton W, Goldstein FC, Zhao L, Steenland K, Levey AI, Hajjar I. Modulation of renin-angiotensin system may slow conversion from mild cognitive impairment to Alzheimer's disease. J Am Geriatr Soc. 2015;63(9):1749&#x2013;1756. doi: 10.1111/jgs.13627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.13627</ArticleId><ArticleId IdType="pmc">PMC4743657</ArticleId><ArticleId IdType="pubmed">26389987</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto E, Mourany L, Colleran R, Whitman C, Tousi B. Utility of montreal cognitive assessment in differentiating dementia with Lewy bodies from Alzheimer's dementia. Am J Alzheimers Dis Other Demen. 2017;32(8):468&#x2013;471. doi: 10.1177/1533317517725811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317517725811</ArticleId><ArticleId IdType="pmc">PMC10852593</ArticleId><ArticleId IdType="pubmed">28871793</ArticleId></ArticleIdList></Reference><Reference><Citation>Assun&#xe7;&#xe3;o SS, Sperling RA, Ritchie C, Kerwin DR, Aisen PS, Lansdall C, Atri A, Cummings J. Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease. Alzheimers Res Ther. 2022;14(1):54. doi: 10.1186/s13195-022-00984-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-022-00984-y</ArticleId><ArticleId IdType="pmc">PMC9017027</ArticleId><ArticleId IdType="pubmed">35440022</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentz DM, Wessels AM, Annapragada AV, Berger AK, Edgar CJ, Gold M, Miller DS, Randolph C, Ryan JM, Wunderlich G, Zoschg MC, Tr&#xe9;pel D, Knopman DS, Staffaroni AM, Bain LJ, Carrillo MC, Weber CJ. Building clinically relevant outcomes across the Alzheimer's disease spectrum. Alzheimers Dement (N Y) 2021;7(1):e12181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8234696</ArticleId><ArticleId IdType="pubmed">34195350</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar CJ, Vradenburg G, Hassenstab J. The 2018 revised FDA guidance for early Alzheimer's disease: establishing the meaningfulness of treatment effects. J Prev Alzheimers Dis. 2019;6(4):223&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">31686092</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36778590</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-4365</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in aging neuroscience</Title><ISOAbbreviation>Front Aging Neurosci</ISOAbbreviation></Journal><ArticleTitle>Defining the role of Interleukin-6 for the development of perioperative neurocognitive disorders: Evidence from clinical and preclinical studies.</ArticleTitle><Pagination><StartPage>1097606</StartPage><MedlinePgn>1097606</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1097606</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnagi.2022.1097606</ELocationID><Abstract><AbstractText>For most, staying "mentally sharp" as they age is a very high priority that may be thwarted by the consequences of a postoperative complication unrelated to the disorder which necessitated the surgical intervention. Perioperative neurocognitive disorder (PND) is an overarching term for cognitive impairment in surgical patients, that includes conditions from delirium to dementia, affecting more than 7 million patients annually in the US, and which threatens both functional independence and life. Clinical trials and meta-analyses have identified the association between PNDs and increased perioperative levels of Interleukin-6 (IL-6), a pleiotropic cytokine that is both necessary and sufficient for postoperative memory decline in a preclinical model of PND. Recently, we reported that, in adult male wild-type mice subjected to tibial fracture under general anesthesia, IL-6 trans-signaling in hippocampal CA1 neurons mediates surgery-induced memory impairment. As there are no therapeutic options for preventing or reversing PNDs, patients and their caregivers, as well as the healthcare industry, endure staggering costs. Olamkicept, a highly selective IL-6 trans-signaling blocker has shown to be efficacious and safe in clinical trials involving patients with inflammatory bowel disease, another condition for which IL-6 trans-signaling is the mediating mechanism. Subject to a demonstration that olamkicept is effective in preventing cognitive impairment in vulnerable (aged and Alzheimer's Disease) preclinical PND models, clinical trials involving aged and/or cognitively impaired surgical patients should be undertaken to study olamkicept's utility for PNDs.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Barreto Chang and Maze.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barreto Chang</LastName><ForeName>Odmara L</ForeName><Initials>OL</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maze</LastName><ForeName>Mervyn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, Center for Cerebrovascular Disease, University of California, San Francisco, San Francisco, CA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Aging Neurosci</MedlineTA><NlmUniqueID>101525824</NlmUniqueID><ISSNLinking>1663-4365</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">IL-6</Keyword><Keyword MajorTopicYN="N">IL-6 trans-signaling</Keyword><Keyword MajorTopicYN="N">Olamkicept</Keyword><Keyword MajorTopicYN="N">PND</Keyword><Keyword MajorTopicYN="N">POD</Keyword><Keyword MajorTopicYN="N">aging</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">perioperative neurocognitive disorder</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>13</Day><Hour>3</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36778590</ArticleId><ArticleId IdType="pmc">PMC9908597</ArticleId><ArticleId IdType="doi">10.3389/fnagi.2022.1097606</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barantke M., Krauss T., Ortak J., Lieb W., Reppel M., Burgdorf C., et al. . (2008). Effects of gender and aging on differential autonomic responses to orthostatic maneuvers. J. Cardiovasc. Electrophysiol. 19, 1296&#x2013;1303. doi: 10.1111/j.1540-8167.2008.01257.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.2008.01257.x</ArticleId><ArticleId IdType="pubmed">18662181</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreto Chang O. L., Possin K. L., Maze M. (2022a). Age-related perioperative neurocognitive disorders: experimental models and Druggable targets. Annu. Rev. Pharmacol. Toxicol. doi: 10.1146/annurev-pharmtox-051921-112525 [Epub ahead of print].</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-051921-112525</ArticleId><ArticleId IdType="pubmed">36100220</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreto Chang O. L., Whitlock E. L., Arias A. D., Tsoy E., Allen I. E., Hellman J., et al. . (2022b). A novel approach for the detection of cognitive impairment and delirium risk in older patients undergoing spine surgery. J. Am. Geriatr. Soc. doi: 10.1111/jgs.18033, PMID: [Epub ahead of print].</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.18033</ArticleId><ArticleId IdType="pmc">PMC9870968</ArticleId><ArticleId IdType="pubmed">36125032</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger M., Murdoch D. M., Staats J. S., Chan C., Thomas J. P., Garrigues G. E., et al. . (2019). Flow cytometry characterization of cerebrospinal fluid monocytes in patients with postoperative cognitive dysfunction: A pilot study. Anesth. Analg. 129, e150&#x2013;e154. doi: 10.1213/ANE.0000000000004179, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004179</ArticleId><ArticleId IdType="pmc">PMC6800758</ArticleId><ArticleId IdType="pubmed">31085945</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger M., Schenning K. J., Brown C. H. T., Deiner S. G., Whittington R. A., Eckenhoff R. G., et al. . (2018). Best practices for postoperative brain health: recommendations from the fifth international perioperative neurotoxicity working group. Anesth. Analg. 127, 1406&#x2013;1413. doi: 10.1213/ANE.0000000000003841, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003841</ArticleId><ArticleId IdType="pmc">PMC6309612</ArticleId><ArticleId IdType="pubmed">30303868</ArticleId></ArticleIdList></Reference><Reference><Citation>Brosseron F., Krauthausen M., Kummer M., Heneka M. T. (2014). Body fluid cytokine levels in mild cognitive impairment and Alzheimer&#x2019;s disease: a comparative overview. Mol. Neurobiol. 50, 534&#x2013;544. doi: 10.1007/s12035-014-8657-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8657-1</ArticleId><ArticleId IdType="pmc">PMC4182618</ArticleId><ArticleId IdType="pubmed">24567119</ArticleId></ArticleIdList></Reference><Reference><Citation>Burton M. D., Johnson R. W. (2012). Interleukin-6 trans-signaling in the senescent mouse brain is involved in infection-related deficits in contextual fear conditioning. Brain Behav. Immun. 26, 732&#x2013;738. doi: 10.1016/j.bbi.2011.10.008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2011.10.008</ArticleId><ArticleId IdType="pmc">PMC3699311</ArticleId><ArticleId IdType="pubmed">22062497</ArticleId></ArticleIdList></Reference><Reference><Citation>Burton M. D., Rytych J. L., Freund G. G., Johnson R. W. (2013). Central inhibition of interleukin-6 trans-signaling during peripheral infection reduced neuroinflammation and sickness in aged mice. Brain Behav. Immun. 30, 66&#x2013;72. doi: 10.1016/j.bbi.2013.01.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2013.01.002</ArticleId><ArticleId IdType="pmc">PMC3641158</ArticleId><ArticleId IdType="pubmed">23354002</ArticleId></ArticleIdList></Reference><Reference><Citation>Calsolaro V., Edison P. (2016). Neuroinflammation in Alzheimer&#x2019;s disease: current evidence and future directions. Alzheimers Dement. 12, 719&#x2013;732. doi: 10.1016/j.jalz.2016.02.010, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2016.02.010</ArticleId><ArticleId IdType="pubmed">27179961</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell I. L., Erta M., Lim S. L., Frausto R., May U., Rose-John S., et al. . (2014). Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain. J. Neurosci. 34, 2503&#x2013;2513. doi: 10.1523/JNEUROSCI.2830-13.2014, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2830-13.2014</ArticleId><ArticleId IdType="pmc">PMC6802757</ArticleId><ArticleId IdType="pubmed">24523541</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao S. J., Chen D., Yang L., Zhu T. (2019). Effects of an abnormal mini-mental state examination score on postoperative outcomes in geriatric surgical patients: a meta-analysis. BMC Anesthesiol. 19:74. doi: 10.1186/s12871-019-0735-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-019-0735-5</ArticleId><ArticleId IdType="pmc">PMC6521510</ArticleId><ArticleId IdType="pubmed">31092206</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Yang N., Li Y., Li Y., Hong J., Wang Q., et al. . (2021). Cholecystokinin octapeptide improves hippocampal glutamatergic synaptogenesis and postoperative cognition by inhibiting induction of A1 reactive astrocytes in aged mice. CNS Neurosci. Ther. 27, 1374&#x2013;1384. doi: 10.1111/cns.13718, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13718</ArticleId><ArticleId IdType="pmc">PMC8504528</ArticleId><ArticleId IdType="pubmed">34402181</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesworth R., Gamage R., Ullah F., Sonego S., Millington C., Fernandez A., et al. . (2021). Spatial memory and microglia activation in a mouse model of chronic Neuroinflammation and the anti-inflammatory effects of Apigenin. Front. Neurosci. 15:699329. doi: 10.3389/fnins.2021.699329, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.699329</ArticleId><ArticleId IdType="pmc">PMC8363202</ArticleId><ArticleId IdType="pubmed">34393713</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang N., Serhan C. N. (2020). Specialized pro-resolving mediator network: an update on production and actions. Essays Biochem. 64, 443&#x2013;462. doi: 10.1042/EBC20200018, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/EBC20200018</ArticleId><ArticleId IdType="pmc">PMC7682745</ArticleId><ArticleId IdType="pubmed">32885825</ArticleId></ArticleIdList></Reference><Reference><Citation>Cibelli M., Fidalgo A. R., Terrando N., Ma D., Monaco C., Feldmann M., et al. . (2010). Role of interleukin-1beta in postoperative cognitive dysfunction. Ann. Neurol. 68, 360&#x2013;368. doi: 10.1002/ana.22082, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22082</ArticleId><ArticleId IdType="pmc">PMC4836445</ArticleId><ArticleId IdType="pubmed">20818791</ArticleId></ArticleIdList></Reference><Reference><Citation>Compton J., Bonderman D. P. (1976). The use of o-dianisidine for serum haptoglobin electrophoresis using cellulose acetate. Clin. Biochem. 9, 104&#x2013;105. doi: 10.1016/S0009-9120(76)80028-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0009-9120(76)80028-8</ArticleId><ArticleId IdType="pubmed">1260999</ArticleId></ArticleIdList></Reference><Reference><Citation>Cribbs D. H., Berchtold N. C., Perreau V., Coleman P. D., Rogers J., Tenner A. J., et al. . (2012). Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J. Neuroinflammation 9:179. doi: 10.1186/1742-2094-9-179</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-179</ArticleId><ArticleId IdType="pmc">PMC3419089</ArticleId><ArticleId IdType="pubmed">22824372</ArticleId></ArticleIdList></Reference><Reference><Citation>Danielson M., Reinsfelt B., Westerlind A., Zetterberg H., Blennow K., Ricksten S. E. (2018). Effects of methylprednisolone on blood-brain barrier and cerebral inflammation in cardiac surgery-a randomized trial. J. Neuroinflammation 15:283. doi: 10.1186/s12974-018-1318-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1318-y</ArticleId><ArticleId IdType="pmc">PMC6158839</ArticleId><ArticleId IdType="pubmed">30261896</ArticleId></ArticleIdList></Reference><Reference><Citation>Degos V., Vacas S., Han Z., Van Rooijen N., Gressens P., Su H., et al. . (2013). Depletion of bone marrow-derived macrophages perturbs the innate immune response to surgery and reduces postoperative memory dysfunction. Anesthesiology 118, 527&#x2013;536. doi: 10.1097/ALN.0b013e3182834d94, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182834d94</ArticleId><ArticleId IdType="pmc">PMC3779063</ArticleId><ArticleId IdType="pubmed">23426204</ArticleId></ArticleIdList></Reference><Reference><Citation>Delaby C., Gabelle A., Blum D., Schraen-Maschke S., Moulinier A., Boulanghien J., et al. . (2015). Central nervous system and peripheral inflammatory processes in Alzheimer&#x2019;s disease: biomarker profiling approach. Front. Neurol. 6:181. doi: 10.3389/fneur.2015.00181</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2015.00181</ArticleId><ArticleId IdType="pmc">PMC4547499</ArticleId><ArticleId IdType="pubmed">26379616</ArticleId></ArticleIdList></Reference><Reference><Citation>Dursun E., Gezen-Ak D., Hanagasi H., Bilgic B., Lohmann E., Ertan S., et al. . (2015). The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer&#x2019;s disease, mild cognitive impairment or Parkinson&#x2019;s disease. J. Neuroimmunol. 283, 50&#x2013;57. doi: 10.1016/j.jneuroim.2015.04.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2015.04.014</ArticleId><ArticleId IdType="pubmed">26004156</ArticleId></ArticleIdList></Reference><Reference><Citation>Escrig A., Canal C., Sanchis P., Fernandez-Gayol O., Montilla A., Comes G., et al. . (2019). IL-6 trans-signaling in the brain influences the behavioral and physio-pathological phenotype of the Tg2576 and 3xTgAD mouse models of Alzheimer&#x2019;s disease. Brain Behav. Immun. 82, 145&#x2013;159. doi: 10.1016/j.bbi.2019.08.005, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2019.08.005</ArticleId><ArticleId IdType="pubmed">31401302</ArticleId></ArticleIdList></Reference><Reference><Citation>Escrig A., Molinero A., Mendez B., Giralt M., Comes G., Sanchis P., et al. . (2020). IL-6 trans-signaling in the brain influences the metabolic phenotype of the 3xTg-AD mouse model of Alzheimer&#x2019;s disease. Cells 9:1605. doi: 10.3390/cells9071605, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9071605</ArticleId><ArticleId IdType="pmc">PMC7407279</ArticleId><ArticleId IdType="pubmed">32630818</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng X., Valdearcos M., Uchida Y., Lutrin D., Maze M., Koliwad S. K. (2017). Microglia mediate postoperative hippocampal inflammation and cognitive decline in mice. JCI Insight 2:e91229. doi: 10.1172/jci.insight.91229, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.91229</ArticleId><ArticleId IdType="pmc">PMC5374063</ArticleId><ArticleId IdType="pubmed">28405620</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci L., Harris T. B., Guralnik J. M., Tracy R. P., Corti M. C., Cohen H. J., et al. . (1999). Serum IL-6 level and the development of disability in older persons. J. Am. Geriatr. Soc. 47, 639&#x2013;646. doi: 10.1111/j.1532-5415.1999.tb01583.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.1999.tb01583.x</ArticleId><ArticleId IdType="pubmed">10366160</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg A., Cervenka S., Jonsson Fagerlund M., Rasmussen L. S., Zetterberg H., Erlandsson Harris H., et al. . (2017). The immune response of the human brain to abdominal surgery. Ann. Neurol. 81, 572&#x2013;582. doi: 10.1002/ana.24909, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24909</ArticleId><ArticleId IdType="pubmed">28253549</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., et al. . (2000). Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908, 244&#x2013;254. doi: 10.1111/j.1749-6632.2000.tb06651.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2000.tb06651.x</ArticleId><ArticleId IdType="pubmed">10911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallowitsch-Puerta M., Tracey K. J. (2005). Immunologic role of the cholinergic anti-inflammatory pathway and the nicotinic acetylcholine alpha 7 receptor. Ann. N. Y. Acad. Sci. 1062, 209&#x2013;219. doi: 10.1196/annals.1358.024, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1358.024</ArticleId><ArticleId IdType="pubmed">16461803</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbers C., Heink S., Korn T., Rose-John S. (2018). Interleukin-6: designing specific therapeutics for a complex cytokine. Nat. Rev. Drug Discov. 17, 395&#x2013;412. doi: 10.1038/nrd.2018.45, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2018.45</ArticleId><ArticleId IdType="pubmed">29725131</ArticleId></ArticleIdList></Reference><Reference><Citation>Garner K. M., Amin R., Johnson R. W., Scarlett E. J., Burton M. D. (2018). Microglia priming by interleukin-6 signaling is enhanced in aged mice. J. Neuroimmunol. 324, 90&#x2013;99. doi: 10.1016/j.jneuroim.2018.09.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2018.09.002</ArticleId><ArticleId IdType="pmc">PMC6699492</ArticleId><ArticleId IdType="pubmed">30261355</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampel H., Haslinger A., Scheloske M., Padberg F., Fischer P., Unger J., et al. . (2005). Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer&#x2019;s disease brain. Eur. Arch. Psychiatry Clin. Neurosci. 255, 269&#x2013;278. doi: 10.1007/s00406-004-0558-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-004-0558-2</ArticleId><ArticleId IdType="pubmed">15565298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickman S. E., Allison E. K., El Khoury J. (2008). Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer&#x2019;s disease mice. J. Neurosci. 28, 8354&#x2013;8360. doi: 10.1523/JNEUROSCI.0616-08.2008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0616-08.2008</ArticleId><ArticleId IdType="pmc">PMC2597474</ArticleId><ArticleId IdType="pubmed">18701698</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch J., Vacas S., Terrando N., Yuan M., Sands L. P., Kramer J., et al. . (2016). Perioperative cerebrospinal fluid and plasma inflammatory markers after orthopedic surgery. J. Neuroinflammation 13:211. doi: 10.1186/s12974-016-0681-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0681-9</ArticleId><ArticleId IdType="pmc">PMC5006595</ArticleId><ArticleId IdType="pubmed">27577265</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovens I. B., Van Leeuwen B. L., Nyakas C., Heineman E., Van Der Zee E. A., Schoemaker R. G. (2015). Postoperative cognitive dysfunction and microglial activation in associated brain regions in old rats. Neurobiol. Learn. Mem. 118, 74&#x2013;79. doi: 10.1016/j.nlm.2014.11.009, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nlm.2014.11.009</ArticleId><ArticleId IdType="pubmed">25460037</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J., Feng X., Valdearcos M., Lutrin D., Uchida Y., Koliwad S. K., et al. . (2018). Interleukin-6 is both necessary and sufficient to produce perioperative neurocognitive disorder in mice. Br. J. Anaesth. 120, 537&#x2013;545. doi: 10.1016/j.bja.2017.11.096, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2017.11.096</ArticleId><ArticleId IdType="pmc">PMC6200097</ArticleId><ArticleId IdType="pubmed">29452810</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J., Zhang Y., Huang C., Feng X., He S., Zhang Y., et al. . (2022). Interleukin-6 trans-signalling in hippocampal CA1 neurones mediates perioperative neurocognitive disorders in mice. Br. J. Anaesth. 129, 923&#x2013;936. doi: 10.1016/j.bja.2022.08.019, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2022.08.019</ArticleId><ArticleId IdType="pubmed">36253222</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter C. A., Jones S. A. (2015). IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 16, 448&#x2013;457. doi: 10.1038/ni.3153, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3153</ArticleId><ArticleId IdType="pubmed">25898198</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinney J. W., Bemiller S. M., Murtishaw A. S., Leisgang A. M., Salazar A. M., Lamb B. T. (2018). Inflammation as a central mechanism in Alzheimer&#x2019;s disease. Alzheimers Dement (N Y) 4, 575&#x2013;590. doi: 10.1016/j.trci.2018.06.014, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2018.06.014</ArticleId><ArticleId IdType="pmc">PMC6214864</ArticleId><ArticleId IdType="pubmed">30406177</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai I. K., Valdearcos M., Morioka K., Saxena S., Feng X., Li R., et al. . (2020). Blocking Kv1.3 potassium channels prevents postoperative neuroinflammation and cognitive decline without impairing wound healing in mice. Br. J. Anaesth. 125, 298&#x2013;307. doi: 10.1016/j.bja.2020.05.018, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.05.018</ArticleId><ArticleId IdType="pmc">PMC7497028</ArticleId><ArticleId IdType="pubmed">32624183</ArticleId></ArticleIdList></Reference><Reference><Citation>Lammers-Lietz F., Akyuz L., Feinkohl I., Lachmann C., Pischon T., Volk H. D., et al. . (2022). Interleukin 8 in postoperative delirium - preliminary findings from two studies. Brain Behav. Immun. Health 20:100419. doi: 10.1016/j.bbih.2022.100419, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100419</ArticleId><ArticleId IdType="pmc">PMC8814304</ArticleId><ArticleId IdType="pubmed">35141571</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S. A., Guttenplan K. A., Clarke L. E., Bennett F. C., Bohlen C. J., Schirmer L., et al. . (2017). Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481&#x2013;487. doi: 10.1038/nature21029, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Yu Y., Zhu S. (2018). Inflammatory markers in postoperative delirium (POD) and cognitive dysfunction (POCD): A meta-analysis of observational studies. PLoS One 13:e0195659. doi: 10.1371/journal.pone.0195659, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0195659</ArticleId><ArticleId IdType="pmc">PMC5895053</ArticleId><ArticleId IdType="pubmed">29641605</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Ramirez M. A., Fischer R., Torres-Badillo C. C., Davies H. A., Logan K., Pfizenmaier K., et al. . (2012). Role of caspases in cytokine-induced barrier breakdown in human brain endothelial cells. J. Immunol. 189, 3130&#x2013;3139. doi: 10.4049/jimmunol.1103460, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1103460</ArticleId><ArticleId IdType="pubmed">22896632</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyra E. S. N. M., Goncalves R. A., Pascoal T. A., Lima-Filho R. A. S., Resende E. P. F., Vieira E. L. M. (2021). Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer&#x2019;s disease. Transl. Psychiatry 11:251. doi: 10.1038/s41398-021-01349-z, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-021-01349-z</ArticleId><ArticleId IdType="pmc">PMC8080782</ArticleId><ArticleId IdType="pubmed">33911072</ArticleId></ArticleIdList></Reference><Reference><Citation>Medzhitov R. (2008). Origin and physiological roles of inflammation. Nature 454, 428&#x2013;435. doi: 10.1038/nature07201, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07201</ArticleId><ArticleId IdType="pubmed">18650913</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller A. H., Maletic V., Raison C. L. (2009). Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 65, 732&#x2013;741. doi: 10.1016/j.biopsych.2008.11.029, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2008.11.029</ArticleId><ArticleId IdType="pmc">PMC2680424</ArticleId><ArticleId IdType="pubmed">19150053</ArticleId></ArticleIdList></Reference><Reference><Citation>Monk T. G., Weldon B. C., Garvan C. W., Dede D. E., Van Der Aa M. T., Heilman K. M., et al. . (2008). Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology 108, 18&#x2013;30. doi: 10.1097/01.anes.0000296071.19434.1e, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000296071.19434.1e</ArticleId><ArticleId IdType="pubmed">18156878</ArticleId></ArticleIdList></Reference><Reference><Citation>Naito Y., Tamai S., Shingu K., Shindo K., Matsui T., Segawa H., et al. . (1992). Responses of plasma adrenocorticotropic hormone, cortisol, and cytokines during and after upper abdominal surgery. Anesthesiology 77, 426&#x2013;431. doi: 10.1097/00000542-199209000-00004, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199209000-00004</ArticleId><ArticleId IdType="pubmed">1355636</ArticleId></ArticleIdList></Reference><Reference><Citation>Neerland B. E., Hall R. J., Seljeflot I., Frihagen F., Maclullich A. M., Raeder J., et al. . (2016). Associations between delirium and preoperative cerebrospinal fluid C-reactive protein, Interleukin-6, and Interleukin-6 receptor in individuals with acute hip fracture. J. Am. Geriatr. Soc. 64, 1456&#x2013;1463. doi: 10.1111/jgs.14238, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.14238</ArticleId><ArticleId IdType="pubmed">27341529</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto N., Yoshizaki K., Tagoh H., Monden M., Kishimoto S., Hirano T., et al. . (1989). Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation. Clin. Immunol. Immunopathol. 50, 399&#x2013;401. doi: 10.1016/0090-1229(89)90147-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0090-1229(89)90147-5</ArticleId><ArticleId IdType="pubmed">2465111</ArticleId></ArticleIdList></Reference><Reference><Citation>Noah A. M., Almghairbi D., Evley R., Moppett I. K. (2021). Preoperative inflammatory mediators and postoperative delirium: systematic review and meta-analysis. Br. J. Anaesth. 127, 424&#x2013;434. doi: 10.1016/j.bja.2021.04.033, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.04.033</ArticleId><ArticleId IdType="pubmed">34218905</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli R. C., Sierra A., Stevens B., Tremblay M. E., Aguzzi A., Ajami B., et al. . (2022). Microglia states and nomenclature: A field at its crossroads. Neuron 110, 3458&#x2013;3483. doi: 10.1016/j.neuron.2022.10.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.020</ArticleId><ArticleId IdType="pmc">PMC9999291</ArticleId><ArticleId IdType="pubmed">36327895</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters M., Blinn G., Solem F., Fischer M., Buschenfelde M. Z., Rose-John S. (1998). In vivo and in vitro activities of the gp130-stimulating designer cytokine hyper-IL-6. J. Immunol. 161, 3575&#x2013;3581. doi: 10.4049/jimmunol.161.7.3575, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.161.7.3575</ArticleId><ArticleId IdType="pubmed">9759879</ArticleId></ArticleIdList></Reference><Reference><Citation>Porcher L., Bruckmeier S., Burbano S. D., Finnell J. E., Gorny N., Klett J., et al. . (2021). Aging triggers an upregulation of a multitude of cytokines in the male and especially the female rodent hippocampus but more discrete changes in other brain regions. J. Neuroinflammation 18:219. doi: 10.1186/s12974-021-02252-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02252-6</ArticleId><ArticleId IdType="pmc">PMC8459490</ArticleId><ArticleId IdType="pubmed">34551810</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringheim G. E., Szczepanik A. M., Petko W., Burgher K. L., Zhu S. Z., Chao C. C. (1998). Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex. Brain Res. Mol. Brain Res. 55, 35&#x2013;44. doi: 10.1016/S0169-328X(97)00356-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-328X(97)00356-2</ArticleId><ArticleId IdType="pubmed">9645958</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose-John S. (2018). Interleukin-6 family cytokines. Cold Spring Harb. Perspect. Biol. 10:10. doi: 10.1101/cshperspect.a028415</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a028415</ArticleId><ArticleId IdType="pmc">PMC5793756</ArticleId><ArticleId IdType="pubmed">28620096</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose-John S. (2021). Therapeutic targeting of IL-6 trans-signaling. Cytokine 144:155577. doi: 10.1016/j.cyto.2021.155577, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2021.155577</ArticleId><ArticleId IdType="pubmed">34022535</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvador A. F., De Lima K. A., Kipnis J. (2021). Neuromodulation by the immune system: a focus on cytokines. Nat. Rev. Immunol. 21, 526&#x2013;541. doi: 10.1038/s41577-021-00508-z, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00508-z</ArticleId><ArticleId IdType="pubmed">33649606</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S., Rodts C., Nuyens V., Lazaron J., Sosnowski V., Verdonk F., et al. . (2020). Preoperative sedentary behavior is neither a risk factor for perioperative neurocognitive disorders nor associated with an increase in peripheral inflammation, a prospective observational cohort study. BMC Anesthesiol. 20:284. doi: 10.1186/s12871-020-01200-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-020-01200-w</ArticleId><ArticleId IdType="pmc">PMC7666527</ArticleId><ArticleId IdType="pubmed">33187477</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber S., Aden K., Bernardes J. P., Conrad C., Tran F., Hoper H., et al. . (2021). Therapeutic Interleukin-6 trans-signaling inhibition by Olamkicept (sgp130Fc) in patients with active inflammatory bowel disease. Gastroenterology 160:e2311</Citation><ArticleIdList><ArticleId IdType="pubmed">33667488</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw A. C., Goldstein D. R., Montgomery R. R. (2013). Age-dependent dysregulation of innate immunity. Nat. Rev. Immunol. 13, 875&#x2013;887. doi: 10.1038/nri3547, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3547</ArticleId><ArticleId IdType="pmc">PMC4096436</ArticleId><ArticleId IdType="pubmed">24157572</ArticleId></ArticleIdList></Reference><Reference><Citation>Simard A. R., Soulet D., Gowing G., Julien J. P., Rivest S. (2006). Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer&#x2019;s disease. Neuron 49, 489&#x2013;502. doi: 10.1016/j.neuron.2006.01.022, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.01.022</ArticleId><ArticleId IdType="pubmed">16476660</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh-Manoux A., Dugravot A., Brunner E., Kumari M., Shipley M., Elbaz A., et al. . (2014). Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife. Neurology 83, 486&#x2013;493. doi: 10.1212/WNL.0000000000000665, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000665</ArticleId><ArticleId IdType="pmc">PMC4141998</ArticleId><ArticleId IdType="pubmed">24991031</ArticleId></ArticleIdList></Reference><Reference><Citation>Song D. K., Im Y. B., Jung J. S., Cho J., Suh H. W., Kim Y. H. (2001). Central beta-amyloid peptide-induced peripheral interleukin-6 responses in mice. J. Neurochem. 76, 1326&#x2013;1335. doi: 10.1046/j.1471-4159.2001.00121.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2001.00121.x</ArticleId><ArticleId IdType="pubmed">11238717</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinberg B. E., Silverman H. A., Robbiati S., Gunasekaran M. K., Tsaava T., Battinelli E., et al. . (2016). Cytokine-specific Neurograms in the sensory Vagus nerve. Bioelectron. Med. 3, 7&#x2013;17. doi: 10.15424/bioelectronmed.2016.00007, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.15424/bioelectronmed.2016.00007</ArticleId><ArticleId IdType="pmc">PMC6039192</ArticleId><ArticleId IdType="pubmed">30003120</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniyan S., Terrando N. (2019). Neuroinflammation and perioperative neurocognitive disorders. Anesth. Analg. 128, 781&#x2013;788. doi: 10.1213/ANE.0000000000004053, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004053</ArticleId><ArticleId IdType="pmc">PMC6437083</ArticleId><ArticleId IdType="pubmed">30883423</ArticleId></ArticleIdList></Reference><Reference><Citation>Terrando N., Gomez-Galan M., Yang T., Carlstrom M., Gustavsson D., Harding R. E., et al. . (2013). Aspirin-triggered resolvin D1 prevents surgery-induced cognitive decline. FASEB J. 27, 3564&#x2013;3571. doi: 10.1096/fj.13-230276, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.13-230276</ArticleId><ArticleId IdType="pubmed">23709617</ArticleId></ArticleIdList></Reference><Reference><Citation>Terrando N., Monaco C., Ma D., Foxwell B. M., Feldmann M., Maze M. (2010). Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc. Natl. Acad. Sci. U. S. A. 107, 20518&#x2013;20522. doi: 10.1073/pnas.1014557107, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1014557107</ArticleId><ArticleId IdType="pmc">PMC2996666</ArticleId><ArticleId IdType="pubmed">21041647</ArticleId></ArticleIdList></Reference><Reference><Citation>Terrando N., Yang T., Wang X., Fang J., Cao M., Andersson U., et al. . (2016). Systemic HMGB1 neutralization prevents postoperative neurocognitive dysfunction in aged rats. Front. Immunol. 7:441. doi: 10.3389/fimmu.2016.00441, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00441</ArticleId><ArticleId IdType="pmc">PMC5075578</ArticleId><ArticleId IdType="pubmed">27822212</ArticleId></ArticleIdList></Reference><Reference><Citation>Uciechowski P., Dempke W. C. M. (2020). Interleukin-6: A Masterplayer in the cytokine network. Oncology 98, 131&#x2013;137. doi: 10.1159/000505099, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000505099</ArticleId><ArticleId IdType="pubmed">31958792</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacas S., Degos V., Tracey K. J., Maze M. (2014). High-mobility group box 1 protein initiates postoperative cognitive decline by engaging bone marrow-derived macrophages. Anesthesiology 120, 1160&#x2013;1167. doi: 10.1097/ALN.0000000000000045, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000045</ArticleId><ArticleId IdType="pmc">PMC3999217</ArticleId><ArticleId IdType="pubmed">24162463</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittington R. A., Planel E., Terrando N. (2017). Impaired resolution of inflammation in Alzheimer&#x2019;s disease: a review. Front. Immunol. 8:1464. doi: 10.3389/fimmu.2017.01464, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01464</ArticleId><ArticleId IdType="pmc">PMC5681480</ArticleId><ArticleId IdType="pubmed">29163531</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann M. A., Cruickshanks K. J., Carlsson C. M., Chappell R., Fischer M. E., et al. . (2014). Long-term systemic inflammation and cognitive impairment in a population-based cohort. J. Am. Geriatr. Soc. 62, 1683&#x2013;1691. doi: 10.1111/jgs.12994, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.12994</ArticleId><ArticleId IdType="pmc">PMC4196672</ArticleId><ArticleId IdType="pubmed">25123210</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Yin Y., Jin M., Li B. (2021). The risk factors for postoperative delirium in adult patients after hip fracture surgery: a systematic review and meta-analysis. Int. J. Geriatr. Psychiatry 36, 3&#x2013;14. doi: 10.1002/gps.5408, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5408</ArticleId><ArticleId IdType="pubmed">32833302</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z., Tanzi R. E. (2006). Alzheimer&#x2019;s disease and post-operative cognitive dysfunction. Exp. Gerontol. 41, 346&#x2013;359. doi: 10.1016/j.exger.2006.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2006.01.014</ArticleId><ArticleId IdType="pubmed">16564662</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Hu J., Zuo W., He P., Xue Q., Feng X., et al. . (2023). Longitudinal profiling of plasma cytokines and its association with postoperative delirium in elderly patients undergoing major lower limb surgery: A prospective observational study. Anesth. Analg. 136, 34&#x2013;42. doi: 10.1213/ANE.0000000000006250, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000006250</ArticleId><ArticleId IdType="pubmed">36534715</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou J., Huang G. F., Xia Q., Li X., Shi J., Sun N. (2021). Electroacupuncture promotes microglial M2 polarization in ischemic stroke via annexin A1. Acupunct. Med. 9645284211057570</Citation><ArticleIdList><ArticleId IdType="pubmed">34894768</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36778453</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2692-8205</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2023</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>bioRxiv : the preprint server for biology</Title><ISOAbbreviation>bioRxiv</ISOAbbreviation></Journal><ArticleTitle>PPAD: A deep learning architecture to predict progression of Alzheimer's disease.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2023.01.28.526045</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2023.01.28.526045</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) is a neurodegenerative disease that affects millions of people worldwide. Mild cognitive impairment (MCI) is an intermediary stage between cognitively normal (CN) state and AD. Not all people who have MCI convert to AD. The diagnosis of AD is made after significant symptoms of dementia such as short-term memory loss are already present. Since AD is currently an irreversible disease, diagnosis at the onset of disease brings a huge burden on patients, their caregivers, and the healthcare sector. Thus, there is a crucial need to develop methods for the early prediction AD for patients who have MCI. Recurrent Neural Networks (RNN) have been successfully used to handle Electronic Health Records (EHR) for predicting conversion from MCI to AD. However, RNN ignores irregular time intervals between successive events which occurs common in EHR data. In this study, we propose two deep learning architectures based on RNN, namely Predicting Progression of Alzheimer's Disease (PPAD) and PPAD-Autoencoder (PPAD-AE). PPAD and PPAD-AE are designed for early predicting conversion from MCI to AD at the next visit and multiple visits ahead for patients, respectively. To minimize the effect of the irregular time intervals between visits, we propose using age in each visit as an indicator of time change between successive visits. Our experimental results conducted on Alzheimer's Disease Neuroimaging Initiative (ADNI) and National Alzheimer's Coordinating Center (NACC) datasets showed that our proposed models outperformed all baseline models for most prediction scenarios in terms of F2 and sensitivity. We also observed that the age feature was one of top features and was able to address irregular time interval problem.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al Olaimat</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dept. of Computer Science and Engineering, University of North Texas, Denton, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Jared</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Dept. of Computer Science and Engineering, University of North Texas, Denton, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saeed</LastName><ForeName>Fahad</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Computing and Information Sciences, Florida International University, Miami, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozdag</LastName><ForeName>Serdar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dept. of Computer Science and Engineering, University of North Texas, Denton, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept. of Math-ematics, University of North Texas, Denton, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BioDiscovery Institute, University of North Texas, Denton, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Alzheimer&#x2019;s Disease Neuroimaging Initiative</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P20 AG068053</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066515</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066508</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066519</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072973</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066462</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066509</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P20 AG068077</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066546</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072972</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072979</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P20 AG068082</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072975</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066444</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066507</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072946</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066518</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066511</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 AG072122</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066512</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG062421</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG024904</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072978</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG062429</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG062422</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG079280</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066530</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM133657</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072977</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG062677</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P20 AG068024</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072958</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG062715</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066506</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066468</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072976</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072947</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072931</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066514</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072959</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>bioRxiv</MedlineTA><NlmUniqueID>101680187</NlmUniqueID><ISSNLinking>2692-8205</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Bioinformatics. 2023 Jun 30;39(39 Suppl 1):i149-i157. doi: 10.1093/bioinformatics/btad249</RefSource><PMID Version="1">37387135</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>13</Day><Hour>3</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36778453</ArticleId><ArticleId IdType="pmc">PMC9915480</ArticleId><ArticleId IdType="doi">10.1101/2023.01.28.526045</ArticleId><ArticleId IdType="pii">2023.01.28.526045</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aisen P. S., Petersen R. C., Donohue M. C., Gamst A., Raman R., Thomas R. G., &#x2026; &amp; Alzheimer&#x2019;s Disease Neuroimaging Initiative. (2010). Clinical Core of the Alzheimer&#x2019;s Disease Neuroimaging Initiative: progress and plans. Alzheimer&#x2019;s &amp; Dementia, 6(3), 239&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2867843</ArticleId><ArticleId IdType="pubmed">20451872</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Association. (2015). 2015 Alzheimer&#x2019;s disease facts and figures. Alzhei-mer&#x2019;s &amp; Dementia, 11(3), 332&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pubmed">25984581</ArticleId></ArticleIdList></Reference><Reference><Citation>Baytas I. M., Xiao C., Zhang X., Wang F., Jain A. K., &amp; Zhou J. (2017, August). Patient subtyping via time-aware LSTM networks. In Proceedings of the 23rd ACM SIGKDD international conference on knowledge discovery and data min-ing (pp. 65&#x2013;74).</Citation></Reference><Reference><Citation>Besser L., Kukull W., Knopman D. S., Chui H., Galasko D., Weintraub S., &#x2026; &amp; Morris J. C. (2018). Version 3 of the National Alzheimer&#x2019;s Coordinating Cen-ter&#x2019;s uniform data set. Alzheimer disease and associated disorders.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6249084</ArticleId><ArticleId IdType="pubmed">30376508</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers K., Wilcock G. K., &amp; Love S. (2003). APOE&#x3b5;4 influences the patholog-ical phenotype of Alzheimer&#x2019;s disease by favouring cerebrovascular over paren-chymal accumulation of A&#x3b2; protein. Neuropathology and applied neurobiology, 29(3), 231&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">12787320</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng B., Liu M., Zhang D., Munsell B. C., &amp; Shen D. (2015). Domain transfer learning for MCI conversion prediction. IEEE Transactions on Biomedical En-gineering, 62(7), 1805&#x2013;1817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4474791</ArticleId><ArticleId IdType="pubmed">25751861</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodfellow I., Bengio Y., &amp; Courville A. (2016). Deep learning. MIT press.</Citation></Reference><Reference><Citation>Greff K., Srivastava R. K., Koutn&#xed;k J., Steunebrink B. R., &amp; Schmidhuber J. (2016). LSTM: A search space odyssey. IEEE transactions on neural networks and learning systems, 28(10), 2222&#x2013;2232.</Citation><ArticleIdList><ArticleId IdType="pubmed">27411231</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall K., Gureje O., Gao S., Ogunniyi A., Hui S. L., Baiyewu O., &#x2026; &amp; Hendrie H. C. (1998). Risk factors and Alzheimer&#x2019;s disease: a comparative study of two communities. Australian and New Zealand journal of psychiatry, 32(5), 698&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pubmed">9805594</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda T., &amp; Yamada M. (2010). Risk factors for Alzheimer&#x2019;s disease. Brain and nerve= Shinkei kenkyu no shinpo, 62(7), 679&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pubmed">20675872</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack C. R. Jr, Bernstein M. A., Borowski B. J., Gunter J. L., Fox N. C., Thompson P. M., &#x2026; &amp; Alzheimer&#x2019;s Disease Neuroimaging Initiative. (2010). Update on the magnetic resonance imaging core of the Alzheimer&#x2019;s disease neuroimaging initi-ative. Alzheimer&#x2019;s &amp; Dementia, 6(3), 212&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2886577</ArticleId><ArticleId IdType="pubmed">20451869</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagust W. J., Bandy D., Chen K., Foster N. L., Landau S. M., Mathis C. A., &#x2026; &amp; Alzheimer&#x2019;s Disease Neuroimaging Initiative. (2010). The Alzheimer&#x2019;s Disease Neuroimaging Initiative positron emission tomography core. Alzheimer&#x2019;s &amp; De-mentia, 6(3), 221&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2920531</ArticleId><ArticleId IdType="pubmed">20451870</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessen F., Wolfsgruber S., Wiese B., Bickel H., M&#xf6;sch E., Kaduszkiewicz H., &#x2026; &amp; on Aging, G. S. (2014). AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimer&#x2019;s &amp; Dementia, 10(1), 76&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">23375567</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L., Lin H., Chen Y., &amp; Alzheimer&#x2019;s Disease Neuroimaging Initiative. (2020). Sex difference in the association of APOE4 with cerebral glucose metabolism in older adults reporting significant memory concern. Neuroscience Letters, 722, 134824.</Citation><ArticleIdList><ArticleId IdType="pubmed">32044391</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Kim S., Risacher S. L., Shen L., Ritchie M. D., Weiner M. W., &#x2026; &amp; Nho K. (2013, September). A graph-based integration of multimodal brain im-aging data for the detection of early mild cognitive impairment (E-MCI). In In-ternational Workshop on Multimodal Brain Image Analysis (pp. 159&#x2013;169). Springer, Cham.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4224282</ArticleId><ArticleId IdType="pubmed">25383392</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee G., Nho K., Kang B., Sohn K. A., &amp; Kim D. (2019). Predicting Alzheimer&#x2019;s disease progression using multi-modal deep learning approach. Scientific re-ports, 9(1), 112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6374429</ArticleId><ArticleId IdType="pubmed">30760848</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., &amp; Fan Y. (2019, April). Early prediction of Alzheimer&#x2019;s disease dementia based on baseline hippocampal MRI and 1-year follow-up cognitive measures using deep recurrent neural networks. In 2019 IEEE 16th International Sympo-sium on Biomedical Imaging (ISBI 2019) (pp. 368&#x2013;371). IEEE.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6892161</ArticleId><ArticleId IdType="pubmed">31803346</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Wang Y., Wang X., Xu H., Li C., &amp; Xin X. (2021). Bi-directional gated recurrent unit neural network based nonlinear equalizer for coherent optical com-munication system. Optics Express, 29(4), 5923&#x2013;5933.</Citation><ArticleIdList><ArticleId IdType="pubmed">33726124</ArticleId></ArticleIdList></Reference><Reference><Citation>Luong D. T. A., &amp; Chandola V. (2018). An Empirical Evaluation of Time-Aware LSTM Autoencoder on Chronic Kidney Disease. CoRR.</Citation></Reference><Reference><Citation>McCombe N., Ding X., Prasad G., Finn D. P., Todd S., McClean P. L., &amp; Wong-Lin K. (2020). Predicting feature imputability in the absence of ground truth. arXiv preprint arXiv:2007.07052.</Citation></Reference><Reference><Citation>Nguyen M., He T., An L., Alexander D. C., Feng J., Yeo B. T., &amp; Alzheimer&#x2019;s Disease Neuroimaging Initiative. (2020). Predicting Alzheimer&#x2019;s disease pro-gression using deep recurrent neural networks. NeuroImage, 222, 117203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7797176</ArticleId><ArticleId IdType="pubmed">32763427</ArticleId></ArticleIdList></Reference><Reference><Citation>Risacher S. L., Shen L., West J. D., Kim S., McDonald B. C., Beckett L. A., &#x2026; &amp; Alzheimer&#x2019;s Disease Neuroimaging Initiative (ADNI. (2010). Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neu-robiology of aging, 31(8), 1401&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2904350</ArticleId><ArticleId IdType="pubmed">20620664</ArticleId></ArticleIdList></Reference><Reference><Citation>Saykin A. J., Shen L., Foroud T. M., Potkin S. G., Swaminathan S., Kim S., &#x2026; &amp; Alzheimer&#x2019;s Disease Neuroimaging Initiative. (2010). Alzheimer&#x2019;s Disease Neu-roimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimer&#x2019;s &amp; dementia, 6(3), 265&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2868595</ArticleId><ArticleId IdType="pubmed">20451875</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xe1;buas-Pereira M., Baldeiras I., Duro D., Santiago B., Ribeiro M. H., Leit&#xe3;o M. J., &#x2026; &amp; Santana I. (2016). Prognosis of early-onset vs. late-onset mild cognitive impairment: comparison of conversion rates and its predictors. Geriatrics, 1(2), 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6371125</ArticleId><ArticleId IdType="pubmed">31022805</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojanowski J. Q., Vandeerstichele H., Korecka M., Clark C. M., Aisen P. S., Petersen R. C., &#x2026; &amp; Alzheimer&#x2019;s Disease Neuroimaging Initiative. (2010). Up-date on the biomarker core of the Alzheimer&#x2019;s Disease Neuroimaging Initiative subjects. Alzheimer&#x2019;s &amp; dementia, 6(3), 230&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2867838</ArticleId><ArticleId IdType="pubmed">20451871</ArticleId></ArticleIdList></Reference><Reference><Citation>Venugopalan J., Tong L., Hassanzadeh H. R., &amp; Wang M. D. (2021). Multimodal deep learning models for early detection of Alzheimer&#x2019;s disease stage. Scientific reports, 11(1), 1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7864942</ArticleId><ArticleId IdType="pubmed">33547343</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner M. W., Aisen P. S., Jack C. R. Jr, Jagust W. J., Trojanowski J. Q., Shaw L., &#x2026; &amp; Alzheimer&#x2019;s Disease Neuroimaging Initiative. (2010). The Alzheimer&#x2019;s disease neuroimaging initiative: progress report and future plans. Alzheimer&#x2019;s &amp; Dementia, 6(3), 202&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2927112</ArticleId><ArticleId IdType="pubmed">20451868</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner M. W., Veitch D. P., Aisen P. S., Beckett L. A., Cairns N. J., Green R. C., &#x2026; &amp; Trojanowski J. Q. (2013). The Alzheimer&#x2019;s Disease Neuroimaging Ini-tiative: a review of papers published since its inception. Alzheimer&#x2019;s &amp; Demen-tia, 9(5), e111&#x2013;e194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4108198</ArticleId><ArticleId IdType="pubmed">23932184</ArticleId></ArticleIdList></Reference><Reference><Citation>Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L. O., &#x2026; &amp; Petersen R. C. (2004). Mild cognitive impairment&#x2013;beyond controversies, to-wards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of internal medicine, 256(3), 240&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">15324367</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong W. (2020). Economic burden of Alzheimer disease and managed care con-siderations. The American journal of managed care, 26(8 Suppl), S177&#x2013;S183.</Citation><ArticleIdList><ArticleId IdType="pubmed">32840331</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Shen D., &amp; Alzheimer&#x2019;s Disease Neuroimaging Initiative. (2012). Multi-modal multi-task learning for joint prediction of multiple regression and classi-fication variables in Alzheimer&#x2019;s disease. NeuroImage, 59(2), 895&#x2013;907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3230721</ArticleId><ArticleId IdType="pubmed">21992749</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36777777</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Testing the knowledge of Alzheimer's disease <i>via</i> an intervention study among community health service center staff in Jiaxing, China.</ArticleTitle><Pagination><StartPage>969653</StartPage><MedlinePgn>969653</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">969653</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2022.969653</ELocationID><Abstract><AbstractText Label="OBJECTIVE">This study aimed to investigate the knowledge status of Alzheimer's disease (AD) among community health service center (CHSC) staff in Jiaxing, China, and to compare the effects of online with offline training.</AbstractText><AbstractText Label="METHODS">A total of 763 people from 12 community health service centers were investigated using a self-created general situation questionnaire and the Alzheimer's Disease Knowledge Scale (ADKS). Among the participants, 261 people who were willing to receive training were randomly divided into two groups according to the institution in which they worked to receive online or offline training, respectively.</AbstractText><AbstractText Label="RESULTS">The average ADKS score was 19.77, and the awareness rate was 65.92%; the results for every field were as follows: treatment and management (81.32%); life impact (77.76%); disease course (75.23%); assessment and diagnosis (68.94%); risk factors (65.05%); symptoms (57.90%); caregiving (44.06%). Education and profession had impacts on the total ADKS scores (<i>P</i> &lt; 0.05). A total of 261 people participated in the training, and there were significant differences in ADKS scores before and after training (<i>P</i> &lt; 0.05). Before the training, there was no significant difference in ADKS score between the two groups; after the training, either (<i>P</i> &gt; 0.05). There were significant differences in the ADKS scores after training in both groups (<i>P</i> &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSION">Community health service center staff in Jiaxing had limited knowledge of AD, particularly in the "symptom" and "caregiving" dimensions. One instance of training on AD-related knowledge to some degree helped to improve this but still fell short of meeting the national requirements. No significant differences were found between offline and online training effects.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Ma, Zhu, Tang, Diao, Qian, Feng and Zhang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Weiwei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Liping</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of General Practice, Jiabei Street Community Health Service Center, Jiaxing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Jiangang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General Practice, Jiabei Street Community Health Service Center, Jiaxing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diao</LastName><ForeName>Wanli</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Liqi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Xiaoyang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaoling</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003153" MajorTopicYN="N">Community Health Services</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">community</Keyword><Keyword MajorTopicYN="N">influencing factors</Keyword><Keyword MajorTopicYN="N">knowledge</Keyword><Keyword MajorTopicYN="N">training methods</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>13</Day><Hour>3</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36777777</ArticleId><ArticleId IdType="pmc">PMC9911520</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2022.969653</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guo T, Landau SM., Jagust WJ. Age, vascular disease, and Alzheimer's disease pathologies in amyloid negative elderly adults. Alzheimers Res Ther. (2021) 13:174. 10.1186/s13195-021-00913-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00913-5</ArticleId><ArticleId IdType="pmc">PMC8520216</ArticleId><ArticleId IdType="pubmed">34654465</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugo J, Ganguli M. Dementia and cognitive impairment: Epidemiology, diagnosis, and treatment. Clin Geriatr Med. (2014) 30:421&#x2013;42. 10.1016/j.cger.2014.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cger.2014.04.001</ArticleId><ArticleId IdType="pmc">PMC4104432</ArticleId><ArticleId IdType="pubmed">25037289</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. . Dementia prevention, intervention, and care. Lancet. (2017) 390:2673&#x2013;734. 10.1016/S0140-6736(17)31363-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31363-6</ArticleId><ArticleId IdType="pubmed">28735855</ArticleId></ArticleIdList></Reference><Reference><Citation>Watermeyer T, Calia C. Neuropsychological assessment in preclinical and prodromal Alzheimer disease: A global perspective. J Glob Health. (2019) 9:e010317. 10.7189/jogh.09.010317</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.09.010317</ArticleId><ArticleId IdType="pmc">PMC6486120</ArticleId><ArticleId IdType="pubmed">31073397</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Wang Y, Wang H, Liu Z, Yu X, Yan J, et al. . Prevalence of mental disorders in China: A cross-sectional epidemiological study. Lancet Psychiatry. (2019) 6:211&#x2013;24. 10.1016/S2215-0366(18)30511-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(18)30511-X</ArticleId><ArticleId IdType="pubmed">30792114</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia J, Wei C, Chen S, Li F, Tang Y, Qin W, et al. . The cost of Alzheimer's disease in China and re-estimation of costs worldwide. Alzheimer's Dement. (2018) 14:483&#x2013;91. 10.1016/j.jalz.2017.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2017.12.006</ArticleId><ArticleId IdType="pubmed">29433981</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter BD, Balsis S, Otilingam PG, Hanson PK, Gatz M. The Alzheimer's Disease Knowledge Scale: Development and psychometric properties. Gerontologist. (2009) 49:236&#x2013;47. 10.1093/geront/gnp023</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnp023</ArticleId><ArticleId IdType="pmc">PMC2667675</ArticleId><ArticleId IdType="pubmed">19363018</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Ribas G, Garc&#xed;a-Arcelay E, Montoya A, Maurino J, Ballesteros J. Quantifying knowledge of Alzheimer's disease: An analysis of the psychometric properties of the Alzheimer's Disease Knowledge Scale. Neurol Therapy. (2021) 21:230. 10.1007/s40120-021-00230-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40120-021-00230-x</ArticleId><ArticleId IdType="pmc">PMC8139996</ArticleId><ArticleId IdType="pubmed">33512697</ArticleId></ArticleIdList></Reference><Reference><Citation>He R, Jing C, Li B, Pang G, Yu H, Sun L, et al. . Reliability and validity of the Chinese version of the Alzheimer's disease knowledge scale. Chin J Nurs. (2013) 48:835&#x2013;7. 10.3761/j.issn.0254-1769.2013.09.022</Citation><ArticleIdList><ArticleId IdType="doi">10.3761/j.issn.0254-1769.2013.09.022</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Lv S, Liang J, Li H, Xu Y. Level of knowledge about Alzheimer's disease Among nursing staff in Suzhou and its influencing factors. Curr Alzheimer Res. (2019) 16:650&#x2013;8. 10.2174/1567205016666190726102935</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205016666190726102935</ArticleId><ArticleId IdType="pubmed">31362656</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Xiao LD, Luo Y, Xiao S-Y, Whitehead C, Davies O. Community health professionals' dementia knowledge, attitudes and care approach: A cross-sectional survey in Changsha, China. BMC Geriatr. (2018) 18:122. 10.1186/s12877-018-0821-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-018-0821-4</ArticleId><ArticleId IdType="pmc">PMC5970511</ArticleId><ArticleId IdType="pubmed">29801476</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Hao L, Jia J. Survey on knowledge status of Alzheimer&#x2032;s disease and influencing factors among community medical and nursing staff in Beijing. Chin J General Practition. (2020) 19:408&#x2013;13. 10.3760/cma.j.cn114798-20190903-00656</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.cn114798-20190903-00656</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth W, Fielding E, Beattie E, Gardner A, Moyle W, Franklin S, et al. . A survey-based study of knowledge of Alzheimer's disease among health care staff. BMC Geriatr. (2013) 13:2. 10.1186/1471-2318-13-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2318-13-2</ArticleId><ArticleId IdType="pmc">PMC3543846</ArticleId><ArticleId IdType="pubmed">23282030</ArticleId></ArticleIdList></Reference><Reference><Citation>Alacreu M, Pardo J, Azor&#xed;n M, Climent MT, Gasull V, Moreno L. Importance of increasing modifiable risk factors knowledge on Alzheimer's disease among community pharmacists and general practitioners in Spain. Front Pharmacol. (2019) 10:860. 10.3389/fphar.2019.00860</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00860</ArticleId><ArticleId IdType="pmc">PMC6704342</ArticleId><ArticleId IdType="pubmed">31474852</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerafa N, Scerri C. Knowledge and pharmacological management of Alzheimer's disease by managing community pharmacists: A nationwide study. Int J Clin Pharm. (2016) 38:1416&#x2013;24. 10.1007/s11096-016-0380-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11096-016-0380-8</ArticleId><ArticleId IdType="pubmed">27655307</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Xu X, Huang Y, Shao S, Chen X, Li J, et al. . Knowledge, attitudes and skills of dementia care in general practice: A cross-sectional study in primary health settings in Beijing, China. BMC Family Practice. (2020) 21:3. 10.1186/s12875-020-01164-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12875-020-01164-3</ArticleId><ArticleId IdType="pmc">PMC7231407</ArticleId><ArticleId IdType="pubmed">32416731</ArticleId></ArticleIdList></Reference><Reference><Citation>He R, Yu H, Li B, Yin X, Sun L, et al. . Influencing factors and understanding situation of Alzheimer's disease among medical workers. Chin J Modern Nurs. (2012) 18:1740&#x2013;5. 10.3760/cma.j.issn.1674-2907.2012.15.002</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.1674-2907.2012.15.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter BD, Zoller SM, Balsis S, Otilingam PG, Gatz M. Demographic and contextual factors related to knowledge about Alzheimer's disease. Am J Alzheimers Dis Other Demen. (2011) 26:121&#x2013;6. 10.1177/1533317510394157</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317510394157</ArticleId><ArticleId IdType="pmc">PMC4441262</ArticleId><ArticleId IdType="pubmed">21233137</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorge C, Cet&#xf3; M, Arias A, Blasco E, Gil MP, L&#xf3;pez R, et al. . Level of understanding of Alzheimer disease among caregivers and the general population. Neurologia. (2018) 36:426&#x2013;32. 10.1016/j.nrleng.2018.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrleng.2018.03.004</ArticleId><ArticleId IdType="pubmed">34238525</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudson JM, Pollux PMJ, Mistry B, Hobson S. Beliefs about Alzheimer's disease in Britain. Aging Ment Health. (2012) 16:828&#x2013;35. 10.1080/13607863.2012.660620</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2012.660620</ArticleId><ArticleId IdType="pubmed">22416945</ArticleId></ArticleIdList></Reference><Reference><Citation>Amado DK, Brucki SMD. Knowledge about Alzheimer's disease in the Brazilian population. Arq Neuropsiquiatr. (2018) 76:775&#x2013;82. 10.1590/0004-282x20180106</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282x20180106</ArticleId><ArticleId IdType="pubmed">30570022</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuri THM, Hong YH, Ming LC, Joffry SM, Othman MF, Neoh CF. Knowledge on Alzheimer's disease among public hospitals and health clinics pharmacists in the state of Selangor, Malaysia. Front Pharmacol. (2017) 8:739. 10.3389/fphar.2017.00739</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2017.00739</ArticleId><ArticleId IdType="pmc">PMC5662870</ArticleId><ArticleId IdType="pubmed">29123479</ArticleId></ArticleIdList></Reference><Reference><Citation>Baral K, Dahal M, Pradhan S. Knowledge regarding Alzheimer's disease among college students of Kathmandu, Nepal. Int J Alzheimer's Dis. (2020) 2020:6173217. 10.1155/2020/6173217</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/6173217</ArticleId><ArticleId IdType="pmc">PMC7199541</ArticleId><ArticleId IdType="pubmed">32494366</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu L, Wang H, Lv X, Ma W, Li W, Yu X. Effects of the training of gommunity doctors on the skills of early recognition of Alzheimer's disease. Chin General Practice. (2015) 22:2697&#x2013;700. 10.3969/j.issn.1007-9572.2015.22.018</Citation><ArticleIdList><ArticleId IdType="doi">10.3969/j.issn.1007-9572.2015.22.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Ding Y, Li Z, Wu Y. Role of modular teaching and training improving the effectiveness of community nursing support work of senior nurses. Chin Nurs Res. (2021) 35:162&#x2013;5. 10.12102/j.issn.1009-6493.2021.01.031</Citation><ArticleIdList><ArticleId IdType="doi">10.12102/j.issn.1009-6493.2021.01.031</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavda P, Pandya C, Solanki D, Dindod S. Is &#x201c;modular&#x201d; the way to go for small group learning in community medicine in undergraduate clinical postings? Int J Appl Basic Med Res. (2016) 6:211&#x2013;4. 10.4103/2229-516X.186970</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2229-516X.186970</ArticleId><ArticleId IdType="pmc">PMC4979306</ArticleId><ArticleId IdType="pubmed">27563590</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryan JL, Asghar-Ali AA. Development and dissemination of an interprofessional online dementia training curriculum. J Am Geriatr Soc. (2020) 68:192&#x2013;7. 10.1111/jgs.16240</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16240</ArticleId><ArticleId IdType="pubmed">31693177</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussotti EA, Leite MTM. Alves ACd, Cristensen K. Online training for health professionals in three regions of Brazil. Revista brasileira de enfermagem. (2016) 69:981&#x2013;5. 10.1590/0034-7167.2016690506</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0034-7167.2016690506</ArticleId><ArticleId IdType="pubmed">27783743</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F, Ma L, Zhou G, Li D, Zhu Z. Observation on the effect of online and offline pre-job training for new nurses. J Nurs. (2020) 27:21&#x2013;4. 10.16460/j.issn1008-9969.2020.18.021</Citation><ArticleIdList><ArticleId IdType="doi">10.16460/j.issn1008-9969.2020.18.021</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36776077</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1877-718X</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Journal of Parkinson's disease</Title><ISOAbbreviation>J Parkinsons Dis</ISOAbbreviation></Journal><ArticleTitle>Neuropsychiatric Symptoms and Caregiver Stress in Parkinson's Disease with Cognitive Impairment, Alzheimer's Disease, and Frontotemporal Dementia.</ArticleTitle><Pagination><StartPage>243</StartPage><EndPage>254</EndPage><MedlinePgn>243-254</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/JPD-223550</ELocationID><Abstract><AbstractText Label="BACKGROUND">A better understanding of factors associated with caregiver burden might facilitate the construction of coping strategies to improve their clinical outcomes and the comprehensive care model for dementia.</AbstractText><AbstractText Label="OBJECTIVE">To investigate the cognitive and neuropsychiatric domains that contribute to caregiver burden in three types of neurodegenerative disorders: Parkinson's disease (PD), Alzheimer's disease (AD), and frontotemporal disease (FTD).</AbstractText><AbstractText Label="METHODS">Eight hundred and fourteen patients and their caregivers were invited to participate; among them, 235 had PD with cognitive impairment; 429 had AD, and 150 had FTD. The evaluation protocol included the Neuropsychiatric Inventory (NPI), the Mini-Mental State Examination, the Chinese Version Verbal Learning Test, the modified Trail Making Test B, semantic fluency, and a geriatric depression score. Statistical comparisons of the cognitive tests, NPI total scores, and caregiver burden among the three diagnosed types of dementia, matched for a Clinical Dementia Rating (CDR) of 0.5 or 1, were performed, and multivariate linear regression models were used to evaluate the parameter significance.</AbstractText><AbstractText Label="RESULTS">Caregivers for patients with PD and FTD showed significant burden increments when the CDR scores changes from 0.5 to 1. For CDR&#x200a;=&#x200a;0.5, the PD group had significantly lower caregiver burdens than the AD group, but the NPI total scores were significantly higher. Factors related to caregiver burden were the presence of delusion among all diagnosis groups, while the impact of NPI total scores related to caregiver burden was the highest in FTD, followed by AD and PD.</AbstractText><AbstractText Label="CONCLUSIONS">At the mild to moderate stages, our results suggested different degrees of significance in terms of the cognitive test scores or NPI subdomains for predicting caregiver stress among the three types of dementia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Yu-Tzu</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chi-Wei</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Cognition and Aging Center, Department of General Neurology, Institutes for translational research in biomedicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Hsin-I</ForeName><Initials>HI</Initials><AffiliationInfo><Affiliation>Cognition and Aging Center, Department of General Neurology, Institutes for translational research in biomedicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Shih-Wei</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Radiology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chen-Chang</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Radiology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Shu-Hua</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Pei-Ning</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Department of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, National Yang-Ming Chia Tung University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chiung-Chih</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Cognition and Aging Center, Department of General Neurology, Institutes for translational research in biomedicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Parkinsons Dis</MedlineTA><NlmUniqueID>101567362</NlmUniqueID><ISSNLinking>1877-7171</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">caregiver stress</Keyword><Keyword MajorTopicYN="N">frontotemporal disease</Keyword><Keyword MajorTopicYN="N">neuropsychiatric inventory</Keyword></KeywordList><CoiStatement>The authors have no conflict of interest to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>13</Day><Hour>2</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36776077</ArticleId><ArticleId IdType="pmc">PMC10041428</ArticleId><ArticleId IdType="doi">10.3233/JPD-223550</ArticleId><ArticleId IdType="pii">JPD223550</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sun Y, Lee HJ, Yang SC, Chen TF, Lin KN, Lin CC, Wang PN, Tang LY, Chiu MJ (2014) A nationwide survey of mild cognitive impairment and dementia, including very mild dementia, in Taiwan., PLoS One 9, e100303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4062510</ArticleId><ArticleId IdType="pubmed">24940604</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen H, Zhang Z, Huang J, Duan L, Wang Q (2011) Mortality of dementia and its major subtypes in urban and rural communities of Beijing, Biomed Environ Sci 24, 483&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">22108413</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuliani G, Galvani M, Sioulis F, Bonetti F, Prandini S, Boari B, Guerzoni F, Gallerani M (2012) Discharge diagnosis and comorbidity profile in hospitalized older patients with dementia, Int J Geriatr Psychiatry 27, 313&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pubmed">21538539</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen NC, Chang CC, Lin KN, Huang CW, Chang WN, Chang YT, Chen C, Yeh YC, Wang PN (2013) Patterns of executive dysfunction in amnestic mild cognitive impairment, Int Psychogeriatr 25, 1181&#x2013;1189.</Citation><ArticleIdList><ArticleId IdType="pubmed">23574879</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL (2014) Advancing researchdiagnostic criteria for Alzheimer&#x2019;s disease: The IWG-2 criteria, Lancet Neurol 13, 614&#x2013;629.</Citation><ArticleIdList><ArticleId IdType="pubmed">24849862</ArticleId></ArticleIdList></Reference><Reference><Citation>Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, Rodriguez-Oroz MC, Troster AI, Weintraub D (2011) MDS Task Force on mild cognitive impairment in Parkinson&#x2019;s disease: Critical review of PD-MCI, Mov Disord 26, 1814&#x2013;1824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3181006</ArticleId><ArticleId IdType="pubmed">21661055</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Aguilar PG, Lopez-Bastida J, Yanes-Lopez V (2006) Impact on health-related quality of life and perceived burden of informal caregivers of individuals with Alzheimer&#x2019;s disease, Neuroepidemiology 27, 136&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">16974108</ArticleId></ArticleIdList></Reference><Reference><Citation>Papastavrou E, Kalokerinou A, Papacostas SS, Tsangari H, Sourtzi P (2007) Caring for a relative with dementia: Family caregiver burden, J Adv Nurs 58, 446&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pubmed">17442030</ArticleId></ArticleIdList></Reference><Reference><Citation>Varela G, Varona L, Anderson K, Sansoni J (2011) Alzheimer&#x2019;s care at home: A focus on caregivers strain, Prof Inferm 64, 113&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3662364</ArticleId><ArticleId IdType="pubmed">21843435</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CY, Musil CM, Zauszniewski JA, Wykle ML (2006) Effects of social support and coping of family caregivers of older adults with dementia in Taiwan, Int J Aging Hum Dev 63, 1&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">16986648</ArticleId></ArticleIdList></Reference><Reference><Citation>Riedijk SR, De Vugt ME, Duivenvoorden HJ, Niermeijer MF, Van Swieten JC, Verhey FR, Tibben A (2006) Caregiver burden, health-related quality of life and coping in dementia caregivers: A comparison of frontotemporal dementia and Alzheimer&#x2019;s disease, Dement Geriatr Cogn Disord 22, 405&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pubmed">16966830</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vugt ME, Riedijk SR, Aalten P, Tibben A, van Swieten JC, Verhey FR (2006) Impact of behavioural problems on spousal caregivers: A comparison between Alzheimer&#x2019;s disease and frontotemporal dementia, Dement Geriatr Cogn Disord 22, 35&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">16679763</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwijsen SA, Kabboord A, Eefsting JA, Hertogh CM, Pot AM, Gerritsen DL, Smalbrugge M (2014) Nurses in distress? An explorative study into the relation between distress and individual neuropsychiatric symptoms of people with dementia in nursing homes, Int J Geriatr Psychiatry 29, 384&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">23963653</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E, Hodges JR (2009) Rate of change of functional abilities in frontotemporal dementia, Dement Geriatr Cogn Disord 28, 419&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pubmed">19907178</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E, Foxe D, Leslie F, Savage S, Hsieh S, Miller L, Hodges JR, Piguet O (2013) The impact of dementia severity on caregiver burden in frontotemporal dementia and Alzheimer disease, Alzheimer Dis Assoc Disord 27, 68&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">22314247</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CC, Lin PH, Chang YT, Chen NC, Huang CW, Lui CC, Huang SH, Chang YH, Lee CC, Lai WA (2015) The impact of admission diagnosis on recurrent or frequent hospitalizations in 3 dementia subtypes: A hospital-based cohort in Taiwan with 4 years longitudinal follow-ups., Medicine (Baltimore) 94, e2091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4652829</ArticleId><ArticleId IdType="pubmed">26579820</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufer DI, Cummings JL, Christine D, Bray T, Castellon S, Masterman D, MacMillan A, Ketchel P, DeKosky ST (1998) Assessing the impact of neuropsychiatric symptoms in Alzheimer&#x2019;s disease: The Neuropsychiatric Inventory Caregiver Distress Scale, J Am Geriatr Soc 46, 210&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pubmed">9475452</ArticleId></ArticleIdList></Reference><Reference><Citation>Aarsland D, Bronnick K, Ehrt U, De Deyn PP, Tekin S, Emre M, Cummings JL (2007) Neuropsychiatric symptoms in patients with Parkinson&#x2019;s disease and dementia: Frequency, profile and associated care giver stress, J Neurol Neurosurg Psychiatry 78, 36&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2117797</ArticleId><ArticleId IdType="pubmed">16820421</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourik JC, Rosso SM, Niermeijer MF, Duivenvoorden HJ, Van Swieten JC, Tibben A (2004) Frontotemporal dementia: Behavioral symptoms and caregiver distress, Dement Geriatr Cogn Disord 18, 299&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">15305107</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballard CG, Margallo-Lana ML (2004) The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities, J Clin Psychiatry 65 Suppl 11, 23&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">15264968</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CC, Chang YY, Chang WN, Lee YC, Wang YL, Lui CC, Huang CW, Liu WL (2009) Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration, Eur J Neurol 16, 1144&#x2013;1150.</Citation><ArticleIdList><ArticleId IdType="pubmed">19486137</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CW, Chang WN, Lui CC, Chen CF, Lu CH, Wang YL, Chen C, Juang YY, Lin YT, Tu MC, Chang CC (2010) Impacts of hyper-homocysteinemia and white matter hyper-intensity in Alzheimer&#x2019;s disease patients with normal creatinine: An MRI-based study with longitudinal follow-up, Curr Alzheimer Res 7, 527&#x2013;533.</Citation><ArticleIdList><ArticleId IdType="pubmed">20455861</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang YT, Huang CW, Chang YH, Chen NC, Lin KJ, Yan TC, Chang WN, Chen SF, Lui CC, Lin PH, Chang CC (2015) Amyloid burden in the hippocampus and default mode network: Relationships with gray matter volume and cognitive performance in mild stage Alzheimer disease., Medicine (Baltimore) 94, e763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4602683</ArticleId><ArticleId IdType="pubmed">25906109</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CW, Tsai MH, Chen NC, Chen WH, Lu YT, Lui CC, Chang YT, Chang WN, Chang AY, Chang CC (2015) Clinical significance of circulating vascular cell adhesion molecule-1 to white matter disintegrity in Alzheimer&#x2019;s dementia, Thromb Haemost 114, 1230&#x2013;1240.</Citation><ArticleIdList><ArticleId IdType="pubmed">26289958</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu YT, Chang WN, Chang CC, Lu CH, Chen NC, Huang CW, Lin WC, Chang YT (2016) Insula volume and salience network are associated with memory decline in Parkinson disease: Complementary analyses of voxel-based morphometry versus volume of interest, Parkinsons Dis 2016, 2939528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4779527</ArticleId><ArticleId IdType="pubmed">26998378</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross R(1994) Diagnostic and statistical manual of mental disorders: DSM-IV 4th ed. American Psychiatric Association, Washington, DC.</Citation></Reference><Reference><Citation>McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer&#x2019;s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer&#x2019;s Disease, Neurology 34, 939&#x2013;944.</Citation><ArticleIdList><ArticleId IdType="pubmed">6610841</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang YT, Huang CW, Chen NC, Lin KJ, Huang SH, Chang WN, Hsu SW, Hsu CW, Chen HH, Chang CC (2016) Hippocampal amyloid burden with downstream fusiform gyrus atrophy correlate with face matching task scores in early stage Alzheimer&#x2019;s disease, Front Aging Neurosci 8, 145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4911390</ArticleId><ArticleId IdType="pubmed">27378917</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria, Neurology 51, 1546&#x2013;1554.</Citation><ArticleIdList><ArticleId IdType="pubmed">9855500</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM, Grossman M (2011) Classification of primaryprogressive aphasia and its variants, Neurology 76, 1006&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059138</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId></ArticleIdList></Reference><Reference><Citation>Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson&#x2019;s disease: Movement Disorder Society Task Force guidelines, Mov Disord 27, 349&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3641655</ArticleId><ArticleId IdType="pubmed">22275317</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia, Neurology 44, 2308&#x2013;2314.</Citation><ArticleIdList><ArticleId IdType="pubmed">7991117</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CC, Kramer JH, Lin KN, Chang WN, Wang YL, Huang CW, Lin YT, Chen C, Wang PN (2010) Validating the Chinese version of the Verbal Learning Test for screening Alzheimer&#x2019;s disease, J Int Neuropsychol Soc 16, 244&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3767760</ArticleId><ArticleId IdType="pubmed">20003579</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitan RM (1955) The relation of the trail making test to organic brain damage, J Consult Psychol 19, 393&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">13263471</ArticleId></ArticleIdList></Reference><Reference><Citation>Szeto JY, Mowszowski L, Gilat M, Walton CC, Naismith SL, Lewis SJ (2016) Mild cognitive impairment in Parkinson&#x2019;s disease: Impact on caregiver outcomes, J Parkinsons Dis 6, 589&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pubmed">27164044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wragg RE, Jeste DV (1989) Overview of depression and psychosis in Alzheimer&#x2019;s disease, Am J Psychiatry 146, 577&#x2013;587.</Citation><ArticleIdList><ArticleId IdType="pubmed">2653053</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuh JL, Liu CK, Mega MS, Wang SJ, Cummings JL (2001) Behavioral disorders and caregivers&#x2019; reaction in Taiwanese patients with Alzheimer&#x2019;s disease, Int Psychogeriatr 13, 121&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">11352329</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu PY, Chung CL (2006) Delusions in patients with very mild, mild and moderate Alzheimer&#x2019;s disease, Acta Neurol Taiwan 15, 21&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">16599280</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow TW, Liu CK, Fuh JL, Leung VP, Tai CT, Chen LW, Wang SJ, Chiu HF, Lam LC, Chen QL, Cummings JL (2002) Neuropsychiatric symptoms of Alzheimer&#x2019;s disease differ in Chinese and American patients, Int J Geriatr Psychiatry 17, 22&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">11802226</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam LC, Tang WK, Leung V, Chiu HF (2001) Behavioral profile of Alzheimer&#x2019;s disease in Chinese elderly&#x2013;a validation study of the Chinese version of the Alzheimer&#x2019;s disease behavioral pathology rating scale, Int J Geriatr Psychiatry 16, 368&#x2013;373.</Citation><ArticleIdList><ArticleId IdType="pubmed">11333423</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DR, McKeith I, Mosimann U, Ghosh-Nodyal A, Thomas AJ (2013) Examining carer stress in dementia: The role of subtype diagnosis and neuropsychiatric symptoms, Int J Geriatr Psychiatry 28, 135&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">22422615</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahieux F, Fenelon G, Flahault A, Manifacier MJ, Michelet D, Boller F (1998) Neuropsychological prediction of dementia in Parkinson&#x2019;s disease, J Neurol Neurosurg Psychiatry 64, 178&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2169963</ArticleId><ArticleId IdType="pubmed">9489527</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy G, Jacobs DM, Tang MX, Cote LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K (2002) Memory and executive function impairment predict dementia in Parkinson&#x2019;s disease, Mov Disord 17, 1221&#x2013;1226.</Citation><ArticleIdList><ArticleId IdType="pubmed">12465060</ArticleId></ArticleIdList></Reference><Reference><Citation>Janvin CC, Aarsland D, Larsen JP (2005) Cognitive predictors of dementia in Parkinson&#x2019;s disease: A community-based, 4-year longitudinal study, J Geriatr Psychiatry Neurol 18, 149&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">16100104</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, Brayne C, Kolachana BS, Weinberger DR, Sawcer SJ, Barker RA (2009) The distinct cognitive syndromes of Parkinson&#x2019;s disease: 5 year follow-up of the CamPaIGN cohort, Brain 132, 2958&#x2013;2969.</Citation><ArticleIdList><ArticleId IdType="pubmed">19812213</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Jin Y, Shi Z, Huo YR, Guan Y, Liu M, Liu S, Ji Y (2017) The effects of behavioral and psychological symptoms on caregiver burden in frontotemporal dementia, Lewy body dementia, and Alzheimer&#x2019;s disease: Clinical experience in China, Aging Ment Health 21, 651&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pubmed">26882509</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutoleau-Bretonniere C, Vercelletto M, Volteau C, Renou P, Lamy E (2008) Zarit burden inventory and activities of daily living in the behavioral variant of frontotemporal dementia, Dement Geriatr Cogn Disord 25, 272&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">18285675</ArticleId></ArticleIdList></Reference><Reference><Citation>Wint DP, Okun MS, Fernandez HH (2004) Psychosis in Parkinson&#x2019;s disease, J Geriatr Psychiatry Neurol 17, 127&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">15312276</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36763306</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2193-8253</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Neurology and therapy</Title><ISOAbbreviation>Neurol Ther</ISOAbbreviation></Journal><ArticleTitle>Assessing What Matters to People Affected by Alzheimer's Disease: A Quantitative Analysis.</ArticleTitle><Pagination><StartPage>505</StartPage><EndPage>527</EndPage><MedlinePgn>505-527</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40120-023-00445-0</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">In this phase of the ongoing What Matters Most study series, designed to evaluate concepts that are meaningful to people affected by Alzheimer's disease (AD), we quantified the importance of symptoms, impacts, and outcomes of AD to people at risk for or with AD and care partners of people with AD.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We administered a web-based survey to individuals at risk for or with AD (Group 1: unimpaired cognition with evidence of AD pathology; Group 2: AD risk factors and subjective cognitive complaints/mild cognitive impairment; Group 3: mild AD) and to care partners of individuals with moderate AD (Group 4) or severe AD (Group 5). Respondents rated the importance of 42 symptoms, impacts, and outcomes on a scale ranging from 1 ("not at all important") to 5 ("extremely important").</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 274 respondents (70.4% female; 63.1% white), over half of patient respondents rated all 42 items as "very important" or "extremely important," while care partners rated fewer items as "very important" or "extremely important." Among the three patient groups, the minimum (maximum) mean importance rating for any item was 3.4 (4.6), indicating that all items were at least moderately to very important. Among care partners of people with moderate or severe AD, the minimum (maximum) mean importance rating was 2.1 (4.4), indicating that most items were rated as at least moderately important. Overall, taking medications correctly, not feeling down or depressed, and staying safe had the highest importance ratings among both patients and care partners, regardless of AD phase.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Concepts of importance to individuals affected by AD go beyond the common understanding of "cognition" or "function" alone, reflecting a desire to maintain independence, overall physical and mental health, emotional well-being, and safety. Preservation of these attributes may be key to understanding whether interventions deliver clinically meaningful outcomes.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hauber</LastName><ForeName>Brett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>RTI Health Solutions, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC, 27709-2194, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paulsen</LastName><ForeName>Russ</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UsAgainstAlzheimer's, Washington, DC, 20043, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krasa</LastName><ForeName>Holly B</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Blue Persimmon Group LLC, Washington, DC, 20016, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vradenburg</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>UsAgainstAlzheimer's, Washington, DC, 20043, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Comer</LastName><ForeName>Meryl</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>UsAgainstAlzheimer's, Washington, DC, 20043, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Leigh F</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>University of North Carolina, Chapel Hill, NC, 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winfield</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of North Carolina, Chapel Hill, NC, 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Potashman</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biogen Inc, Cambridge, MA, 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartry</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lundbeck LLC, Deerfield, IL, 60015, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ, 08540, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Hilary</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Boehringer Ingelheim, Burlington, ON, L7L 5H4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffman</LastName><ForeName>Deborah L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Takeda Pharmaceuticals, Cambridge, MA, 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wieberg</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Home Instead Inc, Omaha, NE, 68154, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kremer</LastName><ForeName>Ian N</ForeName><Initials>IN</Initials><AffiliationInfo><Affiliation>LEAD Coalition (Leaders Engaged on Alzheimer's Disease), Washington, DC, 20043, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Geraldine A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Memory Advocate Peers (MAP), New York, NY, 10023, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>James M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Memory Advocate Peers (MAP), New York, NY, 10023, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lappin</LastName><ForeName>Debra</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Faegre Drinker Consulting, Washington, DC, 20001, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Allison D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Faegre Drinker Consulting, Washington, DC, 20001, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frangiosa</LastName><ForeName>Terry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>UsAgainstAlzheimer's, Washington, DC, 20043, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biggar</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>UsAgainstAlzheimer's, Washington, DC, 20043, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slota</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>RTI Health Solutions, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC, 27709-2194, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romano</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>RTI Health Solutions, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC, 27709-2194, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DiBenedetti</LastName><ForeName>Dana B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>RTI Health Solutions, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC, 27709-2194, USA. ddibenedetti@rti.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Neurol Ther</MedlineTA><NlmUniqueID>101637818</NlmUniqueID><ISSNLinking>2193-6536</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Caregiver</Keyword><Keyword MajorTopicYN="N">Clinical meaningfulness</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Patient</Keyword><Keyword MajorTopicYN="N">Preference</Keyword><Keyword MajorTopicYN="N">Value</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>10</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36763306</ArticleId><ArticleId IdType="pmc">PMC10043143</ArticleId><ArticleId IdType="doi">10.1007/s40120-023-00445-0</ArticleId><ArticleId IdType="pii">10.1007/s40120-023-00445-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aisen PS, Cummings J, Jack CR, Jr, Morris JC, Sperling R, Frolich L, et al. On the path to 2025: understanding the Alzheimer's disease continuum. Alzheimers Res Ther. 2017;9(1):60. doi: 10.1186/s13195-017-0283-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-017-0283-5</ArticleId><ArticleId IdType="pmc">PMC5549378</ArticleId><ArticleId IdType="pubmed">28793924</ArticleId></ArticleIdList></Reference><Reference><Citation>Insel PS, Weiner M, Mackin RS, Mormino E, Lim YY, Stomrud E, et al. Determining clinically meaningful decline in preclinical Alzheimer disease. Neurology. 2019;93(4):e322&#x2013;e333. doi: 10.1212/WNL.0000000000007831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000007831</ArticleId><ArticleId IdType="pmc">PMC6669933</ArticleId><ArticleId IdType="pubmed">31289148</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartry A, Aldhouse NVJ, Al-Zubeidi T, Sanon M, Stefanacci RG, Knight SL. The conceptual relevance of assessment measures in patients with mild/mild-moderate Alzheimer's disease. Alzheimers Dement (Amst) 2018;10:498&#x2013;508. doi: 10.1016/j.dadm.2018.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dadm.2018.07.006</ArticleId><ArticleId IdType="pmc">PMC6180432</ArticleId><ArticleId IdType="pubmed">30320202</ArticleId></ArticleIdList></Reference><Reference><Citation>DiBenedetti DB, Slota C, Wronski SL, Vradenburg G, Comer M, Callahan LF, et al. Assessing what matters most to patients with or at risk for Alzheimer's and care partners: a qualitative study evaluating symptoms, impacts, and outcomes. Alzheimers Res Ther. 2020;12(1):90. doi: 10.1186/s13195-020-00659-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00659-6</ArticleId><ArticleId IdType="pmc">PMC7393916</ArticleId><ArticleId IdType="pubmed">32731886</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauber B, DiBenedetti D, Vradenburg G, Callahan L, Potashman M, Krasa H, et al. Identifying what matters to people with and at risk for Alzheimer's disease and their care partners: concept elicitation and item development. Presented at the 12th Clinical Trials in Alzheimer's Disease Meeting; 4 Dec&#x2013;7 Dec 2019. San Diego, California.</Citation></Reference><Reference><Citation>Gordon MF, Lenderking WR, Duhig A, Chandler J, Lundy JJ, Miller DS, et al. Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: the qualitative research phase. Alzheimers Dement. 2016;12(1):75&#x2013;84. doi: 10.1016/j.jalz.2015.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2015.04.008</ArticleId><ArticleId IdType="pubmed">26079412</ArticleId></ArticleIdList></Reference><Reference><Citation>Jutten RJ, Peeters CFW, Leijdesdorff SMJ, Visser PJ, Maier AB, Terwee CB, et al. Detecting functional decline from normal aging to dementia: development and validation of a short version of the Amsterdam IADL Questionnaire. Alzheimers Dement (Amst) 2017;8:26&#x2013;35. doi: 10.1016/j.dadm.2017.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dadm.2017.03.002</ArticleId><ArticleId IdType="pmc">PMC5403784</ArticleId><ArticleId IdType="pubmed">28462387</ArticleId></ArticleIdList></Reference><Reference><Citation>Tochel C, Smith M, Baldwin H, Gustavsson A, Ly A, Bexelius C, et al. What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic review. Alzheimers Dement (Amst) 2019;11:231&#x2013;247. doi: 10.1016/j.dadm.2018.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dadm.2018.12.003</ArticleId><ArticleId IdType="pmc">PMC6411507</ArticleId><ArticleId IdType="pubmed">30906845</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean K, Wilcock G. Living with mild cognitive impairment: the patient's and carer's experience. Int Psychogeriatr. 2012;24(6):871&#x2013;881. doi: 10.1017/S104161021100264X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S104161021100264X</ArticleId><ArticleId IdType="pubmed">22251799</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwood K, Graham JE, Fay S, Investigators A. Goal setting and attainment in Alzheimer's disease patients treated with donepezil. J Neurol Neurosurg Psychiatry. 2002;73(5):500&#x2013;507. doi: 10.1136/jnnp.73.5.500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.73.5.500</ArticleId><ArticleId IdType="pmc">PMC1738123</ArticleId><ArticleId IdType="pubmed">12397141</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrios PG, Gonzalez RP, Hanna SM, Lunde AM, Fields JA, Locke DE, et al. Priority of treatment outcomes for caregivers and patients with mild cognitive impairment: preliminary analyses. Neurol Ther. 2016;5(2):183&#x2013;192. doi: 10.1007/s40120-016-0049-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40120-016-0049-1</ArticleId><ArticleId IdType="pmc">PMC5130916</ArticleId><ArticleId IdType="pubmed">27506698</ArticleId></ArticleIdList></Reference><Reference><Citation>Beard RL, Fetterman DJ, Wu B, Bryant L. The two voices of Alzheimer's: attitudes toward brain health by diagnosed individuals and support persons. Gerontologist. 2009;49(Suppl 1):S40&#x2013;S49. doi: 10.1093/geront/gnp083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnp083</ArticleId><ArticleId IdType="pubmed">19525216</ArticleId></ArticleIdList></Reference><Reference><Citation>Ropacki MT, Hannesdottir K, Hendrix S, Gordon MF, Stephenson D, Coons SJ, et al. Clinically meaningful outcomes in early Alzheimer disease: a consortia-driven approach to identifying what matters to patients. Ther Innov Regul Sci. 2017;51(3):380&#x2013;390. doi: 10.1177/2168479016689712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2168479016689712</ArticleId><ArticleId IdType="pubmed">30231712</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson J, Saunders S, Muniz Terrera G, Ritchie C, Evans A, Luz S, et al. What matters to people with memory problems, healthy volunteers and health and social care professionals in the context of developing treatment to prevent Alzheimer's dementia? A qualitative study. Health Expect. 2019;22(3):504&#x2013;517. doi: 10.1111/hex.12876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hex.12876</ArticleId><ArticleId IdType="pmc">PMC6543163</ArticleId><ArticleId IdType="pubmed">30809895</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartry A, Menne H, Wronski S, Paulson R, Callahan L, Potashman M, et al. Evaluation of what matters most in existing clinical outcomes assessments in Alzheimer's Disease. Presented at the Alzheimer's Association Virtual International Conference; 27 Jul&#x2013;30 Jul 2020.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36760033</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-4523</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of applied gerontology : the official journal of the Southern Gerontological Society</Title><ISOAbbreviation>J Appl Gerontol</ISOAbbreviation></Journal><ArticleTitle>Does Avoiding Distressing Thoughts and Feelings Influence the Relationship between Carer Subjective Burden and Anxiety Symptoms in Family Carers of People with Dementia?</ArticleTitle><Pagination><StartPage>1760</StartPage><EndPage>1769</EndPage><MedlinePgn>1760-1769</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/07334648231156858</ELocationID><Abstract><AbstractText>Anxiety remains understudied in family carers of people with dementia. Understanding factors that moderate the relationship between stressors and anxiety symptoms in this population is critical to inform interventions. This study examined whether generic experiential avoidance (AAQ-II) and experiential avoidance specific to caregiving-related thoughts and feelings (EACQ) moderate the relationship between subjective burden (ZBI-12) and anxiety symptoms (GAD-7) in carers of people with dementia. The first model (<i>R</i><sup>2</sup> = .66, <i>&#x2206;R</i><sup><i>2</i></sup> = .03) exploring the moderating effect of AAQ-II demonstrated a significant interaction term between AAQ-II and subjective burden. The second model (<i>R</i><sup>2</sup> = .53, <i>&#x2206;R</i><sup><i>2</i></sup> = .03), exploring the moderating effect of EACQ, demonstrated a significant interaction term between EACQ and subjective burden. These results provide evidence that carers with higher levels of experiential avoidance may be particularly prone to the negative effect of subjective burden on anxiety symptoms. Clinical implications for assessment of experiential avoidance and its treatment in carers of people with dementia are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Van Hout</LastName><ForeName>Elien</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-2956-7575</Identifier><AffiliationInfo><Affiliation>School of Health Sciences, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Milena L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>School of Health Sciences, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mioshi</LastName><ForeName>Eneida</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Health Sciences, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kishita</LastName><ForeName>Naoko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>School of Health Sciences, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Appl Gerontol</MedlineTA><NlmUniqueID>8606502</NlmUniqueID><ISSNLinking>0733-4648</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004644" MajorTopicYN="N">Emotions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013315" MajorTopicYN="N">Stress, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067656" MajorTopicYN="Y">Optimism</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">anxiety</Keyword><Keyword MajorTopicYN="N">caregivers</Keyword><Keyword MajorTopicYN="N">carer stressors</Keyword><Keyword MajorTopicYN="N">psychological inflexibility</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>10</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36760033</ArticleId><ArticleId IdType="pmc">PMC10394954</ArticleId><ArticleId IdType="doi">10.1177/07334648231156858</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdi S., Spann A., Borilovic J., de Witte L., Hawley M. (2019). Understanding the care and support needs of older people: A scoping review and categorisation using the WHO international classification of functioning, disability and health framework (ICF). BMC Geriatrics, 19(1), 195. 10.1186/s12877-019-1189-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-019-1189-9</ArticleId><ArticleId IdType="pmc">PMC6647108</ArticleId><ArticleId IdType="pubmed">31331279</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali S., Bokharey I. Z. (2016). Caregiving in dementia: Emotional and behavioral challenges. Educational Gerontology, 42(7), 455&#x2013;464. 10.1080/03601277.2016.1156375</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03601277.2016.1156375</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Society . (2014). Dementia UK: 2014 edition. Alzheimer&#x2019;s Society.</Citation></Reference><Reference><Citation>B&#xe9;dard M., Molloy D. W., Squire L., Dubois S., Lever J. A., O'Donnell M. (2001). The Zarit burden Interview: A new short version and screening version. Gerontologist, 41(5), 652&#x2013;657. 10.1093/geront/41.5.652</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/41.5.652</ArticleId><ArticleId IdType="pubmed">11574710</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond F. W., Hayes S. C., Baer R. A., Carpenter K. M., Guenole N., Orcutt H. K., Waltz T., Zettle R. D. (2011). Preliminary psychometric properties of the acceptance and action questionnaire-II: A revised measure of psychological inflexibility and experiential avoidance. Behavior Therapy, 42(4), 676&#x2013;688. 10.1016/j.beth.2011.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beth.2011.03.007</ArticleId><ArticleId IdType="pubmed">22035996</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J., Cohen P., West S. G., Aiken L. S. (2003). Applied multiple regression/correlation analysis for the behavioral sciences (3rd ed.). Lawrence Erlbaum Associates Publishers.</Citation></Reference><Reference><Citation>Cookson C., Luzon O., Newland J., Kingston J. (2020). Examining the role of cognitive fusion and experiential avoidance in predicting anxiety and depression. Psychology and Psychotherapy: Theory, Research and Practice, 93(3), 456&#x2013;473. 10.1111/papt.12233</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/papt.12233</ArticleId><ArticleId IdType="pubmed">30994261</ArticleId></ArticleIdList></Reference><Reference><Citation>Del-Pino-Casado R., Priego-Cubero E., L&#xf3;pez-Mart&#xed;nez C., Orgeta V. (2021). Subjective caregiver burden and anxiety in informal caregivers: A systematic review and meta-analysis. PLoS One, 16(3), Article e0247143. 10.1371/journal.pone.0247143</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247143</ArticleId><ArticleId IdType="pmc">PMC7920375</ArticleId><ArticleId IdType="pubmed">33647035</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauth E. B., Novak J. R., Levin M. E. (2022). Outcomes from a pilot online Acceptance and Commitment Therapy program for dementia family caregivers. Aging and Mental Health, 26(8), 1620&#x2013;1629. 10.1080/13607863.2021.1942432</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2021.1942432</ArticleId><ArticleId IdType="pubmed">34233133</ArticleId></ArticleIdList></Reference><Reference><Citation>Fledderus M., Oude Voshaar M. A. H., ten Klooster P. M., Bohlmeijer E. T. (2012). Further evaluation of the psychometric properties of the acceptance and action questionnaire&#x2013;II. Psychological Assessment, 24(4), 925&#x2013;936. 10.1037/a0028200</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0028200</ArticleId><ArticleId IdType="pubmed">22545700</ArticleId></ArticleIdList></Reference><Reference><Citation>Fri&#xf0;riksd&#xf3;ttir N., Saevarsd&#xf3;ttir T., Halfd&#xe1;nard&#xf3;ttir S., J&#xf3;nsd&#xf3;ttir A., Magn&#xfa;sd&#xf3;ttir H., Olafsd&#xf3;ttir K. L., Gu&#xf0;mundsd&#xf3;ttir G., Gunnarsd&#xf3;ttir S. (2011). Family members of cancer patients: Needs, quality of life and symptoms of anxiety and depression. Acta Oncologica, 50(2), 252&#x2013;258. 10.3109/0284186x.2010.529821</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0284186x.2010.529821</ArticleId><ArticleId IdType="pubmed">21231786</ArticleId></ArticleIdList></Reference><Reference><Citation>Froelich L., Llad&#xf3; A., Khandker R. K., Pedr&#xf3;s M., Black C. M., S&#xe1;nchez D&#xed;az E. J., Chekani F., Ambegaonkar B. (2021). Quality of life and caregiver burden of Alzheimer&#x2019;s Disease among community dwelling patients in Europe: Variation by disease severity and progression. Journal of Alzheimer&#x2019;s Disease Reports, 5(1), 791&#x2013;804. 10.3233/adr-210025</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/adr-210025</ArticleId><ArticleId IdType="pmc">PMC8609484</ArticleId><ArticleId IdType="pubmed">34870105</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe1;mez W., Chmielewski M., Kotov R., Ruggero C., Watson D. (2011). Development of a measure of experiential avoidance: The multidimensional experiential avoidance questionnaire. Psychological Assessment, 23(3), 692&#x2013;713. 10.1037/a0023242</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0023242</ArticleId><ArticleId IdType="pubmed">21534697</ArticleId></ArticleIdList></Reference><Reference><Citation>George C., Ferreira N. (2020). Carer burden and positive gain in dementia. Working With Older People, 24(2), 113&#x2013;123. 10.1108/WWOP-02-2020-0009</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/WWOP-02-2020-0009</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes A. F. (2013). Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. The Guilford Press. 10.1111/jedm.12050</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jedm.12050</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes S. C., Levin M. E., Plumb-Vilardaga J., Villatte J. L., Pistorello J. (2013). Acceptance and commitment therapy and contextual behavioral science: Examining the progress of a distinctive model of behavioral and cognitive therapy. Behavior Therapy, 44(2), 180&#x2013;198. 10.1016/j.beth.2009.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beth.2009.08.002</ArticleId><ArticleId IdType="pmc">PMC3635495</ArticleId><ArticleId IdType="pubmed">23611068</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes S. C., Strosahl K., Wilson K. G., Bissett R. T., Pistorello J., Toarmino D., Polusny M. A., Dykstra T. A., Batten S. V., Bergan J., Stewart S. H., Zvolensky M. J., Eifert G. H., Bond F. W., Forsyth J. P., Karekla M., McCurry S. M. (2004). Measuring experiential avoidance: A preliminary test of a working model. The Psychological Record, 54(4), 553&#x2013;578. 10.1007/BF03395492</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03395492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaddour L., Kishita N. (2020). Anxiety in informal dementia carers: A meta-analysis of prevalence. Journal of Geriatric Psychiatry and Neurology, 33(3), 161&#x2013;172. 10.1177/0891988719868313</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988719868313</ArticleId><ArticleId IdType="pubmed">31409196</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishita N., Contreras M. L., West J., Mioshi E. (2020). Exploring the impact of carer stressors and psychological inflexibility on depression and anxiety in family carers of people with dementia. Journal of Contextual Behavioral Science, 17(1), 119&#x2013;125. 10.1016/j.jcbs.2020.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcbs.2020.07.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishita N., Gould R. L., Farquhar M., Contreras M., Van Hout E., Losada A., Cabrera I., Hornberger M., Richmond E., McCracken L. M. (2022). Internet-delivered guided self-help acceptance and commitment therapy for family carers of people with dementia (iACT4CARERS): A feasibility study. Aging and Mental Health, 26(10), 1933&#x2013;1941. 10.1080/13607863.2021.1985966</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2021.1985966</ArticleId><ArticleId IdType="pmc">PMC9629048</ArticleId><ArticleId IdType="pubmed">34617489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishita N., Hammond L., Dietrich C. M., Mioshi E. (2018). Which interventions work for dementia family carers?: An updated systematic review of randomized controlled trials of carer interventions. International Psychogeriatrics, 30(11), 1679&#x2013;1696. 10.1017/s1041610218000947</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610218000947</ArticleId><ArticleId IdType="pubmed">30017008</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraemer H. C., Morgan G. A., Leech N. L., Gliner J. A., Vaske J. J., Harmon R. J. (2003). Measures of clinical significance. Journal of the American Academy of Child and Adolescent Psychiatry, 42(12), 1524&#x2013;1529. 10.1097/00004583-200312000-00022</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004583-200312000-00022</ArticleId><ArticleId IdType="pubmed">14627890</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai D. W. L. (2012). Effect of financial costs on caregiving burden of family caregivers of older adults. SAGE Open, 2(4), 215824401247046. 10.1177/2158244012470467</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2158244012470467</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H. Y., Yang C. T., Wang Y. N., Hsu W. C., Huang T. H., Lin Y. E., Liu C. Y., Shyu Y. I. L. (2017). Balancing competing needs mediates the association of caregiving demand with caregiver role strain and depressive symptoms of dementia caregivers: A cross-sectional study. Journal of Advanced Nursing, 73(12), 2962&#x2013;2972. 10.1111/jan.13379</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jan.13379</ArticleId><ArticleId IdType="pubmed">28816364</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Heffernan C., Tan J. (2020). Caregiver burden: A concept analysis. International Journal of Nursing Sciences, 7(4), 438&#x2013;445. 10.1016/j.ijnss.2020.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnss.2020.07.012</ArticleId><ArticleId IdType="pmc">PMC7644552</ArticleId><ArticleId IdType="pubmed">33195757</ArticleId></ArticleIdList></Reference><Reference><Citation>Loh A. Z., Tan J. S., Zhang M. W., Ho R. C. (2017). The global prevalence of anxiety and depressive symptoms among caregivers of stroke survivors. Journal of the American Medical Directors Association, 18(2), 111&#x2013;116. 10.1016/j.jamda.2016.08.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2016.08.014</ArticleId><ArticleId IdType="pubmed">27742585</ArticleId></ArticleIdList></Reference><Reference><Citation>Losada A., M&#xe1;rquez-Gonz&#xe1;lez M., Romero-Moreno R., L&#xf3;pez J. (2014). Development and validation of the experiential avoidance in caregiving questionnaire (EACQ). Aging and Mental Health, 18(7), 897&#x2013;904. 10.1080/13607863.2014.896868</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2014.896868</ArticleId><ArticleId IdType="pubmed">24678984</ArticleId></ArticleIdList></Reference><Reference><Citation>McCabe C. J., Kim D. S., King K. M. (2018). Improving present practices in the visual display of interactions. Advances in Methods and Practices in Psychological Science, 1(2), 147&#x2013;165. 10.1177/2515245917746792</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2515245917746792</ArticleId><ArticleId IdType="pmc">PMC8078831</ArticleId><ArticleId IdType="pubmed">33912789</ArticleId></ArticleIdList></Reference><Reference><Citation>National Collaborating Centre for Mental Health . (2018). The dementia care pathway. Full implementation guidance. National Collaborating Centre for Mental Health.</Citation></Reference><Reference><Citation>Ong C. W., Lee E. B., Levin M. E., Twohig M. P. (2019). A review of AAQ variants and other context-specific measures of psychological flexibility. Journal of Contextual Behavioral Science, 12(1), 329&#x2013;346. 10.1016/j.jcbs.2019.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcbs.2019.02.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Rising K. L., Salcedo V. J., Amadio G., Casten R., Chang A., Gentsch A., O&#x2019;Hayer C. V., Sarpoulaki N., Worster B., Gerolamo A. M. (2022). Living through the pandemic: The voices of persons with dementia and their caregivers. Journal of Applied Gerontology, 41(1), 30&#x2013;35. 10.1177/07334648211036399</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/07334648211036399</ArticleId><ArticleId IdType="pubmed">34344205</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmalz J. E., Murrell A. R. (2010). Measuring experiential avoidance in adults: The avoidance and fusion questionnaire. International Journal of Behavioral Consultation and Therapy, 6(3), 198&#x2013;213. 10.1037/h0100908</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/h0100908</ArticleId></ArticleIdList></Reference><Reference><Citation>Shieh G. (2011, Nov). Clarifying the role of mean centring in multicollinearity of interaction effects. British Journal of Mathematical and Statistical Psychology, 64(3), 462&#x2013;477. 10.1111/j.2044-8317.2010.02002.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2044-8317.2010.02002.x</ArticleId><ArticleId IdType="pubmed">21973096</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha N. (2020). Detecting multicollinearity in regression analysis. American Journal of Applied Mathematics and Statistics, 8(2), 39&#x2013;42. 10.12691/ajams-8-2-1</Citation><ArticleIdList><ArticleId IdType="doi">10.12691/ajams-8-2-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith K. J., George C., Ferriera N. (2018). Factors emerging from the &#x201c;Zarit Burden Interview&#x201d; and predictive variables in a UK sample of caregivers for people with dementia. International Psychogeriatrics, 30(11), 1671&#x2013;1678. 10.1017/S1041610218000315</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610218000315</ArticleId><ArticleId IdType="pubmed">29562953</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinhoven P., Drost d. R. J. M., van Hemert A. M., Penninx B. W. (2014). A longitudinal study of experiential avoidance in emotional disorders. Behavior Therapy, 45(6), 840&#x2013;850. 10.1016/j.beth.2014.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beth.2014.07.001</ArticleId><ArticleId IdType="pubmed">25311292</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer R. L., Kroenke K., Williams J. B., L&#xf6;we B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. The Archives of Internal Medicine, 166(10), 1092&#x2013;1097. 10.1001/archinte.166.10.1092</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.10.1092</ArticleId><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Trindade I. A., Mendes A. L., Ferreira N. B. (2020). The moderating effect of psychological flexibility on the link between learned helplessness and depression symptomatology: A preliminary study. Journal of Contextual Behavioral Science, 15(1), 68&#x2013;72. 10.1016/j.jcbs.2019.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcbs.2019.12.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyndall I., Waldeck D., Pancani L., Whelan R., Roche B., Dawson D. L. (2019). The acceptance and action questionnaire-II (AAQ-II) as a measure of experiential avoidance: Concerns over discriminant validity. Journal of Contextual Behavioral Science, 12(1), 278&#x2013;284. 10.1016/j.jcbs.2018.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcbs.2018.09.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan-Johnston T. I., Quickert R. E., MacDonald T. K. (2017). Psychological flexibility under fire: Testing the incremental validity of experiential avoidance. Personality and Individual Differences, 105(1), 335&#x2013;349. 10.1016/j.paid.2016.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.paid.2016.10.011</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36759811</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>09</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>What matters in development and sustainment of community dementia friendly initiatives and why? A realist multiple case study.</ArticleTitle><Pagination><StartPage>296</StartPage><MedlinePgn>296</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">296</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-023-15125-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Dementia friendly communities (DFCs) are seen as key to participation of people with dementia and carers. Dementia-friendly initiatives (DFI) are important building blocks for the growth of DFCs. Therefore, it is essential to understand how DFIs are developed and sustained to secure the growth of DFCs. This study identifies contextual factors and mechanisms that influence the development and sustainment of Dutch DFIs. It also explains how these contextual factors and mechanisms are interrelated and the outcomes to which they lead.</AbstractText><AbstractText Label="METHODS">Mixed methods, namely interviews, observations, documentation and focus groups, were used for this realist multiple case study. Participants were professionals (n&#x2009;=&#x2009;46), volunteers (n&#x2009;=&#x2009;20), people with dementia (n&#x2009;=&#x2009;1) and carers (n&#x2009;=&#x2009;2) who were involved in development and sustainment of DFIs in four Dutch DFCs.</AbstractText><AbstractText Label="RESULTS">This study revealed three middle-range program theories as final outcomes: development of a support base, collaboration, and participation in DFIs by people with dementia and carers. These theories address institutional, organisational, interpersonal and individual levels in the community that are essential in development and sustainment of DFIs.</AbstractText><AbstractText Label="CONCLUSIONS">The development and sustainment of DFIs requires the development of a support base, collaboration, and participation in DFIs by people with dementia and their carers.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thijssen</LastName><ForeName>Marjolein</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ healthcare), Nijmegen, The Netherlands. marjolein.thijssen@radboudumc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboud University Medical Center, Radboud Alzheimer Center, Nijmegen, The Netherlands. marjolein.thijssen@radboudumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuijer-Siebelink</LastName><ForeName>Wietske</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>HAN University of Applied Sciences, School of Education, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboud University Medical Center, Radboudumc Health Academy, Research on Learning and Education, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lexis</LastName><ForeName>Monique A S</ForeName><Initials>MAS</Initials><AffiliationInfo><Affiliation>Zuyd University of Applied Sciences, Research Centre Assistive Technology in Care, Heerlen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nijhuis-van der Sanden</LastName><ForeName>Maria W G</ForeName><Initials>MWG</Initials><AffiliationInfo><Affiliation>Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ healthcare), Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniels</LastName><ForeName>Ramon</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Zuyd University of Applied Sciences, Research Centre Assistive Technology in Care, Heerlen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graff</LastName><ForeName>Maud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ healthcare), Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboud University Medical Center, Radboud Alzheimer Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>733050844</GrantID><Acronym>ZONMW_</Acronym><Agency>ZonMw</Agency><Country>Netherlands</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017144" MajorTopicYN="N">Focus Groups</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Community</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Dementia friendly communities</Keyword><Keyword MajorTopicYN="N">Dementia friendly initiatives</Keyword><Keyword MajorTopicYN="N">Levels of change development</Keyword><Keyword MajorTopicYN="N">Realist approach</Keyword><Keyword MajorTopicYN="N">Social participation</Keyword><Keyword MajorTopicYN="N">Sustainment</Keyword></KeywordList><CoiStatement>The authors have no competing interests or conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>10</Day><Hour>0</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36759811</ArticleId><ArticleId IdType="pmc">PMC9909928</ArticleId><ArticleId IdType="doi">10.1186/s12889-023-15125-9</ArticleId><ArticleId IdType="pii">10.1186/s12889-023-15125-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Prince M, Comas-Herrera A, Knapp M, Guerchet M, Karagiannidou M. World Alzheimer report 2016: improving healthcare for people living with dementia: coverage, quality and costs now and in the future. 2016.</Citation></Reference><Reference><Citation>Alzheimer Society. Guidance for communities registering for the recognition process for dementia-friendly communities. London:&#xa0;Alzheimer's society; 2013.</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Disease International . Dementia Friendly Communities Key principles. 2016.</Citation></Reference><Reference><Citation>Smith K, Gee S, Sharrock T, Croucher M. Developing a dementia-friendly Christchurch: perspectives of people with dementia. Australas J Ageing. 2016;35(3):188&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">27061350</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckner S, Darlington N, Woodward M, Buswell M, Mathie E, Arthur A, et al. Dementia friendly communities in England: a scoping study. Int J Geriatr Psychiatry. 2019;34(8):1235&#x2013;1243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6766876</ArticleId><ArticleId IdType="pubmed">30993756</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson T. Mapping dementia-friendly communities across europe: a study commissioned by the European Foundations&#x2019; Initiative On Dementia (EFID) 2016.</Citation></Reference><Reference><Citation>van Haaren P, Kalisvaart I, Westhoff E. Evaluatie Deltaplan Dementie. 2019.</Citation></Reference><Reference><Citation>Scheltens P, De Visser M, Bekkenkamp D, Kwint K. Deltaplan Dementie: National Strategy in the Netherlands DeltaPlan. The Hague: Alzheimer Europe Conference; 2019.</Citation></Reference><Reference><Citation>Novak LS, Horne E, Brackett JR, Meyer K, Ajtai RM. Dementia-friendly communities: a review of current literature and reflections on implementation. Curr Geriatr Rep. 2020;9(3):176&#x2013;182.</Citation></Reference><Reference><Citation>Goodman C, Antony A, Buckner S, Buswel M, Darlington N, Dickinson A, et al. National Institute for Health Research Policy Research Programme Project Dementia Friendly Communities: The DEMCOM evaluation (PR-R15&#x2013;0116-21003) Final report. 2020.&#xa0;https://uhra.herts.ac.uk/handle/2299/23477. Accessed 31 Jan 2023.</Citation></Reference><Reference><Citation>Hebert CA, Scales K. Dementia friendly initiatives: a state of the science review. Dementia (London) 2019;18(5):1858&#x2013;1895.</Citation><ArticleIdList><ArticleId IdType="pubmed">28933191</ArticleId></ArticleIdList></Reference><Reference><Citation>Towards a dementia-inclusive society: WHO toolkit for dementia-friendly initiatives (DFIs). Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.</Citation></Reference><Reference><Citation>Alzheimer Disease International. Netherlands - Dementia Friendly Communities: Alzheimer Disease International; n.d. [30-8-2020]. Available from: https://www.alz.co.uk/dementia-friendly-communities/netherlands.</Citation></Reference><Reference><Citation>Vermeulen W. Decentralization of social policy in the Netherlands in: Anlysis CNBfEP, editor. 2015.</Citation></Reference><Reference><Citation>Ministry of Health WaS. Wet Maatschappelijke Ondersteuning 2015 den Haag: Rijksoverheid; 2015 [Available from: https://www.rijksoverheid.nl/onderwerpen/zorg-en-ondersteuning-thuis/wmo-2015.</Citation></Reference><Reference><Citation>Ministry of Health WaS, Foundation DA. Samen dementievriendelijk 2016 [Available from: https://www.samendementievriendelijk.nl/.</Citation></Reference><Reference><Citation>Thijssen M, Daniels R, Lexis M, Jansens R, Peeters J, Chadborn N, et al. How do community based dementia friendly initiatives work for people with dementia and their caregivers, and why? A rapid realist review. Int J Geriatr Psychiatry. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9299867</ArticleId><ArticleId IdType="pubmed">34825742</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodward M, Arthur A, Darlington N, Buckner S, Killett A, Thurman J, et al. The place for dementia-friendly communities in England and its relationship with epidemiological need. Int J Geriatr Psychiatry. 2019;34(1):67&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6585629</ArticleId><ArticleId IdType="pubmed">30248208</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon K, Bail K, Neville S. Dementia-friendly community initiatives: an integrative review. J Clin Nurs. 2019;28(11&#x2013;12):2035&#x2013;2045.</Citation><ArticleIdList><ArticleId IdType="pubmed">30554458</ArticleId></ArticleIdList></Reference><Reference><Citation>Meerveld J. The Dutch National Programme for a dementia-inclusive society &#x2013; a collaboration involving national and local authorities, associations and companies. The Hague: Alzheimer Europe Conference; 2019.</Citation></Reference><Reference><Citation>Barclay G, Tatler R, Kinross S. Work package 7 dementia-friendly communities. Final report summary version: European Union Joint Action Act on Dementia; 2019.&#xa0;https://www.actondementia.eu/.</Citation></Reference><Reference><Citation>Blood I, Milton S. Evidence review of dementia-friendly communities. Imogen Blood &amp; Associates &amp; innovations in Dementia. 2017.</Citation></Reference><Reference><Citation>Pawson R, Greenhalgh T, Harvey G, Walshe K. Realist review--a new method of systematic review designed for complex policy interventions. J Health Serv Res Policy. 2005;10(Suppl 1):21&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">16053581</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong G. In: Emmel N, Greenhalgh J, Manzano A, Monaghan M, Dalkin S, editors. Data gathering in realist reviews: looking for needles in haystacks. UK: Doing Realist Research Sage UK; 2018. p. 131&#x2013;46.</Citation></Reference><Reference><Citation>Punton M, Isabel V, Leavy J, Michaelis C, Boydell E. Reality bites: making realist evaluation useful in the real world. 2020.</Citation></Reference><Reference><Citation>Westhorp G. Realist impact evaluation: an introduction. 2014.</Citation></Reference><Reference><Citation>Punton M, Vogel I, Lloyd R. Reflections from a realist evaluation in progress: scaling ladders and stitching theory.&#xa0;Sussex: Centre for Development Impact 2016; 2016. Contract No.: 18</Citation></Reference><Reference><Citation>Pawson R, Tilley N. Realist evaluation. 2004.</Citation></Reference><Reference><Citation>Westhorp G. Developing complexity-consistent theory in a realist investigation. Evaluation. 2013;19(4):364&#x2013;382.</Citation></Reference><Reference><Citation>Yin RK. Case study research and applications: design and methods. 4th ed.&#xa0;USA: Sage publications; 2009.</Citation></Reference><Reference><Citation>Bressan V, Hansen H, Koldby K, Andersen KD, Snijder A, Tageo V, et al. Needs, issues, and expectations on dementia care at home across Europe to inform policy development: findings from a transnational research study. Health Policy. 2021;125(8):1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">34210512</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton MQ. Qualitative research &amp; evaluation methods: integrating theory and practice. Sage publications; 2014.</Citation></Reference><Reference><Citation>Manzano A. The craft of interviewing in realist evaluation. Evaluation. 2016;22(3):342&#x2013;360.</Citation></Reference><Reference><Citation>Weger ED, Vooren NV, Luijkx KG, Baan CA, Drewes HW. Achieving successful community engagement: a rapid realist review. BMC Health Serv Res. 2018;18(1):285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5899371</ArticleId><ArticleId IdType="pubmed">29653537</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagosh J, Pluye P, Macaulay AC, Salsberg J, Henderson J, Sirett E, et al. Assessing the outcomes of participatory research: protocol for identifying, selecting, appraising and synthesizing the literature for realist review. Implement Sci. 2011;6(1):1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3072934</ArticleId><ArticleId IdType="pubmed">21418604</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalkin SM, Greenhalgh J, Jones D, Cunningham B, Lhussier M. What&#x2019;s in a mechanism? Development of a key concept in realist evaluation. Implement Sci. 2015;10(1):1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4408605</ArticleId><ArticleId IdType="pubmed">25885787</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagosh J, Bush PL, Salsberg J, Macaulay AC, Greenhalgh T, Wong G, et al. A realist evaluation of community-based participatory research: partnership synergy, trust building and related ripple effects. BMC Public Health. 2015;15:725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4520009</ArticleId><ArticleId IdType="pubmed">26223523</ArticleId></ArticleIdList></Reference><Reference><Citation>Westhorp G. Understanding mechanisms in realist evaluation and research. N E, J G, A M, M M, S D, editors. Doing realist research. London: Sage; 2018.</Citation></Reference><Reference><Citation>Westhorp G. Using complexity-consistent theory for evaluating complex systems. Evaluation. 2012;18(4):405&#x2013;420.</Citation></Reference><Reference><Citation>Byng R, Norman I, Redfern S. Using realistic evaluation to evaluate a practice-level intervention to improve primary healthcare for patients with long-term mental illness. Evaluation. 2005;11(1):69&#x2013;93.</Citation></Reference><Reference><Citation>RAMESES . Retroduction in realist evaluation. The RAMESES II Project. RAMESES; 2017.</Citation></Reference><Reference><Citation>Jagosh J. Retroductive theorizing in Pawson and Tilley's applied scientific realism. J Crit Realism. 2020;19(2):121&#x2013;130.</Citation></Reference><Reference><Citation>Mukumbang FC, Kabongo EM, Eastwood JG. Examining the application of Retroductive theorizing in realist-informed studies. Int J Qual Methods. 2021;20.&#xa0;10.1177/16094069211053516.</Citation></Reference><Reference><Citation>Gilmore B, McAuliffe E, Power J, Valli&#xe8;res F. Data analysis and synthesis within a realist evaluation: toward more transparent methodological approaches. Int J Qual Methods. 2019;18.&#xa0;10.1177/1609406919859754.</Citation></Reference><Reference><Citation>Jagosh J. Realist Programme Theory, Middle Range Theory (Formal Theory) Southampton: Middle Range Programme Theory CARES Summer School; 2019.</Citation></Reference><Reference><Citation>Funnell SC, Rogers PJ. Purposeful program theory: effective use of theories of change and logic models. John Wiley &amp; Sons; 2011.</Citation></Reference><Reference><Citation>Morton T, Wong G, Atkinson T, Brooker D. Sustaining community-based interventions for people affected by dementia long term: the SCI-Dem realist review. BMJ Open. 2021;11(7):e047789.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8264885</ArticleId><ArticleId IdType="pubmed">34233990</ArticleId></ArticleIdList></Reference><Reference><Citation>Donkers HW, Van der Veen DJ, Teerenstra S, Vernooij-Dassen MJ, Nijhuis-Vander Sanden MWG, Graff MJL. Evaluating the social fitness Programme for older people with cognitive problems and their caregivers: lessons learned from a failed trial. BMC Geriatr. 2018;18(1):237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6172728</ArticleId><ArticleId IdType="pubmed">30286714</ArticleId></ArticleIdList></Reference><Reference><Citation>Education CfARa . Dementia Friendly Toolkit Madison: Center for Aging Research and Education. 2021.</Citation></Reference><Reference><Citation>Alzheimer's Ao . Dementia Friendly Communities Toolkit. 2021.</Citation></Reference><Reference><Citation>Australia Fd . Creating Dementia Friendly Communities Community toolkit.: Fight dementia Australia. 2021.</Citation></Reference><Reference><Citation>Kretzmann J, McKnight JP. Assets-based community development. Natl Civ Rev. 1996;85(4):23&#x2013;29.</Citation></Reference><Reference><Citation>van de Venter E, Redwood S. Does an asset-based community development project promote health and wellbeing? Lancet. 2016;388(2):S108.</Citation></Reference><Reference><Citation>Agdal R, Midtg&#xe5;rd IH, Meidell V. Can asset-based community development with children and youth enhance the level of participation in health promotion projects? A qualitative Meta-synthesis. Int J Environ Res Public Health. 2019;16(19). 10.3390/ijerph16193778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6801434</ArticleId><ArticleId IdType="pubmed">31597340</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd CP, Hayes L, Wilson RL, Bearsley-Smith C. Harnessing the social capital of rural communities for youth mental health: an asset-based community development framework. Aust J Rural Health. 2008;16(4):189&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pubmed">18652605</ArticleId></ArticleIdList></Reference><Reference><Citation>McCammon SL. Systems of care as asset-building communities: implementing strengths-based planning and positive youth development. Am J Community Psychol. 2012;49(3&#x2013;4):556&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">22532342</ArticleId></ArticleIdList></Reference><Reference><Citation>Torku A, Chan APC, Yung EHK. Age-friendly cities and communities: a review and future directions. Ageing Soc. 2021;41(10):2242&#x2013;2279.</Citation></Reference><Reference><Citation>Kobayashi KM, Cloutier DS, Khan M, Fitzgerald K. Asset based community development to promote healthy aging in a rural context in Western Canada: notes from the field. J Community Pract. 2020;28(1):66&#x2013;76.</Citation></Reference><Reference><Citation>Sturge J, Klaassens M, Jones CA, L&#xe9;gar&#xe9; F, Elf M, Weitkamp G, et al. Exploring assets of people with memory problems and dementia in public space: a qualitative study. Wellbeing Space Soc. 2021;2.&#xa0;https://research.rug.nl/en/publications/exploring-assets-of-people-with-memory-problems-and-dementia-in-p.</Citation></Reference><Reference><Citation>Chadborn N, van der Marck M. Illuminating community services and assets towards better dementia care. Perspect Public Health. 2019;139(3):125.</Citation><ArticleIdList><ArticleId IdType="pubmed">31074344</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman S, Swaffer K. Assets-based approaches and dementia-friendly communities. Dementia (London, England) 2018;17(2):131&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">29299934</ArticleId></ArticleIdList></Reference><Reference><Citation>Heward M, Innes A, Cutler C, Hambidge S. Dementia-friendly communities: challenges and strategies for achieving stakeholder involvement. Health Soc Care Commun. 2017;25(3):858&#x2013;867.</Citation><ArticleIdList><ArticleId IdType="pubmed">27406118</ArticleId></ArticleIdList></Reference><Reference><Citation>Innes A, Smith SK, Bushell S. Dementia friendly care: methods to improve stakeholder engagement and decision making. J HealthcLeader. 2021;13:183&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8379145</ArticleId><ArticleId IdType="pubmed">34429678</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascale F, Pantzartzis E, Krystallis I, Price ADF. Rationales and practices for dynamic stakeholder engagement and disengagement. Evidence from dementia-friendly health and social care environments. Constr Manag Econ. 2020;38(7):623&#x2013;639.</Citation></Reference><Reference><Citation>Keogh F, Carney P, O'Shea E. Innovative methods for involving people with dementia and carers in the policymaking process. Health Expect. 2021;24(3):800&#x2013;809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8235887</ArticleId><ArticleId IdType="pubmed">33650760</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36750799</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2318</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>07</Day></PubDate></JournalIssue><Title>BMC geriatrics</Title><ISOAbbreviation>BMC Geriatr</ISOAbbreviation></Journal><ArticleTitle>Development and validation of care stress management scale in family caregivers for people with Alzheimer: a sequential-exploratory mixed-method study.</ArticleTitle><Pagination><StartPage>82</StartPage><MedlinePgn>82</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">82</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12877-023-03785-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Caring for a person with Alzheimer's disease is stressful for caregivers. So that, considering all the emotional and financial costs imposed on the families of Alzheimer's patients, stress from caring is an issue that cannot be ignored and plans need to be developed to help these caregivers to manage the care properly. The current study was designed to develop a valid and reliable care stress management scale for family caregivers of patients with Alzheimer's.</AbstractText><AbstractText Label="METHODS">This study is a methodological study with a sequential-exploratory mixed-method approach that was performed in two-phase: develop the caring stress management scale and evaluate the psychometric properties of the scale. In the first phase, 14 semi-structured face-to-face interviews were performed with family caregivers of patients with Alzheimer's. The interviews were transcribed immediately and an item pool with 275 items was prepared. After removing the duplicate or overlapping code, the initial format of the caring stress management scale (CSMS) was designed. In the second step, the items of the CSMS were evaluated using face and content validity. After that, the construct validity was evaluated using exploratory factor analysis, confirmatory factor analysis, and convergent and divergent validity respectively. Finally, the reliability was assessed by stability and internal consistency. The sample size was 435 and data was gathered via an online form questionnaire.</AbstractText><AbstractText Label="RESULTS">This study designed the CSMS with two factors including emotional-focused coping (4 items) and problem-focused coping (4 items) that explained 51.00% of the total variance. The results of the confirmatory factor analysis showed a good model fit. Furthermore, the internal consistency and stability of this scale were acceptable.</AbstractText><AbstractText Label="CONCLUSION">The results showed that the care stress management scale has two factors in Iranian family caregivers and it is valid and reliable and can be used by therapists and researchers.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharif Nia</LastName><ForeName>Hamid</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Traditional and Complementary Medicine Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hosseini</LastName><ForeName>Lida</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran. l.hosseini69@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashghali Farahani</LastName><ForeName>Mansoureh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centers for Nursing Care Research, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran. m_negar110@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Froelicher</LastName><ForeName>Erika Sivarajan</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Department of Physiological Nursing, Department of Epidemiology &amp; Biostatistics, Schools of Nursing and Medicine, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Geriatr</MedlineTA><NlmUniqueID>100968548</NlmUniqueID><ISSNLinking>1471-2318</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000223" MajorTopicYN="N">Adaptation, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005163" MajorTopicYN="N">Factor Analysis, Statistical</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer</Keyword><Keyword MajorTopicYN="N">Psychometrics properties</Keyword><Keyword MajorTopicYN="N">Reliability</Keyword><Keyword MajorTopicYN="N">Stress management</Keyword><Keyword MajorTopicYN="N">Validity</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>0</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36750799</ArticleId><ArticleId IdType="pmc">PMC9903488</ArticleId><ArticleId IdType="doi">10.1186/s12877-023-03785-6</ArticleId><ArticleId IdType="pii">10.1186/s12877-023-03785-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lindeza P, Rodrigues M, Costa J, Guerreiro M, Rosa MM. Impact of dementia on informal care: a systematic review of family caregivers&#x2019; perceptions. BMJ Support Palliat Care. 2020.&#xa0;https://spcare.bmj.com/content/early/2022/08/21/bmjspcare-2020-002242.info.</Citation><ArticleIdList><ArticleId IdType="pubmed">33055092</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-C&#xe1;mara S, Palomino-Moral P&#xc1;, Moral-Fern&#xe1;ndez L, Fr&#xed;as-Osuna A, Parra-Anguita L, del Pino-Casado R. Perceived needs of the family caregivers of people with dementia in a Mediterranean setting: a qualitative study. Int J Environ Res Public Health. 2019;16(6):993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6466168</ArticleId><ArticleId IdType="pubmed">30893902</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikkhah M, Heravi-Karimooi M, Montazeri A, Rejeh N, Sharif Nia H. Psychometric properties the Iranian version of older People&#x2019;s quality of life questionnaire (OPQOL) Health Qual Life Outcomes. 2018;16(1):174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6126014</ArticleId><ArticleId IdType="pubmed">30185194</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerchet M, Prince M, Prina M. Numbers of people with dementia worldwide: An update to the estimates in the World Alzheimer Report 2015. 2020.</Citation></Reference><Reference><Citation>Manzini CSS, Vale FAC. Emotional disorders evidenced by family caregivers of older people with Alzheimer&#x2019;s disease. Dement Neuropsychol. 2020;14:56&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7077868</ArticleId><ArticleId IdType="pubmed">32206199</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashrafizadeh H, Gheibizadeh M, Rassouli M, Hajibabaee F, Rostami S. Explain the experience of family caregivers regarding Care of Alzheimer's patients: a qualitative study. Front Psychol. 2021;12:699959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8264438</ArticleId><ArticleId IdType="pubmed">34248803</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujisawa R, Colombo F. The long-term care workforce: overview and strategies to adapt supply to a growing demand. OECD Health Work: Papers. 2009;1:62&#x2013;71.</Citation></Reference><Reference><Citation>Brodaty H, Donkin M. Family caregivers of people with dementia. Dialogues Clin Neurosci. 2009;11(2):217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3181916</ArticleId><ArticleId IdType="pubmed">19585957</ArticleId></ArticleIdList></Reference><Reference><Citation>Erol R, Brooker D, Peel E. Project report Alzheimer&#x2019;s disease international (ADI), London. 2015. Women and dementia: a global research review.</Citation></Reference><Reference><Citation>Shakiba Zahed ME, Eslami AA, Barekatain M, Hassanzadeh A, Zamani-Alavijeh F. Stress as a challenge in promoting mental health among dementia caregivers. J Educ Health Promot. 2020;9:65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255562</ArticleId><ArticleId IdType="pubmed">32490000</ArticleId></ArticleIdList></Reference><Reference><Citation>Son J, Erno A, Shea DG, Femia EE, Zarit SH, Parris Stephens MA. The caregiver stress process and health outcomes. J Aging Health. 2007;19(6):871&#x2013;887.</Citation><ArticleIdList><ArticleId IdType="pubmed">18165286</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiao CY, Wu HS, Hsiao CY. Caregiver burden for informal caregivers of patients with dementia: a systematic review. Int Nurs Rev. 2015;62(3):340&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">26058542</ArticleId></ArticleIdList></Reference><Reference><Citation>Etters L, Goodall D, Harrison BE. Caregiver burden among dementia patient caregivers: a review of the literature. J Am Acad Nurse Pract. 2008;20(8):423&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">18786017</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitaliano PP, Zhang J, Scanlan JM. Is caregiving hazardous to one's physical health? A meta-analysis. Psychol Bull. 2003;129(6):946.</Citation><ArticleIdList><ArticleId IdType="pubmed">14599289</ArticleId></ArticleIdList></Reference><Reference><Citation>Garity J. Stress, learning style, resilience factors, and ways of coping in Alzheimer family caregivers. Am J Alzheimers Dis. 1997;12(4):171&#x2013;178.</Citation></Reference><Reference><Citation>Lindsey PL, Buckwalter KC. Psychotic events in Alzheimer&#x2019;s disease: application of the PLST model. J Gerontol Nurs. 2009;35(8):20&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3135972</ArticleId><ArticleId IdType="pubmed">19681559</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarus RS, Folkman S. Stress, appraisal, and coping. Springer publishing company; 1984.</Citation></Reference><Reference><Citation>Sharif Nia H, Pahlevan Sharif S, Goudarzian AH, Allen KA, Jamali S, Heydari Gorji MA. The relationship between religious coping and self-care behaviors in Iranian medical students. J Relig Health. 2017;56(6):2109&#x2013;2117.</Citation><ArticleIdList><ArticleId IdType="pubmed">28229351</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenmakers EC, van Tilburg TG, Fokkema T. Problem-focused and emotion-focused coping options and loneliness: how are they related? Eur J Ageing. 2015;12(2):153&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5549139</ArticleId><ArticleId IdType="pubmed">28804352</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman JL, Tetrick LE. Problem-focused versus emotion-focused coping strategies and repatriation adjustment. 2009. pp. 69&#x2013;88.</Citation></Reference><Reference><Citation>Siu OL, Lo BCY, Ng TK, Wang H. Social support and student outcomes: the mediating roles of psychological capital, study engagement, and problem-focused coping. Curr Psychol. 2021:1&#x2013;10.&#xa0;https://link.springer.com/article/10.1007/s12144-021-01621-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12144-021-01621-x</ArticleId><ArticleId IdType="pmc">PMC9209831</ArticleId><ArticleId IdType="pubmed">35756898</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhadi A, Noroozian M, Mohammadi F, Foroughan M, Rassouli M, Sadeghmoghadam L, et al. Positive experiences of caregiving in family caregivers of older adults with dementia: a content analysis study. ISMJ. 2018;21(4):319&#x2013;334.</Citation></Reference><Reference><Citation>Damianakis T, Wilson K, Marziali E. Family caregiver support groups: spiritual reflections&#x2019; impact on stress management. Aging Mental Health. 2018;22(1):70&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">27647207</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufer DI, Cummings JL, Christine D, Bray T, Castellon S, Masterman D, et al. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the neuropsychiatric inventory caregiver distress scale. J Am Geriatr Soc. 1998;46(2):210&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pubmed">9475452</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidsdottir SR, Snaedal J, Karlsdottir G, Atladottir I, Hannesdottir K. Validation of the Icelandic version of the neuropsychiatric inventory with caregiver distress (NPI-D) Nordic J Psychiatry. 2012;66(1):26&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">21770826</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L, Wang L, Yang X, Feng Q. Zarit caregiver burden interview: development, reliability and validity of the Chinese version. Psychiatry Clin Neurosci. 2009;63(6):730&#x2013;734.</Citation><ArticleIdList><ArticleId IdType="pubmed">19781014</ArticleId></ArticleIdList></Reference><Reference><Citation>Shali M, Ghaffari F, Joolaee S, Ebadi A. Development and psychometric evaluation of the patient safety violation scale in medical oncology units in Iran. Asian Pac J Cancer Prev. 2016;17(9):4341&#x2013;4347.</Citation><ArticleIdList><ArticleId IdType="pubmed">27797241</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawshe CH. A quantitative approach to content validity. Pers Psychol. 1975;28(4):563&#x2013;575.</Citation></Reference><Reference><Citation>Sharif Nia H, Sivarajan Froelicher E, Hosseini L, Ashghali Farahani M, Hejazi S. Development and validation of the care challenge scale in family caregivers of people with Alzheimer&#x2019;s disease. Front Public Health. 2022;10:921858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9366672</ArticleId><ArticleId IdType="pubmed">35968470</ArticleId></ArticleIdList></Reference><Reference><Citation>MacCallum RC, Widaman KF, Zhang S, Hong S. Sample size in factor analysis. Psychol Methods. 1999;4(1):84.</Citation></Reference><Reference><Citation>Sharif Nia H, Haghdoost AA, Ebadi A, Soleimani MA, Yaghoobzadeh A, Abbaszadeh A, et al. Psychometric properties of the king spiritual intelligence questionnaire (KSIQ) in physical veterans of Iran-Iraq warfare. J Military Med. 2015;17(3):145&#x2013;153.</Citation></Reference><Reference><Citation>Golino HF, Epskamp S. Exploratory graph analysis: A new approach for estimating the number of dimensions in psychological research. PLoS One. 2017;12(6):e0174035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5465941</ArticleId><ArticleId IdType="pubmed">28594839</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen AP, Gross GM, Golino HF, Silvia PJ, Kwapil TR. Exploratory graph analysis of the multidimensional schizotypy scale. Schizophr Res. 2019;206:43&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">30573405</ArticleId></ArticleIdList></Reference><Reference><Citation>Golino HF, Demetriou AJI. Estimating the dimensionality of intelligence like data using exploratory graph analysis. Intelligence. 2017;62:54&#x2013;70.</Citation></Reference><Reference><Citation>Epskamp S, Maris G, Waldorp LJ, Borsboom D. TWhoptAmros, scale, development t. Network psychometrics. 2018. pp. 953&#x2013;986.</Citation></Reference><Reference><Citation>Bahrami N, Yaghoobzadeh A, Sharif Nia H, Soliemani M, Haghdoost A. Psychometric properties of the Persian version of Larsons sexual satisfaction questionnaire in a sample of Iranian infertile couples. Iran J Epidemiol. 2016;12(2):18&#x2013;31.</Citation></Reference><Reference><Citation>Sharif Nia H, Kaur H, Khoshnavay Fomani F, Rahmatpour P, Kaveh O, Pahlevan Sharif S, et al. Psychometric properties of the Impact of Events Scale-Revised (IES-R) among general Iranian population during the COVID-19 pandemic. Front Psychiatry. 2021;12:692498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8365034</ArticleId><ArticleId IdType="pubmed">34408679</ArticleId></ArticleIdList></Reference><Reference><Citation>Henseler J, Ringle CM, Sarstedt M. A new criterion for assessing discriminant validity in variance-based structural equation modeling. J Acad Mark Sci. 2015;43(1):115&#x2013;135.</Citation></Reference><Reference><Citation>Mohammadbeigi A, Mohammadsalehi N, Aligol M. Validity and reliability of the instruments and types of measurments in health applied researches. J Rafsanjan Univ Med Sci. 2015;13(12):1153&#x2013;1170.</Citation></Reference><Reference><Citation>Javali SB, Gudaganavar NV, Raj SM. Effect of varying sample size in estimation of coefficients of internal consistency. 2011.</Citation></Reference><Reference><Citation>Hosseini L, Sharif Nia H, Ashghali Farahani M. Development and psychometric evaluation of family caregivers&#x2019; hardiness scale: a sequential-exploratory mixed-method study. Front Psychol. 2022;3:807049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9010881</ArticleId><ArticleId IdType="pubmed">35432109</ArticleId></ArticleIdList></Reference><Reference><Citation>Terwee CB, Prinsen C, Chiarotto A, De Vet H, Bouter LM, Alonso J, et al. COSMIN methodology for assessing the content validity of PROMs&#x2013;user manual. Amsterdam: VU University Medical Center; 2018.</Citation></Reference><Reference><Citation>Molavi P, Salvat Ghojehbeiglou H, Nadr Mohammadi M, Ghalaei S. Effectiveness of stress management training on reducing perceived stress in veterans with PTSD. Iranian J War Public Health. 2019;11(2):67&#x2013;72.</Citation></Reference><Reference><Citation>Lazarus RS. Coping theory and research: past, present, and future. 1993. pp. 366&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">8346332</ArticleId></ArticleIdList></Reference><Reference><Citation>Picken J. The coping strategies, adjustment and well being of male inmates in the prison environment. Int J Criminol. 2012;29:1&#x2013;22.</Citation></Reference><Reference><Citation>Sawang S, Oei TP. The ways of coping Checklist revision-Asian version (WCCL-ASIAN): a new factor structure with confirmatory factor. 2009.</Citation></Reference><Reference><Citation>Roesch SC, Aldridge AA, Huff TL, Langner K, Villodas F, Bradshaw K. On the dimensionality of the proactive coping inventory: 7, 5, 3 factors? Anxiety Stress Coping. 2009;22(3):327&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">19253071</ArticleId></ArticleIdList></Reference><Reference><Citation>Strutton D, Lumpkin JR. Problem-and emotion-focused coping dimensions and sales presentation effectiveness. J Acad Mark Sci. 1994;22(1):28&#x2013;37.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36750227</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1099-1166</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>International journal of geriatric psychiatry</Title><ISOAbbreviation>Int J Geriatr Psychiatry</ISOAbbreviation></Journal><ArticleTitle>A shared decision-making model about care for people with severe dementia: A qualitative study based on nutrition and hydration decisions in acute hospitals.</ArticleTitle><Pagination><StartPage>e5884</StartPage><MedlinePgn>e5884</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e5884</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/gps.5884</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To understand the decision-making processes regarding eating and drinking for hospital patients with severe dementia and use this data to modify a decision-making model about care for people with severe dementia.</AbstractText><AbstractText Label="METHODS">From January to May 2021, qualitative semi-structured interviews were conducted with 29 family carers and hospital staff in England who cared for people with severe dementia during hospital admissions. Interviews were transcribed verbatim and analysed using codebook thematic analysis.</AbstractText><AbstractText Label="RESULTS">We demonstrated a modified decision-making model consisting of six stages of the decision-making process: (i) identify a decision to be made; (ii) exchange information and recognise emotions; (iii) clarify values and preferences of all involved; (iv) consider feasibility of each choice; (v) share preferred choice and make a final decision; and (vi) deliver the decision, monitor outcomes and renegotiation. From this study, decision-making needed to be shared among all people involved and address holistic needs and personal values of people with dementia and family carers. However, hospital staff often made assumptions about the persons' ability to eat and drink without adequate consultation with family carers. The process was impacted by ward culture, professional practice, and legal framework, which might overlook cultural and personal beliefs of the persons and families. Treatment escalation plans could help inform stepwise treatments, create realistic expectations, and guide future decisions.</AbstractText><AbstractText Label="CONCLUSIONS">Our decision-making model provides clear stages of decision-making processes and can be used to guide clinical practice and policy around care decisions for eating and drinking, which is often poorly supported.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. International Journal of Geriatric Psychiatry published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anantapong</LastName><ForeName>Kanthee</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3190-4355</Identifier><AffiliationInfo><Affiliation>Marie Curie Palliative Care Research Department, UCL Division of Psychiatry, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sampson</LastName><ForeName>Elizabeth L</ForeName><Initials>EL</Initials><Identifier Source="ORCID">0000-0001-8929-7362</Identifier><AffiliationInfo><Affiliation>Marie Curie Palliative Care Research Department, UCL Division of Psychiatry, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychological Medicine, Royal London Hospital, East London NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-7757-5353</Identifier><AffiliationInfo><Affiliation>Marie Curie Palliative Care Research Department, UCL Division of Psychiatry, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Ageing Population Studies, Research Department of Primary Care and Population Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MCCC-FCO-11-U</GrantID><Acronym>MCCC_</Acronym><Agency>Marie Curie</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MCRGS-20171219-8004</GrantID><Acronym>MCCC_</Acronym><Agency>Marie Curie</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Geriatr Psychiatry</MedlineTA><NlmUniqueID>8710629</NlmUniqueID><ISSNLinking>0885-6230</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Int J Geriatr Psychiatry. 2023 Sep;38(9):e5997. doi: 10.1002/gps.5997</RefSource><PMID Version="1">37655477</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003657" MajorTopicYN="Y">Decision Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">caregiver</Keyword><Keyword MajorTopicYN="N">decision</Keyword><Keyword MajorTopicYN="N">hospital care</Keyword><Keyword MajorTopicYN="N">person-centred care</Keyword><Keyword MajorTopicYN="N">qualitative research</Keyword></KeywordList><CoiStatement>The authors report there are no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>19</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36750227</ArticleId><ArticleId IdType="pmc">PMC10108087</ArticleId><ArticleId IdType="doi">10.1002/gps.5884</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mitchell SL. Advanced dementia. N Engl J Med. 2015;373(13):1276&#x2010;11. 10.1056/NEJMc1509349</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1509349</ArticleId><ArticleId IdType="pmc">PMC4685690</ArticleId><ArticleId IdType="pubmed">26398084</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinagawa S, Honda K, Kashibayashi T, Shigenobu K, Nakayama K, Ikeda M. Classifying eating&#x2010;related problems among institutionalized people with dementia. Psychiatr Clin Neurosci. 2016;70(4):175&#x2010;181. 10.1111/pcn.12375</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.12375</ArticleId><ArticleId IdType="pubmed">26556570</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivi GA, Bertolucci PH, Schultz RR. Nutrition in severe dementia. Curr Gerontol Geriatr Res. 2012;2012:983056&#x2010;983057. 10.1155/2012/983056</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/983056</ArticleId><ArticleId IdType="pmc">PMC3356862</ArticleId><ArticleId IdType="pubmed">22645608</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosvik J, Rokstad AMM. What are the needs of people with dementia in acute hospital settings, and what interventions are made to meet these needs? A systematic integrative review of the literature. BMC Health Serv Res. 2020;20(1):723. 10.1186/s12913-020-05618-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-05618-3</ArticleId><ArticleId IdType="pmc">PMC7412803</ArticleId><ArticleId IdType="pubmed">32767987</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence V, Samsi K, Murray J, Harari D, Banerjee S. Dying well with dementia: qualitative examination of end&#x2010;of&#x2010;life care. Br J Psychiatry. 2011;199(5):417&#x2010;422. 10.1192/bjp.bp.111.093989</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.bp.111.093989</ArticleId><ArticleId IdType="pubmed">21947653</ArticleId></ArticleIdList></Reference><Reference><Citation>Keuning&#x2010;Plantinga A, Roodbol P, van Munster BC, Finnema EJ. Experiences of informal caregivers of people with dementia with nursing care in acute hospitals: a descriptive mixed&#x2010;methods study. J Adv Nurs. 2021;77(12):4887&#x2010;4899. 10.1111/jan.15042</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jan.15042</ArticleId><ArticleId IdType="pmc">PMC9292992</ArticleId><ArticleId IdType="pubmed">34532873</ArticleId></ArticleIdList></Reference><Reference><Citation>Anantapong K, Davies N, Chan J, McInnerney D, Sampson EL. Mapping and understanding the decision&#x2010;making process for providing nutrition and hydration to people living with dementia: a systematic review. BMC Geriatr. 2020;20(1):520. 10.1186/s12877-020-01931-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-020-01931-y</ArticleId><ArticleId IdType="pmc">PMC7709405</ArticleId><ArticleId IdType="pubmed">33267831</ArticleId></ArticleIdList></Reference><Reference><Citation>Teno JM, Mitchell SL, Skinner J, et&#xa0;al. Churning: the association between health care transitions and feeding tube insertion for nursing home residents with advanced cognitive impairment. J Palliat Med. 2009;12(4):359&#x2010;362. 10.1089/jpm.2008.0168</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jpm.2008.0168</ArticleId><ArticleId IdType="pmc">PMC2700356</ArticleId><ArticleId IdType="pubmed">19327073</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies N, Barrado&#x2010;Martin Y, Vickerstaff V, et&#xa0;al. Enteral tube feeding for people with severe dementia. Cochrane Database Syst Rev. 2021;8:CD013503. 10.1002/14651858.CD013503.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013503.pub2</ArticleId><ArticleId IdType="pmc">PMC8407048</ArticleId><ArticleId IdType="pubmed">34387363</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Health . Mental Capacity Act; 2005.</Citation></Reference><Reference><Citation>Samsi K, Manthorpe J. Everyday decision&#x2010;making in dementia: findings from a longitudinal interview study of people with dementia and family carers. Int Psychogeriatr. 2013;25(6):949&#x2010;961. 10.1017/S1041610213000306</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610213000306</ArticleId><ArticleId IdType="pubmed">23510662</ArticleId></ArticleIdList></Reference><Reference><Citation>Anantapong K, Barrado&#x2010;Martin Y, Nair P, et&#xa0;al. How do people living with dementia perceive eating and drinking difficulties? A qualitative study. Age Ageing. 2021;50(5):1820&#x2010;1828. 10.1093/ageing/afab108</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afab108</ArticleId><ArticleId IdType="pmc">PMC8522686</ArticleId><ArticleId IdType="pubmed">34120181</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison Dening K, King M, Jones L, Vickestaff V, Sampson EL. Advance care planning in dementia: do family carers know the treatment preferences of people with early dementia? PLoS One. 2016;11(7):e0159056. 10.1371/journal.pone.0159056</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0159056</ArticleId><ArticleId IdType="pmc">PMC4943594</ArticleId><ArticleId IdType="pubmed">27410259</ArticleId></ArticleIdList></Reference><Reference><Citation>Anantapong K, Davies N. Talking about future decision&#x2010;making capacity and advance care planning in diagnosis disclosure of dementia. Int Psychogeriatr. 2021;33(11):1119&#x2010;1121. 10.1017/S1041610221000648</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610221000648</ArticleId><ArticleId IdType="pubmed">33926599</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrado&#x2010;Martin Y, Hatter L, Moore KJ, et&#xa0;al. Nutrition and hydration for people living with dementia near the end of life: a qualitative systematic review. J Adv Nurs. 2021;77(2):664&#x2010;680. 10.1111/jan.14654</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jan.14654</ArticleId><ArticleId IdType="pmc">PMC7898342</ArticleId><ArticleId IdType="pubmed">33249602</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner A, Eccles FJ, Elvish R, Simpson J, Keady J. The experience of caring for patients with dementia within a general hospital setting: a meta&#x2010;synthesis of the qualitative literature. Aging Ment Health. 2017;21(1):66&#x2010;76. 10.1080/13607863.2015.1109057</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2015.1109057</ArticleId><ArticleId IdType="pubmed">26553275</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller LM, Whitlatch CJ, Lyons KS. Shared decision&#x2010;making in dementia: a review of patient and family carer involvement. Dementia (London). 2016;15(5):1141&#x2010;1157. 10.1177/1471301214555542</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301214555542</ArticleId><ArticleId IdType="pubmed">25370075</ArticleId></ArticleIdList></Reference><Reference><Citation>Legare F, Stacey D, Gagnon S, et&#xa0;al. Validating a conceptual model for an inter&#x2010;professional approach to shared decision making: a mixed methods study. J Eval Clin Pract. 2011;17(4):554&#x2010;564. 10.1111/j.1365-2753.2010.01515.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2753.2010.01515.x</ArticleId><ArticleId IdType="pmc">PMC3170704</ArticleId><ArticleId IdType="pubmed">20695950</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, Clarke V. Thematic Analysis: A Practical Guide. SAGE Publications Ltd.; 2021.</Citation></Reference><Reference><Citation>Sque M, Walker W, Long&#x2010;Sutehall T. Research with bereaved families: a framework for ethical decision&#x2010;making. Nurs Ethics. 2014;21(8):946&#x2010;955. 10.1177/0969733014521097</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0969733014521097</ArticleId><ArticleId IdType="pubmed">24615590</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy E, Dingwall R, Greatbatch D, Parker S, Watson P. Qualitative research methods in health technology assessment: a review of the literature. Health Technol Assess. 1998;2(16):iii&#x2010;ix. 1&#x2013;274. 10.3310/hta2160</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/hta2160</ArticleId><ArticleId IdType="pubmed">9919458</ArticleId></ArticleIdList></Reference><Reference><Citation>Britten N. Qualitative interviews in medical research. BMJ. 1995;311(6999):251&#x2010;253. 10.1136/bmj.311.6999.251</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.311.6999.251</ArticleId><ArticleId IdType="pmc">PMC2550292</ArticleId><ArticleId IdType="pubmed">7627048</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, Clarke V. Successful Qualitative Research: A Practical Guide for Beginners. SAGE Publication Ltd.; 2013.</Citation></Reference><Reference><Citation>Braun V, Clarke V. One size fits all? What counts as quality practice in (reflexive) thematic analysis? Qual Res Psychol. 2021;18(3):328&#x2010;352. 10.1080/14780887.2020.1769238</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14780887.2020.1769238</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbour RS. Checklists for improving rigour in qualitative research: a case of the tail wagging the dog? BMJ. 2001;322(7294):1115&#x2010;1117. 10.1136/bmj.322.7294.1115</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.322.7294.1115</ArticleId><ArticleId IdType="pmc">PMC1120242</ArticleId><ArticleId IdType="pubmed">11337448</ArticleId></ArticleIdList></Reference><Reference><Citation>Chewning B, Bylund CL, Shah B, Arora NK, Gueguen JA, Makoul G. Patient preferences for shared decisions: a systematic review. Patient Educ Couns. 2012;86(1):9&#x2010;18. 10.1016/j.pec.2011.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2011.02.004</ArticleId><ArticleId IdType="pmc">PMC4530615</ArticleId><ArticleId IdType="pubmed">21474265</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooker D, Kitwood T. Dementia Reconsidered, Revisited; The Person Still Comes First. Open University Press; 2019.</Citation></Reference><Reference><Citation>Donnelly S, &#xd3; Coim&#xed;n D, O'Donnell D, et&#xa0;al. Assisted decision&#x2010;making and interprofessional collaboration in the care of older people: a qualitative study exploring perceptions of barriers and facilitators in the acute hospital setting. J Interprof Care. 2021;35(6):1&#x2010;11. 10.1080/13561820.2020.1863342</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13561820.2020.1863342</ArticleId><ArticleId IdType="pubmed">33588668</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley R, Godfrey M, Young J. The impacts of family involvement on general hospital care experiences for people living with dementia: an ethnographic study. Int J Nurs Stud. 2019;96:72&#x2010;81. 10.1016/j.ijnurstu.2019.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2019.04.004</ArticleId><ArticleId IdType="pubmed">31053337</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley R, Godfrey M, Young J. Knowledge exchanges and decision&#x2010;making within hospital dementia care triads: an ethnographic study. Gerontologist. 2021;61(6):954&#x2010;964. 10.1093/geront/gnaa216</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnaa216</ArticleId><ArticleId IdType="pmc">PMC8521779</ArticleId><ArticleId IdType="pubmed">33598713</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood RH. Feeding decisions in advanced dementia. J R Coll Physicians Edinb. 2014;44(3):232&#x2010;237. 10.4997/JRCPE.2014.310</Citation><ArticleIdList><ArticleId IdType="doi">10.4997/JRCPE.2014.310</ArticleId><ArticleId IdType="pubmed">25318402</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrado&#x2010;Martin Y, Nair P, Anantapong K, et&#xa0;al. Family caregivers' and professionals' experiences of supporting people living with dementia's nutrition and hydration needs towards the end of life. Health Soc Care Community. 2021;30(1):307&#x2010;318. 10.1111/hsc.13404</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hsc.13404</ArticleId><ArticleId IdType="pubmed">33955630</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair P, Barrado&#x2010;Martin Y, Anantapong K, et&#xa0;al. Experiences of carers and people with dementia from ethnic minority groups managing eating and drinking at home in the United Kingdom. Nutrients. 2022;14(12):2395. 10.3390/nu14122395</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14122395</ArticleId><ArticleId IdType="pmc">PMC9230659</ArticleId><ArticleId IdType="pubmed">35745124</ArticleId></ArticleIdList></Reference><Reference><Citation>Courtright KR, Srinivasan TL, Madden VL, et&#xa0;al. &#x201c;I don't have time to sit and talk with them&#x201d;: hospitalists' perspectives on palliative care consultation for patients with dementia. J Am Geriatr Soc. 2020;68(10):2365&#x2010;2372. 10.1111/jgs.16712</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16712</ArticleId><ArticleId IdType="pmc">PMC8485634</ArticleId><ArticleId IdType="pubmed">32748393</ArticleId></ArticleIdList></Reference><Reference><Citation>Anantapong K, Davies N, Sampson EL. Communication between the multidisciplinary team and families regarding nutrition and hydration for people with severe dementia in acute hospitals: a qualitative study. Age Ageing. 2022;51(11):1&#x2010;10. 10.1093/ageing/afac230</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afac230</ArticleId><ArticleId IdType="pmc">PMC9701106</ArticleId><ArticleId IdType="pubmed">36434801</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansjee D. An acute model of care to guide eating &amp; drinking decisions in the frail elderly with dementia and dysphagia. Geriatrics. 2018;3(4):65. 10.3390/geriatrics3040065</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/geriatrics3040065</ArticleId><ArticleId IdType="pmc">PMC6371181</ArticleId><ArticleId IdType="pubmed">31011100</ArticleId></ArticleIdList></Reference><Reference><Citation>Soar N, Birns J, Sommerville P, Lang A, Archer S. Approaches to eating and drinking with acknowledged risk: a systematic review. Dysphagia. 2021;36(1):54&#x2010;66. 10.1007/s00455-020-10107-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00455-020-10107-0</ArticleId><ArticleId IdType="pubmed">32239275</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson K, Dewing J. Strategies to prevent dehydration in older people with dementia: a literature review. Nurs Older People. 2020;32(1):27&#x2010;33. 10.7748/nop.2019.e1208</Citation><ArticleIdList><ArticleId IdType="doi">10.7748/nop.2019.e1208</ArticleId><ArticleId IdType="pubmed">31769256</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewing J, Dijk S. What is the current state of care for older people with dementia in general hospitals? A literature review. Dementia (London). 2016;15(1):106&#x2010;124. 10.1177/1471301213520172</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301213520172</ArticleId><ArticleId IdType="pubmed">24459188</ArticleId></ArticleIdList></Reference><Reference><Citation>Featherstone K, Northcott A. Wandering the Wards: An Ethnography of Hospital Care and Its Consequences for People Living with Dementia. Routledge; 2020.</Citation></Reference><Reference><Citation>Mays N, Pope C. Rigour and qualitative research. BMJ. 1995;311(6997):109&#x2010;112. 10.1136/bmj.311.6997.109</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.311.6997.109</ArticleId><ArticleId IdType="pmc">PMC2550154</ArticleId><ArticleId IdType="pubmed">7613363</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson MF, McKee KJ, Dahlberg L, et&#xa0;al. A comparison of spouse and non&#x2010;spouse carers of people with dementia: a descriptive analysis of Swedish national survey data. BMC Geriatr. 2021;21(1):338. 10.1186/s12877-021-02264-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02264-0</ArticleId><ArticleId IdType="pmc">PMC8170983</ArticleId><ArticleId IdType="pubmed">34078292</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogg C, Griffiths P, Meredith P, Bridges J. Hospital outcomes of older people with cognitive impairment: an integrative review. Int J Geriatr Psychiatr. 2018;33(9):1177&#x2010;1197. 10.1002/gps.4919</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4919</ArticleId><ArticleId IdType="pmc">PMC6099229</ArticleId><ArticleId IdType="pubmed">29947150</ArticleId></ArticleIdList></Reference><Reference><Citation>Anantapong K, Bruun A, Walford A, et&#xa0;al. Co&#x2010;design development of a decision guide on eating and drinking for people with severe dementia during acute hospital admissions. Health Expect. 2022:1&#x2010;17. 10.1111/hex.13672</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hex.13672</ArticleId><ArticleId IdType="pmc">PMC10010093</ArticleId><ArticleId IdType="pubmed">36647692</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies N, Schiowitz B, Rait G, Vickerstaff V, Sampson EL. Decision aids to support decision&#x2010;making in dementia care: a systematic review. Int Psychogeriatr. 2019;26(10):1&#x2010;17. 10.1017/S1041610219000826</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610219000826</ArticleId><ArticleId IdType="pubmed">31347482</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36749854</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-5279</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</Title><ISOAbbreviation>Alzheimers Dement</ISOAbbreviation></Journal><ArticleTitle>Outcome measures for Alzheimer's disease: A global inter-societal Delphi consensus.</ArticleTitle><Pagination><StartPage>2707</StartPage><EndPage>2729</EndPage><MedlinePgn>2707-2729</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/alz.12945</ELocationID><Abstract><AbstractText Label="INTRODUCTION">We aim to provide guidance on outcomes and measures for use in patients with Alzheimer's clinical syndrome.</AbstractText><AbstractText Label="METHODS">A consensus group of 20 voting members nominated by 10 professional societies, and a non-voting chair, used a Delphi approach and modified GRADE criteria.</AbstractText><AbstractText Label="RESULTS">Consensus was reached on priority outcomes (n&#xa0;=&#xa0;66), measures (n&#xa0;=&#xa0;49) and statements (n&#xa0;=&#xa0;37) across nine domains. A number of outcomes and measurement instruments were ranked for: Cognitive abilities; Functional abilities/dependency; Behavioural and neuropsychiatric symptoms; Patient quality of life (QoL); Caregiver QoL; Healthcare and treatment-related outcomes; Medical investigations; Disease-related life events; and Global outcomes.</AbstractText><AbstractText Label="DISCUSSION">This work provides indications on the domains and ideal pertinent measurement instruments that clinicians may wish to use to follow patients with cognitive impairment. More work is needed to develop instruments that are more feasible in the context of the constraints of clinical routine.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Alzheimer's &amp; Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ellison</LastName><ForeName>Tim S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>PharmaGenesis London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cappa</LastName><ForeName>Stefano F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Scuola Universitaria Superiore IUSS Pavia, Pavia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dementia Research Center, IRCCS Mondino Foundation, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garrett</LastName><ForeName>Dawne</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Royal College of Nursing, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Georges</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Alzheimer Europe, Luxembourg, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwatsubo</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Unit for Early and Exploratory Clinical Development, The University of Tokyo Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kramer</LastName><ForeName>Joel H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Memory and Aging Center, University of California, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehmann</LastName><ForeName>Maryna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>World Dementia Council, George, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lyketsos</LastName><ForeName>Constantine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Richman Family Precision Medicine Center of Excellence in Alzheimer's Disease, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University and Medicine, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maier</LastName><ForeName>Andrea B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Medicine and Aged Care, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Behavioural and Movement Sciences, Department of Human Movement Sciences, Vrije Universiteit, Amsterdam Movement Sciences, Amsterdam, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Healthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Healthy Longevity, National University Health System, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merrilees</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Memory and Aging Center, University of California, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>John C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University, St. Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naismith</LastName><ForeName>Sharon L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>School of Psychology, The University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nobili</LastName><ForeName>Flavio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>UO Clinica Neurologica, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico San Martino, Genova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Child and Mother Health, University of Genoa, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pahor</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Aging and Geriatric Research, Institute on Aging, University of Florida College of Medicine, Gainesville, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pond</LastName><ForeName>Dimity</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Faculty of Health and Medicine, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soysal</LastName><ForeName>Pinar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Society of Geriatric Medicine, Dementia Special Interest Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandenbulcke</LastName><ForeName>Mathieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neuropsychiatry, Department of Neurosciences, Leuven Brain Institute, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geriatric Psychiatry, University Psychiatric Centre KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Alzheimer's Association, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visser</LastName><ForeName>Pieter Jelle</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNS), Maastricht University, Maastricht, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alzheimer Center, Department of Neurology, Neuroscience Campus Amsterdam, Amsterdam University Medical Center, VU Medical Center, Amsterdam, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institute, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiner</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frisoni</LastName><ForeName>Giovanni B</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Department of Readaptation and Geriatrics, Geneva University and University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG066444</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG003991</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG026276</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG032289</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG024904</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG019724</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG032438</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG004953</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG032289</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Alzheimers Dement</MedlineTA><NlmUniqueID>101231978</NlmUniqueID><ISSNLinking>1552-5260</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003697" MajorTopicYN="N">Delphi Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">Delphi</Keyword><Keyword MajorTopicYN="N">consensus</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">measures</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword></KeywordList><CoiStatement>CONFLICT OF INTEREST. S.F.C. has received speaker fees from, and participated in advisory boards organized by, Biogen, F. Hoffmann-La Roche Ltd., Nutricia. T.S.E. is an employee of PharmaGenesis London, a medical communications consultancy based in the UK. G.B.F. has received funding from the following private donors under the supervision of the Private Foundation of Geneva University Hospitals: A.P.R.A. &#x2013; Association Suisse pour la Recherche sur la Maladie d&#x2019;Alzheimer, Gen&#xe8;ve; Fondation Segr&#xe9;, Gen&#xe8;ve; Ivan Pictet, Gen&#xe8;ve; Fondazione Agusta, Lugano; Fondation Chmielewski, Gen&#xe8;ve; Nicole et Ren&#xe9; Keller, Gen&#xe8;ve; Fondation Minkoff, Gen&#xe8;ve; Race Against Dementia Foundation, London, UK; F. Hoffmann-La Roche Ltd.; OM Pharma; EISAI Pharmaceuticals; Biogen Pharmaceuticals. G.B.F&#x2019;s competitive research projects are funded by H2020, Innovative Medicines Initiative (IMI), IMI2, Swiss National Science Foundation, and VELUX Foundation. In the past 36 months, G.B.F. has received consulting fees from Biogen, Diadem, F. Hoffmann-La Roche Ltd., and payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing or educational events from Biogen, F. Hoffmann-La Roche Ltd. (all to his institution). G.B.F. reports no conflicts of interest for the current manuscript. D.G. is a former professional lead for older people and dementia care at the Royal College of Nursing, UK, and a board member of the International psychogeriatric Association. J.G. is the Executive Director of Alzheimer Europe, which receives grants and support for its activities from the EU health and research programs and from private and public organizations and institutions. T.I. has served as a consultant or advisory board member for Eisai, Biogen, and F. Hoffmann-La Roche Ltd., and is funded by the Japan Agency for Medical Research and Development. J.H.K. has served as a consultant for Biogen and has received royalties from Pearson, Inc. C.L. has served as a consultant or advisory board member for AstraZeneca, GlaxoSmithKline, Eisai, Novartis, Forest Laboratories, Supernus Pharmaceuticals, Adlyfe, Takeda, Wyeth, Lundbeck, Merz Pharma, Eli Lilly and Company, Pfizer, Genentech, Elan Corporation, NFL Players Association, NFL Benefits Office, Avanir Pharmaceuticals, Zinfandel Pharmaceuticals, Bristol Myers Squibb, Abbvie, Janssen Pharmaceuticals, Orion Pharma, Otsuka Pharmaceutical, Laboratoires Servier, Astellas Pharma, F. Hoffmann-La Roche Ltd., Karuna, SVB Leerink, Maplight Therapeutics, Axsome Therapeutics, Global Institute on Addictions, GW Research Limited, and Merck. A.B.M. has received fees from Abbott Laboratories and Nutricia for serving as a consultant and an advisory board member, and for teaching lessons. J.M. has been funded by National Institutes of Health (NIH) grants #5R0I AF062639, R01 AG0567152, and P01AG019724. J.C.M. has been funded by NIH grants # P30 AG066444, P01AG003991, P01AG026276, U19 AG032438, and U19 AG024904. Neither J.C.M. nor his family owns stock or has equity interest (outside of mutual funds or other externally directed accounts) in any pharmaceutical or biotechnology company. S.L.N. has received fees from Nutricia and F. Hoffmann-La Roche Ltd., for speaking or participating in workshops. S.L.N. is a consultant for Brain Protection Company, and has served as an advisory board member for Alzheimer&#x2019;s Disease Research Foundation Australia. F.N. has received fees from Bial, Biogen, GE Healthcare, and F. Hoffmann-La Roche Ltd., for teaching lessons and for serving as a consultant and advisory board member. D.P. is an Honorary Professor at the University of Newcastle, Australia, and in the past three years has served as a consultant for Biogen and F. Hoffmann-La Roche Ltd. D.P. is part of a group that runs GP training for Dementia Training Australia. M.L., M.P., L.R., P.S., and M.V. report no conflicts of interest. P.J.V. received a research grant from Biogen, which was paid to the University. C.J.W. is a full-time employee of the Alzheimer&#x2019;s Association. M.W. has served as a consultant for: Acumen Pharmaceuticals, Alzeca Biosciences, Alzheon, Inc., AlzPath, Anven Biosciences, Baird Equity Capital, BioClinica, Cerecin, Cytox, Dolby Family Ventures, Duke University, Eli Lilly and Company, FUJIFILM-Toyama Chemical Co., Garfield Weston Foundation, Genentech, Guidepoint Global, Indiana University, Japanese Organization for Medical Device Development, Inc. (JOMDD), NervGen Pharma, Nestle/Nestec, NIH, Merck Sharp &amp; Dohme Ltd., PeerView Internal Medicine, Patient-Centered Outcomes Research Institute / Patient-Powered Research Network (PCORI/PPRN), F. Hoffmann-La Roche Ltd., T3D Therapeutics, University of Southern California (USC), Medscape, Eisai, and Vida Ventures. M.W. has acted as a speaker/lecturer for: The Buck Institute for Research on Aging, China Association for Alzheimer&#x2019;s Disease (CAAD), Japan Society for Dementia Research, and the Korean Dementia Society. M.W. has traveled with support from: the University of Southern California (USC), NervGen Pharma, The American Society of Functional Neuroradiology, and the Clinical Trials on Alzheimer&#x2019;s Disease conference. M.W. holds stock with Alzeca Biosciences, AlzPath, and Anven Biosciences, and has stock options with Alzheon, Inc. M.W. receives research support from the following sources: NIH; Department of Defense; PCORI; California Department of Public Health; University of Michigan; Siemens; Biogen; The Larry L. Hillblom Foundation; Alzheimer&#x2019;s Association; The State of California; Johnson &amp; Johnson; Kevin and Connie Shanahan; GE Healthcare; Vanderbilt University Medical Center; Australian Catholic University (Healthy Brain Initiative-Brain Health Registry); The Stroke Foundation; and the Veterans Administration.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>14</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36749854</ArticleId><ArticleId IdType="mid">NIHMS1958824</ArticleId><ArticleId IdType="pmc">PMC11010236</ArticleId><ArticleId IdType="doi">10.1002/alz.12945</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Collaborators GBDDF. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7:e105&#x2013;e125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8810394</ArticleId><ArticleId IdType="pubmed">34998485</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X-J, Zeng L, Zhang R. Cloud delphi method. International Journal of Uncertainty, Fuzziness and Knowledge-based Systems. 2012;20:77&#x2013;97.</Citation></Reference><Reference><Citation>2020 Alzheimer&#x2019;s disease facts and figures. Alzheimers Dement. 2020;16:391&#x2013;460.</Citation><ArticleIdList><ArticleId IdType="pubmed">32157811</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheltens P, Blennow K, Breteler MM, et al. Alzheimer&#x2019;s disease. Lancet. 2016;388:505&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pubmed">26921134</ArticleId></ArticleIdList></Reference><Reference><Citation>Food US and Administration Drug. Aducanumab prescribing information. 2021.</Citation></Reference><Reference><Citation>Scharre DW. Preclinical, prodromal, and dementia stages of Alzheimer&#x2019;s disease. Pract Neurol. 2019:36&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Tochel C, Smith M, Baldwin H, et al. What outcomes are important to patients with mild cognitive impairment or Alzheimer&#x2019;s disease, their caregivers, and health-care professionals? A systematic review. Alzheimers Dement (Amst). 2019;11:231&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6411507</ArticleId><ArticleId IdType="pubmed">30906845</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding AJE, Morbey H, Ahmed F, et al. A core outcome set for non-pharmacological community-based interventions for people living with dementia at home: a systematic review of outcome measurement instruments. Gerontologist. 2020;61:e435&#x2013;e448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8599310</ArticleId><ArticleId IdType="pubmed">32583858</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding AJE, Morbey H, Ahmed F, et al. What is important to people living with dementia?: the &#x2018;long-list&#x2019; of outcome items in the development of a core outcome set for use in the evaluation of non-pharmacological community-based health and social care interventions. BMC Geriatr. 2019;19:94&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6437989</ArticleId><ArticleId IdType="pubmed">30917790</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly ST, Harding AJE, Morbey H, et al. What is important to people with dementia living at home? A set of core outcome items for use in the evaluation of non-pharmacological community-based health and social care interventions. Age Ageing. 2020;49:664&#x2013;671.</Citation></Reference><Reference><Citation>Couch E, Lawrence V, Co M, Prina M. Outcomes tested in non-pharmacological interventions in mild cognitive impairment and mild dementia: a scoping review. BMJ Open. 2020;10:e035980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204934</ArticleId><ArticleId IdType="pubmed">32317262</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison JK, Noel-Storr AH, Demeyere N, Reynish EL, Quinn TJ. Outcomes measures in a decade of dementia and mild cognitive impairment trials. Alzheimers Res Ther. 2016;8:48&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5116815</ArticleId><ArticleId IdType="pubmed">27866472</ArticleId></ArticleIdList></Reference><Reference><Citation>Katona C, Livingston G, Cooper C, Ames D, Brodaty H, Chiu E. International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia. Int Psychogeriatr. 2007;19:345&#x2013;354.</Citation><ArticleIdList><ArticleId IdType="pubmed">17386120</ArticleId></ArticleIdList></Reference><Reference><Citation>Moniz-Cook E, Vernooij-Dassen M, Woods R, et al. A European consensus on outcome measures for psychosocial intervention research in dementia care. Aging Ment Health. 2008;12:14&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">18297476</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster L, Groskreutz D, Grinbergs-Saull A, et al. Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations. Health Technol Assess. 2017;21:1&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5494514</ArticleId><ArticleId IdType="pubmed">28625273</ArticleId></ArticleIdList></Reference><Reference><Citation>EU Joint Programme. Neurodegenerative Disease Research: JPND
https://wwwneurodegenerationresearcheu/wp-content/uploads/2015/10/JPND-Report-Fountainpdf
2015.</Citation></Reference><Reference><Citation>International Consortium for Health Outcomes Measurement. https://wwwichomorg/medical-conditions/dementia/2016</Citation></Reference><Reference><Citation>Nelson M, Smith M, Ly A, Tochel C, Bauer A, Gustavsson A, et al.
ROADMAP: D2.3 Stakeholder generated lists of priority RWE relevant outcomes and D2.4 Disease progression and outcomes classification matrix. https://roadmap-alzheimerorg/wp-content/uploads/2018/07/ROADMAP_D23D24pdf
2018.</Citation></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr, Bennett DA, Blennow K, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement. 2018;14:535&#x2013;562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Posner H, Curiel R, Edgar C, et al. Outcomes assessment in clinical trials of Alzheimer&#x2019;s Disease and its precursors: readying for short-term and long-term clinical trial needs. Innov Clin Neurosci. 2017;14:22&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5373792</ArticleId><ArticleId IdType="pubmed">28386518</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobart J, Cano S, Posner H, et al. Putting the Alzheimer&#x2019;s cognitive test to the test I: traditional psychometric methods. Alzheimers Dement. 2013;9:S4&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23253777</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares-Junior JWL, de Souza ACC, Alves GS, Bonfadini JC, Siqueira-Neto JI, Braga-Neto P. Cognitive assessment tools for screening older adults with low levels of education: a critical review. Front Psychiatry. 2019;10:878&#x2013;889.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6923219</ArticleId><ArticleId IdType="pubmed">31920741</ArticleId></ArticleIdList></Reference><Reference><Citation>Scazufca M, Almeida OP, Vallada HP, Tasse WA, Menezes PR. Limitations of the Mini-Mental State Examination for screening dementia in a community with low socioeconomic status: results from the Sao Paulo Ageing &amp; Health Study. Eur Arch Psychiatry Clin Neurosci. 2009;259:8&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">18560791</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrd DA, Rivera-Mindt MG. Neuropsychology&#x2019;s race problem does not begin or end with demographically adjusted norms. Nat Rev Neurol. 2022;18:125&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">35017715</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitas S, Simoes MR, Maroco J, Alves L, Santana I. Construct validity of the Montreal Cognitive Assessment (MoCA). J Int Neuropsychol Soc. 2012;18:242&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">22115097</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitas S, Simoes MR, Alves L, Santana I. Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord. 2013;27:37&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">22193353</ArticleId></ArticleIdList></Reference><Reference><Citation>Arevalo-Rodriguez I, Smailagic N, Roque-Figuls M, et al. Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2021;7:CD010783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8406467</ArticleId><ArticleId IdType="pubmed">34313331</ArticleId></ArticleIdList></Reference><Reference><Citation>Creavin ST, Wisniewski S, Noel-Storr AH, et al. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev. 2016:CD011145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8812342</ArticleId><ArticleId IdType="pubmed">26760674</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis DH, Creavin ST, Yip JL, Noel-Storr AH, Brayne C, Cullum S. Montreal Cognitive Assessment for the detection of dementia. Cochrane Database Syst Rev. 2021;7:CD010775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8407452</ArticleId><ArticleId IdType="pubmed">34255351</ArticleId></ArticleIdList></Reference><Reference><Citation>Utoomprurkporn N, Woodall K, Stott J, Costafreda SG, Bamiou DE. Hearing-impaired population performance and the effect of hearing interventions on Montreal Cognitive Assessment (MoCA): systematic review and meta-analysis. Int J Geriatr Psychiatry. 2020;35:962&#x2013;971.</Citation><ArticleIdList><ArticleId IdType="pubmed">32458435</ArticleId></ArticleIdList></Reference><Reference><Citation>Pye A, Charalambous AP, Leroi I, Thodi C, Dawes P. Screening tools for the identification of dementia for adults with age-related acquired hearing or vision impairment: a scoping review. Int Psychogeriatr. 2017;29:1771&#x2013;1784.</Citation><ArticleIdList><ArticleId IdType="pubmed">28691649</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean K, Jenkinson C, Wilcock G, Walker Z. Exploring the experiences of people with mild cognitive impairment and their caregivers with particular reference to healthcare - a qualitative study. Int Psychogeriatr. 2014;26:475&#x2013;485.</Citation><ArticleIdList><ArticleId IdType="pubmed">24284179</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon MF, Lenderking WR, Duhig A, et al. Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: the qualitative research phase. Alzheimers Dement. 2016;12:75&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">26079412</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu YF, Haase JE. Experience and perspectives of caregivers of spouse with mild cognitive impairment. Curr Alzheimer Res. 2009;6:384&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2867606</ArticleId><ArticleId IdType="pubmed">19689238</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu YY, Haase JE. Content validity and acceptability of the daily enhancement of meaningful activity program: intervention for mild cognitive impairment patient-spouse dyads. J Neurosci Nurs. 2011;43:317&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220889</ArticleId><ArticleId IdType="pubmed">22089409</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann J, Grimm C, Rychlik R, Brunner H. Benefit of therapies in Alzheimer&#x2019;s disease - the perspective of family nursing. Gesundh okon Qual Manag. 2011;16:160&#x2013;165.</Citation></Reference><Reference><Citation>Ropacki MT, Hannesdottir K, Hendrix S, et al. Clinically meaningful outcomes in early Alzheimer Disease: a consortia-driven approach to identifying what matters to patients. Ther Innov Regul Sci. 2017;51:380&#x2013;390.</Citation><ArticleIdList><ArticleId IdType="pubmed">30231712</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartry A, Aldhouse NVJ, Al-Zubeidi T, Sanon M, Stefanacci RG, Knight SL. The conceptual relevance of assessment measures in patients with mild/mild-moderate Alzheimer&#x2019;s disease. Alzheimers Dement (Amst). 2018;10:498&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6180432</ArticleId><ArticleId IdType="pubmed">30320202</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanassov V, Rojas-Rozo L, Sourial R, Yang XQ, Vedel I. Needs of patients with dementia and their caregivers in primary care: lessons learned from the Alzheimer plan of Quebec. BMC Fam Pract. 2021;22:186&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8441033</ArticleId><ArticleId IdType="pubmed">34525960</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng E, Becker BW, Woo E, Knopman DS, Cummings JL, Lu PH. Utility of the functional activities questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease. Alzheimer Dis Assoc Disord. 2010;24:348&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2997338</ArticleId><ArticleId IdType="pubmed">20592580</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimers Dement. 2011;7:270&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3312027</ArticleId><ArticleId IdType="pubmed">21514249</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JD, Lo-Ciganic WH, Shao H, Pahor M, Manini TM. Trajectories of short physical performance battery are strongly associated with future major mobility disability: results from the LIFE study. J Clin Med. 2020;9:2332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7465072</ArticleId><ArticleId IdType="pubmed">32707877</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao E, Hsiung GR, Sossi V, et al. Cerebral amyloid-beta deposition Is associated with impaired gait speed and lower extremity function. J Alzheimers Dis. 2019;71:S41&#x2013;S9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30741682</ArticleId></ArticleIdList></Reference><Reference><Citation>McGhee DJ, Ritchie CW, Thompson PA, Wright DE, Zajicek JP, Counsell CE. A systematic review of biomarkers for disease progression in Alzheimer&#x2019;s disease. PLoS One. 2014;9:e88854.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3928315</ArticleId><ArticleId IdType="pubmed">24558437</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence E, Vegvari C, Ower A, Hadjichrysanthou C, De Wolf F, Anderson RM. A systematic review of longitudinal studies which measure Alzheimer&#x2019;s Disease biomarkers. J Alzheimers Dis. 2017;59:1359&#x2013;1379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5611893</ArticleId><ArticleId IdType="pubmed">28759968</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes J, Bartlett JW, van de Pol LA, et al. A meta-analysis of hippocampal atrophy rates in Alzheimer&#x2019;s disease. Neurobiol Aging. 2009;30:1711&#x2013;1723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2773132</ArticleId><ArticleId IdType="pubmed">18346820</ArticleId></ArticleIdList></Reference><Reference><Citation>Franko E, Joly O. Alzheimer&#x2019;s Disease Neuroimaging I. Evaluating Alzheimer&#x2019;s disease progression using rate of regional hippocampal atrophy. PLoS One. 2013;8:e71354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3741167</ArticleId><ArticleId IdType="pubmed">23951142</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings LA, Palimaru A, Corona MG, et al. Patient and caregiver goals for dementia care. Qual Life Res. 2017;26:685&#x2013;693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5382930</ArticleId><ArticleId IdType="pubmed">28000094</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412&#x2013;2414.</Citation><ArticleIdList><ArticleId IdType="pubmed">8232972</ArticleId></ArticleIdList></Reference><Reference><Citation>McDougall F, Edgar C, Mertes M, et al. Psychometric properties of the clinical dementia rating - sum of boxes and other cognitive and functional outcomes in a prodromal Alzheimer&#x2019;s Disease population. J Prev Alzheimers Dis. 2021;8:151&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pubmed">33569561</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Xiong C, Aschenbrenner AJ, et al. Item response theory analysis of the Clinical Dementia Rating. Alzheimers Dement. 2021;17:534&#x2013;542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8016711</ArticleId><ArticleId IdType="pubmed">33215873</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139:1136&#x2013;1139.</Citation><ArticleIdList><ArticleId IdType="pubmed">7114305</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulino Ramirez Diaz S, Gil Gregorio P, Manuel Ribera Casado J, et al. The need for a consensus in the use of assessment tools for Alzheimer&#x2019;s disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer&#x2019;s Disease Consortium&#x2019;s (EADC) survey. Int J Geriatr Psychiatry. 2005;20:744&#x2013;748.</Citation><ArticleIdList><ArticleId IdType="pubmed">16035121</ArticleId></ArticleIdList></Reference><Reference><Citation>Avella JR. Delphi panels: research design, procedures, advantages, and challenges. Int J Dr Stud. 2016;11:305&#x2013;321.</Citation></Reference><Reference><Citation>Ashford JW, Schmitt FA, Bergeron MF, et al. Now is the time to improve cognitive screening and assessment for clinical and research advancement. J Alzheimers Dis. 2022;87:305&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">35431257</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen B, Fahy S, Cunningham CJ, et al. Screening for dementia in an Irish community sample using MMSE: a comparison of norm-adjusted versus fixed cut-points. Int J Geriatr Psychiatry. 2005;20:371&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">15799072</ArticleId></ArticleIdList></Reference><Reference><Citation>Huppert FA, Cabelli ST, Matthews FE, Function MRCC, Ageing S. Brief cognitive assessment in a UK population sample - distributional properties and the relationship between the MMSE and an extended mental state examination. BMC Geriatr. 2005;5:7&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1134657</ArticleId><ArticleId IdType="pubmed">15869717</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrag A, Schott JM. Alzheimer&#x2019;s Disease Neuroimaging I. What is the clinically relevant change on the ADAS-Cog. J Neurol Neurosurg Psychiatry. 2012;83:171&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">22019547</ArticleId></ArticleIdList></Reference><Reference><Citation>Estevez-Gonzalez A, Kulisevsky J, Boltes A, Otermin P, Garcia-Sanchez C. Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer&#x2019;s disease: comparison with mild cognitive impairment and normal aging. Int J Geriatr Psychiatry. 2003;18:1021&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pubmed">14618554</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbuthnott K, Frank J. Trail making test, part B as a measure of executive control: validation using a set-switching paradigm. J Clin Exp Neuropsychol. 2000;22:518&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">10923061</ArticleId></ArticleIdList></Reference><Reference><Citation>Tombaugh TN. Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol. 2004;19:203&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">15010086</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke&#x2019;s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry. 2006;21:1078&#x2013;1085.</Citation><ArticleIdList><ArticleId IdType="pubmed">16977673</ArticleId></ArticleIdList></Reference><Reference><Citation>Larner AJ. Addenbrooke&#x2019;s Cognitive Examination-Revised (ACE-R) in day-to-day clinical practice. Age Ageing. 2007;36:685&#x2013;686.</Citation><ArticleIdList><ArticleId IdType="pubmed">17881421</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotomskis A, Margeviciute R, Germanavicius A, Kaubrys G, Budrys V, Bagdonas A. Differential diagnosis of depression and Alzheimer&#x2019;s disease with the Addenbrooke&#x2019;s Cognitive Examination-Revised (ACE-R). BMC Neurol. 2015;15:57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4415229</ArticleId><ArticleId IdType="pubmed">25924912</ArticleId></ArticleIdList></Reference><Reference><Citation>Vittengl JR, White CN, McGovern RJ, Morton BJ. Comparative validity of seven scoring systems for the instrumental activities of daily living scale in rural elders. Aging Ment Health. 2006;10:40&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">16338813</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng TP, Niti M, Chiam PC, Kua EH. Physical and cognitive domains of the Instrumental Activities of Daily Living: validation in a multiethnic population of Asian older adults. J Gerontol A Biol Sci Med Sci. 2006;61:726&#x2013;735.</Citation><ArticleIdList><ArticleId IdType="pubmed">16870636</ArticleId></ArticleIdList></Reference><Reference><Citation>Cromwell DA, Eagar K, Poulos RG. The performance of instrumental activities of daily living scale in screening for cognitive impairment in elderly community residents. J Clin Epidemiol. 2003;56:131&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">12654407</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi Y, Ding L, Wen H, Wu J, Makimoto K, Liao X. Is Barthel Index suitable for assessing activities of daily living in patients with dementia. Front Psychiatry. 2020;11:282&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7225343</ArticleId><ArticleId IdType="pubmed">32457659</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikkes SA, de Lange-de Klerk ES, Pijnenburg YA, et al. A new informant-based questionnaire for instrumental activities of daily living in dementia. Alzheimers Dement. 2012;8:536&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pubmed">23102123</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikkes SA, Pijnenburg YA, Knol DL, de Lange-de Klerk ES, Scheltens P, Uitdehaag BM. Assessment of instrumental activities of daily living in dementia: diagnostic value of the Amsterdam Instrumental Activities of Daily Living Questionnaire. J Geriatr Psychiatry Neurol. 2013;26:244&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">24212244</ArticleId></ArticleIdList></Reference><Reference><Citation>Koster N, Knol DL, Uitdehaag BM, Scheltens P, Sikkes SA. The sensitivity to change over time of the Amsterdam IADL Questionnaire((c)). Alzheimers Dement. 2015;11:1231&#x2013;1240.</Citation><ArticleIdList><ArticleId IdType="pubmed">25598195</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubbelman MA, Verrijp M, Facal D, et al. The influence of diversity on the measurement of functional impairment: an international validation of the Amsterdam IADL Questionnaire in eight countries. Alzheimers Dement (Amst). 2020;12:e12021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7219786</ArticleId><ArticleId IdType="pubmed">32420446</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914&#x2013;919.</Citation><ArticleIdList><ArticleId IdType="pubmed">14044222</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308&#x2013;2314.</Citation><ArticleIdList><ArticleId IdType="pubmed">7991117</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufer DI, Cummings JL, Ketchel P, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12:233&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">11001602</ArticleId></ArticleIdList></Reference><Reference><Citation>Korner A, Lauritzen L, Abelskov K, et al. The Geriatric Depression Scale and the Cornell Scale for Depression in Dementia. A validity study. Nord J Psychiatry. 2006;60:360&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">17050293</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell Scale for Depression in Dementia. Biol Psychiatry. 1988;23:271&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pubmed">3337862</ArticleId></ArticleIdList></Reference><Reference><Citation>Kertzman SG, Treves IA, Treves TA, Vainder M, Korczyn AD. Hamilton Depression Scale in dementia. Int J Psychiatry Clin Pract. 2002;6:91&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">24931934</ArticleId></ArticleIdList></Reference><Reference><Citation>Radakovic R, Abrahams S. Developing a new apathy measurement scale: dimensional Apathy Scale. Psychiatry Res. 2014;219:658&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pubmed">24972546</ArticleId></ArticleIdList></Reference><Reference><Citation>Logsdon RG, Gibbons LE, McCurry SM, Teri L. Assessing quality of life in older adults with cognitive impairment. Psychosom Med. 2002;64:510&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pubmed">12021425</ArticleId></ArticleIdList></Reference><Reference><Citation>Torisson G, Stavenow L, Minthon L, Londos E. Reliability, validity and clinical correlates of the Quality of Life in Alzheimer&#x2019;s disease (QoL-AD) scale in medical inpatients. Health Qual Life Outcomes. 2016;14:90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4908755</ArticleId><ArticleId IdType="pubmed">27301257</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SC, Lamping DL, Banerjee S, et al. Development of a new measure of health-related quality of life for people with dementia: dEMQOL. Psychol Med. 2007;37:737&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pubmed">17176501</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendriks AAJ, Smith SC, Chrysanthaki T, Black N. Reliability and validity of a self-administration version of DEMQOL-Proxy. Int J Geriatr Psychiatry. 2017;32:734&#x2013;741.</Citation><ArticleIdList><ArticleId IdType="pubmed">27272129</ArticleId></ArticleIdList></Reference><Reference><Citation>Easton T, Milte R, Crotty M, Ratcliffe J. An empirical comparison of the measurement properties of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U for older people in residential care. Qual Life Res. 2018;27:1283&#x2013;1294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5891554</ArticleId><ArticleId IdType="pubmed">29305782</ArticleId></ArticleIdList></Reference><Reference><Citation>EuroQol G. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">10109801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufer DI, Cummings JL, Christine D, et al. Assessing the impact of neuropsychiatric symptoms in Alzheimer&#x2019;s disease: the Neuropsychiatric Inventory Caregiver Distress Scale. J Am Geriatr Soc. 1998;46:210&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pubmed">9475452</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980;20:649&#x2013;655.</Citation><ArticleIdList><ArticleId IdType="pubmed">7203086</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarit SH, Todd PA, Zarit JM. Subjective burden of husbands and wives as caregivers: a longitudinal study. Gerontologist. 1986;26:260&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">3721233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ankri J, Andrieu S, Beaufils B, Grand A, Henrard JC. Beyond the global score of the Zarit Burden Interview: useful dimensions for clinicians. Int J Geriatr Psychiatry. 2005;20:254&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pubmed">15717336</ArticleId></ArticleIdList></Reference><Reference><Citation>Voormolen DC, van Exel J, Brouwer W, et al. A validation study of the CarerQol instrument in informal caregivers of people with dementia from eight European countries. Qual Life Res. 2021;30:577&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7886819</ArticleId><ArticleId IdType="pubmed">33113082</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis KL, Marin DB, Kane R, et al. The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer&#x2019;s disease. Int J Geriatr Psychiatry. 1997;12:978&#x2013;988.</Citation><ArticleIdList><ArticleId IdType="pubmed">9395929</ArticleId></ArticleIdList></Reference><Reference><Citation>Hankins M The reliability of the twelve-item general health questionnaire (GHQ-12) under realistic assumptions. BMC Public Health. 2008;8:355&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2572064</ArticleId><ArticleId IdType="pubmed">18854015</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton M A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC495331</ArticleId><ArticleId IdType="pubmed">14399272</ArticleId></ArticleIdList></Reference><Reference><Citation>Radloff LS. The use of the Center for Epidemiologic Studies Depression Scale in adolescents and young adults. J Youth Adolesc. 1991;20:149&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">24265004</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566&#x2013;572.</Citation><ArticleIdList><ArticleId IdType="pubmed">7104545</ArticleId></ArticleIdList></Reference><Reference><Citation>Berk M, Ng F, Dodd S, et al. The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use. J Eval Clin Pract. 2008;14:979&#x2013;983.</Citation><ArticleIdList><ArticleId IdType="pubmed">18462279</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider LS, Olin JT, Doody RS, et al. Validity and reliability of the Alzheimer&#x2019;s Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer&#x2019;s Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11(2):S22&#x2013;32. Suppl.</Citation><ArticleIdList><ArticleId IdType="pubmed">9236949</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanley J, Howlett SE, Dunn T, Rockwood K. The Clinician&#x2019;s Interview-Based Impression of Change (Plus caregiver input) and goal attainment in two dementia drug trials: clinical meaningfulness and the initial treatment response. Alzheimers Dement. 2021;17:856&#x2013;865.</Citation><ArticleIdList><ArticleId IdType="pubmed">33928754</ArticleId></ArticleIdList></Reference><Reference><Citation>Salva A, Coll-Planas L, Bruce S, et al. Nutritional assessment of residents in long-term care facilities (LTCFs): recommendations of the task force on nutrition and ageing of the IAGG European region and the IANA. J Nutr Health Aging. 2009;13:475&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pubmed">19536415</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuttall FQ. Body mass index: obesity, BMI, and health: a critical review. Nutr Today. 2015;50:117&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4890841</ArticleId><ArticleId IdType="pubmed">27340299</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith GE, Chandler M, Fields JA, Aakre J, Locke DEC. A survey of patient and partner outcome and treatment preferences in mild cognitive impairment. J Alzheimers Dis. 2018;63:1459&#x2013;1468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6027859</ArticleId><ArticleId IdType="pubmed">29843239</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson J, Saunders S, Muniz Terrera G, et al. What matters to people with memory problems, healthy volunteers and health and social care professionals in the context of developing treatment to prevent Alzheimer&#x2019;s dementia? A qualitative study. Health Expect. 2019;22:504&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6543163</ArticleId><ArticleId IdType="pubmed">30809895</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahn DA, Salmon DP, Butters N, et al. Detection of dementia of the Alzheimer type in a population-based sample: neuropsychological test performance. J Int Neuropsychol Soc. 1995;1:252&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pubmed">9375219</ArticleId></ArticleIdList></Reference><Reference><Citation>Hale L, Mayland E, Jenkins M, et al. Constructing normalcy in dementia care: carers&#x2019; perceptions of their roles and the supports they need. Gerontologist. 2020;60:905&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pubmed">31722390</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37:323&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pubmed">7069156</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabert MH, Albert SM, Borukhova-Milov L, et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology. 2002;58:758&#x2013;764.</Citation><ArticleIdList><ArticleId IdType="pubmed">11889240</ArticleId></ArticleIdList></Reference><Reference><Citation>Devanand DP, Liu X, Tabert MH, et al. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer&#x2019;s disease. Biol Psychiatry. 2008;64:871&#x2013;879.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2613777</ArticleId><ArticleId IdType="pubmed">18723162</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall GA, Zoller AS, Lorius N, et al. Functional Activities Questionnaire items that best discriminate and predict progression from clinically normal to mild cognitive impairment. Curr Alzheimer Res. 2015;12:493&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4448081</ArticleId><ArticleId IdType="pubmed">26017560</ArticleId></ArticleIdList></Reference><Reference><Citation>Roedl KJ, Wilson LS, Fine J. A systematic review and comparison of functional assessments of community-dwelling elderly patients. J Am Assoc Nurse Pract. 2016;28:160&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">25964008</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold DA. An examination of instrumental activities of daily living assessment in older adults and mild cognitive impairment. J Clin Exp Neuropsychol. 2012;34:11&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">22053873</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigby T, Johnson DK, Taylor A, Galvin JE. Comparison of the caregiving experience of grief, burden, and quality of life in dementia with Lewy bodies, Alzheimer&#x2019;s Disease, and Parkinson&#x2019;s Disease dementia. J Alzheimers Dis. 2021;80:421&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8483604</ArticleId><ArticleId IdType="pubmed">33554912</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 1997;48:S10&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9153155</ArticleId></ArticleIdList></Reference><Reference><Citation>Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998;28:551&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pubmed">9626712</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis K, Pichora-Fuller MK, Chasteen AL, Marchuk V, Singh G, Smith SL. Effects of hearing and vision impairments on the Montreal Cognitive Assessment. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2015;22:413&#x2013;437.</Citation><ArticleIdList><ArticleId IdType="pubmed">25325767</ArticleId></ArticleIdList></Reference><Reference><Citation>Blieszner R, Roberto KA. Care partner responses to the onset of mild cognitive impairment. Gerontologist. 2010;50:11&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">19491355</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronner K, Perneczky R, McCabe R, Kurz A, Hamann J. Which medical and social decision topics are important after early diagnosis of Alzheimer&#x2019;s Disease from the perspectives of people with Alzheimer&#x2019;s Disease, spouses and professionals. BMC Res Notes. 2016;9:149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4782346</ArticleId><ArticleId IdType="pubmed">26956520</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenthal Gelman C La Lucha&#x201d;: the experiences of Latino family caregivers of patients with Alzheimer&#x2019;s disease. Clin Gerontol. 2010;33:181&#x2013;193.</Citation></Reference><Reference><Citation>Joosten-Weyn Banningh L, Vernooij-Dassen M, Rikkert MO, Teunisse JP. Mild cognitive impairment: coping with an uncertain label. Int J Geriatr Psychiatry. 2008;23:148&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">17578843</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenardt MH, da Silva SC, Hautsch Willig M, Seima MD. Elderly with Alzheimer&#x2019;s disease: the care and the knowledge of the familial caregiver. Revista Mineira de Endfermagem. 2010;14:301&#x2013;307.</Citation></Reference><Reference><Citation>Macrae H &#x2018;Making the best you can of it&#x2019;: living with early-stage Alzheimer&#x2019;s disease. Sociol Health Illn. 2008;30:396&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pubmed">18298633</ArticleId></ArticleIdList></Reference><Reference><Citation>Prince M, Wimo A, Guerchet M, Ali G, Wu Y-T, Prina M. World Alzheimer Report 2015. The global impact of dementia: an analysis of prevalence, incidence, cost and trends. Alzheimer&#x2019;s Dis Int;2015:1&#x2013;87.</Citation></Reference><Reference><Citation>Harris-Kojetin L, Sengupta M, Park-Lee E, et al. Long-Term Care Providers and services users in the United States: data from the National Study of Long-Term Care Providers, 2013&#x2013;2014. Vital Health Stat. 2016;3:x&#x2013;xii. 1&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">27023287</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenfeld RM, Nnacheta LC, Corrigan MD. Clinical consensus statement development manual. Otolaryngol Head Neck Surg. 2015;153:S1&#x2013;S14.</Citation><ArticleIdList><ArticleId IdType="pubmed">26527615</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36739588</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1099-1166</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>International journal of geriatric psychiatry</Title><ISOAbbreviation>Int J Geriatr Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment-related aspects of apathy from depression in neurocognitive disorders.</ArticleTitle><Pagination><StartPage>e5882</StartPage><MedlinePgn>e5882</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e5882</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/gps.5882</ELocationID><Abstract><AbstractText Label="OBJECTIVES">This narrative review describes the clinical features of apathy and depression in individuals with neurocognitive disorders (NCDs), with the goal of differentiating the two syndromes on the basis of clinical presentation, diagnostic criteria, neuropathological features, and contrasting responses to treatments.</AbstractText><AbstractText Label="METHODS">Literature was identified using PubMed, with search terms to capture medical conditions of interest; additional references were also included based on our collective experience and knowledge of the literature.</AbstractText><AbstractText Label="RESULTS">Evidence from current literature supports the distinction between the two disorders; apathy and depression occur with varying prevalence in individuals with NCDs, pose different risks of progression to dementia, and have distinct, if overlapping, neurobiological underpinnings. Although apathy is a distinct neuropsychiatric syndrome, distinguishing apathy from depression can be challenging, as both conditions may occur concurrently and share several overlapping features. Apathy is associated with unfavorable outcomes, especially those with neurodegenerative etiologies (e.g., Alzheimer's disease) and is associated with an increased burden for both patients and caregivers. Diagnosing apathy is important not only to serve as the basis for appropriate treatment, but also for the development of novel targeted interventions for this condition. Although there are currently no approved pharmacologic treatments for apathy, the research described in this review supports apathy as a distinct neuropsychiatric condition that warrants specific treatments aimed at alleviating patient disability.</AbstractText><AbstractText Label="CONCLUSIONS">Despite differences between these disorders, both apathy and depression pose significant challenges to patients, their families, and caregivers; better diagnostics are needed to develop more tailored treatment and support.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. International Journal of Geriatric Psychiatry published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lanct&#xf4;t</LastName><ForeName>Krista L</ForeName><Initials>KL</Initials><Identifier Source="ORCID">0000-0001-7024-6637</Identifier><AffiliationInfo><Affiliation>Departments of Psychiatry and of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuropsychopharmacology Research Group, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bernick Chair in Geriatric Psychopharmacology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ismail</LastName><ForeName>Zahinoor</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Departments of Psychiatry, Clinical Neurosciences, and Community Health Sciences, Hotchkiss Brain Institute, O'Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bawa</LastName><ForeName>Kritleen K</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Departments of Psychiatry and of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuropsychopharmacology Research Group, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cummings</LastName><ForeName>Jeffrey L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0001-8944-4158</Identifier><AffiliationInfo><Affiliation>Department of Brain Health, Chambers-Grundy Center for Transformative Neuroscience, School of Integrated Health Sciences, University of Nevada Las Vegas (UNLV), Las Vegas, Nevada, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Husain</LastName><ForeName>Masud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Experimental Psychology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mortby</LastName><ForeName>Moyra E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>School of Psychology, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Research Australia, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robert</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cognition Behaviour Technology Lab, University C&#xf4;te d'Azur (UCA), Nice, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre M&#xe9;moire, Le Centre Hospitalier Universitaire de Nice, Nice, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P20 GM109025</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072980</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 AG071476</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Geriatr Psychiatry</MedlineTA><NlmUniqueID>8710629</NlmUniqueID><ISSNLinking>0885-6230</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057565" MajorTopicYN="Y">Apathy</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019965" MajorTopicYN="N">Neurocognitive Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009042" MajorTopicYN="N">Motivation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">apathy</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">diagnosis neuropsychiatric impairment</Keyword><Keyword MajorTopicYN="N">neurocognitive disorders</Keyword></KeywordList><CoiStatement>
<b>Krista L. Lanct&#xf4;t</b>: Consultant or Advisory Board member for BioXcel Therapeutics, Cerevel Therapeutics, Eisai Co, Ltd, GW Pharmaceuticals, ICG Pharma, Kondor Pharma, H Lundbeck A/S, Merck Sharp Dohme, Novo Nordisk, Praxis Therapeutics; <b>Krista L. Lanct&#xf4;t</b> is supported by the Alzheimer's Disease Drug Discovery Foundation (ADDF) and the Bernick Chair in Geriatric Psychopharmacology; <b>Kritleen K. Bawa</b> has nothing to disclose; <b>Jeffrey L. Cummings</b>: Consultant to Acadia, Alkahast, AlphaCognition, AriBio, Avanir, Axsome, Behren Therapeutics, Biogen, Biohaven, Cassava, Cerecin, Cortexyme, Diadem, EIP Pharma, Eisai, GemVax, Genentech, Green Valley, Grifols, Janssen, LSP, Merck, NervGen, Novo Nordisk, Oligomerix, Ono, Otsuka, PRODEO, Prothena, ReMYND, Renew, Resverlogix, Roche, Signant Health, Suven, United Neuroscience, and Unlearn AI pharmaceutical, assessment, and investment companies. <b>Jeffrey L. Cummings</b> is supported by NIGMS grant P20GM109025; NINDS grant U01NS093334; NIA grant R01AG053798; NIA grant P20AG068053; NIA grant R35AG71476; Alzheimer's Disease Drug Discovery Foundation (ADDF); and the Joy Chambers&#x2010;Grundy Endowment; <b>Masud Husain</b>: Consultant for Lilly, Otsuka Pharmaceuticals, and Sumitomo Dainippon Pharma; <b>Moyra E. Mortby</b> has nothing to disclose; <b>Philippe Robert</b> has nothing to disclose; <b>Zahinoor Ismail</b>: has served at scientific advisory boards and/or as a consultant to Lundbeck/Otsuka. His institution has received funds from Acadia, Biogen, and Roche.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>5</Day><Hour>14</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36739588</ArticleId><ArticleId IdType="pmc">PMC10107127</ArticleId><ArticleId IdType="doi">10.1002/gps.5882</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Miller DS, Robert P, Ereshefsky L, et&#xa0;al. Diagnostic criteria for apathy in neurocognitive disorders. Alzheimers Dement. 2021;17(12):1892&#x2010;14. 10.1002/alz.12358</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12358</ArticleId><ArticleId IdType="pmc">PMC8835377</ArticleId><ArticleId IdType="pubmed">33949763</ArticleId></ArticleIdList></Reference><Reference><Citation>
United States Census Bureau
. An Aging World; 2015. Updated March 28, 2016. Accessed July 5, 2022. https://www.census.gov/library/publications/2016/demo/P95&#x2010;16&#x2010;1.html
</Citation></Reference><Reference><Citation>Leung DK, Chan WC, Spector A, Wong GH. Prevalence of depression, anxiety, and apathy symptoms across dementia stages: a systematic review and meta&#x2010;analysis. Int J Geriatr Psychiatry. 2021;36(9):1330&#x2010;1344. 10.1002/gps.5556</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5556</ArticleId><ArticleId IdType="pubmed">33905138</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins JD, Henley SM, Su&#xe1;rez&#x2010;Gonz&#xe1;lez A. A systematic review of the prevalence of depression, anxiety, and apathy in frontotemporal dementia, atypical and young&#x2010;onset Alzheimer's disease, and inherited dementia. Int Psychogeriatr. 2020:1&#x2010;20. 10.1017/s1041610220001118</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610220001118</ArticleId><ArticleId IdType="pubmed">32684177</ArticleId></ArticleIdList></Reference><Reference><Citation>Paoli RA, Botturi A, Ciammola A, et&#xa0;al. Neuropsychiatric burden in Huntington's disease. Brain Sci. 2017;7(6):67. 10.3390/brainsci7060067</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci7060067</ArticleId><ArticleId IdType="pmc">PMC5483640</ArticleId><ArticleId IdType="pubmed">28621715</ArticleId></ArticleIdList></Reference><Reference><Citation>Flavell J, Nestor PJ. A systematic review of apathy and depression in progressive supranuclear palsy. J Geriatr Psychiatry Neurol. 2022;35(3):280&#x2010;292. 10.1177/0891988721993545</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988721993545</ArticleId><ArticleId IdType="pubmed">33567955</ArticleId></ArticleIdList></Reference><Reference><Citation>Mele B, Van S, Holroyd&#x2010;Leduc J, Ismail Z, Pringsheim T, Goodarzi Z. Diagnosis, treatment and management of apathy in Parkinson's disease: a scoping review. BMJ Open. 2020;10(9):e037632. 10.1136/bmjopen-2020-037632</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-037632</ArticleId><ArticleId IdType="pmc">PMC7482451</ArticleId><ArticleId IdType="pubmed">32907903</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Cooper CA, Weintraub D, Dahodwala N. Pharmacological treatment of apathy in Lewy body disorders: a systematic review. Parkinsonism Relat Disord. 2019;60:14&#x2010;24. 10.1016/j.parkreldis.2018.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2018.11.002</ArticleId><ArticleId IdType="pubmed">30470658</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L. Depression, anxiety, and apathy in mild cognitive impairment: current perspectives. Front Aging Neurosci. 2020;12:9. 10.3389/fnagi.2020.00009</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2020.00009</ArticleId><ArticleId IdType="pmc">PMC7002324</ArticleId><ArticleId IdType="pubmed">32082139</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortby ME, Adler L, Ag&#xfc;era&#x2010;Ortiz L, et&#xa0;al. Apathy as a treatment target in Alzheimer's disease: implications for clinical trials. Am J Geriatr Psychiatry. 2022;30(2):119&#x2010;147. 10.1016/j.jagp.2021.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2021.06.016</ArticleId><ArticleId IdType="pubmed">34315645</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy ML, Cummings JL, Fairbanks LA, et&#xa0;al. Apathy is not depression. J Neuropsychiatry Clin Neurosci. 1998;10(3):314&#x2010;319. 10.1176/jnp.10.3.314</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/jnp.10.3.314</ArticleId><ArticleId IdType="pubmed">9706539</ArticleId></ArticleIdList></Reference><Reference><Citation>Benoit M, Berrut G, Doussaint J, et&#xa0;al. Apathy and depression in mild Alzheimer's disease: a cross&#x2010;sectional study using diagnostic criteria. J Alzheimers Dis. 2012;31(2):325&#x2010;334. 10.3233/jad-2012-112003</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-2012-112003</ArticleId><ArticleId IdType="pubmed">22543849</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CYM, Baber W, Dening T, Yates J. &#x201c;He just doesn't want to get out of the chair and do it&#x201d;: the impact of apathy in people with dementia on their carers. Int J Environ Res Public Health. 2021;18(12):6317. 10.3390/ijerph18126317</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18126317</ArticleId><ArticleId IdType="pmc">PMC8296153</ArticleId><ArticleId IdType="pubmed">34207955</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappell NL, Penning M. Behavioural problems and distress among caregivers of people with dementia. Ageing Soc. 1996;16(1):57&#x2010;73. 10.1017/s0144686x00003135</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0144686x00003135</ArticleId></ArticleIdList></Reference><Reference><Citation>Feast A, Moniz&#x2010;Cook E, Stoner C, Charlesworth G, Orrell M. A systematic review of the relationship between behavioral and psychological symptoms (BPSD) and caregiver well&#x2010;being. Int Psychogeriatr. 2016;28(11):1761&#x2010;1774. 10.1017/s1041610216000922</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610216000922</ArticleId><ArticleId IdType="pubmed">27345942</ArticleId></ArticleIdList></Reference><Reference><Citation>Onyike CU, Sheppard J.&#x2010;ME, Tschanz JT, et&#xa0;al. Epidemiology of apathy in older adults: the Cache County Study. Am J Geriatr psychiatry. 2007;15(5):365&#x2010;375. 10.1097/01.jgp.0000235689.42910.0d</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jgp.0000235689.42910.0d</ArticleId><ArticleId IdType="pubmed">17463187</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard E, Schmand B, Eikelenboom P, et&#xa0;al. Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non&#x2010;depressed subjects. Dementia Geriatr Cogn Disord. 2012;33(2&#x2010;3):204&#x2010;209. 10.1159/000338239</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000338239</ArticleId><ArticleId IdType="pubmed">22722671</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruthirakuhan M, Herrmann N, Vieira D, Gallagher D, Lanct&#xf4;t KL. The roles of apathy and depression in predicting Alzheimer disease: a longitudinal analysis in older adults with mild cognitive impairment. Am J Geriatr Psychiatry. 2019;27(8):873&#x2010;882. 10.1016/j.jagp.2019.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2019.02.003</ArticleId><ArticleId IdType="pmc">PMC6646066</ArticleId><ArticleId IdType="pubmed">30910421</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeager CA, Hyer L. Apathy in dementia: relations with depression, functional competence, and quality of life. Psychol Rep. 2008;102(3):718&#x2010;722. 10.2466/pr0.102.3.718-722</Citation><ArticleIdList><ArticleId IdType="doi">10.2466/pr0.102.3.718-722</ArticleId><ArticleId IdType="pubmed">18763441</ArticleId></ArticleIdList></Reference><Reference><Citation>Hongisto K, Hallikainen I, Selander T, et&#xa0;al. Quality of life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5&#x2010;year prospective ALSOVA cohort study. Int J Geriatr Psychiatry. 2018;33(1):47&#x2010;57. 10.1002/gps.4666</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4666</ArticleId><ArticleId IdType="pubmed">28067961</ArticleId></ArticleIdList></Reference><Reference><Citation>Baethge C, Goldbeck&#x2010;Wood S, Mertens S. SANRA&#x2010;a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4(1):5. 10.1186/s41073-019-0064-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41073-019-0064-8</ArticleId><ArticleId IdType="pmc">PMC6434870</ArticleId><ArticleId IdType="pubmed">30962953</ArticleId></ArticleIdList></Reference><Reference><Citation>Chase TN. Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment. Neurotox Res. 2011;19(2):266&#x2010;278. 10.1007/s12640-010-9196-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-010-9196-9</ArticleId><ArticleId IdType="pubmed">20473601</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; 2013.</Citation></Reference><Reference><Citation>Marin R. Differential diagnosis and classification of apathy. Am J Psychiatry. 1990;147(1):22&#x2010;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">2403472</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL, Mega M, Gray K, Rosenberg&#x2010;Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308. 10.1212/wnl.44.12.2308</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.44.12.2308</ArticleId><ArticleId IdType="pubmed">7991117</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert P, Clairet S, Benoit M, et&#xa0;al. The Apathy Inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int J Geriatr&#xa0;Psychiatry. 2002;17(12):1099&#x2010;1105. 10.1002/gps.755</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.755</ArticleId><ArticleId IdType="pubmed">12461757</ArticleId></ArticleIdList></Reference><Reference><Citation>Sockeel P, Dujardin K, Devos D, Deneve C, Dest&#xe9;e A, Defebvre L. The Lille Apathy Rating Scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2006;77(5):579&#x2010;584. 10.1136/jnnp.2005.075929</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2005.075929</ArticleId><ArticleId IdType="pmc">PMC2117430</ArticleId><ArticleId IdType="pubmed">16614016</ArticleId></ArticleIdList></Reference><Reference><Citation>Starkstein SE, Leentjens AF. The nosological position of apathy in clinical practice. J Neurol Neurosurg Psychiatry. 2008;79(10):1088&#x2010;1092. 10.1136/jnnp.2007.136895</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2007.136895</ArticleId><ArticleId IdType="pubmed">18187477</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuss D, Van Reekum R, Murphy KJ. Differentiation of states and causes of apathy. In: Borod J, ed. The Neuropsychology of Emotion. Oxford University Press; 2000:340&#x2010;363.</Citation></Reference><Reference><Citation>Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res. 1991;38(2):143&#x2010;162. 10.1016/0165-1781(91)90040-v</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(91)90040-v</ArticleId><ArticleId IdType="pubmed">1754629</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang Y.&#x2010;S, Lockwood P, Apps MA, Muhammed K, Husain M. Distinct subtypes of apathy revealed by the apathy motivation index. PLoS One. 2017;12(1):e0169938. 10.1371/journal.pone.0169938</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0169938</ArticleId><ArticleId IdType="pmc">PMC5226790</ArticleId><ArticleId IdType="pubmed">28076387</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang YS, Lockwood PL, Kienast A, et&#xa0;al. Differential impact of behavioral, social, and emotional apathy on Parkinson's disease. Ann Clin Transl Neurol. 2018;5(10):1286&#x2010;1291. 10.1002/acn3.626</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.626</ArticleId><ArticleId IdType="pmc">PMC6186939</ArticleId><ArticleId IdType="pubmed">30349863</ArticleId></ArticleIdList></Reference><Reference><Citation>Klar VS, Ang YS, Lockwood P, et&#xa0;al. Assessment of apathy in neurological patients using the Apathy Motivation Index caregiver version. J Neuropsychol. 2022;16(11):236&#x2010;258. 10.1111/jnp.12262</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnp.12262</ArticleId><ArticleId IdType="pmc">PMC9290131</ArticleId><ArticleId IdType="pubmed">34532963</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanct&#xf4;t KL, Scherer RW, Li A, et&#xa0;al. Measuring apathy in Alzheimer's disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): a comparison of instruments. Am J Geriatr Psychiatry. 2021;29(1):81&#x2010;89. 10.1016/j.jagp.2020.05.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2020.05.020</ArticleId><ArticleId IdType="pmc">PMC7704818</ArticleId><ArticleId IdType="pubmed">32565008</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss ME, Sperry SD. An informant&#x2010;based assessment of apathy in Alzheimer disease. Neuropsychiatry Neuropsychol Behav Neurol. 2002;15(3):176&#x2010;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">12218710</ArticleId></ArticleIdList></Reference><Reference><Citation>Radakovic R, Abrahams S. Developing a new apathy measurement scale: Dimensional Apathy Scale. Psychiatry Res. 2014;219(3):658&#x2010;663. 10.1016/j.psychres.2014.06.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2014.06.010</ArticleId><ArticleId IdType="pubmed">24972546</ArticleId></ArticleIdList></Reference><Reference><Citation>Radakovic R, Starr JM, Abrahams S. A novel assessment and profiling of multidimensional apathy in Alzheimer's disease. J Alzheimers Dis. 2017;60(1):57&#x2010;67. 10.3233/jad-170292</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-170292</ArticleId><ArticleId IdType="pubmed">28759970</ArticleId></ArticleIdList></Reference><Reference><Citation>Radakovic R, Davenport R, Starr JM, Abrahams S. Apathy dimensions in Parkinson's disease. Int J Geriatr Psychiatry. 2018;33(1):151&#x2010;158. 10.1002/gps.4697</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4697</ArticleId><ArticleId IdType="pubmed">28247480</ArticleId></ArticleIdList></Reference><Reference><Citation>Radakovic R, Stephenson L, Colville S, Swingler R, Chandran S, Abrahams S. Multidimensional apathy in ALS: validation of the Dimensional Apathy Scale. J Neurol Neurosurg Psychiatry. 2016;87(6):663&#x2010;669. 10.1136/jnnp-2015-310772</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310772</ArticleId><ArticleId IdType="pubmed">26203157</ArticleId></ArticleIdList></Reference><Reference><Citation>Stout JC, Ready RE, Grace J, Malloy PF, Paulsen JS. Factor analysis of the frontal systems behavior scale (FrSBe). Assessment. 2003;10(1):79&#x2010;85. 10.1177/1073191102250339</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073191102250339</ArticleId><ArticleId IdType="pubmed">12675387</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeghari R, Manera V, Fabre R, et&#xa0;al. The &#x201c;Interest Game&#x201d;: a ludic application to improve apathy assessment in patients with neurocognitive disorders. J Alzheimers Dis. 2020;74(2):669&#x2010;677. 10.3233/jad-191282</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-191282</ArticleId><ArticleId IdType="pubmed">32083586</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;Matarrubia M, Mat&#xed;as&#x2010;Guiu JA, Moreno&#x2010;Ramos T, et&#xa0;al. Validation of the Lille's Apathy Rating Scale in very mild to moderate dementia. Am J Geriatr Psychiatry. 2016;24(7):517&#x2010;527. 10.1016/j.jagp.2015.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2015.09.004</ArticleId><ArticleId IdType="pubmed">26803583</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail Z, Ag&#xfc;era&#x2010;Ortiz L, Brodaty H, et&#xa0;al. The Mild Behavioral Impairment Checklist (MBI&#x2010;C): a rating scale for neuropsychiatric symptoms in pre&#x2010;dementia populations. J Alzheimers Dis. 2017;56(3):929&#x2010;938. 10.3233/jad-160979</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-160979</ArticleId><ArticleId IdType="pmc">PMC5652315</ArticleId><ArticleId IdType="pubmed">28059789</ArticleId></ArticleIdList></Reference><Reference><Citation>de Medeiros K, Robert P, Gauthier S, et&#xa0;al. The Neuropsychiatric Inventory&#x2010;Clinician Rating Scale (NPI&#x2010;C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. Int Psychogeriatr. 2010;22(6):984&#x2010;994. 10.1017/s1041610210000876</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610210000876</ArticleId><ArticleId IdType="pmc">PMC3314709</ArticleId><ArticleId IdType="pubmed">20594384</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J. The Neuropsychiatric Inventory: development and applications. J Geriatr Psychiatry Neurol. 2020;33(2):73&#x2010;84. 10.1177/0891988719882102</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988719882102</ArticleId><ArticleId IdType="pmc">PMC8505128</ArticleId><ArticleId IdType="pubmed">32013737</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufer DI, Cummings JL, Ketchel P, et&#xa0;al. Validation of the NPI&#x2010;Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233&#x2010;239. 10.1176/jnp.12.2.233</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/jnp.12.2.233</ArticleId><ArticleId IdType="pubmed">11001602</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisberg B, Auer SR, Monteiro IM. Behavioral pathology in Alzheimer's disease (BEHAVE&#x2010;AD) Rating Scale. Int Psychogeriatr. 1997;8(S3):301&#x2010;308. 10.1017/s1041610297003529</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610297003529</ArticleId><ArticleId IdType="pubmed">9154579</ArticleId></ArticleIdList></Reference><Reference><Citation>Devanand DP. Use of the Columbia University Scale to assess psychopathology in Alzheimer's disease. Int Psychogeriatr. 1997;9(S1):137&#x2010;142. 10.1017/s104161029700481x</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s104161029700481x</ArticleId><ArticleId IdType="pubmed">9447437</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell scale for depression in dementia. Biol Psychiatry. 1988;23(3):271&#x2010;284. 10.1016/0006-3223(88)90038-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-3223(88)90038-8</ArticleId><ArticleId IdType="pubmed">3337862</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunderland T, Minichiello M. Dementia mood assessment scale. Int Psychogeriatr. 1997;8(suppl 3):329&#x2010;331. 10.1017/s1041610297003578</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610297003578</ArticleId><ArticleId IdType="pubmed">9154584</ArticleId></ArticleIdList></Reference><Reference><Citation>Yesavage JA, Brink TL, Rose TL, et&#xa0;al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37&#x2010;49. 10.1016/0022-3956(82)90033-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3956(82)90033-4</ArticleId><ArticleId IdType="pubmed">7183759</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56&#x2010;62. 10.1136/jnnp.23.1.56</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.23.1.56</ArticleId><ArticleId IdType="pmc">PMC495331</ArticleId><ArticleId IdType="pubmed">14399272</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery SA, &#xc5;sberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382&#x2010;389. 10.1192/bjp.134.4.382</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.134.4.382</ArticleId><ArticleId IdType="pubmed">444788</ArticleId></ArticleIdList></Reference><Reference><Citation>Leontjevas R, van Hooren S, Mulders A. The Montgomery&#x2010;Asberg Depression Rating Scale and the Cornell Scale for Depression in Dementia: a validation study with patients exhibiting early&#x2010;onset dementia. Am J Geriatr Psychiatry. 2009;17(1):56&#x2010;64. 10.1097/jgp.0b013e31818b4111</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/jgp.0b013e31818b4111</ArticleId><ArticleId IdType="pubmed">19092312</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller&#x2010;Thomsen T, Arlt S, Mann U, Ma&#xdf; R, Ganzer S. Detecting depression in Alzheimer's disease: evaluation of four different scales. Arch Clin Neuropsychol. 2005;20(2):271&#x2010;276. 10.1016/j.acn.2004.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acn.2004.03.010</ArticleId><ArticleId IdType="pubmed">15708735</ArticleId></ArticleIdList></Reference><Reference><Citation>Leentjens AF, Verhey FR, Lousberg R, Spitsbergen H, Wilmink FW. The validity of the Hamilton and Montgomery&#x2010;&#xc5;sberg Depression Rating Scales as screening and diagnostic tools for depression in Parkinson's disease. Int J Geriatr Psychiatry. 2000;15(7):644&#x2010;649. 10.1002/1099-1166(200007)15:7&lt;644::aid-gps167&gt;3.0.co;2-l</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1099-1166(200007)15:7&lt;644::aid-gps167&gt;3.0.co;2-l</ArticleId><ArticleId IdType="pubmed">10918346</ArticleId></ArticleIdList></Reference><Reference><Citation>Ketharanathan T, Hanwella R, Weerasundera R, de Silva VA. Diagnostic validity and factor analysis of Montgomery&#x2010;Asberg depression rating scale in Parkinson disease population. J Geriatr Psychiatry Neurol. 2016;29(3):115&#x2010;119. 10.1177/0891988715606232</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988715606232</ArticleId><ArticleId IdType="pubmed">26392481</ArticleId></ArticleIdList></Reference><Reference><Citation>Leontjevas R, Gerritsen DL, Vernooij&#x2010;Dassen MJ, Smalbrugge M, Koopmans RT. Comparative validation of proxy&#x2010;based Montgomery&#x2010;&#xc5;sberg depression rating scale and Cornell scale for depression in dementia in nursing home residents with dementia. Am J Geriatr Psychiatry. 2012;20(11):985&#x2010;993. 10.1097/jgp.0b013e318233152b</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/jgp.0b013e318233152b</ArticleId><ArticleId IdType="pubmed">21989316</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke AD, Goldfarb D, Bollam P, Khokher S. Diagnosing and treating depression in patients with Alzheimer's disease. Neurol Ther. 2019;8(2):325&#x2010;350. 10.1007/s40120-019-00148-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40120-019-00148-5</ArticleId><ArticleId IdType="pmc">PMC6858899</ArticleId><ArticleId IdType="pubmed">31435870</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh L, McDonald WM, Cummings J, Ravina B, NINDS/NIMH Work Group on Depression and Parkinson's Disease . Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group. Mov Disord. 2006;21(2):148&#x2010;158. 10.1002/mds.20723</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.20723</ArticleId><ArticleId IdType="pubmed">16211591</ArticleId></ArticleIdList></Reference><Reference><Citation>Olin JT, Schneider LS, Katz IR, et&#xa0;al. Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry. 2002;10(2):125&#x2010;128. 10.1097/00019442-200203000-00003</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00019442-200203000-00003</ArticleId><ArticleId IdType="pubmed">11925273</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin RS, Firinciogullari S, Biedrzycki RC. The sources of convergence between measures of apathy and depression. J Affect Disord. 1993;28(1):7&#x2010;14. 10.1016/0165-0327(93)90072-r</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-0327(93)90072-r</ArticleId><ArticleId IdType="pubmed">8326082</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagariello P, Girardi P, Amore M. Depression and apathy in dementia: same syndrome or different constructs? A critical review. Arch Gerontol Geriatr. 2009;49(2):246&#x2010;249. 10.1016/j.archger.2008.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2008.09.002</ArticleId><ArticleId IdType="pubmed">19022508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ligthart SA, Richard E, Fransen NL, et&#xa0;al. Association of vascular factors with apathy in community&#x2010;dwelling elderly individuals. Arch Gerontol Geriatr. 2012;69(6):636&#x2010;642. 10.1001/archgenpsychiatry.2011.1858</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archgenpsychiatry.2011.1858</ArticleId><ArticleId IdType="pubmed">22664551</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Z, Wang L, Zhang H, et&#xa0;al. Apathy as a risky neuropsychiatric syndrome of progression from normal aging to mild cognitive impairment and dementia: a systematic review and meta&#x2010;analysis. Front Psychiatry. 2021;12:792168. 10.3389/fpsyt.2021.792168</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.792168</ArticleId><ArticleId IdType="pmc">PMC8721876</ArticleId><ArticleId IdType="pubmed">34987434</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dalen JW, van Wanrooij LL, van Charante EPM, Brayne C, van Gool WA, Richard E. Association of apathy with risk of incident dementia: a systematic review and meta&#x2010;analysis. JAMA Psychiatry. 2018;75(10):1012&#x2010;1021. 10.1001/jamapsychiatry.2018.1877</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2018.1877</ArticleId><ArticleId IdType="pmc">PMC6233800</ArticleId><ArticleId IdType="pubmed">30027214</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson JC, Harris J, Sollom AC, et&#xa0;al. Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease. J Neuropsychiatry Clin Neurosci. 2012;24(1):53&#x2010;60. 10.1176/appi.neuropsych.11030057</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.neuropsych.11030057</ArticleId><ArticleId IdType="pubmed">22450614</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connor CM, Clemson L, Hornberger M, et&#xa0;al. Longitudinal change in everyday function and behavioral symptoms in frontotemporal dementia. Neurol Clin Pract. 2016;6(5):419&#x2010;428. 10.1212/cpj.0000000000000264</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/cpj.0000000000000264</ArticleId><ArticleId IdType="pmc">PMC5100706</ArticleId><ArticleId IdType="pubmed">27847684</ArticleId></ArticleIdList></Reference><Reference><Citation>De Paepe A, Ara A, Garcia&#x2010;Gorro C, et&#xa0;al. Gray matter vulnerabilities predict longitudinal development of apathy in Huntington's disease. Mov Disord. 2021;36(9):2162&#x2010;2172. 10.1002/mds.28638</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28638</ArticleId><ArticleId IdType="pubmed">33998063</ArticleId></ArticleIdList></Reference><Reference><Citation>Landes AM, Sperry SD, Strauss ME. Prevalence of apathy, dysphoria, and depression in relation to dementia severity in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 2005;17(3):342&#x2010;349. 10.1176/jnp.17.3.342</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/jnp.17.3.342</ArticleId><ArticleId IdType="pubmed">16179656</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou R, Lin J, Liu K, et&#xa0;al. Evolution of apathy in early Parkinson's disease: a 4&#x2010;year prospective cohort study. Front Aging Neurosci. 2021;12:620762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7901914</ArticleId><ArticleId IdType="pubmed">33633560</ArticleId></ArticleIdList></Reference><Reference><Citation>Caga J, Turner MR, Hsieh S, et&#xa0;al. Apathy is associated with poor prognosis in amyotrophic lateral sclerosis. Eur J Neurol. 2016;23(5):891&#x2010;897. 10.1111/ene.12959</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12959</ArticleId><ArticleId IdType="pubmed">26822417</ArticleId></ArticleIdList></Reference><Reference><Citation>Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta&#x2010;analysis, and metaregression analysis. Arch Gen Psychiatry. 2006;63(5):530&#x2010;538. 10.1001/archpsyc.63.5.530</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.63.5.530</ArticleId><ArticleId IdType="pmc">PMC3530614</ArticleId><ArticleId IdType="pubmed">16651510</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourao RJ, Mansur G, Malloy&#x2010;Diniz LF, Castro Costa E, Diniz BS. Depressive symptoms increase the risk of progression to dementia in subjects with mild cognitive impairment: systematic review and meta&#x2010;analysis. Int J Geriatr Psychiatry. 2016;31(8):905&#x2010;911. 10.1002/gps.4406</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4406</ArticleId><ArticleId IdType="pubmed">26680599</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopetz S, Steele CD, Brandt J, et&#xa0;al. Characteristics and outcomes of dementia residents in an assisted living facility. Int J Geriatr Psychiatry. 2000;15(7):586&#x2010;593. 10.1002/1099-1166(200007)15:7&lt;586::aid-gps148&gt;3.0.co;2-d</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1099-1166(200007)15:7&lt;586::aid-gps148&gt;3.0.co;2-d</ArticleId><ArticleId IdType="pubmed">10918338</ArticleId></ArticleIdList></Reference><Reference><Citation>Okura T, Plassman BL, Steffens DC, Llewellyn DJ, Potter GG, Langa KM. Prevalence of neuropsychiatric symptoms and their association with functional limitations in older adults in the United States: the aging, demographics, and memory study. J Am Geriatr Soc. 2010;58(2):330&#x2010;337. 10.1111/j.1532-5415.2009.02680.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2009.02680.x</ArticleId><ArticleId IdType="pmc">PMC2875937</ArticleId><ArticleId IdType="pubmed">20374406</ArticleId></ArticleIdList></Reference><Reference><Citation>Freels S, Cohen D, Eisdorfer C, et&#xa0;al. Functional status and clinical findings in patients with Alzheimer's disease. J Gerontol. 1992;47(6):M177&#x2010;M182. 10.1093/geronj/47.6.m177</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronj/47.6.m177</ArticleId><ArticleId IdType="pubmed">1430852</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle PA, Malloy PF, Salloway S, Cahn&#x2010;Weiner DA, Cohen R, Cummings JL. Executive dysfunction and apathy predict functional impairment in Alzheimer disease. Am J Geriatr Psychiatry. 2003;11(2):214&#x2010;221. 10.1097/00019442-200303000-00012</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00019442-200303000-00012</ArticleId><ArticleId IdType="pubmed">12611751</ArticleId></ArticleIdList></Reference><Reference><Citation>Burton RL, O'Connell ME, Morgan DG. Cognitive and neuropsychiatric correlates of functional impairment across the continuum of no cognitive impairment to dementia. Arch Clin Neuropsychol. 2018;33(7):795&#x2010;807. 10.1093/arclin/acx112</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acx112</ArticleId><ArticleId IdType="pubmed">29190312</ArticleId></ArticleIdList></Reference><Reference><Citation>Conde&#x2010;Sala JL, Garre&#x2010;Olmo J, Turr&#xf3;&#x2010;Garriga O, Vilalta&#x2010;Franch J, L&#xf3;pez&#x2010;Pousa S. Differential features of burden between spouse and adult&#x2010;child caregivers of patients with Alzheimer's disease: an exploratory comparative design. Int J Nurs Stud. 2010;47(10):1262&#x2010;1273. 10.1016/j.ijnurstu.2010.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2010.03.001</ArticleId><ArticleId IdType="pubmed">20374966</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci M, Guidoni SV, Sepe&#x2010;Monti M, et&#xa0;al. Clinical findings, functional abilities and caregiver distress in the early stage of dementia with Lewy bodies (DLB) and Alzheimer's disease (AD). Arch Gerontol Geriatr. 2009;49(2):e101&#x2010;e104. 10.1016/j.archger.2008.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2008.10.001</ArticleId><ArticleId IdType="pubmed">19084284</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai C.&#x2010;F, Hwang W.&#x2010;S, Lee J.&#x2010;J, et&#xa0;al. Predictors of caregiver burden in aged caregivers of demented older patients. BMC Geriatr. 2021;21(1):1&#x2010;9. 10.1186/s12877-021-02007-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02007-1</ArticleId><ArticleId IdType="pmc">PMC7809883</ArticleId><ArticleId IdType="pubmed">33446114</ArticleId></ArticleIdList></Reference><Reference><Citation>Landes AM, Sperry SD, Strauss ME, Geldmacher DS. Apathy in Alzheimer's disease. J Am Geriatr Soc. 2001;49(12):1700&#x2010;1707. 10.1046/j.1532-5415.2001.49282.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1532-5415.2001.49282.x</ArticleId><ArticleId IdType="pubmed">11844006</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyketsos CG, Steele C, Baker L, et&#xa0;al. Major and minor depression in Alzheimer's disease: prevalence and impact. J Neuropsychiatry Clin Neurosci. 1997;9(4):556&#x2010;561.</Citation><ArticleIdList><ArticleId IdType="pubmed">9447496</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrisi M, De Cola MC, Marra A, De Luca R, Bramanti P, Calabr&#xf2; RS. Neuropsychiatric symptoms in dementia may predict caregiver burden: a Sicilian exploratory study. Psychogeriatrics. 2017;17(2):103&#x2010;107. 10.1111/psyg.12197</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/psyg.12197</ArticleId><ArticleId IdType="pubmed">27411501</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite A, Bebbington P, Skelton&#x2010;Robinson M, Orrell M. Social factors and depression in carers of people with dementia. Int J Geriatr Psychiatry. 2004;19(6):582&#x2010;587. 10.1002/gps.1136</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.1136</ArticleId><ArticleId IdType="pubmed">15211540</ArticleId></ArticleIdList></Reference><Reference><Citation>Wongpakaran N, van Reekum R, Wongpakaran T, Clarke D. Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: a case&#x2010;control study. Ann Gen Psychiatry. 2007;6(1):7. 10.1186/1744-859x-6-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1744-859x-6-7</ArticleId><ArticleId IdType="pmc">PMC1820592</ArticleId><ArticleId IdType="pubmed">17313684</ArticleId></ArticleIdList></Reference><Reference><Citation>Starkstein SE, Ingram L, Garau M, Mizrahi R. On the overlap between apathy and depression in dementia. J Neurol Neurosurg Psychiatry. 2005;76(8):1070&#x2010;1074. 10.1136/jnnp.2004.052795</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2004.052795</ArticleId><ArticleId IdType="pmc">PMC1739766</ArticleId><ArticleId IdType="pubmed">16024880</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollocks MJ, Lawrence AJ, Brookes RL, et&#xa0;al. Differential relationships between apathy and depression with white matter microstructural changes and functional outcomes. Brain. 2015;138(12):3803&#x2010;3815. 10.1093/brain/awv304</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv304</ArticleId><ArticleId IdType="pmc">PMC4655344</ArticleId><ArticleId IdType="pubmed">26490330</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay J, Tuladhar AM, Hollocks MJ, et&#xa0;al. Apathy is associated with large&#x2010;scale white matter network disruption in small vessel disease. Neurology. 2019;92(11):e1157&#x2010;e1167. 10.1212/wnl.0000000000007095</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000007095</ArticleId><ArticleId IdType="pmc">PMC6511108</ArticleId><ArticleId IdType="pubmed">30737341</ArticleId></ArticleIdList></Reference><Reference><Citation>Starkstein SE, Petracca G, Chemerinski E, Kremer J. Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry. 2001;158(6):872&#x2010;877. 10.1176/appi.ajp.158.6.872</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.158.6.872</ArticleId><ArticleId IdType="pubmed">11384893</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin RS, Firinciogullari S, Biedrzycki RC. Group differences in the relationship between apathy and depression. J Nerv Ment Dis. 1994;182(4):235&#x2010;239. 10.1097/00005053-199404000-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005053-199404000-00008</ArticleId><ArticleId IdType="pubmed">10678322</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail Z, Gatchel J, Bateman DR, et&#xa0;al. Affective and emotional dysregulation as pre&#x2010;dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria. Int Psychogeriatr. 2018;30(2):185&#x2010;196. 10.1017/s1041610217001880</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610217001880</ArticleId><ArticleId IdType="pubmed">28899446</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida O, Hankey G, Yeap B, Golledge J, Flicker L. Depression as a modifiable factor to decrease the risk of dementia. Transl Psychiatry. 2017;7(5):e1117. 10.1038/tp.2017.90</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2017.90</ArticleId><ArticleId IdType="pmc">PMC5534958</ArticleId><ArticleId IdType="pubmed">28463236</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh&#x2010;Manoux A, Dugravot A, Fournier A, et&#xa0;al. Trajectories of depressive symptoms before diagnosis of dementia: a 28&#x2010;year follow&#x2010;up study. JAMA Psychiatry. 2017;74(7):712&#x2010;718. 10.1001/jamapsychiatry.2017.0660</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2017.0660</ArticleId><ArticleId IdType="pmc">PMC5710246</ArticleId><ArticleId IdType="pubmed">28514478</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapiainen V, Hartikainen S, Taipale H, Tiihonen J, Tolppanen A.&#x2010;M. Hospital&#x2010;treated mental and behavioral disorders and risk of Alzheimer's disease: a nationwide nested case&#x2010;control study. Psychiatry. 2017;43:92&#x2010;98. 10.1016/j.eurpsy.2017.02.486</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eurpsy.2017.02.486</ArticleId><ArticleId IdType="pubmed">28388490</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Li W, Li G, Xiao S. Prefrontal A&#x3b2; pathology influencing the pathway from apathy to cognitive decline in non&#x2010;dementia elderly. Transl Psychiatry. 2021;11(1):1&#x2010;8. 10.1038/s41398-021-01653-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-021-01653-8</ArticleId><ArticleId IdType="pmc">PMC8523745</ArticleId><ArticleId IdType="pubmed">34663799</ArticleId></ArticleIdList></Reference><Reference><Citation>Wouts L, van Kessel M, Beekman AT, Marijnissen RM, Oude Voshaar RC. Empirical support for the vascular apathy hypothesis: a structured review. Int J Geriatr Psychiatry. 2020;35(1):3&#x2010;11. 10.1002/gps.5217</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5217</ArticleId><ArticleId IdType="pmc">PMC6916153</ArticleId><ArticleId IdType="pubmed">31617249</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisiecka&#x2010;Ford DM, Tozer DJ, Morris RG, Lawrence AJ, Barrick TR, Markus HS. Involvement of the reward network is associated with apathy in cerebral small vessel disease. J Affect Disord. 2018;232:116&#x2010;121. 10.1016/j.jad.2018.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2018.02.006</ArticleId><ArticleId IdType="pmc">PMC5884309</ArticleId><ArticleId IdType="pubmed">29481995</ArticleId></ArticleIdList></Reference><Reference><Citation>Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol. 2011;7(6):323&#x2010;331. 10.1038/nrneurol.2011.60</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.60</ArticleId><ArticleId IdType="pmc">PMC3327554</ArticleId><ArticleId IdType="pubmed">21537355</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen MC, Chan L, Tan L, Tan E. Depression, anxiety, and apathy in Parkinson's disease: insights from neuroimaging studies. Eur J Neurol. 2016;23(6):1001&#x2010;1019. 10.1111/ene.13002</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13002</ArticleId><ArticleId IdType="pmc">PMC5084819</ArticleId><ArticleId IdType="pubmed">27141858</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzahrani H, Venneri A. Cognitive and neuroanatomical correlates of neuropsychiatric symptoms in Parkinson's disease: a systematic review. J Neurol Sci. 2015;356(1&#x2013;2):32&#x2010;44. 10.1016/j.jns.2015.06.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2015.06.037</ArticleId><ArticleId IdType="pubmed">26123201</ArticleId></ArticleIdList></Reference><Reference><Citation>Boublay N, Schott A, Krolak&#x2010;Salmon P. Neuroimaging correlates of neuropsychiatric symptoms in Alzheimer's disease: a review of 20 years of research. Eur J Neurol. 2016;23(10):1500&#x2010;1509. 10.1111/ene.13076</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13076</ArticleId><ArticleId IdType="pubmed">27435186</ArticleId></ArticleIdList></Reference><Reference><Citation>Benoit M, Robert PH. Imaging correlates of apathy and depression in Parkinson's disease. J Neurol Sci. 2011;310(1&#x2013;2):58&#x2010;60. 10.1016/j.jns.2011.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2011.07.006</ArticleId><ArticleId IdType="pubmed">21831400</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Dang M, Zhang Z. Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease: a systematic review of symptom&#x2010;general and&#x2013;specific lesion patterns. Mol Neurodegener. 2021;16(1):1&#x2010;22. 10.1186/s13024-021-00456-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00456-1</ArticleId><ArticleId IdType="pmc">PMC8186099</ArticleId><ArticleId IdType="pubmed">34099005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosti&#x107; VS, Filippi M. Neuroanatomical correlates of depression and apathy in Parkinson's disease: magnetic resonance imaging studies. J Neurol Sci. 2011;310(1&#x2013;2):61&#x2010;63. 10.1016/j.jns.2011.05.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2011.05.036</ArticleId><ArticleId IdType="pubmed">21684552</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL. Frontal&#x2010;subcortical circuits and human behavior. Arch Neurol. 1993;50(8):873&#x2010;880. 10.1001/archneur.1993.00540080076020</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1993.00540080076020</ArticleId><ArticleId IdType="pubmed">8352676</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolova LG, Akopyan GG, Partiali N, et&#xa0;al. Structural correlates of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord. 2007;24(2):91&#x2010;97. 10.1159/000103914</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000103914</ArticleId><ArticleId IdType="pubmed">17570907</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dyck CH, Arnsten AF, Padala PR, et&#xa0;al. Neurobiologic rationale for treatment of apathy in Alzheimer's disease with methylphenidate. Am J Geriatr Psychiatry. 2021;29(1):51&#x2010;62. 10.1016/j.jagp.2020.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7641967</ArticleId><ArticleId IdType="pubmed">32461027</ArticleId></ArticleIdList></Reference><Reference><Citation>Starkstein SE, Mizrahi R, Capizzano AA, Acion L, Brockman S, Power BD. Neuroimaging correlates of apathy and depression in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 2009;21(3):259&#x2010;265. 10.1176/jnp.2009.21.3.259</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/jnp.2009.21.3.259</ArticleId><ArticleId IdType="pubmed">19776304</ArticleId></ArticleIdList></Reference><Reference><Citation>Matuskova V, Ismail Z, Nikolai T, et&#xa0;al. Mild behavioral impairment is associated with atrophy of entorhinal cortex and hippocampus in a memory clinic cohort. Front Aging Neurosci. 2021;13:643271. 10.3389/fnagi.2021.643271</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.643271</ArticleId><ArticleId IdType="pmc">PMC8180573</ArticleId><ArticleId IdType="pubmed">34108874</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall GA, Monserratt L, Harwood D, Mandelkern M, Cummings JL, Sultzer DL. Positron emission tomography metabolic correlates of apathy in Alzheimer disease. Arch Neurol. 2007;64(7):1015&#x2010;1020. 10.1001/archneur.64.7.1015</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.64.7.1015</ArticleId><ArticleId IdType="pubmed">17620493</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura S, Shimada H, Niwa F, et&#xa0;al. Tau&#x2010;induced focal neurotoxicity and network disruption related to apathy in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2018;89(11):1208&#x2010;1214. 10.1136/jnnp-2018-317970</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-317970</ArticleId><ArticleId IdType="pmc">PMC6227800</ArticleId><ArticleId IdType="pubmed">29884723</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori T, Shimada H, Shinotoh H, et&#xa0;al. Apathy correlates with prefrontal amyloid &#x3b2; deposition in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2014;85(4):449&#x2010;455. 10.1136/jnnp-2013-306110</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-306110</ArticleId><ArticleId IdType="pubmed">24133289</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyre HA, Siddarth P, van Dyk K, et&#xa0;al. Neural correlates of apathy in late&#x2010;life depression: a pilot [18F] FDDNP positron emission tomography study. Psychogeriatrics. 2017;17(3):186&#x2010;193. 10.1111/psyg.12213</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/psyg.12213</ArticleId><ArticleId IdType="pmc">PMC5540328</ArticleId><ArticleId IdType="pubmed">28130887</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori C, Pierantozzi M, Chiaravalloti A, et&#xa0;al. When cognitive decline and depression coexist in the elderly: CSF biomarkers analysis can differentiate Alzheimer's disease from late&#x2010;life depression. Front Aging Neurosci. 2018;10:38. 10.3389/fnagi.2018.00038</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00038</ArticleId><ArticleId IdType="pmc">PMC5829060</ArticleId><ArticleId IdType="pubmed">29527163</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden JS, Gustafson L, et&#xa0;al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546&#x2010;1554. 10.1212/wnl.51.6.1546</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.51.6.1546</ArticleId><ArticleId IdType="pubmed">9855500</ArticleId></ArticleIdList></Reference><Reference><Citation>Basavaraju R, Feng X, France J, Huey ED, Provenzano FA. Depression is associated with preserved cortical thickness relative to apathy in frontotemporal dementia. J Geriatr Psychiatry Neurol. 2020;35(1):78&#x2010;88. 10.1177/0891988720964258</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988720964258</ArticleId><ArticleId IdType="pmc">PMC8026775</ArticleId><ArticleId IdType="pubmed">33030106</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao R, Chen H.&#x2010;Y, Gill S, Naude J, Smith EE, Ismail Z. Plasma &#x3b2;&#x2010;amyloid in mild behavioural impairment&#x2013;neuropsychiatric symptoms on the Alzheimer's continuum. J Geriatr Psychiatry Neurol. 2021;35(3):434&#x2010;441. 10.1177/08919887211016068</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08919887211016068</ArticleId><ArticleId IdType="pubmed">34036829</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakers I, Verhey F, Scheltens P, et&#xa0;al. Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment. Psychol Med. 2013;43(5):911&#x2010;920. 10.1017/s0033291712001870</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0033291712001870</ArticleId><ArticleId IdType="pmc">PMC4104501</ArticleId><ArticleId IdType="pubmed">22954311</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruthirakuhan MT, Herrmann N, Abraham EH, Chan S, Lanct&#xf4;t KL. Pharmacological interventions for apathy in Alzheimer's disease. Cochrane Database Syst Rev. 2018;5(5):CD012197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6494556</ArticleId><ArticleId IdType="pubmed">29727467</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgese MG, Trabace L. Monoaminergic system modulation in depression and Alzheimer's disease: a new standpoint? Front Pharmacol. 2019;10:483. 10.3389/fphar.2019.00483</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00483</ArticleId><ArticleId IdType="pmc">PMC6533589</ArticleId><ArticleId IdType="pubmed">31156428</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association . American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium. American Psychiatric Pub; 2006.</Citation></Reference><Reference><Citation>American Psychiatric Association . American Psychiatric Association Practice Guidelines for the Treatment of Depression across Three Age Cohorts. American Psychiatric Association; 2019.</Citation></Reference><Reference><Citation>Benoit M, Andrieu S, Lechowski L, Gillette&#x2010;Guyonnet S, Robert P, Vellas B. Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription. Int J Geriatr Psychiatry. 2008;23(4):409&#x2010;414. 10.1002/gps.1895</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.1895</ArticleId><ArticleId IdType="pubmed">17918770</ArticleId></ArticleIdList></Reference><Reference><Citation>Padala PR, Padala KP, Majagi AS, Garner KK, Dennis RA, Sullivan DH. Selective serotonin reuptake inhibitors&#x2010;associated apathy syndrome: a cross sectional study. Medicine (Baltim). 2020;99(33):e21497. 10.1097/md.0000000000021497</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/md.0000000000021497</ArticleId><ArticleId IdType="pmc">PMC7437849</ArticleId><ArticleId IdType="pubmed">32871995</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnhart WJ, Makela EH, Latocha MJ. SSRI&#x2010;induced apathy syndrome: a clinical review. J Psychiatr Pract. 2004;10(3):196&#x2010;199. 10.1097/00131746-200405000-00010</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00131746-200405000-00010</ArticleId><ArticleId IdType="pubmed">15330228</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H, Cai M, Wang H. Emotional blunting in patients with major depressive disorder: a brief non&#x2010;systematic review of current research. Front Psychiatry. 2021;12:792960. 10.3389/fpsyt.2021.792960</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.792960</ArticleId><ArticleId IdType="pmc">PMC8712545</ArticleId><ArticleId IdType="pubmed">34970173</ArticleId></ArticleIdList></Reference><Reference><Citation>McCabe C, Mishor Z, Cowen PJ, Harmer CJ. Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biol Psychiatry. 2010;67(5):439&#x2010;445. 10.1016/j.biopsych.2009.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2009.11.001</ArticleId><ArticleId IdType="pmc">PMC2828549</ArticleId><ArticleId IdType="pubmed">20034615</ArticleId></ArticleIdList></Reference><Reference><Citation>Mintzer J, Lanct&#xf4;t KL, Scherer RW, et&#xa0;al. Effect of methylphenidate on apathy in patients with Alzheimer disease: the ADMET 2 randomized clinical trial. JAMA Neurol. 2021;78(11):1324&#x2010;1332. 10.1001/jamaneurol.2021.3356</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.3356</ArticleId><ArticleId IdType="pmc">PMC8477302</ArticleId><ArticleId IdType="pubmed">34570180</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg PB, Lanct&#xf4;t KL, Drye LT, et&#xa0;al. Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo&#x2010;controlled trial. J Clin Psychiatry. 2013;74(8):810&#x2010;816. 10.4088/jcp.12m08099</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/jcp.12m08099</ArticleId><ArticleId IdType="pmc">PMC3902018</ArticleId><ArticleId IdType="pubmed">24021498</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogdan A, Manera V, Koenig A, David R. Pharmacologic approaches for the management of apathy in neurodegenerative disorders. Front Pharmacol. 2020;10:1581. 10.3389/fphar.2019.01581</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.01581</ArticleId><ArticleId IdType="pmc">PMC6989486</ArticleId><ArticleId IdType="pubmed">32038253</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelderblom H, W&#xfc;stenberg T, McLean T, et&#xa0;al. Bupropion for the treatment of apathy in Huntington's disease: a multicenter, randomised, double&#x2010;blind, placebo&#x2010;controlled, prospective crossover trial. PLoS One. 2017;12(3):e0173872. 10.1371/journal.pone.0173872</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0173872</ArticleId><ArticleId IdType="pmc">PMC5360242</ArticleId><ArticleId IdType="pubmed">28323838</ArticleId></ArticleIdList></Reference><Reference><Citation>Manera V, Abrahams S, Ag&#xfc;era&#x2010;Ortiz L, et&#xa0;al. Recommendations for the nonpharmacological treatment of apathy in brain disorders. Am J Geriatr Psychiatry. 2020;28(4):410&#x2010;420. 10.1016/j.jagp.2019.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2019.07.014</ArticleId><ArticleId IdType="pubmed">31495772</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodaty H, Burns K. Nonpharmacological management of apathy&#xa0;in dementia: a systematic review. Am J Geriatr Psychiatry. 2012;20(7):549&#x2010;564. 10.1097/jgp.0b013e31822be242</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/jgp.0b013e31822be242</ArticleId><ArticleId IdType="pubmed">21860324</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishita N, Backhouse T, Mioshi E. Nonpharmacological interventions to improve depression, anxiety, and quality of life (QoL) in people with dementia: an overview of systematic reviews. Geriatr Psychiatry Neurol. 2020;33(1):28&#x2010;41. 10.1177/0891988719856690</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988719856690</ArticleId><ArticleId IdType="pubmed">31203712</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert P, Albrengues C, Fabre R, et&#xa0;al. Efficacy of serious exergames in improving neuropsychiatric symptoms in neurocognitive disorders: results of the X&#x2010;TORP cluster randomized trial. Alzheimers Dement (N Y). 2021;7(1):e12149. 10.1002/trc2.12149</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12149</ArticleId><ArticleId IdType="pmc">PMC8112479</ArticleId><ArticleId IdType="pubmed">34013018</ArticleId></ArticleIdList></Reference><Reference><Citation>Suemoto CK, Apolinario D, Nakamura&#x2010;Palacios EM, et&#xa0;al. Effects of a non&#x2010;focal plasticity protocol on apathy in moderate Alzheimer's disease: a randomized, double&#x2010;blind, sham&#x2010;controlled trial. Brain&#xa0;Stimul. 2014;7(2):308&#x2010;313. 10.1016/j.brs.2013.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2013.10.003</ArticleId><ArticleId IdType="pubmed">24262299</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagattini C, Zanni M, Barocco F, et&#xa0;al. Enhancing cognitive training effects in Alzheimer's disease: rTMS as an add&#x2010;on treatment. Brain Stimul. 2020;13(6):1655&#x2010;1664. 10.1016/j.brs.2020.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2020.09.010</ArticleId><ArticleId IdType="pubmed">33002645</ArticleId></ArticleIdList></Reference><Reference><Citation>Khedr EM, Salama RH, Abdel Hameed M, Abo Elfetoh N, Seif P. Therapeutic role of transcranial direct current stimulation in Alzheimer disease patients: double&#x2010;blind, placebo&#x2010;controlled clinical trial. Neurorehabil Neural Repair. 2019;33(5):384&#x2010;394. 10.1177/1545968319840285</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1545968319840285</ArticleId><ArticleId IdType="pubmed">30940012</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed MA, Darwish ES, Khedr EM, Ali AM. Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia. J Neurol. 2012;259(1):83&#x2010;92. 10.1007/s00415-011-6128-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-011-6128-4</ArticleId><ArticleId IdType="pubmed">21671144</ArticleId></ArticleIdList></Reference><Reference><Citation>Padala PR, Boozer EM, Lensing SY, et&#xa0;al. Neuromodulation for apathy in Alzheimer's disease: a double&#x2010;blind, randomized, sham&#x2010;controlled pilot study. J Alzheimers Dis. 2020;77(4):1483&#x2010;1493. 10.3233/jad-200640</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-200640</ArticleId><ArticleId IdType="pmc">PMC7683089</ArticleId><ArticleId IdType="pubmed">32925060</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacas SM, Stella F, Loureiro JC, Sim&#xf5;es do Couto F, Oliveira&#x2010;Maia AJ, Forlenza OV. Noninvasive brain stimulation for behavioural and&#xa0;psychological symptoms of dementia: a systematic review and&#xa0;meta&#x2010;analysis. Int J Geriatr psychiatry. 2019;34(9):1336&#x2010;1345. 10.1002/gps.5003</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5003</ArticleId><ArticleId IdType="pubmed">30246461</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36739557</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-9567</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Journal of interprofessional care</Title><ISOAbbreviation>J Interprof Care</ISOAbbreviation></Journal><ArticleTitle>Designing an interprofessional dementia specialty clinic: Conceptualization and evaluation of a patient-centered model.</ArticleTitle><Pagination><StartPage>254</StartPage><EndPage>261</EndPage><MedlinePgn>254-261</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/13561820.2022.2060194</ELocationID><Abstract><AbstractText>The need for blueprints to design specialty care interprofessional collaboration (IPC) models is urgent, given the expanding aging population and current challenges in dementia diagnosis and treatment. We describe key steps creating an interprofessional outpatient dementia specialty clinic, efforts to sustain the model, and evaluation of interprofessional effectiveness and clinician satisfaction. The conception for the Comprehensive Memory Center was informed by qualitative research methodologies including focus groups, interviews, and literature reviews. Quantitative evaluation included satisfaction surveys and team effectiveness measures. The IPC model diverges from typical dementia practices through its interprofessional team, visit structure, approach to decision-making, in-house services, and community collaborations. Team retreats and workshops helped build clinician knowledge of interprofessional values and practices to sustain the IPC model. In the first 3.5&#xa0;years, we served nearly 750 patients and their caregivers. Team evaluation results revealed that increased access to consultation and sharing the workload and emotional burden were beneficial. The majority of team members preferred the IPC model to traditional models of clinical care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aguirre</LastName><ForeName>Alyssa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, The University of Texas at Austin Dell Medical School, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Texas at Austin, Steve Hicks School of Social Work, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hilsabeck</LastName><ForeName>Robin C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Neurology, The University of Texas at Austin Dell Medical School, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Mahar</LastName><ForeName>Kerry</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, The University of Texas at Austin Dell Medical School, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Psychology-Neuropsychology, Advocate Aurora Health, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carberry</LastName><ForeName>Kathleen E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Neurology, The University of Texas at Austin Dell Medical School, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Texas at Austin, McCombs School of Business, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayers</LastName><ForeName>Gayle</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, The University of Texas at Austin Dell Medical School, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Psychiatry, Ascension Seton Healthcare, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertelson</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ascension Seton Healthcare, Neurology, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rousseau</LastName><ForeName>Justin F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department of Neurology, The University of Texas at Austin Dell Medical School, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paydarfar</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, The University of Texas at Austin Dell Medical School, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Interprof Care</MedlineTA><NlmUniqueID>9205811</NlmUniqueID><ISSNLinking>1356-1820</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007400" MajorTopicYN="Y">Interprofessional Relations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003210" MajorTopicYN="N">Concept Formation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017144" MajorTopicYN="N">Focus Groups</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018802" MajorTopicYN="N">Patient-Centered Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003299" MajorTopicYN="N">Cooperative Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010348" MajorTopicYN="N">Patient Care Team</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer disease</Keyword><Keyword MajorTopicYN="N">Collaborative care</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Health care</Keyword><Keyword MajorTopicYN="N">Interprofessional team</Keyword><Keyword MajorTopicYN="N">Patient-centered</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>5</Day><Hour>14</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36739557</ArticleId><ArticleId IdType="doi">10.1080/13561820.2022.2060194</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36734521</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-6612</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Australasian journal on ageing</Title><ISOAbbreviation>Australas J Ageing</ISOAbbreviation></Journal><ArticleTitle>Evaluation of an educational program for people with dementia and their caregivers.</ArticleTitle><Pagination><StartPage>517</StartPage><EndPage>526</EndPage><MedlinePgn>517-526</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ajag.13172</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study evaluated the impact of a 5-week educational and supportive program for people newly diagnosed with dementia and their caregivers.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study involved a pretest-posttest survey followed by interviews. Wilcoxon signed-rank test was conducted to determine postprogram changes. Kruskal-Wallis tests measured variation in responses between the people with dementia and their caregivers. Interviews were analysed using the NVivo software identifying themes against the program objectives of improving knowledge on dementia, coping strategies, communication and support services for people with dementia and their caregivers.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-three dyads (n&#xa0;=&#xa0;106) completed the survey. There were significant improvements in participants' level of understanding of dementia (z&#xa0;=&#xa0;-8.04, p&#x2009;&lt;&#x2009;0.001), knowledge of local services (z&#xa0;=&#xa0;-8.11, p&#x2009;&lt;&#x2009;0.001) and coping with life with dementia (z&#xa0;=&#xa0;-6.93, p&#x2009;&lt;&#x2009;0.001). These findings were consistent with interview data from 16 dyads.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The increasing number of people with dementia and their caregivers living in the community present health challenges. Programs that assist this group to function well in the community are important. Evaluation of this program indicated improved outcomes in relation to adjusting to life with dementia, enhancing knowledge, fostering communication and reducing feelings of isolation. Areas of improvement included lengthening the program with ongoing contact sessions with program facilitators and other participants. Given the positive effects of the program on this vulnerable group of people, it maybe useful for health-care agencies involved in dementia care to conduct this type of program as a matter of routine treatment and care for people newly diagnosed with dementia.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Australasian Journal on Ageing published by John Wiley &amp; Sons Australia, Ltd on behalf of AJA Inc&#x2019;.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>O'Connell</LastName><ForeName>Beverly</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-9733-5218</Identifier><AffiliationInfo><Affiliation>School of Nursing and Midwifery, Edith Cowan University, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghosh</LastName><ForeName>Manonita</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0522-1959</Identifier><AffiliationInfo><Affiliation>School of Nursing and Midwifery, Edith Cowan University, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunham</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4902-8683</Identifier><AffiliationInfo><Affiliation>School of Nursing and Midwifery, Edith Cowan University, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smyth</LastName><ForeName>Aisling</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9793-6395</Identifier><AffiliationInfo><Affiliation>School of Nursing and Midwifery, Edith Cowan University, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Alzheimer's WA</Agency><Country/></Grant><Grant><Agency>Edith Cowan University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Australas J Ageing</MedlineTA><NlmUniqueID>9808874</NlmUniqueID><ISSNLinking>1440-6381</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000223" MajorTopicYN="N">Adaptation, Psychological</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">caregivers</Keyword><Keyword MajorTopicYN="N">community health care</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">education of patients</Keyword><Keyword MajorTopicYN="N">program evaluation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>7</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36734521</ArticleId><ArticleId IdType="doi">10.1111/ajag.13172</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Patterson C. World Alzheimer report 2018. The state of the art of dementia research: new frontiers. 2018. Accessed August 7, 2022. https://www.alzint.org/u/WorldAlzheimerReport2018.pdf</Citation></Reference><Reference><Citation>Brown L, Hansnata E, La HA. Economic cost of dementia in Australia 2016-2056: report prepared for Alzheimer's Australia. 2017. Accessed February 10, 2022. https://www.dementia.org.au/sites/default/files/NATIONAL/documents/The-economic-cost-of-dementia-in-Australia-2016-to-2056.pdf</Citation></Reference><Reference><Citation>Dementia Australia. Dementia statistics. 2022. Accessed August 7, 2022. https://www.dementia.org.au/statistics</Citation></Reference><Reference><Citation>Brodaty H, Donkin M. Family caregivers of people with dementia. Dialogues Clin Neurosci. 2009;11(2):217-228. doi:10.31887/DCNS.2009.11.2/hbrodaty</Citation></Reference><Reference><Citation>Lindeza P, Rodrigues M, Costa J, Guerreiro M, Rosa MM. Impact of dementia on informal care: a systematic review of family caregivers' perceptions. BMJ Support Palliat Care. 2020;1-12. doi:10.1136/bmjspcare-2020-002242</Citation></Reference><Reference><Citation>Chiao CY, Wu HS, Hsiao CY. Caregiver burden for informal caregivers of patients with dementia: a systematic review. Int Nurs Rev. 2015;62(3):340-350. doi:10.1111/inr.12194</Citation></Reference><Reference><Citation>Cuijpers P. Depressive disorders in caregivers of dementia patients: a systematic review. Aging Ment Health. 2005;9(4):325-330. doi:10.1080/13607860500090078</Citation></Reference><Reference><Citation>Frank L, Lloyd A, Flynn JA, et al. Impact of cognitive impairment on mild dementia patients and mild cognitive impairment patients and their informants. Int Psychogeriatr. 2006;18(1):151-162. doi:10.1017/S1041610205002450</Citation></Reference><Reference><Citation>Caddell LS, Clare L. I'm still the same person: the impact of early-stage dementia on identity. Dementia. 2011;10(3):379-398. doi:10.1177/1471301211408255</Citation></Reference><Reference><Citation>Batsch NL, Mittelman MS. World Alzheimer report 2012. Overcoming the stigma of dementia. Alzheimer's Disease International (ADI); 2012. Accessed July 17, 2022. https://www.alzint.org/u/WorldAlzheimerReport2012.pdf</Citation></Reference><Reference><Citation>Doyle C. International perspectives on dementia education, training and knowledge transfer. Int Psychogeriatr. 2009;21(S1):S1-S2. doi:10.1017/S1041610209008734</Citation></Reference><Reference><Citation>Peeters JM, Van Beek A, Meerveld JH, Spreeuwenberg PM, Francke AL. Informal caregivers of persons with dementia, their use of and needs for specific professional support: a survey of the National Dementia Programme. BMC Nurs. 2010;9(1):1-8.</Citation></Reference><Reference><Citation>Ghosh M, Dunham M, O'Connell B. Systematic review of dyadic psychoeducational programs for persons with dementia and their family caregivers. J Clin Nurs. 2022;1-21. https://doi.org/10.1111/jocn.16570</Citation></Reference><Reference><Citation>Van't Leven N, Prick A-EJ, Groenewoud JG, Roelofs PD, de Lange J, Pot AM. Dyadic interventions for community-dwelling people with dementia and their family caregivers: a systematic review. Int Psychogeriatr. 2013;25(10):1581-1603. doi:10.1017/S1041610213000860</Citation></Reference><Reference><Citation>Vandepitte S, Van Den Noortgate N, Putman K, Verhaeghe S, Verdonck C, Annemans L. Effectiveness of respite care in supporting informal caregivers of persons with dementia: a systematic review. Int J Geriatr Psychiatry. 2016;31(12):1277-1288. doi:10.1002/gps.4504</Citation></Reference><Reference><Citation>Lorenz K, Freddolino PP, Comas-Herrera A, Knapp M, Damant J. Technology-based tools and services for people with dementia and carers: mapping technology onto the dementia care pathway. Dementia. 2017;18(2):725-741. doi:10.1177/1471301217691617</Citation></Reference><Reference><Citation>Eggenberger E, Heimerl K, Bennett MI. Communication skills training in dementia care: a systematic review of effectiveness, training content, and didactic methods in different care settings. Int Psychogeriatr. 2013;25(3):345-358. doi:10.1017/S1041610212001664</Citation></Reference><Reference><Citation>Stockwell-Smith G, Moyle W, Kellett U. The impact of early psychosocial intervention on self-efficacy of care recipient/carer dyads living with early-stage dementia-a mixed-methods study. J Adv Nurs. 2018;74(9):2167-2180. doi:10.1111/jan.13710</Citation></Reference><Reference><Citation>Whitlatch CJ, Judge K, Zarit SH, Femia E. Dyadic intervention for family caregivers and care receivers in early-stage dementia. Gerontologist. 2006;46(5):688-694. doi:10.1093/geront/46.5.688</Citation></Reference><Reference><Citation>IBM SPSS Statistics for Windows [Computer software]. Version 25.0. IBM Corp; 2017.</Citation></Reference><Reference><Citation>Miles MB, Huberman AM, Salda&#xf1;a J. Qualitative Data Analysis: A Methods Sourcebook. Sage Publications; 2018.</Citation></Reference><Reference><Citation>Steenfeldt V&#xd8;, Aagerup LC, Jacobsen AH, Skj&#xf8;dt U. Becoming a family caregiver to a person with dementia: a literature review on the needs of family caregivers. SAGE Open Nurs. 2021;7:23779608211029073. doi:10.1177/23779608211029073</Citation></Reference><Reference><Citation>Aminzadeh F, Byszewski A, Molnar FJ, Eisner M. Emotional impact of dementia diagnosis: exploring persons with dementia and caregivers' perspectives. Aging Ment Health. 2007;11(3):281-290. doi:10.1080/13607860600963695</Citation></Reference><Reference><Citation>La Fontaine J, Buckell A, Knibbs T, Palfrey M. Early and timely intervention in dementia: pre-assessment counselling. In: Clinical Psychology in the Early Stage Dementia Care Pathway. Vol 6. The British Psychological Society; 2014:1-24. https://www.researchgate.net/profile/Richard-Cheston/publication/327829735_Post-diagnostic_support_for_people_living_with_dementia/links/5ba7565145851574f7dfdbb9/Post-diagnostic-support-for-people-living-with-dementia.pdf#page=8. Accessed July 18, 2022.</Citation></Reference><Reference><Citation>McDermott O, Charlesworth G, Hogervorst E, et al. Psychosocial interventions for people with dementia: a synthesis of systematic reviews. Aging Ment Health. 2019;23(4):393-403. doi:10.1080/13607863.2017.1423031</Citation></Reference><Reference><Citation>Terayama H, Sakurai H, Namioka N, et al. Caregivers' education decreases depression symptoms and burden in caregivers of patients with dementia. Psychogeriatrics. 2018;18(5):327-333. doi:10.1111/psyg.12337</Citation></Reference><Reference><Citation>Childers KM. Synthesis of the literature: variables influencing caregiver use or nonuse of supportive services. SAGE Open Nurs. 2019;5:2377960819838411. doi:10.1177/2377960819838411</Citation></Reference><Reference><Citation>Brodaty H, Thomson C, Thompson C, Fine M. Why caregivers of people with dementia and memory loss don't use services. Int J Geriatr Psychiatry. 2005;20(6):537-546. doi:10.1002/gps.1322</Citation></Reference><Reference><Citation>Dugmore O, Orrell M, Spector A. Qualitative studies of psychosocial interventions for dementia: a systematic review. Aging Ment Health. 2015;19(11):955-967. doi:10.1080/13607863.2015.1011079</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36733496</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1432-2277</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Transplant international : official journal of the European Society for Organ Transplantation</Title><ISOAbbreviation>Transpl Int</ISOAbbreviation></Journal><ArticleTitle>Subjective Cognition is Related to Patient-Reported Symptom Distress and Work Productivity Among Liver Transplant Recipients.</ArticleTitle><Pagination><StartPage>10863</StartPage><MedlinePgn>10863</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">10863</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/ti.2023.10863</ELocationID><Abstract><AbstractText>Cognitive decline may prevent liver transplant (LT) recipients from staying healthy and independent. This study examined associations of objective and subjective, rated by LT recipients and caregivers, cognitive decline with patient-reported physical and psychological symptom distress, ability to perform household tasks, and workplace productivity among LT recipients. Sixty pairs of LT recipients and caregivers participated in this cross-sectional study. Subjective cognition was measured by the Everyday Cognition. Objective cognition was assessed with four cognitive tests, including the Repeatable Battery for the Assessment of Neuropsychological Status. Patient-reported outcomes were assessed with the Rotterdam Symptom Checklist-Modified, Profile of Mood States-Short Form, Creative Therapy Consultants Homemaking Assessment, and Work Limitations Questionnaire. Linear regression analyses related objective and subjective cognition to the patient-reported outcomes. While objective cognitive decline was not associated with any patient-reported outcomes, subjective cognitive decline was significantly associated with the outcomes. Higher LT recipient self-rated cognitive decline was associated with higher physical symptom distress ( <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mi>&#x3b2;</mml:mi></mml:mrow> </mml:math> = 0.30, <i>p</i> = 0.006) and workplace productivity loss ( <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mi>&#x3b2;</mml:mi></mml:mrow> </mml:math> = 14.85, <i>p</i> &lt; 0.0001). Higher caregiver-rated cognitive decline was associated with lower household tasks performance ( <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mi>&#x3b2;</mml:mi></mml:mrow> </mml:math> = -18.55, <i>p</i> = 0.015). Findings suggest to consider subjective cognition when developing an individualized post-transplant care plan.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Ko, Ridner and Gifford.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Dami</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Nursing, Bouv&#xe9; College of Health Sciences, Northeastern University, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ridner</LastName><ForeName>Sheila H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>School of Nursing, Vanderbilt University, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gifford</LastName><ForeName>Katherine A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Vanderbilt Memory and Alzheimer's Center, Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Transpl Int</MedlineTA><NlmUniqueID>8908516</NlmUniqueID><ISSNLinking>0934-0874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cognitive function</Keyword><Keyword MajorTopicYN="N">liver transplant recipients</Keyword><Keyword MajorTopicYN="N">patient-reported outcomes</Keyword><Keyword MajorTopicYN="N">subjective cognition</Keyword><Keyword MajorTopicYN="N">symptom distress</Keyword><Keyword MajorTopicYN="N">work productivity</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>1</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36733496</ArticleId><ArticleId IdType="pmc">PMC9886575</ArticleId><ArticleId IdType="doi">10.3389/ti.2023.10863</ArticleId><ArticleId IdType="pii">10863</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kwong AJ, Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, et al. OPTN/SRTR 2019 Annual Data Report: Liver. Am J Transpl (2021) 21(S2):208&#x2013;315. 10.1111/ajt.16494</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16494</ArticleId><ArticleId IdType="pubmed">33595192</ArticleId></ArticleIdList></Reference><Reference><Citation>Serper M, Asrani S, VanWagner L, Reese PP, Kim M, Wolf MS. Redefining Success after Liver Transplantation: From Mortality toward Function and Fulfillment. Liver Transpl (2022) 28(2):304&#x2013;13. 10.1002/lt.26325</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.26325</ArticleId><ArticleId IdType="pmc">PMC10236315</ArticleId><ArticleId IdType="pubmed">34608746</ArticleId></ArticleIdList></Reference><Reference><Citation>Burra P, Germani G, Gnoato F, Lazzaro S, Russo FP, Cillo U, et al. Adherence in Liver Transplant Recipients. Liver Transpl (2011) 17:760&#x2013;70. 10.1002/lt.22294</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.22294</ArticleId><ArticleId IdType="pubmed">21384527</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulder MB, Borgsteede SD, Darwish Murad S, Landman CS, Metselaar HJ, Hunfeld NGM. Medication-Related Problems in Liver Transplant Recipients in the Outpatient Setting: A Dutch Cohort Study. Front Pharmacol (2021) 12:637090. 10.3389/fphar.2021.637090</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.637090</ArticleId><ArticleId IdType="pmc">PMC8111087</ArticleId><ArticleId IdType="pubmed">33986672</ArticleId></ArticleIdList></Reference><Reference><Citation>Leven EA, Annunziato R, Helcer J, Lieber SR, Knight CS, Wlodarkiewicz C, et al. Medication Adherence and Rejection Rates in Older vs Younger Adult Liver Transplant Recipients. Clin Transpl (2017) 31:e12981. 10.1111/ctr.12981</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ctr.12981</ArticleId><ArticleId IdType="pmc">PMC5485915</ArticleId><ArticleId IdType="pubmed">28370346</ArticleId></ArticleIdList></Reference><Reference><Citation>Huda A, Newcomer R, Harrington C, Keeffe EB, Esquivel CO. Employment after Liver Transplantation: A Review. Transpl Proc (2015) 47(2):233&#x2013;9. 10.1016/j.transproceed.2014.10.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transproceed.2014.10.022</ArticleId><ArticleId IdType="pubmed">25769555</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko D, Bratzke LC. Cognitive Function in Liver Transplant Recipients Who Survived More Than 6 Months. Prog Transpl (2020) 30(4):335&#x2013;41. 10.1177/1526924820958144</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1526924820958144</ArticleId><ArticleId IdType="pubmed">32964795</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahluwalia V, Wade JB, White MB, Gilles HS, Heuman DM, Fuchs M, et al. Liver Transplantation Significantly Improves Global Functioning and Cerebral Processing. Liver Transpl (2016) 22(10):1379&#x2013;90. 10.1002/lt.24498</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.24498</ArticleId><ArticleId IdType="pmc">PMC5036999</ArticleId><ArticleId IdType="pubmed">27339647</ArticleId></ArticleIdList></Reference><Reference><Citation>Campagna F, Montagnese S, Schiff S, Biancardi A, Mapelli D, Angeli P, et al. Cognitive Impairment and Electroencephalographic Alterations before and after Liver Transplantation: What Is Reversible? Liver Transpl (2014) 20(8):977&#x2013;86. 10.1002/lt.23909</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.23909</ArticleId><ArticleId IdType="pubmed">24809329</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolansky MA, Hawkins MAW, Schaefer JT, Sattar A, Gunstad J, Redle JD, et al. Association between Poorer Cognitive Function and Reduced Objectively Monitored Medication Adherence in Patients with Heart Failure. Circ Heart Fail (2016) 9(12):e002475. 10.1161/CIRCHEARTFAILURE.116.002475</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.116.002475</ArticleId><ArticleId IdType="pmc">PMC5131517</ArticleId><ArticleId IdType="pubmed">27895069</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser J, Dietrich J, Amiri M, R&#xfc;schel I, Akbaba H, Hantke N, et al. Cognitive Performance and Psychological Distress in Breast Cancer Patients at Disease Onset. Front Psychol (2019) 10:2584. 10.3389/fpsyg.2019.02584</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2019.02584</ArticleId><ArticleId IdType="pmc">PMC6873390</ArticleId><ArticleId IdType="pubmed">31803117</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung MS, Zhang M, Askren MK, Berman MG, Peltier S, Hayes DF, et al. Cognitive Dysfunction and Symptom burden in Women Treated for Breast Cancer: a Prospective Behavioral and fMRI Analysis. Brain Imaging Behav (2017) 11(1):86&#x2013;97. 10.1007/s11682-016-9507-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-016-9507-8</ArticleId><ArticleId IdType="pubmed">26809289</ArticleId></ArticleIdList></Reference><Reference><Citation>Glanz BI, D&#xe9;gano IR, Rintell DJ, Chitnis T, Weiner HL, Healy BC. Work Productivity in Relapsing Multiple Sclerosis: Associations with Disability, Depression, Fatigue, Anxiety, Cognition, and Health-Related Quality of Life. Value Health (2012) 15(8):1029&#x2013;35. 10.1016/j.jval.2012.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2012.07.010</ArticleId><ArticleId IdType="pubmed">23244804</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Ah D, Storey S, Crouch A. Relationship between Self-Reported Cognitive Function and Work-Related Outcomes in Breast Cancer Survivors. J Cancer Surviv (2018) 12(2):246&#x2013;55. 10.1007/s11764-017-0664-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11764-017-0664-6</ArticleId><ArticleId IdType="pubmed">29222703</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko D, Dietrich MS, Gifford KA, Ridner SH. Subjective Cognition Reported by Caregivers Is Correlated With Objective Cognition in Liver Transplant Recipients. Liver Transpl (2022) 28(2):269&#x2013;79. 10.1002/lt.26213</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.26213</ArticleId><ArticleId IdType="pmc">PMC8785255</ArticleId><ArticleId IdType="pubmed">34137503</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance DE, Bail J, Enah C, Palmer J, Hoenig A. The Impact of Employment on Cognition and Cognitive reserve: Implications across Diseases and Aging. Nurs Res Rev (2016) 6:61&#x2013;71. 10.2147/NRR.S115625</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NRR.S115625</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research Electronic Data Capture (REDCap)&#x2014;A Metadata-Driven Methodology and Workflow Process for Providing Translational Research Informatics Support. J Biomed Inform (2009) 42(2):377&#x2013;81. 10.1016/j.jbi.2008.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O&#x2019;Neal L, et al. The REDCap Consortium: Building an International Community of Software Platform Partners. J Biomed Inform (2019) 95:103208. 10.1016/j.jbi.2019.103208</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Farias ST, Mungas D, Reed BR, Cahn-Weiner D, Jagust W, Baynes K, et al. The Measurement of Everyday Cognition (ECog): Scale Development and Psychometric Properties. Neuropsychology (2008) 22(4):531&#x2013;44. 10.1037/0894-4105.22.4.531</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0894-4105.22.4.531</ArticleId><ArticleId IdType="pmc">PMC2877034</ArticleId><ArticleId IdType="pubmed">18590364</ArticleId></ArticleIdList></Reference><Reference><Citation>Farias ST, Huss O, Chan ML, Ruiz R. Revisions and Updates to the Everyday Cognition (ECog) Scales. Alzheimers Dement (2020) 16(6):e043263. 10.1002/alz.043263</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.043263</ArticleId></ArticleIdList></Reference><Reference><Citation>Randolph C, Tierney MC, Mohr E, Chase TN. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary Clinical Validity. J Clin Exp Neuropsychol (1998) 20(3):310&#x2013;9. 10.1076/jcen.20.3.310.823</Citation><ArticleIdList><ArticleId IdType="doi">10.1076/jcen.20.3.310.823</ArticleId><ArticleId IdType="pubmed">9845158</ArticleId></ArticleIdList></Reference><Reference><Citation>Duff K, Hobson VL, Beglinger LJ, O&#x2019;Bryant SE. Diagnostic Accuracy of the RBANS in Mild Cognitive Impairment: Limitations on Assessing Milder Impairments. Arch Clin Neuropsychol (2010) 25(5):429&#x2013;41. 10.1093/arclin/acq045</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acq045</ArticleId><ArticleId IdType="pmc">PMC2904671</ArticleId><ArticleId IdType="pubmed">20570820</ArticleId></ArticleIdList></Reference><Reference><Citation>Aceto P, Perilli V, Lai C, Ciocchetti P, Vitale F, Sollazzi L. Postoperative Cognitive Dysfunction after Liver Transplantation. Gen Hosp Psychiatry (2015) 37(2):109&#x2013;15. 10.1016/j.genhosppsych.2014.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2014.12.001</ArticleId><ArticleId IdType="pubmed">25550172</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Cubillo I, Peri&#xe1;&#xf1;Ez JA, Adrover-Roig D, Rodr&#xed;Guez-S&#xe1;Nchez JM, R&#xed;Os-Lago M, Tirapu J, et al. Construct Validity of the Trail Making Test: Role of Task-Switching, Working Memory, Inhibition/interference Control, and Visuomotor Abilities. J Int Neuropsychol Soc (2009) 15:438&#x2013;50. 10.1017/S1355617709090626</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1355617709090626</ArticleId><ArticleId IdType="pubmed">19402930</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters GS, Caplan D. The Reliability and Stability of Verbal Working Memory Measures. Behav Res (2003) 35(4):550&#x2013;64. 10.3758/BF03195534</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/BF03195534</ArticleId><ArticleId IdType="pubmed">14748499</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinlay A. Rey Complex Figure Test. In: Encyclopedia of Child Behavior and Development. Boston, MA: Springer; (2011). p. 1264&#x2013;5. 10.1007/978-0-387-79061-9_2437</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-0-387-79061-9_2437</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss E, Sherman EMS, Spreen O. A Compendium of Neuropsychological Tests. third. New York: Oxford University Press; (2006). p. 811.</Citation></Reference><Reference><Citation>Berry DTR, Allen RS, Schmitt FA. Rey-Osterrieth Complex Figure: Psychometric Characteristics in a Geriatric Sample. Clin Neuropsychol (1991) 5(2):143&#x2013;53. 10.1080/13854049108403298</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854049108403298</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein KD, Denniston M, Baker F, Dent M, Hann DM, Bushhouse S, et al. Validation of a Modified Rotterdam Symptom Checklist for Use with Cancer Patients in the United States. Pain Symptom Manage (2003) 26(5):975&#x2013;89. 10.1016/S0885-3924(03)00321-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0885-3924(03)00321-X</ArticleId><ArticleId IdType="pubmed">14585549</ArticleId></ArticleIdList></Reference><Reference><Citation>Curran SL, Andrykowski MA, Studts JL. Short Form of the Profile of Mood States (POMS-SF): Psychometric Information. Psychol Assess (1995) 7(1):80&#x2013;3. 10.1037/1040-3590.7.1.80</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/1040-3590.7.1.80</ArticleId></ArticleIdList></Reference><Reference><Citation>
Creative Therapy Consultants. Evaluating a Homemaking Assessment for Broader Application to Practice (2016. 
). www.creativetherapyconsultants.ca/publications/# (Accessed April 28, 2018).</Citation></Reference><Reference><Citation>
Creative Therapy Consultants. The Creative Therapy Consultants Homemaking Assessment: Administration Guide (2016. 
). www.creativetherapyconsultants.ca/publications/# (Accessed April 28, 2018).</Citation></Reference><Reference><Citation>Lerner D, Amick BC, Lee JC, Rooney T, Rogers WH, Chang H, et al. Relationship of Employee-Reported Work Limitations to Work Productivity. Med Care (2003) 41(5):649&#x2013;59. 10.1097/01.MLR.0000062551.76504.A9</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.MLR.0000062551.76504.A9</ArticleId><ArticleId IdType="pubmed">12719689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerner D, Amick BC, Rogers WH, Malspeis S, Bungay K, Cynn D. The Work Limitations Questionnaire. Med Care (2001) 39(1):72&#x2013;85. 10.1097/00005650-200101000-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-200101000-00009</ArticleId><ArticleId IdType="pubmed">11176545</ArticleId></ArticleIdList></Reference><Reference><Citation>Mapi Research Trust. Work Limitations Questionnaire Version 1.0: Scaling and Scoring. Lyon, France: Mapi Research Trust; (2018).</Citation></Reference><Reference><Citation>Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and Mortality Among Patients on the Liver-Transplant Waiting List. N Engl J Med (2008) 359(10):1018&#x2013;26. 10.1056/NEJMoa0801209</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0801209</ArticleId><ArticleId IdType="pmc">PMC4374557</ArticleId><ArticleId IdType="pubmed">18768945</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas AG, Ruck JM, Shaffer AA, Haugen CE, Ying H, Warsame F, et al. Kidney Transplant Outcomes in Recipients with Cognitive Impairment: A National Registry and Prospective Cohort Study. Transplantation (2019) 103(7):1504&#x2013;13. 10.1097/TP.0000000000002431</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000002431</ArticleId><ArticleId IdType="pmc">PMC6393218</ArticleId><ArticleId IdType="pubmed">30153224</ArticleId></ArticleIdList></Reference><Reference><Citation>Lycke M, Lefebvre T, Pottel L, Pottel H, Ketelaars L, Stellamans K, et al. Subjective, but Not Objective, Cognitive Complaints Impact Long-Term Quality of Life in Cancer Patients. J Psychoso Oncol (2019) 37(4):427&#x2013;40. 10.1080/07347332.2018.1504154</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07347332.2018.1504154</ArticleId><ArticleId IdType="pubmed">30798774</ArticleId></ArticleIdList></Reference><Reference><Citation>Zlatar ZZ, Muniz M, Galasko D, Salmon DP. Subjective Cognitive Decline Correlates with Depression Symptoms and Not with Concurrent Objective Cognition in a Clinic-Based Sample of Older Adults. J Gerontol B Psychol Sci Soc Sci (2018) 73(7):1198&#x2013;202. 10.1093/geronb/gbw207</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbw207</ArticleId><ArticleId IdType="pmc">PMC6146771</ArticleId><ArticleId IdType="pubmed">28329816</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;hooghe MB, De Cock A, Van Remoortel A, Benedict RHB, Eelen P, Peeters E, et al. Correlations of Health Status Indicators with Perceived Neuropsychological Impairment and Cognitive Processing Speed in Multiple Sclerosis. Mult Scler Relat Disord (2019) 39:101904. 10.1016/j.msard.2019.101904</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2019.101904</ArticleId><ArticleId IdType="pubmed">31981931</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicol C, Ownsworth T, Cubis L, Nguyen W, Foote M, Pinkham MB. Subjective Cognitive Functioning and Associations with Psychological Distress in Adult Brain Tumour Survivors. J Cancer Surviv (2019) 13(5):653&#x2013;62. 10.1007/s11764-019-00784-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11764-019-00784-8</ArticleId><ArticleId IdType="pubmed">31313128</ArticleId></ArticleIdList></Reference><Reference><Citation>Chokka P, Bougie J, Rampakakis E, Proulx J. Assessment in Work Productivity and the Relationship with Cognitive Symptoms (AtWoRC): Primary Analysis from a Canadian Open-Label Study of Vortioxetine in Patients with Major Depressive Disorder (MDD). CNS Spectr (2019) 24(3):338&#x2013;47. 10.1017/S1092852918000913</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1092852918000913</ArticleId><ArticleId IdType="pmc">PMC6676443</ArticleId><ArticleId IdType="pubmed">29792585</ArticleId></ArticleIdList></Reference><Reference><Citation>Huda A, Newcomer R, Harrington C, Blegen MG, Keeffe EB. High Rate of Unemployment after Liver Transplantation: Analysis of the United Network for Organ Sharing Database. Liver Transpl (2012) 18:89&#x2013;99. 10.1002/lt.22408</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.22408</ArticleId><ArticleId IdType="pubmed">21837745</ArticleId></ArticleIdList></Reference><Reference><Citation>Saab S, Wiese C, Ibrahim AB, Peralta L, Durazo F, Han S, et al. Employment and Quality of Life in Liver Transplant Recipients. Liver Transpl (2007) 13(9):1330&#x2013;8. 10.1002/lt.21247</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.21247</ArticleId><ArticleId IdType="pubmed">17763388</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller LS, Brown CL, Mitchell MB, Williamson GM. Activities of Daily Living Are Associated with Older Adult Cognitive Status: Caregiver versus Self-Reports. J Appl Gerontol (2013) 32(1):3&#x2013;30. 10.1177/0733464811405495</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464811405495</ArticleId><ArticleId IdType="pubmed">25473924</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36732059</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2702</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>15-16</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of clinical nursing</Title><ISOAbbreviation>J Clin Nurs</ISOAbbreviation></Journal><ArticleTitle>Perspectives of people with Parkinson's disease and family carers about disease management in community settings: A&#xa0;cross-country qualitative study.</ArticleTitle><Pagination><StartPage>5201</StartPage><EndPage>5218</EndPage><MedlinePgn>5201-5218</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jocn.16636</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To explore perceptions of people with Parkinson's disease and family carers about the use and impact of health and social care services, community and voluntary sector resources for the management of Parkinson's disease.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Resources from outside the formal health care system and collaborations between different levels and sectors could address the unmet needs of people with Parkinson's disease and their family carers and improve the management of Parkinson's disease in the community setting.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A qualitative exploratory study was carried out in Denmark, Norway, Spain and the United Kingdom and was reported using the COREQ.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Individual semi-structured interviews were conducted with people with Parkinson's disease and family carers between May and August 2020. Interviews were digitally recorded, transcribed verbatim and analysed using thematic analysis. A meta-ethnographic approach was used to analyse and synthesise cross-national findings.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Forty-seven people with Parkinson's disease and 39 family carers participated in the four countries. Four themes and eight sub-themes emerged: (1) Personalised care for needs throughout the Parkinson's disease journey; (2) Accessibility of different types of support systems (including initiatives to support emotional well-being, physical rehabilitation, information on the healthcare services, voluntary associations and community groups); (3) Multiagency collaborations, a more comprehensive approach; (4) Acknowledgment of people with Parkinson's and family carers own role in Parkinson's disease management.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">An integrated and person-and-community-centred approach, which includes the participation of the health, social, voluntary and community sectors, is desired by people with Parkinson's disease and their family carers to improve the management of Parkinson's in the community setting. These findings could contribute to the creation of more sustainable care systems at the European level that would better respond to individual and changing needs in people with Parkinson's disease and their family carers, and in other long-term conditions.</AbstractText><AbstractText Label="PATIENT OR PUBLIC CONTRIBUTION" NlmCategory="UNASSIGNED">The Patient and Public Involvement groups contributed to the design of the study, the interview guides and validation of findings.</AbstractText><AbstractText Label="RELEVANCE TO CLINICAL PRACTICE" NlmCategory="CONCLUSIONS">This study will inform the management of Parkinson's disease at the community level and the use of resources not only directly linked to the health system. Taking into account all the actors that provide care and support to people with Parkinson' disease and family carers facilitates the creation of strategies that better respond to individual needs. Nurses and other health and social care professionals in the community and specialist levels of care should collaborate to develop multisectoral strategies that promote personalised and integrated care throughout the Parkinson's journey.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Journal of Clinical Nursing published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Navarta-S&#xe1;nchez</LastName><ForeName>M Victoria</ForeName><Initials>MV</Initials><Identifier Source="ORCID">0000-0002-9122-2260</Identifier><AffiliationInfo><Affiliation>Nursing Department, Faculty of Medicine, Universidad Aut&#xf3;noma de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmar-Santos</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2294-390X</Identifier><AffiliationInfo><Affiliation>Nursing Department, Faculty of Medicine, Universidad Aut&#xf3;noma de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedraz-Marcos</LastName><ForeName>Azucena</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4641-6891</Identifier><AffiliationInfo><Affiliation>The Carlos III Health Institute (ISCIII), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reidy</LastName><ForeName>Claire</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0013-6843</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soilemezi</LastName><ForeName>Dia</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8831-9419</Identifier><AffiliationInfo><Affiliation>Department of Psychology, University of Portsmouth, Portsmouth, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haahr</LastName><ForeName>Anita</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8373-176X</Identifier><AffiliationInfo><Affiliation>Research Centre for Health and Welfare Technology, Programme for Rehabilitation, VIA University College, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nursing and Healthcare, Department of Public Health, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xf8;rensen</LastName><ForeName>Dorthe</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-6362-3385</Identifier><AffiliationInfo><Affiliation>Research Centre for Health and Welfare Technology, Programme for Rehabilitation, VIA University College, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smidt</LastName><ForeName>Helle R&#xf8;nn</ForeName><Initials>HR</Initials><Identifier Source="ORCID">0000-0003-2987-5540</Identifier><AffiliationInfo><Affiliation>Research Centre for Health and Welfare Technology, Programme for Rehabilitation, VIA University College, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bragstad</LastName><ForeName>Line Kildal</ForeName><Initials>LK</Initials><Identifier Source="ORCID">0000-0002-9645-3770</Identifier><AffiliationInfo><Affiliation>Department of Public Health Sciences and CHARM - Research Center for Habilitation and Rehabilitation Models and Services, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rehabilitation Science and Health Technology, Oslo Metropolitan University, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hjelle</LastName><ForeName>Ellen Gabrielsen</ForeName><Initials>EG</Initials><Identifier Source="ORCID">0000-0003-1983-995X</Identifier><AffiliationInfo><Affiliation>Department of Public Health Sciences and CHARM - Research Center for Habilitation and Rehabilitation Models and Services, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rehabilitation Science and Health Technology, Oslo Metropolitan University, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haavaag</LastName><ForeName>Silje Bj&#xf8;rnsen</ForeName><Initials>SB</Initials><Identifier Source="ORCID">0000-0002-0960-3479</Identifier><AffiliationInfo><Affiliation>Department of Public Health Sciences, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Portillo</LastName><ForeName>Mari Carmen</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0003-1583-6612</Identifier><AffiliationInfo><Affiliation>NIHR Applied Research Collaboration Wessex, University of Southampton, School of Health Sciences, Southampton, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Alzheimer&#xb4;s Society</Agency><Country/></Grant><Grant><Agency>Autonomous University of Madrid and the Ministry of Universities of the Spanish Government (Recovery, Transformation and Resilience Plan)</Agency><Country/></Grant><Grant><Agency>DAM Foundation</Agency><Country/></Grant><Grant><Agency>EU Joint Programme - Neurodegenerative Disease Research</Agency><Country/></Grant><Grant><Agency>Innovation Fund Denmark</Agency><Country/></Grant><Grant><Agency>Research Council of Norway</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Clin Nurs</MedlineTA><NlmUniqueID>9207302</NlmUniqueID><ISSNLinking>0962-1067</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012947" MajorTopicYN="N">Social Work</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Parkinson's disease</Keyword><Keyword MajorTopicYN="N">integrated care</Keyword><Keyword MajorTopicYN="N">long-term conditions</Keyword><Keyword MajorTopicYN="N">management</Keyword><Keyword MajorTopicYN="N">multisectoral action</Keyword><Keyword MajorTopicYN="N">nursing</Keyword><Keyword MajorTopicYN="N">patient experience</Keyword><Keyword MajorTopicYN="N">patient involvement</Keyword><Keyword MajorTopicYN="N">personalised care</Keyword><Keyword MajorTopicYN="N">qualitative research</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>2</Day><Hour>21</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36732059</ArticleId><ArticleId IdType="doi">10.1111/jocn.16636</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Bloem, B. R., Henderson, E. J., Dorsey, E. R., Okun, M. S., Okubadejo, N., Chan, P., Andrejack, J., Darweesh, S., &amp; Munneke, M. (2020). Integrated and patient-centred management of Parkinson's disease: a network model for reshaping chronic neurological care. The Lancet, 19(7), 623-634. https://doi.org/10.1016/S1474-4422(20)30064-8</Citation></Reference><Reference><Citation>Bovolenta, T. M., de Azevedo Silva, S. M., Arb Saba, R., Borges, V., Ferraz, H. B., &amp; Felicio, A. C. (2017). Systematic review and critical analysis of cost studies associated with Parkinson's disease. Parkinson's Disease, 2017, 1-11. https://doi.org/10.1155/2017/3410946</Citation></Reference><Reference><Citation>Braun, V., &amp; Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77-101. https://doi.org/10.1191/1478088706qp063oa</Citation></Reference><Reference><Citation>Braun, V., Clarke, V., &amp; Weate, P. (2016). Using thematic analysis in sport and exercise research. In B. Smith &amp; A. C. Sparkes (Eds.), Routledge handbook of qualitative research in sport and exercise (pp. 191-205). Routledge.</Citation></Reference><Reference><Citation>Champagne, E. R., &amp; Muise, A. (2022). Responsiveness and relationship satisfaction in couples coping with Parkinson's disease: a pilot study. Psychological Reports, 125(2), 804-821. https://doi.org/10.1177/0033294121998032</Citation></Reference><Reference><Citation>Chen, J. J. (2010). Parkinson's disease: health-related quality of life, economic cost, and implications of early treatment. The American Journal of Managed Care, 16, S87-S93.</Citation></Reference><Reference><Citation>Chu, H. S., &amp; Jang, H. Y. (2022). Exploring unmet information needs of people with Parkinson's disease and their families: focusing on information sharing in an online patient community. International Journal of Environmental Research and Public Health, 19(5), 1-10. https://doi.org/10.3390/ijerph19052521</Citation></Reference><Reference><Citation>Corbett, T. K., Cummings, A., Lee, K., Calman, L., Fenerty, V., Farrington, N., Lewis, L., Young, A., Boddington, H., Wiseman, T., Richardson, A., Foster, C., &amp; Bridges, J. (2020). Planning and optimising CHAT&amp;PLAN: A conversation-based intervention to promote person-centred care for older people living with multimorbidity. PLoS One, 15(10), e0240516. https://doi.org/10.1371/journal.pone.0240516</Citation></Reference><Reference><Citation>Department of Health &amp; Social Care. (2021). Integration and Innovation: working together to improve health and social care for all [Internet]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/960548/integration-and-innovation-working-together-to-improve-health-and-social-care-for-all-web-version.pdf</Citation></Reference><Reference><Citation>Domingos, J., Radder, D., Riggare, S., Godinho, C., Dean, J., Graziano, M., de Vries, N. M., Ferreira, J., &amp; Bloem, B. R. (2019). Implementation of a community-based exercise program for Parkinson patients: using boxing as an example. Journal of Parkinson's Disease, 9(3), 615-623. https://doi.org/10.3233/JPD-191616</Citation></Reference><Reference><Citation>Dorsey, E. R., &amp; Bloem, B. R. (2018). The Parkinson pandemic-a call to action. JAMA Neurology, 75(1), 9-10. https://doi.org/10.1001/jamaneurol.2017.3299</Citation></Reference><Reference><Citation>Dorsey, E. R., Vlaanderen, F. P., Engelen, L. J., Kieburtz, K., Zhu, W., Biglan, K. M., Faber, M. J., &amp; Bloem, B. R. (2016). Moving Parkinson care to the home. Movement Disorders: Official Journal of the Movement Disorder Society, 31(9), 1258-1262. https://doi.org/10.1002/mds.26744</Citation></Reference><Reference><Citation>Fabbri, M., Caldas, A. C., Ramos, J. B., Sanchez-Ferro, &#xc1;., Antonini, A., R&#x16f;&#x17e;i&#x10d;ka, E., Lynch, T., Rascol, O., Grimes, D., Eggers, C., Mestre, T. A., &amp; Ferreira, J. J. (2020). Moving towards home-based community-centred integrated care in Parkinson's disease. Parkinsonism &amp; Related Disorders, 78, 21-26. https://doi.org/10.1016/j.parkreldis.2020.07.001</Citation></Reference><Reference><Citation>Fereday, J., &amp; Muir-Cochrane, E. (2006). Demonstrating rigor using thematic analysis: a hybrid approach of inductive and deductive coding and theme development. International Journal of Qualitative Methods, 5, 80-92. https://doi.org/10.1177/160940690600500107</Citation></Reference><Reference><Citation>GBD 2016 Neurology Collaborators. (2019). Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. Neurology, 18(5), 459-480. https://doi.org/10.1016/S1474-4422(18)30499-X</Citation></Reference><Reference><Citation>Giacobbe, A., Au, K., Nguyen, O. T., Moore, K., Dinh, E., Ramirez-Zamora, A., Okun, M. S., &amp; Almeida, L. (2021). Geospatial analysis of persons with movement disorders living in underserved regions. Tremor and Other Hyperkinetic Movements, 11, 34. https://doi.org/10.5334/tohm.635</Citation></Reference><Reference><Citation>Hulshoff, M. J., Book, E., Dahodwala, N., Tanner, C. M., Robertson, C., &amp; Marras, C. (2021). Current knowledge on the evolution of care partner burden, needs, and coping in Parkinson's disease. Movement Disorders Clinical Practice, 8(4), 510-520. https://doi.org/10.1002/mdc3.13201</Citation></Reference><Reference><Citation>Kaltenborn, Z., Paul, K., Kirsch, J. D., Aylward, M., Rogers, E. A., Rhodes, M. T., &amp; Usher, M. G. (2021). Super fragmented: a nationally representative cross-sectional study exploring the fragmentation of inpatient care among super-utilizers. BMC Health Services Research, 21(1), 338. https://doi.org/10.1186/s12913-021-06323-5</Citation></Reference><Reference><Citation>Lee, J., Kim, Y., Kim, S., Kim, Y., Lee, Y. J., &amp; Sohn, Y. H. (2019). Unmet needs of people with Parkinson's disease: A cross-sectional study. Journal of Advanced Nursing, 75(12), 3504-3514. https://doi.org/10.1111/jan.14147</Citation></Reference><Reference><Citation>Lincoln, Y., &amp; Guba, E. G. (1985). Naturalistic inquiry. Sage.</Citation></Reference><Reference><Citation>Lubomski, M., Davis, R. L., &amp; Sue, C. M. (2021). Health-Related quality of life for Parkinson's disease patients and their caregivers. Journal of movement disorders, 14(1), 42-52 10.14802/jmd.20079</Citation></Reference><Reference><Citation>McAlister, F. A., Youngson, E., &amp; Kaul, P. (2017). Patients with heart failure readmitted to the original hospital have better outcomes than those readmitted elsewhere. Journal of the American Heart Association, 6(5), e004892. https://doi.org/10.1161/JAHA.116.004892</Citation></Reference><Reference><Citation>Merritt, R. K., Hotham, S., Graham, L., &amp; Schrag, A. (2018). The subjective experience of Parkinson's disease: a qualitative study in 60 people with mild to moderate Parkinson's in 11 European countries. European Journal of Person Centered Healthcare, 6(3), 447-453. https://doi.org/10.5750/ejpch.v6i3.1536</Citation></Reference><Reference><Citation>Navarta-S&#xe1;nchez, M. V., Caparr&#xf3;s, N., Riverol Fern&#xe1;ndez, M., De Cerio, D., Ayesa, S., Urs&#xfa;a Sesma, M. E., &amp; Portillo, M. C. (2017). Core elements to understand and improve coping with Parkinson's disease in patients and family carers: A focus group study. Journal of Advanced Nursing, 73(11), 2609-2621. https://doi.org/10.1111/jan.13335</Citation></Reference><Reference><Citation>Noblit, G. W., &amp; Hare, R. D. (1988). Meta-ethnography: Synthesizing qualitative studies (Vol. 11). Sage Publications.</Citation></Reference><Reference><Citation>Nowell, L. S., Norris, J. M., White, D. E., &amp; Moules, N. J. (2017). Thematic analysis: Striving to meet the trustworthiness criteria. International Journal of Qualitative Methods, 16, 1-13. https://doi.org/10.1177/1609406917733847</Citation></Reference><Reference><Citation>Pigott, J. S., Kane, E. J., Ambler, G., Walters, K., &amp; Schrag, A. (2022). Systematic review and meta-analysis of clinical effectiveness of self-management interventions in Parkinson's disease. BMC Geriatrics, 22(1), 45. https://doi.org/10.1186/s12877-021-02656-2</Citation></Reference><Reference><Citation>Portillo, M. C., Kennedy, A., Todorova, E., Regaira, E., Wensing, M., Foss, C., Lionis, C., Vassilev, I., Goev, V., &amp; Rogers, A. (2017). Interventions and working relationships of voluntary organisations for diabetes self-management: A cross-national study. International Journal of Nursing Studies, 70, 58-70. https://doi.org/10.1016/j.ijnurstu.2017.02.001</Citation></Reference><Reference><Citation>Portillo, M. C., Regaira, E., Pumar-M&#xe9;ndez, M. J., Mujika, A., Vassilev, I., Rogers, A., Wensing, M., Foss, C., Knutsen, I. R., Todorova, E., Roukova, P., Kennedy, A., Serrano, M., Lionis, C., Angelaki, A., Patelarou, E., &amp; Koetsenruijter, J. (2015). Voluntary organizations and community groups as new partners in diabetes self-management and education: a critical interpretative synthesis. The Diabetes Educator, 41(5), 550-568. https://doi.org/10.1177/0145721715594026</Citation></Reference><Reference><Citation>Rajan, R., Brennan, L., Bloem, B. R., Dahodwala, N., Gardner, J., Goldman, J. G., Grimes, D. A., Iansek, R., Kov&#xe1;cs, N., McGinley, J., Parashos, S. A., Piemonte, M., &amp; Eggers, C. (2020). Integrated care in Parkinson's disease: a systematic review and meta-analysis. Movement Disorders: Official Journal of the Movement Disorder Society, 35(9), 1509-1531. https://doi.org/10.1002/mds.28097</Citation></Reference><Reference><Citation>Roberts, K., Dowell, A., &amp; Nie, J. B. (2019). Attempting rigour and replicability in thematic analysis of qualitative research data; a case study of codebook development. BMC Medical Research Methodology, 19(1), 66. https://doi.org/10.1186/s12874-019-0707-y</Citation></Reference><Reference><Citation>Rutten, S., van den Heuvel, O. A., de Kruif, A., Schoonmade, L. J., Schumacher, E., Vermunt, K., Hagen, R., van Wegen, E., &amp; Rutten, K. (2021). The subjective experience of living with Parkinson's disease: A meta-ethnography of qualitative literature. Journal of Parkinson's Disease, 11(1), 139-151. https://doi.org/10.3233/JPD-202299</Citation></Reference><Reference><Citation>Shepperd, S., Doll, H., Angus, R. M., Clarke, M. J., Iliffe, S., Kalra, L., Ricauda, N. A., Tibaldi, V., &amp; Wilson, A. D. (2009). Avoiding hospital admission through provision of hospital care at home: a systematic review and meta-analysis of individual patient data. CMAJ: Canadian Medical Association Journal, 180(2), 175-182. https://doi.org/10.1503/cmaj.081491</Citation></Reference><Reference><Citation>Skivington, K., Matthews, L., Simpson, S. A., Craig, P., Baird, J., Blazeby, J. M., Boyd, K. A., Craig, N., French, D. P., McIntosh, E., Petticrew, M., Rycroft-Malone, J., White, M., &amp; Moore, L. (2021). A new framework for developing and evaluating complex interventions: Update of Medical Research Council guidance. BMJ (Clinical research ed.), 374, 1-11, n2061. https://doi.org/10.1136/bmj.n2061</Citation></Reference><Reference><Citation>Soilemezi, D., Roberts, H. C., Navarta-S&#xe1;nchez, M. V., Kunkel, D., Ewings, S., Reidy, C., &amp; Portillo, M. C. (2022). Managing Parkinson's during the COVID-19 pandemic: perspectives from people living with Parkinson's and health professionals. Journal of Clinical Nursing, 1-12. https://doi.org/10.1111/jocn.16367. Online ahead of print.</Citation></Reference><Reference><Citation>The Lancet Neurology. (2020). Developing therapies for Parkinson's disease. The Lancet. Neurology, 19(10), 797. https://doi.org/10.1016/S1474-4422(20)30320-3</Citation></Reference><Reference><Citation>Thorstensen-Woll, C., Wellings, D., Crump, H., &amp; Graham, C. (2021). Understanding integration: how to listen to and learn from people and communities. The King's Fund https://www.kingsfund.org.uk/publications/understanding-integration-listen-people-communities</Citation></Reference><Reference><Citation>Titova, N., &amp; Chaudhuri, K. R. (2017). Personalized medicine in Parkinson's disease: Time to be precise. Movement Disorders: Official Journal of the Movement Disorder Society, 32(8), 1147-1154. https://doi.org/10.1002/mds.27027</Citation></Reference><Reference><Citation>Todorova, A., Jenner, P., &amp; Ray Chaudhuri, K. (2014). Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected. Practical Neurology, 14(5), 310-322. https://doi.org/10.1136/practneurol-2013-000741</Citation></Reference><Reference><Citation>Tong, A., Sainsbury, P., &amp; Craig, J. (2007). Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care, 19(6), 349-357. https://doi.org/10.1093/intqhc/mzm042</Citation></Reference><Reference><Citation>Tuijt, R., Tan, A., Armstrong, M., Pigott, J., Read, J., Davies, N., Walters, K., &amp; Schrag, A. (2020). Self-Management components as experienced by people with Parkinson's disease and their carers: a systematic review and synthesis of the qualitative literature. Parkinson's Disease, 2020, 1-10, 8857385. https://doi.org/10.1155/2020/8857385</Citation></Reference><Reference><Citation>Valentijn, P. P., Pereira, F., Sterner, C. W., Vrijhoef, H., Ruwaard, D., Hegbrant, J., &amp; Strippoli, G. (2019). Validation of the Rainbow Model of Integrated Care Measurement Tools (RMIC-MTs) in renal care for patient and care providers. PLoS One, 14(9), e0222593. https://doi.org/10.1371/journal.pone.0222593</Citation></Reference><Reference><Citation>van Halteren, A. D., Munneke, M., Smit, E., Thomas, S., Bloem, B. R., &amp; Darweesh, S. (2020). Personalized care management for persons with Parkinson's disease. Journal of Parkinson's Disease, 10(s1), S11-S20. https://doi.org/10.3233/JPD-202126</Citation></Reference><Reference><Citation>Vatter, S., McDonald, K. R., Stanmore, E., Clare, L., McCormick, S. A., &amp; Leroi, I. (2018). A qualitative study of female caregiving spouses' experiences of intimate relationships as cognition declines in Parkinson's disease. Age and Ageing, 47(4), 604-610. https://doi.org/10.1093/ageing/afy049</Citation></Reference><Reference><Citation>Wieringa, G., Dale, M., &amp; Eccles, F. (2022). Adjusting to living with Parkinson's disease; a meta-ethnography of qualitative research. Disability and Rehabilitation, 44(23), 6949-6968. https://doi.org/10.1080/09638288.2021.1981467</Citation></Reference><Reference><Citation>Wood, S., Finnis, A., Khan, H., &amp; Ejbye, J. (2016). At the heart of health: realising the value of people and communities. Health Foundation and Nesta https://www.nesta.org.uk/report/at-the-heart-of-health-realising-the-value-of-people-and-communities/</Citation></Reference><Reference><Citation>World Health Organization - Regional Office for Europe. (2018). Multisectoral and intersectoral action for improved health and well-being for all: mapping of the WHO European Region Governance for a sustainable future: improving health and well-being for all (2018) [Internet]. https://www.euro.who.int/en/about-us/regional-director/regional-directors-emeritus/dr-zsuzsanna-jakab,-2010-2019/health-2020-the-european-policy-for-health-and-well-being/publications/2018/multisectoral-and-intersectoral-action-for-improved-health-and-well-being-for-all-mapping-of-the-who-european-region-governance-for-a-sustainable-future-improving-health-and-well-being-for-all-2018</Citation></Reference><Reference><Citation>World Health Organization. Regional Office for Europe, European Observatory on Health Systems and Policies, Nolte, E., Knai, C., &amp; Saltman, R. B. (2014). Assessing chronic disease management in European health systems: concepts and approaches. World Health Organization. Regional Office for Europe https://apps.who.int/iris/handle/10665/326351</Citation></Reference><Reference><Citation>Yang, W., Hamilton, J. L., Kopil, C., Beck, J. C., Tanner, C. M., Albin, R. L., Ray Dorsey, E., Dahodwala, N., Cintina, I., Hogan, P., &amp; Thompson,&#xa0;T. (2020). Current and projected future economic burden of Parkinson's disease in the U.S. NPJ Parkinson's Disease, 6, 15. https://doi.org/10.1038/s41531-020-0117-1</Citation></Reference><Reference><Citation>Ypinga, J., de Vries, N. M., Boonen, L., Koolman, X., Munneke, M., Zwinderman, A. H., &amp; Bloem, B. R. (2018). Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: a retrospective analysis of medical claims data. The Lancet. Neurology, 17(2), 153-161. https://doi.org/10.1016/S1474-4422(17)30406-4</Citation></Reference><Reference><Citation>Zaman, M. S., Ghahari, S., &amp; McColl, M. A. (2021). Barriers to accessing healthcare services for people with Parkinson's disease: a scoping review. Journal of Parkinson's Disease, 11(4), 1537-1553. https://doi.org/10.3233/JPD-212735</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36726285</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1545-3847</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Season>Apr-Jun</Season></PubDate></JournalIssue><Title>Gerontology &amp; geriatrics education</Title><ISOAbbreviation>Gerontol Geriatr Educ</ISOAbbreviation></Journal><ArticleTitle>Growing older with intellectual and developmental disabilities: Implementing and evaluating a project ECHO for dementia education.</ArticleTitle><Pagination><StartPage>180</StartPage><EndPage>196</EndPage><MedlinePgn>180-196</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/02701960.2023.2168269</ELocationID><Abstract><AbstractText>The needs of the rapidly expanding population of adults growing older with intellectual and developmental disabilities (IDD) and their families span both the IDD and the aging service systems. The use of Project ECHO (Extension for Community Healthcare Outcomes) for professional education can bridge gaps and span boundaries between them at the macro, meso, and micro levels. A series of 10 ECHO sessions over 12&#x2009;months was developed, incorporating key content on IDD and AD/ADRD for 145 providers in over 20 agencies. Impacts were assessed by a follow-up survey sent to participants after each program. The evaluation included quantitative assessment of ECHO features and a retrospective pre- and posttest of knowledge acquisition; a separate item assessed intention to apply information. Qualitative data were collected from open-ended items. The case presentation and discussion were the most effective ECHO components. Knowledge acquisition was significant for all sessions; most important uses included providing better care to clients/patients, training staff, and educating family and/or caregivers. Participants were aligned with two distinct groups, one with a predominant knowledge focus, the other with an emphasis on networking. Project ECHO can bridge gaps and span boundaries between the IDD and aging care systems at multiple levels, improving interprofessional collaboration and care by addressing both knowledge and networking needs of providers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Phillip G</ForeName><Initials>PG</Initials><Identifier Source="ORCID">0000-0002-6018-0686</Identifier><AffiliationInfo><Affiliation>Rhode Island Geriatric Education Center, University of Rhode Island, Kingston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ansello</LastName><ForeName>Edward F</ForeName><Initials>EF</Initials><AffiliationInfo><Affiliation>Virginia Geriatric Education Center, Virginia Commonwealth University, Richmond, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helm</LastName><ForeName>Faith</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Rhode Island Geriatric Education Center, University of Rhode Island, Kingston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanzer</LastName><ForeName>Ray</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Rhode Island Geriatric Education Center, University of Rhode Island, Kingston, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Gerontol Geriatr Educ</MedlineTA><NlmUniqueID>8101294</NlmUniqueID><ISSNLinking>0270-1960</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002658" MajorTopicYN="Y">Developmental Disabilities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008607" MajorTopicYN="Y">Intellectual Disability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005853" MajorTopicYN="N">Geriatrics</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015397" MajorTopicYN="N">Program Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016730" MajorTopicYN="N">Program Development</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s Disease and Alzheimer&#x2019;s Disease Related Dementias (AD/ADRD)</Keyword><Keyword MajorTopicYN="N">intellectual disability</Keyword><Keyword MajorTopicYN="N">networking</Keyword><Keyword MajorTopicYN="N">professional education</Keyword><Keyword MajorTopicYN="N">program evaluation</Keyword><Keyword MajorTopicYN="N">project ECHO</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>28</Day><Hour>21</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>2</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36726285</ArticleId><ArticleId IdType="doi">10.1080/02701960.2023.2168269</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36726055</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2318</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>BMC geriatrics</Title><ISOAbbreviation>BMC Geriatr</ISOAbbreviation></Journal><ArticleTitle>Prevalence of visual impairment in older people living with dementia and its impact: a scoping review.</ArticleTitle><Pagination><StartPage>63</StartPage><MedlinePgn>63</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">63</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12877-022-03581-8</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">Visual impairment (VI) and dementia both increase with age, and it is likely that many older people are living with both conditions. This scoping review aims to investigate the prevalence and types of VI among older people living with dementia, and the impact of VI on older people living with dementia and their caregivers.</AbstractText><AbstractText Label="METHODS">This scoping review used Arksey and O'Malley's methodological framework. Studies in any setting involving people living with dementia and some assessment of either VI, eye diseases causing VI or the impact of VI were included.</AbstractText><AbstractText Label="RESULTS">Thirty-six studies were included. Thirty-one studies reported the prevalence of VI in older people living with dementia, while ten studies reported on impacts of VI on people living with dementia. Only one study reported on impacts on caregivers. The prevalence of VI or specific eye diseases among older people living with dementia ranged from 0.2 to 74%. The impacts of VI on older people living with dementia included increased use of hospital services, increased disability and dependency, reduced social engagement, negative emotions, increased abnormal behaviours, loss of hobbies, difficulty in using visual aids or memory aids, and greater Neuropsychiatric Inventory symptoms. And the impacts on caregivers included increased conflict and physical exhaustion.</AbstractText><AbstractText Label="CONCLUSION">VI is common in older people living with dementia and is associated with negative impacts on those with dementia and their caregivers. However, heterogeneity between studies in terms of setting and method for assessing and defining VI make it difficult to compare findings among studies. Further research is needed, particularly assessing the impact on caregivers.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wanyu</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>School of Public Health, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Timothy V</ForeName><Initials>TV</Initials><AffiliationInfo><Affiliation>Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, Sydney, NSW, 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, Royal North Shore Hospital, Reserve Rd, St Leonards, NSW, 2065, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vision Eye Institute, Level 3, 270 Victoria Ave, Chatswood, Sydney, NSW, 2067, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poulos</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>HammondCare, 4/207B Pacific Hwy, St Leonards, Sydney, NSW, 2065, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Population Health, The University of NSW, Samuels Building, Samuel Terry Ave, Kensington, Sydney, NSW, 2033, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanaway</LastName><ForeName>Fiona F</ForeName><Initials>FF</Initials><AffiliationInfo><Affiliation>School of Public Health, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2006, Australia. fiona.stanaway@sydney.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Geriatr</MedlineTA><NlmUniqueID>100968548</NlmUniqueID><ISSNLinking>1471-2318</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015354" MajorTopicYN="Y">Vision, Low</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005128" MajorTopicYN="Y">Eye Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Age-related macular degeneration</Keyword><Keyword MajorTopicYN="N">Alzheimer&#x2019;s</Keyword><Keyword MajorTopicYN="N">Cataract</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Glaucoma</Keyword><Keyword MajorTopicYN="N">Older adults</Keyword><Keyword MajorTopicYN="N">Scoping review</Keyword><Keyword MajorTopicYN="N">Sight loss</Keyword><Keyword MajorTopicYN="N">Visual impairment</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>2</Day><Hour>0</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36726055</ArticleId><ArticleId IdType="pmc">PMC9890816</ArticleId><ArticleId IdType="doi">10.1186/s12877-022-03581-8</ArticleId><ArticleId IdType="pii">10.1186/s12877-022-03581-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>GBD 2016 Dementia Collaborators Global, regional, and national burden of Alzheimer's disease and other dementias, 1990&#x2013;2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):88&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6291454</ArticleId><ArticleId IdType="pubmed">30497964</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourne RG, White RA, Flaxman S, Mascarenhas M, Price H, et al. The Global Burden of Disease Study: The impact of vision loss: prevalence and trends of blindness and visual impairment over the past 28 years. Investig Ophthalmol Vis Sci. 2012;53(14):3175.</Citation></Reference><Reference><Citation>Rees G, Fenwick EK, Keeffe JE, Mellor D, EL L. Detection of depression in patients with low vision. Am Academy of Optom. 2009;86(12):1328&#x2013;1336.</Citation><ArticleIdList><ArticleId IdType="pubmed">19844188</ArticleId></ArticleIdList></Reference><Reference><Citation>Stelmack J. Quality of life of low-vision patients and outcomes of low-vision rehabilitation. Optom Vis Sci. 2001;78(5):335&#x2013;342.</Citation><ArticleIdList><ArticleId IdType="pubmed">11384011</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrusjak W, Barbosa A, Mountain G. Identifying and managing hearing and vision loss in older people in care homes: a scoping review of the evidence. Gerontologist. 2020;60(3):e155&#x2013;e168.</Citation><ArticleIdList><ArticleId IdType="pubmed">31322168</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin MY, Gutierrez PR, Stone KLY, et al. Vision impairment and combined vision and hearing impairment predict cognitive and functional decline in older women. J Am Geriatr Soc. 2004;52(12):1996&#x2013;2002.</Citation><ArticleIdList><ArticleId IdType="pubmed">15571533</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu PL, Cohen HJ, Fillenbaum GG, Burchett BM, Whitson HE. Association of co-Existing Impairments in cognition and self-rated vision and hearing with health outcomes in older adults. Gerontol Geriatr Med. 2016:2:2333721415623495. 10.1177/2333721415623495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4820285</ArticleId><ArticleId IdType="pubmed">27054148</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitson HE, Cousins SW, Burchett BM, Hybels CF, Pieper CF, Cohen HJ. The combined effect of visual impairment and cognitive impairment on disability in older people. J Am Geriatr Soc. 2007;55(6):885&#x2013;891.</Citation><ArticleIdList><ArticleId IdType="pubmed">17537089</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence V, Murray J. Understanding the experiences and needs of people with dementia and sight loss. Working with Older People. 2009;13(3):29&#x2013;33.</Citation></Reference><Reference><Citation>Bunn F, Burn AM, Goodman C, et al. Comorbidity and dementia: a scoping review of the literature. BMC Med. 2014;12:192. 10.1186/s12916-014-0192-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4229610</ArticleId><ArticleId IdType="pubmed">25358236</ArticleId></ArticleIdList></Reference><Reference><Citation>Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19&#x2013;32.</Citation></Reference><Reference><Citation>Abdullah AB. Visual problems of the aged. Trans Ophthalmol Soc U K. 1965;85:233&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">5227184</ArticleId></ArticleIdList></Reference><Reference><Citation>Amjad H, Snyder SH, Wolff JL, Oh E, Samus QM. Before hospice: symptom burden, dementia, and social participation in the last year of life. J Palliat Med. 2019;22(9):1106&#x2013;1114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6735320</ArticleId><ArticleId IdType="pubmed">31058566</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayer AU, Ferrari F, Erb C. High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur Neurol. 2002;47(3):165&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">11914555</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayer AU, Keller ON, Ferrari F, Maag KP. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson&#x2019;s disease. Am J Ophthalmol. 2002;133(1):135&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">11755850</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett HQ, Norton S, Bunn F, et al. The impact of dementia on service use by individuals with a comorbid health condition: a comparison of two cross-sectional analyses conducted approximately 10 years apart. BMC Med. 2018;16(1):114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6056993</ArticleId><ArticleId IdType="pubmed">30037332</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen M, Edgar DF, Hancock B, et al. The prevalence of visual impairment in people with dementia (the PrOVIDe study): a cross-sectional study of people aged 60&#x2013;89 years with dementia and qualitative exploration of individual, carer and professional perspectives. Southampton (UK): NIHR Journals Library; 2016. 10.3310/hsdr04210.</Citation><ArticleIdList><ArticleId IdType="pubmed">27489923</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcenac G, Herard ME, Kergoat MJ, et al. Assessment of visual function in institutionalized elderly patients. J Am Med Dir Assoc. 2009;10(1):45&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">19111852</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra VBN, Schoenberg BS. Conditions associated with Alzheimer's disease at death: case-control study. Neurology. 1986;36(2):209&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">3945392</ArticleId></ArticleIdList></Reference><Reference><Citation>Chriqui E, Law C, Kergoat MJ, Leclerc BS, Kergoat H. Visual impairment in older institutionalised Canadian seniors with dementia. Ophthalmic Physiol Opt. 2017;37(2):225&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">28211177</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung SDHJ, Chen CH, Lin HC, Tsai MC, Sheu JJ. Dementia is associated with open-angle glaucoma: a population-based study. Eye (Lond) 2015;29(10):1340&#x2013;1346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815685</ArticleId><ArticleId IdType="pubmed">26160529</ArticleId></ArticleIdList></Reference><Reference><Citation>Clague FMS, McLean G, Reynish E, Guthrie B. Comorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data. Age Ageing. 2017;46(1):33&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">28181629</ArticleId></ArticleIdList></Reference><Reference><Citation>Deardorff WJ, Liu PL, Sloane R, et al. Association of sensory and cognitive impairment with healthcare utilization and cost in older adults. J Am Geriatr Soc. 2019;67(8):1617&#x2013;1624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6684393</ArticleId><ArticleId IdType="pubmed">30924932</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost S, Guymer R, Aung KZ, et al. Alzheimer's disease and the early signs of age-related macular degeneration. Curr Alzheimer Res. 2016;13(11):1259&#x2013;1266.</Citation><ArticleIdList><ArticleId IdType="pubmed">27335042</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamedani AG, VanderBeek BL, Willis AW. Blindness and visual impairment in the Medicare population: disparities and association with hip fracture and neuropsychiatric outcomes. Ophthalmic Epidemiol. 2019;26(4):279&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6641987</ArticleId><ArticleId IdType="pubmed">31062638</ArticleId></ArticleIdList></Reference><Reference><Citation>Heun RSD, Potluri R, Natalwala A. Alzheimer's disease and co-morbidity: increased prevalence and possible risk factors of excess mortality in a naturalistic 7-year follow-up. Eur Psychiatry. 2013;28(1):40&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">21924588</ArticleId></ArticleIdList></Reference><Reference><Citation>John NG. Cataracts and Alzheimer disease. Alzheimer Dis Assoc Disord. 1999;13(2):118&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">10372956</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang H. Correlates of social engagement in nursing home residents with dementia. Asian Nurs Res. 2012;6(2):75&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">25030831</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiely KM, Mortby ME, Anstey KJ. Differential associations between sensory loss and neuropsychiatric symptoms in adults with and without a neurocognitive disorder. Int Psychogeriatr. 2018;30(2):261&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pubmed">28724467</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosse NM, De Groot MH, Vuillerme N, Hortobagyi T, Lamoth CJC. Factors related to the high fall rate in long-term care residents with dementia. Int Psychogeriatr. 2015;27(5):803&#x2013;814.</Citation><ArticleIdList><ArticleId IdType="pubmed">25465203</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai SWLC, Liao KF. Glaucoma may be a non-memory manifestation of Alzheimer's disease in older people. Int Psychogeriatr. 2017;27:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552085</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;pp&#xf6;nen MKIR, R&#xe4;ih&#xe4; IJ, Vahlberg TJ, Loikas SM, Takala TI, Puolijoki H, Irjala KM, Kivel&#xe4; SL. Undiagnosed diseases in patients with dementia--a potential target group for intervention. Dement Geriatr Cogn Disord. 2004;18(3&#x2013;4):321&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pubmed">15305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, He P, Guo C, Chen G, Li N, Zheng X. Association between sensory impairment and dementia in older adults: evidence from China. J Am Geriatr Soc. 2018;66(3):480&#x2013;486.</Citation><ArticleIdList><ArticleId IdType="pubmed">29319875</ArticleId></ArticleIdList></Reference><Reference><Citation>Marquie M, Castilla-Marti M, Valero S, et al. Visual impairment in aging and cognitive decline: experience in a memory clinic. Sci Rep. 2019;9(1):8698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6581941</ArticleId><ArticleId IdType="pubmed">31213626</ArticleId></ArticleIdList></Reference><Reference><Citation>Morse AR, Teresi J, Rosenthal B, Holmes D, Yatzkan ES. Visual acuity assessment in persons with dementia. J Vis Impair Blind. 2004;98(9):560&#x2013;566.</Citation></Reference><Reference><Citation>Muurinen SM, Soini HH, Suominen MH, Saarela RK, Savikko NM, Pitkala KH. Vision impairment and nutritional status among older assisted living residents. Arch Gerontol Geriatr. 2014;58(3):384&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pubmed">24398167</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyman SR, Innes A, Heward M. Social care and support needs of community-dwelling people with dementia and concurrent visual impairment. Aging Ment Health. 2017;21(9):961&#x2013;967.</Citation><ArticleIdList><ArticleId IdType="pubmed">27215277</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel N, Stagg B, Ehrlich JR. The impact of comorbid visual impairment and dementia on activity limitations in older adults. Invest Ophthalmol Vis Sci. 2019;60(9):3635.</Citation></Reference><Reference><Citation>Pelletier A-A, Theoret M-E, Boutin T, et al. Prevalence of glaucoma in hospitalized older adults with Alzheimer's disease. Can J Neurol Sci. 2014;41(2):206&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">24534032</ArticleId></ArticleIdList></Reference><Reference><Citation>Prince M, Acosta D, Ferri CP, et al. The association between common physical impairment and dementia in low and middle income countries, and, among people with dementia, their association with cognitive function and disability. A 10/66 Dementia Research Group population-based study. Int J Geriatr Psychiatry. 2011;26(5):511&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pubmed">20669334</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilnak GJ, Deans JR, Doraiswamy PM, Stinnett S, Whitson HE, Lad EM. Comorbidity of age-related macular degeneration with Alzheimer's disease: a histopathologic case-control study. PLoS One. 2019;14(9):e0223199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6768473</ArticleId><ArticleId IdType="pubmed">31568508</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura H, Kawakami H, Kanamoto T, et al. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. J Neurol Sci. 2006;246(1&#x2013;2):79&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">16564058</ArticleId></ArticleIdList></Reference><Reference><Citation>Varadaraj V, Chung SE, Swiatek KS, et al. Caring for older adults with vision impairment and dementia. Innov. Aging. 2020;4(6):igaa043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7657090</ArticleId><ArticleId IdType="pubmed">33209994</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams MA, Silvestri V, Craig D, Passmore A, Silvestri G. The prevalence of age-related macular degeneration in Alzheimer's disease. J Alzheimers Dis. 2014;42(3):909&#x2013;914.</Citation><ArticleIdList><ArticleId IdType="pubmed">25024309</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittich W, Al-Yawer F, Phillips N. Visual acuity and contrast sensitivity at various stages of cognitive impairment in the COMPASS-ND study. Invest Ophthalmol Vis Sci. 2019;60(9):5913.</Citation></Reference><Reference><Citation>Wong MY, Chen CL, Ong YT, et al. High prevalence of undiagnosed eye diseases in individuals with dementia. J Am Geriatr Soc. 2015;63(1):192&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">25597578</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence V, Murray J, Ffytche D, Banerjee S. "out of sight, out of mind": a qualitative study of visual impairment and dementia from three perspectives: corrigendum. Int Psychogeriatr. 2009;21(3):519.</Citation><ArticleIdList><ArticleId IdType="pubmed">19265571</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12):e1221&#x2013;e1234.</Citation><ArticleIdList><ArticleId IdType="pubmed">29032195</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer MR, Pluijm SM, Lips P, et al. Different aspects of visual impairment as risk factors for falls and fractures in older men and women. J Bone Miner Res. 2004;19(9):1539&#x2013;1547.</Citation><ArticleIdList><ArticleId IdType="pubmed">15312256</ArticleId></ArticleIdList></Reference><Reference><Citation>van Doorn C, Gruber-Baldini AL, Zimmerman S, et al. Dementia as a risk factor for falls and fall injuries among nursing home residents. J Am Geriatr Soc. 2003;51(9):1213&#x2013;1218.</Citation><ArticleIdList><ArticleId IdType="pubmed">12919232</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36719721</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1929-0748</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2023</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>JMIR research protocols</Title><ISOAbbreviation>JMIR Res Protoc</ISOAbbreviation></Journal><ArticleTitle>A Web-Based Decision Aid for Caregivers of Persons With Dementia With Firearm Access (Safe at Home Study): Protocol for a Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>e43702</StartPage><MedlinePgn>e43702</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e43702</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/43702</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Firearm safety among individuals with Alzheimer disease and related dementias (ADRD) is an underdiscussed and underresearched concern in the United States, especially given the growing population of community-dwelling adults with ADRD. The "Safety in Dementia" (SiD) web-based decision aid was developed to support caregivers in addressing firearm access; the efficacy of SiD is unknown.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Through the SiD decision aid, the Safe at Home (S@H) study aims to support caregivers in making decisions about home safety that align with their goals and values, and behaviors regarding firearm access for persons with ADRD and firearm access.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The S@H study is a 2-armed randomized controlled trial to test the effect of the SiD decision aid on caregivers of community-dwelling adults with ADRD who have firearm access. S@H aims to recruit 500 ADRD caregivers (age &#x2265;18 years, fluent in English or Spanish, and in the United States) through online or social media advertisements and through relevant organizations. Participants are randomized to view SiD or a control website at their own pace; all participants complete web-based questionnaires at baseline, 2 weeks, 2 months, and 6 months. The primary outcome is immediate preparation for decision-making; secondary outcomes include longitudinal decision outcomes and self-reported modifications to firearm access. The relative reach and effectiveness of each recruitment method (online/social media and through relevant organizations) will be assessed by examining differences in caregiver participation, retention rates, and relative cost.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study enrollment began in May 2022. As of December 2022, a total of 117 participants had enrolled.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The S@H study is the first randomized trial of a firearm safety decision aid for ADRD caregivers. The results from this study will inform how best to support caregivers in decision-making regarding firearm safety. Further, results may guide approaches for recruiting caregivers and for dissemination of resources.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov NCT05173922; https://clinicaltrials.gov/ct2/show/NCT05173922.</AbstractText><AbstractText Label="INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)" NlmCategory="UNASSIGNED">DERR1-10.2196/43702.</AbstractText><CopyrightInformation>&#xa9;Virginia McCarthy, Jennifer Portz, Stacy M Fischer, Emily Greenway, Rachel L Johnson, Christopher E Knoepke, Daniel D Matlock, Faris Omeragic, Ryan A Peterson, Megan L Ranney, Marian E Betz. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 31.01.2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>McCarthy</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-9265-054X</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Injury and Violence Prevention Center, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Portz</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3107-3598</Identifier><AffiliationInfo><Affiliation>Division of General Internal Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fischer</LastName><ForeName>Stacy M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0003-2814-7576</Identifier><AffiliationInfo><Affiliation>Division of General Internal Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Greenway</LastName><ForeName>Emily</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-4683-7717</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Johnson</LastName><ForeName>Rachel L</ForeName><Initials>RL</Initials><Identifier Source="ORCID">0000-0003-3002-5412</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Knoepke</LastName><ForeName>Christopher E</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0003-3521-7157</Identifier><AffiliationInfo><Affiliation>Adult and Child Center for Outcomes Research and Delivery Science, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Matlock</LastName><ForeName>Daniel D</ForeName><Initials>DD</Initials><Identifier Source="ORCID">0000-0001-9597-9642</Identifier><AffiliationInfo><Affiliation>Adult and Child Center for Outcomes Research and Delivery Science, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Eastern Colorado Geriatric Research Education and Clinical Center, Rocky Mountain Regional VA Medical Center, Aurora, CO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Geriatric Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Omeragic</LastName><ForeName>Faris</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-0509-9754</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Peterson</LastName><ForeName>Ryan A</ForeName><Initials>RA</Initials><Identifier Source="ORCID">0000-0002-4650-5798</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ranney</LastName><ForeName>Megan L</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0002-8450-9642</Identifier><AffiliationInfo><Affiliation>Brown-Lifespan Center for Digital Health, Brown University, Providence, RI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, Brown University, Providence, RI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, Warren Alpert Medical School, Brown University, Providence, RI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Betz</LastName><ForeName>Marian E</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0003-1643-6565</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Injury and Violence Prevention Center, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Eastern Colorado Geriatric Research Education and Clinical Center, Rocky Mountain Regional VA Medical Center, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05173922</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG076364</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Res Protoc</MedlineTA><NlmUniqueID>101599504</NlmUniqueID><ISSNLinking>1929-0748</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ADRD</Keyword><Keyword MajorTopicYN="N">Alzheimers</Keyword><Keyword MajorTopicYN="N">caregiver</Keyword><Keyword MajorTopicYN="N">decision</Keyword><Keyword MajorTopicYN="N">decision aid decision-making</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">firearms</Keyword><Keyword MajorTopicYN="N">storage</Keyword><Keyword MajorTopicYN="N">web-based</Keyword></KeywordList><CoiStatement>Conflicts of Interest: MLR declares the following conflicts: grants from the Center for Disease Control (CDC) and the National Institutes of Health (NIH); unpaid Senior Strategic Advisor to the American Foundation for Firearm Injury Reduction in Medicine (AFFIRM) at the Aspen Institute; unpaid Board of Directors for the NonViolence Institute of Rhode Island 2022.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>31</Day><Hour>11</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36719721</ArticleId><ArticleId IdType="pmc">PMC9929727</ArticleId><ArticleId IdType="doi">10.2196/43702</ArticleId><ArticleId IdType="pii">v12i1e43702</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen C, Zissimopoulos JM. Racial and ethnic differences in trends in dementia prevalence and risk factors in the United States. Alzheimers Dement (N Y) 2018;4:510&#x2013;520. doi: 10.1016/j.trci.2018.08.009. 
 
S2352-8737(18)30052-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2018.08.009</ArticleId><ArticleId IdType="pmc">PMC6197734</ArticleId><ArticleId IdType="pubmed">30364652</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer's Association  2020 Alzheimer's disease facts and figures. Alzheimers Dement. 2020 Mar 10;16(3):391&#x2013;460. doi: 10.1002/alz.12068. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12068</ArticleId><ArticleId IdType="doi">10.1002/alz.12068</ArticleId></ArticleIdList></Reference><Reference><Citation>Boots LMM, de Vugt ME, van Knippenberg RJ, Kempen GI, Verhey FR. A systematic review of internet-based supportive interventions for caregivers of patients with dementia. Int J Geriatr Psychiatry. 2014 Apr;29(4):331&#x2013;344. doi: 10.1002/gps.4016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4016</ArticleId><ArticleId IdType="pubmed">23963684</ArticleId></ArticleIdList></Reference><Reference><Citation>Betz ME, Ranney ML, Knoepke CE, Johnson RL, Pallin R, Miller M, Wintemute GJ. Dementia and firearms: an exploratory survey of caregiver needs. J Gen Intern Med. 2019 Oct;34(10):1984&#x2013;1986. doi: 10.1007/s11606-019-05089-1. 
 
10.1007/s11606-019-05089-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-019-05089-1</ArticleId><ArticleId IdType="pmc">PMC6816792</ArticleId><ArticleId IdType="pubmed">31197733</ArticleId></ArticleIdList></Reference><Reference><Citation>Betz ME, Azrael D, Johnson RL, Knoepke CE, Ranney ML, Wintemute GL, Matlock D, Suresh K, Miller M. Views on firearm safety among caregivers of people with Alzheimer disease and related dementias. JAMA Netw Open. 2020 Jul 01;3(7):e207756. doi: 10.1001/jamanetworkopen.2020.7756. 
 
2768246</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.7756</ArticleId><ArticleId IdType="pmc">PMC7364369</ArticleId><ArticleId IdType="pubmed">32667652</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker K, Horowitz JM, Igielnik R, Oliphant JB, Brown A. America's complex relationship with guns: an in-depth look at the attitudes and experiences of U.S. adults. Pew Research Center. 2017.  [2022-07-28].  
 https://www.pewresearch.org/social-trends/2017/06/22/americas-complex-relationship-with-guns/
</Citation></Reference><Reference><Citation>Betz ME, Miller M, Matlock DD, Wintemute GJ, Johnson RL, Grogan C, Lum HD, Knoepke CE, Ranney ML, Suresh K, Azrael D. Older firearm owners and advance planning: results of a national survey. Ann Intern Med. 2021 Mar;174(2):279&#x2013;282. doi: 10.7326/M20-2280. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-2280?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.7326/M20-2280</ArticleId><ArticleId IdType="pmc">PMC8422861</ArticleId><ArticleId IdType="pubmed">33017563</ArticleId></ArticleIdList></Reference><Reference><Citation>Polzer E, Nearing K, Knoepke CE, Matlock DD, McCourt A, Betz ME. Firearm access in dementia: legal and logistic challenges for caregivers. Int Rev Psychiatry. 2021 Nov;33(7):653&#x2013;661. doi: 10.1080/09540261.2021.1887098. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09540261.2021.1887098</ArticleId><ArticleId IdType="pmc">PMC8484338</ArticleId><ArticleId IdType="pubmed">33792478</ArticleId></ArticleIdList></Reference><Reference><Citation>Betz ME, Azrael D, Johnson RL, Knoepke CE, Ranney ML, Wintemute GJ, Matlock D, Suresh K, Miller M. Views on firearm safety among caregivers of people with Alzheimer disease and related dementias. JAMA Netw Open. 2020 Jul 01;3(7):e207756. doi: 10.1001/jamanetworkopen.2020.7756. 
 
2768246</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.7756</ArticleId><ArticleId IdType="pmc">PMC7364369</ArticleId><ArticleId IdType="pubmed">32667652</ArticleId></ArticleIdList></Reference><Reference><Citation>Conejero I, Navucet S, Keller J, Oli&#xe9; E, Courtet P, Gabelle A. A complex relationship between suicide, dementia, and amyloid: a narrative review. Front Neurosci. 2018;12:371. doi: 10.3389/fnins.2018.00371. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00371</ArticleId><ArticleId IdType="pmc">PMC5992441</ArticleId><ArticleId IdType="pubmed">29910709</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartzell JW, Geary R, Gyure K, Chivukula VR, Haut MW. Completed suicide in an autopsy-confirmed case of early onset Alzheimer's disease. Neurodegener Dis Manag. 2018 Apr;8(2):81&#x2013;88. doi: 10.2217/nmt-2017-0045. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt-2017-0045?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.2217/nmt-2017-0045</ArticleId><ArticleId IdType="pmc">PMC6367712</ArticleId><ArticleId IdType="pubmed">29319406</ArticleId></ArticleIdList></Reference><Reference><Citation>WISQARS (Web-based Injury Statistics Query and Reporting System) National Center for Injury Prevention and Control. 2021.  [2022-04-18].  
 https://www.cdc.gov/injury/wisqars/index.html
.</Citation></Reference><Reference><Citation>Schmutte T, Olfson M, Maust DT, Xie M, Marcus SC. Suicide risk in first year after dementia diagnosis in older adults. Alzheimers Dement. 2022 Mar;18(2):262&#x2013;271. doi: 10.1002/alz.12390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12390</ArticleId><ArticleId IdType="pmc">PMC8613307</ArticleId><ArticleId IdType="pubmed">34036738</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen T, Makaroun LK, Conwell Y, Betz M. Violence in older adults: scope, impact, challenges, and strategies for prevention. Health Aff (Millwood) 2019 Oct;38(10):1630&#x2013;1637. doi: 10.1377/hlthaff.2019.00577. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2019.00577</ArticleId><ArticleId IdType="pmc">PMC7327526</ArticleId><ArticleId IdType="pubmed">31589527</ArticleId></ArticleIdList></Reference><Reference><Citation>Demographics of social media users and adoption in the United States. Pew Research Center. 2021.  [2022-07-31].  
 https://www.pewresearch.org/internet/fact-sheet/social-media/
</Citation></Reference><Reference><Citation>Green BM, Van Horn KT, Gupte K, Evans M, Hayes S, Bhowmick A. Assessment of adaptive engagement and support model for people with chronic health conditions in online health communities: combined content analysis. J Med Internet Res. 2020 Jul 07;22(7):e17338. doi: 10.2196/17338. 
 
v22i7e17338</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/17338</ArticleId><ArticleId IdType="pmc">PMC7380984</ArticleId><ArticleId IdType="pubmed">32492651</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen RA, Adams PF. Use of the internet for health information: United States, 2009. National Center for Health Statistics. 2011.  [2022-07-30].  
 https://www.cdc.gov/nchs/products/databriefs/db66.htm
.</Citation><ArticleIdList><ArticleId IdType="pubmed">22142942</ArticleId></ArticleIdList></Reference><Reference><Citation>Recommendations from the NIH AD Research Summit 2015. National Institute on Aging. 2015.  [2022-07-31].  
 https://www.nia.nih.gov/research/recommendations-nih-ad-research-summit-2015
.</Citation></Reference><Reference><Citation>Recommendations from the NIH AD Research Summit 2018. National Institute on Aging. 2018.  [2022-07-31].  
 https://www.nia.nih.gov/research/administration/recommendations-nih-ad-research-summit-2018
.</Citation></Reference><Reference><Citation>Next steps for research on informal caregiving. National Institute on Aging. 2014.  [2022-12-22].  
 https://www.nia.nih.gov/sites/default/files/2017-08/gerald-summary_11-21-14_0.pdf
.</Citation></Reference><Reference><Citation>Schulz R, Beach SR, Czaja SJ, Martire LM, Monin JK. Family caregiving for older adults. Annu Rev Psychol. 2020 Jan 04;71(1):635&#x2013;659. doi: 10.1146/annurev-psych-010419-050754. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-psych-010419-050754</ArticleId><ArticleId IdType="pmc">PMC7291827</ArticleId><ArticleId IdType="pubmed">31905111</ArticleId></ArticleIdList></Reference><Reference><Citation>Dam AEH, de Vugt ME, van Boxtel MP, Verhey FR. Effectiveness of an online social support intervention for caregivers of people with dementia: the study protocol of a randomised controlled trial. Trials. 2017 Aug 29;18(1):395. doi: 10.1186/s13063-017-2097-y. 
 
10.1186/s13063-017-2097-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-017-2097-y</ArticleId><ArticleId IdType="doi">10.1186/s13063-017-2097-y</ArticleId><ArticleId IdType="pmc">PMC5575867</ArticleId><ArticleId IdType="pubmed">28851406</ArticleId></ArticleIdList></Reference><Reference><Citation>Glueckauf RL, Loomis JS. Alzheimer's caregiver support online: lessons learned, initial findings and future directions. NRE. 2003 Jun 27;18(2):135&#x2013;146. doi: 10.3233/nre-2003-18206.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/nre-2003-18206</ArticleId><ArticleId IdType="pubmed">12867676</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Carrasco M, Otermin P, P&#xe9;rez-Camo V, Pujol J, Ag&#xfc;era L, Mart&#xed;n M J, Gobartt AL, Pons S, Bala&#xf1;&#xe1; M. EDUCA study: psychometric properties of the Spanish version of the Zarit caregiver burden scale. Aging Ment Health. 2010 Aug;14(6):705&#x2013;711. doi: 10.1080/13607860903586094.922871266</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607860903586094</ArticleId><ArticleId IdType="pubmed">20544413</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis BA, Williams DM, Neighbors CJ, Jakicic JM, Marcus BH. Cost analysis of internet vs. print interventions for physical activity promotion. Psychol Sport Exerc. 2010 May 01;11(3):246&#x2013;249. doi: 10.1016/j.psychsport.2009.10.002. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychsport.2009.10.002</ArticleId><ArticleId IdType="pmc">PMC2853814</ArticleId><ArticleId IdType="pubmed">20401164</ArticleId></ArticleIdList></Reference><Reference><Citation>Serafini JD, Damianakis T, Marziali E. Clinical practice standards and ethical issues applied to a virtual group intervention for spousal caregivers of people with Alzheimer's. Soc Work Health Care. 2007 Apr 05;44(3):225&#x2013;243. doi: 10.1300/J010v44n03_07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J010v44n03_07</ArticleId><ArticleId IdType="pubmed">17548277</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connor A. Ottawa decision support framework. 2006.  [2022-07-30].  
 https://decisionaid.ohri.ca/docs/develop/ODSF.pdf
.</Citation></Reference><Reference><Citation>Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q. 1984;11(1):1&#x2013;47. doi: 10.1177/109019818401100101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/109019818401100101</ArticleId><ArticleId IdType="pubmed">6392204</ArticleId></ArticleIdList></Reference><Reference><Citation>Matlock DD, Spatz ES. Design and testing of tools for shared decision making. Circ: Cardiovasc Qual Outcomes. 2014 May;7(3):487&#x2013;492. doi: 10.1161/circoutcomes.113.000289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circoutcomes.113.000289</ArticleId><ArticleId IdType="pubmed">24714602</ArticleId></ArticleIdList></Reference><Reference><Citation>Polzer ER, Nearing K, Knoepke CE, Matlock DD, Azrael D, Siry BJ, Meador L, Betz ME. "Safety in Dementia": development of an online caregiver tool for firearm, driving, and home safety. J Am Geriatr Soc. 2020 Sep;68(9):2137&#x2013;2139. doi: 10.1111/jgs.16693. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16693</ArticleId><ArticleId IdType="pmc">PMC7722111</ArticleId><ArticleId IdType="pubmed">32628279</ArticleId></ArticleIdList></Reference><Reference><Citation>Betz ME. Safety in dementia. 2019.  [2022-03-23].  
 https://safetyindementia.org/
</Citation></Reference><Reference><Citation>National Institutes of Health, Department of Health and Human Services . In: Encyclopedia of Law Enforcement. Sullivan LE, Rosen MS, Schulz DM, Haberfeld MR, editors. Thousand Oaks, CA: SAGE Publications, Inc; 2004.</Citation></Reference><Reference><Citation>Charness N, Demiris G, Krupinski E. Designing Telehealth for an Aging Population: A Human Factors Perspective. Boca Raton, FL: CRC Press; 2011.</Citation></Reference><Reference><Citation>Czaja SJ, Boot WR, Charness N, Rogers WA. Designing for older adults: principles and creative human factors approaches. 3rd ed. Boca Raton, FL: CRC Press; 2019.</Citation></Reference><Reference><Citation>Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46(12):1417&#x2013;1432. doi: 10.1016/0895-4356(93)90142-n.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-4356(93)90142-n</ArticleId><ArticleId IdType="pubmed">8263569</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000 Dec 15;25(24):3186&#x2013;3191. doi: 10.1097/00007632-200012150-00014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-200012150-00014</ArticleId><ArticleId IdType="pubmed">11124735</ArticleId></ArticleIdList></Reference><Reference><Citation>Betz ME, Polzer E, Nearing K, Knoepke CE, Johnson RL, Meador L, Matlock DD. Feasibility and acceptability of a web-based caregiver decision aid (safety in dementia) for firearm access: pilot randomized controlled trial. JMIR Form Res. 2021 Sep 22;5(9):e30990. doi: 10.2196/30990. 
 
v5i9e30990</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/30990</ArticleId><ArticleId IdType="pmc">PMC8495566</ArticleId><ArticleId IdType="pubmed">34550082</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G&#xf8;tzsche PC, Krle&#x17e;a-Jeri&#x107; K, Hr&#xf3;bjartsson A, Mann H, Dickersin K, Berlin JA, Dor&#xe9; CJ, Parulekar WR, Summerskill WSM, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013 Mar 05;158(3):200&#x2013;207. doi: 10.7326/0003-4819-158-3-201302050-00583. 
 
1556168</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-158-3-201302050-00583?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.7326/0003-4819-158-3-201302050-00583</ArticleId><ArticleId IdType="pmc">PMC5114123</ArticleId><ArticleId IdType="pubmed">23295957</ArticleId></ArticleIdList></Reference><Reference><Citation>Eysenbach G, CONSORT-EHEALTH Group  CONSORT-EHEALTH: improving and standardizing evaluation reports of web-based and mobile health interventions. J Med Internet Res. 2011 Dec 31;13(4):e126. doi: 10.2196/jmir.1923. 
 
v13i4e126</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.1923</ArticleId><ArticleId IdType="pmc">PMC3278112</ArticleId><ArticleId IdType="pubmed">22209829</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepucha KR, Abhyankar P, Hoffman AS, Bekker HL, LeBlanc A, Levin CA, Ropka M, Shaffer VA, Sheridan SL, Stacey D, Stalmeier P, Vo H, Wills CE, Thomson R. Standards for universal reporting of patient decision aid evaluation studies: the development of SUNDAE checklist. BMJ Qual Saf. 2018 May;27(5):380&#x2013;388. doi: 10.1136/bmjqs-2017-006986. 
 
bmjqs-2017-006986</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjqs-2017-006986</ArticleId><ArticleId IdType="pmc">PMC5965362</ArticleId><ArticleId IdType="pubmed">29269567</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari G, Hassanein K, Deaves R. Debiasing investors with decision support systems: an experimental investigation. Decis Supp Syst. 2008 Dec;46(1):399&#x2013;410. doi: 10.1016/j.dss.2008.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dss.2008.07.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Stacey D, L&#xe9;gar&#xe9; F, Col NF, Bennett CL, Barry MJ, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Thomson R, Trevena L, Wu JHC. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014 Jan 28;(1):CD001431. doi: 10.1002/14651858.CD001431.pub4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001431.pub4</ArticleId><ArticleId IdType="pubmed">24470076</ArticleId></ArticleIdList></Reference><Reference><Citation>Home safety checklist for Alzheimer's disease. National Institute on Aging.  [2022-05-22].  
 https://www.nia.nih.gov/health/home-safety-checklist-alzheimers-disease
.</Citation></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)&#x2014;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377&#x2013;381. doi: 10.1016/j.jbi.2008.08.010. 
 
S1532-0464(08)00122-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN, REDCap Consortium  The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. 
 
S1532-0464(19)30126-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet. 2002 Feb;359(9306):614&#x2013;618. doi: 10.1016/s0140-6736(02)07750-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(02)07750-4</ArticleId><ArticleId IdType="pubmed">11867132</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopwood J, Walker N, McDonagh L, Rait G, Walters K, Iliffe S, Ross J, Davies N. Internet-based interventions aimed at supporting family caregivers of people with dementia: systematic review. J Med Internet Res. 2018 Jun 12;20(6):e216. doi: 10.2196/jmir.9548. 
 
v20i6e216</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.9548</ArticleId><ArticleId IdType="pmc">PMC6019848</ArticleId><ArticleId IdType="pubmed">29895512</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepucha K, Ozanne E, Silvia K, Partridge A, Mulley AG. An approach to measuring the quality of breast cancer decisions. Patient Educ Couns. 2007 Mar;65(2):261&#x2013;269. doi: 10.1016/j.pec.2006.08.007.S0738-3991(06)00266-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2006.08.007</ArticleId><ArticleId IdType="pubmed">17023138</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepucha KR, Borkhoff CM, Lally J, Levin CA, Matlock DD, Ng CJ, Ropka ME, Stacey D, Joseph-Williams N, Wills CE, Thomson R. Establishing the effectiveness of patient decision aids: key constructs and measurement instruments. BMC Med Inform Decis Mak. 2013;13 Suppl 2(Suppl 2):S12. doi: 10.1186/1472-6947-13-S2-S12. 
 
1472-6947-13-S2-S12</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6947-13-S2-S12</ArticleId><ArticleId IdType="doi">10.1186/1472-6947-13-S2-S12</ArticleId><ArticleId IdType="pmc">PMC4044563</ArticleId><ArticleId IdType="pubmed">24625035</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett C, Graham ID, Kristjansson E, Kearing SA, Clay KF, O'Connor AM. Validation of a preparation for decision making scale. Patient Educ Couns. 2010 Jan;78(1):130&#x2013;133. doi: 10.1016/j.pec.2009.05.012.S0738-3991(09)00232-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2009.05.012</ArticleId><ArticleId IdType="pubmed">19560303</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connor AM. Decision self-efficacy scale. 1995.  [2022-02-24].  
 https://decisionaid.ohri.ca/docs/develop/Tools/Decision_SelfEfficacy.pdf
.</Citation></Reference><Reference><Citation>Betz ME, Knoepke CE, Simpson S, Siry BJ, Clement A, Saunders T, Johnson R, Azrael D, Boudreaux ED, Omeragic F, Adams LM, Almond S, Juarez-Colunga E, Matlock DD. An interactive web-based lethal means safety decision aid for suicidal adults (lock to live): pilot randomized controlled trial. J Med Internet Res. 2020 Jan 29;22(1):e16253. doi: 10.2196/16253. 
 
v22i1e16253</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/16253</ArticleId><ArticleId IdType="pmc">PMC7016618</ArticleId><ArticleId IdType="pubmed">32012056</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller M, Salhi C, Barber C, Azrael D, Beatriz E, Berrigan J, Brandspigel S, Betz ME, Runyan C. Changes in firearm and medication storage practices in homes of youths at risk for suicide: results of the SAFETY study, a clustered, emergency department-based, multisite, stepped-wedge trial. Ann Emerg Med. 2020 Aug;76(2):194&#x2013;205. doi: 10.1016/j.annemergmed.2020.02.007.S0196-0644(20)30104-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2020.02.007</ArticleId><ArticleId IdType="pubmed">32307124</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarit SH, Zarit JM. The Memory and Behavior Problems Checklist and the Burden Interview. University Park, PA: Gerontology Center, The Pennsylvania State University; 1990.</Citation></Reference><Reference><Citation>B&#xe9;dard M, Molloy D, Squire L, Dubois S, Lever J, O'Donnell M. The Zarit burden interview: a new short version and screening version. Gerontologist. 2001 Oct;41(5):652&#x2013;657. doi: 10.1093/geront/41.5.652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/41.5.652</ArticleId><ArticleId IdType="pubmed">11574710</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarlow BJ, Wisniewski SR, Belle SH, Rubert M, Ory MG, Gallagher-Thompson D. Positive aspects of caregiving. Res Aging. 2016 Aug 17;26(4):429&#x2013;453. doi: 10.1177/0164027504264493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0164027504264493</ArticleId></ArticleIdList></Reference><Reference><Citation>Siow JYM, Chan A, &#xd8;stbye T, Cheng GH, Malhotra R. Validity and reliability of the positive aspects of caregiving (PAC) scale and development of its shorter version (S-PAC) among family caregivers of older adults. Gerontologist. 2017 Aug 01;57(4):e75&#x2013;e84. doi: 10.1093/geront/gnw198.gnw198</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnw198</ArticleId><ArticleId IdType="pubmed">28082275</ArticleId></ArticleIdList></Reference><Reference><Citation>Las Hayas C, L&#xf3;pez de Arroyabe Elena, Calvete E. Positive aspects of caregiving in Spanish caregivers of individuals with acquired brain injury. Rehabil Psychol. 2014 May;59(2):193&#x2013;202. doi: 10.1037/a0035622.2014-09036-001</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0035622</ArticleId><ArticleId IdType="pubmed">24635012</ArticleId></ArticleIdList></Reference><Reference><Citation>Diggle P, Heagerty P, Liang K, Zeger S. Analysis of Longitudinal Data. Oxford, UK: Oxford University Press; 2002.</Citation></Reference><Reference><Citation>Fitzmaurice G, Davidian M, Verbeke G, Molenberghs G, editors. Longitudinal Data Analysis. New York: Chapman and Hall/CRC; 2008.</Citation></Reference><Reference><Citation>Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Dor&#xe9; C, Williamson PR, Altman DG, Montgomery A, Lim P, Berlin J, Senn S, Day S, Barbachano Y, Loder E. Guidelines for the content of statistical analysis plans in clinical trials. JAMA. 2017 Dec 19;318(23):2337&#x2013;2343. doi: 10.1001/jama.2017.18556. 
 
2666509</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.18556</ArticleId><ArticleId IdType="pubmed">29260229</ArticleId></ArticleIdList></Reference><Reference><Citation>Leach MJ, Ziaian T, Francis A, Agnew T. Recruiting dementia caregivers into clinical trials: lessons learnt from the Australian TRANSCENDENT trial. Alzheimer Dis Assoc Disord. 2016;30(4):338&#x2013;344. doi: 10.1097/WAD.0000000000000149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0000000000000149</ArticleId><ArticleId IdType="pubmed">27227995</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh L, Johns B, Liu S, Vedula S, Li T, Puhan M. Cost-effectiveness of health research study participant recruitment strategies: a systematic review. Clin Trials. 2014 Oct;11(5):576&#x2013;583. doi: 10.5167/uzh-106671. doi: 10.1177/1740774514540371.1740774514540371</Citation><ArticleIdList><ArticleId IdType="doi">10.5167/uzh-106671</ArticleId><ArticleId IdType="doi">10.1177/1740774514540371</ArticleId><ArticleId IdType="pubmed">24980278</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.</Citation></Reference><Reference><Citation>R Core Team  R: a language and environment for statistical computing. R Foundation for Statistical Computing. 2022.  [2022-12-23].  
 https://cran.r-project.org/doc/manuals/r-release/fullrefman.pdf
.</Citation></Reference><Reference><Citation>Leslie M, Khayatzadeh-Mahani A, MacKean G. Recruitment of caregivers into health services research: lessons from a user-centred design study. Res Involv Engagem. 2019;5(1):17. doi: 10.1186/s40900-019-0150-6. 
 
150</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40900-019-0150-6</ArticleId><ArticleId IdType="doi">10.1186/s40900-019-0150-6</ArticleId><ArticleId IdType="pmc">PMC6528243</ArticleId><ArticleId IdType="pubmed">31139432</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschman EC. Men, dogs, guns, and cars&#x2014;the semiotics of rugged individualism. J Advert. 2003 Apr;32(1):9&#x2013;22. doi: 10.1080/00913367.2003.10601001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00913367.2003.10601001</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierre JM. The psychology of guns: risk, fear, and motivated reasoning. Palgrave Commun. 2019 Dec 10;5(1):159. doi: 10.1057/s41599-019-0373-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1057/s41599-019-0373-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Barry MJ, Edgman-Levitan S. Shared decision making&#x2014;pinnacle of patient-centered care. N Engl J Med. 2012 Mar 01;366(9):780&#x2013;781. doi: 10.1056/NEJMp1109283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1109283</ArticleId><ArticleId IdType="pubmed">22375967</ArticleId></ArticleIdList></Reference><Reference><Citation>Betz ME, Wintemute GJ. Physician counseling on firearm safety: a new kind of cultural competence. JAMA. 2015 Aug 04;314(5):449&#x2013;450. doi: 10.1001/jama.2015.7055. 
 
2422552</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.7055</ArticleId><ArticleId IdType="pmc">PMC4559221</ArticleId><ArticleId IdType="pubmed">26241594</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownson RC, Jacobs JA, Tabak RG, Hoehner CM, Stamatakis KA. Designing for dissemination among public health researchers: findings from a national survey in the United States. Am J Public Health. 2013 Sep;103(9):1693&#x2013;1699. doi: 10.2105/AJPH.2012.301165.</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2012.301165</ArticleId><ArticleId IdType="pmc">PMC3966680</ArticleId><ArticleId IdType="pubmed">23865659</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitlin LN, Baier RR, Jutkowitz E, Baker ZG, Gustavson AM, Sefcik JS, Hodgson NA, Koeuth S, Gaugler JE. Dissemination and implementation of evidence-based dementia care using embedded pragmatic trials. J Am Geriatr Soc. 2020 Jul;68 Suppl 2(Suppl 2):S28&#x2013;S36. doi: 10.1111/jgs.16622. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16622</ArticleId><ArticleId IdType="pmc">PMC7470172</ArticleId><ArticleId IdType="pubmed">32589277</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen EL, Head KJ, McGladrey MJ, Hoover AG, Vanderpool RC, Bridger C, Carman A, Crosby RA, Darling E, Tucker-McLaughlin M, Winterbauer N. Designing for dissemination: lessons in message design from "1-2-3 pap". Health Commun. 2015;30(2):196&#x2013;207. doi: 10.1080/10410236.2014.974130. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10410236.2014.974130</ArticleId><ArticleId IdType="pmc">PMC4753793</ArticleId><ArticleId IdType="pubmed">25470444</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36718247</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2333-7214</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2023</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Gerontology &amp; geriatric medicine</Title><ISOAbbreviation>Gerontol Geriatr Med</ISOAbbreviation></Journal><ArticleTitle>Cultural and Social Factors in Care Delivery Among African American Caregivers of Persons With Dementia: A Scoping Review.</ArticleTitle><Pagination><StartPage>23337214231152002</StartPage><MedlinePgn>23337214231152002</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">23337214231152002</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/23337214231152002</ELocationID><Abstract><AbstractText>Cultural and social factors significantly influence the care provided to persons with dementia. This scoping review aimed to map emerging evidence on the influence of cultural and social factors on care delivery among Africa American caregivers of persons with dementia, especially during the COVID-19 pandemic. Using a systematic scoping review approach, we identified 21 studies on cultural and social factors influencing care delivery. The search included EMBASE, CINAHL, the Cochrane Database of Systematic Reviews, JBI Evidence Synthesis, and Epistemonicos. A narrative synthesis of the data revealed that cultural and social factors greatly influence African American caregivers of persons with dementia and COVID-19 in care delivery, who perceive caregiving as a responsibility and not just a job. These caregivers are additionally guided by their racial identity and faith beliefs, integrating family values and culture into caregiving. African American caregivers showed compassion and resilient care selfperceptions. Supporting compassionate care delivery by African American caregivers requires an understanding of the social and cultural factors which drive their commitment to quality care for older adults with dementia in a pandemic environment.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Idorenyin Imoh</LastName><ForeName>Udoh</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0002-0370-4076</Identifier><AffiliationInfo><Affiliation>University of North Texas, Denton, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charity</LastName><ForeName>Tinofirei</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-5735-2862</Identifier><AffiliationInfo><Affiliation>University of North Texas, Denton, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gerontol Geriatr Med</MedlineTA><NlmUniqueID>101662571</NlmUniqueID><ISSNLinking>2333-7214</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s/dementia</Keyword><Keyword MajorTopicYN="N">caregiving and management</Keyword><Keyword MajorTopicYN="N">health care disparity</Keyword><Keyword MajorTopicYN="N">race/ethnicity</Keyword><Keyword MajorTopicYN="N">scoping review</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>31</Day><Hour>1</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36718247</ArticleId><ArticleId IdType="pmc">PMC9880147</ArticleId><ArticleId IdType="doi">10.1177/23337214231152002</ArticleId><ArticleId IdType="pii">10.1177_23337214231152002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abramsohn E. M., Paradise K. M., Glover C. M., Benjamins M., Douglas L., Jerome J., Kim M. L., Kostas T., Mata D., Padron F., Shah R. C., Lindau S. T. (2022). CommunityRx: Optimizing a community resource referral intervention for minority dementia caregivers. Journal of Applied Gerontology, 41(1), 113&#x2013;123. 10.1177/07334648211005594</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/07334648211005594</ArticleId><ArticleId IdType="pmc">PMC8501155</ArticleId><ArticleId IdType="pubmed">33834890</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander J. L., Kennedy N. A., Ibraheim H., Anandabaskaran S., Saifuddin A., Castro Seoane R., Liu Z., Nice R., Bewshea C., D&#x2019;Mello A., Constable L., Jones G. R., Balarajah S., Fiorentino F., Sebastian S., Irving P. M., Hicks L. C., Williams H. R. T., Kent A. J., . . . Pollock K. (2022). COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): A multicentre, prospective, case-control study. The Lancet Gastroenterology &amp; Hepatology, 7(4), 342&#x2013;352. 10.1016/s2468-1253(22)00005-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2468-1253(22)00005-x</ArticleId><ArticleId IdType="pmc">PMC8813209</ArticleId><ArticleId IdType="pubmed">35123676</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandre B., Reynaud E., Osiurak F., Navarro J. (2018). Acceptance and acceptability criteria: A literature review. Cognition Technology &amp; Work, 20(2), 165&#x2013;177. 10.1007/s10111-018-0459-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10111-018-0459-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Association. (2016). 2016 Alzheimer&#x2019;s disease facts and figures. Alzheimer&#x2019;s &amp; Dementia, 12(4), 459&#x2013;509. 10.1016/j.jalz.2016.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2016.03.001</ArticleId><ArticleId IdType="pubmed">27570871</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Association. (2019). 2019 Alzheimer&#x2019;s disease facts and figures. Alzheimer&#x2019;s &amp; Dementia, 15(3), 321&#x2013;387. 10.1016/j.jalz.2019.01.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.01.010</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>
Alzheimer&#x2019;s Association. (2022). 2022
Alzheimer&#x2019;s disease facts and figures. Special report &#x2013; More than normal
aging: Understanding mild cognitive impairment. https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf</Citation></Reference><Reference><Citation>
Alzheimer&#x2019;s Association. (n.d.). African-Americans and
Alzheimer&#x2019;s disease: The silent epidemic. https://www.alz.org/media/Documents/african-americans-silent-epidemic-r.pdf</Citation></Reference><Reference><Citation>Ameis S. H., Lai M. C., Mulsant B. H., Szatmari P. (2020). Coping, fostering resilience, and driving care innovation for autistic people and their families during the COVID-19 pandemic and beyond. Molecular Autism, 11(1), 61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7374665</ArticleId><ArticleId IdType="pubmed">32698850</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda M. P., Knight B. G. (1997). The influence of ethnicity and culture on the caregiver stress and coping process: A sociocultural review and analysis. The Gerontologist, 37(3), 342&#x2013;354. 10.1093/geront/37.3.342</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/37.3.342</ArticleId><ArticleId IdType="pubmed">9203758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashley N. R., Kleinpeter C. H. (2002). Gender differences in coping strategies of spousal dementia caregivers. Journal of Human Behavior in the Social Environment, 6(2), 29&#x2013;46. 10.1300/j137v06n02_03</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/j137v06n02_03</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker K. L., Robertson N. (2008). Coping with caring for someone with dementia: Reviewing the literature about men. Aging &amp; Mental Health, 12(4), 413&#x2013;422. 10.1080/13607860802224250</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607860802224250</ArticleId><ArticleId IdType="pubmed">18791888</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes D. E., Beiser A. S., Lee A., Langa K. M., Koyama A., Preis S. R., Neuhaus J., McCammon R. J., Yaffe K., Seshadri S., Haan M. N., Weir D. R. (2014). Development and validation of a brief dementia screening indicator for primary care. Alzheimer&#x2019;s &amp; Dementia, 10(6), 656&#x2013;665.e1. 10.1016/j.jalz.2013.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2013.11.006</ArticleId><ArticleId IdType="pmc">PMC4119094</ArticleId><ArticleId IdType="pubmed">24491321</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartzokis G. (2004). Age-related myelin breakdown: A developmental model of cognitive decline and Alzheimer&#x2019;s disease. Neurobiology of Aging, 25(1), 5&#x2013;18. 10.1016/j.neurobiolaging.2003.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2003.03.001</ArticleId><ArticleId IdType="pubmed">14675724</ArticleId></ArticleIdList></Reference><Reference><Citation>Birhane M., Bressler S., Chang G., Clark T., Dorough L., Fischer M., Watkins L. F., Goldstein J. M., Kugeler K., Langley G., Lecy K., Martin S., Medalla F., Mitruka K., Nolen L., Sadigh K., Spratling R., Thompson G., Trujillo A. (2021). COVID-19 vaccine breakthrough infections reported to CDC&#x2014;United States, January 1&#x2013;April 30, 2021. MMWR. Morbidity and Mortality Weekly Report, 70(21), 792&#x2013;793. 10.15585/mmwr.mm7021e3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7021e3</ArticleId><ArticleId IdType="pmc">PMC8158893</ArticleId><ArticleId IdType="pubmed">34043615</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonds Johnson K., Brewster G. S., Cicero E., Hepburn K., Clevenger C. K., Daniel G., Pak V., Paul S., Epps F. (2022). Promoting caregiver mastery in Black American dementia caregivers. The Gerontologist, 62(5), 685&#x2013;693. 10.1093/geront/gnab147</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnab147</ArticleId><ArticleId IdType="pmc">PMC9154278</ArticleId><ArticleId IdType="pubmed">34610111</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonner G. J., Freels S., Ferrans C., Steffen A., Suarez M. L., Dancy B. L., Watkins Y. J., Collinge W., Hart A. S., Aggarwal N. T., Wilkie D. J. (2021). Advance care planning for African American caregivers of relatives with dementias: Cluster randomized controlled trial. American Journal of Hospice and Palliative Medicine, 38(6), 547&#x2013;556. 10.1177/1049909120916127</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1049909120916127</ArticleId><ArticleId IdType="pmc">PMC8443116</ArticleId><ArticleId IdType="pubmed">32308012</ArticleId></ArticleIdList></Reference><Reference><Citation>Brewster G. S., Bonds K., McLennon S., Moss K. O., Epps F., Lopez R. P. (2020). Missing the mark: The complexity of African American dementia family caregiving. Journal of Family Nursing, 26(4), 294&#x2013;301. 10.1177/1074840720945329</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1074840720945329</ArticleId><ArticleId IdType="pmc">PMC7721986</ArticleId><ArticleId IdType="pubmed">32757815</ArticleId></ArticleIdList></Reference><Reference><Citation>Brewster G. S., Epps F., Dye C. E., Hepburn K., Higgins M. K., Parker M. L. (2020). The effect of the &#x201c;Great Village&#x201d; on psychological outcomes, burden, and mastery in African American caregivers of persons living with dementia. Journal of Applied Gerontology, 39(10), 1059&#x2013;1068. 10.1177/0733464819874574</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464819874574</ArticleId><ArticleId IdType="pmc">PMC7080571</ArticleId><ArticleId IdType="pubmed">31535922</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalano D., Holloway L., Mpofu E. (2018). Mental health interventions for parent carers of children with autistic spectrum disorder: Practice guidelines from a critical interpretive synthesis (CIS) systematic review. International Journal of Environmental Research and Public Health, 15(2), 341. 10.3390/ijerph15020341</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph15020341</ArticleId><ArticleId IdType="pmc">PMC5858410</ArticleId><ArticleId IdType="pubmed">29443933</ArticleId></ArticleIdList></Reference><Reference><Citation>Challis D., von Abendorff R., Brown P., Chesterman J., Hughes J. (2002). Care management, dementia care and specialist mental health services: An evaluation. International Journal of Geriatric Psychiatry, 17(4), 315&#x2013;325. 10.1002/gps.595</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.595</ArticleId><ArticleId IdType="pubmed">11994884</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiao C. Y., Wu H. S., Hsiao C. Y. (2015). Caregiver burden for informal caregivers of patients with dementia: A systematic review. International Nursing Review, 62(3), 340&#x2013;350. 10.1111/inr.12194</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/inr.12194</ArticleId><ArticleId IdType="pubmed">26058542</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S. A., Sabik N. J., Cook S. K., Azzoli A. B., Mendez-Luck C. A. (2019). Differences within differences: Gender inequalities in caregiving intensity vary by race and ethnicity in informal caregivers. Journal of Cross-Cultural Gerontology, 34(3), 245&#x2013;263. 10.1007/s10823-019-09381-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10823-019-09381-9</ArticleId><ArticleId IdType="pubmed">31407137</ArticleId></ArticleIdList></Reference><Reference><Citation>Cothran F. A., Chang E., Beckett L., Bidwell J. T., Price C. A., Gallagher-Thompson D. (2022). A landscape of subjective and objective stress in African-American dementia family caregivers. Western Journal of Nursing Research, 44(3), 239&#x2013;249. 10.1177/01939459211062956</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01939459211062956</ArticleId><ArticleId IdType="pmc">PMC8908689</ArticleId><ArticleId IdType="pubmed">34865588</ArticleId></ArticleIdList></Reference><Reference><Citation>Cothran F. A., Paun O., Strayhorn S., Barnes L. L. (2022). &#x2018;Walk a mile in my shoes&#x2019;: African American caregiver perceptions of caregiving and self-care. Ethnicity and Health, 27(2), 435&#x2013;452. 10.1080/13557858.2020.1734777</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13557858.2020.1734777</ArticleId><ArticleId IdType="pmc">PMC9137429</ArticleId><ArticleId IdType="pubmed">32116006</ArticleId></ArticleIdList></Reference><Reference><Citation>Covinsky K. E., Yaffe K. (2004). Dementia, prognosis, and the needs of patients and caregivers. Annals of Internal Medicine, 140(7), 573&#x2013;574. 10.7326/0003-4819-140-7-200404060-00019</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-140-7-200404060-00019</ArticleId><ArticleId IdType="pubmed">15068987</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox C. (1999). Race and caregiving: Patterns of service use by African American and White caregivers of persons with Alzheimer&#x2019;s disease. Journal of Gerontological Social Work, 32(2), 5&#x2013;19. 10.1300/J083v32n02_02</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J083v32n02_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang S., Badiye A., Kelkar G. (2008). The dementia caregiver&#x2013;a primary care approach. Southern Medical Journal, 101(12), 1246&#x2013;1251. 10.1097/SMJ.0b013e318187cccc</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SMJ.0b013e318187cccc</ArticleId><ArticleId IdType="pubmed">19005434</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilworth-Anderson P., Gibson B. E. (2002). The cultural influence of values, norms, meanings, and perceptions in understanding dementia in ethnic minorities. Alzheimer Disease and Associated Disorders, 16, S56&#x2013;S63.</Citation><ArticleIdList><ArticleId IdType="pubmed">12351916</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilworth-Anderson P., Moon H., Aranda M. P. (2020). Dementia caregiving research: Expanding and reframing the lens of diversity, inclusivity, and intersectionality. The Gerontologist, 60(5), 797&#x2013;805. 10.1093/geront/gnaa050</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnaa050</ArticleId><ArticleId IdType="pmc">PMC7362616</ArticleId><ArticleId IdType="pubmed">32667672</ArticleId></ArticleIdList></Reference><Reference><Citation>Disbrow E. A., Arnold C. L., Glassy N., Tilly C. M., Langdon K. M., Gungor D., Davis T. C. (2021). Alzheimer disease and related dementia resources: Perspectives of African American and Caucasian family caregivers in northwest Louisiana. Journal of Applied Gerontology, 40(2), 209&#x2013;219. 10.1177/0733464820904568</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464820904568</ArticleId><ArticleId IdType="pmc">PMC8637937</ArticleId><ArticleId IdType="pubmed">32046583</ArticleId></ArticleIdList></Reference><Reference><Citation>Doris S. F., Cheng S., Wang J. (2018). Unravelling positive aspects of caregiving in dementia: An integrative review of research literature. International Journal of Nursing Studies, 79, 1&#x2013;26. 10.1016/j.ijnurstu.2017.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2017.10.008</ArticleId><ArticleId IdType="pubmed">29128685</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabius C. D., Wolff J. L., Kasper J. D. (2020). Race differences in characteristics and experiences of black and white caregivers of older Americans. The Gerontologist, 60(7), 1244&#x2013;1253. 10.1093/geront/gnaa042</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnaa042</ArticleId><ArticleId IdType="pmc">PMC7491434</ArticleId><ArticleId IdType="pubmed">32400881</ArticleId></ArticleIdList></Reference><Reference><Citation>
Family Caregiver Alliance. (2022).
Caregiver statistics: Demographics. https://www.caregiver.org/resource/caregiver-statistics-demographics/</Citation></Reference><Reference><Citation>Fortinsky R. H., Kulldorff M., Kleppinger A., Kenyon-Pesce L. (2009). Dementia care consultation for family caregivers: Collaborative model linking an Alzheimer&#x2019;s association chapter with primary care physicians. Aging &amp; Mental Health, 13(2), 162&#x2013;170. 10.1080/13607860902746160</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607860902746160</ArticleId><ArticleId IdType="pubmed">19347683</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher-Thompson D., Choryan Bilbrey A., Apesoa-Varano E. C., Ghatak R., Kim K. K., Cothran F. (2020). Conceptual framework to guide intervention research across the trajectory of dementia caregiving. The Gerontologist, 60(Suppl 1), S29&#x2013;S40. 10.1093/geront/gnz157</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnz157</ArticleId><ArticleId IdType="pmc">PMC7019661</ArticleId><ArticleId IdType="pubmed">32057080</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher-Thompson D., Coon D. W., Solano N., Ambler C., Rabinowitz Y., Thompson L. W. (2003). Change in indices of distress among Latino and Anglo female caregivers of elderly relatives with dementia: Site-specific results from the REACH national collaborative study. The Gerontologist, 43(4), 580&#x2013;591. 10.1093/geront/43.4.580</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/43.4.580</ArticleId><ArticleId IdType="pubmed">12937336</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher-Thompson D., Haley W., Guy D., Rupert M., Arg&#xfc;elles T., Zeiss L. M., Long C., Tennstedt S., Ory M. (2003). Tailoring psychological interventions for ethnically diverse dementia caregivers. Clinical Psychology Science and Practice, 10(4), 423&#x2013;438. 10.1093/clipsy.bpg042</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clipsy.bpg042</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaugler J. E., Kane R. L., Newcomer R. (2007). Resilience and transitions from dementia caregiving. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences, 62(1), 38&#x2013;44. 10.1093/geronb/62.1.p38</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/62.1.p38</ArticleId><ArticleId IdType="pubmed">17284556</ArticleId></ArticleIdList></Reference><Reference><Citation>Given C. W., Given B. A., Stommel M., Azzouz F. (1999). The impact of new demands for assistance on caregiver depression: Tests using an inception cohort. The Gerontologist, 39(1), 76&#x2013;85. 10.1093/geront/39.1.76</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/39.1.76</ArticleId><ArticleId IdType="pubmed">10028773</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez R. G., White D. A. (2006). Using verbal fluency to detect very mild dementia of the Alzheimer type. Archives of Clinical Neuropsychology, 21(8), 771&#x2013;775. 10.1016/j.acn.2006.06.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acn.2006.06.012</ArticleId><ArticleId IdType="pubmed">17011743</ArticleId></ArticleIdList></Reference><Reference><Citation>Green T. L., King K. M. (2009). Experiences of male patients and wife-caregivers in the first year post-discharge following minor stroke: A descriptive qualitative study. International Journal of Nursing Studies, 46(9), 1194&#x2013;1200. 10.1016/j.ijnurstu.2009.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2009.02.008</ArticleId><ArticleId IdType="pubmed">19303597</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarino A., Favieri F., Boncompagni I., Agostini F., Cantone M., Casagrande M. (2019). Executive functions in Alzheimer disease: A systematic review. Frontiers in Aging Neuroscience, 10, 437. 10.3389/fnagi.2018.00437</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00437</ArticleId><ArticleId IdType="pmc">PMC6341024</ArticleId><ArticleId IdType="pubmed">30697157</ArticleId></ArticleIdList></Reference><Reference><Citation>Haley W. E., Gitlin L. N., Wisniewski S. R., Mahoney D. F., Coon D. W., Winter L., Corcoran M., Schinfeld S., Ory M. (2004). Well-being, appraisal, and coping in African-American and Caucasian dementia caregivers: Findings from the REACH study. Aging &amp; Mental Health, 8(4), 316&#x2013;329. 10.1080/13607860410001728998</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607860410001728998</ArticleId><ArticleId IdType="pubmed">15370048</ArticleId></ArticleIdList></Reference><Reference><Citation>Haley W. E., LaMonde L. A., Han B., Narramore S., Schonwetter R. (2000). Family caregiving in hospice: Effects on psychological and health functioning among spousal caregivers of hospice patients with lung cancer or dementia. The Hospice Journal, 15(4), 1&#x2013;18. 10.1080/0742-969x.2000.11882959</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0742-969x.2000.11882959</ArticleId><ArticleId IdType="pubmed">11876341</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen B. R., Hodgson N. A., Budhathoki C., Gitlin L. N. (2020). Caregiver reactions to aggressive behaviors in persons with dementia in a diverse, community-dwelling sample. Journal of Applied Gerontology, 39(1), 50&#x2013;61. 10.1177/0733464818756999</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464818756999</ArticleId><ArticleId IdType="pmc">PMC5824433</ArticleId><ArticleId IdType="pubmed">29457520</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz M. (2010). Dementia caregiving characteristics, elder impairment, and caregiver strain and burden. Iowa State University Digital Repository, Theses and Dissertations. 10.31274/ETD-180810-1560</Citation><ArticleIdList><ArticleId IdType="doi">10.31274/ETD-180810-1560</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilgeman M. M., Allen R. S., Snow A. L., Durkin D. W., DeCoster J., Burgio L. (2014). Preserving Identity and Planning for Advance Care (PIPAC): Preliminary outcomes from a patient-centered intervention for individuals with mild dementia. Aging &amp; Mental Health, 18(4), 411&#x2013;424. 10.1080/13607863.2013.868403</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2013.868403</ArticleId><ArticleId IdType="pubmed">24359036</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaizik C., Caga J., Camino J., O&#x2019;Connor C. M., McKinnon C., Oyebode J. R., Piguet O., Hodges J. R., Mioshi E. (2017). Factors underpinning caregiver burden in frontotemporal dementia differ in spouses and their children. Journal of Alzheimer&#x2019;s Disease, 56(3), 1109&#x2013;1117. 10.3233/JAD-160852</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160852</ArticleId><ArticleId IdType="pmc">PMC5302027</ArticleId><ArticleId IdType="pubmed">28106550</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlin N. J. (2004). An analysis of religiosity and exercise as predictors of support group attendance and caregiver burden while caring for a family member with Alzheimer&#x2019;s disease. Journal of Mental Health and Aging, 10(2), 99&#x2013;106. 10.1037/t48466-00</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/t48466-00</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman A. V., Kosberg J. I., Leeper J. D., Tang M. (2010). Social support, caregiver burden, and life satisfaction in a sample of rural African American and white caregivers of older persons with dementia. Journal of Gerontological Social Work, 53(3), 251&#x2013;269. 10.1080/01634370903478989</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01634370903478989</ArticleId><ArticleId IdType="pubmed">20336572</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosberg J. I., Kaufman A. V., Burgio L. D., Leeper J. D., Sun F. (2007). Family caregiving to those with dementia in rural Alabama: Racial similarities and differences. Journal of Aging and Health, 19(1), 3&#x2013;21. 10.1177/0898264306293604</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0898264306293604</ArticleId><ArticleId IdType="pubmed">17215199</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampe N., Desai N., Norton-Brown T., Nowakowski A., Glueckauf R. (2022). African American lay pastoral care facilitators&#x2019; perspectives on dementia caregiver education and training. The Qualitative Report, 27(2), 324&#x2013;339. 10.46743/2160-3715/2022.4917</Citation><ArticleIdList><ArticleId IdType="doi">10.46743/2160-3715/2022.4917</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Tang F. (2015). More caregiving, less working: Caregiving roles and gender difference. Journal of Applied Gerontology, 34(4), 465&#x2013;483. 10.1177/0733464813508649</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464813508649</ArticleId><ArticleId IdType="pubmed">24652908</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Hu L., Mao X., Shen Y., Xue H., Hou P., Liu Y. (2020). Health literacy, social support, and care ability for caregivers of dementia patients: Structural equation modeling. Geriatric Nursing, 41(5), 600&#x2013;607. 10.1016/j.gerinurse.2020.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gerinurse.2020.03.014</ArticleId><ArticleId IdType="pubmed">32327281</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Marino V., Howard V., Haley W., Roth D. (2021). Positive aspects of caregiving in incident and long-term caregivers: Role of social engagement and distress. Aging &amp; Mental Health, 27, 87&#x2013;93. 10.1080/13607863.2021.2000935</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2021.2000935</ArticleId><ArticleId IdType="pmc">PMC9126189</ArticleId><ArticleId IdType="pubmed">34749554</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez O. L., Kuller L. H., Becker J. T., Jagust W. J., DeKosky S. T., Fitzpatrick A., Breitner J., Lyketsos C., Kawas C., Carlson M. (2005). Classification of vascular dementia in the cardiovascular health study cognition study. Neurology, 64(9), 1539&#x2013;1547. 10.1212/01.WNL.0000159860.19413.C4</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000159860.19413.C4</ArticleId><ArticleId IdType="pubmed">15883314</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch C. (2020). World Alzheimer Report 2019: Attitudes to dementia, a global survey: Public health: Engaging people in ADRD research. Alzheimer&#x2019;s &amp; Dementia, 16, e038255. 10.1002/alz.038255</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.038255</ArticleId></ArticleIdList></Reference><Reference><Citation>Margallo-Lana M., Reichelt K., Hayes P., Lee L., Fossey J., O&#x2019;Brien J., Ballard C. (2001). Longitudinal comparison of depression, coping, and turnover among NHS and private sector staff caring for people with dementia. BMJ, 322(7289), 769&#x2013;770. 10.1136/bmj.322.7289.769</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.322.7289.769</ArticleId><ArticleId IdType="pmc">PMC30553</ArticleId><ArticleId IdType="pubmed">11282862</ArticleId></ArticleIdList></Reference><Reference><Citation>Martindale-Adams J., Tah T., Finke B., LaCounte C., Higgins B. J., Nichols L. O. (2017). Implementation of the REACH model of dementia caregiver support in American Indian and Alaska Native communities. Translational Behavioral Medicine, 7(3), 427&#x2013;434. 10.1007/s13142-017-0505-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13142-017-0505-1</ArticleId><ArticleId IdType="pmc">PMC5645288</ArticleId><ArticleId IdType="pubmed">28585164</ArticleId></ArticleIdList></Reference><Reference><Citation>McLennon S. M., Anderson J. G., Epps F., Rose K. M. (2020). &#x201c;It&#x2019;s just part of life&#x201d;: African American daughters caring for parents with dementia. Journal of Women &amp; Aging, 32(2), 168&#x2013;182. 10.1080/08952841.2018.1547002</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08952841.2018.1547002</ArticleId><ArticleId IdType="pubmed">30457489</ArticleId></ArticleIdList></Reference><Reference><Citation>Meller S. (2001). A comparison of the wellbeing of family caregivers of elderly patients hospitalized with physical impairments versus the caregivers of patients hospitalized with dementia. Journal of the American Medical Directors Association, 2(2), 60&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">12812591</ArticleId></ArticleIdList></Reference><Reference><Citation>
Mental Health America. (2022). Caregiving
in BIPOC communities. https://mhanational.org/caregiving-bipoc-communities</Citation></Reference><Reference><Citation>Miller B. L., Ikonte C., Ponton M., Levy M., Boone K., Darby A., Berman N., Mena I., Cummings J. L. (1997). A study of the Lund-Manchester research criteria for frontotemporal dementia: Clinical and single-photon emission CT correlations. Neurology, 48(4), 937&#x2013;942. 10.1212/wnl.48.4.937</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.48.4.937</ArticleId><ArticleId IdType="pubmed">9109881</ArticleId></ArticleIdList></Reference><Reference><Citation>
Moore A. R., Knight R. P., Tinofirei C., Amey F. (2020). Long-term care: Influences
on funding schemes among aging Americans. Seniors
Housing Care Journal, 28(1),
77&#x2013;94. https://www.nic.org/publications/analytics/senior-housing-investment-journal/</Citation></Reference><Reference><Citation>Oliver S., Alexander K., Bennett S. G., Hepburn K., Henry J., Clevenger C. K., Epps F. (2022). Experiences of Black American dementia caregivers during the COVID-19 pandemic. Journal of Family Nursing, 28, 195&#x2013;204. 10.1177/10748407221102465</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10748407221102465</ArticleId><ArticleId IdType="pmc">PMC9280120</ArticleId><ArticleId IdType="pubmed">35674329</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M. J., McKenzie J. E., Bossuyt P. M., Boutron I., Hoffmann T. C., Mulrow C. D., Shamseer L., Tetzlaff J. M., Akl E. A., Brennan S. E., Chou R., Glanville J., Grimshaw J. M., Hr&#xf3;bjartsson A., Lalu M. M., Li T., Loder E. W., Mayo-Wilson E., McDonald S., . . . Moher D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed), 372, n71. 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Parrish E. (2019). Delirium superimposed on dementia: Challenges and opportunities. Nursing Clinics of North America, 54(4), 541&#x2013;550. 10.1016/j.cnur.2019.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnur.2019.07.004</ArticleId><ArticleId IdType="pubmed">31703779</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira C., LaRoche A., Arredondo B., Pugh E., Disbrow E., Reekes T. H., Brickell E., Boettcher A., Sawyer R. J. (2022). Evaluating racial disparities in healthcare system utilization and caregiver burden among older adults with dementia. Clinical Neuropsychologist, 36(2), 353&#x2013;366. 10.1080/13854046.2021.1951844</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2021.1951844</ArticleId><ArticleId IdType="pubmed">34338590</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters M. D., Godfrey C. M., Khalil H., McInerney P., Parker D., Soares C. B. (2015). Guidance for conducting systematic scoping reviews. JBI Evidence Implementation, 13(3), 141&#x2013;146. 10.1097/XEB.0000000000000050</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/XEB.0000000000000050</ArticleId><ArticleId IdType="pubmed">26134548</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters M. D., Marnie C., Tricco A. C., Pollock D., Munn Z., Alexander L., McInerney P., Godfrey C. M., Khalil H. (2020). Updated methodological guidance for the conduct of scoping reviews. JBI Evidence Synthesis, 18(10), 2119&#x2013;2126. 10.11124/JBIES-20-00167</Citation><ArticleIdList><ArticleId IdType="doi">10.11124/JBIES-20-00167</ArticleId><ArticleId IdType="pubmed">33038124</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettigrew C., Brichko R., Black B., O&#x2019;Connor M. K., Austrom M. G., Robinson M. T., Lindauer A., Shah R. C., Peavy G. M., Meyer K., Schmitt F. A., Lingler J. H., Domoto-Reilly K., Farrar-Edwards D., Albert M. (2020). Attitudes toward advance care planning among persons with dementia and their caregivers. International Psychogeriatrics, 32(5), 585&#x2013;599. 10.1017/S1041610219000784</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610219000784</ArticleId><ArticleId IdType="pmc">PMC6962575</ArticleId><ArticleId IdType="pubmed">31309906</ArticleId></ArticleIdList></Reference><Reference><Citation>Picot S. J., Debanne S. M., Namazi K. H., Wykle M. L. (1997). Religiosity and perceived rewards of black and white caregivers. The Gerontologist, 37(1), 89&#x2013;101. 10.1093/geront/37.1.89</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/37.1.89</ArticleId><ArticleId IdType="pubmed">9046710</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinquart M., S&#xf6;rensen S. (2011). Spouses, adult children, and children-in-law as caregivers of older adults: A meta-analytic comparison. Psychology and Aging, 26(1), 1&#x2013;14. 10.1037/a0021863</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0021863</ArticleId><ArticleId IdType="pmc">PMC4449135</ArticleId><ArticleId IdType="pubmed">21417538</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratt M., Stevens A., Thuku M., Butler C., Skidmore B., Wieland L. S., Clemons M., Kanji S., Hutton B. (2019). Benefits and harms of medical cannabis: A scoping review of systematic reviews. Systematic Reviews, 8(1), 320. 10.1186/s13643-019-1243-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-019-1243-x</ArticleId><ArticleId IdType="pmc">PMC6905063</ArticleId><ArticleId IdType="pubmed">31823819</ArticleId></ArticleIdList></Reference><Reference><Citation>Prince M., Ali G. C., Guerchet M., Prina A. M., Albanese E., Wu Y. T. (2016). Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimer&#x2019;s Research &amp; Therapy, 8(1), 23. 10.1186/s13195-016-0188-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-016-0188-8</ArticleId><ArticleId IdType="pmc">PMC4967299</ArticleId><ArticleId IdType="pubmed">27473681</ArticleId></ArticleIdList></Reference><Reference><Citation>Prince M. J., Wu F., Guo Y., Gutierrez Robledo L. M., O&#x2019;Donnell M., Sullivan R., Yusuf S. (2015). The burden of disease in older people and implications for health policy and practice. Lancet, 385(9967), 549&#x2013;562. 10.1016/S0140-6736(14)61347-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)61347-7</ArticleId><ArticleId IdType="pubmed">25468153</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth D. L., Haley W. E., Owen J. E., Clay O. J., Goode K. T. (2001). Latent growth models of the longitudinal effects of dementia caregiving: A comparison of African American and White family caregivers. Psychology and Aging, 16(3), 427&#x2013;436. citation2001/09/01 00:00Roth DL</Citation><ArticleIdList><ArticleId IdType="pubmed">11554521</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz R., McGinnis K. A., Zhang S., Martire L. M., Hebert R. S., Beach S. R., Zdaniuk B., Czaja S. J., Belle S. H. (2008). Dementia patient suffering and caregiver depression. Alzheimer Disease and Associated Disorders, 22(2), 170&#x2013;176. 10.1097/WAD.0b013e31816653cc</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0b013e31816653cc</ArticleId><ArticleId IdType="pmc">PMC2782456</ArticleId><ArticleId IdType="pubmed">18525290</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott C. B., Clay O. J., Epps F., Cothran F. A., Williams I. C. (2020). Associations of knowledge of Alzheimer&#x2019;s disease and memory loss and employment status with burden in African American and Caucasian family caregivers. Dementia, 19(3), 847&#x2013;860. 10.1177/1471301218788147</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301218788147</ArticleId><ArticleId IdType="pubmed">30043638</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloan D. H., Johnston D., Fabius C., Pyatt T., Antonsdottir I., Reuland M., Spliedt M., Samus Q. M. (2022). Transcending inequities in dementia care in black communities: Lessons from the maximizing independence at home care coordination program. Dementia, 21(5), 1653&#x2013;1668. 10.1177/14713012221085808</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14713012221085808</ArticleId><ArticleId IdType="pubmed">35634792</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloane P. D., Zimmerman S., Suchindran C., Reed P., Wang L., Boustani M., Sudha S. (2002). The public health impact of Alzheimer&#x2019;s disease, 2000-2050: Potential implication of treatment advances. Annual Review of Public Health, 23(1), 213&#x2013;231. 10.1146/annurev.publhealth.23.100901.140525</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.publhealth.23.100901.140525</ArticleId><ArticleId IdType="pubmed">11910061</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Z. S., Hamade W., Menkin J., de Pacheco R. G., Gans D., Weintraub N., Garcia M., Guerrero L. R., Reuben D. B. (2021). Dementia and falls management in underserved populations: The cognition and mobility care management program. Journal of the American Geriatrics Society, 69(1), 210&#x2013;215. 10.1111/jgs.16835</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16835</ArticleId><ArticleId IdType="pubmed">32978784</ArticleId></ArticleIdList></Reference><Reference><Citation>
United Nations. (2022). World population
prospects 2022: Summary of results. Department of
Economic and Social Affairs, Population Division, UN
DESA/POP/2022/TR/NO.3. https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/wpp2022_summary_of_results.pdf</Citation></Reference><Reference><Citation>Vasileiou K., Barnett J., Barreto M., Vines J., Atkinson M., Lawson S., Wilson M. (2017). Experiences of loneliness associated with being an informal caregiver: A qualitative investigation. Frontiers in Psychology, 8, 585. 10.3389/fpsyg.2017.00585</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2017.00585</ArticleId><ArticleId IdType="pmc">PMC5395647</ArticleId><ArticleId IdType="pubmed">28469589</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace Williams S., Dilworth-Anderson P., Goodwin P. Y. (2003). Caregiver role strain: The contribution of multiple roles and available resources in African-American women. Aging &amp; Mental Health, 7(2), 103&#x2013;112. 10.1080/1360786031000072312</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1360786031000072312</ArticleId><ArticleId IdType="pubmed">12745388</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. (2017). Global action plan on the public health response to dementia 2017 &#x2013; 2025. 10.1080/13607863.2018.1544213</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2018.1544213</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Lee Y., Kim B. J., Chen L. (2021). Determinants of discretionary and non-discretionary service utilization among caregivers of people with dementia: Focusing on the race/ethnic differences. Home Health Care Services Quarterly, 40(1), 75&#x2013;92. 10.1080/01621424.2020.1805083</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621424.2020.1805083</ArticleId><ArticleId IdType="pubmed">32799762</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36715553</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>Anesthetic-loaded nanodroplets with focused ultrasound reduces agitation in Alzheimer's mice.</ArticleTitle><Pagination><StartPage>507</StartPage><EndPage>519</EndPage><MedlinePgn>507-519</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51737</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Alzheimer's disease (AD) is often associated with neuropsychiatric symptoms, including agitation and aggressive behavior. These symptoms increase with disease severity, ranging from 10% in mild cognitive impairment to 50% in patients with moderate-to-severe AD, pose a great risk for self-injury and injury to caregivers, result in high rates of institutionalization and great suffering for patients and families. Current pharmacological therapies have limited efficacy and a high potential for severe side effects. Thus, there is a growing need to develop novel therapeutics tailored to safely and effectively reduce agitation and aggressive behavior in AD. Here, we investigate for the first time the use of focused ultrasound combined with anesthetic-loaded nanodroplets (nanoFUS) targeting the amygdala (key structure in the neurocircuitry of agitation) as a novel minimally invasive tool to modulate local neural activity and reduce agitation and aggressive behavior in the TgCRND8 AD transgenic mice.</AbstractText><AbstractText Label="METHODS">Male and female animals were tested in the resident-intruder (i.e., aggressive behavior) and open-field tests (i.e., motor agitation) for baseline measures, followed by treatment with active- or sham-nanoFUS. Behavioral testing was then repeated after treatment.</AbstractText><AbstractText Label="RESULTS">Active-nanoFUS neuromodulation reduced aggressive behavior and agitation in male mice, as compared to sham-treated controls. Treatment with active-nanoFUS increased the time male mice spent in social-non-aggressive behaviors.</AbstractText><AbstractText Label="INTERPRETATION">Our results show that neuromodulation with active-nanoFUS may be a potential therapeutic tool for the treatment of neuropsychiatric symptoms, with special focus on agitation and aggressive behaviors. Further studies are necessary to establish cellular, molecular and long-term behavioral changes following treatment with nanoFUS.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gouveia</LastName><ForeName>Flavia Venetucci</ForeName><Initials>FV</Initials><Identifier Source="ORCID">0000-0003-0029-1269</Identifier><AffiliationInfo><Affiliation>Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Ontario, M4N 3M5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lea-Banks</LastName><ForeName>Harriet</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Physical Sciences Platform, Sunnybrook Research Institute, Toronto, Ontario, M4N 3M5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aubert</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Ontario, M4N 3M5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory Medicine &amp; Pathobiology, University of Toronto, Toronto, Ontario, M5S 1A1, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipsman</LastName><ForeName>Nir</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Ontario, M4N 3M5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harquail Centre for Neuromodulation, Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurosurgery, University of Toronto, Toronto, Ontario, M5T 1P5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hynynen</LastName><ForeName>Kullervo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Physical Sciences Platform, Sunnybrook Research Institute, Toronto, Ontario, M4N 3M5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biophysics, University of Toronto, Toronto, Ontario, M5S 1A1, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, M5S 1A1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamani</LastName><ForeName>Clement</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Ontario, M4N 3M5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harquail Centre for Neuromodulation, Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurosurgery, University of Toronto, Toronto, Ontario, M5T 1P5, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 EB003268</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000777">Anesthetics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000374" MajorTopicYN="N">Aggression</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000777" MajorTopicYN="Y">Anesthetics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>K.H. is the founder of FUS Instruments, a company that commercializes the preclinical FUS system. The authors declare no further competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>30</Day><Hour>9</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36715553</ArticleId><ArticleId IdType="pmc">PMC10109287</ArticleId><ArticleId IdType="doi">10.1002/acn3.51737</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Breijyeh Z, Karaman R. Comprehensive review on Alzheimer's disease: causes and treatment. Molecules. 2020;25(24):5789. doi:10.3390/molecules25245789</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25245789</ArticleId><ArticleId IdType="pmc">PMC7764106</ArticleId><ArticleId IdType="pubmed">33302541</ArticleId></ArticleIdList></Reference><Reference><Citation>Brookmeyer R, Abdalla N, Kawas CH, Corrada MM. Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States. Alzheimers Dement. 2018;14(2):121&#x2010;129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5803316</ArticleId><ArticleId IdType="pubmed">29233480</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrarini C, Russo M, Dono F, et&#xa0;al. Agitation and dementia: prevention and treatment strategies in acute and chronic conditions. Front Neurol. 2021;12:644317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8085397</ArticleId><ArticleId IdType="pubmed">33935943</ArticleId></ArticleIdList></Reference><Reference><Citation>Magierski R, Sobow T, Schwertner E, Religa D. Pharmacotherapy of behavioral and psychological symptoms of dementia: state of the art and future Progress. Front Pharmacol. 2020;11:1168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7413102</ArticleId><ArticleId IdType="pubmed">32848775</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J, Mintzer J, Brodaty H, et&#xa0;al. Agitation in cognitive disorders: international psychogeriatric association provisional consensus clinical and research definition. Int Psychogeriatr. 2015;27(1):7&#x2010;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4301197</ArticleId><ArticleId IdType="pubmed">25311499</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu S&#x2010;H, Ha JH, Park D&#x2010;H, Yu J, Livingston G. Persistence of neuropsychiatric symptoms over six months in mild cognitive impairment in community&#x2010;dwelling Korean elderly. Int Psychogeriatr. 2011;23(2):214&#x2010;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">20863423</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. Jama. 2002;288(12):1475&#x2010;1483.</Citation><ArticleIdList><ArticleId IdType="pubmed">12243634</ArticleId></ArticleIdList></Reference><Reference><Citation>Kales HC, Gitlin LN, Lyketsos CG. Detroit expert panel on assessment and Management of Neuropsychiatric Symptoms of dementia. Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel. J Am Geriatr Soc. 2014;62(4):762&#x2010;769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4146407</ArticleId><ArticleId IdType="pubmed">24635665</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng S&#x2010;T. Dementia caregiver burden: a research update and critical analysis. Curr Psychiatry Rep. 2017;19(9):64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5550537</ArticleId><ArticleId IdType="pubmed">28795386</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeste DV, Blazer D, Casey D, et&#xa0;al. ACNP white paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology. 2008;33(5):957&#x2010;970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2553721</ArticleId><ArticleId IdType="pubmed">17637610</ArticleId></ArticleIdList></Reference><Reference><Citation>Trzepacz PT, Yu P, Bhamidipati PK, et&#xa0;al. Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease. Alzheimers Dement. 2013;9(5 Suppl):S95&#x2010;S104.e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3955297</ArticleId><ArticleId IdType="pubmed">23253778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruthirakuhan M, Lanct&#xf4;t KL, Di Scipio M, et&#xa0;al. Biomarkers of agitation and aggression in Alzheimer's disease: a systematic review. Alzheimers Dement. 2018;14(10):1344&#x2010;1376.</Citation><ArticleIdList><ArticleId IdType="pubmed">29940162</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunst J, Marecek R, Klobusiakova P, et&#xa0;al. Patterns of Grey matter atrophy at different stages of Parkinson's and Alzheimer's diseases and relation to cognition. Brain Topogr. 2019;32(1):142&#x2010;160.</Citation><ArticleIdList><ArticleId IdType="pubmed">30206799</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirono N, Mega MS, Dinov ID, Mishkin F, Cummings JL. Left frontotemporal hypoperfusion is associated with aggression in patients with dementia. Arch Neurol. 2000;57(6):861&#x2010;866.</Citation><ArticleIdList><ArticleId IdType="pubmed">10867784</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanct&#xf4;t KL, Herrmann N, Nadkarni NK, Leibovitch FS, Caldwell CB, Black SE. Medial temporal hypoperfusion and aggression in Alzheimer disease. Arch Neurol. 2004;61(11):1731&#x2010;1737.</Citation><ArticleIdList><ArticleId IdType="pubmed">15534184</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida T, Mori T, Yamazaki K, et&#xa0;al. Relationship between regional cerebral blood flow and neuropsychiatric symptoms in dementia with Lewy bodies. Int J Geriatr Psychiatry. 2015;30(10):1068&#x2010;1075.</Citation><ArticleIdList><ArticleId IdType="pubmed">25694273</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright CI, Dickerson BC, Feczko E, Negeira A, Williams D. A functional magnetic resonance imaging study of amygdala responses to human faces in aging and mild Alzheimer's disease. Biol Psychiatry. 2007;62(12):1388&#x2010;1395.</Citation><ArticleIdList><ArticleId IdType="pubmed">17336945</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair RJR. The neurobiology of impulsive aggression. J Child Adolesc Psychopharmacol. 2016;26(1):4&#x2010;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4779272</ArticleId><ArticleId IdType="pubmed">26465707</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouveia FV, Hamani C, Fonoff ET, et&#xa0;al. Amygdala and hypothalamus: historical overview with focus on aggression. Neurosurgery. 2019;85(1):11&#x2010;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6565484</ArticleId><ArticleId IdType="pubmed">30690521</ArticleId></ArticleIdList></Reference><Reference><Citation>Helmy M, Zhang J, Wang H. Neurobiology and neural circuits of aggression. Adv Exp Med Biol. 2020;1284:9&#x2010;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">32852736</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosell DR, Siever LJ. The neurobiology of aggression and violence. CNS Spectr. 2015;20(3):254&#x2010;279.</Citation><ArticleIdList><ArticleId IdType="pubmed">25936249</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouveia FV, Germann J, de Morais R, et&#xa0;al. Longitudinal changes after amygdala surgery for intractable aggressive behavior: clinical, imaging genetics, and deformation&#x2010;based morphometry study&#x2010;a case series. Neurosurgery. 2021;88(2):E158&#x2010;E169.</Citation><ArticleIdList><ArticleId IdType="pubmed">33026432</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouveia FV, Germann J, Devenyi GA, et&#xa0;al. Bilateral amygdala radio&#x2010;frequency ablation for refractory aggressive behavior alters local cortical thickness to a pattern found in non&#x2010;refractory patients. Front Hum Neurosci. 2021;15:653631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8219880</ArticleId><ArticleId IdType="pubmed">34177490</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturm V, Fricke O, B&#xfc;hrle CP, et&#xa0;al. DBS in the basolateral amygdala improves symptoms of autism and related self&#x2010;injurious behavior: a case report and hypothesis on the pathogenesis of the disorder. Front Hum Neurosci. 2012;6:341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3549527</ArticleId><ArticleId IdType="pubmed">23346052</ArticleId></ArticleIdList></Reference><Reference><Citation>Lea&#x2010;Banks H, Hynynen K. Sub&#x2010;millimetre precision of drug delivery in the brain from ultrasound&#x2010;triggered nanodroplets. J Control Release. 2021;338:731&#x2010;741.</Citation><ArticleIdList><ArticleId IdType="pubmed">34530050</ArticleId></ArticleIdList></Reference><Reference><Citation>Lea&#x2010;Banks H, O'Reilly MA, Hamani C, Hynynen K. Localized anesthesia of a specific brain region using ultrasound&#x2010;responsive barbiturate nanodroplets. Theranostics. 2020;10(6):2849&#x2010;2858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7052887</ArticleId><ArticleId IdType="pubmed">32194839</ArticleId></ArticleIdList></Reference><Reference><Citation>Lea&#x2010;Banks H, Meng Y, Wu S&#x2010;K, Belhadjhamida R, Hamani C, Hynynen K. Ultrasound&#x2010;sensitive nanodroplets achieve targeted neuromodulation. J Control Release. 2021;332:30&#x2010;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8089063</ArticleId><ArticleId IdType="pubmed">33600879</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosel F, Pelley JMS, Franklin TB. Behavioural and psychological symptoms of dementia in mouse models of Alzheimer's disease&#x2010;related pathology. Neurosci Biobehav Rev. 2020;112:634&#x2010;647.</Citation><ArticleIdList><ArticleId IdType="pubmed">32070692</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosel F, Hamilton JS, Harrison SL, Godin V, Franklin TB. Reduced social investigation and increased injurious behavior in transgenic 5xFAD mice. J Neurosci Res. 2021;99(1):209&#x2010;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">31912571</ArticleId></ArticleIdList></Reference><Reference><Citation>Chishti MA, Yang DS, Janus C, et&#xa0;al. Early&#x2010;onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem. 2001;276(24):21562&#x2010;21570.</Citation><ArticleIdList><ArticleId IdType="pubmed">11279122</ArticleId></ArticleIdList></Reference><Reference><Citation>Janus C, Welzl H, Hanna A, et&#xa0;al. Impaired conditioned taste aversion learning in APP transgenic mice. Neurobiol Aging. 2004;25(9):1213&#x2010;1219.</Citation><ArticleIdList><ArticleId IdType="pubmed">15312967</ArticleId></ArticleIdList></Reference><Reference><Citation>DaSilva KA, Brown ME, McLaurin J. Reduced oligomeric and vascular amyloid&#x2010;beta following immunization of TgCRND8 mice with an Alzheimer's DNA vaccine. Vaccine. 2009;27(9):1365&#x2010;1376.</Citation><ArticleIdList><ArticleId IdType="pubmed">19150380</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu C, Li Q&#x2010;P, Su Z&#x2010;R, et&#xa0;al. Nano&#x2010;honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer's disease via inhibiting neuropathology and modulating gut microbiota. J Advert Res. 2022;35:231&#x2010;243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8721355</ArticleId><ArticleId IdType="pubmed">35024199</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes&#x2010;Canteli M, Kruyer A, Fernandez&#x2010;Nueda I, et&#xa0;al. Long&#x2010;term dabigatran treatment delays Alzheimer's disease pathogenesis in the TgCRND8 mouse model. J Am Coll Cardiol. 2019;74(15):1910&#x2010;1923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6822166</ArticleId><ArticleId IdType="pubmed">31601371</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon CT, Shah K, Lin C, et&#xa0;al. Time course of focused ultrasound effects on &#x3b2;&#x2010;amyloid plaque pathology in the TgCRND8 mouse model of Alzheimer's disease. Sci Rep. 2018;8(1):14061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6145880</ArticleId><ArticleId IdType="pubmed">30232364</ArticleId></ArticleIdList></Reference><Reference><Citation>Janus C, Pearson J, McLaurin J, et&#xa0;al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 2000;408(6815):979&#x2010;982.</Citation><ArticleIdList><ArticleId IdType="pubmed">11140685</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchatta O, Chaibi I, Baba AA, Ba&#x2010;M'Hamed S, Bennis M. The effects of topiramate on isolation&#x2010;induced aggression: a behavioral and immunohistochemical study in mice. Psychopharmacology (Berl). 2020;237(8):2451&#x2010;2467.</Citation><ArticleIdList><ArticleId IdType="pubmed">32430516</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann A, Lisboa SF, Sonego AB, Coutinho D, Gomes FV, Guimar&#xe3;es FS. Cannabidiol attenuates aggressive behavior induced by social isolation in mice: involvement of 5&#x2010;HT1A and CB1 receptors. Prog Neuropsychopharmacol Biol Psychiatry. 2019;94:109637.</Citation><ArticleIdList><ArticleId IdType="pubmed">31054943</ArticleId></ArticleIdList></Reference><Reference><Citation>Encarnacion A, Horie N, Keren&#x2010;Gill H, Bliss TM, Steinberg GK, Shamloo M. Long&#x2010;term behavioral assessment of function in an experimental model for ischemic stroke. J Neurosci Methods. 2011;196(2):247&#x2010;257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3539723</ArticleId><ArticleId IdType="pubmed">21256866</ArticleId></ArticleIdList></Reference><Reference><Citation>Crispim Junior CF, Pederiva CN, Bose RC, Garcia VA, Lino&#x2010;de&#x2010;Oliveira C, Marino&#x2010;Neto J. ETHOWATCHER: validation of a tool for behavioral and video&#x2010;tracking analysis in laboratory animals. Comput Biol Med. 2012;42(2):257&#x2010;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">22204867</ArticleId></ArticleIdList></Reference><Reference><Citation>Seibenhener ML, Wooten MC. Use of the open field maze to measure locomotor and anxiety&#x2010;like behavior in mice. J Vis Exp. 2015;96:e52434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4354627</ArticleId><ArticleId IdType="pubmed">25742564</ArticleId></ArticleIdList></Reference><Reference><Citation>Lea&#x2010;Banks H, Wu S&#x2010;K, Lee H, Hynynen K. Ultrasound&#x2010;triggered oxygen&#x2010;loaded nanodroplets enhance and monitor cerebral damage from sonodynamic therapy. Nanotheranostics. 2022;6(4):376&#x2010;387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9254362</ArticleId><ArticleId IdType="pubmed">35795341</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Y, Pople CB, Lea&#x2010;Banks H, et&#xa0;al. Focused ultrasound neuromodulation. Int Rev Neurobiol. 2021;159:221&#x2010;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">34446247</ArticleId></ArticleIdList></Reference><Reference><Citation>Cora MC, Kooistra L, Travlos G. Vaginal cytology of the laboratory rat and mouse: review and criteria for the staging of the estrous cycle using stained vaginal smears. Toxicol Pathol. 2015;43(6):776&#x2010;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">25739587</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Reilly MA, Muller A, Hynynen K. Ultrasound insertion loss of rat parietal bone appears to be proportional to animal mass at submegahertz frequencies. Ultrasound Med Biol. 2011;37(11):1930&#x2010;1937.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3228246</ArticleId><ArticleId IdType="pubmed">21925788</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsje P, Wetzels RB, Lucassen PL, Pot AM, Koopmans RT. The course of neuropsychiatric symptoms in community&#x2010;dwelling patients with dementia: a systematic review. Int Psychogeriatr. 2015;27(3):385&#x2010;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">25403309</ArticleId></ArticleIdList></Reference><Reference><Citation>Lea&#x2010;Banks H, O'Reilly MA, Hynynen K. Ultrasound&#x2010;responsive droplets for therapy: a review. J Control Release. 2019;293:144&#x2010;154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6459400</ArticleId><ArticleId IdType="pubmed">30503398</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S&#x2010;Y, Fix SM, Arena CB, et&#xa0;al. Focused ultrasound&#x2010;facilitated brain drug delivery using optimized nanodroplets: vaporization efficiency dictates large molecular delivery. Phys Med Biol. 2018;63(3):035002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5823501</ArticleId><ArticleId IdType="pubmed">29260735</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CC, Sheeran PS, Wu S&#x2010;Y, Olumolade OO, Dayton PA, Konofagou EE. Targeted drug delivery with focused ultrasound&#x2010;induced blood&#x2010;brain barrier opening using acoustically&#x2010;activated nanodroplets. J Control Release. 2013;172(3):795&#x2010;804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3866692</ArticleId><ArticleId IdType="pubmed">24096019</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez C, Arnt J, Hyttel J, Moltzen EK. The role of serotonergic mechanisms in inhibition of isolation&#x2010;induced aggression in male mice. Psychopharmacology (Berl). 1993;110(1&#x2013;2):53&#x2010;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">7870899</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander G, Hanna A, Serna V, Younkin L, Younkin S, Janus C. Increased aggression in males in transgenic Tg2576 mouse model of Alzheimer's disease. Behav Brain Res. 2011;216(1):77&#x2010;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">20655336</ArticleId></ArticleIdList></Reference><Reference><Citation>Thurmond JB. Technique for producing and measuring territorial aggression using laboratory mice. Physiol Behav. 1975;14(6):879&#x2010;881.</Citation><ArticleIdList><ArticleId IdType="pubmed">1237905</ArticleId></ArticleIdList></Reference><Reference><Citation>Foti F, Bilel S, Tirri M, et&#xa0;al. Low&#x2010;normal doses of methiopropamine induce aggressive behaviour in mice. Psychopharmacology (Berl). 2021;238(7):1847&#x2010;1856.</Citation><ArticleIdList><ArticleId IdType="pubmed">33770233</ArticleId></ArticleIdList></Reference><Reference><Citation>Miczek KA, Maxson SC, Fish EW, Faccidomo S. Aggressive behavioral phenotypes in mice. Behav Brain Res. 2001;125(1&#x2013;2):167&#x2010;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">11682108</ArticleId></ArticleIdList></Reference><Reference><Citation>St John RD, Corning PA. Maternal aggression in mice. Behav Biol. 1973;9(5):635&#x2010;639.</Citation><ArticleIdList><ArticleId IdType="pubmed">4796850</ArticleId></ArticleIdList></Reference><Reference><Citation>Bories C, Guitton MJ, Julien C, et&#xa0;al. Sex&#x2010;dependent alterations in social behaviour and cortical synaptic activity coincide at different ages in a model of Alzheimer's disease. PLoS One. 2012;7(9):e46111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3454358</ArticleId><ArticleId IdType="pubmed">23029404</ArticleId></ArticleIdList></Reference><Reference><Citation>Moechars D, Gilis M, Kuip&#xe9;ri C, Laenen I, van Leuven F. Aggressive behaviour in transgenic mice expressing APP is alleviated by serotonergic drugs. Neuroreport. 1998;9(16):3561&#x2010;3564.</Citation><ArticleIdList><ArticleId IdType="pubmed">9858360</ArticleId></ArticleIdList></Reference><Reference><Citation>Vloeberghs E, Van Dam D, Coen K, et&#xa0;al. Aggressive male APP23 mice modeling behavioral alterations in dementia. Behav Neurosci. 2006;120(6):1380&#x2010;1383.</Citation><ArticleIdList><ArticleId IdType="pubmed">17201483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballard C, Corbett A. Agitation and aggression in people with Alzheimer's disease. Curr Opin Psychiatry. 2013;26(3):252&#x2010;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">23528917</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendash GW, King DL, Gordon MN, et&#xa0;al. Progressive, age&#x2010;related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin&#x2010;1 transgenes. Brain Res. 2001;891(1&#x2013;2):42&#x2010;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">11164808</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalonde R, Fukuchi K, Strazielle C. APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD). Neurosci Biobehav Rev. 2012;36(5):1357&#x2010;1375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3340431</ArticleId><ArticleId IdType="pubmed">22373961</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao KK, Borchelt DR, Olson K, et&#xa0;al. Age&#x2010;related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron. 1995;15(5):1203&#x2010;1218.</Citation><ArticleIdList><ArticleId IdType="pubmed">7576662</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldifassi MC, Baur R, Sigel E. Functional sites involved in modulation of the GABAA receptor channel by the intravenous anesthetics propofol, etomidate and pentobarbital. Neuropharmacology. 2016;105:207&#x2010;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">26767954</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen RW. GABA receptor: positive and negative allosteric modulators. Neuropharmacology. 2018;136(Pt A):10&#x2010;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6027637</ArticleId><ArticleId IdType="pubmed">29407219</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuschinsky K, Seidel G, Reetz E, Meyer&#x2010;Burgdorf C. The effect of pentobarbital on brain 5&#x2010;HT metabolism in mice. Experientia. 1973;29(7):826&#x2010;827.</Citation><ArticleIdList><ArticleId IdType="pubmed">4724714</ArticleId></ArticleIdList></Reference><Reference><Citation>Miczek KA, de Almeida RMM, Kravitz EA, Rissman EF, de Boer SF, Raine A. Neurobiology of escalated aggression and violence. J Neurosci. 2007;27(44):11803&#x2010;11806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2667097</ArticleId><ArticleId IdType="pubmed">17978016</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi A, Quadros IM, de Almeida RMM, Miczek KA. Behavioral and pharmacogenetics of aggressive behavior. Curr Top Behav Neurosci. 2012;12:73&#x2010;138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3864145</ArticleId><ArticleId IdType="pubmed">22297576</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36715000</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-203X</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>International psychogeriatrics</Title><ISOAbbreviation>Int Psychogeriatr</ISOAbbreviation></Journal><ArticleTitle>Apathy and depression in mild cognitive impairment: distinct longitudinal trajectories and clinical outcomes.</ArticleTitle><Pagination><StartPage>633</StartPage><EndPage>642</EndPage><MedlinePgn>633-642</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S1041610222001089</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Apathy is a common symptom in mild cognitive impairment (MCI) and may predict progression to dementia. Little research, however, has investigated the longitudinal trajectory of apathy in patients with MCI or controlled for depression, which can mimic apathy, when examining its clinical correlates. The current study sought to address these issues.</AbstractText><AbstractText Label="DESIGN">A prospective longitudinal study was conducted over 3 years.</AbstractText><AbstractText Label="SETTING">Nine memory clinics around Australia.</AbstractText><AbstractText Label="PARTICIPANTS">One hundred and eighty-five patients with MCI at baseline.</AbstractText><AbstractText Label="MEASUREMENTS">Measures of cognition, function, neuropsychiatric symptoms, caregiver burden, and medication use were completed annually with additional assessments at 3 and 6 months. Patients were also assessed for dementia by expert clinicians at these time points.</AbstractText><AbstractText Label="RESULTS">Of 164 patients who completed measures of neuropsychiatric symptoms, 59 (36.0%) had apathy and 61 (37.2%) had depression. The proportion affected by apathy and overall apathy scores increased over time, in contrast to measures of depression, which remained relatively stable. Apathy was associated with incident dementia and worse cognition, function, neuropsychiatric symptoms, and caregiver burden independent of both depression and incident dementia. Depression was associated with worse function, albeit to lesser degree than apathy, and neuropsychiatric symptoms.</AbstractText><AbstractText Label="CONCLUSIONS">Apathy increases in MCI and is associated with worse clinical outcomes. These findings provide further evidence for apathy as a marker of clinical decline in older people and poorer outcomes across neurocognitive disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Connors</LastName><ForeName>Michael H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Centre for Healthy Brain Ageing, UNSW Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira-Pinto</LastName><ForeName>Armando</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Public Health, The University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ames</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Ageing Research Institute, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Melbourne Academic Unit for Psychiatry of Old Age, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woodward</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Austin Hospital, Heidelberg, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brodaty</LastName><ForeName>Henry</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-9487-6617</Identifier><AffiliationInfo><Affiliation>Centre for Healthy Brain Ageing, UNSW Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int Psychogeriatr</MedlineTA><NlmUniqueID>9007918</NlmUniqueID><ISSNLinking>1041-6102</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Int Psychogeriatr. 2023 Nov;35(11):598-600. doi: 10.1017/S1041610223000042</RefSource><PMID Version="1">36714964</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057565" MajorTopicYN="Y">Apathy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">apathy</Keyword><Keyword MajorTopicYN="N">behavioral and psychological symptoms of dementia</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">mild cognitive impairment</Keyword><Keyword MajorTopicYN="N">neuropsychiatric symptoms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>30</Day><Hour>4</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36715000</ArticleId><ArticleId IdType="doi">10.1017/S1041610222001089</ArticleId><ArticleId IdType="pii">S1041610222001089</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36710674</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-8908</ISSN><JournalIssue CitedMedium="Internet"><Volume>92</Volume><Issue>1</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Texas Alzheimer's Research and Care Consortium (TARCC) Cohort-Based Analysis.</ArticleTitle><Pagination><StartPage>129</StartPage><EndPage>139</EndPage><MedlinePgn>129-139</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-220826</ELocationID><Abstract><AbstractText Label="BACKGROUND">Apathy is among the neuropsychiatric symptoms frequently observed in people with cognitive impairment. It has been postulated to be a potential predictor of conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD).</AbstractText><AbstractText Label="OBJECTIVE">To detect conversion rates from MCI to AD, and to determine the effect of apathy on the progression to AD in patients with MCI enrolled in the Texas Alzheimer's Research and Care Consortium (TARCC) cohort.</AbstractText><AbstractText Label="METHODS">Apathy was determined by a positive response to the respective item in the Neuropsychiatric Inventory -Questionnaire (NPI-Q) completed by family members or caregivers. The final dataset included 2,897 observations from 1,092 individuals with MCI at the baseline. Kaplan-Meier survival curves were estimated to provide indices of the probability of conversion to AD over time across all individuals as well as between those with and without apathy. Cox proportional hazards regression measured the hazard associated with apathy and several other predictors of interest.</AbstractText><AbstractText Label="RESULTS">Over a period of 8.21 years, 17.3% of individuals had conversion from MCI to AD (n&#x200a;=&#x200a;190 of 1,092 total individuals) across observations. The median time-to-conversion across all participants was 6.41 years. Comparing individuals with apathy (n&#x200a;=&#x200a;158) versus without apathy (n&#x200a;=&#x200a;934), 36.1% and 14.2% had conversion to AD, respectively. The median time-to-conversion was 3.79 years for individuals with apathy and 6.83 years for individuals without apathy. Cox proportional hazards regression found significant effects of several predictors, including apathy, on time-to-conversion. Age and cognitive performance were found to moderate the relationship between apathy and time-to-conversion.</AbstractText><AbstractText Label="CONCLUSIONS">Apathy is associated with progression from MCI to AD, suggesting that it might improve risk prediction and aid targeted intervention delivery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salem</LastName><ForeName>Haitham</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchting</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzales</LastName><ForeName>Mitzi M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Biggs Institute, University of Texas Health Science Center, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seshadri</LastName><ForeName>Sudha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biggs Institute, University of Texas Health Science Center, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira</LastName><ForeName>Antonio L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG044271</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057565" MajorTopicYN="Y">Apathy</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013781" MajorTopicYN="N" Type="Geographic">Texas</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">apathy</Keyword><Keyword MajorTopicYN="N">mild cognitive impairment</Keyword><Keyword MajorTopicYN="N">neuropsychiatric symptoms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>30</Day><Hour>3</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36710674</ArticleId><ArticleId IdType="doi">10.3233/JAD-220826</ArticleId><ArticleId IdType="pii">JAD220826</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36710420</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-4523</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of applied gerontology : the official journal of the Southern Gerontological Society</Title><ISOAbbreviation>J Appl Gerontol</ISOAbbreviation></Journal><ArticleTitle>What Facilitates or Hampers Living at Home With Advanced Dementia Until the End of Life? A Qualitative Study Using Retrospective Interviews Among Family Caregivers, General Practitioners, and Case Managers.</ArticleTitle><Pagination><StartPage>1404</StartPage><EndPage>1413</EndPage><MedlinePgn>1404-1413</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/07334648231153722</ELocationID><Abstract><AbstractText>This study provides insight into circumstances that facilitate or hamper living at home with advanced dementia until the end of life. Interviews were held with 11 bereaved family caregivers, two general practitioners, and nine case managers, related to a total of 12 persons with advanced dementia who had recently died. Persons with dementia who lived at home until the end of life often had family caregivers that received timely support from professionals and their social network. In the cases where the person with dementia could not live at home until the end of life, safety issues, severely challenging behavior, and high care dependency of the person with dementia played key roles. Case management and a continuous process of advance care planning will improve the chance that the end-of-life setting is in accordance with the key values and needs of both the person with dementia and family caregivers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Jong</LastName><ForeName>Loes M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Netherlands Institute for Health Services Research (Nivel), Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Francke</LastName><ForeName>Anneke L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Netherlands Institute for Health Services Research (Nivel), Utrecht, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public and Occupational Health, Amsterdam Public Health Research Institute, VU University, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donker</LastName><ForeName>G&#xe9;</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Netherlands Institute for Health Services Research (Nivel), Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Buuse</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Alzheimer Netherlands, Amersfoort, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Heide</LastName><ForeName>Iris</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-9709-7261</Identifier><AffiliationInfo><Affiliation>Netherlands Institute for Health Services Research (Nivel), Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Appl Gerontol</MedlineTA><NlmUniqueID>8606502</NlmUniqueID><ISSNLinking>0733-4648</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071959" MajorTopicYN="Y">Case Managers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058005" MajorTopicYN="Y">General Practitioners</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003643" MajorTopicYN="N">Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013727" MajorTopicYN="Y">Terminal Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">advance care planning</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">end of life</Keyword><Keyword MajorTopicYN="N">palliative care</Keyword><Keyword MajorTopicYN="N">qualitative methods</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>30</Day><Hour>0</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36710420</ArticleId><ArticleId IdType="doi">10.1177/07334648231153722</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36706328</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-4156</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>1</Issue><PubDate><MedlineDate>2023 Jan-Mar 01</MedlineDate></PubDate></JournalIssue><Title>Alzheimer disease and associated disorders</Title><ISOAbbreviation>Alzheimer Dis Assoc Disord</ISOAbbreviation></Journal><ArticleTitle>Development and Validation of a Multidimensional Short Version Zarit Burden Interview (ZBI-9) for Caregivers of Persons With Cognitive Impairment.</ArticleTitle><Pagination><StartPage>59</StartPage><EndPage>65</EndPage><MedlinePgn>59-65</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/WAD.0000000000000537</ELocationID><Abstract><AbstractText Label="BACKGROUND">There is a lack of appreciation of the full dimensionality of the original 22-item Zarit Burden Interview (ZBI) in the development of short versions. Existing short versions are premised upon a 1-factor or 2-factor structure or statistical techniques for item selection. Thus, there is a need for ZBI short versions that considers the multidimensional constructs of role strain, personal strain, and worry about performance (WaP) during item selection to provide a more holistic and comprehensive evaluation.</AbstractText><AbstractText Label="PURPOSE">To develop and validate a short version of ZBI through a combined quantitative and qualitative approach that incorporates the validated 4-factor structure of role strain demands; role strain-control; personal strain, and WaP.</AbstractText><AbstractText Label="PATIENTS">We studied 202 caregivers of patients with dementia (84.2%) or mild cognitive impairment (15.8%) attending a memory clinic in Singapore.</AbstractText><AbstractText Label="METHODS">Confirmatory factor analysis and qualitative considerations from expert consensus were used for item selection. Confirmatory factor analysis fit statistics support the 4-factor structure. The 9-item ZBI-9 showed good internal consistency (Cronbach's &#x3b1;=0.87) and convergent validity with anxiety and depression (Pearson correlation: Hospital Anxiety and Depression sub-scales, r&#x2265;0.56, P &lt;0.001; ZBI- 22, r=0.95, P &lt;0.001). Using a cut-off score of &#x2265;13, ZBI-9 displayed good discriminatory ability for depressive symptoms (area under curve=0.79, P &lt;0.001; sensitivity=70%, specificity=75%). The ZBI-9 also displayed comparable performance to the 22-item full version and three 12-item short versions.</AbstractText><AbstractText Label="CONCLUSION">The ZBI-9 is a multidimensional short-version assessment tool for caregivers of persons with dementia and mild cognitive impairment that is reliable, valid, and discriminates depressive symptoms.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhi-Xiang</LastName><ForeName>Lim</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Nursing Research Unit, Nursing Service.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Wee Shiong</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Institute of Geriatrics and Active Aging, Tan Tock Seng Hospital, 11 Jan Tan Tock Seng.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lee Kong Chian School of Medicine, Nanyang Technological University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Ee-Yuee</ForeName><Initials>EY</Initials><Identifier Source="ORCID">0000-0001-8662-4487</Identifier><AffiliationInfo><Affiliation>Nursing Research Unit.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alice Lee Centre of Nursing Studies, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Alzheimer Dis Assoc Disord</MedlineTA><NlmUniqueID>8704771</NlmUniqueID><ISSNLinking>0893-0341</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005163" MajorTopicYN="N">Factor Analysis, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>15</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36706328</ArticleId><ArticleId IdType="pmc">PMC9946168</ArticleId><ArticleId IdType="doi">10.1097/WAD.0000000000000537</ArticleId><ArticleId IdType="pii">00002093-202301000-00009</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980;20:649&#x2013;655.</Citation><ArticleIdList><ArticleId IdType="pubmed">7203086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko K-T, Yip P-K, Liu S-I, et al. . Chinese version of the Zarit Caregiver Burden Interview: a validation study. Am J Geriatr Psychiatry. 2008;16:513&#x2013;518.</Citation><ArticleIdList><ArticleId IdType="pubmed">18515696</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai Y, Tamiya N, Yano E. The short version of the Japanese version of the Zarit Caregiver Burden Interview (J-ZBI_8): its reliability and validity. Jap J Geriatr. 2003;40:497&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">14579721</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;dard M, Molloy DW, Squire L, et al. . The Zarit Burden Interview: a new short version and screening version. Gerontologist. 2001;41:652&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pubmed">11574710</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew TM, Yap P. A 3-item screening scale for caregiver burden in dementia caregiving: Scale development and score mapping to the 22-item Zarit Burden Interview. J Am Med Dir Assoc. 2019;20:629&#x2013;633.e612.</Citation><ArticleIdList><ArticleId IdType="pubmed">30591383</ArticleId></ArticleIdList></Reference><Reference><Citation>Gort AM, Mingot M, March J, et al. . Short Zarit scale in dementias. Med Clin (Barc). 2010;135:447&#x2013;449.</Citation><ArticleIdList><ArticleId IdType="pubmed">20637482</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau S, Ali N, Lim JP, et al. . ZBI multidimensionality: The salience of worry about performance. Int Psychogeriatr. 2019;31:909&#x2013;911.</Citation><ArticleIdList><ArticleId IdType="pubmed">30472976</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight BG, Fox LS, Chou C-P. Factor structure of the burden interview. J Clin Geropsychol. 2000;6:249&#x2013;258.</Citation></Reference><Reference><Citation>Lau S, Chong MS, Ali N, et al. . Caregiver burden: Looking Beyond the Unidimensional Total Score. Alzh Dis Assoc Dis. 2015;29:338&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pubmed">25710249</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballesteros J, Santos B, Gonz&#xe1;lez-Fraile E, et al. . Unidimensional 12-item Zarit Caregiver Burden Interview for the assessment of dementia caregivers&#x2019; burden obtained by item response theory. Value Health. 2012;15:1141&#x2013;1147.</Citation><ArticleIdList><ArticleId IdType="pubmed">23244818</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Chong MS, Chan PCM, et al. . Worry About Caregiving Performance: A Confirmatory Factor Analysis. Front Med. 2018;5:79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5874286</ArticleId><ArticleId IdType="pubmed">29623277</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitlatch CJ, Zarit SH, von Eye A. Efficacy of interventions with caregivers: a reanalysis. Gerontologist. 1991;31:9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">2007480</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyzer L, Ali NB, Chew AP, et al. . Worry about Performance: Unravelling the Relationship between &#x2018;Doing More&#x2019; and &#x2018;Doing Better&#x2019;. J Nutr Health Aging. 2019;23:843&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pubmed">31641734</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim WS, Cheah WK, Ali N, et al. . Worry about performance: a unique dimension of caregiver burden. Int Psychogeriatr. 2014;26:677&#x2013;686.</Citation><ArticleIdList><ArticleId IdType="pubmed">24382159</ArticleId></ArticleIdList></Reference><Reference><Citation>Branger C, O&#x2019;Connell ME, Morgan DG. Factor Analysis of the 12-Item Zarit Burden Interview in Caregivers of Persons Diagnosed With Dementia. J Appl Gerontol. 2016;35:489&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pubmed">24652929</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang JY-m, Ho AH-y, Luo H, et al. . Validating a Cantonese short version of the Zarit Burden Interview (CZBI-Short) for dementia caregivers. Aging Ment Health. 2016;20:996&#x2013;1001.</Citation><ArticleIdList><ArticleId IdType="pubmed">26016419</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetz C, Coste J, Lemetayer F, et al. . Item reduction based on rigorous methodological guidelines is necessary to maintain validity when shortening composite measurement scales. J Clin Epidemiol. 2013;66:710&#x2013;718.</Citation><ArticleIdList><ArticleId IdType="pubmed">23566375</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheah WK, Han HC, Chong MS, et al. . Multidimensionality of the Zarit Burden Interview across the severity spectrum of cognitive impairment: an Asian perspective. Int Psychogeriatr. 2012;24:1846.</Citation><ArticleIdList><ArticleId IdType="pubmed">22874633</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjelland I, Dahl AA, Haug TT, et al. . The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52:69&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">11832252</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh HW, Hau K-T, Grayson D.Maydeu-Olivares A, McArdle JJ. Goodness of Fit in Structural Equation Models. Contemporary psychometrics: A festschrift for Roderick P. McDonald. Mahwah, NJ, US: Lawrence Erlbaum Associates Publishers; 2005:275&#x2013;340.</Citation></Reference><Reference><Citation>Moran LA, Guyatt GH, Norman GR. Establishing the minimal number of items for a responsive, valid, health-related quality of life instrument. J Clin Epidemiol. 2001;54:571&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">11377117</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe9;bert R, Bravo G, Pr&#xe9;ville M. Reliability, validity and reference values of the Zarit Burden Interview for assessing informal caregivers of community-dwelling older persons with dementia. Can J Aging/La Revue Canadienne du vieillissement. 2000;19:494&#x2013;507.</Citation></Reference><Reference><Citation>Zarzycki M, Morrison V, Bei E, et al. . Cultural and societal motivations for being informal caregivers: A qualitative systematic review and meta-synthesis. Health Psychol Rev. 2022;5:1&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">35081864</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Bern-Klug M. I should be doing more for my parent: Chinese adult children&#x2019;s worry about performance in providing care for their oldest-old parents. Int Psychogeriatr. 2016;28:303.</Citation><ArticleIdList><ArticleId IdType="pubmed">26490084</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenwood N, Smith R. Motivations for being informal carers of people living with dementia: a systematic review of qualitative literature. BMC Geriatr. 2019;19:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6580594</ArticleId><ArticleId IdType="pubmed">31208351</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng ST, Au A, Losada A, et al. . Psychological Interventions for Dementia Caregivers: What We Have Achieved, What We Have Learned. Curr Psychiatry Rep. 2019;21:59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6554248</ArticleId><ArticleId IdType="pubmed">31172302</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Hu N, Yu Y, et al. . Trajectories of Multidimensional Caregiver Burden in Chinese Informal Caregivers for Dementia: Evidence from Exploratory and Confirmatory Factor Analysis of the Zarit Burden Interview. J Alzheimers Dis. 2017;59:1317&#x2013;1325.</Citation><ArticleIdList><ArticleId IdType="pubmed">28759966</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36706322</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-4156</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>2</Issue><PubDate><MedlineDate>2023 Apr-Jun 01</MedlineDate></PubDate></JournalIssue><Title>Alzheimer disease and associated disorders</Title><ISOAbbreviation>Alzheimer Dis Assoc Disord</ISOAbbreviation></Journal><ArticleTitle>Hypothesis: Dementia Diminishes Interdependence in Health and Quality of Life Among Spousal Partners.</ArticleTitle><Pagination><StartPage>174</StartPage><EndPage>177</EndPage><MedlinePgn>174-177</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/WAD.0000000000000539</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nyman</LastName><ForeName>Samuel R</ForeName><Initials>SR</Initials><Identifier Source="ORCID">0000-0003-1963-0814</Identifier><AffiliationInfo><Affiliation>Bournemouth University Clinical Research Unit.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casey</LastName><ForeName>Chloe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Integrative Wellbeing Research Centre, Faculty of Health &amp; Social Sciences, Bournemouth University, Bournemouth.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenwood</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centre for Health and Social Care Research, Faculty of Health, Social Care and Education, Kingston University London and St George's University of London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02864056</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>CDF-2015-08-030</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Alzheimer Dis Assoc Disord</MedlineTA><NlmUniqueID>8704771</NlmUniqueID><ISSNLinking>0893-0341</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000223" MajorTopicYN="N">Adaptation, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013315" MajorTopicYN="N">Stress, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018454" MajorTopicYN="N">Spouses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>15</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36706322</ArticleId><ArticleId IdType="doi">10.1097/WAD.0000000000000539</ArticleId><ArticleId IdType="pii">00002093-202304000-00017</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bastawrous M. Caregiver burden--a critical discussion. Int J Nurs Stud. 2013;50:431&#x2013;441.</Citation></Reference><Reference><Citation>Prince M, Knapp M, Guerchet M, et al. Dementia UK: Update, second edition. London: Alzheimer&#x2019;s Society; 2014.</Citation></Reference><Reference><Citation>Wimo A, Reed CC, Dodel R, et al. The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer&#x2019;s disease in three European countries--study design and baseline findings. J Alzheimers Dis. 2013;36:385&#x2013;399.</Citation></Reference><Reference><Citation>The WHOQOL Group. The World Health Organization Quality of Life assessment (WHOQOL): Position paper from the World Health Organization. Soc Sci Med. 1995;41:1403&#x2013;1409.</Citation></Reference><Reference><Citation>Kiecolt-Glaser JK, Wilson SJ. Lovesick: How couples&#x2019; relationships influence health. Annu Rev Clin Psychol. 2017;13:421&#x2013;443.</Citation></Reference><Reference><Citation>Bourassa KJ, Memel M, Woolverton C, et al. A dyadic approach to health, cognition, and quality of life in aging adults. Psychol Aging. 2015;30:449&#x2013;461.</Citation></Reference><Reference><Citation>Schoebi D. The coregulation of daily affect in marital relationships. J Fam Psychol. 2008;22:595&#x2013;604.</Citation></Reference><Reference><Citation>Ferraris G, Dang S, Woodford J, et al. Dyadic interdependence in non-spousal caregiving dyads&#x2019; wellbeing: a systematic review. Front Psychol. 2022;13:882389.</Citation></Reference><Reference><Citation>Lethin C, Renom-Guiteras A, Zwakhalen S, et al. Psychological well-being over time among informal caregivers caring for persons with dementia living at home. Aging Ment Health. 2017;21:1138&#x2013;1146.</Citation></Reference><Reference><Citation>Wilson RS, Sytsma J, Barnes LL, et al. Anosognosia in Dementia. Curr Neurol Neurosci Rep. 2016;16:77.</Citation></Reference><Reference><Citation>Butler R, Radhakrishnan R. Dementia: Systematic review 1001. BMJ Clin Evid. 2012;9:e1001.</Citation></Reference><Reference><Citation>Conde-Sala JL, Rene-Ramirez R, Turro-Garriga O, et al. Clinical differences in patients with Alzheimer&#x2019;s disease according to the presence or absence of anosognosia: implications for perceived quality of life. J Alzheimers Dis. 2013;33:1105&#x2013;1116.</Citation></Reference><Reference><Citation>Nyman SR, Ingram W, Sanders J, et al. Randomised controlled trial of the effect of Tai Chi on postural balance of people with dementia. Clin Int Aging. 2019;14:2017&#x2013;2029.</Citation></Reference><Reference><Citation>Lowery D, Cerga-Pashoja A, Iliffe S, et al. The effect of exercise on behavioural and psychological symptoms of dementia: the EVIDEM-E randomised controlled clinical trial. Int J Geriatr Psychiatry. 2014;29:819&#x2013;827.</Citation></Reference><Reference><Citation>Enright J, O&#x2019;Connell ME, Branger C, et al. Identity, relationship quality, and subjective burden in caregivers of persons with dementia. Dementia. 2020;19:1855&#x2013;1871.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36701529</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1744-8360</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Expert review of neurotherapeutics</Title><ISOAbbreviation>Expert Rev Neurother</ISOAbbreviation></Journal><ArticleTitle>Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson's disease: current evidence and future perspectives.</ArticleTitle><Pagination><StartPage>25</StartPage><EndPage>43</EndPage><MedlinePgn>25-43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/14737175.2023.2173576</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Non-motor symptoms (NMS) affect patients with Parkinson's disease (PD) from the prodromal to the advanced stages. NMS phenotypes greatly vary and have a huge impact on patients' and caregivers' quality of life (QoL). The management of cognitive and neuropsychiatric NMS remains an unmet need.</AbstractText><AbstractText Label="AREAS COVERED">The authors, herein, review the dopaminergic and non-dopaminergic pathogenesis, clinical features, assessment, and pharmacological and non-pharmacological treatments of cognitive and neuropsychiatric NMS in PD. They discuss the current evidence and report the findings of an overview of ongoing trials on pharmacological and selected non-pharmacological strategies.</AbstractText><AbstractText Label="EXPERT OPINION">The treatment of cognitive and neuropsychiatric NMS in PD is poorly explored, and therapeutic options are unsatisfactory. Pharmacological treatment of cognitive NMS is based on symptomatic active principles used in Alzheimer's disease. Dopamine agonists, selective serotonin, and serotonin-norepinephrine reuptake inhibitors have some evidence on PD-related depression. Clozapine, quetiapine, and pimavanserin may be considered for psychosis in PD. Evidence on the treatment of other neuropsychiatric NMS is limited or lacking. Addressing pathophysiological and clinical issues, which hamper solid evidence on the treatment of cognitive and neuropsychiatric NMS, may reduce the impact on QoL for PD patients and their caregivers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mantovani</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zucchella</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Section of Neurology, Department of Neurosciences, Verona University Hospital, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argyriou</LastName><ForeName>Andreas A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0003-2131-7114</Identifier><AffiliationInfo><Affiliation>Department of Neurology, "Agios Andreas" State General Hospital of Patras, Patras, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamburin</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Rev Neurother</MedlineTA><NlmUniqueID>101129944</NlmUniqueID><ISSNLinking>1473-7175</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>333DO1RDJY</RegistryNumber><NameOfSubstance UI="D012701">Serotonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018491">Dopamine Agonists</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012701" MajorTopicYN="N">Serotonin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018491" MajorTopicYN="N">Dopamine Agonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Assessment</Keyword><Keyword MajorTopicYN="N">non-motor symptoms</Keyword><Keyword MajorTopicYN="N">non-pharmacological treatment</Keyword><Keyword MajorTopicYN="N">parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">pathophysiology</Keyword><Keyword MajorTopicYN="N">pharmacological treatment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>26</Day><Hour>14</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36701529</ArticleId><ArticleId IdType="doi">10.1080/14737175.2023.2173576</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36699807</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2470-5470</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2023</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Chronic stress (Thousand Oaks, Calif.)</Title><ISOAbbreviation>Chronic Stress (Thousand Oaks)</ISOAbbreviation></Journal><ArticleTitle>Dementia, Substance Misuse, and Social Determinants of Health: American Indian and Alaska Native Peoples' Prevention, Service, and Care.</ArticleTitle><Pagination><StartPage>24705470221149479</StartPage><MedlinePgn>24705470221149479</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">24705470221149479</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/24705470221149479</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">American Indian and Alaska Native (AI/AN) peoples are disproportionately impacted by substance use disorders (SUDs) and health consequences in contrast to all racial/ethnic groups in the United States. This is alarming that AI/AN peoples experience significant health disparities and disease burden that are exacerbated by settler-colonial traumas expressed through prejudice, stigma, discrimination, and systemic and structural inequities. One such compounding disease for AI/AN peoples that is expected to increase but little is known is Alzheimer's disease and related dementias (ADRD). AI/AN approaches for understanding and treating disease have long been rooted in culture, context, and worldview. Thus, culturally based prevention, service, and caregiving are critical to optimal outcomes, and investigating cultural beliefs regarding ADRD can provide insights into linkages of chronic stressors, disease, prevention and treatment, and the role of substance misuse.</AbstractText><AbstractText Label="METHOD" NlmCategory="UNASSIGNED">To understand the cultural practices and values that compose AI/AN Elder beliefs and perceptions of ADRD, a grounded theory, qualitative study was conducted. Twelve semistructured interviews with AI/AN Elders (M age&#x2009;=&#x2009;73; female&#x2009;=&#x2009;8, male&#x2009;=&#x2009;4) assessed the etiology, course, treatment, caregiving, and the culturally derived meanings of ADRD, which provides a frame of understanding social determinants of health (SDH; eg, healthcare equity, community context) and impacts (eg, historical trauma, substance misuse) across the lifespan.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Qualitative analyses specific to disease etiology, barriers to treatment, and SDH revealed 6 interrelated and nested subthemes elucidating both the resilience and the chronic stressors and barriers faced by AI/AN peoples that directly impact prevention, disease progression, and related services: (1) postcolonial distress; (2) substance misuse; (3) distrust of Western medicine; (4) structural inequities; (5) walking in two worlds; and (6) decolonizing and indigenizing medicine.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Barriers to optimal wellbeing and SDH for AI/AN peoples are understood through SUDs, ADRD, and compounding symptoms upheld by colonial traumas and postcolonial distress. En masse historical and contemporary discrimination and stress, particularly within Western medicine, both contextualizes the present and points to the ways in which the strengths, wisdom, and balance inherent in AI/AN culture are imperative to the holistic health and healing of AI/AN peoples, families, and communities.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Crouch</LastName><ForeName>Maria C</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0001-9520-5479</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.</Affiliation><Identifier Source="RINGGOLD">12228</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheromiah Salazar</LastName><ForeName>Maredyth B R</ForeName><Initials>MBR</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Alaska Anchorage, Anchorage, AK, USA.</Affiliation><Identifier Source="RINGGOLD">3291</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Steven J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0003-1217-0202</Identifier><AffiliationInfo><Affiliation>Department of Psychology, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation><Identifier Source="RINGGOLD">6614</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosich</LastName><ForeName>Rosellen M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Alaska Anchorage, Anchorage, AK, USA.</Affiliation><Identifier Source="RINGGOLD">3291</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F32 AA029627</GrantID><Acronym>AA</Acronym><Agency>NIAAA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R25 DA035163</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Chronic Stress (Thousand Oaks)</MedlineTA><NlmUniqueID>101701229</NlmUniqueID><ISSNLinking>2470-5470</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">American Indian/Alaska Native</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">historical trauma</Keyword><Keyword MajorTopicYN="N">social determinants of health</Keyword><Keyword MajorTopicYN="N">substance use</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>26</Day><Hour>2</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36699807</ArticleId><ArticleId IdType="pmc">PMC9869198</ArticleId><ArticleId IdType="doi">10.1177/24705470221149479</ArticleId><ArticleId IdType="pii">10.1177_24705470221149479</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lewis JP, Manson SM, Jernigan VB, et al.. &#x201c;Making sense of a disease that makes no sense&#x201d;: understanding Alzheimer&#x2019;s disease and related disorders among caregivers and providers within Alaska Native communities. Gerontologist. 2021; 61(3): 363&#x2013;373. doi:10.1093/geront/gnaa102</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnaa102</ArticleId><ArticleId IdType="pmc">PMC8023374</ArticleId><ArticleId IdType="pubmed">32789474</ArticleId></ArticleIdList></Reference><Reference><Citation>National Indian Council on Aging. The state of Tribal Elders. www.nicoa.org/the-state-of-tribal-elders/
(2019, accessed 29 July 2022).</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Association. 2022 Alzheimer&#x2019;s disease facts and figures: Special report more than normal aging. www.alz.org/media/documents/alzheimers-facts-and-figures.pdf
(2022, accessed 29 July 2022).</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Healthy brain initiative, road map for Indian country. www.cdc.gov/aging/healthybrain/pdf/hbi-road-map-for-indian-country-508.pdf
(2019, accessed 20 July 2022).</Citation></Reference><Reference><Citation>Wang X, Huang W, Su L, et al.. Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer&#x2019;s disease. Mol Neurodegener. 2020; 15(1): 1&#x2013;27. doi:10.1186/s13024-020-00395-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00395-3</ArticleId><ArticleId IdType="pmc">PMC7507636</ArticleId><ArticleId IdType="pubmed">32962744</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellmar TC, Brandt EN, Jr, Baird MA. Health and behavior: the interplay of biological, behavioral, and social influences: summary of an Institute of Medicine report. Am J Health Promot. 2002; 16(4): 206&#x2013;219. doi:10.4278/0890-1171-16.4.206</Citation><ArticleIdList><ArticleId IdType="doi">10.4278/0890-1171-16.4.206</ArticleId><ArticleId IdType="pubmed">11913326</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipina SJ. The biological side of social determinants: neural costs of childhood poverty. Prospects. 2016; 46(2): 265&#x2013;280. doi:10.1007/s11125-017-9390-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11125-017-9390-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh G, Daus G, Allender M, et al.. Social determinants of health in the United States: addressing major health inequality trends for the nation, 1935&#x2013;2016. Int J MCH AIDS. 2017; 6(2): 139&#x2013;164. doi:10.21106/ijma.236</Citation><ArticleIdList><ArticleId IdType="doi">10.21106/ijma.236</ArticleId><ArticleId IdType="pmc">PMC5777389</ArticleId><ArticleId IdType="pubmed">29367890</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Social determinants of health. www.who.int/health-topics/social-determinants-of-health#tab=tab_3
(2019, accessed 20 July 2022).</Citation></Reference><Reference><Citation>Office of Disease Prevention and Health Promotion. Social determinants of health. www.health.gov/healthypeople/priority-areas/social-determinants-health
(2020, accessed 1 July 2022).</Citation></Reference><Reference><Citation>Majoka MA, Schimming C. Effect of social determinants of health on cognition and risk of Alzheimer disease and related dementias. Clin Ther. 2021; 43(6): 922&#x2013;929. doi:10.1016/j.clinthera.2021.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2021.05.005</ArticleId><ArticleId IdType="pubmed">34103175</ArticleId></ArticleIdList></Reference><Reference><Citation>Marden JR, Tchetgen Tchetgen EJ, Kawachi I, et al.. Contribution of socioeconomic status at 3 life-course periods to late-life memory function and decline: early and late predictors of dementia risk. Am J Epidemiol. 2017; 186(7): 805&#x2013;814. doi:10.1093/aje/kwx155</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwx155</ArticleId><ArticleId IdType="pmc">PMC5859987</ArticleId><ArticleId IdType="pubmed">28541410</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayeda ER, Glymour MM, Quesenberry CP, et al.. Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Alzheimers Dement. 2016; 12(3): 216&#x2013;224. doi:10.1016/j.jalz.2015.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2015.12.007</ArticleId><ArticleId IdType="pmc">PMC4969071</ArticleId><ArticleId IdType="pubmed">26874595</ArticleId></ArticleIdList></Reference><Reference><Citation>Momtaz Y, Haron SA, Hamid TA, et al.. Does food insufficiency in childhood contribute to dementia in later life? Clin Interv Aging. 2014; 10: 49&#x2013;53. doi:10.2147/cia.s69220</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/cia.s69220</ArticleId><ArticleId IdType="pmc">PMC4279670</ArticleId><ArticleId IdType="pubmed">25565786</ArticleId></ArticleIdList></Reference><Reference><Citation>Na M, Dou N, Ji N, et al.. Food insecurity and cognitive function in middle to older adulthood: a systematic review. Adv Nutr. 2020; 11(3): 667&#x2013;676. doi:10.1093/advances/nmz122</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmz122</ArticleId><ArticleId IdType="pmc">PMC7231583</ArticleId><ArticleId IdType="pubmed">31711095</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong M, Tieu L, Lee CT, et al.. Factors associated with food insecurity among older homeless adults: results from the HOPE HOME study. J Public Health. 2019; 41(2): 240&#x2013;249. doi:10.1093/pubmed/fdy063</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pubmed/fdy063</ArticleId><ArticleId IdType="pmc">PMC6636692</ArticleId><ArticleId IdType="pubmed">29617886</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt JF, Buckingham W, Kim AJ, et al.. Association of neighborhood-level disadvantage with cerebral and hippocampal volume. JAMA Neurol. 2020; 77(4): 451&#x2013;460. doi:10.1001/jamaneurol.2019.4501</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.4501</ArticleId><ArticleId IdType="pmc">PMC6990953</ArticleId><ArticleId IdType="pubmed">31904767</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennon JC, Aita SL, Bene V, et al.. Black and white individuals differ in dementia prevalence, risk factors, and symptomatic presentation. Alzheimers Dement. 2022; 18(8): 1461&#x2013;1471. doi:10.1002/alz.12509</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12509</ArticleId><ArticleId IdType="pmc">PMC9160212</ArticleId><ArticleId IdType="pubmed">34854531</ArticleId></ArticleIdList></Reference><Reference><Citation>Power MC, Bennett EE, Turner RW, et al.. Trends in relative incidence and prevalence of dementia across non-Hispanic black and white individuals in the United States, 2000-2016. JAMA Neurol. 2021; 78(3): 275&#x2013;284. doi:10.1001/jamaneurol.2020.447</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.447</ArticleId><ArticleId IdType="pmc">PMC7953306</ArticleId><ArticleId IdType="pubmed">33252617</ArticleId></ArticleIdList></Reference><Reference><Citation>Braveman P, Egerter S, Williams DR. The social determinants of health: coming of age. Ann Rev Public Health. 2011; 32(1): 381&#x2013;398. doi:10.1146/annurev-publhealth-031210-101218</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-publhealth-031210-101218</ArticleId><ArticleId IdType="pubmed">21091195</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen L, Damon S. Social determinants of health and response to disease associated with health outcomes of American Indian and Alaska Native patients. JAMA Netw Open. 2022; 5(3): e224827. doi:10.1001/jamanetworkopen.2022.4827</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.4827</ArticleId><ArticleId IdType="pubmed">35353172</ArticleId></ArticleIdList></Reference><Reference><Citation>Amen DG, Darmal B, Raji CA, et al.. Discriminative properties of hippocampal hypoperfusion in marijuana users compared to healthy controls: implications for marijuana administration in Alzheimer&#x2019;s dementia. J Alzheime&#x2019;s Dis. 2017; 56(1): 261&#x2013;273. doi:10.3233/JAD-160833</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160833</ArticleId><ArticleId IdType="pubmed">27886010</ArticleId></ArticleIdList></Reference><Reference><Citation>Dublin S, Walker RL, Gray SL, et al.. Prescription opioids and risk of dementia or cognitive decline: a prospective cohort study. J Am Geriatr Soc, 2015;63(8): 1519&#x2013;1526. doi:10.1111/jgs.13562</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.13562</ArticleId><ArticleId IdType="pmc">PMC4776316</ArticleId><ArticleId IdType="pubmed">26289681</ArticleId></ArticleIdList></Reference><Reference><Citation>Ettcheto M, Olloquequi J, S&#xe1;nchez-L&#xf3;pez E, et al.. Benzodiazepines and related drugs as a risk factor in Alzheimer&#x2019;s disease dementia. Front Aging Neurosci. 2020; 11: 344. doi:10.3389/fnagi.2019.00344</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2019.00344</ArticleId><ArticleId IdType="pmc">PMC6960222</ArticleId><ArticleId IdType="pubmed">31969812</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassing LB. Light alcohol consumption does not protect cognitive function: a longitudinal prospective study. Front Aging Neurosci. 2018; 10: 81. doi:10.3389/fnagi.2018.00081</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00081</ArticleId><ArticleId IdType="pmc">PMC5879951</ArticleId><ArticleId IdType="pubmed">29632484</ArticleId></ArticleIdList></Reference><Reference><Citation>Topiwala A, Ebmeier KP. Effects of drinking on late-life brain and cognition. Evid Based Ment Health. 2018; 21(1): 12&#x2013;15. doi:10.1136/eb-2017-102820</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/eb-2017-102820</ArticleId><ArticleId IdType="pmc">PMC10270452</ArticleId><ArticleId IdType="pubmed">29273599</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameon JA, Skewes MC. Historical trauma and substance use among American Indian people with current substance use problems. Psychol Addict Behav. 2021; 35(3): 295&#x2013;309. doi:10.1037/adb0000729</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/adb0000729</ArticleId><ArticleId IdType="pmc">PMC8084991</ArticleId><ArticleId IdType="pubmed">33829816</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitesell NR, Beals J, Big Crow C, et al.. Epidemiology and etiology of substance use among American Indians and Alaska Natives: risk, protection, and implications for prevention. Am J Drug Alcohol Abuse, 2012; 38(5): 376&#x2013;382. doi:10.3109/00952990.2012.694527</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00952990.2012.694527</ArticleId><ArticleId IdType="pmc">PMC4436971</ArticleId><ArticleId IdType="pubmed">22931069</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonds VW, Goins RT, Krantz EM, et al.. Cultural identity and patient trust among older American Indians. J Gen Intern Med. 2014; 29(3): 500&#x2013;506. doi:10.1007/s11606-013-2578-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-013-2578-y</ArticleId><ArticleId IdType="pmc">PMC3930784</ArticleId><ArticleId IdType="pubmed">24002621</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawagley AO. Alaska Native education: history and adaptation in the new millennium. J Am Indian Educ. 1999; 39(1): 31&#x2013;51. www.jstor.org/stable/24398059</Citation></Reference><Reference><Citation>Kawagley AO, Barnhardt R. Education indigenous to place: Western science meets Native reality.
www.ankn.uaf.edu/curriculum/Articles/BarnhardtKawagley/EIP.html
(1998, accessed 1 July 2022).</Citation></Reference><Reference><Citation>Kawagley AO, Norris-Tull D, Norris-Tull RA. The indigenous worldview of Yupiaq culture: its scientific nature and relevance to the practice and teaching of science. J Res Sci Teach. 1998; 35(2): 133&#x2013;144. doi:10.1002/(SICI)1098-2736(199802)35:2&lt;133::AID-TEA4&gt;3.0.CO;2-T</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-2736(199802)35:2&lt;133::AID-TEA4&gt;3.0.CO;2-T</ArticleId></ArticleIdList></Reference><Reference><Citation>Brayboy BMJ. Toward a tribal critical race theory in education. Urban Rev. 2005; 37(5): 425&#x2013;446. doi:10.1007/s11256-005-0018-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11256-005-0018-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Gone JP. Reconsidering American Indian historical trauma: lessons from an early Gros Ventre war narrative. Transcul Psychiatry. 2014; 51(3): 387&#x2013;406. doi:10.1177/1363461513489722</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1363461513489722</ArticleId><ArticleId IdType="pubmed">23765681</ArticleId></ArticleIdList></Reference><Reference><Citation>David EJR, Derthick AO. What is internalized oppression, and so what? In: David EJR. (ed) Internalized oppression: the psychology of marginalized groups. Springer; 2014: 1&#x2013;30.</Citation></Reference><Reference><Citation>McBride BA. Aspects of community healing: experiences of the Sault Sainte Marie Tribe of Chippewa Indians. Am Indian Alsk Native Ment Health Res. 2003; 11(1): 67&#x2013;83. doi:10.5820/aian.1101.2003.67</Citation><ArticleIdList><ArticleId IdType="doi">10.5820/aian.1101.2003.67</ArticleId><ArticleId IdType="pubmed">12955632</ArticleId></ArticleIdList></Reference><Reference><Citation>Duran E, Firehammer J, Gonzalez J. Liberation psychology as the path toward healing cultural soul wounds. J Couns Dev. 2008; 86(3): 288&#x2013;295. doi:10.1002/j.1556-6678.2008.tb00511.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1556-6678.2008.tb00511.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirmayer LJ, Gone JP, Moses J. Rethinking historical trauma. Transcul Psychiatry. 2014; 51(3): 299&#x2013;319. doi:10.1177/1363461514536358</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1363461514536358</ArticleId><ArticleId IdType="pubmed">24855142</ArticleId></ArticleIdList></Reference><Reference><Citation>Farahmand P, Arshed A, Bradley MV. Systemic racism and substance use disorders. Psychiatric Ann. 2020; 50(11): 494&#x2013;498. doi:10.3928/00485713-20201008-01</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/00485713-20201008-01</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams DR, Lawrence JA, Davis BA. Racism and health: evidence and needed research. Annu Rev Public Health. 2019; 40(1): 105&#x2013;125. doi:10.1146/annurev-publhealth-040218-043750</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-publhealth-040218-043750</ArticleId><ArticleId IdType="pmc">PMC6532402</ArticleId><ArticleId IdType="pubmed">30601726</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronfenbrenner U. Toward an experimental ecology of human development. Am Psychol. 1977; 32(7): 513&#x2013;531. doi:10.1037/0003-066X.32.7.513</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0003-066X.32.7.513</ArticleId></ArticleIdList></Reference><Reference><Citation>Fish J, Syed M. Native Americans in higher education: an ecological systems perspective. J Coll Stud Dev. 2018; 59(4): 387&#x2013;403. doi:10.1353/csd.2018.0038</Citation><ArticleIdList><ArticleId IdType="doi">10.1353/csd.2018.0038</ArticleId></ArticleIdList></Reference><Reference><Citation>Crouch MC, Rosich RM. Alaska Native peoples&#x2019; perceptions of memory and dementia: belief models and expectations. University of Alaska Anchorage; 2022.</Citation></Reference><Reference><Citation>Lykes MB. Participatory and action research as a transformative praxis: responding to humanitarian crises from the margins. Am Psychol. 2013; 68(8): 774&#x2013;783. doi:10.1037/a0034360</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0034360</ArticleId><ArticleId IdType="pubmed">24320677</ArticleId></ArticleIdList></Reference><Reference><Citation>Whyte WF, Greenwood DJ, Lazes P. Participatory action research through practice to science in social research. In: Whyte WF. (ed) Participatory action research. Sage; 1991: 19&#x2013;98.</Citation></Reference><Reference><Citation>Oetting ER, Beauvais F. Orthogonal cultural identification theory: the cultural identification of minority adolescents. Int J Addict. 1991; 25(5-6 A): 655&#x2013;685. doi:10.3109/10826089109077265</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10826089109077265</ArticleId><ArticleId IdType="pubmed">2101397</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne CV, Ka&#x2019;opua LS, Jervis LL, et al.. United States indigenous populations and dementia: is there a case for culture-based psychosocial interventions? Gerontologist. 2017; 57(6): 1011&#x2013;1019. doi:10.1093/geront/gnw059</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnw059</ArticleId><ArticleId IdType="pmc">PMC6281323</ArticleId><ArticleId IdType="pubmed">27048710</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute for Policy Research. What drives Native American poverty? Sociologist Beth Redbird&#x2019;s research points to job loss, not education, as a key driver. www.ipr.northwestern.edu/news/2020/redbird-what-drives-native-american-poverty.html
(2020, accessed 25 June 2022)</Citation></Reference><Reference><Citation>Lemche E. Early life stress and epigenetics in late-onset Alzheimer&#x2019;s dementia: a systematic review. Curr Genomics 2018; 19(7): 522&#x2013;602. doi:10.2174/1389202919666171229145156</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389202919666171229145156</ArticleId><ArticleId IdType="pmc">PMC6194433</ArticleId><ArticleId IdType="pubmed">30386171</ArticleId></ArticleIdList></Reference><Reference><Citation>McEwen BS, Gianaros PJ. Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease. Ann N Y Acad Sci. 2010; 1186(1): 190&#x2013;222. doi:10.1111/j.1749-6632.2009.05331.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2009.05331.x</ArticleId><ArticleId IdType="pmc">PMC2864527</ArticleId><ArticleId IdType="pubmed">20201874</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller GE, Chen E, Parker KJ. Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms. Psychol Bull. 2011; 137(6): 959&#x2013;997. doi:10.1037/a0024768</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0024768</ArticleId><ArticleId IdType="pmc">PMC3202072</ArticleId><ArticleId IdType="pubmed">21787044</ArticleId></ArticleIdList></Reference><Reference><Citation>Mail PD, Heurtin-Roberts S, Martin SE, et al.. Alcohol use among American Indians and Alaska Natives: multiple perspectives on a complex problem. Vol. 2. US Dept Health Human Services; 2003.</Citation></Reference><Reference><Citation>Mukamal KJ, Kuller LH, Fitzpatrick AL, et al.. Prospective study of alcohol consumption and risk of dementia in older adults. JAMA. 2003; 289(11): 1405&#x2013;1413. doi:10.1001/jama.289.11.1405</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.289.11.1405</ArticleId><ArticleId IdType="pubmed">12636463</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeman T, Epel E, Gruenewald T, et al.. Socio-economic differentials in peripheral biology: cumulative allostatic load. Ann N Y Acad Sci. 2010; 1186(1): 223&#x2013;239. doi:10.1111/j.1749-6632.2009.05341.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2009.05341.x</ArticleId><ArticleId IdType="pubmed">20201875</ArticleId></ArticleIdList></Reference><Reference><Citation>Braveman P, Marchi K, Egerter S, et al.. Poverty, near-poverty, and hardship around the time of pregnancy. Matern Child Health J. 2010; 14(1): 20&#x2013;35. doi:10.1007/s10995-008-0427-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10995-008-0427-0</ArticleId><ArticleId IdType="pubmed">19037715</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams DR, Mohammed SA. Discrimination and racial disparities in health: evidence and needed research. J Behav Med. 2009; 32(1): 20&#x2013;47. doi:10.1007/s10865-008-9185-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10865-008-9185-0</ArticleId><ArticleId IdType="pmc">PMC2821669</ArticleId><ArticleId IdType="pubmed">19030981</ArticleId></ArticleIdList></Reference><Reference><Citation>Health and Human Services Office of Minority Health. Profile: American Indian/Alaska Native. www.minorityhealth.hhs.gov/omh/browse.aspx?lvl=3&amp;lvlid=62
(2019, accessed 12 June 2022).</Citation></Reference><Reference><Citation>Indigenous Corporate Trainings. A brief definition of decolonization and indigenization. www.ictinc.ca/blog/a-brief-definition-of-decolonization-and-indigenization
(2017, accessed 12 June 2022).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36694373</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1099-1166</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>International journal of geriatric psychiatry</Title><ISOAbbreviation>Int J Geriatr Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Digital resilience monitoring of informal caregivers of persons with dementia for early detection of overburden: Development and pilot testing.</ArticleTitle><Pagination><StartPage>e5869</StartPage><MedlinePgn>e5869</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e5869</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/gps.5869</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Informal caregiving is becoming increasingly important in dementia care, but causes a considerable burden on caregivers which impacts their wellbeing. We aimed to develop and pilot test a digital monitoring tool (REsilience Monitor for INformal caregivers in Dementia [REMIND]) for wellbeing and resilience of informal caregivers to provide timely support and thereby prevent their overburden and eventually crises admissions of persons with dementia.</AbstractText><AbstractText Label="METHODS">A human-centered design method based on co-creation with informal caregivers and professionals was used to design REMIND. During co-creation meetings and in-between sprint sessions, a point of focus was formulated, and a prototype was created. Case manager-caregiver duos pilot-tested REMIND for 3&#xa0;months. Semi-structured interviews were conducted to determine usability and acceptability. Thematic analysis was applied to the transcripts.</AbstractText><AbstractText Label="RESULTS">Informal caregivers and professionals with varying backgrounds participated in three co-creation meetings. Defined point of focus was to develop a tool that is able to provide insight into the experienced burden of informal caregivers. The REMIND prototype consisted of weekly questions about wellbeing and resilience for informal caregivers and a dashboard with answers for case managers. Eight case managers and 13 informal caregivers considered REMIND easy-to-use. Informal caregivers mentioned that REMIND stimulated self-reflection. Case managers appreciated the tool's ability to gain insight in the actual wellbeing of informal caregivers.</AbstractText><AbstractText Label="CONCLUSIONS">The REMIND tool developed in co-creation with end-users potentially increases insight in actual wellbeing of informal caregivers for both caregivers and case managers. A long-term (controlled) follow-up study is needed to evaluate REMIND's impact on caregiver burden and crisis admissions.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. International Journal of Geriatric Psychiatry published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oostra</LastName><ForeName>Dorien L</ForeName><Initials>DL</Initials><Identifier Source="ORCID">0000-0003-2463-7690</Identifier><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboudumc Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vos</LastName><ForeName>Wouter L</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olde Rikkert</LastName><ForeName>Marcel G M</ForeName><Initials>MGM</Initials><Identifier Source="ORCID">0000-0003-1397-1677</Identifier><AffiliationInfo><Affiliation>Radboudumc Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Donders Institute for Brain Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieuwboer</LastName><ForeName>Minke S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-2193-4908</Identifier><AffiliationInfo><Affiliation>Radboudumc Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HAN University of Applied Sciences, Academy of Health and Vitality, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Marieke</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0675-9678</Identifier><AffiliationInfo><Affiliation>Radboudumc Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Donders Institute for Brain Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Primary and Community Care, Donders Institute for Brain Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Geriatr Psychiatry</MedlineTA><NlmUniqueID>8710629</NlmUniqueID><ISSNLinking>0885-6230</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">case management</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">informal caregiver support</Keyword><Keyword MajorTopicYN="N">informal caregiver wellbeing</Keyword><Keyword MajorTopicYN="N">monitoring</Keyword><Keyword MajorTopicYN="N">primary care</Keyword></KeywordList><CoiStatement>None to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36694373</ArticleId><ArticleId IdType="pmc">PMC10108106</ArticleId><ArticleId IdType="doi">10.1002/gps.5869</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Francke A, Heide I, Bruin S, et&#xa0;al. Een samenhangend beeld van dementie en dementiezorg: kerncijfers, behoeften, aanbod en impact. Themarapportage van de Staat van Volksgezondheid en Zorg; 2018.</Citation></Reference><Reference><Citation>Wimo A, von Strauss E, Nordberg G, Sassi F, Johansson L. Time spent on informal and formal care giving for persons with dementia in Sweden. Health Pol. 2002;61(3):255&#x2010;11. 10.1016/s0168-8510(02)00010-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0168-8510(02)00010-6</ArticleId><ArticleId IdType="pubmed">12098519</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiao CY, Wu HS, Hsiao CY. Caregiver burden for informal caregivers of patients with dementia: a systematic review. Int Nurs Rev. 2015;62(3):340&#x2010;350. 10.1111/inr.12194</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/inr.12194</ArticleId><ArticleId IdType="pubmed">26058542</ArticleId></ArticleIdList></Reference><Reference><Citation>Heide I, Veer A, Buuse S, Francke A. Dementiemonitor Mantelzorg 2020. Mantelzorgers over belasting, ondersteuning, zorg en de impact van mantelzorg op hun leven; 2020.</Citation></Reference><Reference><Citation>Baumgarten M, Battista RN, Infante&#x2010;Rivard C, Hanley JA, Becker R, Gauthier S. The psychological and physical health of family members caring for an elderly person with dementia. J Clin Epidemiol. 1992;45(1):61&#x2010;70. 10.1016/0895-4356(92)90189-t</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-4356(92)90189-t</ArticleId><ArticleId IdType="pubmed">1738013</ArticleId></ArticleIdList></Reference><Reference><Citation>Butcher HK, Holkup PA, Buckwalter KC. The experience of caring for a family member with Alzheimer's disease. West J Nurs Res. 2001;23(1):33&#x2010;55. 10.1177/019394590102300104</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/019394590102300104</ArticleId><ArticleId IdType="pubmed">11216023</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodaty H, Donkin M. Family caregivers of people with dementia. Dialogues Clin Neurosci. 2009;11(2):217&#x2010;228. 10.31887/dcns.2009.11.2/hbrodaty</Citation><ArticleIdList><ArticleId IdType="doi">10.31887/dcns.2009.11.2/hbrodaty</ArticleId><ArticleId IdType="pmc">PMC3181916</ArticleId><ArticleId IdType="pubmed">19585957</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadak T, Zdon SF, Ishado E, Zaslavsky O, Borson S. Potentially preventable hospitalizations in dementia: family caregiver experiences. Int Psychogeriatrics. 2017;29(7):1201&#x2010;1211. 10.1017/S1041610217000217</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610217000217</ArticleId><ArticleId IdType="pubmed">28349858</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledgerd R, Hoe J, Hoare Z, et&#xa0;al. Identifying the causes, prevention and management of crises in dementia. An online survey of stakeholders. Int J Geriatr Psychiatr. 2016;31(6):638&#x2010;647. 10.1002/gps.4371</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4371</ArticleId><ArticleId IdType="pubmed">26489696</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias R, Santos RL, Sousa MF, et&#xa0;al. Resilience of caregivers of people with dementia: a systematic review of biological and psychosocial determinants. Trends Psychiatry Psychother. 2015;37(1):12&#x2010;19. 10.1590/2237-6089-2014-0032</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/2237-6089-2014-0032</ArticleId><ArticleId IdType="pubmed">25860562</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa RDL, Sim&#xf5;es&#x2010;Neto JP, Santos RL, et&#xa0;al. Caregivers' resilience in mild and moderate Alzheimer's disease. Aging Ment Health. 2020;24(2):250&#x2010;258. 10.1080/13607863.2018.1533520</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2018.1533520</ArticleId><ArticleId IdType="pubmed">30499333</ArticleId></ArticleIdList></Reference><Reference><Citation>Joling KJ, Windle G, Dr&#xf6;es R.&#x2010;M, Huisman M, Hertogh CMM, Woods RT. What are the essential features of resilience for informal caregivers of people living with dementia? A Delphi consensus examination. Aging Ment Health. 2017;21(5):509&#x2010;517. 10.1080/13607863.2015.1124836</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2015.1124836</ArticleId><ArticleId IdType="pubmed">26689489</ArticleId></ArticleIdList></Reference><Reference><Citation>Toot S, Devine M, Akporobaro A, Orrell M. Causes of hospital admission for people with dementia: a systematic review and meta&#x2010;analysis. J Am Med Dir Assoc. 2013;14(7):463&#x2010;470. 10.1016/j.jamda.2013.01.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2013.01.011</ArticleId><ArticleId IdType="pubmed">23510826</ArticleId></ArticleIdList></Reference><Reference><Citation>Afonso&#x2010;Argil&#xe9;s FJ, Meyer G, Stephan A, et&#xa0;al. Emergency department and hospital admissions among people with dementia living at home or in nursing homes: results of the European RightTimePlaceCare project on their frequency, associated factors and costs. BMC Geriatr. 2020;20(1):1&#x2010;13. 10.1186/s12877-020-01835-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-020-01835-x</ArticleId><ArticleId IdType="pmc">PMC7643440</ArticleId><ArticleId IdType="pubmed">33153444</ArticleId></ArticleIdList></Reference><Reference><Citation>Pihet S, Passini CM, Eicher M. Good and bad days: fluctuations in the burden of informal dementia caregivers, an experience sampling study. Nurs Res. 2017;66(6):421&#x2010;431. 10.1097/NNR.0000000000000243</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NNR.0000000000000243</ArticleId><ArticleId IdType="pubmed">29095373</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeken F, Rezo A, Hinz M, Discher R, Rapp MA. Evaluation of technology&#x2010;based interventions for informal caregivers of patients with dementia&#x2014;a meta&#x2010;analysis of randomized controlled trials. Am J Geriatr Psychiatr. 2019;27(4):426&#x2010;445. 10.1016/j.jagp.2018.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2018.12.003</ArticleId><ArticleId IdType="pubmed">30642650</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen AP, Buckley MM, Cryan JF, et&#xa0;al. Informal caregiving for dementia patients: the contribution of patient characteristics and behaviours to caregiver burden. Age ageing. 2020;49(1):52&#x2010;56. 10.1093/ageing/afz128</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afz128</ArticleId><ArticleId IdType="pubmed">31755532</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherwood PR, Given CW, Given BA, Von Eye A. Caregiver burden and depressive symptoms: analysis of common outcomes in caregivers of elderly patients. J Aging Health. 2005;17(2):125&#x2010;147. 10.1177/0898264304274179</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0898264304274179</ArticleId><ArticleId IdType="pubmed">15750048</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrede C, Braakman&#x2010;Jansen A, van Gemert&#x2010;Pijnen L. Requirements for unobtrusive monitoring to support home&#x2010;based dementia care: qualitative study among formal and informal caregivers. Original paper. JMIR Aging. 2021;4(2):e26875. 10.2196/26875</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/26875</ArticleId><ArticleId IdType="pmc">PMC8076981</ArticleId><ArticleId IdType="pubmed">33843596</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischoff EW, Akkermans R, Bourbeau J, van Weel C, Vercoulen JH, Schermer TR. Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial. BMJ. 2012;345:e7642. 10.1136/bmj.e7642</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.e7642</ArticleId><ArticleId IdType="pmc">PMC3514071</ArticleId><ArticleId IdType="pubmed">23190905</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartels SL, van Knippenberg RJ, Viechtbauer W, et&#xa0;al. Intervention mechanisms of an experience sampling intervention for spousal carers of people with dementia: a secondary analysis using momentary data. Aging Ment Health. 2020;26(2):1&#x2010;9. 10.1080/13607863.2020.1857692</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2020.1857692</ArticleId><ArticleId IdType="pubmed">33291998</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders EB&#x2010;N, Stappers PJ. Co&#x2010;creation and the new landscapes of design. CoDesign. 2008;4(1):5&#x2010;18. 10.1080/15710880701875068</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15710880701875068</ArticleId></ArticleIdList></Reference><Reference><Citation>Palumbo R. Contextualizing co&#x2010;production of health care: a systematic literature review. Int J Public Sect Manag. 2016;29(1):72&#x2010;90. 10.1108/Ijpsm-07-2015-0125</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/Ijpsm-07-2015-0125</ArticleId></ArticleIdList></Reference><Reference><Citation>Flood M, Ennis M, Ludlow A, et&#xa0;al. Research methods from human&#x2010;centered design: potential applications in pharmacy and health services research. Res Soc Adm Pharm. 2021;17(12):2036&#x2010;2043. 10.1016/j.sapharm.2021.06.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sapharm.2021.06.015</ArticleId><ArticleId IdType="pubmed">34229952</ArticleId></ArticleIdList></Reference><Reference><Citation>Melles M, Albayrak A, Goossens R. Innovating health care: key characteristics of human&#x2010;centered design. Int J Qual Health Care. 2021;33(Supplement_1):37&#x2010;44. 10.1093/intqhc/mzaa127</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intqhc/mzaa127</ArticleId><ArticleId IdType="pmc">PMC7802070</ArticleId><ArticleId IdType="pubmed">33068104</ArticleId></ArticleIdList></Reference><Reference><Citation>
Standard d:school
. Design Thinking Bootleg; 2021. Accessed August 18, 2021. https://dschool.stanford.edu/resources/design&#x2010;thinking&#x2010;bootleg
</Citation></Reference><Reference><Citation>Nieuwboer MS, Richters A, van der Marck MA. Triple aim improvement for individuals, services and society in dementia care: the DementiaNet collaborative care approach. Z Gerontol Geriatr. 2017;50(Suppl 2):78&#x2010;83. Dreifache Verbesserung der Ziele in der Demenzversorgung fur Individuen, Gesundheitsdienstleister und die Gesellschaft: Die netzwerkbasierte Versorgung durch DementiaNet. 10.1007/s00391-017-1196-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00391-017-1196-4</ArticleId><ArticleId IdType="pmc">PMC5409810</ArticleId><ArticleId IdType="pubmed">28220251</ArticleId></ArticleIdList></Reference><Reference><Citation>Richters A, Nieuwboer MS, Olde Rikkert MGM, Melis RJF, Perry M, van der Marck MA. Longitudinal multiple case study on effectiveness of network&#x2010;based dementia care towards more integration, quality of care, and collaboration in primary care. PLoS One. 2018;13(6):e0198811. 10.1371/journal.pone.0198811</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198811</ArticleId><ArticleId IdType="pmc">PMC6021091</ArticleId><ArticleId IdType="pubmed">29949608</ArticleId></ArticleIdList></Reference><Reference><Citation>Barambones J, Moral C, Ferre X, Villalba&#x2010;Mora E. A Scrum&#x2010;Based Development Process to Support Co&#x2010;creation with Elders in the eHealth Domain. Springer; 2020:105&#x2010;117.</Citation></Reference><Reference><Citation>Schaller S, Marinova&#x2010;Schmidt V, Setzer M, et&#xa0;al. Usefulness of a tailored eHealth service for informal caregivers and professionals in the dementia treatment and care setting: the eHealthMonitor dementia portal. JMIR Res Protoc. 2016;5(2):e4354. 10.2196/resprot.4354</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/resprot.4354</ArticleId><ArticleId IdType="pmc">PMC4822652</ArticleId><ArticleId IdType="pubmed">27050401</ArticleId></ArticleIdList></Reference><Reference><Citation>Elo S, Kyng&#xe4;s H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107&#x2010;115. 10.1111/j.1365-2648.2007.04569.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2648.2007.04569.x</ArticleId><ArticleId IdType="pubmed">18352969</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser A, Korstjens I. Series: practical guidance to qualitative research. Part 3: sampling, data collection and analysis. Eur J Gen Pract. 2018;24(1):9&#x2010;18. 10.1080/13814788.2017.1375091</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13814788.2017.1375091</ArticleId><ArticleId IdType="pmc">PMC5774281</ArticleId><ArticleId IdType="pubmed">29199486</ArticleId></ArticleIdList></Reference><Reference><Citation>Given LM. 100 Questions (And Answers) about Qualitative Research. SAGE publications; 2015.</Citation></Reference><Reference><Citation>Ong HL, Vaingankar JA, Abdin E, et&#xa0;al. Resilience and burden in caregivers of older adults: moderating and mediating effects of perceived social support. BMC Psychiatr. 2018;18(1):1&#x2010;9. 10.1186/s12888-018-1616-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-018-1616-z</ArticleId><ArticleId IdType="pmc">PMC5793423</ArticleId><ArticleId IdType="pubmed">29385985</ArticleId></ArticleIdList></Reference><Reference><Citation>Richters A, Olde Rikkert MG, van Exel NJ, Melis RJ, van der Marck MA. Perseverance time of informal caregivers for institutionalized elderly: construct validity and test&#x2010;retest reliability of a single&#x2010;question instrument. J Am Med Dir Assoc. 2016;17(8):761&#x2010;762. 10.1016/j.jamda.2016.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2016.05.001</ArticleId><ArticleId IdType="pubmed">27301591</ArticleId></ArticleIdList></Reference><Reference><Citation>Pot A, Dyck R, Deeg D. Ervaren druk door informele zorg&#x2010;Constructie van een schaal. Tijdschr Gerontol Geriatr. 1995;26(5):214&#x2010;219.</Citation><ArticleIdList><ArticleId IdType="pubmed">8750982</ArticleId></ArticleIdList></Reference><Reference><Citation>Eijk L, Kempen G, Sonderen F. Een korte schaal voor het meten van sociale steun bij ouderen: de SSL12&#x2010;I. Tijdschr Gerontol Geriatr. 1994;25(5):192&#x2010;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">7974641</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoso AM, Lutomski JE, Hofman CS, et&#xa0;al. Development of a patient&#x2010;reported outcome measure for geriatric care: the older persons and informal caregivers survey short form. Value Health. 2018;21(10):1198&#x2010;1204. 10.1016/j.jval.2018.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2018.02.011</ArticleId><ArticleId IdType="pubmed">30314621</ArticleId></ArticleIdList></Reference><Reference><Citation>Jongenelis K, Gerritsen DL, Pot AM, et&#xa0;al. Construction and validation of a patient&#x2010; and user&#x2010;friendly nursing home version of the Geriatric Depression Scale. Int J Geriatr Psychiatr. 2007;22(9):837&#x2010;842. 10.1002/gps.1748</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.1748</ArticleId><ArticleId IdType="pubmed">17199236</ArticleId></ArticleIdList></Reference><Reference><Citation>Richters A, Melis RJ, Olde Rikkert MG, van der Marck MA. The international dementia alliance instrument for feasible and valid staging of individuals with dementia by informal caregivers. J Am Geriatr Soc. 2016;64(8):1674&#x2010;1678. 10.1111/jgs.14205</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.14205</ArticleId><ArticleId IdType="pubmed">27304200</ArticleId></ArticleIdList></Reference><Reference><Citation>Oostra DL, Nieuwboer MS, Rikkert MGO, Perry M. Development and pilot testing of quality improvement indicators for integrated primary dementia care. BMJ Open Qual. 2020;9(2):e000916. 10.1136/bmjoq-2020-000916</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjoq-2020-000916</ArticleId><ArticleId IdType="pmc">PMC7295433</ArticleId><ArticleId IdType="pubmed">32540949</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: assessing the ability to bounce back. Int J Behav Med. 2008;15(3):194&#x2010;200. 10.1080/10705500802222972</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10705500802222972</ArticleId><ArticleId IdType="pubmed">18696313</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernooij&#x2010;Dassen MJ, Felling AJ, Brummelkamp E, Dauzenberg MG, van den Bos GA, Grol R. Assessment of caregiver's competence in dealing with the burden of caregiving for a dementia patient: a Short Sense of Competence Questionnaire (SSCQ) suitable for clinical practice. J Am Geriatr Soc. 1999;47(2):256&#x2010;257. 10.1111/j.1532-5415.1999.tb04588.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.1999.tb04588.x</ArticleId><ArticleId IdType="pubmed">9988301</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitges&#x2010;Maci&#xe1; E, Bonete&#x2010;L&#xf3;pez B, S&#xe1;nchez&#x2010;Cabaco A, Oltra&#x2010;Cucarella J. Effects of e&#x2010;Health training and social support interventions for informal caregivers of people with dementia&#x2014;a narrative review. Int J Environ Res Publ Health. 2021;18(15):7728. 10.3390/ijerph18157728</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18157728</ArticleId><ArticleId IdType="pmc">PMC8345641</ArticleId><ArticleId IdType="pubmed">34360020</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler&#x2010;Davis S, Barnett D, Kelley J, Curtis D. Potential for digital monitoring to enhance wellbeing at home for people with mild dementia and their family carers. J Alzheim Dis. 2020;73(3):867&#x2010;872. 10.3233/Jad-190844</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/Jad-190844</ArticleId><ArticleId IdType="pmc">PMC7081090</ArticleId><ArticleId IdType="pubmed">31884471</ArticleId></ArticleIdList></Reference><Reference><Citation>Boots L, de Vugt ME, Van Knippenberg R, Kempen G, Verhey F. A systematic review of Internet&#x2010;based supportive interventions for caregivers of patients with dementia. Int J Geriatr Psychiatr. 2014;29(4):331&#x2010;344. 10.1002/gps.4016</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4016</ArticleId><ArticleId IdType="pubmed">23963684</ArticleId></ArticleIdList></Reference><Reference><Citation>Torkamani M, McDonald L, Aguayo IS, et&#xa0;al. A randomized controlled pilot study to evaluate a technology platform for the assisted living of people with dementia and their carers. J Alzheim Dis. 2014;41(2):515&#x2010;523. 10.3233/Jad-132156</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/Jad-132156</ArticleId><ArticleId IdType="pubmed">24643137</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorca&#x2010;Cabrera J, Grau C, Mart&#xed;&#x2010;Arques R, Raigal&#x2010;Aran L, Falc&#xf3;&#x2010;Pegueroles A, Albacar&#x2010;Riob&#xf3;o N. Effectiveness of health web&#x2010;based and mobile app&#x2010;based interventions designed to improve informal caregiver's well&#x2010;being and quality of life: a systematic review. Int J Med Inf. 2020;134:104003. 10.1016/j.ijmedinf.2019.104003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2019.104003</ArticleId><ArticleId IdType="pubmed">31790857</ArticleId></ArticleIdList></Reference><Reference><Citation>Dam AE, Christie HL, Smeets CM, van Boxtel MP, Verhey FR, de Vugt ME. Process evaluation of a social support platform &#x2018;Inlife&#x2019; for caregivers of people with dementia. Internet Interv. 2019;15:18&#x2010;27. 10.1016/j.invent.2018.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.invent.2018.09.002</ArticleId><ArticleId IdType="pmc">PMC6257912</ArticleId><ArticleId IdType="pubmed">30510911</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopwood J, Walker N, McDonagh L, et&#xa0;al. Internet&#x2010;based interventions aimed at supporting family caregivers of people with dementia: systematic review. Review. J Med Internet Res. 2018;20(6):e216. 10.2196/jmir.9548</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.9548</ArticleId><ArticleId IdType="pmc">PMC6019848</ArticleId><ArticleId IdType="pubmed">29895512</ArticleId></ArticleIdList></Reference><Reference><Citation>Kajiyama B, Thompson LW, Eto&#x2010;Iwase T, et&#xa0;al. Exploring the effectiveness of an Internet&#x2010;based program for reducing caregiver distress using the iCare Stress Management e&#x2010;Training Program. Aging Ment Health. 2013;17(5):544&#x2010;554. 10.1080/13607863.2013.775641</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2013.775641</ArticleId><ArticleId IdType="pmc">PMC3695021</ArticleId><ArticleId IdType="pubmed">23461355</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwaanswijk M, Peeters JM van Beek AP, Meerveld JH, Francke AL. Informal caregivers of people with dementia: problems, needs and support in the initial stage and in subsequent stages of dementia: a questionnaire survey. 2013;7:6&#x2010;13 (1874&#x2010;4346 (Print)).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3551235</ArticleId><ArticleId IdType="pubmed">23346266</ArticleId></ArticleIdList></Reference><Reference><Citation>Meiland F, Hattink B, Overmars&#x2010;Marx T, et&#xa0;al. Participation of end users in the design of assistive technology for people with mild to severe cognitive problems; the European Rosetta project. Int Psychogeriatr. 2014;26(5):769&#x2010;779. 10.1017/S1041610214000088</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610214000088</ArticleId><ArticleId IdType="pubmed">24507571</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;ttgens I, Oertelt&#x2010;Prigione S. The application of human&#x2010;centered design approaches in health research and innovation: a narrative review of current practices. JMIR mHealth uHealth. 2021;9(12):e28102. 10.2196/28102</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/28102</ArticleId><ArticleId IdType="pmc">PMC8691403</ArticleId><ArticleId IdType="pubmed">34874893</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthew&#x2010;Maich N, Harris L, Ploeg J, et&#xa0;al. Designing, implementing, and evaluating mobile health technologies for managing chronic conditions in older adults: a scoping review. JMIR mHealth uHealth. 2016;4(2):e5127. 10.2196/mhealth.5127</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/mhealth.5127</ArticleId><ArticleId IdType="pmc">PMC4919548</ArticleId><ArticleId IdType="pubmed">27282195</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36692517</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2731-7099</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Innere Medizin (Heidelberg, Germany)</Title><ISOAbbreviation>Inn Med (Heidelb)</ISOAbbreviation></Journal><ArticleTitle>[General aspects of dementia disorders].</ArticleTitle><Pagination><StartPage>127</StartPage><EndPage>130</EndPage><MedlinePgn>127-130</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00108-022-01462-1</ELocationID><Abstract><AbstractText>The prevalence of dementia increases with age. In rare cases, people younger than 65 years old are also affected, with substantial consequences for the professional life. The symptoms depend on the form of dementia and can vary individually. Impairment of short-term memory is not always in the foreground and other neurocognitive domains, such as the disturbance of executive functions can have a&#xa0;significant impact on the ability to cope with everyday life. Pathophysiologically, neurodegenerative dementias with the major forms of Alzheimer's dementia, Lewy body dementia, and frontotemporal dementia are distinguished from vascular dementias. Mixed forms are common. There is no curative treatment, but progression can be slowed by nonpharmacological measures and, especially in Alzheimer's dementia, by pharmacological treatment. Appropriate measures can promote independence and autonomy for as long as possible; however, in the course of the disease restrictions in the extended activities of independent living will initially occur, such as banking transactions, use of means of transport and, in the further course, also in the basic activities of daily living. Legal capacity and the ability to consent to health interventions are restricted sooner or later; however, this must always be evaluated for the specific situation and is not generally the case with the diagnosis of dementia. Instruments such as living wills, identification of a&#xa0;health care proxy, and advanced care planning should be used at an early stage. To decrease family caregiver burden with the increased risk of developing depression, supportive, accompanying measures and education are of great importance.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zieschang</LastName><ForeName>Tania</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Abteilung f&#xfc;r Geriatrie, Department f&#xfc;r Versorgungsforschung, Fakult&#xe4;t VI Medizin und Gesundheitswissenschaften, Carl von Ossietzky Universit&#xe4;t Oldenburg, Oldenburg, Deutschland. tania.zieschang@uni-oldenburg.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geriatrisches Zentrum Oldenburg (GZO), Universit&#xe4;tsklinik f&#xfc;r Geriatrie, Klinikum Oldenburg, Rahel-Straus-Str.&#xa0;10, 26133, Oldenburg, Deutschland. tania.zieschang@uni-oldenburg.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xfc;tze</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sektion Neurogeriatrie, Medizinisch-Geriatrische Klinik, AGAPLESION Frankfurter Diakonie Kliniken, Wilhelm-Epstein-Str.&#xa0;4, 60431, Frankfurt am Main, Deutschland. schuetze@em.uni-frankfurt.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Allgemeine Aspekte demenzieller Erkrankungen.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Inn Med (Heidelb)</MedlineTA><NlmUniqueID>9918384885306676</NlmUniqueID><ISSNLinking>2731-7080</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020961" MajorTopicYN="Y">Lewy Body Disease</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ger"><AbstractText>Demenzen treten mit zunehmendem Lebensalter vermehrt auf. In seltenen F&#xe4;llen sind auch j&#xfc;ngere Menschen betroffen, mit erheblichem Einfluss auf die Berufst&#xe4;tigkeit. Die Symptome h&#xe4;ngen von der Demenzform ab und k&#xf6;nnen individuell unterschiedlich ausgepr&#xe4;gt sein. Nicht immer steht die St&#xf6;rung des Kurzzeitged&#xe4;chtnisses im Vordergrund, vielmehr k&#xf6;nnen andere neurokognitive Dom&#xe4;nen wie die St&#xf6;rung der Exekutivfunktion sich erheblich auf die Alltagsf&#xe4;higkeit auswirken. Pathophysiologisch werden die neurodegenerativen Demenzen mit den wichtigsten Formen Alzheimer-Demenz, Lewy-K&#xf6;rperchen-Demenz und frontotemporale Demenz abgegrenzt von den vaskul&#xe4;ren Demenzen. Mischformen sind h&#xe4;ufig. Eine kurative Therapie besteht nicht, die Progression kann jedoch durch nichtpharmakologische Ma&#xdf;nahmen und, insbesondere bei der Alzheimer-Demenz, auch durch pharmakologische Therapie abgebremst werden. Es gilt, die Selbstst&#xe4;ndigkeit und Autonomie betroffener Patienten zu f&#xf6;rdern. Im Verlauf kommt es jedoch zun&#xe4;chst zu Einschr&#xe4;nkungen in den erweiterten Aktivit&#xe4;ten der selbstst&#xe4;ndigen Lebensf&#xfc;hrung wie Bankgesch&#xe4;ften, Nutzung von Verkehrsmitteln und im weiteren Verlauf auch den basalen Funktionen der Selbsthilfef&#xe4;higkeit. Gesch&#xe4;ftsf&#xe4;higkeit und Einwilligungsf&#xe4;higkeit in Bezug auf gesundheitliche Eingriffe sind fr&#xfc;her oder sp&#xe4;ter eingeschr&#xe4;nkt. Dies muss jedoch immer wieder f&#xfc;r die konkrete Situation evaluiert werden und liegt nicht grunds&#xe4;tzlich mit der Diagnose Demenz vor. Fr&#xfc;hzeitig sollten Instrumente wie die Patientenverf&#xfc;gung, Vorsorgevollmacht oder vorausschauende Gesundheitsplanung (&#x201e;advance care planning&#x201c;) genutzt werden. Pflegende Angeh&#xf6;rige sind h&#xe4;ufig stark belastet und haben ein erh&#xf6;htes Risiko, an einer Depression zu erkranken. Daher sind unterst&#xfc;tzende begleitende Ma&#xdf;nahmen von gro&#xdf;er Bedeutung.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Activities of daily living/skills</Keyword><Keyword MajorTopicYN="N">Autonomy</Keyword><Keyword MajorTopicYN="N">Decision making/skills</Keyword><Keyword MajorTopicYN="N">Family caregivers</Keyword><Keyword MajorTopicYN="N">Neurodegenerative diseases</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>24</Day><Hour>11</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36692517</ArticleId><ArticleId IdType="doi">10.1007/s00108-022-01462-1</ArticleId><ArticleId IdType="pii">10.1007/s00108-022-01462-1</ArticleId></ArticleIdList><ReferenceList><Title>Literatur</Title><Reference><Citation>Bronner&#xa0;K, Bodner&#xa0;L, Jox&#xa0;RJ et&#xa0;al (2020) Entwicklung einer Entscheidungshilfe f&#xfc;r partizipative Vorausplanungen f&#xfc;r Menschen mit Demenz und deren Angeh&#xf6;rige. Nervenarzt 91:1032&#x2013;1039. https://doi.org/10.1007/s00115-020-00911-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00115-020-00911-2</ArticleId></ArticleIdList></Reference><Reference><Citation>DGGG, DGPPN, DGN (Hrsg) (2020) Einwilligung von Menschen mit Demenz in medizinische Ma&#xdf;nahmen: Interdisziplin&#xe4;re S2k-Leitlinie f&#xfc;r die medizinische Praxis. Kohlhammer, Stuttgart</Citation></Reference><Reference><Citation>Eggenberger&#xa0;E, Heimerl&#xa0;K, Bennett&#xa0;MI (2013) Communication skills training in dementia care: a&#xa0;systematic review of effectiveness, training content, and didactic methods in different care settings. Int Psychogeriatr 25:345&#x2013;358</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610212001664</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton&#xa0;MP, Brody&#xa0;EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179&#x2013;186</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/9.3_Part_1.179</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez&#xa0;OL, Kuller&#xa0;LH (2019) Epidemiology of aging and associated cognitive disorders: prevalence and incidence of Alzheimer&#x2019;s disease and other dementias. Handb Clin Neurol 167:139&#x2013;148</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-804766-8.00009-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney&#xa0;FI, Barthel&#xa0;DW (1965) Functional evaluation: the Barthel&#xa0;Index. Md State Med&#xa0;J 14:61&#x2013;65</Citation></Reference><Reference><Citation>Maier W, Deuschl G (2016) S3&#x2011;Leitlinie Demenzen www.dgn.org/leitlinien/3176-leitlinie-diagnose-und-therapie-von-demenzen-2016 . Zugegriffen: 05.09.2022</Citation></Reference><Reference><Citation>Pujades-Rodriguez&#xa0;M, Assi&#xa0;V, Gonzalez-Izquierdo&#xa0;A et al (2018) The diagnosis, burden and prognosis of dementia: a record-linkage cohort study in England. PLoS ONE 13(6):e199026. https://doi.org/10.1371/journal.pone.0199026</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0199026</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe&#xa0;SE, Greenhill&#xa0;B, Butchard&#xa0;S, Day&#xa0;J (2021) The meaning of autonomy when living with dementia: a Q&#x2011;method investigation. Dementia 20:1875&#x2013;1890</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301220973067</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36683507</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-8908</ISSN><JournalIssue CitedMedium="Internet"><Volume>92</Volume><Issue>1</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>12</EndPage><MedlinePgn>1-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-220871</ELocationID><Abstract><AbstractText>An estimated 6.5 million Americans aged 65 years or older have Alzheimer's disease (AD), which will grow to 13.8 million Americans by 2060. Despite the growing burden of dementia, no fundamental change in drug development for AD has been seen in&#x200a;&gt;&#x200a;20 years. Currently approved drugs for AD produce only modest symptomatic improvements in cognition with small effect sizes. A growing mismatch exists between the urgent need to develop effective drugs for symptomatic AD and the largely failed search for disease modification. The failure rate of clinical trials in AD is high overall, and in particular for disease-modifying therapies. Research efforts in AD have focused predominantly on amyloid-&#x3b2; and tau pathologies, but limiting clinical research to these "classical hallmarks" of the disease does not address the most urgent patient, caregiver, or societal needs. Rather, clinical research should consider the complex pathophysiology of AD. Innovative approaches are needed that provide outside-the-box thinking, and re-imagine trial design, interventions, and outcomes as well as progress in proteomics and fluid biomarker analytics for both diagnostics and disease monitoring. A new approach offering a highly specific, yet multi-pronged intervention that exerts positive modulation on the HGF/MET neurotrophic system is currently being tested in mid-to-late-stage clinical trials in mild to moderate AD. Findings from such trials may provide data to support novel approaches for development of innovative drugs for treating AD at various disease stages, including among patients already symptomatic, and may offer benefits for other neurodegenerative diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moebius</LastName><ForeName>Hans J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Athira Pharma, Inc., Bothell, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Church</LastName><ForeName>Kevin J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Athira Pharma, Inc., Bothell, WA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67256-21-7</RegistryNumber><NameOfSubstance UI="D017228">Hepatocyte Growth Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C066855">HGF protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017228" MajorTopicYN="Y">Hepatocyte Growth Factor</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076722" MajorTopicYN="N">Drug Development</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">HGF/MET</Keyword><Keyword MajorTopicYN="N">hepatocyte growth factor</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">neurotrophic</Keyword><Keyword MajorTopicYN="N">pathogenesis</Keyword><Keyword MajorTopicYN="N">synaptogenesis</Keyword></KeywordList><CoiStatement>HJM and KJC are employees of and hold stock in Athira Pharma, Inc.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>23</Day><Hour>3</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36683507</ArticleId><ArticleId IdType="pmc">PMC10041442</ArticleId><ArticleId IdType="doi">10.3233/JAD-220871</ArticleId><ArticleId IdType="pii">JAD220871</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alzheimer&#x2019;s Association (2022) Alzheimer&#x2019;s disease facts and figures. Alzheimers Dement 18, 700&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pubmed">35289055</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2019 Dementia Forecasting Collaborators (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7, e105&#x2013;e125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8810394</ArticleId><ArticleId IdType="pubmed">34998485</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, Cummings J, van der Flier WM (2021) Alzheimer&#x2019;s disease. Lancet 397, 1577&#x2013;1590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354300</ArticleId><ArticleId IdType="pubmed">33667416</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahami Monfared AA, Byrnes MJ, White LA, Zhang Q (2022) The humanistic and economic burden of Alzheimer&#x2019;s disease. Neurol Ther 11, 553&#x2013;569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9095804</ArticleId><ArticleId IdType="pubmed">35192176</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T (2022) Lecanemab in early Alzheimer&#x2019;s disease. N Engl J Med 388, 9&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">36449413</ArticleId></ArticleIdList></Reference><Reference><Citation>Caroli A, Frisoni GB; Alzheimer&#x2019;s Disease Neuroimaging Initiative (2010) The dynamics of Alzheimer&#x2019;s disease biomarkers in the Alzheimer&#x2019;s Disease Neuroimaging Initiative cohort. Neurobiol Aging 31, 1263&#x2013;1274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3467365</ArticleId><ArticleId IdType="pubmed">20538373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ower AK, Hadjichrysanthou C, Gras L, Goudsmit J, Anderson RM, de Wolf F; Alzheimer&#x2019;s Disease Neuroimaging Initiative (2018) Temporal association patterns and dynamics of amyloid-&#x3b2; and tau in Alzheimer&#x2019;s disease. Eur J Epidemiol 33, 657&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6061138</ArticleId><ArticleId IdType="pubmed">29071500</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerejeira J, Lagarto L, Mukaetova-Ladinska EB (2012) Behavioral and psychological symptoms of dementia. Front Neurol 3, 73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3345875</ArticleId><ArticleId IdType="pubmed">22586419</ArticleId></ArticleIdList></Reference><Reference><Citation>Deb A, Thornton JD, Sambamoorthi U, Innes K (2017) Direct and indirect cost of managing Alzheimer&#x2019;s disease and related dementias in the United States. Expert Rev Pharmacoecon Outcomes Res 17, 189&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5494694</ArticleId><ArticleId IdType="pubmed">28351177</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Hayek YH, Wiley RE, Khoury CP, Daya RP, Ballard C, Evans AR, Karran M, Molinuevo JL, Norton M, Atri A (2019) Tip of the iceberg: Assessing the global socioeconomic costs of Alzheimer&#x2019;s disease and related dementias and strategic implications for stakeholders. J Alzheimers Dis 70, 323&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6700654</ArticleId><ArticleId IdType="pubmed">31256142</ArticleId></ArticleIdList></Reference><Reference><Citation>Dauphinot V, Potashman M, Levitchi-Benea M, Su R, Rubino I, Krolak-Salmon P (2022) Economic and caregiver impact of Alzheimer&#x2019;s disease across the disease spectrum: A cohort study. Alzheimers Res Ther 14, 34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8841058</ArticleId><ArticleId IdType="pubmed">35151368</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong W (2020) Economic burden of Alzheimer disease and managed care considerations. Am J Manag Care 26(8 Suppl), S177&#x2013;S183.</Citation><ArticleIdList><ArticleId IdType="pubmed">32840331</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xfc;bker A, Zwakhalen SM, Challis D, Suhonen R, Karlsson S, Zabalegui A, Soto M, Saks K, Sauerland D (2015) Costs of care for people with dementia just before and after nursing home placement: Primary data from eight European countries. Eur J Health Econ 16, 689&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pubmed">25069577</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiegl K, Luttenberger K, Graessel E, Becker L, Scheel J, Pendergrass A (2021) Predictors of institutionalization in users of day care facilities with mild cognitive impairment to moderate dementia. BMC Health Serv Res 21, 1009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8461860</ArticleId><ArticleId IdType="pubmed">34556085</ArticleId></ArticleIdList></Reference><Reference><Citation>Weimer DL, Sager MA (2009) Early identification and treatment of Alzheimer&#x2019;s disease: Social and fiscal outcomes. Alzheimers Dement 5, 215&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2785909</ArticleId><ArticleId IdType="pubmed">19362885</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman HH, Pirttila T, Dartigues JF, Everitt B, Van Baelen B, Schwalen S, Kavanagh S (2009) Treatment with galantamine and time to nursing home placement in Alzheimer&#x2019;s disease patients with and without cerebrovascular disease. Int J Geriatr Psychiatry 24, 479&#x2013;488.</Citation><ArticleIdList><ArticleId IdType="pubmed">18985627</ArticleId></ArticleIdList></Reference><Reference><Citation>Wattmo C, Londos E, Minthon L (2018) Short-term response to cholinesterase inhibitors in Alzheimer&#x2019;s disease delays time to nursing home placement. Curr Alzheimer Res 15, 905&#x2013;916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6174634</ArticleId><ArticleId IdType="pubmed">29732972</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimo A, Winblad B, Stoeffler A, Wirth Y, Moebius HJ (2003) Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer&#x2019;s disease. Pharmacoeconomics 21, 327&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">12627986</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu CW, Sano M (2006) Economic considerations in the management of Alzheimer&#x2019;s disease. Clin Interv Aging 1, 143&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2695165</ArticleId><ArticleId IdType="pubmed">18044111</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittelman MS, Haley WE, Clay OJ, Roth DL (2006) Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease. Neurology 67, 1592&#x2013;1599.</Citation><ArticleIdList><ArticleId IdType="pubmed">17101889</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam J, Jun H, Cho SK, Hanson M, Mattke S (2021) Projection of budgetary savings to US state Medicaid programs from reduced nursing home use due to an Alzheimer&#x2019;s disease treatment. Alzheimers Dement 13, e12159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7968122</ArticleId><ArticleId IdType="pubmed">33748394</ArticleId></ArticleIdList></Reference><Reference><Citation>Prados MJ, Liu Y, Jun H, Lam J, Mattke S (2022) Projecting the long-term societal value of a disease-modifying treatment for Alzheimer&#x2019;s disease in the United States. Alzheimers Dement 18, 142&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9303743</ArticleId><ArticleId IdType="pubmed">35142025</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J, Lai TJ, Hemrungrojn S, Mohandas E, Yun Kim S, Nair G, Dash A (2016) Role of donepezil in the management of neuropsychiatric symptoms in Alzheimer&#x2019;s disease and dementia with Lewy bodies. CNS Neurosci Ther 22, 159&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6203446</ArticleId><ArticleId IdType="pubmed">26778658</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon CY, Lee B (2021) Prevalence of behavioral and psychological symptoms of dementia in community-dwelling dementia patients: A systematic review. Psychiatry 12, 741059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8566725</ArticleId><ArticleId IdType="pubmed">34744832</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A, Biswas A, Roy A, Biswas S, Gangopadhyay G, Das SK (2017) Behavioural and psychological symptoms of dementia: Correlates and impact on caregiver distress. Dement Geriatr Cogn Dis Extra 7, 354&#x2013;365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5731149</ArticleId><ArticleId IdType="pubmed">29282408</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunusa I, Alsumali A, Garba AE, Regestein QR, Eguale T (2019) Assessment of reported comparative effectiveness and safety of atypical antipsychotics in the treatment of behavioral and psychological symptoms of dementia: A network meta-analysis. JAMA Netw Open 2, e190828.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6583313</ArticleId><ArticleId IdType="pubmed">30901041</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J (2021) New approaches to symptomatic treatments for Alzheimer&#x2019;s disease. Neurodegener 16, 2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7805095</ArticleId><ArticleId IdType="pubmed">33441154</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B, Noh GO, Kim K (2021) Behavioural and psychological symptoms of dementia in patients with Alzheimer&#x2019;s disease and family caregiver burden: A path analysis. Geriatr 21, 160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934246</ArticleId><ArticleId IdType="pubmed">33663416</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayton S, Bush AI (2021) Beta-amyloid: The known unknowns. Ageing Res Rev 65, 101212.</Citation><ArticleIdList><ArticleId IdType="pubmed">33188924</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisoni GB, Altomare D, Thal DR, Ribaldi F, van der Kant R, Ossenkoppele R, Blennow K, Cummings J, van Duijn C, Nilsson PM, Dietrich PY, Scheltens P, Dubois B (2022) The probabilistic model of Alzheimer disease: The amyloid hypothesis revised. Nat Rev Neurosci 23, 53&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8840505</ArticleId><ArticleId IdType="pubmed">34815562</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiss AB, Montufar N, DeLeon J, Pinkhasov A, Gomolin IH, Glass AD, Arain HA, Stecker MM (2021) Alzheimer disease clinical trials targeting amyloid: Lessons learned from success in mice and failure in humans. Neurologist 26, 52&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">33646990</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbagh MN, Hendrix S, Harrison JE (2019) FDA position statement &#x201c;Early Alzheimer&#x2019;s disease: Developing drugs for treatment, Guidance for Industry&#x201d;. Alzheimers Dement 5, 13&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6804505</ArticleId><ArticleId IdType="pubmed">31650002</ArticleId></ArticleIdList></Reference><Reference><Citation>Birks J (2006) Cholinesterase inhibitors for Alzheimer&#x2019;s disease. Cochrane Database Syst Rev, CD005593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9006343</ArticleId><ArticleId IdType="pubmed">16437532</ArticleId></ArticleIdList></Reference><Reference><Citation>Budd Haeberlein S, Salloway S, Aisen P, Chalkias S, Chen T, Cohen S, Dent G, Hansson O, Harrison K, von Hehn C, Iwatsubo T, Mallinckrodt C, Mummery CJ, Muralidharan KK, Nestorov I, Nisenbaum L, Rajagovindan R, Skordos L, Tian Y, van Dyck CH, Vellas B, Wu S, Zhu Y, Sandrock A Evaluation of aducanumab efficacy in early Alzheimer&#x2019;s disease. Paper presented at 15th International Conference on Alzheimer&#x2019;s &amp; Parkinson&#x2019;s Diseases virtual conference, March 9-14, 2021.</Citation></Reference><Reference><Citation>McShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE, Maayan N, Ware J, Debarros J (2019) Memantine for dementia. Cochrane Database Syst Rev 3, CD003154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6425228</ArticleId><ArticleId IdType="pubmed">30891742</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwood K (2004) Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer&#x2019;s disease. J Neurol Neurosurg Psychiatry 75, 677&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1763555</ArticleId><ArticleId IdType="pubmed">15090558</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauthier S, Wirth Y, Moebius HJ (2005) Effects of memantine on behavioural symptoms in Alzheimer&#x2019;s disease patients: An analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies. Int J Geriatr Psychiatry 20, 459&#x2013;464.</Citation><ArticleIdList><ArticleId IdType="pubmed">15852444</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J, Feldman HH, Scheltens P (2019) The &#x201c;rights&#x201d; of precision drug development for Alzheimer&#x2019;s disease. Alzheimers Res Therapy 11, 76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6717388</ArticleId><ArticleId IdType="pubmed">31470905</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayaprolu S, Higginbotham L, Bagchi P, Watson CM, Zhang T, Levey AI, Rangaraju S, Seyfried NT (2021) Systems-based proteomics to resolve the biology of Alzheimer&#x2019;s disease beyond amyloid and tau. Neuropsychopharmacology 46, 98&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7689445</ArticleId><ArticleId IdType="pubmed">32898852</ArticleId></ArticleIdList></Reference><Reference><Citation>van Bokhoven P, de Wilde A, Vermunt L, Leferink PS, Heetveld S, Cummings J, Scheltens P, Vijverberg EGB (2021) The Alzheimer&#x2019;s disease drug development landscape. Alzheimers Res Ther 13, 186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8582156</ArticleId><ArticleId IdType="pubmed">34763720</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignon A, Salvador-Prince L, Lehmann S, Perrier V, Torrent J (2021) Deconstructing Alzheimer&#x2019;s disease: How to bridge the gap between experimental models and the human pathology? Int J Mol Sci 22, 8769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8395727</ArticleId><ArticleId IdType="pubmed">34445475</ArticleId></ArticleIdList></Reference><Reference><Citation>de Aquino CH (2021) Methodological issues in randomized clinical trials for prodromal Alzheimer&#x2019;s and Parkinson&#x2019;s disease. Front Neurol 12, 694329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8377160</ArticleId><ArticleId IdType="pubmed">34421799</ArticleId></ArticleIdList></Reference><Reference><Citation>Aisen PS, Bateman RJ, Carrillo M, Doody R, Johnson K, Sims JR, Sperling R, Vellas B (2021) Platform trials to expedite drug development in Alzheimer&#x2019;s disease: A report from the EU/US CTAD Task Force. J Prev Alzheimers Dis 8, 306&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8136263</ArticleId><ArticleId IdType="pubmed">34101788</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J, Ritter A, Zhong K (2018) Clinical trials for disease-modifying therapies in Alzheimer&#x2019;s disease: A primer, lessons learned, and a blueprint for the future. Alzheimers Dis 64, S3&#x2013;S22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6004914</ArticleId><ArticleId IdType="pubmed">29562511</ArticleId></ArticleIdList></Reference><Reference><Citation>Leber P (1996) Observations and suggestions on antidementia drug development. Alzheimer Dis Assoc Disord 10, 31&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">8876787</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J, Aisen PS, DuBois B, Fr&#xf6;lich L, Jack CR Jr, Jones RW, Morris JC, Raskin J, Dowsett SA, Scheltens P (2016) Drug development in Alzheimer&#x2019;s disease: The path to 2025. Alzheimers Res Ther 8, 39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5028936</ArticleId><ArticleId IdType="pubmed">27646601</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, Hampel H, Jagust WJ, Johnson KA, Knopman DS, Petersen RC, Scheltens P, Sperling RA, Dubois B (2016) A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87, 539&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4970664</ArticleId><ArticleId IdType="pubmed">27371494</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xf8;ntvedt GR, Lauridsen C, Berge G, White LR, Salvesen &#xd8;, Br&#xe5;then G, Sando SB (2020) The amyloid, tau, and neurodegeneration (A/T/N) classification applied to a clinical research cohort with long-term follow-up. J Alzheimers Dis 74, 829&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7242836</ArticleId><ArticleId IdType="pubmed">32116257</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin RR, Xue YY, Li XY, Chen YH, Tao QQ, Wu ZY (2021) Optimal combinations of AT(N) biomarkers to determine longitudinal cognition in the Alzheimer&#x2019;s disease. Front Aging Neurosci 13, 718959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8377373</ArticleId><ArticleId IdType="pubmed">34421579</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampel H, Cummings J, Blennow K, Gao P, Jack CR Jr, Vergallo A (2021) Developing the ATX(N) classification for use across the Alzheimer disease continuum. Nat Rev Neurol 17, 580&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pubmed">34239130</ArticleId></ArticleIdList></Reference><Reference><Citation>Decourt B, D&#x2019;Souza GX, Shi J, Ritter A, Suazo J, Sabbagh MN (2022) The cause of Alzheimer&#x2019;s disease: The theory of multipathology convergence to chronic neuronal stress. Aging Dis 13, 37&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8782548</ArticleId><ArticleId IdType="pubmed">35111361</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, Higginbotham LA, Guajardo A, White B, Troncoso JC, Thambisetty M, Montine TJ, Lee EB, Trojanowski JQ, Beach TG, Reiman EM, Haroutunian V, Wang M, Schadt E, Zhang B, Dickson DW, Ertekin-Taner N, Golde TE, Petyuk VA, De Jager PL, Bennett DA, Wingo TS, Rangaraju S, Hajjar I, Shulman JM, Lah JJ, Levey AI, Seyfried NT (2020) Large-scale proteomic analysis of Alzheimer&#x2019;s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Med 26, 769&#x2013;780.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405761</ArticleId><ArticleId IdType="pubmed">32284590</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS, Amieva H, Petersen RC, Ch&#xe9;telat G, Holtzman DM, Hyman BT, Nixon RA, Jones DT (2021) Alzheimer disease. Nat Rev Dis Primers 7, 33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8574196</ArticleId><ArticleId IdType="pubmed">33986301</ArticleId></ArticleIdList></Reference><Reference><Citation>Boder EJ, Banerjee IA (2021) Alzheimer&#x2019;s disease: Current perspectives and advances in physiological modeling. Bioengineering 8, 211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8698996</ArticleId><ArticleId IdType="pubmed">34940364</ArticleId></ArticleIdList></Reference><Reference><Citation>Higginbotham L, Ping L, Dammer EB, Duong DM, Zhou M, Gearing M, Hurst C, Glass JD, Factor SA, Johnson ECB, Hajjar I, Lah JJ, Levey AI, Seyfried NT (2020) Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer&#x2019;s disease. Sci Adv 6, eaaz9360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577712</ArticleId><ArticleId IdType="pubmed">33087358</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullard A (2021) Failure of first anti-tau antibody in Alzheimer disease highlights risks of history repeating. Nat Rev Drug Discov 20, 3&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">33303932</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxford AE, Stewart ES, Rohn TT (2020) Clinical trials in Alzheimer&#x2019;s disease: A hurdle in the path of remedy. Int J Alzheimers Dis 2020, 5380346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7152954</ArticleId><ArticleId IdType="pubmed">32308993</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, Bejanin A, Bombois S, Epelbaum S, Teichmann M, Habert MO, Nordberg A, Blennow K, Galasko D, Stern Y, Rowe CC, Salloway S, Schneider LS, Cummings JL, Feldman HH (2021) Clinical diagnosis of Alzheimer&#x2019;s disease: Recommendations of the International Working Group. Lancet Neurol 20, 484&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339877</ArticleId><ArticleId IdType="pubmed">33933186</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank B, Ally M, Tripodis Y, Puzo C, Labriolo C, Hurley L, Martin B, Palmisano J, Chan L, Steinberg E, Turk K, Budson A, O&#xc2;&#x2019;Connor M, Au R, Qiu WQ, Goldstein L, Kukull W, Kowall N, Killiany R, Stern R, Stein T, McKee A, Mez J, Alosco M (2022) Trajectories of cognitive decline in brain donors with autopsy-confirmed Alzheimer disease and cerebrovascular disease. Neurology 98, e2454&#x2013;e2464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9231841</ArticleId><ArticleId IdType="pubmed">35444054</ArticleId></ArticleIdList></Reference><Reference><Citation>Kametani F, Hasegawa M (2018) Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer&#x2019;s disease. Front Neurosci 12, 25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5797629</ArticleId><ArticleId IdType="pubmed">29440986</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbagh M, Miller J, Jones S, Ritter A, Shi J, DeCourt B, Wint D (2021) Does informant-based reporting of cognitive decline correlate with age-adjusted hippocampal volume in mild cognitive impairment and Alzheimer&#x2019;s disease? J Alzheimers Dis Rep 5, 207&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075551</ArticleId><ArticleId IdType="pubmed">33981957</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J (2018) Lessons learned from Alzheimer disease: Clinical trials with negative outcomes. Clin Transl Sci 11, 147&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5866992</ArticleId><ArticleId IdType="pubmed">28767185</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrup K (2022) Fallacies in neuroscience: The Alzheimer&#x2019;s Edition. eNeuro 9, ENEURO.0530-21.2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8856698</ArticleId><ArticleId IdType="pubmed">35144999</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacono D, Resnick SM, O&#x2019;Brien R, Zonderman AB, An Y, Pletnikova O, Rudow G, Crain B, Troncoso JC (2014) Mild cognitive impairment and asymptomatic Alzheimer disease subjects: Equivalent &#x3b2;-amyloid and tau loads with divergent cognitive outcomes. J Neuropathol Exp Neurol 73, 295&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4062187</ArticleId><ArticleId IdType="pubmed">24607960</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Nievas BG, Stein TD, Tai HC, Dols-Icardo O, Scotton TC, Barroeta-Espar I, Fernandez-Carballo L, de Munain EL, Perez J, Marquie M, Serrano-Pozo A, Frosch MP, Lowe V, Parisi JE, Petersen RC, Ikonomovic MD, L&#xf3;pez OL, Klunk W, Hyman BT, G&#xf3;mez-Isla T (2013) Dissecting phenotypic traits linked to human resilience to Alzheimer&#x2019;s pathology. Brain 136, 2510&#x2013;2526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3722351</ArticleId><ArticleId IdType="pubmed">23824488</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SJ, Tsai HH, Tsai LK, Tang SC, Lee BC, Liu HM, Yen RF, Jeng JS (2019) Advances in cerebral amyloid angiopathy imaging. Ther Adv Neurol Disord 12, 1756286419844113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6501479</ArticleId><ArticleId IdType="pubmed">31105769</ArticleId></ArticleIdList></Reference><Reference><Citation>Klohs J (2019) An integrated view on vascular dysfunction in Alzheimer&#x2019;s disease. Dis 19, 109&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pubmed">32062666</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Jiang XF, Zhang HQ, Sun JH, Pei H, Ma LN, Cao Y, Li H (2021) Interactions between glial cells and the blood-brain barrier and their role in Alzheimer&#x2019;s disease. Ageing Res Rev 72, 101483.</Citation><ArticleIdList><ArticleId IdType="pubmed">34610479</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R, Yee KL, Sumbria RK (2017) Tumor necrosis factor &#x3b1; inhibition for Alzheimer&#x2019;s disease. J Cent Nerv Syst Dis 9, 1179573517709278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5436834</ArticleId><ArticleId IdType="pubmed">28579870</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs N, Theunissen B (2022) It&#x2019;s groundhog day! What can the history of science say about the crisis in Alzheimer&#x2019;s disease research? J Alzheimers Dis 90, 1401&#x2013;1415.</Citation><ArticleIdList><ArticleId IdType="pubmed">36278350</ArticleId></ArticleIdList></Reference><Reference><Citation>Duara R, Barker W (2022) Heterogeneity in Alzheimer&#x2019;s disease diagnosis and progression rates: Implications for therapeutic trials. Neurotherapeutics 19, 8&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9130395</ArticleId><ArticleId IdType="pubmed">35084721</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiannopoulou KG, Anastasiou AI, Zachariou V, Pelidou SH (2019) Reasons for failed trials of disease-modifying treatments for Alzheimer disease and their contribution in recent research. Biomedicines 7, 97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6966425</ArticleId><ArticleId IdType="pubmed">31835422</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels AM, Andersen SW, Dowsett SA, Siemers ER (2018) The Integrated Alzheimer&#x2019;s Disease Rating Scale (iADRS) Findings from the EXPEDITION3 Trial. J Prev Alzheimers Dis 5, 134&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">29616706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Logovinsky V, Hendrix SB, Stanworth SH, Perdomo C, Xu L, Dhadda S, Do I, Rabe M, Luthman J, Cummings J, Satlin A (2016) ADCOMS: A composite clinical outcome for prodromal Alzheimer&#x2019;s disease trials. J Neurol Neurosurg Psychiatry 87, 993&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5013117</ArticleId><ArticleId IdType="pubmed">27010616</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien PC (1984) Procedures for comparing samples with multiple endpoints. Biometrics 40, 1079&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pubmed">6534410</ArticleId></ArticleIdList></Reference><Reference><Citation>
NQMedical, AP/PD2021. https://www.prweb.com/releases/nq_medical_a_digital_biomarker_discovery_platform_unveils_latest_alzheimers_disease_clinical_trial_results_at_ad_pd_2021_international_conference/prweb17785720.htm</Citation></Reference><Reference><Citation>
Unlearn, AP/PD2021. https://www.unlearn.ai/post/ad-pd-2021-unlearn-will-present-novel-ai-driven-approaches-to-enabling-smaller-more-efficient-alzheimers-clinical-trials</Citation></Reference><Reference><Citation>Food and Drug Administration Guidance for Industry (2018) Early Alzheimer&#x2019;s Disease: Developing Drugs for Treatment.</Citation></Reference><Reference><Citation>Funakoshi H, Nakamura T (2011) Hepatocyte growth factor (HGF): Neutrophic functions and therapeutic implications for neuronal injury/disease. Curr Signal Tranduct Ther 6, 156&#x2013;167.</Citation></Reference><Reference><Citation>Desole C, Gallo S, Vitacolonna A, Montarolo F, Bertolotto A, Vivien D, Comoglio P, Crepaldi T (2021) HGF and MET: From brain development to neurological disorders. Front Cell Dev Biol 9, 683609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8220160</ArticleId><ArticleId IdType="pubmed">34179015</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T, Mizuno S (2010) The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci 86, 588&#x2013;610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3081175</ArticleId><ArticleId IdType="pubmed">20551596</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T, Sakai K, Nakamura T, Matsumoto K (2011) Hepatocyte growth factor twenty years on: Much more than a growth factor. J Gastroenterol Hepatol 26 Suppl 1, 188&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">21199531</ArticleId></ArticleIdList></Reference><Reference><Citation>Akita H, Takagi N, Ishihara N, Takagi K, Murotomi K, Funakoshi H, Matsumoto K, Nakamura T, Takeo S (2008) Hepatocyte growth factor improves synaptic localization of the NMDA receptor and intracellular signaling after excito- toxic injury in cultured hippocampal neurons. Exp Neurol 210, 83&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">18001712</ArticleId></ArticleIdList></Reference><Reference><Citation>Maina F, Klein R (1999) Hepatocyte growth factor, a versatile signal for developing neurons. Nat Neurosci 2, 213&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">10195212</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicoleau C, Benzakour O, Agasse F, Thiriet N, Petit J, Prestoz L, Roger M, Jaber M, Coronas V (2009) Endogenous hepatocyte growth factor is a niche signal for subventricular zone neural stem cell amplification and self-renewal. Stem Cells 27, 408&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">18988709</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyndall SJ, Walikonis RS (2006) The receptor tyrosine kinase Met and its ligand hepatocyte growth factor are clustered at excitatory synapses and can enhance clustering of synaptic proteins. Cell Cycle 5, 1560&#x2013;1568.</Citation><ArticleIdList><ArticleId IdType="pubmed">16861928</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada T, Tsubouchi H, Daikuhara Y, Prat M, Comoglio PM, McGeer PL, McGeer EG (1004) Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissues. Brain Res 637, 308&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pubmed">8180811</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun W, Funakoshi H, Nakamura T (2002) Localization and functional role of hepatocyte growth factor (HGF) and its receptor c-met in the rat developing cerebral cortex. Brain Res Mol Brain Res 103, 36&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">12106690</ArticleId></ArticleIdList></Reference><Reference><Citation>Akimoto M, Baba A, Ikeda-Matsuo Y, Yamada MK, Itamura R, Nishiyama N, Ikegaya Y, Matsuki N (2004) Hepatocyte growth factor as an enhancer of NMDA currents and synaptic plasticity in the hippocampus. Neuroscience 128, 155&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">15450362</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimamura M, Sato N, Waguri S, Uchiyama Y, Hayashi T, Iida H, Nakamura T, Ogihara T, Kaneda Y, Morishita R (2006) Gene transfer of hepatocyte growth factor gene improves learning and memory in the chronic stage of cerebral infarction. Hypertension 47, 742&#x2013;751.</Citation><ArticleIdList><ArticleId IdType="pubmed">16505200</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi D, Sato N, Shimamura M, Kurinami H, Takeda S, Shinohara M, Suzuki S, Kojima M, Ogihara T, Morishita R (2008) Alleviation of A&#x3b2;-induced cognitive impairment by ultrasound-mediated gene transfer of HGF in a mouse model. Gene Therapy 15, 561&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">18288214</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen JA (2013) Mesenchymal stem cell transplantation in multiple sclerosis. J Neurol Sci 333, 43&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3624046</ArticleId><ArticleId IdType="pubmed">23294498</ArticleId></ArticleIdList></Reference><Reference><Citation>Doeppner TR, Kaltwasser B, ElAli A, Zechariah A, Hermann D, B&#xe4;hr M (2011) Acute hepatocyte growth factor treatment induces long-term neuroprotection and stroke recovery via mechanisms involving neural precursor cell proliferation and differentiation. J Cereb Blood Flow Metab 31, 1251&#x2013;1262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3099629</ArticleId><ArticleId IdType="pubmed">21119693</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura K, Fujiyoshi K, Yamane J, Toyota F, Hikishima K, Nomura T, Funakoshi H, Nakamura T, Aoki M, Toyama Y, Okano H, Nakamura M (2011) Human hepatocyte growth factor promotes functional recovery in primates after spinal cord injury. PLoS One 6, e27706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3226561</ArticleId><ArticleId IdType="pubmed">22140459</ArticleId></ArticleIdList></Reference><Reference><Citation>Koike H, Ishida A, Shimamura M, Mizuno S, Nakamura T, Ogihara T, Kaneda Y, Morishita R (2006) Prevention of onset of Parkinson&#x2019;s disease by gene transfer of human hepatocyte growth factor in rodent model: A model of gene therapy for Parkinson&#x2019;s disease. Gene Therapy 13, 1639&#x2013;1644.</Citation><ArticleIdList><ArticleId IdType="pubmed">16791285</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun W, Funakoshi H, Nakamura T (2002) Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J Neurosci 22, 6537&#x2013;6548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758174</ArticleId><ArticleId IdType="pubmed">12151533</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenton H, Finch PW, Rubin JS, Rosenberg JM, Taylor WG, Kuo-Leblanc V, Rodriguez-Wolf M, Baird A, Schipper HM, Stopa EG (1998) Hepatocyte growth factor (HGF/SF) in Alzheimer&#x2019;s disease. Brain Res 779, 262&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pubmed">9473690</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuboi Y, Kakimoto K, Nakajima M, Akatsu H, Yamamoto T, Ogawa K, Ohnishi T, Daikuhara Y, Yamada T (2003) Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer&#x2019;s disease. Acta Neurol Scand 107, 81&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">12580855</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao LJ, Wang ZT, Ma YH, Zhang W, Dong Q, Yu JT, Tan L; Alzheimer&#x2019;s Disease Neuroimaging Initiative (2021) Associations of the cerebrospinal fluid hepatocyte growth factor with Alzheimer&#x2019;s disease pathology and cognitive function. BMC Neurol 21, 387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8493684</ArticleId><ArticleId IdType="pubmed">34615471</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamasaki H, Honda H, Suzuki SO, Hokama M, Kiyohara Y, Nakabeppu Y, Iwaki T (2014) Down-regulation of MET in hippocampal neurons of Alzheimer&#x2019;s disease brains. Neuropathology 34, 84&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">24444253</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell KFS, Ducatenzeiler A, Ribeiro-da-Silva A, Duff K, Bennett DA, Claudio Cuello A (2006) The amyloid pathology progresses in a neurotransmitter-specific manner. Neurobiol Aging 27, 1644&#x2013;1657.</Citation><ArticleIdList><ArticleId IdType="pubmed">16271419</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson J, Jambrina E, Li J, Marston H, Menzies F, Phillips K, Gilmour G (2019) Targeting the synapse in Alzheimer&#x2019;s disease. Front Neurosci 13, 735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6664030</ArticleId><ArticleId IdType="pubmed">31396031</ArticleId></ArticleIdList></Reference><Reference><Citation>Mufson EJ, Binder L, Counts SE, DeKosky ST, de Toledo-Morrell L, Ginsberg SD, Ikonomovic MD, Perez SE, Scheff SW (2012) Mild cognitive impairment: Pathology and mechanisms. Acta Neuropathol 123, 13&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3282485</ArticleId><ArticleId IdType="pubmed">22101321</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe DJ (2002) Alzheimer&#x2019;s disease is a synaptic failure. Science 298, 789&#x2013;791.</Citation><ArticleIdList><ArticleId IdType="pubmed">12399581</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston JL, Reda SM, Setti SE, Taylor RW, Berthiaume A-A, Walker WE, Wu W, Moebius HJ, Church KJ (2022) Fosgonimeton, a novel positive hepatocyte modulator of theHGF/METsystem, promotes neurotrophic and precognitive effects in models of dementia. Neurotherapeutics, doi.org/10.1007/s13311-022-01325-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10121968</ArticleId><ArticleId IdType="pubmed">36538176</ArticleId></ArticleIdList></Reference><Reference><Citation>Reda S, Johnston J, Taylor RW, Church K (2022) Fosgonimeton, a novel, small molecule positive modulator of the HGF/MET system is neuroprotective in primary neuron culture. Alzheimers Dement 18(Suppl 10), e065874.</Citation></Reference><Reference><Citation>Hua X, Church K, Walker W, Hostis P, Viardot G, Danjou P, Hendrix S, Moebius HJ (2022) Safety, tolerability, pharmacokinetics, and pharmacodynamics of the positive modulator of HGF/MET, fosgonimeton, in healthy volunteers and subjects with Alzheimer&#x2019;s disease: Randomized, placebo-controlled, double-blind, phase I clinical trial. J Alzheimers Dis 86, 1399&#x2013;1413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9108585</ArticleId><ArticleId IdType="pubmed">35180125</ArticleId></ArticleIdList></Reference><Reference><Citation>Moebius HJ, Church K, Ooi K-B (2022) Study design and participant characteristics of a Phase 2 trial of fosgonimeton, a novel treatment for mild to moderate Alzheimer&#x2019;s disease. Presented at the AD/PD 2022 International Conference, Barcelona, Spain.</Citation></Reference><Reference><Citation>Moebius HJ, Bernick CB, Winner P, Maalouf J, Ooi K-B, Dickson SP, Hendrix SB, Church K, Olichney JM (2022) ACT-AD: Fosgonimeton in mild-to-moderate Alzheimer&#x2019;s disease &#x2013;First results of a randomized, placebo-controlled, 26-week Phase 2 proof-of-concept trial. Alzheimers Dement 18(Suppl 10), e061572.</Citation></Reference><Reference><Citation>Olichney J, Xia J, Church KJ, Moebius HJ (2022) Predictive power of cognitive biomarkers in neurodegenerative disease drug development: Utility of the P300 event-related potential. Neural Plast 2022, 2104880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9666049</ArticleId><ArticleId IdType="pubmed">36398135</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampel H, Nistic&#xf2; R, Seyfried NT, Levey AI, Modeste E, Lemercier P, Baldacci F, Toschi N, Garaci F, Perry G, Emanuele E, Valenzuela PL, Lucia A, Urbani A, Sancesario GM, Mapstone M, Corbo M, Vergallo A, Lista S; Alzheimer Precision Medicine Initiative (APMI) (2021) Omics sciences for systems biology in Alzheimer&#x2019;s disease: State-of-the-art of the evidence. Ageing Res Rev 69, 101346.</Citation><ArticleIdList><ArticleId IdType="pubmed">33915266</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J, Lanct&#xf4;t K (2022) Phase II Drug Development for Alzheimer&#x2019;s Disease: A Panel Discussion. Presented at the Alzheimer&#x2019;s Association International Conference.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36675330</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>04</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Feasibility, Acceptability, and Efficacy of Home-Based Transcranial Direct Current Stimulation on Pain in Older Adults with Alzheimer's Disease and Related Dementias: A Randomized Sham-Controlled Pilot Clinical Trial.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">401</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12020401</ELocationID><Abstract><AbstractText>Although transcranial direct current stimulation (tDCS) is emerging as a convenient pain relief modality for several chronic pain conditions, its feasibility, acceptability, and preliminary efficacy on pain in patients with Alzheimer's disease and related dementias (ADRD) have not been investigated. The purpose of this pilot study was to assess the feasibility, acceptability, and preliminary efficacy of 5, 20-min home-based tDCS sessions on chronic pain in older adults with ADRD. We randomly assigned 40 participants to active (<i>n</i> = 20) or sham (<i>n</i> = 20) tDCS. Clinical pain intensity was assessed using a numeric rating scale (NRS) with patients and a proxy measure (MOBID-2) with caregivers. We observed significant reductions of pain intensity for patients in the active tDCS group as reflected by both pain measures (NRS: Cohen's d = 0.69, <i>p</i>-value = 0.02); MOBID-2: Cohen's d = 1.12, <i>p</i>-value = 0.001). Moreover, we found home-based tDCS was feasible and acceptable intervention approach for pain in ADRD. These findings suggest the need for large-scale randomized controlled studies with larger samples and extended versions of tDCS to relieve chronic pain on the long-term for individuals with ADRD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martorella</LastName><ForeName>Geraldine</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>College of Nursing, Florida State University, Tallahassee, FL 32306, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Hongyu</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-4131-3164</Identifier><AffiliationInfo><Affiliation>College of Nursing, Florida State University, Tallahassee, FL 32306, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, Florida State University, Tallahassee, FL 32306, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Duo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Statistics, Florida State University, Tallahassee, FL 32306, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Lindsey</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>College of Nursing, Florida State University, Tallahassee, FL 32306, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathis</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9921-9608</Identifier><AffiliationInfo><Affiliation>The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>JuYoung</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Phyllis &amp; Harvey Sandler School of Social Work, Florida Atlantic University College of Social Work and Criminal Justice, Boca Raton, FL 33431, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheffler</LastName><ForeName>Julia</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9784-1134</Identifier><AffiliationInfo><Affiliation>College of Medicine, Florida State University, Tallahassee, FL 32306, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granville</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>College of Medicine, Florida State University, Tallahassee, FL 32306, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira</LastName><ForeName>Antonio L</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0002-9621-5422</Identifier><AffiliationInfo><Affiliation>The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulz</LastName><ForeName>Paul E</ForeName><Initials>PE</Initials><Identifier Source="ORCID">0000-0003-0676-002X</Identifier><AffiliationInfo><Affiliation>The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Hyochol</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-9998-4876</Identifier><AffiliationInfo><Affiliation>College of Nursing, Florida State University, Tallahassee, FL 32306, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>TARCC 2020-23-93-II</GrantID><Agency>Texas Alzheimer's Research and Care Consortium</Agency><Country/></Grant><Grant><GrantID>R01NR019051</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R15NR018050</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R15 NR018050</GrantID><Acronym>NR</Acronym><Agency>NINR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NR019051</GrantID><Acronym>NR</Acronym><Agency>NINR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease and related dementias</Keyword><Keyword MajorTopicYN="N">acceptability</Keyword><Keyword MajorTopicYN="N">efficacy</Keyword><Keyword MajorTopicYN="N">feasibility</Keyword><Keyword MajorTopicYN="N">pain</Keyword><Keyword MajorTopicYN="N">transcranial direct current stimulation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>1</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36675330</ArticleId><ArticleId IdType="pmc">PMC9860690</ArticleId><ArticleId IdType="doi">10.3390/jcm12020401</ArticleId><ArticleId IdType="pii">jcm12020401</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goodman R.A., Lochner K.A., Thambisetty M., Wingo T.S., Posner S.F., Ling S.M. Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011&#x2013;2013. Alzheimers Dement. 2017;13:28&#x2013;37. doi: 10.1016/j.jalz.2016.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2016.04.002</ArticleId><ArticleId IdType="pmc">PMC5104686</ArticleId><ArticleId IdType="pubmed">27172148</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Association: 2016 Alzheimer&#x2019;s disease facts and figures. Alzheimers Dement. 2016;12:459&#x2013;509. doi: 10.1016/j.jalz.2016.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2016.03.001</ArticleId><ArticleId IdType="pubmed">27570871</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews K.A., Xu W., Gaglioti A.H., Holt J.B., Croft J.B., Mack D., McGuire L.C. Racial and ethnic estimates of Alzheimer&#x2019;s disease and related dementias in the United States (2015&#x2013;2060) in adults aged &#x2265; 65 years. Alzheimers Dement. 2019;15:17&#x2013;24. doi: 10.1016/j.jalz.2018.06.3063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.06.3063</ArticleId><ArticleId IdType="pmc">PMC6333531</ArticleId><ArticleId IdType="pubmed">30243772</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbett A., Husebo B., Malcangio M., Staniland A., Cohen-Mansfield J., Aarsland D., Ballard C. Assessment and treatment of pain in people with dementia. Nat. Rev. Neurol. 2012;8:264&#x2013;274. doi: 10.1038/nrneurol.2012.53.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2012.53</ArticleId><ArticleId IdType="pubmed">22487749</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel K.V., Guralnik J.M., Dansie E.J., Turk D.C. Prevalence and impact of pain among older adults in the United States: Findings from the 2011 National Health and Aging Trends Study. Pain. 2013;154:2649&#x2013;2657. doi: 10.1016/j.pain.2013.07.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2013.07.029</ArticleId><ArticleId IdType="pmc">PMC3843850</ArticleId><ArticleId IdType="pubmed">24287107</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kooten J., Binnekade T.T., van der Wouden J.C., Stek M.L., Scherder E.J., Husebo B.S., Smalbrugge M., Hertogh C.M. A Review of Pain Prevalence in Alzheimer&#x2019;s, Vascular, Frontotemporal and Lewy Body Dementias. Dement. Geriatr. Cogn. Disord. 2016;41:220&#x2013;232. doi: 10.1159/000444791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000444791</ArticleId><ArticleId IdType="pubmed">27160163</ArticleId></ArticleIdList></Reference><Reference><Citation>Beerens H.C., Sutcliffe C., Renom-Guiteras A., Soto M.E., Suhonen R., Zabalegui A., Bokberg C., Saks K., Hamers J.P. RightTimePlaceCare C: Quality of life and quality of care for people with dementia receiving long term institutional care or professional home care: The European Right Time Place Care study. J. Am. Med. Dir. Assoc. 2014;15:54&#x2013;61. doi: 10.1016/j.jamda.2013.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2013.09.010</ArticleId><ArticleId IdType="pubmed">24220139</ArticleId></ArticleIdList></Reference><Reference><Citation>Achterberg W., Lautenbacher S., Husebo B., Erdal A., Herr K. Pain in dementia. Pain Rep. 2020;5:e803. doi: 10.1097/PR9.0000000000000803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PR9.0000000000000803</ArticleId><ArticleId IdType="pmc">PMC7004504</ArticleId><ArticleId IdType="pubmed">32072098</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn H., Horgas A. The relationship between pain and disruptive behaviors in nursing home resident with dementia. BMC Geriatr. 2013;13:14. doi: 10.1186/1471-2318-13-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2318-13-14</ArticleId><ArticleId IdType="pmc">PMC3573898</ArticleId><ArticleId IdType="pubmed">23399452</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn H., Garvan C., Lyon D. Pain and Aggression in Nursing Home Residents With Dementia: Minimum Data Set 3.0 Analysis. Nurs. Res. 2015;64:256&#x2013;263. doi: 10.1097/NNR.0000000000000099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NNR.0000000000000099</ArticleId><ArticleId IdType="pubmed">26126060</ArticleId></ArticleIdList></Reference><Reference><Citation>Volicer L., Frijters D.H., Van der Steen J.T. Relationship between symptoms of depression and agitation in nursing home residents with dementia. Int. J. Geriatr. Psychiatry. 2011;27:749&#x2013;754. doi: 10.1002/gps.2800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.2800</ArticleId><ArticleId IdType="pubmed">21956820</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherder E.J., Eggermont L., Plooij B., Oudshoorn J., Vuijk P.J., Pickering G., Lautenbacher S., Achterberg W., Oosterman J. Relationship between Chronic Pain and Cognition in Cognitively Intact Older Persons and in Patients with Alzheimer&#x2019;s Disease. Gerontology. 2008;54:50&#x2013;58. doi: 10.1159/000113216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000113216</ArticleId><ArticleId IdType="pubmed">18185014</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin P.-C., Lin L.-C., Shyu Y.-I.L., Hua M.-S. Predictors of pain in nursing home residents with dementia: A cross-sectional study. J. Clin. Nurs. 2011;20:1849&#x2013;1857. doi: 10.1111/j.1365-2702.2010.03695.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2702.2010.03695.x</ArticleId><ArticleId IdType="pubmed">21592246</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dalen-Kok A.H., Pieper M.J.C., De Waal M.W.M., Lukas A., Husebo B.S., Achterberg W.P. Association between pain, neuropsychiatric symptoms, and physical function in dementia: A systematic review and meta-analysis. BMC Geriatr. 2015;15:19. doi: 10.1186/s12877-015-0048-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-015-0048-6</ArticleId><ArticleId IdType="pmc">PMC4564980</ArticleId><ArticleId IdType="pubmed">26354753</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid M.C., Henderson C.R., Jr Papaleontiou M., Amanfo L., Olkhovskaya Y., Moore A.A., Parikh S.S., Turner B.J. Characteristics of older adults receiving opioids in primary care: Treatment duration and outcomes. Pain Med. 2010;11:1063&#x2013;1071. doi: 10.1111/j.1526-4637.2010.00883.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1526-4637.2010.00883.x</ArticleId><ArticleId IdType="pmc">PMC3697923</ArticleId><ArticleId IdType="pubmed">20642732</ArticleId></ArticleIdList></Reference><Reference><Citation>Karafin M.S., Chen G., Wandersee N.J., Brandow A.M., Hurley R.W., Simpson P., Ward D., Li S.-J., Field J.J. Chronic pain in adults with sickle cell disease is associated with alterations in functional connectivity of the brain. PLoS ONE. 2019;14:e0216994. doi: 10.1371/journal.pone.0216994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0216994</ArticleId><ArticleId IdType="pmc">PMC6527293</ArticleId><ArticleId IdType="pubmed">31107926</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwilym S.E., Keltner J.R., Warnaby C.E., Carr A.J., Chizh B., Chessell I., Tracey I. Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients. Arthritis Rheum. 2009;61:1226&#x2013;1234. doi: 10.1002/art.24837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24837</ArticleId><ArticleId IdType="pubmed">19714588</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiramatsu T., Nakanishi K., Yoshimura S., Yoshino A., Adachi N., Okamoto Y., Yamawaki S., Ochi M. The dorsolateral prefrontal network is involved in pain perception in knee osteoarthritis patients. Neurosci. Lett. 2014;581:109&#x2013;114. doi: 10.1016/j.neulet.2014.08.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2014.08.027</ArticleId><ArticleId IdType="pubmed">25168605</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofat N., Smee C., Hermansson M., Howard M., Baker E.H., Howe F.A., Barrick T.R. Functional MRI demonstrates pain perception in hand osteoarthritis has features of central pain processing. J. Biomed. Graph. Comput. 2013;3:20. doi: 10.5430/jbgc.v3n4p20.</Citation><ArticleIdList><ArticleId IdType="doi">10.5430/jbgc.v3n4p20</ArticleId><ArticleId IdType="pmc">PMC3842594</ArticleId><ArticleId IdType="pubmed">24294351</ArticleId></ArticleIdList></Reference><Reference><Citation>Kindler L.L., Bennett R., Jones K.D. Central Sensitivity Syndromes: Mounting Pathophysiologic Evidence to Link Fibromyalgia with Other Common Chronic Pain Disorders. Pain Manag. Nurs. 2011;12:15&#x2013;24. doi: 10.1016/j.pmn.2009.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmn.2009.10.003</ArticleId><ArticleId IdType="pmc">PMC3052797</ArticleId><ArticleId IdType="pubmed">21349445</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumaradev S., Fayosse A., Dugravot A., Dumurgier J., Roux C., Kivim&#xe4;ki M., Singh-Manoux A., Sabia S. Timeline of pain before dementia diagnosis: A 27-year follow-up study. Pain. 2020;162:1578&#x2013;1585. doi: 10.1097/j.pain.0000000000002080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002080</ArticleId><ArticleId IdType="pmc">PMC7985036</ArticleId><ArticleId IdType="pubmed">33003109</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Liu H. Association between widespread pain and dementia, Alzheimer&#x2019;s disease and stroke: A cohort study from the Framingham Heart Study. Reg. Anesth. Pain Med. 2021;46:879&#x2013;885. doi: 10.1136/rapm-2021-102733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rapm-2021-102733</ArticleId><ArticleId IdType="pubmed">34400574</ArticleId></ArticleIdList></Reference><Reference><Citation>Defrin R., Amanzio M., de Tommaso M., Dimova V., Filipovic S., Finn D.P., Gimenez-Llort L., Invitto S., Jensen-Dahm C., Lautenbacher S., et al. Experimental pain processing in individuals with cognitive impairment: Current state of the science. Pain. 2015;156:1396&#x2013;1408. doi: 10.1097/j.pain.0000000000000195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000000195</ArticleId><ArticleId IdType="pubmed">26181216</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson A.R., Iversen W.L., Carter M.A., Moss K.O., Cowan R.L., Monroe T.B. Experimentally evoked pain in Alzheimer&#x2019;s disease. J. Am. Assoc. Nurse Prac. 2021;34:18&#x2013;25. doi: 10.1097/JXX.0000000000000580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JXX.0000000000000580</ArticleId><ArticleId IdType="pmc">PMC9118535</ArticleId><ArticleId IdType="pubmed">33731557</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole L.J., Farrell M., Duff E., Barber J.B., Egan G., Gibson S.J. Pain sensitivity and fMRI pain-related brain activity in Alzheimer&#x2019;s disease. Brain. 2006;129:2957&#x2013;2965. doi: 10.1093/brain/awl228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl228</ArticleId><ArticleId IdType="pubmed">16951408</ArticleId></ArticleIdList></Reference><Reference><Citation>Beach P.A., Huck J.T., Zhu D.C., Bozoki A.C. Altered Behavioral and Autonomic Pain Responses in Alzheimer&#x2019;s Disease Are Associated with Dysfunctional Affective, Self-Reflective and Salience Network Resting-State Connectivity. Front. Aging Neurosci. 2017;9:297. doi: 10.3389/fnagi.2017.00297.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00297</ArticleId><ArticleId IdType="pmc">PMC5603705</ArticleId><ArticleId IdType="pubmed">28959201</ArticleId></ArticleIdList></Reference><Reference><Citation>Monroe T.B., Beach P.A., Bruehl S.P., Dietrich M.S., Rogers B.P., Gore J.C., Atalla S.W., Cowan R.L. The Impact of Alzheimer&#x2019;s Disease on the Resting State Functional Connectivity of Brain Regions Modulating Pain: A Cross Sectional Study. J. Alzheimers Dis. 2017;57:71&#x2013;83. doi: 10.3233/JAD-161187.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-161187</ArticleId><ArticleId IdType="pmc">PMC6461741</ArticleId><ArticleId IdType="pubmed">28222526</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole L.J., Gavrilescu M., Johnston L.A., Gibson S.J., Farrell M.J., Egan G.F. The impact of Alzheimer&#x2019;s disease on the functional connectivity between brain regions underlying pain perception. Eur. J. Pain. 2011;15:e561&#x2013;e568.</Citation><ArticleIdList><ArticleId IdType="pubmed">21257326</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunk S., Zuidema S., Koch K., Lautenbacher S., De Deyn P.P., Kunz M. Pain processing in older adults with dementia-related cognitive impairment is associated with frontal neurodegeneration. Neurobiol. Aging. 2021;106:139&#x2013;152. doi: 10.1016/j.neurobiolaging.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2021.06.009</ArticleId><ArticleId IdType="pubmed">34274699</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefaucheur J.-P., Antal A., Ayache S.S., Benninger D.H., Brunelin J., Cogiamanian F., Cotelli M., De Ridder D., Ferrucci R., Langguth B., et al. Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS) Clin. Neurophysiol. 2016;128:56&#x2013;92. doi: 10.1016/j.clinph.2016.10.087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2016.10.087</ArticleId><ArticleId IdType="pubmed">27866120</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods A.J., Antal A., Bikson M., Boggio P.S., Brunoni A.R., Celnik P., Cohen L.G., Fregni F., Herrmann C.S., Kappenman E.S., et al. A technical guide to tDCS, and related non-invasive brain stimulation tools. Clin. Neurophysiol. 2016;127:1031&#x2013;1048. doi: 10.1016/j.clinph.2015.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2015.11.012</ArticleId><ArticleId IdType="pmc">PMC4747791</ArticleId><ArticleId IdType="pubmed">26652115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler S.K., Turkeltaub P.E., Benson J.G., Hamilton R.H. Differences in the experience of active and sham transcranial direct current stimulation. Brain Stimul. 2012;5:155&#x2013;162. doi: 10.1016/j.brs.2011.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2011.02.007</ArticleId><ArticleId IdType="pmc">PMC3270148</ArticleId><ArticleId IdType="pubmed">22037128</ArticleId></ArticleIdList></Reference><Reference><Citation>United States Food and Drug Administration: Medical Device Regulatory Framework: Part812-Investigational Device Exemptions. The Food and Drug Administration (FDA); Silver Spring, MD, USA: 2015.</Citation></Reference><Reference><Citation>Fregni F., Nitsche M.A., Loo C., Brunoni A.R., Marangolo P., Leite J., Carvalho S., Bolognini N., Caumo W., Paik N.-J., et al. Regulatory considerations for the clinical and research use of transcranial direct current stimulation (tDCS): Review and recommendations from an expert panel. Clin. Res. Regul. Aff. 2014;32:22&#x2013;35. doi: 10.3109/10601333.2015.980944.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10601333.2015.980944</ArticleId><ArticleId IdType="pmc">PMC4431691</ArticleId><ArticleId IdType="pubmed">25983531</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn H., Woods A.J., Kunik M.E., Bhattacharjee A., Chen Z., Choi E., Fillingim R.B. Efficacy of transcranial direct current stimulation over primary motor cortex (anode) and contralateral supraorbital area (cathode) on clinical pain severity and mobility performance in persons with knee osteoarthritis: An experimenter- and participant-blinded, randomized, sham-controlled pilot clinical study. Brain Stimul. 2017;10:902&#x2013;909. doi: 10.1016/j.brs.2017.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2017.05.007</ArticleId><ArticleId IdType="pmc">PMC5568498</ArticleId><ArticleId IdType="pubmed">28566193</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn H., Suchting R., Woods A.J., Miao H., Green C., Cho R.Y., Choi E., Fillingim R. Bayesian analysis of the effect of transcranial direct current stimulation on experimental pain sensitivity in older adults with knee osteoarthritis: Randomized sham-controlled pilot clinical study. J. Pain Res. 2018;11:2071&#x2013;2082. doi: 10.2147/JPR.S173080.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S173080</ArticleId><ArticleId IdType="pmc">PMC6166765</ArticleId><ArticleId IdType="pubmed">30310309</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchting R., Colpo G.D., Rocha N.P., Ahn H. The Effect of Transcranial Direct Current Stimulation on Inflammation in Older Adults With Knee Osteoarthritis: A Bayesian Residual Change Analysis. Biol. Res. Nurs. 2019;22:57&#x2013;63. doi: 10.1177/1099800419869845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1099800419869845</ArticleId><ArticleId IdType="pmc">PMC7068751</ArticleId><ArticleId IdType="pubmed">31416344</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn H., Sorkpor S., Miao H., Zhong C., Jorge R., Park L., Abdi S., Cho R.Y. Home-based self-administered transcranial direct current stimulation in older adults with knee osteoarthritis pain: An open-label study. J. Clin. Neurosci. 2019;66:61&#x2013;65. doi: 10.1016/j.jocn.2019.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2019.05.023</ArticleId><ArticleId IdType="pubmed">31153751</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn H., Zhong C., Miao H., Chaoul A., Park L., Yen I.H., Vila M.A., Sorkpor S., Abdi S. Efficacy of combining home-based transcranial direct current stimulation with mindfulness-based meditation for pain in older adults with knee osteoarthritis: A randomized controlled pilot study. J. Clin. Neurosci. 2019;70:140&#x2013;145. doi: 10.1016/j.jocn.2019.08.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2019.08.047</ArticleId><ArticleId IdType="pubmed">31421990</ArticleId></ArticleIdList></Reference><Reference><Citation>Luedtke K., Rushton A., Wright C., Geiss B., Juergens T.P., May A. Transcranial direct current stimulation for the reduction of clinical and experimentally induced pain: A systematic review and meta-analysis. Clin. J. Pain. 2012;28:452&#x2013;461. doi: 10.1097/AJP.0b013e31823853e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AJP.0b013e31823853e3</ArticleId><ArticleId IdType="pubmed">22569218</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connell N.E., Wand B.M., Marston L., Spencer S., Desouza L.H. Non-invasive brain stimulation techniques for chronic pain. Cochrane Database Syst. Rev. 2014:CD008208. doi: 10.1002/14651858.CD008208.pub4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD008208.pub4</ArticleId><ArticleId IdType="pubmed">24729198</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaseghi B., Zoghi M., Jaberzadeh S. Does anodal transcranial direct current stimulation modulate sensory perception and pain? A meta-analysis study. Clin. Neurophysiol. 2014;125:1847&#x2013;1858. doi: 10.1016/j.clinph.2014.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2014.01.020</ArticleId><ArticleId IdType="pubmed">24555922</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen J.-P., Nizard J., Keravel Y., Lefaucheur J.-P. Invasive brain stimulation for the treatment of neuropathic pain. Nat. Rev. Neurol. 2011;7:699&#x2013;709. doi: 10.1038/nrneurol.2011.138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.138</ArticleId><ArticleId IdType="pubmed">21931348</ArticleId></ArticleIdList></Reference><Reference><Citation>Peyron R., Faillenot I., Mertens P., Laurent B., Garcia-Larrea L. Motor cortex stimulation in neuropathic pain. Correlations between analgesic effect and hemodynamic changes in the brain. A PET study. Neuroimage. 2007;34:310&#x2013;321. doi: 10.1016/j.neuroimage.2006.08.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2006.08.037</ArticleId><ArticleId IdType="pubmed">17055297</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefaucheur J.-P. A comprehensive database of published tDCS clinical trials (2005&#x2013;2016) Neurophysiol. Clin. 2016;46:319&#x2013;398. doi: 10.1016/j.neucli.2016.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucli.2016.10.002</ArticleId><ArticleId IdType="pubmed">27865707</ArticleId></ArticleIdList></Reference><Reference><Citation>Majdi A., van Boekholdt L., Sadigh-Eteghad S., Mc Laughlin M. A systematic review and meta-analysis of transcranial direct-current stimulation effects on cognitive function in patients with Alzheimer&#x2019;s disease. Mol. Psychiatry. 2022;27:2000&#x2013;2009. doi: 10.1038/s41380-022-01444-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01444-7</ArticleId><ArticleId IdType="pubmed">35115703</ArticleId></ArticleIdList></Reference><Reference><Citation>Martorella G., Mathis K., Miao H., Wang D., Park L., Ahn H. Self-administered Transcranial Direct Current Stimulation for Pain in Older Adults with Knee Osteoarthritis: A Randomized Controlled Trial. Brain Stimul. 2022;15:902&#x2013;909. doi: 10.1016/j.brs.2022.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2022.06.003</ArticleId><ArticleId IdType="pmc">PMC9387776</ArticleId><ArticleId IdType="pubmed">35690388</ArticleId></ArticleIdList></Reference><Reference><Citation>Martorella G., Mathis K., Miao H., Wang D., Park L., Ahn H. Efficacy of Home-Based Transcranial Direct Current Stimulation on Experimental Pain Sensitivity in Older Adults with Knee Osteoarthritis: A Randomized, Sham-Controlled Clinical Trial. J. Clin. Med. 2022;11:5209. doi: 10.3390/jcm11175209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11175209</ArticleId><ArticleId IdType="pmc">PMC9457351</ArticleId><ArticleId IdType="pubmed">36079139</ArticleId></ArticleIdList></Reference><Reference><Citation>Charvet L.E., Kasschau M., Datta A., Knotkova H., Stevens M., Alonzo A., Loo C., Krull K.R., Bikson M. Remotely-supervised transcranial direct current stimulation (tDCS) for clinical trials: Guidelines for technology and protocols. Front. Syst. Neurosci. 2015;9:26. doi: 10.3389/fnsys.2015.00026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnsys.2015.00026</ArticleId><ArticleId IdType="pmc">PMC4362220</ArticleId><ArticleId IdType="pubmed">25852494</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibaut A., O&#x2019;Brien A.T., Fregni F. Strategies for replacing non-invasive brain stimulation sessions: Recommendations for designing neurostimulation clinical trials. Expert Rev. Med. Devices. 2017;14:633&#x2013;649. doi: 10.1080/17434440.2017.1352470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17434440.2017.1352470</ArticleId><ArticleId IdType="pubmed">28681660</ArticleId></ArticleIdList></Reference><Reference><Citation>Probst J.C., Laditka S.B., Wang J.-Y., Johnson A.O. Effects of residence and race on burden of travel for care: Cross sectional analysis of the 2001 US National Household Travel Survey. BMC Health Serv. Res. 2007;7:40. doi: 10.1186/1472-6963-7-40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6963-7-40</ArticleId><ArticleId IdType="pmc">PMC1851736</ArticleId><ArticleId IdType="pubmed">17349050</ArticleId></ArticleIdList></Reference><Reference><Citation>Witham M., McMurdo M.E.T. How to Get Older People Included in Clinical Studies. Drugs Aging. 2007;24:187&#x2013;196. doi: 10.2165/00002512-200724030-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00002512-200724030-00002</ArticleId><ArticleId IdType="pubmed">17362048</ArticleId></ArticleIdList></Reference><Reference><Citation>Cammisuli D.M., Cignoni F., Ceravolo R., Bonuccelli U., Castelnuovo G. Transcranial Direct Current Stimulation (tDCS) as a Useful Rehabilitation Strategy to Improve Cognition in Patients With Alzheimer&#x2019;s Disease and Parkinson&#x2019;s Disease: An Updated Systematic Review of Randomized Controlled Trials. Front. Neurol. 2022;12 doi: 10.3389/fneur.2021.798191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.798191</ArticleId><ArticleId IdType="pmc">PMC8847129</ArticleId><ArticleId IdType="pubmed">35185754</ArticleId></ArticleIdList></Reference><Reference><Citation>Andr&#xe9; S., Heinrich S., Kayser F., Menzler K., Kesselring J., Khader P.H., Lefaucheur J.-P., Mylius V. At-home tDCS of the left dorsolateral prefrontal cortex improves visual short-term memory in mild vascular dementia. J. Neurol. Sci. 2016;369:185&#x2013;190. doi: 10.1016/j.jns.2016.07.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.07.065</ArticleId><ArticleId IdType="pubmed">27653887</ArticleId></ArticleIdList></Reference><Reference><Citation>Im J.J., Jeong H., Bikson M., Woods A.J., Unal G., Oh J.K., Na S., Park J.-S., Knotkova H., Song I.-U., et al. Effects of 6-month at-home transcranial direct current stimulation on cognition and cerebral glucose metabolism in Alzheimer&#x2019;s disease. Brain Stimul. 2019;12:1222&#x2013;1228. doi: 10.1016/j.brs.2019.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2019.06.003</ArticleId><ArticleId IdType="pmc">PMC6703942</ArticleId><ArticleId IdType="pubmed">31196835</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo-Saavedra L., Gebodh N., Bikson M., Diaz-Cruz C., Brandao R., Coutinho L., Truong D., Datta A., Shani-Hershkovich R., Weiss M., et al. Clinically Effective Treatment of Fibromyalgia Pain With High-Definition Transcranial Direct Current Stimulation: Phase II Open-Label Dose Optimization. J. Pain. 2015;17:14&#x2013;26. doi: 10.1016/j.jpain.2015.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2015.09.009</ArticleId><ArticleId IdType="pmc">PMC5777157</ArticleId><ArticleId IdType="pubmed">26456677</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris J.C. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology. 1993;43:2412&#x2013;2414. doi: 10.1212/WNL.43.11.2412-a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.43.11.2412-a</ArticleId><ArticleId IdType="pubmed">8232972</ArticleId></ArticleIdList></Reference><Reference><Citation>Knotkova H., Riggs A., Berisha D., Borges H., Bernstein H., Patel V., Truong D.Q., Unal G., Arce D., Datta A., et al. Automatic M1-SO Montage Headgear for Transcranial Direct Current Stimulation (TDCS) Suitable for Home and High-Throughput In-Clinic Applications. Neuromodulation Technol. Neural Interface. 2018;22:904&#x2013;910. doi: 10.1111/ner.12786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ner.12786</ArticleId><ArticleId IdType="pubmed">29762886</ArticleId></ArticleIdList></Reference><Reference><Citation>Fregni F., Gimenes R., Valle A.C., Ferreira M.J.L., Rocha R.R., Natalle L., Bravo R., Rigonatti S.P., Freedman S.D., Nitsche M.A., et al. A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia. Arthritis Rheum. 2006;54:3988&#x2013;3998. doi: 10.1002/art.22195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22195</ArticleId><ArticleId IdType="pubmed">17133529</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandiga P.C., Hummel F.C., Cohen L.G. Transcranial DC stimulation (tDCS): A tool for double-blind sham-controlled clinical studies in brain stimulation. Clin. Neurophysiol. 2006;117:845&#x2013;850. doi: 10.1016/j.clinph.2005.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2005.12.003</ArticleId><ArticleId IdType="pubmed">16427357</ArticleId></ArticleIdList></Reference><Reference><Citation>Dworkin R.H., Turk D.C., McDermott M.P., Peirce-Sandner S., Burke L.B., Cowan P., Farrar J.T., Hertz S., Raja S.N., Rappaport B.A., et al. Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain. 2009;146:238&#x2013;244. doi: 10.1016/j.pain.2009.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2009.08.019</ArticleId><ArticleId IdType="pubmed">19836888</ArticleId></ArticleIdList></Reference><Reference><Citation>Husebo B.S. Mobilization-Observation-Behaviour-Intensity-Dementia-2 Pain Scale (MOBID-2) J. Physiother. 2017;63:261. doi: 10.1016/j.jphys.2017.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphys.2017.07.003</ArticleId><ArticleId IdType="pubmed">28939312</ArticleId></ArticleIdList></Reference><Reference><Citation>Husebo B., Ostelo R., Strand L. The MOBID -2 pain scale: Reliability and responsiveness to pain in patients with dementia. Eur. J. Pain. 2014;18:1419&#x2013;1430. doi: 10.1002/ejp.507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.507</ArticleId><ArticleId IdType="pmc">PMC4230478</ArticleId><ArticleId IdType="pubmed">24799157</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen-Mansfield J., Marx M.S., Rosenthal A.S. A Description of Agitation in a Nursing Home. J. Gerontol. 1989;44:M77&#x2013;M84. doi: 10.1093/geronj/44.3.M77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronj/44.3.M77</ArticleId><ArticleId IdType="pubmed">2715584</ArticleId></ArticleIdList></Reference><Reference><Citation>Koss E., Weiner M., Ernesto C., Cohen-Mansfield J., Ferris S.H., Grundman M., Schafer K., Sano M., Thal L.J., Thomas R., et al. Assessing patterns of agitation in Alzheimer&#x2019;s disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer&#x2019;s Disease Cooperative Study. Alzheimer Dis. Assoc. Disord. 1997;11((Suppl. 2)):S45&#x2013;S50. doi: 10.1097/00002093-199700112-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002093-199700112-00007</ArticleId><ArticleId IdType="pubmed">9236952</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen-Mansfield J., Libin A. Assessment of agitation in elderly patients with dementia: Correlations between informant rating and direct observation. Int. J. Geriatr. Psychiatry. 2004;19:881&#x2013;891. doi: 10.1002/gps.1171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.1171</ArticleId><ArticleId IdType="pubmed">15352147</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen-Mansfield J., Libin A. Verbal and physical non-aggressive agitated behaviors in elderly persons with dementia: Robustness of syndromes. J. Psychiatr. Res. 2005;39:325&#x2013;332. doi: 10.1016/j.jpsychires.2004.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2004.08.009</ArticleId><ArticleId IdType="pubmed">15725431</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J.L., Mega M., Gray K., Rosenberg-Thompson S., Carusi D.A., Gornbein J. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308. doi: 10.1212/WNL.44.12.2308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.44.12.2308</ArticleId><ArticleId IdType="pubmed">7991117</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J.L. The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology. 1997;48((Suppl. 6)):10S&#x2013;16S. doi: 10.1212/WNL.48.5_Suppl_6.10S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.48.5_Suppl_6.10S</ArticleId><ArticleId IdType="pubmed">9153155</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J. The Neuropsychiatric Inventory: Development and Applications. J. Geriatr. Psychiatry Neurol. 2020;33:73&#x2013;84. doi: 10.1177/0891988719882102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988719882102</ArticleId><ArticleId IdType="pmc">PMC8505128</ArticleId><ArticleId IdType="pubmed">32013737</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Hopewell S., Schulz K.F., Montori V., Gotzsche P.C., Devereaux P.J., Elbourne D., Egger M., Altman D.G. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2844943</ArticleId><ArticleId IdType="pubmed">20332511</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillick B.T., Feyma T., Menk J., Usset M., Vaith A., Wood T.J., Worthington R., Krach L. Safety and Feasibility of Transcranial Direct Current Stimulation in Pediatric Hemiparesis: Randomized Controlled Preliminary Study. Phys. Ther. 2015;95:337&#x2013;349. doi: 10.2522/ptj.20130565.</Citation><ArticleIdList><ArticleId IdType="doi">10.2522/ptj.20130565</ArticleId><ArticleId IdType="pmc">PMC4348714</ArticleId><ArticleId IdType="pubmed">25413621</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha Y.-H., Urbano D., Pariseau N. Randomized Single Blind Sham Controlled Trial of Adjunctive Home-Based tDCS after rTMS for Mal De Debarquement Syndrome: Safety, Efficacy, and Participant Satisfaction Assessment. Brain Stimul. 2016;9:537&#x2013;544. doi: 10.1016/j.brs.2016.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2016.03.016</ArticleId><ArticleId IdType="pubmed">27117283</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen D.L., Attkisson C.C., Hargreaves W.A., Nguyen T.D. Assessment of client/patient satisfaction: Development of a general scale. Eval. Progr. Plan. 1979;2:197&#x2013;207. doi: 10.1016/0149-7189(79)90094-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0149-7189(79)90094-6</ArticleId><ArticleId IdType="pubmed">10245370</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T.D., Attkisson C., Stegner B.L. Assessment of patient satisfaction: Development and refinement of a Service Evaluation Questionnaire. Eval. Progr. Plan. 1983;6:299&#x2013;313. doi: 10.1016/0149-7189(83)90010-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0149-7189(83)90010-1</ArticleId><ArticleId IdType="pubmed">10267258</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikson M., Grossman P., Thomas C., Zannou A.L., Jiang J., Adnan T., Mourdoukoutas A.P., Kronberg G., Truong D., Boggio P., et al. Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016. Brain Stimul. 2016;9:641&#x2013;661. doi: 10.1016/j.brs.2016.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2016.06.004</ArticleId><ArticleId IdType="pmc">PMC5007190</ArticleId><ArticleId IdType="pubmed">27372845</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrar J.T., Young J.P., Jr., LaMoreaux L., Werth J.L., Poole R.M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149&#x2013;158. doi: 10.1016/S0304-3959(01)00349-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3959(01)00349-9</ArticleId><ArticleId IdType="pubmed">11690728</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena V., Pal A. Role of Transcranial Direct Current Stimulation in the Management of Alzheimer&#x2019;s Disease: A Meta-analysis of Effects, Adherence and Adverse Effects. Clin. Psychopharmacol. Neurosci. 2021;19:589&#x2013;599. doi: 10.9758/cpn.2021.19.4.589.</Citation><ArticleIdList><ArticleId IdType="doi">10.9758/cpn.2021.19.4.589</ArticleId><ArticleId IdType="pmc">PMC8553534</ArticleId><ArticleId IdType="pubmed">34690114</ArticleId></ArticleIdList></Reference><Reference><Citation>Riggs A., Patel V., Paneri B., Portenoy R.K., Bikson M., Knotkova H. At-Home Transcranial Direct Current Stimulation (tDCS) With Telehealth Support for Symptom Control in Chronically-Ill Patients With Multiple Symptoms. Front. Behav. Neurosci. 2018;12 doi: 10.3389/fnbeh.2018.00093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnbeh.2018.00093</ArticleId><ArticleId IdType="pmc">PMC5972211</ArticleId><ArticleId IdType="pubmed">29872381</ArticleId></ArticleIdList></Reference><Reference><Citation>Montero-Hernandez S., Martorella G., Miao H., Pollonini L., Ahn H. Inter- and Intra-Region Functional Connectivity in Nonpharmacological Pain Management; Proceedings of the Society of Functional Near-Infrared Spectroscopy 2022 Conference; Boston, MA, USA. 9&#x2013;12 October 2022.</Citation></Reference><Reference><Citation>Pollonini L., Miao H., Ahn H. Longitudinal effect of transcranial direct current stimulation on knee osteoarthritis patients measured by functional infrared spectroscopy: A pilot study. Neurophotonics. 2020;7:025004. doi: 10.1117/1.NPh.7.2.025004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1117/1.NPh.7.2.025004</ArticleId><ArticleId IdType="pmc">PMC7203445</ArticleId><ArticleId IdType="pubmed">32411812</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollonini L., Montero-Hernandez S., Park L., Miao H., Mathis K., Ahn H. Functional Near-Infrared Spectroscopy to Assess Central Pain Responses in a Nonpharmacologic Treatment Trial of Osteoarthritis. J. Neuroimaging. 2020;30:808&#x2013;814. doi: 10.1111/jon.12782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jon.12782</ArticleId><ArticleId IdType="pmc">PMC7719610</ArticleId><ArticleId IdType="pubmed">32896933</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeser D., Meindl T., Bor J., Palm U., Pogarell O., Mulert C., Brunelin J., M&#xf6;ller H.-J., Reiser M., Padberg F. Prefrontal Transcranial Direct Current Stimulation Changes Connectivity of Resting-State Networks during fMRI. J. Neurosci. 2011;31:15284&#x2013;15293. doi: 10.1523/JNEUROSCI.0542-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0542-11.2011</ArticleId><ArticleId IdType="pmc">PMC6703525</ArticleId><ArticleId IdType="pubmed">22031874</ArticleId></ArticleIdList></Reference><Reference><Citation>Naegel S., Biermann J., Theysohn N., Kleinschnitz C., Diener H.-C., Katsarava Z., Obermann M., Holle D. Polarity-specific modulation of pain processing by transcranial direct current stimulation&#x2014;A blinded longitudinal fMRI study. J. Headache Pain. 2018;19:99. doi: 10.1186/s10194-018-0924-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-018-0924-5</ArticleId><ArticleId IdType="pmc">PMC6755563</ArticleId><ArticleId IdType="pubmed">30355321</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummiford C.M., Nascimento T.D., Foerster B.R., Clauw D.J., Zubieta J.-K., Harris R.E., DaSilva A.F. Changes in resting state functional connectivity after repetitive transcranial direct current stimulation applied to motor cortex in fibromyalgia patients. Arthritis Res. Ther. 2016;18:40. doi: 10.1186/s13075-016-0934-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-016-0934-0</ArticleId><ArticleId IdType="pmc">PMC4741001</ArticleId><ArticleId IdType="pubmed">26842987</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Silva J.T., Letzen J.E., Haythornthwaite J.A., Finan P.H., Campbell C.M., Seminowicz D. Do chronic pain and comorbidities affect brain function in sickle cell patients? A systematic review of neuroimaging and treatment approaches. Pain. 2019;160:1933&#x2013;1945. doi: 10.1097/j.pain.0000000000001591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001591</ArticleId><ArticleId IdType="pmc">PMC6699910</ArticleId><ArticleId IdType="pubmed">31045749</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao S., Fisher D.W., Yu T., Dong H. The link between chronic pain and Alzheimer&#x2019;s disease. J. Neuroinflamm. 2019;16:204. doi: 10.1186/s12974-019-1608-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1608-z</ArticleId><ArticleId IdType="pmc">PMC6836339</ArticleId><ArticleId IdType="pubmed">31694670</ArticleId></ArticleIdList></Reference><Reference><Citation>Husebo B.S., Corbett A. Dementia: Pain management in dementia--the value of proxy measures. Nat. Rev. Neurol. 2014;10:313&#x2013;314. doi: 10.1038/nrneurol.2014.66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.66</ArticleId><ArticleId IdType="pubmed">24709891</ArticleId></ArticleIdList></Reference><Reference><Citation>Amspoker A.B., Snow A.L., Renn B., Block P., Pickens S., Morgan R.O., Kunik M.E. Patient Versus Informal Caregiver Proxy Reports of Pain Interference in Persons With Dementia. J. Appl. Gerontol. 2020;40:414&#x2013;422. doi: 10.1177/0733464820902632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464820902632</ArticleId><ArticleId IdType="pubmed">32026743</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares D.R.B., Okazaki J.E.F., Santana M.V.D.A., Pinto A.C.P.N., Tutiya K.K., Gazoni F.M., Pinto C.B., Santos F.C., Fregni F., Trevisani V.F.M. Motor cortex transcranial direct current stimulation effects on knee osteoarthritis pain in elderly subjects with dysfunctional descending pain inhibitory system: A randomized controlled trial. Brain Stimul. 2021;14:477&#x2013;487. doi: 10.1016/j.brs.2021.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2021.02.018</ArticleId><ArticleId IdType="pubmed">33684598</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo C.K., Husain M.M., McDonald W.M., Aaronson S., O&#x2019;Reardon J.P., Alonzo A., Weickert C.S., Martin D.M., McClintock S.M., Mohan A., et al. International randomized-controlled trial of transcranial Direct Current Stimulation in depression. Brain Stimul. 2018;11:125&#x2013;133. doi: 10.1016/j.brs.2017.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2017.10.011</ArticleId><ArticleId IdType="pubmed">29111077</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco-Barrios K., Cardenas-Rojas A., Thibaut A., Costa B., Ferreira I., Caumo W., Fregni F. Methods and strategies of tDCS for the treatment of pain: Current status and future directions. Expert Rev. Med. Devices. 2020;17:879&#x2013;898. doi: 10.1080/17434440.2020.1816168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17434440.2020.1816168</ArticleId><ArticleId IdType="pmc">PMC7674241</ArticleId><ArticleId IdType="pubmed">32845195</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36655645</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1972-6007</ISSN><JournalIssue CitedMedium="Internet"><Volume>174</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>La Clinica terapeutica</Title><ISOAbbreviation>Clin Ter</ISOAbbreviation></Journal><ArticleTitle>Oral THC: CBD cannabis extract in main symptoms of Alzheimer disease: agitation and weight loss.</ArticleTitle><Pagination><StartPage>53</StartPage><EndPage>60</EndPage><MedlinePgn>53-60</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7417/CT.2023.5009</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Ten million new cases of dementia are recorded annually worldwide, with agitation and idiopathic weight loss being the most common symptoms. Several pharmacological therapies have emerged in recent years, but the clinical use of cannabis extracts in older patients with AD is constantly growing. This retrospective, analytical, observational, spontaneous trial aimed to enhance the clinical action of THC: CBD cannabis extract administration in AD patients with severe symptoms such as agitation, weight loss, cognitive impairment, and sleep disturbance.</AbstractText><AbstractText Label="METHODS">Thirty patients (9 men and 21 women) diagnosed with mild, moderate, or severe AD, aged 65-90 years, appealing to our Second Opinion Medical Consultation (Modena, Italy), were enrolled and required to use oil-diluted cannabis extract, Bedrocan&#xae; (22% THC, 0.5% CBD, Olive Oil 50 ml), twice a day for 12 weeks. The efficacy of cannabinoid therapy was evaluated at baseline and 12 weeks after therapy, employing three self-administered questionnaires completed by the parents of the enrolled patients: NPI-Q, CMAI, and MMSE.</AbstractText><AbstractText Label="KEY FINDINGS">The NPI-Q demonstrated a reduction (p&lt;0.0001) in agitation, apathy, irritability, sleep disturbances, and eating disturbances, consequently improving caregiver distress. Levels of physically and verbally aggressive behaviours, measured using the CMAI questionnaire, were lower (p&lt;0.0001) in all patients. The MMSSE questionnaire confirmed a significant decrease (p&lt;0.0001) in cognitive impairment in 45% of the patients.</AbstractText><AbstractText Label="CONCLUSION">Our anecdotical, spontaneous, and observational study demonstrated the efficacy and safety of oil-diluted cannabis extract in patients with AD. The limitations of our study are: 1) small patient cohort, 2) absence of control group, 3) self-administered questionnaires that are the most practical but not objective instruments to assess the neurologic functions of AD patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Palmieri</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Second Opinion Medical Network, Modena (MO), Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Surgery and Surgical Specialties, University of Modena and Reggio Emilia, Modena (MO), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vadal&#xe0;</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Second Opinion Medical Network, Modena (MO), Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Clin Ter</MedlineTA><NlmUniqueID>0372604</NlmUniqueID><ISSNLinking>0009-9074</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002186">Cannabinoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002188" MajorTopicYN="Y">Cannabis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002186" MajorTopicYN="Y">Cannabinoids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AD</Keyword><Keyword MajorTopicYN="N">Alzheimer disease</Keyword><Keyword MajorTopicYN="N">Bedrocan&#xae;</Keyword><Keyword MajorTopicYN="N">CBD</Keyword><Keyword MajorTopicYN="N">THC</Keyword><Keyword MajorTopicYN="N">agitation</Keyword><Keyword MajorTopicYN="N">cannabis</Keyword><Keyword MajorTopicYN="N">extract</Keyword><Keyword MajorTopicYN="N">galenical preparation</Keyword><Keyword MajorTopicYN="N">oil</Keyword><Keyword MajorTopicYN="N">weight loss</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36655645</ArticleId><ArticleId IdType="doi">10.7417/CT.2023.5009</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36655568</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-2684</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Dementia (London, England)</Title><ISOAbbreviation>Dementia (London)</ISOAbbreviation></Journal><ArticleTitle><i>iSupport-Brasil</i>: Cross-cultural adaptation of the content included in the iSupport program for caregivers of people who have dementia.</ArticleTitle><Pagination><StartPage>533</StartPage><EndPage>549</EndPage><MedlinePgn>533-549</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/14713012231152555</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Examine the process of culturally adapting the content of the World Health Organization iSupport program for family caregivers of people living with dementia in Brazil.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">This is a multicenter and methodological study to cross-culturally adapt the iSupport program. Initially, the content of the iSupport program was translated into Brazilian Portuguese by professional translator trained in Psychology, with mastery of the original language of the content (English). Focus groups were then held with caregivers/former caregivers of people who have dementia (<i>n</i> = 24) and health professionals specialized in aging (<i>n</i> = 24). The participants had access to part of the iSupport material for analysis purposes. Semi-structured interviews were conducted between June and September 2019. All the interviews were recorded and transcribed in full for subsequent analysis. All the ethical aspects were respected.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The translator implemented some cross-cultural adaptations, such as substituting 69 proper names used in the original version by names of different Brazilian regions. In relation to the analysis of the material and comments from the focus groups, in general, all the participants had positive opinions about the material included in iSupport. Some changes were suggested in relation to the terminology and examples given in the modules to better fit the Brazilian culture and health systems, and links to relevant pages of the local Alzheimer's association were included. All the linguistic and cultural adaptations proposed were systematically documented and duly justified in structured forms provided by the World Health Organization, which approved all of them after verification of fidelity.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The product of this research is the first version of the <i>iSupport-Brasil</i> program and the inclusion of its content in a digital platform. For the most part, the content offered in iSupport proved to be an important online tool to provide support and diverse information to the caregivers of people who have dementia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Monteiro</LastName><ForeName>Diana Q</ForeName><Initials>DQ</Initials><Identifier Source="ORCID">0000-0002-3130-4096</Identifier><AffiliationInfo><Affiliation>Department of Gerontology, 67828Universidade Federal de S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ottaviani</LastName><ForeName>Ana C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0003-4037-4587</Identifier><AffiliationInfo><Affiliation>Department of Gerontology, 67828Universidade Federal de S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campos</LastName><ForeName>Camila R F</ForeName><Initials>CRF</Initials><Identifier Source="ORCID">0000-0001-8700-153X</Identifier><AffiliationInfo><Affiliation>Postgraduate Programme in Psychology, 67828Universidade Federal de S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barham</LastName><ForeName>Elizabeth J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0002-7270-4918</Identifier><AffiliationInfo><Affiliation>Postgraduate Programme in Psychology, 67828Universidade Federal de S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil; Department of Psychology, 67828Universidade Federal de S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>D&#xe9;borah</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-6616-533X</Identifier><AffiliationInfo><Affiliation>Universidad Andr&#xe9;s Bello, Faculty of Nursing, Campus Vi&#xf1;a del Mar, Vi&#xf1;a del Mar, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Millennium Institute for Care Research, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, School of Medicine, 58804Universidade Federal de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Cruz</LastName><ForeName>Keila C T</ForeName><Initials>KCT</Initials><Identifier Source="ORCID">0000-0001-8146-8323</Identifier><AffiliationInfo><Affiliation>Department of Nursing, Faculty of Health Sciences, 28127Universidade de Bras&#xed;lia, Bras&#xed;lia, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavarini</LastName><ForeName>Sofia C I</ForeName><Initials>SCI</Initials><Identifier Source="ORCID">0000-0001-9359-8600</Identifier><AffiliationInfo><Affiliation>Department of Gerontology, 67828Universidade Federal de S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil; Postgraduate Programme in Nursing, 67828Universidade Federal de S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Souza Orlandi</LastName><ForeName>Fabiana</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-5714-6890</Identifier><AffiliationInfo><Affiliation>Department of Gerontology, 67828Universidade Federal de S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil; Postgraduate Programme in Nursing, 67828Universidade Federal de S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zazzetta</LastName><ForeName>Marisa S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0001-6544-767X</Identifier><AffiliationInfo><Affiliation>Department of Gerontology, 67828Universidade Federal de S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil; Postgraduate Programme in Nursing, 67828Universidade Federal de S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacinto</LastName><ForeName>Alessandro F</ForeName><Initials>AF</Initials><Identifier Source="ORCID">0000-0002-1977-5880</Identifier><AffiliationInfo><Affiliation>Postgraduate Program in Translational Medicine, Department of Medicine, 58804Universidade Federal de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corr&#xea;a</LastName><ForeName>Larissa</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4596-4845</Identifier><AffiliationInfo><Affiliation>Postgraduate Programme in Nursing, 67828Universidade Federal de S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grat&#xe3;o</LastName><ForeName>Aline C M</ForeName><Initials>ACM</Initials><Identifier Source="ORCID">0000-0002-8508-0251</Identifier><AffiliationInfo><Affiliation>Department of Gerontology, 67828Universidade Federal de S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil; Postgraduate Programme in Nursing, 67828Universidade Federal de S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Dementia (London)</MedlineTA><NlmUniqueID>101128698</NlmUniqueID><ISSNLinking>1471-3012</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003431" MajorTopicYN="N">Cross-Cultural Comparison</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">caregivers</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">internet-based intervention</Keyword><Keyword MajorTopicYN="N">older adult</Keyword><Keyword MajorTopicYN="N">translation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>19</Day><Hour>5</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36655568</ArticleId><ArticleId IdType="doi">10.1177/14713012231152555</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36655345</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1364-6915</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>Aging &amp; mental health</Title><ISOAbbreviation>Aging Ment Health</ISOAbbreviation></Journal><ArticleTitle>The Positive Aspects of Caregiving Scale can be shortened to six items: application of item response theory.</ArticleTitle><Pagination><StartPage>1929</StartPage><EndPage>1937</EndPage><MedlinePgn>1929-1937</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/13607863.2023.2165622</ELocationID><Abstract><AbstractText Label="OBJECTIVE">For nearly two decades, with one exception, researchers have used the Positive Aspects of Caregiving Scale (PACS) without a close examination of how the items behave. This study examined PACS' measurement model and item response characteristics, including differential item functioning (DIF) by race.</AbstractText><AbstractText Label="METHODS">Item response theory was used to analyze the baseline data of the Resources for Enhancing Alzheimer's Caregiver Health (REACH) I trial (<i>N</i>&#x2009;=&#x2009;1229). Bifactor confirmatory models were estimated to assess dimensionality, and whether the items behaved differently in African Americans and Hispanics, with Whites serving as the comparison, were examined using the multiple-indicators multiple-causes model.</AbstractText><AbstractText Label="RESULTS">For both 9- and 11-item versions, 1-factor and bifactor solutions supported a unidimensional structure. However, the items performed generally poorly in differentiating levels of the latent construct, especially between moderate and high true scores. Additionally, five items were found to have DIF, which were unrelated to relationship differences among racial groups. While African Americans and Hispanics reported higher positive gains than Whites, their differences were accentuated by the DIF items as a whole. A 6-item version called PACS-II was created by removing the DIF items. Besides reducing estimated racial differences, PACS-II removed race-based heterogeneity of variance that was evidenced in the original, longer versions.</AbstractText><AbstractText Label="CONCLUSIONS">Being free of racial bias, PACS-II is preferred over the original versions, though the ceiling effect of measurement (prevalence of extreme scores on the high end) remains to be an issue for improvement.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Sheung-Tak</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Department of Health and Physical Education, The Education University of Hong Kong, Ting Kok, Hong Kong.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Aging Ment Health</MedlineTA><NlmUniqueID>9705773</NlmUniqueID><ISSNLinking>1360-7863</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006630" MajorTopicYN="N">Hispanic or Latino</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="Y">Psychometrics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063505" MajorTopicYN="N">Racism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="Y">Surveys and Questionnaires</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000095223" MajorTopicYN="N">White</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001741" MajorTopicYN="N">Black or African American</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076782" MajorTopicYN="N">Race Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Differential item functioning</Keyword><Keyword MajorTopicYN="N">Ethnic minority</Keyword><Keyword MajorTopicYN="N">Positive aspects of caregiving</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>19</Day><Hour>3</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36655345</ArticleId><ArticleId IdType="doi">10.1080/13607863.2023.2165622</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36650552</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1745-6215</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>17</Day></PubDate></JournalIssue><Title>Trials</Title><ISOAbbreviation>Trials</ISOAbbreviation></Journal><ArticleTitle>The impact of different researchers to capture quality of life measures in a dementia randomised controlled trial.</ArticleTitle><Pagination><StartPage>33</StartPage><MedlinePgn>33</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">33</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13063-022-07064-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Capturing changes in health and wellbeing within randomised controlled trials (RCTs) can be complex. The precision and accuracy of outcome scales to measure change is crucial, and therefore, consideration needs to be given to potential measurement errors when collecting these outcomes. Many RCTs use multiple researchers to collect data, which has the potential to introduce variation in measurements. This study aimed to identify if there was a measurable effect of using different researchers to collect repeated assessments of quality of life (QoL) at different time points.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A previously conducted study assessing the impact of reminiscence therapy on participants with dementia and carer (PwD-carer) dyads, 'REMCARE' (Reminiscence groups for people with dementia and their family caregivers), provided the platform for this exploratory secondary analysis. Data was categorised into two broad groups: those where the same researcher attended all assessments and those where different researchers undertook the assessments. ANCOVA (analysis of covariance) models used in the original REMCARE analysis with the addition of the 'researcher-continuity' variable were run on two QoL measures, the QoL-AD (Quality of Life in Alzheimer's Disease) and QCPR (Quality of the Caregiving Relationship).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Three hundred thirty PwD-carer dyads were included in the analysis. For the PwD, a statistically significant effect was found on the researcher continuity variable for the QoL-AD and QCPR outcome measures at follow-up 1 but not at follow-up 2 signifying an impact of researcher attendance at the first follow-up but not follow-up 2. For the carer data, analyses revealed no statistically significant effects at follow-up 1; however, the QoL-AD measure at follow-up 2 was found to be statistically significant.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These exploratory results indicate the possible impact of researcher continuity on QoL outcomes in dementia studies. Further research is required to explore this further and establish causality. If demonstrated, this would have implications for the planning of future empirical studies in dementia, in order to reduce this potential source of bias.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0960-9843</Identifier><AffiliationInfo><Affiliation>NWORTH Clinical Trials Unit, Bangor University, Holyhead Road, Bangor, Gwynedd, LL57 2PZ, UK. r.evans@bangor.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brocklehurst</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>NWORTH Clinical Trials Unit, Bangor University, Holyhead Road, Bangor, Gwynedd, LL57 2PZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>NWORTH Clinical Trials Unit, Bangor University, Holyhead Road, Bangor, Gwynedd, LL57 2PZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoare</LastName><ForeName>Zo&#xeb;</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>NWORTH Clinical Trials Unit, Bangor University, Holyhead Road, Bangor, Gwynedd, LL57 2PZ, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trials</MedlineTA><NlmUniqueID>101263253</NlmUniqueID><ISSNLinking>1745-6215</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008568" MajorTopicYN="N">Memory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bias</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Outcome measurement</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">Randomised controlled trial</Keyword><Keyword MajorTopicYN="N">Researcher continuity</Keyword><Keyword MajorTopicYN="N">Researcher effect</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>17</Day><Hour>23</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36650552</ArticleId><ArticleId IdType="pmc">PMC9843939</ArticleId><ArticleId IdType="doi">10.1186/s13063-022-07064-4</ArticleId><ArticleId IdType="pii">10.1186/s13063-022-07064-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Association, A. P . Diagnostic and Statistical Manual of Mental Disorders (DSM-5&#xae;) American Psychiatric Publishing; 2013.</Citation></Reference><Reference><Citation>Banerjee S, Samsi K, Petrie CD, Alvir J, Treglia M, Schwam EM, del Valle M. What do we know about quality of life in dementia? A review of the emerging evidence on the predictive and explanatory value of disease specific measures of health related quality of life in people with dementia. Int J Geriatric Psychiatry. 2009;24(1):15&#x2013;24. doi: 10.1002/gps.2090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.2090</ArticleId><ArticleId IdType="pubmed">18727132</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell K, Fahmy E, Gordon D. Quantitative conversations: the importance of developing rapport in standardised interviewing. Qual Quant. 2016;50(1):193&#x2013;212. doi: 10.1007/s11135-014-0144-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11135-014-0144-2</ArticleId><ArticleId IdType="pmc">PMC4705135</ArticleId><ArticleId IdType="pubmed">26792949</ArticleId></ArticleIdList></Reference><Reference><Citation>Corp IBM. IBM SPSS Statistics for Windows, Version 25.0. Armonk: IBM Corp; 2017.</Citation></Reference><Reference><Citation>Davis RE, Couper MP, Janz NK, Caldwell CH, Resnicow K. Interviewer effects in public health surveys. Health Educ Res. 2010;25(1):14&#x2013;26. doi: 10.1093/her/cyp046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/her/cyp046</ArticleId><ArticleId IdType="pmc">PMC2805402</ArticleId><ArticleId IdType="pubmed">19762354</ArticleId></ArticleIdList></Reference><Reference><Citation>Doody O, Noonan M. Preparing and conducting interviews to collect data. Nurs Res. 2013;20(5):28&#x2013;32. doi: 10.7748/nr2013.05.20.5.28.e327.</Citation><ArticleIdList><ArticleId IdType="doi">10.7748/nr2013.05.20.5.28.e327</ArticleId><ArticleId IdType="pubmed">23687846</ArticleId></ArticleIdList></Reference><Reference><Citation>Dow J, Robinson J, Robalino S, Finch T, McColl E, Robinson L. How best to assess quality of life in informal carers of people with dementia; a systematic review of existing outcome measures. PLoS One. 2018;13(3):e0193398. doi: 10.1371/journal.pone.0193398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0193398</ArticleId><ArticleId IdType="pmc">PMC5851581</ArticleId><ArticleId IdType="pubmed">29538433</ArticleId></ArticleIdList></Reference><Reference><Citation>Ettema TP, Droes R-M, Lange JD, Mellenbergh GJ, Ribbe MW. A review of quality of life instruments used in dementia. Qual Life Res. 2005;14(3):675&#x2013;686. doi: 10.1007/s11136-004-1258-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-004-1258-0</ArticleId><ArticleId IdType="pubmed">16022061</ArticleId></ArticleIdList></Reference><Reference><Citation>Facts for the media. (n.d.). Alzheimer&#x2019;s Society. Retrieved 29 March 2020, from https://www.alzheimers.org.uk/about-us/news-and-media/facts-media</Citation></Reference><Reference><Citation>Grace-Martin K. ANCOVA Assumptions: When Slopes are Unequal. The Analysis Factor. 2013.</Citation></Reference><Reference><Citation>Gr&#xe4;ske J, Schmidt A, Schmidt S, Laporte Uribe F, Thyrian JR, Michalowsky B, Sch&#xe4;fer-Walkmann S, Wolf-Ostermann K. Quality of life in persons with dementia using regional dementia care network services in Germany: a one-year follow-up study. Health Qual Life Outcomes. 2018;16(1):181. doi: 10.1186/s12955-018-0990-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-018-0990-z</ArticleId><ArticleId IdType="pmc">PMC6137910</ArticleId><ArticleId IdType="pubmed">30217190</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillemin M, Heggen K. Rapport and respect: negotiating ethical relations between researcher and participant. Med Health Care Philos. 2009;12(3):291&#x2013;299. doi: 10.1007/s11019-008-9165-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11019-008-9165-8</ArticleId><ArticleId IdType="pubmed">18853283</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill RJ, Hall NE. A note on rapport and the quality of interview data. Southwestern Soc Sci Quart. 1963;44(3):247&#x2013;255.</Citation></Reference><Reference><Citation>Hoe J, Hancock G, Livingston G, Woods B, Challis D, Orrell M. Changes in the quality of life of people with dementia living in care homes. Alzheimer Dis Assoc Disord. 2009;23(3):285&#x2013;290. doi: 10.1097/WAD.0b013e318194fc1e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0b013e318194fc1e</ArticleId><ArticleId IdType="pmc">PMC2759656</ArticleId><ArticleId IdType="pubmed">19812472</ArticleId></ArticleIdList></Reference><Reference><Citation>How dementia progresses. (n.d.). Alzheimer&#x2019;s Society. Retrieved 31 March 2020, from https://www.alzheimers.org.uk/about-dementia/symptoms-and-diagnosis/how-dementia-progresses</Citation></Reference><Reference><Citation>Kobak K. Inaccuracy in clinical trials: effects and methods to control inaccuracy. Curr Alzheimer Res. 2010;7(7):637&#x2013;641. doi: 10.2174/156720510793499057.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720510793499057</ArticleId><ArticleId IdType="pubmed">20704557</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis F, Schaffer SK, Sussex J, O&#x2019;Neill P, Cockcroft L. The Trajectory of Dementia in the UK - Making a Difference. 2014. p. 62.</Citation></Reference><Reference><Citation>Logsdon RG, Gibbons LE, McCurry SM, Teri L. Quality of life in Alzheimer&#x2019;s disease: Patient and caregiver reports. J Mental Health Aging. 1999;5(1):21&#x2013;32.</Citation></Reference><Reference><Citation>Lyketsos CG, Gonzales-Salvador T, Chin JJ, Baker A, Black B, Rabins P. A follow-up study of change in quality of life among persons with dementia residing in a long-term care facility. Int J Geriatric Psychiatry. 2003;18(4):275&#x2013;281. doi: 10.1002/gps.796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.796</ArticleId><ArticleId IdType="pubmed">12673600</ArticleId></ArticleIdList></Reference><Reference><Citation>Naglie G. Quality of life in dementia. Can J Neurol Sci. 2007;34(S1):S57&#x2013;S61. doi: 10.1017/S0317167100005588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0317167100005588</ArticleId><ArticleId IdType="pubmed">17469684</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannucci CJ, Wilkins EG. Identifying and avoiding bias in research. Plastic Reconstruct Surg. 2010;126(2):619&#x2013;625. doi: 10.1097/PRS.0b013e3181de24bc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PRS.0b013e3181de24bc</ArticleId><ArticleId IdType="pmc">PMC2917255</ArticleId><ArticleId IdType="pubmed">20679844</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitts MJ, Miller-Day M. Upward turning points and positive rapport-development across time in researcher&#x2014;participant relationships. Qual Res. 2007;7(2):177&#x2013;201. doi: 10.1177/1468794107071409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1468794107071409</ArticleId></ArticleIdList></Reference><Reference><Citation>Quality Of Life. (n.d.). Lexico Dictionaries | English. Retrieved 30 March 2020, from https://www.lexico.com/definition/quality_of_life</Citation></Reference><Reference><Citation>Ready RE, Ott BR. Quality of life measures for dementia. Health Qual Life Outcomes. 2003;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC155631</ArticleId><ArticleId IdType="pubmed">12740036</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheffer J. Dealing with missing data. Research Letters in the Information and Mathematical Sciences. 2002;3:153&#x2013;60.</Citation></Reference><Reference><Citation>Spruytte N, Audenhove C, Lammertyn F, Storms G. The quality of the caregiving relationship in informal care for older adults with dementia and chronic psychiatric patients. Psychol Psychother. 2002;75(3):295&#x2013;311. doi: 10.1348/147608302320365208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1348/147608302320365208</ArticleId><ArticleId IdType="pubmed">12396755</ArticleId></ArticleIdList></Reference><Reference><Citation>Streiner DL. Health Measurement Scales. OUP Oxford; 2008.</Citation></Reference><Reference><Citation>Treweek S, Bevan S, Bower P, Campbell M, Christie J, Clarke M, Collett C, Cotton S, Devane D, El Feky A, Flemyng E, Galvin S, Gardner H, Gillies K, Jansen J, Littleford R, Parker A, Ramsay C, Restrup L, Williamson PR. Trial Forge Guidance 1: What is a Study Within A Trial (SWAT)? Trials. 2018;19(1):139. doi: 10.1186/s13063-018-2535-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-018-2535-5</ArticleId><ArticleId IdType="pmc">PMC5824570</ArticleId><ArticleId IdType="pubmed">29475444</ArticleId></ArticleIdList></Reference><Reference><Citation>West BT, Blom AG. Explaining interviewer effects: a research synthesis. J Survey Stat Methodol. 2016;smw024. 10.1093/jssam/smw024.</Citation></Reference><Reference><Citation>Woods B, Thorgrimsen L, Spector A, Royan L, Orrell M. Improved quality of life and cognitive stimulation therapy in dementia. Aging Mental Health. 2006;10(3):219&#x2013;226. doi: 10.1080/13607860500431652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607860500431652</ArticleId><ArticleId IdType="pubmed">16777649</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods R, Bruce E, Edwards R, Elvish R, Hoare Z, Hounsome B, et al. REMCARE: Reminiscence groups for people with dementia and their family caregivers &#x2013; effectiveness and cost-effectiveness pragmatic multicentre randomised trial. Health Technol Assess. 2012;16(48). 10.3310/hta16480.</Citation><ArticleIdList><ArticleId IdType="pubmed">23211271</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation . Global action plan on the public health response to dementia 2017&#x2014;2025. WHO; 2017. p. 52.</Citation></Reference><Reference><Citation>Wu Y-T, Fratiglioni L, Matthews FE, Lobo A, Breteler MMB, Skoog I, Brayne C. Dementia in western Europe: Epidemiological evidence and implications for policy making. Lancet Neurol. 2016;15(1):116&#x2013;124. doi: 10.1016/S1474-4422(15)00092-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)00092-7</ArticleId><ArticleId IdType="pubmed">26300044</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36648146</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-5279</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</Title><ISOAbbreviation>Alzheimers Dement</ISOAbbreviation></Journal><ArticleTitle>Catalyzing dementia care through the learning health system and consumer health information technology.</ArticleTitle><Pagination><StartPage>2197</StartPage><EndPage>2207</EndPage><MedlinePgn>2197-2207</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/alz.12918</ELocationID><Abstract><AbstractText>To advance care for persons with Alzheimer's disease and related dementias (ADRD), real-world health system effectiveness research must actively engage those affected to understand what works, for whom, in what setting, and for how long-an agenda central to learning health system (LHS) principles. This perspective discusses how emerging payment models, quality improvement initiatives, and population health strategies present opportunities to embed best practice principles of ADRD care within the LHS. We discuss how stakeholder engagement in an ADRD LHS when embedding, adapting, and refining prototypes can ensure that products are viable when implemented. Finally, we highlight the promise of consumer-oriented health information technologies in supporting persons living with ADRD and their care partners and delivering embedded ADRD interventions at scale. We aim to stimulate progress toward sustainable infrastructure paired with person- and family-facing innovations that catalyze broader transformation of ADRD care.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Alzheimer's &amp; Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wolff</LastName><ForeName>Jennifer L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-7898-3903</Identifier><AffiliationInfo><Affiliation>Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DesRoches</LastName><ForeName>Catherine M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>OpenNotes/Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amjad</LastName><ForeName>Halima</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burgdorf</LastName><ForeName>Julia G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Center for Home Care Policy &amp; Research, Visiting Nurse Service of New York, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caffrey</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Springer Science+Business Media LLC, Oracle Magazine, Computer Technology and Applications Program, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabius</LastName><ForeName>Chanee D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gleason</LastName><ForeName>Kelly T</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Johns Hopkins University School of Nursing, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Ariel R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chen-Tan</ForeName><Initials>CT</Initials><Identifier Source="ORCID">0000-0002-8678-7945</Identifier><AffiliationInfo><Affiliation>University of Colorado, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nothelle</LastName><ForeName>Stephanie K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peereboom</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>Danielle S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riffin</LastName><ForeName>Catherine A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Division of Geriatrics and Palliative Medicine, Weill Cornell Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lum</LastName><ForeName>Hillary D</ForeName><Initials>HD</Initials><AffiliationInfo><Affiliation>Division of Geriatric Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 AG072310</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 AG063546</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 AG060170</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066587</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG077011</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AG064036</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 AG061275</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AG072037</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AG066576</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Alzheimers Dement</MedlineTA><NlmUniqueID>101231978</NlmUniqueID><ISSNLinking>1552-5260</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000080891" MajorTopicYN="Y">Learning Health System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058996" MajorTopicYN="N">Quality Improvement</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">health equity</Keyword><Keyword MajorTopicYN="N">implementation science</Keyword><Keyword MajorTopicYN="N">learning health system</Keyword><Keyword MajorTopicYN="N">patient portal</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>17</Day><Hour>8</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36648146</ArticleId><ArticleId IdType="mid">NIHMS1861011</ArticleId><ArticleId IdType="pmc">PMC10182243</ArticleId><ArticleId IdType="doi">10.1002/alz.12918</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Association As. 2022 Alzheimer&#x2019;s disease facts and figures. Alzheimer's &amp; dementia : the journal of the Alzheimer's Association. 2022. doi:10.1002/alz.12638 2022. https://alz-journals.onlinelibrary.wiley.com/doi/epdf/10.1002/alz.12638</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12638</ArticleId><ArticleId IdType="doi">10.1002/alz.12638</ArticleId><ArticleId IdType="pubmed">35289055</ArticleId></ArticleIdList></Reference><Reference><Citation>NASEM. Meeting the challenge of caring for persons living with dementia and their care partners and caregivers: a way forward. National Academies Press; 2021. Accessed 5/1/2021. https://www.nap.edu/catalog/26026/meeting-the-challenge-of-caring-for-persons-living-with-dementia-and-their-care-partners-and-caregivers</Citation><ArticleIdList><ArticleId IdType="pubmed">33625814</ArticleId></ArticleIdList></Reference><Reference><Citation>Amjad H, Roth DL, Sheehan OC, Lyketsos CG, Wolff JL, Samus QM. Underdiagnosis of Dementia: an Observational Study of Patterns in Diagnosis and Awareness in US Older Adults. Journal of general internal medicine. Mar 5 2018;doi:10.1007/s11606-018-4377-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-018-4377-y</ArticleId><ArticleId IdType="pmc">PMC6025653</ArticleId><ArticleId IdType="pubmed">29508259</ArticleId></ArticleIdList></Reference><Reference><Citation>Amjad H, Roth DL, Samus QM, Yasar S, Wolff JL. Potentially Unsafe Activities and Living Conditions of Older Adults with Dementia. Journal of the American Geriatrics Society. Jun 2016;64(6):1223&#x2013;32. doi:10.1111/jgs.14164</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.14164</ArticleId><ArticleId IdType="pmc">PMC4914464</ArticleId><ArticleId IdType="pubmed">27253366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper JD, Freedman VA, Spillman BC, Wolff JL. The disproportionate impact of dementia on family and unpaid caregiving to older adults. Health affairs. 2015;34(10):1642&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4635557</ArticleId><ArticleId IdType="pubmed">26438739</ArticleId></ArticleIdList></Reference><Reference><Citation>NASEM. Families Caring for an Aging America. 2016. https://nam.edu/families-caring-for-an-aging-america/</Citation><ArticleIdList><ArticleId IdType="pubmed">27905704</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff JL, Freedman VA, Mulcahy JF, Kasper JD. Family Caregivers' Experiences With Health Care Workers in the Care of Older Adults With Activity Limitations. JAMA Netw Open. Jan 3 2020;3(1):e1919866. doi:10.1001/jamanetworkopen.2019.19866</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.19866</ArticleId><ArticleId IdType="pmc">PMC6991279</ArticleId><ArticleId IdType="pubmed">31977063</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan CM, Sachs GA, Lamantia MA, Unroe KT, Arling G, Boustani MA. Redesigning systems of care for older adults with Alzheimer's disease. Health affairs. Apr 2014;33(4):626&#x2013;32. doi:10.1377/hlthaff.2013.1260</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2013.1260</ArticleId><ArticleId IdType="pmc">PMC5337406</ArticleId><ArticleId IdType="pubmed">24711324</ArticleId></ArticleIdList></Reference><Reference><Citation>Bott NT, Sheckter CC, Yang D, et al. Systems Delivery Innovation for Alzheimer Disease. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. Feb 2019;27(2):149&#x2013;161. doi:10.1016/j.jagp.2018.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2018.09.015</ArticleId><ArticleId IdType="pmc">PMC6331256</ArticleId><ArticleId IdType="pubmed">30477913</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler M, Gaugler JE. Care interventions for people with dementia (PWD) and their caregivers. 2020.</Citation></Reference><Reference><Citation>NASEM. Reducing the Impact of Dementia in America. National Academy Press; 2021:286. Accessed 8/15/2021. https://www.nap.edu/catalog/26175/reducing-the-impact-of-dementia-in-america-a-decadal-survey</Citation></Reference><Reference><Citation>IOM. Best care at lower cost: the path to continuously learning health care in America. 2013. Accessed 1/15/2022. https://nap.nationalacademies.org/catalog/13444/best-care-at-lower-cost-the-path-to-continuously-learning</Citation><ArticleIdList><ArticleId IdType="pubmed">24901184</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilmore-Bykovskyi AL, Jin Y, Gleason C, et al. Recruitment and retention of underrepresented populations in Alzheimer's disease research: A systematic review. Alzheimers Dement (N Y). 2019;5:751&#x2013;770. doi:10.1016/j.trci.2019.09.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2019.09.018</ArticleId><ArticleId IdType="pmc">PMC6944728</ArticleId><ArticleId IdType="pubmed">31921966</ArticleId></ArticleIdList></Reference><Reference><Citation>NQF. Priority setting for health care performance measurement: Addressing performance measure gaps for dementia, including Alzheimer's Disease. 2014. October
15, 2014. http://www.qualityforum.org/priority_setting_for_healthcare_performance_measurement_alzheimers_disease.aspx</Citation></Reference><Reference><Citation>Reuben D, Levin J, Frank J, et al. Closing the dementia care gap: Can referral to Alzheimer's Association chapters help? Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review. Alzheimer's &amp; dementia : the journal of the Alzheimer's Association. Nov 2009;5(6):498&#x2013;502. doi:10.1016/j.jalz.2009.01.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2009.01.024</ArticleId><ArticleId IdType="pmc">PMC3688281</ArticleId><ArticleId IdType="pubmed">19896589</ArticleId></ArticleIdList></Reference><Reference><Citation>Riffin C, Griffin JM, Brody L, et al. Engaging and Supporting Care Partners of Persons With Dementia in Health-Care Delivery: Results From a National Consensus Conference. Public Policy Aging Rep. 2022;32(2):58&#x2013;65. doi:10.1093/ppar/prac004</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ppar/prac004</ArticleId><ArticleId IdType="pmc">PMC9118070</ArticleId><ArticleId IdType="pubmed">35607366</ArticleId></ArticleIdList></Reference><Reference><Citation>Riffin C, Wolff JL, Estill M, Prabhu S, Pillemer KA. Caregiver Needs Assessment in Primary Care: Views of Clinicians, Staff, Patients, and Caregivers. Journal of the American Geriatrics Society. Mar 13 2020;doi:10.1111/jgs.16401</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16401</ArticleId><ArticleId IdType="pmc">PMC7325837</ArticleId><ArticleId IdType="pubmed">32167573</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgdorf J, Roth DL, Riffin C, Wolff JL. Factors Associated with Receipt of Training Among Caregivers of Older Adults. JAMA internal medicine. Apr 8 2019;179(6):833&#x2013;835. doi:10.1001/jamainternmed.2018.8694</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2018.8694</ArticleId><ArticleId IdType="pmc">PMC6547146</ArticleId><ArticleId IdType="pubmed">30958503</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgdorf JG, Arbaje AI, Stuart EA, Wolff JL. Unmet family caregiver training needs associated with acute care utilization during home health care. Journal of the American Geriatrics Society. Jul 2021;69(7):1887&#x2013;1895. doi:10.1111/jgs.17138</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17138</ArticleId><ArticleId IdType="pmc">PMC8273145</ArticleId><ArticleId IdType="pubmed">33772759</ArticleId></ArticleIdList></Reference><Reference><Citation>Amjad H, Mulcahy J, Kasper JD, et al. Do Caregiving Factors Affect Hospitalization Risk Among Disabled Older Adults? Journal of the American Geriatrics Society. Jan 2021;69(1):129&#x2013;139. doi:10.1111/jgs.16817</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16817</ArticleId><ArticleId IdType="pmc">PMC7856284</ArticleId><ArticleId IdType="pubmed">32964422</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgdorf JG, Fabius CD, Riffin C, Wolff JL. Receipt of Posthospitalization Care Training Among Medicare Beneficiaries' Family Caregivers. JAMA Netw Open. Mar 1 2021;4(3):e211806. doi:10.1001/jamanetworkopen.2021.1806</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.1806</ArticleId><ArticleId IdType="pmc">PMC7967076</ArticleId><ArticleId IdType="pubmed">33724393</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene SM, Reid RJ, Larson EB. Implementing the learning health system: from concept to action. Research Support, Non-U.S. Gov't. Annals of internal medicine. Aug 7 2012;157(3):207&#x2013;10. doi:10.7326/0003-4819-157-3-201208070-00012</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-157-3-201208070-00012</ArticleId><ArticleId IdType="pubmed">22868839</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuben DB, Evertson LC, Wenger NS, et al. The University of California at Los Angeles Alzheimer's and Dementia Care program for comprehensive, coordinated, patient-centered care: preliminary data. Journal of the American Geriatrics Society. Dec 2013;61(12):2214&#x2013;2218. doi:10.1111/jgs.12562</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.12562</ArticleId><ArticleId IdType="pmc">PMC3889469</ArticleId><ArticleId IdType="pubmed">24329821</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollister BA, Yeh J, Ross L, Schlesinger J, Cherry D. Building an advocacy model to improve the dementia-capability of health plans in California. Journal of the American Geriatrics Society. Dec 2021;69(12):3641&#x2013;3649. doi:10.1111/jgs.17429</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17429</ArticleId><ArticleId IdType="pubmed">34476815</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuzzio L, Hanson LR, Reuben DB, et al. Transforming Dementia Care Through Pragmatic Clinical Trials Embedded in Learning Healthcare Systems. Journal of the American Geriatrics Society. Jul 2020;68 Suppl 2:S43&#x2013;S48. doi:10.1111/jgs.16629</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16629</ArticleId><ArticleId IdType="pmc">PMC7419336</ArticleId><ArticleId IdType="pubmed">32589283</ArticleId></ArticleIdList></Reference><Reference><Citation>Lees Haggerty K, Epstein-Lubow G, Spragens LH, et al. Recommendations to Improve Payment Policies for Comprehensive Dementia Care. Journal of the American Geriatrics Society. Nov 2020;68(11):2478&#x2013;2485. doi:10.1111/jgs.16807</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16807</ArticleId><ArticleId IdType="pubmed">32975812</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal SD, Basu S, Landon BE. The Underuse of Medicare's Prevention and Coordination Codes in Primary Care : A Cross-Sectional and Modeling Study. Annals of internal medicine. Jun 28 2022;doi:10.7326/M21-4770</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-4770</ArticleId><ArticleId IdType="pmc">PMC9933078</ArticleId><ArticleId IdType="pubmed">35759760</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz SK, Llorente MD, Sanders AE, et al. Quality Improvement in Dementia Care: Dementia Management Quality Measurement Set 2018 Implementation Update. Am J Psychiatry. Feb 1 2020;177(2):175&#x2013;181. doi:10.1176/appi.ajp.2019.19121290</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2019.19121290</ArticleId><ArticleId IdType="pubmed">32008398</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes DE, Zhou J, Walker RL, et al. Development and Validation of eRADAR: A Tool Using EHR Data to Detect Unrecognized Dementia. Journal of the American Geriatrics Society. Jan 2020;68(1):103&#x2013;111. doi:10.1111/jgs.16182</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16182</ArticleId><ArticleId IdType="pmc">PMC7094818</ArticleId><ArticleId IdType="pubmed">31612463</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuben DB, Hackbarth AS, Wenger NS, Tan ZS, Jennings LA. An Automated Approach to Identifying Patients with Dementia Using Electronic Medical Records. Journal of the American Geriatrics Society. Mar 2017;65(3):658&#x2013;659. doi:10.1111/jgs.14744</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.14744</ArticleId><ArticleId IdType="pubmed">28152164</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayton DR, Gardam ML, Pritchard EK, et al. Patient-Reported Outcome Measures to Inform Care of People With Dementia-A Systematic Scoping Review. The Gerontologist. Jul 13 2021;61(5):e185&#x2013;e194. doi:10.1093/geront/gnz179</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnz179</ArticleId><ArticleId IdType="pubmed">32369109</ArticleId></ArticleIdList></Reference><Reference><Citation>Riffin C, Wolff JL, Pillemer KA. Assessing and Addressing Family Caregivers' Needs and Risks in Primary Care. Journal of the American Geriatrics Society. Nov 20 2020;doi:10.1111/jgs.16945</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16945</ArticleId><ArticleId IdType="pmc">PMC8062767</ArticleId><ArticleId IdType="pubmed">33217776</ArticleId></ArticleIdList></Reference><Reference><Citation>Vick J, Amjad H, Smith KC, et al. "Let him speak:" A descriptive qualitative study of the roles and behaviors of family companions in primary care visits among older adults with cognitive impairment. International journal of geriatric psychiatry. 2018;33(1):e103&#x2013;e112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5862540</ArticleId><ArticleId IdType="pubmed">28585721</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunsaker AE, Schmidt K, Lingler JH. Discussing dementia-related behaviors during medical visits for people with Alzheimer's disease. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't. American journal of Alzheimer's disease and other dementias. May 2010;25(3):248&#x2013;54. doi:10.1177/1533317509357734</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317509357734</ArticleId><ArticleId IdType="pmc">PMC3055741</ArticleId><ArticleId IdType="pubmed">20147601</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford A, Upchurch C, Bass D, et al. Knowledge of documented dementia diagnosis and treatment in veterans and their caregivers. Comparative Study Research Support, Non-U.S. Gov't. American journal of Alzheimer's disease and other dementias. Mar 2011;26(2):127&#x2013;33. doi:10.1177/1533317510394648</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317510394648</ArticleId><ArticleId IdType="pmc">PMC10845555</ArticleId><ArticleId IdType="pubmed">21273206</ArticleId></ArticleIdList></Reference><Reference><Citation>Haikio K, Sagbakken M, Rugkasa J. Dementia and patient safety in the community: a qualitative study of family carers' protective practices and implications for services. BMC health services research. Sep 5 2019;19(1):635. doi:10.1186/s12913-019-4478-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-019-4478-2</ArticleId><ArticleId IdType="pmc">PMC6728989</ArticleId><ArticleId IdType="pubmed">31488131</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings LA, Reuben DB, Evertson LC, et al. Unmet needs of caregivers of individuals referred to a dementia care program. Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S. Journal of the American Geriatrics Society. Feb 2015;63(2):282&#x2013;9. doi:10.1111/jgs.13251</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.13251</ArticleId><ArticleId IdType="pmc">PMC4332558</ArticleId><ArticleId IdType="pubmed">25688604</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds TL, Ali N, Zheng K. What Do Patients and Caregivers Want? A Systematic Review of User Suggestions to Improve Patient Portals. AMIA Annu Symp Proc. 2020;2020:1070&#x2013;1079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075519</ArticleId><ArticleId IdType="pubmed">33936483</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonio MG, Petrovskaya O, Lau F. The State of Evidence in Patient Portals: Umbrella Review. Journal of medical Internet research. Nov 11 2020;22(11):e23851. doi:10.2196/23851</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/23851</ArticleId><ArticleId IdType="pmc">PMC7688386</ArticleId><ArticleId IdType="pubmed">33174851</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff JL, Dukhanin V, Burgdorf JG, DesRoches CM. Shared Access to Patient Portals for Older Adults: Implications for Privacy and Digital Health Equity. JMIR Aging. 2022;5(2)doi:10.2196/34628</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/34628</ArticleId><ArticleId IdType="pmc">PMC9118085</ArticleId><ArticleId IdType="pubmed">35507405</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum HD, Brungardt A, Jordan SR, et al. Design and Implementation of Patient Portal-Based Advance Care Planning Tools. Journal of pain and symptom management. Jan 2019;57(1):112&#x2013;117 e2. doi:10.1016/j.jpainsymman.2018.10.500</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2018.10.500</ArticleId><ArticleId IdType="pmc">PMC6314208</ArticleId><ArticleId IdType="pubmed">30595147</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V, Lun P, Ehrler F, Puhan MA, Mutsch M. Electronic Patient-Generated Health Data to Facilitate Disease Prevention and Health Promotion: Scoping Review. Journal of medical Internet research. Oct 14 2019;21(10):e13320. doi:10.2196/13320</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/13320</ArticleId><ArticleId IdType="pmc">PMC6914107</ArticleId><ArticleId IdType="pubmed">31613225</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleason KT, Peereboom D, Wec A, Wolff JL. Patient Portals to Support Care Partner Engagement in Adolescent and Adult Populations: Scoping Review JAMA Netw Open. 2022;in press</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9857556</ArticleId><ArticleId IdType="pubmed">36576738</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafir A, Ritchie CS, Garrett SB, et al. "Captive by the Uncertainty"-Experiences with Anticipatory Guidance for People Living with Dementia and Their Caregivers at a Specialty Dementia Clinic. Journal of Alzheimer's disease : JAD. 2022;86(2):787&#x2013;800. doi:10.3233/JAD-215203</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-215203</ArticleId><ArticleId IdType="pmc">PMC9717709</ArticleId><ArticleId IdType="pubmed">35124641</ArticleId></ArticleIdList></Reference><Reference><Citation>Moehead A, DeSouza K, Walsh K, Pit SW. A Web-Based Dementia Education Program and its Application to an Australian Web-Based Dementia Care Competency and Training Network: Integrative Systematic Review. Journal of medical Internet research. Jan 22 2020;22(1):e16808. doi:10.2196/16808</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/16808</ArticleId><ArticleId IdType="pmc">PMC7003124</ArticleId><ArticleId IdType="pubmed">32012077</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai-Seale M, Dillon EC, Yang Y, et al. Physicians' Well-Being Linked To In-Basket Messages Generated By Algorithms In Electronic Health Records. Health affairs. Jul 2019;38(7):1073&#x2013;1078. doi:10.1377/hlthaff.2018.05509</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2018.05509</ArticleId><ArticleId IdType="pubmed">31260371</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis FD, Williams MS, Stametz RA. Geisinger's effort to realize its potential as a learning health system: A progress report. Learn Health Syst. Apr 2021;5(2):e10221. doi:10.1002/lrh2.10221</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lrh2.10221</ArticleId><ArticleId IdType="pmc">PMC8051344</ArticleId><ArticleId IdType="pubmed">33889731</ArticleId></ArticleIdList></Reference><Reference><Citation>Easterling D, Perry AC, Woodside R, Patel T, Gesell SB. Clarifying the concept of a learning health system for healthcare delivery organizations: Implications from a qualitative analysis of the scientific literature. Learn Health Syst. Apr 2022;6(2):e10287. doi:10.1002/lrh2.10287</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lrh2.10287</ArticleId><ArticleId IdType="pmc">PMC9006535</ArticleId><ArticleId IdType="pubmed">35434353</ArticleId></ArticleIdList></Reference><Reference><Citation>Guisado-Fernandez E, Blake C, Mackey L, et al. A Smart Health Platform for Measuring Health and Well-Being Improvement in People With Dementia and Their Informal Caregivers: Usability Study. JMIR Aging. Jul 23 2020;3(2):e15600. doi:10.2196/15600</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/15600</ArticleId><ArticleId IdType="pmc">PMC7413274</ArticleId><ArticleId IdType="pubmed">32706650</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Green BB, Laws R, et al. Pragmatic (trial) informatics: a perspective from the NIH Health Care Systems Research Collaboratory. Journal of the American Medical Informatics Association : JAMIA. Sep 1 2017;24(5):996&#x2013;1001. doi:10.1093/jamia/ocx016</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx016</ArticleId><ArticleId IdType="pmc">PMC6916747</ArticleId><ArticleId IdType="pubmed">28340241</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Hammond WE, Nahm M, et al. Electronic health records based phenotyping in next-generation clinical trials: a perspective from the NIH Health Care Systems Collaboratory. Journal of the American Medical Informatics Association : JAMIA. Dec 2013;20(e2):e226&#x2013;31. doi:10.1136/amiajnl-2013-001926</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-001926</ArticleId><ArticleId IdType="pmc">PMC3861929</ArticleId><ArticleId IdType="pubmed">23956018</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36642866</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1099-1166</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>International journal of geriatric psychiatry</Title><ISOAbbreviation>Int J Geriatr Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Tailoring STrAtegies for RelaTives for Black and South Asian dementia family carers in the United Kingdom: A mixed methods study.</ArticleTitle><Pagination><StartPage>e5868</StartPage><MedlinePgn>e5868</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e5868</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/gps.5868</ELocationID><Abstract><AbstractText Label="OBJECTIVES">We culturally adapted STrAtegies for RelaTives (START), a clinically and cost-effective intervention for dementia family carers, for Black and South Asian families. It had previously been delivered to family carers around the time of diagnosis, when most people with dementia had very mild, mild or moderate dementia.</AbstractText><AbstractText Label="METHODS">We interviewed a maximum variation sample of family carers (phase one; n&#xa0;=&#xa0;15 South Asian; n&#xa0;=&#xa0;11 Black) about what aspect of START, required cultural adaptation, then analysed it thematically using the Cultural Treatment Adaptation Framework then adapted it in English and into Urdu. Facilitators then delivered START individually to carers (phase two; n&#xa0;=&#xa0;13 South Asian; n&#xa0;=&#xa0;8 Black). We assessed acceptability and feasibility through the number of sessions attended, score for fidelity to the intervention and interviewing family carers about their experiences. We used the Hospital Anxiety and Depression Scale. to examine whether immediate changes in family carers' mental health were in line with previous studies.</AbstractText><AbstractText Label="RESULTS">In phase one we made adaptations to peripheral elements of START, clarifying language, increasing illustrative vignettes numbers, emphasising privacy and the facilitator's cultural competence and making images ethnically diverse. In phase two 21 family carers consented to receive the adapted intervention; 12 completed &#x2265;5/8 sessions; four completed fewer sessions and five never started. Baseline HADS score (n&#xa0;=&#xa0;21) was 14.4 (SD&#xa0;=&#xa0;9.8) but for those who we were able to follow up was 12.3 (SD 8.1) and immediately post-intervention was 11.3 (n&#xa0;=&#xa0;10; SD&#xa0;=&#xa0;6.1). Family carers were positive about the adapted START and continued to use elements after the intervention.</AbstractText><AbstractText Label="CONCLUSIONS">Culturally adapted START was acceptable and feasible in South Asian and Black UK-based family carers and changes in mental health were in line with those in the original clinical trial. Our study shows that culturally inclusive START was also acceptable. Changes made in adaptations were relevant to all populations. We now use the adapted version for all family carers irrespective of ethnicity.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. International Journal of Geriatric Psychiatry published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Webster</LastName><ForeName>Lucy</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Psychiatry, UCL, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Health Services Studies, University of Kent, Canterbury, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amador</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Psychiatry, UCL, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rapaport</LastName><ForeName>Penny</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Psychiatry, UCL, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Camden and Islington NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukadam</LastName><ForeName>Naaheed</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-8635-9521</Identifier><AffiliationInfo><Affiliation>Division of Psychiatry, UCL, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Camden and Islington NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sommerlad</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8895-7055</Identifier><AffiliationInfo><Affiliation>Division of Psychiatry, UCL, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Camden and Islington NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Tiffeny</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Psychiatry, UCL, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Javed</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Psychiatry, UCL, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roche</LastName><ForeName>Mo&#xef;se</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0342-9190</Identifier><AffiliationInfo><Affiliation>Division of Psychiatry, UCL, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lord</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Centre for Applied Dementia Studies, University of Bradford, Bradford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bharadia</LastName><ForeName>Trishna</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Patient and Public Representative &amp; Patient Author, Buckinghamshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahman-Amin</LastName><ForeName>Malayka</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Alzheimer's Society, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lang</LastName><ForeName>Iain</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Exeter Medical School, University of Exeter, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Livingston</LastName><ForeName>Gill</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Psychiatry, UCL, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Camden and Islington NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Geriatr Psychiatry</MedlineTA><NlmUniqueID>8710629</NlmUniqueID><ISSNLinking>0885-6230</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044383" MajorTopicYN="N">Black People</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cultural adaption</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">ethnicity</Keyword><Keyword MajorTopicYN="N">family carers</Keyword><Keyword MajorTopicYN="N">mental health</Keyword><Keyword MajorTopicYN="N">psychological intervention</Keyword></KeywordList><CoiStatement>Gill Livingston, Andrew Sommerlad, Naaheed Mukadam and Penny Rapaport are supported by the University College London Hospitals' National Institute for Health Research (NIHR) Biomedical Research Centre (UCLH NIHR BRC). Gill Livingston is supported by the National Institute for Health Research ARC North Thames and as an NIHR senior investigator. Mo&#xef;se Roche is funded by Alzheimer's Society UK (404 AS&#x2010;PhD&#x2010;17b&#x2010;007). The views expressed in this publication are those of the author(s) and not necessarily those of the funders or National Institute for Health Research or the Department of Health and Social Care.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>16</Day><Hour>0</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36642866</ArticleId><ArticleId IdType="pmc">PMC10107806</ArticleId><ArticleId IdType="doi">10.1002/gps.5868</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mahoney R, Regan C, Katona C, Livingston G. Anxiety and depression in family caregivers of people with Alzheimer disease: the LASER&#x2010;AD study. Am J Geriatric Psychiatry. 2005;13(9):795&#x2010;13. 10.1097/00019442-200509000-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00019442-200509000-00008</ArticleId><ArticleId IdType="pubmed">16166409</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper C, Balamurali TB, Livingston G. A systematic review of the prevalence and covariates of anxiety in caregivers of people with dementia. Int Psychogeriatrics. 2007;19(2):175&#x2010;195. 10.1017/s1041610206004297</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610206004297</ArticleId><ArticleId IdType="pubmed">17005068</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston G, Barber J, Rapaport P, et&#xa0;al. Clinical effectiveness of a manual based coping strategy programme (START, STrAtegies for RelaTives) in promoting the mental health of carers of family members with dementia: pragmatic randomised controlled trial. BMJ. 2013;347(oct25 2):f6276. 10.1136/bmj.f6276</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f6276</ArticleId><ArticleId IdType="pmc">PMC3808082</ArticleId><ArticleId IdType="pubmed">24162942</ArticleId></ArticleIdList></Reference><Reference><Citation>Knapp M, King D, Romeo R, et&#xa0;al. Cost effectiveness of a manual based coping strategy programme in promoting the mental health of family carers of people with dementia (the START (STrAtegies for RelaTives) study): a pragmatic randomised controlled trial. BMJ. 2013;347(oct25 2):f6342. 10.1136/bmj.f6342</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f6342</ArticleId><ArticleId IdType="pmc">PMC3808080</ArticleId><ArticleId IdType="pubmed">24162943</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston G, Barber J, Rapaport P, et&#xa0;al. Long&#x2010;term clinical and cost&#x2010;effectiveness of psychological intervention for family carers of people with dementia: a single&#x2010;blind, randomised, controlled trial. Lancet Psychiatr. 2014;1(7):539&#x2010;548. 10.1016/s2215-0366(14)00073-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2215-0366(14)00073-x</ArticleId><ArticleId IdType="pubmed">26361313</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston GM, O'Keeffe M, Rapaport A. Clinical effectiveness of START (STrAtegies for RelaTives) psychological intervention for family carers and the effects on cost of care for people with dementia: six year follow&#x2010;up of a randomised controlled trial. Br J&#xa0;Psychiatry. 2019;216:8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31298169</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida OP, Khan KM, Hankey GJ, Yeap BB, Golledge J, Flicker L. 150 minutes of vigorous physical activity per week predicts survival and successful ageing: a population&#x2010;based 11&#x2010;year longitudinal study of 12 201 older Australian men. Br J Sports Med.&#xa0;2014;48(3):220&#x2010;225. 10.1136/bjsports-2013-092814</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2013-092814</ArticleId><ArticleId IdType="pubmed">24002240</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuerk R, Sauer J. Dementia in a Black and minority ethnic population: characteristics of presentation to an inner London memory service. B J Psych Bull. 2015;39(4):162&#x2010;166. 10.1192/pb.bp.114.047753</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/pb.bp.114.047753</ArticleId><ArticleId IdType="pmc">PMC4706140</ArticleId><ArticleId IdType="pubmed">26755947</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukadam N, Cooper C, Livingston G. A systematic review of ethnicity and pathways to care in dementia. Int J Geriatr Psychiatr. 2011;26(1):12&#x2010;20. 10.1002/gps.2484</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.2484</ArticleId><ArticleId IdType="pubmed">21157846</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukadam N, Waugh A, Cooper C, Livingston G. What would encourage help&#x2010;seeking for memory problems among UK&#x2010;based South Asians? A qualitative study. BMJ Open. 2015;5(9):e007990. 10.1136/bmjopen-2015-007990</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2015-007990</ArticleId><ArticleId IdType="pmc">PMC4567682</ArticleId><ArticleId IdType="pubmed">26362662</ArticleId></ArticleIdList></Reference><Reference><Citation>Berwald S, Roche M, Adelman S, Mukadam N, Livingston G. Black African and Caribbean British Communities' perceptions of memory problems: &#x201c;We don't do dementia&#x201d;. PLoS One. 2016;11(4):e0151878. 10.1371/journal.pone.0151878</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0151878</ArticleId><ArticleId IdType="pmc">PMC4821595</ArticleId><ArticleId IdType="pubmed">27045999</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner P, Goldstein D, Karpas DS, Chan L, Lai C. Help&#x2010;seeking for dementia: a systematic review of the literature. Alzheimer Dis Assoc Disord. 2014;28(4):299&#x2010;310. 10.1097/wad.0000000000000065</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/wad.0000000000000065</ArticleId><ArticleId IdType="pubmed">25321607</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner P, Mittelman MS, Goldstein D, Heinik J. Family stigma and caregiver burden in Alzheimer's disease. Gerontol. 2012;52(1):89&#x2010;97. 10.1093/geront/gnr117</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnr117</ArticleId><ArticleId IdType="pubmed">22048807</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheston R, Baghirathan S, Hui R, Shears P, Chacun A, Currie K. The Dementia Experiences of People from Caribbean, Chinese and South Asian Communities in Bristol Alzheimer's Society; 2017.</Citation></Reference><Reference><Citation>James T, Mukadam N, Sommerlad A, Ceballos SG, Livingston G. Culturally tailored therapeutic interventions for people affected by dementia: a systematic review and new conceptual model. Lancet Healthy Longev. 2021;2(3):e171&#x2010;e179. 10.1016/s2666-7568(21)00001-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2666-7568(21)00001-5</ArticleId><ArticleId IdType="pubmed">36098113</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord K, Rapaport P, Cooper C, Livingston G. Disseminating START: training clinical psychologists and admiral nurses as trainers in a psychosocial intervention for carers of people with dementia's depressive and anxiety symptoms. BMJ Open. 2017;7(8):e017759. 10.1136/bmjopen-2017-017759</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-017759</ArticleId><ArticleId IdType="pmc">PMC5724092</ArticleId><ArticleId IdType="pubmed">28827274</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52(2):69&#x2010;77. 10.1016/s0022-3999(01)00296-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3999(01)00296-3</ArticleId><ArticleId IdType="pubmed">11832252</ArticleId></ArticleIdList></Reference><Reference><Citation>Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcome. 2003;1:29. 10.1186/1477-7525-1-29</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-1-29</ArticleId><ArticleId IdType="pmc">PMC183845</ArticleId><ArticleId IdType="pubmed">12914662</ArticleId></ArticleIdList></Reference><Reference><Citation>Barry TL, Kaiser KL, Atwood JR. Reliability, validity, and scoring of the health status questionnaire&#x2010;12 version 2.0. J Nurs Meas. 2007;15(1):24&#x2010;35. 10.1891/106137407780851778</Citation><ArticleIdList><ArticleId IdType="doi">10.1891/106137407780851778</ArticleId><ArticleId IdType="pubmed">17665818</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettit T, Livingston G, Manela M, Kitchen G, Katona C, Bowling A. Validation and normative data of health status measures in older people: the Islington study. Int J Geriatr Psychiatr. 2001;16(11):1061&#x2010;1070. 10.1002/gps.479</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.479</ArticleId><ArticleId IdType="pubmed">11746652</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu J, Leino A. Advancement in the maturing science of cultural adaptations of evidence&#x2010;based interventions. J Consult Clin Psychol. 2017;85(1):45&#x2010;57. 10.1037/ccp0000145</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/ccp0000145</ArticleId><ArticleId IdType="pubmed">28045287</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommerlad A, Manela M, Cooper C, Rapaport P, Livingston G. START (STrAtegies for RelaTives) coping strategy for family carers of adults with dementia: qualitative study of participants' views about the intervention. BMJ Open. 2014;4(6):e005273. 10.1136/bmjopen-2014-005273</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-005273</ArticleId><ArticleId IdType="pmc">PMC4054623</ArticleId><ArticleId IdType="pubmed">24898089</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns E, Fenwick J, Schmied V, Sheehan A. Reflexivity in midwifery research: the insider/outsider debate. Midwifery. 2012;28(1):52&#x2010;60. 10.1016/j.midw.2010.10.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.midw.2010.10.018</ArticleId><ArticleId IdType="pubmed">21130547</ArticleId></ArticleIdList></Reference><Reference><Citation>Stott J, Orrell M, Charlesworth G. Validity and usefulness of the Hospital Anxiety and Depression Scale in Carers of people with dementia: evidence from confirmatory factor analysis, concurrent validity, and measurement invariance in a large sample. Am J Geriatric Psychiatry. 2017;25(11):1270&#x2010;1280. 10.1016/j.jagp.2017.05.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2017.05.017</ArticleId><ArticleId IdType="pubmed">28709755</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper C, Selwood A, Blanchard M, Walker Z, Blizard R, Livingston G. The determinants of family carers' abusive behaviour to people with dementia: results of the CARD study. J Affect Disord. 2010;121(1&#x2010;2):136&#x2010;142. 10.1016/j.jad.2009.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2009.05.001</ArticleId><ArticleId IdType="pubmed">19446884</ArticleId></ArticleIdList></Reference><Reference><Citation>Maters GA, Sanderman R, Kim AY, Coyne JC. Problems in cross&#x2010;cultural use of the hospital anxiety and depression scale:&#x201c;no butterflies in the desert&#x201d;. PLoS One. 2013;8(8):e70975. 10.1371/journal.pone.0070975</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0070975</ArticleId><ArticleId IdType="pmc">PMC3743400</ArticleId><ArticleId IdType="pubmed">23976969</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36641428</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2318</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>14</Day></PubDate></JournalIssue><Title>BMC geriatrics</Title><ISOAbbreviation>BMC Geriatr</ISOAbbreviation></Journal><ArticleTitle>Validation of the Benefits of Being a Caregiver Scale (BBCS) - further development of an independent characteristic of informal caregiving.</ArticleTitle><Pagination><StartPage>26</StartPage><MedlinePgn>26</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">26</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12877-022-03650-y</ELocationID><Abstract><AbstractText Label="BACKGROUND">Although larger amounts of scientific attention have been directed toward the concept of positive aspects of caregiving (PAC) in recent years, a globally uniform definition and a suitable, scientifically valid questionnaire for all informal caregivers have yet to be developed. On the basis of the questionnaires that already exist for measuring PAC, the authors aimed to (a) concretize the concept and (b) develop a new scale by focusing only on items that show that family caregivers experience a benefit for themselves and that the benefit they experience is the result of their caregiving activities.</AbstractText><AbstractText Label="METHODS">The Benefits of Being a Caregiver Scale (BBCS) was validated on data from 961 informal caregivers. Cronbach's alpha was calculated to assess the internal consistency of the items, and a factor analysis was conducted to determine the structure of the BBCS. The discriminatory power and item difficulties were examined. Construct validity was established by testing four hypotheses.</AbstractText><AbstractText Label="RESULTS">The factor analysis confirmed the single-factor structure of the BBCS. Cronbach's alpha for the total scale was 0.922. One of the 15 items did not show good to very good discriminatory power and was excluded from the final version of the scale. A higher BBCS score was observed if the caregiver experienced more positive aspects of caregiving and tended to have better general coping skills and a positive relationship with the care-receiver. The BBCS score was not associated with the subjective burden of the caregiver. Results confirmed the validity of the BBCS.</AbstractText><AbstractText Label="CONCLUSION">The BBCS is a valid assessment instrument for measuring the benefits that caregivers experience from their caregiving work and can easily be used in research and practice. The BBCS is available free of charge in English and German ( http://www.caregiver-benefits.de ).</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pendergrass</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Centre of Health Services Research in Medicine, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany. anna.pendergrass@uk-erlangen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei&#xdf;</LastName><ForeName>Saskia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>German Alzheimer Society, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohleder</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Psychology, Chair of Health Psychology, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graessel</LastName><ForeName>Elmar</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Centre of Health Services Research in Medicine, Universit&#xe4;tsklinikum Erlangen, Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Geriatr</MedlineTA><NlmUniqueID>100968548</NlmUniqueID><ISSNLinking>1471-2318</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000223" MajorTopicYN="Y">Adaptation, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005163" MajorTopicYN="N">Factor Analysis, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Benefits of Being a Caregiver Scale</Keyword><Keyword MajorTopicYN="N">Discriminatory power</Keyword><Keyword MajorTopicYN="N">Factor analysis</Keyword><Keyword MajorTopicYN="N">Item difficulty</Keyword><Keyword MajorTopicYN="N">Positive aspects of caregiving</Keyword><Keyword MajorTopicYN="N">Reliability</Keyword><Keyword MajorTopicYN="N">Validity</Keyword></KeywordList><CoiStatement>The authors declare that there are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>14</Day><Hour>23</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36641428</ArticleId><ArticleId IdType="pmc">PMC9840821</ArticleId><ArticleId IdType="doi">10.1186/s12877-022-03650-y</ArticleId><ArticleId IdType="pii">10.1186/s12877-022-03650-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Garc&#xed;a-Castro FJ, Alba A, Blanca MJ. The role of character strengths in predicting gains in informal caregivers of dementia. Aging Ment Health. 2021;25(1):32&#x2013;37. doi: 10.1080/13607863.2019.1667298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2019.1667298</ArticleId><ArticleId IdType="pubmed">31530163</ArticleId></ArticleIdList></Reference><Reference><Citation>Pristavec T. The burden and benefits of caregiving: A latent class analysis. Gerontologist. 2019;59(6):1078&#x2013;1091. doi: 10.1093/geront/gny022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gny022</ArticleId><ArticleId IdType="pmc">PMC6858826</ArticleId><ArticleId IdType="pubmed">29659788</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarlow BJ, Wisniewski SR, Belle SH, Rubert M, Ory MG, Gallagher-Thompson D. Positive aspects of caregiving: Contributions of the REACH project to the development of new measures for Alzheimer&#x2019;s caregiving. Res Aging. 2004;26(4):429&#x2013;453. doi: 10.1177/0164027504264493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0164027504264493</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton MP, Kleban MH, Moss M, Rovine M, Glicksman A. Measuring caregiving appraisal. J Gerontol. 1989;44(3):P61&#x2013;P71. doi: 10.1093/geronj/44.3.P61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronj/44.3.P61</ArticleId><ArticleId IdType="pubmed">2715587</ArticleId></ArticleIdList></Reference><Reference><Citation>Faba J, Villar F, Giuliani MF. Development of a measure to evaluate gains among spanish dementia caregivers: The gains associated with caregiving (GAC) scale. Arch Gerontol Geriatr. 2017;68:76&#x2013;83. doi: 10.1016/j.archger.2016.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2016.09.004</ArticleId><ArticleId IdType="pubmed">27668548</ArticleId></ArticleIdList></Reference><Reference><Citation>Zank S, Schacke C, Leipold B. Berliner Inventar zur Angeh&#xf6;rigenbelastung-Demenz (BIZA-D) Z Klin Psychol Psychother. 2006;35(4):296&#x2013;305. doi: 10.1026/1616-3443.35.4.296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1026/1616-3443.35.4.296</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap P, Luo N, Ng WY, Chionh HL, Lim J, Goh J. Gain in Alzheimer care INstrument&#x2013;A new scale to measure caregiving gains in dementia. Am J Geriatr Psychiatry. 2010;18(1):68&#x2013;76. doi: 10.1097/JGP.0b013e3181bd1dcd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JGP.0b013e3181bd1dcd</ArticleId><ArticleId IdType="pubmed">20094020</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudson P. Positive aspects and challenges associated with caring for a dying relative at home. Int J Palliat Nurs. 2004;10(2):58&#x2013;65. doi: 10.12968/ijpn.2004.10.2.12454.</Citation><ArticleIdList><ArticleId IdType="doi">10.12968/ijpn.2004.10.2.12454</ArticleId><ArticleId IdType="pubmed">15039608</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendergrass A, Mittelman M, Graessel E, &#xd6;zbe D, Karg N. Predictors of the personal benefits and positive aspects of informal caregiving. Aging Ment Health.&#xa0;2018;23(11);1533&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">30428698</ArticleId></ArticleIdList></Reference><Reference><Citation>Semiatin AM, O'Connor MK. The relationship between self-efficacy and positive aspects of caregiving in Alzheimer's disease caregivers. Aging Mental Health. 2012;16(6):683&#x2013;688. doi: 10.1080/13607863.2011.651437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2011.651437</ArticleId><ArticleId IdType="pubmed">22360626</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz R, Belle SH, Czaja SJ, McGinnis KA, Stevens A, Zhang S. Long-term care placement of dementia patients and caregiver health and well-being. JAMA. 2004;292(8):961&#x2013;967. doi: 10.1001/jama.292.8.961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.292.8.961</ArticleId><ArticleId IdType="pubmed">15328328</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd J, Patterson T, Muers J. The positive aspects of caregiving in dementia: A critical review of the qualitative literature. Dementia. 2016;15(6):1534&#x2013;1561. doi: 10.1177/1471301214564792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301214564792</ArticleId><ArticleId IdType="pubmed">25547208</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders S. Is the glass half empty or full? Reflections on strain and gain in cargivers of individuals with Alzheimer's disease. Soc Work Health Care. 2005;40(3):57&#x2013;73. doi: 10.1300/J010v40n03_04.</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J010v40n03_04</ArticleId><ArticleId IdType="pubmed">15837668</ArticleId></ArticleIdList></Reference><Reference><Citation>Haley WE, Allen JY, Grant JS, Clay OJ, Perkins M, Roth DL. Problems and benefits reported by stroke family caregivers: results from a prospective epidemiological study. Stroke. 2009;40(6):2129&#x2013;2133. doi: 10.1161/STROKEAHA.108.545269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.108.545269</ArticleId><ArticleId IdType="pmc">PMC2707750</ArticleId><ArticleId IdType="pubmed">19407230</ArticleId></ArticleIdList></Reference><Reference><Citation>Picot SJF, Youngblut J, Zeller R. Development and testing of a measure of perceived caregiver rewards in adults. J Nurs Meas. 1997;5(1):33&#x2013;52. doi: 10.1891/1061-3749.5.1.33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1891/1061-3749.5.1.33</ArticleId><ArticleId IdType="pubmed">9505468</ArticleId></ArticleIdList></Reference><Reference><Citation>Strawbridge WJ: The effects of social factors on adult children caring for older parents. University of Washington; 1991.</Citation></Reference><Reference><Citation>Farran CJ, Miller BH, Kaufman JE, Donner E, Fogg L. Finding meaning through caregiving: Development of an instrument for family caregivers of persons with Alzheimer's disease. J Clin Psychol. 1999;55(9):1107&#x2013;1125. doi: 10.1002/(SICI)1097-4679(199909)55:9&lt;1107::AID-JCLP8&gt;3.0.CO;2-V.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4679(199909)55:9&lt;1107::AID-JCLP8&gt;3.0.CO;2-V</ArticleId><ArticleId IdType="pubmed">10576325</ArticleId></ArticleIdList></Reference><Reference><Citation>Orbell S, Hopkins N, Gillies B. Measuring the impact of informal caring. J Community Appl Soc Psychol. 1993;3(2):149&#x2013;163. doi: 10.1002/casp.2450030207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/casp.2450030207</ArticleId></ArticleIdList></Reference><Reference><Citation>Given CW, Given B, Stommel M, Collins C, King S, Franklin S. The caregiver reaction assessment (CRA) for caregivers to persons with chronic physical and mental impairments. Res Nurs Health. 1992;15(4):271&#x2013;283. doi: 10.1002/nur.4770150406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nur.4770150406</ArticleId><ArticleId IdType="pubmed">1386680</ArticleId></ArticleIdList></Reference><Reference><Citation>Schofield HL, Murphy B, Herrman H, Bloch S, Singh B. Family caregiving: Measurement of emotional well-being and various aspects of the caregiving role. Psychol Med. 1997;27(3):647&#x2013;657. doi: 10.1017/S0033291797004820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291797004820</ArticleId><ArticleId IdType="pubmed">9153685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinney JM, Stephens MAP. Hassles and uplifts of giving care to a family member with dementia. Psychol Aging. 1989;4(4):402&#x2013;408. doi: 10.1037/0882-7974.4.4.402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0882-7974.4.4.402</ArticleId><ArticleId IdType="pubmed">2515874</ArticleId></ArticleIdList></Reference><Reference><Citation>Motenko AK. The frustrations, gratifications, and well-being of dementia caregivers. Gerontologist. 1989;29(2):166&#x2013;172. doi: 10.1093/geront/29.2.166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/29.2.166</ArticleId><ArticleId IdType="pubmed">2753378</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer BJ. Gain in the caregiving experience: Where are we? What next? Gerontologist. 1997;37(2):218&#x2013;232. doi: 10.1093/geront/37.2.218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/37.2.218</ArticleId><ArticleId IdType="pubmed">9127978</ArticleId></ArticleIdList></Reference><Reference><Citation>Graessel E, Berth H, Lichte T, Grau H. Subjective caregiver burden: validity of the 10-item short version of the Burden Scale for Family Caregivers BSFC-s. BMC Geriatr. 2014;14(23):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3942019</ArticleId><ArticleId IdType="pubmed">24555474</ArticleId></ArticleIdList></Reference><Reference><Citation>Carver CS. You want to measure coping but your protocol's too long: consider the Brief COPE. Int J Behav Med. 1997;4(1):92&#x2013;100. doi: 10.1207/s15327558ijbm0401_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1207/s15327558ijbm0401_6</ArticleId><ArticleId IdType="pubmed">16250744</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogner K, Landrock U: Answer tendencies in standardized surveys. [Antworttendenzen in standardisierten Umfragen]. Gesis Survey Guidlines 2015:1&#x2013;12. https://doi.org/12.10.15465/gesis-sg_016.</Citation></Reference><Reference><Citation>Wimo A, Winblad B. Resource utilization in dementia: "RUD Lite". Brain Aging. 2003;3(1):48&#x2013;59.</Citation></Reference><Reference><Citation>Bortz J, D&#xf6;ring N. Forschungsmethoden und Evaluation: f&#xfc;r Human- und Sozialwissenschaftler. Berlin, Heidelberg: Springer; 2006.</Citation></Reference><Reference><Citation>Pakenham KI, Cox S. Effects of benefit finding, social support and caregiving on youth adjustment in a parental illness context. J Child Fam Stud. 2018;27(8):2491&#x2013;2506. doi: 10.1007/s10826-018-1088-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10826-018-1088-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Solberg MA, Gridley MK, Peters RM. The factor structure of the brief cope: A systematic review. West J Nurs Res. 2022;44(6):612&#x2013;627. doi: 10.1177/01939459211012044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01939459211012044</ArticleId><ArticleId IdType="pubmed">33942676</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner MH, Mrug S, Schwebel DC, Phipps S, Whelan K, Madan-Swain A. Demographic, medical, and psychosocial predictors of benefit finding among caregivers of childhood cancer survivors. Psycho-Oncol. 2017;26(1):125&#x2013;132. doi: 10.1002/pon.4014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pon.4014</ArticleId><ArticleId IdType="pmc">PMC4959962</ArticleId><ArticleId IdType="pubmed">26489522</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum HD, Lo D, Hooker S, Bekelman DB. Caregiving in heart failure: Relationship quality is associated with caregiver benefit finding and caregivber burden. Heart Lung. 2014;43(4):306&#x2013;310. doi: 10.1016/j.hrtlng.2014.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2014.05.002</ArticleId><ArticleId IdType="pmc">PMC5711727</ArticleId><ArticleId IdType="pubmed">24992881</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanji H, Anderson KE, Gruber-Baldini AL, Fishman PS, Reich SG, Weiner WJ, Shulman LM. Mutuality of the marital relationship in Parkinson's Disease. Mov Disord. 2008;23(13):1843&#x2013;1849. doi: 10.1002/mds.22089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.22089</ArticleId><ArticleId IdType="pubmed">18759355</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;ring N, Bortz J. Forschungsmethoden und Evaluation in den Sozial- und Humanwissenschaften. Berlin, Heidelberg: Springer; 2016.</Citation></Reference><Reference><Citation>Ong AD, Weiss DJ. The impact of anonymity on responses to sensitive questions. J Appl Soc Psychol. 2000;30(8):1691&#x2013;1708. doi: 10.1111/j.1559-1816.2000.tb02462.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1559-1816.2000.tb02462.x</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36640914</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-6300</ISSN><JournalIssue CitedMedium="Internet"><Volume>128</Volume><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of chemical neuroanatomy</Title><ISOAbbreviation>J Chem Neuroanat</ISOAbbreviation></Journal><ArticleTitle>Evaluation of anti-Alzheimer activity of Echinacea purpurea extracts in aluminum chloride-induced neurotoxicity in rat model.</ArticleTitle><Pagination><StartPage>102234</StartPage><MedlinePgn>102234</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jchemneu.2023.102234</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0891-0618(23)00004-2</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) is one of the neurodegenerative illnesses that impair individual life &amp; increase the demand for caregivers with no available curative medication right now. Therefore, there is a growing concern about employing herbal medicine to limit AD progression &amp; improve patients' life quality, thus potentiating its add-on therapy. In addition, herbs are cost-effective &amp; accessible with nearly no side effects. In the same vein, our study aimed to investigate the potency of Echinacea purpurea (EP) flower extracts to ameliorate the neurodegenerative effect of Aluminum chloride (AlCl3) in a rat model. Moreover, mechanistic studies, including impact on the cholinesterase activity, redox status, inflammatory mediators, behavior performance, glucose level &amp; histopathology, were carried on. Our results showed that 250&#xa0;mg/kg of Aqueous (AQ) &amp; Alcoholic (AL) extracts of EP inhibited cholinesterase, restored oxidative balance, down-regulated IL-6 &amp; TNF-&#x3b1; cytokines &amp; improved behavior performance in vivo that was reflected in the brain picture by decreasing neuronal degeneration &amp; amyloid plaques in cerebral cortex &amp; hippocampus. The potency of both extracts was compared to reference drugs &amp; AlCl3 positive control group. The AQ extract showed greater potency against COX-1, COX-2 &amp; &#x3b1;-amylase in vitro, while the AL extract was more potent against cholinesterase in vitro, inflammatory cytokines, behavior &amp; pathological improvement in vivo. Conclusively EP overcame AlCl3-induced neurobehavioral toxicity in the rat model via different pathways, which support its regular administration to postpone progressive neural damage in AD patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohamed</LastName><ForeName>Salma M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, 12211 Giza, Egypt. Electronic address: salmamostafa14@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shalaby</LastName><ForeName>Mostafa A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, 12211 Giza, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Mokaddem</LastName><ForeName>Asmaa K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Pathology, Faculty of Veterinary Medicine, Cairo University, 12211 Giza, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Banna</LastName><ForeName>Ahmed H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Michael Sayegh Faculty of Pharmacy, Aqaba University of Technology, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Banna</LastName><ForeName>Hossny A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, 12211 Giza, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nabil</LastName><ForeName>Ghazal</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, 12211 Giza, Egypt. Electronic address: Gazal_nabil@cu.edu.eg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Chem Neuroanat</MedlineTA><NlmUniqueID>8902615</NlmUniqueID><ISSNLinking>0891-0618</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>3CYT62D3GA</RegistryNumber><NameOfSubstance UI="D000077410">Aluminum Chloride</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.1.8</RegistryNumber><NameOfSubstance UI="D002802">Cholinesterases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077410" MajorTopicYN="N">Aluminum Chloride</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002802" MajorTopicYN="N">Cholinesterases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020900" MajorTopicYN="Y">Echinacea</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aluminum chloride</Keyword><Keyword MajorTopicYN="N">Alzheimer's</Keyword><Keyword MajorTopicYN="N">Anti-inflammatory</Keyword><Keyword MajorTopicYN="N">Anti-oxidant</Keyword><Keyword MajorTopicYN="N">Echinacea purpurea</Keyword></KeywordList><CoiStatement>Conflict of Interest The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>14</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36640914</ArticleId><ArticleId IdType="doi">10.1016/j.jchemneu.2023.102234</ArticleId><ArticleId IdType="pii">S0891-0618(23)00004-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36628782</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2860</ISSN><JournalIssue CitedMedium="Internet"><Volume>135</Volume><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Artificial intelligence in medicine</Title><ISOAbbreviation>Artif Intell Med</ISOAbbreviation></Journal><ArticleTitle>A self-supervised algorithm to detect signs of social isolation in the elderly from daily activity sequences.</ArticleTitle><Pagination><StartPage>102454</StartPage><MedlinePgn>102454</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.artmed.2022.102454</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0933-3657(22)00206-8</ELocationID><Abstract><AbstractText>Considering the increasing aging of the population, multi-device monitoring of the activities of daily living (ADL) of older people becomes crucial to support independent living and early detection of symptoms of mental illnesses, such as depression and Alzheimer's disease. Anomalies can anticipate the diagnosis of these pathologies in the patient's normal behavior, such as reduced hygiene, changes in sleep habits, and fewer social interactions. These abnormalities are often subtle and hard to detect. Especially using non-intrusive monitoring devices might cause anomaly detectors to generate false alarms or ignore relevant clues. This limitation may hinder their usage by caregivers. Furthermore, the notion of abnormality here is context and patient-dependent, thus requiring untrained approaches. To reduce these problems, we propose a self-supervised model for multi-sensor time series signals based on Hyperbolic uncertainty for Anomaly Detection, which we dub HypAD. HypAD estimates uncertainty end-to-end, thanks to hyperbolic neural networks, and integrates it into the "classic" notion of reconstruction loss in anomaly detection. Based on hyperbolic uncertainty, HypAD introduces the principle of a detectable anomaly. HypAD assesses whether it is sure about the input signal and fails to reconstruct it because it is anomalous or whether the high reconstruction loss is due to the model uncertainty, e.g., a complex but regular signal (cf. this parallels the residual model error upon training). The proposed solution has been incorporated into an end-to-end ADL monitoring system for elderly patients in retirement homes, developed within a funded project leveraging an interdisciplinary consortium of computer scientists, engineers, and geriatricians. Healthcare professionals were involved in the design and verification process to foster trust in the system. In addition, the system has been equipped with explainability features.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prenkaj</LastName><ForeName>Bardh</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Sapienza University of Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aragona</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sapienza University of Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flaborea</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sapienza University of Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galasso</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Sapienza University of Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gravina</LastName><ForeName>Saverio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>DS TECH, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podo</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Sapienza University of Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reda</LastName><ForeName>Emilia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Giomi RSA, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velardi</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Sapienza University of Rome, Italy. Electronic address: velardi@di.uniroma1.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Artif Intell Med</MedlineTA><NlmUniqueID>8915031</NlmUniqueID><ISSNLinking>0933-3657</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="Y">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057187" MajorTopicYN="N">Independent Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012934" MajorTopicYN="N">Social Isolation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ADL</Keyword><Keyword MajorTopicYN="N">Anomaly detection</Keyword><Keyword MajorTopicYN="N">Elderly social isolation</Keyword><Keyword MajorTopicYN="N">HyperNN</Keyword><Keyword MajorTopicYN="N">Hyperbolic uncertainty</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>4</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36628782</ArticleId><ArticleId IdType="doi">10.1016/j.artmed.2022.102454</ArticleId><ArticleId IdType="pii">S0933-3657(22)00206-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36627641</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1758-9193</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>10</Day></PubDate></JournalIssue><Title>Alzheimer's research &amp; therapy</Title><ISOAbbreviation>Alzheimers Res Ther</ISOAbbreviation></Journal><ArticleTitle>More extensive hypometabolism and higher mortality risk in patients with right- than left-predominant neurodegeneration of the anterior temporal lobe.</ArticleTitle><Pagination><StartPage>11</StartPage><MedlinePgn>11</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">11</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13195-022-01146-w</ELocationID><Abstract><AbstractText Label="BACKGROUND">Left-predominant neurodegeneration of the anterior temporal lobe (ATL) and the associated syndrome termed semantic variant primary progressive aphasia (svPPA) are well characterized. Less is known about right-predominant neurodegeneration of the ATL, which has been associated with the clinical syndrome named right temporal variant of frontotemporal dementia (rtvFTD). Here, we assessed glucose metabolism across the brain, cognitive performance, and mortality in patients with right-predominant neurodegeneration of the ATL.</AbstractText><AbstractText Label="METHODS">Patients with predominant hypometabolism of the ATL on FDG PET (as a measure of neurodegeneration) were retrospectively identified and categorized into those with asymmetrical right, left, or symmetric bilateral involvement (N&#x2009;=&#x2009;10, 17, and 8). We compared whole-brain, normalized regional glucose metabolism using SPM12, cognitive performance on the CERAD Neuropsychological Assessment Battery, and mortality risk (age- and sex-adjusted Cox proportional hazard model) between groups.</AbstractText><AbstractText Label="RESULTS">Hypometabolism was most pronounced and extensive in patients with right-predominant neurodegeneration of the ATL. Beyond the right temporal lobe, right frontal and left temporal lobes were affected in these patients. Cognitive performance was similarly impaired in all three groups, with predominant naming and hippocampal-dependent memory deficits. Mortality risk was 6.1 times higher in patients with right- than left-predominant ATL neurodegeneration (p&#x2009;&lt;&#x2009;0.05). Median survival duration after PET was shortest in patients with right- and longest in patients with left-predominant ATL neurodegeneration (5.7 vs 8.3&#xa0;years after examination).</AbstractText><AbstractText Label="DISCUSSION">More extensive neurodegeneration and shorter survival duration in patients with right- than left-predominant neurodegeneration of the ATL might indicate that the former consult memory clinics at a later disease stage, when symptoms like naming and episodic memory deficits have already emerged. At the time of diagnosis, the shorter survival duration of patients with right- than left-predominant ATL neurodegeneration should be kept in mind when counseling patients and caregivers.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Frings</LastName><ForeName>Lars</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9377-8935</Identifier><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Medical Center - University of Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany. lars.frings@uniklinik-freiburg.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Geriatrics and Gerontology, Medical Center - University of Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany. lars.frings@uniklinik-freiburg.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blazhenets</LastName><ForeName>Ganna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Medical Center - University of Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binder</LastName><ForeName>Raphael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Medical Center - University of Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bormann</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology and Clinical Neuroscience, Medical Center - University of Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hellwig</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Philipp T</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Medical Center - University of Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Alzheimers Res Ther</MedlineTA><NlmUniqueID>101511643</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013702" MajorTopicYN="Y">Temporal Lobe</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012660" MajorTopicYN="N">Semantics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anterior temporal lobe</Keyword><Keyword MajorTopicYN="N">FDG PET</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Semantic dementia</Keyword><Keyword MajorTopicYN="N">Survival</Keyword><Keyword MajorTopicYN="N">rtvFTD</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>10</Day><Hour>23</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36627641</ArticleId><ArticleId IdType="pmc">PMC9830748</ArticleId><ArticleId IdType="doi">10.1186/s13195-022-01146-w</ArticleId><ArticleId IdType="pii">10.1186/s13195-022-01146-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006&#x2013;1014. doi: 10.1212/WNL.0b013e31821103e6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31821103e6</ArticleId><ArticleId IdType="pmc">PMC3059138</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson SA, Patterson K, Hodges JR. Left/right asymmetry of atrophy in semantic dementia: behavioral-cognitive implications. Neurology. 2003;61(9):1196&#x2013;1203. doi: 10.1212/01.WNL.0000091868.28557.B8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000091868.28557.B8</ArticleId><ArticleId IdType="pubmed">14610120</ArticleId></ArticleIdList></Reference><Reference><Citation>Curet Burleson AX, Pham NTT, Buciuc M, Botha H, Duffy JR, Clark HM, et al. Neurobehavioral characteristics of FDG-PET defined right-dominant semantic dementia: a longitudinal study. Dement Geriatr Cogn Disord. 2021;50(1):17&#x2013;28. doi: 10.1159/000513979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000513979</ArticleId><ArticleId IdType="pmc">PMC8243786</ArticleId><ArticleId IdType="pubmed">33756466</ArticleId></ArticleIdList></Reference><Reference><Citation>Joubert S, Felician O, Barbeau E, Ranjeva JP, Christophe M, Didic M, et al. The right temporal lobe variant of frontotemporal dementia: cognitive and neuroanatomical profile of three patients. J Neurol. 2006;253(11):1447&#x2013;1458. doi: 10.1007/s00415-006-0232-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-006-0232-x</ArticleId><ArticleId IdType="pubmed">16773268</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan D, Anderson V, Pijnenburg Y, Whitwell J, Barnes J, Scahill R, et al. The clinical profile of right temporal lobe atrophy. Brain. 2009;132(Pt 5):1287&#x2013;1298. doi: 10.1093/brain/awp037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp037</ArticleId><ArticleId IdType="pubmed">19297506</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulugut Erkoyun H, Groot C, Heilbron R, Nelissen A, van Rossum J, Jutten R, et al. A clinical-radiological framework of the right temporal variant of frontotemporal dementia. Brain. 2020;143(9):2831&#x2013;2843. doi: 10.1093/brain/awaa225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa225</ArticleId><ArticleId IdType="pmc">PMC9172625</ArticleId><ArticleId IdType="pubmed">32830218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumfor F, Landin-Romero R, Devenney E, Hutchings R, Grasso R, Hodges JR, et al. On the right side? A longitudinal study of left- versus right-lateralized semantic dementia. Brain. 2016;139(Pt 3):986&#x2013;998. doi: 10.1093/brain/awv387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv387</ArticleId><ArticleId IdType="pubmed">26811253</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodges JR, Davies R, Xuereb J, Kril J, Halliday G. Survival in frontotemporal dementia. Neurology. 2003;61(3):349&#x2013;354. doi: 10.1212/01.WNL.0000078928.20107.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000078928.20107.52</ArticleId><ArticleId IdType="pubmed">12913196</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyle-Gilchrist IT, Dick KM, Patterson K, Vazquez Rodriquez P, Wehmann E, Wilcox A, et al. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology. 2016;86(18):1736&#x2013;1743. doi: 10.1212/WNL.0000000000002638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002638</ArticleId><ArticleId IdType="pmc">PMC4854589</ArticleId><ArticleId IdType="pubmed">27037234</ArticleId></ArticleIdList></Reference><Reference><Citation>Kansal K, Mareddy M, Sloane KL, Minc AA, Rabins PV, McGready JB, et al. Survival in frontotemporal dementia phenotypes: a meta-analysis. Dement Geriatr Cogn Disord. 2016;41(1&#x2013;2):109&#x2013;122. doi: 10.1159/000443205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000443205</ArticleId><ArticleId IdType="pubmed">26854827</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberson ED, Hesse JH, Rose KD, Slama H, Johnson JK, Yaffe K, et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology. 2005;65(5):719&#x2013;725. doi: 10.1212/01.wnl.0000173837.82820.9f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000173837.82820.9f</ArticleId><ArticleId IdType="pubmed">16157905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodges JR, Mitchell J, Dawson K, Spillantini MG, Xuereb JH, McMonagle P, et al. Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases. Brain. 2010;133(Pt 1):300&#x2013;306. doi: 10.1093/brain/awp248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp248</ArticleId><ArticleId IdType="pubmed">19805492</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546&#x2013;1554. doi: 10.1212/WNL.51.6.1546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.51.6.1546</ArticleId><ArticleId IdType="pubmed">9855500</ArticleId></ArticleIdList></Reference><Reference><Citation>Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer&#x2019;s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995;36(7):1238&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">7790950</ArticleId></ArticleIdList></Reference><Reference><Citation>Frings L, Hellwig S, Spehl TS, Bormann T, Buchert R, Vach W, et al. Asymmetries of amyloid-beta burden and neuronal dysfunction are positively correlated in Alzheimer&#x2019;s disease. Brain. 2015;138(Pt 10):3089&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">26280595</ArticleId></ArticleIdList></Reference><Reference><Citation>Speck I, Arndt S, Thurow J, Blazhenets G, Aschendorff A, Meyer PT, et al. (18)F-FDG PET imaging of the inferior colliculus in asymmetric hearing loss. J Nucl Med. 2020;61(3):418&#x2013;422. doi: 10.2967/jnumed.119.231407.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.119.231407</ArticleId><ArticleId IdType="pubmed">31481576</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R, et al. The consortium to establish a registry for Alzheimer&#x2019;s disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer&#x2019;s disease. Neurology. 1993;43(12):2457&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">8255439</ArticleId></ArticleIdList></Reference><Reference><Citation>Berres M, Monsch AU, Bernasconi F, Thalmann B, Stahelin HB. Normal ranges of neuropsychological tests for the diagnosis of Alzheimer&#x2019;s disease. Stud Health Technol Inform. 2000;77:195&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11187541</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolls ET, Huang CC, Lin CP, Feng J, Joliot M. Automated anatomical labelling atlas 3. Neuroimage. 2020;206:116189. doi: 10.1016/j.neuroimage.2019.116189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2019.116189</ArticleId><ArticleId IdType="pubmed">31521825</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233&#x2013;239. doi: 10.1176/jnp.12.2.233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/jnp.12.2.233</ArticleId><ArticleId IdType="pubmed">11001602</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergeron D, Gorno-Tempini ML, Rabinovici GD, Santos-Santos MA, Seeley W, Miller BL, et al. Prevalence of amyloid-beta pathology in distinct variants of primary progressive aphasia. Ann Neurol. 2018;84(5):729&#x2013;740. doi: 10.1002/ana.25333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25333</ArticleId><ArticleId IdType="pmc">PMC6354051</ArticleId><ArticleId IdType="pubmed">30255971</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet. 2015;386(10004):1672&#x2013;1682. doi: 10.1016/S0140-6736(15)00461-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)00461-4</ArticleId><ArticleId IdType="pmc">PMC5970949</ArticleId><ArticleId IdType="pubmed">26595641</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghesani V, Battistella G, Mandelli ML, Welch A, Weis E, Younes K, et al. Regional and hemispheric susceptibility of the temporal lobe to FTLD-TDP type C pathology. Neuroimage Clin. 2020;28:102369. doi: 10.1016/j.nicl.2020.102369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2020.102369</ArticleId><ArticleId IdType="pmc">PMC7426562</ArticleId><ArticleId IdType="pubmed">32798912</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesulam MM, Coventry CA, Bigio EH, Sridhar J, Gill N, Fought AJ, et al. Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia. Brain. 2022;145(6):2133&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9246707</ArticleId><ArticleId IdType="pubmed">35441216</ArticleId></ArticleIdList></Reference><Reference><Citation>Domoto-Reilly K, Sapolsky D, Brickhouse M, Dickerson BC. Alzheimer&#x2019;s Disease Neuroimaging I. Naming impairment in Alzheimer&#x2019;s disease is associated with left anterior temporal lobe atrophy. Neuroimage. 2012;63(1):348&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3665400</ArticleId><ArticleId IdType="pubmed">22728617</ArticleId></ArticleIdList></Reference><Reference><Citation>Frings L, Kloppel S, Teipel S, Peters O, Frolich L, Pantel J, et al. Left anterior temporal lobe sustains naming in Alzheimer&#x2019;s dementia and mild cognitive impairment. Curr Alzheimer Res. 2011;8(8):893&#x2013;901. doi: 10.2174/156720511798192673.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720511798192673</ArticleId><ArticleId IdType="pubmed">21592050</ArticleId></ArticleIdList></Reference><Reference><Citation>Frings L, Spehl TS, Hull M, Meyer PT. Left anterior temporal glucose metabolism and not amyloid-beta load predicts naming impairment in Alzheimer&#x2019;s disease. Curr Alzheimer Res. 2016;13(6):678&#x2013;681. doi: 10.2174/1567205013666160322141955.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205013666160322141955</ArticleId><ArticleId IdType="pubmed">27001678</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman M, McMillan C, Moore P, Ding L, Glosser G, Work M, et al. What&#x2019;s in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer&#x2019;s disease, frontotemporal dementia and corticobasal degeneration. Brain. 2004;127(Pt 3):628&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">14761903</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Whitwell JL, Knopman DS, Boeve BF, Vemuri P, Senjem ML, et al. Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology. 2009;73(18):1443&#x2013;1450. doi: 10.1212/WNL.0b013e3181bf9945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bf9945</ArticleId><ArticleId IdType="pmc">PMC2779005</ArticleId><ArticleId IdType="pubmed">19884571</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerch C, Misselwitz B, Sitzer M, Berger K, Steinmetz H, Neumann-Haefelin T, et al. Difference in recognition of right and left hemispheric stroke. Lancet. 2005;366(9483):392&#x2013;393. doi: 10.1016/S0140-6736(05)67024-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)67024-9</ArticleId><ArticleId IdType="pubmed">16054939</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36609056</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1545-7214</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</Title><ISOAbbreviation>Am J Geriatr Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Projection of Care Partners' Preferences in the Proxy Assessments of Everyday Preferences for Persons With Cognitive Impairment.</ArticleTitle><Pagination><StartPage>254</StartPage><EndPage>263</EndPage><MedlinePgn>254-263</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jagp.2022.12.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1064-7481(22)00578-4</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Bias in surrogate decision-making can occur when proxy decision-makers overestimate the degree to which their preferences are shared by others, resulting in a projection of their beliefs onto others. The purpose of this study is to assess projection of care partners' preferences onto surrogate assessments of everyday preferences for persons with cognitive impairment (CI) and to address clinical and demographic factors as predictors of projection.</AbstractText><AbstractText Label="METHODS">The sample included 116 dyads of persons with CI (Clinical Dementia Rating Scale score &#x2265; 0.5) and their care partners. The Preferences for Everyday Living Inventory (PELI) was used to assess importance of preferences among persons with CI. Care partners completed two separate PELI assessments: one from the perspective of the persons with CI (i.e., acting as a surrogate decision-maker) and one from their own perspective. To assess for projection of care partners' preferences onto surrogate assessments of preferences for persons with CI, two-step regression with multivariable-adjusted general linear models was used.</AbstractText><AbstractText Label="RESULTS">Significant projection was noted within the PELI domains of autonomous choice, personal growth, and keeping a routine (p &lt; 0.005). More significant cognitive impairment was associated with increased projection within the PELI domains of autonomous choice and personal growth (p &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSION">The results of this study suggest that projection of care partners' own preferences may be a significant source of bias in proxy decision-making regarding everyday preferences for persons with CI, particularly for those with more significant CI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wilkins</LastName><ForeName>James M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>McLean Hospital (JMW, BPF), Belmont, MA; Harvard Medical School (JMW, JJL, TGI, BTH, DB, BPF, OIO), Boston, MA. Electronic address: jwilkins1@mclean.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Locascio</LastName><ForeName>Joseph J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Harvard Medical School (JMW, JJL, TGI, BTH, DB, BPF, OIO), Boston, MA; Department of Neurology (JJL, TGI, BTH, DB, OIO), Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital, Boston, MA; Harvard Catalyst Biostatistical Consulting (JJL), Harvard Catalyst/CTSA, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez-Isla</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Harvard Medical School (JMW, JJL, TGI, BTH, DB, BPF, OIO), Boston, MA; Department of Neurology (JJL, TGI, BTH, DB, OIO), Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyman</LastName><ForeName>Bradley T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Harvard Medical School (JMW, JJL, TGI, BTH, DB, BPF, OIO), Boston, MA; Department of Neurology (JJL, TGI, BTH, DB, OIO), Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blacker</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Harvard Medical School (JMW, JJL, TGI, BTH, DB, BPF, OIO), Boston, MA; Department of Neurology (JJL, TGI, BTH, DB, OIO), Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital, Boston, MA; Department of Psychiatry (DB, OIO), Massachusetts General Hospital, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forester</LastName><ForeName>Brent P</ForeName><Initials>BP</Initials><AffiliationInfo><Affiliation>McLean Hospital (JMW, BPF), Belmont, MA; Harvard Medical School (JMW, JJL, TGI, BTH, DB, BPF, OIO), Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okereke</LastName><ForeName>Olivia I</ForeName><Initials>OI</Initials><AffiliationInfo><Affiliation>Harvard Medical School (JMW, JJL, TGI, BTH, DB, BPF, OIO), Boston, MA; Department of Neurology (JJL, TGI, BTH, DB, OIO), Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital, Boston, MA; Department of Psychiatry (DB, OIO), Massachusetts General Hospital, Boston, MA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>L30 AG060475</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG062421</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG005134</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Am J Geriatr Psychiatry</MedlineTA><NlmUniqueID>9309609</NlmUniqueID><ISSNLinking>1064-7481</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Geriatr Psychiatry. 2023 Apr;31(4):264-266. doi: 10.1016/j.jagp.2022.12.189</RefSource><PMID Version="1">36621387</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019727" MajorTopicYN="N">Proxy</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003657" MajorTopicYN="N">Decision Making</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">autonomy and self-efficacy</Keyword><Keyword MajorTopicYN="N">decision making</Keyword><Keyword MajorTopicYN="N">psychosocial preferences</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>7</Day><Hour>16</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36609056</ArticleId><ArticleId IdType="mid">NIHMS1856993</ArticleId><ArticleId IdType="pmc">PMC10023418</ArticleId><ArticleId IdType="doi">10.1016/j.jagp.2022.12.005</ArticleId><ArticleId IdType="pii">S1064-7481(22)00578-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shalowitz DI, Garrett-Mayer E, Wendler D: The accuracy of surrogate decision makers: a systematic review. ArchInternMed 2006; 166:493&#x2013;497</Citation><ArticleIdList><ArticleId IdType="pubmed">16534034</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouellet JA, Mecca MC, Tinetti ME, et al.: Education outcomes of a multisite, virtual, interprofessional training in patient priorities aligned care. [Internet]. J Am Geriatr Soc 2022; 70:E5&#x2013;E7</Citation><ArticleIdList><ArticleId IdType="pubmed">34741462</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagerlin A, Ditto PH, Danks JH, et al.: Projection in surrogate decisions about life-sustaining medical treatments. Health Psychol 2001; 20:166&#x2013;175</Citation><ArticleIdList><ArticleId IdType="pubmed">11403214</ArticleId></ArticleIdList></Reference><Reference><Citation>Pruchno RA, Lemay EP, Feild L, et al.: Spouse as health care proxy for dialysis patients: whose preferences matter? Gerontologist 2005; 45:812&#x2013;819</Citation><ArticleIdList><ArticleId IdType="pubmed">16326663</ArticleId></ArticleIdList></Reference><Reference><Citation>Moorman SM, Hauser RM, Carr D: Do Older Adults Know Their Spouses&#x2019; End-of-Life Treatment Preferences? Res Aging 2009; 31:463&#x2013;491</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2699181</ArticleId><ArticleId IdType="pubmed">20046978</ArticleId></ArticleIdList></Reference><Reference><Citation>McDade-Montez E, Watson D, Beer A: Similarity, agreement, and assumed similarity in proxy end-of-life decision making. Fam Syst Health 2013; 31:366&#x2013;381</Citation><ArticleIdList><ArticleId IdType="pubmed">23957875</ArticleId></ArticleIdList></Reference><Reference><Citation>Marks MAZ, Arkes HR: Patient and surrogate disagreement in end-of-life decisions: can surrogates accurately predict patients&#x2019; preferences? Med Decis Making 28:524&#x2013;531</Citation><ArticleIdList><ArticleId IdType="pubmed">18566485</ArticleId></ArticleIdList></Reference><Reference><Citation>Epley N, Keysar B, Van Boven L, et al.: Perspective taking as egocentric anchoring and adjustment. J Pers Soc Psychol 2004; 87:327&#x2013;339</Citation><ArticleIdList><ArticleId IdType="pubmed">15382983</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller LM, Whitlatch CJ, Lyons KS: Shared decision-making in dementia: A review of patient and family carer involvement. Dementia 2016; 15:1141&#x2013;1157</Citation><ArticleIdList><ArticleId IdType="pubmed">25370075</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins JM, Locascio JJ, Gunther JM, et al.: Differences in Assessment of Everyday Preferences Between People With Cognitive Impairment and Their Care Partners: The Role of Neuropsychiatric Symptoms. Am J Geriatr psychiatry 2020; 28:1070&#x2013;1078</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7415491</ArticleId><ArticleId IdType="pubmed">32144001</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins JM, Locascio JJ, Gunther JM, et al.: Longitudinal differences in everyday preferences: Comparisons between people with cognitive impairment and their care partners. Int J Geriatr Psychiatry 2021;</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8901800</ArticleId><ArticleId IdType="pubmed">34498322</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins JM, Locascio JJ, Gomez-Isla T, et al.: Longitudinal Changes in Neuropsychiatric Symptoms: Impact of Discrepancy in Everyday Preferences Between Persons With Cognitive Impairment and Their Care Partners. Am J Geriatr Psychiatry 2022; 30:619&#x2013;623</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983425</ArticleId><ArticleId IdType="pubmed">34801383</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Haitsma K, Curyto K, Spector A, et al.: The preferences for everyday living inventory: scale development and description of psychosocial preferences responses in community-dwelling elders. Gerontologist 2013; 53:582&#x2013;595</Citation><ArticleIdList><ArticleId IdType="pubmed">22936532</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub S, Salmon D, Mercaldo N, et al.: The Alzheimer&#x2019;s Disease Centers&#x2019; Uniform Data Set (UDS): The neuropsychologic test battery. Alzheimer Dis Assoc Disord 2009; 23:91&#x2013;101</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2743984</ArticleId><ArticleId IdType="pubmed">19474567</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43:2412&#x2013;2414</Citation><ArticleIdList><ArticleId IdType="pubmed">8232972</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufer DI, Cummings JL, Ketchel P, et al.: Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 2000; 12:233&#x2013;239</Citation><ArticleIdList><ArticleId IdType="pubmed">11001602</ArticleId></ArticleIdList></Reference><Reference><Citation>Yesavage JA, Sheikh JI: GERIATRIC DEPRESSION SCALE (GDS): Recent Evidence and Development of a Shorter Version. Clin Gerontol 1986; 5:165&#x2013;173</Citation></Reference><Reference><Citation>Nasreddine ZS, Phillips NA, B&#xe9;dirian V, et al.: The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53:695&#x2013;699</Citation><ArticleIdList><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;id&#xe1;k Z: Rectangular Confidence Regions for the Means of Multivariate Normal Distributions. J Am Stat Assoc 1967; 62:626&#x2013;633</Citation></Reference><Reference><Citation>Pinquart M, S&#xf6;rensen S: Associations of stressors and uplifts of caregiving with caregiver burden and depressive mood: a meta-analysis. J Gerontol B Psychol Sci Soc Sci 2003; 58:P112&#x2013;128</Citation><ArticleIdList><ArticleId IdType="pubmed">12646594</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeifer L, Drobetz R, Fankhauser S, et al.: Caregiver rating bias in mild cognitive impairment and mild Alzheimer&#x2019;s disease: impact of caregiver burden and depression on dyadic rating discrepancy across domains. Int psychogeriatrics 2013; 25:1345&#x2013;1355</Citation><ArticleIdList><ArticleId IdType="pubmed">23651733</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrillo LA, McMahan RD, Tang V, et al.: Older Adult and Surrogate Perspectives on Serious, Difficult, and Important Medical Decisions. J Am Geriatr Soc 2018; 66:1515&#x2013;1523</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6167167</ArticleId><ArticleId IdType="pubmed">29972594</ArticleId></ArticleIdList></Reference><Reference><Citation>Su CT, McMahan RD, Williams BA, et al.: Family matters: effects of birth order, culture, and family dynamics on surrogate decision-making. J Am Geriatr Soc 2014; 62:175&#x2013;182</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4130561</ArticleId><ArticleId IdType="pubmed">24383459</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36604704</PMID><DateRevised><Year>2023</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1758-9193</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>05</Day></PubDate></JournalIssue><Title>Alzheimer's research &amp; therapy</Title><ISOAbbreviation>Alzheimers Res Ther</ISOAbbreviation></Journal><ArticleTitle>Correction: Treatment needs of dementia with Lewy bodies according to patients, caregivers, and physicians: a cross-sectional, observational, questionnaire-based study in Japan.</ArticleTitle><Pagination><StartPage>4</StartPage><MedlinePgn>4</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13195-022-01155-9</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>Mamoru</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan. mhashimoto@med.kindai.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuropsychiatry, Kindai University Faculty of Medicine, Osakasayama, Japan. mhashimoto@med.kindai.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manabe</LastName><ForeName>Yuta</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Dementia and Geriatric Medicine, Division of Clinical Science, Kanagawa Dental University School of Dentistry, Yokosuka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamaguchi</LastName><ForeName>Takuhiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toya</LastName><ForeName>Shunji</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Affairs, Sumitomo Pharma Co., Ltd., Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikeda</LastName><ForeName>Manabu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016425">Published Erratum</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Alzheimers Res Ther</MedlineTA><NlmUniqueID>101511643</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumFor"><RefSource>Alzheimers Res Ther. 2022 Dec 15;14(1):188. doi: 10.1186/s13195-022-01130-4</RefSource><PMID Version="1">36522749</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>5</Day><Hour>23</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36604704</ArticleId><ArticleId IdType="pmc">PMC9814419</ArticleId><ArticleId IdType="doi">10.1186/s13195-022-01155-9</ArticleId><ArticleId IdType="pii">10.1186/s13195-022-01155-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hashimoto M, Manabe Y, Yamaguchi T, et al. Treatment needs of dementia with Lewy bodies according to patients, caregivers, and physicians: a cross-sectional, observational, questionnaire-based study in Japan. Alz Res Therapy. 2022;14:188. doi: 10.1186/s13195-022-01130-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-022-01130-4</ArticleId><ArticleId IdType="pmc">PMC9751509</ArticleId><ArticleId IdType="pubmed">36522749</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36594914</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0098-9134</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of gerontological nursing</Title><ISOAbbreviation>J Gerontol Nurs</ISOAbbreviation></Journal><ArticleTitle>Navigating Disease-Modifying Treatments for Alzheimer's Disease: Focusing on Medications in Phase 3 Clinical Trials.</ArticleTitle><Pagination><StartPage>6</StartPage><EndPage>10</EndPage><MedlinePgn>6-10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3928/00989134-20221205-02</ELocationID><Abstract><AbstractText>Over the past 18 months, there has been scrutiny and controversy over the U.S. Food and Drug Administration's accelerated approval of aducanumab, a novel monoclonal antibody to treat Alzheimer's disease and prevent disease progression. As clinicians, educators, and advocates for our patients and caregivers impacted daily by this debilitating illness, this approval reinforces the need to maintain vigilance and awareness about emerging agents. The intent of the current article is to highlight some of the medications in Phase 3 clinical trials and share resources and updates on disease-modifying agents and their unique pharmacology. [<i>Journal of Gerontological Nursing, 49</i>(1), 6-10.].</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brandt</LastName><ForeName>Nicole J</ForeName><Initials>NJ</Initials></Author><Author ValidYN="Y"><LastName>Wheeler</LastName><ForeName>Carrie</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Courtin</LastName><ForeName>S Orion</ForeName><Initials>SO</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Gerontol Nurs</MedlineTA><NlmUniqueID>7510258</NlmUniqueID><ISSNLinking>0098-9134</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D061067">Antibodies, Monoclonal, Humanized</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017326" MajorTopicYN="N">Clinical Trials, Phase III as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061067" MajorTopicYN="Y">Antibodies, Monoclonal, Humanized</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>3</Day><Hour>10</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36594914</ArticleId><ArticleId IdType="doi">10.3928/00989134-20221205-02</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36593897</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2667-2421</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>IBRO neuroscience reports</Title><ISOAbbreviation>IBRO Neurosci Rep</ISOAbbreviation></Journal><ArticleTitle>Review of Alzheimer's disease drugs and their relationship with neuron-glia interaction.</ArticleTitle><Pagination><StartPage>64</StartPage><EndPage>76</EndPage><MedlinePgn>64-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ibneur.2022.11.005</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) is the most common cause of dementia worldwide. Because Alzheimer's disease has no known treatment, sufferers and their caregivers must concentrate on symptom management. Astrocytes and microglia are now known to play distinct physiological roles in synaptic function, the blood-brain barrier, and neurovascular coupling. Consequently, the search for drugs that can slow the degenerative process in dementia sufferers continues because existing drugs are designed to alleviate the symptoms of Alzheimer's disease. Drugs that address pathological changes without interfering with the normal function of glia, such as eliminating amyloid-beta deposits, are prospective treatments for neuroinflammatory illnesses. Because neuron-astrocytes-microglia interactions are so complex, developing effective, preventive, and therapeutic medications for AD will necessitate novel methodologies and strategic targets. This review focused on existing medications used in treating AD amongst which include Donepezil, Choline Alphoscerate, Galantamine, Dextromethorphan, palmitoylethanolamide, citalopram, resveratrol, and solanezumab. This review summarizes the effects of these drugs on neurons, astrocytes, and microglia interactions based on their pharmacokinetic properties, mechanism of action, dosing, and clinical presentations.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ajenikoko</LastName><ForeName>Michael Kunle</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Faculty of Biomedical Sciences, Kampala International University, Western Campus, Ishaka, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ajagbe</LastName><ForeName>Abayomi Oyeyemi</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Faculty of Basic Medical Sciences, College of Health Sciences, Nile University of Nigeria, P.M.B. 900001 Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onigbinde</LastName><ForeName>Oluwanisola Akanji</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Faculty of Basic Medical Sciences, College of Health Sciences, Nile University of Nigeria, P.M.B. 900001 Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okesina</LastName><ForeName>Akeem Ayodeji</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine and Community Health, School of Health Sciences, College of Medicine and Health Sciences, University of Rwanda, Rwanda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tijani</LastName><ForeName>Ahmad Adekilekun</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Faculty of Basic Medical Sciences, Modibbo Adama University, Yola, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>IBRO Neurosci Rep</MedlineTA><NlmUniqueID>101775148</NlmUniqueID><ISSNLinking>2667-2421</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alphoscerate</Keyword><Keyword MajorTopicYN="N">Alzheimer</Keyword><Keyword MajorTopicYN="N">Dextromethorphan</Keyword><Keyword MajorTopicYN="N">Galantamine</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Neuron-glia</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>3</Day><Hour>1</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36593897</ArticleId><ArticleId IdType="pmc">PMC9803919</ArticleId><ArticleId IdType="doi">10.1016/j.ibneur.2022.11.005</ArticleId><ArticleId IdType="pii">S2667-2421(22)00094-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>2020 Alzheimer&#x2019;s disease facts and figures, 2020. Alzheimer&#x2019;s &amp; Dementia, vol. 16(no. 3), pp. 391&#x2013;460. &#x2329;10.1002/alz.12068&#x232a;.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12068</ArticleId><ArticleId IdType="pubmed">32157811</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboukhatwa M., Dosanjh L., Luo Y. Antidepressants are a rational complementary therapy for the treatment of Alzheimer&#x2019;s disease. Mol. Neurodegener. 2010;5(1):10. doi: 10.1186/1750-1326-5-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-5-10</ArticleId><ArticleId IdType="pmc">PMC2845130</ArticleId><ArticleId IdType="pubmed">20226030</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeloye D., Auta A., Ezejimofor M., Oyedokun A., Harhay M.O., Rudan I., Chan K.Y. Prevalence of dementia in Nigeria: a systematic review of the evidence. J. Glob. Health Rep. 2019;3 doi: 10.29392/joghr.3.e2019014.</Citation><ArticleIdList><ArticleId IdType="doi">10.29392/joghr.3.e2019014</ArticleId><ArticleId IdType="pmc">PMC6746335</ArticleId><ArticleId IdType="pubmed">31528708</ArticleId></ArticleIdList></Reference><Reference><Citation>Adlimoghaddam A., Neuendorff M., Roy B., Albensi B.C. A review of clinical treatment considerations of donepezil in severe Alzheimer&#x2019;s disease. CNS Neurosci. Ther. 2018;24(10):876&#x2013;888. doi: 10.1111/cns.13035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13035</ArticleId><ArticleId IdType="pmc">PMC6489741</ArticleId><ArticleId IdType="pubmed">30058285</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae M., Han S.Y., Kim E.-S., You B.H., Kim Y.-M., Cho J., Chin Y.-W., Choi Y.H. Effect of water extract of mangosteen pericarp on donepezil pharmacokinetics in mice. Molecules. 2021;26(17):5246. doi: 10.3390/molecules26175246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26175246</ArticleId><ArticleId IdType="pmc">PMC8434012</ArticleId><ArticleId IdType="pubmed">34500680</ArticleId></ArticleIdList></Reference><Reference><Citation>Beggiato S., Tomasini M.C., Cassano T., Ferraro L. Chronic oral palmitoylethanolamide administration rescues cognitive deficit and reduces neuroinflammation, oxidative stress, and glutamate levels in A transgenic murine model of Alzheimer&#x2019;s disease. J. Clin. Med. 2020;9(2) doi: 10.3390/jcm9020428.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020428</ArticleId><ArticleId IdType="pmc">PMC7074257</ArticleId><ArticleId IdType="pubmed">32033363</ArticleId></ArticleIdList></Reference><Reference><Citation>Beggiato S., Tomasini M.C., Ferraro L. Palmitoylethanolamide (PEA) as a potential therapeutic agent in Alzheimer&#x2019;s disease. Front. Pharm. 2019;10:821. doi: 10.3389/fphar.2019.00821.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00821</ArticleId><ArticleId IdType="pmc">PMC6667638</ArticleId><ArticleId IdType="pubmed">31396087</ArticleId></ArticleIdList></Reference><Reference><Citation>Birks J.S., Harvey R.J. Donepezil for dementia due to Alzheimer&#x2019;s disease. Cochrane Database of Systematic Reviews. 2018;2018(6) doi: 10.1002/14651858.CD001190.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001190.pub3</ArticleId><ArticleId IdType="pmc">PMC6513124</ArticleId><ArticleId IdType="pubmed">29923184</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobermin L.D., Roppa R.H.A., Quincozes-Santos A. Adenosine receptors as a new target for resveratrol-mediated glioprotection. Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 2019;1865(3):634&#x2013;647. doi: 10.1016/j.bbadis.2019.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2019.01.004</ArticleId><ArticleId IdType="pubmed">30611861</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouter Y., Noguerola J.S.L., Tucholla P., Crespi G.A.N., Parker M.W., Wiltfang J., Miles L.A., Bayer T.A. Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models. Acta Neuropathol. 2015;130(5):713&#x2013;729. doi: 10.1007/s00401-015-1489-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1489-x</ArticleId><ArticleId IdType="pubmed">26467270</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodaty H., Woodward M., Boundy K., Barnes N., Allen G. A naturalistic study of galantamine for Alzheimer's disease. CNS Drugs. 2006;20(11):935&#x2013;943. doi: 10.2165/00023210-200620110-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00023210-200620110-00006</ArticleId><ArticleId IdType="pubmed">17044730</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronzuoli M.R., Facchinetti R., Steardo L., Romano A., Stecca C., Passarella S., Steardo L., Cassano T., Scuderi C. Palmitoylethanolamide dampens reactive astrogliosis and improves neuronal trophic support in a triple transgenic model of Alzheimer&#x2019;s disease: in vitro and in vivo evidence. Oxid. Med. Cell. Longev. 2018;2018:1&#x2013;14. doi: 10.1155/2018/4720532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/4720532</ArticleId><ArticleId IdType="pmc">PMC5822864</ArticleId><ArticleId IdType="pubmed">29576849</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J. Clin. Investig. 2006;116(4):905&#x2013;915. doi: 10.1172/JCI26836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI26836</ArticleId><ArticleId IdType="pmc">PMC1409740</ArticleId><ArticleId IdType="pubmed">16557302</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson M.J., Cameron Thrash J., Walter B. The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin. Neurosci. Res. 2006;6(5):237&#x2013;245. doi: 10.1016/j.cnr.2006.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnr.2006.09.004</ArticleId><ArticleId IdType="pmc">PMC2630233</ArticleId><ArticleId IdType="pubmed">19169437</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter S.F., Herholz K., Rosa-Neto P., Pellerin L., Nordberg A., Zimmer E.R. Astrocyte biomarkers in Alzheimer&#x2019;s disease. Trends Mol. Med. 2019;25(2):77&#x2013;95. doi: 10.1016/j.molmed.2018.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2018.11.006</ArticleId><ArticleId IdType="pubmed">30611668</ArticleId></ArticleIdList></Reference><Reference><Citation>Casale R., Symeonidou Z., Ferfeli S., Micheli F., Scarsella P., Paladini A. Food for special medical purposes and nutraceuticals for pain: a narrative review. Pain Ther. 2021;10(1):225&#x2013;242. doi: 10.1007/s40122-021-00239-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40122-021-00239-y</ArticleId><ArticleId IdType="pmc">PMC8119521</ArticleId><ArticleId IdType="pubmed">33594594</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerbai F., Lana D., Nosi D., Petkova-Kirova P., Zecchi S., Brothers H.M., Wenk G.L., Giovannini M.G. The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus. PLoS One. 2012;7(9) doi: 10.1371/journal.pone.0045250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0045250</ArticleId><ArticleId IdType="pmc">PMC3445467</ArticleId><ArticleId IdType="pubmed">23028880</ArticleId></ArticleIdList></Reference><Reference><Citation>Chechneva O.V., Mayrhofer F., Daugherty D.J., Pleasure D.E., Hong J.-S., Deng W. Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord. Neurobiol. Dis. 2011;44(1):63&#x2013;72. doi: 10.1016/j.nbd.2011.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.06.004</ArticleId><ArticleId IdType="pmc">PMC3153572</ArticleId><ArticleId IdType="pubmed">21704706</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheignon C., Tomas M., Bonnefont-Rousselot D., Faller P., Hureau C., Collin F. Oxidative stress and the amyloid beta peptide in Alzheimer&#x2019;s disease. Redox Biol. 2018;14:450&#x2013;464. doi: 10.1016/j.redox.2017.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2017.10.014</ArticleId><ArticleId IdType="pmc">PMC5680523</ArticleId><ArticleId IdType="pubmed">29080524</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z.R., Somogyi A.A., Bochner F. Simultaneous determination of dextromethorphan and three metabolites in plasma and urine using high-performance liquid chromatography with application to their disposition in man. Ther. Drug Monit. 1990;12(1):97&#x2013;104. doi: 10.1097/00007691-199001000-00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007691-199001000-00018</ArticleId><ArticleId IdType="pubmed">2305428</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin-Chan M., Navarro-Yepes J., Quintanilla-Vega B. Environmental pollutants as risk factors for neurodegenerative disorders: alzheimer and Parkinson diseases. Front. Cell. Neurosci. 2015:9. doi: 10.3389/fncel.2015.00124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00124</ArticleId><ArticleId IdType="pmc">PMC4392704</ArticleId><ArticleId IdType="pubmed">25914621</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi M., Lee S.-M., Kim D., Im H.-I., Kim H.-S., Jeong Y.H. Disruption of the astrocyte&#x2013;neuron interaction is responsible for the impairments in learning and memory in 5XFAD mice: an Alzheimer&#x2019;s disease animal model. Mol. Brain. 2021;14(1):111. doi: 10.1186/s13041-021-00823-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-021-00823-5</ArticleId><ArticleId IdType="pmc">PMC8272251</ArticleId><ArticleId IdType="pubmed">34246283</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu D., Liu F. Pathological changes of tau related to Alzheimer&#x2019;s disease. ACS Chem. Neurosci. 2019;10(2):931&#x2013;944. doi: 10.1021/acschemneuro.8b00457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.8b00457</ArticleId><ArticleId IdType="pubmed">30346708</ArticleId></ArticleIdList></Reference><Reference><Citation>Courtney C. Long-term donepezil treatment in 565 patients with Alzheimer&#x2019;s disease (AD2000): randomised double-blind trial. Lancet. 2004;363(9427):2105&#x2013;2115. doi: 10.1016/S0140-6736(04)16499-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(04)16499-4</ArticleId><ArticleId IdType="pubmed">15220031</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Agostino G., Russo R., Avagliano C., Cristiano C., Meli R., Calignano A. Palmitoylethanolamide protects against the amyloid-&#x3b2;25&#x2013;35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease. Neuropsychopharmacology. 2012;37(7):1784&#x2013;1792. doi: 10.1038/npp.2012.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2012.25</ArticleId><ArticleId IdType="pmc">PMC3358748</ArticleId><ArticleId IdType="pubmed">22414817</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasuri K., Zhang L., Kim S.O.K.F., Bruce-Keller A.J., Keller J.N. Dietary and donepezil modulation of mTOR signaling and neuroinflammation in the brain. Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 2016;1862(2):274&#x2013;283. doi: 10.1016/j.bbadis.2015.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2015.11.002</ArticleId><ArticleId IdType="pmc">PMC4959420</ArticleId><ArticleId IdType="pubmed">26554604</ArticleId></ArticleIdList></Reference><Reference><Citation>Delekate A., F&#xfc;chtemeier M., Schumacher T., Ulbrich C., Foddis M., Petzold G.C. Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer&#x2019;s disease mouse model. Nat. Commun. 2014;5(1):5422. doi: 10.1038/ncomms6422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6422</ArticleId><ArticleId IdType="pubmed">25406732</ArticleId></ArticleIdList></Reference><Reference><Citation>Deyn P.P. de, Dam D. van., editors. Animal Models of Dementia. Humana Press; 2011.</Citation></Reference><Reference><Citation>D&#xed;az-Lucena D., Gutierrez-Mecinas M., Moreno B., Mart&#xed;nez-S&#xe1;nchez J.L., Pifarr&#xe9; P., Garc&#xed;a A. Mechanisms involved in the remyelinating effect of sildenafil. J. Neuroimmune Pharm. 2018;13(1):6&#x2013;23. doi: 10.1007/s11481-017-9756-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-017-9756-3</ArticleId><ArticleId IdType="pubmed">28776122</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Bachiller M.I., P&#xe9;rez C., Gonz&#xe1;lez-Mu&#xf1;oz G.C., Conde S., L&#xf3;pez M.G., Villarroya M., Garc&#xed;a A.G., Rodr&#xed;guez-Franco M.I. Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer&#x2019;s disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties. J. Med. Chem. 2010;53(13):4927&#x2013;4937. doi: 10.1021/jm100329q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm100329q</ArticleId><ArticleId IdType="pubmed">20545360</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamage R., Wagnon I., Rossetti I., Childs R., Niedermayer G., Chesworth R., Gyengesi E. Cholinergic modulation of glial function during aging and chronic neuroinflammation. Front. Cell. Neurosci. 2020;14 doi: 10.3389/fncel.2020.577912.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.577912</ArticleId><ArticleId IdType="pmc">PMC7594524</ArticleId><ArticleId IdType="pubmed">33192323</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudig M., Richarz U., Han J., Van Baelen B., Schauble B. Effects of galantamine in Alzheimers disease: double-blind withdrawal studies evaluating sustained versus interrupted treatment. Curr. Alzheimer Res. 2011;8(7):771&#x2013;780. doi: 10.2174/156720511797633205.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720511797633205</ArticleId><ArticleId IdType="pubmed">21707533</ArticleId></ArticleIdList></Reference><Reference><Citation>Genade T., Lang D.M. Resveratrol extends lifespan and preserves glia but not neurons of the Nothobranchius guentheri optic tectum. Exp. Gerontol. 2013;48(2):202&#x2013;212. doi: 10.1016/j.exger.2012.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2012.11.013</ArticleId><ArticleId IdType="pubmed">23220248</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshi N., Morgan R.K., Lein P.J., Seker E. A primary neural cell culture model to study neuron, astrocyte, and microglia interactions in neuroinflammation. Journal of Neuroinflammation. 2020;17(1):155. doi: 10.1186/s12974-020-01819-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01819-z</ArticleId><ArticleId IdType="pmc">PMC7216677</ArticleId><ArticleId IdType="pubmed">32393376</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampel H., Schneider L.S., Giacobini E., Kivipelto M., Sindi S., Dubois B., Broich K., Nistic&#xf2; R., Aisen P.S., Lista S. Advances in the therapy of Alzheimer&#x2019;s disease: targeting amyloid beta and tau and perspectives for the future. Expert Rev. Neurother. 2015;15(1):83&#x2013;105. doi: 10.1586/14737175.2015.995637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14737175.2015.995637</ArticleId><ArticleId IdType="pubmed">25537424</ArticleId></ArticleIdList></Reference><Reference><Citation>Honig L.S., Vellas B., Woodward M., Boada M., Bullock R., Borrie M., Hager K., Andreasen N., Scarpini E., Liu-Seifert H., Case M., Dean R.A., Hake A., Sundell K., Poole Hoffmann V., Carlson C., Khanna R., Mintun M., DeMattos R., Siemers K., et al. Trial of solanezumab for mild dementia due to Alzheimer&#x2019;s disease. N. Engl. J. Med. 2018;378(4):321&#x2013;330. doi: 10.1056/NEJMoa1705971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1705971</ArticleId><ArticleId IdType="pubmed">29365294</ArticleId></ArticleIdList></Reference><Reference><Citation>Imbimbo B.P., Ottonello S., Frisardi V., Solfrizzi V., Greco A., Seripa D., Pilotto A., Panza F. Solanezumab for the treatment of mild-to-moderate Alzheimer&#x2019;s disease. Expert Rev. Clin. Immunol. 2012;8(2):135&#x2013;149. doi: 10.1586/eci.11.93.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eci.11.93</ArticleId><ArticleId IdType="pubmed">22288451</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiguro S., Shinada T., Wu Z., Karimazawa M., Uchidate M., Nishimura E., Yasuno Y., Ebata M., Sillapakong P., Ishiguro H., Ebata N., Ni J., Jiang M., Goryo M., Otsu K., Harada H., Suzuki K. A novel cyclic peptide (Naturido) modulates glia&#x2013;neuron interactions in vitro and reverses ageing-related deficits in senescence-accelerated mice. PLoS One. 2021;16(1) doi: 10.1371/journal.pone.0245235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245235</ArticleId><ArticleId IdType="pmc">PMC7840003</ArticleId><ArticleId IdType="pubmed">33503058</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur D., Sharma V., Deshmukh R. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer&#x2019;s disease. Inflammopharmacology. 2019;27(4):663&#x2013;677. doi: 10.1007/s10787-019-00580-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-019-00580-x</ArticleId><ArticleId IdType="pubmed">30874945</ArticleId></ArticleIdList></Reference><Reference><Citation>Keady J., Clarke C.L., Page S., editors. Partnerships in Community Mental Health Nursing and Dementia Care: Practice Perspectives. Open University Press; 2007.</Citation></Reference><Reference><Citation>Kelly D.L., McMahon R.P., Weiner E., Boggs D.L., Dickinson D., Conley R.R., Buchanan R.W. Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia. Schizophr. Res. 2008;103(1&#x2013;3):161&#x2013;168. doi: 10.1016/j.schres.2008.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.schres.2008.04.027</ArticleId><ArticleId IdType="pmc">PMC2547986</ArticleId><ArticleId IdType="pubmed">18550339</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.G., Moon M., Choi J.G., Park G., Kim A.-J., Hur J., Lee K.-T., Oh M.S. Donepezil inhibits the amyloid-beta oligomer-induced microglial activation in vitro and in vivo. NeuroToxicology. 2014;40:23&#x2013;32. doi: 10.1016/j.neuro.2013.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2013.10.004</ArticleId><ArticleId IdType="pubmed">24189446</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.S., Choi J., Yoon B.-E. Neuron-glia interactions in neurodevelopmental disorders. Cells. 2020;9(10):2176. doi: 10.3390/cells9102176.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9102176</ArticleId><ArticleId IdType="pmc">PMC7601502</ArticleId><ArticleId IdType="pubmed">32992620</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi E., Nakano M., Kubota K., Himuro N., Mizoguchi S., Chikenji T., Otani M., Mizue Y., Nagaishi K., Fujimiya M. Activated forms of astrocytes with higher GLT-1 expression are associated with cognitive normal subjects with Alzheimer pathology in human brain. Sci. Rep. 2018;8(1):1712. doi: 10.1038/s41598-018-19442-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-19442-7</ArticleId><ArticleId IdType="pmc">PMC5786045</ArticleId><ArticleId IdType="pubmed">29374250</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostrzewa R.M., editor. Handbook of Neurotoxicity. Springer Reference; 2014.</Citation></Reference><Reference><Citation>Kou X., Chen N. Resveratrol as a natural autophagy regulator for prevention and treatment of Alzheimer&#x2019;s disease. Nutrients. 2017;9(9) doi: 10.3390/nu9090927.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9090927</ArticleId><ArticleId IdType="pmc">PMC5622687</ArticleId><ArticleId IdType="pubmed">28837083</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuchibhotla K.V., Lattarulo C.R., Hyman B.T., Bacskai B.J. Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science. 2009;323(5918):1211&#x2013;1215. doi: 10.1126/science.1169096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1169096</ArticleId><ArticleId IdType="pmc">PMC2884172</ArticleId><ArticleId IdType="pubmed">19251629</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon K.J., Kim M.K., Lee E.J., Kim J.N., Choi B.-R., Kim S.Y., Cho K.S., Han J.-S., Kim H.Y., Shin C.Y., Han S.-H. Effects of donepezil, an acetylcholinesterase inhibitor, on neurogenesis in a rat model of vascular dementia. J. Neurol. Sci. 2014;347(1&#x2013;2):66&#x2013;77. doi: 10.1016/j.jns.2014.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.09.021</ArticleId><ArticleId IdType="pubmed">25266713</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert D., Vandevoorde S., Jonsson K.-O., Fowler C. The palmitoylethanolamide family: a new class of anti-inflammatory agents&#xa0;? Curr. Med. Chem. 2002;9(6):663&#x2013;674. doi: 10.2174/0929867023370707.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867023370707</ArticleId><ArticleId IdType="pubmed">11945130</ArticleId></ArticleIdList></Reference><Reference><Citation>Lana D., Melani A., Pugliese A.M., Cipriani S., Nosi D., Pedata F., Giovannini M.G. The neuron-astrocyte-microglia triad in a rat model of chronic cerebral hypoperfusion: protective effect of dipyridamole. Front. Aging Neurosci. 2014:6. doi: 10.3389/fnagi.2014.00322.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2014.00322</ArticleId><ArticleId IdType="pmc">PMC4245920</ArticleId><ArticleId IdType="pubmed">25505884</ArticleId></ArticleIdList></Reference><Reference><Citation>Lana D., Ugolini F., Melani A., Nosi D., Pedata F., Giovannini M.G. The neuron-astrocyte-microglia triad in CA3 after chronic cerebral hypoperfusion in the rat: protective effect of dipyridamole. Exp. Gerontol. 2017;96:46&#x2013;62. doi: 10.1016/j.exger.2017.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2017.06.006</ArticleId><ArticleId IdType="pubmed">28606482</ArticleId></ArticleIdList></Reference><Reference><Citation>Lao K., Ji N., Zhang X., Qiao W., Tang Z., Gou X. Drug development for Alzheimer&#x2019;s disease: review. J. Drug Target. 2019;27(2):164&#x2013;173. doi: 10.1080/1061186X.2018.1474361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1061186X.2018.1474361</ArticleId><ArticleId IdType="pubmed">29732929</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauterbach E.C., Shillcutt S.D., Phillips D.E. Neuropathology of Drug Addictions and Substance Misuse. Elsevier; 2016. Dextromethorphan and dextrorphan as heuristic rapid-acting, conventional, and treatment-resistant antidepressants, with substance abuse considerations; pp. 707&#x2013;717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-800634-4.00071-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.-H., Jeong S.-K., Kim B.C., Park K.W., Dash A. Donepezil across the spectrum of Alzheimer&#x2019;s disease: dose optimization and clinical relevance. Acta Neurol. Scand. 2015;131(5):259&#x2013;267. doi: 10.1111/ane.12386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12386</ArticleId><ArticleId IdType="pubmed">25690270</ArticleId></ArticleIdList></Reference><Reference><Citation>Lines J., Baraibar A.M., Fang C., Martin E.D., Aguilar J., Lee M.K., Araque A., Kofuji P. Astrocyte&#x2010;neuronal network interplay is disrupted in Alzheimer&#x2019;s disease mice. Glia. 2022;70(2):368&#x2013;378. doi: 10.1002/glia.24112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.24112</ArticleId><ArticleId IdType="pmc">PMC8665078</ArticleId><ArticleId IdType="pubmed">34726298</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisak R.P., Nedelkoska L., Benjamins J.A. Effects of dextromethorphan on glial cell function: proliferation, maturation, and protection from cytotoxic molecules: dextromethorphan and glial cell function. Glia. 2014;62(5):751&#x2013;762. doi: 10.1002/glia.22639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22639</ArticleId><ArticleId IdType="pubmed">24526455</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisak R.P., Nedelkoska L., Benjamins J.A. Sigma-1 receptor agonists as potential protective therapies in multiple sclerosis. J. Neuroimmunol. 2020;342 doi: 10.1016/j.jneuroim.2020.577188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2020.577188</ArticleId><ArticleId IdType="pubmed">32179326</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Chang L., Song Y., Li H., Wu Y. The role of NMDA receptors in Alzheimer&#x2019;s disease. Front. Neurosci. 2019;13:43. doi: 10.3389/fnins.2019.00043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00043</ArticleId><ArticleId IdType="pmc">PMC6375899</ArticleId><ArticleId IdType="pubmed">30800052</ArticleId></ArticleIdList></Reference><Reference><Citation>Madeira J., Schindler S., Klegeris A. A new look at auranofin, dextromethorphan and rosiglitazone for reduction of glia-mediated inflammation in neurodegenerative diseases. Neural Regen. Res. 2015;10(3):391. doi: 10.4103/1673-5374.153686.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.153686</ArticleId><ArticleId IdType="pmc">PMC4396100</ArticleId><ArticleId IdType="pubmed">25878586</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui K., Mishima M., Nagai Y., Yuzuriha T., Yoshimura T. Absorption, distribution, metabolism, and excretion of donepezil (Aricept) after a single oral administration to rat. Drug Metab. Dispos.: Biol. Fate Chem. 1999;27(12):1406&#x2013;1414.</Citation><ArticleIdList><ArticleId IdType="pubmed">10570021</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercatelli R., Lana D., Bucciantini M., Giovannini M.G., Cerbai F., Quercioli F., Zecchi&#x2010;Orlandini S., Delfino G., Wenk G.L., Nosi D. Clasmatodendrosis and &#x3b2;&#x2010;amyloidosis in aging hippocampus. FASEB J. 2016;30(4):1480&#x2013;1491. doi: 10.1096/fj.15-275503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.15-275503</ArticleId><ArticleId IdType="pubmed">26722005</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliorini C., Porciatti E., Luczkowski M., Valensin D. Structural characterization of Cu2+, Ni2+ and Zn2+ binding sites of model peptides associated with neurodegenerative diseases. Coord. Chem. Rev. 2012;256(1&#x2013;2):352&#x2013;368. doi: 10.1016/j.ccr.2011.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccr.2011.07.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Moussa C., Hebron M., Huang X., Ahn J., Rissman R.A., Aisen P.S., Turner R.S. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer&#x2019;s disease. J. Neuroinflamm. 2017;14(1):1. doi: 10.1186/s12974-016-0779-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0779-0</ArticleId><ArticleId IdType="pmc">PMC5234138</ArticleId><ArticleId IdType="pubmed">28086917</ArticleId></ArticleIdList></Reference><Reference><Citation>Mubangizi V., Maling S., Obua C., Tsai A.C. Prevalence and correlates of Alzheimer&#x2019;s disease and related dementias in rural Uganda: cross-sectional, population-based study. BMC Geriatr. 2020;20(1):48. doi: 10.1186/s12877-020-1461-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-020-1461-z</ArticleId><ArticleId IdType="pmc">PMC7011370</ArticleId><ArticleId IdType="pubmed">32041525</ArticleId></ArticleIdList></Reference><Reference><Citation>Namuli J.D. In: Brain Degeneration and Dementia in Sub-Saharan Africa. Musisi S., Jacobson S., editors. Springer; New York: 2015. A case of Alzheimer&#x2019;s dementia in Uganda; pp. 247&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-2456-1_17</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarrete M., Perea G., de Sevilla D.F., G&#xf3;mez-Gonzalo M., N&#xfa;&#xf1;ez A., Mart&#xed;n E.D., Araque A. Astrocytes mediate in vivo cholinergic-induced synaptic plasticity. PLoS Biol. 2012;10(2) doi: 10.1371/journal.pbio.1001259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1001259</ArticleId><ArticleId IdType="pmc">PMC3279365</ArticleId><ArticleId IdType="pubmed">22347811</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumeister K.L., Riepe M.W. Bupropion and citalopram in the APP23 mouse model of Alzheimer&#x2019;s disease: a study in a dry-land maze. Int. J. Alzheimer&#x2019;s Dis. 2012;2012:1&#x2013;7. doi: 10.1155/2012/673584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/673584</ArticleId><ArticleId IdType="pmc">PMC3465969</ArticleId><ArticleId IdType="pubmed">23056993</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh, S., Agrawal, S., Sabir, S., Taylor, A., 2022. Dextromethorphan. In StatPearls. StatPearls Publishing. &#x2329;http://www.ncbi.nlm.nih.gov/books/NBK538216/&#x232a;.</Citation><ArticleIdList><ArticleId IdType="pubmed">30855804</ArticleId></ArticleIdList></Reference><Reference><Citation>Olawande T.I., Ajayi M.P., Amoo E.O., Olawole-Isaac A. Treatment pathways of Alzheimer in Nigeria. Heliyon. 2020;6(12) doi: 10.1016/j.heliyon.2020.e05724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2020.e05724</ArticleId><ArticleId IdType="pmc">PMC7736722</ArticleId><ArticleId IdType="pubmed">33344795</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzine M., Gulberti S., Ramalanjaona N., Magdalou J., Fournel-Gigleux S. The UDP-glucuronosyltransferases of the blood-brain barrier: their role in drug metabolism and detoxication. Front. Cell. Neurosci. 2014:8. doi: 10.3389/fncel.2014.00349.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00349</ArticleId><ArticleId IdType="pmc">PMC4211562</ArticleId><ArticleId IdType="pubmed">25389387</ArticleId></ArticleIdList></Reference><Reference><Citation>Panza F., Frisardi V., Imbimbo B.P., Seripa D., Solfrizzi V., Pilotto A. Monoclonal antibodies against &#x3b2;-amyloid (A&#x3b2;) for the treatment of Alzheimer&#x2019;s disease: the A&#x3b2; target at a crossroads. Expert Opin. Biol. Ther. 2011;11(6):679&#x2013;686. doi: 10.1517/14712598.2011.579099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14712598.2011.579099</ArticleId><ArticleId IdType="pubmed">21501112</ArticleId></ArticleIdList></Reference><Reference><Citation>Parnetti L., Amenta F., Gallai V. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data. Mech. Ageing Dev. 2001;122(16):2041&#x2013;2055. doi: 10.1016/S0047-6374(01)00312-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0047-6374(01)00312-8</ArticleId><ArticleId IdType="pubmed">11589921</ArticleId></ArticleIdList></Reference><Reference><Citation>Raskind M.A., Peskind E.R., Wessel T., Yuan W., the Galantamine USA- Study Group Galantamine in AD: a 6-month randomized, placebo-controlled trial with a 6-month extension. Neurology. 2000;54(12):2261&#x2013;2268. doi: 10.1212/WNL.54.12.2261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.54.12.2261</ArticleId><ArticleId IdType="pubmed">10881250</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy A.P., Yin X., Sawant N., Reddy P.H. Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer&#x2019;s disease. Hum. Mol. Genet. 2021;30(10):847&#x2013;864. doi: 10.1093/hmg/ddab054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddab054</ArticleId><ArticleId IdType="pmc">PMC8355469</ArticleId><ArticleId IdType="pubmed">33615359</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci G., Volpi L., Pasquali L., Petrozzi L., Siciliano G. Astrocyte&#x2013;neuron interactions in neurological disorders. J. Biol. Phys. 2009;35(4):317&#x2013;336. doi: 10.1007/s10867-009-9157-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10867-009-9157-9</ArticleId><ArticleId IdType="pmc">PMC2750745</ArticleId><ArticleId IdType="pubmed">19669420</ArticleId></ArticleIdList></Reference><Reference><Citation>Roher A.E., Maarouf C.L., Kokjohn T.A., Belden C., Serrano G., Sabbagh M.S., Beach T.G. Chemical and neuropathological analyses of an Alzheimer&#x2019;s disease patient treated with solanezumab. Am. J. Neurodegener. Dis. 2016;5(4):158&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5043095</ArticleId><ArticleId IdType="pubmed">27725918</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo A.K., Dandapat J., Dash U.C., Kanhar S. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer&#x2019;s disease. J. Ethnopharmacol. 2018;215:42&#x2013;73. doi: 10.1016/j.jep.2017.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2017.12.015</ArticleId><ArticleId IdType="pubmed">29248451</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito T., Hisahara S., Iwahara N., Emoto M.C., Yokokawa K., Suzuki H., Manabe T., Matsumura A., Suzuki S., Matsushita T., Kawamata J., Sato-Akaba H., Fujii H.G., Shimohama S. Early administration of galantamine from preplaque phase suppresses oxidative stress and improves cognitive behavior in APPswe/PS1dE9 mouse model of Alzheimer&#x2019;s disease. Free Radic. Biol. Med. 2019;145:20&#x2013;32. doi: 10.1016/j.freeradbiomed.2019.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2019.09.014</ArticleId><ArticleId IdType="pubmed">31536772</ArticleId></ArticleIdList></Reference><Reference><Citation>Sa&#x142;aciak K., Pytka K. Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders. Neurosci. Biobehav. Rev. 2021 doi: 10.1016/j.neubiorev.2021.10.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2021.10.037</ArticleId><ArticleId IdType="pmc">PMC8559442</ArticleId><ArticleId IdType="pubmed">34736882</ArticleId></ArticleIdList></Reference><Reference><Citation>Salman M.M., Al-Obaidi Z., Kitchen P., Loreto A., Bill R.M., Wade-Martins R. Advances in applying computer-aided drug design for neurodegenerative diseases. Int. J. Mol. Sci. 2021;22(9):4688. doi: 10.3390/ijms22094688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094688</ArticleId><ArticleId IdType="pmc">PMC8124449</ArticleId><ArticleId IdType="pubmed">33925236</ArticleId></ArticleIdList></Reference><Reference><Citation>Samadi H., Sultzer D. Solanezumab for Alzheimer&#x2019;s disease. Expert Opin. Biol. Ther. 2011;11(6):787&#x2013;798. doi: 10.1517/14712598.2011.578573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14712598.2011.578573</ArticleId><ArticleId IdType="pubmed">21504387</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandhir R., Yadav A., Sunkaria A., Singhal N. Nano-antioxidants: an emerging strategy for intervention against neurodegenerative conditions. Neurochem. Int. 2015;89:209&#x2013;226. doi: 10.1016/j.neuint.2015.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2015.08.011</ArticleId><ArticleId IdType="pubmed">26315960</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawda C., Moussa C., Turner R.S. Resveratrol for Alzheimer&#x2019;s disease: Alzheimer&#x2019;s disease. Ann. N. Y. Acad. Sci. 2017;1403(1):142&#x2013;149. doi: 10.1111/nyas.13431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.13431</ArticleId><ArticleId IdType="pmc">PMC5664214</ArticleId><ArticleId IdType="pubmed">28815614</ArticleId></ArticleIdList></Reference><Reference><Citation>Scapicchio P.L. Revisiting choline alphoscerate profile: a new, perspective, role in dementia. Int. J. Neurosci. 2013;123(7):444&#x2013;449. doi: 10.3109/00207454.2013.765870.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00207454.2013.765870</ArticleId><ArticleId IdType="pubmed">23387341</ArticleId></ArticleIdList></Reference><Reference><Citation>Schipke C.G., Heuser I., Peters O. Antidepressants act on glial cells: SSRIs and serotonin elicit astrocyte calcium signaling in the mouse prefrontal cortex. J. Psychiatr. Res. 2011;45(2):242&#x2013;248. doi: 10.1016/j.jpsychires.2010.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2010.06.005</ArticleId><ArticleId IdType="pubmed">20619420</ArticleId></ArticleIdList></Reference><Reference><Citation>Scuderi C., Valenza M., Stecca C., Esposito G., Carrat&#xf9; M.R., Steardo L. Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-&#x3b1;. J. Neuroinflamm. 2012;9:49. doi: 10.1186/1742-2094-9-49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-49</ArticleId><ArticleId IdType="pmc">PMC3315437</ArticleId><ArticleId IdType="pubmed">22405189</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine Y., Suzuki K., Ramachandran P.V., Blackburn T.P., Ashby C.R. Acute and repeated administration of fluoxetine, citalopram, and paroxetine significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. Synapse. 2007;61(2):72&#x2013;77. doi: 10.1002/syn.20349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/syn.20349</ArticleId><ArticleId IdType="pubmed">17117425</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah D., Gsell W., Wahis J., Luckett E.S., Jamoulle T., Vermaercke B., Preman P., Moechars D., Hendrickx V., Jaspers T., Craessaerts K., Horr&#xe9; K., Wolfs L., Fiers M., Holt M., Thal D.R., Callaerts-Vegh Z., D&#x2019;Hooge R., Vandenberghe R., De Strooper B., et al. Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer&#x2019;s disease. Cell Rep. 2022;40(8) doi: 10.1016/j.celrep.2022.111280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.111280</ArticleId><ArticleId IdType="pmc">PMC9433881</ArticleId><ArticleId IdType="pubmed">36001964</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin C.Y., Kim H.-S., Cha K.-H., Kim H.J., Choi W.S., Jang S.W., Sohn U.D. Pharmacological evaluation and safety of a donepezil patch. Die Pharm. 2020;75(12):656&#x2013;661. doi: 10.1691/ph.2020.0588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1691/ph.2020.0588</ArticleId><ArticleId IdType="pubmed">33303060</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaper S.D., Facci L., Barbierato M., Zusso M., Bruschetta G., Impellizzeri D., Cuzzocrea S., Giusti P. N-palmitoylethanolamine and neuroinflammation: a novel therapeutic strategy of resolution. Mol. Neurobiol. 2015;52(2):1034&#x2013;1042. doi: 10.1007/s12035-015-9253-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9253-8</ArticleId><ArticleId IdType="pubmed">26055231</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaper S.D., Facci L., Giusti P. Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator. Mol. Neurobiol. 2013;48(2):340&#x2013;352. doi: 10.1007/s12035-013-8487-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8487-6</ArticleId><ArticleId IdType="pubmed">23813098</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith G.S., Kramer E., Ma Y., Hermann C.R., Dhawan V., Chaly T., Eidelberg D. Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer&#x2019;s disease. Brain. 2009;132(2):392&#x2013;401. doi: 10.1093/brain/awn326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awn326</ArticleId><ArticleId IdType="pmc">PMC2640217</ArticleId><ArticleId IdType="pubmed">19153152</ArticleId></ArticleIdList></Reference><Reference><Citation>Solntseva E.I., Kapai N.A., Popova O.V., Rogozin P.D., Skrebitsky V.G. The involvement of sigma1 receptors in donepezil-induced rescue of hippocampal LTP impaired by beta-amyloid peptide. Brain Res. Bull. 2014;106:56&#x2013;61. doi: 10.1016/j.brainresbull.2014.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2014.06.002</ArticleId><ArticleId IdType="pubmed">24956443</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson J., Nutma E., van der Valk P., Amor S. Inflammation in CNS neurodegenerative diseases. Immunology. 2018;154(2):204&#x2013;219. doi: 10.1111/imm.12922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12922</ArticleId><ArticleId IdType="pmc">PMC5980185</ArticleId><ArticleId IdType="pubmed">29513402</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumner I.L., Edwards R.A., Asuni A.A., Teeling J.L. Antibody engineering for optimized immunotherapy in Alzheimer&#x2019;s disease. Front. Neurosci. 2018;12:254. doi: 10.3389/fnins.2018.00254.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00254</ArticleId><ArticleId IdType="pmc">PMC5924811</ArticleId><ArticleId IdType="pubmed">29740272</ArticleId></ArticleIdList></Reference><Reference><Citation>Taherian M., Norenberg M.D., Panickar K.S., Shamaladevi N., Ahmad A., Rahman P., Jayakumar A.R. Additive effect of resveratrol on astrocyte swelling post-exposure to ammonia, ischemia and trauma in vitro. Neurochem. Res. 2020;45(5):1156&#x2013;1167. doi: 10.1007/s11064-020-02997-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-020-02997-1</ArticleId><ArticleId IdType="pubmed">32166573</ArticleId></ArticleIdList></Reference><Reference><Citation>Takata N., Mishima T., Hisatsune C., Nagai T., Ebisui E., Mikoshiba K., Hirase H. Astrocyte calcium signaling transforms cholinergic modulation to cortical plasticity in vivo. J. Neurosci. 2011;31(49):18155&#x2013;18165. doi: 10.1523/JNEUROSCI.5289-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5289-11.2011</ArticleId><ArticleId IdType="pmc">PMC6634158</ArticleId><ArticleId IdType="pubmed">22159127</ArticleId></ArticleIdList></Reference><Reference><Citation>Tariot P.N., Solomon P.R., Morris J.C., Kershaw P., Lilienfeld S., Ding C., the Galantamine USA-Study Group A 5-month, randomized, Placebo-controlled trial of galantamine in AD. Neurology. 2000;54(12):2269&#x2013;2276. doi: 10.1212/WNL.54.12.2269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.54.12.2269</ArticleId><ArticleId IdType="pubmed">10881251</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayeb H.O., Murray E.D., Price B.H., Tarazi F.I. Bapineuzumab and solanezumab for Alzheimer&#x2019;s disease: is the &#x2018;amyloid cascade hypothesis&#x2019; still alive? Expert Opin. Biol. Ther. 2013;13(7):1075&#x2013;1084. doi: 10.1517/14712598.2013.789856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14712598.2013.789856</ArticleId><ArticleId IdType="pubmed">23574434</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayebati S.K., Di Tullio M.A., Tomassoni D., Amenta F. Neuroprotective effect of treatment with galantamine and choline alphoscerate on brain microanatomy in spontaneously hypertensive rats. J. Neurol. Sci. 2009;283(1&#x2013;2):187&#x2013;194. doi: 10.1016/j.jns.2009.02.349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2009.02.349</ArticleId><ArticleId IdType="pubmed">19304299</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayebati S.K., Martinelli I., Moruzzi M., Amenta F., Tomassoni D. Choline and choline alphoscerate do not modulate inflammatory processes in the rat brain. Nutrients. 2017;9(10) doi: 10.3390/nu9101084.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9101084</ArticleId><ArticleId IdType="pmc">PMC5691701</ArticleId><ArticleId IdType="pubmed">28961195</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor C.P., Traynelis S.F., Siffert J., Pope L.E., Matsumoto R.R. Pharmacology of dextromethorphan: relevance to dextromethorphan/quinidine (Nuedexta&#xae;) clinical use. Pharm. Ther. 2016;164:170&#x2013;182. doi: 10.1016/j.pharmthera.2016.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2016.04.010</ArticleId><ArticleId IdType="pubmed">27139517</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomassoni D., Avola R., Mignini F., Parnetti L., Amenta F. Effect of treatment with choline alphoscerate on hippocampus microanatomy and glial reaction in spontaneously hypertensive rats. Brain Res. 2006;1120(1):183&#x2013;190. doi: 10.1016/j.brainres.2006.08.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2006.08.068</ArticleId><ArticleId IdType="pubmed">16989788</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosto G., Talarico G., Lenzi G.L., Bruno G. Effect of citalopram in treating hypersexuality in an Alzheimer&#x2019;s Disease case. Neurol. Sci. 2008;29(4):269&#x2013;270. doi: 10.1007/s10072-008-0979-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-008-0979-1</ArticleId><ArticleId IdType="pubmed">18810603</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugolini F., Lana D., Nardiello P., Nosi D., Pantano D., Casamenti F., Giovannini M.G. Different patterns of neurodegeneration and glia activation in CA1 and CA3 hippocampal regions of TgCRND8 mice. Front. Aging Neurosci. 2018;10:372. doi: 10.3389/fnagi.2018.00372.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00372</ArticleId><ArticleId IdType="pmc">PMC6243135</ArticleId><ArticleId IdType="pubmed">30483118</ArticleId></ArticleIdList></Reference><Reference><Citation>Villarroya M., Garc&#xed;a A.G., Marco-Contelles J., L&#xf3;pez M.G. An update on the pharmacology of galantamine. Expert Opin. Investig. Drugs. 2007;16(12):1987&#x2013;1998. doi: 10.1517/13543784.16.12.1987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/13543784.16.12.1987</ArticleId><ArticleId IdType="pubmed">18042006</ArticleId></ArticleIdList></Reference><Reference><Citation>Vulink N.C.C., Westenberg H.G.M., van Nieuwerburgh F., Deforce D., Fluitman S.B.A.H.A., Meinardi J.S.C., Denys D. Catechol-O-methyltranferase gene expression is associated with response to citalopram in obsessive-compulsive disorder. Int. J. Psychiatry Clin. Pract. 2012;16(4):277&#x2013;283. doi: 10.3109/13651501.2011.653375.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13651501.2011.653375</ArticleId><ArticleId IdType="pubmed">22414277</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Cella M., Mallinson K., Ulrich J.D., Young K.L., Robinette M.L., Gilfillan S., Krishnan G.M., Sudhakar S., Zinselmeyer B.H., Holtzman D.M., Cirrito J.R., Colonna M. TREM2 lipid sensing sustains the microglial response in an Alzheimer&#x2019;s disease model. Cell. 2015;160(6):1061&#x2013;1071. doi: 10.1016/j.cell.2015.01.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.01.049</ArticleId><ArticleId IdType="pmc">PMC4477963</ArticleId><ArticleId IdType="pubmed">25728668</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., Zhao L., Chen X., Cheng X., Zhang Y. Galantamine attenuates amyloid-&#x3b2; deposition and astrocyte activation in APP/PS1 transgenic mice. Exp. Gerontol. 2015;72:244&#x2013;250. doi: 10.1016/j.exger.2015.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2015.10.015</ArticleId><ArticleId IdType="pubmed">26521029</ArticleId></ArticleIdList></Reference><Reference><Citation>Xapelli S., Di&#xf3;genes M.J., Crunelli V., Fitzsimons C.P., Vaz S.H. Editorial: glial and neural stem cells as new therapeutic targets for neurodegenerative disorders. Front. Cell. Neurosci. 2020;14:71. doi: 10.3389/fncel.2020.00071.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00071</ArticleId><ArticleId IdType="pmc">PMC7147613</ArticleId><ArticleId IdType="pubmed">32317936</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie H., Wen H., Zhang D., Liu L., Liu B., Liu Q., Jin Q., Ke K., Hu M., Chen X. Designing of dual inhibitors for GSK-3&#x3b2; and CDK5: virtual screening and in vitro biological activities study. Oncotarget. 2017;8(11):18118&#x2013;18128. doi: 10.18632/oncotarget.15085.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.15085</ArticleId><ArticleId IdType="pmc">PMC5392312</ArticleId><ArticleId IdType="pubmed">28179579</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L., Kang H., Xu Q., Chen M.J., Liao Y., Thiyagarajan M., O&#x2019;Donnell J., Christensen D.J., Nicholson C., Iliff J.J., Takano T., Deane R., Nedergaard M. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373&#x2013;377. doi: 10.1126/science.1241224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1241224</ArticleId><ArticleId IdType="pmc">PMC3880190</ArticleId><ArticleId IdType="pubmed">24136970</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P.-P., Huang E.Y.-K., Yeh G.-C., Tao P.-L. Co-administration of dextromethorphan with methamphetamine attenuates methamphetamine-induced rewarding and behavioral sensitization. J. Biomed. Sci. 2006;13(5):695&#x2013;702. doi: 10.1007/s11373-006-9096-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11373-006-9096-4</ArticleId><ArticleId IdType="pubmed">16865411</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamudio S., Fregoso T., Miranda A., De La Cruz F., Flores G. Strain differences of dopamine receptor levels and dopamine related behaviors in rats. Brain Res. Bull. 2005;65(4):339&#x2013;347. doi: 10.1016/j.brainresbull.2005.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2005.01.009</ArticleId><ArticleId IdType="pubmed">15811600</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Shi J.-S., Zhou H., Wilson B., Hong J.-S., Gao H.-M. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions. Mol. Pharm. 2010;78(3):466&#x2013;477. doi: 10.1124/mol.110.064535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.110.064535</ArticleId><ArticleId IdType="pmc">PMC2939485</ArticleId><ArticleId IdType="pubmed">20554604</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N., Gordon M.L. Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients. Clin. Interv. Aging. 2018;13:1963&#x2013;1970. doi: 10.2147/CIA.S159920.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S159920</ArticleId><ArticleId IdType="pmc">PMC6187917</ArticleId><ArticleId IdType="pubmed">30349215</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L., Cheng X., Zhong C. Implications of successful symptomatic treatment in Parkinson&#x2019;s disease for therapeutic strategies of Alzheimer&#x2019;s disease. ACS Chem. Neurosci. 2019;10(2):922&#x2013;930. doi: 10.1021/acschemneuro.8b00450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.8b00450</ArticleId><ArticleId IdType="pubmed">30474958</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36588502</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-5279</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</Title><ISOAbbreviation>Alzheimers Dement</ISOAbbreviation></Journal><ArticleTitle>Apathy in patients with Alzheimer's disease is a cost-driving factor.</ArticleTitle><Pagination><StartPage>2853</StartPage><EndPage>2864</EndPage><MedlinePgn>2853-2864</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/alz.12915</ELocationID><Abstract><AbstractText Label="BACKGROUND">Apathy is the most frequent neuropsychiatric symptom in patients with dementia of the Alzheimer's type (DAT). We analyzed the influence of apathy on the resource use of DAT patients and their caregivers.</AbstractText><AbstractText Label="METHODS">Included were baseline data of 107 DAT patients from a randomized clinical trial on apathy treatment. The Resource Utilization in Dementia (RUD) instrument assessed costs over a 1-month period prior to baseline. Cost predictors were determined via a least absolute shrinkage and selection operator (LASSO).</AbstractText><AbstractText Label="RESULTS">On average, total monthly costs were &#x20ac;3070, of which &#x20ac;2711 accounted for caregivers' and &#x20ac;359 for patients' costs. An increase of one point in the Apathy Evaluation Scale resulted in a 4.1% increase in total costs.</AbstractText><AbstractText Label="DISCUSSION">Apathy is a significant cost driving factor for total costs in mild to moderate DAT. Effective treatment of apathy might be associated with reduced overall costs in DAT.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Alzheimer's &amp; Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kruse</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8490-8363</Identifier><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Center for Translational Neurological and Behavioural Research, University Duisburg-Essen, Duisburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maier</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University Hospital Cologne, Medical Faculty, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spottke</LastName><ForeName>Annika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bach</LastName><ForeName>Jan-Philipp</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Neurology, Philipps-University Marburg, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartels</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, University Medical Center Goettingen (UMG), Georg-August-University, Goettingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buerger</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute for Stroke and Dementia Research, Klinikum der Universit&#xe4;t M&#xfc;nchen, Ludwig-Maximilians-Universit&#xe4;t LMU, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fellgiebel</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Mental Health in Old Age, Landeskrankenhaus (A&#xf6;R), Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fliessbach</LastName><ForeName>Klaus</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fr&#xf6;lich</LastName><ForeName>Lutz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Geriatric Psychiatry, Zentralinstitut f&#xfc;r Seelische Gesundheit Mannheim, University of Heidelberg, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hausner</LastName><ForeName>Lucrezia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Medical Statistics and Computational Biology, Faculty of Medicine, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hellmich</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medical Statistics and Computational Biology, Faculty of Medicine, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kl&#xf6;ppel</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospital of Old Age Psychiatry, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klostermann</LastName><ForeName>Arne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Charit&#xe9; Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kornhuber</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Friedrich Alexander University Erlangen-N&#xfc;rnberg, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laske</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Charit&#xe9; Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Priller</LastName><ForeName>Josef</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuropsychiatry, Charit&#xe9; Berlin &amp; Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richter-Schmidinger</LastName><ForeName>Tanja</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Friedrich Alexander University Erlangen-N&#xfc;rnberg, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Anja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Klinik f&#xfc;r Neurodegenerative Erkrankungen und Gerontopsychiatrie, University of Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah-Hosseini</LastName><ForeName>Kija</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Medical Statistics and Computational Biology, Faculty of Medicine, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teipel</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychosomatic Medicine, University Hospital of Rostock, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Arnim</LastName><ForeName>Christine A F</ForeName><Initials>CAF</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University Hospital, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiltfang</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, University Medical Center Goettingen (UMG), Georg-August-University, Goettingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Goettingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Wurp</LastName><ForeName>Hendrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Center for Translational Neurological and Behavioural Research, University Duisburg-Essen, Duisburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, TU Dortmund University, Dortmund, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dodel</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Center for Translational Neurological and Behavioural Research, University Duisburg-Essen, Duisburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Philipps-University Marburg, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jessen</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University Hospital Cologne, Medical Faculty, Cologne, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Alzheimers Dement</MedlineTA><NlmUniqueID>101231978</NlmUniqueID><ISSNLinking>1552-5260</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057565" MajorTopicYN="Y">Apathy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">apathy</Keyword><Keyword MajorTopicYN="N">cost of illness</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">economics</Keyword><Keyword MajorTopicYN="N">resource use</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>2</Day><Hour>3</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36588502</ArticleId><ArticleId IdType="doi">10.1002/alz.12915</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Wimo A, Guerchet M, Ali GC, et&#xa0;al. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimer's Dement. 2017. doi:10.1016/j.jalz.2016.07.150</Citation></Reference><Reference><Citation>Kongpakwattana K, Dejthevaporn C, Krairit O, Dilokthornsakul P, Mohan D, Chaiyakunapruk N. A real-world evidence analysis of associations among costs, quality of life, and disease-severity indicators of Alzheimer's disease in Thailand. Value Health. 2019;22:1137-1145. doi:10.1016/j.jval.2019.04.1937</Citation></Reference><Reference><Citation>Lenox-Smith A, Reed C, Lebrec J, Belger M, Jones RW. Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study. BMC Geriatr. 2016;16:195. doi:10.1186/s12877-016-0371-6</Citation></Reference><Reference><Citation>Ku L-JE, Pai M-C, Shih P-Y. Economic impact of dementia by disease severity: exploring the relationship between stage of dementia and cost of care in Taiwan. PLoS One. 2016;11:e0148779. doi:10.1371/journal.pone.0148779</Citation></Reference><Reference><Citation>Wimo A, Reed CC, Dodel R, et&#xa0;al. The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries-study design and baseline findings. J Alzheimers Dis. 2013;36:385-399. doi:10.3233/JAD-122392</Citation></Reference><Reference><Citation>Rapp T, Andrieu S, Molinier L, et&#xa0;al. Exploring the relationship between Alzheimer's disease severity and longitudinal costs. Value Health. 2012;15:412-419. doi:10.1016/j.jval.2012.02.003</Citation></Reference><Reference><Citation>Zhu CW, Scarmeas N, Torgan R, et&#xa0;al. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease. Neurology. 2006;67:998-1005. doi:10.1212/01.wnl.0000230160.13272.1b</Citation></Reference><Reference><Citation>W&#xfc;bker A, Zwakhalen SMG, Challis D, et&#xa0;al. Costs of care for people with dementia just before and after nursing home placement: primary data from eight European countries. Eur J Health Econ. 2015;16:689-707. doi:10.1007/s10198-014-0620-6</Citation></Reference><Reference><Citation>Br&#xfc;ggenj&#xfc;rgen B, Andersohn F, Ezzat N, Lacey L, Willich S. Medical management, costs, and consequences of Alzheimer's disease in Germany: an analysis of health claims data. J Med Econ. 2015;18:466-473. doi:10.3111/13696998.2015.1014090</Citation></Reference><Reference><Citation>Kiencke P, Rychlik R, Grimm C, Daniel D. Krankheitskosten bei Alzheimer-Demenz. Med Klin (Munich). 2010;105:327-333. doi:10.1007/s00063-010-1060-4</Citation></Reference><Reference><Citation>Dodel R, Belger M, Reed C, et&#xa0;al. Determinants of societal costs in Alzheimer's disease: gERAS study baseline results. Alzheimer's Dement. 2015. doi:10.1016/j.jalz.2015.02.005</Citation></Reference><Reference><Citation>Joling KJ, Sch&#xf6;pe J, Van Hout HPJ, Van Marwijk HWJ, Van Der Horst HE, Bosmans JE. Predictors of societal costs in dementia patients and their informal caregivers: a two-year prospective cohort study. Am J Geriatr Psychiatry. 2015. doi:10.1016/j.jagp.2015.06.008</Citation></Reference><Reference><Citation>J&#xf6;nsson L, J&#xf6;nhagen ME, Kilander L, et&#xa0;al. Determinants of costs of care for patients with Alzheimer's disease. Int J Geriatr Psychiatry. 2006. doi:10.1002/gps.1489</Citation></Reference><Reference><Citation>Gustavsson A, Cattelin F, J&#xf6;nsson L. Costs of care in a mild-to-moderate Alzheimer clinical trial sample: key resources and their determinants. Alzheimer's Dement. 2011. doi:10.1016/j.jalz.2010.06.002</Citation></Reference><Reference><Citation>Gustavsson A, Brinck P, Bergvall N, et&#xa0;al. Predictors of costs of care in Alzheimer's disease: a multinational sample of 1222 patients. Alzheimer's Dement. 2011. doi:10.1016/j.jalz.2010.09.001</Citation></Reference><Reference><Citation>Reese JP, He&#xdf;mann P, Seeberg G, et&#xa0;al. Cost and care of patients with Alzheimer's disease: clinical predictors in german health care settings. J Alzheimer's Dis. 2011. doi:10.3233/JAD-2011-110539</Citation></Reference><Reference><Citation>Bergvall N, Brinck P, Eek D, et&#xa0;al. Relative importance of patient disease indicators on informal care and caregiver burden in Alzheimer's disease. Int Psychogeriatrics. 2011. doi:10.1017/S1041610210000785</Citation></Reference><Reference><Citation>Frazer M, Abler V, Halpern R, Skoog B, Rashid N. Burden of illness among patients with dementia-related psychosis. J Manag Care Spec Pharm. 2021. doi:10.18553/JMCP.2021.27.3.367</Citation></Reference><Reference><Citation>Herrmann N, Lanct&#xf4;t KL, Sambrook R, et&#xa0;al. The contribution of neuropsychiatric symptoms to the cost of dementia care. Int J Geriatr Psychiatry. 2006;21:972-976. doi:10.1002/gps.1594</Citation></Reference><Reference><Citation>Rattinger GB, Sanders CL, Vernon E, et&#xa0;al. Neuropsychiatric symptoms in patients with dementia and the longitudinal costs of informal care in the Cache County population. Alzheimer's {&#x2216;&amp;} Dement (New York, N Y). 2019;5:81-88. doi:10.1016/j.trci.2019.01.002</Citation></Reference><Reference><Citation>Leung DKY, Chan WC, Spector A, Wong GHY. Prevalence of depression, anxiety, and apathy symptoms across dementia stages: a systematic review and meta-analysis. Int J Geriatr Psychiatry. 2021. doi:10.1002/gps.5556</Citation></Reference><Reference><Citation>Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, Dekosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. J Am Med Assoc. 2002;288:1475-1483. doi:10.1001/jama.288.12.1475</Citation></Reference><Reference><Citation>Hongisto K, Hallikainen I, Selander T, et&#xa0;al. Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study. Int J Geriatr Psychiatry. 2018;33:47-57. doi:10.1002/gps.4666</Citation></Reference><Reference><Citation>Zhao QF, Tan L, Wang HF, et&#xa0;al. The prevalence of neuropsychiatric symptoms in Alzheimer's disease: systematic review and meta-analysis. J Affect Disord. 2016;190:264-271. doi:10.1016/j.jad.2015.09.069</Citation></Reference><Reference><Citation>Dauphinot V, Delphin-Combe F, Mouchoux C, et&#xa0;al. Risk factors of caregiver burden among patients with Alzheimer's disease or related disorders: a cross-sectional study. J Alzheimer's Dis. 2015;44:907-916. doi:10.3233/JAD-142337</Citation></Reference><Reference><Citation>Maier F, Spottke A, Bach JP, et&#xa0;al. Bupropion for the treatment of apathy in Alzheimer disease: a randomized clinical trial. JAMA Netw Open. 2020;3:e206027. doi:10.1001/jamanetworkopen.2020.6027</Citation></Reference><Reference><Citation>McKhann G, Drachman D, M F, R K, D P, E S. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.</Citation></Reference><Reference><Citation>Robert P, Onyike CU, Leentjens AFG, et&#xa0;al. Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry. 2009;24:98-104. doi:10.1016/j.eurpsy.2008.09.001</Citation></Reference><Reference><Citation>Lueken U. Psychometric properties of a German version of the apathy evaluation scale. Fortschritte Der Neurol Psychiatr. 2006;74:714-722. doi:10.1055/s-2006-932164</Citation></Reference><Reference><Citation>Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 2012;48:10S-16S. doi:10.1212/wnl.48.5_suppl_6.10s</Citation></Reference><Reference><Citation>Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389. doi:10.1192/bjp.134.4.382</Citation></Reference><Reference><Citation>Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984;141. doi:10.1176/ajp.141.11.1356</Citation></Reference><Reference><Citation>Galasko D, Bennett D, Sano M, et&#xa0;al. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997.</Citation></Reference><Reference><Citation>Logsdon RG, Gibbons LE, McCurry SM, Teri L. Quality of life in Alzheimer's disease: patient and caregiver reports. J Ment Health Aging. 1999;5:21-32.</Citation></Reference><Reference><Citation>Wimo A, Gustavsson A, J&#xf6;nsson L, Winblad B, Hsu M-A, Gannon B. Application of Resource Utilization in Dementia (RUD) instrument in a global setting. Alzheimer's {&#x2216;&amp;} Dement J Alzheimer's Assoc. 2013;9:429-435.e17. doi:10.1016/j.jalz.2012.06.008</Citation></Reference><Reference><Citation>Bock J-O, Brettschneider C, Seidl H, et&#xa0;al. Ermittlung standardisierter Bewertungss&#xe4;tze aus gesellschaftlicher Perspektive f&#xfc;r die gesundheits&#xf6;konomische Evaluation. Gesundheitswesen. 2015;77:53-61. doi:10.1055/s-0034-1374621</Citation></Reference><Reference><Citation>Bruckenberger E. Stagnation bei der Krankenhausfinanzierung. F&#xfc;hren Und Wirtschaften Im Krankenhaus. 1997;14:206-208.</Citation></Reference><Reference><Citation>Haas C, Larbig M, Sch&#xf6;pke T, et&#xa0;al. Gutachten zur ambulanten Notfallversorgung im Krankenhaus. Dtsch Krankenhausgesellschat Dtsch Gesellschaft F&#xfc;r Interdiziplin&#xe4;re Notfall- Und Akutmedizin. 2015:1-82.</Citation></Reference><Reference><Citation>Statistisches Bundesamt (DESTATIS). Preise. Verbraucherpreisindizes f&#xfc;r Deutschland. Jahresbericht 2020. 2020.</Citation></Reference><Reference><Citation>Vertrag gem&#xe4;&#xdf;&#xa7;89 SGB XI vom 02.11.2017 &#xfc;ber die Verg&#xfc;tung von Pflegesachleistungen gem&#xe4;&#xdf;&#xa7;36 SGB XI mit G&#xfc;ltigkeit f&#xfc;r ab dem 01.02.2018 erbrachte Leistungen f&#xfc;r Pflegedienste, die bei einem der an diesem Vertrag beteiligten Verb&#xe4;nde der Leistungserbringer 2018.</Citation></Reference><Reference><Citation>Statistisches Bundesamt (DESTATIS). Pflegestatistik 2019: Pflege im Rahmen der Pflegeversicherung Deutschlandergebnisse 2019.</Citation></Reference><Reference><Citation>Bundesministerium f&#xfc;r Gesundheit, editor. Sechster Bericht der Bundesregierung &#xfc;ber die Entwicklung der Pflegeversicherung und den Stand der pflegerischen Versorgung in der Bundesrepublik Deutschland 2016.</Citation></Reference><Reference><Citation>Einkommenssteuergesetz. &#xa7; 9 Abs. 1 Nr. 4 Einkommenssteuergesetz (EStG) n.d.</Citation></Reference><Reference><Citation>IGES Institut GmbH. G-DRG-Begleitforschung gem&#xe4;&#xdf;&#xa7;17b Abs. 8 KHG: Endbericht des dritten Forschungszyklus (2008 bis 2010): Untersuchung im Auftrag des deutschen DRG-Institus (InEK) 2013.</Citation></Reference><Reference><Citation>Wirtschafts-und Sozialwissenschaftliches Institut (WSI). Arbeitspapier 15: Was verdienen Sozialp&#xe4;dagoginnen und Sozialp&#xe4;dagogen? Eine Analyse von Einkommensdaten auf Basis der WSI-Lohnspiegel-Datenbank 2012.</Citation></Reference><Reference><Citation>Liste Rote, Rote Liste 2016: Arzneimittelverzeichnis f&#xfc;r Deutschland (einschlie&#xdf;lich EU-Zulassungen und bestimmter Medizinprodukte). 56. Ausgab. Frankfurt Am Main: Rote Liste Service GmbH; 2016.</Citation></Reference><Reference><Citation>Costa N, Derumeaux H, Rapp T, Garnault V, Ferlicoq L, Gillette S, et&#xa0;al. Methodological considerations in cost of illness studies on Alzheimer disease. Health Econ Rev. 2012. doi:10.1186/2191-1991-2-18</Citation></Reference><Reference><Citation>IBM Corp. IBM SPSS Statistics for Windows 2019.</Citation></Reference><Reference><Citation>4.0.0. RDCT. A Language and Environment for Statistical Computing. 2020.</Citation></Reference><Reference><Citation>Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ. 2000;320:1197-1200. doi:10.1136/bmj.320.7243.1197</Citation></Reference><Reference><Citation>Tishbirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc Ser B. 1996.</Citation></Reference><Reference><Citation>Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010. doi:10.18637/jss.v033.i01</Citation></Reference><Reference><Citation>Roider J, Ngoepe A, Muenchhoff M, Adland E, Groll A, Ndung'u T, et&#xa0;al. Increased regulatory T-cell activity and enhanced T-cell homeostatic signaling in slow progressing HIV-infected children. Front Immunol. 2019. doi:10.3389/fimmu.2019.00213</Citation></Reference><Reference><Citation>Dodd S, Bassi A, Bodger K, Williamson P. A comparison of multivariable regression models to analyse cost data. J Eval Clin Pract. 2006;12:76-86. doi:10.1111/j.1365-2753.2006.00610.x</Citation></Reference><Reference><Citation>Lindholm C, Gustavsson A, J&#xf6;nsson L, Wimo A. Costs explained by function rather than diagnosis - Results from the SNAC Nordanstig elderly cohort in Sweden. Int J Geriatr Psychiatry. 2013. doi:10.1002/gps.3844</Citation></Reference><Reference><Citation>Bogdan A, Manera V, Koenig A, David R. Pharmacologic approaches for the management of apathy in neurodegenerative disorders. Front Pharmacol. 2020. doi:10.3389/fphar.2019.01581</Citation></Reference><Reference><Citation>Manera V, Abrahams S, Ag&#xfc;era-Ortiz L, Bremond F, David R, Fairchild K, et&#xa0;al. Recommendations for the nonpharmacological treatment of apathy in brain disorders. Am J Geriatr Psychiatry. 2019. doi:10.1016/j.jagp.2019.07.014</Citation></Reference><Reference><Citation>Mintzer J, Lanct&#xf4;t KL, Scherer RW, Rosenberg PB, Herrmann N, Van Dyck CH, et&#xa0;al. Effect of methylphenidate on apathy in patients with Alzheimer disease: the ADMET 2 randomized clinical trial. JAMA Neurol. 2021. doi:10.1001/jamaneurol.2021.3356</Citation></Reference><Reference><Citation>Statistisches Bundesamt (DESTATIS). Durchschnittliche Bruttomonatsverdienste - Deutschland 2019.</Citation></Reference><Reference><Citation>Krauth C, Hessel F, Hansmeier T, Wasem J, Seitz R, Schweikert B. Empirische Bewertungss&#xe4;tze in der gesundheits&#xf6;konomischen Evaluation - ein Vorschlag der AG Methoden der gesundheits&#xf6;konomischen Evaluation (AG MEG). Gesundheitswesen. 2005;67:736-746. doi:10.1055/s-2005-858698</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36588382</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1998-4057</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Season>Jan-Mar</Season></PubDate></JournalIssue><Title>Journal of Indian Prosthodontic Society</Title><ISOAbbreviation>J Indian Prosthodont Soc</ISOAbbreviation></Journal><ArticleTitle>Denture tracker for edentulous Alzheimer's patients.</ArticleTitle><Pagination><StartPage>96</StartPage><EndPage>98</EndPage><MedlinePgn>96-98</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/jips.jips_223_22</ELocationID><Abstract><AbstractText>Dementia in Alzheimer's disease complicates the caregivers in tracking the patients. Many options are discussed in the literature. A novel technique is essential to improve the quality of life and to assist in locating the patients. The Global Position System (GPS) trackers are attached to dentures and the movements are observed through a mobile application. This technique discusses on a simple method of tracking Alzheimer's edentulous patients with the support of removable dentures. Denture tracking devices are a secured form of tracking patients. A GPS device in dentures assists in locating the patient's movement and supports the caretakers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chander</LastName><ForeName>Naveen Gopi</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>Department of Prosthodontics, Sri Ramaswami Memorial Dental College, Chennai, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>Dodla Vishal</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Department of Prosthodontics, Sri Ramaswami Memorial Dental College, Chennai, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>J Indian Prosthodont Soc</MedlineTA><NlmUniqueID>101255941</NlmUniqueID><ISSNLinking>0972-4052</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009066" MajorTopicYN="Y">Mouth, Edentulous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003829" MajorTopicYN="N">Denture, Partial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">Global Position System tracker</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">wandering behavior</Keyword></KeywordList><CoiStatement>None</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>2</Day><Hour>1</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36588382</ArticleId><ArticleId IdType="pmc">PMC10088451</ArticleId><ArticleId IdType="doi">10.4103/jips.jips_223_22</ArticleId><ArticleId IdType="pii">JIndianProsthodontSoc_2023_23_1_96_365944</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, et al. Alzheimer's disease. Lancet. 2016;388:505&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">26921134</ArticleId></ArticleIdList></Reference><Reference><Citation>Atri A. The Alzheimer's disease clinical spectrum: Diagnosis and management. Med Clin North Am. 2019;103:263&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">30704681</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnard-Brak L, Richman DM, Owen DC. Assessing wandering risk among individuals with Alzheimer's disease and dementia: A pilot study. Psychogeriatrics. 2018;18:388&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">29987882</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon O, Lawlor MC. Beyond V40.31: Narrative phenomenology of wandering in autism and dementia. Cult Med Psychiatry. 2018;42:206&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5976522</ArticleId><ArticleId IdType="pubmed">29368117</ArticleId></ArticleIdList></Reference><Reference><Citation>Petonito G, Muschert GW, Carr DC, Kinney JM, Robbins EJ, Brown JS. Programs to locate missing and critically wandering elders: A critical review and a call for multiphasic evaluation. Gerontologist. 2013;53:17&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3551207</ArticleId><ArticleId IdType="pubmed">22565495</ArticleId></ArticleIdList></Reference><Reference><Citation>Gergerich E, Davis L. Silver alerts: A notification system for communities with missing adults. J Gerontol Soc Work. 2017;60:232&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">28409711</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang WL, Jiang MJ, Gu BB, Wei YM, Fan SN, Liao W, et al. Tooth loss as a risk factor for dementia: Systematic review and meta-analysis of 21 observational studies. BMC Psychiatry. 2018;18:345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6195976</ArticleId><ArticleId IdType="pubmed">30342524</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36588335</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-5828</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>13</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Current Alzheimer research</Title><ISOAbbreviation>Curr Alzheimer Res</ISOAbbreviation></Journal><ArticleTitle>Development and Psychometric Validation of the 27 Item Zarit Caregiver Interview for Alzheimer's Disease (ZCI-AD-27).</ArticleTitle><Pagination><StartPage>878</StartPage><EndPage>891</EndPage><MedlinePgn>878-891</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2174/1567205020666221230103505</ELocationID><Abstract><AbstractText Label="BACKGROUND">Caring for an individual with Alzheimer's disease (AD) is an allencompassing challenge that affects daily life. Assessment of the care partner experience is needed to support the development and evaluation of successful interventions for people with AD and their care partners. We developed the 27-item Zarit Caregiver Interview for Alzheimer's Disease (ZCI-AD-27) to assess the impact of informal caregiving in the context of AD.</AbstractText><AbstractText Label="OBJECTIVE">We assessed the psychometric validity of the ZCI-AD-27 in a population of care partners for individuals with moderate AD, and established thresholds for meaningful score change.</AbstractText><AbstractText Label="METHODS">Secondary data were obtained from informal care partners of participants in a clinical trial (NCT01677754). Psychometric analyses were conducted to assess validity, reliability, and responsiveness of the ZCI-AD-27. Anchor-based and distribution-based methods were performed to determine clinically meaningful score change.</AbstractText><AbstractText Label="RESULTS">The ZCI-AD-27 had a 12-domain factor structure, including a second-order domain termed Humanistic impact that included four key domains (Physical, Emotional, Social, and Daily life) as confirmed by confirmatory factor analysis with the adequate fit. Internal consistency (Cronbach's alpha ranging from 0.66 to 0.93 for domains), convergent validity, and discriminant validity indicated the good performance of the ZCI-AD-27. Known-groups validity analyses showed a greater impact on care partners with increasing disease severity. Responsiveness results demonstrated that the ZCI-AD- 27 is sensitive to change over time and meaningful change analyses indicated a range of meaningful score changes in this population.</AbstractText><AbstractText Label="CONCLUSION">The ZCI-AD-27 is a comprehensive, psychometrically valid measure to assess the impact of caring for individuals with moderate AD.</AbstractText><CopyrightInformation>Copyright&#xa9; Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bernaards</LastName><ForeName>Coen A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Product Development Data Sciences, Genentech, Inc., South San Francisco, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Kathrin I</ForeName><Initials>KI</Initials><AffiliationInfo><Affiliation>Patient Centered Outcomes Research, Roche Products Limited, Welwyn Garden City, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rylands</LastName><ForeName>Angela J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Patient Centered Outcomes Research, Roche Products Limited, Welwyn Garden City, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gater</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Patient Centered Outcomes Research, Adelphi Values, Bollington, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tolley</LastName><ForeName>Chloe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Patient Centered Outcomes Research, Adelphi Values, Bollington, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarit</LastName><ForeName>Steven H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Human Development and Family Studies, The Pennsylvania State University, University Park, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lansdall</LastName><ForeName>Claire J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Centered Outcomes Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Alzheimer Res</MedlineTA><NlmUniqueID>101208441</NlmUniqueID><ISSNLinking>1567-2050</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Zarit Burden Interview</Keyword><Keyword MajorTopicYN="N">Zarit Caregiver Interview</Keyword><Keyword MajorTopicYN="N">caregiver</Keyword><Keyword MajorTopicYN="N">caregiverreported outcomes</Keyword><Keyword MajorTopicYN="N">psychometrics</Keyword><Keyword MajorTopicYN="N">validation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest, financial or otherwise.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>2</Day><Hour>1</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36588335</ArticleId><ArticleId IdType="pmc">PMC10278238</ArticleId><ArticleId IdType="doi">10.2174/1567205020666221230103505</ArticleId><ArticleId IdType="pii">CAR-EPUB-128531</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alzheimer&#x2019;s Association. 2021 Alzheimer&#x2019;s disease facts and figures. Alzheimers Dement. 2021;17(3):327&#x2013;406. doi: 10.1002/alz.12328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12328</ArticleId><ArticleId IdType="pubmed">33756057</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Durme T., Macq J., Jeanmart C., Gobert M. Tools for measuring the impact of informal caregiving of the elderly: A literature review. Int. J. Nurs. Stud. 2012;49(4):490&#x2013;504. doi: 10.1016/j.ijnurstu.2011.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2011.10.011</ArticleId><ArticleId IdType="pubmed">22078211</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeken J.F., Taylor K.L., Mangan P., Yabroff K.R., Ingham J.M. Care for the caregivers: A review of self-report instruments developed to measure the burden, needs, and quality of life of informal caregivers. J. Pain Symptom Manage. 2003;26(4):922&#x2013;953. doi: 10.1016/S0885-3924(03)00327-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0885-3924(03)00327-0</ArticleId><ArticleId IdType="pubmed">14527761</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarit S.H., Reever K.E., Bach-Peterson J. Relatives of the impaired elderly: Correlates of feelings of burden. Gerontologist. 1980;20(6):649&#x2013;655. doi: 10.1093/geront/20.6.649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/20.6.649</ArticleId><ArticleId IdType="pubmed">7203086</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarit S.H., Orr N.K., Zarit J.M. The hidden victims of Alzheimer&#x2019;s disease: Families under stress. New York: NYU Press; 1985.</Citation></Reference><Reference><Citation>B&#xe9;dard M., Pedlar D., Martin N.J., Malott O., Stones M.J. Burden in caregivers of cognitively impaired older adults living in the community: Methodological issues and determinants. Int. Psychogeriatr. 2000;12(3):307&#x2013;332. doi: 10.1017/S1041610200006426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610200006426</ArticleId><ArticleId IdType="pubmed">11081952</ArticleId></ArticleIdList></Reference><Reference><Citation>Gater A., Rofail D., Marshall C., et al. Assessing the impact of caring for a person with schizophrenia: Development of the schizophrenia caregiver questionnaire. Patient. 2015;8(6):507&#x2013;520. doi: 10.1007/s40271-015-0114-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40271-015-0114-3</ArticleId><ArticleId IdType="pmc">PMC4662958</ArticleId><ArticleId IdType="pubmed">25680337</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajabi-Mashhadi M.T., Mashhadinejad H., Ebrahimzadeh M.H., Golhasani-Keshtan F., Ebrahimi H., Zarei Z. The zarit caregiver burden interview short form (ZBI-12) in spouses of veterans with chronic spinal cord injury, validity and reliability of the Persian version. Arch. Bone Jt. Surg. 2015;3(1):56&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4322127</ArticleId><ArticleId IdType="pubmed">25692171</ArticleId></ArticleIdList></Reference><Reference><Citation>Springate B.A., Tremont G. Dimensions of caregiver burden in dementia: Impact of demographic, mood, and care recipient variables. Am. J. Geriatr. Psychiatry. 2014;22(3):294&#x2013;300. doi: 10.1016/j.jagp.2012.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2012.09.006</ArticleId><ArticleId IdType="pmc">PMC3723767</ArticleId><ArticleId IdType="pubmed">23567422</ArticleId></ArticleIdList></Reference><Reference><Citation>Flynn Longmire C.V., Knight B.G. Confirmatory factor analysis of a brief version of the Zarit Burden Interview in Black and White dementia caregivers. Gerontologist. 2011;51(4):453&#x2013;462. doi: 10.1093/geront/gnr011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnr011</ArticleId><ArticleId IdType="pmc">PMC3146806</ArticleId><ArticleId IdType="pubmed">21402646</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves-Pereira M., Gonz&#xe1;lez-Fraile E., Santos-Zorroz&#xfa;a B., et al. Assessment of the consequences of caregiving in psychosis: a psychometric comparison of the Zarit Burden Interview (ZBI) and the Involvement Evaluation Questionnaire (IEQ). Health Qual. Life Outcomes. 2017;15(1):63. doi: 10.1186/s12955-017-0626-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-017-0626-8</ArticleId><ArticleId IdType="pmc">PMC5382493</ArticleId><ArticleId IdType="pubmed">28381222</ArticleId></ArticleIdList></Reference><Reference><Citation>Rofail D., Regnault A., le Scouiller S., Lambert J., Zarit S.H. Assessing the impact on caregivers of patients with schizophrenia: Psychometric validation of the Schizophrenia Caregiver Questionnaire (SCQ). BMC Psychiatry. 2016;16(1):245. doi: 10.1186/s12888-016-0951-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-016-0951-1</ArticleId><ArticleId IdType="pmc">PMC4950699</ArticleId><ArticleId IdType="pubmed">27431493</ArticleId></ArticleIdList></Reference><Reference><Citation>Nave S., Doody R.S., Boada M., et al. Sembragiline in moderate Alzheimer&#x2019;s disease: Results of a randomized, double-blind, placebo-controlled phase II trial (MAyflOwer RoAD). J. Alzheimers Dis. 2017;58(4):1217&#x2013;1228. doi: 10.3233/JAD-161309.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-161309</ArticleId><ArticleId IdType="pmc">PMC5523913</ArticleId><ArticleId IdType="pubmed">28550255</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohs R.C., Knopman D., Petersen R.C., et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer&#x2019;s Disease Assessment Scale that broaden its scope. The Alzheimer&#x2019;s Disease Cooperative Study. Alzheimer Dis. Assoc. Disord. 1997;11(Suppl. 2):13&#x2013;21. doi: 10.1097/00002093-199700112-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002093-199700112-00003</ArticleId><ArticleId IdType="pubmed">9236948</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen W.G., Mohs R.C., Davis K.L. A new rating scale for Alzheimer&#x2019;s disease. Am. J. Psychiatry. 1984;141(11):1356&#x2013;1364. doi: 10.1176/ajp.141.11.1356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/ajp.141.11.1356</ArticleId><ArticleId IdType="pubmed">6496779</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state. J. Psychiatr. Res. 1975;12(3):189&#x2013;198. doi: 10.1016/0022-3956(75)90026-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3956(75)90026-6</ArticleId><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Galasko D., Bennett D., Sano M., et al. An inventory to assess activities of daily living for clinical trials in Alzheimer&#x2019;s disease. The Alzheimer&#x2019;s Disease Cooperative Study. Alzheimer Dis. Assoc. Disord. 1997;11(Suppl. 2):S33&#x2013;S39. doi: 10.1097/00002093-199700112-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002093-199700112-00005</ArticleId><ArticleId IdType="pubmed">9236950</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahle-Wrobleski K., Coley N., Lepage B., et al. Understanding the complexities of functional ability in Alzheimer&#x2019;s disease: More than just basic and instrumental factors. Curr. Alzheimer Res. 2014;11(4):357&#x2013;366. doi: 10.2174/1567205011666140317101419.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205011666140317101419</ArticleId><ArticleId IdType="pmc">PMC4021450</ArticleId><ArticleId IdType="pubmed">24635843</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin R.S., Biedrzycki R.C., Firinciogullari S. Reliability and validity of the apathy evaluation scale. Psychiatry Res. 1991;38(2):143&#x2013;162. doi: 10.1016/0165-1781(91)90040-V.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(91)90040-V</ArticleId><ArticleId IdType="pubmed">1754629</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexopoulos G.S., Abrams R.C., Young R.C., Shamoian C.A. Cornell scale for depression in dementia. Biol. Psychiatry. 1988;23(3):271&#x2013;284. doi: 10.1016/0006-3223(88)90038-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-3223(88)90038-8</ArticleId><ArticleId IdType="pubmed">3337862</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisberg B., Borenstein J., Salob S.P., Ferris S.H., Franssen E., Georgotas A. Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment. J. Clin. Psychiatry. 1987;48:9&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">3553166</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisberg B., Monteiro I., Torossian C., et al. The Behave-AD assessment system: A perspective, a commentary on new findings, and a historical review. Dement. Geriatr. Cogn. Disord. 2014;38(1-2):89&#x2013;146. doi: 10.1159/000357839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000357839</ArticleId><ArticleId IdType="pmc">PMC4216810</ArticleId><ArticleId IdType="pubmed">24714384</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisberg B., Ferris S.H., de Leon M.J., Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am. J. Psychiatry. 1982;139(9):1136&#x2013;1139. doi: 10.1176/ajp.139.9.1136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/ajp.139.9.1136</ArticleId><ArticleId IdType="pubmed">7114305</ArticleId></ArticleIdList></Reference><Reference><Citation>Brod M., Stewart A.L., Sands L., Walton P. Conceptualization and measurement of quality of life in dementia: The dementia quality of life instrument (DQoL). Gerontologist. 1999;39(1):25&#x2013;36. doi: 10.1093/geront/39.1.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/39.1.25</ArticleId><ArticleId IdType="pubmed">10028768</ArticleId></ArticleIdList></Reference><Reference><Citation>Knekta E., Runyon C., Eddy S. One size doesn&#x2019;t fit all: Using factor analysis to gather validity evidence when using surveys in your research. CBE Life Sci. Educ. 2019;18(1):rm1&#x2013;rm1. doi: 10.1187/cbe.18-04-0064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1187/cbe.18-04-0064</ArticleId><ArticleId IdType="pmc">PMC6757227</ArticleId><ArticleId IdType="pubmed">30821600</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandalos D.L., Finney S.J. Factor analysis: Exploratory and confirmatory. The reviewer&#x2019;s guide to quantitative methods in the social science. New York: Routledge; 2010. pp. 93&#x2013;114.</Citation></Reference><Reference><Citation>Marsh H.W., Hau K.T., Wen Z. In search of golden rules: Comment on hypothesis-testing approaches to setting cutoff values for fit indexes and dangers in overgeneralizing Hu and Bentler&#x2019;s (1999) findings. Struct. Equ. Model. 2004;11(3):320&#x2013;341. doi: 10.1207/s15328007sem1103_2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1207/s15328007sem1103_2</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVon H.A., Block M.E., Moyle-Wright P., et al. A psychometric toolbox for testing validity and reliability. J. Nurs. Scholarsh. 2007;39(2):155&#x2013;164. doi: 10.1111/j.1547-5069.2007.00161.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1547-5069.2007.00161.x</ArticleId><ArticleId IdType="pubmed">17535316</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer C.E., Langbehn D., Tabrizi S.J., Papoutsi M. Test-retest reliability of measures commonly used to measure striatal dysfunction across multiple testing sessions: A longitudinal study. Front. Psychol. 2018;8:2363. doi: 10.3389/fpsyg.2017.02363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2017.02363</ArticleId><ArticleId IdType="pmc">PMC5770367</ArticleId><ArticleId IdType="pubmed">29375455</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicchetti D.V. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol. Assess. 1994;6(4):284&#x2013;290. doi: 10.1037/1040-3590.6.4.284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/1040-3590.6.4.284</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicchetti D.V., Sparrow S.S. Assessment of adaptive behavior in young children. Developmental assessment in clinical child psychology: A handbook. New York: Pergamon Press; 1990. pp. 222&#x2013;239.</Citation></Reference><Reference><Citation>Mokkink L.B., Terwee C.B., Patrick D.L., et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J. Clin. Epidemiol. 2010;63(7):737&#x2013;745. doi: 10.1016/j.jclinepi.2010.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.02.006</ArticleId><ArticleId IdType="pubmed">20494804</ArticleId></ArticleIdList></Reference><Reference><Citation>Crosby R.D., Kolotkin R.L., Williams G.R. Defining clinically meaningful change in health-related quality of life. J. Clin. Epidemiol. 2003;56(5):395&#x2013;407. doi: 10.1016/S0895-4356(03)00044-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-4356(03)00044-1</ArticleId><ArticleId IdType="pubmed">12812812</ArticleId></ArticleIdList></Reference><Reference><Citation>Balsis S., Benge J.F., Lowe D.A., Geraci L., Doody R.S. How do scores on the ADAS-Cog, MMSE, and CDR-SOB correspond? Clin. Neuropsychol. 2015;29(7):1002&#x2013;1009. doi: 10.1080/13854046.2015.1119312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2015.1119312</ArticleId><ArticleId IdType="pubmed">26617181</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Bryant S.E., Lacritz L.H., Hall J., et al. Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer&#x2019;s coordinating center database. Arch. Neurol. 2010;67(6):746&#x2013;749. doi: 10.1001/archneurol.2010.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.115</ArticleId><ArticleId IdType="pmc">PMC2888493</ArticleId><ArticleId IdType="pubmed">20558394</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsaeed D., Orlu M., Smith F. Optimising medication use along dementia progression: Recommendations from a qualitative study. Healthcare (Basel) 2021;9(8):982. doi: 10.3390/healthcare9080982.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare9080982</ArticleId><ArticleId IdType="pmc">PMC8391125</ArticleId><ArticleId IdType="pubmed">34442119</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones R.W., Lebrec J., Kahle-Wrobleski K., et al. Disease progression in mild dementia due to Alzheimer disease in an 18-month observational study (GERAS): The impact on costs and caregiver outcomes. Dement. Geriatr. Cogn. Disord. Extra. 2017;7(1):87&#x2013;100. doi: 10.1159/000461577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000461577</ArticleId><ArticleId IdType="pmc">PMC5465649</ArticleId><ArticleId IdType="pubmed">28611822</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlozzi N.E., Sherman C.W., Angers K., Belanger M.P., Austin A.M., Ryan K.A. Caring for an individual with mild cognitive impairment: a qualitative perspective of health-related quality of life from caregivers. Aging Ment. Health. 2018;22(9):1196&#x2013;1204. doi: 10.1080/13607863.2017.1341468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2017.1341468</ArticleId><ArticleId IdType="pmc">PMC6141353</ArticleId><ArticleId IdType="pubmed">28699777</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhikav V., Anand K.S., Sachdeva A., Mishra P. Perceived caregiver stress in Alzheimer&#x2032;s disease and mild cognitive impairment: A case control study. Ann. Indian Acad. Neurol. 2016;19(1):58&#x2013;62. doi: 10.4103/0972-2327.167695.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0972-2327.167695</ArticleId><ArticleId IdType="pmc">PMC4782554</ArticleId><ArticleId IdType="pubmed">27011630</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer K.I., Bernaards C.A., Holt T., McDougall F., Lansdall C.J. Psychometric validation of the 27-item zarit caregiver interview for Alzheimer&#x2019;s disease (ZCI-AD-27) for prodromal-to-mild Alzheimer&#x2019;s disease. Qual. Life Res. 2022;31(2):S143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10278238</ArticleId><ArticleId IdType="pubmed">36588335</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38313766</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2573-4393</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>4</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>OBM integrative and complimentary medicine</Title><ISOAbbreviation>OBM Integr Compliment Med</ISOAbbreviation></Journal><ArticleTitle>Maximizing the Benefit of Respite for Dementia Caregivers: A Study Protocol Describing the Development &amp; Evaluation of the Time for Living &amp; Caring (TLC) Intervention.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">040</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.21926/obm.icm.2304040</ELocationID><Abstract><AbstractText>Dementia caregivers are susceptible to adverse physical and mental health outcomes, given the often prolonged and challenging care and support they provide to family members with Alzheimer's Disease and Related Dementias (ADRD). This report describes a community-engaged implementation of a novel behavioral intervention - an "app" (interactive website) called TLC (Time for Living and Caring) that coaches caregivers on how to maximize the benefits associated with respite time. The rationale and features of the TLC intervention and the full research protocol used to develop and then evaluate its feasibility, acceptability, and initial efficacy are described here.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Utz</LastName><ForeName>Rebecca L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>University of Utah, College of Social and Behavioral Sciences, 260 South Central Campus Drive, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caserta</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Utah, College of Nursing, 10 S. 2000 E., Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iacob</LastName><ForeName>Eli</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Utah, College of Nursing, 10 S. 2000 E., Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sparks</LastName><ForeName>Catharine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Utah, College of Social and Behavioral Sciences, 260 South Central Campus Drive, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stark</LastName><ForeName>Louisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Utah, School of Medicine, 27 S. Mario Capecchi Dr, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terrill</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Utah, College of Health, 15 N 2030 East, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Amber</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Utah, College of Social and Behavioral Sciences, 260 South Central Campus Drive, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Bob</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University of Utah, College of Nursing, 10 S. 2000 E., Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG061946</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>OBM Integr Compliment Med</MedlineTA><NlmUniqueID>101751096</NlmUniqueID><ISSNLinking>2573-4393</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Respite</Keyword><Keyword MajorTopicYN="N">caregiver</Keyword><Keyword MajorTopicYN="N">community-engaged research</Keyword><Keyword MajorTopicYN="N">online intervention</Keyword><Keyword MajorTopicYN="N">protocol</Keyword></KeywordList><CoiStatement>Competing Interests The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>5</Day><Hour>4</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38313766</ArticleId><ArticleId IdType="mid">NIHMS1961428</ArticleId><ArticleId IdType="pmc">PMC10838170</ArticleId><ArticleId IdType="doi">10.21926/obm.icm.2304040</ArticleId><ArticleId IdType="pii">040</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alzheimer&#x2019;s Association. 2018 Alzheimer&#x2019;s disease facts and figures. Alzheimer&#x2019;s Dementia 2018; 14: 367&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>AARP, National Alliance for Caregiving. Caregiving in the United States 2020 Washington, DC: AARP; 2020. Doi: 10.26419/ppi.00103.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.26419/ppi.00103.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Adelman RD, Tmanova LL, Delgado D, Dion S, Lachs MS. Caregiver burden: A clinical review. J Am Med Assoc 2014; 311: 1052&#x2013;1060.</Citation><ArticleIdList><ArticleId IdType="pubmed">24618967</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz R, Beach SR, Czaja SJ, Martire LM, Monin JK. Family caregiving for older adults. Annu Rev Psychol 2020; 71: 635&#x2013;659.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7291827</ArticleId><ArticleId IdType="pubmed">31905111</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper JD, Freedman VA, Spillman BC, Wolff JL. The disproportionate impact of dementia on family and unpaid caregiving to older adults. Health Aff 2015; 34: 1642&#x2013;1649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4635557</ArticleId><ArticleId IdType="pubmed">26438739</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheltens P, Blennow K, Breteler MM, De Strooper B, Frisoni GB, Salloway S, et al. Alzheimer&#x2019;s disease. Lancet 2016; 388: 505&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pubmed">26921134</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz R, Burgio L, Burns R, Eisdorfer C, Gallagher Thompson D, et al. Resources for enhancing alzheimer&#x2019;s caregiver health (REACH): Overview, site-specific outcomes, and future directions. Gerontologist 2003; 43: 514&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2579756</ArticleId><ArticleId IdType="pubmed">12937330</ArticleId></ArticleIdList></Reference><Reference><Citation>Czaja SJ, Schulz R, Belle SH, Burgio LD, Armstrong N, Gitlin LN, et al. Data and safety monitoring in social behavioral intervention trials: The REACH II experience. Clin Trials 2006; 3: 107&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1484572</ArticleId><ArticleId IdType="pubmed">16773953</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer OL, Liu X, Tancredi D, Ramirez AS, Schulz R, Hinton L. Acculturation level and caregiver outcomes from a randomized intervention trial to enhance caregivers&#x2019; health: Evidence from REACH II. Aging Ment Health 2018; 22: 730&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5654701</ArticleId><ArticleId IdType="pubmed">28436694</ArticleId></ArticleIdList></Reference><Reference><Citation>Badr H, Carmack CL, Diefenbach MA. Psychosocial interventions for patients and caregivers in the age of new communication technologies: Opportunities and challenges in cancer care. J Health Commun 2015; 20: 328&#x2013;342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4361271</ArticleId><ArticleId IdType="pubmed">25629218</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgeois MS, Schulz R, Burgio L. Interventions for caregivers of patients with Alzheimer&#x2019;s disease: A review and analysis of content, process, and outcomes. Int J Aging Hum Dev 1996; 43: 35&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">8886875</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi NC, Demiris G, Lewis FM, Walker AJ, Langer SL. Behavioral and educational interventions to support family caregivers in end-of-life care: A systematic review. Am J Hosp Palliat Care 2016; 33: 894&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pubmed">26157046</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooke DD, McNally L, Mulligan KT, Harrison MJ, Newman SP. Psychosocial interventions for caregivers of people with dementia: A systematic review. Aging Ment Health 2001; 5:120&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">11511059</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz R, O&#x2019;Brien A, Czaja S, Ory M, Norris R, Martire LM, et al. Dementia caregiver intervention research: In search of clinical significance. Gerontologist 2002; 42: 589&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2579772</ArticleId><ArticleId IdType="pubmed">12351794</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitlatch CJ, Zarit SH, von Eye A. Efficacy of interventions with caregivers: A reanalysis. Gerontologist 1991; 31: 9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">2007480</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaugler JE, Jarrott SE, Zarit SH, Stephens MA, Townsend A, Greene R. Adult day service use and reductions in caregiving hours: Effects on stress and psychological well&#x2010;being for dementia caregivers. Int J Geriatr Psychiatry 2003; 18: 55&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">12497556</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaugler JE, Zarit SH, Townsend A, Parris Stephens MA, Greene R. Evaluating community-based programs for dementia caregivers: The cost implications of adult day services. J Appl Gerontol 2003; 22: 118&#x2013;133.</Citation></Reference><Reference><Citation>Gaugler JE, Reese M, Tanler R. Care to plan: An online tool that offers tailored support to dementia caregivers. Gerontologist 2016; 56: 1161&#x2013;1174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5181391</ArticleId><ArticleId IdType="pubmed">26603183</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund DA, Utz R, Caserta MS, Wright SD. Examining what caregivers do during respite time to make respite more effective. J Appl Gerontol 2009; 28: 109&#x2013;131.</Citation></Reference><Reference><Citation>Utz RL, Lund DA, Caserta MS, Wright SD. The benefits of respite time-use: A comparison of employed and nonemployed caregivers. J Appl Gerontol 2012; 31: 438&#x2013;461.</Citation></Reference><Reference><Citation>Kirk RS, Kagan J. A research agenda for respite care: Deliberations of an expert panel of researchers, advocates and funders Chapel Hill, NC: ARCH National Respite Network and Resource Center; 2015.</Citation></Reference><Reference><Citation>Zarit SH, Bangerter LR, Liu Y, Rovine MJ. Exploring the benefits of respite services to family caregivers: Methodological issues and current findings. Aging Ment Health 2017; 21: 224&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5550302</ArticleId><ArticleId IdType="pubmed">26729467</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarit SH, Stephens MA, Townsend A, Greene R. Stress reduction for family caregivers: Effects of adult day care use. J Gerontol Ser B 1998; 53: S267&#x2013;S277.</Citation><ArticleIdList><ArticleId IdType="pubmed">9750575</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarit SH, Kim K, Femia EE, Almeida DM, Klein LC. The effects of adult day services on family caregivers&#x2019; daily stress, affect, and health: Outcomes from the Daily Stress and Health (DaSH) study. Gerontologist 2014; 54: 570&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4155447</ArticleId><ArticleId IdType="pubmed">23690056</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans D Exploring the concept of respite. J Adv Nurs 2013; 69: 1905&#x2013;1915.</Citation><ArticleIdList><ArticleId IdType="pubmed">23157453</ArticleId></ArticleIdList></Reference><Reference><Citation>Recognize, Assist, Include, Support, Engage (RAISE) Family Caregiver Act, United States House of Representatives, 115th Congress (Session 1) Sess (2017/2018).</Citation></Reference><Reference><Citation>Kosloski K, Montgomery RJ. The effects of respite on caregivers of Alzheimer&#x2019;s patients: One-year evaluation of the Michigan Model Respite Programs. J Appl Gerontol 1993; 12: 4&#x2013;17.</Citation></Reference><Reference><Citation>S&#xf6;rensen S, Pinquart M, Duberstein P. How effective are interventions with caregivers? An updated meta-analysis. Gerontologist 2002; 42: 356&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pubmed">12040138</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund DA, Utz RL, Caserta MS, Wright SD, Llanque SM, Lindfelt C, et al. Time for living and caring: An intervention to make respite more effective for caregivers. Int J Aging Hum Dev 2014; 79: 157&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4388419</ArticleId><ArticleId IdType="pubmed">25536704</ArticleId></ArticleIdList></Reference><Reference><Citation>Seleen DR. The congruence between actual and desired use of time by older adults: A predictor of life satisfaction. Gerontologist 1982; 22: 95&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">7067999</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute on Aging NIoH. Alzheimer&#x2019;s Disease Summit [Internet]
New York, NY: National Institute on Aging NioH; 2015. Available from: www.nia.nih.gov/research.</Citation></Reference><Reference><Citation>Czaja SJ, Loewenstein D, Schulz R, Nair SN, Perdomo D. A videophone psychosocial intervention for dementia caregivers. Am J Geriatr Psychiatry 2013; 21: 1071&#x2013;1081.</Citation><ArticleIdList><ArticleId IdType="pubmed">23831174</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitlatch CJ, Orsulic Jeras S. Meeting the informational, educational, and psychosocial support needs of persons living with dementia and their family caregivers. Gerontologist 2018; 58: S58&#x2013;S73.</Citation><ArticleIdList><ArticleId IdType="pubmed">29361068</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlomann A, Seifert A, Zank S, Woopen C, Rietz C. Use of Information and Communication Technology (ICT) devices among the oldest-old: Loneliness, anomie, and autonomy. Innovation Aging 2020; 4: igz050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6938466</ArticleId><ArticleId IdType="pubmed">31911953</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltes PB, Baltes MM. Psychological perspectives on successful aging: The model of selective optimization with compensation. In: Successful aging: Perspectives from the behavioral sciences Cambridge, UK: Cambridge University Press; 2010. pp. 1&#x2013;34.</Citation></Reference><Reference><Citation>Gignac MA, Cott C, Badley EM. Adaptation to disability: Applying selective optimization with compensation to the behaviors of older adults with osteoarthritis. Psychol Aging 2002; 17: 520&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pubmed">12243392</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker ER, Wexler B, DiIorio C, Escoffery C, McCarty F, Yeager KA. Content and characteristics of goals created during a self-management intervention for people with epilepsy. J Neurosci Nurs 2009; 41: 312&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pubmed">19998682</ArticleId></ArticleIdList></Reference><Reference><Citation>Bovend&#x2019;Eerdt TJ, Botell RE, Wade DT. Writing SMART rehabilitation goals and achieving goal attainment scaling: A practical guide. Clin Rehabil 2009; 23: 352&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">19237435</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoppmann CA, Poetter U, Klumb PL. Dyadic conflict in goal-relevant activities affects well-being and psychological functioning in employed parents: Evidence from daily time-samples. Time Soc 2013; 22: 356&#x2013;370.</Citation></Reference><Reference><Citation>Gollwitzer PM, Sheeran P. Implementation intentions and goal achievement: A meta&#x2010;analysis of effects and processes. Adv Exp Social Psychol 2016; 38: 69&#x2013;119.</Citation></Reference><Reference><Citation>Gollwitzer PM, Gawrilow C, Oettingen G. The power of planning: Self-control by effective goal-striving. In: Self control in society, mind, and brain Oxford, UK: Oxford University Press; 2010. pp. 279&#x2013;296.</Citation></Reference><Reference><Citation>Webb TL, Sheeran P. Does changing behavioral intentions engender behavior change? A meta-analysis of the experimental evidence. Psychol Bull 2006; 132: 249&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pubmed">16536643</ArticleId></ArticleIdList></Reference><Reference><Citation>Judge KS, Bass DM, Snow AL, Wilson NL, Morgan R, Looman WJ, et al. Partners in dementia care: A care coordination intervention for individuals with dementia and their family caregivers. Gerontologist 2011; 51: 261&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pubmed">21242317</ArticleId></ArticleIdList></Reference><Reference><Citation>Vancouver JB, Weinhardt JM, Schmidt AM. A formal, computational theory of multiple-goal pursuit: Integrating goal-choice and goal-striving processes. J Appl Psychol 2010; 95: 985&#x2013;1008.</Citation><ArticleIdList><ArticleId IdType="pubmed">20804232</ArticleId></ArticleIdList></Reference><Reference><Citation>National Research Council. The subjective well-being module of the American Time Use Survey: Assessment for its continuation Washington, DC, US: National Academies Press; 2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">23166965</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakowski W Evaluating psychosocial interventions for promoting self-care behaviors among older adults. In: Self-care in later life: Research, program, and policy issues New York, NY: Springer; 1998. pp. 85&#x2013;117.</Citation></Reference><Reference><Citation>Rakowski W Disease prevention and health promotion among older adults. In: Aging, Health, and Behaviors Newbury Park, CA: Sage Publications; 1992. pp. 239&#x2013;275.</Citation></Reference><Reference><Citation>Beach SR, Schulz R, Donovan H, Rosland AM. Family caregiving during the COVID-19 pandemic. Gerontologist 2021; 61: 650&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083337</ArticleId><ArticleId IdType="pubmed">33847355</ArticleId></ArticleIdList></Reference><Reference><Citation>Chyu J, Cantu P, Mehta N, Markides K. Caregiving for people with dementia or cognitive impairment during the COVID-19 pandemic: A review. Gerontol Geriatr Med 2022; 8: 23337214221132369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9585366</ArticleId><ArticleId IdType="pubmed">36299916</ArticleId></ArticleIdList></Reference><Reference><Citation>Damian AC, Ciobanu AM, Anghele C, Papacocea IR, Manea MC, Iliu&#x21b;&#x103; FP, et al. Caregiving for dementia patients during the coronavirus pandemic. J Clin Med 2023; 12: 2616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10095033</ArticleId><ArticleId IdType="pubmed">37048700</ArticleId></ArticleIdList></Reference><Reference><Citation>Lightfoot E, Moone RP. Caregiving in times of uncertainty: Helping adult children of aging parents find support during the COVID-19 outbreak. J Gerontol Soc Work 2020; 63: 542&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">32449648</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson Lane SG, Leggett AN, Johnson FU, Leonard N, Carmichael AG, Oxford G, et al. Caregiving in the COVID&#x2010;19 pandemic: Family adaptations following an intensive care unit hospitalisation. J Clin Nurs 2022. Doi: 10.1111/jocn.16560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.16560</ArticleId><ArticleId IdType="pmc">PMC9874809</ArticleId><ArticleId IdType="pubmed">36262026</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan K, Sadler T, Brauner D, Pollack HA, Konetzka RT. Caregiving for older adults with dementia during the time of COVID-19: A multi-state exploratory qualitative study. J Appl Gerontol 2023. Doi: 10.1177/07334648231175414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/07334648231175414</ArticleId><ArticleId IdType="pmc">PMC10214026</ArticleId><ArticleId IdType="pubmed">37231705</ArticleId></ArticleIdList></Reference><Reference><Citation>Onken L PRECEDE&#x2010;PROCEED and the NIDA stage model: The value of a conceptual framework for intervention research. J Public Health Dent 2011; 71: S18&#x2013;S19.</Citation><ArticleIdList><ArticleId IdType="pubmed">21656945</ArticleId></ArticleIdList></Reference><Reference><Citation>Onken LS, Carroll KM, Shoham V, Cuthbert BN, Riddle M. Reenvisioning clinical science: Unifying the discipline to improve the public health. Clin Psychol Sci 2014; 2: 22&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4374633</ArticleId><ArticleId IdType="pubmed">25821658</ArticleId></ArticleIdList></Reference><Reference><Citation>Utz RL, Terrill AL, Thompson A. Online interventions to support family caregivers: The value of community-engaged research practices. J Prev Interv Community 2023; 51: 238&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691858</ArticleId><ArticleId IdType="pubmed">34053412</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Disease Fact Sheet Washington, D C: U.S. Department of Health and Human Services; 2015; Pub No 15&#x2013;6423.</Citation></Reference><Reference><Citation>Fritz MS, MacKinnon DP. Required sample size to detect the mediated effect. Psychol Sci 2007; 18: 233&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2843527</ArticleId><ArticleId IdType="pubmed">17444920</ArticleId></ArticleIdList></Reference><Reference><Citation>Caserta M, Utz R, Lund D, De Vries B. Sampling, recruitment, and retention in a bereavement intervention study: Experiences from the Living After Loss Project. Omega 2010; 61: 181&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2948412</ArticleId><ArticleId IdType="pubmed">20873532</ArticleId></ArticleIdList></Reference><Reference><Citation>File T, Ryan C. Computer and Internet Use in the United States: 2013 Washington, DC: U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau; 2014.</Citation></Reference><Reference><Citation>National Research Council. The Subjective Well-Being Module of the American Time Use Survey: Assessment for Its Continuation [Internet]
Washington, DC: The National Academies Press; 2012. Available from: http://www.nap.edu/catalog.php?record_id=13535.</Citation><ArticleIdList><ArticleId IdType="pubmed">23166965</ArticleId></ArticleIdList></Reference><Reference><Citation>Caserta MS, Lund DA, Wright SD. Exploring the Caregiver Burden Inventory (CBI): Further evidence for a multidimensional view of burden. Int J Aging Hum Dev 1996; 43: 21&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">8886874</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney DF, Tarlow BJ, Jones RN. Effects of an automated telephone support system on caregiver burden and anxiety: Findings from the REACH for TLC intervention study. Gerontologist 2003; 43: 556&#x2013;567.</Citation><ArticleIdList><ArticleId IdType="pubmed">12937334</ArticleId></ArticleIdList></Reference><Reference><Citation>Himmelfarb S, Murrell SA. Reliability and validity of five mental health scales in older persons. J Gerontol 1983; 38: 333&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">6841929</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimond M, Lund DA, Caserta MS. The role of social support in the first two years of bereavement in an elderly sample. Gerontologist 1987; 27: 599&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">3678899</ArticleId></ArticleIdList></Reference><Reference><Citation>Utz RL, Swenson KL, Caserta M, Lund D, DeVries B. Feeling lonely versus being alone: Loneliness and social support among recently bereaved persons. J Gerontol Ser B 2014; 69: 85&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3894128</ArticleId><ArticleId IdType="pubmed">24056690</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore CG, Carter RE, Nietert PJ, Stewart PW. Recommendations for planning pilot studies in clinical and translational research. Clin Transl Sci 2011; 4: 332&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3203750</ArticleId><ArticleId IdType="pubmed">22029804</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturdy G, Hillman D, Green D, Jenkins S, Cecins N, Eastwood P. Feasibility of high-intensity, interval-based respiratory muscle training in COPD. Chest 2003; 123: 142&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">12527615</ArticleId></ArticleIdList></Reference><Reference><Citation>Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, et al. A tutorial on pilot studies: The what, why and how. BMC Med Res Methodol 2010; 10: 1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2824145</ArticleId><ArticleId IdType="pubmed">20053272</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale: An updated literature review. J Psychosom Res 2002; 52: 69&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">11832252</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisniewski SR, Belle SH, Coon DW, Marcus SM, Ory MG, Burgio LD, et al. The resources for enhancing Alzheimer&#x2019;s caregiver health (REACH): Project design and baseline characteristics. Psychol Aging 2003; 18: 375&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2577188</ArticleId><ArticleId IdType="pubmed">14518801</ArticleId></ArticleIdList></Reference><Reference><Citation>Belle SH, Burgio L, Burns R, Coon D, Czaja SJ, Gallagher Thompson D, et al. Enhancing the quality of life of dementia caregivers from different ethnic or racial groups: A randomized, controlled trial. Ann Intern Med 2006; 145: 727&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2585490</ArticleId><ArticleId IdType="pubmed">17116917</ArticleId></ArticleIdList></Reference><Reference><Citation>Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Social Behav 1995; 80&#x2013;94. Doi: 10.2307/2626958.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2626958</ArticleId><ArticleId IdType="pubmed">7560851</ArticleId></ArticleIdList></Reference><Reference><Citation>Utz RL, Caserta M, Lund D. An evaluation of the living after loss intervention-part 1: Do bereavement-related outcomes vary by the content of support groups? Grief Matters 2013; 16: 32&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4204648</ArticleId><ArticleId IdType="pubmed">24976788</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham M Parental influences on the gendered division of housework. Am Sociol Rev 2001; 66: 184&#x2013;203.</Citation></Reference><Reference><Citation>Nielsen L, Riddle M, King JW, Aklin WM, Chen W, Clark D, et al. The NIH science of behavior change program: Transforming the science through a focus on mechanisms of change. Behav Res Ther 2018; 101: 3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5756516</ArticleId><ArticleId IdType="pubmed">29110885</ArticleId></ArticleIdList></Reference><Reference><Citation>Donaldson GW. General linear contrasts on latent variable means: Structural equation hypothesis tests for multivariate clinical trials. Stat Med 2003; 22: 2893&#x2013;2917.</Citation><ArticleIdList><ArticleId IdType="pubmed">12953287</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKinnon DP, Fairchild AJ, Fritz MS. Mediation analysis. Annu Rev Psychol 2007; 58: 593&#x2013;614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2819368</ArticleId><ArticleId IdType="pubmed">16968208</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole DA, Maxwell SE. Testing mediational models with longitudinal data: Questions and tips in the use of structural equation modeling. J Abnorm Psychol 2003; 112: 558&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">14674869</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: The RE-AIM framework. Am J Public Health 1999; 89: 1322&#x2013;1327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1508772</ArticleId><ArticleId IdType="pubmed">10474547</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzewaltowski DA, Glasgow RE, Klesges LM, Estabrooks PA, Brock E. RE-AIM: Evidence-based standards and a Web resource to improve translation of research into practice. Ann Behav Med 2004; 28: 75&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">15454353</ArticleId></ArticleIdList></Reference><Reference><Citation>Jilcott S, Ammerman A, Sommers J, Glasgow RE. Applying the RE-AIM framework to assess the public health impact of policy change. Ann Behav Med 2007; 34: 105&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">17927550</ArticleId></ArticleIdList></Reference><Reference><Citation>Harden SM, Smith ML, Ory MG, Smith Ray RL, Estabrooks PA, Glasgow RE. RE-AIM in clinical, community, and corporate settings: Perspectives, strategies, and recommendations to enhance public health impact. Front Public Health 2018; 6. Doi: 10.3389/fpubh.2018.00071.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2018.00071</ArticleId><ArticleId IdType="pmc">PMC5874302</ArticleId><ArticleId IdType="pubmed">29623270</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtrop JS, Rabin BA, Glasgow RE. Qualitative approaches to use of the RE-AIM framework: Rationale and methods. BMC Health Serv Res 2018; 18: 177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5851243</ArticleId><ArticleId IdType="pubmed">29534729</ArticleId></ArticleIdList></Reference><Reference><Citation>Holzmeyer C Open science initiatives: Challenges for public health promotion. Health Promot Int 2019; 34: 624&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pubmed">29522095</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36574501</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1758-5341</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>The Gerontologist</Title><ISOAbbreviation>Gerontologist</ISOAbbreviation></Journal><ArticleTitle>Determining Evidence for Family Caregiver Communication: Associating Communication Behaviors With Breakdown and Repair.</ArticleTitle><Pagination><StartPage>1395</StartPage><EndPage>1404</EndPage><MedlinePgn>1395-1404</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/geront/gnac193</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">Communication is fundamental for dementia care. The trouble source repair (TSR) framework can identify strategies that facilitate or impede communication in dyadic interactions.</AbstractText><AbstractText Label="RESEARCH DESIGN AND METHODS">A secondary analysis of videos (N = 221) from a clinical trial of a family caregiver telehealth intervention was analyzed using sequential behavioral coding of communication behaviors and breakdowns for 53 caregiver and person with dementia dyads. Coded data from 3,642 30-s observations were analyzed using penalized regression for feature selection followed by Bayesian mixed-effects modeling to identify communication strategies associated with communication breakdown and repair.</AbstractText><AbstractText Label="RESULTS">Breakdown (coded as 0) was associated with caregivers changing topic (median = -11.45, 95% credibility interval [CrI; -24.34, -4.37]), ignoring (median = -11.49, 95% CrI [-24.49, -4.72]), giving commands (median = -10.74, 95% CrI [-24.22, -3.38]), and taking over the task (median = -4.06, 95% CrI [-7.28, -1.77]). Successful repair of breakdown was associated with verbalizing understanding (median = 0.46, 95% CrI [0.09, 0.86]), tag questions, (median = 2.4, 95% CrI [0.33, 5.35]), and silence (median = 0.78, 95% CrI [0.42, 1.15]) and negatively associated with ignoring and changing topic (median = -3.63, 95% CrI [-4.81, -2.57] and -2.51 [-3.78, -1.33], respectively).</AbstractText><AbstractText Label="DISCUSSION AND IMPLICATIONS">The TSR was effective in identifying specific communication strategies to avoid (changing topic, ignoring, commands, and taking over the task) and to use to repair breakdown (verbalize understanding, tag questions, and silence). Future research is needed to test these strategies and explore the potential effects of dementia stage, diagnosis, and dyad characteristics in additional samples. Behavioral coding provides evidence of communication best practices as a basis for family caregiver communication training.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Kristine N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>School of Nursing, University of Kansas Medical Center, Kansas City, Kansas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alzheimer's Disease Research Center, University of Kansas, Fairway, Kansas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coleman</LastName><ForeName>Carissa K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>School of Nursing, University of Kansas Medical Center, Kansas City, Kansas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jinxiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 AG066491</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gerontologist</MedlineTA><NlmUniqueID>0375327</NlmUniqueID><ISSNLinking>0016-9013</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="N">Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007398" MajorTopicYN="N">Interpersonal Relations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Best practices</Keyword><Keyword MajorTopicYN="N">Care partner</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">In-home care</Keyword><Keyword MajorTopicYN="N">Person-centered care</Keyword></KeywordList><CoiStatement>We have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>14</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36574501</ArticleId><ArticleId IdType="pmc">PMC10474591</ArticleId><ArticleId IdType="doi">10.1093/geront/gnac193</ArticleId><ArticleId IdType="pii">6961754</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alsawy, S., Mansell, W., McEvoy, P., &amp; Tai, S. (2017). What is good communication for people living with dementia? A mixed-methods systematic review. International Psychogeriatrics, 29(11), 1785&#x2013;1800. doi:10.1017/s1041610217001429</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610217001429</ArticleId><ArticleId IdType="pubmed">28756788</ArticleId></ArticleIdList></Reference><Reference><Citation>
Alzheimer&#x2019;s Association. (2021, October 25). Alzheimer&#x2019;s disease facts and figures report. https://www.alz.org/alzheimers-dementia/facts-figures</Citation></Reference><Reference><Citation>Barnes, C. J., &amp; Markham, C. (2018). A pilot study to evaluate the effectiveness of an individualized and cognitive behavioural communication intervention for informal carers of people with dementia: The talking sense programme. International Journal of Language and Communication Disorders, 53(3), 615&#x2013;627. doi:10.1111/1460-6984.12375</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1460-6984.12375</ArticleId><ArticleId IdType="pubmed">29460337</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauner, E. (2018). Coding interaction: A technical introduction. In Brauner E., Boos M., &amp; Kolbe M. (Eds.), The Cambridge handbook of group interaction analysis (pp. 165&#x2013;190). Cambridge University Press. doi:10.1017/9781316286302.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/9781316286302.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauner, E., Boos, M., &amp; Kolbe, M. (Eds.). (2018). The Cambridge handbook of group interaction analysis. Cambridge University Press. doi:10.1017/9781316286302</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/9781316286302</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman, C. K., Aly, I. M., Dunham, A., Inderhees, K., Richardson, M., Wilson, P., Berkley, A., Savundranayagam, M., &amp; Williams, K. (2022). Developing behavioral coding to understand family communication breakdown in dementia care. Western Journal of Nursing Research. 44(3), 250&#x2013;259. doi:10.1177/01939459211062957</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01939459211062957</ArticleId><ArticleId IdType="pmc">PMC8837727</ArticleId><ArticleId IdType="pubmed">34859729</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman, C. K., Medvene L. J., &amp; Van Haitsma, K. (2013). A person-centered care intervention for geriatric certified nursing assistants. Gerontologist, 53(4), 687&#x2013;698. doi:10.1093/geront/gns135</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gns135</ArticleId><ArticleId IdType="pubmed">23114564</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman, C. K., &amp; Williams, K. (2018). Visualizing communication behaviors and breakdowns in caregiver and person with dementia dyads. Innovation in Aging, 2(Suppl. 1), 1010. doi:10.1093/geroni/igy031.3730</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geroni/igy031.3730</ArticleId></ArticleIdList></Reference><Reference><Citation>Coupland, N., Coupland, J., Giles, H., &amp; Henwood, K. (1988). Accommodating the elderly: Invoking and extending a theory. Language in Society, 17(1), 1&#x2013;41. doi:10.1017/s0047404500012574</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0047404500012574</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggenberger, E., Heimerl, K., &amp; Bennett, M. I. (2013). Communication skills training in dementia care: A systematic review of effectiveness, training content, and didactic methods in different care settings. International Psychogeriatrics, 25(3), 345&#x2013;358. doi:10.1017/S1041610212001664</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610212001664</ArticleId><ArticleId IdType="pubmed">23116547</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelman, A., Jakulin, A., Pittau, M. G., &amp; Su, Y. S. (2008). A weakly informative default prior distribution for logistic and other regression models. Annals of Applied Statistics, 2(4), 1360&#x2013;1383. doi:10.48550/arXiv.0901.4011</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.0901.4011</ArticleId></ArticleIdList></Reference><Reference><Citation>Haak, N. J. (2002). Maintaining connections: Understanding communication from the perspective of persons with dementia. Alzheimer&#x2019;s Care Quarterly, 3, 116&#x2013;131.</Citation></Reference><Reference><Citation>Kim, S., Shaw, C., Williams, K. N., &amp; Hein, M. (2019). Typology of technology-supported dementia care interventions from an in-home telehealth trial. Western Journal of Nursing Research, 41(12), 1724&#x2013;1746. doi:10.1177/0193945919825861</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0193945919825861</ArticleId><ArticleId IdType="pmc">PMC6661218</ArticleId><ArticleId IdType="pubmed">30688175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitwood, T. M., &amp; Kitwood, T. M. (1997). Dementia reconsidered: The person comes first (Vol. 20, pp. 7&#x2013;8). Open university press.</Citation></Reference><Reference><Citation>Klodnicka Kouri, K., Ducharme, F. C., &amp; Giroux, F. (2011). A psychoeducational intervention focused on communication for caregivers of a family member in the early stage of Alzheimer&#x2019;s disease: Results of an experimental study. Dementia, 10(3), 435&#x2013;453. doi:10.1177/1471301211408124</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301211408124</ArticleId></ArticleIdList></Reference><Reference><Citation>Lann-Wolcott, H., Medvene, L. J., &amp; Williams, K. (2011). Measuring the person-centeredness of caregivers working with nursing home residents with dementia. Behavior Therapy, 42, 89&#x2013;99. doi:10.1016/j.beth.2010.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beth.2010.02.005</ArticleId><ArticleId IdType="pmc">PMC3593191</ArticleId><ArticleId IdType="pubmed">21292055</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddle, J., Smith-Conway, E. R., Baker, R., Angwin, A. J., Gallois, C., Copland, D. A., Pachana, N. A., Humphreys, M. S., Byrne, G. J., &amp; Chenery, H. J. (2012). Memory and communication support strategies in dementia: Effect of a training program for informal caregivers. International Psychogeriatrics, 24(9), 1927&#x2013;1942. doi:10.1017/s1041610212001366</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610212001366</ArticleId><ArticleId IdType="pubmed">23092595</ArticleId></ArticleIdList></Reference><Reference><Citation>Machiels, M., Metzelthin, S. F., Hamers, J. P., &amp; Zwakhalen, S. M. (2017). Interventions to improve communication between people with dementia and nursing staff during daily nursing care: A systematic review. International Journal of Nursing Studies, 66, 37&#x2013;46. doi:10.1016/j.ijnurstu.2016.11.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2016.11.017</ArticleId><ArticleId IdType="pubmed">27951433</ArticleId></ArticleIdList></Reference><Reference><Citation>McGilton, K. S., Boscart, V., Fox, M., Sidani, S., Rochon, E., &amp; Sorin-Peters, R. (2009). A systematic review of the effectiveness of communication interventions for health care providers caring for patients in residential care settings. Worldviews on Evidence-Based Nursing, 6(3), 149&#x2013;159. doi:10.1111/j.1741-6787.2009.00155.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1741-6787.2009.00155.x</ArticleId><ArticleId IdType="pubmed">19523033</ArticleId></ArticleIdList></Reference><Reference><Citation>Medvene, L. J., &amp; Coleman, C. K. (2012). Exploring the applicability of interdependence theory to CNA-resident relationships. Research in Gerontololgical Nursing, 5(1), 43&#x2013;54. doi:10.3928/19404921-20110329-01</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/19404921-20110329-01</ArticleId><ArticleId IdType="pubmed">21485973</ArticleId></ArticleIdList></Reference><Reference><Citation>Monin, J. K., &amp; Schulz, R. (2009). Interpersonal effects of suffering in older adult caregiving relationships. Psychology and Aging, 24(3), 681&#x2013;695. doi:10.1037/a0016355</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0016355</ArticleId><ArticleId IdType="pmc">PMC2765123</ArticleId><ArticleId IdType="pubmed">19739924</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris, L., Horne, M., McEvoy, P., &amp; Williamson, T. (2018). Communication training interventions for family and professional carers of people living with dementia: A systematic review of effectiveness, acceptability, and conceptual basis. Aging Mental Health, 22(7), 863&#x2013;880. doi:10.1080/13607863.2017.1399343</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2017.1399343</ArticleId><ArticleId IdType="pubmed">29125324</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute on Aging. (2017, May 17). Communication and behavior problems: Resources for Alzheimer&#x2019;s caregivers. https://www.nia.nih.gov/health/communication-and-behavior-problems-resources-alzheimers-caregivers</Citation></Reference><Reference><Citation>Nguyen, H., Terry, D., Phan, H., Vickers, J., &amp; McInerney, F. (2019). Communication training and its effects on carer and care-receiver outcomes in dementia settings: A systematic review. Journal of Clinical Nursing, 28(7&#x2013;8), 1050&#x2013;1069. doi:10.1111/jocn.14697</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.14697</ArticleId><ArticleId IdType="pubmed">30357952</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke, D. J., Lobchuk M. M., Thompson, G. N., &amp; Lengyel, C. (2022). Expanding the conversation: A person-centered Communication Enhancement Model. Dementia, 21(5), 1596&#x2013;1617. doi:10.1177/14713012221080252</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14713012221080252</ArticleId><ArticleId IdType="pmc">PMC9243449</ArticleId><ArticleId IdType="pubmed">35465734</ArticleId></ArticleIdList></Reference><Reference><Citation>Orange, J. B., Lubinski, R. B., &amp; Higginbotham, D. J. (1996). Conversational repair by individuals with dementia of the Alzheimer&#x2019;s type. Journal Speech and Hearing Research, 39(4), 881&#x2013;895. doi:10.1044/jshr.3904.881</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/jshr.3904.881</ArticleId><ArticleId IdType="pubmed">8844567</ArticleId></ArticleIdList></Reference><Reference><Citation>Orange, J. B., Van Gennep, K. M., Miller, L., &amp; Johnson, A. M. (1998). Resolution of communication breakdown in dementia of the Alzheimer&#x2019;s type: A longitudinal study. Journal of Applied Communication Research, 26(1), 120&#x2013;138. doi:10.1080/00909889809365495</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00909889809365495</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins, L., Felstead, C., Stott, J., &amp; Spector, A. (2022). Communication training programmes for informal caregivers of people living with dementia: A systematic review. Journal of Clinical Nursing, 31(19&#x2013;20), 2737&#x2013;2753. doi:10.1111/jocn.16175</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.16175</ArticleId><ArticleId IdType="pubmed">34927300</ArticleId></ArticleIdList></Reference><Reference><Citation>

Reisberg, B. (1988). Functional assessment staging (FAST). Psychopharmacology Bulletin, 24(4), 653&#x2013;659. https://www.ncbi.nlm.nih.gov/pubmed/3249767</Citation><ArticleIdList><ArticleId IdType="pubmed">3249767</ArticleId></ArticleIdList></Reference><Reference><Citation>Resnick, B., Galik, E., McPherson, R., Boltz, M., Van Haitsma, K., &amp; Kolanowski, A. (2022). Gender differences in disease, function, and behavioral symptoms in residents with dementia. Western Journal of Nursing Research, 44(9), 812&#x2013;821. doi:10.1177/01939459211018822</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01939459211018822</ArticleId><ArticleId IdType="pmc">PMC8627520</ArticleId><ArticleId IdType="pubmed">34044668</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan, E. B., Meredith, S. D., Maclean, M. J., &amp; Orange, J. B. (1995). Changing the way we talk with elders: Promoting health using the communication enhancement model. International Journal of Aging and Human Development, 41(2), 89&#x2013;107. doi:10.2190/fp05-fm8v-0y9f-53fx</Citation><ArticleIdList><ArticleId IdType="doi">10.2190/fp05-fm8v-0y9f-53fx</ArticleId><ArticleId IdType="pubmed">8550234</ArticleId></ArticleIdList></Reference><Reference><Citation>Savundranayagam, M. Y., &amp; Orange, J. B. (2011). Relationships between appraisals of caregiver communication strategies and burden among spouses and adult children. International Psychogeriatrics, 23(9), 1470&#x2013;1478. doi:10.1017/s1041610211000408</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610211000408</ArticleId><ArticleId IdType="pubmed">21429284</ArticleId></ArticleIdList></Reference><Reference><Citation>Savundranayagam, M. Y., &amp; Orange, J. B. (2014). Matched and mismatched appraisals of the effectiveness of communication strategies by family caregivers of persons with Alzheimer&#x2019;s disease. International Journal of Language and Communication Disorders, 49(1), 49&#x2013;59. doi:10.1111/1460-6984.12043</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1460-6984.12043</ArticleId><ArticleId IdType="pubmed">24372885</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw, C., Williams, K. N., &amp; Perkhounkova, Y. (2018). Educating nursing home staff in dementia sensitive communication: Impact on antipsychotic medication use. Journal of the American Medical Directors Association, 19(12), 1129&#x2013;1132. doi:10.1016/j.jamda.2018.09.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2018.09.030</ArticleId><ArticleId IdType="pmc">PMC6261475</ArticleId><ArticleId IdType="pubmed">30471803</ArticleId></ArticleIdList></Reference><Reference><Citation>Small, J. A., &amp; Gutman, G. (2002). Recommended and reported use of communication strategies in Alzheimer caregiving. Alzheimer Disease and Associated Disorders, 16(4), 270&#x2013;278. doi:10.1097/00002093-200210000-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002093-200210000-00009</ArticleId><ArticleId IdType="pubmed">12468902</ArticleId></ArticleIdList></Reference><Reference><Citation>Small, J. A., Gutman, G., Makela, S., &amp; Hillhouse, B. (2003). Effectiveness of communication strategies used by caregivers of persons with Alzheimer&#x2019;s disease during activities of daily living. Journal of Speech, Language, and Hearing Research, 46(2), 353&#x2013;367. doi:10.1044/1092-4388(2003/028))</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/1092-4388(2003/028)</ArticleId><ArticleId IdType="pubmed">14700377</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani, R. (1996). Regression shrinkage and selection via the Lasso. Journal of the Royal Statistical Society Series B (Methodological), 58(1), 267&#x2013;288. doi:10.1111/j.2517-6161.1996.tb02080.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2517-6161.1996.tb02080.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Tjia, J., Hunnicutt, J. N., Herndon, L., Blanks, C. R., Lapane, K. L., &amp; Wehry, S. (2017). Association of a communication training program with use of antipsychotics in nursing homes. JAMA Internal Medicine, 177(6), 846&#x2013;853. doi:10.1001/jamainternmed.2017.0746</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2017.0746</ArticleId><ArticleId IdType="pmc">PMC5818825</ArticleId><ArticleId IdType="pubmed">28418449</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, C. L., &amp; Parker, C. (2012). Development of an observer rating scale for caregiver communication in persons with Alzheimer&#x2019;s disease. Issues in Mental Health Nursing, 33(4), 244&#x2013;250. doi:10.3109/01612840.2011.653040</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01612840.2011.653040</ArticleId><ArticleId IdType="pubmed">22468590</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, K., Blyler, D., Vidoni, E. D., Shaw, C., Wurth, J., Seabold, D., Perkhounkova, Y., &amp; van Sciver, A. (2018). A randomized trial using telehealth technology to link caregivers with dementia care experts for in-home caregiving support: FamTechCare protocol. Research in Nursing and Health, 41(3), 219&#x2013;227. doi:10.1002/nur.21869</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nur.21869</ArticleId><ArticleId IdType="pmc">PMC6003850</ArticleId><ArticleId IdType="pubmed">29504666</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, K. N. (2006). Improving outcomes of nursing home interactions. Research in Nursing and Health, 29(2), 121&#x2013;133. doi:10.1002/nur.20117</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nur.20117</ArticleId><ArticleId IdType="pubmed">16532478</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, K. N., Boyle, D. K., Herman, R. E., Coleman, C. K., &amp; Hummert, M. L. (2012). Psychometric analysis of the emotional tone rating scale: A measure of person-centered communication. Clinical Gerontologist, 35(5), 376&#x2013;389. doi:10.1080/07317115.2012.702648</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07317115.2012.702648</ArticleId><ArticleId IdType="pmc">PMC3601757</ArticleId><ArticleId IdType="pubmed">23519545</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, K. N., Perkhounkova, Y., Bossen, A., &amp; Hein, M. (2016). Nursing home staff intentions for learned communication skills: Knowledge to practice. Journal of Gerontological Nursing, 42(3), 26&#x2013;34. doi:10.3928/00989134-20160212-06</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/00989134-20160212-06</ArticleId><ArticleId IdType="pmc">PMC4841447</ArticleId><ArticleId IdType="pubmed">26934971</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, K. N., Perkhounkova, Y., Herman, R., &amp; Bossen, A. (2017). A communication intervention to reduce resistiveness in dementia care: A cluster randomized controlled trial. Gerontologist, 57(4), 707&#x2013;718. doi:10.1093/geront/gnw047</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnw047</ArticleId><ArticleId IdType="pmc">PMC5881770</ArticleId><ArticleId IdType="pubmed">27048705</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, K. N., Perkhounkova, Y., Shaw, C. A., Hein, M., Vidoni, E., &amp; Coleman, C. K. (2019). Supporting family caregivers with technology for dementia home care: A randomized controlled trial. Innovation in Aging, 3(3), igz037. doi:10.1093/geroni/igz037</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geroni/igz037</ArticleId><ArticleId IdType="pmc">PMC6794215</ArticleId><ArticleId IdType="pubmed">31660443</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36571504</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-5415</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of the American Geriatrics Society</Title><ISOAbbreviation>J Am Geriatr Soc</ISOAbbreviation></Journal><ArticleTitle>"Been there, done that:" A grounded theory of future caregiver preparedness in former caregivers of parents living with dementia.</ArticleTitle><Pagination><StartPage>1495</StartPage><EndPage>1504</EndPage><MedlinePgn>1495-1504</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jgs.18209</ELocationID><Abstract><AbstractText Label="BACKGROUND">Family caregivers offer essential support to persons living with dementia (PLWD). Providing care for more than one family member or close other across adulthood is becoming increasingly common, yet little is known about the ways that caregiving experiences shape caregiver preparedness. The current study presents a grounded theory of future caregiver preparedness in former caregivers of PLWD.</AbstractText><AbstractText Label="METHOD">A coding team (five coders and two auditors) used Consensual Qualitative Research and grounded theory techniques to analyze transcripts from 32 semi-structured interviews with midlife former caregivers of parents who died following advanced Alzheimer's disease and related dementias.</AbstractText><AbstractText Label="RESULTS">Qualitative analysis revealed two dimensions of future caregiver preparedness: caregiving confidence and caregiving insights. Narratives from caregiving experiences informed participants' descriptions of their future caregiver preparedness. Though some former caregivers described a positive (i.e., boosted or sustained) sense of caregiving confidence following care for their parents, others described a diminished (i.e., restricted or impeded) sense of confidence. Regardless of their confidence, all caregivers described specific caregiving insights related to one or more categories (i.e., caregiving self-conduct, care systems and resources, and relating with a care partner).</AbstractText><AbstractText Label="CONCLUSIONS">Preparedness for future caregiving following recent care for a PLWD varies: For some, past experiences appear to offer cumulative advantages in anticipating future care roles, whereas for others, past experiences may contribute to apprehension towards, or rejection of, future care roles. Entering new caregiving roles with diminished confidence may have negative consequences for caregivers' and care partners' wellbeing. Multidimensional assessment of future caregiver preparedness in former caregivers of PLWD may support development of resources for former caregivers entering new caregiving roles.</AbstractText><CopyrightInformation>&#xa9; 2022 The American Geriatrics Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mroz</LastName><ForeName>Emily L</ForeName><Initials>EL</Initials><Identifier Source="ORCID">0000-0003-4539-0252</Identifier><AffiliationInfo><Affiliation>Section of Geriatrics, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piechota</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Social and Behavioral Sciences, Yale School of Public Health, New Haven, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Talha</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-4895-3583</Identifier><AffiliationInfo><Affiliation>Section of Geriatrics, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matta-Singh</LastName><ForeName>Tara D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>School of Social Work, University of South Florida, Tampa, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abboud</LastName><ForeName>Anissa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Health Policy, Yale School of Public Health, New Haven, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Shubam</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychological Science, Kennesaw State University, Kennesaw, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Marney A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0001-9856-6608</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fried</LastName><ForeName>Terri R</ForeName><Initials>TR</Initials><Identifier Source="ORCID">0000-0001-8083-8265</Identifier><AffiliationInfo><Affiliation>Section of Geriatrics, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monin</LastName><ForeName>Joan K</ForeName><Initials>JK</Initials><Identifier Source="ORCID">0000-0002-1729-0230</Identifier><AffiliationInfo><Affiliation>Department of Social and Behavioral Sciences, Yale School of Public Health, New Haven, Connecticut, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG021342</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AG019134</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Geriatr Soc</MedlineTA><NlmUniqueID>7503062</NlmUniqueID><ISSNLinking>0002-8614</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066296" MajorTopicYN="N">Grounded Theory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010290" MajorTopicYN="N">Parents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease and related dementias</Keyword><Keyword MajorTopicYN="N">caregiving trajectories</Keyword><Keyword MajorTopicYN="N">narrative identity</Keyword><Keyword MajorTopicYN="N">qualitative research</Keyword><Keyword MajorTopicYN="N">self-efficacy</Keyword></KeywordList><CoiStatement><b>Conflict of Interest:</b> The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>7</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>26</Day><Hour>9</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36571504</ArticleId><ArticleId IdType="mid">NIHMS1859119</ArticleId><ArticleId IdType="pmc">PMC10175151</ArticleId><ArticleId IdType="doi">10.1111/jgs.18209</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Academies of Sciences E, Medicine. Improving Outcomes for Individuals Living with Dementia. Reducing the Impact of Dementia in America: A Decadal Survey of the Behavioral and Social Sciences. National Academies Press; (US: ); 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">34613684</ArticleId></ArticleIdList></Reference><Reference><Citation>Redfoot D, Feinberg L, Houser AN. The aging of the baby boom and the growing care gap: A look at future declines in the availability of family caregivers. AARP Public Policy Institute; Washington, DC; 2013.</Citation></Reference><Reference><Citation>Gaugler JE. Unpaid Dementia Caregiving: A Policy and Public Health Imperative. Public Policy &amp; Aging Report. 2022;</Citation></Reference><Reference><Citation>Prevention TAsAaCfDCa. Healthy Brain Initiative, state and local public health partnerships to address dementia: The 2018&#x2013;2023 road map. Alzheimer&#x2019;s Association. https://www.cdc.gov/aging/pdf/2018-2023-Road-Map-508.pdf</Citation></Reference><Reference><Citation>Bennett AV, Hanson LC, Epstein-Lubow G, &amp; Zimmerman S Priorities for Person and Caregiver Relevant Outcomes in Dementia Intervention Research. 2022:9. 2021&#x2013;2022 Lived Experience Panel</Citation></Reference><Reference><Citation>Archbold PG, Stewart BJ, Greenlick MR, Harvath T. Mutuality and preparedness as predictors of caregiver role strain. Research in nursing &amp; health. 1990;13(6):375&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pubmed">2270302</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherbring M Effect of caregiver perception of preparedness on burden in an oncology population. 2002:E70&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12096297</ArticleId></ArticleIdList></Reference><Reference><Citation>Petruzzo A, Biagioli V, Durante A, et al. Influence of preparedness on anxiety, depression, and quality of life in caregivers of heart failure patients: testing a model of path analysis. Patient Education and Counseling. 2019;102(5):1021&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pubmed">30611564</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterling MR, Barbaranelli C, Riegel B, et al. The influence of preparedness, mutuality, and self-efficacy on home care workers&#x2019; contribution to self-care in heart failure: a structural equation modeling analysis. Journal of Cardiovascular Nursing. 2022;37(2):146&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8196074</ArticleId><ArticleId IdType="pubmed">33315614</ArticleId></ArticleIdList></Reference><Reference><Citation>Pucciarelli G, Lyons KS, Petrizzo A, et al. Protective Role of Caregiver Preparedness on the Relationship Between Depression and Quality of Life in Stroke Dyads. Stroke. 2022;53(1):145&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">34496626</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant M, Sun V, Fujinami R, et al. Family caregiver burden, skills preparedness, and quality of life in non-small-cell lung cancer. NIH Public Access; 2013:337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3695406</ArticleId><ArticleId IdType="pubmed">23803267</ArticleId></ArticleIdList></Reference><Reference><Citation>Shyu Y-IL, Yang C-T, Huang C-C, Kuo H-C, Chen S-T, Hsu W-C. Influences of mutuality, preparedness, and balance on caregivers of patients with dementia. Journal of Nursing Research. 2010;18(3):155&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">20808075</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez-Baena B, Romero-Grimaldi C. Predictive model for the preparedness level of the family caregiver. International Journal of Nursing Practice. 2022:e13057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9285821</ArticleId><ArticleId IdType="pubmed">35388583</ArticleId></ArticleIdList></Reference><Reference><Citation>Families Caring for an Aging America. The National Academies Press; 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">27905704</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk LM, Stajduhar KI, Outcalt L. What family caregivers learn when providing care at the end of life: A qualitative secondary analysis of multiple datasets. Palliative &amp; supportive care. 2015;13(3):425&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">24524561</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriksson A, &#xc5;restedt K. Exploring factors and caregiver outcomes associated with feelings of preparedness for caregiving in family caregivers in palliative care: a correlational, cross-sectional study. Palliative medicine. 2013;27(7):639&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pubmed">23670720</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz R, Beach SR, Czaja SJ, Martire LM, Monin JK. Family caregiving for older adults. Annual review of psychology. 2020;71:635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7291827</ArticleId><ArticleId IdType="pubmed">31905111</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaugler J Bridging the Family Care Gap. Academic Press; 2021:496pp.</Citation></Reference><Reference><Citation>Basu I, Mukhopadhyay S. Psychological health of dementia caregivers: An overview. Dementia Care. 2021:199&#x2013;226.</Citation></Reference><Reference><Citation>Fast J, Keating N, Eales J, Kim C, Lee Y. Trajectories of family care over the lifecourse: evidence from Canada. Ageing &amp; Society. 2021;41(5):1145&#x2013;1162.</Citation></Reference><Reference><Citation>Bromley MC, Blieszner R. Planning for long-term care: Filial behavior and relationship quality of adult children with independent parents. Family Relations. 1997:155&#x2013;162.</Citation></Reference><Reference><Citation>Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. International journal for quality in health care. 2007;19(6):349&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">17872937</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill CE, Knox S. Essentials of consensual qualitative research. American Psychological Association; 2021.</Citation></Reference><Reference><Citation>Strauss A, Corbin J. Grounded theory methodology: An overview. 1994;</Citation></Reference><Reference><Citation>Glaser BG, Strauss AL. The Discovery of Grounded Theory: Strategies for Qualitative Research, Chicago: Aldine Publishing, c1967. 1967;</Citation></Reference><Reference><Citation>McAdams DP. The life story interview. Northwestern University, Evanston, IL; 2008.</Citation></Reference><Reference><Citation>Schumm WR, Paff-Bergen LA, Hatch RC, et al. Concurrent and discriminant validity of the Kansas Marital Satisfaction Scale. Journal of Marriage and the Family. 1986:381&#x2013;387.</Citation></Reference><Reference><Citation>Charmaz K Constructing grounded theory. sage; 2014.</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Disease Facts and Figures. Alzheimer&#x2019;s Association. https://www.alz.org/alzheimers-dementia/facts-figures#:~:text=More%20than%2011%20million%20Americans,valued%20at%20nearly%20%24272%20billion.</Citation></Reference><Reference><Citation>Boltz M, Chippendale T, Resnick B, Galvin JE. Anxiety in family caregivers of hospitalized persons with dementia: contributing factors and responses. Alzheimer disease and associated disorders. 2015;29(3):236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4714710</ArticleId><ArticleId IdType="pubmed">25635341</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschman KB, Hodgson NA. Evidence-based interventions for transitions in care for individuals living with dementia. The Gerontologist. 2018;58(suppl_1):S129&#x2013;S140.</Citation><ArticleIdList><ArticleId IdType="pubmed">29361067</ArticleId></ArticleIdList></Reference><Reference><Citation>Miron AM, Groves CL, Thompson AE, McFadden SH, Bowers HR, DeBraal JM. Fear of Incompetence in Family Caregivers and Dementia Care Transitions. The International Journal of Aging and Human Development. 2022:00914150221106075.</Citation><ArticleIdList><ArticleId IdType="pubmed">35686309</ArticleId></ArticleIdList></Reference><Reference><Citation>Snyder CR. The psychology of hope: You can get there from here. Simon and Schuster; 1994.</Citation></Reference><Reference><Citation>Snyder CR, Harris C, Anderson JR, et al. The will and the ways: development and validation of an individual-differences measure of hope. Journal of personality and social psychology. 1991;60(4):570.</Citation><ArticleIdList><ArticleId IdType="pubmed">2037968</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrell BR, Ruel N, Borneman T, Koczywas M, Cristea M. Family Caregiver Preparedness: Developing an Educational Intervention for Symptom Management. Clinical Journal of Oncology Nursing. 2022;26(2):165&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">35302549</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostwald SK, Godwin KM, Cron SG, Kelley CP, Hersch G, Davis S. Home-based psychoeducational and mailed information programs for stroke-caregiving dyads post-discharge: a randomized trial. Disability and Rehabilitation. 2014;36(1):55&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">23594060</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H-L, Kuo L-M, Chen Y-S, et al. A home-based training program improves caregivers&#x2019; skills and dementia patients&#x2019; aggressive behaviors: a randomized controlled trial. The American journal of geriatric psychiatry. 2013;21(11):1060&#x2013;1070.</Citation><ArticleIdList><ArticleId IdType="pubmed">23933422</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherry M, Ablett J, Dickson JM, Powell D, Sikdar S, Salmon P. A qualitative study of the processes by which carers of people with dementia derive meaning from caring. Aging &amp; mental health. 2019;23(1):69&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">29105501</ArticleId></ArticleIdList></Reference><Reference><Citation>Blinka MD, Liu C, Sheehan OC, Rhodes JD, Roth DL. Family caregivers emphasise patience and personal growth: a qualitative analysis from the Caregiving Transitions Study. Age and Ageing. 2022;51(2):afab266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9356532</ArticleId><ArticleId IdType="pubmed">35932240</ArticleId></ArticleIdList></Reference><Reference><Citation>Hitchcock C, Werner-Seidler A, Blackwell SE, Dalgleish T. Autobiographical episodic memory-based training for the treatment of mood, anxiety and stress-related disorders: A systematic review and meta-analysis. Clinical Psychology Review. 2017;52:92&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">28086133</ArticleId></ArticleIdList></Reference><Reference><Citation>Speer ME, Ibrahim S, Schiller D, Delgado MR. Finding positive meaning in memories of negative events adaptively updates memory. Nature communications. 2021;12(1):1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8593143</ArticleId><ArticleId IdType="pubmed">34782605</ArticleId></ArticleIdList></Reference><Reference><Citation>Enright J, O&#x2019;Connell ME, Branger C, Kirk A, Morgan D. Identity, relationship quality, and subjective burden in caregivers of persons with dementia. Dementia. 2020;19(6):1855&#x2013;1871.</Citation><ArticleIdList><ArticleId IdType="pubmed">30360653</ArticleId></ArticleIdList></Reference><Reference><Citation>Rippon I, Quinn C, Martyr A, et al. The impact of relationship quality on life satisfaction and well-being in dementia caregiving dyads: Findings from the IDEAL study. Aging &amp; mental health. 2020;24(9):1411&#x2013;1420.</Citation><ArticleIdList><ArticleId IdType="pubmed">31140291</ArticleId></ArticleIdList></Reference><Reference><Citation>Soskolne V, Halevy-Levin S, Cohen A. The socio-cultural context of family caregiving and psychological distress: A comparison of immigrant and non-immigrant caregivers in Israel. Aging and Mental Health. 2007;11(1):3&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">17164152</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin CD. More than the work: Race and gender differences in caregiving burden. Journal of Family Issues. 2000;21(8):986&#x2013;1005.</Citation></Reference><Reference><Citation>Morycz R Caregiving families and cross-cultural perspectives. Caregiving Systems. Routledge; 2019:67&#x2013;74.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36565125</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-8908</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><Issue>3</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Hospitalizations and Emergency Room Admissions by Mexican American Older Adults with and without Dementia and Caregiver Mental Health.</ArticleTitle><Pagination><StartPage>1185</StartPage><EndPage>1195</EndPage><MedlinePgn>1185-1195</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-220997</ELocationID><Abstract><AbstractText Label="BACKGROUND">Evidence from predominately non-Hispanic White populations indicates that emergency room (ER) admissions and hospitalizations by older adults with and without dementia are associated with caregiver stress and depressive symptoms. These results may not generalize to Hispanic populations because of cultural differences in caregiving roles, responsibilities, and perspectives about care burden.</AbstractText><AbstractText Label="OBJECTIVE">Investigate the association between ER admissions and hospitalizations by Mexican American older adults with and without dementia and symptoms of depression and stress among family caregivers.</AbstractText><AbstractText Label="METHODS">Data came from the 2010/11 wave of the Hispanic Established Populations for the Epidemiologic Study of the Elderly and Medicare claims files. The final sample included 326 older adults and their caregivers. Negative binomial regression was used to model the association between hospitalizations and ER admissions by older adults in the previous two years and caregivers' depressive symptoms and stress in 2010/11.</AbstractText><AbstractText Label="RESULTS">The number of older adult ER admissions and hospitalizations was not associated with caregiver depressive symptoms. Two or more ER admissions (incident rate ratio [IRR]&#x200a;=&#x200a;1.26, 95% CI&#x200a;=&#x200a;1.05-1.51) and two or more hospitalizations (IRR&#x200a;=&#x200a;1.32, 95% CI&#x200a;=&#x200a;1.07-1.61) were associated with significantly higher caregiver stress. Additionally, ER admissions and hospitalizations for a circulatory disease or injury and poisoning were associated with significantly higher caregiver stress. These associations were not modified by the care recipient's dementia status.</AbstractText><AbstractText Label="CONCLUSION">Hospitalizations and ER admissions by older Mexican Americans were associated with greater caregiver stress but not depressive symptoms. These associations were similar for caregivers to older adults with and without dementia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Downer</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Population Health &amp; Health Disparities, School of Public and Population Health, University of Texas Medical Branch, Galveston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sealy Center on Aging, University of Texas Medical Branch, Galveston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chih-Ying</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Occupational Therapy, School of Health Professions, University of Texas Medical Branch, Galveston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Snih</LastName><ForeName>Soham</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Population Health &amp; Health Disparities, School of Public and Population Health, University of Texas Medical Branch, Galveston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sealy Center on Aging, University of Texas Medical Branch, Galveston, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG010939</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MD010355</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG059301</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 HD101589</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG024832</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 AG058789</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG068988</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 HD101589</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017058" MajorTopicYN="Y">Mexican Americans</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006278" MajorTopicYN="N">Medicare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Caregivers</Keyword><Keyword MajorTopicYN="N">Mexican Americans</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">health services</Keyword></KeywordList><CoiStatement>CONFLICT OF INTEREST. The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>4</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36565125</ArticleId><ArticleId IdType="mid">NIHMS1873730</ArticleId><ArticleId IdType="pmc">PMC9946698</ArticleId><ArticleId IdType="doi">10.3233/JAD-220997</ArticleId><ArticleId IdType="pii">JAD220997</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Feder J (2020) COVID-19 and the future of long-term care: The urgency of enhanced federal financing. J Aging Soc Policy 32, 350&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">32441573</ArticleId></ArticleIdList></Reference><Reference><Citation>Scales K (2021) It is time to resolve the direct care workforce crisis in long-term care. Gerontologist 61, 497&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499598</ArticleId><ArticleId IdType="pubmed">32853357</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrington C, Wiener JM, Ross L, Musumeci M, Key issues in long-term services and supports quality, https://collections.nlm.nih.gov/master/borndig/101717233/Issue-Brief-Key-Issues-in-Long-Term-Services-and-Supports-Quality.pdf, Accessed
November 22, 2022.</Citation></Reference><Reference><Citation>Favreault M, Dey J, Long-term services and supports for older Americans: Risks and financing, 2020 Research Brief, https://aspe.hhs.gov/sites/default/files/private/pdf/265126/LTSSOlAmRB.pdf, Accessed
January 24, 2022.</Citation></Reference><Reference><Citation>National Alliance for Caregiving and AARP, Caregiving in the U.S. 2020: A Focused Look at Family Caregivers of Adults Age 50+, https://www.caregiving.org/wp-content/uploads/2021/05/AARP1340_RR_Caregiving50Plus_508.pdf, Accessed
October 15, 2022.</Citation></Reference><Reference><Citation>Koyanagi A, DeVylder JE, Stubbs B, Carvalho AF, Veronese N, Haro JM, Santini ZI (2018) Depression, sleep problems, and perceived stress among informal caregivers in 58 low-, middle-, and high-income countries: A cross-sectional analysis of community-based surveys. J Psychiatr Res 96, 115&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">29031131</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman S, Sloane PD, Ward K, Beeber A, Reed D, Lathren C, Matchar B, Gwyther L (2018) Helping dementia caregivers manage medical problems: Benefits of an educational resource. Am J Alzheimers Dis Other Demen 33, 176&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6237200</ArticleId><ArticleId IdType="pubmed">29301414</ArticleId></ArticleIdList></Reference><Reference><Citation>Terum TM, Andersen JR, Rongve A, Aarsland D, Svends-boe EJ, Testad I (2017) The relationship of specific items on the Neuropsychiatric Inventory to caregiver burden in dementia: A systematic review. Int J Geriatr Psychiatry 32, 703&#x2013;717.</Citation><ArticleIdList><ArticleId IdType="pubmed">28317166</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Lee J, Bakker TJ, Duivenvoorden HJ, Droes RM (2014) Multivariate models of subjective caregiver burden in dementia: A systematic review. Ageing Res Rev 15, 76&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">24675045</ArticleId></ArticleIdList></Reference><Reference><Citation>Downer B, Al Snih S, Chou LN, Kuo YF, Raji M, Markides KS, Ottenbacher KJ (2021) Changes in health care use by Mexican American Medicare beneficiaries before and after a diagnosis of dementia. J Gerontol A Biol Sci Med Sci 76, 534&#x2013;542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7907487</ArticleId><ArticleId IdType="pubmed">32944734</ArticleId></ArticleIdList></Reference><Reference><Citation>Downer B, Al Snih S, Raji M, Chou LN, Kuo YF, Markides KS, Ottenbacher KJ (2020) Healthcare utilization of Mexican-American Medicare beneficiaries with and without Alzheimer&#x2019;s disease and related dementias. PLoS One 15, e0227681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6961888</ArticleId><ArticleId IdType="pubmed">31940401</ArticleId></ArticleIdList></Reference><Reference><Citation>Boltz M, Chippendale T, Resnick B, Galvin JE (2015) Anxiety in family caregivers of hospitalized persons with dementia: Contributing factors and responses. Alzheimer Dis Assoc Disord 29, 236&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4714710</ArticleId><ArticleId IdType="pubmed">25635341</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgstaller M, Mayer H, Schiess C, Saxer S (2018) Experiences and needs of relatives of people with dementia in acute hospitals-A meta-synthesis of qualitative studies. J Clin Nurs 27, 502&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">28639361</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein-Lubow G, Gaudiano B, Darling E, Hinckley M, Tremont G, Kohn R, Marino LJ Jr, Salloway S, Grinnell R, Miller IW (2012) Differences in depression severity in family caregivers of hospitalized individuals with dementia and family caregivers of outpatients with dementia. Am J Geriatr Psychiatry 20, 815&#x2013;819.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3487168</ArticleId><ArticleId IdType="pubmed">21997604</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu CW, Cosentino S, Ornstein K, Gu Y, Andrews H, Stern Y (2015) Use and cost of hospitalization in dementia: Longitudinal results from a community-based study. Int J Geriatr Psychiatry 30, 833&#x2013;841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4414886</ArticleId><ArticleId IdType="pubmed">25351909</ArticleId></ArticleIdList></Reference><Reference><Citation>Oney M, White L, Coe NB (2022) Out-of-pocket costs attributable to dementia: A longitudinal analysis. J Am Geriatr Soc 70, 1538&#x2013;1545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9106861</ArticleId><ArticleId IdType="pubmed">35278213</ArticleId></ArticleIdList></Reference><Reference><Citation>United States Census Bureau, 65 and older population grows rapidy as Baby Boomers age, https://www.census.gov/newsroom/press-releases/2020/65-older-population-grows.html, Accessed
October 10, 2022</Citation></Reference><Reference><Citation>Krogstad JM, Noe-Bustamante L, Key facts about US Latinos for National Hispanic Heritage Month, https://www.pewresearch.org/fact-tank/2022/09/23/key-facts-about-u-s-latinos-for-national-hispanic-heritage-month/, Accessed
October 18, 2022.</Citation></Reference><Reference><Citation>USC Edward R. Roybal Institute on Aging and the Latinos Against Alzheimer&#x2019;s Network, Latinos and Alzheimer&#x2019;s Disease: Numbers Behind the Crisis, https://www.usagainstalzheimers.org/network/latinos/latinos-and-alzheimers-new-numbers-behind-crisis-infographics, Accessed
October 15, 2022.</Citation></Reference><Reference><Citation>Knight BG, Sayegh P (2010) Cultural values and caregiving: The updated sociocultural stress and coping model. J Gerontol B Psychol Sci Soc Sci 65B, 5&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">19934166</ArticleId></ArticleIdList></Reference><Reference><Citation>Losada A, Marquez-Gonzalez M, Vara-Garcia C, Barrera-Caballero S, Cabrera I, Gallego-Alberto L, Olmos R, Romero-Moreno R (2020) Measuring familism in dementia family caregivers: The revised familism scale. Aging Ment Health 24, 784&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pubmed">30621433</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez-Luck CA, Anthony KP (2016) Marianismo and caregiving role beliefs among U.S.-born and immigrant Mexican women. J Gerontol B Psychol Sci Soc Sci 71, 926&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4982386</ArticleId><ArticleId IdType="pubmed">26362602</ArticleId></ArticleIdList></Reference><Reference><Citation>Rote SM, Angel JL, Moon H, Markides K (2019) Caregiving across diverse populations: New evidence from the National Study of Caregiving and Hispanic EPESE. Innov Aging 3, igz033.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6733633</ArticleId><ArticleId IdType="pubmed">31517066</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim P, Patten E, The Sandwich Generation: Rising financial burdens for middle-aged Americans, https://www.pewresearch.org/social-trends/2013/01/30/the-sandwich-generation/, Accessed
November 22, 2022.</Citation></Reference><Reference><Citation>Rote SM, Moon H (2018) Racial/Ethnic differences in caregiving frequency: Does immigrant status matter? J Gerontol B Psychol Sci Soc Sci 73, 1088&#x2013;1098.</Citation><ArticleIdList><ArticleId IdType="pubmed">27573991</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantu PA, Angel JL (2017) Demography of living arrangements among oldest-old Mexican Americans: Evidence from the Hispanic Epidemiologic Study of the Elderly. J Aging Health 29, 1015&#x2013;1038.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6380186</ArticleId><ArticleId IdType="pubmed">30231830</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyawaki CE (2016) Caregiving practice patterns of Asian, Hispanic, and Non-Hispanic White American family caregivers of older adults across generations. J Cross Cult Gerontol 31, 35&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">26810575</ArticleId></ArticleIdList></Reference><Reference><Citation>Connell CM, Gibson GD (1997) Racial, ethnic, and cultural differences in dementia caregiving: Review and analysis. Gerontologist 37, 355&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">9203759</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon HE, Haley WE, Rote SM, Sears JS (2020) Caregiver well-being and burden: Variations by race/ethnicity and care recipient nativity status. Innov Aging 4, igaa045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7679974</ArticleId><ArticleId IdType="pubmed">33241124</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Li L (2022) Evaluating the positive experience of caregiving: A systematic review of the positive aspects of caregiving scale. Gerontologist 62, e493&#x2013;e507.</Citation><ArticleIdList><ArticleId IdType="pubmed">34216215</ArticleId></ArticleIdList></Reference><Reference><Citation>Markides KS, Rudkin L, Angel RJ, Espino DV (1997) Health status of Hispanic elderly. In Racial and Ethnic Differences in the Health of Older Americans, Martin LG, Soldo BJ, eds. National Academy Press, Washington, DC, pp. 285&#x2013;300.</Citation></Reference><Reference><Citation>Downer B, Al Snih S, Chou LN, Kuo YF, Markides KS, Ottenbacher KJ (2019) Differences in hospitalizations, emergency room admissions, and outpatient visits among Mexican-American Medicare beneficiaries. BMC Geriatr 19, 136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6528336</ArticleId><ArticleId IdType="pubmed">31113371</ArticleId></ArticleIdList></Reference><Reference><Citation>Radloff LS (1977) The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Measure 1, 385&#x2013;401.</Citation></Reference><Reference><Citation>Warttig SL, Forshaw MJ, South J, White AK (2013) New, normative, English-sample data for the Short Form Perceived Stress Scale (PSS-4). J Health Psychol 18, 1617&#x2013;1628.</Citation><ArticleIdList><ArticleId IdType="pubmed">24155195</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S, Williamson G (1988) Perceived stress in a probability sample of the United States. In The Social Psychology of Health, Spacapan S, Oskamp S, eds. SAGE, Newbury Park, CA, pp. 385&#x2013;396.</Citation></Reference><Reference><Citation>Center for Medicare and Medicaid Services, CMS Chronic Conditions Data Warehouse. CCW condition algorithms, https://www.ccwdata.org/documents/10280/19139421/ccw-chronic-condition-algorithms.pdf, Accessed
January 24, 2022.</Citation></Reference><Reference><Citation>CMS Chronic Conditions Data Warehouse, CCW chronic conditions for Alzheimer&#x2019;s disease, related disorders, or senile dementia, https://www.ccwdata.org/web/guest/condition-categories,</Citation></Reference><Reference><Citation>Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 44, 2308&#x2013;2314.</Citation><ArticleIdList><ArticleId IdType="pubmed">7991117</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Ferguson JF, Generoso G, Ho JE, Kalani R, Khan SS, Kissela BM, Knutson KL, Levine DA, Lewis TT, Liu J, Loop MS, Ma J, Mussolino ME, Navaneethan SD, Perak AM, Poudel R, Rezk-Hanna M, Roth GA, Schroeder EB, Shah SH, Thacker EL, VanWagner LB, Virani SS, Voecks JH, Wang NY, Yaffe K, Martin SS (2022) Heart disease and stroke statistics-2022 update: A Report from the American Heart Association. Circulation 145, e153&#x2013;e639.</Citation><ArticleIdList><ArticleId IdType="pubmed">35078371</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitko L, McIlvennan CK, Bidwell JT, Dionne-Odom JN, Dunlay SM, Lewis LM, Meadows G, Sattler ELP, Schulz R, Str&#xf6;mberg A; American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; Council on Clinical Cardiology; and Council on Lifestyle and Cardiometabolic Health (2020) Family caregiving for individuals with heart failure: A scientific statement from the American Heart Association. Circulation 141, e864&#x2013;e878.</Citation><ArticleIdList><ArticleId IdType="pubmed">32349542</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke RE, Jones J, Ho PM, Bekelman DB (2014) Caregivers&#x2019; perceived roles in caring for patients with heart failure: What do clinicians need to know? J Card Fail 20, 731&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pubmed">25084216</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith TO, Pearson M, Pfeiffer K, Crotty M, Lamb SE (2019) Caregiver interventions for adults discharged from the hospital: Systematic review and meta-analysis. J Am Geriatr Soc 67, 1960&#x2013;1969.</Citation><ArticleIdList><ArticleId IdType="pubmed">31350918</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagle KC, Skopelja EN, Campbell NL (2018) Caregiver-based interventions to optimize medication safety in vulnerable elderly adults: A systematic evidence-based review. J Am Geriatr Soc 66, 2128&#x2013;2135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6235742</ArticleId><ArticleId IdType="pubmed">30136714</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadak T, Foster Zdon S, Ishado E, Zaslavsky O, Borson S (2017) Potentially preventable hospitalizations in dementia: Family caregiver experiences. Int Psychogeriatr 29, 1201&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pubmed">28349858</ArticleId></ArticleIdList></Reference><Reference><Citation>Adelman RD, Tmanova LL, Delgado D, Dion S, Lachs MS (2014) Caregiver burden: A clinical review. JAMA 311, 1052&#x2013;1060.</Citation><ArticleIdList><ArticleId IdType="pubmed">24618967</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez IL, Acosta Gonzalez E (2022) Care v. caring: Obligation, duty, and love among Latino Alzheimer&#x2019;s family caregivers. J Appl Gerontol 41, 1744&#x2013;1751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9232946</ArticleId><ArticleId IdType="pubmed">35484911</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez IL, Acosta Gonzalez E, Quintero C, Vania MJ (2022) The experience of Alzheimer&#x2019;s disease family caregivers in a Latino community: Expectations and incongruences in support services. J Gerontol B Psychol Sci Soc Sci 77, 1083&#x2013;1093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9159067</ArticleId><ArticleId IdType="pubmed">34543386</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollica MA, Smith AW, Kent EE (2020) Caregiving tasks and unmet supportive care needs of family caregivers: A U.S. population-based study. Patient Educ Couns 103, 626&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pubmed">31704030</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell JF, Whitney RL, Young HM (2019) Family caregiving in serious illness in the United States: Recommendations to support an invisible workforce. J Am Geriatr Soc 67, S451&#x2013;S456.</Citation><ArticleIdList><ArticleId IdType="pubmed">31074854</ArticleId></ArticleIdList></Reference><Reference><Citation>Guterman EL, Allen IE, Josephson SA, Merrilees JJ, Dulaney S, Chiong W, Lee K, Bonasera SJ, Miller BL, Possin KL (2019) Association between caregiver depression and emergency department use among patients with dementia. JAMA Neurol 76, 1166&#x2013;1173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6618767</ArticleId><ArticleId IdType="pubmed">31282955</ArticleId></ArticleIdList></Reference><Reference><Citation>Haley WE, Roth DL, Sheehan OC, Rhodes JD, Huang J, Blinka MD, Howard VJ (2020) Effects of transitions to family caregiving on well-being: A longitudinal population-based study. J Am Geriatr Soc 68, 2839&#x2013;2846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8297567</ArticleId><ArticleId IdType="pubmed">32835436</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth DL, Brown SL, Rhodes JD, Haley WE (2018) Reduced mortality rates among caregivers: Does family caregiving provide a stress-buffering effect? Psychol Aging 33, 619&#x2013;629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6002922</ArticleId><ArticleId IdType="pubmed">29723004</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson T, Ly A, Schnier C, Rannikm&#xe4;e K, Bush K, Brayne C, Quinn TJ, Sudlow CLM; UK Biobank Neurode-generative Outcomes Group and Dementias Platform UK (2018) Identifying dementia cases with routinely collected health data: A systematic review. Alzheimers Dement 14, 1038&#x2013;1051.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6105076</ArticleId><ArticleId IdType="pubmed">29621480</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu CW, Ornstein KA, Cosentino S, Gu Y, Andrews H, Stern Y (2019) Misidentification of dementia in Medicare claims and related costs. J Am Geriatr Soc 67, 269&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6429550</ArticleId><ArticleId IdType="pubmed">30315744</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin PJ, Daly AT, Olchanski N, Cohen JT, Neumann PJ, Faul JD, Fillit HM, Freund KM (2021) Dementia diagnosis disparities by race and ethnicity. Med Care 59, 679&#x2013;686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8263486</ArticleId><ArticleId IdType="pubmed">34091580</ArticleId></ArticleIdList></Reference><Reference><Citation>Arroyo-Johnson C, Mincey KD, Ackermann N, Milam L, Goodman MS, Colditz GA (2016) Racial and ethnic heterogeneity in self-reported diabetes prevalence trends across Hispanic subgroups, National Health Interview Survey, 1997&#x2013;2012. Prev Chronic Dis 13, E10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4722936</ArticleId><ArticleId IdType="pubmed">26796518</ArticleId></ArticleIdList></Reference><Reference><Citation>Daviglus ML, Talavera GA, Aviles-Santa ML, Allison M, Cai J, Criqui MH, Gellman M, Giachello AL, Gouskova N, Kaplan RC, LaVange L, Penedo F, Perreira K, Pirzada A, Schneiderman N, Wassertheil-Smoller S, Sorlie PD, Stamler J (2012) Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA 308, 1775&#x2013;1784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3777250</ArticleId><ArticleId IdType="pubmed">23117778</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez K, Penman-Aguilar A, Chang M-H, Moonesinghe R, Castellanos T, Rodr&#xed;guez-Lainz A, Schieber R; Centers for Disease Control and Prevention (CDC) (2015) Vital Signs: Leading causes of death, prevalence of diseases and risk factors, and use of health services among Hispanics in the United States &#x2014; 2009&#x2013;2013. MMWR Morb Mortal Wkly Rep 64, 469&#x2013;478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4584552</ArticleId><ArticleId IdType="pubmed">25950254</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36543532</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1470-2738</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of epidemiology and community health</Title><ISOAbbreviation>J Epidemiol Community Health</ISOAbbreviation></Journal><ArticleTitle>Variability in perceived burden and health trajectories among older caregivers: a population-based study in Sweden.</ArticleTitle><Pagination><StartPage>125</StartPage><EndPage>132</EndPage><MedlinePgn>125-132</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/jech-2022-219095</ELocationID><Abstract><AbstractText Label="BACKGROUND">The negative effects of informal caregiving are determined by the characteristics of the caregiver-care receiver dyad and the context of care. In this study, we aimed to identify which subgroups of older informal caregivers (1) experience the greatest subjective burden and (2) incur a faster decline in objective health status.</AbstractText><AbstractText Label="METHODS">From a total of 3363 older participants in the Swedish National study on Aging and Care in Kungsholmen (SNAC-K), we identified 629 informal caregivers (19.2%, mean age 69.9 years). Limitations to life and perceived burden were self-reported, and objective health status was quantified using the comprehensive clinical and functional Health Assessment Tool (HAT) score (range: 0-10). Ordered logistic regressions and linear mixed models were used to estimate the associations between caregiving-related exposures and subjective outcomes (cross-sectionally) and objective health trajectories (over 12 years), respectively.</AbstractText><AbstractText Label="RESULTS">Having a dual role (providing and receiving care simultaneously), caring for a spouse, living in the same household as the care receiver and spending more hours on caregiving were associated with more limitations and burden. In addition, having a dual role (&#x3b2;=-0.12, 95%&#x2009;CI -0.23 to -0.02) and caring for a spouse (&#x3b2;=-0.08, 95%&#x2009;CI -0.14 to -0.02) were associated with a faster HAT score decline. Being female and having a poor social network were associated with an exacerbation of the health decline.</AbstractText><AbstractText Label="CONCLUSIONS">Both the heterogeneity among caregivers and the related contextual factors should be accounted for by policymakers as well as in future research investigating the health impact of informal caregiving.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kirvalidze</LastName><ForeName>Mariam</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6773-3792</Identifier><AffiliationInfo><Affiliation>Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Solna, Sweden mariam.kirvalidze@ki.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beridze</LastName><ForeName>Giorgi</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-2615-226X</Identifier><AffiliationInfo><Affiliation>Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wimo</LastName><ForeName>Anders</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0963-5750</Identifier><AffiliationInfo><Affiliation>Division of Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morin</LastName><ForeName>Lucas</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8486-8610</Identifier><AffiliationInfo><Affiliation>Inserm CIC 1431, University Hospital of Besan&#xe7;on, Besan&#xe7;on, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calder&#xf3;n-Larra&#xf1;aga</LastName><ForeName>Amaia</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9064-9222</Identifier><AffiliationInfo><Affiliation>Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Solna, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stockholm Gerontology Research Center, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Epidemiol Community Health</MedlineTA><NlmUniqueID>7909766</NlmUniqueID><ISSNLinking>0143-005X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="Y">Health Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018454" MajorTopicYN="N">Spouses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006262" MajorTopicYN="N">Health</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AGING</Keyword><Keyword MajorTopicYN="N">GERONTOLOGY</Keyword><Keyword MajorTopicYN="N">HEALTH</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>21</Day><Hour>21</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36543532</ArticleId><ArticleId IdType="pmc">PMC9872244</ArticleId><ArticleId IdType="doi">10.1136/jech-2022-219095</ArticleId><ArticleId IdType="pii">jech-2022-219095</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
U.S. Family Caregiver Alliance . Definitions, 2021. Available: https://www.caregiver.org/resource/definitions-0/
</Citation></Reference><Reference><Citation>Roth DL, Fredman L, Haley WE. Informal caregiving and its impact on health: a reappraisal from population-based studies. Gerontologist 2015;55:309&#x2013;19. 10.1093/geront/gnu177</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnu177</ArticleId><ArticleId IdType="pmc">PMC6584119</ArticleId><ArticleId IdType="pubmed">26035608</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinquart M, S&#xf6;rensen S. Correlates of physical health of informal caregivers: a meta-analysis. J Gerontol B Psychol Sci Soc Sci 2007;62:P126&#x2013;37. 10.1093/geronb/62.2.P126</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/62.2.P126</ArticleId><ArticleId IdType="pubmed">17379673</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper C, Balamurali TBS, Livingston G. A systematic review of the prevalence and covariates of anxiety in caregivers of people with dementia. Int Psychogeriatr 2007;19:175&#x2013;95. 10.1017/S1041610206004297</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610206004297</ArticleId><ArticleId IdType="pubmed">17005068</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Regional Office for the Eastern Mediterranean . The growing need for home health care for the elderly: home health care for the elderly as an integral part of primary health care services, 2015: 1&#x2013;24.</Citation></Reference><Reference><Citation>Broese van Groenou MI, De Boer A. Providing informal care in a changing society. Eur J Ageing 2016;13:271&#x2013;9. 10.1007/s10433-016-0370-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10433-016-0370-7</ArticleId><ArticleId IdType="pmc">PMC4992501</ArticleId><ArticleId IdType="pubmed">27610055</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimo A, Elmst&#xe5;hl S, Fratiglioni L, et al. . Formal and informal care of community-living older people: a population-based study from the Swedish national study on aging and care. J Nutr Health Aging 2017;21:17&#x2013;24. 10.1007/s12603-016-0747-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-016-0747-5</ArticleId><ArticleId IdType="pubmed">27999845</ArticleId></ArticleIdList></Reference><Reference><Citation>Jegermalm M, Sundstr&#xf6;m G. Stereotyper kring omsorgsgivare och det svenska omsorgspanoramat. Eur J Soc Work 2015;18:185&#x2013;97. 10.1080/13691457.2014.892476</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13691457.2014.892476</ArticleId></ArticleIdList></Reference><Reference><Citation>Potier F, Degryse J-M, Bihin B, et al. . Health and frailty among older spousal caregivers: an observational cohort study in Belgium. BMC Geriatr 2018;18:1&#x2013;9. 10.1186/s12877-018-0980-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-018-0980-3</ArticleId><ArticleId IdType="pmc">PMC6258488</ArticleId><ArticleId IdType="pubmed">30477431</ArticleId></ArticleIdList></Reference><Reference><Citation>Bom J, Bakx P, Schut F, et al. . The impact of informal caregiving for older adults on the health of various types of caregivers: a systematic review. Gerontologist 2019;59:e629&#x2013;42. 10.1093/geront/gny137</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gny137</ArticleId><ArticleId IdType="pmc">PMC6850889</ArticleId><ArticleId IdType="pubmed">30395200</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindt N, van Berkel J, Mulder BC. Determinants of overburdening among informal carers: a systematic review. BMC Geriatr 2020;20:1&#x2013;12. 10.1186/s12877-020-01708-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-020-01708-3</ArticleId><ArticleId IdType="pmc">PMC7448315</ArticleId><ArticleId IdType="pubmed">32847493</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe9;rain P, Zech E. Informal caregiver burnout? Development of a theoretical framework to understand the impact of caregiving. Front Psychol 2019;10:1748. 10.3389/fpsyg.2019.01748</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2019.01748</ArticleId><ArticleId IdType="pmc">PMC6689954</ArticleId><ArticleId IdType="pubmed">31428015</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekstr&#xf6;m H, Auoja NL, Elmst&#xe5;hl S, et al. . High burden among older family caregivers is associated with high prevalence of symptoms: data from the Swedish study &#x201c;Good Aging in Sk&#xe5;ne (G&#xc5;S)&#x201d;. J Aging Res 2020;2020:1&#x2013;9. 10.1155/2020/5272130</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/5272130</ArticleId><ArticleId IdType="pmc">PMC7399755</ArticleId><ArticleId IdType="pubmed">32774920</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenwood N, Smith R. The oldest carers: a narrative review and synthesis of the experiences of carers aged over 75 years. Maturitas 2016;94:161&#x2013;72. 10.1016/j.maturitas.2016.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2016.10.001</ArticleId><ArticleId IdType="pubmed">27823738</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmst&#xe5;hl S, Lundholm-Auoja N, Ekstr&#xf6;m H, et al. . Being an older family caregiver does not impact healthcare and mortality: data from the study &#x2018;Good Aging in Sk&#xe5;ne&#x2019;. Scand J Public Health 2020:1&#x2013;9. 10.1177/1403494820960648</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1403494820960648</ArticleId><ArticleId IdType="pmc">PMC8873283</ArticleId><ArticleId IdType="pubmed">33158401</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekwall AK, Hallberg IR. The association between caregiving satisfaction, difficulties and coping among older family caregivers. J Clin Nurs 2007;16:832&#x2013;44. 10.1111/j.1365-2702.2006.01382.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2702.2006.01382.x</ArticleId><ArticleId IdType="pubmed">17462034</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnellan WJ, Bennett KM, Soulsby LK. What are the factors that facilitate or hinder resilience in older spousal dementia carers? A qualitative study. Aging Ment Health 2015;19:932&#x2013;9. 10.1080/13607863.2014.977771</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2014.977771</ArticleId><ArticleId IdType="pubmed">25410637</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoni G, Marengoni A, Calder&#xf3;n-Larra&#xf1;aga A, et al. . Defining health trajectories in older adults with five clinical indicators. J Gerontol A Biol Sci Med Sci 2017;72:1123&#x2013;9. 10.1093/gerona/glw204</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glw204</ArticleId><ArticleId IdType="pmc">PMC5861965</ArticleId><ArticleId IdType="pubmed">28329788</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastawrous M. Caregiver burden--a critical discussion. Int J Nurs Stud 2013;50:431&#x2013;41. 10.1016/j.ijnurstu.2012.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2012.10.005</ArticleId><ArticleId IdType="pubmed">23131724</ArticleId></ArticleIdList></Reference><Reference><Citation>Straatmann VS, Dekhtyar S, Meinow B, et al. . Unplanned hospital care use in older adults: the role of psychological and social well-being. J Am Geriatr Soc 2020;68:272&#x2013;80. 10.1111/jgs.16313</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16313</ArticleId><ArticleId IdType="pubmed">31956993</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson MF, McKee KJ, Dahlberg L, et al. . A comparison of spouse and non-spouse carers of people with dementia: a descriptive analysis of Swedish national survey data. BMC Geriatr 2021;21:1&#x2013;11. 10.1186/s12877-021-02264-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02264-0</ArticleId><ArticleId IdType="pmc">PMC8170983</ArticleId><ArticleId IdType="pubmed">34078292</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlberg L, Demack S, Bambra C. Age and gender of informal carers: a population-based study in the UK. Health Soc Care Community 2007;15:439&#x2013;45. 10.1111/j.1365-2524.2007.00702.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2524.2007.00702.x</ArticleId><ArticleId IdType="pubmed">17685989</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaschowitz J, Brandt M. Health effects of informal caregiving across Europe: a longitudinal approach. Soc Sci Med 2017;173:72&#x2013;80. 10.1016/j.socscimed.2016.11.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2016.11.036</ArticleId><ArticleId IdType="pubmed">27930918</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfl&#xfc;ger K. Study into the impact of EU policies on family carers. The European Older People&#x2019;s Platform 2005;2004.</Citation></Reference><Reference><Citation>Carers UK. The growing pressure on older carers; 2015.</Citation></Reference><Reference><Citation>McGee HM, Molloy G, O'Hanlon A, et al. . Older people--recipients but also providers of informal care: an analysis among community samples in the Republic of Ireland and Northern Ireland. Health Soc Care Community 2008;16:548&#x2013;53. 10.1111/j.1365-2524.2008.00806.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2524.2008.00806.x</ArticleId><ArticleId IdType="pubmed">18808512</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobinac A, van Exel NJA, Rutten FFH, et al. . Caring for and caring about: disentangling the caregiver effect and the family effect. J Health Econ 2010;29:549&#x2013;56. 10.1016/j.jhealeco.2010.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhealeco.2010.05.003</ArticleId><ArticleId IdType="pubmed">20579755</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearlin LI, Mullan JT, Semple SJ, et al. . Caregiving and the stress process: an overview of concepts and their measures. Gerontologist 1990;30:583&#x2013;94. 10.1093/geront/30.5.583</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/30.5.583</ArticleId><ArticleId IdType="pubmed">2276631</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornwell EY, Waite LJ. Social disconnectedness, perceived isolation, and health among older adults. J Health Soc Behav 2009;50:31&#x2013;48. 10.1177/002214650905000103</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/002214650905000103</ArticleId><ArticleId IdType="pmc">PMC2756979</ArticleId><ArticleId IdType="pubmed">19413133</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinquart M, S&#xf6;rensen S. Gender differences in caregiver stressors, social resources, and health: an updated meta-analysis. J Gerontol B Psychol Sci Soc Sci 2006;61:P33&#x2013;45. 10.1093/geronb/61.1.P33</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/61.1.P33</ArticleId><ArticleId IdType="pubmed">16399940</ArticleId></ArticleIdList></Reference><Reference><Citation>Adelman RD, Tmanova LL, Delgado D, et al. . Caregiver burden: a clinical review. JAMA 2014;311:1052&#x2013;9. 10.1001/jama.2014.304</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.304</ArticleId><ArticleId IdType="pubmed">24618967</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xfc;decke D, Mnich E, Kofahl C. The impact of sociodemographic factors on the utilisation of support services for family caregivers of elderly dependents - results from the German sample of the EUROFAMCARE study. Psychosoc Med 2012;9:Doc06. 10.3205/psm000084</Citation><ArticleIdList><ArticleId IdType="doi">10.3205/psm000084</ArticleId><ArticleId IdType="pmc">PMC3488802</ArticleId><ArticleId IdType="pubmed">23133500</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoller EP. Males as helpers: the role of sons, relatives, and friends. Gerontologist 1990;30:228&#x2013;35. 10.1093/geront/30.2.228</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/30.2.228</ArticleId><ArticleId IdType="pubmed">2347505</ArticleId></ArticleIdList></Reference><Reference><Citation>Young HM, Bell JF, Whitney RL, et al. . Social determinants of health: underreported heterogeneity in systematic reviews of caregiver interventions. Gerontologist 2020;60:S14&#x2013;28. 10.1093/geront/gnz148</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnz148</ArticleId><ArticleId IdType="pmc">PMC7019663</ArticleId><ArticleId IdType="pubmed">32057083</ArticleId></ArticleIdList></Reference><Reference><Citation>Pruchno RA, Brill JE, Shands Y, et al. . Convenience samples and caregiving research: how generalizable are the findings? Gerontologist 2008;48:820&#x2013;7. 10.1093/geront/48.6.820</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/48.6.820</ArticleId><ArticleId IdType="pubmed">19139255</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36541134</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1938-2715</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The American journal of hospice &amp; palliative care</Title><ISOAbbreviation>Am J Hosp Palliat Care</ISOAbbreviation></Journal><ArticleTitle>Advance Care Planning Among Older Adults with Cognitive Impairment.</ArticleTitle><Pagination><StartPage>1182</StartPage><EndPage>1189</EndPage><MedlinePgn>1182-1189</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/10499091221146255</ELocationID><Abstract><AbstractText>In this study, we used data from the Health and Retirement Study (HRS) to investigate factors associated with older adults' engagement with advance care planning (ACP) across varying levels of cognitive functioning status. Our analysis used a sample of 17,698 participants in the HRS 2014 survey. Survey descriptive procedures (Proc SurveyMeans, Proc SurveyFreq) and logistic regression procedures (Proc SurveyLogistic) were used. Race, ethnicity, level of cognition, education, age, and number of chronic diseases consistently predicted ACP. Participants with lower levels of cognition were less likely to have a living will and durable power of attorney for healthcare (DPOAH). African American and Hispanic participants, younger participants, and those with lower cognition and education levels were less likely to engage in ACP. Marital status and loneliness predicted ACP engagement. Some results varied across the cognition cohorts. Our results indicated that sociodemographic status, together with health and cognitive status, has a significant role in predicting ACP. The results can provide valuable insights on ACP for older adults with or at risk of Alzheimer's disease and related dementia and other cognitive impairments, caregivers, families, and healthcare providers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rahemi</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-1126-2287</Identifier><AffiliationInfo><Affiliation>School of Nursing, Clemson University, Clemson, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malatyali</LastName><ForeName>Ayse</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nursing Systems Department, College of Nursing, University of Central Florida, Orlando, FL, USA.</Affiliation><Identifier Source="RINGGOLD">6243</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adams</LastName><ForeName>Swann A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Epidemiology &amp; Biostatistics, College of Nursing, University of South Carolina, Columbia, SC, USA.</Affiliation><Identifier Source="RINGGOLD">2629</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarr&#xed;n</LastName><ForeName>Olga F</ForeName><Initials>OF</Initials><AffiliationInfo><Affiliation>School of Nursing, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demiris</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Nursing, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation><Identifier Source="RINGGOLD">6572</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parker</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>School of Nursing, Clemson University, Clemson, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghaiumy Anaraky</LastName><ForeName>Reza</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Computing, Clemson University, Clemson, SC, USA.</Affiliation><Identifier Source="RINGGOLD">2545</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dye</LastName><ForeName>Cheryl J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, Clemson University, Clemson, SC, USA.</Affiliation><Identifier Source="RINGGOLD">2545</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG059294</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Hosp Palliat Care</MedlineTA><NlmUniqueID>9008229</NlmUniqueID><ISSNLinking>1049-9091</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032722" MajorTopicYN="Y">Advance Care Planning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016224" MajorTopicYN="N">Living Wills</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease and related dementia</Keyword><Keyword MajorTopicYN="N">advance care planning</Keyword><Keyword MajorTopicYN="N">durable power of attorney for healthcare</Keyword><Keyword MajorTopicYN="N">end-of-life care</Keyword><Keyword MajorTopicYN="N">health and retirement study</Keyword><Keyword MajorTopicYN="N">living will</Keyword><Keyword MajorTopicYN="N">older adults</Keyword><Keyword MajorTopicYN="N">sociodemographic status</Keyword></KeywordList><CoiStatement>Declaration of Conflicting InterestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>21</Day><Hour>4</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36541134</ArticleId><ArticleId IdType="mid">NIHMS1875653</ArticleId><ArticleId IdType="pmc">PMC10282104</ArticleId><ArticleId IdType="doi">10.1177/10499091221146255</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alzheimer&#x2019;s Association Report. 2021 Alzheimer&#x2019;s disease facts and figures. Alzheimer&#x2019;s Dement. 2021;17(3):327&#x2013;406. doi:10.1002/alz.12328</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12328</ArticleId><ArticleId IdType="pubmed">33756057</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Neurological Disorders Stroke NI of H. Focus on Alzheimer&#x2019;s Disease and Related Dementias; 2022. https://www.ninds.nih.gov/Current-Research/Focus-Disorders/Alzheimers-Related-Dementias.
Accessed April 21, 2022.</Citation></Reference><Reference><Citation>Nelson P, Brayne C, Flanagan M, et al. Frequency of LATE neuropathologic change across the spectrum of Alzheimer&#x2019;s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts. Acta Neuropathol. 2022. Published online. doi:10.1007/s00401-022-02444-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-022-02444-1</ArticleId><ArticleId IdType="pmc">PMC9552938</ArticleId><ArticleId IdType="pubmed">35697880</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews KA, Xu W, Gaglioti AH, et al. Racial and ethnic estimates of Alzheimer &#x2019; s disease and related dementias in the United States (2015&#x2013;2060) in adults aged 65 years. Alzheimer&#x2019;s Dement. 2019;15(1):17&#x2013;24. doi:10.1016/j.jalz.2018.06.3063</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.06.3063</ArticleId><ArticleId IdType="pmc">PMC6333531</ArticleId><ArticleId IdType="pubmed">30243772</ArticleId></ArticleIdList></Reference><Reference><Citation>Amjad H, Roth DL, Sheehan OC, Lyketsos CG, Wolff JL, Samus QM. Underdiagnosis of dementia: An observational study of patterns in diagnosis and awareness in US older adults. J Gen Intern Med. 2018;33(7):1131&#x2013;1138. doi:10.1007/s1160</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s1160</ArticleId><ArticleId IdType="pmc">PMC6025653</ArticleId><ArticleId IdType="pubmed">29508259</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman RF, Albert MS, Alonso A, et al. Associations between midlife vascular risk factors and 25-year incident dementia in the atherosclerosis risk in communities (ARIC) cohort. JAMA Neurol. 2017;47(10):1246&#x2013;1254. doi:10.1001/jamaneurol.2017.1658</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.1658</ArticleId><ArticleId IdType="pmc">PMC5710244</ArticleId><ArticleId IdType="pubmed">28783817</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipnicki DM, Sachdev PS, Crawford J, et al. Risk factors for late-life cognitive decline and variation with age and sex in the sydney memory and ageing study. PLoS One. 2013;8(6): e65841. doi:10.1371/journal.pone.0065841</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0065841</ArticleId><ArticleId IdType="pmc">PMC3683032</ArticleId><ArticleId IdType="pubmed">23799051</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones K, Birchley G, Huxtable R, Walter T, Dixon J. End of life care: A scoping review of experiences of advance care planning for people with dementia. Dementia. 2019;18(3):825&#x2013;845. doi: 10.1177/1471301216676121</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301216676121</ArticleId><ArticleId IdType="pubmed">27821714</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan T, M-amen K, Mckeown J. The advance care planning experiences of people with dementia, family caregivers and professionals: A synthesis of the qualitative literature. 2017; 6(4):380&#x2013;389. doi:10.21037/apm.2017.06.15.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/apm.2017.06.15</ArticleId><ArticleId IdType="pubmed">28754049</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettigrew C, Brichko R, Black B, et al. Attitudes toward advance care planning among persons with dementia and their caregivers. Int Psychogeriatr. 2020;32(5):585&#x2013;599. doi:10.1017/S1041610219000784</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610219000784</ArticleId><ArticleId IdType="pmc">PMC6962575</ArticleId><ArticleId IdType="pubmed">31309906</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudore R, Lum H, You J, et al. Defining advance care planning for adults: A consensus definition from a multidisciplinary Delphi panel. J Pain Symptom Manag. 2017;53(5):821&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5728651</ArticleId><ArticleId IdType="pubmed">28062339</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudore RL, Fried TR. Redefining the &#x201c;planning&#x201d; in advance care planning: Preparing for end-of-life decision making. Ann Intern Med. 2010;153(4):256&#x2013;261. doi:10.7326/0003-4819-153-4-201008170-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-153-4-201008170-00008</ArticleId><ArticleId IdType="pmc">PMC2935810</ArticleId><ArticleId IdType="pubmed">20713793</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison S, Meier DE, Arnold RM. What&#x2019;s wrong with advance care planning? J Am Med Assoc. 2021;326(15):1575&#x2013;1576. doi: 10.1001/jama.2021.16430</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.16430</ArticleId><ArticleId IdType="pmc">PMC9373875</ArticleId><ArticleId IdType="pubmed">34623373</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahan RD, Tellez I, Sudore RL. Deconstructing the complexities of advance care planning outcomes: What do we know and where do we go? A scoping review. J Am Geriatr Soc. 2021; 69(1):234&#x2013;244. doi:10.1111/jgs.16801</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16801</ArticleId><ArticleId IdType="pmc">PMC7856112</ArticleId><ArticleId IdType="pubmed">32894787</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen J, Bernacki R, Paladino J. Shifting to serious illness communication. J Am Med Assoc. Published online. 2022. doi: 10.1001/jama.2021.23695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.23695</ArticleId><ArticleId IdType="pubmed">34994773</ArticleId></ArticleIdList></Reference><Reference><Citation>Golant SM. Self-reliant older baby boomers: Are now better connected to goods, services, and care. J Am Soc Aging. 2017; 41(2):79&#x2013;87. https://www.jstor.org/stable/26556287</Citation></Reference><Reference><Citation>Dalton MA, Langdon TP. Estate Planning. 13th ed. New York, NY: Money Education; 2022.</Citation></Reference><Reference><Citation>Sonnega A, Faul J, Ofstedal M, Langa K, Phillips J, Weir D. Cohort profile: The health and retirement study (HRS). Int J Epidemiol. 2014;43(2):576&#x2013;585. doi:10.1093/ije/dyu067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyu067</ArticleId><ArticleId IdType="pmc">PMC3997380</ArticleId><ArticleId IdType="pubmed">24671021</ArticleId></ArticleIdList></Reference><Reference><Citation>Winship C, Radbill L. Sampling weights and regression analysis. Socio Methods Res. 1994;23(2):230&#x2013;257. doi:10.1177/0049124194023002004</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0049124194023002004</ArticleId></ArticleIdList></Reference><Reference><Citation>Langa KM, Larson EB, Crimmins EM, et al. A comparison of the prevalence of dementia in the United States in 2000 and 2012. JAMA Intern Med. 2017;177(1):51&#x2013;58. doi:10.1001/jamainternmed.2016.6807</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2016.6807</ArticleId><ArticleId IdType="pmc">PMC5195883</ArticleId><ArticleId IdType="pubmed">27893041</ArticleId></ArticleIdList></Reference><Reference><Citation>Crimmins EM, Kim JK, Langa KM, Weir DR. Assessment of cognition using surveys and neuropsychological assessment: The health and retirement study and the aging, demographics, and memory study. J Gerontol. 2011(suppl 1):i162&#x2013;i171. doi:10.1093/geronb/gbr048</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbr048</ArticleId><ArticleId IdType="pmc">PMC3165454</ArticleId><ArticleId IdType="pubmed">21743047</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis JR. Three stories about the value of advance care planning. JAMA. 2021;326(21):2133&#x2013;2134. doi:10.1001/jama.2021.21075</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.21075</ArticleId><ArticleId IdType="pubmed">34874415</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaster B, Larson EB, Curtis JR. Advance directives for dementia meeting a unique challenge. J Am Med Assoc. 2017; 318(22):2175&#x2013;2176. doi:10.1001/jama.2017.16473</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.16473</ArticleId><ArticleId IdType="pubmed">29114779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahemi Z, Williams CL. Older adults of underrepresented populations and their end-of-life preferences: An integrative review. Adv Nurs Sci. 2016;39(4). doi:10.1097/ANS.0000000000000148</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANS.0000000000000148</ArticleId><ArticleId IdType="pubmed">27677181</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahemi Z. Planning ahead for end-of-life healthcare among Iranian-American older adults: Attitudes and communication of healthcare wishes. J Cross Cult Gerontol. 2019. Published online. doi:10.1007/s10823-019-09371-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10823-019-09371-x</ArticleId><ArticleId IdType="pubmed">31073970</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahemi Z, Dunphy L, Newman D. Preferences regarding and communication about end-of-life care among older Iranian-American adults. West J Nurs Res. 2019. Published online. doi:10.1177/0193945919832304</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0193945919832304</ArticleId><ArticleId IdType="pubmed">30793665</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlovic M, Smith K, Mossialos E. Racial and ethnic differences in end-of-life care in the United States: Evidence from the health and retirement study (HRS). SSM-Popul Heal. 2019;7:100331. doi:10.1016/j.ssmph.2018.100331</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ssmph.2018.100331</ArticleId><ArticleId IdType="pmc">PMC6305800</ArticleId><ArticleId IdType="pubmed">30623009</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahemi Z, Williams CL. Does ethnicity matter&#x2014;cultural factors underlying older adults&#x2019; end-of-life care preferences: A systematic review. Geriatr Nurs. 2020;41(2). doi:10.1016/j.gerinurse.2019.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gerinurse.2019.07.001</ArticleId><ArticleId IdType="pubmed">31320127</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen JY, Hilgeman MM, Allen RS. Prospective end-of-life treatment decisions and perceived vulnerability: Future time left to live and memory self-efficacy. Aging Ment Health. 2011;15(1): 122&#x2013;131. doi:10.1080/13607863.2010.505229</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2010.505229</ArticleId><ArticleId IdType="pubmed">20924818</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen JO, Solway E, Kirch M, et al. Experiences of everyday ageism and the health of older US adults. JAMA Netw Open. 2022; 5(6):E2217240. doi:10.1001/jamanetworkopen.2022.17240</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.17240</ArticleId><ArticleId IdType="pmc">PMC9201677</ArticleId><ArticleId IdType="pubmed">35704314</ArticleId></ArticleIdList></Reference><Reference><Citation>Financial advisors and Alzheimer&#x2019;s disease. Financial Advisors and Alzheimer&#x2019;s Disease: What You Need to Know; 2022. https://www.alz.org/advisors/alz-fy16-pg.pdf</Citation></Reference><Reference><Citation>Noh H, Kwak J. End-of-life decision making for persons with dementia: Proxies &#x2019; perception of support. Dementia. 2018. Published online. doi:10.1177/1471301216648473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301216648473</ArticleId><ArticleId IdType="pubmed">27165983</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried TR, Cohen AB, Harris JE, Moreines L. Cognitively impaired older persons&#x2019; and caregivers&#x2019; perspectives on dementia-specific advance care planning. J Am Geriatr Soc. 2021;69(4): 932&#x2013;937. doi: 10.1111/jgs.16953</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16953</ArticleId><ArticleId IdType="pmc">PMC8300881</ArticleId><ArticleId IdType="pubmed">33216955</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Association Report. Alzheimer&#x2019;s disease facts and figures. Alzheimer&#x2019;s Dement. 2020;16:391&#x2013;460. doi:10.1002/alz.12068</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12068</ArticleId></ArticleIdList></Reference><Reference><Citation>Koss CS, Baker TA. Where there&#x2019;s a will: The link between estate planning and disparities in advance care planning by white and Black older adults. Res Aging. 2018;40(3):281&#x2013;302. doi:10.1177/0164027517697116</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0164027517697116</ArticleId><ArticleId IdType="pubmed">29298597</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong M, Hye E, Kimberly Y, Margaret JJ. Facilitators and barriers for advance care planning among ethnic and racial minorities in the U. S.: A systematic review of the current literature. J Immigr Minor Health. 2018;20(5):1277&#x2013;1287. doi: 10.1007/s10903-017-0670-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10903-017-0670-9</ArticleId><ArticleId IdType="pubmed">29124502</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson-Brantley H, Buller C, Befort C, Ellerbeck E, Shifter A, Ellis S. Using implementation science to further the adoption and implementation of advance care planning in rural primary care. J Nurs Scholarsh. 2020;52(1):55&#x2013;64. doi:10.1111/jnu.12513</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnu.12513</ArticleId><ArticleId IdType="pmc">PMC6953624</ArticleId><ArticleId IdType="pubmed">31545557</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahemi Z, Parker V. Does culture matter? Young and middle-aged Iranian-American adults&#x2019; perspectives regarding end-of-life care planning. Am J Hospice Palliat Med. 2021. Published online. doi:10.1177/10499091211036894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10499091211036894</ArticleId><ArticleId IdType="pubmed">34365832</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng H Advance care planning in Chinese seniors: Cultural perspectives. J Palliat Care. 2018;33(4):242&#x2013;246. doi:10.1177/0825859718763644</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0825859718763644</ArticleId><ArticleId IdType="pubmed">29569520</ArticleId></ArticleIdList></Reference><Reference><Citation>Centre for Biomedical Ethics. A Singapore Bioethics Casebook: Making Difficult Decisions with Patients and Families; 2017. http://www.bioethicscasebook.sg/</Citation></Reference><Reference><Citation>Khosla N, Curl AL, Washington KT. Trends in engagement in advance care planning behaviors and the role of socioeconomic status. Am J Hospice Palliat Med. 2016;33(7):651&#x2013;657. doi:10.1177/1049909115581818</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1049909115581818</ArticleId><ArticleId IdType="pubmed">25900854</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S, Kim M, McDonough IM. Do older adults with Alzheimer&#x2019;s disease engage in estate planning and advance care planning preparation? Aging Ment Health. 2019;23(7):872&#x2013;879. doi:10.1080/13607863.2018.1461192</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2018.1461192</ArticleId><ArticleId IdType="pmc">PMC6193860</ArticleId><ArticleId IdType="pubmed">29667427</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon J, Karagiannidou M, Knapp M. The effectiveness of advance care planning in improving end-of-life outcomes for people with dementia and their carers: A systematic review and critical discussion. J Pain Symptom Manag. 2018;55(1):132&#x2013;150. doi:10.1016/j.jpainsymman.2017.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2017.04.009</ArticleId><ArticleId IdType="pubmed">28827062</ArticleId></ArticleIdList></Reference><Reference><Citation>Teno JM, Gozalo P, Mitchell SL, Kuo S, Fulton AT, Mor V. Feeding tubes and the prevention or healing of pressure ulcers. Arch Intern Med. 2012;172(9):697&#x2013;701. doi:10.1001/archinternmed.2012.1200</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2012.1200</ArticleId><ArticleId IdType="pmc">PMC3555136</ArticleId><ArticleId IdType="pubmed">22782196</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahemi Z, Williams CL. Development of a dignity-enhancing model of caring for older adults. Int J Hum Caring. 2015;19(3): 36&#x2013;42.</Citation></Reference><Reference><Citation>Rahemi Z, Williams CL, Tappen RM, Engstrom GA. Health-related decisions for serious illness among ethnically diverse older adults. Adv Nurs Sci. 2018;41(1):84&#x2013;97. doi:10.1097/ANS.0000000000000192</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANS.0000000000000192</ArticleId><ArticleId IdType="pubmed">29140805</ArticleId></ArticleIdList></Reference><Reference><Citation>Maryland MOLST Training Task Force. Maryland MOLST FAQs; 2018. https://marylandmolst.org/docs/Maryland_MOLST_FAQs.pdf</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36540000</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-4523</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of applied gerontology : the official journal of the Southern Gerontological Society</Title><ISOAbbreviation>J Appl Gerontol</ISOAbbreviation></Journal><ArticleTitle>Characteristics of Asian American Family Caregivers of Older Adults Compared to Caregivers of Other Racial/Ethnic Groups: Behavioral Risk Factor Surveillance System 2015-2020.</ArticleTitle><Pagination><StartPage>1101</StartPage><EndPage>1107</EndPage><MedlinePgn>1101-1107</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/07334648221146257</ELocationID><Abstract><AbstractText>Asian Americans (AAs) are the fastest-growing racial/ethnic minority group in the United States. While otherwise highly heterogeneous, AAs overall value filial piety and eldercare. This study compared the health and caregiving experiences of AA caregivers of older adults to AA non-caregivers and caregivers of older adults across racial/ethnic groups. We used 2015-2020 Behavioral Risk Factor Surveillance System data for 315 AA caregivers and 3822 AA non-caregivers, plus 395 American Indian/Alaska Native, 1883 Black, 1292 Hispanic, and 20,321 non-Hispanic White caregivers. Among AAs, 4.3% were caregivers, a lower proportion than in other racial/ethnic groups. Most AA caregivers were female (59%), married (71%), in excellent/very good/good health (76%), and with at least one chronic health condition (66%). Other than relationship to care recipients, caregivers' experiences were similar across racial/ethnic groups: most cared for &lt;20 hours/week and provided household and personal care. Efforts to support AA caregivers should be attentive to cultural practices.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miyawaki</LastName><ForeName>Christina E</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0002-1234-1588</Identifier><AffiliationInfo><Affiliation>Graduate College of Social Work, 14743University of Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouldin</LastName><ForeName>Erin D</ForeName><Initials>ED</Initials><Identifier Source="ORCID">0000-0001-7550-309X</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, 14434University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alzheimer's Disease and Healthy Aging Program, 1242Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Christopher A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Alzheimer's Disease and Healthy Aging Program, 1242Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGuire</LastName><ForeName>Lisa C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Alzheimer's Disease and Healthy Aging Program, 1242Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Markides</LastName><ForeName>Kyriakos S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>School of Public and Population Health, 12338University of Texas Medical Branch, Galveston, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CC999999</GrantID><Acronym>ImCDC</Acronym><Agency>Intramural CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Appl Gerontol</MedlineTA><NlmUniqueID>8606502</NlmUniqueID><ISSNLinking>0733-4648</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001213" MajorTopicYN="Y">Asian</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040343" MajorTopicYN="N">Behavioral Risk Factor Surveillance System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005006" MajorTopicYN="N">Ethnicity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008913" MajorTopicYN="N">Minority Groups</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">caregiving</Keyword><Keyword MajorTopicYN="N">ethnicity</Keyword><Keyword MajorTopicYN="N">foreign-born</Keyword><Keyword MajorTopicYN="N">health</Keyword><Keyword MajorTopicYN="N">race</Keyword></KeywordList><CoiStatement>Declaration of Conflicting Interests. The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>21</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36540000</ArticleId><ArticleId IdType="mid">NIHMS1919615</ArticleId><ArticleId IdType="pmc">PMC10408680</ArticleId><ArticleId IdType="doi">10.1177/07334648221146257</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>American Association of Retired Persons (AARP) (2014). Caregiving among asian Americans and pacific islanders age 50+. https://www.aarp.org/content/dam/aarp/research/surveys_statistics/general/2014/caregiving-among-asian-americans-and-pacific-islanders-age-50-plus.doi.10.26419%252Fres.00092.001.pdf</Citation></Reference><Reference><Citation>Budiman B, &amp; Ruiz NG (2021). Key facts about Asian Americans, a diverse and growing population. Pew Research Center. https://www.pewresearch.org/fact-tank/2021/04/29/key-facts-about-asian-americans/</Citation></Reference><Reference><Citation>Do YK, Norton EC, Stearns SC, &amp; Van Houtven CH (2015). Informal care and caregiver&#x2019;s health. Health Economics, 24(2), 224&#x2013;237. 10.1002/hec.3012</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hec.3012</ArticleId><ArticleId IdType="pmc">PMC4201633</ArticleId><ArticleId IdType="pubmed">24753386</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng HM, Chuang DM, Yang F, Yang Y, Liu WM, Liu LH, &amp; Tian HM (2018). Prevalence and determinants of depression in caregivers of cancer patients: A systematic review and meta-analysis. Medicine, 97(39), Article e11863. 10.1097/MD.0000000000011863</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000011863</ArticleId><ArticleId IdType="pmc">PMC6181540</ArticleId><ArticleId IdType="pubmed">30278483</ArticleId></ArticleIdList></Reference><Reference><Citation>Johns Hopkins Medicine (2020). National asian pacific islander American heritage month. https://www.hopkinsmedicine.org/diversity/_documents/asian-american-pacific-islander-heritage-guide.pdf</Citation></Reference><Reference><Citation>Jones N, Marks R, Ramirez R, &amp; Rios-Vargas M (2021). 2020 Census illuminates racial and ethnic composition of the country. U.S. Census Bureau. https://www.census.gov/library/stories/2021/08/improved-race-ethnicity-measures-reveal-united-states-population-much-more-multiracial.html</Citation></Reference><Reference><Citation>Kramer EJ, Kwong K, Lee E, &amp; Chung H (2002). Cultural factors influencing the mental health of Asian Americans. Culture and Medicine, 176(4), 227&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1071736</ArticleId><ArticleId IdType="pubmed">12208826</ArticleId></ArticleIdList></Reference><Reference><Citation>Lendon JP, Rome V, &amp; Sengupta M (2021). Variations between adult day services centers in the United States by the racial and ethnic case-mix of center participants. Journal of Applied Gerontology, 40(9), 1029&#x2013;1038. 10.1177/0733464820934996</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464820934996</ArticleId><ArticleId IdType="pmc">PMC7775908</ArticleId><ArticleId IdType="pubmed">32613885</ArticleId></ArticleIdList></Reference><Reference><Citation>Lien YF, &amp; Huang HM (2017). Challenges in intergenerational caregiving for frail older people: A multiple case study. Nursing and Health Sciences, 19(1), 81&#x2013;87. 10.1111/nhs.12314</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nhs.12314</ArticleId><ArticleId IdType="pubmed">28026105</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Guo M, Mao W, &amp; Chi I (2018). Geographic distance and intergenerational relationships in Chinese migrant families. Journal of Ethnic &amp; Cultural Diversity in Social Work, 27(4), 328&#x2013;345. 10.1080/15313204.2018.1520167</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15313204.2018.1520167</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyawaki CE (2015). A review of ethnicity, culture, and acculturation among Asian caregivers of older adults (2000-2012). SAGE Open, 5(1), 1&#x2013;18. 10.1177/2158244014566365</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2158244014566365</ArticleId><ArticleId IdType="pmc">PMC4517686</ArticleId><ArticleId IdType="pubmed">26229736</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyawaki CE (2017). Association of filial responsibility, ethnicity, and acculturation among Japanese-American family caregivers of older adults. The Journal of Applied Gerontology, 36(3), 296&#x2013;319. 10.1177/0733464815581484</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464815581484</ArticleId><ArticleId IdType="pmc">PMC4608849</ArticleId><ArticleId IdType="pubmed">25883044</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyawaki CE (2020). Caregiving attitude and needs of later generation Chinese-American family caregivers of older adults. Journal of Family Issues. 41(12), 0192513X2093036. 10.1177/0192513X20930366</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0192513X20930366</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon HE, Haley WE, Rote SM, &amp; Sears JS (2020). Caregiver well-being and burden: Variations by race/ethnicity and care recipient nativity status. Innovation in Aging, 4(6), igaa045. 10.1093/geroni/igaa045</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geroni/igaa045</ArticleId><ArticleId IdType="pmc">PMC7679974</ArticleId><ArticleId IdType="pubmed">33241124</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugraheni SE, &amp; Hastings JF (2021). Family-based caregiving: Does lumping Asian Americans together do more harm than good? Journal of Social, Behavioral, &amp; Health Sciences, 15(1), 87&#x2013;103. 10.5590/JSBHS.2021.15.1.07</Citation><ArticleIdList><ArticleId IdType="doi">10.5590/JSBHS.2021.15.1.07</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinquart M, &amp; Sorensen S (2005). Ethnic differences in stressors, resources, and psychological outcomes of family caregiving: A meta analysis. Gerontologist, 45(1), 90&#x2013;106. 10.1093/geront/45.1.90</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/45.1.90</ArticleId><ArticleId IdType="pubmed">15695420</ArticleId></ArticleIdList></Reference><Reference><Citation>Radford J. (2019). Key findings about U.S. immigrants. Pew Research Center. https://www.pewresearch.org/fact-tank/2019/06/17/key-findings-about-u-s-immigrants/</Citation></Reference><Reference><Citation>Rote SM, Angel JL, Moon H, &amp; Markides K (2019). Caregiving across diverse populations: New evidence from the national study of caregiving and hispanic EPESE. Innovation in Aging, 3(2), igz033. 10.1093/geroni/igz033</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geroni/igz033</ArticleId><ArticleId IdType="pmc">PMC6733633</ArticleId><ArticleId IdType="pubmed">31517066</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz R, &amp; Sherwood PR (2008). Physical and mental health effects of family caregiving. The American Journal of Nursing, 108(9 Suppl), 23&#x2013;27. 10.1097/01.NAJ.0000336406.45248.4c</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.NAJ.0000336406.45248.4c</ArticleId><ArticleId IdType="pmc">PMC2791523</ArticleId><ArticleId IdType="pubmed">18797217</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang XR, Robinson KM, &amp; Carter-Harris L (2014). Prevalence of chronic illnesses and characteristics of chronically ill informal caregivers of persons with dementia. Age and Ageing, 43(1), 137&#x2013;141. 10.1093/ageing/aft142</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/aft142</ArticleId><ArticleId IdType="pmc">PMC4047288</ArticleId><ArticleId IdType="pubmed">24072413</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36530085</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-8908</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><Issue>3</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Consumer and Healthcare Professional Led Priority Setting for Quality Use of Medicines in People with Dementia: Gathering Unanswered Research Questions.</ArticleTitle><Pagination><StartPage>933</StartPage><EndPage>960</EndPage><MedlinePgn>933-960</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-220827</ELocationID><Abstract><AbstractText Label="BACKGROUND">Historically, research questions have been posed by the pharmaceutical industry or researchers, with little involvement of consumers and healthcare professionals.</AbstractText><AbstractText Label="OBJECTIVE">To determine what questions about medicine use are important to people living with dementia and their care team and whether they have been previously answered by research.</AbstractText><AbstractText Label="METHODS">The James Lind Alliance Priority Setting Partnership process was followed. A national Australian qualitative survey on medicine use in people living with dementia was conducted with consumers (people living with dementia and their carers including family, and friends) and healthcare professionals. Survey findings were supplemented with key informant interviews and relevant published documents (identified by the research team). Conventional content analysis was used to generate summary questions. Finally, evidence checking was conducted to determine if the summary questions were 'unanswered'.</AbstractText><AbstractText Label="RESULTS">A total of 545 questions were submitted by 228 survey participants (151 consumers and 77 healthcare professionals). Eight interviews were conducted with key informants and four relevant published documents were identified and reviewed. Overall, analysis resulted in 68 research questions, grouped into 13 themes. Themes with the greatest number of questions were related to co-morbidities, adverse drug reactions, treatment of dementia, and polypharmacy. Evidence checking resulted in 67 unanswered questions.</AbstractText><AbstractText Label="CONCLUSION">A wide variety of unanswered research questions were identified. Addressing unanswered research questions identified by consumers and healthcare professionals through this process will ensure that areas of priority are targeted in future research to achieve optimal health outcomes through quality use of medicines.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reeve</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, SA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geriatric Medicine Research, Faculty of Medicine and College of Pharmacy, Dalhousie University and Nova Scotia Health Authority, Halifax, NS, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chenoweth</LastName><ForeName>Lynn</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Healthy Brain Ageing, University of New South Wales, Kensington, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawan</LastName><ForeName>Mouna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Pharmacy, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Tuan Anh</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, SA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Ageing Research Institute, Parkville, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Health Sciences, Swinburne University of Technology, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Strategy and Policy Institute, Ministry of Health of Vietnam, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalisch Ellett</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilmartin-Thomas</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Edwin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Pharmacy, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sluggett</LastName><ForeName>Janet K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UniSA Allied Health and Human Performance, University of South Australia, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quirke</LastName><ForeName>Lyntara S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Consumer advocate, Dementia Australia, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Kham</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, SA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Ageing Research Institute, Parkville, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Health Sciences, Swinburne University of Technology, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Strategy and Policy Institute, Ministry of Health of Vietnam, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ailabouni</LastName><ForeName>Nagham</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, SA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pharmacy Australia Centre of Excellence, Health and Behavioural Science Department, School of Pharmacy, University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cowan</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>James Lind Alliance, University of Southampton, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinclair</LastName><ForeName>Ron</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Consumer advocate, Dementia Australia, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de la Perrelle</LastName><ForeName>Lenore</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>College of Education, Psychology and Social Work, Flinders University, SA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Nursing and Health Sciences, Flinders University, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deimel</LastName><ForeName>Judy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Central Adelaide Local Health Network (CALHN) Memory Service, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>To</LastName><ForeName>Josephine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Aged Care, Rehabilitation and Palliative Care, Northern Adelaide Local Health Network, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daly</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Family Health Medical Group, Adelaide, SA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sensus Cognition, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitehead</LastName><ForeName>Craig</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Rehabilitation, Aged and Palliative Care, Southern Adelaide Local Health Network, SA Health, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hilmer</LastName><ForeName>Sarah N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Kolling Institute of Medical Research, Northern Clinical School, Faculty of Medicine and Health, University of Sydney and Royal North Shore Hospital, St Leonards, NSW, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006292" MajorTopicYN="N">Health Priorities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Caregivers</Keyword><Keyword MajorTopicYN="N">clinical decision-making</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">deprescription</Keyword><Keyword MajorTopicYN="N">health services research</Keyword><Keyword MajorTopicYN="N">multiple chronic conditions</Keyword><Keyword MajorTopicYN="N">pharmacy research</Keyword><Keyword MajorTopicYN="N">polypharmacy</Keyword></KeywordList><CoiStatement>Authors&#x2019; disclosures available online (https://www.j-alz.com/manuscript-disclosures/22-0827r2).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>19</Day><Hour>2</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36530085</ArticleId><ArticleId IdType="pmc">PMC9912715</ArticleId><ArticleId IdType="doi">10.3233/JAD-220827</ArticleId><ArticleId IdType="pii">JAD220827</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Evans I, Thornton H, Chalmers I, Glasziou P (2011) Testing Treatments: Better Research for Better Healthcare, Pinter and Martin, London.</Citation><ArticleIdList><ArticleId IdType="pubmed">22171402</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallon D, Chard J, Dieppe P (2000) Relation between agendas of the research community and the research consumer. Lancet 355, 2037&#x2013;2040.</Citation><ArticleIdList><ArticleId IdType="pubmed">10885355</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowe S, Fenton M, Hall M, Cowan K, Chalmers I (2015) Patients&#x2019;, clinicians&#x2019; and the research communities&#x2019; priorities for treatment research: There is an important mismatch. Res Involv Engagem 1, 2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5598091</ArticleId><ArticleId IdType="pubmed">29062491</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers I, Glasziou P (2009) Avoidable waste in the production and reporting of research evidence. Lancet 374, 86&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">19525005</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowe S, Giles C (2016) Making patient relevant clinical research a reality. BMJ 355, i6627.</Citation><ArticleIdList><ArticleId IdType="pubmed">28011462</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris ZS, Wooding S, Grant J (2011) The answer is 17 years, what is the question: Understanding time lags in translational research. J R Soc Med 104, 510&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241518</ArticleId><ArticleId IdType="pubmed">22179294</ArticleId></ArticleIdList></Reference><Reference><Citation>Concannon TW, Fuster M, Saunders T, Patel K, Wong JB, Leslie LK, Lau J (2014) A systematic review of stakeholder engagement in comparative effectiveness and patient-centered outcomes research. J Gen Intern Med 29, 1692&#x2013;1701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4242886</ArticleId><ArticleId IdType="pubmed">24893581</ArticleId></ArticleIdList></Reference><Reference><Citation>
Minogue V, Wells B (2019) Patients and the public are essential to reducing researchwaste. BMJ Opin 9 Aug 2019. https://blogs.bmj.com/bmj/2019/08/09/virginia-minogue-and-bill-wells-patients-and-the-public-are-essential-to-reducing-research-waste/</Citation></Reference><Reference><Citation>Chalmers I, Atkinson P, Fenton M, Firkins L, Crowe S, Cowan K (2013) Tackling treatment uncertainties together: The evolution of the James Lind Initiative, 2003-2013. J R Soc Med 106, 482&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3842854</ArticleId><ArticleId IdType="pubmed">23824330</ArticleId></ArticleIdList></Reference><Reference><Citation>
Quality Use of Medicines (QUM), Australian Government Department of Health, https://www.health.gov.au/internet/main/publishing.nsf/Content/nmp-quality.htm, 7th March 2019, Accessed 15th July 2020.</Citation></Reference><Reference><Citation>Australian Government Department of Health and Aged Care (2002) The National Strategy for Quality Use of Medicines, Australia.</Citation></Reference><Reference><Citation>Pharmaceutical Society of Australia (2019) Medicine Safety: Take Care, PSA, Australia.</Citation></Reference><Reference><Citation>World Health Organization (2019) Medication Safety in Polypharmacy: Technical Report, Geneva.</Citation></Reference><Reference><Citation>
Aitken M, Gorokhovich L (2012) Advancing the responsible use of medicines: Applying levers for change. Available at SSRN: https://ssrn.com/abstract=2222541 or https://ssrn.com/abstract=2222541</Citation></Reference><Reference><Citation>
Australian Institute of Health and Welfare (2021) Dementia in Australia. https://www.aihw.gov.au/reports/dementia/dementia-in-aus/contents/population-health-impacts-of-dementia/prevalence-of-dementia</Citation></Reference><Reference><Citation>
World Health Organization (2017) Global action plan on the public health response to dementia 2017&#x2013;2025. https://www.who.int/publications/i/item/global-action-plan-on-the-public-health-response-to-dementia-2017&#x2014;2025</Citation></Reference><Reference><Citation>Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivim&#xe4;ki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selb&#xe6;k G, Teri L, Mukadam N (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396, 413&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392084</ArticleId><ArticleId IdType="pubmed">32738937</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeve E, Bell S, Hilmer SN (2014) Barriers to optimising prescribing and deprescribing in older adults with dementia: A narrative review Curr Clin Pharmacol 10, 168&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">26338170</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawan MJ, Moga DC, Ma MJ, Ng JC, Johnell K, Gnjidic D (2021) The value of deprescribing in older adults with dementia: A narrative review. Expert Rev Clin Pharmacol 14, 1367&#x2013;1382.</Citation><ArticleIdList><ArticleId IdType="pubmed">34311630</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert CC, Boustani M, Callahan CM, Perkins AJ, Carney CP, Fox C, Unverzagt F, Hui S, Hendrie HC (2006) Comorbidity profile of dementia patients in primary care: Are they sicker? J Am Geriatr Soc 54, 104&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">16420205</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen F, Viitanen M, Halvorsen D, Straume B, Engstad T (2011) Co-morbidity and drug treatment in Alzheimer&#x2019;s disease. A cross sectional study of participants in the Dementia Study in Northern Norway. BMC Geriatr 11, 58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3204237</ArticleId><ArticleId IdType="pubmed">21970467</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau DT, Mercaldo ND, Harris AT, Trittschuh E, Shega J, Weintraub S (2010) Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord 24, 56&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2837122</ArticleId><ArticleId IdType="pubmed">19561441</ArticleId></ArticleIdList></Reference><Reference><Citation>Fereshtehnejad SM, Johnell K, Eriksdotter M (2014) Anti-dementia drugs and co-medication among patients with Alzheimer&#x2019;s disease: Investigating real-world drug use in clinical practice using the Swedish Dementia Quality Registry (SveDem). Drugs Aging 31, 215&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">24497071</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan ECK, Jokanovic N, Koponen MP, Thomas D, Hilmer SN, Bell JS (2015) Prevalence of analgesic use in people with and without dementia or cognitive impairment in aged care facilities: A systematic review and meta-analysis. Curr Clin Pharmacol 10, 194&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">26338172</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosboom PR, Alfonso H, Almeida OP, Beer C (2012) Use of potentially harmful medications and health-related quality of life among people with dementia living in residential aged care facilities. Dement Geriatr Cogn Dis Extra 2, 361&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3522451</ArticleId><ArticleId IdType="pubmed">23277778</ArticleId></ArticleIdList></Reference><Reference><Citation>Draper B, Brodaty H, Low L-F, Saab D, Lie D, Richards V, Paton H (2001) Use of psychotropics in Sydney nursing homes: Associations with depression, psychosis, and behavioral disturbances. Int Psychogeriatr 13, 107&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">11352328</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet T (2014) Addressing global dementia. Lancet 383, 2185.</Citation><ArticleIdList><ArticleId IdType="pubmed">24976313</ArticleId></ArticleIdList></Reference><Reference><Citation>Nygaard A, Halvorsrud L, Linnerud S, Grov EK, Bergland A (2019) The James Lind Alliance process approach: Scoping review. BMJ Open 9, e027473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6720333</ArticleId><ArticleId IdType="pubmed">31473612</ArticleId></ArticleIdList></Reference><Reference><Citation>
Whiting C (2020) Priority Setting Partnerships: Celebrating 16 years of work to reduce research waste, Cochrane UK, https://www.evidentlycochrane.net/priority-setting-partnerships-celebrating-16-years-of-work-to-reduce-research-waste/, Accessed August 20, 2022.</Citation></Reference><Reference><Citation>
The James Lind Alliance, http://www.jla.nihr.ac.uk/, Accessed July 16, 2022.</Citation></Reference><Reference><Citation>Bethell J, Pringle D, Chambers LW, Cohen C, Commisso E, Cowan K, Fehr P, Laupacis A, Szeto P, McGilton KS (2018) Patient and public involvement in identifying dementia research priorities. J Am Geriatr Soc 66, 1608&#x2013;1612.</Citation><ArticleIdList><ArticleId IdType="pubmed">30084194</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly S, Lafortune L, Hart N, Cowan K, Fenton M, Brayne C, Dementia Priority Setting Partnership (2015) Dementia priority setting partnership with the James Lind Alliance: Using patient and public involvement and the evidence base to inform the research agenda. Age Ageing 44, 985&#x2013;993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4621237</ArticleId><ArticleId IdType="pubmed">26504119</ArticleId></ArticleIdList></Reference><Reference><Citation>James Lind Alliance (2021) JLA Guidebook, UK.</Citation></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O&#x2019;Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN (2019) The RED Cap consortium: Building an international community of software platform partners. J Biomed Inform 95, 103208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)&#x2014;A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42, 377&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Malterud K, Siersma VD, Guassora AD (2016) Sample size in qualitative interview studies: Guided by information power. Qual Health Res 26, 1753&#x2013;1760.</Citation><ArticleIdList><ArticleId IdType="pubmed">26613970</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, Burroughs H, Jinks C (2018) Saturation in qualitative research: Exploring its conceptualization and operationalization. Qual Quant 52, 1893&#x2013;1907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5993836</ArticleId><ArticleId IdType="pubmed">29937585</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh H-F, Shannon SE (2005) Three approaches to qualitative content analysis. Qual Health Res 15, 1277&#x2013;1288.</Citation><ArticleIdList><ArticleId IdType="pubmed">16204405</ArticleId></ArticleIdList></Reference><Reference><Citation>
Evidence checking process: Quality Use of Medicines in People Living with Dementia Priority Setting Partnership (PSP), https://www.jla.nihr.ac.uk/priority-setting-partnerships/quality-use-of-medicines-in-people-living-with-dementia-Australia/downloads/Quality-Use-of-Medicines-in%20People-Living-with-Dementia-Australia-PSP-Evidence-checking-process.pdf, Accessed May 2022.</Citation></Reference><Reference><Citation>Guideline Adaptation Committee (2016) Clinical Practice Guidelines and Principles of Care for People with Dementia. Guideline Adaption Committee, Sydney.</Citation></Reference><Reference><Citation>Dementia Australia (2019) Medication Use byPeople Living with Dementia.</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Disease International (2019) World Alzheimer Report 2019: Attitudes to dementia, London.</Citation></Reference><Reference><Citation>Royal Commission into Aged Care Quality and Safety (2019) Interim Report: Neglect, Australia.</Citation></Reference><Reference><Citation>Parsons C (2017) Polypharmacy and inappropriate medication use in patients with dementia: An underresearched problem. Ther Adv Drug Saf 8, 31&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5298466</ArticleId><ArticleId IdType="pubmed">28203365</ArticleId></ArticleIdList></Reference><Reference><Citation>Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, Hayward RA (2011) Examining the evidence: A systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med 26, 783&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3138606</ArticleId><ArticleId IdType="pubmed">21286840</ArticleId></ArticleIdList></Reference><Reference><Citation>Jongsma KR, van Bruchem-Visser RL, van de Vathorst S, Mattace Raso FUS (2016) Has dementia research lost its sense of reality? A descriptive analysis of eligibility criteria of Dutch dementia research protocols. Neth J Med 74, 201&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">27323673</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurdo MET, Witham MD, Gillespie ND (2005) Including older people in clinical research. BMJ 331, 1036&#x2013;1037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1283170</ArticleId><ArticleId IdType="pubmed">16269472</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeve E, Trenaman SC, Rockwood K, Hilmer SN (2017) Pharmacokinetic and pharmacodynamic alterations in older people with dementia. Expert Opin Drug Metab Toxicol 13, 651&#x2013;668.</Citation><ArticleIdList><ArticleId IdType="pubmed">28460576</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher D, Ailabouni N, Mangoni AA, Wiese MD, Reeve E (2021) Alterations in drug disposition in older adults: A focus on geriatric syndromes. Expert Opin Drug Metab Toxicol 17, 41&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">33078628</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooke J (2019) Equity of people with dementia in research, why does this issue remain? J Clin Nurs 28, 3723&#x2013;3724.</Citation><ArticleIdList><ArticleId IdType="pubmed">31219203</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks J, Savitch N, Gridley K (2017) Removing the &#x2018;gag&#x2019;: Involving people with dementia in research as advisers and participants. Soc Res Pract, 3-14.</Citation></Reference><Reference><Citation>Taylor JS, DeMers SM, Vig EK, Borson S (2012) The disappearing subject: Exclusion of people with cognitive impairment and dementia from geriatrics research. J Am Geriatr Soc 60, 413&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">22288835</ArticleId></ArticleIdList></Reference><Reference><Citation>Boniol M, McIsaac M, Xu L, Wuliji T, Diallo K J C (2019) Gender equity in the health workforce: Analysis of 104 countries.Working paper 1.World Health Organization (WHO/HIS/HWF/Gender/WP1/2019.1), Geneva. License: CC BY-NC-SA 3.0 IGO.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36516659</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-5134</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Patient education and counseling</Title><ISOAbbreviation>Patient Educ Couns</ISOAbbreviation></Journal><ArticleTitle>Young-onset dementia: A systematic review of the psychological and social impact on relatives.</ArticleTitle><Pagination><StartPage>107585</StartPage><MedlinePgn>107585</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pec.2022.107585</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0738-3991(22)00868-0</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Young-onset dementia (YOD) has significant impact for the affected person, but also has far-reaching effects on the family. Additionally, biological relatives have an increased genetic risk of developing the condition themselves. This review aimed to identify the psychological and social impacts of YOD in the family, for asymptomatic relatives.</AbstractText><AbstractText Label="METHODS">A systematic review of key databases for empirical studies about the lived experience of biological relatives at risk for YOD was performed. Data was collated and interpreted via narrative synthesis.</AbstractText><AbstractText Label="RESULTS">The majority of the nineteen included studies were qualitative and explored the experiences of children with a parent with YOD. Five themes were developed: (1) Onset of YOD disrupts family functioning (2) Emotional impact is significant and varied (3) Uncertain future (due to uncertainty of diagnosis, care-giving responsibilities, and their own increased genetic risk) (4) Lack of visibility in health care and society (5) Coping strategies include physical/cognitive distancing, and emotion-focused coping.</AbstractText><AbstractText Label="CONCLUSION">Our findings demonstrate a diagnosis of YOD significantly impacts the lives of relatives, yet their experiences and needs often go unnoticed.</AbstractText><AbstractText Label="PRACTICE IMPLICATIONS">We present a practical framework of questions and strategies for care of relatives, mapped to the self-regulation model of genetic counselling.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wiggins</LastName><ForeName>Maddison</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia. Electronic address: Maddison.wiggins@health.nsw.gov.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McEwen</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sexton</LastName><ForeName>Adrienne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Genomic Medicine Department, The Royal Melbourne Hospital, Parkville, VIC, Australia; Department of Medicine Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Patient Educ Couns</MedlineTA><NlmUniqueID>8406280</NlmUniqueID><ISSNLinking>0738-3991</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012922" MajorTopicYN="N">Social Change</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010290" MajorTopicYN="N">Parents</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000223" MajorTopicYN="N">Adaptation, Psychological</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Early onset Alzheimer disease</Keyword><Keyword MajorTopicYN="N">Familial dementia</Keyword><Keyword MajorTopicYN="N">Frontotemporal, dementia</Keyword><Keyword MajorTopicYN="N">Genetic counselling</Keyword><Keyword MajorTopicYN="N">Predictive genetic testing</Keyword><Keyword MajorTopicYN="N">Psychosocial support</Keyword><Keyword MajorTopicYN="N">Young-onset dementia</Keyword></KeywordList><CoiStatement>Conflict of interest Maddison Wiggins completed this study as part of a Master of Genetic Counselling qualification. AS and AM have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>14</Day><Hour>18</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36516659</ArticleId><ArticleId IdType="doi">10.1016/j.pec.2022.107585</ArticleId><ArticleId IdType="pii">S0738-3991(22)00868-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36513918</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1179-1969</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Drugs &amp; aging</Title><ISOAbbreviation>Drugs Aging</ISOAbbreviation></Journal><ArticleTitle>Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011-2022 Update.</ArticleTitle><Pagination><StartPage>21</StartPage><EndPage>32</EndPage><MedlinePgn>21-32</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40266-022-00992-5</ELocationID><Abstract><AbstractText>Neuropsychiatric symptoms affect most patients with dementia over the course of the disease. They include a wide variety of symptoms from apathy and depression to psychosis, irritability, impulsivity and agitation. These symptoms are associated with significant distress to the patient and caregivers, as well as more rapid progression of dementia, institutionalisation and higher mortality. The first-line management of the neuropsychiatric symptoms of dementia should be non-pharmacological. If medications are required, antipsychotics are commonly chosen. Second-generation antipsychotics such as risperidone, olanzapine, quetiapine and aripiprazole are prescribed more often than first-generation antipsychotics, such as haloperidol. The aim of this review is to provide an update on findings on adverse outcomes and clinical implications of antipsychotic use in dementia. These medications may increase mortality and can be associated with adverse events including pneumonia, cerebrovascular events, parkinsonian symptoms or higher rates of venous thromboembolism. Risks related to antipsychotic use in dementia are moderated by a number of modifiable and non-modifiable factors such as co-prescribing of other medications, medical and psychiatric co-morbidities, and demographics such as age and sex, making individualised treatment decisions challenging. Antipsychotics have further been associated with an increased risk of reliance on long-term care and institutionalisation, and they might not be cost-effective for healthcare systems. Many of these risks can potentially be mitigated by close physical health monitoring of antipsychotic treatment, as well as early withdrawal of pharmacotherapy when clinically possible.</AbstractText><CopyrightInformation>&#xa9; 2022. Crown.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rogowska</LastName><ForeName>Marianna</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0441-8995</Identifier><AffiliationInfo><Affiliation>South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Monks Orchard Road, Beckenham, London, UK. marianna.rogowska@nhs.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thornton</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Monks Orchard Road, Beckenham, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Creese</LastName><ForeName>Byron</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-6490-6037</Identifier><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Exeter Medical School, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velayudhan</LastName><ForeName>Latha</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7712-930X</Identifier><AffiliationInfo><Affiliation>South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Monks Orchard Road, Beckenham, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aarsland</LastName><ForeName>Dag</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-6314-216X</Identifier><AffiliationInfo><Affiliation>South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Monks Orchard Road, Beckenham, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stavanger University Hospital, Stavanger, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ballard</LastName><ForeName>Clive</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0022-5632</Identifier><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stavanger University Hospital, Stavanger, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsamakis</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-0063-8413</Identifier><AffiliationInfo><Affiliation>South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Monks Orchard Road, Beckenham, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Second Department of Psychiatry, National and Kapodistrian University of Athens, School of Medicine, University General Hospital 'ATTIKON', Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4435-6397</Identifier><AffiliationInfo><Affiliation>South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Monks Orchard Road, Beckenham, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mueller</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9816-1686</Identifier><AffiliationInfo><Affiliation>South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Monks Orchard Road, Beckenham, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_17214</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/T045302/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/V049879/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/W014386/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drugs Aging</MedlineTA><NlmUniqueID>9102074</NlmUniqueID><ISSNLinking>1170-229X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>N7U69T4SZR</RegistryNumber><NameOfSubstance UI="D000077152">Olanzapine</NameOfSubstance></Chemical><Chemical><RegistryNumber>L6UH7ZF8HC</RegistryNumber><NameOfSubstance UI="D018967">Risperidone</NameOfSubstance></Chemical><Chemical><RegistryNumber>2S3PL1B6UJ</RegistryNumber><NameOfSubstance UI="D000069348">Quetiapine Fumarate</NameOfSubstance></Chemical><Chemical><RegistryNumber>12794-10-4</RegistryNumber><NameOfSubstance UI="D001569">Benzodiazepines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="Y">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077152" MajorTopicYN="N">Olanzapine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018967" MajorTopicYN="N">Risperidone</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011618" MajorTopicYN="Y">Psychotic Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069348" MajorTopicYN="N">Quetiapine Fumarate</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001569" MajorTopicYN="N">Benzodiazepines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>RS has received research support from Janssen, GSK and Takeda. DA has received research support and/or honoraria from Astra-Zeneca, H. Lundbeck, Novartis Pharmaceuticals and GE Health, and serves as a paid consultant for H. Lundbeck and Axovant. CB has received honoraria and grant funding from Acadia Pharmaceuticals, Lundbeck, Takeda and Axovant pharmaceutical companies. CB leads the Alzheimer&#x2019;s disease psychosis (ADP) investigators group and has received honoraria from Lundbeck, Lilly, Otusaka and Orion pharmaceutical companies. MR, MT, BC, LV, KT and CM declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>13</Day><Hour>23</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36513918</ArticleId><ArticleId IdType="pmc">PMC9747539</ArticleId><ArticleId IdType="doi">10.1007/s40266-022-00992-5</ArticleId><ArticleId IdType="pii">10.1007/s40266-022-00992-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. Dementia. World Health Organization Fact Sheets. 2021. https://www.who.int/news-room/fact-sheets/detail/dementia. Accessed 20 Sep 2021.</Citation></Reference><Reference><Citation>World Health Organization. Global action plan on the public health response to dementia 2017-2025. 2017. https://apps.who.int/iris/bitstream/handle/10665/259615/9789241513487-eng.pdf?sequence=1. Accessed 26 Oct 2021.</Citation></Reference><Reference><Citation>Cloak N, Khalili Y Al. Behavioral And Psychological Symptoms In Dementia. StatPearls. 2020. https://www.ncbi.nlm.nih.gov/books/NBK551552/. Accessed 20 Sep 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerlach LB, Kales HC. Managing behavioral and psychological symptoms of dementia. Psychiatr Clin North Am. 2018;41(1):127&#x2013;139. doi: 10.1016/J.PSC.2017.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PSC.2017.10.010</ArticleId><ArticleId IdType="pubmed">29412841</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao QF, et al. The prevalence of neuropsychiatric symptoms in Alzheimer&#x2019;s disease: systematic review and meta-analysis. J Affect Disord. 2016;190:264&#x2013;271. doi: 10.1016/J.JAD.2015.09.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JAD.2015.09.069</ArticleId><ArticleId IdType="pubmed">26540080</ArticleId></ArticleIdList></Reference><Reference><Citation>Calsolaro V, et al. Behavioral and psychological symptoms in dementia (BPSD) and the use of antipsychotics. Pharmaceuticals. 2021;14(3):246. doi: 10.3390/ph14030246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14030246</ArticleId><ArticleId IdType="pmc">PMC8002184</ArticleId><ArticleId IdType="pubmed">33803277</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C, John C, Perera G, Aarsland D, Ballard C, Stewart R. Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes. Eur J Epidemiol. 2021;36(1):89&#x2013;101. doi: 10.1007/s10654-020-00643-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-020-00643-2</ArticleId><ArticleId IdType="pmc">PMC7847435</ArticleId><ArticleId IdType="pubmed">32415541</ArticleId></ArticleIdList></Reference><Reference><Citation>Eissa N, Sadeq A, Sasse A, Sadek B. Role of neuroinflammation in autism spectrum disorder and the emergence of brain histaminergic system. Lessons also for BPSD? Front Pharmacol. 2020;11:886. doi: 10.3389/FPHAR.2020.00886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FPHAR.2020.00886</ArticleId><ArticleId IdType="pmc">PMC7309953</ArticleId><ArticleId IdType="pubmed">32612529</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail Z, et al. Psychosis in Alzheimer disease&#x2014;mechanisms, genetics and therapeutic opportunities. Nat Rev Neurol. 2022;18(3):131&#x2013;144. doi: 10.1038/s41582-021-00597-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-021-00597-3</ArticleId><ArticleId IdType="pmc">PMC9074132</ArticleId><ArticleId IdType="pubmed">34983978</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher AR, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA. 2011;306(12):1359&#x2013;1369. doi: 10.1001/JAMA.2011.1360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMA.2011.1360</ArticleId><ArticleId IdType="pubmed">21954480</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence [NICE]. Dementia: assessment, management and support for people living with dementia and their carers. NICE guideline [NG97]. 2018. https://www.nice.org.uk/guidance/ng97/chapter/Recommendations. Accessed 26 Oct 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">30011160</ArticleId></ArticleIdList></Reference><Reference><Citation>Gareri P, De Fazio P, Manfredi VGL, De Sarro G. Use and safety of antipsychotics in behavioral disorders in elderly people with dementia. J Clin Psychopharmacol. 2014;34(1):109&#x2013;123. doi: 10.1097/JCP.0b013e3182a6096e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JCP.0b013e3182a6096e</ArticleId><ArticleId IdType="pubmed">24158020</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294(15):1934&#x2013;1943. doi: 10.1001/JAMA.294.15.1934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMA.294.15.1934</ArticleId><ArticleId IdType="pubmed">16234500</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Iersel MB, Zuidema SU, Koopmans RTCM, Verhey FRJ, Rikkert MGMO. Antipsychotics for behavioural and psychological problems in elderly people with dementia: a systematic review of adverse events. Drugs Aging. 2005;22(10):845&#x2013;858. doi: 10.2165/00002512-200522100-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00002512-200522100-00004</ArticleId><ArticleId IdType="pubmed">16245958</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinkley KE, Sturm AM, Porter K, Nahata MC. Efficacy and safety of atypical antipsychotics for behavioral and psychological symptoms of dementia among community dwelling adults. J Pharm Pract. 2020;33(1):7&#x2013;14. doi: 10.1177/0897190018771272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0897190018771272</ArticleId><ArticleId IdType="pubmed">29695193</ArticleId></ArticleIdList></Reference><Reference><Citation>Tampi RR, Tampi DJ, Rogers K, Alagarsamy S. Antipsychotics in the management of behavioral and psychological symptoms of dementia: maximizing gain and minimizing harm. Neurodegener Dis Manag. 2020;10(1):5&#x2013;8. doi: 10.2217/nmt-2019-0036.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt-2019-0036</ArticleId><ArticleId IdType="pubmed">32027552</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison SL, Buckley BJR, Lane DA, Underhill P, Lip GYH. Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications. Pharmacol Res. 2021;167:105534. doi: 10.1016/j.phrs.2021.105534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2021.105534</ArticleId><ArticleId IdType="pmc">PMC9759831</ArticleId><ArticleId IdType="pubmed">33677103</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association The American Psychiatric association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia. Am Psychiatr Assoc. 2016 doi: 10.1176/appi.books.9780890426807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.books.9780890426807</ArticleId><ArticleId IdType="pmc">PMC6519629</ArticleId><ArticleId IdType="pubmed">31997967</ArticleId></ArticleIdList></Reference><Reference><Citation>Seibert M, et al. Efficacy and safety of pharmacotherapy for Alzheimer&#x2019;s disease and for behavioural and psychological symptoms of dementia in older patients with moderate and severe functional impairments: a systematic review of controlled trials. Alzheimers Res Ther. 2021;13(1):131. doi: 10.1186/S13195-021-00867-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S13195-021-00867-8</ArticleId><ArticleId IdType="pmc">PMC8285815</ArticleId><ArticleId IdType="pubmed">34271969</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;hlbauer V, M&#xf6;hler R, Dichter MN, Zuidema SU, K&#xf6;pke S, Luijendijk HJ. Antipsychotics for agitation and psychosis in people with Alzheimer&#x2019;s disease and vascular dementia. Cochrane Database Syst Rev. 2021;12(12):13304. doi: 10.1002/14651858.CD013304.PUB2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013304.PUB2</ArticleId><ArticleId IdType="pmc">PMC8678509</ArticleId><ArticleId IdType="pubmed">34918337</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristensson JH, Zahirovic I, Londos E, Modig S. Medications causing potential cognitive impairment are common in nursing home dementia units&#x2014;A cross-sectional study. Explor Res Clin Soc Pharm. 2021;3:100054. doi: 10.1016/J.RCSOP.2021.100054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.RCSOP.2021.100054</ArticleId><ArticleId IdType="pmc">PMC9031036</ArticleId><ArticleId IdType="pubmed">35480606</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard R, Burns A, Schneider L. Antipsychotic prescribing to people with dementia during COVID-19. Lancet Neurol. 2020;19(11):892. doi: 10.1016/S1474-4422(20)30370-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30370-7</ArticleId><ArticleId IdType="pmc">PMC7577650</ArticleId><ArticleId IdType="pubmed">33098796</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu KY, et al. Dementia wellbeing and COVID-19: review and expert consensus on current research and knowledge gaps. Int J Geriatr Psychiatry. 2021;36(11):1597&#x2013;1639. doi: 10.1002/GPS.5567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/GPS.5567</ArticleId><ArticleId IdType="pmc">PMC8237017</ArticleId><ArticleId IdType="pubmed">34043836</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen RE, Lolk A, Rodrigo-Domingo M, Valentin JB, Andersen K. Antipsychotic treatment effects on cardiovascular, cancer, infection, and intentional self-harm as cause of death in patients with Alzheimer&#x2019;s dementia. Eur Psychiatry. 2017;42:14&#x2013;23. doi: 10.1016/j.eurpsy.2016.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eurpsy.2016.11.013</ArticleId><ArticleId IdType="pmc">PMC7126709</ArticleId><ArticleId IdType="pubmed">28199869</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunusa I, Alsumali A, Garba AE, Regestein QR, Eguale T. Assessment of reported comparative effectiveness and safety of atypical antipsychotics in the treatment of behavioral and psychological symptoms of dementia: a network meta-analysis. JAMA Netw open. 2019;2(3):e190828. doi: 10.1001/jamanetworkopen.2019.0828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.0828</ArticleId><ArticleId IdType="pmc">PMC6583313</ArticleId><ArticleId IdType="pubmed">30901041</ArticleId></ArticleIdList></Reference><Reference><Citation>Siafis S, Tzachanis D, Samara M, Papazisis G. Antipsychotic drugs: from receptor-binding profiles to metabolic side effects. Curr Neuropharmacol. 2018;16(8):1210. doi: 10.2174/1570159X15666170630163616.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X15666170630163616</ArticleId><ArticleId IdType="pmc">PMC6187748</ArticleId><ArticleId IdType="pubmed">28676017</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, Snyder GL, Vanover KE. Dopamine targeting drugs for the treatment of schizophrenia: past, present. Curr Top Med Chem. 2016;16:3385&#x2013;3403. doi: 10.2174/1568026616666160608.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026616666160608</ArticleId><ArticleId IdType="pmc">PMC5112764</ArticleId><ArticleId IdType="pubmed">27291902</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin B, Liu H. Comparative efficacy and safety of therapy for the behavioral and psychological symptoms of dementia: a systemic review and Bayesian network meta-analysis. J Neurol. 2019;266(10):2363&#x2013;2375. doi: 10.1007/s00415-019-09200-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09200-8</ArticleId><ArticleId IdType="pubmed">30666436</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunusa I, Rashid N, Demos GN, Mahadik BS, Abler VC, Rajagopalan K. Comparative outcomes of commonly used off-label atypical antipsychotics in the treatment of dementia-related psychosis: a network meta-analysis. Adv Ther. 2022;39(5):1993&#x2013;2008. doi: 10.1007/S12325-022-02075-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S12325-022-02075-8</ArticleId><ArticleId IdType="pmc">PMC9056477</ArticleId><ArticleId IdType="pubmed">35247186</ArticleId></ArticleIdList></Reference><Reference><Citation>Stummer L, Markovic M, Maroney M. Brexpiprazole in the treatment of schizophrenia and agitation in Alzheimer&#x2019;s disease. Neurodegener Dis Manag. 2020;10(4):205&#x2013;217. doi: 10.2217/nmt-2020-0013.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt-2020-0013</ArticleId><ArticleId IdType="pubmed">32618483</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossberg GT, et al. Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer&#x2019;s dementia: two 12-week, randomized, double-blind Placebo-Controlled Trials. Am J Geriatr Psychiatry. 2020;28(4):383&#x2013;400. doi: 10.1016/J.JAGP.2019.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JAGP.2019.09.009</ArticleId><ArticleId IdType="pubmed">31708380</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballard C, et al. Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer&#x2019;s disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study. Lancet Neurol. 2018;17(3):213&#x2013;222. doi: 10.1016/S1474-4422(18)30039-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30039-5</ArticleId><ArticleId IdType="pubmed">29452684</ArticleId></ArticleIdList></Reference><Reference><Citation>Andalo D. FDA approves pimavanserin to treat hallucinations and delusions in Parkinson&#x2019;s disease. Pharm J. 2016 doi: 10.1211/PJ.2016.20201108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1211/PJ.2016.20201108</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballard C, Youakim JM, Coate B, Stankovic S. Pimavanserin in Alzheimer&#x2019;s disease psychosis: efficacy in patients with more pronounced psychotic symptoms. J Prev Alzheimer&#x2019;s Dis. 2019;6(1):27&#x2013;33. doi: 10.14283/jpad.2018.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.14283/jpad.2018.30</ArticleId><ArticleId IdType="pubmed">30569083</ArticleId></ArticleIdList></Reference><Reference><Citation>Tariot PN, et al. Trial of pimavanserin in dementia-related psychosis. N Engl J Med. 2021;385(4):309&#x2013;319. doi: 10.1056/NEJMOA2034634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMOA2034634</ArticleId><ArticleId IdType="pubmed">34289275</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralph SJ, Espinet AJ. Increased all-cause mortality by antipsychotic drugs: updated review and meta-analysis in dementia and general mental health care. J Alzheimer&#x2019;s Dis Reports. 2018;2(1):1&#x2013;26. doi: 10.3233/adr-170042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/adr-170042</ArticleId><ArticleId IdType="pmc">PMC6159703</ArticleId><ArticleId IdType="pubmed">30480245</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen RE, Lolk A, Valentin JB, Andersen K. Cumulative dosages of antipsychotic drugs are associated with increased mortality rate in patients with Alzheimer&#x2019;s dementia. Acta Psychiatr Scand. 2016;134(4):314&#x2013;320. doi: 10.1111/acps.12614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acps.12614</ArticleId><ArticleId IdType="pubmed">27357602</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xf8;rgaard A, et al. Effect of antipsychotics on mortality risk in patients with dementia with and without comorbidities. J Am Geriatr Soc. 2022;70(4):1169&#x2013;1179. doi: 10.1111/JGS.17623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/JGS.17623</ArticleId><ArticleId IdType="pubmed">35029305</ArticleId></ArticleIdList></Reference><Reference><Citation>Langballe EM, Engdahl B, Nordeng H, Ballard C, Aarsland D, Selb&#xe6;k G. Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study. Am J Geriatr Psychiatry. 2014;22(4):321&#x2013;331. doi: 10.1016/J.JAGP.2013.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JAGP.2013.06.007</ArticleId><ArticleId IdType="pubmed">24016844</ArticleId></ArticleIdList></Reference><Reference><Citation>Maust DT, et al. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiat. 2015;72(5):438&#x2013;445. doi: 10.1001/jamapsychiatry.2014.3018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2014.3018</ArticleId><ArticleId IdType="pmc">PMC4439579</ArticleId><ArticleId IdType="pubmed">25786075</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen A, Copeli F, Metzger E, Cloutier A, Osser DN. The psychopharmacology algorithm project at the harvard south shore program: an update on management of behavioral and psychological symptoms in dementia. Psychiatry Res. 2021;295:113641. doi: 10.1016/j.psychres.2020.113641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113641</ArticleId><ArticleId IdType="pubmed">33340800</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson JW, Schneeweiss S, Vanderweele TJ, Blacker D. Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis. PLoS ONE. 2014;9(8):e105376. doi: 10.1371/journal.pone.0105376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0105376</ArticleId><ArticleId IdType="pmc">PMC4139353</ArticleId><ArticleId IdType="pubmed">25140533</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh TC, et al. Mortality risk of atypical antipsychotics for behavioral and psychological symptoms of dementia: a meta-analysis, meta-regression, and trial sequential analysis of randomized controlled trials. J Clin Psychopharmacol. 2019;39(5):472&#x2013;478. doi: 10.1097/JCP.0000000000001083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JCP.0000000000001083</ArticleId><ArticleId IdType="pubmed">31433335</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard R, Costafreda SG, Karcher K, Coppola D, Berlin JA, Hough D. Baseline characteristics and treatment-emergent risk factors associated with cerebrovascular event and death with risperidone in dementia patients. Br J Psychiatry. 2016;209(5):378&#x2013;384. doi: 10.1192/bjp.bp.115.177683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.bp.115.177683</ArticleId><ArticleId IdType="pubmed">27388570</ArticleId></ArticleIdList></Reference><Reference><Citation>Liperoti R, et al. Antipsychotic drug interactions and mortality among nursing home residents with cognitive impairment. J Clin Psychiatry. 2017;78(1):e76&#x2013;e81. doi: 10.4088/JCP.15m10303.</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.15m10303</ArticleId><ArticleId IdType="pubmed">28129493</ArticleId></ArticleIdList></Reference><Reference><Citation>Malekizadeh Y, et al. Whole transcriptome in silico screening implicates cardiovascular and infectious disease in the mechanism of action underlying atypical antipsychotic side effects. Alzheimer&#x2019;s Dement. Transl Res Clin Interv. 2020;6(1):e12078. doi: 10.1002/trc2.12078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12078</ArticleId><ArticleId IdType="pmc">PMC7443741</ArticleId><ArticleId IdType="pubmed">32864416</ArticleId></ArticleIdList></Reference><Reference><Citation>Beauchemin M, et al. Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: risperidone alters the cardiac proteomic signature in mice. Pharmacol Res. 2020;152:104589. doi: 10.1016/J.PHRS.2019.104589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PHRS.2019.104589</ArticleId><ArticleId IdType="pmc">PMC7060507</ArticleId><ArticleId IdType="pubmed">31874253</ArticleId></ArticleIdList></Reference><Reference><Citation>Pariente A, et al. Antipsychotic use and myocardial infarction in older patients with treated dementia. Arch Intern Med. 2012;172(8):648&#x2013;653. doi: 10.1001/ARCHINTERNMED.2012.28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/ARCHINTERNMED.2012.28</ArticleId><ArticleId IdType="pubmed">22450214</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxwell CJ, et al. Relevance of frailty to mortality associated with the use of antipsychotics among community-residing older adults with impaired cognition. Pharmacoepidemiol Drug Saf. 2018;27(3):289&#x2013;298. doi: 10.1002/pds.4385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4385</ArticleId><ArticleId IdType="pubmed">29318705</ArticleId></ArticleIdList></Reference><Reference><Citation>Watt JA, et al. Safety of pharmacologic interventions for neuropsychiatric symptoms in dementia: a systematic review and network meta-analysis. BMC Geriatr. 2020;20(1):212. doi: 10.1186/s12877-020-01607-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-020-01607-7</ArticleId><ArticleId IdType="pmc">PMC7298771</ArticleId><ArticleId IdType="pubmed">32546202</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis M, et al. Risk of adverse outcomes for older people with dementia prescribed antipsychotic medication: a population based e-cohort study. Neurol Ther. 2017;6(1):57&#x2013;77. doi: 10.1007/s40120-016-0060-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40120-016-0060-6</ArticleId><ArticleId IdType="pmc">PMC5447553</ArticleId><ArticleId IdType="pubmed">28054240</ArticleId></ArticleIdList></Reference><Reference><Citation>Zivkovic S, Koh CH, Kaza N, Jackson CA. Antipsychotic drug use and risk of stroke and myocardial infarction: a systematic review and meta-analysis. BMC Psychiatry. 2019;19(1):189. doi: 10.1186/s12888-019-2177-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-019-2177-5</ArticleId><ArticleId IdType="pmc">PMC6585081</ArticleId><ArticleId IdType="pubmed">31221107</ArticleId></ArticleIdList></Reference><Reference><Citation>Koponen M, et al. Antipsychotic use and risk of stroke among community-dwelling people with Alzheimer&#x2019;s disease. J Am Med Dir Assoc. 2022;23(6):1059&#x2013;1065.e4. doi: 10.1016/J.JAMDA.2021.09.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JAMDA.2021.09.036</ArticleId><ArticleId IdType="pubmed">34717887</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajamaki B, Hartikainen S, Tolppanen AM. Psychotropic drug-associated pneumonia in older adults. Drugs Aging. 2020;37(4):241&#x2013;261. doi: 10.1007/s40266-020-00754-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40266-020-00754-1</ArticleId><ArticleId IdType="pmc">PMC7096389</ArticleId><ArticleId IdType="pubmed">32107741</ArticleId></ArticleIdList></Reference><Reference><Citation>Beeber AS, Zimmerman S, Wretman CJ, Palmertree S, Patel K, Sloane PD. Potential side effects and adverse events of antipsychotic use for residents with dementia in assisted living: implications for prescribers, staff, and families. J Appl Gerontol. 2022;41(3):798&#x2013;805. doi: 10.1177/07334648211023678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/07334648211023678</ArticleId><ArticleId IdType="pmc">PMC8695622</ArticleId><ArticleId IdType="pubmed">34160299</ArticleId></ArticleIdList></Reference><Reference><Citation>Seppala LJ, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II Psychotropics. J Am Med Dir Assoc. 2018;19(4):371.e11&#x2013;371.e17. doi: 10.1016/J.JAMDA.2017.12.098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JAMDA.2017.12.098</ArticleId><ArticleId IdType="pubmed">29402652</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakarias JK, et al. Risk of hospitalization and hip fracture associated with psychotropic polypharmacy in patients with dementia: a nationwide register-based study. Int J Geriatr Psychiatry. 2021;36(11):1691&#x2013;1698. doi: 10.1002/GPS.5587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/GPS.5587</ArticleId><ArticleId IdType="pubmed">34076293</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyer AH, Murphy C, Lawlor B, Kennelly SP. Long-term antipsychotic use and cognitive decline in community-dwelling older adults with mild&#x2013;moderate Alzheimer disease: data from NILVAD. Int J Geriatr Psychiatry. 2021;36(11):1708&#x2013;1721. doi: 10.1002/gps.5591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5591</ArticleId><ArticleId IdType="pubmed">34173272</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto M, et al. Relationship between dementia severity and behavioral and psychological symptoms of dementia in dementia with lewy bodies and Alzheimer&#x2019;s disease patients. Dement Geriatr Cogn Dis Extra. 2015;5(2):244. doi: 10.1159/000381800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000381800</ArticleId><ArticleId IdType="pmc">PMC4483492</ArticleId><ArticleId IdType="pubmed">26195980</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapiainen V, et al. The risk of head injuries associated with antipsychotic use among persons with Alzheimer&#x2019;s disease. J Am Geriatr Soc. 2020;68(3):595&#x2013;602. doi: 10.1111/jgs.16275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16275</ArticleId><ArticleId IdType="pubmed">31912482</ArticleId></ArticleIdList></Reference><Reference><Citation>Sezgin M, Bilgic B, Tinaz S, Emre M. Parkinson&#x2019;s disease dementia and lewy body disease. Semin Neurol. 2019;39(2):274&#x2013;282. doi: 10.1055/S-0039-1678579/ID/JR180061-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/S-0039-1678579/ID/JR180061-37</ArticleId><ArticleId IdType="pubmed">30925619</ArticleId></ArticleIdList></Reference><Reference><Citation>Badwal K, Kiliaki SA, Dugani SB, Pagali SR. Psychosis management in lewy body dementia: a comprehensive clinical approach. J Geriatr Psychiatry Neurol. 2022;35(3):255&#x2013;261. doi: 10.1177/0891988720988916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988720988916</ArticleId><ArticleId IdType="pubmed">33461372</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J, et al. Pimavanserin for patients with Parkinson&#x2019;s disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet. 2014;383(9916):533&#x2013;540. doi: 10.1016/S0140-6736(13)62106-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)62106-6</ArticleId><ArticleId IdType="pubmed">24183563</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor DM, Barnes TRE, Young AH. The Maudsley prescribing guidelines in psychiatry. 14. New York: John Wiley &amp; Sons Ltd.; 2021.</Citation></Reference><Reference><Citation>Sepassi A, Watanabe JH. Emergency department visits for psychotropic-related adverse drug events in older adults with alzheimer disease, 2013&#x2013;2014. Ann Pharmacother. 2019;53(12):1173&#x2013;1183. doi: 10.1177/1060028019866927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1060028019866927</ArticleId><ArticleId IdType="pubmed">31342766</ArticleId></ArticleIdList></Reference><Reference><Citation>Koponen M, et al. Accumulation of hospital days among antipsychotic initiators with Alzheimer&#x2019;s disease. J Am Med Dir Assoc. 2019;20(12):1488&#x2013;1494.e3. doi: 10.1016/j.jamda.2019.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2019.07.009</ArticleId><ArticleId IdType="pubmed">31466934</ArticleId></ArticleIdList></Reference><Reference><Citation>Nerius M, Johnell K, Garcia-Ptacek S, Eriksdotter M, Haenisch B, Doblhammer G. The impact of antipsychotic drugs on long-term care, nursing home admission, and death in dementia patients. J Gerontol Ser A Biol Sci Med Sci. 2018;73(10):1396&#x2013;1402. doi: 10.1093/gerona/glx239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glx239</ArticleId><ArticleId IdType="pmc">PMC6132113</ArticleId><ArticleId IdType="pubmed">29228107</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo Z, Lin J, Bat BKK, Chan TK, Yip BHK, Tsoi KKF. Cost-effectiveness of pharmacological therapies for people with Alzheimer&#x2019;s disease and other dementias: a systematic review and meta-analysis. Cost Eff Resour Alloc. 2022;20(1):19. doi: 10.1186/S12962-022-00354-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12962-022-00354-3</ArticleId><ArticleId IdType="pmc">PMC9022294</ArticleId><ArticleId IdType="pubmed">35443684</ArticleId></ArticleIdList></Reference><Reference><Citation>Husebo BS, Ballard C, Sandvik R, Nilsen OB, Aarsland D. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. The BMJ. 2011;343:d4065. doi: 10.1136/BMJ.D4065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.D4065</ArticleId><ArticleId IdType="pmc">PMC3137923</ArticleId><ArticleId IdType="pubmed">21765198</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolinsky D, Drake K, Bostwick J. Diagnosis and management of neuropsychiatric symptoms in Alzheimer&#x2019;s disease. Curr Psychiatry Rep. 2018;20(12):1&#x2013;13. doi: 10.1007/s11920-018-0978-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11920-018-0978-8</ArticleId><ArticleId IdType="pubmed">30367272</ArticleId></ArticleIdList></Reference><Reference><Citation>Keszycki RM, Ficher DW, Dong H. The hyperactivity-impulsivity-irritiability-disinhibition-aggression-agitation domain in Alzheimer&#x2019;s disease: current management and future directions. Front Pharmacol. 2019;10:1109. doi: 10.3389/FPHAR.2019.01109.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FPHAR.2019.01109</ArticleId><ArticleId IdType="pmc">PMC6777414</ArticleId><ArticleId IdType="pubmed">31611794</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neil ME, Freeman M, Christensen V, Telerant R, Addleman A, Kansagara D. A Systematic evidence review of non-pharmacological interventions for behavioral symptoms of dementia. Portland: Department of Veterans Affairs (US); 2011.</Citation><ArticleIdList><ArticleId IdType="pubmed">21634073</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P. Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst Rev. 2011;2:8191. doi: 10.1002/14651858.cd008191.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.cd008191.pub2</ArticleId><ArticleId IdType="pubmed">21328305</ArticleId></ArticleIdList></Reference><Reference><Citation>Kongpakwattana K, Sawangjit R, Tawankanjanachot I, Bell JS, Hilmer SN, Chaiyakunapruk N. Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis. Br J Clin Pharmacol. 2018;84(7):1445. doi: 10.1111/BCP.13604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/BCP.13604</ArticleId><ArticleId IdType="pmc">PMC6005613</ArticleId><ArticleId IdType="pubmed">29637593</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. The BMJ. 2017;357:j2099. doi: 10.1136/bmj.j2099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j2099</ArticleId><ArticleId IdType="pmc">PMC5441081</ArticleId><ArticleId IdType="pubmed">28536104</ArticleId></ArticleIdList></Reference><Reference><Citation>Okura T, Plassman BL, Steffens DC, Llewellyn DJ, Potter GG, Langa KM. Neuropsychiatric symptoms and the risk of institutionalization and death: the aging, demographics, and memory study. J Am Geriatr Soc. 2011;59(3):473&#x2013;481. doi: 10.1111/J.1532-5415.2011.03314.X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/J.1532-5415.2011.03314.X</ArticleId><ArticleId IdType="pmc">PMC3088883</ArticleId><ArticleId IdType="pubmed">21391937</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters ME, et al. Neuropsychiatric symptoms as predictors of progression to severe Alzheimer&#x2019;s dementia and death: the cache county dementia progression study. Am J Psychiatry. 2015;172(5):460&#x2013;465. doi: 10.1176/APPI.AJP.2014.14040480/ASSET/IMAGES/LARGE/APPI.AJP.2014.14040480F1.JPEG.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/APPI.AJP.2014.14040480/ASSET/IMAGES/LARGE/APPI.AJP.2014.14040480F1.JPEG</ArticleId><ArticleId IdType="pmc">PMC4416978</ArticleId><ArticleId IdType="pubmed">25585033</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Leeuwen E, et al. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2018;3(3):7726. doi: 10.1002/14651858.CD007726.PUB3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD007726.PUB3</ArticleId><ArticleId IdType="pmc">PMC8407230</ArticleId><ArticleId IdType="pubmed">29605970</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence [NICE]. Psychosis and schizophrenia in adults: prevention and management. Clinical guideline [CG178]. 2014. https://www.nice.org.uk/guidance/cg178/chapter/1-Recommendations. Accessed 30 Jul 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36502867</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-7064</ISSN><JournalIssue CitedMedium="Internet"><Volume>226</Volume><PubDate><Year>2023</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>Neuropharmacology</Title><ISOAbbreviation>Neuropharmacology</ISOAbbreviation></Journal><ArticleTitle>Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease.</ArticleTitle><Pagination><StartPage>109371</StartPage><MedlinePgn>109371</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuropharm.2022.109371</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0028-3908(22)00430-0</ELocationID><Abstract><AbstractText>About 10 million new cases of dementia develop worldwide each year, of which up to 70% are attributable to Alzheimer's disease (AD). In addition to the widely known symptoms of memory loss and cognitive impairment, AD patients frequently develop non-cognitive symptoms, referred to as behavioral and psychological symptoms of dementia (BPSDs). Sleep disorders are often associated with AD, but mood alterations, notably depression and apathy, comprise the most frequent class of BPSDs. BPSDs negatively affect the lives of AD patients and their caregivers, and have a significant impact on public health systems and the economy. Because treatments currently available for AD are not disease-modifying and mainly aim to ameliorate some of the cognitive symptoms, elucidating the mechanisms underlying mood alterations and other BPSDs in AD may reveal novel avenues for progress in AD therapy. Purinergic signaling is implicated in the pathophysiology of several central nervous system (CNS) disorders, such as AD, depression and sleep disorders. Here, we review recent findings indicating that purinergic receptors, mainly the A<sub>1</sub>, A<sub>2A</sub>, and P2X7 subtypes, are associated with the development/progression of AD. Current evidence suggests that targeting purinergic signaling may represent a promising therapeutic approach in AD and related conditions. This article is part of the Special Issue on "Purinergic Signaling: 50 years".</AbstractText><CopyrightInformation>Copyright &#xa9; 2022. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Deidiane Elisa</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Chemistry Institute, University of S&#xe3;o Paulo (USP), S&#xe3;o Paulo, Brazil. Electronic address: deidiane@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petiz</LastName><ForeName>Lyvia Lintzmaier</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Universidade Federal do Paran&#xe1;, Curitiba, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glaser</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Chemistry Institute, University of S&#xe3;o Paulo (USP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira-Giacomelli</LastName><ForeName>&#xc1;gatha</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Chemistry Institute, University of S&#xe3;o Paulo (USP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrejew</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Chemistry Institute, University of S&#xe3;o Paulo (USP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saab</LastName><ForeName>Fernando de Azevedo Ribeiro</ForeName><Initials>FAR</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Chemistry Institute, University of S&#xe3;o Paulo (USP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milanis</LastName><ForeName>Milena da Silva</ForeName><Initials>MDS</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Chemistry Institute, University of S&#xe3;o Paulo (USP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campos</LastName><ForeName>Henrique Correia</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Laboratory of Neurophysiology, Department of Physiology, Federal University of S&#xe3;o Paulo (UNIFESP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sampaio</LastName><ForeName>Vanessa Fernandes Arnaud</ForeName><Initials>VFA</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Chemistry Institute, University of S&#xe3;o Paulo (USP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Banca</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Chemistry Institute, University of S&#xe3;o Paulo (USP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Longo</LastName><ForeName>Beatriz Monteiro</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Laboratory of Neurophysiology, Department of Physiology, Federal University of S&#xe3;o Paulo (UNIFESP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lameu</LastName><ForeName>Claudiana</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Chemistry Institute, University of S&#xe3;o Paulo (USP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>International Collaborative Centre on Big Science Plan for Purinergic Signalling, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China; Acupuncture and Chronobiology Key Laboratory of Sichuan Province, Chengdu, 610075, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resende</LastName><ForeName>Rodrigo Ribeiro</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Immunology, Federal University of Minas Gerais Belo Horizonte, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Sergio T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ulrich</LastName><ForeName>Henning</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Chemistry Institute, University of S&#xe3;o Paulo (USP), S&#xe3;o Paulo, Brazil; International Collaborative Centre on Big Science Plan for Purinergic Signalling, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China. Electronic address: henning@iq.usp.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Neuropharmacology</MedlineTA><NlmUniqueID>0236217</NlmUniqueID><ISSNLinking>0028-3908</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001526" MajorTopicYN="N">Behavioral Symptoms</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012893" MajorTopicYN="Y">Sleep Wake Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">Depressive disorders</Keyword><Keyword MajorTopicYN="N">Purinergic signaling</Keyword><Keyword MajorTopicYN="N">Sleep disorders</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>12</Day><Hour>8</Hour><Minute>55</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36502867</ArticleId><ArticleId IdType="doi">10.1016/j.neuropharm.2022.109371</ArticleId><ArticleId IdType="pii">S0028-3908(22)00430-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36502322</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-8908</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><Issue>2</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Diagnosis and Care Use for People with Young-Onset Dementia in Primary Care in the Netherlands.</ArticleTitle><Pagination><StartPage>653</StartPage><EndPage>662</EndPage><MedlinePgn>653-662</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-220713</ELocationID><Abstract><AbstractText Label="BACKGROUND">Timely diagnosis and adequate care is important for persons with young-onset dementia (YOD) and their caregivers, due to the high impact of the disease. Initiating care can be difficult for the general practitioner (GP) and other healthcare professionals.</AbstractText><AbstractText Label="OBJECTIVE">Provide insight in the care use of persons with YOD and identify factors influencing care use.</AbstractText><AbstractText Label="METHODS">A primary care register was used for this study. Information on the care use of persons with YOD was extracted from the GPs written notes. Information entailed time until start of care use, reasons and factors influencing the GP's decision, and reasons and factors influencing actual care use were included. Analyses included quantitative explorative descriptive analyses, and qualitative manifest content analyses.</AbstractText><AbstractText Label="RESULTS">75 persons with YOD were included in this study. The main reason for GPs to refer for diagnosis was concerns of caregivers. After diagnosis, 72% of the persons were assigned a case manager, 42.7% received day care, and 44% were admitted to a long-term care facility. A higher percentage of persons without a case manager was admitted to a long-term care facility (64%) compared to the persons with a case manager (36%). Reasons for not initiating care were reluctancy of the persons with YOD or their caregivers, the person deceased, or because the GP did not refer for care.</AbstractText><AbstractText Label="CONCLUSION">Care use differed between persons due to different needs and reasons. Although most persons with YOD receive care in the years after diagnosis, there are still factors that could be improved.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hendriks</LastName><ForeName>Stevie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peetoom</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tange</LastName><ForeName>Huibert</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Care and Public Health Research Institute (CAPHRI), Department of Family Medicine, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papma</LastName><ForeName>Janne</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Flier</LastName><ForeName>Wiesje M</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology and Data Science, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koopmans</LastName><ForeName>Raymond</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medical Center, Radboud, Department of Primary and Community Care, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboudumc Alzheimer Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joachim en Anna, center for specialized geriatriccare, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakker</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medical Center, Radboud, Department of Primary and Community Care, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboudumc Alzheimer Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Groenhuysen, Center for Specialized Geriatric Care, Roosendaal, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xf6;hler</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Vugt</LastName><ForeName>Marjolein</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004644" MajorTopicYN="Y">Emotions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Delivery of health care</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">middle aged</Keyword></KeywordList><CoiStatement>Authors&#x2019; disclosures available online (https://www.j-alz.com/manuscript-disclosures/22-0713r1).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>11</Day><Hour>4</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36502322</ArticleId><ArticleId IdType="pmc">PMC9912727</ArticleId><ArticleId IdType="doi">10.3233/JAD-220713</ArticleId><ArticleId IdType="pii">JAD220713</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hendriks S, Peetoom K, Bakker C, Van Der Flier WM, Papma JM, Koopmans R, Verhey FRJ, De Vugt M, K&#xf6;hler S, Withall A (2021) Global prevalence of young-onset dementia: A systematic review and meta-analysis. JAMA Neurol 78, 1080&#x2013;1090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8290331</ArticleId><ArticleId IdType="pubmed">34279544</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Veen D, Bakker C, Peetoom K, Pijnenburg Y, Papma J, group Ps, de Vugt M, Koopmans R (2022) Provisional consensus on the nomenclature and operational definition of dementia at a young age, a Delphi study. Int J Geriatr Psychiatry 37, 10.1002/gps.5691.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9305901</ArticleId><ArticleId IdType="pubmed">35156239</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Veen D, Bakker C, Peetoom K, Pijnenburg Y, Papma JM, de Vugt M, Koopmans R, Group PS (2021) An integrative literature review on the nomenclature and definition of dementia at a young age. J Alzheimers Dis 83, 1891&#x2013;1916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8609678</ArticleId><ArticleId IdType="pubmed">34487041</ArticleId></ArticleIdList></Reference><Reference><Citation>Draper B, Cations M, White F, Trollor J, Loy C, Brodaty H, Sachdev P, Gonski P, Demirkol A, Cumming RG (2016) Time to diagnosis in young-onset dementia and its determinants: The INSPIRED study. J Geriatr Psychiatry 31, 1217&#x2013;1224.</Citation><ArticleIdList><ArticleId IdType="pubmed">26807846</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvello-Alme M, Br&#xe5;then G, White LR, Sando SB (2021) Time to diagnosis in young onset Alzheimer&#x2019;s disease: A population-based study from Central Norway. J Alzheimers Dis 82, 965&#x2013;974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8461696</ArticleId><ArticleId IdType="pubmed">34120901</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Vliet D, De Vugt ME, Bakker C, Pijnenburg YAL, Vernooij-Dassen M, Koopmans R, Verhey FRJ (2013) Time to diagnosis in young-onset dementia as compared with late-onset dementia. Psychol Med 43, 423&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pubmed">22640548</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Vliet D, de Vugt ME, Bakker C, Koopmans RTCM, Verhey FRJ (2010) Impact of early onset dementia on caregivers: A review. Int J Geriatr Psychiatry 25, 1091&#x2013;1100.</Citation><ArticleIdList><ArticleId IdType="pubmed">20957692</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayly M, O&#x2019;Connell ME, Kortzman A, Peacock S, Morgan DG, Kirk A (2021) Family carers&#x2019; narratives of the financial consequences of young onset dementia. Dementia 20, 2708&#x2013;2724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670747</ArticleId><ArticleId IdType="pubmed">33877946</ArticleId></ArticleIdList></Reference><Reference><Citation>Busted LM, Nielsen DS, Birkelund R (2020) &#x201c;Sometimes it feels like thinking in syrup&#x201d;&#x2013; the experience of losing sense of self in those with young onset dementia. Int J Qual Stud Health Well-being 15, 1734277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7067159</ArticleId><ArticleId IdType="pubmed">32111147</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirico I, Ottoboni G, Linarello S, Ferriani E, Marrocco E, ChattatR (2022) Family experience of young-onset dementia: The perspectives of spouses and children. Aging Mental Health 26, 2243&#x2013;2251.</Citation><ArticleIdList><ArticleId IdType="pubmed">34842004</ArticleId></ArticleIdList></Reference><Reference><Citation>Millenaar JK, Bakker C, Koopmans RTCM, Verhey FRJ, Kurz A, de Vugt ME (2016) The care needs and experiences with the use of services of people with young-onset dementia and their caregivers: A systematic review. Int J Geriatr Psychiatry 31, 1261&#x2013;1276.</Citation><ArticleIdList><ArticleId IdType="pubmed">27271788</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen O, Vos SJB, Handels R, Vermunt L, Verheij R, Verhey FRJ, van Hout H, Visser PJ, Joling KJ (2020) Duration of care trajectories in persons with dementia differs according to demographic and clinical characteristics. J Am Med Dir Assoc 21, 1102&#x2013;1107.</Citation><ArticleIdList><ArticleId IdType="pubmed">32113914</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley JS, Salpeter SR (2015) A risk-benefit assessment of dementia medications: Systematic review of the evidence. Drugs Aging 32, 453&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pubmed">25941104</ArticleId></ArticleIdList></Reference><Reference><Citation>Netherlands/Vilans A (2013) Zorgstandaard dementie [The national standard for dementia care] (in Dutch).</Citation></Reference><Reference><Citation>Bentsen BG (1986) International classification of primary care. Scand J Prim Health Care 4, 43&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">3961309</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatfield C (1986) Exploratory data analysis. Eur J Oper Res 23, 5&#x2013;13.</Citation></Reference><Reference><Citation>Hsieh H-F, Shannon SE (2005) Three approaches to qualitative content analysis. Qual Health Res 15, 1277&#x2013;1288.</Citation><ArticleIdList><ArticleId IdType="pubmed">16204405</ArticleId></ArticleIdList></Reference><Reference><Citation>Tombaugh TN, McIntyre NJ (1992) The Mini-Mental State Examination: A comprehensive review. J Am Geriatr Soc 40, 922&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pubmed">1512391</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruinsma J, Peetoom K, Bakker C, Boots L, Verhey F, de Vugt M (2022) &#x2018;They simply do not understand&#x2019;: A focus group study exploring the lived experiences of family caregivers of people with frontotemporal dementia. Aging Mental Health 26, 277&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pubmed">33325262</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivieri P, Hamelin L, Lagarde J, Hahn V, Guichart-Gomez E, Rou&#xe9;-Jagot C, Sarazin M (2021) Characterization of the initial complaint and care pathways prior to diagnosis in very young sporadic Alzheimer&#x2019;s disease. Alzheimers Res Therapy 13, 90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086269</ArticleId><ArticleId IdType="pubmed">33926533</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Vliet D, de Vugt ME, Bakker C, Koopmans RTCM, Pijnenburg YAL, Vernooij-Dassen MJFJ, Verhey FRJ (2011) Caregivers&#x2019; perspectives on the pre-diagnostic period in early onset dementia: A long and winding road. Int Psychogeriatr 23, 1393&#x2013;1404.</Citation><ArticleIdList><ArticleId IdType="pubmed">21729410</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Malley M, Carter J, Stamou V, LaFontaine J, Oyebode J, Parkes J (2021) Receiving a diagnosis of young onset dementia: A scoping review of lived experiences. Aging Mental Health 25, 1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">31647324</ArticleId></ArticleIdList></Reference><Reference><Citation>Spreadbury JH, Kipps CM (2018) Understanding important issues in young-onset dementia care: The perspective of healthcare professionals. Neurodegener Dis Manag 8, 37&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">29372815</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ministry of Health, Welfare and Sports (October 2020). National Dementia Strategy 2021-2030. www.government.nl.</Citation></Reference><Reference><Citation>Khanassov V, Vedel I (2016) Family physician&#x2013; case manager collaboration and needs of patients with dementia and their caregivers: A systematic mixed studies review. Ann Fam Med 14, 166&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4781521</ArticleId><ArticleId IdType="pubmed">26951593</ArticleId></ArticleIdList></Reference><Reference><Citation>Corvol A, Dreier A, Prudhomm J, Thyrian JR, Hoffmann W, Somme D (2017) Consequences of clinical case management for caregivers: A systematic review. Int J Geriatr Psychiatry 32, 473&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pubmed">28181696</ArticleId></ArticleIdList></Reference><Reference><Citation>Giebel C, Robertson S, Beaulen A, Zwakhalen S, Allen D, Verbeek H (2021) &#x201c;Nobody seems to know where to even turn to&#x201d;: Barriers in accessing and utilising dementia care services in England and The Netherlands. Int J Environ Res Public Health 18, 12233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8622725</ArticleId><ArticleId IdType="pubmed">34831989</ArticleId></ArticleIdList></Reference><Reference><Citation>Prince M, Comas-Herrera A, Knapp M, Guerchet M, Karagiannidou M (2016) World Alzheimer Report 2016. Improving healthcare for people living with dementia: Coverage, quality and costs now and in the future. Alzheimer&#x2019;s Disease International, London.</Citation></Reference><Reference><Citation>Bakker C, de Vugt ME, van Vliet D, Verhey FRJ, Pijnenburg YA, Vernooij-Dassen MJFJ, Koopmans RTCM (2013) Predictors of the time to institutionalization in young-versus late-onset dementia: Results from the Needs in Young Onset Dementia (NeedYD) study. J Am Med Dir Assoc 14, 248&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">23123009</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephan A, Bieber A, Hopper L, Joyce R, Irving K, Zanetti O, Portolani E, Kerpershoek L, Verhey F, De Vugt M (2018) Barriers and facilitators to the access to and use of formal dementia care: Findings of a focus group study with people with dementia, informal carers and health and social care professionals in eight European countries. BMC Geriatr 18, 131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5987478</ArticleId><ArticleId IdType="pubmed">29866102</ArticleId></ArticleIdList></Reference><Reference><Citation>Boots LMM, Wolfs CAG, Verhey FRJ, Kempen GIJM, de Vugt ME (2015) Qualitative study on needs and wishes of early-stage dementia caregivers: The paradox between needing and accepting help. Int Psychogeriatr 27, 927&#x2013;936.</Citation><ArticleIdList><ArticleId IdType="pubmed">25566686</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim L, Zhang A, Lim L, Choong T-M, Silva E, Ng A, Kandiah N (2018) High caregiver burden in young onset dementia: What factors need attention? J Alzheimers Dis 61, 537&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pubmed">29171995</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36482678</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-4523</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of applied gerontology : the official journal of the Southern Gerontological Society</Title><ISOAbbreviation>J Appl Gerontol</ISOAbbreviation></Journal><ArticleTitle>Enhancing Dementia Knowledge and Self-Efficacy of In-Home Supportive Services Caregivers Through Online Training.</ArticleTitle><Pagination><StartPage>617</StartPage><EndPage>626</EndPage><MedlinePgn>617-626</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/07334648221144023</ELocationID><Abstract><AbstractText>California's In-Home Supportive Services (IHSS) program provides vital home care to low-income consumers, some of whom live with Alzheimer's disease or related dementias (ADRD). Yet, most IHSS caregivers receive little or no training in dementia care. We present preliminary descriptive results of the IHSS + ADRD Training Project, a 10-week, competency-based, dementia training program, delivered online, for IHSS caregivers, in Alameda County. Increase in dementia knowledge and self-efficacy at training completion supports the importance of continuing and expanding this work.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Jarmin</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4826-6583</Identifier><AffiliationInfo><Affiliation>Institute for Health &amp; Aging, Department of Social &amp; Behavioral Sciences, School of Nursing, 8785University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pond</LastName><ForeName>Brittney</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-6098-4695</Identifier><AffiliationInfo><Affiliation>Institute for Health &amp; Aging, Department of Social &amp; Behavioral Sciences, School of Nursing, 8785University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beld</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Health &amp; Aging, Department of Social &amp; Behavioral Sciences, School of Nursing, 8785University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Caregiver Advancement, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mauricio</LastName><ForeName>Juvenal</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Caregiver Advancement, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mata-Pacheco</LastName><ForeName>Juliana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Caregiver Advancement, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eldridge</LastName><ForeName>Corinne</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Caregiver Advancement, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Leslie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Health &amp; Aging, Department of Social &amp; Behavioral Sciences, School of Nursing, 8785University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Appl Gerontol</MedlineTA><NlmUniqueID>8606502</NlmUniqueID><ISSNLinking>0733-4648</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020377" MajorTopicYN="N">Self Efficacy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006699" MajorTopicYN="Y">Home Care Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011203" MajorTopicYN="N">Poverty</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">caregiving</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">home care</Keyword><Keyword MajorTopicYN="N">training</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>9</Day><Hour>3</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36482678</ArticleId><ArticleId IdType="pmc">PMC9996798</ArticleId><ArticleId IdType="doi">10.1177/07334648221144023</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>California Department of Social
Services . (n.d.). In home supportive
services program. https://www.cdss.ca.gov/in-home-supportive-services</Citation></Reference><Reference><Citation>Cook A.
(2017). Home care worker training and people with
Alzheimer&#x2019;s disease and related dementias: Ideas for state
policymakers. PHI. https://www.phinational.org/wp-content/uploads/2017/11/Home-Care-Workers-and-Alzheimers-PHI-Nov-2017.pdf</Citation></Reference><Reference><Citation>Epstein-Lubow G., Gaudiano B., Hinckley M., Salloway S., Miller I. (2010). Evidence for the validity of the American medical association&#x2019;s caregiver self-assessment questionnaire as a screening measure for depression. Journal of the American Geriatrics Society, 58(2), 387&#x2013;388. 10.1111/j.1532-5415.2009.02701.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2009.02701.x</ArticleId><ArticleId IdType="pubmed">20370867</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinoza R.
(2022). The impact of COVID-19 on direct care
workers. http://generations.asaging.org/impact-covid-19-direct-care-workers</Citation></Reference><Reference><Citation>Fortinsky R., Kercher K., Burant C. (2002). Measurement and correlates of family caregiver self-efficacy for managing dementia. Aging &amp; Mental Health, 6(2), 153&#x2013;160. 10.1080/13607860220126763</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607860220126763</ArticleId><ArticleId IdType="pubmed">12028884</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvin J. E., Roe C. M., Xiong C., Morris J. C. (2006). Validity and reliability of the AD8 informant interview in dementia. Neurology, 67(11), 1942&#x2013;1948. 10.1212/01.wnl.0000247042.15547.eb</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000247042.15547.eb</ArticleId><ArticleId IdType="pubmed">17159098</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero L. R., Eldridge C., Tan Z. (2020). Competency-based training for in-home supportive services providers of consumers with ADRD. Gerontology &amp; Geriatrics Education, 41(1), 121&#x2013;132. 10.1080/02701960.2019.1658579</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02701960.2019.1658579</ArticleId><ArticleId IdType="pubmed">31451093</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K., Spitzer R., Williams J. (2003). The patient health questionnaire-2: Validity of a two-item depression screener. Medical Care, 41(11), 1284&#x2013;1292. 10.1097/01.MLR.0000093487.78664.3C</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.MLR.0000093487.78664.3C</ArticleId><ArticleId IdType="pubmed">14583691</ArticleId></ArticleIdList></Reference><Reference><Citation>Maroufizadeh S., Omani-Samani R., Almasi-Hashiani A., Amini P., Sepidarkish M. (2019). The reliability and validity of the patient health questionnaire-9 (PHQ-9) and PHQ-2 in patients with infertility. Reproductive Health, 16(1), 137. 10.1186/s12978-019-0802-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12978-019-0802-x</ArticleId><ArticleId IdType="pmc">PMC6734346</ArticleId><ArticleId IdType="pubmed">31500644</ArticleId></ArticleIdList></Reference><Reference><Citation>Newcomer R., Harrington C., Hulett D., Kang T., Ko M., Bindman A. (2018). Health care use before and after entering long-term services and supports. Journal of Applied Gerontology, 37(1), 26&#x2013;40. 10.1177/0733464816641393</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464816641393</ArticleId><ArticleId IdType="pubmed">27091879</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker L. J., Fabius C., Rivers E., Taylor J. L. (2022). Is dementia-specific caregiving compared with non-dementia caregiving associated with physical difficulty among caregivers for community-dwelling adults? Journal of Applied Gerontology, 41(4), 1074&#x2013;1080. 10.1177/07334648211014352</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/07334648211014352</ArticleId><ArticleId IdType="pmc">PMC8664093</ArticleId><ArticleId IdType="pubmed">34041929</ArticleId></ArticleIdList></Reference><Reference><Citation>Pleasant M., Molinari V., Dobbs D., Meng H., Hyer K. (2020). Effectiveness of online dementia caregivers training programs: A systematic review. Geriatric Nursing, 41(6), 921&#x2013;935. 10.1016/j.gerinurse.2020.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gerinurse.2020.07.004</ArticleId><ArticleId IdType="pubmed">32703628</ArticleId></ArticleIdList></Reference><Reference><Citation>Polacsek M., Goh A., Malta S., Hallam B., Gahan L., Cooper C., Low L.-F., Livingston G., Panayiotou A., Loi S., Omori M., Savvas S., Batchelor F., Ames D., Doyle C., Scherer S., Dow B. (2020). &#x2018;I know they are not trained in dementia&#x2019;: Addressing the need for specialist dementia training for home care workers. Health &amp; Social Care in the Community, 28(2), 475&#x2013;484. 10.1111/hsc.12880</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hsc.12880</ArticleId><ArticleId IdType="pubmed">31646701</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross L., Beld M., Yeh J.
(2021). Alzheimer&#x2019;s disease and related dementias facts
and figures in California: Current status and future projections.
California Department of Public Health.
https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CDCB/CDPH_Document_Library/Alzheimers'_Disease_Program/151764_Alzheimers_Disease_Facts_and_Figures_Report_ADA.pdf</Citation></Reference><Reference><Citation>Sheehan O. C., Haley W. E., Howard V. J., Huang J., Rhodes J. D., Roth D. L. (2021). Stress, burden, and well-being in dementia and nondementia caregivers: Insights from the caregiving transitions study. The Gerontologist, 61(5), 670&#x2013;679. 10.1093/geront/gnaa108</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnaa108</ArticleId><ArticleId IdType="pmc">PMC8276607</ArticleId><ArticleId IdType="pubmed">32816014</ArticleId></ArticleIdList></Reference><Reference><Citation>Toye C., Lester L., Popescu A., McInerney F., Andrews S., Robinson A. (2014). Dementia knowledge assessment tool version two: Development of a tool to inform preparation for care planning and delivery in families and care staff. Dementia, 13(2), 248&#x2013;256. 10.1177/1471301212471960</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301212471960</ArticleId><ArticleId IdType="pubmed">24339059</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36478657</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-5279</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</Title><ISOAbbreviation>Alzheimers Dement</ISOAbbreviation></Journal><ArticleTitle>A framework for addressing Alzheimer's disease: Without a frame, the work has no aim.</ArticleTitle><Pagination><StartPage>1568</StartPage><EndPage>1578</EndPage><MedlinePgn>1568-1578</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/alz.12869</ELocationID><Abstract><AbstractText>Confronting Alzheimer's disease (AD) involves patients, healthcare professionals, supportive services, caregivers, and government agencies interacting along a continuum from initial awareness to diagnosis, treatment, support, and care. This complex scope presents a challenge for health system transformation supporting individuals at risk for, or diagnosed with, AD. The AD systems preparedness framework was developed to help health systems identify specific opportunities to implement and evaluate focused improvement programs. The framework is purposely flexible to permit local adaptation across different health systems and countries. Health systems can develop solutions tailored to system-specific priorities considered within the context of the overall framework. Example metric concepts and initiatives are provided for each of ten areas of focus. Examples of funded projects focusing on screening and early detection are provided. It is our hope that stakeholders utilize the common framework to generate and share additional implementation evidence to benefit individuals with AD.</AbstractText><CopyrightInformation>&#xa9; 2022 Davos Alzheimer's Collaborative and The Authors. Alzheimer's &amp; Dementia published by Wiley Periodicals LLC on behalf of Alzheimer'ss Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ball</LastName><ForeName>Daniel E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Davos Alzheimer's Collaborative, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattke</LastName><ForeName>Soeren</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Economic and Social Research, University of Southern California, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frank</LastName><ForeName>Lori</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The New York Academy of Medicine, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>James F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Davos Alzheimer's Collaborative, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noritake</LastName><ForeName>Ryoji</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Health and Global Policy Institute, Grand Cube 3F, Otemachi Financial City, Global Business Hub Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacLeod</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Davos Alzheimer's Collaborative, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bridgeable, Toronto, Ontario, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benham-Hermetz</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Alzheimer's Research UK, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurzman</LastName><ForeName>Alissa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Davos Alzheimer's Collaborative, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>High Lantern Group, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>World Economic Forum, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrell</LastName><ForeName>Phyllis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Davos Alzheimer's Collaborative, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Alzheimers Dement</MedlineTA><NlmUniqueID>101231978</NlmUniqueID><ISSNLinking>1552-5260</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>8</Day><Hour>13</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36478657</ArticleId><ArticleId IdType="doi">10.1002/alz.12869</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Boccardi M, Handels R, Gold M, et&#xa0;al. Clinical research in dementia: a perspective on implementing innovation. Alzheimers Dement. 2022;18(11):2352-2367.</Citation></Reference><Reference><Citation>Lees Haggerty K, Campetti R, Stoeckle RJ, et&#xa0;al. Dissemination of a successful dementia care program: lessons from early adopters. J Am Geriatr Soc. 2022. doi:10.1111/jgs.17887</Citation></Reference><Reference><Citation>Reuben DB, Evertson LC, Jackson-Stoeckle R, et&#xa0;al. Dissemination of a successful dementia care program: lessons to facilitate spread of innovations. J Am Geriatr Soc. 2022. doi:10.1111/jgs.17900</Citation></Reference><Reference><Citation>Nichols E, Steinmetz JD, Vollset SE, et&#xa0;al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. The Lancet Public Health. 2022;7(2):e105-e125. doi:10.1016/S2468-2667(21)00249-8</Citation></Reference><Reference><Citation>Khachaturian AS, Hoffman Director DP, Frank L, Petersen R, Carson BR, Khachaturian ZS. Zeroing out preventable disability: daring to dream the impossible dream for dementia care. Alzheimer's &amp; Dementia. 2017;13(10):1077-1080. doi:10.1016/j.jalz.2017.09.003</Citation></Reference><Reference><Citation>Khachaturian ZS. Alzheimer's Disease-Modernizing Concept, Biological Diagnosis and Therapy. Karger Publishers; 2012:179-188. Perspectives on Alzheimer's disease: past, present and future.</Citation></Reference><Reference><Citation>Baker K, Irving A. Co-producing approaches to the management of dementia through social prescribing. Social Policy &amp; Administration. 2016;50(3):379-397. doi:10.1111/spol.12127</Citation></Reference><Reference><Citation>$5 million grant to study noninvasive, low-cost methods for early detection of Alzheimer's. 02-01-2021, https://www.regenstrief.org/article/d3-grant-study-early-detection-alzheimers/</Citation></Reference><Reference><Citation>Rittel HWJ, Webber MM. Dilemmas in a general theory of planning. Policy Sciences. 1973;4(2):155-169. doi:10.1007/BF01405730</Citation></Reference><Reference><Citation>Deming WE. Out of the Crisis. Massachusetts Institute of Technology; 1986.</Citation></Reference><Reference><Citation>Reynolds M, Sarriot E, Swanson RC, Rusoja E. Navigating systems ideas for health practice: towards a common learning device. Journal of Evaluation in Clinical Practice. 2018;24(3):619-628. doi:10.1111/jep.12872</Citation></Reference><Reference><Citation>Fulmer TP, Pelton L. Age-friendly health systems - A guide to using the 4Ms while caring for older adults. Institute for Healthcare Improvement. 2022.</Citation></Reference><Reference><Citation>Mitchell SL, Mor V, Harrison J, McCarthy EP. Embedded pragmatic trials in dementia care: realizing the Vision of the NIA IMPACT Collaboratory. Journal of the American Geriatrics Society. 2020;68(S2):S1-S7. doi:10.1111/jgs.16621</Citation></Reference><Reference><Citation>Siva N. New global initiative to tackle Alzheimer's disease. Lancet. 2021;397(10274):568-569. doi:10.1016/s0140-6736(21)00364-0</Citation></Reference><Reference><Citation>BOLD Public Health Centers of Excellence Recipients. Centers for Disease Control and Prevention. Updated 07-16-2021. Accessed 10-05-2022, https://www.cdc.gov/aging/funding/phc/index.html</Citation></Reference><Reference><Citation>Zimmerman S, Fazio S. Measurement to improve care and outcomes for persons with Alzheimer's disease and dementia. Alzheimer's &amp; Dementia: Translational Research &amp; Clinical Interventions. 2022;8(1):e12359. doi:10.1002/trc2.12359</Citation></Reference><Reference><Citation>Salzman T, Sarquis-Adamson Y, Son S, Montero-Odasso M, Fraser S. Associations of multidomain interventions with improvements in cognition in mild cognitive impairment: a Systematic Review and Meta-analysis. JAMA Network Open. 2022;5(5):e226744-e226744. doi:10.1001/jamanetworkopen.2022.6744</Citation></Reference><Reference><Citation>Kivipelto M, Mangialasche F, Snyder HM, et&#xa0;al. World-Wide FINGERS Network: a global approach to risk reduction and prevention of dementia. Alzheimer's &amp; Dementia. 2020;16(7):1078-1094. doi:10.1002/alz.12123</Citation></Reference><Reference><Citation>Nianogo RA, Rosenwohl-Mack A, Yaffe K, Carrasco A, Hoffmann CM, Barnes DE. Risk factors associated with Alzheimer disease and related dementias by sex and race and ethnicity in the US. JAMA Neurology. 2022. doi:10.1001/jamaneurol.2022.0976</Citation></Reference><Reference><Citation>World Health Organization. Global status report on the public health response to dementia. 2021:137. September 1, 2021.</Citation></Reference><Reference><Citation>Van Asbroeck S, van Boxtel MPJ, Steyaert J, et&#xa0;al. Increasing knowledge on dementia risk reduction in the general population: results of a public awareness campaign. Preventive Medicine. 2021;147:106522. doi:10.1016/j.ypmed.2021.106522</Citation></Reference><Reference><Citation>Dubois B, Padovani A, Scheltens P, Rossi A, Dell'Agnello G. Timely diagnosis for Alzheimer's disease: a literature review on benefits and challenges. Journal of Alzheimer's Disease. 2016;49:617-631. doi:10.3233/JAD-150692</Citation></Reference><Reference><Citation>Parker M, Barlow S, Hoe J, Aitken L. Persistent barriers and facilitators to seeking help for a dementia diagnosis: a systematic review of 30 years of the perspectives of carers and people with dementia. International Psychogeriatrics. 2020;32(5):611-634. doi:10.1017/S1041610219002229</Citation></Reference><Reference><Citation>Ritchie CW, Waymont JMJ, Pennington C, et&#xa0;al. The Scottish Brain Health Service Model: rationale and scientific basis for a National Care Pathway of Brain Health Services in Scotland. The Journal of Prevention of Alzheimer's Disease. 2022;9(2):348-358. 10.14283/jpad.2021.63</Citation></Reference><Reference><Citation>The value of knowing. 2011:12. Accessed 05-05-2022. https://www.alzheimer-europe.org/sites/default/files/alzheimer_europe_survey_2011_the_value_of_knowing.pdf</Citation></Reference><Reference><Citation>Garrison L Jr, Baumgart M, El-Hayek Y, Holzapfel D, Leibman C. Defining elements of value in Alzheimer's disease. Value &amp; Outcomes Spotlight. 2021;7(1S):S7-S11.</Citation></Reference><Reference><Citation>Prados MJ, Liu Y, Jun H, Lam J, Mattke S. Projecting the long-term societal value of a disease-modifying treatment for Alzheimer's disease in the United States. Alzheimer's &amp; Dementia. 2022;18(1):142-151. doi:10.1002/alz.12578</Citation></Reference><Reference><Citation>Wang L, Laurentiev J, Yang J, et&#xa0;al. Development and validation of a deep learning model for earlier detection of cognitive decline from clinical notes in electronic health records. JAMA Network Open. 2021;4(11):e2135174-e2135174. doi:10.1001/jamanetworkopen.2021.35174</Citation></Reference><Reference><Citation>Palazzo L, Hsu C, Barnes DE, et&#xa0;al. Patient and caregiver perspectives on a tool to increase recognition of undiagnosed dementia: a qualitative study. BMC Geriatrics. 2021;21(1):604. doi:10.1186/s12877-021-02523-0</Citation></Reference><Reference><Citation>Dubois B, Villain N, Frisoni GB, et&#xa0;al. Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. Lancet Neurol. 2021;20(6):484-496. doi:10.1016/S1474-4422(21)00066-1</Citation></Reference><Reference><Citation>Galasko DR, Grill JD, Lingler JH. Heidebrink JL, and for the Symptomatic Subcommittee of the Advisory Group on Risk Evidence Education for D. A Blood Test for Alzheimer's Disease: it's about Time or Not Ready for Prime Time. J Alzheimers Dis. 2022. doi:10.3233/JAD-215490</Citation></Reference><Reference><Citation>Hansson O, Edelmayer RM, Boxer AL, et&#xa0;al. The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease. Alzheimer's &amp; Dementia. 2022;18(12):2669-2686. doi:10.1002/alz.12756</Citation></Reference><Reference><Citation>Teunissen CE, Verberk IMW, Thijssen EH, et&#xa0;al. Blood-based biomarkers for Alzheimer's disease: towards clinical implementation. Lancet Neurol. 2022;21(1):66-77. doi:10.1016/S1474-4422(21)00361-6</Citation></Reference><Reference><Citation>Seeher K, Cataldi R, Dua T, Kestel D. Inequitable access to dementia diagnosis and care in low-resource settings - A Global Perspective. Clinical Gerontologist. 2022:1-5. doi:10.1080/07317115.2022.2054391</Citation></Reference><Reference><Citation>Mattke S, Cho SK, Bittner T, Hlavka J, Hanson M. Blood-based biomarkers for Alzheimer's pathology and the diagnostic process for a disease-modifying treatment: projecting the impact on the cost and wait times. Alzheimers Dement (Amst). 2020;12(1). doi:10.1002/dad2.12081</Citation></Reference><Reference><Citation>McLaughlin CG, Wyszewianski L. Access to care: remembering old lessons. Health Serv Res. 2002;37(6):1441-1443. doi:10.1111/1475-6773.12171</Citation></Reference><Reference><Citation>Molony SL, Kolanowski A, Van Haitsma K, Rooney KE. Person-centered assessment and care planning. The Gerontologist. 2018;58(1):S32-S47. doi:10.1093/geront/gnx173</Citation></Reference><Reference><Citation>Weiss J, Tumosa N, Perweiler E, et&#xa0;al. Workforce gaps in dementia education and training: stakeholder Group Paper. Research Summit on Dementia Care. 2017.</Citation></Reference><Reference><Citation>Weiss J, Tumosa N, Perweiler E, et&#xa0;al. Critical workforce gaps in dementia education and training. Journal of the American Geriatrics Society. 2020;68(3):625-629. doi:10.1111/jgs.16341</Citation></Reference><Reference><Citation>National Academies of Sciences, Engineering, and, Medicine. Meeting the Challenge of Caring for Persons Living with Dementia and Their Care Partners and Caregivers: A Way Forward. The National Academies Press. 2021.</Citation></Reference><Reference><Citation>Lees Haggerty K, Epstein-Lubow G, Spragens LH, et&#xa0;al. Recommendations to improve payment policies for comprehensive dementia care. Journal of the American Geriatrics Society. 2020;68(11):2478-2485. doi:10.1111/jgs.16807</Citation></Reference><Reference><Citation>Comprehensive Care for Alzheimer's Act, S. 1125, U.S. Senate, 117th Congress sess (Stabenow SD 2021). 04-14-2021. Accessed 08-10-2022.</Citation></Reference><Reference><Citation>Foster NL, Bondi MW, Das R, et&#xa0;al. Quality improvement in neurology: mild cognitive impairment quality measurement set. Neurology. 2019;93(16):705-713. doi:10.1212/WNL.0000000000008259</Citation></Reference><Reference><Citation>Aragon&#xe8;s E, L&#xf3;pez-Cortacans G, Cardoner N, et&#xa0;al. Barriers, facilitators, and proposals for improvement in the implementation of a collaborative care program for depression: a qualitative study of primary care physicians and nurses. BMC Health Services Research. 2022;22(1):446. doi:10.1186/s12913-022-07872-z</Citation></Reference><Reference><Citation>Davos Alzheimer's Collaborative Announces Early Detection Grants. 2022. Accessed 7-29-2022. https://www.davosalzheimerscollaborative.org/news-and-press/, https://www.davosalzheimerscollaborative.org/news-and-press/davos-alzheimers-collaborative-announces-health-system-grant-recipients</Citation></Reference><Reference><Citation>Li LC, Grimshaw JM, Nielsen C, Judd M, Coyte PC, Graham ID. Evolution of Wenger's concept of community of practice. Implementation Science. 2009;4(1):11. doi:10.1186/1748-5908-4-11</Citation></Reference><Reference><Citation>National Academies of Sciences Engineering, and Medicine. Reducing the Impact of Dementia in America: A Decadal Survey of the Behavioral and Social Sciences. The National Academies Press. 2021:360.</Citation></Reference><Reference><Citation>Khachaturian ZS. Emerging trends in biomedicine and health technology innovation: addressing the Global Challenge of Alzheimer's. OECD Science, Technology and Industry Policy Papers. 2013.</Citation></Reference><Reference><Citation>Healthy Brain Initiative, State and Local Public Health Partnerships to Address Dementia: The 2018-2023 Road Map. 2018. Accessed 05-09-2022. https://www.cdc.gov/aging/pdf/2018-2023-Road-Map-508.pdf</Citation></Reference><Reference><Citation>Defining dementia friendly initiatives. 2020. Accessed 05-09-2022. https://worlddementiacouncil.org/sites/default/files/2020-12/DFIs%20-%20Paper%201_V18.pdf</Citation></Reference><Reference><Citation>Institute of Medicine. Cognitive Aging: Progress in Understanding and Opportunities for Action. The National Academies Press. 2015.</Citation></Reference><Reference><Citation>Brain health: A new way to think about dementia risk reduction. 2021. Accessed 05-03-2022. https://www.alzheimersresearchuk.org/wp-content/uploads/2021/01/ARUK_TBH_PolicyReport_05May21.pdf</Citation></Reference><Reference><Citation>National Academies of Sciences, Engineering, and Medicine. Preventing cognitive decline and dementia: A way forward. The National Academies Press. 2017.</Citation></Reference><Reference><Citation>Chowdhary N, Barbui C, Anstey KJ, et&#xa0;al. Reducing the risk of cognitive decline and dementia: wHO recommendations. Frontiers in Neurology. 2021;12.</Citation></Reference><Reference><Citation>Livingston G, Huntley J, Sommerlad A, et&#xa0;al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020;396(10248):413-446.</Citation></Reference><Reference><Citation>Boustani M, Alder CA, Solid CA, Reuben D. An alternative payment model to support widespread use of collaborative dementia care models. Health Aff (Millwood). 2019;38(1):54-59. doi:10.1377/hlthaff.2018.05154</Citation></Reference><Reference><Citation>Baumgart M. An alternative payment model could deliver better care to people with dementia - and save Medicare money. Alzheimer's Impact Movement blog. 2020. Accessed 4-21-2022. https://alzimpact.org/blog/post/id/182</Citation></Reference><Reference><Citation>Bernstein Sideman A, Chalmer R, Ayers E, et&#xa0;al. Lessons from detecting cognitive impairment including dementia (DetectCID) in primary care. J Alzheimers Dis. 2022;86(2):655-665. doi:10.3233/JAD-215106</Citation></Reference><Reference><Citation>Nagai Y, Kojima S, Kowa H, et&#xa0;al. Kobe project for the exploration of newer strategies to reduce the social burden of dementia: a study protocol of cohort and intervention studies. BMJ Open. 2021;11(6):e050948. doi:10.1136/bmjopen-2021-050948</Citation></Reference><Reference><Citation>World Health Organization. Integrated care for older people (ICOPE): guidance for person-centred assessment and pathways in primary care. Accessed 05-10-2022, https://www.who.int/publications/i/item/WHO-FWC-ALC-19.1</Citation></Reference><Reference><Citation>Gonz&#xe1;lez-Bautista E, de Souto, Barreto P, Andrieu S, Rolland Y, Vellas B. What day is today? Cognitive capacity and the risk of incident dementia in the context of integrated care for older people (ICOPE Step 1). Aging Clin Exp Res. 2021;33(11):3135-3139. doi:10.1007/s40520-021-01803-4</Citation></Reference><Reference><Citation>Jack CR, Bennett DA, Blennow K, et&#xa0;al. NIA-AA Research Framework: toward a biological definition of Alzheimer's disease. Alzheimer's &amp; Dementia. 2018;14(4):535-562. doi:10.1016/j.jalz.2018.02.018</Citation></Reference><Reference><Citation>Marulappa N, Anderson NN, Bethell J, et&#xa0;al. How to implement person-centred care and support for dementia in outpatient and home/community settings: scoping review. BMC Health Services Research. 2022;22(1):541. doi:10.1186/s12913-022-07875-w</Citation></Reference><Reference><Citation>Borson S, Boustani MA, Buckwalter KC, et&#xa0;al. Report on milestones for care and support under the U.S. National Plan to Address Alzheimer's Disease. Alzheimer's &amp; Dementia. 2016;12(3):334-369. doi:10.1016/j.jalz.2016.01.005</Citation></Reference><Reference><Citation>Olivari BS, French ME, McGuire LC. The public health road map to respond to the growing dementia crisis. Innovation in Aging. 2020;4(1):1-11. doi:10.1093/geroni/igz043</Citation></Reference><Reference><Citation>Fazio S, Pace D, Maslow K, Zimmerman S, Kallmyer B. Alzheimer's association dementia care practice recommendations. The Gerontologist. 2018;58(1):S1-S9. doi:10.1093/geront/gnx182</Citation></Reference><Reference><Citation>Schultz SK, Llorente MD, Sanders AE, et&#xa0;al. Quality improvement in dementia care: dementia management quality measurement set 2018 implementation update. American Journal of Psychiatry. 2020;177(2):175-181. doi:10.1176/appi.ajp.2019.19121290</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36476106</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2150-7759</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Season>Apr-Jun</Season></PubDate></JournalIssue><Title>AJOB neuroscience</Title><ISOAbbreviation>AJOB Neurosci</ISOAbbreviation></Journal><ArticleTitle>Journeying to Ixtlan: Ethics of Psychedelic Medicine and Research for Alzheimer's Disease and Related Dementias.</ArticleTitle><Pagination><StartPage>107</StartPage><EndPage>123</EndPage><MedlinePgn>107-123</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21507740.2022.2148771</ELocationID><Abstract><AbstractText>In this paper, we examine the case of psychedelic medicine for Alzheimer's disease and related dementias (AD/ADRD). These "mind-altering" drugs are not currently offered as treatments to persons with AD/ADRD, though there is growing interest in their use to treat underlying causes and associated psychiatric symptoms. We present a research agenda for examining the ethics of psychedelic medicine and research involving persons living with AD/ADRD, and offer preliminary analyses of six ethical issues: the impact of psychedelics on autonomy and consent; the impact of "ego dissolution" on persons experiencing a pathology of self; how psychedelics might impact caregiving; the potential exploitation of patient desperation; institutional review boards' orientation to psychedelic research; and methods to mitigate inequity. These ethical issues are magnified for AD/ADRD but bear broader relevance to psychedelic medicine and research in other clinical populations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peterson</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5192-3348</Identifier><AffiliationInfo><Affiliation>George Mason University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Largent</LastName><ForeName>Emily A</ForeName><Initials>EA</Initials><Identifier Source="ORCID">0000-0002-7536-5077</Identifier><AffiliationInfo><Affiliation>University of Pennsylvania Perelman School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Holly Fernandez</ForeName><Initials>HF</Initials><Identifier Source="ORCID">0000-0001-7813-9879</Identifier><AffiliationInfo><Affiliation>University of Pennsylvania Perelman School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlawish</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Pennsylvania Perelman School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sisti</LastName><ForeName>Dominic</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2282-9253</Identifier><AffiliationInfo><Affiliation>University of Pennsylvania Perelman School of Medicine.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 AG069805</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG010124</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 AG064123</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AJOB Neurosci</MedlineTA><NlmUniqueID>101518076</NlmUniqueID><ISSNLinking>2150-7759</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006213">Hallucinogens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>AJOB Neurosci. 2023 Apr-Jun;14(2):136-138. doi: 10.1080/21507740.2023.2188296</RefSource><PMID Version="1">37097843</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>AJOB Neurosci. 2023 Apr-Jun;14(2):139-141. doi: 10.1080/21507740.2023.2188297</RefSource><PMID Version="1">37097844</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>AJOB Neurosci. 2023 Apr-Jun;14(2):124-126. doi: 10.1080/21507740.2023.2188278</RefSource><PMID Version="1">37097850</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>AJOB Neurosci. 2023 Apr-Jun;14(2):104-106. doi: 10.1080/21507740.2023.2188311</RefSource><PMID Version="1">37097851</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>AJOB Neurosci. 2023 Apr-Jun;14(2):55-57. doi: 10.1080/21507740.2023.2188312</RefSource><PMID Version="1">37097853</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>AJOB Neurosci. 2023 Apr-Jun;14(2):131-134. doi: 10.1080/21507740.2023.2188291</RefSource><PMID Version="1">37097855</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>AJOB Neurosci. 2023 Apr-Jun;14(2):134-136. doi: 10.1080/21507740.2023.2188295</RefSource><PMID Version="1">37097859</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>AJOB Neurosci. 2023 Apr-Jun;14(2):129-131. doi: 10.1080/21507740.2023.2188287</RefSource><PMID Version="1">37097862</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>AJOB Neurosci. 2023 Apr-Jun;14(2):101-103. doi: 10.1080/21507740.2023.2188302</RefSource><PMID Version="1">37097867</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>AJOB Neurosci. 2023 Apr-Jun;14(2):142-144. doi: 10.1080/21507740.2023.2188308</RefSource><PMID Version="1">37097873</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>AJOB Neurosci. 2023 Apr-Jun;14(2):145-147. doi: 10.1080/21507740.2023.2188309</RefSource><PMID Version="1">37097874</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>AJOB Neurosci. 2023 Apr-Jun;14(2):126-129. doi: 10.1080/21507740.2023.2188281</RefSource><PMID Version="1">37097876</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006213" MajorTopicYN="Y">Hallucinogens</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Psychiatry</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">drug use</Keyword><Keyword MajorTopicYN="N">drugs</Keyword><Keyword MajorTopicYN="N">psychoactive drugs</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>8</Day><Hour>10</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36476106</ArticleId><ArticleId IdType="doi">10.1080/21507740.2022.2148771</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38550934</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2752-6143</ISSN><JournalIssue CitedMedium="Internet"><Volume>1</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Cambridge prisms. Precision medicine</Title><ISOAbbreviation>Camb Prism Precis Med</ISOAbbreviation></Journal><ArticleTitle>Applications of artificial intelligence in dementia research.</ArticleTitle><Pagination><StartPage>e9</StartPage><MedlinePgn>e9</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/pcm.2022.10</ELocationID><Abstract><AbstractText>More than 50 million older people worldwide are suffering from dementia, and this number is estimated to increase to 150 million by 2050. Greater caregiver burdens and financial impacts on the healthcare system are expected as we wait for an effective treatment for dementia. Researchers are constantly exploring new therapies and screening approaches for the early detection of dementia. Artificial intelligence (AI) is widely applied in dementia research, including machine learning and deep learning methods for dementia diagnosis and progression detection. Computerized apps are also convenient tools for patients and caregivers to monitor cognitive function changes. Furthermore, social robots can potentially provide daily life support or guidance for the elderly who live alone. This review aims to provide an overview of AI applications in dementia research. We divided the applications into three categories according to different stages of cognitive impairment: (1) cognitive screening and training, (2) diagnosis and prognosis for dementia, and (3) dementia care and interventions. There are numerous studies on AI applications for dementia research. However, one challenge that remains is comparing the effectiveness of different AI methods in real clinical settings.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsoi</LastName><ForeName>Kelvin K F</ForeName><Initials>KKF</Initials><AffiliationInfo><Affiliation>JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Sha Tin, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanley Ho Big Data Decision Analytics Research Centre, The Chinese University of Hong Kong, Sha Tin, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Pingping</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-1107-5246</Identifier><AffiliationInfo><Affiliation>JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Sha Tin, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dowling</LastName><ForeName>N Maritza</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Acute and Chronic tableCare, School of Nursing, The George Washington University, Washington, DC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Titiner</LastName><ForeName>Jodi R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Alzheimer's Association, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagner</LastName><ForeName>Maude</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurological Sciences, Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capuano</LastName><ForeName>Ana W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Department of Neurological Sciences, Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donohue</LastName><ForeName>Michael C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Alzheimer's Therapeutic Research Institute (ATRI), University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Camb Prism Precis Med</MedlineTA><NlmUniqueID>9918609886206676</NlmUniqueID><ISSNLinking>2752-6143</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AI</Keyword><Keyword MajorTopicYN="N">cognition</Keyword><Keyword MajorTopicYN="N">deep learning</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword></KeywordList><CoiStatement>The authors declare none.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>6</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>6</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>29</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38550934</ArticleId><ArticleId IdType="pmc">PMC10953738</ArticleId><ArticleId IdType="doi">10.1017/pcm.2022.10</ArticleId><ArticleId IdType="pii">S2752614322000102</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmed S, Haigh AM, de Jager CA and Garrard P (2013) Connected speech as a marker of disease progression in autopsy-proven Alzheimer&#x2019;s disease. Brain 136(Pt 12), 3727&#x2013;3737. 10.1093/brain/awt269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt269</ArticleId><ArticleId IdType="pmc">PMC3859216</ArticleId><ArticleId IdType="pubmed">24142144</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.</Citation></Reference><Reference><Citation>Anastasio TJ (2021) Predicting the potency of anti-Alzheimer&#x2019;s drug combinations using machine learning. Processes 9(2), 264. 10.3390/pr9020264.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pr9020264</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker JT, Boller F, Lopez OL, Saxton J and McGonigle KL (1994) The natural history of Alzheimer&#x2019;s disease. Archives of Neurology 51(6), 585&#x2013;594.</Citation><ArticleIdList><ArticleId IdType="pubmed">8198470</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltrami D, Gagliardi G, Rossini Favretti R, Ghidoni E, Tamburini F and Calza L (2018. ) Speech analysis by natural language processing techniques: a possible tool for very early detection of cognitive decline? Frontiers in Aging Neuroscience 10, 369. 10.3389/fnagi.2018.00369.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00369</ArticleId><ArticleId IdType="pmc">PMC6243042</ArticleId><ArticleId IdType="pubmed">30483116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchard RW (2007) Diagnostic criteria of dementia. The Canadian Journal of Neurological Sciences 34(Suppl 1), S11&#x2013;S18. 10.1017/s0317167100005497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0317167100005497</ArticleId><ArticleId IdType="pubmed">17469675</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter KA and Huang XD (2018) Machine learning-based virtual screening and its applications to Alzheimer&#x2019;s drug discovery: a review. Current Pharmaceutical Design 24(28), 3347&#x2013;3358. 10.2174/1381612824666180607124038.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612824666180607124038</ArticleId><ArticleId IdType="pmc">PMC6327115</ArticleId><ArticleId IdType="pubmed">29879881</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha J, Voigt-Antons J-N, Trahms C, O&#x2019;Sullivan JL, Gellert P, Kuhlmey A and Nordheim J (2019) Finding critical features for predicting quality of life in tablet-based serious games for dementia. Quality and User Experience 4(1), 1&#x2013;20. 10.1007/s41233-019-0028-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41233-019-0028-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan JYC, Yau STY, Kwok TCY, and Tsoi KKF (2021. ) Diagnostic performance of digital cognitive tests for the identification of MCI and dementia: a systematic review. Ageing Research Reviews 72, 101506. 10.1016/j.arr.2021.101506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2021.101506</ArticleId><ArticleId IdType="pubmed">34744026</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CH, Lin CH, Liu CY, Huang CS, Chen SJ, Lin WC and Lane HY (2021) Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer&#x2019;s disease: machine learning approaches. Journal of Psychopharmacology 35(3), 265&#x2013;272. 10.1177/0269881120972331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269881120972331</ArticleId><ArticleId IdType="pubmed">33586518</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelberg GR, Neuhaus M, Mothershaw A, Mahoney R and Caffery LJ (2022) Mobile apps for dementia awareness, support, and prevention &#x2013; review and evaluation. Disability and Rehabilitation 44, 4909&#x2013;4920. 10.1080/09638288.2021.1914755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638288.2021.1914755</ArticleId><ArticleId IdType="pubmed">34034601</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, Jankovic F, Marinsek N, Foschini L, Kourtis L, Signorini A and Trister A (2019) Developing measures of cognitive impairment in the real world from consumer-grade multimodal sensor streams. In Proceedings of the 25th ACM SIGKDD International Conference on Knowledge Discovery &amp; Data Mining. New York: Association for Computing Machinery, pp. 2145&#x2013;2155.</Citation></Reference><Reference><Citation>Chen Y and Pham TD (2013) Development of a brain MRI-based hidden Markov model for dementia recognition. Biomedical Engineering Online 12(1), 1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4028867</ArticleId><ArticleId IdType="pubmed">24564961</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu PY, Tang HP, Wei CY, Zhang CY, Hung GU and Zhou WH (2019) NMD-12: a new machine-learning derived screening instrument to detect mild cognitive impairment and dementia. PLoS One 14(3), e0213430. 10.1371/journal.pone.0213430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0213430</ArticleId><ArticleId IdType="pmc">PMC6407752</ArticleId><ArticleId IdType="pubmed">30849106</ArticleId></ArticleIdList></Reference><Reference><Citation>Chodosh J, Petitti DB, Elliott M, Hays RD, Crooks VC, Reuben DB and Wenger N (2004) Physician recognition of cognitive impairment: evaluating the need for improvement. Journal of the American Geriatrics Society 52(7), 1051&#x2013;1059.</Citation><ArticleIdList><ArticleId IdType="pubmed">15209641</ArticleId></ArticleIdList></Reference><Reference><Citation>Deepa R, Shanmugam A and Tamilselvan E (2017) EEG feature extraction and classification of Alzheimer&#x2019;s disease using support vector machine classifier. International Journal of Electronics, Electrical and Computational System 6(8), 165&#x2013;169.</Citation></Reference><Reference><Citation>Ding S, Zhu Z and Zhang X (2017) An overview on semi-supervised support vector machine. Neural Computing and Applications 28(5), 969&#x2013;978. 10.1007/s00521-015-2113-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00521-015-2113-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimighahnavieh MA, Luo SH and Chiong R (2020) Deep learning to detect Alzheimer&#x2019;s disease from neuroimaging: a systematic literature review. Computer Methods and Programs in Biomedicine 187, 105242. 10.1016/j.cmpb.2019.105242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2019.105242</ArticleId><ArticleId IdType="pubmed">31837630</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst RL and Hay JW (1994) The US economic and social costs of Alzheimer&#x2019;s disease revisited. American Journal of Public Health 84, 1261&#x2013;1264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1615456</ArticleId><ArticleId IdType="pubmed">8059882</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang J, Li Y, Liu R, Pang X, Li C, Yang R and Du GH (2015) Discovery of multitarget-directed ligands against Alzheimer&#x2019;s disease through systematic prediction of chemical-protein interactions. Journal of Chemical Information and Modeling 55(1), 149&#x2013;164. 10.1021/ci500574n.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci500574n</ArticleId><ArticleId IdType="pubmed">25531792</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang J, Pieper AA, Nussinov R, Lee G, Bekris L, Leverenz JB and Cheng F (2020) Harnessing endophenotypes and network medicine for Alzheimer&#x2019;s drug repurposing. Medicinal Research Reviews 40(6), 2386&#x2013;2426. 10.1002/med.21709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21709</ArticleId><ArticleId IdType="pmc">PMC7561446</ArticleId><ArticleId IdType="pubmed">32656864</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang JS, Zhang PY, Wang Q, Chiang CW, Zhou YD, Hou Y and Cheng FX (2022) Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer&#x2019;s disease. Alzheimers Research &amp; Therapy 14(1), 7. 10.1186/s13195-021-00951-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00951-z</ArticleId><ArticleId IdType="pmc">PMC8751379</ArticleId><ArticleId IdType="pubmed">35012639</ArticleId></ArticleIdList></Reference><Reference><Citation>Forbes KE, Venneri A and Shanks MF (2002) Distinct patterns of spontaneous speech deterioration: an early predictor of Alzheimer&#x2019;s disease. Brain and Cognition 48(2&#x2013;3), 356&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">12030467</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia SD, Ritchie CW and Luz S (2020) Artificial intelligence, speech, and language processing approaches to monitoring Alzheimer&#x2019;s disease: a systematic review. Journal of Alzheimer&#x2019;s Disease 78(4), 1547&#x2013;1574. 10.3233/jad-200888.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-200888</ArticleId><ArticleId IdType="pmc">PMC7836050</ArticleId><ArticleId IdType="pubmed">33185605</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S and Pedersen NL (2006) Role of genes and environments for explaining Alzheimer disease. Archives of General Psychiatry 63(2), 168&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">16461860</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghafurian M, Hoey J and Dautenhahn K (2021) Social robots for the care of persons with dementia. ACM Transactions on Human-Robot Interaction 10(4), 1&#x2013;31. 10.1145/3469653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/3469653</ArticleId></ArticleIdList></Reference><Reference><Citation>Greaves CV and Rohrer JD (2019) An update on genetic frontotemporal dementia. Journal of Neurology 266(8), 2075&#x2013;2086. 10.1007/s00415-019-09363-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09363-4</ArticleId><ArticleId IdType="pmc">PMC6647117</ArticleId><ArticleId IdType="pubmed">31119452</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerreiro R, Escott-Price V, Hernandez DG, Kun-Rodrigues C, Ross OA, Orme T and Bras J (2019) Heritability and genetic variance of dementia with Lewy bodies. Neurobiology of Disease 127, 492&#x2013;501. 10.1016/j.nbd.2019.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.04.004</ArticleId><ArticleId IdType="pmc">PMC6588425</ArticleId><ArticleId IdType="pubmed">30953760</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschberg J and Manning CD (2006) Advances in natural language processing. Science 349, 6245.</Citation><ArticleIdList><ArticleId IdType="pubmed">26185244</ArticleId></ArticleIdList></Reference><Reference><Citation>Huff FJ (1986) Equivalent forms of the Boston naming test. Journal of Clinical and Experimental Neuropsychology 8(5), 556&#x2013;562.</Citation><ArticleIdList><ArticleId IdType="pubmed">3805252</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung L, Liu C, Woldum E, Au-Yeung A, Berndt A, Wallsworth C and Chaudhury H (2019) The benefits of and barriers to using a social robot PARO in care settings: a scoping review. BMC Geriatrics 19(1), 232. 10.1186/s12877-019-1244-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-019-1244-6</ArticleId><ArticleId IdType="pmc">PMC6708202</ArticleId><ArticleId IdType="pubmed">31443636</ArticleId></ArticleIdList></Reference><Reference><Citation>Iaboni A, Spasojevic S, Newman K, Schindel Martin L, Wang A, Ye B and Khan SS (2022) Wearable multimodal sensors for the detection of behavioral and psychological symptoms of dementia using personalized machine learning models. Alzheimer&#x2019;s &amp; Dementia: Diagnosis, Assessment &amp; Disease Monitoring 14(1), e12305. 10.1002/dad2.12305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dad2.12305</ArticleId><ArticleId IdType="pmc">PMC9043905</ArticleId><ArticleId IdType="pubmed">35496371</ArticleId></ArticleIdList></Reference><Reference><Citation>Ieracitano C, Mammone N, Hussain A, and Morabito FC (2020) A novel multi-modal machine learning based approach for automatic classification of EEG recordings in dementia. Neural Networks 123, 176&#x2013;190. 10.1016/j.neunet.2019.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neunet.2019.12.006</ArticleId><ArticleId IdType="pubmed">31884180</ArticleId></ArticleIdList></Reference><Reference><Citation>Irazoki E, Contreras-Somoza LM, Toribio-Guzman JM, Jenaro-Rio C, van der Roest H and Franco-Martin MA (2020) Technologies for cognitive training and cognitive rehabilitation for people with mild cognitive impairment and dementia. A systematic review. Frontiers in Psychology 11, 648. 10.3389/fpsyg.2020.00648.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2020.00648</ArticleId><ArticleId IdType="pmc">PMC7179695</ArticleId><ArticleId IdType="pubmed">32373018</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaffe J and Feldstein S (1970) Rhythms of Dialogue, Vol. 8. New York: Academic Press.</Citation></Reference><Reference><Citation>Jaya Shree LK and Venkateshwarlu B (2021) Automatic detection of EEG as biomarker using deep learning: a review. Annals of the Romanian Society for Cell Biology 25, 6502&#x2013;6511.</Citation></Reference><Reference><Citation>Karapapas C and Goumopoulos C (2021) Mild cognitive impairment detection using machine learning models trained on data collected from serious games. Applied Sciences-Basel 11(17), 8184. 10.3390/app11178184.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app11178184</ArticleId></ArticleIdList></Reference><Reference><Citation>Knesevich JW, LaBarge E and Edwards D (1986) Predictive value of the Boston naming test in mild senile dementia of the Alzheimer type. Psychiatry Research 19(2), 155&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">3786607</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS, Boeve BF and Petersen RC (2003) Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clinic Proceedings 78(10), 1290&#x2013;1308. 10.4065/78.10.1290.</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/78.10.1290</ArticleId><ArticleId IdType="pubmed">14531488</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutentakis D, Pilozzi A and Huang X (2020) Designing socially assistive robots for Alzheimer&#x2019;s disease and related dementia patients and their caregivers: where we are and where we are headed. Healthcare (Basel) 8(2), 73. 10.3390/healthcare8020073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8020073</ArticleId><ArticleId IdType="pmc">PMC7349047</ArticleId><ArticleId IdType="pubmed">32225117</ArticleId></ArticleIdList></Reference><Reference><Citation>Krizhevsky A, Sutskever I and Hinton GE (2012) ImageNet Classification with Deep Convolutional Neural Networks, Advances in Neural Information Processing Systems, Vol. 25. Curran Associates.</Citation></Reference><Reference><Citation>Kumar S, Oh I, Schindler S, Lai AM, Payne PRO and Gupta A (2021) Machine learning for modeling the progression of Alzheimer disease dementia using clinical data: a systematic literature review. Jamia Open 4(3), 00ab052. 10.1093/jamiaopen/ooab052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamiaopen/ooab052</ArticleId><ArticleId IdType="pmc">PMC8327375</ArticleId><ArticleId IdType="pubmed">34350389</ArticleId></ArticleIdList></Reference><Reference><Citation>Law M, Sutherland C, Ahn HS, MacDonald BA, Peri K, Johanson DL and Broadbent E (2019) Developing assistive robots for people with mild cognitive impairment and mild dementia: a qualitative study with older adults and experts in aged care. BMJ Open 9(9), e031937. 10.1136/bmjopen-2019-031937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2019-031937</ArticleId><ArticleId IdType="pmc">PMC6773341</ArticleId><ArticleId IdType="pubmed">31551392</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang H, Sun X, Sun Y, and Gao Y (2017) Text feature extraction based on deep learning: a review. EURASIP Journal on Wireless Communications and Networking 2017(1), 211. 10.1186/s13638-017-0993-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13638-017-0993-1</ArticleId><ArticleId IdType="pmc">PMC5732309</ArticleId><ArticleId IdType="pubmed">29263717</ArticleId></ArticleIdList></Reference><Reference><Citation>
Luz S, de la Fuente S and Albert P (2018) A method for analysis of patient speech in dialogue for dementia detection. Preprint, https://arxiv.org/abs/1811.09919.</Citation></Reference><Reference><Citation>
Luz S, 
Haider, F.
, de la Fuente S, Fromm D and MacWhinney B (2020) Alzheimer&#x2019;s Dementia Recognition through Spontaneous Speech: the address challenge. Preprint, arXiv:200406833.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Frick P and Neumann M (2014) The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathologica 127(3), 347&#x2013;357. 10.1007/s00401-013-1232-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1232-4</ArticleId><ArticleId IdType="pubmed">24356984</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek N, Baker MR, Mann C, and Greene J (2017) Electroencephalographic markers in dementia. Acta Neurologica Scandinavica 135(4), 388&#x2013;393. 10.1111/ane.12638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12638</ArticleId><ArticleId IdType="pubmed">27430350</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinescu RV, Oxtoby NP, Young AL, Bron EE, Toga AW, Weiner MW and Alexander DC (2021) The Alzheimer&#x2019;s disease prediction of longitudinal evolution (TADPOLE) challenge: results after 1 year follow-up. Journal of Machine Learning for Biomedical Imaging 1, 19.</Citation></Reference><Reference><Citation>McKhann GDD, Folstein M, Katzman R, Price D and Stadlan EM (1984) Clinical diagnosis of Alzheimer&#x2019;s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer&#x2019;s disease. Neurology 34, 939&#x2013;944.</Citation><ArticleIdList><ArticleId IdType="pubmed">6610841</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao Y, Jiang H, Liu H, and Yao YD (2017) An Alzheimer&#x2019;s disease related genes identification method based on multiple classifier integration. Computer Methods and Programs in Biomedicine 150, 107&#x2013;115. 10.1016/j.cmpb.2017.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2017.08.006</ArticleId><ArticleId IdType="pubmed">28859826</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra R and Li B (2020) The application of artificial intelligence in the genetic study of Alzheimer&#x2019;s disease. Aging and Disease 11(6), 1567&#x2013;1584. 10.14336/ad.2020.0312.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/ad.2020.0312</ArticleId><ArticleId IdType="pmc">PMC7673858</ArticleId><ArticleId IdType="pubmed">33269107</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC (2006) Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria. Archives of Neurology 63(1), 15&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">16401731</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller KD, Koscik RL, Hermann BP, Johnson SC and Turkstra LS (2017) Declines in connected language are associated with very early mild cognitive impairment: results from the Wisconsin registry for Alzheimer&#x2019;s prevention. Frontiers in Aging Neuroscience 9, 437. 10.3389/fnagi.2017.00437.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00437</ArticleId><ArticleId IdType="pmc">PMC5767238</ArticleId><ArticleId IdType="pubmed">29375365</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F and Vos T (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. The Lancet Public Health 7(2), e105&#x2013;e125. 10.1016/s2468-2667(21)00249-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2468-2667(21)00249-8</ArticleId><ArticleId IdType="pmc">PMC8810394</ArticleId><ArticleId IdType="pubmed">34998485</ArticleId></ArticleIdList></Reference><Reference><Citation>Panegyres PK, Berry R and Burchell J (2016) Early dementia screening. Diagnostics (Basel) 6(1), 6. 10.3390/diagnostics6010006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics6010006</ArticleId><ArticleId IdType="pmc">PMC4808821</ArticleId><ArticleId IdType="pubmed">26838803</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini E, Ballerini L, Hernandez MDCV, Chappell FM, Gonzalez-Castro V, Anblagan D and Wardlaw JM (2018) Machine learning of neuroimaging for assisted diagnosis of cognitive impairment and dementia: a systematic review. Alzheimer&#x2019;s and Dementia: Diagnosis, Assessment and Disease Monitoring 10, 519&#x2013;535. 10.1016/j.dadm.2018.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dadm.2018.07.004</ArticleId><ArticleId IdType="pmc">PMC6197752</ArticleId><ArticleId IdType="pubmed">30364671</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine 256(3), 183&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">15324362</ArticleId></ArticleIdList></Reference><Reference><Citation>Pino M, Boulay M, Jouen F, and Rigaud AS (2015) &#x201c;Are we ready for robots that care for us?&#x201d; Attitudes and opinions of older adults toward socially assistive robots. Frontiers in Aging Neuroscience 7, 141. 10.3389/fnagi.2015.00141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2015.00141</ArticleId><ArticleId IdType="pmc">PMC4512026</ArticleId><ArticleId IdType="pubmed">26257646</ArticleId></ArticleIdList></Reference><Reference><Citation>Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W and Ferri CP (2013) The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 9(1), 63&#x2013;75.e2. 10.1016/j.jalz.2012.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2012.11.007</ArticleId><ArticleId IdType="pubmed">23305823</ArticleId></ArticleIdList></Reference><Reference><Citation>
Prince M, Comas-Herrera A, Knapp M, Guerchet M and Karagiannidou M (2016) World Alzheimer Report 2016: Improving Healthcare for People Living with Dementia: Coverage, Quality and Costs Now and in the Future. Alzheimer&#x2019;s Disease International. Available at https://www.alz.co.uk/research/world-report-2016.</Citation></Reference><Reference><Citation>Ritchie C, Smailagic N, Noel-Storr AH, Ukoumunne O, Ladds EC and Martin S (2017) CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer&#x2019;s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database of Systematic Reviews 3, CD010803. 10.1002/14651858.CD010803.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010803.pub2</ArticleId><ArticleId IdType="pmc">PMC6464349</ArticleId><ArticleId IdType="pubmed">28328043</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez S, Hug C, Todorov P, Moret N, Boswell SA, Evans K and Sokolov A (2021) Machine learning identifies candidates for drug repurposing in Alzheimer&#x2019;s disease. Nature Communications 12(1), 1033. 10.1038/s41467-021-21330-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21330-0</ArticleId><ArticleId IdType="pmc">PMC7884393</ArticleId><ArticleId IdType="pubmed">33589615</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Aranda C, Waterloo K, Johnsen SH, Eldevik P, Sparr S, Wikran GC and Vangberg TR (2016) Neuroanatomical correlates of verbal fluency in early Alzheimer&#x2019;s disease and normal aging. Brain and Language 155&#x2013;156, 24&#x2013;35. 10.1016/j.bandl.2016.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bandl.2016.03.001</ArticleId><ArticleId IdType="pubmed">27062691</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeter C, Mueller S, Volkhardt M, Einhorn E, Huijnen C, van den Heuvel H and Gross HM (2013) Realization and user evaluation of a companion robot for people with mild cognitive impairments. In 2013 IEEE International Conference on Robotics and Automation IEEE.</Citation></Reference><Reference><Citation>Sharma N, Kolekar MH and Jha K (2021) EEG based dementia diagnosis using multi-class support vector machine with motor speed cognitive test. Biomedical Signal Processing and Control 63, 102102. 10.1016/j.bspc.2020.102102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bspc.2020.102102</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims R, Hill M, Williams J (2020) The multiplex model of the genetics of Alzheimer&#x2019;s disease. Nature Neuroscience 23(3), 311&#x2013;322. 10.1038/s41593-020-0599-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0599-5</ArticleId><ArticleId IdType="pubmed">32112059</ArticleId></ArticleIdList></Reference><Reference><Citation>Spooner A, Chen E, Sowmya A, Sachdev P, Kochan NA, Trollor J and Brodaty H (2020) A comparison of machine learning methods for survival analysis of high-dimensional clinical data for dementia prediction. Scientific Reports 10(1), 20410. 10.1038/s41598-020-77220-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-77220-w</ArticleId><ArticleId IdType="pmc">PMC7683682</ArticleId><ArticleId IdType="pubmed">33230128</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamate D, Kim M, Proitsi P, Westwood S, Baird A, Nevado-Holgado A and Legido-Quigley C (2019) A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: results from the European medical information framework for Alzheimer disease biomarker discovery cohort. Alzheimer&#x2019;s and Dementia: Translational Research and Clinical Interventions 5, 933&#x2013;938. 10.1016/j.trci.2019.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2019.11.001</ArticleId><ArticleId IdType="pmc">PMC6928349</ArticleId><ArticleId IdType="pubmed">31890857</ArticleId></ArticleIdList></Reference><Reference><Citation>Stancin I, Cifrek M and Jovic A (2021) A review of EEG signal features and their application in driver drowsiness detection systems. Sensors (Basel) 21(11), 3786. 10.3390/s21113786.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/s21113786</ArticleId><ArticleId IdType="pmc">PMC8198610</ArticleId><ArticleId IdType="pubmed">34070732</ArticleId></ArticleIdList></Reference><Reference><Citation>Staudinger T and Polikar R (2011) Analysis of complexity based EEG features for the diagnosis of Alzheimer&#x2019;s disease. In Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual International Conference, pp. 2033&#x2013;2036. 10.1109/IEMBS.2011.6090374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/IEMBS.2011.6090374</ArticleId><ArticleId IdType="pubmed">22254735</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk HI, Lee SW, Shen DG, and The Alzheimer&#x2019;s Disease Neuroimaging Initiative (2016) Deep sparse multi-task learning for feature selection in Alzheimer&#x2019;s disease diagnosis. Brain Structure &amp; Function 221(5), 2569&#x2013;2587. 10.1007/s00429-015-1059-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00429-015-1059-y</ArticleId><ArticleId IdType="pmc">PMC4714963</ArticleId><ArticleId IdType="pubmed">25993900</ArticleId></ArticleIdList></Reference><Reference><Citation>Thabtah F, Mampusti E, Peebles D, Herradura R and Varghese J (2019) A mobile-based screening system for data analyses of early dementia traits detection. Journal of Medical Systems 44(1), 24. 10.1007/s10916-019-1469-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10916-019-1469-0</ArticleId><ArticleId IdType="pubmed">31828523</ArticleId></ArticleIdList></Reference><Reference><Citation>Thabtah F, Peebles D, Retzler J, and Hathurusingha C (2020) A review of dementia screening tools based on mobile application. Health and Technology 10(5), 1011&#x2013;1022. 10.1007/s12553-020-00426-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12553-020-00426-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Thabtah F, Peebles D, Retzler J, and Hathurusingha C (2020) Dementia medical screening using mobile applications: a systematic review with a new mapping model. Journal of Biomedical Informatics 111, 103573. 10.1016/j.jbi.2020.103573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2020.103573</ArticleId><ArticleId IdType="pubmed">32961306</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian JQ, Smith G, Guo H, Liu BY, Pan ZH, Wang ZJ and Fang RG (2021) Modular machine learning for Alzheimer&#x2019;s disease classification from retinal vasculature. Scientific Reports 11(1), 238. 10.1038/s41598-020-80312-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80312-2</ArticleId><ArticleId IdType="pmc">PMC7794289</ArticleId><ArticleId IdType="pubmed">33420208</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzimourta KD, Christou V, Tzallas AT, Giannakeas N, Astrakas LG, Angelidis P and Tsipouras MG (2021) Machine learning algorithms and statistical approaches for Alzheimer&#x2019;s disease analysis based on resting-state EEG recordings: a systematic review. International Journal of Neural Systems 31(5), 2130002. 10.1142/S0129065721300023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0129065721300023</ArticleId><ArticleId IdType="pubmed">33588710</ArticleId></ArticleIdList></Reference><Reference><Citation>Valcour VG, Masaki KH, Curb JD and Blanchette PL (2000) The detection of dementia in the primary care setting. Archives of Internal Medicine 160(19), 2964&#x2013;2968.</Citation><ArticleIdList><ArticleId IdType="pubmed">11041904</ArticleId></ArticleIdList></Reference><Reference><Citation>Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G and Zhao S (2019) Applications of machine learning in drug discovery and development. Nature Reviews Drug Discovery 18(6), 463&#x2013;477. 10.1038/s41573-019-0024-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-019-0024-5</ArticleId><ArticleId IdType="pmc">PMC6552674</ArticleId><ArticleId IdType="pubmed">30976107</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharajah Y, Ramanan VK, Iyer R, and Vemuri P (2019) Predicting short-term MCI-to-AD progression using imaging, CSF, genetic factors, cognitive resilience, and demographics. Scientific Reports 9(1), 2235. 10.1038/s41598-019-38793-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-38793-3</ArticleId><ArticleId IdType="pmc">PMC6381141</ArticleId><ArticleId IdType="pubmed">30783207</ArticleId></ArticleIdList></Reference><Reference><Citation>Varma VR, Oommen AM, Varma S, Casanova R, An Y, and rews RM and Thambisetty M (2018) Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study. PLoS Medicine 15(1), e1002482. 10.1371/journal.pmed.1002482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002482</ArticleId><ArticleId IdType="pmc">PMC5784884</ArticleId><ArticleId IdType="pubmed">29370177</ArticleId></ArticleIdList></Reference><Reference><Citation>Venneri A, Jahn-Carta C, De Marco M, Quaranta D and Marra C (2018) Diagnostic and prognostic role of semantic processing in preclinical Alzheimer&#x2019;s disease. Biomarkers in Medicine 12(6), 637&#x2013;651.</Citation><ArticleIdList><ArticleId IdType="pubmed">29896968</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SD, Du ZZ, Ding M, Rodriguez-Paton A and Song T (2022) KG-DTI: a knowledge graph based deep learning method for drug-target interaction predictions and Alzheimer&#x2019;s disease drug repositions. Applied Intelligence 52(1), 846&#x2013;857. 10.1007/s10489-021-02454-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10489-021-02454-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner J, Engelbart M and Schultz T (2017) Manual and automatic transcriptions in dementia detection from speech. Interspeech 2017, 3117&#x2013;3121.</Citation></Reference><Reference><Citation>Williams JP, Storlie CB, Therneau TM, Clifford Jr. RJ and Hannig J (2019) A Bayesian approach to multistate hidden Markov models: application to dementia progression. Journal of the American Statistical Association 115(529), 16&#x2013;31. 10.1080/01621459.2019.1594831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.2019.1594831</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization.</Citation></Reference><Reference><Citation>Xu L, Liang G, Liao C, Chen GD and Chang CC (2018) An efficient classifier for Alzheimer&#x2019;s disease genes identification. Molecules 23(12), 3140. 10.3390/molecules23123140.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23123140</ArticleId><ArticleId IdType="pmc">PMC6321377</ArticleId><ArticleId IdType="pubmed">30501121</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang XG, Lv W, Chen YZ, and Xue Y (2010) In silico prediction and screening of gamma-secretase inhibitors by molecular descriptors and machine learning methods. Journal of Computational Chemistry 31(6), 1249&#x2013;1258. 10.1002/jcc.21411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.21411</ArticleId><ArticleId IdType="pubmed">19847781</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterberg H (2019) Blood-based biomarkers for Alzheimer&#x2019;s disease &#x2013; an update. Journal of Neuroscience Methods 319, 2&#x2013;6. 10.1016/j.jneumeth.2018.10.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneumeth.2018.10.025</ArticleId><ArticleId IdType="pubmed">30352211</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Huntley J, Bhome R, Holmes B, Cahill J, Gould RL and Howard R (2019) Effect of computerised cognitive training on cognitive outcomes in mild cognitive impairment: a systematic review and meta-analysis. BMJ Open 9(8), e027062. 10.1136/bmjopen-2018-027062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-027062</ArticleId><ArticleId IdType="pmc">PMC6701629</ArticleId><ArticleId IdType="pubmed">31427316</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu FB, Li XN, Tang HP, He Z, Zhang CY, Hung GU, Zhou WH (2020) Machine learning for the preliminary diagnosis of dementia. Scientific Programming 2020, 1&#x2013;10. 10.1155/2020/5629090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/5629090</ArticleId><ArticleId IdType="pmc">PMC10938949</ArticleId><ArticleId IdType="pubmed">38486686</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36445170</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-2865</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Physiotherapy research international : the journal for researchers and clinicians in physical therapy</Title><ISOAbbreviation>Physiother Res Int</ISOAbbreviation></Journal><ArticleTitle>Effects of telehealth on functional capacity, mental health and quality of life among older people with dementia: LAPESI telehealth protocol for a randomized controlled trial.</ArticleTitle><Pagination><StartPage>e1981</StartPage><MedlinePgn>e1981</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pri.1981</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Telehealth can be an alternative action at a distance that can help as a form of motor intervention, alleviating the deleterious effects arising from social distancing on functional capacity, mental health and quality of life among older people with dementia during the COVID-19 pandemic.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">We aim to analyze the effects of a telehealth program on functional capacity, mental health and quality of life among older people with dementia and their caregivers.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">seventy-eight individuals with mild and moderate dementia and their caregivers will answer an anamnesis and be evaluated through Clinical Dementia Assessment Score. They will also be evaluated by blinded examiners in terms of functional capacity (Activities of Daily Living Questionnaire and World Health Organization Disability Assessment Schedule 2.0), mental health (Mini-Mental State Examination, Clock Drawing Test, Verbal Fluency test and the Neuropsychiatric Inventor) and quality of life (Quality of Life in Alzheimer's Disease scale). Afterward, the volunteers will be randomized into the telehealth training group and the control group. The TR will perform systematic physical and cognitive exercises in 50-min sessions three times a week with professional monitoring, while the CG will receive non-systematized guidance, both for 12&#xa0;weeks. Participants will be evaluated at baseline, immediately after the three-month interventions and with a 12-week follow- up.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Technological approaches such as telehealth can be a viable alternative in home care service during times of pandemic. We expect that older people with dementia and their caregivers have high adherence to the telehealth program and improve their functional capacity, mental health and quality of life of older people with dementia. Telehealth is an alternative that can contribute to public policies and the development of effective intervention strategies that neutralize adverse outcomes. It can also be presented as an alternative to home care services, which could reduce demands for health resources.</AbstractText><CopyrightInformation>&#xa9; 2022 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsen</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy, Federal University of S&#xe3;o Carlos, S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreatto</LastName><ForeName>Carla Andreza de Almeida</ForeName><Initials>CAA</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy, Federal University of S&#xe3;o Carlos, S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aily</LastName><ForeName>J&#xe9;ssica Bianca</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy, Federal University of S&#xe3;o Carlos, S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelicioni</LastName><ForeName>Paulo Henrique Silva</ForeName><Initials>PHS</Initials><Identifier Source="ORCID">0000-0003-3168-3388</Identifier><AffiliationInfo><Affiliation>School of Health Sciences, University of New South Wales, Randwick, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Research Australia, Randwick, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neto</LastName><ForeName>D&#xe9;cio Bueno</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy, Federal University of S&#xe3;o Carlos, S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattiello</LastName><ForeName>Stela M&#xe1;rcia</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy, Federal University of S&#xe3;o Carlos, S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomes</LastName><ForeName>Grace Ang&#xe9;lica de Oliveira</ForeName><Initials>GAO</Initials><AffiliationInfo><Affiliation>Departament of Gerontology, Federal University of S&#xe3;o Carlos, S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Andrade</LastName><ForeName>Larissa Pires</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>Department of Physiotherapy, Federal University of S&#xe3;o Carlos, S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Funda&#xe7;&#xe3;o de Amparo &#xe0; Pesquisa do Estado de S&#xe3;o Paulo</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Physiother Res Int</MedlineTA><NlmUniqueID>9612022</NlmUniqueID><ISSNLinking>1358-2267</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">disability and health</Keyword><Keyword MajorTopicYN="N">international classification of functioning</Keyword><Keyword MajorTopicYN="N">telehealth</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>29</Day><Hour>9</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36445170</ArticleId><ArticleId IdType="doi">10.1002/pri.1981</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Almathami, H. K. Y., Win, K. T., &amp; Vlahu-Gjorgievska, E. (2020). Barriers and facilitators that influence telemedicine-based, real-time, online consultation at patients&#x2019; homes: Systematic literature review. Journal of Medical Internet Research, 22(2), e16407. https://doi.org/10.2196/16407</Citation></Reference><Reference><Citation>Altieri, M., &amp; Santangelo, G. (2021). The psychological impact of COVID-19 pandemic and lockdown on caregivers of people with dementia. American Journal of Geriatric Psychiatry, 29(1), 27-34. https://doi.org/10.1016/j.jagp.2020.10.009</Citation></Reference><Reference><Citation>Andrade, L. P., Gobbi, L. T., Coelho, F. G., Christofoletti, G., Costa, J. L. R., &amp; Stella, F. (2013). Benefits of multimodal exercise intervention for postural control and frontal cognitive functions in individuals with Alzheimer's disease: A controlled trial. Journal of the American Geriatrics Society, 11(61), 1919-1926.</Citation></Reference><Reference><Citation>Azevedo, L. V. S., Calandri, I. L., Slachevsky, A., Graviotto, H. G., Santos Vieira, M. C., Andrade, C. B. D., Rossetti, A. P., Generoso, A. B., Carmona, K. C., Pinto, L. A. C., Sorbara, M., Pinto, A., Guajardo, T., Olavarria, L., Thumala, D., Crivelli, L., Vivas, L., Allegri, R. F., Barbosa, M. T., &amp; Caramelli, P. (2021). Impact of social isolation on people with dementia and their family caregivers. Journal of Alzheimer's Disease, 81(2), 1-11. (Preprint). https://doi.org/10.3233/jad-201580</Citation></Reference><Reference><Citation>Brucki, S., Nitrini, R., Caramelli, P., Bertolucci, P. H., &amp; Okamoto, I. H. (2003). Sugest&#xf5;es para o uso do mini-exame do estado mental no Brasil. Arquivos de Neuro-psiquiatria, 61(3B), 777-781. https://doi.org/10.1590/s0004-282x2003000500014</Citation></Reference><Reference><Citation>Canonici, A. P., Andrade, L. P. D., Gobbi, S., Santos-galduroz, R. F., Gobbi, L. T. B., &amp; Stella, F. (2012). Functional dependence and caregiver burden in Alzheimer's disease: A controlled trial on the benefits of motor intervention. Psychogeriatrics, 12(3), 186-192. https://doi.org/10.1111/j.1479-8301.2012.00407.x</Citation></Reference><Reference><Citation>Castro, S. S., Leite, C. F., Osterbrock, C., Santos, M. T., &amp; Adery, R. (2015). Avalia&#xe7;&#xe3;o de sa&#xfa;de e defici&#xea;ncia: Manual do WHO disability assessment Schedule (WHODAS 2.0). Universidade Federal do Tri&#xe2;ngulo Mineiro-UFTM. http://Www.Uftm.Edu.Br/Paginas/Curso/Cod/1532/T/Projeto+Whodas</Citation></Reference><Reference><Citation>Cezar, N. O. C., Ansai, J. H., de Oliveira, M. P. B., da Silva, D. C. P., de Lima Gomes, W., Barreiros, B. A., Langelli, T. d. C. O., &amp; de Andrade, L. P. (2021). Feasibility of improving strength and functioning and decreasing the risk of falls in older adults with Alzheimer's dementia: A randomized controlled home-based exercise trial. Archives of Gerontology and Geriatrics, 96, 104476. https://doi.org/10.1016/j.archger.2021.104476</Citation></Reference><Reference><Citation>Cezar, N. O. C., Aprahamian, I., Ansai, J. H., de Oliveira, M. P. B., da Silva, D. C. P., de Lima Gomes, W., Barreiros, B. A., Langelli, T. d. C. O., &amp; de Andrade, L. P. (2021). Feasibility of reducing frailty components in older adults with Alzheimer's dementia: A randomized controlled home-based exercise trial (AD- HOMEX). Experimental Gerontology, 150, 111390. https://doi.org/10.1016/j.exger.2021.111390</Citation></Reference><Reference><Citation>Cezar, N. O. D. C., Ansai, J. H., &amp; de Andrade, L. P. (2021). Home-based multimodal exercise program in older people with Alzheimer disease: Randomized controlled trial protocol. Physiotherapy Research International, 26(2), e1899. https://doi.org/10.1002/pri.1899</Citation></Reference><Reference><Citation>Christofoletti, G., Oliani, M. M., Bucken-Gobbi, L. T., Gobbi, S., Beinotti, F., &amp; Stella, F. (2011). Physical activity attenuates neuropsychiatric disturbances and caregiver burden in patients with dementia. Clinics,&#xa0;66(4), 613-618. https://doi.org/10.1590/s1807-59322011000400015</Citation></Reference><Reference><Citation>Cotelli, M., Manenti, R., Brambilla, M., Gobbi, E., Ferrari, C., Binetti, G., &amp; Cappa, S. F. (2019). Cognitive telerehabilitation in mild cognitive impairment, Alzheimer&#x2019;s disease and frontotemporal dementia: A systematic review. Journal of Telemedicine and Telecare, 25(2), 67-79. https://doi.org/10.1177/1357633x17740390</Citation></Reference><Reference><Citation>Cuffaro, L., Di Lorenzo, F., Bonavita, S., Tedeschi, G., Leocani, L., &amp; Lavorgna, L. (2020). Dementia care and COVID-19 pandemic: A necessary digital revolution. Neurological Sciences, 41(8), 1977-1979. https://doi.org/10.1007/s10072-020-04512-4</Citation></Reference><Reference><Citation>Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., &amp; Gornbein, J. (1994). The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia. Neurology, 44(12), 2308. https://doi.org/10.1212/wnl.44.12.2308</Citation></Reference><Reference><Citation>Delbaere, K., T. Smith, S., &amp; Lord, S. R. (2011). Development and initial validation of the iconographical falls efficacy scale. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences, 66(6), 674-680. https://Www.Neura.Edu.Au/Wp-%20Content/Uploads/2016/05/Icon-Fes_10item-House.pdf</Citation></Reference><Reference><Citation>Di Lorito, C., Masud, T., Gladman, J., Godfrey, M., Dunlop, M., Bosco, A., &amp; Harwood, R. H. (2021). Deconditioning in people living with dementia during the COVID-19 pandemic: Qualitative study from the Promoting Activity, Independence and Stability in Early Dementia (PrAISED) process evaluation. BMC geriatrics, 21(1), 1-10.</Citation></Reference><Reference><Citation>Dinesen, B., Nonnecke, B., Lindeman, D., Toft, E., Kidholm, K., Jethwani, K., Nesbitt, T., Spindler, H., Oestergaard, C. U., Southard, J. A., Gutierrez, M., Anderson, N., Albert, N. M., &amp; Han, J. J. (2016). Personalized telehealth in the future: A global research agenda. Journal of Medical Internet Research, 18(3), e5257. https://doi.org/10.2196/jmir.5257</Citation></Reference><Reference><Citation>Du, Z., Li, Y., Li, J., Zhou, C., Li, F., &amp; Yang, X. (2018). Physical activity can improve cognition in patients with Alzheimer&#x2019;s disease: A systematic review and meta-analysis of randomized controlled trials. Clinical Interventions in Aging, 13, 1593-1603. https://doi.org/10.2147/cia.s169565</Citation></Reference><Reference><Citation>Farran, C. J., Paun, O., Cothran, F., Etkin, C. D., Rajan, K. B., Eisenstein, A., &amp; Navaie, M. (2016). Impact of an individualized physical activity intervention on improving mental health outcomes in family caregivers of persons with dementia: A randomized controlled trial. AIMS Medical Science, 3(1), 15.</Citation></Reference><Reference><Citation>Franco, M. R., Pinto, R. Z., Delbaere, K., Eto, B. Y., Faria, M. S., Aoyagi, G. A., Steffens, D., &amp; Pastre, C. M. (2018). Cross-cultural adaptation and measurement properties testing of the iconographical falls efficacy scale (Icon-FES). Brazilian Journal of Physical Therapy, 22(4), 291-303. https://doi.org/10.1016/j.bjpt.2018.01.003</Citation></Reference><Reference><Citation>Fritz, N. E., Cheek, F. M., &amp; Nichols-Larsen, D. S. (2015). Motor-cognitive dual-task training in neurologic disorders: A systematic review. Journal of Neurologic Physical Therapy: Journal of Neurologic Physical Therapy, 39(3), 142-153. https://doi.org/10.1097/npt.0000000000000090</Citation></Reference><Reference><Citation>Gledhill, N. (2002). Physical activity readiness medical examination Canada&#x2019;s physical activity guide to healthy active living. Health Canada, Minister of Public Works and Government Services. https://Www.Chp.Gov.Hk/Archive/Epp/Files/Parmed-X.Pdf</Citation></Reference><Reference><Citation>Hernandez, S. S. S., Vital, T. M., Gobbi, S., Costa, J. L. R., &amp; Stella, F. (2011). Atividade f&#xed;sica e sintomas neuropsiqui&#xe1;tricos em pacientes com dem&#xea;ncia de Alzheimer. Motriz: Revista de Educa&#xe7;&#xe3;o F&#xed;sica, 17(3), 533-543. https://doi.org/10.1590/s1980-65742011000300016</Citation></Reference><Reference><Citation>Hollis, S., &amp; Campbell, F. (1999). What is meant by intention to treat analysis? Survey of published randomised controlled trials. Bmj, 319(7211), 670-674. https://doi.org/10.1136/bmj.319.7211.670</Citation></Reference><Reference><Citation>Hutchinson, M., Wendt, N., &amp; Smith, S. T. (2018). Trial implementation of a telerehabilitation exercise system in residential aged care. Studies in Health Technology and Informatics, 246, 62-74.</Citation></Reference><Reference><Citation>Iyer, S., Mehta, P., Weith, J., Hoang-Gia, D., Moore, J., Carlson, C., Choe, P., Sakai, E., &amp; Gould, C. (2021). Converting a geriatrics clinic to virtual visits during COVID-19: A case study. Journal of Primary Care &amp; Community Health, 12, 21501327211000235. https://doi.org/10.1177/21501327211000235</Citation></Reference><Reference><Citation>Jelcic, N., Agostini, M., Meneghello, F., Buss&#xe8;, C., Parise, S., Galano, A., Tonin, P., Dam, M., Busse, C., &amp; Cagnin, A. (2014). Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer&#x2019;s disease: A pilot study. Clinical Interventions in Aging, 9, 1605. https://doi.org/10.2147/cia.s68145</Citation></Reference><Reference><Citation>Julie, S. Y., Pittman, C., Price, C. L., Nieman, C. L., &amp; Oh, E. S. (2021). Telemedicine and dementia care: A systematic review of barriers and facilitators. Journal of the American Medical Directors Association.</Citation></Reference><Reference><Citation>Kirk-Sanchez, N. J., &amp; McGough, E. L. (2014). Physical exercise and cognitive performance in the elderly: Current perspectives. Clinical Interventions in Aging, 9, 51.</Citation></Reference><Reference><Citation>Kumar, A., &amp; Salinas, J. (2021). The long-term public health impact of social distancing on brain health: Topical review. International Journal of Environmental Research and Public Health, 18(14), 7307. https://doi.org/10.3390/ijerph18147307</Citation></Reference><Reference><Citation>Lezak, M. D. (1995). Neuropsychological assessment (3rd ed.). Oxford University Press.</Citation></Reference><Reference><Citation>Lopez, O. L., Becker, J. T., Sweet, R. A., Klunk, W., Kaufer, D. I., Saxton, J., Habeych, M., &amp; DeKosky, S. T. (2003). Psychiatric symptoms vary with the severity of dementia in probable Alzheimer's disease. Journal of Neuropsychiatry and Clinical Neurosciences, 15(3), 346-353. https://doi.org/10.1176/jnp.15.3.346</Citation></Reference><Reference><Citation>Luzardo, A. R., Gorini, M. I. P. C., &amp; Silva, A. P. S. S. D. (2006). Caracter&#xed;sticas de idosos com doen&#xe7;a de Alzheimer e seus cuidadores: uma s&#xe9;rie de casos em um servi&#xe7;o de neurogeriatria. Texto &amp; Contexto-Enfermagem, 15(4), 587-594. https://doi.org/10.1590/s0104-07072006000400006</Citation></Reference><Reference><Citation>Medeiros, M. E. D., &amp; Guerra, R. O. (2009). Tradu&#xe7;&#xe3;o, adapta&#xe7;&#xe3;o cultural e an&#xe1;lise das propriedades psicom&#xe9;tricas do Activities of Daily Living Questionnaire (ADLQ) para avalia&#xe7;&#xe3;o funcional de pacientes com a doen&#xe7;a de Alzheimer. Brazilian Journal of Physical Therapy, 13(3), 257-266. https://doi.org/10.1590/s1413-35552009005000027</Citation></Reference><Reference><Citation>Monta&#xf1;o, M. B. M. M., &amp; Ramos, L. R. (2005). Validade da vers&#xe3;o em portugu&#xea;s da Clinical Dementia Rating. Revista de Sa&#xfa;de P&#xfa;blica, 39(6), 912-917. https://doi.org/10.1590/s0034-89102005000600007</Citation></Reference><Reference><Citation>Moreira, A., Alvarelh&#xe3;o, J., Silva, A. G., Costa, R., &amp; Queir&#xf3;s, A. (2015). Tradu&#xe7;&#xe3;o e valida&#xe7;&#xe3;o para portugu&#xea;s do WHODAS 2.0-12 itens em pessoas com 55 ou mais anos. Revista Portuguesa de Sa&#xfa;de P&#xfa;blica, 33(2), 179-182. https://doi.org/10.1016/j.rpsp.2015.06.003</Citation></Reference><Reference><Citation>Morris, J. C. (1993). Current vision and scoring rules the clinical dementia rating (CDR). Neurology, 43(11), 2412-2414. https://doi.org/10.1212/wnl.43.11.2412-a</Citation></Reference><Reference><Citation>Nicol, G. E., Piccirillo, J. F., Mulsant, B. H., &amp; Lenze, E. J. (2020). Action at a distance: Geriatric research during a pandemic. Journal of the American Geriatrics Society, 68(5), 922-925. https://doi.org/10.1111/jgs.16443</Citation></Reference><Reference><Citation>Novelli, M. M. P. C. (2006). Valida&#xe7;&#xe3;o da escala de qualidade de vida (QdV-DA) para pacientes com doen&#xe7;a de Alzheimer e seus respectivos cuidadores/familiares. Doctoral dissertation, Universidade de S&#xe3;o Paulo.</Citation></Reference><Reference><Citation>Nunes, E. D., &amp; Santos, R. R. (2008). Dem&#xea;ncia irreversiveis. In Principios b&#xe1;sicos de geriatria E gerontologia (1 Ed, pp. 313-342). Belo Horizonte.</Citation></Reference><Reference><Citation>Pelicioni, P. H., &amp; Lord, S. R. (2020). COVID-19 will severely impact older people's lives, and in many more ways than you think. Brazilian Journal of Physical Therapy, 24(4), 293-294. https://doi.org/10.1016/j.bjpt.2020.04.005</Citation></Reference><Reference><Citation>Realdon, O., Rossetto, F., Nalin, M., Baroni, I., Cabinio, M., Fioravanti, R., Saibene, F. L., Alberoni, M., Mantovani, F., Romano, M., Nemni, R., &amp; Baglio, F. (2016). Technology-enhanced multi-domain at home continuum of care program with respect to usual care for people with cognitive impairment: The ability-TelerehABILITation study protocol for a randomized controlled trial. BMC Psychiatry, 16(1), 1-9. https://doi.org/10.1186/s12888-016-1132-y</Citation></Reference><Reference><Citation>Realdon, O., Rossetto, F., Nalin, M., Baroni, I., Romano, M., Catania, F., &amp; Ability, C. (2018). The technology-enhanced ability continuum-of-care home program for people with cognitive disorders: Concept design and scenario of use. In International symposium on pervasive computing Paradigms for mental health (pp. 64-73). Springer.</Citation></Reference><Reference><Citation>Rokstad, A. M. M., R&#xf8;svik, J., Fossberg, M., &amp; Eriksen, S. (2021). The COVID-19 pandemic as experienced by the spouses of home-dwelling people with dementia-a qualitative study. BMC Geriatrics, 21(1), 1-9. https://doi.org/10.1186/s12877-021-02551-w</Citation></Reference><Reference><Citation>Rolland, Y., Pillard, F., Klapouszczak, A., Reynish, E., Thomas, D., Andrieu, S., Rivi&#xe8;re, D., &amp; Vellas, B. (2007). Exercise program for nursing home residents with Alzheimer's disease: A 1-year randomized, controlled trial. Journal of the American Geriatrics Society, 55(2), 158-165. https://doi.org/10.1111/j.1532-5415.2007.01035.x</Citation></Reference><Reference><Citation>Santos, J. G. D., Andrade, L. P. D., Pereira, J. R., Stein, A. M., Pedroso, R. V., &amp; Costa, J. L. R. (2013). An&#xe1;lise de protocolos com interven&#xe7;&#xe3;o motora domiciliar para pacientes com doen&#xe7;a de Alzheimer: uma revis&#xe3;o sistem&#xe1;tica. Revista Brasileira de Geriatria e Gerontologia, 16(3), 615-631. https://doi.org/10.1590/s1809-98232013000300018</Citation></Reference><Reference><Citation>Sekhon, H., Sekhon, K., Launay, C., Afililo, M., Innocente, N., Vahia, I., Rej, S., &amp; Beauchet, O. (2021). Telemedicine and the rural dementia population: A systematic review. Maturitas, 143, 105-114. https://doi.org/10.1016/j.maturitas.2020.09.001</Citation></Reference><Reference><Citation>Singer, J. O. (2020). Impacto da pandemia do coronav&#xed;rus nos cuidadores de pacientes com doen&#xe7;a de alzheimer. http://Abraz.Org.Br/Web/2020/04/17/O-Impacto-Da-%20Pandemia-Do-Coronavirus-Nos-Cuidadores-De-Pacientes-Com-Doenca-De-Alzheimer/</Citation></Reference><Reference><Citation>Stella, F., Canonici, A. P., Gobbi, S., Galduroz, R. F. S., Ca&#xe7;&#xe3;o, J. D. C., &amp; Gobbi, L. T. B. (2011). Attenuation of neuropsychiatric symptoms and caregiver burden in Alzheimer's disease by motor intervention: A controlled trial. Clinics, 66(8), 1353-1360. https://doi.org/10.1590/s1807-59322011000800008</Citation></Reference><Reference><Citation>Sunderland, T., Hill, J. L., Mellow, A. M., Lawlor, B. A., Gundersheimer, J., Newhouse, P. A., &amp; Grafman, J. H. (1989). Clock drawing in Alzheimer's disease: A novel measure of dementia severity. Journal of the American Geriatrics Society, 37(8), 725-729. https://doi.org/10.1111/j.1532-5415.1989.tb02233.x</Citation></Reference><Reference><Citation>Teri, L., Logsdon, R. G., McCurry, S. M., Pike, K. C., &amp; McGough, E. L. (2020). Translating an evidence-based multicomponent intervention for older adults with dementia and caregivers. The Gerontologist, 60(3), 548-557. https://doi.org/10.1093/geront/gny122</Citation></Reference><Reference><Citation>Turunen, M., Hokkanen, L., B&#xe4;ckman, L., Stigsdotter-Neely, A., H&#xe4;nninen, T., Paajanen, T., Soininen, H., Kivipelto, M., &amp; Ngandu, T. (2019). Computer-based cognitive training for older adults: Determinants of adherence. PLoS One, 14(7), e0219541. https://doi.org/10.1371/journal.pone.0219541</Citation></Reference><Reference><Citation>Vanvan Doorn-Atten, M. N., de Groot, L. C., Romea, A. C., Schwartz, S., De Vries, J. H., &amp; Haveman-Nies, A. (2019). Implementation of a multicomponent telemonitoring intervention to improve nutritional status of community-dwelling older adults: A process evaluation. Public Health Nutrition, 22(2), 363-374. https://doi.org/10.1017/s1368980018002185</Citation></Reference><Reference><Citation>Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., Dighe, A., Griffin, J. T., Baguelin, M., Bhatia, S., Boonyasiri, A., Cori, A., Cucunuba, Z., FitzJohn, R., Gaythorpe, K., &amp; Ferguson, N. M. (2020). Estimates of the severity of coronavirus disease 2019: A model-based analysis. The Lancet Infectious Diseases, 20(6), 669-677. https://doi.org/10.1016/s1473-3099(20)30243-7</Citation></Reference><Reference><Citation>World Health Organization (2020). Critical preparedness, readiness and response actions for COVID-19. Interim Guidance, 1-3. https://www.Who.Int/Publications-%20Detail/Critical-Preparedness-Readiness-And-Response-Actions-For-Covid-19</Citation></Reference><Reference><Citation>Zucchella, C., Sinforiani, E., Tamburin, S., Federico, A., Mantovani, E., Bernini, S., Casale, R., &amp; Bartolo, M. (2018). The multidisciplinary approach to Alzheimer's disease and dementia. A narrative review of non-pharmacological treatment. Frontiers in Neurology, 9, 1058. https://doi.org/10.3389/fneur.2018.01058</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36437642</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-4833</ISSN><JournalIssue CitedMedium="Internet"><Volume>191</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>American journal of medical genetics. Part A</Title><ISOAbbreviation>Am J Med Genet A</ISOAbbreviation></Journal><ArticleTitle>Personal social networks of people with Down syndrome.</ArticleTitle><Pagination><StartPage>690</StartPage><EndPage>698</EndPage><MedlinePgn>690-698</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ajmg.a.63059</ELocationID><Abstract><AbstractText>Studies in the neurotypical population have demonstrated that personal social networks can mitigate cognitive decline and the development of Alzheimer disease. To assess whether these benefits can also be extended to people with Down syndrome (DS), we studied whether and how personal networks can be measured in this population. We adapted a personal networks instrument previously created, validated, and implemented for the neurotypical population. We created two versions of the survey: one for participants with DS, ages 25 and older, and another for their study partners, who spent a minimum of 10&#xa0;h/wk in a caregiver role. Participants with DS gave concordant data to those of study partners. Their personal networks included a median network size of 7.50, density 0.80, constraint 46.00, and effective size 3.07. Personal networks were composed of 50% kin, 80% who live within 15&#x2009;miles, and 80% who eat a healthy diet. In this proof-of-principle study, we demonstrated that the personal networks of people with DS can be quantitatively analyzed, with no statistical difference between self-report and parent-proxy report. Future research efforts can now evaluate interventions to enhance personal networks for preventing Alzheimer disease in this population.</AbstractText><CopyrightInformation>&#xa9; 2022 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Skotko</LastName><ForeName>Brian G</ForeName><Initials>BG</Initials><Identifier Source="ORCID">0000-0002-5232-9882</Identifier><AffiliationInfo><Affiliation>Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krell</LastName><ForeName>Kavita</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-7905-871X</Identifier><AffiliationInfo><Affiliation>Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haugen</LastName><ForeName>Kelsey</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieves</LastName><ForeName>Amber</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Stroke and Cerebrovascular Diseases, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hospital Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhand</LastName><ForeName>Amar</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6470-7548</Identifier><AffiliationInfo><Affiliation>Division of Stroke and Cerebrovascular Diseases, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hospital Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Genet A</MedlineTA><NlmUniqueID>101235741</NlmUniqueID><ISSNLinking>1552-4825</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004314" MajorTopicYN="Y">Down Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060756" MajorTopicYN="N">Social Networking</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer disease</Keyword><Keyword MajorTopicYN="N">Down syndrome</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">personal networks</Keyword><Keyword MajorTopicYN="N">social networks</Keyword><Keyword MajorTopicYN="N">trisomy 21</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>28</Day><Hour>2</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36437642</ArticleId><ArticleId IdType="doi">10.1002/ajmg.a.63059</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Antonarakis, S. E., Skotko, B. G., Rafii, M. S., Strydom, A., Pape, S. E., Bianchi, D. W., Sherman, S. L., &amp; Reeves, R. H. (2020). Down syndrome. Nature Reviews. Disease Primers, 6(1), 9. https://doi.org/10.1038/s41572-019-0143-7</Citation></Reference><Reference><Citation>Ballard, C., Mobley, W., Hardy, J., Williams, G., &amp; Corbett, A. (2016). Dementia in Down's syndrome. The Lancet Neurology, 15(6), 622-636. https://doi.org/10.1016/S1474-4422(16)00063-6</Citation></Reference><Reference><Citation>Bayen, E., Possin, K. L., Chen, Y., Cleret de Langavant, L., &amp; Yaffe, K. (2018). Prevalence of aging, dementia, and multimorbidity in older adults with down syndrome. JAMA Neurology, 75(11), 1399-1406. https://doi.org/10.1001/jamaneurol.2018.2210</Citation></Reference><Reference><Citation>Capone, G. T., Chicoine, B., Bulova, P., Stephens, M., Hart, S., Crissman, B., Videlefsky, A., Myers, K., Roizen, N., Esbensen, A., Peterson, M., Santoro, S., Woodward, J., Martin, B., Smith, D., &amp; Down Syndrome Medical Interest Group DSMIG-USA Adult Health Care Workgroup. (2018). Co-occurring medical conditions in adults with down syndrome: A systematic review toward the development of health care guidelines. American Journal of Medical Genetics. Part A, 176(1), 116-133. https://doi.org/10.1002/ajmg.a.38512</Citation></Reference><Reference><Citation>CDC. (2022, August 23). Life expectancy. Retrieved from: https://www.cdc.gov/nchs/fastats/life-expectancy.htm</Citation></Reference><Reference><Citation>Crooks, V. C., Lubben, J., Petitti, D. B., Little, D., &amp; Chiu, V. (2008). Social network, cognitive function, and dementia incidence among elderly women. American Journal of Public Health, 98(7), 1221-1227. https://doi.org/10.2105/AJPH.2007.115923</Citation></Reference><Reference><Citation>Curtin, C., Bandini, L. G., Must, A., Gleason, J., Lividini, K., Phillips, S., Eliasziw, M., Maslin, M., &amp; Fleming, R. K. (2013). Parent support improves weight loss in adolescents and young adults with Down syndrome. The Journal of Pediatrics, 163(5), 8.e1. https://doi.org/10.1016/j.jpeds.2013.06.081</Citation></Reference><Reference><Citation>de Graaf, G., Buckley, F., &amp; Skotko, B. G. (2017). Estimation of the number of people with down syndrome in the United States. Genetics in Medicine, 19(4), 439-447. https://doi.org/10.1038/gim.2016.127</Citation></Reference><Reference><Citation>de Graaf, G., Buckley, F., &amp; Skotko, B. G. (2022). People living with Down syndrome in the USA: Births and population. Retrieved from: https://docs.downsyndromepopulation.org/factsheets/down-syndrome-population-usa-factsheet.pdf</Citation></Reference><Reference><Citation>Dhand, A., Luke, D. A., Lang, C. E., &amp; Lee, J.-M. (2016). Social networks and neurological illness. Nature Reviews. Neurology, 12(10), 605-612. https://doi.org/10.1038/nrneurol.2016.119</Citation></Reference><Reference><Citation>Dhand, A., Podury, A., Choudhry, N., Narayanan, S., Shin, M., &amp; Mehl, M. R. (2022). Leveraging social networks for the assessment and Management of Neurological Patients. Seminars in Neurology, 42(2), 136-148. https://doi.org/10.1055/s-0042-1744532</Citation></Reference><Reference><Citation>Dhand, A., White, C. C., Johnson, C., Xia, Z., &amp; De Jager, P. L. (2018). A scalable online tool for quantitative social network assessment reveals potentially modifiable social environmental risks. Nature Communications, 9(1), 3930. https://doi.org/10.1038/s41467-018-06408-6</Citation></Reference><Reference><Citation>Fleming, R. K., Stokes, E. A., Curtin, C., Bandini, L. G., Gleason, J., Scampini, R., Maslin, M. C. T., &amp; Hamad, C. (2008). Behavioral health in developmental disabilities: A comprehensive program of nutrition, exercise, and weight reduction. International Journal of Behavioral and Consultation Therapy, 4(3), 287-296. https://doi.org/10.1037/h0100858</Citation></Reference><Reference><Citation>Fratiglioni, L., Paillard-Borg, S., &amp; Winblad, B. (2004). An active and socially integrated lifestyle in late life might protect against dementia. The Lancet. Neurology, 3(6), 343-353. https://doi.org/10.1016/S1474-4422(04)00767-7</Citation></Reference><Reference><Citation>Harris, P. A., Taylor, R., Minor, B. L., Elliott, V., Fernandez, M., O'Neal, L., McLeod, L., Delacqua, G., Delacqua, F., Kirby, J., Duda, S. N., &amp; REDCap Consortium. (2019). The REDCap consortium: Building an international community of software platform partners. Journal of Biomedical Informatics, 95, 103208. https://doi.org/10.1016/j.jbi.2019.103208</Citation></Reference><Reference><Citation>Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., &amp; Conde, J. G. (2009). Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377-381. https://doi.org/10.1016/j.jbi.2008.08.010</Citation></Reference><Reference><Citation>Holt-Lunstad, J., Smith, T. B., &amp; Layton, J. B. (2010). Social relationships and mortality risk: A meta-analytic review. PLoS Medicine, 7(7), e1000316. https://doi.org/10.1371/journal.pmed.1000316</Citation></Reference><Reference><Citation>Hultsch, D. F., Hertzog, C., Small, B. J., &amp; Dixon, R. A. (1999). Use it or lose it: Engaged lifestyle as a buffer of cognitive decline in aging? Psychology and Aging, 14(2), 245-263. https://doi.org/10.1037//0882-7974.14.2.245</Citation></Reference><Reference><Citation>Patient-Centered Outcomes Research Institute. (2021, March 10). Intellectual and/or Developmental Disabilities | PCORI. Retrieved from: https://www.pcori.org/collection/intellectual-andor-developmental-disabilities</Citation></Reference><Reference><Citation>Kotwal, A. A., Kim, J., Waite, L., &amp; Dale, W. (2016). Social function and cognitive status: Results from a US nationally representative survey of older adults. Journal of General Internal Medicine, 31(8), 854-862. https://doi.org/10.1007/s11606-016-3696-0</Citation></Reference><Reference><Citation>Lott, I. T., &amp; Head, E. (2019). Dementia in down syndrome: Unique insights for Alzheimer disease research. Nature Reviews. Neurology, 15(3), 135-147. https://doi.org/10.1038/s41582-018-0132-6</Citation></Reference><Reference><Citation>Oreskovic, N. M., Cottrell, C., Torres, A., Patsiogiannis, V., Santoro, S., Nichols, D., Moore, C., &amp; Skotko, B. G. (2020). Physical activity patterns in adults with Down syndrome. Journal of Applied Research in Intellectual Disabilities: JARID, 33(6), 1457-1464. https://doi.org/10.1111/jar.12773</Citation></Reference><Reference><Citation>Peng, S., Roth, A. R., Apostolova, L. G., Saykin, A. J., &amp; Perry, B. L. (2022). Cognitively stimulating environments and cognitive reserve: The case of personal social networks. Neurobiology of Aging, 112, 197-203. https://doi.org/10.1016/j.neurobiolaging.2022.01.004</Citation></Reference><Reference><Citation>Perry, B. L., Roth, A. R., Peng, S., Risacher, S. L., Saykin, A. J., &amp; Apostolova, L. G. (2021). Social networks and cognitive reserve: Network structure moderates the association between Amygdalar volume and cognitive outcomes. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences, 77(8), 1490-1500. https://doi.org/10.1093/geronb/gbab192</Citation></Reference><Reference><Citation>Prust, M., Halm, A., Nedelcu, S., Nieves, A., &amp; Dhand, A. (2021). Head-to-Head comparison of social network assessments in stroke survivors. The Neurohospitalist, 11(1), 18-24. https://doi.org/10.1177/1941874420945889</Citation></Reference><Reference><Citation>Santoro, S. L., Donelan, K., &amp; Constantine, M. (2022). Proxy-report in individuals with intellectual disability: A scoping review. Journal of Applied Research in Intellectual Disabilities, 35, 1088-1108. https://doi.org/10.1111/jar.13013</Citation></Reference><Reference><Citation>Sinai, A., Mokrysz, C., Bernal, J., Bohnen, I., Bonell, S., Courtenay, K., Dodd, K., Gazizova, D., Hassiotis, A., Hillier, R., McBrien, J., McCarthy, J., Mukherji, K., Naeem, A., Perez-Achiaga, N., Rantell, K., Sharma, V., Thomas, D., Walker, Z., &#x2026; Strydom, A. (2018). Predictors of age of diagnosis and survival of Alzheimer's disease in Down syndrome. Journal of Alzheimer's Disease, 61(2), 717-728. https://doi.org/10.3233/JAD-170624</Citation></Reference><Reference><Citation>Skotko, B. G., Levine, S. P., &amp; Goldstein, R. (2011). Self-perceptions from people with down syndrome. American Journal of Medical Genetics. Part A, 155A(10), 2360-2369. https://doi.org/10.1002/ajmg.a.34235</Citation></Reference><Reference><Citation>Strydom, A., Shooshtari, S., Lee, L., Raykar, V., Torr, J., Tsiouris, J., Jokinen, N., Courtenay, K., Bass, N., Sinnema, M., &amp; Maaskant, M. (2010). Dementia in older adults with intellectual disabilities-Epidemiology, presentation, and diagnosis. Journal of Policy and Practice in Intellectual Disabilities, 7(2), 96-110. https://doi.org/10.1111/j.1741-1130.2010.00253.x</Citation></Reference><Reference><Citation>Wilson, R. S., Krueger, K. R., Arnold, S. E., Schneider, J. A., Kelly, J. F., Barnes, L. L., Tang, Y., &amp; Bennett, D. A. (2007). Loneliness and risk of Alzheimer disease. Archives of General Psychiatry, 64(2), 234-240. https://doi.org/10.1001/archpsyc.64.2.234</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36427288</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-5415</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of the American Geriatrics Society</Title><ISOAbbreviation>J Am Geriatr Soc</ISOAbbreviation></Journal><ArticleTitle>Impact of diagnosed (vs undiagnosed) dementia on family caregiving experiences.</ArticleTitle><Pagination><StartPage>1236</StartPage><EndPage>1242</EndPage><MedlinePgn>1236-1242</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jgs.18155</ELocationID><Abstract><AbstractText Label="BACKGROUND">Most older adults with Alzheimer's disease and related dementias (ADRD) do not receive a timely formal diagnosis, although formal diagnosis is linked to improved outcomes. Little is known about how a recognized formal diagnosis impacts family caregivers, who provide crucial support for older adults experiencing ADRD.</AbstractText><AbstractText Label="METHODS">We analyzed 2017 National Health and Aging Trends Study and linked National Study of Caregiving data for a nationally representative sample of 724 (weighted n&#xa0;=&#xa0;5,431,551) caregivers who assisted an older adult with probable dementia. Probable dementia was determined via previously validated composite measure. We modeled caregiver experiences as a function of recognized formal ADRD diagnosis using weighted, logistic regression and adjusting for the relevant older adult and caregiver characteristics.</AbstractText><AbstractText Label="RESULTS">Among caregivers who assisted an older adult with probable dementia, those assisting an individual with recognized formal ADRD diagnosis were significantly more likely to report emotional difficulty (aOR: 1.77; p&#xa0;=&#xa0;0.03) and family disagreement over the older adult's care (aOR: 5.53; p&#xa0;=&#xa0;0.03). They were also more likely to assist with communication during doctors' visits (aOR: 9.71; p&#x2009;&lt;&#x2009;0.001) and to receive caregiving-related training (aOR: 2.59; p&#xa0;=&#xa0;0.01).</AbstractText><AbstractText Label="CONCLUSIONS">While a timely ADRD diagnosis may help ensure access to needed supports for older adult and caregiver alike, diagnosis must be linked to support as they navigate resultant complex emotions. Formal diagnosis is linked to caregiver integration with, and support from, the older adult's team of health care providers; therefore, reducing existing disparities in timely diagnosis is necessary to ensure all caregivers have equal access to support.</AbstractText><CopyrightInformation>&#xa9; 2022 The American Geriatrics Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burgdorf</LastName><ForeName>Julia G</ForeName><Initials>JG</Initials><Identifier Source="ORCID">0000-0002-3356-1897</Identifier><AffiliationInfo><Affiliation>Center for Home Care Policy &amp; Research, VNS Health, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amjad</LastName><ForeName>Halima</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 AG064036</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 AG063237</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Geriatr Soc</MedlineTA><NlmUniqueID>7503062</NlmUniqueID><ISSNLinking>0002-8614</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057210" MajorTopicYN="N">Delayed Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="Y">Family</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005192" MajorTopicYN="Y">Family Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010348" MajorTopicYN="N">Patient Care Team</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013315" MajorTopicYN="N">Stress, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095223" MajorTopicYN="N">White</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072858" MajorTopicYN="N">Psychosocial Support Systems</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer dementia</Keyword><Keyword MajorTopicYN="N">caregiving</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">family caregiver</Keyword></KeywordList><CoiStatement><i>Conflicts of interest:</i> Authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>25</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36427288</ArticleId><ArticleId IdType="mid">NIHMS1851179</ArticleId><ArticleId IdType="pmc">PMC10089946</ArticleId><ArticleId IdType="doi">10.1111/jgs.18155</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alzheimer&#x2019;s Association. 2021 Alzheimer&#x2019;s disease facts and figures. (2021). Alzheimer&#x2019;s &amp; dementia : the journal of the Alzheimer&#x2019;s Association, 17(3), 327&#x2013;406. Doi:10.1002/alz.12328</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12328</ArticleId><ArticleId IdType="pubmed">33756057</ArticleId></ArticleIdList></Reference><Reference><Citation>What Is Dementia? Symptoms, Types, and Diagnosis. National Institute on Aging. Accessed
June 2, 2021. https://www.nia.nih.gov/health/what-dementia-symptoms-types-and-diagnosis</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Association. 2019 Alzheimer&#x2019;s disease facts and figures. (2019). Alzheimer&#x2019;s &amp; dementia : the journal of the Alzheimer&#x2019;s Association, 15(3), 321&#x2013;387. doi:10.1016/j.jalz.2019.01.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.01.010</ArticleId><ArticleId IdType="pubmed">19426951</ArticleId></ArticleIdList></Reference><Reference><Citation>Assistant Secretary for Planning and Evaluation (ASPE). ASPE Issue Brief: A Profile of Older Adults with Dementia and their caregivers. (2019). https://aspe.hhs.gov/system/files/pdf/260391/DemChartIB.pdf</Citation></Reference><Reference><Citation>Bynum JP, Rabins PV, Weller W, Niefeld M, Anderson GF, Wu AW. The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use. J Am Geriatr Soc. 2004;52(2):187&#x2013;194. Doi:10.1111/j.1532-5415.2004.52054.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2004.52054.x</ArticleId><ArticleId IdType="pubmed">14728626</ArticleId></ArticleIdList></Reference><Reference><Citation>Beach SR, Schulz R, Friedman EM, Rodakowski J, Martsolf RG, James AE. Adverse Consequences of Unmet Needs for Care in High-Need/High-Cost Older Adults. J Gerontol B Psychol Sci Soc Sci. 2020;75(2):459&#x2013;470. Doi:10.1093/geronb/gby021</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gby021</ArticleId><ArticleId IdType="pubmed">29471360</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper JD, Freedman VA, Spillman BC, Wolff JL. The Disproportionate Impact Of Dementia On Family And Unpaid Caregiving To Older Adults. Health Aff (Millwood). Oct 2015;34(10):1642&#x2013;9. Doi:10.1377/hlthaff.2015.0536</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2015.0536</ArticleId><ArticleId IdType="pmc">PMC4635557</ArticleId><ArticleId IdType="pubmed">26438739</ArticleId></ArticleIdList></Reference><Reference><Citation>National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; Board on Health Sciences Policy; Committee on Care Interventions for Individuals with Dementia and Their Caregivers, Stroud C, Larson EB, eds. Meeting the Challenge of Caring for Persons Living with Dementia and Their Care Partners and Caregivers: A Way Forward. Washington (DC): National Academies Press (US); February 23, 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33625814</ArticleId></ArticleIdList></Reference><Reference><Citation>Riffin C, Van Ness PH, Wolff JL, Fried T. Multifactorial Examination of Caregiver Burden in a National Sample of Family and Unpaid Caregivers. J Am Geriatr Soc. Feb 2019;67(2):277&#x2013;283. Doi:10.1111/jgs.15664</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.15664</ArticleId><ArticleId IdType="pmc">PMC6367031</ArticleId><ArticleId IdType="pubmed">30452088</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford A, Kunik ME, Schulz P, Williams SP, Singh H. Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors. Alzheimer Dis Assoc Disord. 2009 Oct-Dec 2009;23(4):306&#x2013;14. Doi:10.1097/WAD.0b013e3181a6bebc</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0b013e3181a6bebc</ArticleId><ArticleId IdType="pmc">PMC2787842</ArticleId><ArticleId IdType="pubmed">19568149</ArticleId></ArticleIdList></Reference><Reference><Citation>Iliffe S, Robinson L, Brayne C, et al. Primary care and dementia: 1. Diagnosis, screening and disclosure. Int J Geriatr Psychiatry. Sep 2009;24(9):895&#x2013;901. Doi:10.1002/gps.2204</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.2204</ArticleId><ArticleId IdType="pubmed">19226529</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson L, Tang E, Taylor JP. Dementia: timely diagnosis and early intervention. Bmj. Jun 16 2015;350:h3029. Doi:10.1136/bmj.h3029</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h3029</ArticleId><ArticleId IdType="pmc">PMC4468575</ArticleId><ArticleId IdType="pubmed">26079686</ArticleId></ArticleIdList></Reference><Reference><Citation>Amjad H, Roth DL, Sheehan OC, Lyketsos CG, Wolff JL, Samus QM. Underdiagnosis of Dementia: an Observational Study of Patterns in Diagnosis and Awareness in US Older Adults. J Gen Intern Med. 07 2018;33(7):1131&#x2013;1138. Doi:10.1007/s11606-018-4377-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-018-4377-y</ArticleId><ArticleId IdType="pmc">PMC6025653</ArticleId><ArticleId IdType="pubmed">29508259</ArticleId></ArticleIdList></Reference><Reference><Citation>Livney MG, Clark CM, Karlawish JH, et al. Ethnoracial differences in the clinical characteristics of Alzheimer&#x2019;s disease at initial presentation at an urban Alzheimer&#x2019;s disease center. Am J Geriatr Psychiatry. May 2011;19(5):430&#x2013;9. Doi:10.1097/JGP.0b013e3181f7d881</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JGP.0b013e3181f7d881</ArticleId><ArticleId IdType="pmc">PMC3085004</ArticleId><ArticleId IdType="pubmed">21522051</ArticleId></ArticleIdList></Reference><Reference><Citation>Lind KE, Hildreth K, Lindrooth R, Morrato E, Crane LA, Perraillon MC. The effect of direct cognitive assessment in the Medicare annual wellness visit on dementia diagnosis rates. Health Serv Res. 04 2021;56(2):193&#x2013;203. Doi:10.1111/1475-6773.13627</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1475-6773.13627</ArticleId><ArticleId IdType="pmc">PMC7968942</ArticleId><ArticleId IdType="pubmed">33481263</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagiadinou M, Plerou A. Brief Cognitive Tests in the Case of Dementia and Alzheimer&#x2019;s Disease Early Diagnosis. Adv Exp Med Biol. 2020;1195:127&#x2013;135. Doi:10.1007/978-3-030-32633-3_17</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-32633-3_17</ArticleId><ArticleId IdType="pubmed">32468467</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimers Dement. May 2011;7(3):263&#x2013;9. Doi:10.1016/j.jalz.2011.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.03.005</ArticleId><ArticleId IdType="pmc">PMC3312024</ArticleId><ArticleId IdType="pubmed">21514250</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CC, Yu JT, Tan L. Biomarkers for preclinical Alzheimer&#x2019;s disease. J Alzheimers Dis. 2014;42(4):1051&#x2013;69. Doi:10.3233/jad-140843</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-140843</ArticleId><ArticleId IdType="pubmed">25024325</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee S, Wittenberg R. Clinical and cost effectiveness of services for early diagnosis and intervention in dementia. Int J Geriatr Psychiatry. Jul 2009;24(7):748&#x2013;54. Doi:10.1002/gps.2191</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.2191</ArticleId><ArticleId IdType="pubmed">19206079</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B, Padovani A, Scheltens P, Rossi A, Dell&#x2019;Agnello G. Timely Diagnosis for Alzheimer&#x2019;s Disease: A Literature Review on Benefits and Challenges. J Alzheimers Dis. 2016;49(3):617&#x2013;31. Doi:10.3233/jad-150692</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-150692</ArticleId><ArticleId IdType="pmc">PMC4927869</ArticleId><ArticleId IdType="pubmed">26484931</ArticleId></ArticleIdList></Reference><Reference><Citation>Amjad H, Roth DL, Samus QM, Yasar S, Wolff JL. Potentially Unsafe Activities and Living Conditions of Older Adults with Dementia. J Am Geriatr Soc. Jun 2016;64(6):1223&#x2013;32. Doi:10.1111/jgs.14164</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.14164</ArticleId><ArticleId IdType="pmc">PMC4914464</ArticleId><ArticleId IdType="pubmed">27253366</ArticleId></ArticleIdList></Reference><Reference><Citation>Derksen E, Vernooij-Dassen M, Gillissen F, Olde Rikkert M, Scheltens P. Impact of diagnostic disclosure in dementia on patients and carers: qualitative case series analysis. Aging Ment Health. Sep 2006;10(5):525&#x2013;31. Doi:10.1080/13607860600638024</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607860600638024</ArticleId><ArticleId IdType="pubmed">16938687</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn MJ, Ju CH, Hill PL. Sense of Purpose Following a Dementia Diagnostic Appointment: Comparing Self- and Other-Reports of Care Recipients and Care Partners. Front Psychol. 2021;12:703478. Doi:10.3389/fpsyg.2021.703478</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2021.703478</ArticleId><ArticleId IdType="pmc">PMC8415023</ArticleId><ArticleId IdType="pubmed">34484054</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokes LA, Combes H, Stokes G. Understanding the dementia diagnosis: the impact on the caregiving experience. Dementia (London). Jan 2014;13(1):59&#x2013;78. Doi:10.1177/1471301212447157</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301212447157</ArticleId><ArticleId IdType="pubmed">24381039</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens DK, Davidson KW, Krist AH, et al. Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement. Jama. Feb 25 2020;323(8):757&#x2013;763. Doi:10.1001/jama.2020.0435</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.0435</ArticleId><ArticleId IdType="pubmed">32096858</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper JD, Freedman VA, Spillman B. (2013). Classification of Persons by Dementia Status in the National Health and Aging Trends Study. https://www.nhats.org/researcher/nhats/methods-documentation?id=technical-papers</Citation></Reference><Reference><Citation>Lee K, Puga F, Pickering CEZ, Masoud SS, White CL. Transitioning into the caregiver role following a diagnosis of Alzheimer&#x2019;s disease or related dementia: A scoping review. Int J Nurs Stud. Aug 2019;96:119&#x2013;131. Doi:10.1016/j.ijnurstu.2019.02.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2019.02.007</ArticleId><ArticleId IdType="pubmed">30851954</ArticleId></ArticleIdList></Reference><Reference><Citation>Black BS, Johnston D, Rabins PV, Morrison A, Lyketsos C, Samus QM. Unmet needs of community-residing persons with dementia and their informal caregivers: findings from the maximizing independence at home study. J Am Geriatr Soc. Dec 2013;61(12):2087&#x2013;2095. Doi:10.1111/jgs.12549</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.12549</ArticleId><ArticleId IdType="pmc">PMC4001885</ArticleId><ArticleId IdType="pubmed">24479141</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols LO, Chang C, Lummus A, et al. The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer&#x2019;s disease. J Am Geriatr Soc. Mar 2008;56(3):413&#x2013;20. Doi:10.1111/j.1532-5415.2007.01569.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2007.01569.x</ArticleId><ArticleId IdType="pmc">PMC2575686</ArticleId><ArticleId IdType="pubmed">18179480</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepburn KW, Tornatore J, Center B, Ostwald SW. Dementia family caregiver training: affecting beliefs about caregiving and caregiver outcomes. J Am Geriatr Soc. Apr 2001;49(4):450&#x2013;7. Doi:10.1046/j.1532-5415.2001.49</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1532-5415.2001.49</ArticleId><ArticleId IdType="pubmed">11347790</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36427013</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-5279</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</Title><ISOAbbreviation>Alzheimers Dement</ISOAbbreviation></Journal><ArticleTitle>Toward comprehensive value assessment for Alzheimer's disease innovations.</ArticleTitle><Pagination><StartPage>1558</StartPage><EndPage>1567</EndPage><MedlinePgn>1558-1567</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/alz.12874</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Assessing medical technologies for Alzheimer's disease (AD) creates challenges for current methods of value assessment. New value assessment approaches for AD are also needed.</AbstractText><AbstractText Label="METHODS">We adapted concepts from health economics to help guide decision makers to more informed decisions about AD therapies and diagnostics.</AbstractText><AbstractText Label="RESULTS">We propose a value framework based on five categories: perspective, value elements, analysis, reporting, and decision making. AD value assessments should include the perspective of the patient-caregiver dyad. We propose a broader array of value elements than currently used. Analytics and decision methods can synthesize evidence for all elements of value. Decisions should use a "deliberative appraisal" approach informed by the composite evidence and be transparently reported.</AbstractText><AbstractText Label="DISCUSSION">Using the proposed framework, the value of forthcoming innovations for AD may be more thoroughly assessed for and by all stakeholders. It can guide decision makers to carefully consider all relevant elements of value contributing to more holistic and transparent decision making.</AbstractText><AbstractText Label="RESEARCH HIGHLIGHTS">Alzheimer's disease challenges common methods of evaluating medical technology. Using current methods, new AD innovations might not be appropriately valued. Poor value assessments will adversely affect patient access to AD innovations. A full AD value framework expands perspective, elements, analysis, decision-making, reporting.</AbstractText><CopyrightInformation>&#xa9; 2022 Eli Lilly and Company and The Authors. Alzheimer's &amp; Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ferrell</LastName><ForeName>Phyllis B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fillit</LastName><ForeName>Howard</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Alzheimer's Drug Discovery Foundation and Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neumann</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wall</LastName><ForeName>J K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>James F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Davos Alzheimer's Collaborative, Wayne, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Alzheimers Dement</MedlineTA><NlmUniqueID>101231978</NlmUniqueID><ISSNLinking>1552-5260</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013672" MajorTopicYN="N">Technology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062069" MajorTopicYN="N">Inventions</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">deliberative appraisal</Keyword><Keyword MajorTopicYN="N">elements of value</Keyword><Keyword MajorTopicYN="N">evidence dashboards</Keyword><Keyword MajorTopicYN="N">health technology assessment</Keyword><Keyword MajorTopicYN="N">multi-criteria decision analysis</Keyword><Keyword MajorTopicYN="N">patient-caregiver perspective</Keyword><Keyword MajorTopicYN="N">value analytics</Keyword><Keyword MajorTopicYN="N">value assessment</Keyword><Keyword MajorTopicYN="N">value framework</Keyword><Keyword MajorTopicYN="N">value measures</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>25</Day><Hour>10</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36427013</ArticleId><ArticleId IdType="doi">10.1002/alz.12874</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>2021 Alzheimer's disease facts and figures. Alzheimers Dement. 2021;17:327-406. doi:10.1002/alz12874.12328</Citation></Reference><Reference><Citation>Wolff JL, Spillman BC, Freedman VA, Kasper JD. A national profile of family and unpaid caregivers who assist older adults with health care activities. JAMA Intern Med. 2016;176:372-379. doi:10.1001/jamainternmed.2015.7664</Citation></Reference><Reference><Citation>Deb A, Thornton JD, Sambamoorthi U, Innes K. Direct and indirect cost of managing alzheimer's disease and related dementias in the United States. Expert Rev Pharmacoecon Outcomes Res. 2017;17:189-202. doi:10.1080/14737167.2017.1313118</Citation></Reference><Reference><Citation>Barbarino P. The essential role of value assessment in addressing the global dementia crisis in Valuing future Alzheimer's disease treatments: the need for a holistic approach. Value Outcomes Spotlight. 2021;7(S1):S5-S6. Accessed May 10, 2022. https://www.ispor.org/publications/journals/value-outcomes-spotlight/vos-archives/issue/view/valuing-future-alz12874heimers-disease-treatments-the-need-for-a-holistic-approach/the-essential-role-of-value-assessment-in-addressing-the-global-dementia-crisis</Citation></Reference><Reference><Citation>Barbarino P, Gustaffson A, Neumann PJ. Long-term value demonstration in Alzheimer's disease: evidence needs in Valuing future Alzheimer's disease treatments: the need for a holistic approach. Value Outcomes Spotlight. 2021;7(S1):S18-S23. Accessed May 10, 2022. https://www.ispor.org/publications/journals/value-outcomes-spotlight/vos-archives/issue/view/valuing-future-alz12874heimers-disease-treatments-the-need-for-a-holistic-approach/long-term-value-demonstration-in-alz12874heimers-disease-evidence-needs</Citation></Reference><Reference><Citation>Kim DD, Silver MC, Kunst N, Cohen JT, Ollendorf DA, Neumann PJ. Perspective and costing in cost-effectiveness analysis, 1974-2018. Pharmacoeconomics. 2020;38:1135-1145. doi:10.1007/s40273-020-00942-2</Citation></Reference><Reference><Citation>Garrison LP, Baumgart M, El-Hayek YH, Holzapfel D, Leibman C. Defining elements of value in Alzheimer's disease in Valuing future Alzheimer's disease treatments: the need for a holistic approach. Value Outcomes Spotlight. 2021;7(S1):S7-S11. Accessed May 10, 2022. https://www.ispor.org/publications/journals/value-outcomes-spotlight/vos-archives/issue/view/valuing-future-alz12874heimers-disease-treatments-the-need-for-a-holistic-approach/defining-elements-of-value-in-alz12874heimers-disease</Citation></Reference><Reference><Citation>Lin PJ, Neumann PJ. Valuing Alzheimer disease therapies-considering costs and benefits beyond the patient. JAMA Netw Open. 2021;4:e2131913. doi:10.1001/jamanetworkopen.2021.31913</Citation></Reference><Reference><Citation>Lin GA, Whittington MD, Synnott PG. Aducanumab for Alzheimer's disease: effectiveness and value; final evidence report and meeting summary. Institute for Clinical and Economic Review, August 5, 2021. Accessed August 26 2021. Available at: https://icer.org/wp-content/uploads/2020/10/ICER_ALZ12874_Final_Report_080521.pdf</Citation></Reference><Reference><Citation>Lakdawalla DN, Doshi JA, Garrison LP, Jr., Phelps CE, Basu A, Danzon PM. Defining elements of value in health care-a health economics approach: an ISPOR special task force report [3]. Value Health. 2018;21:131-139. doi:10.1016/j.jval.2017.12.007</Citation></Reference><Reference><Citation>Sanders GD, Neumann PJ, Basu A, et&#xa0;al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316:1093-1103. doi:10.1001/jama.2016.12195</Citation></Reference><Reference><Citation>Institute for Clinical and Economic Review. ICER's reference case for economic evaluations: principles and rationale. Jan. 31, 2020. Accessed January 10 2022. https://icer.org/wp-content/uploads/2020/10/ICER_Reference_Case_013120.pdf</Citation></Reference><Reference><Citation>Drummond MF, Neumann PJ, Sullivan SD, et&#xa0;al. Analytic considerations in applying a general economic evaluation reference case to gene therapy. Value Health. 2019;22:661-668. doi:10.1016/j.jval.2019.03.012</Citation></Reference><Reference><Citation>Neumann PJ. Toward better data dashboards for US drug value assessments. Value Health. 2021;24:1484-1489. doi:10.1016/j.jval.2021.04.1287</Citation></Reference><Reference><Citation>Henshall C, Schuller T, Forum HTP. Health technology assessment, value-based decision making, and innovation. Int J Technol Assess Health Care. 2013;29:353-359. doi:10.1017/s0266462313000378</Citation></Reference><Reference><Citation>Porter ME. What is value in health care? N Engl J Med. 2010;363:2477-2481. doi:10.1056/nejmp1011024</Citation></Reference><Reference><Citation>Lu YY, Ellis J, Yang Z, et&#xa0;al. Satisfaction with a family-focused intervention for mild cognitive impairment dyads. J Nurs Scholarsh. 2016;48:334-344. doi:10.1111/jnu.12214</Citation></Reference><Reference><Citation>Fillit HM, Gutterman EM, Brooks RL. Impact of donepezil on caregiving burden for patients with Alzheimer's disease. Int Psychogeriatr. 2000;12:389-401. doi:10.1017/s1041610200006499</Citation></Reference><Reference><Citation>Robinson RL, Rentz DM, Bruemmer V, et&#xa0;al. Observation of patient and caregiver burden associated with early Alzheimer's disease in the United States: design and baseline findings of the GERAS-US cohort study1. J Alzheimers Dis. 2019;72:279-292. doi:10.3233/jad-190430</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013: Process and methods [PMG9]. April 4, 2013. Accessed March 14 2022. https://www.nice.org.uk/process/pmg9/chapter/the-reference-case?msclkid=4f622041a3cb11ecba8a46e11b57c24c</Citation></Reference><Reference><Citation>Leys M. Health care policy: qualitative evidence and health technology assessment. Health Policy. 2003;65:217-226. doi:10.1016/s0168-8510(02)00209-9</Citation></Reference><Reference><Citation>Cameron WB. Informal Sociology: A Casual Introduction to Sociological Thinking. Random House; 1963.</Citation></Reference><Reference><Citation>Murphy E, Dingwall R, Parker S. Qualitative research methods in health technology assessment: a review of the literature. Health Technol Assess. 1998;2(16):1-274.</Citation></Reference><Reference><Citation>Facey K, Boivin A, Gracia J. Patients&#x2019; perspectives in health technology assessment: a route to robust evidence and fair deliberation. Int J Technol Assess Health Care. 2010;26(3):334-340. doi:10.1017/S0266462310000395</Citation></Reference><Reference><Citation>DiBenedetti DB, Slota C, Wronski SL, et&#xa0;al. Assessing what matters most to patients with or at risk for Alzheimer's and care partners: a qualitative study evaluating symptoms, impacts, and outcomes. Alzheimers Res Ther. 2020;12(1):90. doi:10.1186/s13195-020-00659-6</Citation></Reference><Reference><Citation>Morse JM. Critical analysis of strategies for determining rigor in qualitative inquiry. Qual Health Res. 2015;25(9):1212-1222. doi:10.1177/1049732315588501</Citation></Reference><Reference><Citation>Kitto SC, Janice Chesters J, Grbich C. Quality in qualitative research. Med J Aust. 2008;188(4):243-246. doi:10.5694/j.1326-5377.2008.tb01595.x</Citation></Reference><Reference><Citation>Basu A, Lynn N, Peschin S, Resendez J. Value assessment in Alzheimer's disease: a focus on equity. Value Outcomes Spotlight. 2021;7(S1):S12-S16. Accessed May 10, 2022. https://www.ispor.org/publications/journals/value-outcomes-spotlight/vos-archives/issue/view/valuing-future-alz12874heimers-disease-treatments-the-need-for-a-holistic-approach/value-assessment-in-alz12874heimers-disease-a-focus-on-equity</Citation></Reference><Reference><Citation>Alzheimer Disease International. Dementia facts &amp; figures. Accessed September 23 2021. Available at: https://www.alz12874int.org/about/dementia-facts-figures</Citation></Reference><Reference><Citation>Yuasa A, Yonemoto N, Demiya S, Foellscher C, Ikeda S. Investigation of factors considered by health technology assessment agencies in eight countries. Pharmacoecon Open. 2021;5(1):57-69. doi:10.1007/s41669-020-00235-6</Citation></Reference><Reference><Citation>Ward T, Mujica-Mota RE, Spencer AE, Medina-Lara A. Incorporating equity concerns in cost-effectiveness analyses: a systematic literature review. Pharmacoeconomics. 2022;40(1):45-64. doi:10.1007/s40273-021-01094-7</Citation></Reference><Reference><Citation>Reed C, Barrett A, Lebrec J, et&#xa0;al. How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease? Health Qual Life Outcomes. 2017;15:16. doi:10.1186/s12955-017-0591-2</Citation></Reference><Reference><Citation>Tochel C, Smith M, Baldwin H, et&#xa0;al. What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic review. Alzheimers Dement (Amst). 2019;11:231-247. doi:10.1016/j.dadm.2018.12.003</Citation></Reference><Reference><Citation>Hauber B, Paulsen R, Callahan L, et&#xa0;al. Quantifying what matters most to patients and care partners in Alzheimer's Disease. Poster presented at the 2020 Alzheimer's Association Virtual International Conference (AAIC), July 29, 2020. Accessed April 7 2022. Available at: https://www.usagainstalz12874heimers.org/sites/default/files/2020-07/40095_Quantifying%20What%20Matters%20Most_0.pdf</Citation></Reference><Reference><Citation>Ito K, Chapman R, Pearson SD, Tafazzoli A, Yaffe K, Gurwitz JH. Evaluation of the cost-effectiveness of drug treatment for Alzheimer disease in a simulation model that includes caregiver and societal factors. JAMA Netw Open. 2021;4:e2129392. doi:10.1001/jamanetworkopen.2021.29392</Citation></Reference><Reference><Citation>McLaughlin T, Feldman H, Fillit H, et&#xa0;al. Dependence as a unifying construct in defining Alzheimer's disease severity. Alzheimers Dement. 2010;6:482-493. doi:10.1016/j.jalz12874.2009.09.004</Citation></Reference><Reference><Citation>Stern Y, Albert SM, Sano M, et&#xa0;al. Assessing patient dependence in Alzheimer's disease. J Gerontol. 1994;49:M216-22. doi:10.1093/geronj/49.5.m216</Citation></Reference><Reference><Citation>Michaud TL, High R, Charlton ME, Murman DL. Dependence stage and pharmacoeconomic outcomes in patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 2017;31:209-217. doi:10.1097/wad.0000000000000198</Citation></Reference><Reference><Citation>Spackman DE, Kadiyala S, Neumann PJ, Veenstra DL, Sullivan SD. The validity of dependence as a health outcome measure in Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2013;28:245-252. doi:10.1177/1533317513481092</Citation></Reference><Reference><Citation>Kahle-Wrobleski K, Andrews JS, Belger M, et&#xa0;al. Dependence levels as interim clinical milestones along the continuum of Alzheimer's disease: 18-month results from the GERAS observational study. J Prev Alzheimers Dis. 2017;4:72-80. doi:10.14283/jpad.2017.2</Citation></Reference><Reference><Citation>Jutkowitz E, Kane RL, Gaugler JE, MacLehose RF, Dowd B, Kuntz KM. Societal and family lifetime cost of dementia: implications for policy. J Am Geriatr Soc. 2017;65:2169-2175. doi:10.1111/jgs.15043</Citation></Reference><Reference><Citation>Lewis F, Schaffer SK, Sussex J, O'Neill P, Cockcroft L. The trajectory of dementia in the UK - making a difference. Report for Alzheimer's Research UK by OHE Consulting. June 9, 2014. Accessed January 19 2022. Available at: https://www.alz12874heimersresearchuk.org/wp-content/uploads/2015/01/OHE-report-Full.pdf?msclkid=c9ff1a3dbc0611ecb3db40178cd60cf4</Citation></Reference><Reference><Citation>Prados MJ, Liu Y, Jun H, Lam J, Mattke S. Projecting the long-term societal value of a disease-modifying treatment for Alzheimer's disease in the United States. Alzheimers Dement. 2022;18:142-151. doi:10.1002/alz12874.12578</Citation></Reference><Reference><Citation>Lakdawalla DN, Phelps CE. Health technology assessment with diminishing returns to health: the Generalized Risk-Adjusted Cost-Effectiveness (GRACE) approach. Value Health. 2021;24:244-249. doi:10.1016/j.jval.2020.10.003</Citation></Reference><Reference><Citation>Defechereux T, Paolucci F, Mirelman A, et&#xa0;al. Health care priority setting in Norway a multicriteria decision analysis. BMC Health Serv Res. 2012;12:39. doi:10.1186/1472-6963-12-39</Citation></Reference><Reference><Citation>Scottish Medicines Consortium. SMC modifiers used in appraising new medicines. 2012. Accessed January 10 2022. Available at: https://www.scottishmedicines.org.uk/media/3565/modifiers.pdf</Citation></Reference><Reference><Citation>Persson U. Value based pricing in Sweden: lessons for design. OHE Seminar Briefing No. 12. London: Office of Health Economics, 2012. Accessed January 10 2022. Available at: https://www.ohe.org/system/files/private/publications/377%20-%20VBP%20in%20Sweden%20Persson%202012.pdf?download=1</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence. NICE health technology evaluations: the manual. Process and methods [PMG36]: January 31, 2022. Accessed February 21 2022. https://www.nice.org.uk/process/pmg36/resources/nice-health-technology-evaluations-the-manual-pdf-72286779244741</Citation></Reference><Reference><Citation>Philipson TJ, Becker G, Goldman D, Murphy KM. Terminal care and the value of life near its end. NBER Working Paper No. 15649. January 2010. https://ssrn.com/abstract=1537768</Citation></Reference><Reference><Citation>Ten Ham RMT, Frederix GWJ, Wu O. et&#xa0;al. Key considerations in the health technology assessment of advanced therapy medicinal products in Scotland, the Netherlands, and England. Value Health. 2022;25(3):390-399. doi:10.1016/j.jval.2021.09.012</Citation></Reference><Reference><Citation>Garrison LP, Austin MJF. The economics of personalized medicine: a model of incentives for value creation and capture. Drug Inf J. 2007;41:501-509. doi:10.1177/009286150704100408</Citation></Reference><Reference><Citation>Garau M, Towse A, Garrison LP, Housman L, Ossa D. Can and should value-based pricing be applied to molecular diagnostics? London: Research Paper 12/03, Office of Health Economics, April 2012. Accessed January 19 2022. https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID2633990_code2358224.pdf?abstractid=2633990&amp;mirid=1</Citation></Reference><Reference><Citation>Zhu H, Mehta M, Huang SM, Wang Y. Toward bridging unmet medical need in early Alzheimer's disease: an evaluation of beta-amyloid (Abeta) plaque burden as a potential drug development tool. Clin Pharmacol Ther. 2022;111:728-731. doi:10.1002/cpt.2536</Citation></Reference><Reference><Citation>EL Ross, Weinberg MS, Arnold SE. Cost-effectiveness of aducanumab and donanemab for early Alzheimer disease in the US. JAMA Neurol. 2022;79(5):478-487. doi:10.1001/jamaneurol.2022.0315</Citation></Reference><Reference><Citation>Tahami Monfared AA, Tafazzoli A, Chavan A, Ye W, Zhang Q. The potential economic value of lecanemab in patients with early Alzheimer's disease using simulation modeling. Neurol Ther. 2022;11(3):1285-1307. doi:10.1007/s40120-022-00373-5</Citation></Reference><Reference><Citation>US Food and Drug Administration. Surrogate endpoint resources for drug and biologic development. July 24, 2018. Accessed April 5, 2022. Available at: https://www.fda.gov/drugs/development-resources/surrogate-endpoint-resources-drug-and-biologic-development</Citation></Reference><Reference><Citation>Elston J, Taylor RS. Use of surrogate outcomes in cost-effectiveness models: a review of United Kingdom health technology assessment reports. Int J Technol Assess Health Care. 2009;25:6-13. doi:10.1017/s0266462309090023</Citation></Reference><Reference><Citation>Busche MA, Hyman BT. Synergy between amyloid-beta and tau in Alzheimer's disease. Nat Neurosci. 2020;23:1183-1193. doi:10.1038/s41593-020-0687-6</Citation></Reference><Reference><Citation>Vreman RA, Mantel-Teeuwisse AK, H&#xf6;vels AM, Leufkens HGM, Goettsch WG. Differences in health technology assessment recommendations among European jurisdictions: the role of practice variations. Value Health. 2020;23(1):10-16. doi:10.1016/j.jval.2019.07.017</Citation></Reference><Reference><Citation>Goldman D, Lakdawalla D, Philipson TJ, Yin W. Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA. Health Econ. 2010;19(10):1109-1116. doi:10.1002/hec.1654</Citation></Reference><Reference><Citation>US Food and Drug Administration. Benefit-risk assessment in drug regulatory decision-making. March 30, 2018. Accessed June 23, 2022. Available at: https://www.fda.gov/files/about%20fda/published/Benefit-Risk-Assessment-in-Drug-Regulatory-Decision-Making.pdf</Citation></Reference><Reference><Citation>Devlin N, Sussex J. Incorporating multiple criteria in HTA: methods and processes. Office of Health Economics. 2011. Accessed April 4 2022. Available at: https://www.ohe.org/system/files/private/publications/350%20-%20IncorporatingMutlipleCriteria.pdf</Citation></Reference><Reference><Citation>Baltussen R, Marsh K, Thokala P, et&#xa0;al. Multicriteria decision analysis to support health technology assessment agencies: benefits, limitations, and the way forward. Value Health. 2019;22:1283-1288. doi:10.1016/j.jval.2019.06.014</Citation></Reference><Reference><Citation>Oortwijn W, Jansen M, Baltussen R. Use of evidence-informed deliberative processes by health technology assessment agencies around the globe. Int J Health Policy Manag. 2020;9:27-33. doi:10.15171/ijhpm.2019.72</Citation></Reference><Reference><Citation>Bond K, Stiffell R, Ollendorf DA. Principles for deliberative processes in health technology assessment. Int J Technol Assess Health Care. 2020:1-8. doi:10.1017/s0266462320000550</Citation></Reference><Reference><Citation>Olchanski N, Cohen J, Neumann P. Unknown unknowns - uncertainty in health technology assessment: a case study of PARP inhibitors for ovarian cancer. Center for Evaluation of Value and Risk in Health. July 14, 2021. Accessed on Sept. 30, 2022. Available at: https://cevr.tuftsmedicalcenter.org/news/2021/unknown-unknowns</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36422822</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2193-8253</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Neurology and therapy</Title><ISOAbbreviation>Neurol Ther</ISOAbbreviation></Journal><ArticleTitle>Treatment Preference for Alzheimer's Disease: A Multicriteria Decision Analysis with Caregivers, Neurologists, and Payors.</ArticleTitle><Pagination><StartPage>211</StartPage><EndPage>227</EndPage><MedlinePgn>211-227</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40120-022-00423-y</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Alzheimer's disease (AD) is a chronic neurodegenerative disorder associated with a high burden of illness. New therapies under development include agents that target amyloid-beta (A&#x3b2;), a key component in AD pathogenesis. Understanding the decision-making process for new AD drugs would help determine if such therapies should be adopted by society. Multicriteria decision analysis (MCDA) was applied to three key stakeholder groups to assess treatment alternatives for AD based on a multitude of decision trade-offs covering main components of care.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">AD caregivers (n&#x2009;=&#x2009;117), neurologists (n&#x2009;=&#x2009;90), and payors (n&#x2009;=&#x2009;90) from the USA received an online survey. The decision problem was broken down into four decision criterion and 12 subcriteria for two treatment scenarios: an A&#x3b2;-targeted therapy vs. the standard of care (SOC). Respondents were asked to indicate how much they preferred one option over another on a scale from 1 (equal preference) to 9 (high preference) based on each criterion and subcriterion. The decision criteria and subcriteria were weighted and presented as partial utility scores (pUS), with higher scores suggesting an increased preference for that decision-making component.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Caregivers and payors applied the highest value to need for intervention (mean pUS&#x2009;=&#x2009;0.303 and 0.259) and clinical outcomes (mean pUS&#x2009;=&#x2009;0.286 and 0.377). In contrast, neurologists placed the highest value on clinical outcomes and types of benefits (mean pUS&#x2009;=&#x2009;0.436 and 0.248). When decision subcriteria were examined, efficacy (mean pUS&#x2009;=&#x2009;0.115, 0.219, and 0.166) and the type of patient benefits (mean pUS&#x2009;=&#x2009;0.135, 0.178, and 0.126) were among the most valued by caregivers, neurologists, and payors.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">All groups placed the highest value on drug efficacy and types of benefit derived by patients. In contrast, cost implications were among the least important aspects in their decision-making.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dranitsaris</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Public Health, Falk College, Syracuse University, 150 Crouse Dr, Syracuse, NY, 13244, USA. george.dranitsaris@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Quanwu</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Eisai, Inc., Nutley, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quill</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Boston Consulting Group, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Boston Consulting Group, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weyrer</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Boston Consulting Group, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dysdale</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Boston Consulting Group, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neumann</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tahami Monfared</LastName><ForeName>Amir Abbas</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Eisai, Inc., Nutley, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Neurol Ther</MedlineTA><NlmUniqueID>101637818</NlmUniqueID><ISSNLinking>2193-6536</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Caregiver preference</Keyword><Keyword MajorTopicYN="N">Multicriteria decision analysis</Keyword><Keyword MajorTopicYN="N">Physician preference</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>24</Day><Hour>11</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36422822</ArticleId><ArticleId IdType="pmc">PMC9837350</ArticleId><ArticleId IdType="doi">10.1007/s40120-022-00423-y</ArticleId><ArticleId IdType="pii">10.1007/s40120-022-00423-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soria Lopez JA, Gonz&#xe1;lez HM, L&#xe9;ger GC. Alzheimer's disease. Handb Clin Neurol. 2019;167:231&#x2013;325. doi: 10.1016/B978-0-12-804766-8.00013-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-804766-8.00013-3</ArticleId><ArticleId IdType="pubmed">31753135</ArticleId></ArticleIdList></Reference><Reference><Citation>Crous-Bou M, Minguill&#xf3;n C, Gramunt N, Molinuevo JL. Alzheimer's disease prevention: from risk factors to early intervention. Alzheimers Res Ther. 2017;12:71. doi: 10.1186/s13195-017-0297-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-017-0297-z</ArticleId><ArticleId IdType="pmc">PMC5596480</ArticleId><ArticleId IdType="pubmed">28899416</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Disease International. The global impact of dementia: an analysis of pervalence, incidence, cost and trends. World Alzheimer Report 2015. London: Alzheimer&#x2019;s Disease International; 2015.</Citation></Reference><Reference><Citation>Takizawa C, Thompson PL, van Walsem A, et al. Epidemiological and economic burden of Alzheimer&#x2019;s disease: a systematic literature review of data across Europe and the United States of America. J Alzheimers Dis. 2015;43:1271&#x2013;1284. doi: 10.3233/JAD-141134.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-141134</ArticleId><ArticleId IdType="pubmed">25159675</ArticleId></ArticleIdList></Reference><Reference><Citation>Deb A, Thornton JD, Sambamoorthi U, Innes K. Direct and indirect cost of managing Alzheimer's disease and related dementias in the United States. Expert Rev Pharmacoecon Outcomes Res. 2017;17:189&#x2013;202. doi: 10.1080/14737167.2017.1313118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737167.2017.1313118</ArticleId><ArticleId IdType="pmc">PMC5494694</ArticleId><ArticleId IdType="pubmed">28351177</ArticleId></ArticleIdList></Reference><Reference><Citation>Weller J, Budson A. Current understanding of Alzheimer's disease diagnosis and treatment. F1000Res 2018;31:F1000 Faculty Rev-1161.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Koca E, Ta&#x15f;kapilio&#x11f;lu &#xd6;, Bakar M. Caregiver burden in different stages of Alzheimer's disease. Noro Psikiyatr Ars. 2017;54:82&#x2013;86. doi: 10.5152/npa.2017.11304.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/npa.2017.11304</ArticleId><ArticleId IdType="pmc">PMC5439478</ArticleId><ArticleId IdType="pubmed">28566965</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira MG, Abreu AR, Rego D, Ferreira G, Lima S. Contributors and moderators of quality of life in caregivers of Alzheimer&#x2019;s disease patient. Exp Aging Res. 2021;47:357&#x2013;372. doi: 10.1080/0361073X.2021.1895594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0361073X.2021.1895594</ArticleId><ArticleId IdType="pubmed">33724160</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider LS, Mangialasche F, Andreasen N, et al. Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014. J Intern Med. 2014;275:251&#x2013;283. doi: 10.1111/joim.12191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12191</ArticleId><ArticleId IdType="pmc">PMC3956752</ArticleId><ArticleId IdType="pubmed">24605808</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P, Sun F. Aducanumab: the first targeted Alzheimer's therapy. Drug Discov Ther. 2021;15:166&#x2013;168. doi: 10.5582/ddt.2021.01061.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2021.01061</ArticleId><ArticleId IdType="pubmed">34234067</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovici GD. Controversy and progress in Alzheimer's Disease&#x2014;FDA approval of aducanumab. N Engl J Med. 2021;385:771&#x2013;774. doi: 10.1056/NEJMp2111320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2111320</ArticleId><ArticleId IdType="pubmed">34320284</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullard A. Landmark Alzheimer's drug approval confounds research community. Nature. 2021;594:309&#x2013;310. doi: 10.1038/d41586-021-01546-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01546-2</ArticleId><ArticleId IdType="pubmed">34103732</ArticleId></ArticleIdList></Reference><Reference><Citation>Decourt B, Boumelhem F, Pope ED 3rd, et al. Critical appraisal of amyloid lowering agents in AD. Curr Neurol Neurosci Rep. 2021;21. 10.1007/s11910-021-01125-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8192384</ArticleId><ArticleId IdType="pubmed">34110536</ArticleId></ArticleIdList></Reference><Reference><Citation>Chisholm O, Sharry P, Phillips L. Multi-criteria decision analysis for benefit-risk analysis by national regulatory authorities. Front Med. 2022;8:820335. doi: 10.3389/fmed.2021.820335.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.820335</ArticleId><ArticleId IdType="pmc">PMC8790083</ArticleId><ArticleId IdType="pubmed">35096913</ArticleId></ArticleIdList></Reference><Reference><Citation>Adunlin G, Diaby V, Montero AJ, Xiao H. Multicriteria decision analysis in oncology. Health Expect. 2015;18:1812&#x2013;1826. doi: 10.1111/hex.12178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hex.12178</ArticleId><ArticleId IdType="pmc">PMC4318795</ArticleId><ArticleId IdType="pubmed">24635949</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermersch P, Martinelli V, Pfleger C, et al. Benefit-risk assessment of cladribine using multi-criteria decision analysis for patients with relapsing-remitting multiple sclerosis. Clin Ther. 2019;41:249&#x2013;260. doi: 10.1016/j.clinthera.2018.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2018.12.015</ArticleId><ArticleId IdType="pubmed">30846120</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohekar S, Ramachandran M. Application of multi-criteria decision making to sustainable energy planning-a review. Renew Sustain Energy Rev. 2004;8:2004. doi: 10.1016/j.rser.2003.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rser.2003.12.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetghebeur MM, Wagner M, Khoury H, et al. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis: applying the EVIDEM framework to medicines appraisal. Med Decis Mak. 2012;32:376&#x2013;388. doi: 10.1177/0272989X11416870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0272989X11416870</ArticleId><ArticleId IdType="pubmed">21987539</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh K, IJzerman M, Thokala P, et al. ISPOR Task Force. Multiple criteria decision analysis for health care decision making-emerging good practices: report 2 of the ISPOR MCDA emerging good practices task force. Value Health. 2016;19:125&#x2013;137. doi: 10.1016/j.jval.2015.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2015.12.016</ArticleId><ArticleId IdType="pubmed">27021745</ArticleId></ArticleIdList></Reference><Reference><Citation>van Til J, Groothuis-Oudshoorn C, Lieferink M, et al. Does technique matter; a pilot study exploring weighting techniques for a multi-criteria decision support framework. Cost Eff Resour Alloc. 2014 doi: 10.1186/1478-7547-12-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1478-7547-12-22</ArticleId><ArticleId IdType="pmc">PMC4406027</ArticleId><ArticleId IdType="pubmed">25904823</ArticleId></ArticleIdList></Reference><Reference><Citation>van Til JA, Dolan JG, Stiggelbout AM, et al. The use of multi-criteria decision analysis weight elicitation techniques in patients with mild cognitive impairment: a pilot study. Patient. 2008;1:127&#x2013;135. doi: 10.2165/01312067-200801020-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/01312067-200801020-00008</ArticleId><ArticleId IdType="pubmed">22272809</ArticleId></ArticleIdList></Reference><Reference><Citation>Garau M, Hampson G, Devlin N, Mazzanti NA, Profico A. Applying a multicriteria decision analysis approach to elicit stakeholders' preferences in Italy: the case of obinutuzumab for rituximab-refractory indolent non-Hodgkin lymphoma. Pharmacoecon Open. 2018;2:153&#x2013;216. doi: 10.1007/s41669-017-0048-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41669-017-0048-x</ArticleId><ArticleId IdType="pmc">PMC5972119</ArticleId><ArticleId IdType="pubmed">29623625</ArticleId></ArticleIdList></Reference><Reference><Citation>Saaty TL. Highlights and critical points in the theory and application of the analytic hierarchy process. Eur J Oper Res. 1984;74:426&#x2013;447. doi: 10.1016/0377-2217(94)90222-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0377-2217(94)90222-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauer F, Schmidt K, Babac A, et al. Comparison of different approaches applied in analytic hierarchy process&#x2014;an example of information needs of patients with rare disease. BMC Med Inform Decis Mak. 2016;16:117. doi: 10.1186/s12911-016-0346-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-016-0346-8</ArticleId><ArticleId IdType="pmc">PMC5016921</ArticleId><ArticleId IdType="pubmed">27613239</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt K, Babac A, Pauer F, et al. Measuring patients' priorities using the analytic hierarchy process in comparison with best-worst-scaling and rating cards: methodological aspects and ranking tasks. Health Econ Rev. 2016;6:50. doi: 10.1186/s13561-016-0130-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13561-016-0130-6</ArticleId><ArticleId IdType="pmc">PMC5108732</ArticleId><ArticleId IdType="pubmed">27844450</ArticleId></ArticleIdList></Reference><Reference><Citation>Goepel KD. Implementation of an online software tool for the analytic hierarchy process (AHP-OS). IJAHP, 10 2018. https://ijahp.org/index.php/IJAHP/article/view/590. Accessed June 15, 2022.</Citation></Reference><Reference><Citation>Jost L. Partitioning diversity into independent alpha and beta components. Ecology. 2007;88:2427&#x2013;2439. doi: 10.1890/06-1736.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1890/06-1736.1</ArticleId><ArticleId IdType="pubmed">18027744</ArticleId></ArticleIdList></Reference><Reference><Citation>Se Thoe E, Fauzi A, Tang YQ, Chamyuang S, Chia AYY. A review on advances of treatment modalities for Alzheimer's disease. Life Sci. 2021;276:119&#x2013;129. doi: 10.1016/j.lfs.2021.119129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119129</ArticleId><ArticleId IdType="pubmed">33515559</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36412170</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-5708</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of geriatric psychiatry and neurology</Title><ISOAbbreviation>J Geriatr Psychiatry Neurol</ISOAbbreviation></Journal><ArticleTitle>Caregiver Experiences Navigating the Diagnostic Journey in a Rapidly Progressing Dementia.</ArticleTitle><Pagination><StartPage>282</StartPage><EndPage>294</EndPage><MedlinePgn>282-294</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/08919887221135552</ELocationID><Abstract><AbstractText Label="INTRODUCTION">People with suspected Alzheimer's disease and related dementias (ADRD) and their families experience a burdensome process while seeking a diagnosis. These challenges are problematic in the most common dementia syndromes, but they can be even more distressing in rarer, atypical syndromes such as rapidly progressive dementias (RPDs), which can be fatal within months from onset. This study is an examination of the diagnostic journey experience from the perspective of caregivers of people who died from the prototypic RPD, sporadic Creutzfeldt-Jakob Disease (sCJD).</AbstractText><AbstractText Label="METHODS">eIn this mixed-methods study, qualitative data were drawn from interviews with former caregivers of 12 people who died from sCJD. Chart review data were drawn from research and clinical chart data about the person with sCJD. Data were analyzed by a multidisciplinary research team using qualitative and descriptive statistical analysis.</AbstractText><AbstractText Label="RESULTS">We identified 4 overarching themes that characterized the experience of the diagnostic journey in sCJD: clinician knowledge, clinician communication, experiences of uncertainty, and the caregiver as advocate. We also identified 4 phases along the diagnostic journey: recognition, the diagnostic workup, diagnosis, and post-diagnosis. Sub-themes within each phase include struggles to recognize what is wrong, complex processes of testing and referrals, delay and disclosure of diagnosis, and access to resources post-diagnosis.</AbstractText><AbstractText Label="CONCLUSIONS">Findings suggest that more work is needed to improve clinician diagnostic knowledge and communication practices. Furthermore, caregivers need better support during the diagnostic journey. What we learn from studying sCJD and other RPDs is likely applicable to other more common dementias.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sideman</LastName><ForeName>Alissa Bernstein</ForeName><Initials>AB</Initials><Identifier Source="ORCID">0000-0002-4433-5748</Identifier><AffiliationInfo><Affiliation>Institute for Health Policy Studies, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Brain Health Institute, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Humanities and Social Sciences, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilissen</LastName><ForeName>Joni</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Global Brain Health Institute, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department Family Medicine &amp; Chronic Care, Vrije Universiteit Brussel(VUB), Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>Krista L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Institute for Health Policy Studies, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Brain Health Institute, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Geriatrics, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garrett</LastName><ForeName>Sarah B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Institute for Health Policy Studies, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terranova</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ritchie</LastName><ForeName>Christine S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Global Brain Health Institute, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Mongan Institute and the Division of Palliative Care and Geriatric Medicine, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geschwind</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K01 AG059831</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 AG059840</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AG055619</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HS022241</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG031189</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AG024892</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AG060590</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG062562</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Geriatr Psychiatry Neurol</MedlineTA><NlmUniqueID>8805645</NlmUniqueID><ISSNLinking>0891-9887</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C565143">Creutzfeldt-Jakob Disease, Sporadic</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007562" MajorTopicYN="Y">Creutzfeldt-Jakob Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">caregiver</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">diagnosis</Keyword><Keyword MajorTopicYN="N">jakob-creutzfeldt</Keyword><Keyword MajorTopicYN="N">misdiagnosis</Keyword><Keyword MajorTopicYN="N">prion</Keyword><Keyword MajorTopicYN="N">rapidly progressing disease</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>4</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36412170</ArticleId><ArticleId IdType="mid">NIHMS1891978</ArticleId><ArticleId IdType="pmc">PMC10265278</ArticleId><ArticleId IdType="doi">10.1177/08919887221135552</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Amjad H, Roth DL, Sheehan OC, Lyketsos CG, Wolff JL, Samus QM. Underdiagnosis of Dementia: an Observational Study of Patterns in Diagnosis and Awareness in US Older Adults. J Gen Intern Med. 2018;33(7):1131-1138. doi:10.1007/s11606-018-4377-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-018-4377-y</ArticleId><ArticleId IdType="pmc">PMC6025653</ArticleId><ArticleId IdType="pubmed">29508259</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford A, Kunik ME, Schulz P, Williams SP, Singh H. Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors. Alzheimer Dis Assoc Disord. 2009;23(4):306-314. doi:10.1097/WAD.0b013e3181a6bebc</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0b013e3181a6bebc</ArticleId><ArticleId IdType="pmc">PMC2787842</ArticleId><ArticleId IdType="pubmed">19568149</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s disease facts and figures. Alzheimer&#x2019;s Dementia. 2020;16(3):391-460. doi:10.1002/alz.12068</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12068</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Boise L, Camicioli R, Morgan DL, Rose JH, Congleton L. Diagnosing dementia: Perspectives of primary care physicians. Gerontol. 1999;39(4):457-464. doi:10.1093/geront/39.4.457</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/39.4.457</ArticleId><ArticleId IdType="pubmed">10495584</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinton L, Franz CE, Reddy G, Flores Y, Kravitz RL, Barker JC. Practice constraints, behavioral problems, and dementia care: primary care physicians&#x2019; perspectives. J Gen Intern Med. 2007;22(11):1487-1492</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2219799</ArticleId><ArticleId IdType="pubmed">17823840</ArticleId></ArticleIdList></Reference><Reference><Citation>Boustani M, Perkins AJ, Fox C, et al.Who refuses the diagnostic assessment for dementia in primary care? Int J Geriatr Psychiatr. 2006;21(6):556-563. doi:10.1002/gps.1524</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.1524</ArticleId><ArticleId IdType="pubmed">16783796</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokomizo JE, Simon SS, de Campos Bottino CM. Cognitive screening for dementia in primary care: a systematic review. Int Psychogeriatr. 2014;26(11):1783-1804. doi:10.1017/S1041610214001082</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610214001082</ArticleId><ArticleId IdType="pubmed">25023857</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordell CB, Borson S, Boustani M, et al.Alzheimer&#x2019;s Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimer's Dementia. 2013;9(2):141-150</Citation><ArticleIdList><ArticleId IdType="pubmed">23265826</ArticleId></ArticleIdList></Reference><Reference><Citation>Iliffe S, Wilcock J. The identification of barriers to the recognition of, and response to, dementia in primary care using a modified focus group approach. Dementia. 2005;4(1):73-85. doi:10.1177/1471301205049191</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301205049191</ArticleId></ArticleIdList></Reference><Reference><Citation>Brayne C, Fox C. Dementia Screening in Primary Care. JAMA. 2007;298(20):2409-2412</Citation><ArticleIdList><ArticleId IdType="pubmed">18042918</ArticleId></ArticleIdList></Reference><Reference><Citation>Russ TC, Calvert L, Morling JR. Attitudes to shared care for patients with dementia: A survey of general practitioners. Dementia. 2013;12(5):606-618. doi:10.1177/1471301212437781</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301212437781</ArticleId><ArticleId IdType="pubmed">24337332</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris DP, Chodosh J, Vassar SD, Vickrey BG, Shapiro MF. Primary care providers&#x2019; views of challenges and rewards of dementia care relative to other conditions. J Am Geriatr Soc. 2009;57(12):2209-2216. doi:10.1111/j.1532-5415.2009.02572.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2009.02572.x</ArticleId><ArticleId IdType="pmc">PMC3832192</ArticleId><ArticleId IdType="pubmed">19943831</ArticleId></ArticleIdList></Reference><Reference><Citation>Boise L, Morgan DL, Kaye J, Camicioli R. Delays in the diagnosis of dementia: Perspectives of family caregivers. Am J Alzheimers Dis Other Demen. 1999;14(1):20-26. doi:10.1177/153331759901400101</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/153331759901400101</ArticleId></ArticleIdList></Reference><Reference><Citation>Geschwind MD, Shu H, Haman A, Sejvar JJ, Miller BL. Rapidly progressive dementia. Ann Neurol. 2008;64(1):97-108. doi:10.1002/ana.21430</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21430</ArticleId><ArticleId IdType="pmc">PMC2647859</ArticleId><ArticleId IdType="pubmed">18668637</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson RW, Torres-Chae CC, Kuo AL, et al.Differential diagnosis of Jakob-Creutzfeldt disease. Arch Neurol. 2012;69(12):1578-1582. doi:10.1001/2013.jamaneurol.79</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/2013.jamaneurol.79</ArticleId><ArticleId IdType="pmc">PMC4401069</ArticleId><ArticleId IdType="pubmed">23229042</ArticleId></ArticleIdList></Reference><Reference><Citation>Geschwind MD. Rapidly progressive dementia. CONTINUUM Lifelong Learning in Neurology. 2016;22(2):510-537. Dementia). doi:10.1212/CON.0000000000000319</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CON.0000000000000319</ArticleId><ArticleId IdType="pmc">PMC4879977</ArticleId><ArticleId IdType="pubmed">27042906</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandeborne L, Van Overbeeke E, Dooms M, De Beleyr B, Huys I. Information needs of physicians regarding the diagnosis of rare diseases: A questionnaire-based study in Belgium. Orphanet J Rare Dis. 2019;14(1):1-11. doi:10.1186/s13023-019-1075-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-019-1075-8</ArticleId><ArticleId IdType="pmc">PMC6500578</ArticleId><ArticleId IdType="pubmed">31054581</ArticleId></ArticleIdList></Reference><Reference><Citation>Chitravas N, Jung RS, Kofskey DM, et al.Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol. 2011;70(3):437-444. doi:10.1002/ana.22454</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22454</ArticleId><ArticleId IdType="pmc">PMC3170496</ArticleId><ArticleId IdType="pubmed">21674591</ArticleId></ArticleIdList></Reference><Reference><Citation>Takada LT, Kim MO, Cleveland RW, et al.Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature. Am J Med Genet, Part B: Neuropsychiatric Genetics. 2017;174(1):36-69. doi:10.1002/ajmg.b.32505</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.b.32505</ArticleId><ArticleId IdType="pmc">PMC7207989</ArticleId><ArticleId IdType="pubmed">27943639</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison KL, Garrett SB, Gilissen J, et al.Developing neuropalliative care for sporadic Creutzfeldt-Jakob Disease. Prion. 2022;16(1):23-39. doi:10.1080/19336896.2022.2043077</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2022.2043077</ArticleId><ArticleId IdType="pmc">PMC8896185</ArticleId><ArticleId IdType="pubmed">35239456</ArticleId></ArticleIdList></Reference><Reference><Citation>ATLAS.ti Scientific Software Development GmbH [ATLAS.ti 22 Mac]. (2022). Retrieved fromhttps://atlasti.com</Citation></Reference><Reference><Citation>Geschwind MD. Prion Diseases. Continuum. 2015;21(6):1612. doi:10.1212/CON.0000000000000251</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CON.0000000000000251</ArticleId><ArticleId IdType="pmc">PMC4879966</ArticleId><ArticleId IdType="pubmed">26633779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovici GD, Wang PN, Levin J, et al.First symptom in sporadic Creutzfeldt-Jakob disease. Neurology. 2006;66(2):286-287. doi:10.1212/01.WNL.0000196440.00297.67</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000196440.00297.67</ArticleId><ArticleId IdType="pubmed">16434680</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson RW, Takada LT, Geschwind MD. Diagnosis and treatment of rapidly progressive dementias. Neurol Clin Pract. 2012;2(3):187-200. doi:10.1212/CPJ.0B013E31826B2AE8</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0B013E31826B2AE8</ArticleId><ArticleId IdType="pmc">PMC3613204</ArticleId><ArticleId IdType="pubmed">23634367</ArticleId></ArticleIdList></Reference><Reference><Citation>Samsi K, Abley C, Campbell S, et al.Negotiating a Labyrinth: Experiences of assessment and diagnostic journey in cognitive impairment and dementia. Int J Geriatr Psychiatr. 2014;29(1):58-67. doi:10.1002/gps.3969</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.3969</ArticleId><ArticleId IdType="pubmed">23625551</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernacki RE, Block SD. Communication about serious illness care goals: A review and synthesis of best practices. JAMA Intern Med. 2014;174(12):1994-2003. doi:10.1001/jamainternmed.2014.5271</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2014.5271</ArticleId><ArticleId IdType="pubmed">25330167</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafir A, Ritchie CS, Garrett SB, et al.Captive by the Uncertainty&#x201d; - Experiences with Anticipatory Guidance for People Living with Dementia and Their Caregivers at a Specialty Dementia Clinic. J Alzheim Dis. 2022;86(2):787-800. doi:10.3233/JAD-215203</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-215203</ArticleId><ArticleId IdType="pmc">PMC9717709</ArticleId><ArticleId IdType="pubmed">35124641</ArticleId></ArticleIdList></Reference><Reference><Citation>Uflacker A, Edmondson MC, Onyike CU, Appleby BS. Caregiver burden in atypical dementias: comparing frontotemporal dementia, Creutzfeldt&#x2013;Jakob disease, and Alzheimer&#x2019;s disease. Int Psychogeriatr. 2016;28(02):269-273. doi:10.1017/S1041610215001647</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610215001647</ArticleId><ArticleId IdType="pubmed">26435062</ArticleId></ArticleIdList></Reference><Reference><Citation>Possin KL, Merrilees JJ, Dulaney S, et al.Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use: The Care Ecosystem Randomized Clinical Trial. 2019. doi:10.1001/jamainternmed.2019.4101</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2019.4101</ArticleId><ArticleId IdType="pmc">PMC6777227</ArticleId><ArticleId IdType="pubmed">31566651</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernacki RE, Block SD. Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med. 2014;174(12):1994-2003. doi:10.1001/JAMAINTERNMED.2014.5271</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMAINTERNMED.2014.5271</ArticleId><ArticleId IdType="pubmed">25330167</ArticleId></ArticleIdList></Reference><Reference><Citation>Geschwind MD, Kuo AL, Wong KS, et al.Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease. Neurology. 2013;81(23):2015-2023. doi:10.1212/WNL.0B013E3182A9F3B4</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0B013E3182A9F3B4</ArticleId><ArticleId IdType="pmc">PMC4211922</ArticleId><ArticleId IdType="pubmed">24122181</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha&#xef;k S, Marcon G, Mallet A, et al.Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2014;13(2):150-158. doi:10.1016/S1474-4422(13)70307-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70307-7</ArticleId><ArticleId IdType="pubmed">24411709</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36409283</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1758-5368</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>Suppl 1</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>13</Day></PubDate></JournalIssue><Title>The journals of gerontology. Series B, Psychological sciences and social sciences</Title><ISOAbbreviation>J Gerontol B Psychol Sci Soc Sci</ISOAbbreviation></Journal><ArticleTitle>Conceptualizing and Operationalizing Collaboration Among Multiple Caregivers of Older Adults.</ArticleTitle><Pagination><StartPage>S27</StartPage><EndPage>S37</EndPage><MedlinePgn>S27-S37</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/geronb/gbac139</ELocationID><Abstract><AbstractText Label="OBJECTIVES">In many families, multiple caregivers support older adults living with dementia. Studying collaboration among caregivers requires consideration of conceptual and methodological issues that have not been fully explored. This study presents a framework for conceptualizing caregiver collaboration and an index that captures variation in collaboration among multiple caregivers within care networks.</AbstractText><AbstractText Label="METHODS">We used data from the 2015 waves of the National Health and Aging Trends Study and National Study of Caregiving (NSOC) to operationalize collaboration among multiple caregivers (N = 1,298) of 552 care recipients (Mage = 83.69, SD = 7.73; 71.6% women; 47.9% possible/probable dementia; 38.9% people of color).</AbstractText><AbstractText Label="RESULTS">The care collaboration index considered individual and overlapping contributions while controlling for the size of the care network (caregivers in network responding to NSOC survey) and total network size (number of caregivers in network) in the statistical model. Larger care networks enabled more collaboration, both in general and across most types of tasks (&#x3b2;s &gt; 0.38). Collaboration was greater among those caring for a Black or Hispanic care recipient, both in general and for household and medical/health tasks specifically (&#x3b2;s &gt; 0.11). Collaboration was also greater among those caring for recipients with probable dementia, both in general and for most tasks (&#x3b2;s &gt; 0.11) but not transportation-related tasks (p = .219).</AbstractText><AbstractText Label="DISCUSSION">Results are examined in the context of care network dynamics and proposed mechanisms linking care collaboration to outcomes for caregivers and recipients. Strengths and limitations of our conceptualization and operationalization of collaboration are discussed.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>Katrina R</ForeName><Initials>KR</Initials><Identifier Source="ORCID">0000-0003-1709-3912</Identifier><AffiliationInfo><Affiliation>School of Social Work, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Group Dynamics, Institute for Social Research, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koumoutzis</LastName><ForeName>Athena</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Sociology and Gerontology, Miami University, Oxford, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Jordan P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0001-8915-8004</Identifier><AffiliationInfo><Affiliation>University of Minnesota Medical School, Duluth Campus, Duluth, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Zhiyong</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-1238-7658</Identifier><AffiliationInfo><Affiliation>Department of Sociology, University of Texas at San Antonio, San Antonio, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yuanjin</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-2492-346X</Identifier><AffiliationInfo><Affiliation>Steve Hicks School of Social Work, the University of Texas at Austin, Austin, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chopik</LastName><ForeName>William J</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Department of Psychology, Michigan State University, East Lansing, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Research Center for Group Dynamics, Institute for Social Research, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG059300</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA046592</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30AG059300</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30CA046592</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Gerontol B Psychol Sci Soc Sci</MedlineTA><NlmUniqueID>9508483</NlmUniqueID><ISSNLinking>1079-5014</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060756" MajorTopicYN="N">Social Networking</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Caregiving</Keyword><Keyword MajorTopicYN="N">Collaboration</Keyword><Keyword MajorTopicYN="N">Social networks</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>21</Day><Hour>10</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36409283</ArticleId><ArticleId IdType="pmc">PMC10010467</ArticleId><ArticleId IdType="doi">10.1093/geronb/gbac139</ArticleId><ArticleId IdType="pii">6835510</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
AARP &amp; National Alliance for Caregiving. (2020). Caregiving in the United States 2020. https://www.aarp.org/ppi/info-2020/caregiving-in-the-united-states.html</Citation></Reference><Reference><Citation>Ali, T., McAvay, G. J., Monin, J. K., &amp; Gill, T. M. (2022). Patterns of caregiving among older adults with and without dementia: A latent class analysis. The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 77(Supplement_1), S74&#x2013;S85. doi:10.1093/geronb/gbab237</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbab237</ArticleId><ArticleId IdType="pmc">PMC9122635</ArticleId><ArticleId IdType="pubmed">35032392</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Association. (2020). 2020 Alzheimer&#x2019;s disease facts and figures. Alzheimer&#x2019;s &amp; Dementia, 16(3), 391&#x2013;460. doi:10.1002/alz.12068</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12068</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson, M. A., &amp; Monin, J. K. (2018). Informal care networks in the context of multimorbidity: Size, composition, and associations with recipient psychological well-being. Journal of Aging and Health, 30(4), 641&#x2013;664. doi:10.1177/0898264316687623</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0898264316687623</ArticleId><ArticleId IdType="pmc">PMC5786491</ArticleId><ArticleId IdType="pubmed">28553797</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes, L. L. (2008). Perceived discrimination and mortality in a population-based study of older adults. American Journal of Public Health, 98(7), 1241. doi:10.2105/AJPH.2007.114397</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2007.114397</ArticleId><ArticleId IdType="pmc">PMC2424090</ArticleId><ArticleId IdType="pubmed">18511732</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes, L. L., &amp; Bennett, D. A. (2014). Alzheimer&#x2019;s disease in African Americans: Risk factors and challenges for the future. Health Affairs, 33(4), 580&#x2013;586. doi:10.1377/hlthaff.2013.1353</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2013.1353</ArticleId><ArticleId IdType="pmc">PMC4084964</ArticleId><ArticleId IdType="pubmed">24711318</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedwell, W. L., Wildman, J. L., DiazGranados, D., Salazar, M., Kramer, W. S., &amp; Salas, E. (2012). Collaboration at work: An integrative multilevel conceptualization. Human Resource Management Review, 22(2), 128&#x2013;145. doi:10.1016/j.hrmr.2011.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrmr.2011.11.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Black, B. S., Johnston, D., Leoutsakos, J., Reuland, M., Kelly, J., Amjad, H., Davis, K., Willink, A., Sloan, D., Lyketsos, C., &amp; Samus, Q. M. (2019). Unmet needs in community-living persons with dementia are common, often non-medical and related to patient and caregiver characteristics. International Psychogeriatrics, 31(11), 1643&#x2013;1654. doi:10.1017/S1041610218002296</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610218002296</ArticleId><ArticleId IdType="pmc">PMC6679825</ArticleId><ArticleId IdType="pubmed">30714564</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantor, M. H. (1979). Neighbors and friends: An overlooked resource in the informal support system. Research on Aging, 1(4), 434&#x2013;463. doi:10.1177/016402757914002</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/016402757914002</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson, W. D., Bangerter, L. R., &amp; Splaine, M. (2020). The politics of caregiving: Taking stock of state-level policies to support family caregivers. Public Policy &amp; Aging Report, 30(2), 62&#x2013;66. doi:10.1093/ppar/praa005</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ppar/praa005</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilworth-Anderson, P., Moon, H., &amp; Aranda, M. P. (2020). Dementia caregiving research: Expanding and reframing the lens of diversity, inclusivity, and intersectionality. Gerontologist, 60(5), 797&#x2013;805. doi:10.1093/geront/gnaa050</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnaa050</ArticleId><ArticleId IdType="pmc">PMC7362616</ArticleId><ArticleId IdType="pubmed">32667672</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilworth-Anderson, P., Williams, I. C., &amp; Gibson, B. E. (2002). Issues of race, ethnicity, and culture in caregiving research: A 20-year review (1980&#x2013;2000). Gerontologist, 42(2), 237&#x2013;272. doi:10.1093/geront/42.2.237</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/42.2.237</ArticleId><ArticleId IdType="pubmed">11914467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducharme, F., L&#xe9;vesque, L., Lachance, L., Kergoat, M.-J., &amp; Coulombe, R. (2011). Challenges associated with transition to caregiver role following diagnostic disclosure of Alzheimer disease: A descriptive study. International Journal of Nursing Studies, 48(9), 1109&#x2013;1119. doi:10.1016/j.ijnurstu.2011.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2011.02.011</ArticleId><ArticleId IdType="pubmed">21376317</ArticleId></ArticleIdList></Reference><Reference><Citation>Esandi, N., Nolan, M., Canga-Armayor, N., Pardavila-Belio, M. I., &amp; Canga-Armayor, A. (2021). Family dynamics and the Alzheimer&#x2019;s disease experience. Journal of Family Nursing, 27(2), 124&#x2013;135. doi:10.1177/1074840720986611</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1074840720986611</ArticleId><ArticleId IdType="pubmed">33563068</ArticleId></ArticleIdList></Reference><Reference><Citation>Fast, J., Keating, N., Otfinowski, P., &amp; Derksen, L. (2004). Characteristics of family/friend care networks of frail seniors. Canadian Journal on Aging/La Revue canadienne du vieillissement, 23(1), 5&#x2013;19. doi:10.1353/cja.2004.0003</Citation><ArticleIdList><ArticleId IdType="doi">10.1353/cja.2004.0003</ArticleId><ArticleId IdType="pubmed">15310087</ArticleId></ArticleIdList></Reference><Reference><Citation>Feld, S., Dunkle, R. E., Schroepfer, T., Shen, H. W. (2006). Expansion of elderly couples&#x2019; IADL caregiver networks beyond the marital dyad. International Journal of Aging and Human Development, 63(2), 95&#x2013;113. doi:10.2190/cw8g-pb6b-ncgh-ht1m</Citation><ArticleIdList><ArticleId IdType="doi">10.2190/cw8g-pb6b-ncgh-ht1m</ArticleId><ArticleId IdType="pubmed">17137029</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster-Fishman, P. G., Berkowitz, S. L., Lounsbury, D. W., Jacobson, S., &amp; Allen, N. A. (2001). Building collaborative capacity in community coalitions: A review and integrative framework. American Journal of Community Psychology, 29(2), 241&#x2013;261. doi:10.1023/A:1010378613583</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1010378613583</ArticleId><ArticleId IdType="pubmed">11446279</ArticleId></ArticleIdList></Reference><Reference><Citation>

Freedman, V. A., Skehan, M. E., Hu, M., Wolff, J., &amp; Kasper, J. D. (2019). National Study of Caregiving I-III User Guide. Baltimore: Johns Hopkins Bloomberg School of Public Health. http://www.nhats.org</Citation></Reference><Reference><Citation>Freedman, V. A., &amp; Spillman, B. C. (2014). Disability and care needs among older Americans. Milbank Quarterly, 92(3), 509&#x2013;541. doi:10.1111/1468-0009.12076</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1468-0009.12076</ArticleId><ArticleId IdType="pmc">PMC4221755</ArticleId><ArticleId IdType="pubmed">25199898</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman, E. M., &amp; Kennedy, D. P. (2021). Typologies of dementia caregiver support networks: A pilot study. Gerontologist, 61(8), 1221&#x2013;1230. doi:10.1093/geront/gnab013</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnab013</ArticleId><ArticleId IdType="pmc">PMC8599268</ArticleId><ArticleId IdType="pubmed">33585929</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman, E. M., Shih, R. A., Langa, K. M., &amp; Hurd, M. D. (2015). US prevalence and predictors of informal caregiving for dementia. Health Affairs, 34(10), 1637&#x2013;1641. doi:10.1377/hlthaff.2015.0510</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2015.0510</ArticleId><ArticleId IdType="pmc">PMC4872631</ArticleId><ArticleId IdType="pubmed">26438738</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves-Pereira, M., Zarit, S. H., Cardoso, A. M., Alves da Silva, J., Papoila, A. L., &amp; Mateos, R. (2020). A comparison of primary and secondary caregivers of persons with dementia. Psychology and Aging, 35(1), 20&#x2013;27. doi:10.1037/pag0000380</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/pag0000380</ArticleId><ArticleId IdType="pubmed">31985246</ArticleId></ArticleIdList></Reference><Reference><Citation>Haley, W. E., West, C. A. C., Wadley, V. G., Ford, G. R., White, F. A., Barrett, J. J., Harrell, L. E., &amp; Roth, D. L. (1995). Psychological, social, and health impact of caregiving: A comparison of Black and White dementia family caregivers and noncaregivers. Psychology and Aging, 10(4), 540&#x2013;552. doi:10.1037/0882-7974.10.4.540</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0882-7974.10.4.540</ArticleId><ArticleId IdType="pubmed">8749581</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall, K. L., Vogel, A. L., Huang, G. C., Serrano, K. J., Rice, E. L., Tsakraklides, S. P., &amp; Fiore, S. M. (2018). The science of team science: A review of the empirical evidence and research gaps on collaboration in science. American Psychologist, 73(4), 532. doi:10.1037/amp0000319</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/amp0000319</ArticleId><ArticleId IdType="pubmed">29792466</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebert, L. E., Weuve, J., Scherr, P. A., &amp; Evans, D. A. (2013). Alzheimer disease in the United States (2010&#x2013;2050) estimated using the 2010 census. Neurology, 80(19), 1778&#x2013;1783. doi:10.1212/wnl.0b013e31828726f5</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0b013e31828726f5</ArticleId><ArticleId IdType="pmc">PMC3719424</ArticleId><ArticleId IdType="pubmed">23390181</ArticleId></ArticleIdList></Reference><Reference><Citation>Karg, N., Graessel, E., Randzio, O., &amp; Pendergrass, A. (2018). Dementia as a predictor of care-related quality of life in informal caregivers: A cross-sectional study to investigate differences in health-related outcomes between dementia and non-dementia caregivers. BMC Geriatrics, 18(1), 189. doi:10.1186/s12877-018-0885-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-018-0885-1</ArticleId><ArticleId IdType="pmc">PMC6108112</ArticleId><ArticleId IdType="pubmed">30139354</ArticleId></ArticleIdList></Reference><Reference><Citation>

Kasper, J. D., Freedman, V. A., &amp; Spillman, B. C. (2013). Classification of persons by dementia status in the National Health and Aging Trends Study. Technical Paper #5. Baltimore: Johns Hopkins University School of Public Health. http://www.nhats.org</Citation></Reference><Reference><Citation>Keith, C. (1995). Family caregiving systems: Models, resources, and values. Journal of Marriage and the Family, 57(1), 179&#x2013;189. doi:10.2307/353826</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/353826</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight, B. G., &amp; Sayegh, P. (2010). Cultural values and caregiving: The updated sociocultural stress and coping model. The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 65(1), 5&#x2013;13. doi:10.1093/geronb/gbp096</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbp096</ArticleId><ArticleId IdType="pubmed">19934166</ArticleId></ArticleIdList></Reference><Reference><Citation>Koehly, L. M., Ashida, S., Schafer, E. J., &amp; Ludden, A. (2015). Caregiving networks-using a network approach to identify missed opportunities. The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 70(1), 143&#x2013;154. doi:10.1093/geronb/gbu111</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbu111</ArticleId><ArticleId IdType="pmc">PMC4296206</ArticleId><ArticleId IdType="pubmed">25224254</ArticleId></ArticleIdList></Reference><Reference><Citation>Lingler, J. H., Sherwood, P. R., Crighton, M. H., Song, M. K., &amp; Happ, M. B. (2008). Conceptual challenges in the study of caregiver&#x2013;care recipient relationships. Nursing Research, 57(5), 367&#x2013;372. doi:10.1097/01.NNR.0000313499.99851.0c</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.NNR.0000313499.99851.0c</ArticleId><ArticleId IdType="pmc">PMC2875992</ArticleId><ArticleId IdType="pubmed">18794721</ArticleId></ArticleIdList></Reference><Reference><Citation>Litwak, E. (1985). Helping the elderly: The complementary roles of informal networks and formal systems. Guilford Press.</Citation></Reference><Reference><Citation>Litwak, E., Messeri, P., &amp; Silverstein, M. (1990). The role of formal and informal groups in providing help to older people. Marriage &amp; Family Review, 15(1&#x2013;2), 171&#x2013;193. doi:10.1300/J002v15n01_09</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J002v15n01_09</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcum, C. S., Ashida, S., &amp; Koehly, L. M. (2020). Primary caregivers in a network context. The Journal of Gerontology, Series B: Psychological Sciences and Social Sciences, 75(1), 125&#x2013;136. doi:10.1093/geronb/gbx165</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbx165</ArticleId><ArticleId IdType="pmc">PMC7179806</ArticleId><ArticleId IdType="pubmed">29304203</ArticleId></ArticleIdList></Reference><Reference><Citation>Marek, L. I., Brock, D. P., &amp; Savla, J. (2015). Evaluating collaboration for effectiveness: Conceptualization and measurement. American Journal of Evaluation, 36(1), 67&#x2013;85. doi:10.1177/1098214014531068</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1098214014531068</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateo, C. M., &amp; Williams, D. R. (2021). Racism: A fundamental driver of racial disparities in health-care quality. Nature Reviews Disease Primers, 7(1), 20. doi:10.1038/s41572-021-00258-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-021-00258-1</ArticleId><ArticleId IdType="pubmed">33707457</ArticleId></ArticleIdList></Reference><Reference><Citation>Messeri, P., Silverstein, M., &amp; Litwak, E. (1993). Choosing optimal support groups: A review and reformulation. Journal of Health and Social Behavior, 34(2), 122&#x2013;137. doi:10.2307/2137239</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2137239</ArticleId><ArticleId IdType="pubmed">8277125</ArticleId></ArticleIdList></Reference><Reference><Citation>Navaie-Waliser, M., Feldman, P. H., Gould, D. A., Levine, C., Kuerbis, A. N., &amp; Donelan, K. (2001). The experiences and challenges of informal caregivers: Common themes and differences among Whites, Blacks, and Hispanics. Gerontologist, 41(6), 733&#x2013;741. doi:10.1093/geront/41.6.733</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/41.6.733</ArticleId><ArticleId IdType="pubmed">11723341</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker, L. J., Fabius, C., Rivers, E., &amp; Taylor, J. L. (2021). Is dementia-specific caregiving compared with non-dementia caregiving associated with physical difficulty among caregivers for community-dwelling adults? Journal of Applied Gerontology, 41(6), 1074&#x2013;1080. doi:10.1177/07334648211014352</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/07334648211014352</ArticleId><ArticleId IdType="pmc">PMC8664093</ArticleId><ArticleId IdType="pubmed">34041929</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearlin, L. I., Mullan, J. T., Semple, S. J., &amp; Skaff, M. M. (1990). Caregiving and the stress process: An overview of concepts and their measures. Gerontologist, 30(5), 583&#x2013;594. doi:10.1093/geront/30.5.583</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/30.5.583</ArticleId><ArticleId IdType="pubmed">2276631</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponnala, S., Weiler, D. T., Gilmore-Bykovskiy, A., Block, L., Kind, A. J., &amp; Werner, N. E. (2018). Towards an understanding of informal care networks of persons with dementia: Perceptions of primary caregivers. Proceedings of the Human Factors and Ergonomics Society Annual Meeting, 62(1), 561&#x2013;562. doi:10.1177/1541931218621128</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1541931218621128</ArticleId></ArticleIdList></Reference><Reference><Citation>Qualls, S. H. (2014). Family therapy with ageing families. In Pachana N. A. &amp; Laidlaw K. (Eds.), The Oxford handbook of clinical geropsychology (pp. 710&#x2013;732). Oxford University Press.</Citation></Reference><Reference><Citation>Schulz, R., Beach, S. R., Czaja, S. J., Martire, L. M., &amp; Monin, J. K. (2020). Family caregiving for older adults. Annual Review of Psychology, 71, 635&#x2013;659. doi:10.1146/annurev-psych-010419-050754</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-psych-010419-050754</ArticleId><ArticleId IdType="pmc">PMC7291827</ArticleId><ArticleId IdType="pubmed">31905111</ArticleId></ArticleIdList></Reference><Reference><Citation>Spillman, B. C., Freedman, V. A., Kasper, J. D., &amp; Wolff, J. L. (2020). Change over time in caregiving networks for older adults with and without dementia. The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 75(7), 1563&#x2013;1572. doi:10.1093/geronb/gbz065</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbz065</ArticleId><ArticleId IdType="pmc">PMC7424285</ArticleId><ArticleId IdType="pubmed">31102533</ArticleId></ArticleIdList></Reference><Reference><Citation>Stommel, M., Given, B. A., Given, C. W., &amp; Collins, C. (1995). The impact of the frequency of care activities on the division of labor between primary caregivers and other care providers. Research on Aging, 17(4), 412&#x2013;433. doi:10.1177/0164027595174003</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0164027595174003</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson, A. M., Perry, J. L., &amp; Miller, T. K. (2007). Conceptualizing and measuring collaboration. Journal of Public Administration Research and Theory, 19(1), 23&#x2013;56. doi:10.1093/jopart/mum036</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jopart/mum036</ArticleId></ArticleIdList></Reference><Reference><Citation>Usita, P. M., Hall, S. S., &amp; Davis, J. C. (2004). Role ambiguity in family caregiving. Journal of Applied Gerontology, 23(1), 20&#x2013;39. doi:10.1177/0733464803253591</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464803253591</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood, D. J., &amp; Gray, B. (1991). Toward a comprehensive theory of collaboration. The Journal of Applied Behavioral Science, 27(2), 139&#x2013;162. doi:10.1177/0021886391272001</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0021886391272001</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, J., Liu, P.-J., &amp; Beach, S. (2021). Multiple caregivers, many minds: Family discord and caregiver outcomes. Gerontologist, 61(5), 661&#x2013;669. doi:10.1093/geront/gnaa067</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnaa067</ArticleId><ArticleId IdType="pubmed">32539097</ArticleId></ArticleIdList></Reference><Reference><Citation>Young, H. M., Bell, J. F., Whitney, R. L., Ridberg, R. A., Reed, S. C., &amp; Vitaliano, P. P. (2020). Social determinants of health: Underreported heterogeneity in systematic reviews of caregiver interventions. Gerontologist, 60(Supplement_1), S14&#x2013;S28. doi:10.1093/geront/gnz148</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnz148</ArticleId><ArticleId IdType="pmc">PMC7019663</ArticleId><ArticleId IdType="pubmed">32057083</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36404541</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-8908</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><Issue>1</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>A Qualitative Study on the Experiences of Therapists Delivering the Promoting Activity, Independence and Stability in Early Dementia (PrAISED) Intervention During the COVID-19 Pandemic.</ArticleTitle><Pagination><StartPage>203</StartPage><EndPage>214</EndPage><MedlinePgn>203-214</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-220424</ELocationID><Abstract><AbstractText Label="BACKGROUND">The Promoting Activity, Independence and Stability in Early Dementia (PrAISED) intervention is a programme of physical activity and exercise designed to maintain participation in activities of daily living, mobility, and quality of life for people living with dementia. During the COVID-19 pandemic first national lockdown in England, the PrAISED physiotherapists, occupational therapists, and rehabilitation support workers adapted to delivering the intervention remotely via telephone or video conferencing.</AbstractText><AbstractText Label="OBJECTIVE">The aim of this study was to explore therapists' experience of delivering the PrAISED intervention during the COVID-19 pandemic and derive implications for clinical practice.</AbstractText><AbstractText Label="METHODS">Qualitative semi-structured interviews were conducted with 16 therapists using purposive sampling. Thematic analysis was used to analyze the transcripts.</AbstractText><AbstractText Label="RESULTS">Therapists reported a change in the relationship between themselves, the person with dementia and the caregiver, with an increased reliance on the caregiver and a loss of autonomy for the person living with dementia. There was concern that this would increase the burden on the caregiver. The therapists reported using creativity to adapt to different modes of delivery. They felt their sessions were mostly focused on providing social and emotional support, and that assessing, progressing, and tailoring the intervention was difficult.</AbstractText><AbstractText Label="CONCLUSION">It is possible to deliver some elements of a physical intervention using remote delivery, but a dual modal approach including remote and face-to-face delivery would optimize treatment efficacy. Educational support would be required to enable people living with dementia and their caregivers to overcome barriers relating to digital literacy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cowley</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Injury, Inflammation and Recovery Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Booth</LastName><ForeName>Vicky</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Injury, Inflammation and Recovery Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Lorito</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unit of Injury, Inflammation and Recovery Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandria</LastName><ForeName>Pooja</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Nairobi, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chadwick</LastName><ForeName>Olivia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanislas</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Isokinetic Medical Group, Harley Street, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunlop</LastName><ForeName>Marianne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Health Sciences, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howe</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Unit of Injury, Inflammation and Recovery Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Health Sciences, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harwood</LastName><ForeName>Rowan H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>School of Health Sciences, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Logan</LastName><ForeName>Pip A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Unit of Injury, Inflammation and Recovery Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Applied Research Collaboration East Midlands (ARC-EM), Nottingham, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nottingham CityCare Partnership CIC, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RP-PG-061- 20007</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">exercise</Keyword><Keyword MajorTopicYN="N">physical activity</Keyword><Keyword MajorTopicYN="N">rehabilitation</Keyword><Keyword MajorTopicYN="N">telerehabilitation</Keyword></KeywordList><CoiStatement>Authors&#x2019; disclosures available online (https://www.j-alz.com/manuscript-disclosures/22-0424r1).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>21</Day><Hour>1</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36404541</ArticleId><ArticleId IdType="pmc">PMC9881024</ArticleId><ArticleId IdType="doi">10.3233/JAD-220424</ArticleId><ArticleId IdType="pii">JAD220424</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Martyr A, Clare L (2012) Executive function and activities of daily living in Alzheimer&#x2019;s disease: A correlational meta-analysis. Dement Geriatr Cogn Disord 33, 189&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">22572810</ArticleId></ArticleIdList></Reference><Reference><Citation>Giebel CM, Sutcliffe C, Stolt M, Karlsson S, Renom-Guiteras A, Soto M, Verbeek H, Zabalegui A, Challis D (2014) Deterioration of basic activities of daily living and their impact on quality of life across different cognitive stages of dementia: A European study. Int Psychogeriatr 26, 1283&#x2013;1293.</Citation><ArticleIdList><ArticleId IdType="pubmed">24784234</ArticleId></ArticleIdList></Reference><Reference><Citation>Giebel CM, Sutcliffe C, Challis D (2015) Activities of daily living and quality of life across different stages of dementia: A UK study. Aging Ment Health 19, 63&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">24831511</ArticleId></ArticleIdList></Reference><Reference><Citation>Potter R, Ellard D, Rees K, Thorogood M (2011) A systematic review of the effects of physical activity on physical functioning, quality of life and depression in older people with dementia. Int J Geriatr Psychiatry 26, 1000&#x2013;1011.</Citation><ArticleIdList><ArticleId IdType="pubmed">21905096</ArticleId></ArticleIdList></Reference><Reference><Citation>Forbes D, Forbes SC, Blake CM, Thiessen EJ, Forbes S (2015) Exercise programs for people with dementia. Cochrane Database Syst Rev 2015, CD006489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9426996</ArticleId><ArticleId IdType="pubmed">25874613</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankevoort CG, van Heuvelen MJG, Boersma F, Luning H, de Jong J, Scherder EJA (2010) Review of effects of physical activity on strength, balance, mobility and ADL performance in elderly subjects with dementia. Dement Geriatr Cogn Disord 30, 392&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">20980758</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyn P, Abreu BC, Ottenbacher KJ (2004) The effects of exercise training on elderly persons with cognitive impairment and dementia: A meta-analysis. Arch Phys Med 85, 1694&#x2013;1704.</Citation><ArticleIdList><ArticleId IdType="pubmed">15468033</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauer K, Schwenk M, Zieschang T, Essig M, Becker C, Oster P (2012) Physical training improves motor performance in people with dementia: A randomized controlled trial. J Am Geriatr Soc 60, 8&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">22211512</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb SE, Sheehan B, Atherton N, Nichols V, Collins H, Mistry D, Dosanjih S, Slowther AM, Khan I, Petrou S, Lall R (2018) Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: Randomised controlled trial. BMJ 361, k1675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5953238</ArticleId><ArticleId IdType="pubmed">29769247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowery D, Cerga-Pashoja A, Iliffe S, Thun&#xe9;-Boyle I, Griffin M, Lee J, Bailey A, Bhattacharya R, Warner J (2014) The effect of exercise on behavioural and psychological symptoms of dementia: The EVIDEM-E randomised controlled clinical trial. Int J Geriatr Psychiatry 29, 819&#x2013;827.</Citation><ArticleIdList><ArticleId IdType="pubmed">24338799</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwenk M, Zieschang T, Englert S, Grewal G, Najafi B, Hauer K (2014) Improvements in gait characteristics after intensive resistance and functional training in people with dementia: A randomised controlled trial. BMC Geriatr 14, 73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4062767</ArticleId><ArticleId IdType="pubmed">24924703</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki T, Shimada H, Makizako H, Doi T, Yoshida D, Tsutsumimoto K, Anan Y, Uemura K, Lee S, Park H, (2012) Effects of multicomponent exercise on cognitive function in older adults with amnestic mild cognitive impairment: A randomized controlled trial. BMC Neurol 12, 128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3534485</ArticleId><ArticleId IdType="pubmed">23113898</ArticleId></ArticleIdList></Reference><Reference><Citation>Telenius EW, Engedal K, Bergland A (2015) Effect of a high-intensity exercise program on physical function and mental health in nursing home residents with dementia: An assessor blinded randomized controlled trial. PloS One 10, e0126102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4431827</ArticleId><ArticleId IdType="pubmed">25974049</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann K, Sobol NA, Frederiksen KS, Beyer N, Vestergaard K, Br&#xe6;ndgaard H, Gottrup H, Lolk A, Wermuth L, Jacobsen S, Laugesen L, Gergelyffy R, H&#xf8;gh P, Bjerregaard E, Vogel A, Johannsen P, Cotman C, Hassalbalch SG, Waldemar G (2015) Moderate to high-intensity physical exercise in patients with Alzheimer&#x2019;s disease. Alzheimers Dement 11, P324&#x2013;P5.</Citation><ArticleIdList><ArticleId IdType="pubmed">26682695</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwenk M, Zieschang T, Oster P, Hauer K (2010) Dual-task performances can be improved in patients with dementia: A randomized controlled trial. Neurology 74, 1961&#x2013;1968.</Citation><ArticleIdList><ArticleId IdType="pubmed">20445152</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitk&#xe4;l&#xe4; KH, P&#xf6;ysti MM, Laakkonen M-L, Tilvis RS, Savikko N, Kautiainen H, Strandberg TE (2013) Effects of the Finnish Alzheimer Disease Exercise Trial (FINALEX): A randomized controlled trial. JAMA Intern Med 173, 894&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pubmed">23589097</ArticleId></ArticleIdList></Reference><Reference><Citation>Prick AE, Lange J, Scherder EJA, Twisk JWR, Pot AM (2016) The effects of a multicomponent dyadic intervention on the mood, behavior, and physical health of people with dementia: A randomized controlled trial. Clin Interv Aging 11, 383&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4820235</ArticleId><ArticleId IdType="pubmed">27099480</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajwa RK, Goldberg SE, Van der Wardt V, Burgon C, Di Lorito C, Godfrey M, Dunlop M, Logan P, Masud T, Gladman J, Smith H, Hood-Moore V, Booth V, Das Nair R, Pollock K, Vedhara K, Edwards RT, Jones C, Hoare Z, Brand A, Harwood RH (2019) A randomised controlled trial of an exercise intervention promoting activity, independence and stability in older adults with mild cognitive impairment and early dementia (PrAISED) - A Protocol. Trials 20, 815.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6937783</ArticleId><ArticleId IdType="pubmed">31888709</ArticleId></ArticleIdList></Reference><Reference><Citation>Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R (2020) COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res 24, 91&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7113610</ArticleId><ArticleId IdType="pubmed">32257431</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith GD, Spiegelhalter D (2020) Shielding from covid-19 should be stratified by risk. BMJ 369, m2063&#x2013;m.</Citation><ArticleIdList><ArticleId IdType="pubmed">32467287</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelman KD, Hartman LM (2009) Telerehabilitation: Policy issues and research tools. Int J Telerehabil 1, 47&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4296776</ArticleId><ArticleId IdType="pubmed">25945162</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentino LA, Skinner MW, Pipe SW (2020) The role of telemedicine in the delivery of health care in the COVID-19 pandemic. Haemophilia 26, e230&#x2013;e231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272827</ArticleId><ArticleId IdType="pubmed">32397000</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Liu S (2018) The old people using intelligent mobile equipment influence extent. In Human Aspects of IT for the Aged Population Applications in Health, Assistance, and Entertainment, Zhou J, Salvendy G, eds. Springer.</Citation></Reference><Reference><Citation>Hayes D (2020) Telerehabilitation for older adults. Geriatr Rehabil 36, 205&#x2013;211.</Citation></Reference><Reference><Citation>Cohen G, Russo MJ, Campos JA, Allegri RF (2020) Living with dementia: Increased level of caregiver stress in times of COVID-19. Int Psychogeriatr 32, 1377&#x2013;1381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7453351</ArticleId><ArticleId IdType="pubmed">32729446</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Lorito C, Pollock K, Harwood R, Nair Rd, Logan P, Goldberg S, Booth V, Godfrey M, Dunlop M, Van Der Wardt V (2019) Protocol for the process evaluation of the promoting activity, independence and stability in early dementia and mild cognitive impairment (PrAISED 2) randomised controlled trial. Maturitas 122, 8&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">30797535</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. Int J Qual Health Care 19, 349&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">17872937</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (2001) World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ 79, 373&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2566407</ArticleId><ArticleId IdType="pubmed">11357217</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowling A (2014) Research Methods in Health: Investigating health and health services, McGraw Hill, Maidenhead.</Citation></Reference><Reference><Citation>Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K (2015) Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health 42, 533&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4012002</ArticleId><ArticleId IdType="pubmed">24193818</ArticleId></ArticleIdList></Reference><Reference><Citation>Guest G, Bunce A, Johnson L (2006) How many interviews are enough?: An experiment with data saturation and variability. Field Methods 18, 59&#x2013;82.</Citation></Reference><Reference><Citation>Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3, 77&#x2013;101.</Citation></Reference><Reference><Citation>Hansen E (2006) Successful Qualitative Health Research. A Practical Introduction. Open University Press, England.</Citation></Reference><Reference><Citation>Etters L, Goodall D, Harrison BE (2008) Caregiver burden among dementia patient caregivers: A review of the literature.. J Am Acad Nurse Pract 20, 423&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">18786017</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards HB, Ijaz S, Whiting PF, Leach V, Richards A, Cullum SJ, Cheston RI, Savovic J (2018) Quality of family relationships and outcomes of dementia: A systematic review. BMJ Open 8, e015538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5780722</ArticleId><ArticleId IdType="pubmed">29358414</ArticleId></ArticleIdList></Reference><Reference><Citation>Hale L, Mayland E, Jenkins M, Buttery Y, Norris P, Butler M, Holland M, Ngocha-Chaderopa E, McKenzie-Green B, Czuba K, Sezier A, Kayes N (2020) Constructing normalcy in dementia care: Carers&#x2019; perceptions of their roles and the supports they need. Gerontologist 60, 905&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pubmed">31722390</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn C, Nelis SM, Martyr A, Morris RG, Victor C, Clare L (2020) Caregiver influences on &#x2018;living well&#x2019; for people with dementia: Findings from the IDEAL study. Aging Ment Health 24, 1505&#x2013;1513.</Citation><ArticleIdList><ArticleId IdType="pubmed">31104475</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris J (2003) Consent and end of life decisions. J Med Ethics 29, 10&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1733671</ArticleId><ArticleId IdType="pubmed">12569187</ArticleId></ArticleIdList></Reference><Reference><Citation>Spindler H, Leerskov K, Joensson K, Nielsen G, Andreasen JJ, Dinesen B (2019) Conventional rehabilitation therapy versus telerehabilitation in cardiac patients: A comparison of motivation, psychological distress, and quality of life. Int J Environ Res Public Health 16, 512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6388222</ArticleId><ArticleId IdType="pubmed">30759761</ArticleId></ArticleIdList></Reference><Reference><Citation>McCabe R, Priebe S (2004) The therapeutic relationship in the treatment of severe mental illness: A review of methods and findings. Int J Soc Psychiatry 50, 115&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">15293429</ArticleId></ArticleIdList></Reference><Reference><Citation>Vowles KE, Thompson M (2012) The patient-provider relationship in chronic pain. Curr Pain Headache Rep 16, 133&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">22274663</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop M, Kayes N, McPherson K (2021) Understanding the therapeutic alliance in stroke rehabilitation. Disabil Rehabil 43, 1074&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">31433673</ArticleId></ArticleIdList></Reference><Reference><Citation>Jootun D, McGhee G (2011) Effective communication with people who have dementia. Nurs Stand 25, 40&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">21469475</ArticleId></ArticleIdList></Reference><Reference><Citation>Mair FS, Hiscock J, Beaton SC (2008) Understanding factors that inhibit or promote the utilization of telecare in chronic lung disease. Chronic Illn 4, 110&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">18583448</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (2012) Patient Experience in Adult NHS Services: Improving the Experience of Care for People Using Adult NHS Services: Patient Experience in Generic Terms. NICE.</Citation><ArticleIdList><ArticleId IdType="pubmed">34260162</ArticleId></ArticleIdList></Reference><Reference><Citation>Green T, Hartley N, Gillespie N (2016) Service provider&#x2019;s experiences of service separation: The case of telehealth. J Serv Res 19, 477&#x2013;494.</Citation></Reference><Reference><Citation>Brody AA, Sadarangani T, Jones TM, Convery K, Groom L, Bristol AA, Daniel D (2020) Family- and person-centered interdisciplinary telehealth: Policy and practice implications following onset of the COVID-19 pandemic. J Gerontol Nurs 46, 9&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7476765</ArticleId><ArticleId IdType="pubmed">32845343</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulik RJ (2008) Human factors in primary care telemedicine encounters. J Telemed Telecare 14, 169&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">18534948</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinkler L, Smith V, Yiannakou Y, Robinson L (2018) Professional identity and the Clinical Research Nurse: A qualitative study exploring issues having an impact on participant recruitment in research. J Adv Nurs 74, 318&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pubmed">28792610</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson H (2002) The perspectives of people with dementia: Research methods and motivations. Jessica Kingsley Publishing, London.</Citation><ArticleIdList><ArticleId IdType="pubmed">27316366</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore TF, Hollett J (2003) Giving voice to persons living with dementia: The researcher&#x2019;s opportunities and challenges. Nurs Sci Q 16, 163&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">12728835</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochford-Brennan H, Keogh F (2020) Giving voice to those directly affected by the COVID-19 pandemic - the experience and reflections of a person with dementia. HRB Open Res 3, 29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7268151</ArticleId><ArticleId IdType="pubmed">32518893</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob S, Furgerson S (2012) Writing interview protocols and conducting interviews: Tips for students new to the field of qualitative research. Qual Rep 17, 1&#x2013;10.</Citation></Reference><Reference><Citation>Cranen K, Groothuis-Oudshoorn CG, Vollenbroek-Hutten MM, Ijzerman MJ (2017) Toward patient-centered telerehabilitation design: Understanding chronic pain patients&#x2019; preferences for web-based exercise telerehabilitation using a discrete choice experiment. Int J Med Res 19, e26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5291864</ArticleId><ArticleId IdType="pubmed">28108429</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy S (2010) Qualitative quality: Eight &#x201c;big-tent&#x201d; criteria for excellent qualitative research. Qual Inq 16, 837&#x2013;851.</Citation></Reference><Reference><Citation>Di Lorito C, Masud T, Gladman J, Godfrey M, Dunlop M, Bosco A, Harwood RH (2021) Deconditioning in people living with dementia during the COVID-19 pandemic: Qualitative study from the Promoting Activity, Independence and Stability in Early Dementia (PrAISED) process evaluation. BMC Ger 21, 529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8495442</ArticleId><ArticleId IdType="pubmed">34620129</ArticleId></ArticleIdList></Reference><Reference><Citation>
Chartered Society of Phyisotherapy (2020) COVID-19: Guide for rapid implementation of remote consultations. Practical advice for physiotherapists and support workers on how to implement remote consultations rapidly and efficiently. Online: https://www.csp.org.uk/publications/covid-19-guide-rapid-implementation-remote-consultations</Citation></Reference><Reference><Citation>Sriram V, Jenkinson C, Peters M (2020) Using rapid cycle tests of change to develop the Carers Assistive Technology Experience Questionnaire: A cognitive interview study in the UK. BMJ Open 11, e042361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7978277</ArticleId><ArticleId IdType="pubmed">33737425</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36402057</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-491X</ISSN><JournalIssue CitedMedium="Internet"><Volume>137</Volume><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>International journal of nursing studies</Title><ISOAbbreviation>Int J Nurs Stud</ISOAbbreviation></Journal><ArticleTitle>Supporting autonomy for people with dementia living in nursing homes: A rapid realist review.</ArticleTitle><Pagination><StartPage>104382</StartPage><MedlinePgn>104382</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijnurstu.2022.104382</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0020-7489(22)00211-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">For people with dementia living in nursing homes, autonomy is important. However, they experience difficulty with being heard as an autonomous person, as well as with expressing their preferences and choices. The question is how to support their autonomy.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Despite extensive efforts to support autonomy in daily care for people with dementia living in nursing homes, we do not know exactly what works for whom, in which context, how and why. The objective of this realist review is to explore what is known in literature on autonomy support interventions for people with dementia in nursing homes.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A rapid realist review of literature.</AbstractText><AbstractText Label="REVIEW METHODS" NlmCategory="METHODS">To understand how autonomy is supported, a realist approach was applied that entailed identifying the research question, searching for information, performing a quality appraisal, extracting data, synthesizing the evidence and validating the findings with a panel of experts. Causal assumptions were derived from articles found in four bibliographic databases (PubMed, PsychInfo, Cochrane and CINAHL) leading to context (C)-mechanism (M)-outcome (O) configurations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Data extraction from the included articles ultimately resulted in sixteen CMO configurations on four themes: a. preferences and choice: interventions for supporting autonomy in nursing homes and their results, b. personal characteristics of residents and family: people with dementia and their family being individuals who have their own character, habits and behaviors, c. competent nursing staff each having their own level of knowledge, competence and need for support, and d. interaction and relationships in care situations: the persons involved are interrelated, continuously interacting in different triangles composed of residents, family members and nursing staff.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The findings showed that results from interventions on autonomy in daily-care situations are likely to be just as related not only with the characteristics and competences of the people involved, but also to how they interact. Autonomy support interventions appear to be successful when the right context factors are considered.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van der Weide</LastName><ForeName>Henny</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University Knowledge Network for Older Adult Care Nijmegen (UKON), Radboudumc Alzheimer Center, Department of Primary and Community Care, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands; Archipel Zorggroep, Eindhoven, the Netherlands. Electronic address: henny.vanderweide@radboudumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lovink</LastName><ForeName>Marleen H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>University Knowledge Network for Older Adult Care Nijmegen (UKON), Department of Primary and Community Care, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luijkx</LastName><ForeName>Katrien G</ForeName><Initials>KG</Initials><AffiliationInfo><Affiliation>Tranzo Department, the Scientific Center for Care and Wellbeing of the Tilburg School of Social and Behavioral Sciences of Tilburg University, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerritsen</LastName><ForeName>Debby L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>University Knowledge Network for Older Adult Care Nijmegen (UKON), Radboudumc Alzheimer Center, Department of Primary and Community Care, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Nurs Stud</MedlineTA><NlmUniqueID>0400675</NlmUniqueID><ISSNLinking>0020-7489</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009735" MajorTopicYN="N">Nursing Homes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009740" MajorTopicYN="Y">Nursing Staff</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autonomy</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Family caregivers</Keyword><Keyword MajorTopicYN="N">Nursing home</Keyword><Keyword MajorTopicYN="N">Nursing staff</Keyword><Keyword MajorTopicYN="N">Realist review</Keyword><Keyword MajorTopicYN="N">Residents</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>19</Day><Hour>18</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36402057</ArticleId><ArticleId IdType="doi">10.1016/j.ijnurstu.2022.104382</ArticleId><ArticleId IdType="pii">S0020-7489(22)00211-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36398491</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-6612</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Australasian journal on ageing</Title><ISOAbbreviation>Australas J Ageing</ISOAbbreviation></Journal><ArticleTitle>Perceptions of people living with dementia regarding patient-centred aspects of their care and caregiver support.</ArticleTitle><Pagination><StartPage>246</StartPage><EndPage>250</EndPage><MedlinePgn>246-250</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ajag.13156</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study examined the perceptions of a sample of Australian people living with dementia regarding the person-centred care and support they received from health professionals and family.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Community-dwelling people living with dementia were invited to complete a cross-sectional survey.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventy-one people participated in the study. More than 90% agreed that health professionals explain who they are, why they are seeing them and listen to what they have to say; 63% agreed that health professionals ask how they would like to be involved in decisions about treatment; 78% agreed health professionals mainly speak to them rather than anyone accompanying them; 76% reported their family 'support you to do tasks by yourself', and 36% indicated that family caregivers 'get frustrated with you'.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Results suggest that people living with dementia have a positive perception of the care and support they receive. Improvements may be needed in how health professionals speak directly to the person living with dementia when exploring how they would like to be involved in treatment decisions. Family caregivers may benefit from education and support on how they can manage frustrations and assist the person they support to maintain their independence.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Australasian Journal on Ageing published by John Wiley &amp; Sons Australia, Ltd on behalf of AJA Inc&#x2019;.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carey</LastName><ForeName>Mariko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunter Medical Research Institute, Newcastle, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cameron</LastName><ForeName>Emilie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunter Medical Research Institute, Newcastle, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mansfield</LastName><ForeName>Elise</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7938-8401</Identifier><AffiliationInfo><Affiliation>College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunter Medical Research Institute, Newcastle, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanson-Fisher</LastName><ForeName>Rob</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunter Medical Research Institute, Newcastle, New South Wales, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>NHMRC Boosting Dementia Research Leadership Fellowship (APP1136168)</Agency><Country/></Grant><Grant><Agency>NHRMC Dementia Team Grant (APP1095078)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Australas J Ageing</MedlineTA><NlmUniqueID>9808874</NlmUniqueID><ISSNLinking>1440-6381</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">caregivers</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">patient-centred care</Keyword><Keyword MajorTopicYN="N">quality of healthcare</Keyword></KeywordList><CoiStatement>No conflicts of interest declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>18</Day><Hour>3</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36398491</ArticleId><ArticleId IdType="pmc">PMC10947192</ArticleId><ArticleId IdType="doi">10.1111/ajag.13156</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Australian Institute of Health Welfare
. Dementia in Australia. 2021. Accessed July 1, 2022. https://www.aihw.gov.au/reports/dementia/dementia&#x2010;in&#x2010;aus
</Citation></Reference><Reference><Citation>LaMantia MA, Stump TE, Messina FC, Miller DK, Callahan CM. Emergency department use among older adults with dementia. Alzheimer Dis Assoc Disord. 2016;30(1):35&#x2010;40. doi:10.1097/wad.0000000000000118</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/wad.0000000000000118</ArticleId><ArticleId IdType="pmc">PMC4764430</ArticleId><ArticleId IdType="pubmed">26523710</ArticleId></ArticleIdList></Reference><Reference><Citation>Byles J, Cavenagh D, Bryant J, et al. Use of medical services by older Australian women with dementia: a longitudinal cohort study. Aust N Z J Public Health. 2021;45(5):497&#x2010;503. doi:10.1111/1753-6405.13146</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1753-6405.13146</ArticleId><ArticleId IdType="pubmed">34309976</ArticleId></ArticleIdList></Reference><Reference><Citation>van Baalen A, Vingerhoets AJJM, Sixma HJ, de Lange J. How to evaluate quality of care from the perspective of people with dementia: an overview of the literature. Dementia. 2011;10(1):112&#x2010;137. doi:10.1177/1471301210369320</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301210369320</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill L, White L, Cameron ID. Interaction in community&#x2010;based aged healthcare: perceptions of people with dementia. Dementia. 2011;10(4):539&#x2010;554. doi:10.1177/1471301211409626</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301211409626</ArticleId></ArticleIdList></Reference><Reference><Citation>Milte R, Shulver W, Killington M, Bradley C, Ratcliffe J, Crotty M. Quality in residential care from the perspective of people living with dementia: the importance of personhood. Arch Gerontol Geriatr. 2016;63:9&#x2010;17. doi:10.1016/j.archger.2015.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2015.11.007</ArticleId><ArticleId IdType="pubmed">26791166</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodaty H, Donkin M. Family caregivers of people with dementia. Dialogues Clin Neurosci. 2009;11(2):217&#x2010;228. doi:10.31887/DCNS.2009.11.2/hbrodaty</Citation><ArticleIdList><ArticleId IdType="doi">10.31887/DCNS.2009.11.2/hbrodaty</ArticleId><ArticleId IdType="pmc">PMC3181916</ArticleId><ArticleId IdType="pubmed">19585957</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeste DV, Palmer BW, Appelbaum PS, et al. A new brief instrument for assessing decisional capacity for clinical research. Arch Gen Psychiatry. 2007;64(8):966&#x2010;974. doi:10.1001/archpsyc.64.8.966</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.64.8.966</ArticleId><ArticleId IdType="pubmed">17679641</ArticleId></ArticleIdList></Reference><Reference><Citation>StataCorp . Stata Statistical Software: Release 11. StataCorp LP; 2009.</Citation></Reference><Reference><Citation>Fortinsky R. Health care triads and dementia care: integrative framework and future directions. Aging Ment Health. 2001;5(Suppl. 1):35&#x2010;48. doi:10.1080/713649999</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/713649999</ArticleId><ArticleId IdType="pubmed">27819512</ArticleId></ArticleIdList></Reference><Reference><Citation>Taghizadeh Larsson A, &#xd6;sterholm JH. How are decisions on care services for people with dementia made and experienced? A systematic review and qualitative synthesis of recent empirical findings. Int Psychogeriatr. 2014;26(11):1849&#x2010;1862. doi:10.1017/s104161021400132x</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s104161021400132x</ArticleId><ArticleId IdType="pubmed">25022286</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller LM, Whitlatch CJ, Lyons KS. Shared decision&#x2010;making in dementia: a review of patient and family carer involvement. Dementia. 2016;15(5):1141&#x2010;1157. doi:10.1177/1471301214555542</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301214555542</ArticleId><ArticleId IdType="pubmed">25370075</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn C, Clare L, Woods RT. Balancing needs: the role of motivations, meanings and relationship dynamics in the experience of informal caregivers of people with dementia. Dementia. 2015;14(2):220&#x2010;237. doi:10.1177/1471301213495863</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301213495863</ArticleId><ArticleId IdType="pubmed">24339101</ArticleId></ArticleIdList></Reference><Reference><Citation>Litzelman K, Skinner HG, Gangnon RE, Nieto FJ, Malecki K, Witt WP. The relationship among caregiving characteristics, caregiver strain, and health&#x2010;related quality of life: evidence from the survey of the health of Wisconsin. Qual Life Res. 2015;24(6):1397&#x2010;1406. doi:10.1007/s11136-014-0874-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-014-0874-6</ArticleId><ArticleId IdType="pmc">PMC4446250</ArticleId><ArticleId IdType="pubmed">25427430</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazzan AA, Shannon H, Ploeg J, Raina P, Oremus M. Association between caregiver quality of life and the care provided to persons with Alzheimer's disease: systematic review. Adv Alzheimers Dis. 2014;3(1):17&#x2010;21. doi:10.4236/aad.2014.31006</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/aad.2014.31006</ArticleId><ArticleId IdType="pmc">PMC3610300</ArticleId><ArticleId IdType="pubmed">23497507</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Qian S, Deng C, Yu P. Understanding interactions between caregivers and care recipients in person&#x2010;centered dementia care: a rapid review. Clin Interv Aging. 2020;15:1637&#x2010;1647. doi:10.2147/CIA.S255454</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S255454</ArticleId><ArticleId IdType="pmc">PMC7500833</ArticleId><ArticleId IdType="pubmed">32982198</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigt&#x2010;Radloff S, de Werd MME, Leonhart R, et al. Structured relearning of activities of daily living in dementia: the randomized controlled REDALI&#x2010;DEM trial on errorless learning. Alzheimers Res Ther. 2017;9(1):22. doi:10.1186/s13195-017-0247-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-017-0247-9</ArticleId><ArticleId IdType="pmc">PMC5364615</ArticleId><ArticleId IdType="pubmed">28335810</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgeois J, Laye M, Lemaire J, et al. Relearning of activities of daily living: a comparison of the effectiveness of three learning methods in patients with dementia of the Alzheimer type. J Nutr Health Aging. 2016;20(1):48&#x2010;55. doi:10.1007/s12603-016-0675-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-016-0675-4</ArticleId><ArticleId IdType="pubmed">26728933</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36394262</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-6984</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>International journal of language &amp; communication disorders</Title><ISOAbbreviation>Int J Lang Commun Disord</ISOAbbreviation></Journal><ArticleTitle>Com-mens: a home-based logopaedic intervention program for communication problems between people with dementia and their caregivers - a single-group mixed-methods pilot study.</ArticleTitle><Pagination><StartPage>704</StartPage><EndPage>722</EndPage><MedlinePgn>704-722</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/1460-6984.12811</ELocationID><Abstract><AbstractText Label="BACKGROUND">Communication difficulties are common in people with dementia, and often present from an early stage. However, direct treatment options for people with dementia that positively influence their daily communication are scarce.</AbstractText><AbstractText Label="AIMS">To evaluate the potential impact and feasibility of a personalized logopaedic intervention.</AbstractText><AbstractText Label="METHODS &amp; PROCEDURES">A total of 40 community-dwelling persons with dementia and their caregivers were recruited. Five experienced speech and language therapists (SLTs) delivered the six-session Com-mens intervention at home. Com-mens aims to improve positive communication between people with dementia and their primary caregivers and comprises five elements: interactive history-taking, dynamic observational assessment, education about the consequences of dementia on communication, development and use of personalized communication tools, use motivational, and person-centred strategies by the SLT. We conducted a single-group mixed-methods pilot study with five measurements: baseline, directly after intervention, and at 3, 6 and 9 months follow-up. Semi-structured interviews and questionnaires for Experienced Communication in Dementia, quality of life, psychological well-being and caregiver burden were conducted. Process evaluation was performed by interviewing participants, drop-outs, SLTs and other stakeholders.</AbstractText><AbstractText Label="OUTCOMES &amp; RESULTS">A total of 32 dyads completed the intervention. Repeated measures analyses revealed no significant changes over time. In the interviews, participants reported a positive impact on their feelings, increased communication skills and better coping with the diagnosis. Participants would recommend the intervention to others. Facilitators were timely delivery, personalized content and adequate reimbursement. Barriers were unfamiliarity with Com-mens among referrers, an overburdened caregiver or disrupted family relationships.</AbstractText><AbstractText Label="CONCLUSIONS &amp; IMPLICATIONS">This newly developed logopaedic intervention is feasible and has a perceived positive impact on both people with dementia and their caregivers, which is confirmed by a stable pattern over a period of 1 year. Future comparative studies are needed to test the effectiveness of personalized interventions in this patient population.</AbstractText><AbstractText Label="WHAT THIS PAPER ADDS">What is already known on the subject? SLTs are experts in the field of communication, but even though communication problems are common between people with dementia and their caregivers, there is a lack of logopaedic guidelines and materials for the direct treatment for this population. Interventions that are available either focus on (professional) caregivers only or aim to enhance cognitive functioning and do not target on joined communication. What this paper adds to the existing knowledge? A newly developed intervention called Com-mens can be provided by trained SLTs and takes an average of six 1-h sessions. The intervention is perceived to be valuable and feasible for people with dementia and their caregivers, by the participants themselves, as well as by healthcare professionals and other stakeholders. What are the potential or actual clinical implications of this work? Dissemination of this intervention will give SLTs skills, tools and materials to provide meaningful care to home-dwelling persons with dementia and their caregivers. Also, persons with dementia and their caregivers will receive education and materials that can help them increase their understanding of communication problems, enhance their communication skills and better cope with the communication problems that result from dementia. We consider the Com-mens intervention to be a valuable addition to the field of speech language therapy and dementia.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. International Journal of Language &amp; Communication Disorders published by John Wiley &amp; Sons Ltd on behalf of Royal College of Speech and Language Therapists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Olthof-Nefkens</LastName><ForeName>Maria W L J</ForeName><Initials>MWLJ</Initials><AffiliationInfo><Affiliation>Zorggroep Maas &amp; Waal, Beneden-Leeuwen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboud university medical center, Department of Primary and Community Care, Radboud Institute for Health Sciences, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboud university medical center, Department of Rehabilitation, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboud university medical center, Radboudumc Alzheimer Center, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Derksen</LastName><ForeName>Els W C</ForeName><Initials>EWC</Initials><AffiliationInfo><Affiliation>Radboud university medical center, Department of Primary and Community Care, Radboud Institute for Health Sciences, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboud university medical center, Radboudumc Alzheimer Center, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Debets</LastName><ForeName>Frieda</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Radboud university medical center, Department of Rehabilitation, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Swart</LastName><ForeName>Bert J M</ForeName><Initials>BJM</Initials><AffiliationInfo><Affiliation>Radboud university medical center, Department of Rehabilitation, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nijhuis-van der Sanden</LastName><ForeName>Maria W G</ForeName><Initials>MWG</Initials><AffiliationInfo><Affiliation>Radboud university medical center, Radboudumc Alzheimer Center, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboud university medical center, Radboud Institute for Health Sciences, Scientific Center for Quality of Care (IQ healthcare), Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalf</LastName><ForeName>Johanna G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Radboud university medical center, Department of Rehabilitation, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboud university medical center, Radboudumc Alzheimer Center, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Lang Commun Disord</MedlineTA><NlmUniqueID>9803709</NlmUniqueID><ISSNLinking>1368-2822</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="N">Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer disease</Keyword><Keyword MajorTopicYN="N">language therapy</Keyword><Keyword MajorTopicYN="N">neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">neurogenic communication disorders</Keyword><Keyword MajorTopicYN="N">pilot projects</Keyword><Keyword MajorTopicYN="N">psychosocial intervention</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword><Keyword MajorTopicYN="N">speech-language pathology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>17</Day><Hour>13</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36394262</ArticleId><ArticleId IdType="doi">10.1111/1460-6984.12811</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Banerjee, S., Willis, R., Graham, N. &amp; Gurland, B.J. (2010) The Stroud/ADI dementia quality framework: a cross-national population-level framework for assessing the quality of life impacts of services and policies for people with dementia and their family carers. International Journal of Geriatric Psychiatry: A journal of the psychiatry of late life and allied sciences, 25, 249-257. https://doi.org/10.1002/gps.2330</Citation></Reference><Reference><Citation>Bayles, K.A. &amp; Tomoeda, C.K. (2014) Cognitive-communication disorders of dementia: definition, diagnosis, and treatment, 2nd edition, San Diego, CA, US: Plural Publishing.</Citation></Reference><Reference><Citation>Braun, V. &amp; Clarke, V. (2006) Using thematic analysis in psychology. Qualitative research in psychology, 3, 77-101. https://doi.org/10.1191/1478088706qp063oa</Citation></Reference><Reference><Citation>Braun, V. &amp; Clarke, V. (2021) Can I use TA? Should I use TA? Should I not use TA? Comparing reflexive thematic analysis and other pattern-based qualitative analytic approaches. Counselling and Psychotherapy Research, 21, 37-47. https://doi.org/10.1191/1478088706qp063oa</Citation></Reference><Reference><Citation>Bredart, A., Marrel, A., Abetz-Webb, L., Lasch, K. &amp; Acquadro, C. (2014) Interviewing to develop Patient-Reported Outcome (PRO) measures for clinical research: eliciting patients' experience. Health and Quality of Life Outcomes [Electronic Resource], 12, 15. https://doi.org/10.1186/1477-7525-12-15</Citation></Reference><Reference><Citation>Brodaty, H., Green, A. &amp; Koschera, A. (2003) Meta-analysis of psychosocial interventions for caregivers of people with dementia. Journal of the American Geriatrics Society, 51(5), 657-664. https://doi.org/10.1034/j.1600-0579.2003.00210.x</Citation></Reference><Reference><Citation>Brouwer, W.B.F., van Exel, N.J.A. &amp; van Gorp, B. (2006) The CarerQol instrument: a new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations. Quality of Life Research, 15, 1005-1021. https://doi.org/10.1007/s11136-005-5994-6</Citation></Reference><Reference><Citation>Brown, S.-J. (1999) Patient-centered communication. Annual Review of Nursing Research, 17, 85-104.</Citation></Reference><Reference><Citation>Barnes, C. J., &amp; Markham, C. (2018). A pilot study to evaluate the effectiveness of an individualized and cognitive behavioural communication intervention for informal carers of people with dementia: The Talking Sense programme. International Journal of Language &amp; Communication Disorders, 53(3), 615-627. https://doi.org/10.1111/1460-6984.12375</Citation></Reference><Reference><Citation>BARNES, C. (2016) A pilot study to evaluate the effectiveness of an individualised and cognitive behavioural communication intervention for informal carers of people with dementia. PhD thesis, University of Portsmouth, Portsmouth.</Citation></Reference><Reference><Citation>Campbell, M., Fitzpatrick, R., Haines, A., Kinmonth, A.L., Sandercock, P., Spiegelhalter, D. &amp; Tyrer, P. (2000) Framework for design and evaluation of complex interventions to improve health. BMJ, 321, 694-696. https://doi.org/10.1136/bmj.321.7262.694</Citation></Reference><Reference><Citation>Cavanaugh, J.T. &amp; Konrad, S.C. (2012) Fostering the development of effective person-centered healthcare communication skills: an interprofessional shared learning model. Work (Reading, Mass.), 41(3), 293-301. https://doi.org/10.3233/wor-2012-1292</Citation></Reference><Reference><Citation>Degen, C., Frankenberg, C., Meyer-K&#xfc;hling, I., Wendelstein, B., Knebel, M., Pantel, J., Zenth&#xf6;fer, A., Rammelsberg, P., Andrejeva, N. &amp; Schr&#xf6;der, J. (2021) Communication skills in nursing home residents with dementia. Zeitschrift f&#xfc;r Gerontologie und Geriatrie, 55(1), 27-31. https://doi.org/10.1007/s00391-021-01929-0</Citation></Reference><Reference><Citation>Donkers, H.W., Van Der Veen, D., Vernooij-Dassen, M., Nijhuis-Van Der Sanden, M. &amp; Graff, M. (2017) Social participation of people with cognitive problems and their caregivers: a feasibility evaluation of the Social Fitness Programme. International journal of geriatric psychiatry, 32, e50-e63. https://doi.org/10.1002/gps.4651</Citation></Reference><Reference><Citation>Dooley, S. &amp; Walshe, M. (2018) Management of cognitive communication difficulties in dementia: a cross-sectional survey of speech &amp; language therapists in Ireland. Unpublished paper. Dublin: Trinity College Dublin.</Citation></Reference><Reference><Citation>Eggenberger, E., Heimerl, K. &amp; Bennett, M.I. (2013) Communication skills training in dementia care: a systematic review of effectiveness, training content, and didactic methods in different care settings. International Psychogeriatrics, 25, 345-58. https://doi.org/10.1017/S1041610212001664</Citation></Reference><Reference><Citation>Eldridge, S.M., Lancaster, G.A., Campbell, M.J., Thabane, L., Hopewell, S., Coleman, C.L. &amp; Bond, C.M. (2016) Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PLoS One, 11, e0150205. https://doi.org/10.1371/journal.pone.0150205</Citation></Reference><Reference><Citation>Fazio, S., Pace, D., Flinner, J. &amp; Kallmyer, B. (2018) The fundamentals of person-centered care for individuals with dementia. The Gerontologist, 58, S10-S19. https://doi.org/10.1093/geront/gnx122</Citation></Reference><Reference><Citation>Graff, M.J., Vernooij-Dassen, M.J., Thijssen, M., Dekker, J., Hoefnagels, W.H. &amp; Rikkert, O., M, G. (2006) Community based occupational therapy for patients with dementia and their care givers: randomised controlled trial. BMJ, 333, 1196. https://doi.org/10.1136/bmj.39001.688843.BE</Citation></Reference><Reference><Citation>Haberstroh, J., Neumeyer, K., Krause, K., Franzmann, J. &amp; Pantel, J. (2011) TANDEM: communication training for informal caregivers of people with dementia. Aging &amp; Mental Health, 15(3), 405-413. https://doi.org/10.1080/13607863.2010.536135</Citation></Reference><Reference><Citation>Hopper, T., Bourgeois, M., Pimentel, J., Dean Qualls, C., Hickey, E., Frymark, T. &amp; Schooling, T. (2013) An evidence-based systematic review on cognitive interventions for individuals with dementia. American Journal of Speech-Language Pathology, 22(1), 126-145. https://doi.org/10.1044/1058-0360(2012/11-0137)</Citation></Reference><Reference><Citation>Kagan, A., Winckel, J., Black, S., Felson Duchan, J., Simmons-Mackie, N. &amp; Square, P. (2004) A set of observational measures for rating support and participation in conversation between adults with aphasia and their conversation partners. Topics in Stroke Rehabilitation, 11, 67-83. https://doi.org/10.1310/CL3V-A94A-DE5C-CVBE</Citation></Reference><Reference><Citation>Kirkevold, M. &amp; Bergland, &#xc5;. (2007) The quality of qualitative data: issues to consider when interviewing participants who have difficulties providing detailed accounts of their experiences. International journal of qualitative studies on health and well-being, 2, 68-75.</Citation></Reference><Reference><Citation>Kitwood, T.M. (1997) Dementia reconsidered: the person comes first. Open University Press Buckingham.</Citation></Reference><Reference><Citation>Krabbe, P.F., Stouthard, M.E., Essink-Bot, M.-L. &amp; Bonsel, G.J. (1999) The effect of adding a cognitive dimension to the EuroQol multiattribute health-status classification system. Journal of clinical epidemiology, 52, 293-301. https://doi.org/10.1016/s0895-4356(98)00163-2</Citation></Reference><Reference><Citation>Lutomski, J.E., Baars, M.A.E, Schalk, B.W.M., Boter, H., Buurman, B.M., Elzen, W.P.J., Jansen, A.P.D., Kempen, G.I.J.M., Steunenberg, B., Steyenberg, E.W., Olde Rikkert, M.G.M. &amp; Melis, R.J.F. (2013) The development of the Older Persons and Informal Caregivers Survey Minimum DataSet (TOPICS-MDS): a large-scale data sharing initiative. PLoS One, 8, e81673. https://doi.org/10.1371/journal.pone.0081673</Citation></Reference><Reference><Citation>Machiels, M., Metzelthin, S.F., Hamers, J.P. &amp; Zwakhalen, S.M. (2017) Interventions to improve communication between people with dementia and nursing staff during daily nursing care: a systematic review. International Journal of Nursing Studies, 66, 37-46. https://doi.org/10.1016/j.ijnurstu.2016.11.017</Citation></Reference><Reference><Citation>Maxim, J. &amp; Bryan, K. (2006) Language, communication and cognition in the dementias. Communication disability in the dementias, 73-124.</Citation></Reference><Reference><Citation>Mok, Z., Steel, G., Russell, C. &amp; Conway, E. (2021) Measuring the interactions of people with dementia and their conversation partners: a preliminary adaption of the Kagan measures of support and participation in conversation. Aging &amp; mental health, 25, 13-21. https://doi.org/10.1080/13607863.2019.1671314</Citation></Reference><Reference><Citation>Moran, J., Bekker, H. &amp; Latchford, G. (2008) Everyday use of patient-centred, motivational techniques in routine consultations between doctors and patients with diabetes. Patient Education and Counseling, 73(2), 224-231. https://doi.org/10.1016/j.pec.2008.07.006</Citation></Reference><Reference><Citation>Morris, L., Horne, M., McEvoy, P. &amp; Williamson, T. (2018) Communication training interventions for family and professional carers of people living with dementia: a systematic review of effectiveness, acceptability and conceptual basis. Aging &amp; Mental Health, 22(7), 863-880. https://doi.org/10.1080/13607863.2017.1399343</Citation></Reference><Reference><Citation>Nys, T. (2016) Autonomy, Trust, and Respect. The Journal of medicine and philosophy, 41(1), 10-24. https://doi.org/10.1093/jmp/jhv036</Citation></Reference><Reference><Citation>Olde Rikkert, M.G. et&#xa0;al. (2011) Validity, reliability, and feasibility of clinical staging scales in dementia: a systematic review. American Journal of Alzheimer's Disease &amp; Other Dementias&#xae;, 26, 357-365. https://doi.org/10.1177/1533317511418954</Citation></Reference><Reference><Citation>Olthof-Nefkens, M.W., Derksen, E.W., De Swart, B.J., Nijhuis-Van der Sanden, M.W. &amp; Kalf, J.G. (2021a) Development of the Experienced Communication in Dementia Questionnaire: a qualitative study. INQUIRY: The Journal of Health Care Organization, Provision, and Financing, 58, 00469580211028181. https://doi.org/10.1177/00469580211028181</Citation></Reference><Reference><Citation>Olthof-Nefkens, M.W., Derksen, E.W., Lambregts, B., De Swart, B.J., Nijhuis-Van der Sanden, M.W. &amp; Kalf, J.G. (2021b) Clinimetric evaluation of the Experienced Communication in Dementia Questionnaire (ECD). The Gerontologist, https://doi.org/10.1093/geront/gnab187</Citation></Reference><Reference><Citation>Olthof-Nefkens, M.W.L.J., Kruse, H., Derksen, E., De Swart, B.J.M., Nijhuis-Van der Sanden, M.W.G. &amp; Kalf, J.G. (2018) Improving communication between persons with mild dementia and their caregivers: qualitative analysis of a practice-based logopaedic intervention. Folia Phoniatrica Et Logopaedica, 70, 124-133. https://doi.org/10.1159/000491081</Citation></Reference><Reference><Citation>Skivington, K., Matthews, L., Simpson, S.A., Craig, P., Baird, J., Blazeby, J.M., Boyd, K.A., Craig, N., French, D.P., McIntosh, E., Petticrew, M., Rycroft-Malone, J., White, M. &amp; Moore, L. (2021) A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ, 374, n2061. https://doi.org/10.1136/bmj.n2061</Citation></Reference><Reference><Citation>Small, J.A. &amp; Gutman, G. (2002) Recommended and reported use of communication strategies in Alzheimer caregiving. Alzheimer Disease and Associated Disorders, 16(4), 270-278.</Citation></Reference><Reference><Citation>Small, J.A., Gutman, G., Makela, S. &amp; Hillhouse, B. (2003) Effectiveness of communication strategies used by caregivers of persons with Alzheimer's disease during activities of daily living. https://doi.org/10.1044/1092-4388(2003/028)</Citation></Reference><Reference><Citation>Stiadle, J.M., Scholar, M. &amp; Zarit, S.H. (2014) Communication problems between caregivers and individuals with dementia: implications for caregiver well-being. Pennsylvania State University State College.</Citation></Reference><Reference><Citation>Tacken, M., Oostveen, J., Debets, F., Kalf, J.G., Rompen, H., Nijhuis-Van der Sanden, M.W.G. &amp; De Swart, B.J.M. (2014) Communicatieproblemen bij dementie. Logopedie, 86 (1-2), 6-15.</Citation></Reference><Reference><Citation>Van Der Zee, K. &amp; Sanderman, R. (1993) RAND-36. Groningen: Northern Centre for health care research, University of Groningen, the Netherlands, 28.</Citation></Reference><Reference><Citation>Wenborn, J., Moniz-Cook, E., Mountain, G., Poland, F., King, M., Omar, R., Morris, S., Vernooij-Dassen, M., Challis, D., Michie, S., Russell, I., Sackley, C., Graff, M., O'Keefe, A., Crellin, N. &amp; Orrell, M. (2016) Community occupational therapy for people with dementia and family carers (COTiD-UK) versus treatment as usual (Valuing Active Life in Dementia [VALID] programme): study protocol for a randomised controlled trial. Trials, 17, 1-10. https://doi.org/10.1186/s13063-015-1150-y</Citation></Reference><Reference><Citation>Wennberg, A., Dye, C., Streetman-Loy, B. &amp; Pham, H. (2015) Alzheimer's patient familial caregivers: a review of burden and interventions. Health &amp; Social Work, 40, e162-e169.</Citation></Reference><Reference><Citation>Wilson, R., Rochon, E., Mihailidis, A. &amp; Leonard, C. (2012) Examining success of communication strategies used by formal caregivers assisting individuals with Alzheimer's disease during an activity of daily living. Journal of Speech, Language, and Hearing Research, 55, 328-341. https://doi.org/10.1044/1092-4388(2011/10-0206)</Citation></Reference><Reference><Citation>Yorkston, K.M., Bourgeois, M.S. &amp; Baylor, C.R. (2010) Communication and aging. Physical Medicine and Rehabilitation Clinics of North America, 21, 309-19. https://doi.org/10.1016/j.pmr.2009.12.011</Citation></Reference><Reference><Citation>Zientz, J., Rackley, A., Chapman, S.B., Hopper, T., Mahendra, N., Kim, E.S. &amp; Cleary, S. (2007) Evidence-based practice recommendations for dementia: educating caregivers on Alzheimer's disease and training communication strategies. Journal of Medical Speech-Language Pathology, 15, liii-lxiv.</Citation></Reference><Reference><Citation>Weterings, R., Olthof-Nefkens, M. W. L. J., Piai, V., Kalf, J. G., &amp; Ruiter, M. B. (2022). Towards a measure of joint verbal functional communication of a person with dementia and the communication partner: an exploratory study. Published as preprint. https://doi.org/10.31234/osf.io/daqeh</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36377267</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1938-8993</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Hispanic health care international : the official journal of the National Association of Hispanic Nurses</Title><ISOAbbreviation>Hisp Health Care Int</ISOAbbreviation></Journal><ArticleTitle>Understanding Attitudes, Beliefs, Behaviors, and Barriers to Hearing Loss Care Among Hispanic Adults and Caregivers.</ArticleTitle><Pagination><StartPage>150</StartPage><EndPage>157</EndPage><MedlinePgn>150-157</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/15404153221137671</ELocationID><Abstract><AbstractText><b>Introduction:</b> While 9.5 million U.S. Hispanic adults have hearing loss, limited research has focused on their hearing care experiences. This study examines the attitudes, beliefs, behaviors, and barriers to hearing care among Hispanic adult patients with hearing loss (HL) and their caregivers. <b>Methods:</b> In a qualitative study, participants were recruited through community organizations, social media, and word of mouth. Participants were interviewed through virtual platforms and audio recorded. The recording was then transcribed verbatim in Spanish, translated to English, and analyzed using a hybrid deductive and inductive content approach. <b>Results:</b> The 12 participants (age 35-92, 83.3% female) comprised seven individuals with HL and three family caregivers. Most participants attributed HL to aging and genetics, and most shared a stigmatized community attitude toward HL that silenced any discussion of it. Barriers to hearing care included high cost, lack of insurance, and language barriers. These resulted in negative experiences with providers and poor access to hearing tests and auditory devices. <b>Conclusions:</b> The study's findings suggest a need to improve access to comprehensive low-cost hearing services and education in the Hispanic community. Additionally, unique challenges of this community should be addressed to promote hearing health and self-management.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burnham</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Nursing, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gamero</LastName><ForeName>Yesenia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Nursing, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Misurelli</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinzon</LastName><ForeName>Maria Mora</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-8090-5509</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine and Community Health &amp; Wisconsin Alzheimer's Institute, Physician Scientist: University of Wisconsin - Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lor</LastName><ForeName>Maichou</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8451-4364</Identifier><AffiliationInfo><Affiliation>School of Nursing, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hisp Health Care Int</MedlineTA><NlmUniqueID>101150304</NlmUniqueID><ISSNLinking>1540-4153</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001290" MajorTopicYN="Y">Attitude</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034381" MajorTopicYN="Y">Hearing Loss</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006630" MajorTopicYN="N">Hispanic or Latino</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hispanic adults</Keyword><Keyword MajorTopicYN="N">Latino adults</Keyword><Keyword MajorTopicYN="N">hearing loss</Keyword><Keyword MajorTopicYN="N">limited English proficiency</Keyword><Keyword MajorTopicYN="N">qualitative study</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>2</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36377267</ArticleId><ArticleId IdType="doi">10.1177/15404153221137671</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36373322</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-8908</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><Issue>1</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Polyunsaturated Fatty Acids Mend Macrophage Transcriptome, Glycome, and Phenotype in the Patients with Neurodegenerative Diseases, Including Alzheimer's Disease.</ArticleTitle><Pagination><StartPage>245</StartPage><EndPage>261</EndPage><MedlinePgn>245-261</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-220764</ELocationID><Abstract><AbstractText Label="BACKGROUND">Macrophages of healthy subjects have a pro-resolution phenotype, upload amyloid-&#x3b2; (A&#x3b2;) into endosomes, and degrade A&#x3b2;, whereas macrophages of patients with Alzheimer's disease (AD) generally have a pro-inflammatory phenotype and lack energy for brain clearance of A&#x3b2;.</AbstractText><AbstractText Label="OBJECTIVE">To clarify the pathogenesis of sporadic AD and therapeutic effects of polyunsaturated fatty acids (PUFA) with vitamins B and D and antioxidants on monocyte/macrophage (MM) migration in the AD brain, MM transcripts in energy and A&#x3b2; degradation, MM glycome, and macrophage clearance of A&#x3b2;.</AbstractText><AbstractText Label="METHODS">We followed for 31.3 months (mean) ten PUFA-supplemented neurodegenerative patients: 3 with subjective cognitive impairment (SCI), 2 with mild cognitive impairment (MCI), 3 MCI/vascular cognitive impairment, 2 with dementia with Lewy bodies, and 7 non-supplemented caregivers. We examined: monocyte migration in the brain and a blood-brain barrier model by immunochemistry and electron microscopy; macrophage transcriptome by RNAseq; macrophage glycome by N-glycan profiling and LTQ-Orbitrap mass spectrometry; and macrophage phenotype and phagocytosis by immunofluorescence.</AbstractText><AbstractText Label="RESULTS">MM invade A&#x3b2; plaques, upload but do not degrade A&#x3b2;, and release A&#x3b2; into vessels, which develop cerebrovascular amyloid angiopathy (CAA); PUFA upregulate energy and A&#x3b2; degradation enzyme transcripts in macrophages; PUFA enhance sialylated N-glycans in macrophages; PUFA reduce oxidative stress and increase pro-resolution MM phenotype, mitochondrial membrane potential, and A&#x3b2; phagocytosis (p&#x200a;&lt;&#x200a;0.001).</AbstractText><AbstractText Label="CONCLUSION">Macrophages of SCI, MCI, and AD patients have interrelated defects in the transcriptome, glycome, A&#x3b2; phagocytosis, and A&#x3b2; degradation. PUFA mend macrophage transcriptome, enrich glycome, enhance A&#x3b2; clearance, and benefit the cognition of early-stage AD patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dover</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell and Developmental Biology, UCLA School of Life Sciences, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Integrated Biology and Physiology, UCLA School of Life Sciences, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moseley</LastName><ForeName>Taylor</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell and Developmental Biology, UCLA School of Life Sciences, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biskaduros</LastName><ForeName>Adrienne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell and Developmental Biology, UCLA School of Life Sciences, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paulchakrabarti</LastName><ForeName>Mousumi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>GlycoAnalytics Core, University of California SanDiego Health Sciences, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Sung Hee</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Entomology and Nematology, and UCDavis Comprehensive Cancer Center, University of California - Davis, Davis, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammock</LastName><ForeName>Bruce</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Entomology and Nematology, and UCDavis Comprehensive Cancer Center, University of California - Davis, Davis, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choudhury</LastName><ForeName>Biswa</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>GlycoAnalytics Core, University of California SanDiego Health Sciences, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaczor-Urbanowicz</LastName><ForeName>Karolina El&#x17c;bieta</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>UCLA Institute for Quantitative and Computational Biosciences, UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urbanowicz</LastName><ForeName>Andrzej</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Control and Computation Engineering, Warsaw University of Technology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morselli</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell and Developmental Biology, UCLA School of Life Sciences, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dang</LastName><ForeName>Johnny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell and Developmental Biology, UCLA School of Life Sciences, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellegrini</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell and Developmental Biology, UCLA School of Life Sciences, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>Ketema</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Integrated Biology and Physiology, UCLA School of Life Sciences, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bentolila</LastName><ForeName>Laurent A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Advanced Light Microscopy and Spectroscopy Laboratory, California Nano Systems Institute, UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiala</LastName><ForeName>Milan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell and Developmental Biology, UCLA School of Life Sciences, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Integrated Biology and Physiology, UCLA School of Life Sciences, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P42 ES004699</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS078410</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 ES030443</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005231">Fatty Acids, Unsaturated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005231" MajorTopicYN="N">Fatty Acids, Unsaturated</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">amyloid-&#x3b2;</Keyword><Keyword MajorTopicYN="N">cerebrovascular amyloid angiopathy</Keyword><Keyword MajorTopicYN="N">coenzyme Q2</Keyword><Keyword MajorTopicYN="N">glycome</Keyword><Keyword MajorTopicYN="N">macrophage</Keyword><Keyword MajorTopicYN="N">mitochondrial membrane potential</Keyword><Keyword MajorTopicYN="N">phagocytosis</Keyword><Keyword MajorTopicYN="N">polyunsaturated fatty acids</Keyword><Keyword MajorTopicYN="N">transcriptome</Keyword></KeywordList><CoiStatement>Authors&#x2019; disclosures avaialblbe online (https://www.j-alz.com/manuscript-disclosures/22-0764r1).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>14</Day><Hour>3</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36373322</ArticleId><ArticleId IdType="pmc">PMC9881025</ArticleId><ArticleId IdType="doi">10.3233/JAD-220764</ArticleId><ArticleId IdType="pii">JAD220764</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer&#x2019;s disease: Progress and problems on the road to therapeutics. Science 297, 353&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">12130773</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle EA, Li YI, Pritchard JK (2017) An expanded view of complex traits: From polygenic to omnigenic. Cell 169, 1177&#x2013;1186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5536862</ArticleId><ArticleId IdType="pubmed">28622505</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiala M, Liu PT, Espinosa-Jeffrey A, Rosenthal MJ, Bernard G, Ringman JM, Sayre J, Zhang L, Zaghi J, Dejbakhsh S, Chiang B, Hui J, Mahanian M, Baghaee A, Hong P, Cashman J (2007) Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer&#x2019;s disease patients are improved by bisdemethoxycurcumin. Proc Natl Acad Sci U S A 104, 12849&#x2013;12854.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1937555</ArticleId><ArticleId IdType="pubmed">17652175</ArticleId></ArticleIdList></Reference><Reference><Citation>Louveau A, Plog BA, Antila S, Alitalo K, Nedergaard M, Kipnis J (2017) Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. J Clin Invest 127, 3210&#x2013;3219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5669566</ArticleId><ArticleId IdType="pubmed">28862640</ArticleId></ArticleIdList></Reference><Reference><Citation>Persidsky Y, Ghorpade A, Rasmussen J, Limoges J, Liu XJ, Stins M, Fiala M, Way D, Kim KS, Witte MH, Weinand M, Carhart L, Gendelman HE (1999) Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am J Pathol 155, 1599&#x2013;1611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866982</ArticleId><ArticleId IdType="pubmed">10550317</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumdar A, Chung H, Dolios G, Wang R, Asamoah N, Lobel P, Maxfield FR (2008) Degradation of fibrillar forms of Alzheimer&#x2019;s amyloid beta-peptide by macrophages. Neurobiol Aging 29, 707&#x2013;715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2424018</ArticleId><ArticleId IdType="pubmed">17222479</ArticleId></ArticleIdList></Reference><Reference><Citation>Avagyan H, Goldenson B, Tse E, Masoumi A, Porter V, Wiedau-Pazos M, Sayre J, Ong R, Mahanian M, Koo P, Bae S, Micic M, Liu PT, Rosenthal MJ, Fiala M (2009) Immune blood biomarkers of Alzheimer disease patients. J Neuroimmunol 210, 67&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">19329192</ArticleId></ArticleIdList></Reference><Reference><Citation>Famenini S, Rigali EA, Olivera-Perez HM, Dang J, Chang MT, Halder R, Rao RV, Pellegrini M, Porter V, Bredesen D, Fiala M (2017) Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on omega-3 supplementation. FASEB J 31, 148&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5161513</ArticleId><ArticleId IdType="pubmed">27677546</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivera-Perez HM, Lam L, Dang J, Jiang W, Rodriguez F, Rigali E, Weitzman S, Porter V, Rubbi L, Morselli M, Pellegrini M, Fiala M (2017) Omega-3 fatty acids increase the unfolded protein response and improve amyloid-beta phagocytosis by macrophages of patients with mild cognitive impairment. FASEB J 31, 4359&#x2013;4369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5602894</ArticleId><ArticleId IdType="pubmed">28634213</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinters HV, Zarow C, Borys E, Whitman JD, Tung S, Ellis WG, Zheng L, Chui HC (2018) Review: Vascular dementia: Clinicopathologic and genetic considerations. Neuropathol Appl Neurobiol 44, 247&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">29380913</ArticleId></ArticleIdList></Reference><Reference><Citation>Butterfield DA, Halliwell B (2019) Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci 20, 148&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9382875</ArticleId><ArticleId IdType="pubmed">30737462</ArticleId></ArticleIdList></Reference><Reference><Citation>Butterfield DA, Boyd-Kimball D (2018) Oxidative stress, amyloid-beta peptide, and altered key molecular pathways in the pathogenesis and progression of Alzheimer&#x2019;s disease. J Alzheimers Dis 62, 1345&#x2013;1367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5870019</ArticleId><ArticleId IdType="pubmed">29562527</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pubmed">10190820</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck JR, Yadagiri P, Capdevila J (1990) Synthesis of epoxyeicosatrienoic acids and heteroatom analogs. Methods Enzymol 187, 357&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">2233353</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang SH, Wagner KM, Morisseau C, Liu JY, Dong H, Wecksler AT, Hammock BD (2011) Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase. J Med Chem 54, 3037&#x2013;3050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3281519</ArticleId><ArticleId IdType="pubmed">21434686</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S, Huber W (2010) Differential expression analysis for sequence count data. Genome Biol 11, R106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3218662</ArticleId><ArticleId IdType="pubmed">20979621</ArticleId></ArticleIdList></Reference><Reference><Citation>Maley F, Trimble RB, Tarentino AL, Plummer TH Jr., (1989) Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases. Anal Biochem 180, 195&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">2510544</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy MR, Townsend RR, Lee YC (1988) Monosaccharide analysis of glycoconjugates by anion exchange chromatography with pulsed amperometric detection. Anal Biochem 170, 54&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">3389518</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiala M, Liu QN, Sayre J, Pop V, Brahmandam V, Graves MC, Vinters HV (2002) Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer&#x2019;s disease brain and damage the blood-brain barrier. Eur J Clin Invest 32, 360&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pubmed">12027877</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiala M, Lau YCC, Aghajani A, Bhargava S, Aminpour E, Kaczor-Urbanowicz KE, Mirzoyan H, Nichols I, Ko MW, Morselli M, Santana J, Dang J, Sayre J, Paul K, Pellegrini M (2020) Omega-3 fatty acids increase amyloid-beta immunity, energy, and circadian rhythm for cognitive protection of Alzheimer&#x2019;s disease patients beyond cholinesterase inhibitors. J Alzheimers Dis 75, 993&#x2013;1002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10190202</ArticleId><ArticleId IdType="pubmed">32390637</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekiyo T, Liu CC, Shinohara M, Li J, Bu G (2012) LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer&#x2019;s amyloid-beta. J Neurosci 32, 16458&#x2013;16465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3508699</ArticleId><ArticleId IdType="pubmed">23152628</ArticleId></ArticleIdList></Reference><Reference><Citation>Qosa H, Abuznait AH, Hill RA, Kaddoumi A (2012) Enhanced brain amyloid-beta clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer&#x2019;s disease. J Alzheimers Dis 31, 151&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3902015</ArticleId><ArticleId IdType="pubmed">22504320</ArticleId></ArticleIdList></Reference><Reference><Citation>Koronyo-Hamaoui M, Sheyn J, Hayden EY, Li S, Fuchs DT, Regis GC, Lopes DHJ, Black KL, Bernstein KE, Teplow DB, Fuchs S, Koronyo Y, Rentsendorj A (2020) Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease. Brain 143, 336&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6935752</ArticleId><ArticleId IdType="pubmed">31794021</ArticleId></ArticleIdList></Reference><Reference><Citation>Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS, Harris TH, Kipnis J (2015) Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4506234</ArticleId><ArticleId IdType="pubmed">26030524</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y, Wei Y, Lautrup S, Yang B, Wang Y, Cordonnier S, Mattson MP, Croteau DL, Bohr VA (2021) NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer&#x2019;s disease via cGAS-STING. Proc Natl Acad Sci U S A 118, e2011226118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8449423</ArticleId><ArticleId IdType="pubmed">34497121</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U, Kong A, Stefansson K (2013) Variant of TREM2associated with the risk of Alzheimer&#x2019;s disease. N Engl J Med 368, 107&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3677583</ArticleId><ArticleId IdType="pubmed">23150908</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemere CA, Maier M, Jiang L, Peng Y, Seabrook TJ (2006) Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: Lessons from mice, monkeys, and humans. Rejuvenation Res 9, 77&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">16608400</ArticleId></ArticleIdList></Reference><Reference><Citation>Leurent C, Goodman JA, Zhang Y, He P, Polimeni JR, Gurol ME, Lindsay M, Frattura L, Sohur US, Viswanathan A, Bednar MM, Smith EE, Ponezumab Trial Study Group, Greenberg SM (2019) Immunotherapy with ponezumab for probable cerebral amyloid angiopathy. Ann Clin Transl Neurol 6, 795&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6469253</ArticleId><ArticleId IdType="pubmed">31020004</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevigny J, Chiao P, Bussi&#xe8;re T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O&#x2019;Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, Rhodes K, Ferrero J, Hang Y, Mikulskis A, Grimm J, Hock C, Nitsch RM, Sandrock A (2016) The antibody aducanumab reduces A&#x3b2; plaques in Alzheimer&#x2019;s disease. Nature 537, 50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">27582220</ArticleId></ArticleIdList></Reference><Reference><Citation>Alakbarzade V, French JM, Howlett DR, Attems J, Francis PT, Stratton S, Clark CN, Pereira AC, Hainsworth AH (2021) Cerebral amyloid angiopathy distribution in older people: A cautionary note. Alzheimers Dement (N Y) 7, e12145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7885797</ArticleId><ArticleId IdType="pubmed">33644295</ArticleId></ArticleIdList></Reference><Reference><Citation>Freund-Levi Y, Hjorth E, Lindberg C, Cederholm T, Faxen-Irving G, Vedin I, Palmblad J, Wahlund LO, Schultzberg M, Basun H, Eriksdotter Jonhagen M (2009) Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer&#x2019;s disease: The OmegAD study. Dement Geriatr Cogn Disord 27, 481&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">19439966</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiala M, Restrepo L, Pellegrini M (2018) Immunotherapy of mild cognitive impairment by omega-3 supplementation: Why are amyloid-beta antibodies and omega-3 not working in clinical trials? J Alzheimers Dis 62, 1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5870008</ArticleId><ArticleId IdType="pubmed">29103035</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazan NG, Musto AE, Knott EJ (2011) Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity. Mol Neurobiol 44, 216&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3180614</ArticleId><ArticleId IdType="pubmed">21918832</ArticleId></ArticleIdList></Reference><Reference><Citation>Spector AA, Fang X, Snyder GD, Weintraub NL (2004) Epoxyeicosatrienoic acids (EETs): Metabolism and biochemical function. Prog Lipid Res 43, 55&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">14636671</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarriello S, Tuazon JP, Corey S, Schimmel S, Rajani M, Gorsky A, Incontri D, Hammock BD, Borlongan CV (2019) Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders. Prog Neurobiol 172, 23&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6993804</ArticleId><ArticleId IdType="pubmed">30447256</ArticleId></ArticleIdList></Reference><Reference><Citation>Morisseau C, Inceoglu B, Schmelzer K, Tsai HJ, Jinks SL, Hegedus CM, Hammock BD (2010) Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids. J Lipid Res 51, 3481&#x2013;3490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2975720</ArticleId><ArticleId IdType="pubmed">20664072</ArticleId></ArticleIdList></Reference><Reference><Citation>Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J (2006) Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: A randomized double-blind trial. Arch Neurol 63, 1402&#x2013;1408.</Citation><ArticleIdList><ArticleId IdType="pubmed">17030655</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr., Weiner M, Shinto L, Aisen PS (2010) Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial. JAMA 304, 1903&#x2013;1911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3259852</ArticleId><ArticleId IdType="pubmed">21045096</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36373319</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-8908</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><Issue>1</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Journal of Alzheimer's disease : JAD</Title><ISOAbbreviation>J Alzheimers Dis</ISOAbbreviation></Journal><ArticleTitle>Dyadic Discrete Choice Experiments Enable Persons with Dementia and Informal Caregivers to Participate in Health Care Decision Making: A Mixed Methods Study.</ArticleTitle><Pagination><StartPage>105</StartPage><EndPage>114</EndPage><MedlinePgn>105-114</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/JAD-220604</ELocationID><Abstract><AbstractText Label="BACKGROUND">Discrete choice experiments (DCEs) may facilitate persons with dementia and informal caregivers to state care preferences. DCEs can be cognitively challenging for persons with dementia.</AbstractText><AbstractText Label="OBJECTIVE">This study aims to design a dementia friendly dyadic DCE that enables persons with dementia and informal caregivers to provide input individually and jointly, by testing the number of attributes and choice tasks persons with dementia can complete and providing insight in their DCE decision-making process.</AbstractText><AbstractText Label="METHODS">This study included three DCE rounds: 1) persons with dementia, 2) informal caregivers, and 3) persons with dementia and informal caregivers together. A flexible DCE design was employed, with increasing choice task complexity to explore cognitive limitations in decision-making. Summary statistics and bivariate comparisons were calculated. A qualitative think-aloud approach was used to gain insight in the DCE decision-making processes. Transcripts were analyzed using thematic analysis.</AbstractText><AbstractText Label="RESULTS">Fifteen person with dementia, 15 informal caregiver, and 14 dyadic DCEs were conducted. In the individual DCE, persons with dementia completed six choice tasks (median), and 80% could complete a choice task with least three attributes. In the dyadic DCE persons with dementia completed eight choice tasks (median) and could handle slightly more attributes. Qualitative results included themes of core components in DCE decision-making such as: understanding the choice task, attribute and level perception, option attractiveness evaluation, decision rule selection, and preference adaptation.</AbstractText><AbstractText Label="CONCLUSION">Persons with dementia can use simple DCE designs. The dyadic DCE was promising for dyads to identify overlapping and discrepant care preferences while reaching consensus.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wammes</LastName><ForeName>Joost D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Geriatric Medicine, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swait</LastName><ForeName>Joffre D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Erasmus Choice Modelling Centre, Erasmus University Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Bekker-Grob</LastName><ForeName>Esther W</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Erasmus Choice Modelling Centre, Erasmus University Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monin</LastName><ForeName>Joan K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Social and Behavioral Sciences, Yale School of Public Health, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labrie</LastName><ForeName>Nanon H M</ForeName><Initials>NHM</Initials><AffiliationInfo><Affiliation>Department of Language, Literature and Communication, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacNeil Vroomen</LastName><ForeName>Janet L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Geriatric Medicine, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Alzheimers Dis</MedlineTA><NlmUniqueID>9814863</NlmUniqueID><ISSNLinking>1387-2877</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002755" MajorTopicYN="N">Choice Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010166" MajorTopicYN="N">Palliative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003657" MajorTopicYN="N">Decision Making</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Care preferences</Keyword><Keyword MajorTopicYN="N">Think aloud study</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">health services</Keyword><Keyword MajorTopicYN="N">informal caregivers</Keyword></KeywordList><CoiStatement>Authors&#x2019; disclosures available online (https://www.j-alz.com/manuscript-disclosures/22-0604r1).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>14</Day><Hour>3</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36373319</ArticleId><ArticleId IdType="pmc">PMC9881026</ArticleId><ArticleId IdType="doi">10.3233/JAD-220604</ArticleId><ArticleId IdType="pii">JAD220604</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>de Bekker-Grob EW, Ryan M, Gerard K (2012) Discrete choice experiments in health economics: A review of the literature. Health Econ 21, 145&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">22223558</ArticleId></ArticleIdList></Reference><Reference><Citation>Soekhai V, de Bekker-Grob EW, Ellis AR, Vass CM (2019) Discrete choice experiments in health economics: Past, present and future. Pharmacoeconomics 37, 201&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6386055</ArticleId><ArticleId IdType="pubmed">30392040</ArticleId></ArticleIdList></Reference><Reference><Citation>Hensher DA, Rose JM, Greene WH (2005) Applied Choice Analysis: A Primer. Cambridge University Press.</Citation></Reference><Reference><Citation>Louviere J, Hensher DA, Swait JD (2000) Stated Choice Methods: Analysis and Application. Cambridge University Press.</Citation></Reference><Reference><Citation>Lancsar E, Louviere J (2008) Conducting discrete choice experiments to inform healthcare decision making: A user&#x2019;s guide. Pharmacoeconomics 26, 661&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pubmed">18620460</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan M, Gerard K, Amaya-Amaya M (2008) Using Discrete Choice Experiments to Value Health and Health Care, Springer, Dordrecht, The Netherlands.</Citation></Reference><Reference><Citation>Heidenreich S, Watson V, Ryan M, Phimister E (2018) Decision heuristic or preference? Attribute non-attendance in discrete choice problems. Health Econ 27, 157&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">28620975</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh S, O&#x2019;Shea E, Pierse T, Kennelly B, Keogh F, Doherty E (2020) Public preferences for home care services for people with dementia: A discrete choice experiment on personhood. Soc Sci Med 245, 112675.</Citation><ArticleIdList><ArticleId IdType="pubmed">31760321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kampanellou E, Chester H, Davies L, Davies S, Giebel C, Hughes J, Challis D, Clarkson P, Members of the HOST-D (Home Support in Dementia) Programme Management Group (2019) Carer preferences for home support services in later stage dementia. Aging Ment Health 23, 60&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">29090948</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryan S, Hardyman W, Bentham P, Buckley A, Laight A (2005) Proxy completion of EQ-5D in patients with dementia. Qual Life Res 14, 107&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">15789945</ArticleId></ArticleIdList></Reference><Reference><Citation>Vullings I, Labrie N, Wammes JD, de Bekker-Grob EW, MacNeil-Vroomen J (2020) Important components for Dutch in-home care based on qualitative interviews with persons with dementia and informal caregivers. Health Expect 23, 1412&#x2013;1419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7752200</ArticleId><ArticleId IdType="pubmed">33026139</ArticleId></ArticleIdList></Reference><Reference><Citation>Wammes JD, Labrie NHM, Agogo GO, Monin JK, de&#xa0;Bekker-Grob EW, MacNeil Vroomen JL (2021) Persons with dementia and informal caregivers prioritizing care: A mixed-methods study. Alzheimers Dement (N Y) 7, e12193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8346735</ArticleId><ArticleId IdType="pubmed">34401467</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Philbin L, Woods B, Holmes E (2020) People with dementia and caregiver preferences for digital life story work service interventions. A discrete choice experiment and digital survey. Aging Ment Health 24, 353&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">30587008</ArticleId></ArticleIdList></Reference><Reference><Citation>Chester H, Clarkson P, Davies L, Sutcliffe C, Davies S, Feast A, Hughes J, Challis D, Members of the HOST-D (Home Support in Dementia) Programme Management Group (2018) People with dementia and carer preferences for home support services in early-stage dementia. Aging Ment Health 22, 270&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pubmed">27849124</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratcliffe J, Hutchinson C, Milte R, Nguyen KH, Welch A, Caporale T, Corlis M, Comans T (2019) How do people with dementia and family carers value dementia-specific quality of life states? An explorative &#x201c;Think Aloud&#x201d; study. Australas J Ageing 38 Suppl 2, 75&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">31496068</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle L, Brady A, Byrne G (2009) An overview of mixed methods research. J Res Nurs 14, 175&#x2013;185.</Citation></Reference><Reference><Citation>Lee SD, Iott B, Banaszak-Holl J, Shih SF, Raj M, Johnson KE, Kiessling K, Moore-Petinak N (2022) Application of mixed methods in health services management research: A systematic review. Med Care Res Rev 79, 331&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pubmed">34253078</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. Int J Qual Health Care 19, 349&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">17872937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempen GI, Meier AJ, Bouwens SF, van Deursen J, Verhey FR (2007) The psychometric properties of the Dutch version of the Telephone Interview Cognitive Status (TICS). Tijdschr Gerontol Geriatr 38, 38&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">17447609</ArticleId></ArticleIdList></Reference><Reference><Citation>Higginson IJ, Gao W, Jackson D, Murray J, Harding R (2010) Short-form Zarit Caregiver Burden Interviews were valid in advanced conditions. J Clin Epidemiol 63, 535&#x2013;542.</Citation><ArticleIdList><ArticleId IdType="pubmed">19836205</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA 185, 914&#x2013;919.</Citation><ArticleIdList><ArticleId IdType="pubmed">14044222</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;&#xe4;skel&#xe4;inen R (2010) Handbook of Translation Studies, pp. 371-374.</Citation></Reference><Reference><Citation>Montoya RM, Horton RS, Vevea JL, Citkowicz M, Lauber EA (2017) A re-examination of the mere exposure effect: The influence of repeated exposure on recognition, familiarity, and liking. Psychol Bull 143, 459&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">28263645</ArticleId></ArticleIdList></Reference><Reference><Citation>Soga N (2018) The relationship between the anchoring effect and the mere exposure effect in commodity selection. Proceedings of the 5th Multidisciplinary International Social Networks, pp. 1-4.</Citation></Reference><Reference><Citation>Braun V, Clarke V (2012) APA Handbook of Research Methods in Psychology, American Psychological Association.</Citation></Reference><Reference><Citation>Scott A (2002) Identifying and analysing dominant preferences in discrete choice experiments: An application in health care. J Econ Psychol 23, 383&#x2013;398.</Citation></Reference><Reference><Citation>Russo JE, Dosher BA (1983) Strategies for multiattribute binary choice. J Exp Psychol Learn Mem Cogn 9, 676&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pubmed">6227682</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchinson C, Milte R, Stanley M, Duff G, Ratcliffe J (2022) Using discrete choice experiments to elicit the service preferences of people with mild intellectual disability: An exploratory study. Health Soc Care Community 30, e1396&#x2013;e1405.</Citation><ArticleIdList><ArticleId IdType="pubmed">34418195</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen J, Clemmensen T, Yssing C (2002) Getting access to what goes on in people&#x2019;s heads? Reflections on the think-aloud technique Proceedings of the second Nordic conference on Human-computer interaction, pp. 101-110.</Citation></Reference><Reference><Citation>Hensher DA, Beck MJ, Rose JM (2011) Accounting for preference and scale heterogeneity in establishing whether it matters who is interviewed to reveal household automobile purchase preferences. Environ Resource Econ 49, 1&#x2013;22.</Citation></Reference><Reference><Citation>Corfman KP, Lehmann DR (1987) Models of cooperative group decision-making and relative influence: An experimental investigation of family purchase decisions. J Consum Res 14, 1&#x2013;13.</Citation></Reference><Reference><Citation>Whitlatch C (2008) Informal caregivers: Communciation and decision making . J Soc Work Educ 44, 73&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">18797237</ArticleId></ArticleIdList></Reference><Reference><Citation>Beharry-Borg N, Hensher DA, Scarpa R (2009) An analytical framework for joint vs separate decisions by couples in choice experiments: The case of coastal water quality in Tobago. Environ Resour Econ 43, 95&#x2013;117.</Citation></Reference><Reference><Citation>Cantarero-Prieto D, Leon PL, Blazquez-Fernandez C, Juan PS, Cobo CS (2020) The economic cost of dementia: A systematic review. Dementia (London) 19, 2637&#x2013;2657.</Citation><ArticleIdList><ArticleId IdType="pubmed">30909718</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36371243</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-5134</ISSN><JournalIssue CitedMedium="Internet"><Volume>106</Volume><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Patient education and counseling</Title><ISOAbbreviation>Patient Educ Couns</ISOAbbreviation></Journal><ArticleTitle>Developing an animated COVID-19 e-curriculum for adults with dementia and caregivers: Challenges and solutions.</ArticleTitle><Pagination><StartPage>180</StartPage><EndPage>187</EndPage><MedlinePgn>180-187</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pec.2022.10.346</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0738-3991(22)00818-7</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Effective education and support for adults with dementia and their caregivers around pandemic issues is critical for protecting them. Animation-based learning has shown promise in patient education. We collaborated with educators and support staff at Alzheimer's Association Connecticut (AACT) to conduct a mixed-methods study and develop an animated e-curriculum addressing pandemic related challenges.</AbstractText><AbstractText Label="METHODS">We conducted focus groups and surveys with dementia and caregiver educators and support staff at AACT for the initial needs assessment and the later e-curriculum evaluation. An interdisciplinary team of educators followed a step-wise process to transform the needs assessment results into an animation based e-curriculum.</AbstractText><AbstractText Label="RESULTS">Participants identified the following pandemic challenges: 1) social isolation, 2) caregiver fatigue, 3) safety, and 4) difficulty navigating the healthcare system. The overall quality and usefulness of the e-curriculum was "very good" or "excellent".</AbstractText><AbstractText Label="CONCLUSIONS">An animated e-curriculum addressing pandemic related issues relevant to adults with dementia and caregivers had positive reviews and was associated with improvement in self-reported ability to perform curriculum objectives among community dementia educators.</AbstractText><AbstractText Label="PRACTICE IMPLICATIONS">The pandemic challenges identified may facilitate the development of further resources. Additionally, this project may serve as a guide for clinicians interested in incorporating animation into education efforts.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oyeyemi</LastName><ForeName>Deborah M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Geriatrics, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omer</LastName><ForeName>Zehra B</ForeName><Initials>ZB</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Geriatrics, Yale University School of Medicine, New Haven, CT, USA; Department of Geriatrics &amp; Extended Care, VA Connecticut Healthcare System, West Haven, CT, 06516, USA. Electronic address: zehra.omer@hmhn.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Bryan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freimund</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Geriatrics, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gummerson</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rink</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Geriatrics, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallant</LastName><ForeName>Noelle</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Geriatrics, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marottoli</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Geriatrics, Yale University School of Medicine, New Haven, CT, USA; Department of Geriatrics &amp; Extended Care, VA Connecticut Healthcare System, West Haven, CT, 06516, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Patient Educ Couns</MedlineTA><NlmUniqueID>8406280</NlmUniqueID><ISSNLinking>0738-3991</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003479" MajorTopicYN="N">Curriculum</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020380" MajorTopicYN="N">Needs Assessment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Animation</Keyword><Keyword MajorTopicYN="N">Caregiver</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Education</Keyword><Keyword MajorTopicYN="N">Pandemic</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>12</Day><Hour>23</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36371243</ArticleId><ArticleId IdType="pmc">PMC9597565</ArticleId><ArticleId IdType="doi">10.1016/j.pec.2022.10.346</ArticleId><ArticleId IdType="pii">S0738-3991(22)00818-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Altieri M., Santangelo G. The psychological impact of COVID-19 pandemic and lockdown on caregivers of people with dementia. Am J Geriatr Psychiatry. 2021;29(1):27&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577876</ArticleId><ArticleId IdType="pubmed">33153872</ArticleId></ArticleIdList></Reference><Reference><Citation>Batsis J.A., DiMilia P.R., Seo L.M., et al. Effectiveness of ambulatory telemedicine care in older adults: a systematic review. J Am Geriatr Soc. 2019;67:1737&#x2013;1749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6684409</ArticleId><ArticleId IdType="pubmed">31066916</ArticleId></ArticleIdList></Reference><Reference><Citation>Berney S., B&#xe9;trancourt M. Does animation enhance learning? A meta-analysis. Comput Educ. 2016;101:150&#x2013;167.</Citation></Reference><Reference><Citation>Black B.S., Johnston D., Rabins P.V., Morrison A., Lyketsos C., Samus Q.M. Unmet needs of community-residing persons with dementia and their informal caregivers: findings from the maximizing independence at home study. J Am Geriatr Soc. 2013;61:2087&#x2013;2095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4001885</ArticleId><ArticleId IdType="pubmed">24479141</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle E.A., MacArthur E.W., Connolly T.M., et al. A narrative literature review of games, animations and simulations to teach research methods and statistics. Comput Educ. 2014;74:1&#x2013;14.</Citation></Reference><Reference><Citation>Brown B., Gao C., Windish D., Moeller J., O'Neill E., Soares S. Becoming clinician-animators: a toolkit and pilot study for novel animated content development in a medical education curriculum. Med Sci Educ. 2020;30:977&#x2013;988.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8368584</ArticleId><ArticleId IdType="pubmed">34457756</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown B., Gielissen K.A., Soares S., Gao C.A., Moeller J., Windish D. Anthropomorphic character animations versus digital chalk talks in a resident diabetes pharmacotherapy curriculum: a randomized controlled trial. J Gen Intern Med. 2022;37(9):2251&#x2013;2258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9202980</ArticleId><ArticleId IdType="pubmed">35710669</ArticleId></ArticleIdList></Reference><Reference><Citation>Canevelli M., Valletta M., Toccaceli Blasi M., et al. Facing dementia during the COVID-19 outbreak. J Am Geriatr Soc. 2020;68:1673&#x2013;1676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300919</ArticleId><ArticleId IdType="pubmed">32516441</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng S.T., Au A., Losada A., Thompson L.W., Gallagher-Thompson D. Psychological interventions for dementia caregivers: what we have achieved, what we have learned. Curr Psychiatry Rep. 2019;21:59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6554248</ArticleId><ArticleId IdType="pubmed">31172302</ArticleId></ArticleIdList></Reference><Reference><Citation>Costanzo M.C., Arcidiacono C., Rodolico A., Panebianco M., Aguglia E., Signorelli M.S. Diagnostic and interventional implications of telemedicine in Alzheimer's disease and mild cognitive impairment: a literature review. Int J Geriatr Psychiatry. 2020;35:12&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">31617247</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahodwala M., Geransar R., Babion J., de Grood J., Sargious P. The impact of the use of video-based educational interventions on patient outcomes in hospital settings: a scoping review. Patient Educ Couns. 2018;101(12):2116&#x2013;2124.</Citation><ArticleIdList><ArticleId IdType="pubmed">30087021</ArticleId></ArticleIdList></Reference><Reference><Citation>Federman A.D., Sano M., Wolf M.S., Siu A.L., Halm E.A. Health literacy and cognitive performance in older adults. J Am Geriatr Soc. 2009;57:1475&#x2013;1480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2754116</ArticleId><ArticleId IdType="pubmed">19515101</ArticleId></ArticleIdList></Reference><Reference><Citation>Gately M.E., Trudeau S.A., Moo L.R. In-home video telehealth for dementia management: implications for rehabilitation. Curr Geriatr Rep. 2019;8:239&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6996201</ArticleId><ArticleId IdType="pubmed">32015957</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;ffler T.N., Leutner D. Instructional animation versus static pictures: a meta-analysis. Learn Instr. 2007;17(6):722&#x2013;738.</Citation></Reference><Reference><Citation>Kasper J.D., Freedman V.A., Spillman B.C., Wolff J.L. The disproportionate impact of dementia on family and unpaid caregiving to older adults. Health Aff (Millwood) 2015;34:1642&#x2013;1649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4635557</ArticleId><ArticleId IdType="pubmed">26438739</ArticleId></ArticleIdList></Reference><Reference><Citation>Leiner M. Patient communication: a multidisciplinary approach using animated cartoons. Health Educ Res. 2004;19:591&#x2013;595.</Citation><ArticleIdList><ArticleId IdType="pubmed">15150139</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxwell E., Simmons M., Franklin L., Arnold J., Pall H. Impact of educational cartoon on pediatric bowel preparation quality at time of colonoscopy. Glob Pedia Health. 2014;1 2333794X14548199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4804678</ArticleId><ArticleId IdType="pubmed">27335902</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer R.E., Moreno R. Animation as an aid to multimedia learning. Educ Psychol Rev. 2002;14:87&#x2013;89.</Citation></Reference><Reference><Citation>Moo L.R., Gately M.E., Jafri Z., Shirk S.D. Home-based video telemedicine for dementia management. Clin Gerontol. 2020;43:193&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">31431147</ArticleId></ArticleIdList></Reference><Reference><Citation>National Center for Health Statistic (NCHS) Mortality Reporting System Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET). Available at: &#x3008;https://www.cdc.gov/coronavirus/2019-ncov/images/need-extra-precautions/high-risk-age.jpg&#x3009;. Accessed October 21, 2021.</Citation></Reference><Reference><Citation>Numbers K., Brodaty H. The effects of the COVID-19 pandemic on people with dementia. Nat Rev Neurol. 2021;17:69&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7786184</ArticleId><ArticleId IdType="pubmed">33408384</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana J., Besche H., Cockrill B. Twelve tips for the production of digital chalk-talk videos. Med Teach. 2017;39(6):653&#x2013;659.</Citation><ArticleIdList><ArticleId IdType="pubmed">28332912</ArticleId></ArticleIdList></Reference><Reference><Citation>Remoli G., Canevelli M., Robertazzo U.M., et al. Supporting and protecting people with dementia in the CoVID-19 pandemic. J Alzheimers Dis. 2021;83(1):43&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">34219720</ArticleId></ArticleIdList></Reference><Reference><Citation>Rising K.L., Salcedo V.J., Amadio G., et al. Living through the pandemic: the voices of persons with dementia and their caregivers. J Appl Gerontol. 2021 7334648211036399.</Citation><ArticleIdList><ArticleId IdType="pubmed">34344205</ArticleId></ArticleIdList></Reference><Reference><Citation>Saengow V.E., Chancharoenchai P., Saartying W., et al. Epilepsy video animation: impact on knowledge and drug adherence in pediatric epilepsy patients and caregivers. Clin Neurol Neurosurg. 2018;172:59&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">29986196</ArticleId></ArticleIdList></Reference><Reference><Citation>Savla J., Roberto K.A., Blieszner R., McCann B.R., Hoyt E., Knight A.L. Dementia caregiving during the "Stay-at-Home" phase of COVID-19 pandemic. J Gerontol B Psychol Sci Soc Sci. 2021;76:e241&#x2013;e245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7546083</ArticleId><ArticleId IdType="pubmed">32827214</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnellinger M., Finkelstein M., Thygeson M.V., Vander Velden H., Karpas A., Madhok M. Animated video vs pamphlet: comparing the success of educating parents about proper antibiotic use. Pediatrics. 2010;125:990&#x2013;996.</Citation><ArticleIdList><ArticleId IdType="pubmed">20385634</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubbe D., Scalia P., Yen R.W., et al. Using pictures to convey health information: a systematic review and meta-analysis of the effects on patient and consumer health behaviors and outcomes. Patient Educ Couns. 2020;103:1935&#x2013;1960.</Citation><ArticleIdList><ArticleId IdType="pubmed">32466864</ArticleId></ArticleIdList></Reference><Reference><Citation>Sep&#xfa;lveda-Loyola W., Rodr&#xed;guez-S&#xe1;nchez I., P&#xe9;rez-Rodr&#xed;guez P., et al. Impact of social isolation due to COVID-19 on health in older people: mental and physical effects and recommendations. J Nutr Health Aging. 2020;24(9):938&#x2013;947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7597423</ArticleId><ArticleId IdType="pubmed">33155618</ArticleId></ArticleIdList></Reference><Reference><Citation>Turkdogan S., Roy C.F., Chartier G., et al. Effect of perioperative patient education via animated videos in patients undergoing head and neck surgery: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2021 doi: 10.1001/jamaoto.2021.3765. (Epub ahead of print.)</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2021.3765</ArticleId><ArticleId IdType="pmc">PMC8719273</ArticleId><ArticleId IdType="pubmed">34967863</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Davis P.B., Gurney M.E., Xu R. COVID-19 and dementia: analyses of risk, disparity, and outcomes from electronic health records in the US. Alzheimers Dement. 2021;17:1297&#x2013;1306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014535</ArticleId><ArticleId IdType="pubmed">33559975</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36369823</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1364-6915</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>Aging &amp; mental health</Title><ISOAbbreviation>Aging Ment Health</ISOAbbreviation></Journal><ArticleTitle>Behavioral and psycho-social impairments among people living with dementia and their management by caregivers in South-Western Uganda: a qualitative study.</ArticleTitle><Pagination><StartPage>1938</StartPage><EndPage>1945</EndPage><MedlinePgn>1938-1945</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/13607863.2022.2146053</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">This study aimed to explore the behavioral and social impairments among people living with dementia (PLWD) in rural southwestern Uganda. It also explored the burden of caregivers for people living with dementia.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This was a qualitative study among people living with dementia and their caregivers. We consecutively enrolled 30 people living with dementia with their caregivers from their homes. We conducted in-depth interviews using a semi-structured interview guide. We did a thematic content analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The themes under-reported behavioral impairment were; difficulty in personal care, physical inactivity, and impaired judgment. Under the social and cognitive impairment theme, there was the failure to be in social gatherings like church, community groups, and markets. Under the caregivers' role, their burden included managing behavioral, social, and cognitive impairments of PLWD. Although caregivers were committed to caring for PLWDs, this required sacrificing time at the expense of income-generating activities.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Dementia hinders the behavioral and social aspects of the affected people. Caregivers are highly burdened to care for PLWD. Strategies to minimize caregivers' burden while caring for people living with dementia are recommended.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arinaitwe</LastName><ForeName>Innocent</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Mbarara, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karungi</LastName><ForeName>Christine K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Grants Administration and Management, Mbarara University of Science and Technology, Mbarara, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gopez</LastName><ForeName>Abigail</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>California University Science and Medicine, Colton, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wakida</LastName><ForeName>Edith K</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Grants Administration and Management, Mbarara University of Science and Technology, Mbarara, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talib</LastName><ForeName>Zohray M</ForeName><Initials>ZM</Initials><AffiliationInfo><Affiliation>Department of Medical Education, California University of Science and Medicine, Colton, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mubangizi</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Family Medicine and Community Practice, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Mbarara, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obua</LastName><ForeName>Celestino</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Office of the Vice-Chancellor, Mbarara University of Science and Technology, Mbarara, Uganda.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R25 TW011210</GrantID><Acronym>TW</Acronym><Agency>FIC NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Aging Ment Health</MedlineTA><NlmUniqueID>9705773</NlmUniqueID><ISSNLinking>1360-7863</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Uganda</Keyword><Keyword MajorTopicYN="N">behavioral impairment</Keyword><Keyword MajorTopicYN="N">burden</Keyword><Keyword MajorTopicYN="N">caregivers</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">social impairment</Keyword></KeywordList><CoiStatement>Disclosure statement. The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>12</Day><Hour>2</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36369823</ArticleId><ArticleId IdType="mid">NIHMS1923638</ArticleId><ArticleId IdType="pmc">PMC10432726</ArticleId><ArticleId IdType="doi">10.1080/13607863.2022.2146053</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abaasa C, Obua C, Wakida EK, &amp; Rukundo GZ (2021). A qualitative investigation of the psychosocial services utilised by care-givers of patients with Alzheimer&#x2019;s disease and related dementias in southwestern Uganda. Ageing &amp; Society, 1&#x2013;14. 10.1017/S0144686X21001276</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0144686X21001276</ArticleId><ArticleId IdType="pmc">PMC10482049</ArticleId><ArticleId IdType="pubmed">37680685</ArticleId></ArticleIdList></Reference><Reference><Citation>Adonteng-Kissi B, Moyle W, &amp; Grealish L (2022). Informal care of older adults with chronic life-limiting illness in Africa: An integrative review. International Social Work, 65(1), 127&#x2013;141. 10.1177/0020872819901164</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0020872819901164</ArticleId></ArticleIdList></Reference><Reference><Citation>Ainamani HE, Alele PE, Rukundo GZ, Maling S, Wakida EK, Obua C, &amp; Tsai AC (2020). Caregiving burden and mental health problems among family Caregivers of people with dementia in rural Uganda. Global Mental Health (Cambridge, England), 7, e13. 10.1017/gmh.2020.7</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/gmh.2020.7</ArticleId><ArticleId IdType="pmc">PMC7379317</ArticleId><ArticleId IdType="pubmed">32742671</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen AP, Buckley MM, Cryan JF, N&#xed; Chorcor&#xe1;in A, Dinan TG, Kearney PM, O&#x2019;Caoimh R, Calnan M, Clarke G, &amp; Molloy DW (2019). Informal caregiving for dementia patients: The contribution of patient characteristics and behaviours to caregiver burden. Age and Ageing, 49(1), 52&#x2013;56. 10.1093/ageing/afz128</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afz128</ArticleId><ArticleId IdType="pubmed">31755532</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Disease International. (2021). About Alzheimer&#x2019;s &amp; dementia. https://www.alzint.org/about/</Citation></Reference><Reference><Citation>Braun V, &amp; Clarke V (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77&#x2013;101. [Database] 10.1191/1478088706qp063oa</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/1478088706qp063oa</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors MH, Seeher K, Teixeira-Pinto A, Woodward M, Ames D, &amp; Brodaty H (2020). Dementia and caregiver burden: A three-year longitudinal study. International Journal of Geriatric Psychiatry, 35(2), 250&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">31821606</ArticleId></ArticleIdList></Reference><Reference><Citation>Crellin NE, Orrell M, McDermott O, &amp; Charlesworth G (2014). Self-efficacy and health-related quality of life in family carers of people with dementia: A systematic review. Aging &amp; Mental Health, 18(8), 954&#x2013;969.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4192898</ArticleId><ArticleId IdType="pubmed">24943873</ArticleId></ArticleIdList></Reference><Reference><Citation>Darby RR, &amp; Dickerson BC (2017). Dementia, decision-making, and capacity. Harvard Review of Psychiatry, 25(6), 270&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5711478</ArticleId><ArticleId IdType="pubmed">29117022</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis M, O Connell T, Johnson S, Cline S, Merikle E, Martenyi F, &amp; Simpson K (2018). Estimating Alzheimer&#x2019;s disease progression rates from normal cognition through mild cognitive impairment and stages of dementia. Current Alzheimer Research, 15(8), 777&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6156780</ArticleId><ArticleId IdType="pubmed">29357799</ArticleId></ArticleIdList></Reference><Reference><Citation>de Mendon&#xe7;a A, Ribeiro F, Guerreiro M, &amp; Garcia C (2004). Frontotemporal mild cognitive impairment. Journal of Alzheimer&#x2019;s Disease: JAD, 6(1), 1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15004322</ArticleId></ArticleIdList></Reference><Reference><Citation>Downs M, &amp; Collins L (2015). Person-centred communication in dementia care. Nursing Standard (Royal College of Nursing (Great Britain): 1987), 30(11), 37&#x2013;41. 10.7748/ns.30.11.37.s45</Citation><ArticleIdList><ArticleId IdType="doi">10.7748/ns.30.11.37.s45</ArticleId><ArticleId IdType="pubmed">26554996</ArticleId></ArticleIdList></Reference><Reference><Citation>Essuman A, Agyemang FA, &amp; Mate-Kole CC (2018). Long-term care for older adults in Africa: Whither now? Journal of the American Medical Directors Association, 19(9), 728&#x2013;730. 10.1016/j.jamda.2018.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2018.07.012</ArticleId><ArticleId IdType="pubmed">30149839</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans N, &amp; Collier L (2019). An exploration of the experience of using calendar reminders for people with dementia and family carers. Dementia (London, England), 18(5), 1912&#x2013;1933. 10.1177/1471301217734916</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301217734916</ArticleId><ArticleId IdType="pubmed">28994304</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazio S, Pace D, Flinner J, &amp; Kallmyer B (2018). The fundamentals of person-centered individuals with dementia. The Gerontologist, 58(suppl_1), S10&#x2013;S19. 10.1093/geront/gnx122</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnx122</ArticleId><ArticleId IdType="pubmed">29361064</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez M, Gobartt AL, &amp; Bala&#xf1;&#xe1; M, The COOPERA Study Group. (2010). Behavioural symptoms in patients with Alzheimer&#x2019;s disease and their association with cognitive impairment. BMC Neurology, 10(1), 1&#x2013;9. 10.1186/1471-2377-10-87</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-10-87</ArticleId><ArticleId IdType="pmc">PMC2955564</ArticleId><ArticleId IdType="pubmed">20920205</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkel SI, e Silva JC, Cohen G, Miller S, &amp; Sartorius N (1997). Behavioral and psychological signs and symptoms of dementia: A consensus statement on current knowledge and implications for research and treatment. International Psychogeriatrics, 8(S3), 497&#x2013;500. 10.1017/S1041610297003943</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610297003943</ArticleId><ArticleId IdType="pubmed">9154615</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson A, Holmes SD, Fields NL, &amp; Richardson VE (2019). Providing care for persons with dementia in rural communities: Informal Caregivers&#x2019; perceptions of supports and services. Journal of Gerontological Social Work, 62(6), 630&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pubmed">31250733</ArticleId></ArticleIdList></Reference><Reference><Citation>Green J, &amp; Thorogood N (2018). Qualitative methods for health research. London: Sage.</Citation></Reference><Reference><Citation>Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D, Li Y, Li Y, Zhu M, Jiao H, Song Y, Shi Y, Zhang H, Gong M, Wei C, Tang Y, Fang B, Guo D, Wang F, &#x2026; Jia J, COAST Group. (2020). Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: A cross-sectional study. The Lancet. Public Health, 5(12), e661&#x2013;e671. 10.1016/S2468-2667(20)30185-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(20)30185-7</ArticleId><ArticleId IdType="pubmed">33271079</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang F, Kong F, &amp; Li S (2021). The association between social support and cognitive impairment among the urban elderly in Jinan, China. Healthcare, 9(11), 1443. https://www.mdpi.com/2227-9032/9/11/1443
https://doi.org/10.3390/healthcare9111443</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare9111443</ArticleId><ArticleId IdType="pmc">PMC8625136</ArticleId><ArticleId IdType="pubmed">34828488</ArticleId></ArticleIdList></Reference><Reference><Citation>Kales HC, Gitlin LN, &amp; Lyketsos CG (2015). Assessment and management of behavioral and psychological symptoms of dementia. BMJ (Clinical Research ed.), 350, h369. 10.1136/bmj.h369</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h369</ArticleId><ArticleId IdType="pmc">PMC4707529</ArticleId><ArticleId IdType="pubmed">25731881</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang B, Karel MJ, Corazzini KN, &amp; McConnell ES (2021). A mixed methods study on the manifestations of behavioural symptoms of dementia among veterans with and without posttraumatic stress disorder. Journal of Advanced Nursing, 77(7), 3176&#x2013;3188.</Citation><ArticleIdList><ArticleId IdType="pubmed">33969916</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawlor BA (2004). Behavioral and psychological symptoms in dementia: The role of atypical antipsychotics. Journal of Clinical Psychiatry, 65, 5&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">15264965</ArticleId></ArticleIdList></Reference><Reference><Citation>Leggett AN, Bugajski BC, Gitlin LN, &amp; Kales HC (2021). Characterizing dementia caregiver style in managing care challenges: Cognitive and behavioral components. Dementia (London, England), 20(6), 2188&#x2013;2204. 10.1177/1471301220988233</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301220988233</ArticleId><ArticleId IdType="pmc">PMC9725115</ArticleId><ArticleId IdType="pubmed">33517792</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd J, Muers J, Patterson TG, &amp; Marczak M (2019). Self-compassion, coping strategies, and caregiver burden in Caregivers of people with dementia. Clinical Gerontologist, 42(1), 47&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">29723129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes Ibanez-Gonzalez D, &amp; Tollman SM (2015). Clinics and churches: Lifeworlds and health-seeking practices of older women with noncommunicable disease in rural South Africa. BMC International Health and Human Rights, 15(1), 12&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4445983</ArticleId><ArticleId IdType="pubmed">26017870</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, &#x2026; Miller DS (2011). Neuropsychiatric symptoms in Alzheimer&#x2019;s disease. Alzheimer&#x2019;s &amp; Dementia, 7, 532&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3299979</ArticleId><ArticleId IdType="pubmed">21889116</ArticleId></ArticleIdList></Reference><Reference><Citation>Majer R, Simon V, Csiba L, Kardos L, Frecska E, &amp; Hortob&#xe1;gyi T (2019). Behavioural and psychological symptoms in neurocognitive disorders: Specific patterns in dementia subtypes. Open Medicine (Warsaw, Poland), 14(1), 307&#x2013;316. 10.1515/med-2019-0028</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/med-2019-0028</ArticleId><ArticleId IdType="pmc">PMC6463819</ArticleId><ArticleId IdType="pubmed">30997394</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayston R, Lloyd-Sherlock P, Gallardo S, Wang H, Huang Y, Montes de Oca V, Ezeah P, Guerra M, Sosa AL, Liu Z, Uwakwe R, Guerchet MM, &amp; Prince M (2017). A journey without maps&#x2014;Understanding the costs of caring for dependent older people in Nigeria, China, Mexico and Peru. PLoS One, 12(8), e0182360. 10.1371/journal.pone.0182360</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0182360</ArticleId><ArticleId IdType="pmc">PMC5546609</ArticleId><ArticleId IdType="pubmed">28787029</ArticleId></ArticleIdList></Reference><Reference><Citation>McNiel P, &amp; Westphal J (2018). Namaste Care&#x2122;: A person-centered care approach for Alzheimer&#x2019;s and advanced dementia. Western Journal of Nursing Research, 40(1), 37&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">27885156</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez MF, Anderson E, &amp; Shapira JS (2005). An investigation of moral judgement in frontotemporal dementia. Cognitive and Behavioral Neurology, 18(4), 193&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">16340391</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohs RC, Doody RS, Morris JC, Ieni JR, Rogers SL, Perdomo CA, &amp; Pratt RD, &#x201c;312&#x201d; Study Group. (2001). A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology, 57(3), 481&#x2013;488. 10.1212/wnl.57.3.481</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.57.3.481</ArticleId><ArticleId IdType="pubmed">11502917</ArticleId></ArticleIdList></Reference><Reference><Citation>Mubangizi V, Maling S, Obua C, &amp; Tsai AC (2020). Prevalence and correlates of Alzheimer&#x2019;s disease and related dementias in rural Uganda: Cross-sectional, population-based study. BMC Geriatrics, 20(1), 48. 10.1186/s12877-020-1461-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-020-1461-z</ArticleId><ArticleId IdType="pmc">PMC7011370</ArticleId><ArticleId IdType="pubmed">32041525</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neill SA, Mason S, Parente G, Donnelly MP, Nugent CD, McClean S, Scotney B, &amp; Craig D (2011). Video reminders as cognitive prosthetics for people with dementia. Ageing International, 36(2), 267&#x2013;282. 10.1007/s12126-010-9089-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12126-010-9089-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Olasoji M, Maude P, &amp; McCauley K (2017). Not sick enough: Experiences of carers of people with mental illness negotiating care for their relatives with mental health services. Journal of Psychiatric and Mental Health Nursing, 24(6), 403&#x2013;411. 10.1111/jpm.12399</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpm.12399</ArticleId><ArticleId IdType="pubmed">28499065</ArticleId></ArticleIdList></Reference><Reference><Citation>Olayinka OO, &amp; Mbuyi NN (2014). Epidemiology of dementia among the elderly in Sub-Saharan Africa. International Journal of Alzheimer&#x2019;s Disease, 2014, 195750. 10.1155/2014/195750</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/195750</ArticleId><ArticleId IdType="pmc">PMC4142168</ArticleId><ArticleId IdType="pubmed">25177512</ArticleId></ArticleIdList></Reference><Reference><Citation>Prince MJ, Wimo A, Guerchet MM, Ali GC, Wu Y-T, &amp; Prina M (2015). The global impact of dementia: An analysis of prevalence, incidence, cost and trends. World Alzheimer Report; 2015.</Citation></Reference><Reference><Citation>Shah RS, Lee H-G, Xiongwei Z, Perry G, Smith MA, &amp; Castellani RJ (2008). Current approaches in the treatment of Alzheimer&#x2019;s disease. Biomedicine &amp; Pharmacotherapy, 62(4), 199&#x2013;207. 10.1016/j.biopha.2008.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2008.02.005</ArticleId><ArticleId IdType="pubmed">18407457</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinberg M, Shao H, Zandi P, Lyketsos CG, Welsh-Bohmer KA, Norton MC, Breitner JCS, Steffens DC, &amp; Tschanz JT, Cache County Investigators. (2008). Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: The Cache County Study. International Journal of Geriatric Psychiatry, 23(2), 170&#x2013;177. 10.1002/gps.1858</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.1858</ArticleId><ArticleId IdType="pmc">PMC2932652</ArticleId><ArticleId IdType="pubmed">17607801</ArticleId></ArticleIdList></Reference><Reference><Citation>Thies W, &amp; Bleiler L (2012). 2012 Alzheimer&#x2019;s disease facts and figures Alzheimer&#x2019;s Association*. Alzheimer&#x2019;s &amp; Dementia, 8(2), 131&#x2013;168. 10.1016/j.jalz.2012.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2012.02.001</ArticleId><ArticleId IdType="pubmed">22404854</ArticleId></ArticleIdList></Reference><Reference><Citation>UBOS. (2016). The National Population and Housing Census 2014 - Main report. Uganda Bureau of Statistics.</Citation></Reference><Reference><Citation>UBOS. (2020). Statistical abstract. https://www.ubos.org/wp-content/uploads/publications/11_2020STATISTICAL__ABSTRACT_2020.pdf</Citation></Reference><Reference><Citation>UBOS. (2021). Uganda National Survey Report 2019/2020. Kampala Uganda. UBOS. https://www.ubos.org/wp-content/uploads/publications/09_2021Uganda-National-Survey-Report-2019-2020.pdf</Citation></Reference><Reference><Citation>World Health Organization. (2021). Fact sheet on dementia. World Health Organisation.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36367770</PMID><DateRevised><Year>2022</Year><Month>11</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1929-0748</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>11</Day></PubDate></JournalIssue><Title>JMIR research protocols</Title><ISOAbbreviation>JMIR Res Protoc</ISOAbbreviation></Journal><ArticleTitle>A Psychosocial Intervention for Supporting Informal Caregivers of Older People With Alzheimer Disease: Protocol for the InnFamiglia Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>e37496</StartPage><MedlinePgn>e37496</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e37496</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/37496</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Dementia is a neurodegenerative syndrome characterized by impaired cognitive functions associated with psychological and behavioral disorders. The informal caregiver has a central role in the life of the person with dementia. Committing a large part of the day to caring for the assisted person inevitably has an effect on the caregiver's life.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study is to analyze the impact of a psychosocial intervention dedicated to a group of informal caregivers of patients with Alzheimer disease. The intervention will be guided by a trained psychologist who will facilitate the participants' expression of their emotional states, as compared to a traditional self-help group.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The intervention described in this paper was designed and developed for the project INNovazione sociale e tecnologica per le FAMIGLIE che assistono malati affetti da Alzheimer (InnFamiglia). The study is designed as a randomized controlled trial (RCT). The RCT includes an experimental group, in which the participants will undertake the psychosocial intervention, and a control group, where participants will receive support according to traditional self-help methodology. Interventions for both groups will last 4 months and will be comprised of 16 sessions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Participant recruitment, enrollment, and data collection began in 2021. Enrollment continued until September 2022, at which time the last group began the intervention. Data collection will be completed by December 2022, and data analysis will be completed by March 2023. The study findings will be published in peer-reviewed scientific journals and will be presented at scientific meetings. Summaries of the results will also be made available to investigators for dissemination within their clinics.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We hypothesize that the experimental group will be more effective in managing caregiver burden and coping strategies and that this will improve the perception of well-being, anxiety, and depression among caregivers. Our study aims to compare two groups receiving different interventions: a self-help group and a psychosocial group with elements of emotional support. This study may also give us more information about the most appropriate ways to support and help caregivers of people with dementia.</AbstractText><AbstractText Label="INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)" NlmCategory="UNASSIGNED">DERR1-10.2196/37496.</AbstractText><CopyrightInformation>&#xa9;Sara Pasquini, Arianna Margaritini, Elena Gambella, Mirko Di Rosa, Elvira Maranesi, Roberta Bevilacqua, Patrizia Civerchia, Giuseppe Pelliccioni. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 11.11.2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Pasquini</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3110-2475</Identifier><AffiliationInfo><Affiliation>IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margaritini</LastName><ForeName>Arianna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3897-6530</Identifier><AffiliationInfo><Affiliation>IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gambella</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-9008-3601</Identifier><AffiliationInfo><Affiliation>IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Rosa</LastName><ForeName>Mirko</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1862-4159</Identifier><AffiliationInfo><Affiliation>IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Maranesi</LastName><ForeName>Elvira</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-2414-3773</Identifier><AffiliationInfo><Affiliation>IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bevilacqua</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3851-3552</Identifier><AffiliationInfo><Affiliation>IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Civerchia</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0586-2171</Identifier><AffiliationInfo><Affiliation>IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Pelliccioni</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-0377-9713</Identifier><AffiliationInfo><Affiliation>IRCCS INRCA, Ancona, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Res Protoc</MedlineTA><NlmUniqueID>101599504</NlmUniqueID><ISSNLinking>1929-0748</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer disease</Keyword><Keyword MajorTopicYN="N">caregiver burden</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">emotional support</Keyword><Keyword MajorTopicYN="N">psychosocial intervention</Keyword><Keyword MajorTopicYN="N">randomized controlled trial</Keyword><Keyword MajorTopicYN="N">self-help</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36367770</ArticleId><ArticleId IdType="pmc">PMC9700238</ArticleId><ArticleId IdType="doi">10.2196/37496</ArticleId><ArticleId IdType="pii">v11i11e37496</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Molyneux GJ, McCarthy GM, McEniff S, Cryan M, Conroy RM. Prevalence and predictors of carer burden and depression in carers of patients referred to an old age psychiatric service. Int Psychogeriatr. 2008 Jun 30;20(06):1193. doi: 10.1017/s1041610208007515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610208007515</ArticleId><ArticleId IdType="pubmed">18588725</ArticleId></ArticleIdList></Reference><Reference><Citation>Dementia Observatory. Istituto Superiore della Sanit&#xe0;.  [2022-11-02].  
 https://www.iss.it/le-demenze
.</Citation></Reference><Reference><Citation>Prevalence of dementia in Europe. Alzheimer Europe.  [2022-11-02].  
 https://www.alzheimer-europe.org/dementia/prevalence-dementia-europe
.</Citation></Reference><Reference><Citation>Dementia in Europe Yearbook 2019: Estimating the Prevalence of Dementia in Europe. Luxembourg: Alzheimer Europe;  [2022-11-02].  
 https://www.alzheimer-europe.org/sites/default/files/alzheimer_europe_dementia_in_europe_yearbook_2019.pdf
.</Citation></Reference><Reference><Citation>Alzheimer's Disease International.  [2022-11-02].  
 https://www.alzint.org
.</Citation></Reference><Reference><Citation>Censis.  [2022-11-02].  
 https://www.censis.it/
</Citation></Reference><Reference><Citation>Zarit SH, Todd PA, Zarit JM. Subjective burden of husbands and wives as caregivers: A longitudinal study. Gerontologist. 1986 Jun;26(3):260&#x2013;266. doi: 10.1093/geront/26.3.260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/26.3.260</ArticleId><ArticleId IdType="pubmed">3721233</ArticleId></ArticleIdList></Reference><Reference><Citation>Adelman RD, Tmanova LL, Delgado D, Dion S, Lachs MS. Caregiver burden: A clinical review. JAMA. 2014 Mar 12;311(10):1052&#x2013;1060. doi: 10.1001/jama.2014.304.1840211</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.304</ArticleId><ArticleId IdType="pubmed">24618967</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Aguilar P, Lopez-Bastida J, Yanes-Lopez V. Impact on health-related quality of life and perceived burden of informal caregivers of individuals with Alzheimer's disease. Neuroepidemiology. 2006;27(3):136&#x2013;142. doi: 10.1159/000095760.95760</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000095760</ArticleId><ArticleId IdType="pubmed">16974108</ArticleId></ArticleIdList></Reference><Reference><Citation>Papastavrou E, Kalokerinou A, Papacostas SS, Tsangari H, Sourtzi P. Caring for a relative with dementia: Family caregiver burden. J Adv Nurs. 2007 Jun;58(5):446&#x2013;457. doi: 10.1111/j.1365-2648.2007.04250.x.JAN4250</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2648.2007.04250.x</ArticleId><ArticleId IdType="pubmed">17442030</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaugler JE, Yu F, Krichbaum K, Wyman JF. Predictors of nursing home admission for persons with dementia. Med Care. 2009 Feb;47(2):191&#x2013;198. doi: 10.1097/MLR.0b013e31818457ce.00005650-200902000-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31818457ce</ArticleId><ArticleId IdType="pubmed">19169120</ArticleId></ArticleIdList></Reference><Reference><Citation>Teahan &#xc1;, Lafferty A, McAuliffe E, Phelan A, O'Sullivan L, O'Shea D, Nicholson E, Fealy G. Psychosocial interventions for family carers of people with dementia: A systematic review and meta-analysis. J Aging Health. 2020 Oct;32(9):1198&#x2013;1213. doi: 10.1177/0898264319899793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0898264319899793</ArticleId><ArticleId IdType="pubmed">31957536</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiegelmann H, Speller S, Verhaert L, Schirra-Weirich L, Wolf-Ostermann K. Psychosocial interventions to support the mental health of informal caregivers of persons living with dementia - A systematic literature review. BMC Geriatr. 2021 Feb 01;21(1):94. doi: 10.1186/s12877-021-02020-4. 
 
10.1186/s12877-021-02020-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02020-4</ArticleId><ArticleId IdType="doi">10.1186/s12877-021-02020-4</ArticleId><ArticleId IdType="pmc">PMC7849618</ArticleId><ArticleId IdType="pubmed">33526012</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooke DD, Mcnally L, Mulligan KT, Harrison MJG, Newman SP. Psychosocial interventions for caregivers of people with dementia: A systematic review. Aging Ment Health. 2015 Jan 07;5(2):120&#x2013;135. doi: 10.1080/13607863.2001.11070746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2001.11070746</ArticleId><ArticleId IdType="pubmed">11511059</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;&#xe7;&#xfc;kg&#xfc;&#xe7;l&#xfc; &#xd6;, Akp&#x131;nar S&#xf6;ylemez B, Yener G, I&#x15f;&#x131;k AT. The effects of support groups on dementia caregivers: A mixed method study. Geriatr Nurs. 2018;39(2):151&#x2013;156. doi: 10.1016/j.gerinurse.2017.07.008.S0197-4572(17)30200-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gerinurse.2017.07.008</ArticleId><ArticleId IdType="pubmed">28826975</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffen AM, Mangum KR. Predicting attendance at dementia family support groups. Am J Alzheimers Dis Other Demen. 2012 Dec;27(8):633&#x2013;639. doi: 10.1177/1533317512465677. 
 
27/8/633</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317512465677?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</ArticleId><ArticleId IdType="doi">10.1177/1533317512465677</ArticleId><ArticleId IdType="pmc">PMC10845561</ArticleId><ArticleId IdType="pubmed">23144147</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien L, Chu H, Guo J, Liao Y, Chang L, Chen C, Chou K. Caregiver support groups in patients with dementia: A meta-analysis. Int J Geriatr Psychiatry. 2011 Oct;26(10):1089&#x2013;1098. doi: 10.1002/gps.2660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.2660</ArticleId><ArticleId IdType="pubmed">21308785</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker D, Mills S, Abbey J. Effectiveness of interventions that assist caregivers to support people with dementia living in the community: A systematic review. Int J Evid Based Healthc. 2008 Jun;6(2):137&#x2013;172. doi: 10.1111/j.1744-1609.2008.00090.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1744-1609.2008.00090.x</ArticleId><ArticleId IdType="pubmed">21631819</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinquart M, S&#xf6;rensen S. Helping caregivers of persons with dementia: Which interventions work and how large are their effects? Int Psychogeriatr. 2006 Dec;18(4):577&#x2013;595. doi: 10.1017/S1041610206003462.S1041610206003462</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610206003462</ArticleId><ArticleId IdType="pubmed">16686964</ArticleId></ArticleIdList></Reference><Reference><Citation>Prince M, Wimo A, Guerchet M, Ali GC, Wu YT, Prina M.  World Alzheimer Report 2015. London, UK: Alzheimer&#x2019;s Disease International; 2015.  [2022-11-02].  
 https://www.alzint.org/resource/world-alzheimer-report-2015/
</Citation></Reference><Reference><Citation>Dam AEH, de Vugt ME, Klinkenberg IPM, Verhey FRJ, van Boxtel MPJ. A systematic review of social support interventions for caregivers of people with dementia: Are they doing what they promise? Maturitas. 2016 Mar;85:117&#x2013;130. doi: 10.1016/j.maturitas.2015.12.008.S0378-5122(15)30092-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2015.12.008</ArticleId><ArticleId IdType="pubmed">26857890</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak M, Guest C. Application of a multidimensional caregiver burden inventory. Gerontologist. 1989 Dec;29(6):798&#x2013;803. doi: 10.1093/geront/29.6.798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/29.6.798</ArticleId><ArticleId IdType="pubmed">2516000</ArticleId></ArticleIdList></Reference><Reference><Citation>Sica C, Magni C, Ghisi M, Alto&#xe8; G, Sighinolfi C, Chiri LR, Franceschini S. Coping Orientation to Problems Experienced-Nuova Versione Italiana (COPE-NVI): Uno strumento per la misura degli stili di coping. Psicoterapia Cognitiva Comportamentale. 2008;14(1):24&#x2013;53. 
 
</Citation></Reference><Reference><Citation>Djukanovic I, Carlsson J, &#xc5;restedt K. Is the Hospital Anxiety and Depression Scale (HADS) a valid measure in a general population 65-80&#xa0;years old? A psychometric evaluation study. Health Qual Life Outcomes. 2017 Oct 04;15(1):193. doi: 10.1186/s12955-017-0759-9. 
 
10.1186/s12955-017-0759-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-017-0759-9</ArticleId><ArticleId IdType="doi">10.1186/s12955-017-0759-9</ArticleId><ArticleId IdType="pmc">PMC5628437</ArticleId><ArticleId IdType="pubmed">28978356</ArticleId></ArticleIdList></Reference><Reference><Citation>Dementia. World Health Organization. 2022. Sep 20,  [2022-11-02].  
 https://www.who.int/news-room/fact-sheets/detail/dementia
.</Citation></Reference><Reference><Citation>Sriram V, Jenkinson C, Peters M. Informal carers' experience of assistive technology use in dementia care at home: A systematic review. BMC Geriatr. 2019 Jun 14;19(1):160. doi: 10.1186/s12877-019-1169-0. 
 
10.1186/s12877-019-1169-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-019-1169-0</ArticleId><ArticleId IdType="doi">10.1186/s12877-019-1169-0</ArticleId><ArticleId IdType="pmc">PMC6567448</ArticleId><ArticleId IdType="pubmed">31196003</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Fraile E, Ballesteros J, Rueda JR, Santos-Zorroz&#xfa;a B, Sol&#xe0; I, McCleery J. Remotely delivered information, training and support for informal caregivers of people with dementia. Cochrane Database Syst Rev. 2021;1:CD006440. doi: 10.1002/14651858.cd006440.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.cd006440.pub3</ArticleId><ArticleId IdType="pmc">PMC8094510</ArticleId><ArticleId IdType="pubmed">33417236</ArticleId></ArticleIdList></Reference><Reference><Citation>Birkenh&#xe4;ger-Gillesse EG, Kollen BJ, Zuidema SU, Achterberg WP. The "more at home with dementia" program: A randomized controlled study protocol to determine how caregiver training affects the well-being of patients and caregivers. BMC Geriatr. 2018 Oct 22;18(1):252. doi: 10.1186/s12877-018-0948-3. 
 
10.1186/s12877-018-0948-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-018-0948-3</ArticleId><ArticleId IdType="doi">10.1186/s12877-018-0948-3</ArticleId><ArticleId IdType="pmc">PMC6196467</ArticleId><ArticleId IdType="pubmed">30348097</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawano Y, Terada S, Takenoshita S, Hayashi S, Oshima Y, Miki T, Yokota O, Yamada N. Patient affect and caregiver burden in dementia. Psychogeriatrics. 2020 Mar;20(2):189&#x2013;195. doi: 10.1111/psyg.12487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/psyg.12487</ArticleId><ArticleId IdType="pubmed">31698515</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36349708</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1479-8301</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society</Title><ISOAbbreviation>Psychogeriatrics</ISOAbbreviation></Journal><ArticleTitle>Functional loss and worsening geriatric assessment parameters are more common in dementia with Lewy bodies than Alzheimer's disease.</ArticleTitle><Pagination><StartPage>77</StartPage><EndPage>85</EndPage><MedlinePgn>77-85</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/psyg.12905</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The main aim of this study was to compare older patients with Alzheimer's disease (AD) to those with dementia with Lewy bodies (DLB) according to their dependency in daily living activities and comprehensive geriatric assessment parameters.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A total of 227 AD and 123 DLB patients underwent a geriatric assessment that included comorbidities, number of drugs used, falls, urinary incontinence, hand grip strength, Mini-Nutritional Assessment (MNA), Tinetti Performance Oriented Mobility Assessment Scale, Insomnia Severity Index (ISI), and Epworth Sleepiness Scale. Basic and instrumental activities of daily living were assessed by the Barthel Index and the Lawton scale, respectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean age of the participants was 83.4&#x2009;years, and 73% were female. There were no statistically significant differences between AD and DLB patients in age, gender, cognitive function, or comorbidities except for coronary artery disease (P&#x2009;&lt;&#x2009;0.05). The number of falls, drugs used, and ISI and Epworth scores were higher in patients with DLB than patients with AD (P&#x2009;&lt;&#x2009;0.05). DLB patients had lower MNA, Tinetti scale, and hand grip strength scores than AD patients. The ratio of patients highly dependent in basic daily activities as a whole was significantly greater in DLB than in AD (P&#x2009;&lt;&#x2009;0.05), but there was no significant difference in the overall levels of dependency in instrumental activities.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">DLB patients are more dependent on their caregivers than AD patients. Nutritional deterioration, sleep disorders, falls, balance and gait problems, decreased muscle strength, and multiple drug use are more common in those with DLB compared to those with AD. The management of older patients with DLB may be more difficult than older patients with AD.</AbstractText><CopyrightInformation>&#xa9; 2022 Japanese Psychogeriatric Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Soysal</LastName><ForeName>Pinar</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-6042-1718</Identifier><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koc Okudur</LastName><ForeName>Saadet</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5034-3720</Identifier><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Manisa State Hospital, Manisa, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uslu</LastName><ForeName>Ferda</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Lee</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Health, Performance, and Wellbeing, Anglia Ruskin University, Cambridge, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychogeriatrics</MedlineTA><NlmUniqueID>101230058</NlmUniqueID><ISSNLinking>1346-3500</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020961" MajorTopicYN="Y">Lewy Body Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015577" MajorTopicYN="N">Geriatric Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018737" MajorTopicYN="N">Hand Strength</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">Lewy bodies</Keyword><Keyword MajorTopicYN="N">activities of daily living</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">nutrition</Keyword><Keyword MajorTopicYN="N">sleep</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>9</Day><Hour>4</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36349708</ArticleId><ArticleId IdType="doi">10.1111/psyg.12905</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Monica Moore MSG, D&#xed;az-Santos M, Vossel K. Alzheimer's Association 2021. Facts and Figures Report.</Citation></Reference><Reference><Citation>Kane JP, Surendranathan A, Bentley A et al. Clinical prevalence of Lewy body dementia. Alzheimers Res Ther 2018; 10: 1-8.</Citation></Reference><Reference><Citation>Mueller C, Soysal P, Rongve A et al. Survival time and differences between dementia with Lewy bodies and Alzheimer's disease following diagnosis: a meta-analysis of longitudinal studies. Ageing Res Rev 2019; 50: 72-80.</Citation></Reference><Reference><Citation>Lee CY, Cheng SJ, Lin HC, Liao Y, Chen PH. Quality of life in patients with dementia with Lewy bodies. Behav Neurol 2018; 2018: 8320901-8320907.</Citation></Reference><Reference><Citation>Bjoerke-Bertheussen J, Ehrt U, Rongve A, Ballard C, Aarsland D. Neuropsychiatric symptoms in mild dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 2012; 34: 1-6.</Citation></Reference><Reference><Citation>McKeith IG, Rowan E, Askew K et al. More severe functional impairment in dementia with lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction. Am J Geriatr Psychiatry 2006; 14: 582-588.</Citation></Reference><Reference><Citation>Gill DP, Hubbard RA, Koepsell TD et al. Differences in rate of functional decline across three dementia types. Alzheimers Dement 2013; 9: S63-S71.</Citation></Reference><Reference><Citation>Bulut EA, Soysal P, Isik AT. Frequency and coincidence of geriatric syndromes according to age groups: single-center experience in Turkey between 2013 and 2017. Clin Interv Aging 2018; 13: 1899-1905.</Citation></Reference><Reference><Citation>Soysal P, Tan SG. The prevalence and co-incidence of geriatric syndromes in older patients with early-stage Alzheimer's disease and dementia with Lewy bodies. Aging Clin Exp Res 2021; 33: 2599-2603.</Citation></Reference><Reference><Citation>McKeith IG, Boeve BF, Dickson DW et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology 2017; 89: 88-100.</Citation></Reference><Reference><Citation>McKhann G, Knopman DS, Chertkow H et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 263-269.</Citation></Reference><Reference><Citation>Folstein MF, Folstein SE, McHugh PR. &#x201c;Mini-mental state&#x201d;. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.</Citation></Reference><Reference><Citation>Nasreddine ZS, Phillips NA, B&#xe9;dirian V et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-699.</Citation></Reference><Reference><Citation>Koc Okudur S, Soysal P. Excessive daytime sleepiness is associated with malnutrition, dysphagia, and vitamin D deficiency in older adults. J Am Med Dir Assoc 2021; 22: 2134-2139.</Citation></Reference><Reference><Citation>Strini V, Piazzetta N, Gallo A, Schiavolin R. Barthel index: creation and validation of two cut-offs using the BRASS index. Acta Biomed 2020; 91: 19-26.</Citation></Reference><Reference><Citation>Isik EI, Yilmaz S, Uysal I, Basar S. Adaptation of the Lawton instrumental activities of daily living scale to Turkish: validity and reliability study. Ann Geriatr Med Res 2020; 24: 35-40.</Citation></Reference><Reference><Citation>Lawton M, Brody E. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179-186.</Citation></Reference><Reference><Citation>Soysal P, Tan SG, Rogowska M et al. Weight loss in Alzheimer's disease, vascular dementia and dementia with Lewy bodies: impact on mortality and hospitalization by dementia subtype. Int J Geriatr Psychiatry 2021; 37.</Citation></Reference><Reference><Citation>Soysal P, Tan SG, Smith L. A comparison of the prevalence of fear of falling between older patients with Lewy body dementia, Alzheimer's disease, and without dementia. Exp Gerontol 2021; 146: 111248.</Citation></Reference><Reference><Citation>Soysal P, Dokuzlar O, Erken N, G&#xfc;nay FSD, Isik AT. The relationship between dementia subtypes and nutritional parameters in older adults. J Am Med Dir Assoc 2020; 21: 1430-1435.</Citation></Reference><Reference><Citation>Svendsboe E, Terum T, Testad I et al. Caregiver burden in family carers of people with dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2016; 31: 1075-1083.</Citation></Reference><Reference><Citation>Hamilton JM, Salmon DP, Raman R et al. Accounting for functional loss in Alzheimer's disease and dementia with Lewy bodies: beyond cognition. Alzheimers Dement 2014; 10: 171-178.</Citation></Reference><Reference><Citation>Stavitsky K, Brickman AM, Scarmeas N et al. The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease. Arch Neurol 2006; 63: 1450-1456.</Citation></Reference><Reference><Citation>Peeters G, Feeney J, Carey D, Kennelly S, Kenny RA. Fear of falling: a manifestation of executive dysfunction? Int J Geriatr Psychiatry 2019; 34: 1275-1282.</Citation></Reference><Reference><Citation>Ehrlich JR, Hassan SE, Stagg BC. Prevalence of falls and fall-related outcomes in older adults with self-reported vision impairment. J Am Geriatr Soc 2019; 67: 239-245.</Citation></Reference><Reference><Citation>Flanigan PM, Khosravi MA, Leverenz JB, Tousi B. Color vision impairment differentiates Alzheimer dementia from dementia with Lewy bodies. J Geriatr Psychiatry Neurol 2018; 31: 97-102.</Citation></Reference><Reference><Citation>Soysal P, Smith L, Tan SG, Capar E, Veronese N, Yang L. Excessive daytime sleepiness is associated with an increased frequency of falls and sarcopenia. Exp Gerontol 2021; 150: 111364.</Citation></Reference><Reference><Citation>Chwiszczuk L, Breitve M, Hynninen M, Gjerstad MD, Aarsland D, Rongve A. Higher frequency and complexity of sleep disturbances in dementia with Lewy bodies as compared to Alzheimer's disease. Neurodegener Dis 2016; 16: 152-160.</Citation></Reference><Reference><Citation>Cagnin A, Fragiacomo F, Camporese G et al. Sleep-wake profile in dementia with Lewy bodies, Alzheimer's disease, and normal aging. J Alzheimers Dis 2017; 55: 1529-1536.</Citation></Reference><Reference><Citation>Saper CB, Fuller PM, Pedersen NP, Lu J, Scammell TE. Sleep state switching. Neuron 2010; 68: 1023-1042.</Citation></Reference><Reference><Citation>Lessig S, Ubhi K, Galasko D et al. Reduced hypocretin (orexin) levels in dementia with Lewy bodies. Neuroreport 2010; 21: 756-760.</Citation></Reference><Reference><Citation>Dauvilliers Y. Insomnia in patients with neurodegenerative conditions. Sleep Med 2007; 8: S27-S34.</Citation></Reference><Reference><Citation>Borda MG, Castellanos-Perilla N, Tovar-Rios DA, Oesterhus R, Soennesyn H, Aarsland D. Polypharmacy is associated with functional decline in Alzheimer's disease and Lewy body dementia. Arch Gerontol Geriatr 2021; 96: 104459.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36346930</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-4156</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>1</Issue><PubDate><MedlineDate>2023 Jan-Mar 01</MedlineDate></PubDate></JournalIssue><Title>Alzheimer disease and associated disorders</Title><ISOAbbreviation>Alzheimer Dis Assoc Disord</ISOAbbreviation></Journal><ArticleTitle>Family Caregiver Comorbidities in Lewy Body Dementia Versus Alzheimer Disease and Associated Disorders.</ArticleTitle><Pagination><StartPage>42</StartPage><EndPage>49</EndPage><MedlinePgn>42-49</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/WAD.0000000000000535</ELocationID><Abstract><AbstractText Label="BACKGROUND">Family caregivers of people living with dementia have high caregiver strain and poor health consequences. Limited research exists on Lewy body dementia (LBD) caregivers and their specific comorbidities. This study aimed to (1) identify the prevalence of self-reported comorbidities among LBD caregivers and (2) contextualize these findings with historical data on caregivers of persons living with Alzheimer disease and associated disorders (ADADs).</AbstractText><AbstractText Label="METHODS">In a national, online survey, LBD family caregivers completed the Self-Administered Comorbidity Questionnaire and we compared these findings with extant literature on ADAD caregiver comorbidities.</AbstractText><AbstractText Label="RESULTS">Among 217 LBD caregivers, 84.3% were female, 39.1% were 64 years old or younger, and 66.8% had &gt;2 years of caregiving experience. Caregivers self-identified as current (83.9%) or former (16.1%) caregivers. The most frequent comorbidities were hypertension (38.2%), depression (35.0%), back pain (34.1%), and arthritis (27.7%). LBD caregivers, particularly younger caregivers, had a higher prevalence of depression compared with ADAD caregivers and older adult populations, and back pain prevalence nearly equivalent to spinal cord injury caregivers.</AbstractText><AbstractText Label="CONCLUSIONS">Our study is the first to illustrate and contextualize specific comorbidities among LBD caregivers. Understanding the causality and impact of these conditions will be critical in designing effective interventions to improve the lives of families affected by LBD.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Jori E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0001-5003-9091</Identifier><AffiliationInfo><Affiliation>Department of Neurological Sciences, Rush University Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moshkovich</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rush University Medical College.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levin</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurological Sciences, Rush University Medical Center.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chicago Medical School - Rosalind Franklin University, North Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akram</LastName><ForeName>Faizan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurological Sciences, Rush University Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hess</LastName><ForeName>Serena P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Neurological Sciences, Rush University Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suresh</LastName><ForeName>Madhuvanthi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurological Sciences, Rush University Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bentley</LastName><ForeName>Cintra D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Lewy Body Dementia Caregiver Advisory Panel, Rush University Medical Center, Chicago.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manak</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Lewy Body Dementia Caregiver Advisory Panel, Rush University Medical Center, Chicago.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattke</LastName><ForeName>Maraline</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Lewy Body Dementia Caregiver Advisory Panel, Rush University Medical Center, Chicago.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Allegra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lewy Body Dementia Caregiver Advisory Panel, Rush University Medical Center, Chicago.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pennsyl</LastName><ForeName>Claire E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Lewy Body Dementia Caregiver Advisory Panel, Rush University Medical Center, Chicago.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierce</LastName><ForeName>Carmen M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Lewy Body Dementia Caregiver Advisory Panel, Rush University Medical Center, Chicago.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voss</LastName><ForeName>Margaret</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Lewy Body Dementia Caregiver Advisory Panel, Rush University Medical Center, Chicago.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lewy Body Dementia Association, Lilburn, GA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schroeder</LastName><ForeName>Karlin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Parkinson's Foundation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chodosh</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Geriatric Medicine and Palliative Care, New York University Grossman School of Medicine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA New York Harbor Healthcare System, Medicine Service, New York, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 NS097615</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG064200</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066512</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Alzheimer Dis Assoc Disord</MedlineTA><NlmUniqueID>8704771</NlmUniqueID><ISSNLinking>0893-0341</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020961" MajorTopicYN="Y">Lewy Body Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>8</Day><Hour>15</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36346930</ArticleId><ArticleId IdType="mid">NIHMS1895719</ArticleId><ArticleId IdType="pmc">PMC10204123</ArticleId><ArticleId IdType="doi">10.1097/WAD.0000000000000535</ArticleId><ArticleId IdType="pii">00002093-202301000-00007</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chari AV, Engberg J, Ray KN, et al. The opportunity costs of informal elder-care in the United States: new estimates from the American Time Use Survey. Health Serv Res. 2015;50:871&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4450934</ArticleId><ArticleId IdType="pubmed">25294306</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89:88&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5496518</ArticleId><ArticleId IdType="pubmed">28592453</ArticleId></ArticleIdList></Reference><Reference><Citation>Donaghy PC, McKeith IG. The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimers Res Ther. 2014;6:46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4255387</ArticleId><ArticleId IdType="pubmed">25484925</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler M, Gaugler JE, Talley KMC, et al. Care Interventions for People Living With Dementia and Their Caregivers. Agency for Healthcare Research and Quality (AHRQ); 2020.</Citation></Reference><Reference><Citation>Bremer P, Cabrera E, Leino-Kilpi H, et al. Informal dementia care: consequences for caregivers&#x2019; health and health care use in 8 European countries. Health Policy. 2015;119:1459&#x2013;1471.</Citation><ArticleIdList><ArticleId IdType="pubmed">26518906</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Liu J, Wang XD, et al. Caregiver burden, sleep quality, depression, and anxiety in dementia caregivers: a comparison of frontotemporal lobar degeneration, dementia with Lewy bodies, and Alzheimer&#x2019;s disease. Int Psychogeriatr. 2018;30:1131&#x2013;1138.</Citation><ArticleIdList><ArticleId IdType="pubmed">29223171</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong MJ, Alliance S, Corsentino P, et al. Cause of death and end-of-life experiences in individuals with dementia with lewy bodies. J Am Geriatr Soc. 2019;67:67&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">30291740</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz J, Allison MA, Ancoli-Israel S, et al. Sleep, type 2 diabetes, dyslipidemia, and hypertension in elderly Alzheimer&#x2019;s caregivers. Arch Gerontol Geriatr. 2013;57:70&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3696346</ArticleId><ArticleId IdType="pubmed">23522093</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilhooly KJ, Gilhooly MLM, Sullivan MP, et al. A meta-review of stress, coping and interventions in dementia and dementia caregiving. BMC Geriatr. 2016;16:106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4872341</ArticleId><ArticleId IdType="pubmed">27193287</ArticleId></ArticleIdList></Reference><Reference><Citation>Suehs BT, Shah SN, Davis CD, et al. Household members of persons with Alzheimer&#x2019;s disease: health conditions, healthcare resource use, and healthcare costs. J Am Geriatr Soc. 2014;62:435&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pubmed">24576203</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangha O, Stucki G, Liang MH, et al. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49:156&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">12687505</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)&#x2013;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu J, Benjenk I, Chen J. Incremental health care expenditures of the spouses of older adults with Alzheimer&#x2019;s diseases and related dementias (ADRD). Am J Geriatr Psychiatry. 2021;29:462&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7525656</ArticleId><ArticleId IdType="pubmed">33071189</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw WS, Patterson TL, Ziegler MG, et al. Accelerated risk of hypertensive blood pressure recordings among Alzheimer caregivers. J Psychosom Res. 1999;46:215&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">10193912</ArticleId></ArticleIdList></Reference><Reference><Citation>Salive ME. Multimorbidity in older adults. Epidemiol Rev. 2013;35:75&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">23372025</ArticleId></ArticleIdList></Reference><Reference><Citation>Luchsinger JA, Tipiani D, Torres-Pati&#xf1;o G, et al. Characteristics and mental health of Hispanic dementia caregivers in New York City. Am J Alzheimers Dis Other Demen. 2015;30:584&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4519428</ArticleId><ArticleId IdType="pubmed">25635108</ArticleId></ArticleIdList></Reference><Reference><Citation>Pajeemas K, Patpiya S, Preeda A, et al. Factors associated with low back pain in non-professional caregivers of dependent spinal cord lesion patients. Int J Caring Sci. 2018;11:471&#x2013;477.</Citation></Reference><Reference><Citation>von K&#xe4;nel R, Mausbach BT, Patterson TL, et al. Increased Framingham Coronary Heart Disease Risk Score in dementia caregivers relative to non-caregiving controls. Gerontology. 2008;54:131&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">18204247</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C, Soysal P, Rongve A, et al. Survival time and differences between dementia with Lewy bodies and Alzheimer&#x2019;s disease following diagnosis: a meta-analysis of longitudinal studies. Ageing Res Rev. 2019;50:72&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">30625375</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagano G, Ferrara N, Brooks DJ, et al. Age at onset and Parkinson disease phenotype. Neurology. 2016;86:1400&#x2013;1407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4831034</ArticleId><ArticleId IdType="pubmed">26865518</ArticleId></ArticleIdList></Reference><Reference><Citation>Hely MA, Morris JG, Reid WG, et al. Sydney multicenter study of Parkinson&#x2019;s disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord. 2005;20:190&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">15551331</ArticleId></ArticleIdList></Reference><Reference><Citation>Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson&#x2019;s disease: the inevitability of dementia at 20 years. Mov Disord. 2008;23:837&#x2013;844.</Citation><ArticleIdList><ArticleId IdType="pubmed">18307261</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorans KS, Mills KT, Liu Y, et al. Trends in prevalence and control of hypertension according to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline. J Am Heart Assoc. 2018;7:e008888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015372</ArticleId><ArticleId IdType="pubmed">29858369</ArticleId></ArticleIdList></Reference><Reference><Citation>Ettman CK, Abdalla SM, Cohen GH, et al. Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Netw Open. 2020;3:e2019686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489837</ArticleId><ArticleId IdType="pubmed">32876685</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearlin LI, Mullan JT, Semple SJ, et al. Caregiving and the stress process: an overview of concepts and their measures. Gerontologist. 1990;30:583&#x2013;594.</Citation><ArticleIdList><ArticleId IdType="pubmed">2276631</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong MJ, Alliance S, Corsentino P, et al. Caregiver-reported barriers to quality end-of-life care in dementia with Lewy bodies: a qualitative analysis. Am J Hosp Palliat Care. 2020;37:728&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7335680</ArticleId><ArticleId IdType="pubmed">31902223</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno V, Mancini D, Ghoche R, et al. High prevalence of physical and sexual aggression to caregivers in advanced Parkinson&#x2019;s disease. Experience in the Palliative Care Program. Parkinsonism Relat Disord. 2016;24:141&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">26786755</ArticleId></ArticleIdList></Reference><Reference><Citation>Stacy KE, Perazzo J, Shatz R, et al. Needs and concerns of Lewy body disease family caregivers: a qualitative study. West J Nurs Res. 2022;44:227&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">34636259</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanemoto H, Sato S, Satake Y, et al. Impact of behavioral and psychological symptoms on caregiver burden in patients with dementia with Lewy bodies. Front Psychiatry. 2021;12:753864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8578553</ArticleId><ArticleId IdType="pubmed">34777057</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadak T, Foster Zdon S, Ishado E, et al. Potentially preventable hospitalizations in dementia: family caregiver experiences. Int Psychogeriatr. 2017;29:1201&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pubmed">28349858</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hoof W, O&#x2019;Sullivan K, O&#x2019;Keeffe M, et al. The efficacy of interventions for low back pain in nurses: a systematic review. Int J Nurs Stud. 2018;77:222&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pubmed">29121556</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagerlund H, Thunborg C, Sandborgh M. Behaviour-directed interventions for problematic person transfer situations in two dementia care dyads: a single-case design study. BMC Geriatr. 2022;22:261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8966167</ArticleId><ArticleId IdType="pubmed">35351026</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Martin P, Macaulay D, Jalundhwala YJ, et al. The long-term direct and indirect economic burden among Parkinson&#x2019;s disease caregivers in the United States. Mov Disord. 2019;34:236&#x2013;245. 10.1002/mds.27579</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27579</ArticleId><ArticleId IdType="pmc">PMC6590233</ArticleId><ArticleId IdType="pubmed">30589953</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Haldeman S, Lu ML, et al. Low back pain prevalence and related workplace psychosocial risk factors: a study using data from the 2010 National Health Interview Survey. J Manipulative Physiol Ther. 2016;39:459&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5530370</ArticleId><ArticleId IdType="pubmed">27568831</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe MA, McCrae CS, Campbell JM, et al. Sleep pattern differences between older adult dementia caregivers and older adult noncaregivers using objective and subjective measures. J Clin Sleep Med. 2008;4:362&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2542494</ArticleId><ArticleId IdType="pubmed">18763429</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolinsky FD, Jones MP, Ullrich F, et al. The concordance of survey reports and Medicare claims in a nationally representative longitudinal cohort of older adults. Med Care. 2014;52:462&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pubmed">24714584</ArticleId></ArticleIdList></Reference><Reference><Citation>Day HR, Parker JD. Self-report of diabetes and claims-based identification of diabetes among Medicare beneficiaries. Natl Health Stat Report. 2013;69:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">24988821</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Zhang B, Smith ML, et al. Concordance between self-reports and Medicare claims among participants in a National Study of Chronic Disease Self-Management Program. Front Public Health. 2015;3:222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4597005</ArticleId><ArticleId IdType="pubmed">26501047</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36342582</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-7365</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Metabolic brain disease</Title><ISOAbbreviation>Metab Brain Dis</ISOAbbreviation></Journal><ArticleTitle>Blood-based biomarkers in Alzheimer's disease: a mini-review.</ArticleTitle><Pagination><StartPage>185</StartPage><EndPage>193</EndPage><MedlinePgn>185-193</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11011-022-01114-1</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) is the most common cause of dementia and has far reaching consequences for patients and their caregivers. Early detection and treatment are key factors in limiting the impact of the disease. However, a definitive diagnosis of AD requires an examination of brain tissue during an autopsy. Although a plethora of biomarkers such as neuroimaging, electrophysiological, and cerebrospinal fluid (CSF) biomarkers are available, their utility is limited to research due to their poor reach and prohibitive cost. In order for biomarkers to be widely used, they need to be accessible, affordable, and conducive for the patient population or disease stage. Blood-based biomarkers may not only be less expensive and more accessible compared to neuroimaging or CSF tests, but they are also preferred by patients with AD as they are much less invasive. In this mini-review article, we expand on the rationale for the use of blood-based biomarkers, review currently available biomarkers and discuss the need for the standardization of these biomarkers. We contrast the blood-based biomarkers with other available biomarkers and discuss the advantages of using a panel of blood-based biomarkers to strengthen their accuracy.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Padala</LastName><ForeName>Sanjana P</ForeName><Initials>SP</Initials><Identifier Source="ORCID">0000-0001-5078-8869</Identifier><AffiliationInfo><Affiliation>Vanderbilt University , 2301 Vanderbilt Place, Nashville, TN, 37235, USA. sanjana.p.padala@vanderbilt.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newhouse</LastName><ForeName>Paul A</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0002-9298-7185</Identifier><AffiliationInfo><Affiliation>Vanderbilt University , 2301 Vanderbilt Place, Nashville, TN, 37235, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Cognitive Medicine, Department of Psychiatry, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA-TVHS Geriatric Research Education and Clinical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01AG066159</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56AG047992</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG066159</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AG047992</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG047992</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Metab Brain Dis</MedlineTA><NlmUniqueID>8610370</NlmUniqueID><ISSNLinking>0885-7490</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Blood-based biomarkers</Keyword><Keyword MajorTopicYN="N">CSF</Keyword><Keyword MajorTopicYN="N">Neuroimaging</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>7</Day><Hour>11</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36342582</ArticleId><ArticleId IdType="mid">NIHMS1946100</ArticleId><ArticleId IdType="pmc">PMC10688968</ArticleId><ArticleId IdType="doi">10.1007/s11011-022-01114-1</ArticleId><ArticleId IdType="pii">10.1007/s11011-022-01114-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Benedet AL, Mila-Aloma M, Vrillon A, Ashton NJ, Pascoal TA, Lussier F, &#x2026; BioCogBank Paris Lariboisiere, c. (2021). Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum. JAMA Neurol, 78(12), 1471&#x2013;1483. doi:10.1001/jamaneurol.2021.3671</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.3671</ArticleId><ArticleId IdType="pmc">PMC8524356</ArticleId><ArticleId IdType="pubmed">34661615</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomarkers Definitions Working, G. (2001). Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther, 69(3), 89&#x2013;95. doi:10.1067/mcp.2001.113989</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mcp.2001.113989</ArticleId><ArticleId IdType="pubmed">11240971</ArticleId></ArticleIdList></Reference><Reference><Citation>Blennow K, &amp; Zetterberg H (2015). The past and the future of Alzheimer&#x2019;s disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events. Front Neurosci, 9, 345. doi:10.3389/fnins.2015.00345</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2015.00345</ArticleId><ArticleId IdType="pmc">PMC4586276</ArticleId><ArticleId IdType="pubmed">26483625</ArticleId></ArticleIdList></Reference><Reference><Citation>Calzetti S, Bortone E, Negrotti A, Zinno L, &amp; Mancia D (2002). Frontal intermittent rhythmic delta activity (FIRDA) in patients with dementia with Lewy bodies: a diagnostic tool? Neurol Sci, 23 Suppl 2, S65&#x2013;66. doi:10.1007/s100720200072</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s100720200072</ArticleId><ArticleId IdType="pubmed">12548346</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YR, Liang CS, Chu H, Voss J, Kang XL, O&#x2019;Connell G, &#x2026; Chou KR (2021). Diagnostic accuracy of blood biomarkers for Alzheimer&#x2019;s disease and amnestic mild cognitive impairment: A meta-analysis. Ageing Res Rev, 71, 101446. doi:10.1016/j.arr.2021.101446</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2021.101446</ArticleId><ArticleId IdType="pubmed">34391944</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J, Aisen P, Lemere C, Atri A, Sabbagh M, &amp; Salloway S (2021). Aducanumab produced a clinically meaningful benefit in association with amyloid lowering. Alzheimers Res Ther, 13(1), 98. doi:10.1186/s13195-021-00838-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00838-z</ArticleId><ArticleId IdType="pmc">PMC8111757</ArticleId><ArticleId IdType="pubmed">33971962</ArticleId></ArticleIdList></Reference><Reference><Citation>de Waal H, Stam CJ, Blankenstein MA, Pijnenburg YA, Scheltens P, &amp; van der Flier WM (2011). EEG abnormalities in early and late onset Alzheimer&#x2019;s disease: understanding heterogeneity. J Neurol Neurosurg Psychiatry, 82(1), 67&#x2013;71. doi:10.1136/jnnp.2010.216432</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.216432</ArticleId><ArticleId IdType="pubmed">20935323</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhiman K, Gupta VB, Villemagne VL, Eratne D, Graham PL, Fowler C, &#x2026; Martins RN (2020). Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer&#x2019;s disease. Alzheimers Dement (Amst), 12(1), e12005. doi:10.1002/dad2.12005</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dad2.12005</ArticleId><ArticleId IdType="pmc">PMC7085283</ArticleId><ArticleId IdType="pubmed">32211500</ArticleId></ArticleIdList></Reference><Reference><Citation>Duits FH, Martinez-Lage P, Paquet C, Engelborghs S, Lleo A, Hausner L, &#x2026; Blennow K (2016). Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study. Alzheimers Dement, 12(2), 154&#x2013;163. doi:10.1016/j.jalz.2015.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2015.08.003</ArticleId><ArticleId IdType="pubmed">26368321</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouw AA, Alsema AM, Tijms BM, Borta A, Scheltens P, Stam CJ, &amp; van der Flier WM (2017). EEG spectral analysis as a putative early prognostic biomarker in nondemented, amyloid positive subjects. Neurobiol Aging, 57, 133&#x2013;142. doi:10.1016/j.neurobiolaging.2017.05.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.05.017</ArticleId><ArticleId IdType="pubmed">28646686</ArticleId></ArticleIdList></Reference><Reference><Citation>Honig LS, Vellas B, Woodward M, Boada M, Bullock R, Borrie M, &#x2026; Siemers E (2018). Trial of Solanezumab for Mild Dementia Due to Alzheimer&#x2019;s Disease. N Engl J Med, 378(4), 321&#x2013;330. doi:10.1056/NEJMoa1705971</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1705971</ArticleId><ArticleId IdType="pubmed">29365294</ArticleId></ArticleIdList></Reference><Reference><Citation>Hull M, Berger M, Volk B, &amp; Bauer J (1996). Occurrence of interleukin-6 in cortical plaques of Alzheimer&#x2019;s disease patients may precede transformation of diffuse into neuritic plaques. Ann N Y Acad Sci, 777, 205&#x2013;212. doi:10.1111/j.1749-6632.1996.tb34420.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.1996.tb34420.x</ArticleId><ArticleId IdType="pubmed">8624085</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, &#x2026; Contributors. (2018). NIA-AA Research Framework: Toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement, 14(4), 535&#x2013;562. doi:10.1016/j.jalz.2018.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.02.018</ArticleId><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr., Petersen RC, Xu YC, O&#x2019;Brien PC, Smith GE, Ivnik RJ, &#x2026; Kokmen E (1999). Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology, 52(7), 1397&#x2013;1403. doi:10.1212/wnl.52.7.1397</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.52.7.1397</ArticleId><ArticleId IdType="pmc">PMC2730146</ArticleId><ArticleId IdType="pubmed">10227624</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ, &#x2026; Zetterberg H (2022). Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurol. doi:10.1001/jamaneurol.2021.5216</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.5216</ArticleId><ArticleId IdType="pubmed">35099509</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemppainen NM, Aalto S, Wilson IA, Nagren K, Helin S, Bruck A, &#x2026; Rinne JO (2007). PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology, 68(19), 1603&#x2013;1606. doi:10.1212/01.wnl.0000260969.94695.56</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000260969.94695.56</ArticleId><ArticleId IdType="pubmed">17485647</ArticleId></ArticleIdList></Reference><Reference><Citation>Keshavan A, Pannee J, Karikari TK, Rodriguez JL, Ashton NJ, Nicholas JM, &#x2026; Schott JM (2021). Population-based blood screening for preclinical Alzheimer&#x2019;s disease in a British birth cohort at age 70. Brain, 144(2), 434&#x2013;449. doi:10.1093/brain/awaa403</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa403</ArticleId><ArticleId IdType="pmc">PMC7940173</ArticleId><ArticleId IdType="pubmed">33479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirmess KM, Meyer MR, Holubasch MS, Knapik SS, Hu Y, Jackson EN, &#x2026; Contois JH (2021). The PrecivityAD test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis. Clin Chim Acta, 519, 267&#x2013;275. doi:10.1016/j.cca.2021.05.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2021.05.011</ArticleId><ArticleId IdType="pmc">PMC10292789</ArticleId><ArticleId IdType="pubmed">34015303</ArticleId></ArticleIdList></Reference><Reference><Citation>Koenig AM, Nobuhara CK, Williams VJ, &amp; Arnold SE (2018). Biomarkers in Alzheimer&#x2019;s, Frontotemporal, Lewy Body, and Vascular Dementias. Focus (Am Psychiatr Publ), 16(2), 164&#x2013;172. doi:10.1176/appi.focus.20170048</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.focus.20170048</ArticleId><ArticleId IdType="pmc">PMC6526853</ArticleId><ArticleId IdType="pubmed">31975911</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon HS, &amp; Koh SH (2020). Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener, 9(1), 42. doi:10.1186/s40035-020-00221-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-020-00221-2</ArticleId><ArticleId IdType="pmc">PMC7689983</ArticleId><ArticleId IdType="pubmed">33239064</ArticleId></ArticleIdList></Reference><Reference><Citation>Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, &#x2026; Alzheimer&#x2019;s Disease Neuroimaging, I. (2011). Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging, 32(7), 1207&#x2013;1218. doi:10.1016/j.neurobiolaging.2009.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2009.07.002</ArticleId><ArticleId IdType="pmc">PMC2891865</ArticleId><ArticleId IdType="pubmed">19660834</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuzy A, Smith R, Cullen NC, Strandberg O, Vogel JW, Binette AP, &#x2026; Hansson O (2022). Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease. JAMA Neurol, 79(2), 149&#x2013;158. doi:10.1001/jamaneurol.2021.4654</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.4654</ArticleId><ArticleId IdType="pmc">PMC8689441</ArticleId><ArticleId IdType="pubmed">34928318</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson N, Zetterberg H, Janelidze S, Insel PS, Andreasson U, Stomrud E, &#x2026; Investigators, A. (2016). Plasma tau in Alzheimer disease. Neurology, 87(17), 1827&#x2013;1835. doi:10.1212/WNL.0000000000003246</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003246</ArticleId><ArticleId IdType="pmc">PMC5089525</ArticleId><ArticleId IdType="pubmed">27694257</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayeux R (2004). Biomarkers: potential uses and limitations. NeuroRx, 1(2), 182&#x2013;188. doi:10.1602/neurorx.1.2.182</Citation><ArticleIdList><ArticleId IdType="doi">10.1602/neurorx.1.2.182</ArticleId><ArticleId IdType="pmc">PMC534923</ArticleId><ArticleId IdType="pubmed">15717018</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayeux R, &amp; Schupf N (2011). Blood-based biomarkers for Alzheimer&#x2019;s disease: plasma Abeta40 and Abeta42, and genetic variants. Neurobiol Aging, 32 Suppl 1, S10&#x2013;19. doi:10.1016/j.neurobiolaging.2011.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.09.004</ArticleId><ArticleId IdType="pmc">PMC3233700</ArticleId><ArticleId IdType="pubmed">22078169</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, &#x2026; Phelps CH(2011). The diagnosis of dementia due to Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimers Dement, 7(3), 263&#x2013;269. doi:10.1016/j.jalz.2011.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.03.005</ArticleId><ArticleId IdType="pmc">PMC3312024</ArticleId><ArticleId IdType="pubmed">21514250</ArticleId></ArticleIdList></Reference><Reference><Citation>Mielke MM, Frank RD, Dage JL, Jeromin A, Ashton NJ, Blennow K, &#x2026; Petersen RC (2021). Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes. JAMA Neurol, 78(9), 1108&#x2013;1117. doi:10.1001/jamaneurol.2021.2293</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.2293</ArticleId><ArticleId IdType="pmc">PMC8314178</ArticleId><ArticleId IdType="pubmed">34309632</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan AR, Touchard S, Leckey C, O&#x2019;Hagan C, Nevado-Holgado AJ, Consortium N., &#x2026; Alzheimer&#x2019;s, D. (2019). Inflammatory biomarkers in Alzheimer&#x2019;s disease plasma. Alzheimers Dement, 15(6), 776&#x2013;787. doi:10.1016/j.jalz.2019.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.03.007</ArticleId><ArticleId IdType="pmc">PMC6565806</ArticleId><ArticleId IdType="pubmed">31047856</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosconi L (2005). Brain glucose metabolism in the early and specific diagnosis of Alzheimer&#x2019;s disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging, 32(4), 486&#x2013;510. doi:10.1007/s00259-005-1762-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-005-1762-7</ArticleId><ArticleId IdType="pubmed">15747152</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabers A, Perna L, Lange J, Mons U, Schartner J, Guldenhaupt J, &#x2026; Brenner H (2018). Amyloid blood biomarker detects Alzheimer&#x2019;s disease. EMBO Mol Med, 10(5). doi:10.15252/emmm.201708763</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201708763</ArticleId><ArticleId IdType="pmc">PMC5938617</ArticleId><ArticleId IdType="pubmed">29626112</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan S, Shanker A, Khera T, &amp; Subramaniam B (2021). Neurofilament light: a narrative review on biomarker utility. Fac Rev, 10, 46. doi:10.12703/r/10-46</Citation><ArticleIdList><ArticleId IdType="doi">10.12703/r/10-46</ArticleId><ArticleId IdType="pmc">PMC8170685</ArticleId><ArticleId IdType="pubmed">34131656</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson BL, Holshouser BA, Britt W 3rd, Mueller C, Baqai W, Patra S, &#x2026; Kirsch WM (2008). Longitudinal metabolic and cognitive changes in mild cognitive impairment patients. Alzheimer Dis Assoc Disord, 22(3), 269&#x2013;277. doi:10.1097/WAD.0b013e3181750a65</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0b013e3181750a65</ArticleId><ArticleId IdType="pubmed">18580584</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborn KE, Khan OA, Kresge HA, Bown CW, Liu D, Moore EE, &#x2026; Jefferson AL (2019). Cerebrospinal fluid and plasma neurofilament light relate to abnormal cognition. Alzheimers Dement (Amst), 11, 700&#x2013;709. doi:10.1016/j.dadm.2019.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dadm.2019.08.008</ArticleId><ArticleId IdType="pmc">PMC6827361</ArticleId><ArticleId IdType="pubmed">31700989</ArticleId></ArticleIdList></Reference><Reference><Citation>Ovod V, Ramsey KN, Mawuenyega KG, Bollinger JG, Hicks T, Schneider T, &#x2026; Bateman RJ (2017). Amyloid beta concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimers Dement, 13(8), 841&#x2013;849. doi:10.1016/j.jalz.2017.06.2266</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2017.06.2266</ArticleId><ArticleId IdType="pmc">PMC5567785</ArticleId><ArticleId IdType="pubmed">28734653</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, Insel PS, Stomrud E, Janelidze S, Zetterberg H, Brix B, &#x2026; Hansson O (2019). Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer&#x2019;s disease. EMBO Mol Med, 11(12), e11170. doi:10.15252/emmm.201911170</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201911170</ArticleId><ArticleId IdType="pmc">PMC6895602</ArticleId><ArticleId IdType="pubmed">31709776</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, Tideman P, Cullen N, Zetterberg H, Blennow K, Alzheimer&#x2019;s Disease Neuroimaging, I., &#x2026; Hansson O (2021). Prediction of future Alzheimer&#x2019;s disease dementia using plasma phospho-tau combined with other accessible measures. Nat Med, 27(6), 1034&#x2013;1042. doi:10.1038/s41591-021-01348-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01348-z</ArticleId><ArticleId IdType="pubmed">34031605</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Grijalba V, Romero J, Pesini P, Sarasa L, Monleon I, San-Jose I, &#x2026; Sarasa M (2019). Plasma Abeta42/40 Ratio Detects Early Stages of Alzheimer&#x2019;s Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study. J Prev Alzheimers Dis, 6(1), 34&#x2013;41. doi:10.14283/jpad.2018.41</Citation><ArticleIdList><ArticleId IdType="doi">10.14283/jpad.2018.41</ArticleId><ArticleId IdType="pubmed">30569084</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillai JA, Bena J, Bebek G, Bekris LM, Bonner-Jackson A, Kou L, &#x2026; Alzheimer&#x2019;s Disease Neuroimaging, I. (2020). Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer&#x2019;s disease. Ann Clin Transl Neurol, 7(7), 1225&#x2013;1239. doi:10.1002/acn3.51109</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51109</ArticleId><ArticleId IdType="pmc">PMC7359114</ArticleId><ArticleId IdType="pubmed">32634865</ArticleId></ArticleIdList></Reference><Reference><Citation>Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, &#x2026; Dominantly Inherited Alzheimer, N. (2019). Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer&#x2019;s disease. Nat Med, 25(2), 277&#x2013;283. doi:10.1038/s41591-018-0304-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0304-3</ArticleId><ArticleId IdType="pmc">PMC6367005</ArticleId><ArticleId IdType="pubmed">30664784</ArticleId></ArticleIdList></Reference><Reference><Citation>Risacher SL, &amp; Saykin AJ (2013). Neuroimaging biomarkers of neurodegenerative diseases and dementia. Semin Neurol, 33(4), 386&#x2013;416. doi:10.1055/s-0033-1359312</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0033-1359312</ArticleId><ArticleId IdType="pmc">PMC3975244</ArticleId><ArticleId IdType="pubmed">24234359</ArticleId></ArticleIdList></Reference><Reference><Citation>Seto M, Weiner RL, Dumitrescu L, &amp; Hohman TJ (2021). Protective genes and pathways in Alzheimer&#x2019;s disease: moving towards precision interventions. Mol Neurodegener, 16(1), 29. doi:10.1186/s13024-021-00452-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00452-5</ArticleId><ArticleId IdType="pmc">PMC8086309</ArticleId><ArticleId IdType="pubmed">33926499</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobow T, Flirski M, Kloszewska I, &amp; Liberski PP (2005). Plasma levels of alpha beta peptides are altered in amnestic mild cognitive impairment but not in sporadic Alzheimer&#x2019;s disease. Acta Neurobiol Exp (Wars), 65(2), 117&#x2013;124. Retrieved from
https://www.ncbi.nlm.nih.gov/pubmed/15960295</Citation><ArticleIdList><ArticleId IdType="pubmed">15960295</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, &#x2026; Cummings JL (2021). A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer&#x2019;s disease with lecanemab, an anti-Abeta protofibril antibody. Alzheimers Res Ther, 13(1), 80. doi:10.1186/s13195-021-00813-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00813-8</ArticleId><ArticleId IdType="pmc">PMC8053280</ArticleId><ArticleId IdType="pubmed">33865446</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, &amp; Pirttila T (2009). Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol, 66(3), 382&#x2013;389. doi:10.1001/archneurol.2008.596</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2008.596</ArticleId><ArticleId IdType="pubmed">19273758</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarkowski E, Liljeroth AM, Minthon L, Tarkowski A, Wallin A, &amp; Blennow K (2003). Cerebral pattern of pro- and anti-inflammatory cytokines in dementias. Brain Res Bull, 61(3), 255&#x2013;260. doi:10.1016/s0361-9230(03)00088-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0361-9230(03)00088-1</ArticleId><ArticleId IdType="pubmed">12909295</ArticleId></ArticleIdList></Reference><Reference><Citation>Tumati S, Herrmann N, Marotta G, Li A, &amp; Lanctot KL (2022). Blood-based biomarkers of agitation in Alzheimer&#x2019;s disease: Advances and future prospects. Neurochem Int, 152, 105250. doi:10.1016/j.neuint.2021.105250</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2021.105250</ArticleId><ArticleId IdType="pubmed">34864088</ArticleId></ArticleIdList></Reference><Reference><Citation>Umemneku Chikere CM, Wilson K, Graziadio S, Vale L, &amp; Allen AJ (2019). Diagnostic test evaluation methodology: A systematic review of methods employed to evaluate diagnostic tests in the absence of gold standard - An update. PLoS One, 14(10), e0223832. doi:10.1371/journal.pone.0223832</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0223832</ArticleId><ArticleId IdType="pmc">PMC6788703</ArticleId><ArticleId IdType="pubmed">31603953</ArticleId></ArticleIdList></Reference><Reference><Citation>West T, Kirmess KM, Meyer MR, Holubasch MS, Knapik SS, Hu Y, &#x2026; Yarasheski KE (2021). A blood-based diagnostic test incorporating plasma Abeta42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis. Mol Neurodegener, 16(1), 30. doi:10.1186/s13024-021-00451-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00451-6</ArticleId><ArticleId IdType="pmc">PMC8088704</ArticleId><ArticleId IdType="pubmed">33933117</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterberg H, &amp; Burnham SC (2019). Blood-based molecular biomarkers for Alzheimer&#x2019;s disease. Mol Brain, 12(1), 26. doi:10.1186/s13041-019-0448-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-019-0448-1</ArticleId><ArticleId IdType="pmc">PMC6437931</ArticleId><ArticleId IdType="pubmed">30922367</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36342454</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0891-9887</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of geriatric psychiatry and neurology</Title><ISOAbbreviation>J Geriatr Psychiatry Neurol</ISOAbbreviation></Journal><ArticleTitle>Demographic and Symptom Correlates of Initial Idiopathic Psychiatric Diagnosis in Frontotemporal Dementia.</ArticleTitle><Pagination><StartPage>193</StartPage><EndPage>200</EndPage><MedlinePgn>193-200</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/08919887221130267</ELocationID><Abstract><AbstractText Label="INTRODUCTION">This study aims to measure frequency and correlates of initial idiopathic psychiatric diagnosis in a cohort of 147 patients with Frontotemporal Dementia (FTD)-spectrum disorders.</AbstractText><AbstractText Label="METHODS">Participants were evaluated at the National Institutes of Health in Bethesda, Maryland. Initial participant diagnoses were determined by chart review and patient and informant interviews. Logistic regression was used to assess the relationships between diagnosis and age of symptom onset, gender, education, family history of psychiatric illness, and family history of dementia. Additional exploratory analyses investigated patients' first symptom type.</AbstractText><AbstractText Label="RESULTS">25% (n=43) of all the patients reviewed were initially misdiagnosed with an idiopathic psychiatric illness, which is less than half the commonly cited 50% rate.<sup>3</sup> Depression was the most common misdiagnosis (46.5%). Family history of dementia, family history of mental illness and an exploratory analysis of behavioral first symptoms suggested significant association with a greater likelihood of initial idiopathic psychiatric diagnosis in FTD patients.</AbstractText><AbstractText Label="DISCUSSION">This data confirms patterns of initial idiopathic psychiatric diagnosis in FTD and elucidates potential factors underlying misdiagnosis. Potential implications for patient outcomes, caregiver burden and healthcare costs are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sejourne</LastName><ForeName>Corinne</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9550-2967</Identifier><AffiliationInfo><Affiliation>Taub Institute for Research in Alzheimer's Disease and The Aging Brain, Columbia University Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dworkin</LastName><ForeName>Jordan D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>New York State Psychiatric Institute, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barker</LastName><ForeName>Megan S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0001-5385-5908</Identifier><AffiliationInfo><Affiliation>Taub Institute for Research in Alzheimer's Disease and The Aging Brain, Columbia University Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manoochehri</LastName><ForeName>Masood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Taub Institute for Research in Alzheimer's Disease and The Aging Brain, Columbia University Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gottesman</LastName><ForeName>Reena T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Department of Neurology, Columbia University Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wassermann</LastName><ForeName>Eric M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Behavioral Neurology Unit, National Institute of Neurological Disorders and Stroke, Bethesda, ML, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tierney</LastName><ForeName>Michael C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Behavioral Neurology Unit, National Institute of Neurological Disorders and Stroke, Bethesda, ML, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huey</LastName><ForeName>Edward D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Taub Institute for Research in Alzheimer's Disease and The Aging Brain, Columbia University Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York State Psychiatric Institute, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Columbia University Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grafman</LastName><ForeName>Jordan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Northwestern University, Chicago, IL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Injury Research Program, Shirley Ryan AbilityLab, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R00 NS060766</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG062268</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH120794</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG079850</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Geriatr Psychiatry Neurol</MedlineTA><NlmUniqueID>8805645</NlmUniqueID><ISSNLinking>0891-9887</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003710" MajorTopicYN="N">Demography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">burden</Keyword><Keyword MajorTopicYN="N">family history</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">misdiagnosis</Keyword><Keyword MajorTopicYN="N">psychiatric symptoms</Keyword></KeywordList><CoiStatement>Declaration of Conflicting Interests. The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>7</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36342454</ArticleId><ArticleId IdType="mid">NIHMS2008086</ArticleId><ArticleId IdType="pmc">PMC11279523</ArticleId><ArticleId IdType="doi">10.1177/08919887221130267</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lima-Silva TB, Bahia VS, Carvalho VA, et al. Neuropsychiatric symptoms, caregiver burden and distress in behavioral-variant frontotemporal dementia and Alzheimer&#x2019;s Disease. Dement Geriatr Cogn Disord. 2015;40(5&#x2013;6):268&#x2013;275. doi:10.1159/000437351</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000437351</ArticleId><ArticleId IdType="pubmed">26302667</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011;134(9):2456&#x2013;2477. doi:10.1093/brain/awr179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011;72(02):126&#x2013;133. doi: 10.4088/JCP.10m06382oli</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.10m06382oli</ArticleId><ArticleId IdType="pmc">PMC3076589</ArticleId><ArticleId IdType="pubmed">21382304</ArticleId></ArticleIdList></Reference><Reference><Citation>Passant U, Elfgren C, Englund E, Gustafson L. Psychiatric symptoms and their psychosocial consequences in frontotemporal dementia. Alzheimer Disease &amp; Associated Disorders. 2005;19(suppl 1):S15&#x2013;S18. doi:10.1097/01.wad.0000183084.22562.5a</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.wad.0000183084.22562.5a</ArticleId><ArticleId IdType="pubmed">16317252</ArticleId></ArticleIdList></Reference><Reference><Citation>Galimberti D, Dell&#x2019;Osso B, Altamura AC, Scarpini E. Psychiatric symptoms in frontotemporal dementia: epidemiology, phenotypes, and differential diagnosis. Biol Psychiatr. 2015; 78(10):684&#x2013;692. doi:10.1016/j.biopsych.2015.03.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2015.03.028</ArticleId><ArticleId IdType="pubmed">25958088</ArticleId></ArticleIdList></Reference><Reference><Citation>Wylie MA, Shnall A, Onyike CU, Huey ED. Management of frontotemporal dementia in mental health and multidisciplinary settings. Int Rev Psychiatry 2013;25(2):230&#x2013;236. doi:10.3109/09540261.2013.776949.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09540261.2013.776949</ArticleId><ArticleId IdType="pmc">PMC3929950</ArticleId><ArticleId IdType="pubmed">23611352</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducharme S, Dols A, Laforce R, et al. Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders. Brain 2020;143(6):1632&#x2013;1650. doi:10.1093/brain/awaa018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa018</ArticleId><ArticleId IdType="pmc">PMC7849953</ArticleId><ArticleId IdType="pubmed">32129844</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerstein AH, Schroeder RW, Baade LE, Lincoln J, Khan AY. Frontotemporal dementia mimicking bipolar disorder. J Psychiatr Pract 2013;19(6):498&#x2013;500. doi:10.1097/01.pra.0000438190.04786.16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.pra.0000438190.04786.16.</ArticleId><ArticleId IdType="pubmed">24241504</ArticleId></ArticleIdList></Reference><Reference><Citation>Pose M, Cetkovich M, Gleichgerrcht E, Ib&#xe1;&#xf1;ez A, Torralva T, Manes F. The overlap of symptomatic dimensions between frontotemporal dementia and several psychiatric disorders that appear in late adulthood. Int Rev Psychiatr. 2013;25(2):159&#x2013;167. doi:10.3109/09540261.2013.769939</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09540261.2013.769939</ArticleId><ArticleId IdType="pubmed">23611346</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibanez N Atypical presentation of frontotemporal dementia masquerading as bipolardisorder and substance abuse: a case report. W Va Med J. 2012;108(4):16&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">22872960</ArticleId></ArticleIdList></Reference><Reference><Citation>Landqvist Wald&#xf6; M, Gustafson L, Passant U, Englund E. Psychotic symptoms in frontotemporal dementia: a diagnostic dilemma? Int Psychogeriatr 2015;27(4):531&#x2013;539. doi:10.1017/S1041610214002580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610214002580</ArticleId><ArticleId IdType="pmc">PMC4413855</ArticleId><ArticleId IdType="pubmed">25486967</ArticleId></ArticleIdList></Reference><Reference><Citation>James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990&#x2013;2017: a systematic analysis for the Global Burden of Disease Study. Lancet. 2018;392(10159): 1789&#x2013;1858.doi:10.1016/S0140-6736(18)32279-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)32279-7</ArticleId><ArticleId IdType="pmc">PMC6227754</ArticleId><ArticleId IdType="pubmed">30496104</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez MF, Shapira JS, McMurtray A, Licht E, Miller BL. Accuracy of the clinical evaluation for frontotemporal dementia. Arch Neurol 2007;64(6):830. doi:10.1001/archneur.64.6.830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.64.6.830</ArticleId><ArticleId IdType="pubmed">17562930</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow TW, Pio FJ, Rockwood K. An international needs assessment of caregivers for frontotemporal dementia. Can J Neurol Sci 2011;38(5):753&#x2013;757. doi:10.1017/S0317167100054147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0317167100054147</ArticleId><ArticleId IdType="pubmed">21856580</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter CA, Kirson NY, Desai U, Cummings AKG, Faries DE, Birnbaum HG. Medical costs of Alzheimer&#x2019;s disease misdiagnosis among US Medicare beneficiaries. Alzheimer&#x2019;s Dementia. 2015;11(8):887&#x2013;895. doi:10.1016/j.jalz.2015.06.1889</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2015.06.1889</ArticleId><ArticleId IdType="pubmed">26206626</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman M, Mickanin J, Onishi K, et al. Progressive nonfluent aphasia: language, cognitive, and pet measures contrasted with probable alzheimer&#x2019;s disease. J Cognit Neurosci. 1996;8(2):135&#x2013;154. doi:10.1162/jocn.1996.8.2.135</Citation><ArticleIdList><ArticleId IdType="doi">10.1162/jocn.1996.8.2.135</ArticleId><ArticleId IdType="pubmed">23971420</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998;51(6): 1546&#x2013;1554. doi:10.1212/WNL.51.6.1546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.51.6.1546</ArticleId><ArticleId IdType="pubmed">9855500</ArticleId></ArticleIdList></Reference><Reference><Citation>Panegyres PK, Graves A, Frencham KA. The clinical differentiation of fronto-temporal dementia from psychiatric disease. Neuropsychiatr Dis Treat. 2007;3(5):637&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2656300</ArticleId><ArticleId IdType="pubmed">19300593</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogan DB, Jett&#xe9; N, Fiest KM, et al. The prevalence and incidence of frontotemporal dementia: a systematic review. Can J Neurol Sci 2016;43(S1):S96&#x2013;S109. doi:10.1017/cjn.2016.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2016.25</ArticleId><ArticleId IdType="pubmed">27307130</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindau M, Almkvist O, Kushi J, et al. First symptoms &#x2013; frontotemporal dementia versus Alzheimer&#x2019;s disease. DEM 2000;11(5):286&#x2013;293. doi:10.1159/000017251</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000017251</ArticleId><ArticleId IdType="pubmed">10940680</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet 2015;386(10004):1672&#x2013;1682. doi:10.1016/S0140-6736(15)00461-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)00461-4</ArticleId><ArticleId IdType="pmc">PMC5970949</ArticleId><ArticleId IdType="pubmed">26595641</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertoux M, Delavest M, de Souza LC, et al. Social cognition and emotional assessment differentiates frontotemporal dementia from depression. J Neurol Neurosurg Psychiatry 2012;83(4):411&#x2013;416. doi:10.1136/jnnp-2011-301849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-301849</ArticleId><ArticleId IdType="pubmed">22291219</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducharme S, Pearl-Dowler L, Gossink F, et al. The frontotemporal dementia versus primary psychiatric disorder (FTD versus PPD) checklist: a bedside clinical tool to identify behavioral variant ftd in patients with late-onset behavioral changes. J Alzheimers Dis. 2019;67(1):113&#x2013;124. doi:10.3233/JAD-180839</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180839</ArticleId><ArticleId IdType="pubmed">30584146</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36325924</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1364-6915</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Aging &amp; mental health</Title><ISOAbbreviation>Aging Ment Health</ISOAbbreviation></Journal><ArticleTitle>The role of pets in the support systems of community-dwelling older adults: a&#xa0;qualitative systematic review.</ArticleTitle><Pagination><StartPage>1377</StartPage><EndPage>1387</EndPage><MedlinePgn>1377-1387</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/13607863.2022.2141196</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">Western countries face ageing populations and increasing numbers of older adults receiving long-term care at home (home care). Approximately 50% of households in Western countries own pets, and while pets impact the health and wellbeing of their owners, most healthcare organisations do not account for the role of pets in the lives of their clients. Due to the lack of research in older adults receiving home care that own pets, this study aimed to review previous qualitative research about the role and significance of pets for older adults in general.</AbstractText><AbstractText Label="METHOD" NlmCategory="UNASSIGNED">PubMed and PsycINFO were systematically searched with variations on (MeSH) terms for older adults (mean age 65&#x2009;years and older), pets, and qualitative study designs. Iterative-inductive thematic analyses were performed in ATLAS.ti.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We included fifteen studies and extracted twenty-eight themes within seven categories: Relational Aspects, Reflection and Meaning, Emotional Aspects, Aspects of Caregiving, Physical Health, Social Aspects, and Bidirectional Behaviour. Older adults reported not only on positive aspects of pet ownership such as the emotional support their pets provided but also on negative aspects such as postponing personal medical treatment.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Older adults perceived pets as important for their health and wellbeing. This implies that care workers may be able to improve home care by accounting for the role of pets of older adults receiving home care. Based on our findings, we suggest that community healthcare organisations develop guidelines and tools for care workers to improve care at home for clients with pets.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reniers</LastName><ForeName>P W A</ForeName><Initials>PWA</Initials><Identifier Source="ORCID">0000-0002-7353-7410</Identifier><AffiliationInfo><Affiliation>Faculty of Psychology and Educational Sciences, Open University of the Netherlands, Heerlen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Declercq</LastName><ForeName>I J N</ForeName><Initials>IJN</Initials><Identifier Source="ORCID">0000-0002-4348-6894</Identifier><AffiliationInfo><Affiliation>Faculty of Psychology and Educational Sciences, Open University of the Netherlands, Heerlen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Primary and Community Care, Radboud University Medical Center, Radboud Institute for Health Sciences, Radboudumc Alzheimer Centre, Nijmegen, The&#xa0;Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hediger</LastName><ForeName>K</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-7202-4816</Identifier><AffiliationInfo><Affiliation>Faculty of Psychology and Educational Sciences, Open University of the Netherlands, Heerlen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Psychology, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enders-Slegers</LastName><ForeName>M-J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-2781-2952</Identifier><AffiliationInfo><Affiliation>Faculty of Psychology and Educational Sciences, Open University of the Netherlands, Heerlen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerritsen</LastName><ForeName>D L</ForeName><Initials>DL</Initials><Identifier Source="ORCID">0000-0002-3356-0237</Identifier><AffiliationInfo><Affiliation>Department of Primary and Community Care, Radboud University Medical Center, Radboud Institute for Health Sciences, Radboudumc Alzheimer Centre, Nijmegen, The&#xa0;Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leontjevas</LastName><ForeName>R</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9689-7611</Identifier><AffiliationInfo><Affiliation>Faculty of Psychology and Educational Sciences, Open University of the Netherlands, Heerlen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Primary and Community Care, Radboud University Medical Center, Radboud Institute for Health Sciences, Radboudumc Alzheimer Centre, Nijmegen, The&#xa0;Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Aging Ment Health</MedlineTA><NlmUniqueID>9705773</NlmUniqueID><ISSNLinking>1360-7863</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Pets</Keyword><Keyword MajorTopicYN="N">community care</Keyword><Keyword MajorTopicYN="N">home care</Keyword><Keyword MajorTopicYN="N">human-animal interaction</Keyword><Keyword MajorTopicYN="N">long-term care</Keyword><Keyword MajorTopicYN="N">older adults</Keyword><Keyword MajorTopicYN="N">social support</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>5</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36325924</ArticleId><ArticleId IdType="doi">10.1080/13607863.2022.2141196</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36317266</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1758-5341</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>The Gerontologist</Title><ISOAbbreviation>Gerontologist</ISOAbbreviation></Journal><ArticleTitle>"Care for Me, Too": A Novel Framework for Improved Communication and Support Between Dementia Caregivers and the Home Health Care Team.</ArticleTitle><Pagination><StartPage>874</StartPage><EndPage>886</EndPage><MedlinePgn>874-886</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/geront/gnac165</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">Identifying and meeting the needs of family and unpaid caregivers (hereafter, "caregivers") during home health (HH) can improve outcomes for patients with Alzheimer's Disease and Related Dementias (ADRD). However, little is known regarding ADRD caregivers' perspectives on communication and support from the HH care team. The study objectives were to identify ADRD caregivers' common support needs during HH and preferences for addressing these needs, to inform future development of an assessment and support intervention.</AbstractText><AbstractText Label="RESEARCH DESIGN AND METHODS" NlmCategory="METHODS">We conducted semistructured key informant interviews with caregivers who had recently assisted a HH patient with ADRD (n = 27). Interview transcripts were analyzed using directed content analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Caregivers identified four major support needs: assistance navigating insurance and service coverage, training on nursing tasks, referral to respite care, and information regarding ADRD disease progression. Caregivers described major barriers to communicating these needs, including never being directly asked about their needs and information discontinuity within the HH care team. Incorporating caregiver recommendations, we propose a new model of assessment and support in which the HH care team (a) proactively asks about caregiver needs, (b) presents available supportive resources, (c) solicits information regarding the patient's needs and routine, and (d) stores and shares this information within the medical record.</AbstractText><AbstractText Label="DISCUSSION AND IMPLICATIONS" NlmCategory="CONCLUSIONS">Findings reveal critical gaps in current patterns of support for ADRD caregivers during HH and suggest directions for an assessment and support intervention that explicitly queries caregivers on their capacity and needs, with content tailored to the HH setting.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burgdorf</LastName><ForeName>Julia G</ForeName><Initials>JG</Initials><Identifier Source="ORCID">0000-0002-3356-1897</Identifier><AffiliationInfo><Affiliation>Center for Home Care Policy and Research, VNS Health, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reckrey</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Home Care Policy and Research, VNS Health, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Sociology, Appalachian State University, Boone, North Carolina, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>VNS Health</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gerontologist</MedlineTA><NlmUniqueID>0375327</NlmUniqueID><ISSNLinking>0016-9013</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="N">Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010348" MajorTopicYN="N">Patient Care Team</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Caregiver burden</Keyword><Keyword MajorTopicYN="N">Cognitive decline</Keyword><Keyword MajorTopicYN="N">Family caregiving</Keyword><Keyword MajorTopicYN="N">Home care services</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>1</Day><Hour>2</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36317266</ArticleId><ArticleId IdType="doi">10.1093/geront/gnac165</ArticleId><ArticleId IdType="pii">6783228</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36314055</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1479-8301</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society</Title><ISOAbbreviation>Psychogeriatrics</ISOAbbreviation></Journal><ArticleTitle>A caregiver's perspective on clinically relevant symptoms in behavioural variant frontotemporal dementia: tools for disease management and trial design.</ArticleTitle><Pagination><StartPage>11</StartPage><EndPage>22</EndPage><MedlinePgn>11-22</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/psyg.12898</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Adequate detection of symptoms and disease progression in behavioural variant frontotemporal dementia (bvFTD) is complex. Dementia cohorts usually utilize cognitive and functional measures, which fail to detect dominant behavioural and social cognitive deficits in bvFTD. Moreover, since patients typically have a loss of insight, caregivers are important informants. This is the first qualitative study to investigate caregiver relevant symptoms during the disease course of bvFTD, aiming to improve tools for diagnosis, progression, and future clinical trials.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Informal caregivers of patients in different disease stages of bvFTD (N&#xa0;=&#xa0;20) were recruited from the neurology outpatient clinic of the Amsterdam UMC and a patient organization for peer support in the Netherlands. Their perspectives on clinical relevance were thoroughly explored during individual semi-structured interviews. Inductive content analysis with open coding was performed by two researchers independently to establish overarching themes and patterns.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Caregivers reported a variety of symptoms, in which (i) loss of emotional connection, (ii) preoccupation and restlessness, and (iii) apathy and dependency compose major themes of relevance for diagnosis and treatment. Within heterogeneous disease trajectories, symptom presence differed between stages and among individuals, which is relevant in the context of progression and outcome measures. Significant socio-emotional changes dominated in early stages, while severe cognitive, behavioural, and physical deterioration shifted focus from predominant personality change to quality of life in later stages.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Caregiver perspectives on target symptoms in bvFTD differ according to clinical stage and patient-caregiver characteristics, with significant socio-emotional changes characterizing early stages. These findings call for more appropriate tools and symptomatic treatments, as well as a personalized approach in treatment of bvFTD and a focus on early stage interventions in clinical trial design.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Psychogeriatrics published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Psychogeriatric Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fieldhouse</LastName><ForeName>Jay L P</ForeName><Initials>JLP</Initials><Identifier Source="ORCID">0000-0002-9664-4075</Identifier><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Neuroscience, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Dijk</LastName><ForeName>Gaby</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Athena Institute, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gillissen</LastName><ForeName>Freek</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Neuroscience, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Engelen</LastName><ForeName>Marie-Paule E</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0001-5293-0806</Identifier><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Neuroscience, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Boer</LastName><ForeName>Sterre C M</ForeName><Initials>SCM</Initials><Identifier Source="ORCID">0000-0002-9595-7221</Identifier><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Neuroscience, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dols</LastName><ForeName>Annemiek</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1964-0318</Identifier><AffiliationInfo><Affiliation>Department of Old Age Psychiatry, GGZ InGeest, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam Neuroscience, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Waal</LastName><ForeName>Hendrik-Jan</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>FTDlotgenoten, patient organization, Nootdorp, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Regeer</LastName><ForeName>Barbara J</ForeName><Initials>BJ</Initials><Identifier Source="ORCID">0000-0002-9044-9367</Identifier><AffiliationInfo><Affiliation>Athena Institute, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vijverberg</LastName><ForeName>Everard G B</ForeName><Initials>EGB</Initials><Identifier Source="ORCID">0000-0003-3879-884X</Identifier><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Neuroscience, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pijnenburg</LastName><ForeName>Yolande A L</ForeName><Initials>YAL</Initials><Identifier Source="ORCID">0000-0003-2464-1905</Identifier><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Neuroscience, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Stichting Dioraphte</Agency><Country/></Grant><Grant><Agency>Stichting Alzheimer Nederland</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychogeriatrics</MedlineTA><NlmUniqueID>101230058</NlmUniqueID><ISSNLinking>1346-3500</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diagnosis</Keyword><Keyword MajorTopicYN="N">disease progression</Keyword><Keyword MajorTopicYN="N">frontotemporal lobar degeneration</Keyword><Keyword MajorTopicYN="N">informal caregivers</Keyword><Keyword MajorTopicYN="N">qualitative research</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>31</Day><Hour>5</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36314055</ArticleId><ArticleId IdType="pmc">PMC10092374</ArticleId><ArticleId IdType="doi">10.1111/psyg.12898</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hogan DB, Jett&#xe9; N, Fiest KM et al. The prevalence and incidence of frontotemporal dementia: a systematic review. Can J Neurol Sci 2016; 43: S96&#x2013;S109.</Citation><ArticleIdList><ArticleId IdType="pubmed">27307130</ArticleId></ArticleIdList></Reference><Reference><Citation>Karnatz T, Monsees J, Wucherer D et al. Burden of caregivers of patients with frontotemporal lobar degeneration&#x2013;a scoping review. Int Psychogeriatr 2019; 33: 1&#x2013;21. 10.1017/S1041610219000176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610219000176</ArticleId><ArticleId IdType="pubmed">30982478</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E, Foxe D, Bpsych LF, Savage S, Hsieh S et al. The impact of dementia severity on caregiver burden in frontotemporal dementia and Alzheimer disease. Alzheimer Dis Assoc Disord 2013; 27: 68&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">22314247</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134: 2456&#x2013;2477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden JS, Gustafson L et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546&#x2013;1554.</Citation><ArticleIdList><ArticleId IdType="pubmed">9855500</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez MF, Shapira JS. Loss of emotional insight in behavioral variant frontotemporal dementia or "frontal anosodiaphoria". Conscious Cogn 2011; 20: 1690&#x2013;1696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3199289</ArticleId><ArticleId IdType="pubmed">21959203</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai RM, Boxer AL. Therapy and clinical trials in frontotemporal dementia: past, present, and future. J Neurochem 2016; 138: 211&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5217534</ArticleId><ArticleId IdType="pubmed">27306957</ArticleId></ArticleIdList></Reference><Reference><Citation>Trieu C, Gossink F, Stek ML, Scheltens P, Pijnenburg YAL, Dols A. Effectiveness of pharmacological interventions for symptoms of behavioral variant frontotemporal dementia: a systematic review. Cogn Behav Neurol 2020; 33: 1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">32132398</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS, Kramer JH, Boeve BF et al. Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain 2008; 131: 2957&#x2013;2968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2725027</ArticleId><ArticleId IdType="pubmed">18829698</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiba T, Yamakawa M, Endo Y, Konno R, Tanimukai S. Experiences of families of people living with frontotemporal dementia: a qualitative systematic review. Psychogeriatrics 2022; 22. 10.1111/psyg.12837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/psyg.12837</ArticleId><ArticleId IdType="pubmed">35429063</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen H, Hellzen O, Stordal E, Enmarker I. Family caregivers experiences of the pre&#x2010;diagnostic stage in frontotemporal dementia. Geriatr Nurs 2019; 40: 246&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pubmed">30424902</ArticleId></ArticleIdList></Reference><Reference><Citation>Massimo L, Evans LK, Benner P. Caring for loved ones with frontotemporal degeneration: the lived experiences of spouses. Geriatr Nurs 2013; 34: 302&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3867267</ArticleId><ArticleId IdType="pubmed">23726759</ArticleId></ArticleIdList></Reference><Reference><Citation>Riedijk S, Duivenvoorden H, Rosso S, Van Swieten J, Niermeijer M, Tibben A. Frontotemporal dementia: change of familial caregiver burden and partner relation in a Dutch cohort of 63 patients. Dement Geriatr Cogn Disord 2008; 26: 398&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">18936543</ArticleId></ArticleIdList></Reference><Reference><Citation>A Voice of the Patient Report: Frontotemporal Degeneration . The Association for Frontotemporal Degeneration (AFTD); 2021. 27&#x2010;10&#x2010;2021.</Citation></Reference><Reference><Citation>Guest G, Bunce A, Johnson L. How many interviews are enough?:an experiment with data saturation and variability. Field Methods 2006; 18: 59&#x2013;82.</Citation></Reference><Reference><Citation>Piguet O, Hornberger M, Mioshi E, Hodges JR. Behavioural&#x2010;variant frontotemporal dementia: diagnosis, clinical staging, and management. Lancet Neurol 2011; 10: 162&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">21147039</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallio H, Pietil&#xe4; A&#x2010;M, Johnson M, Kangasniemi M. Systematic methodological review: developing a framework for a qualitative semi&#x2010;structured interview guide. J Adv Nurs 2016; 72: 2954&#x2013;2965.</Citation><ArticleIdList><ArticleId IdType="pubmed">27221824</ArticleId></ArticleIdList></Reference><Reference><Citation>Tassoul M, Buijs J. Clustering: an essential step from diverging to converging. Creat Innov Manag 2007; 16: 16&#x2013;26.</Citation></Reference><Reference><Citation>Gossink FT, Vijverberg EG, Krudop W et al. Psychosis in behavioral variant frontotemporal dementia. Neuropsychiatr Dis Treat 2017; 13: 1099&#x2013;1106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5402723</ArticleId><ArticleId IdType="pubmed">28458550</ArticleId></ArticleIdList></Reference><Reference><Citation>Merrilees J, Dowling GA, Hubbard E, Mastick J, Ketelle R, Miller BL. Characterization of apathy in persons with frontotemporal dementia and the impact on family caregivers. Alzheimer Dis Assoc Disord 2013; 27: 62&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3383924</ArticleId><ArticleId IdType="pubmed">22261729</ArticleId></ArticleIdList></Reference><Reference><Citation>Yassuda MS, Lima da Silva TB, O'Connor CM et al. Apathy and functional disability in behavioral variant frontotemporal dementia. Neurol Clin Pract 2018; 8: 120&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5914747</ArticleId><ArticleId IdType="pubmed">29708208</ArticleId></ArticleIdList></Reference><Reference><Citation>Poos JM, Jiskoot LC, Papma JM, van Swieten JC, van den Berg E. Meta&#x2010;analytic review of memory impairment in behavioral variant frontotemporal dementia. J Int Neuropsychol Soc 2018; 24: 593&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7282860</ArticleId><ArticleId IdType="pubmed">29552997</ArticleId></ArticleIdList></Reference><Reference><Citation>Besser LM, Galvin JE. Perceived burden among caregivers of patients with frontotemporal degeneration in the United States. Int Psychogeriatr 2019; 31: 1191&#x2013;1201.</Citation><ArticleIdList><ArticleId IdType="pubmed">30398132</ArticleId></ArticleIdList></Reference><Reference><Citation>Gossink F, Pijnenburg Y, Scheltens P et al. An intervention programme for caregivers of dementia patients with frontal behavioural changes: an explorative study with controlled effect on sense of competence. Psychogeriatrics 2018; 18: 451&#x2013;459.</Citation><ArticleIdList><ArticleId IdType="pubmed">30066463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruinsma J, Peetoom K, Bakker C, Boots L, Verhey F, de Vugt M. &#x2018;They simply do not understand&#x2019;: a focus group study exploring the lived experiences of family caregivers of people with frontotemporal dementia. Aging Ment Health 2020; 26: 277&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pubmed">33325262</ArticleId></ArticleIdList></Reference><Reference><Citation>Gossink FT, Vijverberg E, Krudop W et al. Predicting progression in the late onset frontal lobe syndrome. Int Psychogeriatr 2019; 31: 743&#x2013;748.</Citation><ArticleIdList><ArticleId IdType="pubmed">30362933</ArticleId></ArticleIdList></Reference><Reference><Citation>Reus LM, Vijverberg EGB, Tijms BM et al. Disease trajectories in behavioural variant frontotemporal dementia, primary psychiatric and other neurodegenerative disorders presenting with behavioural change. J Psychiatr Res 2018; 104: 183&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">30103065</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodich A, Crespi C, Santi GC, Cappa SF, Cerami C. Evaluation of discriminative detection abilities of social cognition measures for the diagnosis of the behavioral variant of frontotemporal dementia: a systematic review. Neuropsychol Rev 2021; 31: 251&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">33040199</ArticleId></ArticleIdList></Reference><Reference><Citation>Arioli M, Crespi C, Canessa N. Social cognition through the lens of cognitive and clinical neuroscience. Biomed Res Int 2018; 2018: 4283427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6158937</ArticleId><ArticleId IdType="pubmed">30302338</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi A, Mendez MF, Kaiser N, Jimenez E, Mather M, Shapira JS. Skin conductance levels may reflect emotional blunting in behavioral variant frontotemporal dementia. J Neuropsychiatry Clin Neurosci 2014; 26: 227&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">25093763</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez MF, Fong SS, Ashla MM, Jimenez EE, Carr AR. Skin conduction levels differentiate frontotemporal dementia from Alzheimer's disease. J Neuropsychiatry Clin Neurosci 2018; 30: 208&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6081247</ArticleId><ArticleId IdType="pubmed">29621927</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumfor F, Hazelton JL, Rushby JA, Hodges JR, Piguet O. Facial expressiveness and physiological arousal in frontotemporal dementia: phenotypic clinical profiles and neural correlates. Cogn Affect Behav Neurosci 2019; 19: 197&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">30488224</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez MF, McMurtray A, Licht E, Shapira JS, Saul RE, Miller BL. The scale for emotional blunting in patients with frontotemporal dementia. Neurocase 2006; 12: 242&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">17000595</ArticleId></ArticleIdList></Reference><Reference><Citation>Kertesz A, Davidson W, Fox H. Frontal behavioral inventory: diagnostic criteria for frontal lobe dementi. Can J Neurol Sci 1997; 24: 29&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">9043744</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagahama Y, Okina T, Suzuki N, Matsuda M. The Cambridge behavioral inventory: validation and application in a memory clinic. J Geriatr Psychiatry Neurol 2006; 19: 220&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pubmed">17085761</ArticleId></ArticleIdList></Reference><Reference><Citation>Wear HJ, Wedderburn CJ, Mioshi E et al. The Cambridge Behavioural inventory revised. Dement Neuropsychol 2008; 2: 102&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5619578</ArticleId><ArticleId IdType="pubmed">29213551</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E, Hsieh S, Savage S, Hornberger M, Hodges JR. Clinical staging and disease progression in frontotemporal dementia. Neurology 2010; 74: 1591&#x2013;1597.</Citation><ArticleIdList><ArticleId IdType="pubmed">20479357</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry 2011; 72: 126&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3076589</ArticleId><ArticleId IdType="pubmed">21382304</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambogi LB, Guimar&#xe3;es HC, de Souza LC, Caramelli P. Treatment of the behavioral variant of frontotemporal dementia: a narrative review. Dement Neuropsychol 2021; 15: 331&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8485641</ArticleId><ArticleId IdType="pubmed">34630920</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Imbimbo B, Lozupone M et al. Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease&#x2010;modifying drugs. Expert Opin Pharmacother 2019; 20: 1091&#x2013;1107.</Citation><ArticleIdList><ArticleId IdType="pubmed">31002267</ArticleId></ArticleIdList></Reference><Reference><Citation>Jesso S, Morlog D, Ross S et al. The effects of oxytocin on social cognition and behaviour in frontotemporal dementia. Brain 2011; 134: 2493&#x2013;2501.</Citation><ArticleIdList><ArticleId IdType="pubmed">21859765</ArticleId></ArticleIdList></Reference><Reference><Citation>Finger EC, MacKinley J, Blair M et al. Oxytocin for frontotemporal dementia: a randomized dose&#x2010;finding study of safety and tolerability. Neurology 2015; 84: 174&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4336088</ArticleId><ArticleId IdType="pubmed">25503617</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow TW, Fridhandler JD, Binns MA et al. Trajectories of behavioral disturbance in dementia. J Alzheimers Dis 2012; 31: 143&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4309273</ArticleId><ArticleId IdType="pubmed">22531424</ArticleId></ArticleIdList></Reference><Reference><Citation>GREGORY CA. Frontal variant of frontotemporal dementia: a cross&#x2010;sectional and longitudinal study of neuropsychiatric features. Psychol Med 1999; 29: 1205&#x2013;1217.</Citation><ArticleIdList><ArticleId IdType="pubmed">10576312</ArticleId></ArticleIdList></Reference><Reference><Citation>Marczinski CA, Davidson W, Kertesz A. A longitudinal study of behavior in frontotemporal dementia and primary progressive aphasia. Cogn Behav Neurol 2004; 17: 185&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">15622012</ArticleId></ArticleIdList></Reference><Reference><Citation>Kertesz A, Blair M, McMonagle P, Munoz DG. The diagnosis and course of frontotemporal dementia. Alzheimer Dis Assoc Disord 2007; 21: 155&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">17545742</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumfor F, Irish M, Leyton C et al. Tracking the progression of social cognition in neurodegenerative disorders. J Neurol Neurosurg Psychiatry 2014; 85: 1076&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">24569686</ArticleId></ArticleIdList></Reference><Reference><Citation>Panza F, Lozupone M, Seripa D et al. Development of disease&#x2010;modifying drugs for frontotemporal dementia spectrum disorders. Nat Rev Neurol 2020; 16: 213&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">32203398</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36289565</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1479-8301</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society</Title><ISOAbbreviation>Psychogeriatrics</ISOAbbreviation></Journal><ArticleTitle>Association between behavioural and psychological symptoms of dementia and residence status in patients with Alzheimer's disease.</ArticleTitle><Pagination><StartPage>45</StartPage><EndPage>51</EndPage><MedlinePgn>45-51</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/psyg.12901</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Examining the relationship between the behavioural and psychological symptoms of dementia (BPSD) and residence status is crucial to improving BPSD and reducing the burden on caregivers. However, studies on how BPSD differ between individuals living at home and those in institutional settings are lacking. We conducted a questionnaire survey among healthcare providers (HCPs) involved in dementia care and nursing to clarify the characteristics of BPSD by residence status in patients with Alzheimer's disease (AD) living at home or in facilities.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We sent questionnaires to HCPs and asked them to answer questions on up to five cases that needed treatment for BPSD and who received long-term care insurance services from 1 April 2016 to 31 March 2017. Responses were received for 371 cases, of which 130 diagnosed with AD were analyzed. The patients were divided into two groups: patients with AD living at home (home care group) and patients with AD living in facilities (facility care group). A Chi-square test was used to identify differences between the two groups. A binomial logistic regression analysis was also conducted to clarify the association between residence status and BPSD.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 130 patients, 72 lived at home (home care group) and 58 resided in facilities (facility care group). None of the background factors was significantly different between the two groups. The Chi-square test indicated that sleep disturbance was significantly more common in the facility care group (60.3% in the facility care group vs. 33.3% in the home care group, P&#xa0;=&#xa0;0.003), while the logistic regression analysis indicated that sleep disturbance was significantly associated with residence status (odds ratio: 2.529, P&#xa0;=&#xa0;0.038).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Sleep disturbances were more frequently observed among patients with AD living in institutions than among those living in their homes.</AbstractText><CopyrightInformation>&#xa9; 2022 Japanese Psychogeriatric Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Midorikawa</LastName><ForeName>Haruhiko</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-1329-0046</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ekoyama</LastName><ForeName>Saori</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tachikawa</LastName><ForeName>Hirokazu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Disaster and Community Psychiatry, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki, 305-8575, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ota</LastName><ForeName>Miho</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki, 305-8575, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamura</LastName><ForeName>Masashi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki, 305-8575, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Takumi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sekine</LastName><ForeName>Aya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ide</LastName><ForeName>Masayuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki, 305-8575, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuzaki</LastName><ForeName>Asaki</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki, 305-8575, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nemoto</LastName><ForeName>Miyuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki, 305-8575, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nemoto</LastName><ForeName>Kiyotaka</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8623-9829</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki, 305-8575, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arai</LastName><ForeName>Tetsuaki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki, 305-8575, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>University of Tsukuba</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychogeriatrics</MedlineTA><NlmUniqueID>101230058</NlmUniqueID><ISSNLinking>1346-3500</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006699" MajorTopicYN="Y">Home Care Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012893" MajorTopicYN="Y">Sleep Wake Disorders</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">BPSD</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">mental health</Keyword><Keyword MajorTopicYN="N">sleep</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>27</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36289565</ArticleId><ArticleId IdType="doi">10.1111/psyg.12901</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>WHO. Global action plan on the public health response to dementia 2017-2025. Available from: http://apps.who.int/iris/bitstream/10665/259615/1/9789241513487-eng.pdf.</Citation></Reference><Reference><Citation>The Cabinet Office, Government of Japan. Annual report on the aging society Japanese, 2016.</Citation></Reference><Reference><Citation>Fern&#xe1;ndez M, Gobartt AL, Bala&#xf1;&#xe1; M, COOPERA Study Group. Behavioral symptoms in patients with Alzheimer's disease and their association with cognitive impairment. BMC Neurol 2010; 10: 87.</Citation></Reference><Reference><Citation>de Oliveira AM, Radanovic M, de Mello PC et al. Nonpharmacological interventions to reduce behavioural and psychological symptoms of dementia: a systematic review. Biomed Res Int 2015; 2015: 218980.</Citation></Reference><Reference><Citation>Robert PH, Verhey FR, Byrne EJ et al. Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur Psychiatry 2005; 20: 490-496.</Citation></Reference><Reference><Citation>Matsumoto N, Ikeda M, Fukuhara R et al. Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community. Dement Geriatr Cogn Disord 2007; 23: 219-224.</Citation></Reference><Reference><Citation>Miyamoto Y, Tachimori H, Ito H. Formal caregiver burden in dementia: impact of behavioral and psychological symptoms of dementia and activities of daily living. Geriatr Nurs 2010; 31: 246-253.</Citation></Reference><Reference><Citation>Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. Behavioral and psychological symptoms of dementia. Front Neurol 2012; 3: 73.</Citation></Reference><Reference><Citation>Pinquart M, S&#xf6;rensen S. Correlates of physical health of informal caregivers: a meta-analysis. J Gerontol B Psychol Sci Soc Sci 2007; 62: P126-P137.</Citation></Reference><Reference><Citation>Feast A, Moniz-Cook E, Stoner C, Charlesworth G, Orrell M. A systematic review of the relationship between behavioral and psychological symptoms (BPSD) and caregiver well-being. Int Psychogeriatr 2016; 28: 1761-1774.</Citation></Reference><Reference><Citation>Toda D, Tsukasaki K, Itatani T, Kyota K, Hino S, Kitamura T. Predictors of potentially harmful behaviour by family caregivers towards patients treated for behavioural and psychological symptoms of dementia in Japan. Psychogeriatrics 2018; 18: 357-364.</Citation></Reference><Reference><Citation>Porter CN, Miller MC, Lane M, Cornman C, Sarsour K, Kahle-Wrobleski K. The influence of caregivers and behavioral and psychological symptoms on nursing home placement of persons with Alzheimer's disease: a matched case-control study. SAGE Open Med 2016; 4: 2050312116661877.</Citation></Reference><Reference><Citation>Thompson Coon J, Abbott R, Rogers M et al. Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: a systematic review. J Am Med Dir Assoc 2014; 15: 706-718.</Citation></Reference><Reference><Citation>Magierski R, Sobow T, Schwertner E, Religa D. Pharmacotherapy of behavioral and psychological symptoms of dementia: state of the art and future progress. Front Pharmacol 2020; 11: 1168.</Citation></Reference><Reference><Citation>Bautrant T, Grino M, Peloso C et al. Impact of environmental modifications to enhance day-night orientation on behavior of nursing home residents with dementia. J Am Med Dir Assoc 2019; 20: 377-381.</Citation></Reference><Reference><Citation>Chaudhury H, Cooke HA, Cowie H, Razaghi L. The influence of the physical environment on residents with dementia in long-term care settings: a review of the empirical literature. Gerontologist 2018; 58: e325-e337. Erratum in: Gerontologist 2017; 57: 597.</Citation></Reference><Reference><Citation>Brodaty H, Draper B, Saab D et al. Psychosis, depression and behavioural disturbances in Sydney nursing home residents: prevalence and predictors. Int J Geriatr Psychiatry 2001; 16: 504-512.</Citation></Reference><Reference><Citation>Selbaek G, Kirkevold &#xd8;, Engedal K. The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. Int J Geriatr Psychiatry 2007; 22: 843-849.</Citation></Reference><Reference><Citation>Zuidema SU, Derksen E, Verhey FR, Koopmans RT. Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia. Int J Geriatr Psychiatry 2007; 22: 632-638.</Citation></Reference><Reference><Citation>Makimoto K, Kang Y, Kobayashi S et al. Prevalence of behavioural and psychological symptoms of dementia in cognitively impaired elderly residents of long-term care facilities in East Asia: a cross-sectional study. Psychogeriatrics 2019; 19: 171-180.</Citation></Reference><Reference><Citation>Kaufer DI, Cummings JL, Ketchel P et al. Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. J Neuropsychiatry Clin Neurosci 2000; 12: 233-239.</Citation></Reference><Reference><Citation>Margallo-Lana M, Swann A, O'Brien J et al. Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments. Int J Geriatr Psychiatry 2001; 16: 39-44.</Citation></Reference><Reference><Citation>Schreiner AS. Aggressive behaviors among demented nursing home residents in Japan. Int J Geriatr Psychiatry 2001; 16: 209-215.</Citation></Reference><Reference><Citation>Ikeda M, Fukuhara R, Shigenobu K et al. Dementia associated mental and behavioural disturbances in elderly people in the community: findings from the first Nakayama study. J Neurol Neurosurg Psychiatry 2004 January; 75: 146-148.</Citation></Reference><Reference><Citation>Higami Y, Kabayama M, Kojiya E et al. Factors associated with behavioral and psychological symptoms in patients with dementia who received home medical treatment: a cross-sectional study (OHCARE study). Nihon Ronen Igakkai Zasshi 2019; 56: 468-477.</Citation></Reference><Reference><Citation>Hashidate H, Harada K, Asakawa Y et al. Behavioral and psychological symptoms in elderly people with cognitive impairment. Differences between assessment at home and at an adult day-care facility. Nihon Koshu Eisei Zasshi 2012; 59: 532-543.</Citation></Reference><Reference><Citation>Baharudin AD, Din NC, Subramaniam P, Razali R. The associations between behavioral-psychological symptoms of dementia (BPSD) and coping strategy, burden of care and personality style among low-income caregivers of patients with dementia. BMC Public Health 2019; 19: 447.</Citation></Reference><Reference><Citation>Song JA, Oh Y. The association between the burden on formal caregivers and behavioral and psychological symptoms of dementia (BPSD) in Korean elderly in nursing homes. Arch Psychiatr Nurs 2015; 29: 346-354.</Citation></Reference><Reference><Citation>Hiyoshi-Taniguchi K, Becker CB, Kinoshita A. What behavioral and psychological symptoms of dementia affect caregiver burnout? Clin Gerontol 2018; 41: 249-254.</Citation></Reference><Reference><Citation>Olsen C, Pedersen I, Bergland A et al. Differences in quality of life in home-dwelling persons and nursing home residents with dementia-a cross-sectional study. BMC Geriatr 2016; 16: 137.</Citation></Reference><Reference><Citation>Karakaya MG, Bilgin SC, Ekici G, K&#xf6;se N, Otman AS. Functional mobility, depressive symptoms, level of independence, and quality of life of the elderly living at home and in the nursing home. J Am Med Dir Assoc 2009; 10: 662-666.</Citation></Reference><Reference><Citation>Wilfling D, Dichter MN, Trutschel D, K&#xf6;pke S. Nurses' burden caused by sleep disturbances of nursing home residents with dementia: multicenter cross-sectional study. BMC Nurs 2020; 19: 83.</Citation></Reference><Reference><Citation>Stevenson DG, Decker SL, Dwyer LL et al. Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. Am J Geriatr Psychiatry 2010; 18: 1078-1092.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36288108</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-7322</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>Journal of women &amp; aging</Title><ISOAbbreviation>J Women Aging</ISOAbbreviation></Journal><ArticleTitle>Female caregivers' contextual complexities and familial power structures within Alzheimer's care.</ArticleTitle><Pagination><StartPage>446</StartPage><EndPage>464</EndPage><MedlinePgn>446-464</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/08952841.2022.2130655</ELocationID><Abstract><AbstractText>In 2021, 11.3 million unpaid caregivers of persons with Alzheimer's disease/Alzheimer's disease and related dementias (AD/ADRD) provided 16 billion hours of unpaid caregiving worth $271.6 billion. This study aimed to fully capture the contextual complexities of the caregiving role acquisition articulated by female family caregivers of those with AD/ADRD, emphasizing assigned meaning to one's lived experience with a critical focus on how family power structures influence caregiving practices. Recorded open structured interview transcripts (<i>N</i>&#x2009;=&#x2009;30) from two qualitative studies with the same two opening questions resulted in a corpus of 481 pages of pooled textual data. The data were analyzed using Utrecht's descriptive and interpretive thematic analysis approach. The interpretive thematic analysis uncovered the theme of intervening to protect and its subthemes of financial exploitation, mistreatment, and endangerment. Based on the evolving analysis, we reanalyzed the data using critical discourse analysis (CDA), drawing from Foucault and feminist CDA to explore the complex but subtle nuances of gender, power, and ideologies. CDA uncovered the theme of compulsory altruism. Ambiguity about violating personhood delayed responses to potentially dangerous behavior and actual harm. Using interpretive thematic and critical discourse analysis, we discovered a deeper understanding of female caregivers' contextual complexities, their journey to becoming a caregiver of a family member with AD/ADRD, and the power structures that relegated caregiving to female family members. This research identified a substantial policy gap in supporting female family caregivers who provide the majority of care to persons with AD/ADRD risking their health and financial security.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>C Harrington</LastName><ForeName>Candace</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-1844-4289</Identifier><AffiliationInfo><Affiliation>University of Louisville School of Nursing, Louisville, Kentucky, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dean-Witt</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7922-897X</Identifier><AffiliationInfo><Affiliation>University of Louisville School of Nursing, Louisville, Kentucky, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Z Cacchione</LastName><ForeName>Pamela</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-1805-7091</Identifier><AffiliationInfo><Affiliation>Family and Community Health, University of Pennsylvania School of Nursing, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Women Aging</MedlineTA><NlmUniqueID>8916635</NlmUniqueID><ISSNLinking>0895-2841</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ADRD</Keyword><Keyword MajorTopicYN="N">critical discourse analysis</Keyword><Keyword MajorTopicYN="N">family caregiver</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>26</Day><Hour>13</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36288108</ArticleId><ArticleId IdType="doi">10.1080/08952841.2022.2130655</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36282451</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1720-8319</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Aging clinical and experimental research</Title><ISOAbbreviation>Aging Clin Exp Res</ISOAbbreviation></Journal><ArticleTitle>Relieving care burden and promoting health-related quality of life for family caregivers of elderly people with Alzheimer's disease via an empowerment program.</ArticleTitle><Pagination><StartPage>73</StartPage><EndPage>83</EndPage><MedlinePgn>73-83</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40520-022-02277-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Effective strategies should be adopted to reduce care burden (CB) and improve health-related quality of life (HRQoL) in family caregivers (FCGs) of elderly people with Alzheimer's disease (AD). Therefore, the purpose of this study was to determine the impact of empowerment program (EP) on CB and HRQoL of FCGs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The present two-group experimental study was conducted on 70 FCGs of the elderly with AD who were selected by convenience sampling and randomly assigned to the empowerment program group (EPG, n&#x2009;=&#x2009;35) and control group (CG, n&#x2009;=&#x2009;35). Data collection tools were 12-item Short Form Health Survey and Zarit Burden Interview. The EP was held for 5&#xa0;weeks, one session of 20 to 30&#xa0;min each week. Data were collected before, immediately and 3 months after EP and analyzed by SPSS version 25 software at a significance level of 0.05.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The results showed a significant decrease in the mean CB score in FCGs of elderly with AD in EPG before, immediately and 3 months after EP (p&#x2009;&lt;&#x2009;0.001). The result also revealed that there was a significant increase in the mean HRQoL score in EPG immediately and 3 months after EP (p&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">According to the results of this study, EP can reduce CB and increase HRQoL in FCGs of elderly with AD. Policymakers and planners active in the field of healthcare for the elderly can benefit from the results of our study to improve the health of FCGs of the elderly with AD.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yazdanmanesh</LastName><ForeName>Mohadeseh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical-Surgical Nursing, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esmaeili</LastName><ForeName>Roghayeh</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3458-0491</Identifier><AffiliationInfo><Affiliation>Department of Medical-Surgical Nursing, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasiri</LastName><ForeName>Maliheh</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1496-7442</Identifier><AffiliationInfo><Affiliation>Department of Basic Sciences, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasli</LastName><ForeName>Parvaneh</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-7882-1592</Identifier><AffiliationInfo><Affiliation>Department of Community Health Nursing, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Vali Asr Ave., Ayatollah Hashemi Rafsanjani Cross Road, Tehran, Iran. p-vasli@sbmu.ac.ir.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Aging Clin Exp Res</MedlineTA><NlmUniqueID>101132995</NlmUniqueID><ISSNLinking>1594-0667</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000084802" MajorTopicYN="N">Caregiver Burden</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">Care burden</Keyword><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Family caregiver</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>25</Day><Hour>11</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36282451</ArticleId><ArticleId IdType="pmc">PMC9593982</ArticleId><ArticleId IdType="doi">10.1007/s40520-022-02277-8</ArticleId><ArticleId IdType="pii">10.1007/s40520-022-02277-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liao X, Huang Y, Zhang Z, et al. Factors associated with health-related quality of life among family caregivers of people with Alzheimer's disease. Psychogeriatrics. 2020;20:398&#x2013;405. doi: 10.1111/psyg.12528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/psyg.12528</ArticleId><ArticleId IdType="pubmed">32027776</ArticleId></ArticleIdList></Reference><Reference><Citation>Vi&#xf1;as-Diez V, Turr&#xf3;-Garriga O, Portellano-Ortiz C, et al. Kinship and cohabitation in relation to caregiver burden in the context of Alzheimer's disease: a 24-month longitudinal study. Int J Geriatr Psychiatry. 2017;32:e72&#x2013;e82. doi: 10.1002/gps.4656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4656</ArticleId><ArticleId IdType="pubmed">28111798</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravari A, Mirzaei T, Salamizadeh A, et al. Effect of the spiritual care training on anxiety reduction in home caregivers of the elderly with Alzheimer disease. Koomesh. 2017;19:467&#x2013;474.</Citation></Reference><Reference><Citation>Bagherbeik Tabrizi L, Navab E, Farokhnezhad AP, et al. Effect of cognitive-behavioral intervention on burden of family caregivers of patients with Alzheimer's disease. HAYAT. 2015;21:94&#x2013;102.</Citation></Reference><Reference><Citation>Abdollahpour I, Nedjat S, Salimi Y. Positive aspects of caregiving and caregiver burden: a study of caregivers of patients with dementia. J Geriatr Psychiatry Neurol. 2018;31:34&#x2013;38. doi: 10.1177/0891988717743590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988717743590</ArticleId><ArticleId IdType="pubmed">29187025</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailes CO, Kelley CM, Parker NM. Caregiver burden and perceived health competence when caring for family members diagnosed with Alzheimer's disease and related dementia. J Am Assoc Nurse Pract. 2016;28:534&#x2013;540. doi: 10.1002/2327-6924.12355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2327-6924.12355</ArticleId><ArticleId IdType="pubmed">27073005</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M, Ryoo JH, Crowder J, et al. A systematic review and meta-analysis on effective interventions for health-related quality of life among caregivers of people with dementia. J Adv Nurs. 2020;76:475&#x2013;489. doi: 10.1111/jan.14262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jan.14262</ArticleId><ArticleId IdType="pubmed">31713880</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafizadeh A, Mirzaee A, Heravi-Karimooi M, et al. Relationship between caregiver burden and demographic characteristics in caregivers of alzheimer's elderly. J Nurs Educ. 2020;9:65&#x2013;73.</Citation></Reference><Reference><Citation>Lamotte G, Shah RC, Lazarov O, et al. Exercise training for persons with Alzheimer's disease and caregivers: a review of dyadic exercise interventions. J Mot Behav. 2017;49:365&#x2013;377. doi: 10.1080/00222895.2016.1241739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00222895.2016.1241739</ArticleId><ArticleId IdType="pmc">PMC5777134</ArticleId><ArticleId IdType="pubmed">27870597</ArticleId></ArticleIdList></Reference><Reference><Citation>Koca E, Ta&#x15f;kapilio&#x11f;lu &#xd6;, Bakar M. Caregiver burden in different stages of Alzheimer's disease. Noro Psikiyatr Ars. 2017;54:82&#x2013;86. doi: 10.5152/npa.2017.11304.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/npa.2017.11304</ArticleId><ArticleId IdType="pmc">PMC5439478</ArticleId><ArticleId IdType="pubmed">28566965</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha P, Desai N, Prakash O, et al. Caregiver burden in Alzheimer-type dementia and psychosis: A comparative study from India. Asian J Psychiatr. 2017;26:86&#x2013;91. doi: 10.5152/npa.2017.11304.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/npa.2017.11304</ArticleId><ArticleId IdType="pubmed">28483100</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafari-Diziche S, Izadi-Avanji F-S, Atoof F et al (2021) Effect of family-centered empowerment model on the care burden of the caregivers of older adults with heart failure. JCCNC 7:275&#x2013;84. 10.32598/JCCNC.7.4.305.3</Citation></Reference><Reference><Citation>Montgomery W, Goren A, Kahle-Wrobleski K, et al. Alzheimer&#x2019;s disease severity and its association with patient and caregiver quality of life in Japan: results of a community-based survey. BMC Geriatr. 2018;18:141. doi: 10.1186/s12877-018-0831-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-018-0831-2</ArticleId><ArticleId IdType="pmc">PMC6000944</ArticleId><ArticleId IdType="pubmed">29898679</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagerstr&#xf6;m C, Elmst&#xe5;hl S, Wranker LS. Analyzing the situation of older family caregivers with a focus on health-related quality of life and pain: a cross-sectional cohort study. Health Qual Life Outcomes. 2020;18:79. doi: 10.1186/s12955-020-01321-3.PMC7082916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-020-01321-3.PMC7082916</ArticleId><ArticleId IdType="pmc">PMC7082916</ArticleId><ArticleId IdType="pubmed">32197633</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafari Nobari S, Vasli P, Hosseini M, et al. Improving health-related quality of life and adherence to health-promoting behaviors among coronary artery bypass graft patients: a non-randomized controlled trial study. Qual Life Res. 2021;30:769&#x2013;780. doi: 10.1007/s11136-020-02675-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-020-02675-3</ArticleId><ArticleId IdType="pubmed">33064290</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazzan AA, Shannon H, Ploeg J, et al. The association between caregiver well-being and care provided to persons with Alzheimer&#x2019;s disease and related disorders. BMC Res Notes. 2016;9:344. doi: 10.1002/2327-6924.12355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2327-6924.12355</ArticleId><ArticleId IdType="pmc">PMC4950605</ArticleId><ArticleId IdType="pubmed">27430976</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehghani Y, Omranifard V, Babamiri M. The effectiveness of communication skills training on caregiving burden and quality of life among family caregivers of elderly with dementia. J Res Behav Sci. 2016;14:161&#x2013;167.</Citation></Reference><Reference><Citation>Kawaharada R, Sugimoto T, Matsuda N, et al. Impact of loss of independence in basic activities of daily living on caregiver burden in patients with Alzheimer's disease: A retrospective cohort study. Geriatr Gerontol Int. 2019;9:1243&#x2013;1247. doi: 10.1111/ggi.13803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ggi.13803</ArticleId><ArticleId IdType="pubmed">31638736</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahgoi A, Sojoodi T, Khoshknab MF, et al. Effects of empowerment program on the burden of care in mothers of children with phenylketonuria. Iran J Child Neurol. 2019;13:53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6451866</ArticleId><ArticleId IdType="pubmed">31037078</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Heide I, van Wezel N, Blom M, et al. Effects of an educational intervention on health-related quality of life among family caregivers of people with dementia with a Turkish or Moroccan immigrant background: Insights from a cluster randomised controlled trial. Patient Educ Couns. 2021;104:1168&#x2013;1175. doi: 10.1016/j.pec.2020.10.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2020.10.029</ArticleId><ArticleId IdType="pubmed">33143906</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon HK, Kim GS. An empowerment program for family caregivers of people with dementia. Public Health Nurs. 2020;37:222&#x2013;233. doi: 10.1111/phn.12690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/phn.12690</ArticleId><ArticleId IdType="pubmed">31797446</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydin HT, Tel H, Guler N, et al. Effect of an educational program on care burden and quality of life for caregivers of patients diagnosed with Alzheimer&#x2019;s disease. J Health Med Nurs. 2020;75:43&#x2013;47. doi: 10.7176/JHMN/75-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.7176/JHMN/75-06</ArticleId></ArticleIdList></Reference><Reference><Citation>Hekmatpou D, Baghban EM, Dehkordi LM. The effect of patient care education on burden of care and the quality of life of caregivers of stroke patients. J Multidiscip Healthc. 2019;12:211. doi: 10.2147/JMDH.S196903.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JMDH.S196903</ArticleId><ArticleId IdType="pmc">PMC6430991</ArticleId><ArticleId IdType="pubmed">30936715</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng S-T, Mak EP, Kwok T, et al. Benefit-finding intervention delivered individually to Alzheimer family caregivers: longer-term outcomes of a randomized double-blind controlled trial. J Gerontol: Series B. 2020;75:1884&#x2013;1893. doi: 10.1093/geronb/gbz118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbz118</ArticleId><ArticleId IdType="pubmed">31556447</ArticleId></ArticleIdList></Reference><Reference><Citation>Leszko M. The effectiveness of psychoeducational and financial intervention to support caregivers of individuals with Alzheimer&#x2019;s disease in Poland. Innov Aging. 2019 doi: 10.1093/geroni/igz026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geroni/igz026</ArticleId><ArticleId IdType="pmc">PMC6677549</ArticleId><ArticleId IdType="pubmed">31392287</ArticleId></ArticleIdList></Reference><Reference><Citation>Montazeri A, Vahdaninia M, Mousavi SJ, et al. The 12-item medical outcomes study short form health survey version 2.0 (SF-12v2): a population-based validation study from Tehran, Iran. Health Qual Life Outcomes. 2011;9:12. doi: 10.1186/1477-7525-9-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-9-12</ArticleId><ArticleId IdType="pmc">PMC3063185</ArticleId><ArticleId IdType="pubmed">21385359</ArticleId></ArticleIdList></Reference><Reference><Citation>Montazeri A, Vahdaninia M, Mousavi SJ, et al. The Iranian version of 12-item Short Form Health Survey (SF-12): factor structure, internal consistency and construct validity. BMC Public Health. 2009;9:1&#x2013;10. doi: 10.1186/1471-2458-9-341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-9-341</ArticleId><ArticleId IdType="pmc">PMC2749829</ArticleId><ArticleId IdType="pubmed">19758427</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarit SH, Todd PA, Zarit JM. Subjective burden of husbands and wives as caregivers: a longitudinal study. Gerontologist. 1986;26:260&#x2013;266. doi: 10.1093/geront/26.3.260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/26.3.260</ArticleId><ArticleId IdType="pubmed">3721233</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Liu Z-w, Li T-x, et al. A comparison of psychometric properties of two common measures of caregiving burden: the family burden interview schedule (FBIS-24) and the Zarit caregiver burden interview (ZBI-22) Health Qual Life Outcomes. 2020;18:1&#x2013;9. doi: 10.1186/s12955-020-01335-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-020-01335-x</ArticleId><ArticleId IdType="pmc">PMC7137330</ArticleId><ArticleId IdType="pubmed">32252766</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasli P. Translation, cross-cultural adaptation, and psychometric testing of perception of family-centered care measurement questionnaires in the hospitalized children in Iran. J Pediatr Nurs. 2018;43:e26&#x2013;e34. doi: 10.1016/j.pedn.2018.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pedn.2018.08.004</ArticleId><ArticleId IdType="pubmed">30104057</ArticleId></ArticleIdList></Reference><Reference><Citation>Pahlavanzadeh S, Heidari FG, Maghsudi J, et al. The effects of family education program on the caregiver burden of families of elderly with dementia disorders. Iran J Nurs Midwifery Res. 2010;15:102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3093163</ArticleId><ArticleId IdType="pubmed">21589771</ArticleId></ArticleIdList></Reference><Reference><Citation>Terracciano A, Artese A, Yeh J, et al. Effectiveness of powerful tools for caregivers on caregiver burden and on care recipient behavioral and psychological symptoms of dementia: A randomized controlled trial. J Am Med Dir Assoc. 2020;21:1121&#x2013;7.e1. doi: 10.1016/j.jamda.2019.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2019.11.011</ArticleId><ArticleId IdType="pmc">PMC7302999</ArticleId><ArticleId IdType="pubmed">31866419</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Xuan C, Yu C, Jin X, Zheng P, Yan J. Effects of comprehensive intervention on life quality among the elderly with Alzheimer Disease and their caregivers based on mixed models. Nurs Open. 2022;9:1412&#x2013;1422. doi: 10.1002/nop2.917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nop2.917</ArticleId><ArticleId IdType="pmc">PMC8859043</ArticleId><ArticleId IdType="pubmed">33988909</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuzu F, Ayd&#x131;n HT. Effects of education on care burden and quality of life to caregivers of patients with COPD. Turk Thorac J. 2022 doi: 10.5152/TurkThoracJ.2022.21002.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/TurkThoracJ.2022.21002</ArticleId><ArticleId IdType="pmc">PMC9450028</ArticleId><ArticleId IdType="pubmed">35404243</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36281546</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-4159</ISSN><JournalIssue CitedMedium="Internet"><Volume>164</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of neurochemistry</Title><ISOAbbreviation>J Neurochem</ISOAbbreviation></Journal><ArticleTitle>Blood plasma protein profiles of neuropsychiatric symptoms and related cognitive decline in older people.</ArticleTitle><Pagination><StartPage>242</StartPage><EndPage>254</EndPage><MedlinePgn>242-254</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jnc.15715</ELocationID><Abstract><AbstractText>Neuropsychiatric symptoms (NPS) severely affect patients and their caregivers, and are associated with worse long-term outcomes. This study tested the hypothesis that altered protein levels in blood plasma could serve as biomarkers of NPS; and that altered protein levels are associated with persisting NPS and cognitive decline over time. We performed a cross-sectional and longitudinal study in older subjects with cognitive impairment and cognitively unimpaired in a memory clinic setting. NPS were recorded through the Neuropsychiatric Inventory Questionnaire (NPI-Q) while cognitive and functional impairment was assessed using the clinical dementia rating sum of boxes (CDR-SoB) score at baseline and follow-up visits. Shotgun proteomic analysis based on liquid chromatography-mass spectrometry was conducted in blood plasma samples, identifying 420 proteins. The presence of Alzheimer's Disease (AD) pathology was determined by cerebrospinal fluid biomarkers. Eighty-five subjects with a mean age of 70 (&#xb1;7.4) years, 62% female and 54% with mild cognitive impairment or mild dementia were included. We found 15 plasma proteins with altered baseline levels in participants with NPS (NPI-Q score&#x2009;&gt;&#x2009;0). Adding those 15 proteins to a reference model based on clinical data (age, CDR-SoB) significantly improved the prediction of NPS (from receiver operating characteristic area under the curve [AUC] 0.75 to AUC 0.91, p&#xa0;=&#x2009;0.004) with a specificity of 89% and a sensitivity of 74%. The identified proteins additionally predicted both persisting NPS and cognitive decline at follow-up visits. The observed associations were independent of the presence of AD pathology. Using proteomics, we identified a panel of specific blood proteins associated with current and future NPS, and related cognitive decline in older people. These findings show the potential of untargeted proteomics to identify blood-based biomarkers of pathological alterations relevant for NPS and related clinical disease progression.</AbstractText><CopyrightInformation>&#xa9; 2022 International Society for Neurochemistry.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rabl</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3189-6554</Identifier><AffiliationInfo><Affiliation>Department of Geriatric Psychiatry, University Hospital of Psychiatry Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Lausanne, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Psychotherapy and Psychosomatics, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dayon</LastName><ForeName>Lo&#xef;c</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Nestl&#xe9; Institute of Food Safety and Analytical Sciences, Nestl&#xe9; Research, Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nestl&#xe9; Institute of Health Sciences, Nestl&#xe9; Research, Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut des Sciences et Ing&#xe9;nierie Chimiques, Ecole Polytechnique F&#xe9;d&#xe9;rale de Lausanne, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowman</LastName><ForeName>Gene L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Nestl&#xe9; Institute of Health Sciences, Nestl&#xe9; Research, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popp</LastName><ForeName>Julius</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0068-0312</Identifier><AffiliationInfo><Affiliation>Department of Geriatric Psychiatry, University Hospital of Psychiatry Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Psychotherapy and Psychosomatics, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Old Age Psychiatry, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SNF 320030_141179</GrantID><Agency>Swiss National Science Foundation</Agency><Country>Switzerland</Country></Grant><Grant><GrantID>320030_204886</GrantID><Agency>Swiss National Science Foundation</Agency><Country>Switzerland</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurochem</MedlineTA><NlmUniqueID>2985190R</NlmUniqueID><ISSNLinking>0022-3042</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001798">Blood Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001798" MajorTopicYN="N">Blood Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">behavioral and psychological symptoms of dementia</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">cognitive decline</Keyword><Keyword MajorTopicYN="N">neuropsychiatric symptoms</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>25</Day><Hour>3</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36281546</ArticleId><ArticleId IdType="doi">10.1111/jnc.15715</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Alvarez, A., Aleixandre, M., Linares, C., Masliah, E., &amp; Moessler, H. (2014). Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's disease. Journal of Alzheimer's Disease, 42(4), 1347-1355.</Citation></Reference><Reference><Citation>Association WM. (2013). World medical association declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA, 310(20), 2191-2194.</Citation></Reference><Reference><Citation>Borland, E., Edgar, C., Stomrud, E., Cullen, N., Hansson, O., &amp; Palmqvist, S. (2022). Clinically relevant changes for cognitive outcomes in preclinical and prodromal cognitive stages: Implications for clinical Alzheimer trials. Neurology, 99(11), e1142-e1153. https://doi.org/10.1212/WNL.0000000000200817</Citation></Reference><Reference><Citation>Bouwman, F. H., Frisoni, G. B., Johnson, S. C., Chen, X., Engelborghs, S., Ikeuchi, T., Paquet, C., Ritchie, C., Bozeat, S., Quevenco, F.-C., &amp; Teunissen, C. (2022). Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios. Alzheimers Dementia (Amst), 14(1), e12314.</Citation></Reference><Reference><Citation>Chen, Y., Dang, M., &amp; Zhang, Z. (2021). Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease: A systematic review of symptom-general and -specific lesion patterns. Molecular Neurodegeneration, 16(1), 38.</Citation></Reference><Reference><Citation>Crutchfield, C. A., Thomas, S. N., Sokoll, L. J., &amp; Chan, D. W. (2016). Advances in mass spectrometry-based clinical biomarker discovery. Clinical Proteomics, 13, 1.</Citation></Reference><Reference><Citation>Dayon, L., Cominetti, O., &amp; Affolter, M. (2022). Proteomics of human biological fluids for biomarker discoveries: Technical advances and recent applications. Expert Review of Proteomics, 19(2), 131-151. https://doi.org/10.1080/14789450.2022.2070477</Citation></Reference><Reference><Citation>Dayon, L., Cominetti, O., Wojcik, J., Galindo, A. N., Oikonomidi, A., Henry, H., Migliavacca, E., Kussmann, M., Bowman, G. L., &amp; Popp, J. (2019). Proteomes of paired human cerebrospinal fluid and plasma: Relation to blood-brain barrier permeability in older adults. Journal of Proteome Research, 18(3), 1162-1174.</Citation></Reference><Reference><Citation>Dayon, L., N&#xfa;&#xf1;ez Galindo, A., Cominetti, O., Corth&#xe9;sy, J., &amp; Kussmann, M. (2017). A highly automated shotgun proteomic workflow: Clinical scale and robustness for biomarker discovery in blood. Methods in Molecular Biology, 2017, 433-449.</Citation></Reference><Reference><Citation>Dayon, L., &amp; Sanchez, J. C. (2012). Relative protein quantification by MS/MS using the tandem mass tag technology. Methods in Molecular Biology, 893, 115-127.</Citation></Reference><Reference><Citation>Dayon, L., Wojcik, J., N&#xfa;&#xf1;ez Galindo, A., Corth&#xe9;sy, J., Cominetti, O., Oikonomidi, A., Henry, H., Migliavacca, E., Bowman, G. L., &amp; Popp, J. (2017). Plasma proteomic profiles of cerebrospinal fluid-defined Alzheimer's disease pathology in older adults. Journal of Alzheimer's Disease, 60(4), 1641-1652.</Citation></Reference><Reference><Citation>DeLong, E. R., DeLong, D. M., &amp; Clarke-Pearson, D. L. (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics, 44(3), 837-845.</Citation></Reference><Reference><Citation>Deutsch, E. W., Csordas, A., Sun, Z., Jarnuczak, A., Perez-Riverol, Y., Ternent, T., Campbell, D. S., Bernal-Llinares, M., Okuda, S., Kawano, S., Moritz, R. L., Carver, J. J., Wang, M., Ishihama, Y., Bandeira, N., Hermjakob, H., &amp; Vizca&#xed;no, J. A. (2017). The ProteomeXchange consortium in 2017: Supporting the cultural change in proteomics public data deposition. Nucleic Acids Research, 45(D1), D1100-D1106.</Citation></Reference><Reference><Citation>Dickerson, B. C., Sperling, R. A., Hyman, B. T., Albert, M. S., &amp; Blacker, D. (2007). Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Archives Of General Psychiatry, 64(12), 1443-1450.</Citation></Reference><Reference><Citation>Dietlin, S., Soto, M., Kiyasova, V., Pueyo, M., de Mauleon, A., Delrieu, J., Ousset, P. J., &amp; Vellas, B. (2019). Neuropsychiatric symptoms and risk of progression to Alzheimer's disease among mild cognitive impairment subjects. Journal of Alzheimer's Disease, 70(1), 25-34.</Citation></Reference><Reference><Citation>Dixon, J. R. (1998). The international conference on harmonization good clinical practice guideline. Quality Assurance, 6(2), 65-74.</Citation></Reference><Reference><Citation>Duits, F. H., Teunissen, C. E., Bouwman, F. H., Visser, P.-J., Mattsson, N., Zetterberg, H., Blennow, K., Hansson, O., Minthon, L., Andreasen, N., Marcusson, J., Wallin, A., Rikkert, M. O., Tsolaki, M., Parnetti, L., Herukka, S.-K., Hampel, H., De Leon, M. J., Schr&#xf6;der, J., &#x2026; van der Flier, W. M. (2014). The cerebrospinal fluid &#x201c;Alzheimer profile&#x201d;: Easily said, but what does it mean? Alzheimers Dementia, 10(6), 713-723.e2.</Citation></Reference><Reference><Citation>Eikelboom, W. S., van den Berg, E., Singleton, E. H., Baart, S. J., Coesmans, M., Leeuwis, A. E., Teunissen, C. E., van Berckel, B. N. M., Pijnenburg, Y. A. L., Scheltens, P., van der Flier, W. M., Ossenkoppele, R., &amp; Papma, J. M. (2021). Neuropsychiatric and cognitive symptoms across the Alzheimer disease clinical Spectrum: Cross-sectional and longitudinal associations. Neurology, 97(13), e1276-e1287.</Citation></Reference><Reference><Citation>Folstein, M. F., Folstein, S. E., &amp; McHugh, P. R. (1975). &#x201c;Mini-mental state&#x201d;. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189-198.</Citation></Reference><Reference><Citation>Geyer, P. E., Holdt, L. M., Teupser, D., &amp; Mann, M. (2017). Revisiting biomarker discovery by plasma proteomics. Molecular Systems Biology, 13(9), 942.</Citation></Reference><Reference><Citation>Gotovac, K., Nikolac Perkovi&#x107;, M., Pivac, N., &amp; Borove&#x10d;ki, F. (2016). Biomarkers of aggression in dementia. Progress in Neuro-Psychopharmacology &amp; Biological Psychiatry, 69, 125-130.</Citation></Reference><Reference><Citation>Guimar&#xe3;es, H. C., Caramelli, P., Fialho, P. P. A., Fran&#xe7;a, E. P., Afonso, M. P. D., &amp; Teixeira, A. L. (2013). Serum levels of soluble TNF-&#x3b1; receptors but not BDNF are associated with apathy symptoms in mild Alzheimer's disease and amnestic mild cognitive impairment. Dementia &amp; Neuropsychologia, 7(3), 298-303.</Citation></Reference><Reference><Citation>Hall, J. R., Wiechmann, A. R., Johnson, L. A., Edwards, M., Barber, R. C., Winter, A. S., Singh, M., &amp; O'Bryant, S. E. (2013). Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer's disease. Journal of Alzheimer's Disease, 35(2), 363-371.</Citation></Reference><Reference><Citation>Helmfors, L., Boman, A., Civitelli, L., Nath, S., Sandin, L., Janefjord, C., McCann, H., Zetterberg, H., Blennow, K., Halliday, G., Brorsson, A.-C., &amp; K&#xe5;gedal, K. (2015). Protective properties of lysozyme on &#x3b2;-amyloid pathology: Implications for Alzheimer disease. Neurobiology of Disease, 83, 122-133.</Citation></Reference><Reference><Citation>Holmes, C., Cunningham, C., Zotova, E., Culliford, D., &amp; Perry, V. H. (2011). Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology, 77(3), 212-218.</Citation></Reference><Reference><Citation>Holmgren, S., Hjorth, E., Schultzberg, M., L&#xe4;rks&#xe4;ter, M., Frenkel, D., Tysen-B&#xe4;ckstr&#xf6;m, A. C., Aarsland, D., &amp; Freund-Levi, Y. (2014). Neuropsychiatric symptoms in dementia-a role for neuroinflammation? Brain Research Bulletin, 108, 88-93.</Citation></Reference><Reference><Citation>Hughes, C. P., Berg, L., Danziger, W. L., Coben, L. A., &amp; Martin, R. L. (1982). A new clinical scale for the staging of dementia. British Journal of Psychiatry, 140, 566-572.</Citation></Reference><Reference><Citation>Ijsselstijn, L., Dekker, L. J. M., Stingl, C., van der Weiden, M. M., Hofman, A., Kros, J. M., Koudstaal, P. J., Sillevis Smitt, P. A. E., Ikram, M. A., Breteler, M. M. B., &amp; Luider, T. M. (2011). Serum levels of pregnancy zone protein are elevated in presymptomatic Alzheimer's disease. Journal of Proteome Research, 10(11), 4902-4910.</Citation></Reference><Reference><Citation>Ismail, Z., Smith, E. E., Geda, Y., Sultzer, D., Brodaty, H., Smith, G., Ag&#xfc;era-Ortiz, L., Sweet, R., Miller, D., Lyketsos, C. G., &amp; ISTAART Neuropsychiatric Symptoms Professional Interest Area. (2016). Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dementia, 12(2), 195-202.</Citation></Reference><Reference><Citation>Katz, S. (1983). Assessing self-maintenance: Activities of daily living, mobility, and instrumental activities of daily living. Journal of the American Geriatrics Society, 31(12), 721-727.</Citation></Reference><Reference><Citation>Kaufer, D. I., Cummings, J. L., Ketchel, P., Smith, V., MacMillan, A., Shelley, T., Lopez, O. L., &amp; DeKosky, S. T. (2000). Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. Journal of Neuropsychiatry and Clinical Neurosciences, 12(2), 233-239.</Citation></Reference><Reference><Citation>Kim, H., &amp; Lee, K. J. (2014). Serum homocysteine levels are correlated with behavioral and psychological symptoms of Alzheimer's disease. Neuropsychiatric Disease and Treatment, 10, 1887-1896.</Citation></Reference><Reference><Citation>Lawton, M. P., &amp; Brody, E. M. (1969). Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist, 9(3), 179-186.</Citation></Reference><Reference><Citation>Lewis, N. A., &amp; Knight, J. E. (2021). Longitudinal associations between C-reactive protein and cognitive performance in normative cognitive ageing and dementia. Age Ageing, 50(6), 2199-2205.</Citation></Reference><Reference><Citation>Ligthart, S. A., Richard, E., Fransen, N. L., Eurelings, L. S. M., Beem, L., Eikelenboom, P., van Gool, W. A., &amp; Moll van Charante, E. P. (2012). Association of vascular factors with apathy in community-dwelling elderly individuals. Archives of General Psychiatry, 69(6), 636-642.</Citation></Reference><Reference><Citation>Lista, S., Faltraco, F., Prvulovic, D., &amp; Hampel, H. (2013). Blood and plasma-based proteomic biomarker research in Alzheimer's disease. Progress in Neurobiology, 101-102, 1-17.</Citation></Reference><Reference><Citation>Lu, G., Liu, W., Huang, X., &amp; Zhao, Y. (2020). Complement factor H levels are decreased and correlated with serum C-reactive protein in late-onset Alzheimer's disease. Arquivos de Neuro-Psiquiatria, 78(2), 76-80.</Citation></Reference><Reference><Citation>Lyketsos, C. G., Carrillo, M. C., Ryan, J. M., Khachaturian, A. S., Trzepacz, P., Amatniek, J., Cedarbaum, J., Brashear, R., &amp; Miller, D. S. (2011). Neuropsychiatric symptoms in Alzheimer's disease. Alzheimers Dementia, 7(5), 532-539.</Citation></Reference><Reference><Citation>Mathys, J., Gholamrezaee, M., Henry, H., von Gunten, A., &amp; Popp, J. (2017). Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia. Experimental Gerontology, 100, 45-53.</Citation></Reference><Reference><Citation>McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Jr., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., Mohs, R. C., Morris, J. C., Rossor, M. N., Scheltens, P., Carrillo, M. C., Thies, B., Weintraub, S., &amp; Phelps, C. H. (2011). The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dementia, 7(3), 263-269.</Citation></Reference><Reference><Citation>Molinuevo, J. L., Blennow, K., Dubois, B., Engelborghs, S., Lewczuk, P., Perret-Liaudet, A., Teunissen, C. E., &amp; Parnetti, L. (2014). The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's biomarkers standardization initiative. Alzheimers Dementia, 10(6), 808-817.</Citation></Reference><Reference><Citation>Morris, J. C. (1993). The clinical dementia rating (CDR): Current version and scoring rules. Neurology, 43(11), 2412-2414.</Citation></Reference><Reference><Citation>Mroczek, M., Clark, C., Dayon, L., Bowman, G. L., &amp; Popp, J. (2022). Cerebrospinal fluid proteome alterations associated with neuropsychiatric symptoms in cognitive decline and Alzheimer's disease. Cells, 11(6), 1030. https://doi.org/10.3390/cells11061030</Citation></Reference><Reference><Citation>Mukaetova-Ladinska, E. B., Abdel-All, Z., Andrade, J., Alves da Silva, J., O'Brien, J. T., &amp; Kalaria, R. N. (2015). Plasma and platelet clusterin ratio is altered in Alzheimer's disease patients with distinct neuropsychiatric symptoms: Findings from a pilot study. International Journal of Geriatric Psychiatry, 30(4), 368-375.</Citation></Reference><Reference><Citation>Nagata, T., Kobayashi, N., Shinagawa, S., Yamada, H., Kondo, K., &amp; Nakayama, K. (2014). Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease. Journal of Neural Transmission (Vienna), 121(4), 433-441.</Citation></Reference><Reference><Citation>Nijholt, D. A. T., Ijsselstijn, L., van der Weiden, M. M., Zheng, P.-P., Sillevis Smitt, P. A. E., Koudstaal, P. J., Luider, T. M., &amp; Kros, J. M. (2015). Pregnancy zone protein is increased in the Alzheimer's disease brain and associates with senile plaques. Journal of Alzheimer's Disease, 46(1), 227-238.</Citation></Reference><Reference><Citation>Panza, F., Frisardi, V., Seripa, D., D'Onofrio, G., Santamato, A., Masullo, C., Logroscino, G., Solfrizzi, V., &amp; Pilotto, A. (2012). Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. Ageing Research Reviews, 11(1), 87-103.</Citation></Reference><Reference><Citation>Peters, M. E., Schwartz, S., Han, D., Rabins, P. V., Steinberg, M., Tschanz, J. T., &amp; Lyketsos, C. G. (2015). Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: The Cache County dementia progression study. American Journal of Psychiatry, 172(5), 460-465.</Citation></Reference><Reference><Citation>Popp, J., Oikonomidi, A., Tautvydait&#x117;, D., Dayon, L., Bacher, M., Migliavacca, E., Henry, H., Kirkland, R., Severin, I., Wojcik, J., Bowman, G. L., Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., &amp; M&#xfc;ller, M. (2017). Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults. Brain, Behavior, and Immunity, 62, 203-211.</Citation></Reference><Reference><Citation>Popp, J., Riad, M., Freymann, K., &amp; Jessen, F. (2007). Diagnostic lumbar puncture performed in the outpatient setting of a memory clinic. Frequency and risk factors of post-lumbar puncture headache. Nervenarzt, 78(5), 547-551.</Citation></Reference><Reference><Citation>Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., &amp; M&#xfc;ller, M. (2011). pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics, 12, 77.</Citation></Reference><Reference><Citation>Ruthirakuhan, M., Herrmann, N., Andreazza, A. C., Verhoeff, N. P. L. G., Gallagher, D., Black, S. E., Kiss, A., &amp; Lanct&#xf4;t, K. L. (2020). Agitation, oxidative stress, and cytokines in Alzheimer disease: Biomarker analyses from a clinical trial with nabilone for agitation. Journal of Geriatric Psychiatry and Neurology, 33(4), 175-184.</Citation></Reference><Reference><Citation>Sandin, L., Bergkvist, L., Nath, S., Kielkopf, C., Janefjord, C., Helmfors, L., Zetterberg, H., Blennow, K., Li, H., Nilsberth, C., Garner, B., Brorsson, A.-C., &amp; K&#xe5;gedal, K. (2016). Beneficial effects of increased lysozyme levels in Alzheimer's disease modelled in Drosophila melanogaster. FEBS J, 283(19), 3508-3522.</Citation></Reference><Reference><Citation>Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., &amp; Van der Flier, W. M. (2016). Alzheimer's disease. Lancet, 388(10043), 505-517.</Citation></Reference><Reference><Citation>Sheikh, F., Ismail, Z., Mortby, M. E., Barber, P., Cieslak, A., Fischer, K., Granger, R., Hogan, D. B., Mackie, A., Maxwell, C. J., Menon, B., Mueller, P., Patry, D., Pearson, D., Quickfall, J., Sajobi, T., Tse, E., Wang, M., Smith, E. E., &amp; PROMPT Registry Investigators. (2018). Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden. International Psychogeriatrics, 30(2), 233-244.</Citation></Reference><Reference><Citation>Shin, I. S., Carter, M., Masterman, D., Fairbanks, L., &amp; Cummings, J. L. (2005). Neuropsychiatric symptoms and quality of life in Alzheimer disease. The American Journal of Geriatric Psychiatry, 13(6), 469-474.</Citation></Reference><Reference><Citation>Showraki, A., Murari, G., Ismail, Z., Barfett, J. J., Fornazzari, L., Munoz, D. G., Schweizer, T. A., &amp; Fischer, C. E. (2019). Cerebrospinal fluid correlates of neuropsychiatric symptoms in patients with Alzheimer's disease/mild cognitive impairment: A systematic review. Journal of Alzheimer's Disease, 71(2), 477-501.</Citation></Reference><Reference><Citation>Solvang, S.-E. H., Nordrehaug, J. E., Aarsland, D., Lange, J., Ueland, P. M., McCann, A., Midttun, &#xd8;., Tell, G. S., &amp; Giil, L. M. (2019). Kynurenines, neuropsychiatric symptoms, and cognitive prognosis in patients with mild dementia. International Journal of Tryptophan Research, 12, 1178646919877883.</Citation></Reference><Reference><Citation>Soni, R. M., Tiwari, S. C., Mahdi, A. A., &amp; Kohli, N. (2019). Serum homocysteine and behavioral and psychological symptoms of dementia: Is there any correlation in Alzheimer's disease? Annals of Neurosciences, 25(3), 152-159.</Citation></Reference><Reference><Citation>Spiegl, K., Luttenberger, K., Graessel, E., Becker, L., Scheel, J., &amp; Pendergrass, A. (2021). Predictors of institutionalization in users of day care facilities with mild cognitive impairment to moderate dementia. BMC Health Services Research, 21(1), 1009.</Citation></Reference><Reference><Citation>Steinberg, M., Shao, H., Zandi, P., Lyketsos, C. G., Welsh-Bohmer, K. A., Norton, M. C., Breitner, J. C. S., Steffens, D. C., Tschanz, J. T., &amp; Cache County Investigators. (2008). Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: The Cache County study. International Journal of Geriatric Psychiatry, 23(2), 170-177.</Citation></Reference><Reference><Citation>Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., &amp; Mesirov, J. P. (2005). Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America, 102(43), 15545-15550.</Citation></Reference><Reference><Citation>Teunissen, C. E., Verberk, I. M. W., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M., &amp; Del Campo, M. (2022). Blood-based biomarkers for Alzheimer's disease: Towards clinical implementation. Lancet Neurology, 21(1), 66-77.</Citation></Reference><Reference><Citation>Theleritis, C., Politis, A., Siarkos, K., &amp; Lyketsos, C. G. (2014). A review of neuroimaging findings of apathy in Alzheimer's disease. International Psychogeriatrics, 26(2), 195-207.</Citation></Reference><Reference><Citation>Vizca&#xed;no, J. A., Csordas, A., del Toro, N., Dianes, J. A., Griss, J., Lavidas, I., Mayer, G., Perez-Riverol, Y., Reisinger, F., Ternent, T., Xu, Q.-W., Wang, R., &amp; Hermjakob, H. (2016). 2016 update of the PRIDE database and its related tools. Nucleic Acids Research, 44(D1), D447-D456.</Citation></Reference><Reference><Citation>Wilkins, M. R., Sanchez, J. C., Gooley, A. A., Appel, R. D., Humphery-Smith, I., Hochstrasser, D. F., &amp; Williams, K. L. (1996). Progress with proteome projects: Why all proteins expressed by a genome should be identified and how to do it. Biotechnology and Genetic Engineering Reviews, 13, 19-50.</Citation></Reference><Reference><Citation>Williams, M. A., Haughton, D., Stevenson, M., Craig, D., Passmore, A. P., &amp; Silvestri, G. (2015). Plasma complement factor H in Alzheimer's disease. Journal of Alzheimer's Disease, 45(2), 369-372.</Citation></Reference><Reference><Citation>Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L.-O., Nordberg, A., B&#xe4;ckman, L., Albert, M., Almkvist, O., Arai, H., Basun, H., Blennow, K., de Leon, M., DeCarli, C., Erkinjuntti, T., Giacobini, E., Graff, C., Hardy, J., &#x2026; Petersen, R. C. (2004). Mild cognitive impairment-beyond controversies, towards a consensus: Report of the international working group on mild cognitive impairment. Journal of Internal Medicine, 256(3), 240-246.</Citation></Reference><Reference><Citation>Zhao, Q.-F., Tan, L., Wang, H.-F., Jiang, T., Tan, M.-S., Lin, T., Xu, W., Li, J.-Q., Wang, J., Lai, T.-J., &amp; Jin-Tai, Y. (2016). The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis. Journal of Affective Disorders, 190, 264-271.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36274581</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-4523</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of applied gerontology : the official journal of the Southern Gerontological Society</Title><ISOAbbreviation>J Appl Gerontol</ISOAbbreviation></Journal><ArticleTitle>Can Technology-Based Social Memory Aids Improve Social Engagement? Perceptions of a Novel Memory Aid for Persons With Memory Concerns.</ArticleTitle><Pagination><StartPage>399</StartPage><EndPage>408</EndPage><MedlinePgn>399-408</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/07334648221134869</ELocationID><Abstract><AbstractText>Social withdrawal and isolation are frequently experienced among people with cognitive impairment, Alzheimer's disease, and Alzheimer's disease related dementias. Few assistive technologies exist to support persons with memory concerns' (PWMC) continuing social engagement. This study aimed to understand PWMC and family caregivers' initial perspectives on the feasibility and utility of a wearable technology-based social memory aid. We recruited 20 dyads, presented the memory aid, and conducted semi-structured interviews from June to August 2020 over Zoom video conferencing. Interviews were transcribed and analyzed using thematic analysis. Overall, participants anticipated the technology could reduce socializing-related stress now and in the future for both members of the care dyad. However, certain features of the memory aid (e.g., visitors must have the app), could limit utility, and participants provided recommendations to enhance the tool. Our findings will inform future technology-enabled social memory aid development for PWMC and family caregivers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Horn</LastName><ForeName>Brenna L</ForeName><Initials>BL</Initials><Identifier Source="ORCID">0000-0002-0949-5674</Identifier><AffiliationInfo><Affiliation>Division of Health Policy and Management, School of Public Health, 43353University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albers</LastName><ForeName>Elizabeth A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Division of Health Policy and Management, School of Public Health, 43353University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Lauren L</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Psychology, 10645Emmanuel College, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jutkowitz</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-1735-8434</Identifier><AffiliationInfo><Affiliation>Department of Health Services, Policy and Practice, 174610Brown University School of Public Health, Providence, RI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Innovation in Long Term Services and Supports, Providence VA Medical Center, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finlay</LastName><ForeName>Jessica M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0003-3427-8003</Identifier><AffiliationInfo><Affiliation>Social Environment and Health Program, Institute for Social Research, 51331University of Michigan, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Millenbah</LastName><ForeName>Ashley N</ForeName><Initials>AN</Initials><Identifier Source="ORCID">0000-0001-6033-0974</Identifier><AffiliationInfo><Affiliation>Division of Health Policy and Management, School of Public Health, 43353University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seifert</LastName><ForeName>Gregory J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Advanced Medical Electronics, Maple Grove, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hedin</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Advanced Medical Electronics, Maple Grove, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knutson</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Minnesota Health Solutions Corp, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kramer</LastName><ForeName>Kevin M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Minnesota Health Solutions Corp, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mikal</LastName><ForeName>Jude P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0001-5394-9592</Identifier><AffiliationInfo><Affiliation>Division of Health Policy and Management, School of Public Health, 43353University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R44 AG063683</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Appl Gerontol</MedlineTA><NlmUniqueID>8606502</NlmUniqueID><ISSNLinking>0733-4648</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058992" MajorTopicYN="N">Social Participation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012656" MajorTopicYN="Y">Self-Help Devices</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">assistive technology</Keyword><Keyword MajorTopicYN="N">caregiving</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">qualitative</Keyword><Keyword MajorTopicYN="N">social engagement</Keyword></KeywordList><CoiStatement>Conflict of interest statement. The Authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>24</Day><Hour>3</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36274581</ArticleId><ArticleId IdType="mid">NIHMS1842060</ArticleId><ArticleId IdType="pmc">PMC9957785</ArticleId><ArticleId IdType="doi">10.1177/07334648221134869</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>AARP. (2016). Caregivers &amp; technology: What they want and need. AARP Research. 10.26419/res.00191.002</Citation><ArticleIdList><ArticleId IdType="doi">10.26419/res.00191.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Foundation of
America. (n.d.). About Alzheimer&#x2019;s disease and dementia.
Retrieved
April
9, 2021, from https://alzfdn.org/caregiving-resources/about-alzheimers-disease-and-dementia/</Citation></Reference><Reference><Citation>Anderson M, &amp; Perrin A (2017). Tech adoption climbs among older Americans. Pew Research.
https://www.pewresearch.org/internet/2017/05/17/tech-adoption-climbs-among-older-adults/</Citation></Reference><Reference><Citation>Borson S, Scanlan JM, Chen P, &amp; Ganguli M (2003). The Mini-Cog as a screen for dementia: Validation in a population-based sample. Journal of the American Geriatrics Society, 51(10), 1451&#x2013;1454. 10.1046/j.1532-5415.2003.51465.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1532-5415.2003.51465.x</ArticleId><ArticleId IdType="pubmed">14511167</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, &amp; Clarke V (2006). Using thematic analysis in psychology. Psychology, 3, 77&#x2013;101. 10.1191/1478088706qp063oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/1478088706qp063oa</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, &amp; Clarke V (2013). Successful qualitative research: A practical guide for beginners. SAGE.</Citation></Reference><Reference><Citation>Chandler MJ, &amp; Shandera-Ochsner AL (2018). Memory compensation in mild
cognitive impairment and dementia. In APA handbook of dementia (pp. 455&#x2013;469).
Washington: American
Psychological Association. http://psycnet.apa.org/fulltext/2018-19589-024.pdf</Citation></Reference><Reference><Citation>Frank L, Lloyd A, &amp; Flynn JA (2006). Impact of cognitive impairment on mild dementia patients and mild cognitive impairment patients and their informants. International Psychogeriatrics, 18(1), 151&#x2013;162. 10.1017/S1041610205002450</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610205002450</ArticleId><ArticleId IdType="pubmed">16403246</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain S, Adam S, Olivier C, Cash H, Ousset PJ, Andrieu S, &amp; Salmon E (2009). Does cognitive impairment influence burden in caregivers of patients with Alzheimer&#x2019;s disease? Journal of Alzheimer&#x2019;s Disease, 17(1), 105&#x2013;114. 10.3233/JAD-2009-1016</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2009-1016</ArticleId><ArticleId IdType="pubmed">19494435</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackett RA, Steptoe A, Cadar D, &amp; Fancourt D (2019). Social engagement before and after dementia diagnosis in the English Longitudinal Study of Ageing. PLOS ONE, 14(8). 10.1371/journal.pone.0220195</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0220195</ArticleId><ArticleId IdType="pmc">PMC6675105</ArticleId><ArticleId IdType="pubmed">31369590</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamel AV, Sims TL, Klassen D, Havey T, &amp; Gaugler JE (2016). Memory Matters. Journal of Gerontological Nursing, 42(7), 15&#x2013;24. 10.3928/00989134-20160201-04</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/00989134-20160201-04</ArticleId><ArticleId IdType="pmc">PMC5458778</ArticleId><ArticleId IdType="pubmed">26870986</ArticleId></ArticleIdList></Reference><Reference><Citation>Holthe T, Halvorsrud L, Karterud D, Hoel K-A, &amp; Lund A (2018). Usability and acceptability of technology for community-dwelling older adults with mild cognitive impairment and dementia: A systematic literature review. Clinical Interventions in Aging, 13, 863&#x2013;886. 10.2147/CIA.S154717</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S154717</ArticleId><ArticleId IdType="pmc">PMC5942395</ArticleId><ArticleId IdType="pubmed">29765211</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiche Wang K, Chen G, &amp; Chen H-G. (2017). A model of technology adoption by older adults. Social Behavior &amp; Personality: An International Journal, 45(4), 563&#x2013;572.</Citation></Reference><Reference><Citation>Jamieson M, Monastra M, Gillies G, Manolov R, Cullen B, McGee-Lennon M, Brewster S, &amp; Evans J (2019). The use of a smartwatch as a prompting device for people with acquired brain injury: A single case experimental design study. Neuropsychological Rehabilitation, 29(4), 513&#x2013;533. 10.1080/09602011.2017.1310658</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09602011.2017.1310658</ArticleId><ArticleId IdType="pubmed">28425328</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeste DV, Palmer BW, Appelbaum PS, Golshan S, Glorioso D, Dunn LB, Kim K, Meeks T, &amp; Kraemer HC (2007). A new brief instrument for assessing decisional capacity for clinical research. Arch Gen Psychiatry, 64(8), 966&#x2013;974. 10.1001/archpsyc.64.8.966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.64.8.966</ArticleId><ArticleId IdType="pubmed">17679641</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruse CS, Fohn J, Umunnakwe G, Patel K, &amp; Patel S (2020). Evaluating the facilitators, barriers, and medical outcomes commensurate with the use of assistive technology to support people with dementia: A systematic review literature. Healthcare, 8(3), 278. 10.3390/healthcare8030278</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8030278</ArticleId><ArticleId IdType="pmc">PMC7551699</ArticleId><ArticleId IdType="pubmed">32824711</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd B, Oudman E, Altgassen M, &amp; Postma A (2019). Smartwatch aids time-based prospective memory in Korsakoff syndrome: A case study. Neurocase, 25(1&#x2013;2), 21&#x2013;25. 10.1080/13554794.2019.1602145</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13554794.2019.1602145</ArticleId><ArticleId IdType="pubmed">30966873</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall C, &amp; Rossman G (2016). Designing qualitative research (6th ed.). SAGE, Thousand Oaks. ISBN:1452271003.</Citation></Reference><Reference><Citation>McCarron HR, Zmora R, &amp; Gaugler JE (2019). A web-based mobile app with a smartwatch to support social engagement in persons with memory loss: Pilot randomized controlled trial. JMIR Aging, 2(1). 10.2196/13378</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/13378</ArticleId><ArticleId IdType="pmc">PMC6715400</ArticleId><ArticleId IdType="pubmed">31518270</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan DL, Ataie J, Carder P, &amp; Hoffman K (2013). Introducing dyadic interviews as a method for collecting qualitative data. Qualitative Health Research, 23(9), 1276&#x2013;1284. 10.1177/1049732313501889</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1049732313501889</ArticleId><ArticleId IdType="pubmed">23925406</ArticleId></ArticleIdList></Reference><Reference><Citation>Moyle W, Jones C, Dwan T, Ownsworth T, &amp; Sung B (2019). Using telepresence for social connection: Views of older people with dementia, families, and health professionals from a mixed methods pilot study. Aging &amp; Mental Health, 23(12), 1643&#x2013;1650. 10.1080/13607863.2018.1509297</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2018.1509297</ArticleId><ArticleId IdType="pubmed">30450924</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappad&#xe0; A, Chattat R, Chirico I, Valente M, &amp; Ottoboni G (2021). Assistive technologies in dementia care: An updated analysis of the literature. Frontiers in Psychology, 12, 644587. 10.3389/fpsyg.2021.644587</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2021.644587</ArticleId><ArticleId IdType="pmc">PMC8024695</ArticleId><ArticleId IdType="pubmed">33841281</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh PK, Troyer AK, Maione AM, &amp; Murphy KJ (2016). The impact of memory change on daily life in normal aging and mild cognitive impairment. The Gerontologist, 56(5), 877&#x2013;885. 10.1093/geront/gnv030</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnv030</ArticleId><ArticleId IdType="pubmed">26035897</ArticleId></ArticleIdList></Reference><Reference><Citation>Perilli V, Lancioni GE, Laporta D, Paparella A, Caff&#xf2; AO, Singh NN, O&#x2019;Reilly MF, Sigafoos J, &amp; Oliva D (2013). A computer-aided telephone system to enable five persons with Alzheimer&#x2019;s disease to make phone calls independently. Research in Developmental Disabilities, 34(6), 1991&#x2013;1997. 10.1016/j.ridd.2013.03.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ridd.2013.03.016</ArticleId><ArticleId IdType="pubmed">23584179</ArticleId></ArticleIdList></Reference><Reference><Citation>Riikonen M, Paavilainen E, &amp; Salo H (2013). Factors supporting the use of technology in daily life of home-living people with dementia. Technology &amp; Disability, 25(4), 233&#x2013;243. 10.3233/TAD-130393</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/TAD-130393</ArticleId></ArticleIdList></Reference><Reference><Citation>Smits S, Oudman E, Altgassen M, &amp; Postma A (2022). Smartwatch reminders are as effective as verbal reminders in patients with Korsakoff&#x2019;s syndrome: Three case studies. Neurocase, 28(1), 48&#x2013;62. 10.1080/13554794.2021.2024237</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13554794.2021.2024237</ArticleId><ArticleId IdType="pubmed">35225145</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriram V, Jenkinson C, &amp; Peters M (2019). Informal carers&#x2019; experience of assistive technology use in dementia care at home: A systematic review. BMC Geriatrics, 19, 160. 10.1186/s12877-019-1169-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-019-1169-0</ArticleId><ArticleId IdType="pmc">PMC6567448</ArticleId><ArticleId IdType="pubmed">31196003</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorpe JR, R&#xf8;nn-Andersen KVH, Bie&#x144; P, &#xd6;zkil AG, Forchhammer BH, &amp; Maier AM (2016). Pervasive assistive technology for people with dementia: A UCD case. Healthcare Technology Letters, 3(4), 297&#x2013;302. 10.1049/htl.2016.0057</Citation><ArticleIdList><ArticleId IdType="doi">10.1049/htl.2016.0057</ArticleId><ArticleId IdType="pmc">PMC5168821</ArticleId><ArticleId IdType="pubmed">28008366</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh V, &amp; Bala H (2008). Technology Acceptance Model 3 and a Research Agenda on Interventions. Decision Sciences, 39(2), 273&#x2013;315. 10.1111/j.1540-5915.2008.00192.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-5915.2008.00192.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh V, Morris MG, Davis GB, &amp; Davis FD (2003). User acceptance of information technology: Toward a unified view. MIS Quarterly, 27(3), 425&#x2013;478. 10.2307/30036540</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/30036540</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson BA (2013). Chapter 30: Memory deficits. In Barnes MP &amp; Good DC (Eds.), Handbook of Clinical Neurology (Vol. 110, pp. 357&#x2013;363). Elsevier. 10.1016/B978-0-444-52901-5.00030-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-52901-5.00030-7</ArticleId><ArticleId IdType="pubmed">23312655</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36273493</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1479-8301</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society</Title><ISOAbbreviation>Psychogeriatrics</ISOAbbreviation></Journal><ArticleTitle>Neuropsychiatric outcomes and caregiver distress in primary progressive aphasia.</ArticleTitle><Pagination><StartPage>52</StartPage><EndPage>62</EndPage><MedlinePgn>52-62</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/psyg.12902</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In this study, we aimed to outline the neuropsychiatric consequences of primary progressive aphasia (PPA) and to understand how neuropsychiatric symptomatology affects distress in caregivers.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The Neuropsychiatric Inventory (NPI) including the distress index (NPI-Distress) was used. Additional information about the caregiver burden was obtained using Zarit Burden Interview (ZBI). NPI, NPI-Distress, and ZBI data from 17 patients with a clinical diagnosis of PPA were compared with 10 stroke aphasia patients. Neuropsychiatric symptomatology was investigated based on three clusters; Mood, Frontal/Comportmental, and Psychotic/Disruptive. Additionally, the Activities of Daily Living Questionnaire (ADLQ) was used to outline the functional impairment. Twelve healthy controls were included to compare the neurocognitive test scores with PPA and stroke aphasia groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A greater number of neuropsychiatric symptoms were observed in the PPA group compared to the stroke aphasia group. The number of symptoms in Mood, and Frontal/Comportmental clusters were greater than the number of symptoms in Psychotic/Disruptive clusters in the PPA group, whereas no significant relationship between the number of symptoms and symptom clusters was found in the stroke aphasia group. In the PPA group, a strong correlation was found between the NPI-Frequency&#xa0;&#xd7;&#xa0;Severity scores and the NPI-Distress scores. Moreover, the NPI-Distress scores in the PPA group strongly correlated with the ZBI scores. Scores for anxiety, irritability/lability, and apathy had a stronger correlation with the NPI-Distress scores compared to the other NPI symptoms. The Communication subscale was the most impaired domain in the PPA group. Travel, and Employment and Recreation subscales showed greater functional impairment in the stroke aphasia group compared to the PPA group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Neuropsychiatric symptoms in PPA in our study were more frequent than previously reported. Furthermore, the distress index of the NPI was not only correlated with the severity of the neuropsychiatric symptoms but also reflected the overall burden on the caregivers in the PPA group.</AbstractText><CopyrightInformation>&#xa9; 2022 Japanese Psychogeriatric Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Seckin</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1342-8084</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Ac&#x131;badem Mehmet Ali Ayd&#x131;nlar University School of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ac&#x131;badem Mehmet Ali Ayd&#x131;nlar University School of Medicine, Alzheimer's Disease and Cognitive Neurology Research Lab, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Y&#x131;ld&#x131;r&#x131;m</LastName><ForeName>Elif</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Economics, Administrative and Social Sciences, Department of Psychology, I&#x15f;&#x131;k University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demir</LastName><ForeName>&#x130;layda</ForeName><Initials>&#x130;</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Istanbul University Aziz Sancar Institute of Experimental Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hulusi Beh&#xe7;et Life Sciences Center, Neuroimaging Lab, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orhun</LastName><ForeName>&#xd6;mer</ForeName><Initials>&#xd6;</Initials><Identifier Source="ORCID">0000-0002-4426-7853</Identifier><AffiliationInfo><Affiliation>Ac&#x131;badem Mehmet Ali Ayd&#x131;nlar University School of Medicine, Alzheimer's Disease and Cognitive Neurology Research Lab, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xfc;lb&#xfc;l</LastName><ForeName>Ezgi</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-1720-386X</Identifier><AffiliationInfo><Affiliation>Ac&#x131;badem Mehmet Ali Ayd&#x131;nlar University School of Medicine, Alzheimer's Disease and Cognitive Neurology Research Lab, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velio&#x11f;lu</LastName><ForeName>H Aziz</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Health Sciences and Technology Research Institute (SABITA), Regenerative and Restorative Medicine Research Center (REMER), functional Imaging and Cognitive-Affective Neuroscience Lab (fINCAN), Istanbul Medipol University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;ktem</LastName><ForeName>&#xd6;get</ForeName><Initials>&#xd6;</Initials><AffiliationInfo><Affiliation>Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul University Faculty of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye&#x15f;ilot</LastName><ForeName>Nil&#xfc;fer</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-9655-9487</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Edip Aktin Stroke Unit, Istanbul University Faculty of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;oban</LastName><ForeName>O&#x11f;uzhan</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neurology, Edip Aktin Stroke Unit, Istanbul University Faculty of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;rvit</LastName><ForeName>Hakan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul University Faculty of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>EC-FP7 co-funded Brain Circulation Scheme</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychogeriatrics</MedlineTA><NlmUniqueID>101230058</NlmUniqueID><ISSNLinking>1346-3500</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001037" MajorTopicYN="Y">Aphasia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018888" MajorTopicYN="Y">Aphasia, Primary Progressive</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Neuropsychiatric Inventory</Keyword><Keyword MajorTopicYN="N">behaviour</Keyword><Keyword MajorTopicYN="N">caregiver burden</Keyword><Keyword MajorTopicYN="N">primary progressive aphasia</Keyword><Keyword MajorTopicYN="N">stroke aphasia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>23</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36273493</ArticleId><ArticleId IdType="doi">10.1111/psyg.12902</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Mesulam MM. Primary progressive aphasia-a language-based dementia. N Engl J Med 2003; 349: 1535-1542.</Citation></Reference><Reference><Citation>Banks SJ, Weintraub S. Neuropsychiatric symptoms in behavioral variant frontotemporal dementia and primary progressive aphasia. J Geriatr Psychiatry Neurol 2008; 21: 133-141.</Citation></Reference><Reference><Citation>Ulugut H, Stek S, Wagemans LEE et al. The natural history of primary progressive aphasia: beyond aphasia. J Neurol 2021; 269: 1375-1385.</Citation></Reference><Reference><Citation>Fatemi Y, Boeve BF, Duffy J et al. Neuropsychiatric aspects of primary progressive aphasia. J Neuropsychiatry Clin Neurosci 2011; 23: 168-172.</Citation></Reference><Reference><Citation>Modirrousta M, Price BH, Dickerson BC. Neuropsychiatric symptoms in primary progressive aphasia: phenomenology, pathophysiology, and approach to assessment and treatment. Neurodegenerative Disease Management 2013; 3: 133-146.</Citation></Reference><Reference><Citation>Singh TD, Duffy JR, Strand EA, Machulda MM, Whitwell JL, Josephs KA. Neuropsychiatric symptoms in primary progressive aphasia and apraxia of speech. Dement Geriatr Cogn Disord 2015; 39: 228-238.</Citation></Reference><Reference><Citation>Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-2314.</Citation></Reference><Reference><Citation>Kaufer DI, Cummings JL, Christine D et al. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the neuropsychiatric inventory caregiver distress scale. J Am Geriatr Soc 1998; 46: 210-215.</Citation></Reference><Reference><Citation>Cummings J. The neuropsychiatric inventory: development and applications. J Geriatr Psychiatry Neurol 2020; 33: 73-84.</Citation></Reference><Reference><Citation>Bozgeyik G, Ipekcioglu D, Yazar MS, Ilnem MC. Behavioural and psychological symptoms of Alzheimer's disease associated with caregiver burden and depression. Psychiatry and Clinical Psychopharmacology 2018; 29: 656-664.</Citation></Reference><Reference><Citation>Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 1980; 20: 649-655.</Citation></Reference><Reference><Citation>Boutoleau-Bretonniere C, Vercelletto M, Volteau C, Renou P, Lamy E. Zarit burden inventory and activities of daily living in the behavioral variant of frontotemporal dementia. Dement Geriatr Cogn Disord 2008; 25: 272-277.</Citation></Reference><Reference><Citation>Bedard M, Molloy DW, Squire L, Dubois S, Lever JA, O'Donnell M. The Zarit burden interview: a new short version and screening version. Gerontologist 2001; 41: 652-657.</Citation></Reference><Reference><Citation>Higginson IJ, Gao W, Jackson D, Murray J, Harding R. Short-form Zarit caregiver burden interviews were valid in advanced conditions. J Clin Epidemiol 2010; 63: 535-542.</Citation></Reference><Reference><Citation>Knutson KM, Zamboni G, Tierney MC, Grafman J. Neural correlates of caregiver burden in cortical basal syndrome and frontotemporal dementia. Dement Geriatr Cogn Disord 2008; 26: 467-474.</Citation></Reference><Reference><Citation>Rymer S, Salloway S, Norton L, Malloy P, Correia S, Monast D. Impaired awareness, behavior disturbance, and caregiver burden in Alzheimer disease. Alzheimer Dis Assoc Disord 2002; 16: 248-253.</Citation></Reference><Reference><Citation>de Vugt ME, Riedijk SR, Aalten P, Tibben A, van Swieten JC, Verhey FR. Impact of behavioural problems on spousal caregivers: a comparison between Alzheimer's disease and frontotemporal dementia. Dement Geriatr Cogn Disord 2006; 22: 35-41.</Citation></Reference><Reference><Citation>Wong S, Irish M, Husain M, Hodges JR, Piguet O, Kumfor F. Apathy and its impact on carer burden and psychological wellbeing in primary progressive aphasia. J Neurol Sci 2020; 416: 117007.</Citation></Reference><Reference><Citation>Hazelton JL, Irish M, Hodges JR, Piguet O, Kumfor F. Cognitive and affective empathy disruption in non-fluent primary progressive aphasia syndromes. Brain Impairment 2016; 18: 117-129.</Citation></Reference><Reference><Citation>Godefroy O, Dubois C, Debachy B, Leclerc M, Kreisler A, Lille SP. Vascular aphasias: main characteristics of patients hospitalized in acute stroke units. Stroke 2002; 33: 702-705.</Citation></Reference><Reference><Citation>Bullain SS, Chriki LS, Stern TA. Aphasia: associated disturbances in affect, behavior, and cognition in the setting of speech and language difficulties. Psychosomatics 2007; 48: 258-264.</Citation></Reference><Reference><Citation>Draper B, Bowring G, Thompson C, Van Heyst J, Conroy P, Thompson J. Stress in caregivers of aphasic stroke patients: a randomized controlled trial. Clin Rehabil 2007; 21: 122-130.</Citation></Reference><Reference><Citation>Di Stefano V, De Angelis MV, Montemitro C et al. Clinical presentation of strokes confined to the insula: a systematic review of literature. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2021; 42: 1697-1704.</Citation></Reference><Reference><Citation>Frey KL, Newman JK, Arciniegas DB, Anderson CA, Ramsberger G. Assessing neuropsychiatric disturbances associated with post-stroke aphasia. J Neuropsychiatry Clin Neurosci 2011; 23: E4-E5.</Citation></Reference><Reference><Citation>Rogalski E, Cobia D, Harrison TM, Wieneke C, Weintraub S, Mesulam MM. Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia. Neurology 2011; 76: 1804-1810.</Citation></Reference><Reference><Citation>Mesulam MM, Thompson CK, Weintraub S, Rogalski EJ. The Wernicke conundrum and the anatomy of language comprehension in primary progressive aphasia. Brain: A Journal of Neurology 2015; 138: 2423-2437.</Citation></Reference><Reference><Citation>Mesulam M, Wieneke C, Rogalski E, Cobia D, Thompson C, Weintraub S. Quantitative template for subtyping primary progressive aphasia. Arch Neurol 2009; 66: 1545-1551.</Citation></Reference><Reference><Citation>Gorno-Tempini ML, Hillis AE, Weintraub S et al. Classification of primary progressive aphasia and its variants. Neurology 2011; 76: 1006-1014.</Citation></Reference><Reference><Citation>Karpouzian-Rogers T, Hurley R, Seckin M et al. Eye movements as a measure of word comprehension deficits in primary progressive aphasia. Brain Lang 2022; 232: 105165.</Citation></Reference><Reference><Citation>G&#xfc;ngen C, Ertan T, Eker E, Ya&#x15f;ar R, Engin F. Reliability and validity of the standardized mini mental state examination in the diagnosis of mild dementia in Turkish population. Turkish Journal of Psychiatry (Turk Psikiyatri Derg) 2002; 13: 273-281.</Citation></Reference><Reference><Citation>To&#x11f;ram B, Mavi&#x15f; &#x130;. Validity, reliability and standardization study of the language assessment test for aphasia. Turk J Neurol 2012; 18: 96-103.</Citation></Reference><Reference><Citation>Rohrer JD, Rossor MN, Warren JD. Apraxia in progressive nonfluent aphasia. J Neurol 2010; 257: 569-574.</Citation></Reference><Reference><Citation>Reitan R, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucso: Tucson Neuropsychology Press, 1993.</Citation></Reference><Reference><Citation>Benton A, Harnsher K, Varney N, Speen O. Contributions to Neuropsychological Assessment. New York: Oxford UP, 1994.</Citation></Reference><Reference><Citation>Randolph C. Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). San Antonio: The Psychological Corporation, 1998.</Citation></Reference><Reference><Citation>Mesulam M. Principles of Behavioral and Cognitive Neurology. Oxford, New York: Oxford University Press, 2000.</Citation></Reference><Reference><Citation>Weintraub S, Mesulam MM. Right cerebral dominance in spatial attention. Further evidence based on ipsilateral neglect. Arch Neurol 1987; 44: 621-625.</Citation></Reference><Reference><Citation>&#xd6;zl&#xfc; A, Y&#x131;ld&#x131;z M, Aker T. A reliability and validity study on the Zarit caregiver burden scale. N&#xf6;ropsikiyatri Ar&#x15f;ivi 2009; 46: 38-42.</Citation></Reference><Reference><Citation>Johnson N, Barion A, Rademaker A, Rehkemper G, Weintraub S. The activities of daily living questionnaire: a validation study in patients with dementia. Alzheimer Dis Assoc Disord 2004; 18: 223-230.</Citation></Reference><Reference><Citation>de la Sablonniere J, Tastevin M, Lavoie M, Laforce R Jr. Longitudinal changes in cognition, Behaviours, and functional abilities in the three Main variants of primary progressive aphasia: a literature review. Brain Sci 2021; 11: 1209.</Citation></Reference><Reference><Citation>Rohrer JD, Warren JD. Phenomenology and anatomy of abnormal behaviours in primary progressive aphasia. J Neurol Sci 2010; 293: 35-38.</Citation></Reference><Reference><Citation>D'Anna L, Mesulam MM, Thiebaut de Schotten M et al. Frontotemporal networks and behavioral symptoms in primary progressive aphasia. Neurology 2016; 86: 1393-1399.</Citation></Reference><Reference><Citation>Lambon Ralph MA. Neurocognitive insights on conceptual knowledge and its breakdown. Philos Trans R Soc Lond B Biol Sci 2014; 369: 20120392.</Citation></Reference><Reference><Citation>Rogalski E, Cobia D, Harrison TM et al. Anatomy of language impairments in primary progressive aphasia. J Neurosci 2011; 31: 3344-3350.</Citation></Reference><Reference><Citation>Catani M, Thiebaut de Schotten M. A Diffusion Tensor Imaging Tractography Atlas for Virtual in Vivo Dissections Cortex. a Journal Devoted to the Study of the Nervous System and Behavior 2008; 44: 1105-1132.</Citation></Reference><Reference><Citation>Von Der Heide RJ, Skipper LM, Klobusicky E, Olson IR. Dissecting the uncinate fasciculus: disorders, controversies and a hypothesis. Brain: A Journal of Neurology. 2013; 136: 1692-1707.</Citation></Reference><Reference><Citation>Rascovsky K, Glasenberg J, Boller A, Grossman M. Conversation deficits and caregiver burden in behavioral variant frontotemporal dementia (bvFTD) and primary progressive aphasia (PPA) (P03.091). Neurology 2013; 80: P03.091.</Citation></Reference><Reference><Citation>Wicklund AH, Johnson N, Rademaker A, Weitner BB, Weintraub S. Profiles of decline in activities of daily living in non-Alzheimer dementia. Alzheimer Dis Assoc Disord 2007; 21: 8-13.</Citation></Reference><Reference><Citation>Magierski R, Sobow T, Schwertner E, Religa D. Pharmacotherapy of behavioral and psychological symptoms of dementia: state of the art and future Progress. Front Pharmacol 2020; 11: 1168.</Citation></Reference><Reference><Citation>Le C, Finger E. Pharmacotherapy for neuropsychiatric symptoms in frontotemporal dementia. CNS Drugs 2021; 35: 1081-1096.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36268979</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1545-2301</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Clinical gerontologist</Title><ISOAbbreviation>Clin Gerontol</ISOAbbreviation></Journal><ArticleTitle>A scoping review of dementia caregiving for Korean Americans and recommendations for future research.</ArticleTitle><Pagination><StartPage>223</StartPage><EndPage>239</EndPage><MedlinePgn>223-239</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/07317115.2022.2133907</ELocationID><Abstract><AbstractText Label="OBJECTIVES">This scoping review aims to examine the caregiving experiences of Korean American caregivers of persons with dementia.</AbstractText><AbstractText Label="METHODS">A comprehensive electronic search was conducted within 5 databases (PubMed, CINAHL, Web of Science, Embase, PsycINFO-ProQuest) for papers published from 01/01/00&#xa0;-01/24/22. Seventeen articles met the inclusion criteria. Thematic analysis was used to summarize key findings from these papers.</AbstractText><AbstractText Label="RESULTS">Most Korean American dementia caregivers were immigrants and wives/daughters/daughters-in-law. Two themes emerged: 1) how Korean American caregivers perceived their caregiving experiences, and 2) how Korean American caregivers perceived their caregiving support services. Korean American caregivers often experience poor mental health and burden. Social support and familism were found to be two of the most important factors that determine their attitudes toward caregiving. Most reported barriers to utilizing public services. Challenges in finding culturally relevant resources were common.</AbstractText><AbstractText Label="CONCLUSIONS">Dementia caregiving is a significant public health problem facing Korean Americans. Recommendations for future research are provided.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ta Park</LastName><ForeName>Van M</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Department of Community Health Systems, School of Nursing, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Asian American Research Center on Health (ARCH), University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multi-Ethnic Health Equity Research Center (MERC), University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ly</LastName><ForeName>Quyen</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>J6-Acuity Adaptable Unit, Stanford Health Care, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Oppenfeld</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>San Francisco Veteran Administration Health Care System, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yelim</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Community Health Systems, School of Nursing, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joo</LastName><ForeName>Yoonmee</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Community Health Systems, School of Nursing, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Hye-Won</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>Somang Society, Cypress, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Memory Impairments and Neurological Disorders, University of California Irvine, Irvine, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhee</LastName><ForeName>YongJoo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Science, Dongduk Women's University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Linda G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Department of Community Health Systems, School of Nursing, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG066530</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG083926</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R24 AG063718</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AG069130</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Gerontol</MedlineTA><NlmUniqueID>8300869</NlmUniqueID><ISSNLinking>0731-7115</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001213" MajorTopicYN="Y">Asian</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018454" MajorTopicYN="N">Spouses</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Korean</Keyword><Keyword MajorTopicYN="N">Korean American</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">dementia caregiving</Keyword><Keyword MajorTopicYN="N">health disparities</Keyword><Keyword MajorTopicYN="N">scoping review</Keyword></KeywordList><CoiStatement>Disclosure statement. No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>21</Day><Hour>8</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36268979</ArticleId><ArticleId IdType="mid">NIHMS1846216</ArticleId><ArticleId IdType="pmc">PMC9928901</ArticleId><ArticleId IdType="doi">10.1080/07317115.2022.2133907</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>AARP Public Policy Institute. (2020). The &#x201c;typical&#x201d; Asian caregiver. Retrieved February
3 from https://www.aarp.org/content/dam/aarp/ppi/2020/05/asian-caregiver.doi.10.26419-2Fppi.00103.007.pdf</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Association. (2020). 2020 Alzheimer&#x2019;s disease facts and figures. Retrieved from https://www.alz.org/aaic/downloads2020/2020_Facts_and_Figures_Fact_Sheet.pdf</Citation><ArticleIdList><ArticleId IdType="pubmed">32157811</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Association. (2021). 2021 Alzheimer&#x2019;s disease facts and figures. Retrieved from https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf</Citation><ArticleIdList><ArticleId IdType="pubmed">33756057</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Association. (2022). What is dementia? Retrieved from https://www.alz.org/alzheimers-dementia/what-is-dementia</Citation></Reference><Reference><Citation>Arksey H, &amp; O&#x2019;Malley L (2005). Scoping studies: Towards a methodological framework. International Journal of Social Research Methodology, 8(1), 19&#x2013;32. doi:10.1080/1364557032000119616</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1364557032000119616</ArticleId></ArticleIdList></Reference><Reference><Citation>Budiman A (2021). Koreans in the U.S. fact sheet. Pew Research Center. Retrieved from https://www.pewresearch.org/social-trends/fact-sheet/asian-americans-koreans-in-the-u-s/.</Citation></Reference><Reference><Citation>Casado BL, Hong M, &amp; Lee SE (2018). Attitudes toward Alzheimer&#x2019;s care-seeking among Korean Americans: Effects of knowledge, stigma, and subjective norm. Gerontologist, 58(2), e25&#x2013;e34. doi:10.1093/geront/gnw253</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnw253</ArticleId><ArticleId IdType="pubmed">28329848</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu P, Edwards J, Levin R, &amp; Thomson J (2000). The use of clinical case management for early stage Alzheimer&#x2019;s patients and their families. American Journal of Alzheimer&#x2019;s Disease and Other Dementias, 15(5), 284&#x2013;290. doi:10.1177/153331750001500506</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/153331750001500506</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun M, Knight BG, &amp; Youn G (2007). Differences in stress and coping models of emotional distress among Korean, Korean-American and White-American caregivers. Aging &amp; Mental Health, 11(1), 20&#x2013;29. doi:10.1080/13607860600736232</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607860600736232</ArticleId><ArticleId IdType="pubmed">17164154</ArticleId></ArticleIdList></Reference><Reference><Citation>Corvol A, Dreier A, Prudhomm J, Thyrian JR, Hoffmann W, &amp; Somme D (2017). Consequences of clinical case management for caregivers: A systematic review. International Journal of Geriatric Psychiatry, 32(5), 473&#x2013;483. doi:10.1002/gps.4679</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4679</ArticleId><ArticleId IdType="pubmed">28181696</ArticleId></ArticleIdList></Reference><Reference><Citation>Covidence systematic review software. (Nodate). Veritas health innovation
www.covidence.org</Citation></Reference><Reference><Citation>Diamond L, Izquierdo K, Canfield D, Matsoukas K, &amp; Gany F (2019). A systematic review of the impact of patient-physician non-english language concordance on quality of care and outcomes. Journal of General Internal Medicine, 34(8), 1591&#x2013;1606. doi:10.1007/s11606-019-04847-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-019-04847-5</ArticleId><ArticleId IdType="pmc">PMC6667611</ArticleId><ArticleId IdType="pubmed">31147980</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauth EB, Jackson MA, Walberg DK, Lee NE, Easom LR, Alston G, &#x2026; Mittelman M (2019). External validity of the New York University caregiver intervention: Key caregiver outcomes across multiple demonstration projects. Journal of Applied Gerontology, 38 (9), 1253&#x2013;1281. doi:10.1177/0733464817714564</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464817714564</ArticleId><ArticleId IdType="pubmed">28645235</ArticleId></ArticleIdList></Reference><Reference><Citation>Francke AL, Verkaik R, Peeters JM, Spreeuwenberg P, de Lange J, &amp; Pot AM (2017). Dementia case management through the eyes of informal carers: A national evaluation study. Dementia (London), 16(5), 642&#x2013;655. doi:10.1177/1471301215614165</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301215614165</ArticleId><ArticleId IdType="pubmed">26552856</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher-Thompson D, Gray HL, Tang PC, Pu CY, Leung LY, Wang PC, &#x2026; Thompson LW (2007). Impact of in-home behavioral management versus telephone support to reduce depressive symptoms and perceived stress in Chinese caregivers: Results of a pilot study [comparative study randomized controlled trial research support, Non-U.S. Gov&#x2019;t]. The American Journal of Geriatric Psychiatry, 15(5), 425&#x2013;434. doi:10.1097/JGP.0b013e3180312028</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JGP.0b013e3180312028</ArticleId><ArticleId IdType="pubmed">17463192</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitlin LN, Marx K, Stanley IH, &amp; Hodgson N (2015). Translating evidence-based dementia caregiving interventions into practice: State-of-the-science and next steps. The Gerontologist, 55(2), 210&#x2013;226. doi:10.1093/geront/gnu123</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnu123</ArticleId><ArticleId IdType="pmc">PMC4542834</ArticleId><ArticleId IdType="pubmed">26035597</ArticleId></ArticleIdList></Reference><Reference><Citation>Glaser B, &amp; Strauss A (1967). The discovery of grounded theory: Strategies for qualitative research. New York: Aldine.</Citation></Reference><Reference><Citation>Holland AT, &amp; Palaniappan LP (2012). Problems with the collection and interpretation of Asian-American health data: Omission, aggregation, and extrapolation. Annals of Epidemiology, 22(6), 397&#x2013;405. doi:10.1016/j.annepidem.2012.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annepidem.2012.04.001</ArticleId><ArticleId IdType="pmc">PMC4324759</ArticleId><ArticleId IdType="pubmed">22625997</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwamasa G, &amp; Sorocco K (2007). The psychology of Asian American older adults. In Leong FT, Inman A, Ebreo A, Yang LH, Kinoshita L, &amp; Fu M (Eds.), Handbook of Asian American psychology (Second ed.). Thousand Oaks, CA: Sage.</Citation></Reference><Reference><Citation>Jang SN, Avendano M, &amp; Kawachi I (2012). Informal caregiving patterns in Korea and European countries: A cross-national comparison. Asian Nursing Research, 6(1), 19&#x2013;26. doi:10.1016/j.anr.2012.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anr.2012.02.002</ArticleId><ArticleId IdType="pubmed">25030687</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang S, &amp; Baik K (2019). Disparity in caregiving and family caregiving issue. Seoul, South Korea: I. f. S. Health.</Citation></Reference><Reference><Citation>Jang SN, &amp; Kawachi I (2019). Care inequality: Care received according to gender, marital status, and socioeconomic status among Korean older adults with disability. International Journal for Equity in Health, 18(1), 105. doi:10.1186/s12939-019-1008-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-019-1008-0</ArticleId><ArticleId IdType="pmc">PMC6610802</ArticleId><ArticleId IdType="pubmed">31269953</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang Y, &amp; Kim MT (2019). Limited English proficiency and health service use in Asian Americans. Journal of Immigrant and Minority Health, 21(2), 264&#x2013;270. doi:10.1007/s10903-018-0763-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10903-018-0763-0</ArticleId><ArticleId IdType="pmc">PMC6252148</ArticleId><ArticleId IdType="pubmed">29797103</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang Y, Kim G, Chiriboga D, &amp; Kallimanis B (2007). A bidimensional model of acculturation for Korean American older adults. Journal of Aging Studies, 21(3), 267&#x2013;275. doi:10.1016/j.jaging.2006.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaging.2006.10.004</ArticleId><ArticleId IdType="pmc">PMC2034290</ArticleId><ArticleId IdType="pubmed">18670580</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang Y, Yoon H, Park NS, Rhee MK, &amp; Chiriboga DA (2018). Asian Americans&#x2019; concerns and plans about Alzheimer&#x2019;s disease: The role of exposure, literacy and cultural beliefs. Health &amp; Social Care in the Community, 26(2), 199&#x2013;206. doi:10.1111/hsc.12509</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hsc.12509</ArticleId><ArticleId IdType="pmc">PMC5799017</ArticleId><ArticleId IdType="pubmed">28980423</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones RW, Lebrec J, Kahle-Wrobleski K, Dell&#x2019;Agnello G, Bruno G, Vellas B, &#x2026; Reed C (2017). Disease progression in mild dementia due to Alzheimer disease in an 18-month observational study (GERAS): The impact on costs and caregiver outcomes. Dementia and Geriatric Cognitive Disorders Extra, 7(1), 87&#x2013;100. doi:10.1159/000461577</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000461577</ArticleId><ArticleId IdType="pmc">PMC5465649</ArticleId><ArticleId IdType="pubmed">28611822</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanaya AM, Hsing AW, Panapasa SV, Kandula NR, Mr GA, Shimbo D, &#x2026; Hong Y (2022). Knowledge gaps, challenges, and opportunities in health and prevention research for Asian Americans, Native Hawaiians, and Pacific Islanders: A report from the 2021 national institutes of health workshop. Annals of Internal Medicine, 175(4), 574&#x2013;589. doi:10.7326/M21-3729</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-3729</ArticleId><ArticleId IdType="pmc">PMC9018596</ArticleId><ArticleId IdType="pubmed">34978851</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper JD, Freedman VA, Spillman BC, &amp; Wolff JL (2015). The disproportionate impact of dementia on family and unpaid caregiving to older adults. Health Affairs, 34 (10), 1642&#x2013;1649. doi:10.1377/hlthaff.2015.0536</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2015.0536</ArticleId><ArticleId IdType="pmc">PMC4635557</ArticleId><ArticleId IdType="pubmed">26438739</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanassov V, &amp; Vedel I (2016). Family physician-case manager collaboration and needs of patients with dementia and their caregivers: A systematic mixed studies review. The Annals of Family Medicine, 14(2), 166&#x2013;177. doi:10.1370/afm.1898</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.1898</ArticleId><ArticleId IdType="pmc">PMC4781521</ArticleId><ArticleId IdType="pubmed">26951593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y (2009). Korean American family postcaregivers on dementia caregiving: A phenomenological inquiry. Journal of Gerontological Social Work, 52(6), 600&#x2013;617. doi:10.1080/01634370903048352</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01634370903048352</ArticleId><ArticleId IdType="pubmed">19598041</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, De Bellis AM, &amp; Xiao LD (2018). The experience of paid family-care workers of people with dementia in South Korea. Asian Nursing Research, 12(1), 34&#x2013;41. doi:10.1016/j.anr.2018.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anr.2018.01.002</ArticleId><ArticleId IdType="pubmed">29463483</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Kehoe P, Gibbs LM, &amp; Lee JA (2019). Caregiving experience of dementia among Korean American family caregivers. Issues in Mental Health Nursing, 40(2), 158&#x2013;165. doi:10.1080/01612840.2018.1534909</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01612840.2018.1534909</ArticleId><ArticleId IdType="pmc">PMC6445682</ArticleId><ArticleId IdType="pubmed">30620625</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim W, Lee TH, Shin J, &amp; Park EC (2017). Depressive symptoms in spouse caregivers of dementia patients: A longitudinal study in South Korea. Geriatrics &amp; Gerontology International, 17(6), 973&#x2013;983. doi:10.1111/ggi.12820</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ggi.12820</ArticleId><ArticleId IdType="pubmed">27302538</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong EH, Deatrick JA, &amp; Evans LK (2010). The experiences of Korean immigrant caregivers of non-English-speaking older relatives with dementia in American nursing homes. Qualitative Health Research, 20 (3), 319&#x2013;329. doi:10.1177/1049732309354279</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1049732309354279</ArticleId><ArticleId IdType="pubmed">19940089</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, &amp; Bronstein LR (2010). When do Korean-American dementia caregivers find meaning in caregiving?: The role of culture and differences between spouse and child caregivers. Journal of Ethnic and Cultural Diversity in Social Work, 19(1), 73&#x2013;86. doi:10.1080/15313200903547756</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15313200903547756</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SE, &amp; Casado BL (2011). Attitudes toward community services use in dementia care among Korean Americans. Clinical Gerontologist, 34(4), 271&#x2013;286. doi:10.1080/07317115.2011.572536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07317115.2011.572536</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SE, Casado BL, &amp; Hong M (2018). Exploring experience and perspectives of foreign-born direct care workers in dementia care: Accounts of Korean American personal care aides caring for older Korean Americans with dementia symptoms. Dementia (London), 17(4), 423&#x2013;438. doi:10.1177/1471301216647832</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301216647832</ArticleId><ArticleId IdType="pubmed">27154964</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Casado B, Lee SE, Hong M, &amp; Hong S (2015). The experience of family caregivers of older Korean Americans with dementia symptoms. Clinical Gerontologist, 38(1), 32&#x2013;48. doi:10.1080/07317115.2014.970316</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07317115.2014.970316</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, &amp; Choi S (2013). Korean American dementia caregivers&#x2019; attitudes toward caregiving: The role of social network versus satisfaction with social support. Journal of Applied Gerontology, 32(4), 422&#x2013;442. doi:10.1177/0733464811431163</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464811431163</ArticleId><ArticleId IdType="pubmed">25474683</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EE, &amp; Farran CJ (2004). Depression among Korean, Korean American, and Caucasian American family caregivers. Journal of Transcultural Nursing, 15(1), 18&#x2013;25. doi:10.1177/1043659603260010</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1043659603260010</ArticleId><ArticleId IdType="pmc">PMC3099181</ArticleId><ArticleId IdType="pubmed">14768412</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JA, Nguyen H, Park J, Tran L, Nguyen T, &amp; Huynh Y (2017). Usages of computers and smartphones to develop dementia care education program for Asian American family caregivers. Healthcare Informatics Research, 23(4), 338&#x2013;342. doi:10.4258/hir.2017.23.4.338</Citation><ArticleIdList><ArticleId IdType="doi">10.4258/hir.2017.23.4.338</ArticleId><ArticleId IdType="pmc">PMC5688035</ArticleId><ArticleId IdType="pubmed">29181245</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, &amp; Smith L (2012). Qualitative research on Korean American dementia caregivers&#x2019; perception of caregiving: Heterogeneity between spouse caregivers and child caregivers. Journal of Human Behavior in the Social Environment, 22(2), 115&#x2013;129. doi:10.1080/10911359.2012.646840</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10911359.2012.646840</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, &amp; Yim N-Y (2013). Korean American dementia family caregivers&#x2019; experience of a psychoeducational support group: Investigation of role of culture. Social Work With Groups, 36(1), 13&#x2013;26. doi:10.1080/01609513.2012.724214</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01609513.2012.724214</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehrer B (1996). The Korean American. New York: Chelsea House Publishers.</Citation></Reference><Reference><Citation>Luborsky MR (1994). The identification and analysis of themes and patterns. In Sankar JGA (Ed.), Qualitative methods in aging research (pp. 189&#x2013;210). Thousand Oaks, CA: SAGE Publications, Inc.</Citation></Reference><Reference><Citation>McKeown S, &amp; Mir ZM (2021). Considerations for conducting systematic reviews: Evaluating the performance of different methods for de-duplicating references. Systematic Reviews, 10(1), 38. doi:10.1186/s13643-021-01583-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-021-01583-y</ArticleId><ArticleId IdType="pmc">PMC7827976</ArticleId><ArticleId IdType="pubmed">33485394</ArticleId></ArticleIdList></Reference><Reference><Citation>Migration Policy Institute. (2017). Korean Immigrants in the United States. Retrieved from https://www.migrationpolicy.org/article/korean-immigrants-united-states</Citation></Reference><Reference><Citation>Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, &amp; Aromataris E (2018). Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Medical Research Methodology, 18(1), 143. doi: 10.1186/s12874-018-0611-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-018-0611-x</ArticleId><ArticleId IdType="pmc">PMC6245623</ArticleId><ArticleId IdType="pubmed">30453902</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen D (2012). The effects of sociocultural factors on older Asian Americans&#x2019; access to care. Journal of Gerontological Social Work, 55(1), 55&#x2013;71. doi:10.1080/01634372.2011.618525</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01634372.2011.618525</ArticleId><ArticleId IdType="pubmed">22220993</ArticleId></ArticleIdList></Reference><Reference><Citation>Oak S, &amp; Martin V (2000). American/Korean contrasts: Patterns and expectations in the US and Korea. Elizabeth, NJ: Weatherhill, Incorporated.</Citation></Reference><Reference><Citation>Pew Research Center. (2017). Key findings about U.S. immigrants. Author. Retrieved from http://www.pewresearch.org/fact-tank/2017/05/03/key-findings-about-u-s-immigrants/</Citation></Reference><Reference><Citation>Pimouguet C, Lavaud T, Dartigues JF, &amp; Helmer C (2010). Dementia case management effectiveness on health care costs and resource utilization: A systematic review of randomized controlled trials. The Journal of Nutrition, Health &amp; Aging, 14(8), 669&#x2013;676. doi:10.1007/s12603-010-0314-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-010-0314-4</ArticleId><ArticleId IdType="pubmed">20922344</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson VE, Fields N, Won S, Bradley E, Gibson A, Rivera G, &amp; Holmes SD (2019). At the intersection of culture: Ethnically diverse dementia caregivers&#x2019; service use. Dementia, 18(5), 1790&#x2013;1809. doi:10.1177/1471301217721304</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301217721304</ArticleId><ArticleId IdType="pubmed">29254375</ArticleId></ArticleIdList></Reference><Reference><Citation>Somme D, Trouve H, Drame M, Gagnon D, Couturier Y, &amp; Saint-Jean O (2012). Analysis of case management programs for patients with dementia: A systematic review. Alzheimer&#x2019;s &amp; Dementia, 8(5), 426&#x2013;436. doi:10.1016/j.jalz.2011.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.06.004</ArticleId><ArticleId IdType="pubmed">22285637</ArticleId></ArticleIdList></Reference><Reference><Citation>Ta Park V, Nguyen K, Tran Y, Yeo G, Tiet Q, Suen J, &amp; Gallagher-Thompson D (2018). Perspectives and insights from Vietnamese American mental health professionals on how to culturally tailor a Vietnamese dementia caregiving program. Clinical Gerontologist, 41(3), 184&#x2013;199. doi:10.1080/07317115.2018.1432734</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07317115.2018.1432734</ArticleId><ArticleId IdType="pubmed">29419364</ArticleId></ArticleIdList></Reference><Reference><Citation>Ta Park VM, Ton V, Tiet QQ, Vuong Q, Yeo G, &amp; Gallagher-Thompson D (2019). Promising results from a pilot study to reduce distress in Vietnamese American dementia and memory loss caregivers. Alzheimer&#x2019;s &amp; Dementia: Translational Research &amp; Clinical Interventions, 5(1), 319&#x2013;327. doi:10.1016/j.trci.2019.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2019.05.006</ArticleId><ArticleId IdType="pmc">PMC6661409</ArticleId><ArticleId IdType="pubmed">31384663</ArticleId></ArticleIdList></Reference><Reference><Citation>Ta Park VM, Ton V, Yeo G, Tiet QQ, Vuong Q, &amp; Gallagher-Thompson D (2019). Vietnamese American dementia caregivers&#x2019; perceptions and experiences of a culturally tailored, evidence-based program to reduce stress and depression. Journal of Gerontological Nursing, 45(9), 39&#x2013;50. doi: 10.3928/00989134-20190813-05</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/00989134-20190813-05</ArticleId><ArticleId IdType="pubmed">31437289</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricco AC, Lillie E, Zarin W, O&#x2019;Brien KK, Colquhoun H, Levac D, &#x2026; Straus SE (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169(7), 467&#x2013;473. doi:10.7326/M18-0850</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-0850</ArticleId><ArticleId IdType="pubmed">30178033</ArticleId></ArticleIdList></Reference><Reference><Citation>USAGov. (2021). Caregiver Support. Retrieved February
18 from https://www.usa.gov/disability-caregiver</Citation></Reference><Reference><Citation>US Department of Health and Human Services. (2022). Increase the proportion of adults with limited English proficiency who say their providers explain things clearly &#x2014; HC/HIT-D11. Retrieved July 28, 2022 from https://health.gov/healthypeople/objectives-and-data/browse-objectives/health-communication/increase-proportion-adults-limited-english-proficiency-who-say-their-providers-explain-things-clearly-hchit-d11</Citation></Reference><Reference><Citation>Yong F, &amp; McCallion P (2003). Hwabyung as caregiving stress among Korean-American caregivers of a relative with dementia. Journal of Gerontological Social Work, 42(2), 3&#x2013;19. doi:10.1300/J083v42n02_02</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J083v42n02_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarit SH, Lee JE, Barrineau MJ, Whitlatch CJ, &amp; Femia EE (2013). Fidelity and acceptability of an adaptive intervention for caregivers: An exploratory study. Aging &amp; Mental Health, 17(2), 197&#x2013;206. doi:10.1080/13607863.2012.717252</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2012.717252</ArticleId><ArticleId IdType="pmc">PMC3570581</ArticleId><ArticleId IdType="pubmed">22943746</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36261123</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-5708</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of geriatric psychiatry and neurology</Title><ISOAbbreviation>J Geriatr Psychiatry Neurol</ISOAbbreviation></Journal><ArticleTitle>Family Carers of People with Dementia in Japan, Spain, and the UK: A Cross-Cultural Comparison of the Relationships between Experiential Avoidance, Cognitive Fusion, and Carer Depression.</ArticleTitle><Pagination><StartPage>254</StartPage><EndPage>264</EndPage><MedlinePgn>254-264</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/08919887221130269</ELocationID><Abstract><AbstractText><b>Objective and research design</b> This study investigated whether the relationship between experiential avoidance and carer depression is mediated by cognitive fusion using path analysis and whether this model differs between family carers from Japan, Spain, and the UK using multi-group path analysis. <b>Results</b> The whole sample model (<i>N</i>&#xa0;= 745) showed a good fit to the data. The direct effect of experiential avoidance on carer depression (<i>&#x3b2;</i>&#xa0;= .10) and its indirect effect on carer depression through cognitive fusion (<i>&#x3b2;</i>&#xa0;= .15) were significant. Examined variables accounted for 45% of the variance of depression. Multi-group path analysis confirmed the same pattern of indirect path across 3 countries, while the direct path was no longer significant in Spanish and UK samples.<b>Conclusion</b> These findings suggest that targeting cognitive fusion may be particularly critical in culturally diverse carers and pre-emptive efforts to reduce experiential avoidance using psychological techniques may be beneficial among family carers prone to cognitive fusion regardless of cultural differences.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kishita</LastName><ForeName>Naoko</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-8453-2714</Identifier><AffiliationInfo><Affiliation>School of Health Sciences, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morimoto</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Faculty of Psychology, Meiji Gakuin University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe1;rquez-Gonz&#xe1;lez</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biological and Clinical Psychology, Universidad Aut&#xf3;noma de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrera-Caballero</LastName><ForeName>Samara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychology, Universidad Rey Juan Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vara-Garc&#xed;a</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychology, Universidad Rey Juan Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Hout</LastName><ForeName>Elien</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-2956-7575</Identifier><AffiliationInfo><Affiliation>School of Health Sciences, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Milena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Health Sciences, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Losada-Baltar</LastName><ForeName>Andr&#xe9;s</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3134-7133</Identifier><AffiliationInfo><Affiliation>Department of Psychology, Universidad Rey Juan Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PB-PG-0418-20001</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Geriatr Psychiatry Neurol</MedlineTA><NlmUniqueID>8805645</NlmUniqueID><ISSNLinking>0891-9887</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003431" MajorTopicYN="N">Cross-Cultural Comparison</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acceptance and commitment therapy</Keyword><Keyword MajorTopicYN="N">alzheimer's disease</Keyword><Keyword MajorTopicYN="N">caregivers</Keyword><Keyword MajorTopicYN="N">cultural-comparison</Keyword><Keyword MajorTopicYN="N">depression</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>19</Day><Hour>19</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36261123</ArticleId><ArticleId IdType="pmc">PMC10114255</ArticleId><ArticleId IdType="doi">10.1177/08919887221130269</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . Global status report on the public health response to dementia. September 1. 2021. Available at:https://www.who.int/publications/i/item/9789240033245</Citation></Reference><Reference><Citation>Yu DSF, Cheng S-T, Wang J. Unravelling positive aspects of caregiving in dementia: An integrative review of research literature. International Journal of Nursing Studies. 2018;79:1-26. doi:10.1016/j.ijnurstu.2017.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2017.10.008</ArticleId><ArticleId IdType="pubmed">29128685</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins R, Kishita N. Prevalence of depression and burden among informal caregivers of people with dementia: A meta-analysis. Ageing and Society. 2020;40(11):2355-2392. doi:10.1017/S0144686X19000527</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0144686X19000527</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson F, van Ommeren M, Flaxman A, Cornett J, Whiteford H, Saxena S. New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis. The Lancet. 2019;394(10194):240-248. doi:10.1016/S0140-6736(19)30934-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30934-1</ArticleId><ArticleId IdType="pmc">PMC6657025</ArticleId><ArticleId IdType="pubmed">31200992</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenmakers B, Buntinx F, Delepeleire J. Factors determining the impact of care-giving on caregivers of elderly patients with dementia. A systematic literature review. Maturitas. 2010;66(2):191-200</Citation><ArticleIdList><ArticleId IdType="pubmed">20307942</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight BG, Sayegh P. Cultural values and caregiving: The updated sociocultural stress and coping model. The Journals of Gerontology: Series B. 2010;65B(1):5-13.</Citation><ArticleIdList><ArticleId IdType="pubmed">19934166</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy: The process and practice of mindful change. 2nd ed.New York: Guilford Press; 2012.</Citation></Reference><Reference><Citation>Rose A, Trounson JS, Louise S, Shepherd S, Ogloff JRP. Mental health, psychological distress, and coping in Australian cross&#x2010;cultural prison populations. Journal of Traumatic Stress. 2020;33(5):794-803. doi:10.1002/jts.22515</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jts.22515</ArticleId><ArticleId IdType="pubmed">32339357</ArticleId></ArticleIdList></Reference><Reference><Citation>Monest&#xe8;s J-L, Karekla M, Jacobs N, et al.Experiential avoidance as a common psychological process in European cultures. European Journal of Psychological Assessment. 2018;34(4):247-257. doi:10.1027/1015-5759/a000327</Citation><ArticleIdList><ArticleId IdType="doi">10.1027/1015-5759/a000327</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras M, Mioshi E, Kishita N. Factors predicting quality of life in family carers of people with dementia: The role of psychological inflexibility. Journal of Contextual Behavioral Science. 2021;22:7-12. doi:10.1016/j.jcbs.2021.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcbs.2021.08.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Moreno R, Losada A, M&#xe1;rquez-Gonz&#xe1;lez M, Mausbach BT. Stressors and anxiety in dementia caregiving: multiple mediation analysis of rumination, experiential avoidance, and leisure. International Psychogeriatrics. 2016;28(11):1835-1844.</Citation><ArticleIdList><ArticleId IdType="pubmed">27457894</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishita N, Contreras ML, West J, Mioshi E. Exploring the impact of carer stressors and psychological inflexibility on depression and anxiety in family carers of people with dementia. Journal of Contextual Behavioral Science. 2020;17:119-125.</Citation></Reference><Reference><Citation>Romero-Moreno R, Mrquez-Gonzlez M, Losada A, Gillanders D, Fernndez-Fernndez V. Cognitive fusion in dementia caregiving: Psychometric properties of the Spanish version of the 'Cognitive Fusion Questionnaire. Behavioral Psychology/ Psicologia Conductual. 2014;22(1):117-132.</Citation></Reference><Reference><Citation>Barrera-Caballero S, Romero-Moreno R, Vara-Garc&#xed;a C, et al.Longitudinal effects of stress and cognitive fusion in anxiety and depressive symptoms of family caregivers. Innovation in Aging. 2021;5:278-278.</Citation></Reference><Reference><Citation>Barrera-Caballero S, Romero-Moreno R, Del Sequeros Pedroso-Chaparro M, et al.Stress, cognitive fusion and comorbid depressive and anxiety symptomatology in dementia caregivers. Psychol Aging. 2021;36(5):667-676.</Citation><ArticleIdList><ArticleId IdType="pubmed">34351188</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardeen JR, Fergus TA. The interactive effect of cognitive fusion and experiential avoidance on anxiety, depression, stress and posttraumatic stress symptoms. Journal of Contextual Behavioral Science. 2016;5(1):1-6.</Citation></Reference><Reference><Citation>Ai X, Xiong L, Siliang W, et al.Relationship between cognitive fusion, experiential avoidance, and obsessive-compulsive symptoms in patients with obsessive-compulsive disorder. Frontiers in Psychology. 2021;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8072044</ArticleId><ArticleId IdType="pubmed">33912117</ArticleId></ArticleIdList></Reference><Reference><Citation>Cookson C, Luzon O, Newland J, Kingston J. Examining the role of cognitive fusion and experiential avoidance in predicting anxiety and depression. Psychology and psychotherapy. 2020;93(3):456-473.</Citation><ArticleIdList><ArticleId IdType="pubmed">30994261</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto H, Kishita N, Kondo H, et al.Reliability and validity of the Japanese version of the Experiential Avoidance in Caregiving Questionnaire (EACQ). Manuscript submitted for publication; 2021.</Citation></Reference><Reference><Citation>Kishita N, Gould RL, Farquhar M, et al.Internet-delivered guided self-help Acceptance and Commitment Therapy for family carers of people with dementia (iACT4CARERS): A feasibility study. Advanced online publication; 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9629048</ArticleId><ArticleId IdType="pubmed">34617489</ArticleId></ArticleIdList></Reference><Reference><Citation>Losada A, M&#xe1;rquez-Gonz&#xe1;lez M, Romero-Moreno R, L&#xf3;pez J. Development and validation of the Experiential Avoidance in Caregiving Questionnaire (EACQ). Aging &amp; Mental Health. 2014;18(7):897-904.</Citation><ArticleIdList><ArticleId IdType="pubmed">24678984</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan E, Deane FP, Crowe T. Pilot of an acceptance and commitment therapy and schema group intervention for mental health carer's interpersonal problems. Journal of Contextual Behavioral Science. 2018;9:53-62.</Citation></Reference><Reference><Citation>Gillanders DT, Bolderston H, Bond FW, et al.The development and initial validation of the cognitive fusion questionnaire. Behavior Therapy. 2014;45(1):83-101.</Citation><ArticleIdList><ArticleId IdType="pubmed">24411117</ArticleId></ArticleIdList></Reference><Reference><Citation>Shima T, Kawai T, Yanagihara M, Kumano H. Validation of the Japanese version of the Cognitive Fusion Questionnaire: The 13-item content revised version and the 7-item version. Japanese Journal of Behavior Therapy. 2016;42(1):73-83.</Citation></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine. 2001;16(9):606-613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Muramatsu K, Kamijima K, Yoshida M, et al.The Patient Health Questionnaire, Japanese version: Validity according to the Mini-International Neuropsychiatric Interview&#x2013;Plus. Psychological Reports. 2007;101(3):952-960.</Citation><ArticleIdList><ArticleId IdType="pubmed">18232454</ArticleId></ArticleIdList></Reference><Reference><Citation>Losada A, Villareal Mdl&#xc1;, Nuevo R, et al.Cross-cultural confirmatory factor analysis of the CES-D in Spanish and Mexican dementia caregivers. The Spanish journal of psychology. 2012;15(2):783-792. doi:10.5209/rev_SJOP.2012.v15.n2.38890</Citation><ArticleIdList><ArticleId IdType="doi">10.5209/rev_SJOP.2012.v15.n2.38890</ArticleId><ArticleId IdType="pubmed">22774452</ArticleId></ArticleIdList></Reference><Reference><Citation>Radloff L. The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement. 1977;1(3):385-401. doi:10.1177/014662167700100306</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/014662167700100306</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro JK. Z-score. In: Lavrakas PJ, ed. Encyclopedia of survey research methods. Thousand Oaks, CA: Sage Publications, Inc.; 2008:968-968.</Citation></Reference><Reference><Citation>Hair JF, Black WC, Babin BJ, Anderson RE. Multivariate data analysis. Harlow, UK: PearsonPearson Education UK; 2013.</Citation></Reference><Reference><Citation>Hu Lt, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural equation Modeling: A Multidisciplinary Journal. 1999;6(1):1-55. doi:10.1080/10705519909540118</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10705519909540118</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopper D, Coughlan J, Mullen M. Structural equation modelling: Guidelines for determining model fit. Electronic Journal of Business Research Methods. 2008;6(1):53-60. doi:10.21427/D7CF7R</Citation><ArticleIdList><ArticleId IdType="doi">10.21427/D7CF7R</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoelter JW. The analysis of covariance structures: Goodness-of-fit indices. Sociological Methods &amp; Research. 1983;11(3):325-344. doi:10.1177/0049124183011003003</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0049124183011003003</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng ST, Zhang F, Li KK, et al.The effectiveness of nonpharmacological interventions for informal dementia caregivers: An updated systematic review and meta-analysis. Psychology and Aging. 2020;35(1):55-77. doi:10.1037/pag0000401</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/pag0000401</ArticleId><ArticleId IdType="pubmed">31985249</ArticleId></ArticleIdList></Reference><Reference><Citation>Young HM, Bell JF, Whitney RL, et al.Social determinants of health: Underreported heterogeneity in systematic reviews of caregiver interventions. The Gerontologist. 2020;60(Suppl 1):S14-S28. doi:10.1093/geront/gnz148</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnz148</ArticleId><ArticleId IdType="pmc">PMC7019663</ArticleId><ArticleId IdType="pubmed">32057083</ArticleId></ArticleIdList></Reference><Reference><Citation>George C, Boyce M, Evans R, Ferreira N. Valuing the caregiver: a feasibility study of an acceptance and commitment therapy (ACT) group intervention for dementia caregivers. Working With Older People: Practical Approaches to Work, Leisure, Lifestyle and Learning. 2020;25(1):94-104. doi:10.1108/WWOP-09-2020-0049</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/WWOP-09-2020-0049</ArticleId></ArticleIdList></Reference><Reference><Citation>Losada A, M&#xe1;rquez-Gonz&#xe1;lez M, Romero-Moreno R, et al.Cognitive&#x2013;behavioral therapy (CBT) versus acceptance and commitment therapy (ACT) for dementia family caregivers with significant depressive symptoms: Results of a randomized clinical trial. Journal of Consulting and Clinical Psychology. 2015;83(4):760-772. doi:10.1037/ccp0000028</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/ccp0000028</ArticleId><ArticleId IdType="pubmed">26075381</ArticleId></ArticleIdList></Reference><Reference><Citation>Marquez-Gonzalez MA-O, Romero-Moreno R, Cabrera I, et al.Tailored versus manualized interventions for dementia caregivers: The functional analysis-guided modular intervention. Psychology and Aging. 2020;35:41-45. doi:10.1037/pag0000412</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/pag0000412</ArticleId><ArticleId IdType="pubmed">31985248</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto H, Nomura N. A group-based cognitive behavioral therapy program for family caregivers of people with dementia: Feasibility and preliminary outcomes. Japanese Journal of Clinical Geropsychology. 2022;3:8-20.</Citation></Reference><Reference><Citation>Gallego-Alberto L, M&#xe1;rquez-Gonz&#xe1;lez M, Romero-Moreno R, Cabrera I, Losada A. Pilot study of a psychotherapeutic intervention for reducing guilt feelings in highly distressed dementia family caregivers (Innovative practice). Dementia. 2021;20(2):759-769. doi:10.1177/1471301219886761</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301219886761</ArticleId><ArticleId IdType="pubmed">31707841</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler NR, Judge KS, Lucas K, et al.Feasibility and acceptability of an acceptance and commitment therapy intervention for caregivers of adults with Alzheimer&#x2019;s disease and related dementias. BMC Geriatrics. 2021;21(1):1-10. doi:10.1186/s12877-021-02078-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02078-0</ArticleId><ArticleId IdType="pmc">PMC7885205</ArticleId><ArticleId IdType="pubmed">33593296</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauth EB, Novak JR, Levin ME. Outcomes from a pilot online Acceptance and Commitment Therapy program for dementia family caregivers. Aging &amp; mental health 2022;26(8):1620-1629. doi:10.1080/13607863.2021.1942432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2021.1942432</ArticleId><ArticleId IdType="pubmed">34233133</ArticleId></ArticleIdList></Reference><Reference><Citation>Han A, Yuen HK, Jenkins J, Yun Lee H. Acceptance and Commitment Therapy (ACT) guided online for distressed caregivers of persons living with dementia. Clinical Gerontologist 2022;45(4):927-938. doi:10.1080/07317115.2021.1908475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07317115.2021.1908475</ArticleId><ArticleId IdType="pubmed">33794127</ArticleId></ArticleIdList></Reference><Reference><Citation>Woidneck MR, Pratt KM, Gundy JM, Nelson CR, Twohig MP. Exploring cultural competence in acceptance and commitment therapy outcomes. Professional Psychology: Research and Practice. 2012;43(3):227-233. doi:10.1037/a0026235</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0026235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabogal F, Mar&#xed;n G, Otero-Sabogal R, Mar&#xed;n BV, Perez-Stable EJ. Hispanic familism and acculturation: What changes and what doesn't? Hispanic Journal of Behavioral Sciences. 1987;9(4):397-412. doi:10.1177/07399863870094003</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/07399863870094003</ArticleId></ArticleIdList></Reference><Reference><Citation>Losada A, Shurgot GR, Knight BG, et al.Cross-cultural study comparing the association of familism with burden and depressive symptoms in two samples of Hispanic dementia caregivers. Aging &amp; Mental Health. 2006;10(1):69-76. doi:10.1080/13607860500307647</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607860500307647</ArticleId><ArticleId IdType="pubmed">16338817</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson C, Evans-Lacko S, Flach C, Thornicroft G. Responses to mental health stigma questions: The importance of social desirability and data collection method. The Canadian Journal of Psychiatry. 2012;57(3):152-160. doi:10.1177/070674371205700304</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/070674371205700304</ArticleId><ArticleId IdType="pubmed">22398001</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36255690</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1720-8319</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Aging clinical and experimental research</Title><ISOAbbreviation>Aging Clin Exp Res</ISOAbbreviation></Journal><ArticleTitle>Implementation of the Community Occupational Therapy in Dementia program in Italy (COTiD-IT): qualitative survey to identify barriers and facilitators in implementation.</ArticleTitle><Pagination><StartPage>53</StartPage><EndPage>60</EndPage><MedlinePgn>53-60</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40520-022-02273-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Community Occupational Therapy in Dementia in Italy (COTID-IT) is a feasible and effective treatment that aims improving the quality of life and well-being of people with dementia and caregivers. The implementation of the program in the national context has not been studied yet.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">The objective of this study is to identify barriers and facilitators in the Italian implementation of the program.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We designed a quantitative cross-sectional survey. A questionnaire was developed to collect descriptive data regarding the respondents, the perceived barriers and facilitators regarding the application of COTiD and possible actions to promote the implementation process.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The questionnaire was sent to all 90 Italian OTs trained in the use of COTiD-IT from 2013 to 2020. 50 people responded (61%). Barriers to the implementation of the COTID-IT included lack of knowledge about Occupational Therapy and the COTID-IT program by other health professionals. In addition, the scarcity of economic funds invested in home rehabilitation is experienced as another significant barrier. Facilitators were found to be the presence of an interprofessional team interested in the COTID-IT program and occupational therapy and the fact that COTID-IT is supported by scientific evidence. The creation of national and regional inter professional education and support groups, the availability of online resources are seen as opportunities to better implement the COTID-IT program.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Implementation of psychosocial interventions is complex. OTs in Italy should be increasingly included within health policies and care programs of people with dementia to promote the use of COTID-IT. Further studies are needed to detail the policy and methodological actions that OTs should take in the future to disseminate and consolidate this intervention.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lanzoni</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9477-1006</Identifier><AffiliationInfo><Affiliation>Cognitive Disorders and Dementia Unit, Department of Primary Care, AUSL Modena, Modena, Italy. a.lanzoni@ausl.mo.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bachelor of Occupational Therapy, University of Modena and Reggio Emilia, Modena, Italy. a.lanzoni@ausl.mo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pozzi</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Applied Sciences and Arts of Southern Switzerland, Centre of Competence On Ageing, Manno, Ticino, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>PhD Student Public, Health University Milano Bicocca, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucchi</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Elisabetta Germani Foundation, Cingia de Botti (CR), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabbo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cognitive Disorders and Dementia Unit, Department of Primary Care, AUSL Modena, Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bachelor of Occupational Therapy, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graff</LastName><ForeName>Maud J L</ForeName><Initials>MJL</Initials><AffiliationInfo><Affiliation>Scientific Institute for Quality of Healthcare and Department of Rehabilitation, Radboud University Medical Center, Radboud Institute for Health Sciences, Radboud Alzheimer Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xf6;pp</LastName><ForeName>Carola M E</ForeName><Initials>CME</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Radboud University Medical Center, Radboud Institute for Health Sciences, Radboud Alzheimer Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Aging Clin Exp Res</MedlineTA><NlmUniqueID>101132995</NlmUniqueID><ISSNLinking>1594-0667</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009788" MajorTopicYN="Y">Occupational Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COTiD</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Implementation</Keyword><Keyword MajorTopicYN="N">Occupational therapy</Keyword><Keyword MajorTopicYN="N">Psychosocial</Keyword><Keyword MajorTopicYN="N">Rehabilitation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36255690</ArticleId><ArticleId IdType="doi">10.1007/s40520-022-02273-y</ArticleId><ArticleId IdType="pii">10.1007/s40520-022-02273-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO (2017) Dementia fact sheet. https://www.who.int/news-room/fact-sheets/detail/dementia .</Citation></Reference><Reference><Citation>Prince MJ et al (2015 World Alzheimer Report 2015 - The global impact of dementia, London, Alzheimer's Disease International</Citation></Reference><Reference><Citation>Logsdon RG, Mccurry SM, Teri L (2007) Evidence-based interventions to improve quality of life for individuals with dementia. Alzheimers care today 8:309&#x2013;318</Citation></Reference><Reference><Citation>Van Den Kieboom R, Snaphaan L, Mark R et al (2020) The trajectory of caregiver burden and risk factors in dementia progression: a systematic review. J Alzheimers Dis 77:1107&#x2013;1115. https://doi.org/10.3233/JAD-200647</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200647</ArticleId></ArticleIdList></Reference><Reference><Citation>Bressan V, Visintini C, Palese A (2020) What do family caregivers of people with dementia need? A mixed-method systematic review. Health Soc Care Communy 28:1942&#x2013;1960. https://doi.org/10.1111/hsc.13048</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hsc.13048</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston G et al (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet commission. The Lancet 396:413&#x2013;446. https://doi.org/10.1016/s0140-6736(20)30367-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)30367-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett S et al (2019) Occupational therapy for people with dementia and their family carers provided at home: a systematic review and meta-analysis. BMJ Open 9:e026308. https://doi.org/10.1136/bmjopen-2018-026308</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-026308</ArticleId></ArticleIdList></Reference><Reference><Citation>Graff MJ et al (2008) Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study. BMJ 336:134&#x2013;138. https://doi.org/10.1136/bmj.39408.481898.BE</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39408.481898.BE</ArticleId></ArticleIdList></Reference><Reference><Citation>Graff MJ et al (2007) Effects of community occupational therapy on quality of life, mood, and health status in dementia patients and their caregivers: a randomized controlled trial. J Gerontol A Biol Sci Med Sci 62:1002&#x2013;1009. https://doi.org/10.1093/gerona/62.9.1002</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/62.9.1002</ArticleId></ArticleIdList></Reference><Reference><Citation>Graff MJ et al (2006) Community based occupational therapy for patients with dementia and their care givers: randomised controlled trial. BMJ 333:1196. https://doi.org/10.1136/bmj.39001.688843.BE</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39001.688843.BE</ArticleId></ArticleIdList></Reference><Reference><Citation>Graff MJL (2015) Community Occupational Therapy in older people with dementia and their caregivers in the Netherlands and Europe. Japan Occupat Therapy Res J (JOTR) 34&#x2013;2</Citation></Reference><Reference><Citation>Wenborn J et al (2016) Community occupational therapy for people with dementia and family carers (COTiD-UK) versus treatment as usual (Valuing Active Life in Dementia [VALID] programme): study protocol for a randomised controlled trial. Trials 17:65. https://doi.org/10.1186/s13063-015-1150-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-015-1150-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigt-Radloff S et al (2011) Why did an effective Dutch complex psycho-social intervention for people with dementia not work in the German healthcare context? Lessons learnt from a process evaluation alongside a multicentre RCT. BMJ Open 1:e000094. https://doi.org/10.1136/bmjopen-2011-000094</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2011-000094</ArticleId></ArticleIdList></Reference><Reference><Citation>Graff M, Thijssen M, Van Melick M et al. (2013) L'ergoth&#xe9;rapie chez les personnes &#xe2;g&#xe9;es atteintes de d&#xe9;mence et leurs aidants, De Boeck Superieur</Citation></Reference><Reference><Citation>Pozzi C et al (2019) A pilot study of community-based occupational therapy for persons with dementia (COTID-IT Program) and their caregivers: evidence for applicability in Italy. Aging Clin Exp Res 31:1299&#x2013;1304. https://doi.org/10.1007/s40520-018-1078-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-018-1078-7</ArticleId></ArticleIdList></Reference><Reference><Citation>PDCDM (1992) DPCM. Definizione e aggiornamento dei livelli essenziali di assistenza, di cui all'articolo 1, comma 7, del decreto legislativo 30 dicembre 1992, n. 502. (17A02015). Gazzetta Ufficiale - Serie Generale, n.65</Citation></Reference><Reference><Citation>Dopp CM, Graff MJ, Rikkert MG et al (2013) Determinants for the effectiveness of implementing an occupational therapy intervention in routine dementia care. Implement Sci 8:131. https://doi.org/10.1186/1748-5908-8-131</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1748-5908-8-131</ArticleId></ArticleIdList></Reference><Reference><Citation>Dopp CM et al (2013) Effectiveness of a multifaceted implementation strategy on physicians&#x2019; referral behavior to an evidence-based psychosocial intervention in dementia: a cluster randomized controlled trial. BMC Fam Pract 14:70. https://doi.org/10.1186/1471-2296-14-70</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2296-14-70</ArticleId></ArticleIdList></Reference><Reference><Citation>Graff MJ, Bergamini L, Chamberlain M et al (2020) Occupational Therapy in the Community. Occupational Therapy for Older People. Springer</Citation></Reference><Reference><Citation>Campbell M et al (2000) Framework for design and evaluation of complex interventions to improve health. BMJ 321:694&#x2013;696. https://doi.org/10.1136/bmj.321.7262.694</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.321.7262.694</ArticleId></ArticleIdList></Reference><Reference><Citation>Van&#x2019;t Leven N et al (2012) Barriers to and facilitators for the use of an evidence-based occupational therapy guideline for older people with dementia and their carers. Int J Geriatr Psychiatry 27:742&#x2013;748. https://doi.org/10.1002/gps.2782</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.2782</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Veen DJ et al (2019) Factors influencing the implementation of home-based stroke rehabilitation: professionals&#x2019; perspective. PLoS ONE 14:e0220226. https://doi.org/10.1371/journal.pone.0220226</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0220226</ArticleId></ArticleIdList></Reference><Reference><Citation>Saint-Pierre C, Herskovic V, Sepulveda M (2018) Multidisciplinary collaboration in primary care: a systematic review. Fam Pract 35:132&#x2013;141. https://doi.org/10.1093/fampra/cmx085</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmx085</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobben C, Van Dongen J, Bokhoven L et al (2016) Best practices interprofessionele samenwerking. Tijdschrift voor praktijkondersteuning 11:6&#x2013;11. https://doi.org/10.1007/s12503-016-0007-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12503-016-0007-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieuwboer MS et al (2018) Identification of influencing factors and strategies to improve communication between general practitioners and community nurses: a qualitative focus group study. Fam Pract 35:619&#x2013;625. https://doi.org/10.1093/fampra/cmy009</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmy009</ArticleId></ArticleIdList></Reference><Reference><Citation>Pingani L et al (2013) Who cares for it? How to provide psychosocial interventions in the community. Int J Soc Psychiatry 59:701&#x2013;705. https://doi.org/10.1177/0020764012453812</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0020764012453812</ArticleId></ArticleIdList></Reference><Reference><Citation>Giezendanner S et al (2019) General practitioners&#x2019; attitudes towards early diagnosis of dementia: a cross-sectional survey. BMC Fam Pract 20:65. https://doi.org/10.1186/s12875-019-0956-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12875-019-0956-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Heard CP (2014) Choosing the path of leadership in occupational therapy. Open J Occupat Therapy 2:2. https://doi.org/10.15453/2168-6408.1055</Citation><ArticleIdList><ArticleId IdType="doi">10.15453/2168-6408.1055</ArticleId></ArticleIdList></Reference><Reference><Citation>Knapp M, Iemmi V, Romeo R (2013) Dementia care costs and outcomes: a systematic review. Int J Geriatr Psychiatry 28:551&#x2013;561. https://doi.org/10.1002/gps.3864</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.3864</ArticleId></ArticleIdList></Reference><Reference><Citation>De Coninck L et al (2017) Home- and community-based occupational therapy improves functioning in frail older people: a systematic review. J Am Geriatr Soc 65:1863&#x2013;1869. https://doi.org/10.1111/jgs.14889</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.14889</ArticleId></ArticleIdList></Reference><Reference><Citation>RER (2021) Lo stato di avanzamento del progetto regionale demenze al 31/12/2020. https://salute.regione.emilia-romagna.it/normativa-e-documentazione/rapporti/demenza/relazione-demenze-2019 .</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36193737</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-4523</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of applied gerontology : the official journal of the Southern Gerontological Society</Title><ISOAbbreviation>J Appl Gerontol</ISOAbbreviation></Journal><ArticleTitle>Longitudinal Predictors of Informant-Rated Involvement of People with Dementia in Everyday Decision-Making: Findings from the IDEAL Program.</ArticleTitle><Pagination><StartPage>290</StartPage><EndPage>301</EndPage><MedlinePgn>290-301</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/07334648221128558</ELocationID><Abstract><AbstractText>The extent to which people with dementia are involved in everyday decision-making is unclear. We explored informant-rated involvement of people with dementia in everyday decision-making over 2&#xa0;years and whether functional, behavioral, and psychological factors related to the person with dementia and the caregiver explain variability in involvement of people with dementia in everyday decision-making. We used IDEAL data for 1182 people with dementia and their caregivers. Baseline mean score on the decision-making involvement scale was 31/45; it minimally declined over time. People with dementia who were female, single, and/or whose caregiver was younger had greater involvement in everyday decision-making than those without these characteristics. Better cognition, fewer functional difficulties, fewer neuropsychiatric symptoms, less caregiver stress, and better informant-rated relationship quality were associated with higher involvement in everyday decision-making. Cognitive and functional rehabilitation, and educational resources for caregivers, could prolong involvement of people with dementia in everyday decision-making.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sabatini</LastName><ForeName>Serena</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3618-6949</Identifier><AffiliationInfo><Affiliation>Faculty of Biomedical Sciences, 27216University of Italian Switzerland, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martyr</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1702-8902</Identifier><AffiliationInfo><Affiliation>Centre for Research in Ageing and Cognitive Health,3286 Faculty of Health and Life Sciences, University of Exeter Medical School, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gamble</LastName><ForeName>Laura D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Population Health Sciences Institute, Newcastle University, Newcastle, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre for Research in Ageing and Cognitive Health,3286 Faculty of Health and Life Sciences, University of Exeter Medical School, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matthews</LastName><ForeName>Fiona E</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Population Health Sciences Institute, Newcastle University, Newcastle, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Robin G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Department of Psychology, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rusted</LastName><ForeName>Jennifer M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-1341-6334</Identifier><AffiliationInfo><Affiliation>School of Psychology, 1948University of Sussex, Brighton, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pentecost</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre for Research in Ageing and Cognitive Health,3286 Faculty of Health and Life Sciences, University of Exeter Medical School, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre for Applied Dementia Studies, Bradford University, Bradford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wolfson Centre for Applied Health Research, Bradford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clare</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Research in Ageing and Cognitive Health,3286 Faculty of Health and Life Sciences, University of Exeter Medical School, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>behalf of the IDEAL study team</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PEC 16-001</GrantID><Acronym>VA</Acronym><Agency>VA</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Appl Gerontol</MedlineTA><NlmUniqueID>8606502</NlmUniqueID><ISSNLinking>0733-4648</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">caregiver stress</Keyword><Keyword MajorTopicYN="N">caregiving</Keyword><Keyword MajorTopicYN="N">cognitive capacity</Keyword><Keyword MajorTopicYN="N">functional ability</Keyword><Keyword MajorTopicYN="N">neuropsychiatric symptoms</Keyword><Keyword MajorTopicYN="N">relationship quality</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>4</Day><Hour>4</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36193737</ArticleId><ArticleId IdType="pmc">PMC9841822</ArticleId><ArticleId IdType="doi">10.1177/07334648221128558</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adler G. (2010). Driving decision-making in older adults with dementia. Dementia, 9(1), 45&#x2013;60. 10.1177/1471301209350289</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301209350289</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer Europe . (2020). Legal capacity and decision making: The ethical implications of lack of legal capacity on the lives of people with dementia.</Citation></Reference><Reference><Citation>American Psychiatric Association . (2013). Diagnostic and statistical manual of mental disorders (DSM-5&#xae;). American Psychiatric Association.</Citation></Reference><Reference><Citation>Bonds K., Song M., Whitlatch C. J., Lyons K. S., Kaye J. A., Lee C. S. (2021). Patterns of dyadic appraisal of decision-making involvement of African American persons living with dementia. The Gerontologist, 61(3), 383&#x2013;391. 10.1093/geront/gnaa086</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnaa086</ArticleId><ArticleId IdType="pmc">PMC8023360</ArticleId><ArticleId IdType="pubmed">32609831</ArticleId></ArticleIdList></Reference><Reference><Citation>Caron C. D., Griffith J., Arcand M. (2005). End-of-life decision making in dementia: The perspective of family caregivers. Dementia, 4(1), 113&#x2013;136. 10.1177/1471301205049193</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301205049193</ArticleId></ArticleIdList></Reference><Reference><Citation>Chunga R. E., Kim K., Liu Y., Zarit S. H. (2021). Family caregivers&#x2019; distress responses to daily behavioral and psychological symptoms of dementia: The moderating role of relationship quality. International Journal of Geriatric Psychiatry, 36(6), 822&#x2013;830. 10.1002/gps.5482</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5482</ArticleId><ArticleId IdType="pubmed">33271629</ArticleId></ArticleIdList></Reference><Reference><Citation>Clare L., Kudlicka A., Oyebode J. R., Jones R. W., Bayer A., Leroi I., Kopelman M., James I. A., Culverwell A., Pool J. (2019. a). Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: The GREAT RCT. Health Technology Assessment, 23(10). 10.3310/hta23100</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/hta23100</ArticleId><ArticleId IdType="pmc">PMC6441850</ArticleId><ArticleId IdType="pubmed">30879470</ArticleId></ArticleIdList></Reference><Reference><Citation>Clare L., Kudlicka A., Oyebode J. R., Jones R. W., Bayer A., Leroi I., Kopelman M., James I. A., Culverwell A., Pool J. (2019. b). Individual goal-oriented cognitive rehabilitation to improve everyday functioning for people with early-stage dementia: A multicentre randomised controlled trial (the GREAT trial). International Journal of Geriatric Psychiatry, 34(5), 709&#x2013;721. 10.1002/gps.5076</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5076</ArticleId><ArticleId IdType="pmc">PMC6593854</ArticleId><ArticleId IdType="pubmed">30724405</ArticleId></ArticleIdList></Reference><Reference><Citation>Clare L., Nelis S. M., Quinn C., Martyr A., Henderson C., Hindle J. V., Jones I. R., Jones R. W., Knapp M., Kopelman M. D. (2014). Improving the experience of dementia and enhancing active life-living well with dementia: Study protocol for the IDEAL study. Health and Quality of Life Outcomes, 12(1), 164&#x2013;173. 10.1093/geroni/igx004.4934</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geroni/igx004.4934</ArticleId><ArticleId IdType="pmc">PMC4260182</ArticleId><ArticleId IdType="pubmed">25433373</ArticleId></ArticleIdList></Reference><Reference><Citation>Clare L., Nelis S. M., Whitaker C. J., Martyr A., Markova I. S., Roth I., Woods R. T., Morris R. G. (2012). Marital relationship quality in early-stage dementia: Perspectives from people with dementia and their spouses. Alzheimer Disease and Associated Disorders, 26(2), 148&#x2013;158. 10.1097/WAD.0b013e318221ba23</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0b013e318221ba23</ArticleId><ArticleId IdType="pubmed">21685780</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins R., Hunt A., Quinn C., Martyr A., Pentecost C., Clare L. (2022). Methods and approaches for enhancing communication with people with moderate-to-severe dementia that can facilitate their inclusion in research and service evaluation: Findings from the IDEAL programme. Dementia, 21(4), 1135&#x2013;1153. 10.1177/14713012211069449</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14713012211069449</ArticleId><ArticleId IdType="pmc">PMC9109550</ArticleId><ArticleId IdType="pubmed">35156412</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis R., Ziomkowski M. K., Veltkamp A. (2017). Everyday decision making in individuals with early-stage Alzheimer&#x2019;s disease: An integrative review of the literature. Research in Gerontological Nursing, 10(5), 240&#x2013;247. 10.3928/19404921-20170831-05</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/19404921-20170831-05</ArticleId><ArticleId IdType="pubmed">28926672</ArticleId></ArticleIdList></Reference><Reference><Citation>Delazer M., Sinz H., Zamarian L., Benke T. (2007). Decision-making with explicit and stable rules in mild Alzheimer&#x2019;s disease. Neuropsychologia, 45(8), 1632&#x2013;1641. 10.1016/j.neuropsychologia.2007.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropsychologia.2007.01.006</ArticleId><ArticleId IdType="pubmed">17328931</ArticleId></ArticleIdList></Reference><Reference><Citation>Feinberg L. F., Whitlatch C. J. (2001, June). Are persons with cognitive impairment able to state consistent choices? The Gerontologist, 41(3), 374&#x2013;382. 10.1093/geront/41.3.374</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/41.3.374</ArticleId><ArticleId IdType="pubmed">11405435</ArticleId></ArticleIdList></Reference><Reference><Citation>Fetherstonhaugh D., Tarzia L., Nay R. (2013). Being central to decision making means I am still here!: The essence of decision making for people with dementia. Journal of Aging Studies, 27(2), 143&#x2013;150. 10.1016/j.jaing.2012.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaing.2012.12.007</ArticleId><ArticleId IdType="pubmed">23561279</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein M. F., Folstein S. E., McHugh P. R. (1975). Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189&#x2013;198. 10.1016/0022-3956(75)90026-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3956(75)90026-6</ArticleId><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene J. G., Smith R., Gardiner M., Timbury G. C. (1982). Measuring behavioural disturbance of elderly demented patients in the community and its effects on relatives: A factor analytic study. Age and Ageing, 11(2), 121&#x2013;126. 10.1093/ageing/11.2.121</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/11.2.121</ArticleId><ArticleId IdType="pubmed">7102472</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Care Consent Act . (1996). https://canlii.ca/t/5563d</Citation></Reference><Reference><Citation>Hirschman K. B., Joyce C. M., James B. D., Xie S. X., Karlawish J. H. T. (2005). Do Alzheimer's disease patients want to participate in a treatment decision, and would their caregivers let them? The Gerontologist, 45(3), 381&#x2013;388. 10.1093/geront/45.3.381</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/45.3.381</ArticleId><ArticleId IdType="pubmed">15933278</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh S., Schubert S., Hoon C., Mioshi E., Hodges J. R. (2013). Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer&#x2019;s disease. Dementia and Geriatric Cognitive Disorders, 36(3&#x2013;4), 242&#x2013;250. 10.1159/000351671</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351671</ArticleId><ArticleId IdType="pubmed">23949210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufer D. I., Cummings J. L., Ketchel P., Smith V., MacMillan A., Shelley T., Lopez O. L., DeKosky S. T. (2000). Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. The Journal of Neuropsychiatry and Clinical Neurosciences, 12(2), 233&#x2013;239. 10.1176/appi.neuropsych.12.2.233</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.neuropsych.12.2.233</ArticleId><ArticleId IdType="pubmed">11001602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H., Chang M., Rose K., Kim S. (2012). Predictors of caregiver burden in caregivers of individuals with dementia. Journal of Advanced Nursing, 68(4), 846&#x2013;855. 10.1111/j.1365-2648.2011.05787.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2648.2011.05787.x</ArticleId><ArticleId IdType="pubmed">21793872</ArticleId></ArticleIdList></Reference><Reference><Citation>Martyr A., Clare L. (2012). Executive function and activities of daily living in Alzheimer&#x2019;s disease: A correlational meta-analysis. Dementia and Geriatric Cognitive Disorders, 33(2&#x2013;3), 189&#x2013;203. 10.1159/000338233</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000338233</ArticleId><ArticleId IdType="pubmed">22572810</ArticleId></ArticleIdList></Reference><Reference><Citation>Martyr A., Nelis S. M., Quinn C., Rusted J. M., Morris R. G., Clare L., on behalf of the Ideal programme team (2019). The relationship between perceived functional difficulties and the ability to live well with mild-to-moderate dementia: Findings from the IDEAL programme. International Journal of Geriatric Psychiatry, 34(8), 1251&#x2013;1261. 10.1002/gps.5128</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5128</ArticleId><ArticleId IdType="pmc">PMC6767698</ArticleId><ArticleId IdType="pubmed">31034650</ArticleId></ArticleIdList></Reference><Reference><Citation>Menne H. L., Judge K. S., Whitlatch C. J. (2009). Predictors of quality of life for individuals with dementia: Implications for intervention. Dementia, 8(4), 543&#x2013;560. 10.1177/1471301209350288</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301209350288</ArticleId></ArticleIdList></Reference><Reference><Citation>Menne H. L., Kinney J. M., Morhardt D. J. (2002). &#x2018;Trying to continue to do as much as they can do&#x2019; Theoretical insights regarding continuity and meaning making in the face of dementia. Dementia, 1(3), 367&#x2013;382. 10.1177/147130120200100308</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/147130120200100308</ArticleId></ArticleIdList></Reference><Reference><Citation>Menne H. L., Tucke S. S., Whitlatch C. J., Feinberg L. F. (2008). Decision-making involvement scale for individuals with dementia and family caregivers. American Journal of Alzheimer&#x2019;s Disease &amp; Other Dementias&#xae;, 23(1), 23&#x2013;29. 10.1177/153317507308312</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/153317507308312</ArticleId><ArticleId IdType="pmc">PMC10846107</ArticleId><ArticleId IdType="pubmed">18276955</ArticleId></ArticleIdList></Reference><Reference><Citation>Menne H. L., Whitlatch C. J. (2007). Decision-making involvement of individuals with dementia. The Gerontologist, 47(6), 810&#x2013;819. 10.1093/geront/47.6.810</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/47.6.810</ArticleId><ArticleId IdType="pubmed">18192634</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller L. M., Whitlatch C. J., Lyons K. S. (2014). Shared decision-making in dementia: A review of patient and family carer involvement. Dementia, 15(5), 1141&#x2013;1157. 10.1177/1471301214555542</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301214555542</ArticleId><ArticleId IdType="pubmed">25370075</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Justice . (2007). Code of practice of the mental capacity act 2005. https://www.gov.uk/government/publications/mental-capacity-act-code-of-practice</Citation></Reference><Reference><Citation>Mondini S., Madella I., Zangrossi A., Bigolin A., Tomasi C., Michieletto M., Villani D., Di Giovanni G., Mapelli D. (2016). Cognitive reserve in dementia: Implications for cognitive training. Frontiers in Aging Neuroscience, 8, 84. 10.3389/fnagi.2016.00084</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2016.00084</ArticleId><ArticleId IdType="pmc">PMC4844602</ArticleId><ArticleId IdType="pubmed">27199734</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris J. C., National Alzheimer&#x2019;s Coordinating Center . (2008). NACC uniform data set (UDS) coding guidebook for initial visit packet.</Citation></Reference><Reference><Citation>Muth&#xe9;n L. K., Muth&#xe9;n B. O. (1998. &#x2013;2017). Mplus user&#x2019;s guide (Eighth Edition).</Citation></Reference><Reference><Citation>Nuzum H., Stickel A., Corona M., Zeller M., Melrose R. J., Wilkins S. S. (2020). Potential benefits of physical activity in MCI and dementia. Behavioural Neurology, 2020, 7807856. 10.1155/2020/7807856</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/7807856</ArticleId><ArticleId IdType="pmc">PMC7037481</ArticleId><ArticleId IdType="pubmed">32104516</ArticleId></ArticleIdList></Reference><Reference><Citation>Opdebeeck C., Katsaris M. A., Martyr A., Lamont R. A., Pickett J. A., Rippon I., Thom J. M., Victor C., Clare L. (2021). What are the benefits of pet ownership and care among people with mild-to-moderate dementia? Findings from the IDEAL programme. Journal of Applied Gerontology, 40(11), 1559&#x2013;1567. 10.1177/0733464820962619</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464820962619</ArticleId><ArticleId IdType="pmc">PMC8564240</ArticleId><ArticleId IdType="pubmed">33025847</ArticleId></ArticleIdList></Reference><Reference><Citation>Opdebeeck C., Martyr A., Clare L. (2016). Cognitive reserve and cognitive function in healthy older people: A meta-analysis. Aging, Neuropsychology, and Cognition, 23(1), 40&#x2013;60. 10.1080/13825585.2015.1041450</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13825585.2015.1041450</ArticleId><ArticleId IdType="pubmed">25929288</ArticleId></ArticleIdList></Reference><Reference><Citation>Perren S., Schmid R., Wettstein A. (2006). Caregivers&#x2019; adaptation to change: The impact of increasing impairment of persons suffering from dementia on their caregivers&#x2019; subjective well-being. Aging &amp; Mental Health, 10(5), 539&#x2013;548. 10.1080/13607860600637844</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607860600637844</ArticleId><ArticleId IdType="pubmed">16938689</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer R. I., Kurosaki T. T., Harrah C. H., Jr, Chance G. M., Filos S. (1982). Measurement of functional activities in older adults in the community. Journal of Gerontology, 37, 323&#x2013;329. 10.1093/geronj/37.3.323</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronj/37.3.323</ArticleId><ArticleId IdType="pubmed">7069156</ArticleId></ArticleIdList></Reference><Reference><Citation>Piguet O., Hornberger M., Mioshi E., Hodges J. R. (2011). Behavioural-variant frontotemporal dementia: Diagnosis, clinical staging, and management. The Lancet Neurology, 10(2), 162&#x2013;172. 10.1016/S1474-4422(10)70299-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70299-4</ArticleId><ArticleId IdType="pubmed">21147039</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn C., Nelis S. M., Martyr A., Morris R. G., Victor C., Clare L. (2020). Caregiver influences on &#x2018;living well&#x2019;for people with dementia: Findings from the IDEAL study. Aging &amp; Mental Health, 24(9), 1505&#x2013;1513. 10.1080/13607863.2019.1602590</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2019.1602590</ArticleId><ArticleId IdType="pubmed">31104475</ArticleId></ArticleIdList></Reference><Reference><Citation>Samsi K., Manthorpe J. (2013). Everyday decision-making in dementia: Findings from a longitudinal interview study of people with dementia and family carers. International Psychogeriatrics, 25(6), 949&#x2013;961. 10.1017/S1041610213000306</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610213000306</ArticleId><ArticleId IdType="pubmed">23510662</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinz H., Zamarian L., Benke T., Wenning G. K., Delazer M. (2008). Impact of ambiguity and risk on decision making in mild Alzheimer&#x2019;s disease. Neuropsychologia, 46(7), 2043&#x2013;2055. 10.1016/j.neuropsychologia.2008.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropsychologia.2008.02.002</ArticleId><ArticleId IdType="pubmed">18339408</ArticleId></ArticleIdList></Reference><Reference><Citation>StataCorp . (2017). Stata statistical software: Release 16. College Station, TX2016.</Citation></Reference><Reference><Citation>Stern Y. (2009). Cognitive reserve. Neuropsychologia, 47(10), 2015&#x2013;2028. 10.1016/j.neuropsychologia.2009.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropsychologia.2009.03.004</ArticleId><ArticleId IdType="pmc">PMC2739591</ArticleId><ArticleId IdType="pubmed">19467352</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson M., McDowell M. E., Taylor B. J. (2018). Concepts for communication about risk in dementia care: A review of the literature. Dementia, 17(3), 359&#x2013;390. 10.1177/1471301216647542</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301216647542</ArticleId><ArticleId IdType="pubmed">27178999</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh G. H., Ju Y. S., Yeon B. K., Shah A. (2004). A longitudinal study of Alzheimer&#x2019;s disease: Rates of cognitive and functional decline. International Journal of Geriatric Psychiatry, 19(9), 817&#x2013;824. 10.1002/gps.1168</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.1168</ArticleId><ArticleId IdType="pubmed">15352138</ArticleId></ArticleIdList></Reference><Reference><Citation>The Department of Health . (2000). The adults with incapacity (Scotland) Act 2000. http://www.legislation.gov.uk/asp/2000/4/contents</Citation></Reference><Reference><Citation>Thein N. W., D'Souza G., Sheehan B. (2011). Expectations and experience of moving to a care home: Perceptions of older people with dementia. Dementia, 10(1), 7&#x2013;18. 10.1177/1471301210392971</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301210392971</ArticleId></ArticleIdList></Reference><Reference><Citation>United Nations&#x2019; Convention on the Rights of Persons with Disabilities . (2022). https://www.un.org/development/desa/disabilities/convention-on-the-rights-of-persons-with-disabilities.html</Citation><ArticleIdList><ArticleId IdType="pubmed">18348362</ArticleId></ArticleIdList></Reference><Reference><Citation>van Horik J. O., Collins R., Martyr A., Henderson C., Jones R. W., Knapp M., Quinn C., Thom J. M., Victor C., Clare L. (2022). Limited receipt of support services among people with mild-to-moderate dementia: Findings from the IDEAL cohort. International Journal of Geriatric Psychiatry, 37(3). 10.1002/gps.5688</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5688</ArticleId><ArticleId IdType="pmc">PMC9306706</ArticleId><ArticleId IdType="pubmed">35128725</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitlatch C., Menne H. L. (2009). Don't forget about me! Decision making by people with dementia. Generations, 33(1), 66&#x2013;73.</Citation></Reference><Reference><Citation>World Health Organization . (2018). ICD-11: International statistical classification of diseases and related health problems: Eleventh revision. World Health Organization. https://apps.who.int/iris/handle/10665/42980</Citation></Reference><Reference><Citation>World Health Organization . (2021). https://www.who.int/news-room/fact-sheets/detail/dementia</Citation></Reference><Reference><Citation>Yates L., Csipke E., Moniz-Cook E., Leung P., Walton H., Charlesworth G., Spector A., Hogervorst E., Mountain G., Orrell M. (2019). The development of the promoting independence in dementia (PRIDE) intervention to enhance independence in dementia. Clinical Interventions in Aging, 14, 1615&#x2013;1630. 10.2147/CIA.S214367</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S214367</ArticleId><ArticleId IdType="pmc">PMC6748161</ArticleId><ArticleId IdType="pubmed">31571842</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36184924</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-4523</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of applied gerontology : the official journal of the Southern Gerontological Society</Title><ISOAbbreviation>J Appl Gerontol</ISOAbbreviation></Journal><ArticleTitle>Creating a Dementia Friendly Community in an African American Neighborhood: Perspectives of People Living with Dementia, Care Partners, Stakeholders, and Community Residents.</ArticleTitle><Pagination><StartPage>280</StartPage><EndPage>289</EndPage><MedlinePgn>280-289</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/07334648221130055</ELocationID><Abstract><AbstractText>A dementia friendly community allows people with dementia and their care partners to remain engaged in their community well into the disease. This study presents the results of primary research aimed at exploring perceptions regarding building a dementia friendly community in an African American neighborhood in northeast Florida. Twelve focus groups and five interviews were conducted with people living with dementia, informal and formal care partners, community stakeholders and neighborhood residents, and analyzed using a grounded theory approach. Three main themes emerged from the analyses, including (1) perceived needs, (2) facilitators and barriers to being dementia friendly, and (3) opportunities for the community to become more dementia friendly. Study findings highlight the unique needs of a single African American neighborhood and the importance of culturally tailoring the dementia friendly model to diverse communities.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bergeron</LastName><ForeName>Caroline D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>156400Outreach, Recruitment and Engagement Core, Alzheimer's Disease Research Center, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Maisha T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>156400Outreach, Recruitment and Engagement Core, Alzheimer's Disease Research Center, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willis</LastName><ForeName>Floyd B</ForeName><Initials>FB</Initials><AffiliationInfo><Affiliation>156400Outreach, Recruitment and Engagement Core, Alzheimer's Disease Research Center, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albertie</LastName><ForeName>Monica L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>156400Outreach, Recruitment and Engagement Core, Alzheimer's Disease Research Center, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wainwright</LastName><ForeName>Jolita D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>156400Outreach, Recruitment and Engagement Core, Alzheimer's Disease Research Center, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fudge</LastName><ForeName>Michelle R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>156400Outreach, Recruitment and Engagement Core, Alzheimer's Disease Research Center, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parfitt</LastName><ForeName>Francine C</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>156400Outreach, Recruitment and Engagement Core, Alzheimer's Disease Research Center, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucas</LastName><ForeName>John A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0001-5805-8799</Identifier><AffiliationInfo><Affiliation>156400Outreach, Recruitment and Engagement Core, Alzheimer's Disease Research Center, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG062677</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG016574</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002377</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Appl Gerontol</MedlineTA><NlmUniqueID>8606502</NlmUniqueID><ISSNLinking>0733-4648</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001741" MajorTopicYN="Y">Black or African American</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017144" MajorTopicYN="N">Focus Groups</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012111" MajorTopicYN="N">Residence Characteristics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">African Americans</Keyword><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">dementia friendly</Keyword><Keyword MajorTopicYN="N">focus groups</Keyword></KeywordList><CoiStatement>Declaration of Conflicting Interests. The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>3</Day><Hour>3</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36184924</ArticleId><ArticleId IdType="mid">NIHMS1868199</ArticleId><ArticleId IdType="pmc">PMC9906431</ArticleId><ArticleId IdType="doi">10.1177/07334648221130055</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>AARP International. (2016). Better together: A comparative analysis of age-friendly and dementia friendly communities. https://static1.squarespace.com/static/559c4229e4b0482682e8df9b/t/5ac7b779575d1f6647a0da53/1523038075662/AARP-SummaryReport_BetterTogether_March2016+%281%29.pdf</Citation></Reference><Reference><Citation>ACT on Alzheimer&#x2019;s. (2021). Dementia friendly communities toolkit. https://www.actonalz.org/dementia-friendly-toolkit</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Association. (2020a). 2020 Alzheimer&#x2019;s disease facts and figures. Alzheimer&#x2019;s &amp; Dementia, 16(3), 391&#x2013;460. 10.1002/alz.12068</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12068</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Association. (2020b). Race, ethnicity, and Alzheimer&#x2019;s. https://www.alz.org/aaic/downloads2020/2020_Race_and_Ethnicity_Fact_Sheet.pdf</Citation></Reference><Reference><Citation>Bronfenbrenner U (1979). The ecology of human development: Experiments by nature and design. Harvard University Press.</Citation></Reference><Reference><Citation>City of Jacksonville (2019). Duval county health zone data. http://apps2.coj.net/City_Council_Public_Notices_Repository/20191108%20CRC%20Duval%20County%20Health%20Zone%20Data.pdf</Citation></Reference><Reference><Citation>Dementia Friendly America. (2021a). Community toolkit. https://www.dfamerica.org/community-toolkit-introduction</Citation></Reference><Reference><Citation>Dementia Friendly America. (2021b). Emerging communities. https://www.dfamerica.org/dfa-communities</Citation></Reference><Reference><Citation>Desin P, Caban-Holt A, Abner E, Van Eldik L, &amp; Schmitt F (2016). Factors associated with unmet needs among African-American dementia care providers. Journal of Gerontology &amp; Geriatric Research, 5(1), 267. 10.4172/2167-7182.1000267</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2167-7182.1000267</ArticleId><ArticleId IdType="pmc">PMC4864855</ArticleId><ArticleId IdType="pubmed">27182464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebert AR, Kulibert D, &amp; McFadden SH (2020). Effects of dementia knowledge and dementia fear on comfort with people having dementia: Implications for dementia-friendly communities. Dementia, 19(8), 2542&#x2013;2554. 10.1177/1471301219827708</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301219827708</ArticleId><ArticleId IdType="pubmed">30739490</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaugler JE, Bain LJ, Mitchell L, Finlay J, Fazio S, Jutkowitz E, the Alzheimer&#x2019;s Association Psychosocial Measurement Work-group Banerjee S, Butrum K, Fazio S, Gaugler J, Gitlin L, Hodgson N, Kallmyer B, Le Meyer O, Logsdon R, Maslow K, &amp; Zimmerman S (2019). Reconsidering frameworks of Alzheimer&#x2019;s dementia when assessing psychosocial outcomes. Alzheimer&#x2019;s &amp; Dementia: Translational Research &amp; Clinical Interventions, 5(1), 388&#x2013;397. 10.1016/j.trci.2019.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2019.02.008</ArticleId><ArticleId IdType="pmc">PMC6708985</ArticleId><ArticleId IdType="pubmed">31463361</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitlin LN, &amp; Hodgson N (2015). Caregivers as therapeutic agents in dementia care. In Family caregiving in the new normal (pp. 305&#x2013;353). Elsevier. 10.1016/B978-0-12-417046-9.00017-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-417046-9.00017-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren A, Montgomery W, Kahle-Wrobleski K, Nakamura T, &amp; Ueda K (2016). Impact of caring for persons with Alzheimer&#x2019;s disease or dementia on caregivers&#x2019; health outcomes: Findings from a community based survey in Japan. BMC Geriatrics, 16(1), 122. 10.1186/s12877-016-0298-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-016-0298-y</ArticleId><ArticleId IdType="pmc">PMC4903014</ArticleId><ArticleId IdType="pubmed">27287238</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung L, Leitch S, Hung R, &amp; Phinney A (2020). Creating dementia-friendly and inclusive communities for social inclusion: A scoping review protocol. BMJ Open, 10(6), e035028. 10.1136/bmjopen-2019-035028</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2019-035028</ArticleId><ArticleId IdType="pmc">PMC7304818</ArticleId><ArticleId IdType="pubmed">32554722</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin P, Daly A, Olchanski N, Cohen JT, Neumann PJ, Faul JD, Fillit HM, &amp; Freund KM (2020). Dementia diagnosis disparities by race and ethnicity: Health services research: Cost of care and implications for intervention. Alzheimer&#x2019;s &amp; Dementia, 16(S10), e043183. 10.1002/alz.043183</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.043183</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S-Y, &amp; Lewis FM (2015). Dementia friendly, dementia capable, and dementia positive: Concepts to prepare for the future. The Gerontologist, 55(2), 237&#x2013;244. 10.1093/geront/gnu122</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnu122</ArticleId><ArticleId IdType="pmc">PMC4553703</ArticleId><ArticleId IdType="pubmed">26035599</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak LS, Horne E, Brackett JR, Meyer K, &amp; Ajtai RM (2020). Dementia-friendly communities: A review of current literature and reflections on implementation. Current Geriatrics Reports, 9(3), 176&#x2013;182. 10.1007/s13670-020-00325-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13670-020-00325-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Odzakovic E, Hellstr&#xf6;m I, Nedlund A-C, &amp; Kullberg A (2021). Health promotion initiative: A dementia-friendly local community in Sweden. Dementia, 20(6), 1971&#x2013;1987. 10.1177/1471301220977736</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301220977736</ArticleId><ArticleId IdType="pmc">PMC8361469</ArticleId><ArticleId IdType="pubmed">33290090</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillipson L, Hall D, Cridland E, Fleming R, Brennan-Horley C, Guggisberg N, Frost D, &amp; Hasan H (2019). Involvement of people with dementia in raising awareness and changing attitudes in a dementia friendly community pilot project. Dementia, 18(7&#x2013;8), 2679&#x2013;2694. 10.1177/1471301218754455</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301218754455</ArticleId><ArticleId IdType="pubmed">29363336</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss A, &amp; Corbin J (1998). Basics of qualitative research: Procedures and techniques for developing grounded theory. Sage Publications.</Citation></Reference><Reference><Citation>Ward R, Clark A, Campbell S, Graham B, Kullberg A, Manji K, Rummery K, &amp; Keady J (2018). The lived neighborhood: Understanding how people with dementia engage with their local environment. International Psychogeriatrics, 30(6), 867&#x2013;880. 10.1017/S1041610217000631</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610217000631</ArticleId><ArticleId IdType="pmc">PMC6088530</ArticleId><ArticleId IdType="pubmed">28462764</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams F, Moghaddam N, Ramsden S, &amp; De Boos D (2019). Interventions for reducing levels of burden amongst informal carers of persons with dementia in the community. A systematic review and meta-analysis of randomised controlled trials. Aging &amp; Mental Health, 23(12), 1629&#x2013;1642. 10.1080/13607863.2018.1515886</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2018.1515886</ArticleId><ArticleId IdType="pubmed">30450915</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36178152</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1364-6915</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>Aging &amp; mental health</Title><ISOAbbreviation>Aging Ment Health</ISOAbbreviation></Journal><ArticleTitle>Development and psychometric testing of the dyadic communication observational coding scheme in DEmentia care (DCODE): family dyadic communication in dementia.</ArticleTitle><Pagination><StartPage>1770</StartPage><EndPage>1779</EndPage><MedlinePgn>1770-1779</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/13607863.2022.2126819</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">Understanding family dyadic communication in dementia is essential to promote the well-being of family caregivers and persons living with dementia. The Dyadic Communication Observational coding scheme in DEmentia care (DCODE) was developed and tested to assess family dyadic communication in dementia.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The DCODE was developed from a review of literature, expert review, and pretesting. A secondary analysis of the 75 in-home care video observations from 19 family caregiver-care recipient dyads was conducted to test psychometric properties.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The DCODE consists of 43 caregiver items and 41 care recipient items. We observed internal consistency, intra-rater reliability, and inter-rater reliability as adequate. Content validity and convergent validity were moderate. Predictive validity was moderate in predicting caregiver burden. The overall psychometric properties demonstrated a moderate quality of the DCODE.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Findings provided the preliminary psychometric evidence of the DCODE as a promising instrument to assess family dyadic communication in dementia. Future testing for concurrent, divergent, and structural validity of the DCODE is needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sohyun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Elaine Marieb College of Nursing, University of Massachusetts, Amherst, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>College of Nursing, University of Iowa, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daack-Hirsch</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College of Nursing, University of Iowa, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Kristine N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>School of Nursing, University of Kansas, Kansas City, KS, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Aging Ment Health</MedlineTA><NlmUniqueID>9705773</NlmUniqueID><ISSNLinking>1360-7863</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">behavior observation techniques</Keyword><Keyword MajorTopicYN="N">caregiving&#x2014;informal</Keyword><Keyword MajorTopicYN="N">communication</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">measurement</Keyword><Keyword MajorTopicYN="N">nonverbal communication</Keyword><Keyword MajorTopicYN="N">video recording</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>30</Day><Hour>7</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36178152</ArticleId><ArticleId IdType="doi">10.1080/13607863.2022.2126819</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36177618</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1573-4056</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>8</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Current medical imaging</Title><ISOAbbreviation>Curr Med Imaging</ISOAbbreviation></Journal><ArticleTitle>Three Class Classification of Alzheimer's Disease Using Deep Neural Networks.</ArticleTitle><Pagination><StartPage>855</StartPage><EndPage>864</EndPage><MedlinePgn>855-864</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2174/1573405618666220929092341</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) is a prevalent type of dementia that can cause neurological brain disorders, poor decision making, impaired memory, mood swings, unstable emotions, and personality change. Deep neural networks are proficient in classifying Alzheimer's disease based on MRI images. This classification assists human experts in diagnosing AD and predicts its future progression. The paper proposes various Deep Neural Networks (DNN) for early AD detection to save cost and time for doctors, radiologists, and caregivers. A 3330-image-based Kaggle dataset is used to train the DNN, including 52 images of AD, 717 images of Mild Cognitive Impairment (MCI), and the remaining images of Cognitive Normal (CN). Stratified partitioning splits the dataset into 80% and 20% proportions for training and validation datasets. Proposed models include DenseNet169, DenseNet201, and Res- Net152 DNNs with additional three fully-connected layers and softmax and Kullback Leibler Divergence (KLD) loss function. These models are trained considering pre-trained, partially pre-trained, and fully re-trained extended base models. The KLD loss function reduces the error and increases accuracy for all models. The partially pre-trained DenseNet201 model outperformed all the other models. DenseNet201 gives the highest accuracy of 99.98% for training, 99.07% for validation, and 95.66% for test datasets. The DenseNet201 model has the highest accuracy in comparison to other state-of-artmethods.</AbstractText><CopyrightInformation>Copyright&#xa9; Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Deep R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, Nirma University, SG Highway, Post: Chandlodia, Gota, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapdi</LastName><ForeName>Rupal A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, Nirma University, SG Highway, Post: Chandlodia, Gota, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Jigna S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, Nirma University, SG Highway, Post: Chandlodia, Gota, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Jitali</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, Nirma University, SG Highway, Post: Chandlodia, Gota, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Med Imaging</MedlineTA><NlmUniqueID>101762461</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">DNN</Keyword><Keyword MajorTopicYN="N">DenseNet</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">ResNet</Keyword><Keyword MajorTopicYN="N">classification</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>30</Day><Hour>3</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36177618</ArticleId><ArticleId IdType="doi">10.2174/1573405618666220929092341</ArticleId><ArticleId IdType="pii">CMIR-EPUB-126635</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36167652</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1545-7214</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</Title><ISOAbbreviation>Am J Geriatr Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Telehealth Support for Dementia Caregivers During the COVID-19 Pandemic: Lessons Learned From the NYU Family Support Program.</ArticleTitle><Pagination><StartPage>14</StartPage><EndPage>21</EndPage><MedlinePgn>14-21</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jagp.2022.08.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1064-7481(22)00497-3</ELocationID><Abstract><AbstractText Label="OBJECTIVES">In response to the needs of dementia caregivers during the COVID-19 pandemic, the NYU Langone Alzheimer's Disease and Related Disorders Family Support Program (FSP) quickly transitioned to providing most services online. To understand how dementia caregivers experienced FSP services after the switch to video telehealth, we conducted qualitative interviews of spouse or partner dementia caregivers.</AbstractText><AbstractText Label="PARTICIPANTS">Ten participants were recruited from a convenience sample of dementia spouse or partner caregivers who used one or more online FSP services offered during the pandemic.</AbstractText><AbstractText Label="DESIGN">Caregivers engaged in semi-structured interviews held via videoconference between May and June 2020. Qualitative analysis of interviews was conducted according to the principles of framework analysis.</AbstractText><AbstractText Label="RESULTS">Caregivers reported high satisfaction with the FSP pre-pandemic and continued to feel supported when services were provided online. They transitioned to video telehealth services with little difficulty.</AbstractText><AbstractText Label="CONCLUSIONS">While video telehealth is frequently cited as beneficial for those in rural communities, socioeconomically disadvantaged groups, or homebound individuals, our findings suggest that video telehealth is also advantageous for dementia caregivers, given their unique barriers, including lack of time due to caregiving responsibilities, lack of respite care for the person with dementia, and the additional burdens of travel time to access in-person services.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>O'Connor</LastName><ForeName>Maureen K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Boston University School of Medicine (MKOC, AHN); VA Bedford Healthcare System (MKOC, AHN, SS).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Roscoe</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Chicago; University of Massachusetts Chan Medical School.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Epstein</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>NYU Langone Health (CE, TD, RS, ES, MSM).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donley</LastName><ForeName>Tiffany</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>NYU Langone Health (CE, TD, RS, ES, MSM).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salant</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>NYU Langone Health (CE, TD, RS, ES, MSM).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Andrew H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Boston University School of Medicine (MKOC, AHN); VA Bedford Healthcare System (MKOC, AHN, SS).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirk</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>VA Bedford Healthcare System (MKOC, AHN, SS).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevenson</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>NYU Langone Health (CE, TD, RS, ES, MSM).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mittelman</LastName><ForeName>Mary S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>NYU Langone Health (CE, TD, RS, ES, MSM). Electronic address: mary.mittelman@nyulangone.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG066512</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG062684</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Am J Geriatr Psychiatry</MedlineTA><NlmUniqueID>9309609</NlmUniqueID><ISSNLinking>1064-7481</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's Disease</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">caregiving</Keyword><Keyword MajorTopicYN="N">comprehensive support</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>27</Day><Hour>23</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36167652</ArticleId><ArticleId IdType="pmc">PMC9424119</ArticleId><ArticleId IdType="doi">10.1016/j.jagp.2022.08.005</ArticleId><ArticleId IdType="pii">S1064-7481(22)00497-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91:157&#x2013;160. doi: 10.23750/abm.v91i1.9397.</Citation><ArticleIdList><ArticleId IdType="doi">10.23750/abm.v91i1.9397</ArticleId><ArticleId IdType="pmc">PMC7569573</ArticleId><ArticleId IdType="pubmed">32191675</ArticleId></ArticleIdList></Reference><Reference><Citation>Giebel C, Hanna K, Cannon J, et al. Decision-making for receiving paid home care for dementia in the time of COVID-19: a qualitative study. BMC Geriatr. 2020;20:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7478902</ArticleId><ArticleId IdType="pubmed">32900360</ArticleId></ArticleIdList></Reference><Reference><Citation>Roach P, Zwiers A, Cox E, et al. Understanding the impact of the COVID-19 pandemic on well-being and virtual care for people living with dementia and care partners living in the community. Dementia. 2020;20:2007&#x2013;2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7952494</ArticleId><ArticleId IdType="pubmed">33381996</ArticleId></ArticleIdList></Reference><Reference><Citation>Savla J, Roberto KA, Blieszner R, et al. Dementia caregiving during the &#x201c;stay-at-home&#x201d; phase of COVID-19 pandemic. J Gerontol Ser B. 2021;76:e241&#x2013;e245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7546083</ArticleId><ArticleId IdType="pubmed">32827214</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashworth M, Baker AH. &#x2018;Time and space&#x2019;: carers&#x2019; views about respite care. Health Soc Care Community. 2000;8:50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">11560674</ArticleId></ArticleIdList></Reference><Reference><Citation>Giebel CM, Challis DJ, Montaldi D. A revised interview for deterioration in daily living activities in dementia reveals the relationship between social activities and well-being. Dementia. 2016;15:1068&#x2013;1081.</Citation><ArticleIdList><ArticleId IdType="pubmed">25280491</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant I, McKibbin CL, Taylor MJ, et al. In-home respite intervention reduces plasma epinephrine in stressed Alzheimer caregivers. Am J Geriatr Psychiatry. 2003;11:62&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">12527541</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodakowski J, Skidmore ER, Rogers JC, et al. Role of social support in predicting caregiver burden. Arch Phys Med Rehabil. 2012;93:2229&#x2013;2236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3508254</ArticleId><ArticleId IdType="pubmed">22824248</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandepitte S, Van Den Noortgate N, Putman K, et al. Effectiveness of respite care in supporting informal caregivers of persons with dementia: a systematic review. Int J Geriatr Psychiatry. 2016;31:1277&#x2013;1288.</Citation><ArticleIdList><ArticleId IdType="pubmed">27245986</ArticleId></ArticleIdList></Reference><Reference><Citation>Coope B, Ballard C, Saad K, et al. The prevalence of depression in the carers of dementia sufferers. Int J Geriatr Psychiatry. 1995;10:237&#x2013;242. doi: 10.1002/gps.930100310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.930100310</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinquart M, S&#xf6;rensen S. Differences between caregivers and noncaregivers in psychological health and physical health: a meta-analysis. Psychol Aging. Jun 2003;18:250&#x2013;267. doi: 10.1037/0882-7974.18.2.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0882-7974.18.2.250</ArticleId><ArticleId IdType="pubmed">12825775</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz R, Sherwood PR. Physical and mental health effects of family caregiving. J Soc Work Educ. 2008;44(suppl 3):105&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2791523</ArticleId><ArticleId IdType="pubmed">18797217</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf6;rensen S, Conwell Y. Issues in dementia caregiving: effects on mental and physical health, intervention strategies, and research needs. Am J Geriatr Psychiatry. 2011;19:491&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3774150</ArticleId><ArticleId IdType="pubmed">21502853</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittelman MS, Roth DL, Clay OJ, et al. Preserving health of Alzheimer caregivers: impact of a spouse caregiver intervention. Am J Geriatr Psychiatry. 2007;15:780&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pubmed">17804831</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittelman MS, Roth DL, Coon DW, et al. Sustained benefit of supportive intervention for depressive symptoms in caregivers of patients with Alzheimer's disease. Am J Psychiatry. 2004;161:850&#x2013;856.</Citation><ArticleIdList><ArticleId IdType="pubmed">15121650</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittelman MS, Roth DL, Haley WE, et al. Effects of a caregiver intervention on negative caregiver appraisals of behavior problems in patients with Alzheimer's disease: results of a randomized trial. J Gerontol Series B. 2004;59:P27&#x2013;P34.</Citation><ArticleIdList><ArticleId IdType="pubmed">14722336</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges-Machado F, Barros D, Ribeiro &#xd3;, et al. The effects of COVID-19 home confinement in dementia care: physical and cognitive decline, severe neuropsychiatric symptoms and increased caregiving burden. Am J Alzheimer's Dis Other Demen. 2020;35</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10623939</ArticleId><ArticleId IdType="pubmed">33295781</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen G, Russo MJ, Campos JA, et al. COVID-19 epidemic in Argentina: worsening of behavioral symptoms in elderly subjects with dementia living in the community. Front Psychiatry. 2020;11 doi: 10.3389/fpsyt.2020.00866.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2020.00866</ArticleId><ArticleId IdType="pmc">PMC7485090</ArticleId><ArticleId IdType="pubmed">33005158</ArticleId></ArticleIdList></Reference><Reference><Citation>Giebel C, Cannon J, Hanna K, et al. Impact of COVID-19 related social support service closures on people with dementia and unpaid carers: a qualitative study. Aging Ment Health. 2020;25:1281&#x2013;1288.</Citation><ArticleIdList><ArticleId IdType="pubmed">32954794</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown EE, Kumar S, Rajji TK, et al. Anticipating and mitigating the impact of the COVID-19 pandemic on Alzheimer's disease and related dementias. Am J Geriatr Psychiatry. 2020;28:712&#x2013;721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7165101</ArticleId><ArticleId IdType="pubmed">32331845</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaitheswaran S, Lakshminarayanan M, Ramanujam V, et al. Experiences and needs of caregivers of persons with dementia in India during the COVID-19 pandemic&#x2014;A qualitative study. Am J Geriatr Psychiatry. 2020;28:1185&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7340037</ArticleId><ArticleId IdType="pubmed">32736918</ArticleId></ArticleIdList></Reference><Reference><Citation>Altieri M, Santangelo G. The psychological impact of COVID-19 pandemic and lockdown on caregivers of people with dementia. Am J Geriatr Psychiatry. 2021;29:27&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577876</ArticleId><ArticleId IdType="pubmed">33153872</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz M, Martin P, Margrett JA, et al. Perceptions of technology among older adults. J Gerontol Nurs. 2013;39:42&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">23244061</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaportzis E, Giatsi Clausen M, Gow AJ. Older adults perceptions of technology and barriers to interacting with tablet computers: a focus group study. Front Psychol. 2017;8:1687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5649151</ArticleId><ArticleId IdType="pubmed">29071004</ArticleId></ArticleIdList></Reference><Reference><Citation>Appleman ER, O'Connor MK, Boucher SJ, et al. Teleneuropsychology clinic development and patient satisfaction. Clin Neuropsychol. 2021;35:819&#x2013;837.</Citation><ArticleIdList><ArticleId IdType="pubmed">33504268</ArticleId></ArticleIdList></Reference><Reference><Citation>Appleman ER, O'Connor MK, Rockefeller W, et al. Using video telehealth to deliver patient-centered collaborative care: the G-IMPACT Pilot. Clin Gerontol. 2020:1&#x2013;10. doi: 10.1080/07317115.2020.1738000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07317115.2020.1738000</ArticleId><ArticleId IdType="pubmed">32228299</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuffaro L, Di Lorenzo F, Bonavita S, et al. Dementia care and COVID-19 pandemic: a necessary digital revolution. Neurolog Sci. 2020;41:1977&#x2013;1979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7298162</ArticleId><ArticleId IdType="pubmed">32556746</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacsu J-DR, O&#x2019;Connell ME, Webster C, et al. A scoping review of COVID-19 experiences of people living with dementia. Can J Public Health. 2021;12:400&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023523</ArticleId><ArticleId IdType="pubmed">33825134</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale NK, Heath G, Cameron E, et al. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13:117. doi: 10.1186/1471-2288-13-117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-13-117</ArticleId><ArticleId IdType="pmc">PMC3848812</ArticleId><ArticleId IdType="pubmed">24047204</ArticleId></ArticleIdList></Reference><Reference><Citation>Glaser BG, Strauss AL. The Discovery of Grounded Theory: Strategies for Qualitative Research. Aldine; 1967.</Citation></Reference><Reference><Citation>Saunders B, Sim J, Kingstone T, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52:1893&#x2013;1907. doi: 10.1007/s11135-017-0574-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11135-017-0574-8</ArticleId><ArticleId IdType="pmc">PMC5993836</ArticleId><ArticleId IdType="pubmed">29937585</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenwald P, Stern ME, Clark S, et al. Older adults and technology: in telehealth, they may not be who you think they are. Int J Emergency Med. 2018;11:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5752645</ArticleId><ArticleId IdType="pubmed">29299704</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan DG, Kosteniuk J, Stewart N, et al. The telehealth satisfaction scale: reliability, validity, and satisfaction with telehealth in a rural memory clinic population. Telemedicine e-Health. 2014;20:997&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457516</ArticleId><ArticleId IdType="pubmed">25272141</ArticleId></ArticleIdList></Reference><Reference><Citation>Laver K, Liu E, Clemson L, et al. Does telehealth delivery of a dyadic dementia care program provide a noninferior alternative to face-to-face delivery of the same program? A randomized, controlled trial. Am J Geriatr Psychiatry. 2020;28:673&#x2013;682.</Citation><ArticleIdList><ArticleId IdType="pubmed">32234275</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodaty H, Thomson C, Thompson C, et al. Why caregivers of people with dementia and memory loss don't use services. Int J Geriatr Psychiatry. 2005;20:537&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pubmed">15920707</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckwalter KC, Davis LL, Wakefield BJ, et al. Telehealth for elders and their caregivers in rural communities. Fam Community Health. 2002;25:31&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">12802140</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim J, Goh J, Chionh HL, et al. Why do patients and their families not use services for dementia? Perspectives from a developed Asian country. Int Psychogeriatr. 2012;24:1571&#x2013;1580.</Citation><ArticleIdList><ArticleId IdType="pubmed">22647248</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y-RR, Schulz PJ. The effect of information communication technology interventions on reducing social isolation in the elderly: a systematic review. J Med Internet Res. 2016;18:e4596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4751336</ArticleId><ArticleId IdType="pubmed">26822073</ArticleId></ArticleIdList></Reference><Reference><Citation>Czaja SJ, Boot WR, Charness N, et al. Improving social support for older adults through technology: Findings from the PRISM randomized controlled trial. Gerontologist. 2018;58:467&#x2013;477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5946917</ArticleId><ArticleId IdType="pubmed">28201730</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorenko JA, Moran C, Flynn M, et al. Social isolation and psychological distress among older adults related to COVID-19: a narrative review of remotely-delivered interventions and recommendations. J Appl Gerontol. 2021;40:3&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">32914668</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosravi P, Rezvani A, Wiewiora A. The impact of technology on older adults&#x2019; social isolation. Comput Hum Behav. 2016;63:594&#x2013;603.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36149829</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1758-5368</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>04</Day></PubDate></JournalIssue><Title>The journals of gerontology. Series B, Psychological sciences and social sciences</Title><ISOAbbreviation>J Gerontol B Psychol Sci Soc Sci</ISOAbbreviation></Journal><ArticleTitle>Refining a Driving Retirement Program for Persons With Dementia and Their Care Partners: A Mixed Methods Evaluation of CarFreeMe&#x2122;-Dementia.</ArticleTitle><Pagination><StartPage>506</StartPage><EndPage>519</EndPage><MedlinePgn>506-519</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/geronb/gbac151</ELocationID><Abstract><AbstractText Label="OBJECTIVES">We adapted the CarFreeMe&#x2122;-Dementia program created by The University of Queensland for drivers in the United States. CarFreeMe&#x2122;-Dementia aims to assist drivers living with dementia and their care partners as they plan for or adjust to driving retirement. This semistructured program focuses on driving retirement education and support. Topics include how dementia affects driving, lifestyle planning, stress management, and alternative transportation options. This study evaluated the feasibility, acceptability, and utility of the CarFreeMe&#x2122;-Dementia intervention.</AbstractText><AbstractText Label="METHODS">This pilot phase of the study included 16 care partners and 11 drivers with memory loss who were preparing for or adjusting to driving retirement. Participants completed 4-8 CarFreeMe&#x2122;-Dementia intervention telehealth sessions. Online surveys (baseline, 1- and 3-month) and postintervention semistructured interviews informed evaluation of the intervention program using a mixed methods approach.</AbstractText><AbstractText Label="RESULTS">This study established initial support for CarFreeMe&#x2122;-Dementia in the United States. Participants indicated the program facilitated dialogue around driving retirement and provided guidance on community engagement without driving. Respondents appreciated the program's emphasis on overall well-being, promoted through lifestyle planning and stress management. They also reported the program offered practical preparation for transitioning to driving retirement.</AbstractText><AbstractText Label="DISCUSSION">The CarFreeMe&#x2122;-Dementia intervention, tailored to an American audience, appears to be a feasible, acceptable, and useful support program for drivers with memory loss (and/or their care partners) who are preparing for or adjusting to driving retirement. Further investigations of the efficacy of the CarFreeMe&#x2122;-Dementia intervention in the United States, as well as in other countries and cultural contexts, are warranted.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peterson</LastName><ForeName>Colleen M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0002-0875-3440</Identifier><AffiliationInfo><Affiliation>Transportation Research Institute, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birkeland</LastName><ForeName>Robyn W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Louwagie</LastName><ForeName>Katie W</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ingvalson</LastName><ForeName>Stephanie N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Lauren L</ForeName><Initials>LL</Initials><Identifier Source="ORCID">0000-0002-7900-1924</Identifier><AffiliationInfo><Affiliation>Department of Psychology and Neuroscience, Emmanuel College, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Theresa L</ForeName><Initials>TL</Initials><Identifier Source="ORCID">0000-0002-6434-7121</Identifier><AffiliationInfo><Affiliation>School of Psychology, The University of Queensland, St Lucia, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liddle</LastName><ForeName>Jacki</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Health and Rehabilitation Sciences, The University of Queensland, St Lucia, Brisbane, Queensland, Australia and the Princess Alexandra Hospital in Woolloongabba, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pachana</LastName><ForeName>Nancy A</ForeName><Initials>NA</Initials><Identifier Source="ORCID">0000-0002-8927-4205</Identifier><AffiliationInfo><Affiliation>School of Psychology, The University of Queensland, St Lucia, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gustafsson</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Health Sciences and Social Work, Griffith University, Nathan, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaugler</LastName><ForeName>Joseph E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0003-4797-485X</Identifier><AffiliationInfo><Affiliation>School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 AG067537</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG067537</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Gerontol B Psychol Sci Soc Sci</MedlineTA><NlmUniqueID>9508483</NlmUniqueID><ISSNLinking>1079-5014</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012179" MajorTopicYN="N">Retirement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001334" MajorTopicYN="Y">Automobile Driving</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Caregiving</Keyword><Keyword MajorTopicYN="N">Observational studies</Keyword><Keyword MajorTopicYN="N">Qualitative methods</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>13</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36149829</ArticleId><ArticleId IdType="pmc">PMC9985324</ArticleId><ArticleId IdType="doi">10.1093/geronb/gbac151</ArticleId><ArticleId IdType="pii">6712607</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aksan, N., Anderson, S. W., Dawson, J., Uc, E., &amp; Rizzo, M. (2015). Cognitive functioning differentially predicts different dimensions of older drivers&#x2019; on-road safety. Accident Analysis and Prevention, 75, 236&#x2013;244. doi:10.1016/j.aap.2014.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aap.2014.12.007</ArticleId><ArticleId IdType="pmc">PMC4386614</ArticleId><ArticleId IdType="pubmed">25525974</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert, M. S. (2011). Changes in cognition. Neurobiology of Aging, 32(1), S58&#x2013;S63. doi:10.1016/j.neurobiolaging.2011.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3929949</ArticleId><ArticleId IdType="pubmed">22078174</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew, C., Traynor, V., &amp; Iverson, D. (2015). An integrative review: Understanding driving retirement decisions for individuals living with a dementia. Journal of Advanced Nursing, 71(12), 2728&#x2013;2740. doi:10.1111/jan.12727</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jan.12727</ArticleId><ArticleId IdType="pubmed">26224421</ArticleId></ArticleIdList></Reference><Reference><Citation>Betz, M. E., Jones, V. C., &amp; Lowenstein, S. R. (2014). Physicians and advance planning for &#x201c;driving retirement.&#x201d; The American Journal of Medicine, 127(8), 689&#x2013;690. doi:10.1016/j.amjmed.2014.03.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2014.03.025</ArticleId><ArticleId IdType="pmc">PMC4343034</ArticleId><ArticleId IdType="pubmed">24704316</ArticleId></ArticleIdList></Reference><Reference><Citation>Betz, M. E., Scott, K., Jones, J., &amp; Diguiseppi, C. (2016). &#x201c;Are you still driving?&#x201d; Metasynthesis of patient preferences for communication with health care providers. Traffic Injury Prevention, 17(4), 367&#x2013;373. doi:10.1080/15389588.2015.1101078</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15389588.2015.1101078</ArticleId><ArticleId IdType="pmc">PMC4842130</ArticleId><ArticleId IdType="pubmed">26507251</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun, V., &amp; Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77&#x2013;101. doi:10.1191/1478088706qp063oa</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/1478088706qp063oa</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, L. B., &amp; Ott, B. R. (2004). Driving and dementia: A review of the literature. Journal of Geriatric Psychiatry and Neurology, 17(4), 232&#x2013;240. doi:10.1177/0891988704269825</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988704269825</ArticleId><ArticleId IdType="pmc">PMC3292210</ArticleId><ArticleId IdType="pubmed">15533995</ArticleId></ArticleIdList></Reference><Reference><Citation>

Carmody, J., Traynor, V., &amp; Steele, A. (2015). Dementia, decision aids and general practice. Australian Family Physician, 44(5), 307&#x2013;310. https://www.racgp.org.au/afp/2015/may/dementia,-decision-aids-and-general-practice/</Citation><ArticleIdList><ArticleId IdType="pubmed">26042403</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee, J. N., Rapoport, M. J., Molnar, F., Herrmann, N., O&#x2019;Neill, D., Marottoli, R., Mitchell, S., Tant, M., Dow, J., Ayotte, D., Lanctot, K. L., McFadden, R., Taylor, J. P., Donaghy, P. C., Olsen, K., Classen, S., Elzohairy, Y., &amp; Carr, D. B. (2017). Update on the risk of motor vehicle collision or driving impairment with dementia: A collaborative international systematic review and meta-analysis. The American Journal of Geriatric Psychiatry, 25(12), 1376&#x2013;1390. doi:10.1016/j.jagp.2017.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2017.05.007</ArticleId><ArticleId IdType="pubmed">28917504</ArticleId></ArticleIdList></Reference><Reference><Citation>Chihuri, S., Mielenz, T. J., DiMaggio, C. J., Betz, M. E., DiGuiseppi, C., Jones, V. C., &amp; Li, G. (2016). Driving cessation and health outcomes in older adults. Journal of the American Geriatrics Society, 64(2), 332&#x2013;341. doi:10.1111/jgs.13931</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.13931</ArticleId><ArticleId IdType="pmc">PMC5021147</ArticleId><ArticleId IdType="pubmed">26780879</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobbs, B. M., Harper, L. A., &amp; Wood, A. (2009). Transitioning from driving to driving cessation: The role of specialized driving cessation support groups for individuals with dementia. Topics in Geriatric Rehabilitation, 25(1), 73&#x2013;86. doi:10.1097/01.TGR.0000346058.32801.95</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.TGR.0000346058.32801.95</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley, D. J., Masaki, K. H., Ross, G. W., &amp; White, L. R. (2000). Driving cessation in older men with incident dementia. Journal of the American Geriatrics Society, 48(8), 928&#x2013;930. doi:10.1111/j.1532-5415.2000.tb06889.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2000.tb06889.x</ArticleId><ArticleId IdType="pubmed">10968296</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraade-Blanar, L. A., Hansen, R. N., Chan, K. C. G., Sears, J. M., Thompson, H. J., Crane, P. K., &amp; Ebel, B. E. (2018). Diagnosed dementia and the risk of motor vehicle crash among older drivers. Accident Analysis and Prevention, 113, 47&#x2013;53. doi:10.1016/j.aap.2017.12.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aap.2017.12.021</ArticleId><ArticleId IdType="pmc">PMC5869102</ArticleId><ArticleId IdType="pubmed">29407668</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaugler, J. E., Bain, L. J., Mitchell, L., Finlay, J., Fazio, S., Jutkowitz, E., Banerjee, S., Butrum, K., Fazio, S., Gaugler, J., Gitlin, L., Hodgson, N., Kallmyer, B., Le Meyer, O., Logsdon, R., Maslow, K., &amp; Zimmerman, S. (2019). Reconsidering frameworks of Alzheimer&#x2019;s dementia when assessing psychosocial outcomes. Alzheimer&#x2019;s and Dementia, 5, 388&#x2013;397. doi:10.1016/j.trci.2019.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2019.02.008</ArticleId><ArticleId IdType="pmc">PMC6708985</ArticleId><ArticleId IdType="pubmed">31463361</ArticleId></ArticleIdList></Reference><Reference><Citation>Gergerich, E. M. (2016). Reporting policy regarding drivers with dementia. Gerontologist, 56(2), 345&#x2013;356. doi:10.1093/geront/gnv143</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnv143</ArticleId><ArticleId IdType="pubmed">26608332</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson, L. A., Liddle, J. M., Lua, S., Hoyle, M. F., Pachana, N. A., Mitchell, G. K., &amp; McKenna, K. T. (2011). Participant feedback and satisfaction with the UQDRIVE groups for driving cessation. Canadian Journal of Occupational Therapy, 78(2), 110&#x2013;117. doi:10.2182/cjot.2011.2.6</Citation><ArticleIdList><ArticleId IdType="doi">10.2182/cjot.2011.2.6</ArticleId><ArticleId IdType="pubmed">21560915</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson, L. A., Liddle, J., Liang, P., Pachana, N., Hoyle, M., Mitchell, G., &amp; McKenna, K. (2012). A driving cessation program to identify and improve transport and lifestyle issues of older retired and retiring drivers. International Psychogeriatrics, 24(5), 794&#x2013;802. doi:10.1017/S1041610211002560</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610211002560</ArticleId><ArticleId IdType="pubmed">22217466</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho, M. -H., Chang, H. R., Liu, M. F., Chien, H. -W., Tang, L. -Y., Chan, S. -Y., Liu, S. -H., John, S., &amp; Traynor, V. (2021). Decision-making in people with dementia or mild cognitive impairment: A narrative review of decision-making tools. Journal of the American Medical Directors Association, 22(10), 2056&#x2013;2062. doi:10.1016/j.jamda.2021.06.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2021.06.034</ArticleId><ArticleId IdType="pubmed">34314703</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudomiet, P., Hurd, M. D., &amp; Rohwedder, S. (2018). Dementia prevalence in the U.S. in 2000 and 2012: Estimates based on a nationally representative study. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 73(Suppl. 1), S10&#x2013;S19. doi:10.1093/geronb/gbx169</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbx169</ArticleId><ArticleId IdType="pmc">PMC6018928</ArticleId><ArticleId IdType="pubmed">29669104</ArticleId></ArticleIdList></Reference><Reference><Citation>Iverson, D. J., Gronseth, G. S., Reger, M. A., Classen, S., Dubinsky, R. M., &amp; Rizzo, M. (2010). Practice parameter update: Evaluation and management of driving risk in dementia. Neurology, 74(16), 1316&#x2013;1324. doi:10.1212/WNL.0b013e3181da3b0f</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181da3b0f</ArticleId><ArticleId IdType="pmc">PMC2860481</ArticleId><ArticleId IdType="pubmed">20385882</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeste, D. V., Palmer, B. W., Appelbaum, P. S., Golshan, S., Glorioso, D., Dunn, L. B., Kim, K., Meeks, T., &amp; Kraemer, H. C. (2007). A new brief instrument for assessing decisional capacity for clinical research. Archives of General Psychiatry, 64(8), 966&#x2013;974. doi:10.1001/archpsyc.64.8.966</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.64.8.966</ArticleId><ArticleId IdType="pubmed">17679641</ArticleId></ArticleIdList></Reference><Reference><Citation>Jetten, J., &amp; Pachana, N. (2012). Not wanting to grow old: A Social Identity Model of Identity Change (SIMIC) analysis of driving cessation among older adults. In J. Jetten, C. Haslam, &amp; S. A. Haslam (Eds.), The social cure: Identity, health and well-being (pp. 97&#x2013;113). Psychology Press.</Citation></Reference><Reference><Citation>Jouk, A., &amp; Tuokko, H. (2017). Development of &#x201c;down the road&#x201d;: An interactive toolkit about driving cessation for dementia caregivers. Educational Gerontology, 43(10), 499&#x2013;510. doi:10.1080/03601277.2017.1355669</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03601277.2017.1355669</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz, S., Ford, A. B., Moskowitz, R. W., Jackson, B. A., &amp; Jaffe, M. W. (1963). Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. Journal of American Medical Association, 185, 914&#x2013;919. doi:10.1001/jama.1963.03060120024016</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1963.03060120024016</ArticleId><ArticleId IdType="pubmed">14044222</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddle, J., Bennett, S., Allen, S., Lie, D., Standen, B., &amp; Pachana, N. (2013). The stages of driving cessation for people with dementia: Needs and challenges. International Psychogeriatrics, 25(12), 2033&#x2013;2046. doi:10.1017/s1041610213001464</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610213001464</ArticleId><ArticleId IdType="pubmed">23992286</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddle, J., Haynes, M., Pachana, N., Mitchell, G., McKenna, K., &amp; Gustafsson, L. (2014). Effect of a group intervention to promote older adults&#x2019; adjustment to driving cessation on community mobility: A randomized controlled trial. Gerontologist, 54(3), 409&#x2013;422. doi:10.1093/geront/gnt019</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnt019</ArticleId><ArticleId IdType="pubmed">23512770</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddle, J., McKenna, K., &amp; Bartlett, H. (2007). Improving outcomes for older retired drivers: The UQDRIVE program. Australian Occupational Therapy Journal, 54(4), 303&#x2013;306. doi:10.1111/j.1440-1630.2006.00614.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1630.2006.00614.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddle, J., Tan, A., Liang, P., Bennett, S., Allen, S., Lie, D., &amp; Pachana, N. (2016). &#x201c;The biggest problem we&#x2019;ve ever had to face&#x201d;: How families manage driving cessation with people with dementia. International Psychogeriatrics, 28(1), 109&#x2013;122. doi:10.1017/S1041610215001441</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610215001441</ArticleId><ArticleId IdType="pubmed">26365085</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., Cooper, C., Fox, N., Gitlin, L. N., Howard, R., Kales, H. C., Larson, E. B., Ritchie, K., Rockwood, K., Sampson, E. L., &amp; Mukadam, N. (2017). Dementia prevention, intervention, and care. Lancet, 390(10113), 2673&#x2013;2734. doi:10.1016/S0140-6736(17)31363-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31363-6</ArticleId><ArticleId IdType="pubmed">28735855</ArticleId></ArticleIdList></Reference><Reference><Citation>Marottoli, R. A., &amp; Coughlin, J. F. (2011). Walking the tightrope: Developing a systems approach to balance safety and mobility for an aging society. Journal of Aging and Social Policy, 23(4), 372&#x2013;383. doi:10.1080/08959420.2011.605655</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08959420.2011.605655</ArticleId><ArticleId IdType="pubmed">21985065</ArticleId></ArticleIdList></Reference><Reference><Citation>Meuser, T. M., Berg-Weger, M., Chibnall, J. T., Harmon, A. C., &amp; Stowe, J. D. (2013). Assessment of Readiness for Mobility Transition (ARMT): A tool for mobility transition counseling with older adults. Journal of Applied Gerontology, 32(4), 484&#x2013;507. doi:10.1177/0733464811425914</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464811425914</ArticleId><ArticleId IdType="pubmed">25474686</ArticleId></ArticleIdList></Reference><Reference><Citation>

Mizenko, A. J., Tefft, B. C., Arnold, L. S., &amp; Grabowski, J. G. (2014). Older American Drivers and Traffic Safety Culture: A LongROAD Study (Technical Report). AAA Foundation for Traffic Safety. https://aaafoundation.org/older-american-drivers-traffic-safety-culture-longroad-study/</Citation></Reference><Reference><Citation>Moye, J., Karel, M. J., Gurrera, R. J., &amp; Azar, A. R. (2006). Neuropsychological predictors of decision-making capacity over 9 months in mild-to-moderate dementia. Journal of General Internal Medicine, 21(1), 78&#x2013;83. doi:10.1111/j.1525-1497.2005.00288.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-1497.2005.00288.x</ArticleId><ArticleId IdType="pmc">PMC1484610</ArticleId><ArticleId IdType="pubmed">16423129</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Highway Traffic Safety Administration. (2021). Older population: 2019 data Traffic Safety Facts. (Report No. DOT HS 813 121). 
National Center for Statistics and Analysis.https://crashstats.nhtsa.dot.gov/Api/Public/ViewPublication/813121</Citation></Reference><Reference><Citation>Naumann, R. B., West, B. A., &amp; Sauber-Schatz, E. K. (2014). At what age do you think you will stop driving? Views of older U.S. adults. Journal of the American Geriatrics Society, 62(10), 1999&#x2013;2001. doi:10.1111/jgs.13050</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.13050</ArticleId><ArticleId IdType="pmc">PMC6521961</ArticleId><ArticleId IdType="pubmed">25333545</ArticleId></ArticleIdList></Reference><Reference><Citation>Ott, B. R., &amp; Daiello, L. A. (2010). How does dementia affect driving in older patients? Aging Health, 6(1), 77&#x2013;85. doi:10.2217/ahe.09.83</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/ahe.09.83</ArticleId><ArticleId IdType="pmc">PMC2847266</ArticleId><ArticleId IdType="pubmed">20368745</ArticleId></ArticleIdList></Reference><Reference><Citation>Pachana, N. A., Jetten, J., Gustafsson, L., &amp; Liddle, J. (2017). To be or not to be (an older driver): Social identity theory and driving cessation in later life. Ageing and Society, 37(8), 1597&#x2013;1608. doi:10.1017/S0144686X16000507</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0144686X16000507</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearlin, L. I., Mullan, J. T., Semple, S. J., &amp; Skaff, M. M. (1990). Caregiving and the stress process: An overview of concepts and their measures. Gerontologist, 30(5), 583&#x2013;594. doi:10.1093/geront/30.5.583</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/30.5.583</ArticleId><ArticleId IdType="pubmed">2276631</ArticleId></ArticleIdList></Reference><Reference><Citation>Pristavec, T. (2018). Social participation in later years: The role of driving mobility. The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 73(8), 1457&#x2013;1469. doi:10.1093/geronb/gbw057</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbw057</ArticleId><ArticleId IdType="pmc">PMC6178969</ArticleId><ArticleId IdType="pubmed">27174892</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin, W., Xiang, X., &amp; Taylor, H. (2020). Driving cessation and social isolation in older adults. Journal of Aging and Health, 32(9), 962&#x2013;971. doi:10.1177/0898264319870400</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0898264319870400</ArticleId><ArticleId IdType="pmc">PMC7901288</ArticleId><ArticleId IdType="pubmed">31431103</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashid, R., Standen, P., Carpenter, H., &amp; Radford, K. (2020). Systematic review and meta-analysis of association between cognitive tests and on-road driving ability in people with dementia. Neuropsychological Rehabilitation, 30(9), 1720&#x2013;1761. doi: 10.1080/09602011.2019.160311</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09602011.2019.160311</ArticleId><ArticleId IdType="pubmed">31018100</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanford, S., Rapoport, M. J., Tuokko, H., Crizzle, A., Hatzifilalithis, S., Laberge, S., &amp; Naglie, G. (2019). Independence, loss, and social identity: Perspectives on driving cessation and dementia. Dementia, 18(7&#x2013;8), 2906&#x2013;2924. doi:10.1177/1471301218762838</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301218762838</ArticleId><ArticleId IdType="pubmed">29534602</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanford, S., Naglie, G., Cameron, D. H., &amp; Rapoport, M. J. (2020). Subjective experiences of driving cessation and dementia: A meta-synthesis of qualitative literature. Clinical Gerontology, 43(2), 135&#x2013;154. doi:10.1080/07317115.2018.1483992</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07317115.2018.1483992</ArticleId><ArticleId IdType="pubmed">29863962</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott, T., Liddle, J., Mitchell, G., Beattie, E., &amp; Pachana, N. (2019). Implementation and evaluation of a driving cessation intervention to improve community mobility and wellbeing outcomes for people living with dementia: Study protocol of the &#x201c;CarFreeMe&#x201d; for people with dementia program. BMC Geriatrics, 19(1), 66. doi:10.1186/s12877-019-1074-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-019-1074-6</ArticleId><ArticleId IdType="pmc">PMC6399961</ArticleId><ArticleId IdType="pubmed">30832581</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott, T., Liddle, J., Sidhu, R., Mitchell, G., Beattie, E., Gustafsson, L., &amp; Pachana, N. (2020). Adaptation of the CarFreeMe driver retirement intervention to provide driving cessation support to older people living with dementia. Brain Impairment, 21(3), 247&#x2013;258. doi:10.1017/BrImp.2020.16</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/BrImp.2020.16</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern, R. A., D&#x2019;Ambrosio, L. A., Mohyde, M., Carruth, S., Tracton-Bishop, B., Hunter, J. C., Hellyar, C., Olshevski, J., Daneshvar, D. H., &amp; Coughlin, J. F. (2008). O3-07-01: At the crossroads: Development and evaluation of a dementia caregiver group intervention to assist in driving cessation. Alzheimer&#x2019;s and Dementia, 4(4S_Part_5), T173&#x2013;T173. doi:10.1016/j.jalz.2008.05.459</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2008.05.459</ArticleId><ArticleId IdType="pmc">PMC2679525</ArticleId><ArticleId IdType="pubmed">19064472</ArticleId></ArticleIdList></Reference><Reference><Citation>Teri, L., Truax, P., Logsdon, R., Uomoto, J., Zarit, S., &amp; Vitaliano, P. P. (1992). Assessment of behavioral problems in dementia: The revised memory and behavior problems checklist. Psychology and Aging, 7(4), 622&#x2013;631. doi:10.1037//0882-7974.7.4.622</Citation><ArticleIdList><ArticleId IdType="doi">10.1037//0882-7974.7.4.622</ArticleId><ArticleId IdType="pubmed">1466831</ArticleId></ArticleIdList></Reference><Reference><Citation>

Vanderbur, M., &amp; Silverstein, N. (2006). Community mobility and dementia: A review of the literature (DOT HS 810 684; pp. 1&#x2013;48). 
Alzheimer&#x2019;s Association Public Policy Division and National Traffic and Highway Safety Administration. https://one.nhtsa.gov/people/injury/olddrive/CommMobilityDementia/pages/CurrentScr-StatePolicy.htm</Citation></Reference><Reference><Citation>Vaughan, L., Hogan, P. E., Rapp, S. R., Dugan, E., Marottoli, R. A., Snively, B. M., Shumaker, S. A., &amp; Sink, K. M. (2015). Driving with mild cognitive impairment or dementia: Cognitive test performance and proxy report of daily life function in older women. Journal of the American Geriatrics Society, 63(9), 1774&#x2013;1782. doi:10.1111/jgs.13634</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.13634</ArticleId><ArticleId IdType="pmc">PMC4841465</ArticleId><ArticleId IdType="pubmed">26338449</ArticleId></ArticleIdList></Reference><Reference><Citation>Versijpt, J., Tant, M., Beyer, I., Bier, J. -C., Cras, P., De Deyn, P. P., De Wit, P., Deryck, O., Hanseeuw, B., Lambert, M., Lemper, J. -C., Mormont, E., Petrovic, M., Picard, G., Salmon, E., Segers, K., Sieben, A., Thiery, E., Tournoy, J., &amp; Ivanoiu, A. (2017). Alzheimer&#x2019;s disease and driving: Review of the literature and consensus guideline from Belgian dementia experts and the Belgian road safety institute endorsed by the Belgian Medical Association. Acta Neurologica Belgica, 117(4), 811&#x2013;819. doi:10.1007/s13760-017-0840-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-017-0840-5</ArticleId><ArticleId IdType="pubmed">28983881</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitlatch, C. J., Schur, D., Noelker, L. S., Ejaz, F. K., &amp; Looman, W. J. (2001). The stress process of family caregiving in institutional settings. Gerontologist, 41(4), 462&#x2013;473. doi:10.1093/geront/41.4.462</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/41.4.462</ArticleId><ArticleId IdType="pubmed">11490044</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36112385</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1758-5368</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>Suppl 1</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>13</Day></PubDate></JournalIssue><Title>The journals of gerontology. Series B, Psychological sciences and social sciences</Title><ISOAbbreviation>J Gerontol B Psychol Sci Soc Sci</ISOAbbreviation></Journal><ArticleTitle>Characteristics and Predictors of Sleep Among Spousal Care Dyads Living With Chronic Conditions.</ArticleTitle><Pagination><StartPage>S38</StartPage><EndPage>S47</EndPage><MedlinePgn>S38-S47</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/geronb/gbac096</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Poor sleep is common among older adults with chronic health conditions and their spousal caregivers. However, dyadic sleep patterns among spouses are underexplored within the literature. This study examines dyadic sleep characteristics and associated contextual factors among spousal care dyads.</AbstractText><AbstractText Label="METHODS">Participants included 462 older adult spousal care dyads from the 2015 National Health and Aging Trends Study and National Study of Caregiving (mean ages of care recipients/caregivers = 79 and 76 years, respectively; 22% of dyads were living with dementia). Self-reported sleep included frequency of (a) trouble falling back asleep among dyads, (b) care-related sleep disturbances among caregivers, and (c) trouble initiating sleep among care recipients. Predictors included between-dyad characteristics such as whether respondents had dementia, care burden and support, relationship quality, neighborhood cohesion, and within-dyad characteristics such as demographics, depression, and positive affect. We conducted multilevel dyadic analysis and actor-partner interdependence modeling.</AbstractText><AbstractText Label="RESULTS">Sleep was correlated more among dyads living with dementia than those with other chronic conditions. Care dyads had poorer sleep if caregivers reported higher care burden; however, better relationship quality marginally ameliorated the association. Depressive symptoms had a partner effect on poorer sleep among care dyads, whereas positive emotions and older age only had an actor effect on better sleep for care recipients and spousal caregivers. Neighborhood cohesion, care support, and other demographic characteristics were not associated with dyadic sleep outcomes.</AbstractText><AbstractText Label="DISCUSSION">Addressing both care recipient- and caregiver-related factors may improve sleep health for both members of the care dyad living with chronic conditions.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yin</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-5100-3023</Identifier><AffiliationInfo><Affiliation>Department of Human Development and Family Studies, Utah State University, Logan, Utah, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Yeonsu</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2244-2323</Identifier><AffiliationInfo><Affiliation>School of Nursing, University of California Los Angeles, California, Los Angeles, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Florence U</ForeName><Initials>FU</Initials><AffiliationInfo><Affiliation>Department of Systems, Populations, and Leadership, School of Nursing, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Lianlian</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0463-2614</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Seung-Won Emily</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Sociology, Anthropology, and Social Work, Texas Tech University, Lubbock, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonucci</LastName><ForeName>Toni C</ForeName><Initials>TC</Initials><Identifier Source="ORCID">0000-0002-1420-5328</Identifier><AffiliationInfo><Affiliation>Department of Psychology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson-Lane</LastName><ForeName>Sheria G</ForeName><Initials>SG</Initials><Identifier Source="ORCID">0000-0002-8986-0941</Identifier><AffiliationInfo><Affiliation>Department of Systems, Populations, and Leadership, School of Nursing, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 AG055668</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG059300</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01AG032947</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 AG065420</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG054004</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30AG059300</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Gerontol B Psychol Sci Soc Sci</MedlineTA><NlmUniqueID>9508483</NlmUniqueID><ISSNLinking>1079-5014</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018454" MajorTopicYN="N">Spouses</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012890" MajorTopicYN="N">Sleep</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Caregiving</Keyword><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">Health outcomes</Keyword><Keyword MajorTopicYN="N">Marriage</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>16</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36112385</ArticleId><ArticleId IdType="pmc">PMC10010479</ArticleId><ArticleId IdType="doi">10.1093/geronb/gbac096</ArticleId><ArticleId IdType="pii">6702158</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alhasan, D. M., Gaston, S. A., Jackson, W. B., 2nd, Williams, P. C., Kawachi, I., &amp; Jackson, C. L. (2020). Neighborhood social cohesion and sleep health by age, sex/gender, and race/ethnicity in the United States. Internaltional Journal of Environmental Research and Public Health, 17(24), 1&#x2013;19. doi:10.3390/ijerph17249475</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17249475</ArticleId><ArticleId IdType="pmc">PMC7767208</ArticleId><ArticleId IdType="pubmed">33348851</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangerter, L. R., Liu, Y., &amp; Zarit, S. H. (2019). Longitudinal trajectories of subjective care stressors: The role of personal, dyadic, and family resources. Aging &amp; Mental Health, 23(2), 255&#x2013;262. doi:10.1080/13607863.2017.1402292</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2017.1402292</ArticleId><ArticleId IdType="pmc">PMC6097957</ArticleId><ArticleId IdType="pubmed">29171960</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings, M. E., Hale, L., &amp; Johnson, D. A. (2020). Physical and social environment relationship with sleep health and disorders. Chest, 157(5), 1304&#x2013;1312. doi:10.1016/j.chest.2019.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2019.12.002</ArticleId><ArticleId IdType="pmc">PMC7268445</ArticleId><ArticleId IdType="pubmed">31870910</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonanni, E., Maestri, M., Tognoni, G., Fabbrini, M., Nucciarone, B., Manca, M. L., Gori, S., Iudice, A., &amp; Murri, L. (2005). Daytime sleepiness in mild and moderate Alzheimer&#x2019;s disease and its relationship with cognitive impairment. Journal of Sleep Research, 14(3), 311&#x2013;317. doi:10.1111/j.1365-2869.2005.00462.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2869.2005.00462.x</ArticleId><ArticleId IdType="pubmed">16120107</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, J. H. (2017). Couples&#x2019; sleep and psychological distress: A dyadic perspective. The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 73(1), 30&#x2013;39. doi:10.1093/geronb/gbx001</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbx001</ArticleId><ArticleId IdType="pubmed">28164225</ArticleId></ArticleIdList></Reference><Reference><Citation>Chunga, R. E., Kim, K., Liu, Y., &amp; Zarit, S. H. (2020). Family caregivers&#x2019; distress responses to daily behavioral and psychological symptoms of dementia: The moderating role of relationship quality. International Journal of Geriatric Psychiatry. Advance online publication. doi:10.1002/gps.5482</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5482</ArticleId><ArticleId IdType="pubmed">33271629</ArticleId></ArticleIdList></Reference><Reference><Citation>Creese, J., B&#xe9;dard, M., Brazil, K., &amp; Chambers, L. (2008). Sleep disturbances in spousal caregivers of individuals with Alzheimer&#x2019;s disease. International Psychogeriatrics, 20(1), 149&#x2013;161. doi:10.1017/S1041610207005339</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610207005339</ArticleId><ArticleId IdType="pubmed">17466086</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsey, T., Keller, P. S., &amp; El-Sheikh, M. (2019). The role of couple sleep concordance in sleep quality: Attachment as a moderator of associations. Journal of Sleep Research, 28(5), e12825. doi:10.1111/jsr.12825</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jsr.12825</ArticleId><ArticleId IdType="pmc">PMC6702108</ArticleId><ArticleId IdType="pubmed">30790373</ArticleId></ArticleIdList></Reference><Reference><Citation>Fee, A., McIlfatrick, S., &amp; Ryan, A. (2020). Examining the support needs of older male spousal caregivers of people with a long-term condition: A systematic review of the literature. International Journal of Older People Nursing, 15(3), e12318. doi:10.1111/opn.12318</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/opn.12318</ArticleId><ArticleId IdType="pubmed">32367662</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman, V. A., &amp; Kasper, J. D. (2019). Cohort profile: The National Health and Aging Trends Study (NHATS). International Journal of Epidemiology, 48(4), 1044&#x2013;1045g. doi:10.1093/ije/dyz109</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyz109</ArticleId><ArticleId IdType="pmc">PMC6934030</ArticleId><ArticleId IdType="pubmed">31237935</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman, V. A., Kasper, J. D., Spillman, B. C., Agree, E. M., Mor, V., Wallace, R. B., &amp; Wolf, D. A. (2014). Behavioral adaptation and late-life disability: A new spectrum for assessing public health impacts. American Journal of Public Health, 104(2), e88&#x2013;e94. doi:10.2105/ajph.2013.301687</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/ajph.2013.301687</ArticleId><ArticleId IdType="pmc">PMC3935680</ArticleId><ArticleId IdType="pubmed">24328656</ArticleId></ArticleIdList></Reference><Reference><Citation>

Freedman, V. A., Skehan, M. E., Hu, M., Wolff, J., &amp; Kasper, J. D.(2019). National Study of Caregiving I&#x2013;III user guide. https://www.nhats.org/sites/default/files/2021-01/NSOC%20I-III%20USER%20GUIDE%20Version%205_Final_2_0.pdf</Citation></Reference><Reference><Citation>Galvin, J. E., Roe, C. M., Powlishta, K. K., Coats, M. A., Muich, S. J., Grant, E., Miller, J. P., Storandt, M., &amp; Morris, J. C. (2005). The AD8: A brief informant interview to detect dementia. Neurology, 65(4), 559&#x2013;564. doi:10.1212/01.wnl.0000172958.95282.2a</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000172958.95282.2a</ArticleId><ArticleId IdType="pubmed">16116116</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaugler, J. E., Yu, F., Krichbaum, K., &amp; Wyman, J. F. (2009). Predictors of nursing home admission for persons with dementia. Medical Care, 47(2), 191&#x2013;198. doi:10.1097/MLR.0b013e31818457ce</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31818457ce</ArticleId><ArticleId IdType="pubmed">19169120</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson, R. H., Gander, P. H., &amp; Jones, L. M. (2014). Understanding the sleep problems of people with dementia and their family caregivers. Dementia (London), 13(3), 350&#x2013;365. doi:10.1177/1471301212473884</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301212473884</ArticleId><ArticleId IdType="pubmed">24339061</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandner, M. A. (2020). Sleep, health, and society. Sleep Medicine Clinics, 15(2), 319&#x2013;340. doi:10.1016/j.jsmc.2020.02.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsmc.2020.02.017</ArticleId><ArticleId IdType="pubmed">32386705</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandner, M. A., Williams, N. J., Knutson, K. L., Roberts, D., &amp; Jean-Louis, G. (2016). Sleep disparity, race/ethnicity, and socioeconomic position. Sleep Medicine, 18, 7&#x2013;18. doi:10.1016/j.sleep.2015.01.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleep.2015.01.020</ArticleId><ArticleId IdType="pmc">PMC4631795</ArticleId><ArticleId IdType="pubmed">26431755</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunn, H. E., Buysse, D. J., Hasler, B. P., Begley, A., &amp; Troxel, W. M. (2015). Sleep concordance in couples is associated with relationship characteristics. Sleep, 38(6), 933&#x2013;939. doi:10.5665/sleep.4744</Citation><ArticleIdList><ArticleId IdType="doi">10.5665/sleep.4744</ArticleId><ArticleId IdType="pmc">PMC4434560</ArticleId><ArticleId IdType="pubmed">25581920</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunn, H. E., Lee, S., Eberhardt, K. R., Buxton, O. M., &amp; Troxel, W. M. (2021). Nightly sleep&#x2013;wake concordance and daily marital interactions. Sleep Health, 7(2), 266&#x2013;272. doi:10.1016/j.sleh.2020.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleh.2020.11.003</ArticleId><ArticleId IdType="pmc">PMC8328191</ArticleId><ArticleId IdType="pubmed">33446469</ArticleId></ArticleIdList></Reference><Reference><Citation>Hale, L., Hill, T. D., Friedman, E., Javier Nieto, F., Galvao, L. W., Engelman, C. D., Malecki, K. M. C., &amp; Peppard, P. E. (2013). Perceived neighborhood quality, sleep quality, and health status: Evidence from the Survey of the Health of Wisconsin. Social Science &amp; Medicine, 79, 16&#x2013;22. doi:10.1016/j.socscimed.2012.07.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2012.07.021</ArticleId><ArticleId IdType="pmc">PMC3733364</ArticleId><ArticleId IdType="pubmed">22901794</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasler, B. P., &amp; Troxel, W. M. (2010). Couples&#x2019; nighttime sleep efficiency and concordance: Evidence for bidirectional associations with daytime relationship functioning. Psychosomatic Medicine, 72(8), 794&#x2013;801. doi:10.1097/PSY.0b013e3181ecd08a</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0b013e3181ecd08a</ArticleId><ArticleId IdType="pmc">PMC2950886</ArticleId><ArticleId IdType="pubmed">20668283</ArticleId></ArticleIdList></Reference><Reference><Citation>

Kasper, J. D., &amp; Freedman, V. A. (2020). National Health and Aging Trends Study user guide: Rounds 1&#x2013;9 final release. https://nhats.org/sites/default/files/2021-04/NHATS_User_Guide_R9_Final_Release_0.pdf</Citation></Reference><Reference><Citation>

Kasper, J. D., Freedman, V. A., &amp; Spillman, B. (2013). Classification of persons by dementia status in the National Health and Aging Trends Study. https://nhatspubdemo.westat.com/scripts/documents/NHATS_Dementia_Technical_Paper_5_Jul2013.pdf</Citation></Reference><Reference><Citation>Kroenke, K., Spitzer, R. L., Williams, J. B., &amp; L&#xf6;we, B. (2009). An ultra-brief screening scale for anxiety and depression: The PHQ-4. Psychosomatics, 50(6), 613&#x2013;621. doi:10.1176/appi.psy.50.6.613</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.psy.50.6.613</ArticleId><ArticleId IdType="pubmed">19996233</ArticleId></ArticleIdList></Reference><Reference><Citation>Lea Steadman, P., Tremont, G., &amp; Duncan Davis, J. (2007). Premorbid relationship satisfaction and caregiver burden in dementia caregivers. Journal of Geriatric Psychiatry and Neurology, 20(2), 115&#x2013;119. doi:10.1177/0891988706298624</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988706298624</ArticleId><ArticleId IdType="pmc">PMC1890033</ArticleId><ArticleId IdType="pubmed">17548782</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, D., Morgan, K., &amp; Lindesay, J. (2007). Effect of institutional respite care on the sleep of people with dementia and their primary caregivers. Journal of the American Geriatrics Society, 55(2), 252&#x2013;258. doi:10.1111/j.1532-5415.2007.01036.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2007.01036.x</ArticleId><ArticleId IdType="pubmed">17302663</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang, J., Aranda, M. P., &amp; Lloyd, D. A. (2020). Association between role overload and sleep disturbance among dementia caregivers: The impact of social support and social engagement. Journal of Aging and Health, 32(10), 1345&#x2013;1354. doi:10.1177/0898264320926062</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0898264320926062</ArticleId><ArticleId IdType="pubmed">32524886</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y., Leggett, A. N., Kim, K., Polenick, C. A., McCurry, S. M., &amp; Zarit, S. H. (2021). Daily sleep, well-being, and adult day services use among dementia care dyads. Aging &amp; Mental Health. Advance online publication. doi:10.1080/13607863.2021.1998354</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2021.1998354</ArticleId><ArticleId IdType="pmc">PMC9109303</ArticleId><ArticleId IdType="pubmed">34761966</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran, M., Lynch, C. A., Walsh, C., Coen, R., Coakley, D., &amp; Lawlor, B. A. (2005). Sleep disturbance in mild to moderate Alzheimer&#x2019;s disease. Sleep Medicine, 6(4), 347&#x2013;352. doi:10.1016/j.sleep.2004.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleep.2004.12.005</ArticleId><ArticleId IdType="pubmed">15978517</ArticleId></ArticleIdList></Reference><Reference><Citation>Norton, M. C., Piercy, K. W., Rabins, P. V., Green, R. C., Breitner, J. C. S., &#xd8;stbye, T., Corcoran, C., Welsh-Bohmer, K. A., Lyketsos, C. G., &amp; Tschanz, J. T. (2009). Caregiver&#x2013;recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study. The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 64(5), 560&#x2013;568. doi:10.1093/geronb/gbp052</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbp052</ArticleId><ArticleId IdType="pmc">PMC2728091</ArticleId><ArticleId IdType="pubmed">19564210</ArticleId></ArticleIdList></Reference><Reference><Citation>Ornstein, K. A., Wolff, J. L., Bollens-Lund, E., Rahman, O.-K., &amp; Kelley, A. S. (2019). Spousal caregivers are caregiving alone in the last years of life. Health Affairs, 38(6), 964&#x2013;972. doi:10.1377/hlthaff.2019.00087</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2019.00087</ArticleId><ArticleId IdType="pmc">PMC6760240</ArticleId><ArticleId IdType="pubmed">31158025</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearlin, L. I., Mullan, J. T., Semple, S. J., &amp; Skaff, M. M. (1990). Caregiving and the stress process: An overview of concepts and their measures. The Gerontologist, 30(5), 583&#x2013;594. doi:10.1093/geront/30.5.583</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/30.5.583</ArticleId><ArticleId IdType="pubmed">2276631</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng, H. L., Lorenz, R. A., &amp; Chang, Y. P. (2019). Factors associated with sleep in family caregivers of individuals with dementia. Perspectives in Psychiatric Care, 55(1), 95&#x2013;102. doi:10.1111/ppc.12307</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ppc.12307</ArticleId><ArticleId IdType="pubmed">29971795</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinquart, M., &amp; S&#xf6;rensen, S. (2007). Correlates of physical health of informal caregivers: A meta-analysis. The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 62(2), 126&#x2013;137. doi:10.1093/geronb/62.2.p126</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/62.2.p126</ArticleId><ArticleId IdType="pubmed">17379673</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinquart, M., &amp; S&#xf6;rensen, S. (2011). Spouses, adult children, and children-in-law as caregivers of older adults: A meta-analytic comparison. Psychology and Aging, 26(1), 1&#x2013;14. doi:10.1037/a0021863</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0021863</ArticleId><ArticleId IdType="pmc">PMC4449135</ArticleId><ArticleId IdType="pubmed">21417538</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson, K. M., Buckwalter, K. C., &amp; Reed, D. (2005). Predictors of use of services among dementia caregivers. Western Journal of Nursing Research, 27(2), 126&#x2013;140. doi:10.1177/0193945904272453</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0193945904272453</ArticleId><ArticleId IdType="pubmed">15695566</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, Y., McCurry, S. M., Fung, C. H., Josephson, K. R., Teng, E., Irwin, M. R., Alessi, C. A., &amp; Martin, J. L. (2018). Sleep and caregiving experiences among caregivers of veterans in an adult day health care program: A pilot study. Clinical Gerontologist, 41(2), 167&#x2013;171. doi:10.1080/07317115.2017.1365795</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07317115.2017.1365795</ArticleId><ArticleId IdType="pmc">PMC5847391</ArticleId><ArticleId IdType="pubmed">28990862</ArticleId></ArticleIdList></Reference><Reference><Citation>Tractenberg, R. E., Singer, C. M., &amp; Kaye, J. A. (2006). Characterizing sleep problems in persons with Alzheimer&#x2019;s disease and normal elderly. Journal of Sleep Research, 15(1), 97&#x2013;103. doi:10.1111/j.1365-2869.2006.00499.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2869.2006.00499.x</ArticleId><ArticleId IdType="pmc">PMC4372193</ArticleId><ArticleId IdType="pubmed">16490008</ArticleId></ArticleIdList></Reference><Reference><Citation>Troxel, W. M., Robles, T. F., Hall, M., &amp; Buysse, D. J. (2007). Marital quality and the marital bed: Examining the covariation between relationship quality and sleep. Sleep Med Reviews, 11(5), 389&#x2013;404. doi:10.1016/j.smrv.2007.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smrv.2007.05.002</ArticleId><ArticleId IdType="pmc">PMC2644899</ArticleId><ArticleId IdType="pubmed">17854738</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschanz, J. T., Piercy, K., Corcoran, C. D., Fauth, E., Norton, M. C., Rabins, P. V., Tschanz, B., Deberard, M. S., Snyder, C., Smith, C., Lee, L., &amp; Lyketsos, C. G. (2013). Caregiver coping strategies predict cognitive and functional decline in dementia: The Cache County Dementia Progression Study. The American Journal of Geriatric Psychiatry, 21(1), 57&#x2013;66. doi:10.1016/j.jagp.2012.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2012.10.005</ArticleId><ArticleId IdType="pmc">PMC3502653</ArticleId><ArticleId IdType="pubmed">23290203</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaffe, K., Fox, P., Newcomer, R., Sands, L., Lindquist, K., Dane, K., &amp; Covinsky, K. E. (2002). Patient and caregiver characteristics and nursing home placement in patients with dementia. Journal of American Medical Association, 287(16), 2090&#x2013;2097. doi:10.1001/jama.287.16.2090</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.287.16.2090</ArticleId><ArticleId IdType="pubmed">11966383</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36109800</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1758-9193</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>Alzheimer's research &amp; therapy</Title><ISOAbbreviation>Alzheimers Res Ther</ISOAbbreviation></Journal><ArticleTitle>A longitudinal study on quality of life along the spectrum of Alzheimer's disease.</ArticleTitle><Pagination><StartPage>132</StartPage><MedlinePgn>132</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">132</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13195-022-01075-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Quality of life (QoL) is an important outcome from the perspective of patients and their caregivers, in both dementia and pre-dementia stages. Yet, little is known about the long-term changes in QoL over time. We aimed to compare the trajectories of QoL between amyloid-positive and amyloid-negative SCD or MCI patients and to evaluate QoL trajectories along the Alzheimer's disease (AD) continuum of cognitively normal to dementia.</AbstractText><AbstractText Label="METHODS">We included longitudinal data of 447 subjective cognitive decline (SCD), 276 mild cognitive impairment (MCI), and 417 AD dementia patients from the Amsterdam Dementia Cohort. We compared QoL trajectories (EQ-5D and visual analog scale (VAS)) between (1) amyloid-positive and amyloid-negative SCD or MCI patients and (2) amyloid-positive SCD, MCI, and dementia patients with linear mixed-effect models. The models were adjusted for age, sex, Charlson Comorbidity Index (CCI), education, and EQ-5D scale (3 or 5 level).</AbstractText><AbstractText Label="RESULTS">In SCD, amyloid-positive participants had a higher VAS at baseline but showed a steeper decline over time in EQ-5D and VAS than amyloid-negative participants. Also, in MCI, amyloid-positive patients had higher QoL at baseline but subsequently showed a steeper decline in QoL over time compared to amyloid-negative patients. When we compared amyloid-positive patients along the Alzheimer continuum, we found no difference between SCD, MCI, or dementia in baseline QoL, but QoL decreased at a faster rate in the dementia stage compared with the of SCD and MCI stages.</AbstractText><AbstractText Label="CONCLUSIONS">QoL decreased at a faster rate over time in amyloid-positive SCD or MCI patients than amyloid-negative patients. QoL decreases over time along the entire AD continuum of SCD, MCI and dementia, with the strongest decrease in dementia patients. Knowledge of QoL trajectories is essential for the future evaluation of treatments in AD.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Mank</LastName><ForeName>Arenda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, De Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands. a.mank@amsterdamumc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands. a.mank@amsterdamumc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health Institute, Amsterdam, The Netherlands. a.mank@amsterdamumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Rijnhart</LastName><ForeName>Judith J M</ForeName><Initials>JJM</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Maurik</LastName><ForeName>Ingrid S</ForeName><Initials>IS</Initials><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, De Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xf6;nsson</LastName><ForeName>Linus</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department for Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Handels</LastName><ForeName>Ron</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department for Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Neuropsychology, Alzheimer Centre Limburg, School for Mental Health and Neurosciences, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakker</LastName><ForeName>Els D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, De Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teunissen</LastName><ForeName>Charlotte E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, VU University Medical Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Berckel</LastName><ForeName>Bart N M</ForeName><Initials>BNM</Initials><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, De Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology &amp; Nuclear Medicine Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Harten</LastName><ForeName>Argonde C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, De Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berkhof</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Flier</LastName><ForeName>Wiesje M</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, De Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/T033371/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Alzheimers Res Ther</MedlineTA><NlmUniqueID>101511643</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058227">Amyloidogenic Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058227" MajorTopicYN="N">Amyloidogenic Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Arenda Mank, Ingrid S. van Maurik, Els D. Bakker and Johannes Berkhof report no financial disclosures or conflicts of interest. Judith J.M. Rijnhart received a grant from the Amsterdam Public Health Research Institute, which was paid to the Amsterdam UMC. Linus J&#xf6;nsson has received consultancy fees from H.Lundbeck A/S. Ron Handels reports the following related to this study: none. Ron Handels reports the following in the past 36 months outside this study: funding (paid to department) from Karolinska Institutet via affiliation, related to projects: SNAC (Sweden public funding 2016-2018), MIND-AD (public-private EU JPND grant 2017-2018), PRODEMOS (public EU H2020 2019-2023), SveDem (Sweden public-private collaboration 2019-2020), EUROFINGERS (public-private EU JPND; 2020-2023); grants (paid to department) from RECAGE H2020 (EU public funding; 2018-2022); grants (paid to department) from various ZonMw projects (NL public funding; 2017-2024); grants (paid to department) from patient association Alzheimer Nederland (NL fellowship; 2017-2019; WE.15-2016-09); grants (paid to department) from ROADMAP (IMI2; public-private collaboration; 2016-2019); consulting fees (paid to department) from institute for Medical Technology Assessment (advisory; 2021; content initiated by Biogen); consulting fees (paid to department) from Biogen Netherlands BV (advisory; 2021); consulting fees (paid to department) from Biogen MA Inc. (advisory; 2020); consulting fees (paid to department) from Eisai Inc. (advisory; 2019). Charlotte E. Teunissen is supported by the European Commission (Marie Curie International Training Network, grant agreement No 860197 (MIRIADE), Innovative Medicines Initiatives 3TR (Horizon 2020, grant no 831434) EPND (IMI 2 Joint Undertaking (JU) under grant agreement No. 101034344 ) and JPND (bPRIDE), National MS Society (Progressive MS alliance) and Health Holland, the Dutch Research Council (ZonMW), Alzheimer Drug Discovery Foundation, The Selfridges Group Foundation, Alzheimer Netherlands, Alzheimer Association. CT is recipient of ABOARD, which is a public-private partnership receiving funding from ZonMW (#73305095007) and Health~Holland, Topsector Life Sciences &amp; Health (PPP-allowance; #LSHM20106). ABOARD also receives funding from Edwin Bouw Fonds and Gieskes-Strijbisfonds. CET has a collaboration contract with ADx Neurosciences, Quanterix and Eli Lilly, performed contract research or received grants from AC-Immune, Axon Neurosciences, Bioconnect, Bioorchestra, Brainstorm Therapeutics, Celgene, EIP Pharma, Eisai, Grifols, Novo Nordisk, PeopleBio, Roche, Toyama, Vivoryon. She serves on editorial boards of Medidact Neurologie/Springer, Alzheimer Research and Therapy, Neurology: Neuroimmunology &amp; Neuroinflammation, and is editor of a Neuromethods book Springer. Bart van Berckel has received research support from EU-FP7, CTMM, ZonMw, NWO and Alzheimer Nederland. BvB has performed contract research for Rodin, IONIS, AVID, Eli Lilly, UCB, DIAN-TUI and Janssen. BvB was a speaker at a symposium organized by Springer Healthcare. BvB has a consultancy agreement with IXICO for the reading of PET scans. BvB is a trainer for GE. BvB only receives financial compensation from Amsterdam UMC. Argonde van Harten was supported by funding from Alzheimer Netherlands, The Alzheimer Drug Discovery Foundation and the VUmc fund. Argonde van Harten has a collaboration contract with Quanterix corp. Wiesje M. van der Flier: research programs of W.M. van der Flier have been funded by ZonMW, NWO, EU-FP7, EU-JPND, Alzheimer Nederland, Hersenstichting CardioVascular Onderzoek Nederland, Health~Holland, Topsector Life Sciences &amp; Health, stichting Dioraphte, Gieskes-Strijbis fonds, stichting Equilibrio, Edwin Bouw fonds, Pasman stichting, stichting Alzheimer &amp; Neuropsychiatrie Foundation, Philips, Biogen MA Inc., Novartis-NL, Life-MI, AVID, Roche BV, Fujifilm, Combinostics. WF holds the Pasman chair. WF is recipient of ABOARD, which is a public-private partnership receiving funding from ZonMW (#73305095007) and Health~Holland, Topsector Life Sciences &amp; Health (PPP-allowance; #LSHM20106). WF has performed contract research for Biogen MA Inc., and Boehringer Ingelheim. WF has been an invited speaker at Boehringer Ingelheim, Biogen MA Inc., Danone, Eisai, WebMD Neurology (Medscape), Springer Healthcare. WF is consultant to Oxford Health Policy Forum CIC, Roche, and Biogen MA Inc. WF participated in advisory boards of Biogen MA Inc. and Roche. All funding is paid to her institution. WF was associate editor of Alzheimer, Research &amp; Therapy in 2020/2021. WF is associate editor at Brain.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>15</Day><Hour>23</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36109800</ArticleId><ArticleId IdType="pmc">PMC9476356</ArticleId><ArticleId IdType="doi">10.1186/s13195-022-01075-8</ArticleId><ArticleId IdType="pii">10.1186/s13195-022-01075-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health. 2022;7(2):e105&#x2013;e25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8810394</ArticleId><ArticleId IdType="pubmed">34998485</ArticleId></ArticleIdList></Reference><Reference><Citation>Dementia: World Health Organization (WHO); 2021 [Available from: https://www.who.int/news-room/fact-sheets/detail/dementia.</Citation></Reference><Reference><Citation>2020 Alzheimer&#x2019;s disease facts and figures. Alzheimer&#x2019;s Dementia. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32157811</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimo A, Handels R, Winblad B, Black CM, Johansson G, Salomonsson S, et al. Quantifying and describing the natural history and costs of Alzheimer&#x2019;s disease and effects of hypothetical interventions. J Alzheimer&#x2019;s Dis. 2020;75(3):891&#x2013;902. doi: 10.3233/JAD-191055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-191055</ArticleId><ArticleId IdType="pmc">PMC7369101</ArticleId><ArticleId IdType="pubmed">32390617</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi M, Brazier J. Health, health-related quality of life, and quality of life: what is the difference? PharmacoEconomics. 2016;34(7):645&#x2013;649. doi: 10.1007/s40273-016-0389-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-016-0389-9</ArticleId><ArticleId IdType="pubmed">26892973</ArticleId></ArticleIdList></Reference><Reference><Citation>Landeiro F, Mughal S, Walsh K, Nye E, Morton J, Williams H, et al. Health-related quality of life in people with predementia Alzheimer&#x2019;s disease, mild cognitive impairment or dementia measured with preference-based instruments: a systematic literature review. Alzheimers Res Ther. 2020;12(1):154. doi: 10.1186/s13195-020-00723-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00723-1</ArticleId><ArticleId IdType="pmc">PMC7677851</ArticleId><ArticleId IdType="pubmed">33208190</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Beek M, van Steenoven I, Ramakers I, Aalten P, Koek HL, Olde Rikkert MGM, et al. Trajectories and determinants of quality of life in dementia with Lewy bodies and Alzheimer&#x2019;s disease. J Alzheimer&#x2019;s Dis. 2019;70(2):389&#x2013;397. doi: 10.3233/JAD-190041.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-190041</ArticleId><ArticleId IdType="pmc">PMC6839497</ArticleId><ArticleId IdType="pubmed">31177218</ArticleId></ArticleIdList></Reference><Reference><Citation>Banning LCP, Janssen E, Hamel REG, de Vugt M, K&#xf6;hler S, Wolfs CAG, et al. Determinants of cross-sectional and longitudinal health-related quality of life in memory clinic patients without dementia. J Geriatr Psychiatry Neurol. 2020;33(5):256&#x2013;264. doi: 10.1177/0891988719882104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988719882104</ArticleId><ArticleId IdType="pmc">PMC7361660</ArticleId><ArticleId IdType="pubmed">31645191</ArticleId></ArticleIdList></Reference><Reference><Citation>Mank A, van Maurik IS, Bakker ED, van de Glind EMM, J&#xf6;nsson L, Kramberger MG, et al. Identifying relevant outcomes in the progression of Alzheimer&#x2019;s disease; what do patients and care partners want to know about prognosis? Alzheimer&#x2019;s Dement (New York, N Y) 2021;7(1):e12189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8377775</ArticleId><ArticleId IdType="pubmed">34458555</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustavsson A, Raket LL, Lilja M, Rutten-Jacobs L, Fues Wahl H, Bagijn M, et al. Health utility in preclinical and prodromal Alzheimer&#x2019;s disease for establishing the value of new disease-modifying treatments-EQ-5D data from the Swedish BioFINDER study. Alzheimer&#x2019;s Dement. 2021;17(11):1832&#x2013;1842. doi: 10.1002/alz.12355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12355</ArticleId><ArticleId IdType="pubmed">33984179</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Flier WM, Pijnenburg YA, Prins N, Lemstra AW, Bouwman FH, Teunissen CE, et al. Optimizing patient care and research: the Amsterdam dementia cohort. J Alzheimer&#x2019;s Dis. 2014;41(1):313&#x2013;327. doi: 10.3233/JAD-132306.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-132306</ArticleId><ArticleId IdType="pubmed">24614907</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Flier WM, Scheltens P. Amsterdam dementia cohort: performing research to optimize care. J Alzheimer&#x2019;s Dis. 2018;62(3):1091&#x2013;1111. doi: 10.3233/JAD-170850.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170850</ArticleId><ArticleId IdType="pmc">PMC5870023</ArticleId><ArticleId IdType="pubmed">29562540</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement. 2011;7(3):270&#x2013;279. doi: 10.1016/j.jalz.2011.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.03.008</ArticleId><ArticleId IdType="pmc">PMC3312027</ArticleId><ArticleId IdType="pubmed">21514249</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303&#x2013;308. doi: 10.1001/archneur.56.3.303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.56.3.303</ArticleId><ArticleId IdType="pubmed">10190820</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessen F. Subjective and objective cognitive decline at the pre-dementia stage of Alzheimer&#x2019;s disease. Eur Arch Psychiatry Clin Neurosci. 2014;264(Suppl 1):S3&#x2013;S7. doi: 10.1007/s00406-014-0539-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-014-0539-z</ArticleId><ArticleId IdType="pubmed">25238934</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin R, Gudex C, Selai C, Herdman M. From translation to version management: a history and review of methods for the cultural adaptation of the EuroQol five-dimensional questionnaire. Value Health. 2014;17(1):70&#x2013;76. doi: 10.1016/j.jval.2013.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2013.10.006</ArticleId><ArticleId IdType="pubmed">24438719</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res Int J Qual Life Asp Treat Care Rehab. 2011;20(10):1727&#x2013;1736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Muehlhausen W, Doll H, Quadri N, Fordham B, O&#x2019;Donohoe P, Dogar N, et al. Equivalence of electronic and paper administration of patient-reported outcome measures: a systematic review and meta-analysis of studies conducted between 2007 and 2013. Health Qual Life Outcomes. 2015;13:167. doi: 10.1186/s12955-015-0362-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-015-0362-x</ArticleId><ArticleId IdType="pmc">PMC4597451</ArticleId><ArticleId IdType="pubmed">26446159</ArticleId></ArticleIdList></Reference><Reference><Citation>EuroQol--a new facility for the measurement of health-related quality of life. Health Policy (Amsterdam, Netherlands). 1990;16(3):199&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">10109801</ArticleId></ArticleIdList></Reference><Reference><Citation>Versteegh MM, Vermeulen KM, Evers SM, De Wit GA, Prenger R, Stolk EA. Dutch tariff for the five-level version of EQ-5D. Value Health. 2016;19(4):343&#x2013;352. doi: 10.1016/j.jval.2016.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2016.01.003</ArticleId><ArticleId IdType="pubmed">27325326</ArticleId></ArticleIdList></Reference><Reference><Citation>van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708&#x2013;715. doi: 10.1016/j.jval.2012.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2012.02.008</ArticleId><ArticleId IdType="pubmed">22867780</ArticleId></ArticleIdList></Reference><Reference><Citation>Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009;73(22):1914&#x2013;1922. doi: 10.1212/WNL.0b013e3181c47cc2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181c47cc2</ArticleId><ArticleId IdType="pmc">PMC2839806</ArticleId><ArticleId IdType="pubmed">19949037</ArticleId></ArticleIdList></Reference><Reference><Citation>Duits FH, Prins ND, Lemstra AW, Pijnenburg YA, Bouwman FH, Teunissen CE, et al. Diagnostic impact of CSF biomarkers for Alzheimer&#x2019;s disease in a tertiary memory clinic. Alzheimer&#x2019;s Dement. 2015;11(5):523&#x2013;532. doi: 10.1016/j.jalz.2014.05.1753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2014.05.1753</ArticleId><ArticleId IdType="pubmed">25156643</ArticleId></ArticleIdList></Reference><Reference><Citation>Tijms BM, Willemse EAJ, Zwan MD, Mulder SD, Visser PJ, van Berckel BNM, et al. Unbiased approach to counteract upward drift in cerebrospinal fluid amyloid-&#x3b2; 1-42 analysis results. Clin Chem. 2018;64(3):576&#x2013;585. doi: 10.1373/clinchem.2017.281055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2017.281055</ArticleId><ArticleId IdType="pubmed">29208658</ArticleId></ArticleIdList></Reference><Reference><Citation>de Wilde A, van der Flier WM, Pelkmans W, Bouwman F, Verwer J, Groot C, et al. Association of amyloid positron emission tomography with changes in diagnosis and patient treatment in an unselected memory clinic cohort: the ABIDE project. JAMA Neurol. 2018;75(9):1062&#x2013;1070. doi: 10.1001/jamaneurol.2018.1346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.1346</ArticleId><ArticleId IdType="pmc">PMC6143118</ArticleId><ArticleId IdType="pubmed">29889941</ArticleId></ArticleIdList></Reference><Reference><Citation>Konijnenberg E, Carter SF, Ten Kate M, den Braber A, Tomassen J, Amadi C, et al. The EMIF-AD PreclinAD study: study design and baseline cohort overview. Alzheimers Res Ther. 2018;10(1):75. doi: 10.1186/s13195-018-0406-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-018-0406-7</ArticleId><ArticleId IdType="pmc">PMC6091034</ArticleId><ArticleId IdType="pubmed">30075734</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245&#x2013;1251. doi: 10.1016/0895-4356(94)90129-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-4356(94)90129-5</ArticleId><ArticleId IdType="pubmed">7722560</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhage F. Intelligence and age: research among the Dutch aged 12 to 77 [in Dutch] Assen: van Gorcum; 1964.</Citation></Reference><Reference><Citation>Gustavsson A, Pemberton-Ross P, Gomez Montero M, Hashim M, Thompson R. Challenges in demonstrating the value of disease-modifying therapies for Alzheimer&#x2019;s disease. Expert Rev Pharmacoecon Outcomes Res. 2020;20(6):563&#x2013;570. doi: 10.1080/14737167.2020.1822738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737167.2020.1822738</ArticleId><ArticleId IdType="pubmed">32951480</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron D, Ubels J, Norstr&#xf6;m F. On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review. Glob Health Action. 2018;11(1):1447828. doi: 10.1080/16549716.2018.1447828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/16549716.2018.1447828</ArticleId><ArticleId IdType="pmc">PMC5930346</ArticleId><ArticleId IdType="pubmed">29564962</ArticleId></ArticleIdList></Reference><Reference><Citation>Johannesson M. Theory and methods of economic evaluation of health care. Deve Health Econo Public Policy. 1996;4:1&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">10158916</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36075074</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1758-5368</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>Suppl 1</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>13</Day></PubDate></JournalIssue><Title>The journals of gerontology. Series B, Psychological sciences and social sciences</Title><ISOAbbreviation>J Gerontol B Psychol Sci Soc Sci</ISOAbbreviation></Journal><ArticleTitle>Paid Care Services and Transitioning out of the Community Among Black and White Older Adults With Dementia.</ArticleTitle><Pagination><StartPage>S91</StartPage><EndPage>S100</EndPage><MedlinePgn>S91-S100</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/geronb/gbac117</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Paid care provided in the home includes important support services for older adults with dementia such as cleaning and personal care assistance. By reducing unmet needs, these services could delay the transition to residential long-term care, but access may differ across racial groups. This study examined the relationship between paid care and transitioning out of the community among Black and White older adults with dementia.</AbstractText><AbstractText Label="METHODS">Using data from 303 participants (29.4% Black) with probable dementia in the 2011 National Health and Aging Trends Study, competing risk hazards models estimated the association between receiving paid care at baseline and the probability of transitioning out of the community over 8 years (through 2019). Covariate selection was guided by the Andersen model of health care utilization.</AbstractText><AbstractText Label="RESULTS">Paid care was associated with lower risk of transitioning out of the community (subhazard ratios [SHR]&#x2005;=&#x2005;0.70, 95% CI [0.50, 0.98]). This effect was similar after controlling for predisposing factors and most prominent after controlling for enabling and need for services factors (SHR&#x2005;=&#x2005;0.65, 95% CI [0.44, 0.95]). There was no racial difference in the use of paid care despite evidence of greater care needs in Blacks. Furthermore, Black participants were less likely to transition out of the community than Whites.</AbstractText><AbstractText Label="DISCUSSION">Paid care services may help delay transitions out of the community. Future research should seek to explain racial differences in access to and/or preferences for home-based, community-based, and residential care.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roche-Dean</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bronson School of Nursing, Western Michigan University, 1903 West Michigan Avenue, Kalamazoo, MI 49008-5345, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baik</LastName><ForeName>Sol</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5081-4956</Identifier><AffiliationInfo><Affiliation>University of Virginia Weldon Cooper Center for Public Service, University of Virginia, 2400 Old Ivy Rd, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>Heehyul</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6967-9328</Identifier><AffiliationInfo><Affiliation>Kent School of Social Work and Family Science, University of Louisville, 2217 S. 3rd st., Louisville, KY 40292, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coe</LastName><ForeName>Norma B</ForeName><Initials>NB</Initials><Identifier Source="ORCID">0000-0003-1228-0938</Identifier><AffiliationInfo><Affiliation>Department of Medical Ethics and Health Policy, University of Pennsylvania, 423 Guardian Drive, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>San Francisco VA Health Care System, 4150 Clement Street, San Francisco, CA 94121, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Social and Behavioral Sciences, University of California San Francisco, 490 Illinois St., Floor 12 San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zahodne</LastName><ForeName>Laura B</ForeName><Initials>LB</Initials><Identifier Source="ORCID">0000-0002-5763-4501</Identifier><AffiliationInfo><Affiliation>Department of Psychology, University of Michigan, 530 Church Street, Ann Arbor, MI 48109, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG059300</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG059300</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Gerontol B Psychol Sci Soc Sci</MedlineTA><NlmUniqueID>9508483</NlmUniqueID><ISSNLinking>1079-5014</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095223" MajorTopicYN="Y">White</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044465" MajorTopicYN="N">White People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044469" MajorTopicYN="N">Racial Groups</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044383" MajorTopicYN="N">Black People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001741" MajorTopicYN="N">Black or African American</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Caregiving</Keyword><Keyword MajorTopicYN="N">Long-term care</Keyword><Keyword MajorTopicYN="N">Minority aging</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>17</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36075074</ArticleId><ArticleId IdType="pmc">PMC10010476</ArticleId><ArticleId IdType="doi">10.1093/geronb/gbac117</ArticleId><ArticleId IdType="pii">6694236</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Andersen, R., &amp; Newman, J. F. (2005). Societal and individual determinants of medical care utilization in the United States. The Milbank Quarterly, 83(4), 95&#x2013;124. doi:10.1111/j.1468-0009.2005.00428.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-0009.2005.00428.x</ArticleId><ArticleId IdType="pubmed">4198894</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda, M. P., Kremer, I. N., Hinton, L., Zissimopoulos, J., Whitmer, R. A., Hummel, C. H., &amp; Fabius, C. (2021). Impact of dementia: Health disparities, population trends, care interventions, and economic costs. Journal of the American Geriatrics Society, 69(7), 1774&#x2013;1783. doi:10.1111/jgs.17345</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17345</ArticleId><ArticleId IdType="pmc">PMC8608182</ArticleId><ArticleId IdType="pubmed">34245588</ArticleId></ArticleIdList></Reference><Reference><Citation>

Babitsch, B., Gohl, D., &amp; Von Lengerke, T. (2012). Re-revisiting Andersen&#x2019;s behavioral model of health services use: A systematic review of studies from 1998&#x2013;2011. GMS Psycho-Social-Medicine, 9, 1&#x2013;15. doi:10.3205%2Fpsm000089</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3488807</ArticleId><ArticleId IdType="pubmed">23133505</ArticleId></ArticleIdList></Reference><Reference><Citation>Black, B. S., Johnston, D., Leoutsakos, J., Reuland, M., Kelly, J., Amjad, H., &amp; Samus, Q. M. (2019). Unmet needs in community-living persons with dementia are common, often non-medical and related to patient and caregiver characteristics. International Psychogeriatrics, 31(11), 1643&#x2013;1654. doi:10.1017/S1041610218002296</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610218002296</ArticleId><ArticleId IdType="pmc">PMC6679825</ArticleId><ArticleId IdType="pubmed">30714564</ArticleId></ArticleIdList></Reference><Reference><Citation>Brewster, G. S., Bonds, K., McLennon, S., Moss, K. O., Epps, F., &amp; Lopez, R. P. (2020). Missing the mark: The complexity of African American dementia family caregiving. Journal of Family Nursing, 26(4), 294&#x2013;301. doi:10.1177/1074840720945329</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1074840720945329</ArticleId><ArticleId IdType="pmc">PMC7721986</ArticleId><ArticleId IdType="pubmed">32757815</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova, M. (2021). Revisiting the role of gender and marital status as risk factors for nursing home entry. The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 76(Suppl. 1), S86&#x2013;S96. doi:10.1093/geronb/gbab004</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbab004</ArticleId><ArticleId IdType="pmc">PMC8495731</ArticleId><ArticleId IdType="pubmed">34101810</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi, W., Graf, E., Hughes, L., Hastie, J., Khatutsky, G., Shuman, S., &amp; Lamont, H. (2019). Community-dwelling older adults with dementia and their caregivers: Key indicators from the National Health and Aging Trends Study. U.S. Department of Health and Human Services.</Citation></Reference><Reference><Citation>Cloutier, M., Gauthier-Loiselle, M., Gagnon-Sanschagrin, P., Guerin, A., Hartry, A., Baker, R. A.,... &amp; Alzheimer&#x2019;s Disease Neuroimaging Initiative. (2019). Institutionalization risk and costs associated with agitation in Alzheimer&#x2019;s disease. Alzheimer&#x2019;s &amp; Dementia: Translational Research &amp; Clinical Interventions, 5, 851&#x2013;861. doi:10.1016/j.trci.2019.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2019.10.004</ArticleId><ArticleId IdType="pmc">PMC6881649</ArticleId><ArticleId IdType="pubmed">31799369</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen, A., &amp; Bulanda, J. R. (2016). Social supports as enabling factors in nursing home admissions: Rural, suburban, and urban differences. Journal of Applied Gerontology, 35(7), 721&#x2013;743. doi:10.1177/0733464814566677</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464814566677</ArticleId><ArticleId IdType="pubmed">25582118</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMaio, F., &amp; Ansell, D. (2018). &#x201c;As natural as the air around us&#x201d;: On the origin and development of the concept of structural violence in health research. International Journal of Health Services, 48(4), 749&#x2013;759. doi:10.1177/0020731418792825</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0020731418792825</ArticleId><ArticleId IdType="pubmed">30092699</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilts, A., Winter, Y., Biebricher, T., Johnson, E. V., V&#xe1;zquez-Arroyo, A. Y., &amp; Cocks, J. (2012). Revisiting Johan Galtung&#x2019;s concept of structural violence. New Political Science, 34(2), e191&#x2013;e227. doi:10.1080/07393148.2012.714959</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07393148.2012.714959</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilworth-Anderson, P., Moon, H., &amp; Aranda, M. P. (2020). Dementia caregiving research: Expanding and reframing the lens of diversity, inclusivity, and intersectionality. The Gerontologist, 60(5), 797&#x2013;805. doi:10.1093/geront/gnaa050</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnaa050</ArticleId><ArticleId IdType="pmc">PMC7362616</ArticleId><ArticleId IdType="pubmed">32667672</ArticleId></ArticleIdList></Reference><Reference><Citation>

Fabius, C. D., &amp; Thomas, K. S. (2019). Examining black&#x2013;white disparities among Medicare beneficiaries in assisted living settings in 2014. Journal of the American Medical Directors Association, 20(6), 703&#x2013;709. doi:10.1016%2Fj.jamda.2018.09.032</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6517087</ArticleId><ArticleId IdType="pubmed">30448156</ArticleId></ArticleIdList></Reference><Reference><Citation>Fine, J. P., &amp; Gray, R. J. (1999). A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association, 94(446), 496&#x2013;509. doi:10.1080/01621459.1999.10474144</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.1999.10474144</ArticleId></ArticleIdList></Reference><Reference><Citation>

Gaugler, J. E., Yu, F., Krichbaum, K.,&amp; Wyman, J. F. (2009). Predictors of nursing home admission for persons with Dementia. Medical Care, 47(2), 191&#x2013;198. http://www.jstor.org/stable/40221859</Citation><ArticleIdList><ArticleId IdType="pubmed">19169120</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelberg, L., Andersen, R. M., &amp; Leake, B. D. (2000). The behavioral model for vulnerable populations: application to medical care use and outcomes for homeless people. Health Services Research, 34(6), 1273&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1089079</ArticleId><ArticleId IdType="pubmed">10654830</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilligan, A. M., Malone, D. C., Warholak, T. L., &amp; Armstrong, E. P. (2013). Health disparities in cost of care in patients with Alzheimer&#x2019;s disease: An analysis across 4 state Medicaid populations. American Journal of Alzheimer&#x2019;s Disease &amp; Other Dementias, 28(1), 84&#x2013;92. doi:10.1177/1533317512467679</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317512467679</ArticleId><ArticleId IdType="pmc">PMC10697230</ArticleId><ArticleId IdType="pubmed">23196405</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammonds, E. M., &amp; Reverby, S. M. (2019). Toward a historically informed analysis of racial health disparities since 1619. American Journal of Public Health, 109(10), 1348&#x2013;1349. doi:10.2105/AJPH.2019.305262</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2019.305262</ArticleId><ArticleId IdType="pmc">PMC6727310</ArticleId><ArticleId IdType="pubmed">31483728</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, R. W., &amp; Wang, C. X. (2019). The financial burden of paid home care on older adults: Oldest and sickest are least likely to have enough income. Health Affairs, 38(6), 994&#x2013;1002. doi:10.1377/hlthaff.2019.00025</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2019.00025</ArticleId><ArticleId IdType="pubmed">31158022</ArticleId></ArticleIdList></Reference><Reference><Citation>

Kasper, J. D. &amp; Freedman, V. A. 2021. National Health and Aging Trends Study user guide: Rounds 1&#x2013;10 final release. Johns Hopkins University School of Public Health.www.NHATS.org.</Citation></Reference><Reference><Citation>Kasper, J. D., Freedman, V. A., Spillman, B. C., &amp; Wolff, J. L. (2015). The disproportionate impact of dementia on family and unpaid caregiving to older adults. Health Affairs, 34(10), 1642&#x2013;1649. doi:10.1377/hlthaff.2015.0536</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2015.0536</ArticleId><ArticleId IdType="pmc">PMC4635557</ArticleId><ArticleId IdType="pubmed">26438739</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman, J. E., Gallo, W. T., &amp; Fahs, M. C. (2020). The contribution of dementia to the disparity in family wealth between black and non-black Americans. Ageing &amp; Society, 40(2), 306&#x2013;327. doi:10.1017/S0144686X18000934</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0144686X18000934</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley, A. S., McGarry, K., Gorges, R., &amp; Skinner, J. S. (2015). The burden of health care costs for patients with dementia in the last 5 years of life. Annals of Internal Medicine, 163(10), 729&#x2013;736. doi:10.7326/M15-0381</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M15-0381</ArticleId><ArticleId IdType="pmc">PMC4809412</ArticleId><ArticleId IdType="pubmed">26502320</ArticleId></ArticleIdList></Reference><Reference><Citation>Luppa, M., Luck, T., Weyerer, S., K&#xf6;nig, H. H., Br&#xe4;hler, E., &amp; Riedel-Heller, S. G. (2010). Prediction of institutionalization in the elderly. A systematic review. Age and Ageing, 39(1), 31&#x2013;38. doi:10.1093/ageing/afp202</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afp202</ArticleId><ArticleId IdType="pubmed">19934075</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch, S. H., Shuster, G., &amp; Lobo, M. L. (2018). The family caregiver experience&#x2014;Examining the positive and negative aspects of compassion satisfaction and compassion fatigue as caregiving outcomes. Aging &amp; Mental Health, 22(11), 1424&#x2013;1431. doi:10.1080/13607863.2017.1364344</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2017.1364344</ArticleId><ArticleId IdType="pubmed">28812375</ArticleId></ArticleIdList></Reference><Reference><Citation>Montaquila, J., Freedman, V. A., Edwards, B., &amp; Kasper, J. D. (2012). National Health and Aging Trends Study round 1 sample design and selection. NHATS Technical Paper, 1, 1&#x2013;8.</Citation></Reference><Reference><Citation>Moon, H., Rote, S., &amp; Haley, W. E. (2018). Factors that contribute to remaining in the community among older adults. Aging &amp; Mental Health, 22(11), 1502&#x2013;1509. doi:10.1080/13607863.2017.1363869</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2017.1363869</ArticleId><ArticleId IdType="pubmed">28799417</ArticleId></ArticleIdList></Reference><Reference><Citation>NHATS Data Collection Procedures: Round 1, 2011. Funded by the National Institute on Aging (U01AG032947 ). www.nhats.org.</Citation></Reference><Reference><Citation>Park, S., &amp; Chen, J. (2020). Racial and ethnic patterns and differences in health care expenditures among Medicare beneficiaries with and without cognitive deficits or Alzheimer&#x2019;s disease and related dementias. BMC Geriatrics, 20(1), 1&#x2013;11. doi:10.1186/s12877-020-01888-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-020-01888-y</ArticleId><ArticleId IdType="pmc">PMC7672830</ArticleId><ArticleId IdType="pubmed">33208121</ArticleId></ArticleIdList></Reference><Reference><Citation>Reckrey, J. M., Federman, A. D., Bollens-Lund, E., Morrison, R. S., &amp; Ornstein, K. A. (2020). Homebound status and the critical role of caregiving support. Journal of Aging &amp; Social Policy, 32(6), 590&#x2013;603. doi:10.1080/08959420.2019.1628625</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08959420.2019.1628625</ArticleId><ArticleId IdType="pmc">PMC6933108</ArticleId><ArticleId IdType="pubmed">31242823</ArticleId></ArticleIdList></Reference><Reference><Citation>Reckrey, J. M., Morrison, R. S., Boerner, K., Szanton, S. L., Bollens-Lund, E., Leff, B., &amp; Ornstein, K. A. (2020). Living in the community with dementia: Who receives paid care? Journal of the American Geriatrics Society, 68(1), 186&#x2013;191. doi:10.1111/jgs.16215</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16215</ArticleId><ArticleId IdType="pmc">PMC6957088</ArticleId><ArticleId IdType="pubmed">31696511</ArticleId></ArticleIdList></Reference><Reference><Citation>

Shiekh, S. I., Cadogan, S. L., Lin, L. Y., Mathur, R., Smeeth, L., &amp; Warren-Gash, C. (2021). Ethnic differences in dementia risk: A systematic review and meta-analysis. Journal of Alzheimer&#x2019;s Disease, 80(1), 337&#x2013;355. doi:10.3233%2FJAD-201209</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075390</ArticleId><ArticleId IdType="pubmed">33554910</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloane, P. D., Yearby, R., Konetzka, R. T., Li, Y., Espinoza, R., &amp; Zimmerman, S. (2021). Addressing systemic racism in nursing homes: A time for action. Journal of the American Medical Directors Association, 22(4), 886&#x2013;892. doi:10.1016/j.jamda.2021.02.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2021.02.023</ArticleId><ArticleId IdType="pubmed">33775548</ArticleId></ArticleIdList></Reference><Reference><Citation>
StataCorp. (2019). Stata statistical software (Version 16) (computer software). StataCorp LLC.https://www.stata.com/</Citation></Reference><Reference><Citation>StataCorp. (2021). Stata survey data reference manual: Release 17. Stata Press.</Citation></Reference><Reference><Citation>Szanton, S. L., Walker, R. K., Roberts, L., Thorpe Jr, R. J., Wolff, J., Agree, E., &amp; Seplaki, C. (2015). Older adults&#x2019; favorite activities are resoundingly active: Findings from the NHATS study. Geriatric Nursing, 36(2), 131&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4775165</ArticleId><ArticleId IdType="pubmed">25619566</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomeer, M. B., Mudrazija, S., &amp; Angel, J. L. (2015). How do race and Hispanic ethnicity affect nursing home admission? Evidence from the Health and Retirement Study. The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 70(4), 628&#x2013;638. doi:10.1093/geronb/gbu114</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbu114</ArticleId><ArticleId IdType="pmc">PMC4462672</ArticleId><ArticleId IdType="pubmed">25204311</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, L., Lee, Y., Kim, B. J., &amp; Chen, L. (2021). Determinants of discretionary and non-discretionary service utilization among caregivers of people with dementia: Focusing on the race/ethnic differences. Home Health Care Services Quarterly, 40(1), 75&#x2013;92. doi:10.1080/01621424.2020.1805083</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621424.2020.1805083</ArticleId><ArticleId IdType="pubmed">32799762</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan, D., Wang, S., Temkin-Greener, H., &amp; Cai, S. (2021). HCBS service spending and nursing home placement for patients with Alzheimer&#x2019;s disease and related dementias: Does race matter? Journal of Applied Gerontology, 41(3), 638&#x2013;649. doi: 10.1111/1475-6773.13353</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1475-6773.13353</ArticleId><ArticleId IdType="pmc">PMC8847325</ArticleId><ArticleId IdType="pubmed">34615409</ArticleId></ArticleIdList></Reference><Reference><Citation>Young, Y., Papenkov, M., Hsu, W. H., Shahid, F., &amp; Kuo, Y. H. (2020). Permanent transition of homecare recipients with dementia to nursing homes in New York State: Risk factors. Geriatric Nursing, 41(5), 553&#x2013;558. doi:10.1016/j.gerinurse.2020.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gerinurse.2020.02.006</ArticleId><ArticleId IdType="pubmed">32216955</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36068999</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1364-6915</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Aging &amp; mental health</Title><ISOAbbreviation>Aging Ment Health</ISOAbbreviation></Journal><ArticleTitle>The relationship of caregiver self-efficacy to caregiver outcomes: a correlation and mediation analysis.</ArticleTitle><Pagination><StartPage>1322</StartPage><EndPage>1328</EndPage><MedlinePgn>1322-1328</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/13607863.2022.2118666</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">Caregivers of individuals with Alzheimer's disease and related dementias experience significant burden and adverse outcomes. Enhancing caregiver self-efficacy has the potential to mitigate these negative impacts, yet little is known about its relationship with other aspects of caregiving. This study examined the relationship between self-efficacy and outcomes; identified factors associated with self-efficacy; examined the mediating role of self-efficacy; and analyzed whether there were racial/ethnic differences.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Data from caregivers (<i>N</i>&#x2009;=&#x2009;243) were collected from the Caring for the Caregiver Network study. Participants' level of self-efficacy, depression, burden, and positive aspects of caregiving was assessed using validated measures.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Two self-efficacy subscales predicted caregiver depression, burden, and positive aspects of caregiving. Being White, a spouse, or having a larger social network predicted lower self-efficacy for obtaining respite. Higher income and lower preparedness predicted lower self-efficacy for controlling upsetting thoughts and responding to disruptive behaviors. Self-efficacy for controlling upsetting thoughts mediated the relationship between preparedness and depression along with the relationship between preparedness and burden. Race/ethnicity did not improve model fit.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Self-efficacy plays an important role in caregiver outcomes. These findings indicate that strategies to improve caregiver self-efficacy should be an integral component of caregiver interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Phongtankuel</LastName><ForeName>Veerawat</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine, New York City, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moxley</LastName><ForeName>Jerad</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine, New York City, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reid</LastName><ForeName>M C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine, New York City, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adelman</LastName><ForeName>Ronald D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine, New York City, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Czaja</LastName><ForeName>Sara J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine, New York City, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K24 AG053462</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NR014434</GrantID><Acronym>NR</Acronym><Agency>NINR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Aging Ment Health</MedlineTA><NlmUniqueID>9705773</NlmUniqueID><ISSNLinking>1360-7863</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ADRD</Keyword><Keyword MajorTopicYN="N">Caregiving</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">preparedness</Keyword><Keyword MajorTopicYN="N">self-efficacy</Keyword></KeywordList><CoiStatement>DECLARATION OF INTEREST STATEMENT. The authors report there are no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>7</Day><Hour>3</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36068999</ArticleId><ArticleId IdType="mid">NIHMS1846358</ArticleId><ArticleId IdType="pmc">PMC9986404</ArticleId><ArticleId IdType="doi">10.1080/13607863.2022.2118666</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Archbold PG, Stewart BJ, Greenlick MR, &amp; Harvath T. (1990). Mutuality and preparedness as predictors of caregiver role strain. Research in Nursing &amp; Health, 375&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pubmed">2270302</ArticleId></ArticleIdList></Reference><Reference><Citation>Au A, Lau KM, Sit E, Cheung G, Lai MK, Wong SKA, &amp; Fok D. (2010). The role of self-efficacy in the Alzheimer&#x2019;s family caregiver stress process: A partial mediator between physical health and depressive symptoms. Clinical Gerontologist, 33(4), 298&#x2013;315. 10.1080/07317115.2010.502817</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07317115.2010.502817</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandura A. (1997). Self-efficacy: The exercise of control. Journal of Cognitive Psychotherapy, 158&#x2013;166.</Citation></Reference><Reference><Citation>B&#xe9;dard M, Molloy DW, Squire L, Dubois S, Lever JA, O&#x2019;Donnell M, &amp; O&#x2019;donnell M. (2001). The Zarit Burden Interview: a new short version and screening version. Gerontologist, 41(5), 652&#x2013;657. 10.1093/geront/41.5.652</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/41.5.652</ArticleId><ArticleId IdType="pubmed">11574710</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng ST, Lam LCW, Kwok T, Ng NSS, &amp; Fung AWT (2013). Self-efficacy is associated with less burden and more gains from behavioral problems of Alzheimer&#x2019;s disease in Hong Kong Chinese caregivers. Gerontologist, 53(1), 71&#x2013;80. 10.1093/geront/gns062</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gns062</ArticleId><ArticleId IdType="pubmed">22563001</ArticleId></ArticleIdList></Reference><Reference><Citation>Covinsky KE, Newcomer R, Fox P, &amp; Wood J. (2003). Patient and Caregiver Characteristics Associated with. J Gen Intern Med, 18, 1006&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1494966</ArticleId><ArticleId IdType="pubmed">14687259</ArticleId></ArticleIdList></Reference><Reference><Citation>Epps F. (2014). The relationship between family obligation and religiosity on caregiving. Geriatric Nursing (New York, N.Y.), 35(2), 126&#x2013;131. 10.1016/j.gerinurse.2013.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gerinurse.2013.11.003</ArticleId><ArticleId IdType="pubmed">24314743</ArticleId></ArticleIdList></Reference><Reference><Citation>Falzarano F, Moxley J, Pillemer K, &amp; Czaja SJ (2021). Family Matters: Cross-Cultural Differences in Familism and Caregiving Outcomes. The Journals of Gerontology: Series B, 77(7), 1&#x2013;11. 10.1093/geronb/gbab160</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbab160</ArticleId><ArticleId IdType="pmc">PMC9255933</ArticleId><ArticleId IdType="pubmed">34473247</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher D, Mhaolain AN, Crosby L, Ryan D, Lacey L, Coen RF, &#x2026; Lawlor BA (2011). Self-efficacy for managing dementia may protect against burden and depression in Alzheimer&#x2019;s caregivers. Aging and Mental Health, 15(6), 663&#x2013;670. 10.1080/13607863.2011.562179</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2011.562179</ArticleId><ArticleId IdType="pubmed">21547745</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilliam CM, &amp; Steffen AM (2006). The relationship between caregiving self-efficacy and depressive symptoms in dementia family caregivers. Aging and Mental Health, 10(2), 79&#x2013;86. 10.1080/13607860500310658</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607860500310658</ArticleId><ArticleId IdType="pubmed">16517482</ArticleId></ArticleIdList></Reference><Reference><Citation>Grano C, Lucidi F, &amp; Violani C. (2017). The relationship between caregiving self-efficacy and depressive symptoms in family caregivers of patients with Alzheimer disease: A longitudinal study. International Psychogeriatrics, 29(7), 1095&#x2013;1103. 10.1017/S1041610217000059</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610217000059</ArticleId><ArticleId IdType="pubmed">28162131</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight BG, Robinson GS, Flynn Longmire CV, Chun M, Nakao K, &amp; Kim JH (2002). Cross cultural issues in caregiving for persons with dementia: Do familism values reduce burden and distress? Ageing International, 27(3), 70&#x2013;94. 10.1007/s12126-003-1003-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12126-003-1003-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopman J, Howe M, Hollenbeck JR, &amp; Sin HP (2015). Small sample mediation testing: misplaced confidence in bootstrapped confidence intervals. Journal of Applied Psychology, 100(1), 194&#x2013;202. 10.1037/a0036635</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0036635</ArticleId><ArticleId IdType="pubmed">24731180</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS (2018). The Telephone Interview for Cognitive Status. Cognitive and Behavioral Neurology, 31(3), 158. 10.1097/WNN.0000000000000166</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNN.0000000000000166</ArticleId><ArticleId IdType="pubmed">30239467</ArticleId></ArticleIdList></Reference><Reference><Citation>Krause N. (1995). Negative interaction and satisfaction with social support among older adults. Journals of Gerontology - Series B Psychological Sciences and Social Sciences, 50 B(2), P59&#x2013;P73. 10.1093/geronb/50B.2.P59</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/50B.2.P59</ArticleId><ArticleId IdType="pubmed">7757834</ArticleId></ArticleIdList></Reference><Reference><Citation>Langa KM, Chernew ME, Kabeto MU, Herzog AR, Ofstedal MB, Willis RJ, &#x2026; Fendrick AM (2001). National estimates of the quantity and cost of informal caregiving for the elderly with dementia. Journal of General Internal Medicine, 16(11), 770&#x2013;778. 10.1046/j.1525-1497.2001.10123.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.10123.x</ArticleId><ArticleId IdType="pmc">PMC1495283</ArticleId><ArticleId IdType="pubmed">11722692</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Hu L, Mao X, Shen Y, Xue H, Hou P, &amp; Liu Y. (2020). Health literacy, social support, and care ability for caregivers of dementia patients: Structural equation modeling. Geriatric Nursing, 41(5), 600&#x2013;607. 10.1016/j.gerinurse.2020.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gerinurse.2020.03.014</ArticleId><ArticleId IdType="pubmed">32327281</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubben JE (1988). Assessing social networks among elderly populations. Fam Community Health, 11(3), 42&#x2013;52.</Citation></Reference><Reference><Citation>Pearlin LI, Mullan JT, Semple SJ, &amp; Skaff MM (1990). Caregiving and the stress process: An overview of concepts and their measures. Gerontologist, 30(5), 583&#x2013;594. 10.1093/geront/30.5.583</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/30.5.583</ArticleId><ArticleId IdType="pubmed">2276631</ArticleId></ArticleIdList></Reference><Reference><Citation>Radloff LS (1977). The CES-D Scale: A Self-Report Depression Scale for Research in the General Population. Applied Psychological Measurement, 1(3), 385&#x2013;401. 10.1177/014662167700100306</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/014662167700100306</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz R, Eden J, &amp; Division M. (2016). Families Caring for an Aging America. 10.17226/23606</Citation><ArticleIdList><ArticleId IdType="doi">10.17226/23606</ArticleId><ArticleId IdType="pubmed">27905704</ArticleId></ArticleIdList></Reference><Reference><Citation>Semiatin AM, &amp; O&#x2019;Connor MK (2012). The relationship between self-efficacy and positive aspects of caregiving in Alzheimer&#x2019;s disease caregivers. Aging and Mental Health, 16(6), 683&#x2013;688. 10.1080/13607863.2011.651437</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2011.651437</ArticleId><ArticleId IdType="pubmed">22360626</ArticleId></ArticleIdList></Reference><Reference><Citation>Shyu YIL, Yang CT, Huang CC, Kuo HC, Chen ST, &amp; Hsu WC (2010). Influences of mutuality, preparedness, and balance on caregivers of patients with dementia. The Journal of Nursing Research&#x202f;: JNR, 18(3), 155&#x2013;163. 10.1097/jnr.0b013e3181ed5845</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/jnr.0b013e3181ed5845</ArticleId><ArticleId IdType="pubmed">20808075</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffen AM, McKibbin C, Zeiss AM, Gallagher-Thompson D, &amp; Bandura A. (2002). The revised scale for caregiving self-efficacy: Reliability and validity studies. Journals of Gerontology - Series B Psychological Sciences and Social Sciences, 57(1), 74&#x2013;86. 10.1093/geronb/57.1.P74</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/57.1.P74</ArticleId><ArticleId IdType="pubmed">11773226</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarlow BJ, Wisniewski SR, Belle SH, Rubert M, Ory MG, &amp; Gallagher-Thompson D. (2004). Positive aspects of caregiving: Contributions of the REACH project to the development of new measures for Alzheimer&#x2019;s caregiving. Research on Aging, 26(4), 429&#x2013;453. 10.1177/0164027504264493</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0164027504264493</ArticleId></ArticleIdList></Reference><Reference><Citation>Victor CR, Rippon I, Quinn C, Nelis SM, Martyr A, Hart N, &#x2026; Clare L. (2021). The prevalence and predictors of loneliness in caregivers of people with dementia: findings from the IDEAL programme. Aging and Mental Health, 25(7), 1232&#x2013;1238. 10.1080/13607863.2020.1753014</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2020.1753014</ArticleId><ArticleId IdType="pubmed">32306759</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36052973</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1364-6915</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Aging &amp; mental health</Title><ISOAbbreviation>Aging Ment Health</ISOAbbreviation></Journal><ArticleTitle>Cross-cultural analysis of the role of ambivalent feelings for understanding caregivers' depressive symptoms.</ArticleTitle><Pagination><StartPage>1307</StartPage><EndPage>1312</EndPage><MedlinePgn>1307-1312</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/13607863.2022.2116407</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">Behavioral and psychological symptoms of dementia (BPSD) are considered to cause ambivalent feelings in caregivers that may contribute to understanding their depressive symptoms. Transnational research is needed in order to increase our knowledge about the cross-cultural equivalence of theoretical models to understand caregivers' mental health. The aim of this study was to cross-culturally analyze the association between BPSD, ambivalent feelings and depressive symptoms in two samples of family caregivers of people with dementia from Spain and the UK.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Participants in this study were 432 caregivers who completed measures of BPSD, ambivalent feelings and depressive symptoms. The association between the assessed variables was tested through path-analysis, with differences between countries tested through multigroup analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The results suggest that the influence of BPSD on caregivers' depressive symptoms is indirect, through ambivalent feelings. The observed associations were equivalent between countries and explained a significant percentage of the variance of depressive symptoms.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The findings of this study provide, for the first time, evidence of equivalent cross-cultural paths analyzing the role of ambivalent feelings for understanding caregivers' depressive symptoms. The practical implications of these results are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Losada-Baltar</LastName><ForeName>Andr&#xe9;s</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3134-7133</Identifier><AffiliationInfo><Affiliation>Department of Psychology, Universidad Rey Juan Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kishita</LastName><ForeName>Naoko</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-8453-2714</Identifier><AffiliationInfo><Affiliation>School of Health Sciences, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez-Gonzalo</LastName><ForeName>Luc&#xed;a</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-2305-3362</Identifier><AffiliationInfo><Affiliation>Department of Psychology, Universidad Rey Juan Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandes-Pires</LastName><ForeName>Jos&#xe9;</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Psychology, Universidad Rey Juan Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huertas-Domingo</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychology, Universidad Rey Juan Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Milena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Health Sciences, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Hout</LastName><ForeName>Elien</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-2956-7575</Identifier><AffiliationInfo><Affiliation>School of Health Sciences, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olazar&#xe1;n</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7320-128X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-Huertas</LastName><ForeName>Jos&#xe9; &#xc1;ngel</ForeName><Initials>J&#xc1;</Initials><AffiliationInfo><Affiliation>Department of Methodology of Behavioral Sciences, Universidad Nacional de Educaci&#xf3;n a Distancia, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe1;rquez-Gonz&#xe1;lez</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6572-8949</Identifier><AffiliationInfo><Affiliation>Department of Biological and Clinical Psychology, Universidad Aut&#xf3;noma de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Aging Ment Health</MedlineTA><NlmUniqueID>9705773</NlmUniqueID><ISSNLinking>1360-7863</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer</Keyword><Keyword MajorTopicYN="N">ambivalence</Keyword><Keyword MajorTopicYN="N">caregiving</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">distress</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>2</Day><Hour>7</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36052973</ArticleId><ArticleId IdType="doi">10.1080/13607863.2022.2116407</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36036728</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-4657</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Season>Jul-Sep</Season></PubDate></JournalIssue><Title>Experimental aging research</Title><ISOAbbreviation>Exp Aging Res</ISOAbbreviation></Journal><ArticleTitle>Overload and Emotional Wellbeing in a Sample of Spanish Caregivers of Alzheimer's Patients during COVID-19 pandemic.</ArticleTitle><Pagination><StartPage>389</StartPage><EndPage>406</EndPage><MedlinePgn>389-406</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/0361073X.2022.2115739</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Carers of Alzheimer's suffer from caregiver overload, anxiety and depression. Changes in caregiving brought about by pandemic restrictions (COVID-19) may play a role. The aim was to explore the caregiver profile and assess the influence of the pandemic on informal and formal caregivers in a Spanish sample.</AbstractText><AbstractText Label="METHOD">Sixty caregivers participated. An ad hoc questionnaire, ZBI, STAI and BDI were administered.</AbstractText><AbstractText Label="RESULTS">Informal caregivers were more overloaded, anxious and depressed than professional caregivers. Both groups perceived themselves to be more sad, worried and stressed than in the pre-pandemic situation. The pandemic-generated variables associated with caregiving did not influence caregiver overload in both groups. In informal caregivers, worsening of the patient with stress and changes in perceived social support with anxiety and depression. In professional caregivers, changes in routine were associated with stress and lower depression and changes in perceived social support with higher caregiver strain. Changes in caregiving routine and changes in perceived social support were predictors of overload and emotional distress in both caregivers.</AbstractText><AbstractText Label="CONCLUSIONS">Overload was not influenced by the pandemic situation. Changes in caregiving routine and lack of social support were found to be predictors of overload and emotional distress in both types of caregivers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Mora</LastName><ForeName>&#xc1;lvaro</ForeName><Initials>&#xc1;</Initials><Identifier Source="ORCID">0000-0003-1869-4840</Identifier><AffiliationInfo><Affiliation>Instituto Universitario para el Desarrollo Social y Sostenible, Universidad de C&#xe1;diz, C&#xe1;diz, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychology, Universidad de C&#xe1;diz, C&#xe1;diz, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mateo Guirola</LastName><ForeName>Tania</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychology, Universidad de C&#xe1;diz, C&#xe1;diz, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mestre</LastName><ForeName>Jos&#xe9; M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Instituto Universitario para el Desarrollo Social y Sostenible, Universidad de C&#xe1;diz, C&#xe1;diz, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychology, Universidad de C&#xe1;diz, C&#xe1;diz, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n e Innovaci&#xf3;n Biom&#xe9;dica de C&#xe1;diz, Universidad de C&#xe1;diz, C&#xe1;diz, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Exp Aging Res</MedlineTA><NlmUniqueID>7603335</NlmUniqueID><ISSNLinking>0361-073X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>29</Day><Hour>10</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36036728</ArticleId><ArticleId IdType="doi">10.1080/0361073X.2022.2115739</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36036081</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1465-3419</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Ethnicity &amp; health</Title><ISOAbbreviation>Ethn Health</ISOAbbreviation></Journal><ArticleTitle>The influence of Latino cultural values on the perceived caregiver role of family members with Alzheimer's disease and related dementias.</ArticleTitle><Pagination><StartPage>619</StartPage><EndPage>633</EndPage><MedlinePgn>619-633</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/13557858.2022.2115018</ELocationID><Abstract><AbstractText Label="OBJECTIVES">We explored how Latino cultural values play a role in perceived caregiving experiences.</AbstractText><AbstractText Label="DESIGN">We conducted a qualitative study that used individual, in-depth, semi-structured interviews with middle-aged and older Latinos who were primary caregivers of family members with Alzheimer's disease and related dementias (ADRD). The interview guide consisted of questions about participants' perceptions of family caregiving and interrelationships between the caregiver and care recipient. The interviews were recorded, translated, and transcribed <i>verbatim</i>. We performed direct content analysis.</AbstractText><AbstractText Label="RESULTS">Participants were caregivers, 50-75 years old (<i>n</i>&#x2009;=&#x2009;16), and the majority were female. We identified four cultural values that were salient to participants' caregiving experiences: (a) <i>familismo</i>, (b) <i>fatalismo</i> (c) <i>marianismo</i>, and (d) <i>machismo</i>.</AbstractText><AbstractText Label="CONCLUSION">Latino cultural values influenced the role of caregiving and caregiving roles of family members with ADRD. Future research should consider these values as they affect different familial and health dynamics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jaldin</LastName><ForeName>Michelle A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Kinesiology and Nutrition, College of Applied Health Sciences, University of Illinois at Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balbim</LastName><ForeName>Guilherme M</ForeName><Initials>GM</Initials><Identifier Source="ORCID">0000-0002-9059-0299</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Faculty of Medicine, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colin</LastName><ForeName>Stephanie J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Kinesiology and Nutrition, College of Applied Health Sciences, University of Illinois at Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marques</LastName><ForeName>Isabela G</ForeName><Initials>IG</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mejia</LastName><ForeName>Jasmine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Kinesiology and Nutrition, College of Applied Health Sciences, University of Illinois at Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magallanes</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College of Medicine, University of Illinois, Rockford, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocha</LastName><ForeName>Judith S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Social Work Program, College of Arts and Sciences, Northeastern Illinois University, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marquez</LastName><ForeName>David X</ForeName><Initials>DX</Initials><Identifier Source="ORCID">0000-0001-8903-4941</Identifier><AffiliationInfo><Affiliation>Department of Kinesiology and Nutrition, College of Applied Health Sciences, University of Illinois at Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ethn Health</MedlineTA><NlmUniqueID>9608374</NlmUniqueID><ISSNLinking>1355-7858</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006630" MajorTopicYN="Y">Hispanic or Latino</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003469" MajorTopicYN="Y">Culture</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012945" MajorTopicYN="Y">Social Values</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005195" MajorTopicYN="Y">Family Relations</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease and related dementias</Keyword><Keyword MajorTopicYN="N">Caregiving</Keyword><Keyword MajorTopicYN="N">Latinos</Keyword><Keyword MajorTopicYN="N">cultural values</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>29</Day><Hour>5</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36036081</ArticleId><ArticleId IdType="doi">10.1080/13557858.2022.2115018</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35996225</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1545-2301</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Clinical gerontologist</Title><ISOAbbreviation>Clin Gerontol</ISOAbbreviation></Journal><ArticleTitle>Modifiable Risk Factors for Brain Health and Dementia and Opportunities for Intervention: A Brief Review.</ArticleTitle><Pagination><StartPage>143</StartPage><EndPage>154</EndPage><MedlinePgn>143-154</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/07317115.2022.2114396</ELocationID><Abstract><AbstractText>Maintaining brain health and promoting healthy lifestyle strategies to manage modifiable risk factors is vital to ensuring well-being for all - not only for the individuals with memory challenges but also their family caregivers and professional providers. In this brief review paper, we highlight modifiable risk and protective factors and opportunities for dementia risk reduction (e.g., limited alcohol use and reduced exposure to air pollution, secondhand smoke, and excessive noise); provide an overview of the World-Wide FINGERS Network and its goal to adapt the original Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) multidomain lifestyle approach in various settings to determine whether the protocol is effective across different populations in varied geographic, cultural, and economic settings and to optimize the model across a continuum of cognitive decline; and, comment on challenges and opportunities for researchers and clinicians including opportunities for risk reduction and intervention in primary care settings and the need to establish linkages across multiple levels of intervention to sustain behavior change in prevention, treatment, and care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Coon</LastName><ForeName>David W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Center for Innovation in Healthy and Resilient Aging, Arizona State University, Tempe, Arizona, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Edson College of Nursing and Health Innovation, Arizona State University, Tempe, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Morales</LastName><ForeName>Abigail</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Edson College of Nursing and Health Innovation, Arizona State University, Tempe, Arizona, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG019610</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Gerontol</MedlineTA><NlmUniqueID>8300869</NlmUniqueID><ISSNLinking>0731-7115</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008019" MajorTopicYN="N">Life Style</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s</Keyword><Keyword MajorTopicYN="N">FINGER</Keyword><Keyword MajorTopicYN="N">U.S. POINTER</Keyword><Keyword MajorTopicYN="N">WW-FINGERS</Keyword><Keyword MajorTopicYN="N">brain health</Keyword><Keyword MajorTopicYN="N">caregiving</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>23</Day><Hour>0</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35996225</ArticleId><ArticleId IdType="doi">10.1080/07317115.2022.2114396</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35989572</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1545-7222</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Season>Spring</Season></PubDate></JournalIssue><Title>The Journal of neuropsychiatry and clinical neurosciences</Title><ISOAbbreviation>J Neuropsychiatry Clin Neurosci</ISOAbbreviation></Journal><ArticleTitle>Incongruences Between Facial Expression and Self-Reported Emotional Reactivity in Frontotemporal Dementia and Related Disorders.</ArticleTitle><Pagination><StartPage>192</StartPage><EndPage>201</EndPage><MedlinePgn>192-201</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1176/appi.neuropsych.21070186</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">Emotional reactivity normally involves a synchronized coordination of subjective experience and facial expression. These aspects of emotional reactivity can be uncoupled by neurological illness and produce adverse consequences for patient and caregiver quality of life because of misunderstandings regarding the patient's presumed internal state. Frontotemporal dementia (FTD) is often associated with altered social and emotional functioning. FTD is a heterogeneous disease, and socioemotional changes in patients could result from altered internal experience, altered facial expressive ability, altered language skills, or other factors. The authors investigated how individuals with FTD subtypes differ from a healthy control group regarding the extent to which their facial expressivity aligns with their self-reported emotional experience.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Using a compound measure of emotional reactivity to assess reactions to three emotionally provocative videos, the authors explored potential explanations for differences in alignment of facial expressivity with emotional experience, including parkinsonism, physiological reactivity, and nontarget verbal responses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Participants with the three main subtypes of FTD all tended to express less emotion on their faces than they did through self-report.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Exploratory analyses suggest that reasons for this incongruence likely differ not only between but also within diagnostic subgroups.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pressman</LastName><ForeName>Peter S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Department of Neurology Behavioral Neurology Section (Pressman, Filley), Alzheimer's and Cognition Center (Pressman, Sillau, Chial), Linda Crnic Institute for Down Syndrome (Chial), and Marcus Institute for Brain Health (Filley), University of Colorado Anschutz Medical Campus, Aurora; Berkeley Psychophysiology Laboratory, University of California, Berkeley (Chen, Casey, Levenson); Memory and Aging Center, University of California, San Francisco (Miller).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Kuan Hua</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Neurology Behavioral Neurology Section (Pressman, Filley), Alzheimer's and Cognition Center (Pressman, Sillau, Chial), Linda Crnic Institute for Down Syndrome (Chial), and Marcus Institute for Brain Health (Filley), University of Colorado Anschutz Medical Campus, Aurora; Berkeley Psychophysiology Laboratory, University of California, Berkeley (Chen, Casey, Levenson); Memory and Aging Center, University of California, San Francisco (Miller).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casey</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology Behavioral Neurology Section (Pressman, Filley), Alzheimer's and Cognition Center (Pressman, Sillau, Chial), Linda Crnic Institute for Down Syndrome (Chial), and Marcus Institute for Brain Health (Filley), University of Colorado Anschutz Medical Campus, Aurora; Berkeley Psychophysiology Laboratory, University of California, Berkeley (Chen, Casey, Levenson); Memory and Aging Center, University of California, San Francisco (Miller).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sillau</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology Behavioral Neurology Section (Pressman, Filley), Alzheimer's and Cognition Center (Pressman, Sillau, Chial), Linda Crnic Institute for Down Syndrome (Chial), and Marcus Institute for Brain Health (Filley), University of Colorado Anschutz Medical Campus, Aurora; Berkeley Psychophysiology Laboratory, University of California, Berkeley (Chen, Casey, Levenson); Memory and Aging Center, University of California, San Francisco (Miller).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chial</LastName><ForeName>Heidi J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Neurology Behavioral Neurology Section (Pressman, Filley), Alzheimer's and Cognition Center (Pressman, Sillau, Chial), Linda Crnic Institute for Down Syndrome (Chial), and Marcus Institute for Brain Health (Filley), University of Colorado Anschutz Medical Campus, Aurora; Berkeley Psychophysiology Laboratory, University of California, Berkeley (Chen, Casey, Levenson); Memory and Aging Center, University of California, San Francisco (Miller).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filley</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Neurology Behavioral Neurology Section (Pressman, Filley), Alzheimer's and Cognition Center (Pressman, Sillau, Chial), Linda Crnic Institute for Down Syndrome (Chial), and Marcus Institute for Brain Health (Filley), University of Colorado Anschutz Medical Campus, Aurora; Berkeley Psychophysiology Laboratory, University of California, Berkeley (Chen, Casey, Levenson); Memory and Aging Center, University of California, San Francisco (Miller).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Bruce L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Department of Neurology Behavioral Neurology Section (Pressman, Filley), Alzheimer's and Cognition Center (Pressman, Sillau, Chial), Linda Crnic Institute for Down Syndrome (Chial), and Marcus Institute for Brain Health (Filley), University of Colorado Anschutz Medical Campus, Aurora; Berkeley Psychophysiology Laboratory, University of California, Berkeley (Chen, Casey, Levenson); Memory and Aging Center, University of California, San Francisco (Miller).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levenson</LastName><ForeName>Robert W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Neurology Behavioral Neurology Section (Pressman, Filley), Alzheimer's and Cognition Center (Pressman, Sillau, Chial), Linda Crnic Institute for Down Syndrome (Chial), and Marcus Institute for Brain Health (Filley), University of Colorado Anschutz Medical Campus, Aurora; Berkeley Psychophysiology Laboratory, University of California, Berkeley (Chen, Casey, Levenson); Memory and Aging Center, University of California, San Francisco (Miller).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 AG063900</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AG064745</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R00 AG059947</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG071151</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neuropsychiatry Clin Neurosci</MedlineTA><NlmUniqueID>8911344</NlmUniqueID><ISSNLinking>0895-0172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005149" MajorTopicYN="N">Facial Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004644" MajorTopicYN="N">Emotions</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">emotion</Keyword><Keyword MajorTopicYN="N">facial expression</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>22</Day><Hour>3</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35989572</ArticleId><ArticleId IdType="mid">NIHMS1879898</ArticleId><ArticleId IdType="pmc">PMC10723939</ArticleId><ArticleId IdType="doi">10.1176/appi.neuropsych.21070186</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Levenson R: Human emotion: a functional view; in The Nature of Emotion: Fundamental Questions. Edited by Ekman P, Davidson R. New York, Oxford, 1994</Citation></Reference><Reference><Citation>Brown CL, Van Doren N, Ford BQ, et al.: Coherence between subjective experience and physiology in emotion: individual differences and implications for well-being. Emotion 2020; 20:818&#x2013;829</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158438</ArticleId><ArticleId IdType="pubmed">30869944</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauss IB, Levenson RW, McCarter L, et al.: The tie that binds? Coherence among emotion experience, behavior, and physiology. Emotion 2005; 5:175&#x2013;190</Citation><ArticleIdList><ArticleId IdType="pubmed">15982083</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MC, Smith MK, Ellgring H: Spontaneous and posed facial expression in Parkinson&#x2019;s disease. J Int Neuropsychol Soc 1996; 2:383&#x2013;391</Citation><ArticleIdList><ArticleId IdType="pubmed">9375163</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney NT, Goodkind MS, Lomen-Hoerth C, et al.: Behaviour, physiology and experience of pathological laughing and crying in amyotrophic lateral sclerosis. Brain 2011; 134:3458&#x2013;3469</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3235565</ArticleId><ArticleId IdType="pubmed">22155983</ArticleId></ArticleIdList></Reference><Reference><Citation>Pentland B, Pitcairn TK, Gray JM, et al.: The effects of reduced expression in Parkinson&#x2019;s disease on impression formation by health professionals. Clin Rehabil 1987; 1:307&#x2013;312</Citation></Reference><Reference><Citation>Hemmesch AR: The detrimental effects of atypical nonverbal behavior on older adults&#x2019; first impressions of individuals with Parkinson&#x2019;s disease. Psychol Aging 2014; 29:521&#x2013;527</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4176769</ArticleId><ArticleId IdType="pubmed">25244472</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL: Involuntary emotional expression disorder: definition, diagnosis, and measurement scales. CNS Spectr 2007; 12: 11&#x2013;16</Citation><ArticleIdList><ArticleId IdType="pubmed">17426670</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz R, Pell MD: When emotion and expression diverge: the social costs of Parkinson&#x2019;s disease. J Clin Exp Neuropsychol 2017; 39:211&#x2013;230</Citation><ArticleIdList><ArticleId IdType="pubmed">27548715</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Whitwell JL, Knopman DS, et al.: Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology 2009; 73:1443&#x2013;1450</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2779005</ArticleId><ArticleId IdType="pubmed">19884571</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno Tempini ML, Hillis AE, Weintraub S, et al.: Classification of primary progressive aphasia and its variants. Neurology 2011; 76: 1006&#x2013;1014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059138</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, et al.: Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134:2456&#x2013;2477</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoglinger GU, Respondek G, Stamelou M, et al.: Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 2017; 32:853&#x2013;864</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5516529</ArticleId><ArticleId IdType="pubmed">28467028</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong MJ, Litvan I, Lang AE, et al.: Criteria for the diagnosis of corticobasal degeneration. Neurology 2013; 80:496&#x2013;503</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3590050</ArticleId><ArticleId IdType="pubmed">23359374</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann GM, Knopman DS, Chertkow H, et al.: The diagnosis of dementia due to Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimers Dement 2011; 7:263&#x2013;269</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3312024</ArticleId><ArticleId IdType="pubmed">21514250</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua AY, Chen KH, Brown CL, et al.: Physiological, behavioral and subjective sadness reactivity in frontotemporal dementia subtypes. Soc Cogn Affect Neurosci 2019; 14:1453&#x2013;1465</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7137727</ArticleId><ArticleId IdType="pubmed">31993653</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckart JA, Sturm VE, Miller BL, et al.: Diminished disgust reactivity in behavioral variant frontotemporal dementia. Neuropsychologia 2012; 50:786&#x2013;790</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3309072</ArticleId><ArticleId IdType="pubmed">22285794</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KH, Lwi SJ, Hua AY, et al.: Increased subjective experience of non-target emotions in patients with frontotemporal dementia and Alzheimer&#x2019;s disease. Curr Opin Behav Sci 2017; 15:77&#x2013;84</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5810592</ArticleId><ArticleId IdType="pubmed">29457053</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranasinghe KG, Rankin KP, Pressman PS, et al.: Distinct subtypes of behavioral variant frontotemporal dementia based on patterns of network degeneration. JAMA Neurol 2016; 73:1078&#x2013;1088</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5024785</ArticleId><ArticleId IdType="pubmed">27429218</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetz CG, Fahn S, Martinez-Martin P, et al.: Movement Disorder Society&#x2013;sponsored revision of the Unified Parkinson&#x2019;s Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 2007; 22:41&#x2013;47</Citation><ArticleIdList><ArticleId IdType="pubmed">17115387</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KH, Wells JL, Otero MC, et al.: Greater experience of negative non-target emotions by patients with neurodegenerative diseases is related to lower emotional well-being in caregivers. Demen Geriat Cogn Disord 2017; 44:245&#x2013;255</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5906194</ArticleId><ArticleId IdType="pubmed">29216633</ArticleId></ArticleIdList></Reference><Reference><Citation>James W: The physical basis of emotion. Psychol Rev 1894; 1: 516&#x2013;529</Citation><ArticleIdList><ArticleId IdType="pubmed">8022955</ArticleId></ArticleIdList></Reference><Reference><Citation>Critchley HD, Wiens S, Rotshtein P, et al.: Neural systems supporting interoceptive awareness. Nat Neurosci 2004; 7:189&#x2013;195</Citation><ArticleIdList><ArticleId IdType="pubmed">14730305</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieuwenhuys R: The insular cortex: a review. Prog Brain Res2012; 195:123&#x2013;163</Citation><ArticleIdList><ArticleId IdType="pubmed">22230626</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Stock J, Kumfor F: Behavioural variant frontotemporal dementia: at the interface of interoception, emotion and social cognition? Cortex 2019; 115:335&#x2013;340</Citation><ArticleIdList><ArticleId IdType="pubmed">28882319</ArticleId></ArticleIdList></Reference><Reference><Citation>Levenson RW: Emotion elicitation with neurological patients; in The Handbook of Emotion Elicitation and Assessment. Edited by Coan JA, Allen JJB. New York, Oxford University Press, 2007</Citation></Reference><Reference><Citation>McKhann G, Drachman D, Folstein M, et al.: Clinical diagnosis of Alzheimer&#x2019;s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer&#x2019;s Disease. Neurology 1984; 34: 939&#x2013;944</Citation><ArticleIdList><ArticleId IdType="pubmed">6610841</ArticleId></ArticleIdList></Reference><Reference><Citation>Litvan I, Agid Y, Calne D, et al.: Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47:1&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">8710059</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden JS, Gustafson L, et al.: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51:1546&#x2013;1554</Citation><ArticleIdList><ArticleId IdType="pubmed">9855500</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross JJ, Levenson RW: Emotional suppression: physiology, self-report, and expressive behavior. J Pers Soc Psychol 1993; 64: 970&#x2013;986</Citation><ArticleIdList><ArticleId IdType="pubmed">8326473</ArticleId></ArticleIdList></Reference><Reference><Citation>Lwi SJ, Haase CM, Shiota MN, et al.: Responding to the emotions of others: age differences in facial expressions and age-specific associations with relational connectedness. Emotion 2019; 19: 1437&#x2013;1449</Citation><ArticleIdList><ArticleId IdType="pubmed">30730167</ArticleId></ArticleIdList></Reference><Reference><Citation>Park HK, Park KH, Yoon B, et al.: Clinical characteristics of parkinsonism in frontotemporal dementia according to subtypes. J Neurol Sci 2017; 372:51&#x2013;56</Citation><ArticleIdList><ArticleId IdType="pubmed">28017247</ArticleId></ArticleIdList></Reference><Reference><Citation>Baizabal-Carvallo JF, Jankovic J: Parkinsonism, movement disorders and genetics in frontotemporal dementia. Nat Rev Neurol 2016; 12:175&#x2013;185</Citation><ArticleIdList><ArticleId IdType="pubmed">26891767</ArticleId></ArticleIdList></Reference><Reference><Citation>WAIS-III: Administration Manual Scoring. San Diego, Harcourt Brace &amp; Company, 1997</Citation></Reference><Reference><Citation>California Verbal Learning Test. San Antonio, Texas, Psychological Corporation, 2000</Citation></Reference><Reference><Citation>Rey Complex Figure Test and Recognition Trial: Professional Manual. Lutz, FL, Psychological Assessment Resources, 1995</Citation></Reference><Reference><Citation>Boston Naming Test. Philadelphia, Lea &amp; Febiger, 1983</Citation></Reference><Reference><Citation>Davis MH: Measuring individual differences in empathy: evidence for a multidimensional approach. J Pers Soc Psychol 1983; 44: 113&#x2013;126</Citation></Reference><Reference><Citation>Yesavage JA, Brink TL, Rose TL, et al.: Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982; 17:37&#x2013;49</Citation><ArticleIdList><ArticleId IdType="pubmed">7183759</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein MF, Folstein SE, McHugh PR: &#x201c;Mini-mental state.&#x201d; A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189&#x2013;198</Citation><ArticleIdList><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43:2412&#x2013;2414</Citation><ArticleIdList><ArticleId IdType="pubmed">8232972</ArticleId></ArticleIdList></Reference><Reference><Citation>Pressman PS, Miller BL: Diagnosis and management of behavioral variant frontotemporal dementia. Biol Psychiatry 2014; 75:574&#x2013;581</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4194080</ArticleId><ArticleId IdType="pubmed">24315411</ArticleId></ArticleIdList></Reference><Reference><Citation>Mote J, Stuart BK, Kring AM: Diminished emotion expressivity but not experience in men and women with schizophrenia. J Abnorm Psychol 2014; 123:796&#x2013;801</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4227961</ArticleId><ArticleId IdType="pubmed">25222047</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper JJ, Ovsiew F: The relationship between schizophrenia and frontotemporal dementia. J Geriatr Psychiatry Neurol 2013; 26:131&#x2013;137</Citation><ArticleIdList><ArticleId IdType="pubmed">23733854</ArticleId></ArticleIdList></Reference><Reference><Citation>Gola KA, Shany-Ur T, Pressman P, et al.: A neural network underlying intentional emotional facial expression in neurodegenerative disease. Neuroimage Clin 2017; 14:672&#x2013;678</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5367861</ArticleId><ArticleId IdType="pubmed">28373956</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman JR, Filley CM, Ross ED, et al.: Aprosodia and prosoplegia with right frontal neurodegeneration. Neurocase 2019; 25:187&#x2013;194</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510567</ArticleId><ArticleId IdType="pubmed">31335278</ArticleId></ArticleIdList></Reference><Reference><Citation>Morecraft RJ, Stilwell-Morecraft KS, Rossing WR: The motor cortex and facial expression: new insights from neuroscience. Neurologist 2004; 10:235&#x2013;249</Citation><ArticleIdList><ArticleId IdType="pubmed">15335441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross ED, Gupta SS, Adnan AM, et al.: Neurophysiology of spontaneous facial expressions: I. Motor control of the upper and lower face is behaviorally independent in adults. Cortex 2016; 76: 28&#x2013;42</Citation><ArticleIdList><ArticleId IdType="pubmed">26854960</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson C, Alcantar O, Rothlind J, et al.: Standardised measurement of self-awareness deficits in FTD and AD. J Neurol Neurosurg Psychiatry 2010; 81:140&#x2013;145</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2820148</ArticleId><ArticleId IdType="pubmed">19204020</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo CC, Sturm VE, Zhou J, et al.: Dominant hemisphere lateralization of cortical parasympathetic control as revealed by frontotemporal dementia. Proc Natl Acad Sci U S A 2016; 113: E2430&#x2013;E2439</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4855566</ArticleId><ArticleId IdType="pubmed">27071080</ArticleId></ArticleIdList></Reference><Reference><Citation>Struhal W, Javor A, Brunner C, et al.: The phoenix from the ashes: cardiovascular autonomic dysfunction in behavioral variant of frontotemporal dementia. J Alzheimers Dis 2014; 42:1041&#x2013;1046</Citation><ArticleIdList><ArticleId IdType="pubmed">25024313</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi A, Jimenez E, Mendez MF: Pavlov&#x2019;s orienting response in frontotemporal dementia. J Neuropsychiatry Clin Neurosci 2017; 29:351&#x2013;356</Citation><ArticleIdList><ArticleId IdType="pubmed">28464702</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong SS, Navarrete CD, Perfecto SE, et al.: Behavioral and autonomic reactivity to moral dilemmas in frontotemporal dementia versus Alzheimer&#x2019;s disease. Soc Neurosci 2017; 12:409&#x2013;418</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5651990</ArticleId><ArticleId IdType="pubmed">27151065</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35971842</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1710-1107</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Canadian journal on aging = La revue canadienne du vieillissement</Title><ISOAbbreviation>Can J Aging</ISOAbbreviation></Journal><ArticleTitle>[Trouble neurocognitif majeur et m&#xe9;thodes optimisant l'apprentissage].</ArticleTitle><Pagination><StartPage>189</StartPage><EndPage>198</EndPage><MedlinePgn>189-198</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0714980822000216</ELocationID><Abstract><AbstractText>Les difficult&#xe9;s cognitives cons&#xe9;cutives aux troubles neurocognitifs majeurs (TNCM) engendrent des enjeux dans la r&#xe9;alisation d'activit&#xe9;s de la vie quotidienne. Ce projet visait &#xe0; identifier aupr&#xe8;s des proches aidants et des intervenants des situations n&#xe9;cessitant des m&#xe9;thodes optimisant l'apprentissage pour faciliter l'engagement de personnes vivant avec un TNCM dans leurs activit&#xe9;s de la vie quotidienne. Des entrevues individuelles semi-dirig&#xe9;es, d'une dur&#xe9;e de 60 &#xe0; 90 minutes, ont &#xe9;t&#xe9; men&#xe9;es aupr&#xe8;s de proches aidants et d'intervenants. Les r&#xe9;sultats montrent que les activit&#xe9;s quotidiennes et domestiques sont notamment affect&#xe9;es par les difficult&#xe9;s &#xe0; rep&#xe9;rer ou &#xe0; utiliser les objets, &#xe0; garder en t&#xea;te la t&#xe2;che en cours, &#xe0; mettre en s&#xe9;quences des &#xe9;tapes, &#xe0; ne pas se laisser distraire par autre chose et &#xe0; constater ses difficult&#xe9;s pour s'y adapter. Les proches aidants souhaitent du soutien dans l'application des m&#xe9;thodes optimisant l'apprentissage pour contribuer au maintien de l'autonomie des personnes vivant avec un TNCM.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Viscogliosi</LastName><ForeName>Chantal</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-7242-8853</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; de Sherbrooke et Centre de recherche sur le vieillissement du CIUSSS de l'Estrie-CHUS, Sherbrooke, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dame</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Sherbrooke et Centre de recherche sur le vieillissement du CIUSSS de l'Estrie-CHUS, Sherbrooke, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mino-Roy</LastName><ForeName>Jordan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Sherbrooke et Centre de recherche sur le vieillissement du CIUSSS de l'Estrie-CHUS, Sherbrooke, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahimaly</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Sherbrooke et Centre de recherche sur le vieillissement du CIUSSS de l'Estrie-CHUS, Sherbrooke, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breton</LastName><ForeName>Viviane</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Sherbrooke, Sherbrooke, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xe9;ry</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre Int&#xe9;gr&#xe9; Universitaire de Sant&#xe9; et de Services Sociaux de la Mauricie et du Centre-du-Qu&#xe9;bec (CIUSSS MCQ), B&#xe9;cancour, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chass&#xe9;</LastName><ForeName>Bernard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Soci&#xe9;t&#xe9; Alzheimer des Maskoutains - Vall&#xe9;e des Patriotes, St-Hilaire, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couturier</LastName><ForeName>Yves</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Sherbrooke et Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giroux</LastName><ForeName>Dominique</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Laval et Centre de recherche en sant&#xe9; durable VITAM, Qu&#xe9;bec, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renaud</LastName><ForeName>Cl&#xe9;mence</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Sherbrooke, Sherbrooke, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Provencher</LastName><ForeName>V&#xe9;ronique</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-8211-7135</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; de Sherbrooke et Centre de recherche sur le vieillissement du CIUSSS de l'Estrie-CHUS, Sherbrooke, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Can J Aging</MedlineTA><NlmUniqueID>8708560</NlmUniqueID><ISSNLinking>0714-9808</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Major neurocognitive disorder</Keyword><Keyword MajorTopicYN="N">Trouble neurocognitif majeur</Keyword><Keyword MajorTopicYN="N">activities of daily living</Keyword><Keyword MajorTopicYN="N">activit&#xe9;s de la vie quotidienne</Keyword><Keyword MajorTopicYN="N">besoin</Keyword><Keyword MajorTopicYN="N">family caregivers</Keyword><Keyword MajorTopicYN="N">home support</Keyword><Keyword MajorTopicYN="N">learning methods</Keyword><Keyword MajorTopicYN="N">m&#xe9;thodes d&#x2019;apprentissage</Keyword><Keyword MajorTopicYN="N">need</Keyword><Keyword MajorTopicYN="N">proches-aidants</Keyword><Keyword MajorTopicYN="N">soutien &#xe0; domicile</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>16</Day><Hour>5</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35971842</ArticleId><ArticleId IdType="doi">10.1017/S0714980822000216</ArticleId><ArticleId IdType="pii">S0714980822000216</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35968798</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1440-1614</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Australian and New Zealand journal of psychiatry</Title><ISOAbbreviation>Aust N Z J Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Distinguishing apathy and depression in dementia: A longitudinal study.</ArticleTitle><Pagination><StartPage>884</StartPage><EndPage>894</EndPage><MedlinePgn>884-894</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/00048674221114597</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Apathy is a common symptom in dementia, though can be difficult to distinguish from depression due to shared features and frequent co-occurrence. As such, a significant limitation of much previous research on apathy is the failure to control for depression. The current study sought to address this by examining the trajectory and clinical correlates of apathy after controlling for depression.</AbstractText><AbstractText Label="METHODS">Seven hundred and seventy-nine patients with dementia were recruited from nine memory clinics around Australia. Measures of dementia severity, cognition, functional ability, neuropsychiatric symptoms, caregiver burden and medication use were completed at baseline and at regular intervals over a 3-year period. Driving and institutionalisation data were obtained throughout the study. Mortality data were obtained from state registries 8 years after baseline.</AbstractText><AbstractText Label="RESULTS">Of the 662 patients with completed measures of neuropsychiatric symptoms, 342 (51.7%) had apathy and 332 (50.2%) had depression at baseline, while 212 (32.0%) had both. Whereas apathy increased over time, depression remained relatively stable. Apathy, but not depression, was associated with greater dementia severity, poorer cognition and function, driving cessation and mortality. Both apathy and depression were associated with greater neuropsychiatric symptoms, psychosis, caregiver burden and institutionalisation.</AbstractText><AbstractText Label="CONCLUSIONS">Apathy increases over the course of dementia and is associated with worse clinical outcomes independent of depression. Distinguishing apathy and depression appears important given their different implications for prognosis and management.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Connors</LastName><ForeName>Michael H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental Health, UNSW Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira-Pinto</LastName><ForeName>Armando</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Public Health, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ames</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Ageing Research Institute, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Academic Unit for Psychiatry of Old Age, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woodward</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Austin Hospital, Heidelberg, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brodaty</LastName><ForeName>Henry</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-9487-6617</Identifier><AffiliationInfo><Affiliation>Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental Health, UNSW Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Aust N Z J Psychiatry</MedlineTA><NlmUniqueID>0111052</NlmUniqueID><ISSNLinking>0004-8674</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057565" MajorTopicYN="Y">Apathy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011618" MajorTopicYN="Y">Psychotic Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">apathy</Keyword><Keyword MajorTopicYN="N">behavioural and psychological symptoms of dementia</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">longitudinal</Keyword><Keyword MajorTopicYN="N">neuropsychiatric symptoms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35968798</ArticleId><ArticleId IdType="doi">10.1177/00048674221114597</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35961638</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1938-2715</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The American journal of hospice &amp; palliative care</Title><ISOAbbreviation>Am J Hosp Palliat Care</ISOAbbreviation></Journal><ArticleTitle>Palliative Care in Advanced Alzheimer's Disease Dementia: Evaluation of the Answers Given by Caregivers and Physicians to the Accuracy of Surprise Question, as a Prognostic Tool.</ArticleTitle><Pagination><StartPage>624</StartPage><EndPage>632</EndPage><MedlinePgn>624-632</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/10499091221121328</ELocationID><Abstract><AbstractText><b>Introduction</b>: Alzheimer's disease (AD) dementia is the sixth leading cause of death in the United States. The surprise question (SQ) "Would you be surprised if this patient were to die within the next 12&#xa0;months?" was used to identify death-risk patients, who could benefit from palliative care. <b>Objective</b>: To examine the prognostic accuracy of the SQ by physicians and caregivers in outpatients with AD dementia. <b>Methods</b>: This is a longitudinal and prospective study involving 101 patients along 1&#xa0;year, applying the SAS 9.2 software and adopting a .05 <i>P</i>-value to assess the variables that influenced answers to the accuracy of SQ using the chi-square test. <b>Results</b>: 27 patients (26.7%) died during the follow-up. When caregivers answered the SQ, it presented a 51.8% sensitivity (CI 31.9 - 71.3), a 66.7% negative predictive value (20.7 - 63.6), a 56.2% specificity (CI 29.8 - 80.2), and a 40.9% positive predictive value of (CI 43.0 - 85.4) with a 53.4% accuracy (CI 38.5 - 68.4). When physicians answered, the SQ had an 88.8% sensitivity (CI 70.8 - 97.6), a 40% negative predictive value (CI 5.2 - 85.3), a 12.5% specificity (CI 1.5 - 38.3), a 63.1% positive predictive value (CI 45.9 - 78.1) with a 60.4% accuracy (CI 45.8 - 75). <b>Conclusion</b>: SQ remains a good tool with high sensitivity for the identification of patients with advanced AD dementia when presented to the attending physician for planning palliative advanced care with accuracy of 60.4% and caregivers' accuracy of 53.4%.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yuyama</LastName><ForeName>Erika Kiyomi</ForeName><Initials>EK</Initials><Identifier Source="ORCID">0000-0001-9955-828X</Identifier><AffiliationInfo><Affiliation>Ribeir&#xe3;o Preto Medical School of the University of S&#xe3;o Paulo [USP], Ribeir&#xe3;o Preto, Brazil.</Affiliation><Identifier Source="RINGGOLD">54539</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>Nereida Kilza da Costa</ForeName><Initials>NKDC</Initials><AffiliationInfo><Affiliation>Ribeir&#xe3;o Preto Medical School of the University of S&#xe3;o Paulo [USP], Ribeir&#xe3;o Preto, Brazil.</Affiliation><Identifier Source="RINGGOLD">54539</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrioli</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Ribeir&#xe3;o Preto Medical School of the University of S&#xe3;o Paulo [USP], Ribeir&#xe3;o Preto, Brazil.</Affiliation><Identifier Source="RINGGOLD">54539</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos</LastName><ForeName>Andr&#xe9; Filipe Junqueira</ForeName><Initials>AFJ</Initials><AffiliationInfo><Affiliation>Ribeir&#xe3;o Preto Medical School of the University of S&#xe3;o Paulo [USP], Ribeir&#xe3;o Preto, Brazil.</Affiliation><Identifier Source="RINGGOLD">54539</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amorim</LastName><ForeName>Rivia Siqueira</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Aracaj&#xfa; University of Sergipe- UFS, Aracaj&#xfa;, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moriguti</LastName><ForeName>Julio Cesar</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Ribeir&#xe3;o Preto Medical School of the University of S&#xe3;o Paulo [USP], Ribeir&#xe3;o Preto, Brazil.</Affiliation><Identifier Source="RINGGOLD">54539</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Hosp Palliat Care</MedlineTA><NlmUniqueID>9008229</NlmUniqueID><ISSNLinking>1049-9091</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010166" MajorTopicYN="N">Palliative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010820" MajorTopicYN="Y">Physicians</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s</Keyword><Keyword MajorTopicYN="N">palliative care</Keyword><Keyword MajorTopicYN="N">surprise question</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>19</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35961638</ArticleId><ArticleId IdType="doi">10.1177/10499091221121328</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35951488</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1758-5341</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>21</Day></PubDate></JournalIssue><Title>The Gerontologist</Title><ISOAbbreviation>Gerontologist</ISOAbbreviation></Journal><ArticleTitle>It's More Than Language: Cultural Adaptation of a Proven Dementia Care Intervention for Hispanic/Latino Caregivers.</ArticleTitle><Pagination><StartPage>558</StartPage><EndPage>567</EndPage><MedlinePgn>558-567</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/geront/gnac120</ELocationID><Abstract><AbstractText>Although Hispanic/Latino older adults are at disproportionate and increased risk for Alzheimer's disease and related dementias, few evidence-based supportive care interventions are specifically developed for or adapted for this population. Adapting a supportive care intervention requires more than Spanish language translation; it necessitates an understanding of cultural nuances and care preferences of Hispanic/Latino families and staff who implement the intervention. This article describes the cultural adaptation of the Adult Day Service Plus intervention for delivery by staff to Hispanic/Latino caregivers, which was guided by the cultural adaptation process model. Also, using the Framework for Reporting Adaptations and Modifications-Enhanced, we discuss (a) when modifications were made, (b) who determined the modifications needed, (c) what aspects of the intervention were modified, (d) the relationship to fidelity and how fidelity was maintained, and (e) reasons for modifications. Modifications to the delivery and content were changed to reflect the values and norms of both the Hispanic/Latino staff and the caregivers they serve. As supportive interventions for caregivers are developed and implemented into real-world settings, inclusion of cultural elements may enhance research participation among Hispanic/Latino provider sites, people living with dementia, and their caregivers. Cultural adaptation is an essential consideration when developing, adapting, and implementing previously tested evidence-based interventions. Cultural adaptation offers an important lens by which to identify contextual factors that influence successful adoption to assure equity in the reach of evidence-based programs.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Parker</LastName><ForeName>Lauren J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marx</LastName><ForeName>Katherine A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Center for Innovative Care in Aging, Johns Hopkins School of Nursing, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nkimbeng</LastName><ForeName>Manka</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7414-921X</Identifier><AffiliationInfo><Affiliation>School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Elma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koeuth</LastName><ForeName>Sokha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College of Nursing and Health Professions, Drexel University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaugler</LastName><ForeName>Joseph E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0003-4797-485X</Identifier><AffiliationInfo><Affiliation>School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gitlin</LastName><ForeName>Laura N</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>Center for Innovative Care in Aging, Johns Hopkins School of Nursing, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Nursing and Health Professions, Drexel University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02927821</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>K01 AG066812</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG049692</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gerontologist</MedlineTA><NlmUniqueID>0375327</NlmUniqueID><ISSNLinking>0016-9013</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007802" MajorTopicYN="N">Language</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014175" MajorTopicYN="N">Translating</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006630" MajorTopicYN="N">Hispanic or Latino</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Caregiving</Keyword><Keyword MajorTopicYN="N">Cultural adaptations</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Implementation</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>11</Day><Hour>13</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35951488</ArticleId><ArticleId IdType="pmc">PMC10028233</ArticleId><ArticleId IdType="doi">10.1093/geront/gnac120</ArticleId><ArticleId IdType="pii">6661305</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alzheimer&#x2019;s Association. (2021). 2021 Alzheimer&#x2019;s disease facts and figures. Alzheimer&#x2019;s and Dementia Journal, 17(3), 327&#x2013;406. doi:10.1002/alz.12328</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12328</ArticleId><ArticleId IdType="pubmed">33756057</ArticleId></ArticleIdList></Reference><Reference><Citation>Aravena, J. M., Gajardo, J., Saguez, R., Hinton, L., &amp; Gitlin, L. N. (2022). Nonpharmacologic interventions for family caregivers of people living with dementia in Latin-America: A scoping review. The American Journal of Geriatric Psychiatry, 30(8), 859&#x2013;877. doi:10.1016/j.jagp.2021.10.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2021.10.013</ArticleId><ArticleId IdType="pubmed">34848116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ar&#xe9;valo-Flechas, L. C., Acton, G., Escamilla, M. I., Bonner, P. N., &amp; Lewis, S. L. (2014). Latino Alzheimer&#x2019;s caregivers: What is important to them? Journal of Managerial Psychology, 29(6), 661&#x2013;684. doi:10.1108/JMP-11-2012-0357</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/JMP-11-2012-0357</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur, P. B., Gitlin, L. N., Kairalla, J. A., &amp; Mann, W. C. (2018). Relationship between the number of behavioral symptoms in dementia and caregiver distress: What is the tipping point? International Psychogeriatrics, 30(8), 1099&#x2013;1107. doi:10.1017/S104161021700237X</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S104161021700237X</ArticleId><ArticleId IdType="pmc">PMC7103581</ArticleId><ArticleId IdType="pubmed">29143722</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumann, A. A., Cabassa, L. J., &amp; Stirman, S. W. (2017). Adaptation in dissemination and implementation science. Dissemination and Implementation Research in Health, 2, 286&#x2013;300. doi:10.1093/oso/9780190683214.003.0017</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oso/9780190683214.003.0017</ArticleId></ArticleIdList></Reference><Reference><Citation>Belle, S. H., Burgio, L., Burns, R., Coon, D., Czaja, S. J., Gallagher-Thompson, D., Gitlin, L. N., Klinger, J., Koepke, K. M., &amp; Lee, C. C. (2006). Enhancing the quality of life of dementia caregivers from different ethnic or racial groups: A randomized, controlled trial. Annals of Internal Medicine, 145(10), 727&#x2013;738. doi:10.7326/0003-4819-145-10-200611210-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-145-10-200611210-00005</ArticleId><ArticleId IdType="pmc">PMC2585490</ArticleId><ArticleId IdType="pubmed">17116917</ArticleId></ArticleIdList></Reference><Reference><Citation>Benish, S. G., Quintana, S., &amp; Wampold, B. E. (2011). Culturally adapted psychotherapy and the legitimacy of myth: A direct-comparison meta-analysis. Journal of Counseling Psychology, 58(3), 279. doi:10.1037/a0023626</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0023626</ArticleId><ArticleId IdType="pubmed">21604860</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernal, G., Bonilla, J., &amp; Bellido, C. (1995). Ecological validity and cultural sensitivity for outcome research: Issues for the cultural adaptation and development of psychosocial treatments with Hispanics. Journal of Abnormal Child Psychology, 23(1), 67&#x2013;82. doi:10.1007/BF01447045</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01447045</ArticleId><ArticleId IdType="pubmed">7759675</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernal, G., Jim&#xe9;nez-Chafey, M. I., &amp; Domenech Rodr&#xed;guez, M. M. (2009). Cultural adaptation of treatments: A resource for considering culture in evidence-based practice. Professional Psychology, 40(4), 361. doi:10.1037/a0016401</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0016401</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernal, G., &amp; S&#xe1;ez-Santiago, E. (2006). Culturally centered psychosocial interventions. Journal of Community Psychology, 34(2), 121&#x2013;132. doi:10.1002/jcop.20096</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcop.20096</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabassa, L. J., &amp; Baumann, A. A. (2013). A two-way street: Bridging implementation science and cultural adaptations of mental health treatments. Implementation Science, 8(1), 1&#x2013;14. doi:10.1186/1748-5908-8-90</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1748-5908-8-90</ArticleId><ArticleId IdType="pmc">PMC3765289</ArticleId><ArticleId IdType="pubmed">23958445</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro, F. G., Barrera, M.Jr., &amp; Holleran Steiker, L. K. (2010). Issues and challenges in the design of culturally adapted evidence-based interventions. Annual Review of Clinical Psychology, 6, 213&#x2013;239. doi:10.1146/annurev-clinpsy-033109-132032</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-clinpsy-033109-132032</ArticleId><ArticleId IdType="pmc">PMC4262835</ArticleId><ArticleId IdType="pubmed">20192800</ArticleId></ArticleIdList></Reference><Reference><Citation>Domenech Rodr&#xed;guez, M. M., Baumann, A. A., &amp; Schwartz, A. L. (2011). Cultural adaptation of an evidence based intervention: From theory to practice in a Latino/a community context. American Journal of Community Psychology, 47(1), 170&#x2013;186. doi:10.1007/s10464-010-9371-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10464-010-9371-4</ArticleId><ArticleId IdType="pubmed">21116707</ArticleId></ArticleIdList></Reference><Reference><Citation>Domenech-Rodriguez, M., &amp; Wieling, E. (2005). Developing culturally appropriate, evidence-based treatments for interventions with ethnic minority populations. Voices of Color, 313, 313&#x2013;334. doi:10.4135/9781452231662.n18</Citation><ArticleIdList><ArticleId IdType="doi">10.4135/9781452231662.n18</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabius, C. D., Wolff, J. L., &amp; Kasper, J. D. (2020). Race differences in characteristics and experiences of Black and White caregivers of older Americans. The Gerontologist, 60(7), 1244&#x2013;1253. doi:10.1093/geront/gnaa042</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnaa042</ArticleId><ArticleId IdType="pmc">PMC7491434</ArticleId><ArticleId IdType="pubmed">32400881</ArticleId></ArticleIdList></Reference><Reference><Citation>Fields, N. L., Anderson, K. A., &amp; Dabelko-Schoeny, H. (2014). The effectiveness of adult day services for older adults: A review of the literature from 2000 to 2011. Journal of Applied Gerontology, 33(2), 130&#x2013;163. doi:10.1177/0733464812443308</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464812443308</ArticleId><ArticleId IdType="pubmed">24652952</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitlin, L. N., Baier, R. R., Jutkowitz, E., Baker, Z. G., Gustavson, A. M., Sefcik, J. S., Hodgson, N. A., Koeuth, S., &amp; Gaugler, J. E. (2020). Dissemination and implementation of evidence-based dementia care using embedded pragmatic trials. Journal of the American Geriatrics Society, 68, S28&#x2013;S36. doi:10.1111/jgs.16622</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16622</ArticleId><ArticleId IdType="pmc">PMC7470172</ArticleId><ArticleId IdType="pubmed">32589277</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitlin, L. N., &amp; Czaja, S. J. (2015). Behavioral intervention research: Designing, evaluating, and implementing. Springer Publishing Company.</Citation></Reference><Reference><Citation>Gitlin, L. N., Marx, K., Scerpella, D., Dabelko-Schoeny, H., Anderson, K. A., Huang, J., Pizzi, L., Jutkowitz, E., Roth, D. L., &amp; Gaugler, J. E. (2019). Embedding caregiver support in community-based services for older adults: A multi-site randomized trial to test the Adult Day Service Plus Program (ADS Plus). Contemporary Clinical Trials, 83, 97&#x2013;108. doi:10.1016/j.cct.2019.06.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2019.06.010</ArticleId><ArticleId IdType="pmc">PMC7069225</ArticleId><ArticleId IdType="pubmed">31238172</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitlin, L. N., Reever, K., Dennis, M. P., Mathieu, E., &amp; Hauck, W. W. (2006). Enhancing quality of life of families who use adult day services: Short- and long-term effects of the adult day services plus program. The Gerontologist, 46(5), 630&#x2013;639. doi:10.1093/geront/46.5.630</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/46.5.630</ArticleId><ArticleId IdType="pubmed">17050754</ArticleId></ArticleIdList></Reference><Reference><Citation>Griner, D., &amp; Smith, T. B. (2006). Culturally adapted mental health intervention: A meta-analytic review. Psychotherapy, 43(4), 531. doi:10.1037/0033-3204.43.4.531</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0033-3204.43.4.531</ArticleId><ArticleId IdType="pubmed">22122142</ArticleId></ArticleIdList></Reference><Reference><Citation>

Harris-Kojetin, L., Sengupta, M., Park-Lee, E., Valverde, R., Caffrey, C., Rome, V., &amp; Lendon, J. (2016). Long-term care providers and services users in the United States: Data from the National Study of Long-Term Care Providers, 2013&#x2013;2014. Vital and Health Statistics. Series 3, (
38), x&#x2013;105. https://www.cdc.gov/nchs/data/series/sr_03/sr03_038.pdf</Citation><ArticleIdList><ArticleId IdType="pubmed">27023287</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms, J. E. (2015). An examination of the evidence in culturally adapted evidence-based or empirically supported interventions. Transcultural Psychiatry, 52(2), 174&#x2013;197. doi:10.1177/1363461514563642</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1363461514563642</ArticleId><ArticleId IdType="pubmed">25534401</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill-Briggs, F., Schumann, K. P., &amp; Dike, O. (2012). Five-step methodology for evaluation and adaptation of print patient health information to meet the &lt;5th grade readability criterion. Medical Care, 50(4), 294. doi:10.1097/MLR.0b013e318249d6c8</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e318249d6c8</ArticleId><ArticleId IdType="pmc">PMC3318988</ArticleId><ArticleId IdType="pubmed">22354210</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang, W. (2006). The psychotherapy adaptation and modification framework: Application to Asian Americans. American Psychologist, 61(7), 702. doi:10.1037/0003-066x.61.7.702</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0003-066x.61.7.702</ArticleId><ArticleId IdType="pubmed">17032070</ArticleId></ArticleIdList></Reference><Reference><Citation>Kally, Z., Cote, S. D., Gonzalez, J., Villarruel, M., Cherry, D. L., Howland, S., Higgins, M., Connolly, L., &amp; Hepburn, K. (2014). The Savvy Caregiver Program: Impact of an evidence-based intervention on the well-being of ethnically diverse caregivers. Journal of Gerontological Social Work, 57(6&#x2013;7), 681&#x2013;693. doi:10.1080/01634372.2013.850584</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01634372.2013.850584</ArticleId><ArticleId IdType="pubmed">24820315</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk, M. A. (2020). Adaptation. In Nilsen P. &amp; Birken S. A. (Eds.), Handbook on implementation science (pp. 317&#x2013;332). Edward Elgar Publishing, Inc.</Citation></Reference><Reference><Citation>Lendon, J. P., Rome, V., &amp; Sengupta, M. (2020). Variations between adult day services centers in the United States by the racial and ethnic case-mix of center participants. Journal of Applied Gerontology, 40(9), 1029&#x2013;1038. doi:10.1177/0733464820934996</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464820934996</ArticleId><ArticleId IdType="pmc">PMC7775908</ArticleId><ArticleId IdType="pubmed">32613885</ArticleId></ArticleIdList></Reference><Reference><Citation>Llanque, S. M., &amp; Enriquez, M. (2012). Interventions for Hispanic caregivers of patients with dementia: A review of the literature. American Journal of Alzheimer&#x2019;s Disease and Other Dementias, 27(1), 23&#x2013;32. doi:10.1177/1533317512439794</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317512439794</ArticleId><ArticleId IdType="pmc">PMC10697336</ArticleId><ArticleId IdType="pubmed">22467412</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews, K. X. (2019). Racial and ethnic estimates of Alzheimer&#x2019;s disease and related dementiasin the United States (2015&#x2013;2060) in adults aged &#x2265;65 years. Alzheimer&#x2019;s &amp; Dementia, 17&#x2013;24. doi:10.1016/j.jalz.2018.06.3063</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.06.3063</ArticleId><ArticleId IdType="pmc">PMC6333531</ArticleId><ArticleId IdType="pubmed">30243772</ArticleId></ArticleIdList></Reference><Reference><Citation>Massett, H. M.-G. (2021). Facilitators, challenges, and messaging strategies for Hispanic/Latino populations participating in Alzheimer&#x2019;s disease and related dementias clinical research: A literature review. Journal of Alzheimer&#x2019;s Disease, 107&#x2013;127. doi:10.3233/JAD-201463</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-201463</ArticleId><ArticleId IdType="pubmed">33998537</ArticleId></ArticleIdList></Reference><Reference><Citation>Minkler, M., Salvatore, A., &amp; Chang, C. (2017). Participatory approaches for study design and analysis in dissemination and implementation research. Dissemination and Implementation Research in Health, 192, 175&#x2013;190. doi:10.1093/oso/9780190683214.003.0011</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oso/9780190683214.003.0011</ArticleId></ArticleIdList></Reference><Reference><Citation>Nkimbeng, M. J., &amp; Parker, L. J. (2021). Diverse, culturally rich approaches to family care in the United States. Bridging the Family Care Gap, 43&#x2013;69. doi:10.1016/B978-0-12-813898-4.00002-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-813898-4.00002-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker, L. J., Fabius, C., Rivers, E., &amp; Taylor, J. L. (2021). Is dementia-specific caregiving compared with non-dementia caregiving associated with physical difficulty among caregivers for community-dwelling adults? Journal of Applied Gerontology, 41(4), 1074&#x2013;1080. doi:10.1177/07334648211014352</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/07334648211014352</ArticleId><ArticleId IdType="pmc">PMC8664093</ArticleId><ArticleId IdType="pubmed">34041929</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker, L. J., &amp; Gitlin, L. N. (2021). Does adult day service use improve well-being of Black caregivers of people living with dementia ? Innovation in Aging, 5(4). doi:10.1093/geroni/igab037</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geroni/igab037</ArticleId><ArticleId IdType="pmc">PMC8570428</ArticleId><ArticleId IdType="pubmed">34754949</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker, L. J., Gaugler, J. E., &amp; Gitlin, L. N. (2022). Use of critical race theory to inform the recruitment of Black/African American Alzheimer&#x2019;s disease caregivers into community-based research. The Gerontologist, 62(5), 742&#x2013;750. doi:10.1093/geront/gnac001</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnac001</ArticleId><ArticleId IdType="pmc">PMC9154262</ArticleId><ArticleId IdType="pubmed">34999789</ArticleId></ArticleIdList></Reference><Reference><Citation>Qui&#xf1;ones, A. R., Mitchell, S. L., Jackson, J. D., Aranda, M. P., Dilworth-Anderson, P., McCarthy, E. P., &amp; Hinton, L. (2020). Achieving health equity in embedded pragmatic trials for people living with dementia and their family caregivers. Journal of the American Geriatrics Society, 68, S8&#x2013;S13. doi:10.1111/jgs.16614</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16614</ArticleId><ArticleId IdType="pmc">PMC7422698</ArticleId><ArticleId IdType="pubmed">32589281</ArticleId></ArticleIdList></Reference><Reference><Citation>Reever, K. E., Mathieu, E., Dennis, M. P., &amp; Gitlin, L. N. (2004). Adult day services plus: Augmenting adult day centers with systematic care management for family caregivers. Alzheimer&#x2019;s Care Today, 5(4), 332&#x2013;9.</Citation></Reference><Reference><Citation>Soto, A., Smith, T. B., Griner, D., Domenech Rodr&#xed;guez, M., &amp; Bernal, G. (2018). Cultural adaptations and therapist multicultural competence: Two meta-analytic reviews. Journal of Clinical Psychology, 74(11), 1907&#x2013;1923. doi:10.1002/jclp.22679</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jclp.22679</ArticleId><ArticleId IdType="pubmed">30091201</ArticleId></ArticleIdList></Reference><Reference><Citation>Stirman, S. W., Baumann, A. A., &amp; Miller, C. J. (2019). The FRAME: an expanded framework for reporting adaptations and modifications to evidence-based interventions. Implementation Science, 14(1), 1&#x2013;10. doi:10.1186/s13012-019-0898-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13012-019-0898-y</ArticleId><ArticleId IdType="pmc">PMC6554895</ArticleId><ArticleId IdType="pubmed">31171014</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter, E., &amp; Pinquart, M. (2020). How effective are dementia caregiver interventions? An updated comprehensive meta-analysis. The Gerontologist, 60(8), e609&#x2013;e619. doi:10.1093/geront/gnz118</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnz118</ArticleId><ArticleId IdType="pubmed">33226434</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35922958</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2702</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>13-14</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of clinical nursing</Title><ISOAbbreviation>J Clin Nurs</ISOAbbreviation></Journal><ArticleTitle>Effects of Humanitude care on people with dementia and caregivers: A scoping review.</ArticleTitle><Pagination><StartPage>2969</StartPage><EndPage>2984</EndPage><MedlinePgn>2969-2984</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jocn.16477</ELocationID><Abstract><AbstractText Label="AIMS AND OBJECTIVES" NlmCategory="OBJECTIVE">This study aimed to comprehensively review the research literature to provide an overview of the effects of Humanitude on people with dementia and their caregivers.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Humanitude is a relationship-centred and compassionate care approach that focuses on improving the communication between people with dementia and their caregivers. There is a lack of updated and comprehensive synthesis on the evidence of the effects of Humanitude in dementia care.</AbstractText><AbstractText Label="DESIGN AND METHODS" NlmCategory="METHODS">This paper adopted the scoping review framework by Arksey and O'Malley. We searched through the following databases: Pubmed, CINAHL, EMBASE, PsycINFO, ProQuest, Scopus and Web of Science from its inception to 3 September 2021. Three investigators independently screened the titles and abstracts and assessed the full-text articles for eligibility. The PRISMA-ScR checklist was included in this scoping review.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We retrieved 1317 articles from databases and grey sources. Eleven studies were included after the screening. The synthesised results suggest that Humanitude can reduce agitation and psychological symptoms and improve the general well-being of people with dementia. Humanitude also has positive effects in improving care communication, empathy, job satisfaction and reducing burnout among caregivers.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Humanitude shows the potential for positive effects on people with dementia and their caregivers. However, most studies did not include a comparator group and could not provide rigorous findings as compared to randomised controlled trials. There is a need for randomised controlled studies to demonstrate the effectiveness of Humanitude on people with dementia and their caregivers.</AbstractText><AbstractText Label="RELEVANCE FOR CLINICAL PRACTICE" NlmCategory="CONCLUSIONS">This paper reviewed the literature on all types of publications that examine the use of Humanitude in people with dementia and their caregivers. Thus, it provided an up-to-date overview of the effects of Humanitude to inform clinical practice.</AbstractText><CopyrightInformation>&#xa9; 2022 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Giang</LastName><ForeName>Thuy-Anh</ForeName><Initials>TA</Initials><Identifier Source="ORCID">0000-0002-6410-8681</Identifier><AffiliationInfo><Affiliation>Department of Rehabilitation Services, Khoo Teck Puat Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health and Social Sciences Cluster, Singapore Institute of Technology, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koh</LastName><ForeName>Jonathan Ern Juan</ForeName><Initials>JEJ</Initials><AffiliationInfo><Affiliation>Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Ling-Jie</ForeName><Initials>LJ</Initials><Identifier Source="ORCID">0000-0002-5338-578X</Identifier><AffiliationInfo><Affiliation>Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Qian-Ci</ForeName><Initials>QC</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Services, Khoo Teck Puat Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chua</LastName><ForeName>Min-Jia</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Khoo Teck Puat Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liew</LastName><ForeName>Tau-Ming</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0000-0003-1555-7752</Identifier><AffiliationInfo><Affiliation>Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Singapore General Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wee</LastName><ForeName>Shiou-Liang</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Health and Social Sciences Cluster, Singapore Institute of Technology, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yap</LastName><ForeName>Philip Lin Kiat</ForeName><Initials>PLK</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Khoo Teck Puat Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Science-Translational &amp; Applied Research (STAR21110)</GrantID><Agency>Alexandra Health Fund Ltd</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Clin Nurs</MedlineTA><NlmUniqueID>9207302</NlmUniqueID><ISSNLinking>0962-1067</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004645" MajorTopicYN="N">Empathy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="N">Communication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's</Keyword><Keyword MajorTopicYN="N">carers</Keyword><Keyword MajorTopicYN="N">geriatric nursing</Keyword><Keyword MajorTopicYN="N">health personnel</Keyword><Keyword MajorTopicYN="N">person-centred care</Keyword><Keyword MajorTopicYN="N">quality of care</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>4</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35922958</ArticleId><ArticleId IdType="doi">10.1111/jocn.16477</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Arksey, H., &amp; O'Malley, L. (2005). Scoping studies: Towards a methodological framework. International Journal of Social Research Methodology, 8(1), 19-32. https://doi.org/10.1080/1364557032000119616</Citation></Reference><Reference><Citation>Biquand, S., &amp; Zittel, B. (2012). Care giving and nursing, work conditions and Humanitude&#xae;. Work, 41(Suppl. 1), 1828-1831. https://doi.org/10.3233/wor-2012-0392-1828</Citation></Reference><Reference><Citation>Bridges-Parlet, S., Knopman, D., &amp; Thompson, T. (1994). A descriptive study of physically aggressive behavior in dementia by direct observation. Journal of the American Geriatrics Society, 42(2), 192-197. https://doi.org/10.1111/j.1532-5415.1994.tb04951.x</Citation></Reference><Reference><Citation>Briggs, R., Dyer, A., Nabeel, S., Collins, R., Doherty, J., Coughlan, T., O'neill, D., &amp; Kennelly, S. P. (2016). Dementia in the acute hospital: The prevalence and clinical outcomes of acutely unwell patients with dementia. QJM: An International Journal of Medicine, 110(1), 33-37. https://doi.org/10.1093/qjmed/hcw114</Citation></Reference><Reference><Citation>Cipriani, G., Lucetti, C., Danti, S., &amp; Nuti, A. (2014). Apathy and dementia. Nosology, assessment and management. The Journal of Nervous and Mental Disease, 202(10), 718-724. https://doi.org/10.1097/nmd.0000000000000190</Citation></Reference><Reference><Citation>Cloak, N., &amp; Al Khalili, Y. (2022). Behavioral And Psychological Symptoms In Dementia. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK551552</Citation></Reference><Reference><Citation>Cooper, C., &amp; Livingston, G. (2014). Mental health/psychiatric issues in elder abuse and neglect. Clinics in Geriatric Medicine, 30(4), 839-850. https://doi.org/10.1016/j.cger.2014.08.011</Citation></Reference><Reference><Citation>Digby, R., Lee, S., &amp; Williams, A. (2017). The experience of people with dementia and nurses in hospital: an integrative review. Journal of Clinical Nursing, 26(9-10), 1152-1171. https://doi.org/10.1111/jocn.13429</Citation></Reference><Reference><Citation>Featherstone, K., Northcott, A., Harden, J., Denning, K. H., Tope, R., Bale, S., &amp; Bridges, J. (2019). Refusal and resistance to care by people living with dementia being cared for within acute hospital wards: an ethnographic study. NIHR Journals Library (Health Services and Delivery Research), 7(11), 1-92. https://doi.org/10.3310/hsdr07110</Citation></Reference><Reference><Citation>Fern&#xe1;ndez, M., Gobartt, A. L., &amp; Bala&#xf1;&#xe1;, M. (2010). Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment. BMC Neurology, 10, 87. https://doi.org/10.1186/1471-2377-10-87</Citation></Reference><Reference><Citation>Fukuyasu, Y., Kataoka, H. U., Honda, M., Iwase, T., Ogawa, H., Sato, M., Watanabe, M., Fujii, C., Wada, J., DeSantis, J., Hojat, M., &amp; Gonnella, J. S. (2021). The effect of Humanitude care methodology on improving empathy: A six-year longitudinal study of medical students in Japan. BMC Medical Education, 21(1), 316. https://doi.org/10.1186/s12909-021-02773-x</Citation></Reference><Reference><Citation>Gineste, Y., Marescotti, R., &amp; Pellissier, J. (2008). Gineste Marescotti&#xae; method &#x201c;Humanitude&#x201d;, and pacification of pathological aggression behavior during nursing care [Short Survey]. Revue de Geriatrie, 33(6 Suppl. A), 2-4 https://www.scopus.com/inward/record.uri?eid=2-s2.0-48949087180&amp;partnerID=40&amp;md5=8df0f1bc47db9f9be5de2ae6e2f09f37 / https://framework.agevillage.com/documents/pdfs/actes_revue_de_geriatrie.pdf</Citation></Reference><Reference><Citation>Gomes Figueiredo, A. M., Pereira, C., de Melo, R. C., &amp; de Paiva Ribeiro, O. (2018). Humanitude care methodology: Difficulties and benefits from its implementation in clinical practice. Revista de Enfermagem Refer&#xea;ncia, 4(17), 53-62. https://doi.org/10.12707/RIV17063</Citation></Reference><Reference><Citation>Harrison, A., &amp; Zohhadi, S. (2005). Professional influences on the provision of mental health care for older people within a general hospital ward. Journal of Psychiatric and Mental Health Nursing, 12(4), 472-480. https://doi.org/10.1111/j.1365-2850.2005.00868.x</Citation></Reference><Reference><Citation>Henriques, L. V. L., Dourado, M., Melo, R., &amp; Tanaka, L. H. (2019). Implementation of the Humanitude Care Methodology: Contribution to the quality of health care. Revista Latino-Americana de Enfermagem, 27, e3123. https://doi.org/10.1590/1518-8345.2430-3123</Citation></Reference><Reference><Citation>Hiyoshi-Taniguchi, K., Becker, C. B., &amp; Kinoshita, A. (2018). What behavioral and psychological symptoms of dementia affect caregiver burnout? Clinical Gerontologist, 41(3), 249-254. https://doi.org/10.1080/07317115.2017.1398797</Citation></Reference><Reference><Citation>Honda, M., Ishikawa, S., Okino, Y., Nakazawa, A., Takebayashi, Y., Delmas, C., Marescotti, R., &amp; Gineste, Y. (2017). A video-based education and analysis system for professional caregivers of cognitive impaired elderlies [Article]. Akademi Sains Malaysia Science Journal, 2017(Special issue 1), 83-86. https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026502009&amp;partnerID=40&amp;md5=fe6d25014ee6340e3244e5b2118ccf96, https://www.akademisains.gov.my/asmsj/article/a-video-based-education-and-analysis-system-for-professional-caregivers-of-cognitive-impaired-elderlies/</Citation></Reference><Reference><Citation>Honda, M., Ito, M., Ishikawa, S., Takebayashi, Y., &amp; Tierney, L., Jr. (2016). Reduction of behavioral psychological symptoms of dementia by multimodal comprehensive care for vulnerable geriatric patients in an acute care hospital: A case series. Case Reports in Medicine, 2016, 4813196. https://doi.org/10.1155/2016/4813196</Citation></Reference><Reference><Citation>Honda, M., Mori, M., Hayashi, S., Moriya, K., Marescotti, R., &amp; Gineste, Y. (2013). The effectiveness of French origin dementia care method; Humanitude to acute care hospitals in Japan [Conference Abstract]. European Geriatric Medicine, 4, S207. https://doi.org/10.1016/j.eurger.2013.07.689</Citation></Reference><Reference><Citation>Ito, M., &amp; Honda, M. (2015). Improvement of behavioral and psychological symptoms of dementia (BPSD) by comprehensive standardized care methodology. Autsin Journal of Clinical Neurology, 2(9), 1073 https://austinpublishinggroup.com/clinical-neurology/fulltext/ajcn-v2-id1073.php</Citation></Reference><Reference><Citation>Ito, M., Honda, M., Marescotti, R., Gineste, Y., Hirayama, R., Shimada, C., &amp; Obuchi, S. (2015). An examination of the influence of Humanitude caregiving on the behavior of older adults with dementia in Japan. In Proceedings of the 8th International Association of Gerontology and Geriatrics European Region Congress. https://framework.agevillage.com/documents/pdfs/2015-poster-etude-mio-ito.pdf</Citation></Reference><Reference><Citation>Javaid, S. F., Giebel, C., Khan, M. A., &amp; Hashim, M. J. (2021). Epidemiology of Alzheimer's disease and other dementias: rising global burden and forecasted trends. F1000Research, 10(425), 425. https://doi.org/10.12688/f1000research.50786.1</Citation></Reference><Reference><Citation>Kobayashi, M., &amp; Honda, M. (2021). The effect of a multimodal comprehensive care methodology for family caregivers of people with dementia. BMC Geriatrics, 21(1), 434. https://doi.org/10.1186/s12877-021-02373-w</Citation></Reference><Reference><Citation>Kobayashi, M., Ito, M., Iwasa, Y., Motohashi, Y., Edahiro, A., Shirobe, M., Hirano, H., Gineste, Y., &amp; Honda, M. (2021). The effect of multimodal comprehensive care methodology training on oral health care professionals' empathy for patients with dementia. BMC Medical Education, 21(1), 315. https://doi.org/10.1186/s12909-021-02760-2</Citation></Reference><Reference><Citation>Kunik, M. E., Snow, A. L., Davila, J. A., Steele, A. B., Balasubramanyam, V., Doody, R. S., Schulz, P. E., Kalavar, J. S., &amp; Morgan, R. O. (2010). Causes of aggressive behavior in patients with dementia. Journal of Clinical Psychiatry, 71(9), 1145-1152. https://doi.org/10.4088/JCP.08m04703oli</Citation></Reference><Reference><Citation>Matsumoto, N., Ikeda, M., Fukuhara, R., Shinagawa, S., Ishikawa, T., Mori, T., Toyota, Y., Matsumoto, T., Adachi, H., Hirono, N., &amp; Tanabe, H. (2007). Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community. Dementia and Geriatric Cognitive Disorders, 23(4), 219-224. https://doi.org/10.1159/000099472</Citation></Reference><Reference><Citation>Mattiasson, A.-C., &amp; Hemberg, M. (1998). Intimacy-meeting needs and respecting privacy in the care of elderly people: What is a good moral attitude on the part of the nurse/carer? Nursing Ethics, 5(6), 527-534.</Citation></Reference><Reference><Citation>Melo, R., Fernandes, D. S. C., Albuquerque, J. S., &amp; Duarte, M. N. (2017). Methodology of care Humanitude in promoting self-care in dependent people: An integrative review. Advances in human factors and ergonomics in healthcare, 187-193. https://doi.org/10.1007/978-3-319-41652-6_18</Citation></Reference><Reference><Citation>Melo, R., Queir&#xf3;s, P. J. P., Tanaka, L. H., Henriques, L. V. L., &amp; Neves, H. L. (2020). Nursing students' relational skills with elders improve through Humanitude care methodology. International Journal of Environmental Research and Public Health, 17(22), 8588. https://doi.org/10.3390/ijerph17228588</Citation></Reference><Reference><Citation>Missotten, P., Squelard, G., Ylieff, M., Di Notte, D., Paquay, L., De Lepeleire, J., &amp; Fontaine, O. (2008). Quality of life in older Belgian people: Comparison between people with dementia, mild cognitive impairment, and controls. International Journal of Geriatric Psychiatry, 23(11), 1103-1109. https://doi.org/10.1002/gps.1981</Citation></Reference><Reference><Citation>Moyle, W., &amp; O'Dwyer, S. (2012). Quality of life in people living with dementia in nursing homes. Current Opinion in Psychiatry, 25(6), 480-484. https://doi.org/10.1097/YCO.0b013e32835a1ccf</Citation></Reference><Reference><Citation>Munn, Z., Peters, M. D. J., Stern, C., Tufanaru, C., McArthur, A., &amp; Aromataris, E. (2018). Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Medical Research Methodology, 18(1), 143. https://doi.org/10.1186/s12874-018-0611-x</Citation></Reference><Reference><Citation>Nowaskie, D., Carvell, C. A., Alder, C. A., LaMantia, M. A., Gao, S., Brown, S., Boustani, M. A., &amp; Austrom, M. G. (2020). Care coordinator assistants: Job satisfaction and the importance of teamwork in delivering person-centered dementia care. Dementia, 19(5), 1560-1572. https://doi.org/10.1177/1471301218802739</Citation></Reference><Reference><Citation>Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hr&#xf3;bjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., &#x2026; Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71</Citation></Reference><Reference><Citation>Prince, M. J., Wimo, A., Guerchet, M. M., Ali, G. C., Wu, Y.-T., &amp; Prina, M. (2015). World Alzheimer Report 2015-The Global Impact of Dementia [Commissioned report]. Alzheimer's Disease International. http://www.alz.co.uk/research/world-report-2015</Citation></Reference><Reference><Citation>Savva, G. M., Zaccai, J., Matthews, F. E., Davidson, J. E., McKeith, I., &amp; Brayne, C. (2009). Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. British Journal of Psychiatry, 194(3), 212-219. https://doi.org/10.1192/bjp.bp.108.049619</Citation></Reference><Reference><Citation>Shepherd, H., Livingston, G., Chan, J., &amp; Sommerlad, A. (2019). Hospitalisation rates and predictors in people with dementia: A systematic review and meta-analysis. BMC Medicine, 17(1), 130. https://doi.org/10.1186/s12916-019-1369-7</Citation></Reference><Reference><Citation>Sim&#xf5;es, M., Salgueiro, N., &amp; Rodrigues, M. (2012). Cuidar em Humanitude: estudo aplicado em cuidados continuados. Revista de Enfermagem Refer&#xea;ncia, III S&#xe9;rie, 6, 81-93. https://doi.org/10.12707/riii1177</Citation></Reference><Reference><Citation>Sontheimer, N., Konnopka, A., &amp; K&#xf6;nig, H.-H. (2021). The excess costs of dementia: A systematic review and meta-analysis. Journal of Alzheimer's Disease, 83(1), 333-354. https://doi.org/10.3233/JAD-210174</Citation></Reference><Reference><Citation>Taemeeyapradit, U., Udomittipong, D., &amp; Tepparak, N. (2014). Characteristics of behavioral and psychological symptoms of dementia, severity and levels of distress on caregivers. Journal of the Medical Association of Thailand, 97(4), 423-430 https://pubmed.ncbi.nlm.nih.gov/24964685/</Citation></Reference><Reference><Citation>Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., Hempel, S., Akl, E. A., Chang, C., McGowan, J., Stewart, L., Hartling, L., Aldcroft, A., Wilson, M. G., Garritty, C., &#x2026; Straus, S. E. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169(7), 467-473. https://doi.org/10.7326/m18-0850</Citation></Reference><Reference><Citation>Yorkston, K. M., Bourgeois, M. S., &amp; Baylor, C. R. (2010). Communication and aging. Physical Medicine and Rehabilitation Clinics, 21(2), 309-319.</Citation></Reference><Reference><Citation>Zhang, H., Zhang, D., Yin, Y., Zhang, C., &amp; Huang, Y. (2019). Costs of hospitalization for dementia in urban China: Estimates from two urban health insurance scheme claims data in Guangzhou city. International Journal of Environmental Research and Public Health, 16(15), 2781. https://doi.org/10.3390/ijerph16152781</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35912847</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-3799</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Clinical nursing research</Title><ISOAbbreviation>Clin Nurs Res</ISOAbbreviation></Journal><ArticleTitle>Religion, Spirituality, and Coping During the Pandemic: Perspectives of Dementia Caregivers.</ArticleTitle><Pagination><StartPage>94</StartPage><EndPage>104</EndPage><MedlinePgn>94-104</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/10547738221115239</ELocationID><Abstract><AbstractText>Religious and spiritual (R/S) practices support individuals during difficult situations. The COVID-19 social distancing restrictions may have limited access to R/S practices for older adults with Alzheimer's disease related dementia (ADRD) and their caregivers, affecting coping and well-being. This qualitative study explored the impact of social distancing on R/S practices and coping in ADRD-caregiver dyads from the perspective of caregivers. Interviews were conducted with 11 family caregivers of older adults with ADRD residing in nursing homes (<i>n</i>&#x2009;=&#x2009;4) or private homes (<i>n</i>&#x2009;=&#x2009;7). Caregivers continued individual and started virtual R/S practices which improved their ability to cope. However, organized R/S practices were unavailable for those with ADRD, but they used prayer and read religious texts which noticeably improved their mood. Healthcare professionals' sharing of individual and community R/S resources available for ADRD-caregiver dyads could decrease anxiety and agitation, while improving their ability to cope with increased isolation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Britt</LastName><ForeName>Katherine Carroll</ForeName><Initials>KC</Initials><Identifier Source="ORCID">0000-0002-5119-1260</Identifier><AffiliationInfo><Affiliation>The University of Texas at Austin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richards</LastName><ForeName>Kathy C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>The University of Texas at Austin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radhakrishnan</LastName><ForeName>Kavita</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The University of Texas at Austin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanags-Louredo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Eunice</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>The University of Texas at Austin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gooneratne</LastName><ForeName>Nalaka S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>University of Pennsylvania, Philadelphia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fry</LastName><ForeName>Liam</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The University of Texas at Austin, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG051588</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Nurs Res</MedlineTA><NlmUniqueID>9208508</NlmUniqueID><ISSNLinking>1054-7738</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000223" MajorTopicYN="N">Adaptation, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029181" MajorTopicYN="N">Spirituality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">caregivers</Keyword><Keyword MajorTopicYN="N">coping</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">religion</Keyword><Keyword MajorTopicYN="N">spirituality</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35912847</ArticleId><ArticleId IdType="mid">NIHMS1832834</ArticleId><ArticleId IdType="pmc">PMC9772110</ArticleId><ArticleId IdType="doi">10.1177/10547738221115239</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Allegri R. F., Sarasola D., Serrano C. M., Taragano F. E., Arizaga R. L., Butman J., Lo&#xf1; L. (2006). Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer&#x2019;s disease. Neuropsychiatric Disease and Treatment, 2(1), 105&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2671738</ArticleId><ArticleId IdType="pubmed">19412452</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Association.
(2019). Spirituality and dementia.
Author. https://www.alz.org/media/Documents/spirituality-rl-2019.pdf</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Association.
(2020). COVID-19 &amp; dementia: Unique consideratons
for the public health community. People living with dementia.
Author. https://www.alz.org/media/Documents/alzheimers-dementia-covid-19-public-health-all-tips-sheets.pdf</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Association.
(2022). Alzheimer&#x2019;s disease facts and figures.
Author. https://www.alz.org/alzheimers-dementia/facts-figures</Citation><ArticleIdList><ArticleId IdType="pubmed">35289055</ArticleId></ArticleIdList></Reference><Reference><Citation>Ano G. G., Vasconcelles E. B. (2005). Religious coping and psychological adjustment to stress: A meta-analysis. Journal of Clinical Psychology, 61(4), 461&#x2013;480. 10.1002/jclp.20049</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jclp.20049</ArticleId><ArticleId IdType="pubmed">15503316</ArticleId></ArticleIdList></Reference><Reference><Citation>Armitage R., Nellums L. B. (2020). COVID-19 and the consequences of isolating the elderly. The Lancet Public Health, 5(5), e256. 10.1016/S2468-2667(20)30061-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(20)30061-X</ArticleId><ArticleId IdType="pmc">PMC7104160</ArticleId><ArticleId IdType="pubmed">32199471</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry K. F. (2005). Spirituality and the
cognitively impaired. Age in Action,
20(1), 1&#x2013;5.
https://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=1010&amp;context=vcoa_case</Citation></Reference><Reference><Citation>Beuscher L., Grando V. T. (2009). Using spirituality to cope with early-stage Alzheimer&#x2019;s disease. Western Journal of Nursing Research, 31(5), 583&#x2013;598. 10.1177/0193945909332776</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0193945909332776</ArticleId><ArticleId IdType="pmc">PMC3079522</ArticleId><ArticleId IdType="pubmed">19282270</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcary M. (2009). The research audit trial
[sic]&#x2014;Enhancing trustworthiness in qualitative inquiry.
The Electronic Journal of Business Research Methods,
7, 11&#x2013;24. https://academic-publishing.org/index.php/ejbrm/article/view/1239</Citation></Reference><Reference><Citation>Caregiving in the U.S.
(2005). National alliance for caregiving;
AARP. https://www.caregiving.org/wp-content/uploads/2020/05/04execsumm.pdf</Citation></Reference><Reference><Citation>Centers for Disease Control and
Prevention. (2020,
September16). Prevalence of disabilities
and health care access by disability status and type among adults&#x2014;United
States, 2016. https://www.cdc.gov/ncbddd/disabilityandhealth/features/kf-adult-prevalence-disabilities.html</Citation></Reference><Reference><Citation>Chen Y., Kim E. S., VanderWeele T. J. (2020). Religious-service attendance and subsequent health and well-being throughout adulthood: Evidence from three prospective cohorts. International Journal of Epidemiology, 49(6), 2030&#x2013;2040. 10.1093/ije/dyaa120</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyaa120</ArticleId><ArticleId IdType="pmc">PMC7825951</ArticleId><ArticleId IdType="pubmed">32793951</ArticleId></ArticleIdList></Reference><Reference><Citation>Coin A., Perissinotto E., Najjar M., Girardi A., Inelmen E. M., Enzi G., Manzato E., Sergi G. (2010). Does religiosity protect against cognitive and behavioral decline in Alzheimer&#x2019;s dementia? Current Alzheimer Research, 7(5), 445&#x2013;452. 10.2174/156720510791383886</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720510791383886</ArticleId><ArticleId IdType="pubmed">20088813</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly L., Fahey-McCarthy E., Timmins F. (2019). The experience of spirituality from the perspective of people living with dementia: A systematic review and meta-synthesis. Dementia, 18(2), 448&#x2013;470. 10.1177/1471301216680425</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301216680425</ArticleId><ArticleId IdType="pubmed">27941158</ArticleId></ArticleIdList></Reference><Reference><Citation>Epps F., Choe J., Alexander K., Brewster G. (2020). Designing worship services to support African-American persons living with dementia. Journal of Religion and Health, 59(4), 2163&#x2013;2176. 10.1007/s10943-020-00993-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10943-020-00993-x</ArticleId><ArticleId IdType="pmc">PMC11194184</ArticleId><ArticleId IdType="pubmed">32020382</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge Y., Sainz M., Gore J., Epps F. (2021). &#x201c;Everything is either sent by God or used by God&#x201d;: An exploratory study on the impact of COVID-19 upon the religious lives of Black families living with dementia. Journal of Religious Health, 60(5), 3193&#x2013;3208. 10.1007/s10943-021-01332-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10943-021-01332-4</ArticleId><ArticleId IdType="pmc">PMC8262582</ArticleId><ArticleId IdType="pubmed">34235606</ArticleId></ArticleIdList></Reference><Reference><Citation>Gore J., Toliver J., Moore M. A., Aycock D., Epps F. (2022). A mixed-methods formative evaluation of a dementia-friendly congregation program for Black churches. International Journal of Environmental Research and Public Health, 19(8), Article 4498. 10.3390/ijerph19084498</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19084498</ArticleId><ArticleId IdType="pmc">PMC9028238</ArticleId><ArticleId IdType="pubmed">35457369</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayward R. D., Krause N. (2013). Trajectories of disability in older adulthood and social support from a religious congregation: A growth curve analysis. Journal of Behavioral Medicine, 36, 354&#x2013;360. 10.1007/s10865-012-9430-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10865-012-9430-4</ArticleId><ArticleId IdType="pmc">PMC3443496</ArticleId><ArticleId IdType="pubmed">22569776</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebert R. S., Dang Q., Schulz R. (2007). Religious beliefs and practices are associated with better mental health in family caregivers of patients with dementia: Findings from the REACH study. The American Journal of Geriatric Psychiatry, 15(4), 292&#x2013;300. 10.1097/01.JGP.0000247160.11769.ab</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.JGP.0000247160.11769.ab</ArticleId><ArticleId IdType="pubmed">17158632</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins P. (2014). &#x201c;It&#x2019;s a consolation&#x201d;: The role of Christian religion for people with dementia who are living in care homes. Journal of Religion, Spirituality, and Aging, 26(4), 320&#x2013;339. 10.1080/15528030.2014.880773</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15528030.2014.880773</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt-Lunstad J., Steptoe A. (2022). Social isolation: An underappreciated determinant of physical health. Current Opinion in Psychology, 43, 232&#x2013;237. 10.1016/j.copsyc.2021.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.copsyc.2021.07.012</ArticleId><ArticleId IdType="pubmed">34438331</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh H. -F., Shannon S. E. (2005). Three approaches to qualitative content analysis. Qualitative Health Research, 15(9), 1277&#x2013;1288. 10.1177/1049732305276687</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1049732305276687</ArticleId><ArticleId IdType="pubmed">16204405</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolley D., Benbow S. M., Grizzell M., Willmott S., Bawn S., Kingston P. (2010). Spirituality and faith in dementia. Dementia, 9(3), 311&#x2013;325. 10.1177/1471301210370645</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301210370645</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones S., Fox S. (2009). Generations online in
2009. Pew Research Center. https://www.pewresearch.org/internet/2009/01/28/generations-online-in-2009</Citation></Reference><Reference><Citation>Katsuno T. (2003). Personal spirituality of persons with early-stage dementia: Is it related to perceived quality of life? Dementia, 2(3), 315&#x2013;335. 10.1177/14713012030023003</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14713012030023003</ArticleId></ArticleIdList></Reference><Reference><Citation>Koenig H. G., King D. E., Carson V. B. (2012). Handbook of religion and health (2nd ed.). Oxford University Press.</Citation></Reference><Reference><Citation>Krause N., Hayward R. D. (2016). Religion, health, and aging. In George L. K., Ferraro K. F. (Eds.), Handbook of aging and the social sciences (8th ed., pp. 251&#x2013;270). Academic Press. 10.1016/B978-0-12-417235-7.00012-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-417235-7.00012-3</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKinlay E., Trevitt C. (2010). Living in aged care: Using spiritual reminiscence to enhance meaning in life for those with dementia. International Journal of Mental Health Nursing, 19(6), 394&#x2013;401. 10.1111/j.1447-0349.2010.00684.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1447-0349.2010.00684.x</ArticleId><ArticleId IdType="pubmed">21054725</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloney K. (2020). Spiritual resources during the
COVID-19 pandemic (2020). Harvard Divinity
School. https://hds.harvard.edu/community-life/religious-and-spiritual-life/spiritual-resources-during-covid-19-pandemic-2020</Citation></Reference><Reference><Citation>Mayring P. (2000). Qualitative content analysis. Forum: Qualitative Social Research, 1(2), Article 20. 10.17169/fqs-1.2.1089</Citation><ArticleIdList><ArticleId IdType="doi">10.17169/fqs-1.2.1089</ArticleId></ArticleIdList></Reference><Reference><Citation>McGee J. S., Myers D. R., Carlson H., Funai A. P., Barclay P. A. (2013). Spirituality, faith, and mild Alzheimer&#x2019;s disease. In Piedmont R. L., Village A. (Eds.), Research in the social scientific study of religion (Vol. 24, pp. 221&#x2013;257). Brill. 10.1163/9789004252073_010</Citation><ArticleIdList><ArticleId IdType="doi">10.1163/9789004252073_010</ArticleId></ArticleIdList></Reference><Reference><Citation>Pargament K. I., Koenig H. G., Perez L. M. (2000). The many methods of religious coping: Development and initial validation of the RCOPE. Journal of Clinical Psychology, 56(4), 519&#x2013;543. 10.1002/(sici)1097-4679(200004)56:4&lt;519::aid-jclp6&gt;3.0.co;2-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1097-4679(200004)56:4&lt;519::aid-jclp6&gt;3.0.co;2-1</ArticleId><ArticleId IdType="pubmed">10775045</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips S. (n.d.). Five COVID-fueled shifts in our religious and
spiritual landscape. Fetzer
Institute. https://fetzer.org/blog/five-covid-fueled-shifts-our-religious-and-spiritual-landscape</Citation></Reference><Reference><Citation>Plangger B., Unterrainer C., Kreh A., Gatterer G., Juen B. (2022). Psychological effects of social isolation during the COVID-19 pandemic 2020. The Journal of Gerontopsychology and Geriatric Psychiatry, 35(1), 17&#x2013;29. 10.1024/1662-9647/a000283</Citation><ArticleIdList><ArticleId IdType="doi">10.1024/1662-9647/a000283</ArticleId></ArticleIdList></Reference><Reference><Citation>Read S., Comas-Herrera A., Grundy E. (2020). Social Isolation and memory decline in later-life. The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 75(2), 367&#x2013;376. 10.1093/geronb/gbz152</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbz152</ArticleId><ArticleId IdType="pmc">PMC6963696</ArticleId><ArticleId IdType="pubmed">31781769</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarmeas N., Brandt J., Albert M., Hadjigeorgiou G., Papadimitriou A., Dubois B., Sarazin M., Devanand D., Honig L., Marder K., Bell K., Wegesin D., Blacker D., Stern Y. (2005). Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Archives of Neurology, 62(10), 1601&#x2013;1608. 10.1001/archneur.62.10.1601</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.62.10.1601</ArticleId><ArticleId IdType="pmc">PMC3028538</ArticleId><ArticleId IdType="pubmed">16216946</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinhauser K. E., Balboni T. A. (2017). State of the science of spirituality and palliative care research: Research landscape and future directions. Journal of Pain and Symptom Management, 54(3), 426&#x2013;427. 10.1016/j.jpainsymman.2017.02.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2017.02.020</ArticleId><ArticleId IdType="pubmed">28733253</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong A., Sainsbury P., Craig J. (2007). Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care, 19(6), 349&#x2013;357. 10.1093/intqhc/mzm042</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intqhc/mzm042</ArticleId><ArticleId IdType="pubmed">17872937</ArticleId></ArticleIdList></Reference><Reference><Citation>Us Against Alzheimer&#x2019;s.
(2022). Mobilizing faith communities in the fight
against Alzheimer&#x2019;s. https://www.usagainstalzheimers.org/networks/faith</Citation></Reference><Reference><Citation>VanderWeele T. J., Yu J., Cozier Y. C., Wise L., Argentieri M. A., Rosenberg L., Palmer J. R., Shields A. E. (2017). Attendance at religious services, prayer, religious coping, and religious/spiritual identity as predictors of all-cause mortality in the Black Women&#x2019;s Health Study. American Journal of Epidemiology, 185(7), 515&#x2013;522. 10.1093/aje/kww179</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kww179</ArticleId><ArticleId IdType="pmc">PMC6354668</ArticleId><ArticleId IdType="pubmed">28338863</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker J. L. (2012). The use of saturation in qualitative research. Canadian Journal of Cardiovascular Nursing, 22(2), 37&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">22803288</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Li T., Barbarino P., Gauthier S., Brodaty H., Molinuevo J. L., Xie H., Sun Y., Yu E., Tang Y., Weidner W., Yu X. (2020). Dementia care during COVID-19. Lancet, 395(10231), 1190&#x2013;1191. 10.1016/S0140-6736(20)30755-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30755-8</ArticleId><ArticleId IdType="pmc">PMC7146671</ArticleId><ArticleId IdType="pubmed">32240625</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Davis P. B., Gurney M. E., Xu R. (2021). COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US. Alzheimer&#x2019;s &amp; Dementia, 17(8), 1297&#x2013;1306. 10.1002/alz.12296</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12296</ArticleId><ArticleId IdType="pmc">PMC8014535</ArticleId><ArticleId IdType="pubmed">33559975</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Group. (1993). Study protocol for the World Health Organization project to develop a quality of life assessment instrument (WHOQOL). Quality of Life Research, 2(2), 153&#x2013;159. 10.1007/BF00435734</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00435734</ArticleId><ArticleId IdType="pubmed">8518769</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwingmann C., Klein C., B&#xfc;ssing A. (2011). Measuring
religiosity/spirituality: Theoretical differentiations and categorization of
instruments. Religions,
2(3), 345&#x2013;357.
https://www.mdpi.com/2077-1444/2/3/345</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35862572</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-9567</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Season>May-Jun</Season></PubDate></JournalIssue><Title>Journal of interprofessional care</Title><ISOAbbreviation>J Interprof Care</ISOAbbreviation></Journal><ArticleTitle>Implementation of interprofessional digital communication tools in primary care for frail older adults: An interview study.</ArticleTitle><Pagination><StartPage>362</StartPage><EndPage>370</EndPage><MedlinePgn>362-370</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/13561820.2022.2086858</ELocationID><Abstract><AbstractText>Communication and coordination between primary healthcare professionals and informal caregivers involved in the care for frail older adults is suboptimal and could benefit from interprofessional digital communication tools. Implementation in daily practice however frequently fails. We aim to identify generic barriers and facilitators experienced by healthcare professionals and informal caregivers during implementation of interprofessional communication tools to improve their long-term use. Qualitative content analysis using individual semi-structured interviews was used for evaluating three different digital communication tools used by interprofessional primary care networks for frail older adults by 28 professionals and 10 caregivers. After transcription and open coding, categories and themes were identified. Barriers and facilitators were related to: tool characteristics, context of use, involvement of professionals and caregivers. The tool improved availability, approachability and users' involvement. The large number of digital systems professionals simultaneously use, and different work agreements hampered tool use. The tools facilitated care coordination, and professionals declared to be better informed about patients' current situations. Overall, interprofessional digital communication tools can facilitate communication in networks for primary elderly care. However, integration between digital systems is needed to reduce the number of tools. Organizations and policy makers have an important role in realizing the tools' long-term use.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oostra</LastName><ForeName>Dorien L</ForeName><Initials>DL</Initials><Identifier Source="ORCID">0000-0003-2463-7690</Identifier><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboudumc Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fierkens</LastName><ForeName>Carlien</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alewijnse</LastName><ForeName>Marloes E J</ForeName><Initials>MEJ</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olde Rikkert</LastName><ForeName>Marcel G M</ForeName><Initials>MGM</Initials><Identifier Source="ORCID">0000-0003-1397-1677</Identifier><AffiliationInfo><Affiliation>Radboudumc Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Radboud University Medical Center, Donders Institute for Brain Cognition and Behaviour, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieuwboer</LastName><ForeName>Minke S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-2193-4908</Identifier><AffiliationInfo><Affiliation>Radboudumc Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Academy of Health and Vitality, HAN University of Applied Sciences, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Marieke</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0675-9678</Identifier><AffiliationInfo><Affiliation>Radboudumc Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Radboud University Medical Center, Donders Institute for Brain Cognition and Behaviour, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Primary and Community Care, Radboud University Medical Center, Donders Institute for Brain Cognition and Behaviour, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Interprof Care</MedlineTA><NlmUniqueID>9205811</NlmUniqueID><ISSNLinking>1356-1820</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016330" MajorTopicYN="Y">Frail Elderly</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007400" MajorTopicYN="Y">Interprofessional Relations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="N">Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Care coordination</Keyword><Keyword MajorTopicYN="N">communication tool</Keyword><Keyword MajorTopicYN="N">frail elderly</Keyword><Keyword MajorTopicYN="N">integrated care</Keyword><Keyword MajorTopicYN="N">interprofessional</Keyword><Keyword MajorTopicYN="N">qualitative research</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>21</Day><Hour>14</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35862572</ArticleId><ArticleId IdType="pmc">PMC10153063</ArticleId><ArticleId IdType="doi">10.1080/13561820.2022.2086858</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bodenheimer, T. (2008). Coordinating care &#x2014; A perilous journey through the health care system. New England Journal of Medicine, 358(10), 1064&#x2013;1071. 10.1056/NEJMhpr0706165</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMhpr0706165</ArticleId><ArticleId IdType="pubmed">18322289</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, J. B., Lewis, L., Ellis, K., Stewart, M., Freeman, T. R., &amp; Kasperski, M. J. (2009). Mechanisms for communicating within primary health care teams. Canadian Family Physician, 55(12), 1216&#x2013;1222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2793231</ArticleId><ArticleId IdType="pubmed">20008604</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong, C. C., Ros, W. J., van Leeuwen, M., &amp; Schrijvers, G. (2016). How professionals share an E-care plan for the elderly in primary care: Evaluating the use of an E-communication tool by different combinations of professionals. Journal of Medical Internet Research, 18(11), e304. 10.2196/jmir.6332</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.6332</ArticleId><ArticleId IdType="pmc">PMC5146326</ArticleId><ArticleId IdType="pubmed">27884811</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong, C. C., Ros, W. J., Van Leeuwen, M., &amp; Schrijvers, G. (2017). The challenge of involving elderly patients in primary care using an electronic communication tool with their professionals: A mixed methods study. Journal of Innovation in Health Informatics, 24(3), 275&#x2013;283. 10.14236/jhi.v24i3.937</Citation><ArticleIdList><ArticleId IdType="doi">10.14236/jhi.v24i3.937</ArticleId><ArticleId IdType="pubmed">29121850</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong, C. C., Ros, W. J., van Leeuwen, M., Witkamp, L., &amp; Schrijvers, G. (2018). Professionals&#x2019; use of a multidisciplinary communication tool for patients with dementia in primary care. CIN: Computers, Informatics, Nursing, 36(4), 193&#x2013;198. Article 29360700. 10.1097/CIN.0000000000000414</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CIN.0000000000000414</ArticleId><ArticleId IdType="pubmed">29360700</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas, H. E., Georgiou, A., Tariq, A., Prgomet, M., Warland, M. A., Armour, M. P., &amp; Westbrook, J. I. (2017). Implementing information and communication technology to support community aged care service integration: Lessons from an Australian aged care provider. International Journal of Integrated Care, 17(1), 9. 10.5334/ijic.2437</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/ijic.2437</ArticleId><ArticleId IdType="pmc">PMC5630080</ArticleId><ArticleId IdType="pubmed">29042851</ArticleId></ArticleIdList></Reference><Reference><Citation>Eldh, A. C., Sverker, A., Bendtsen, P., &amp; Nilsson, E. (2020). Health care professionals&#x2019; experience of a digital tool for patient exchange, anamnesis, and triage in primary care: Qualitative study. JMIR Human Factors, 7(4), e21698. 10.2196/21698</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/21698</ArticleId><ArticleId IdType="pmc">PMC7769692</ArticleId><ArticleId IdType="pubmed">33315014</ArticleId></ArticleIdList></Reference><Reference><Citation>Elo, S., &amp; Kyng&#xe4;s, H. (2008). The qualitative content analysis process. Journal of Advanced Nursing, 62(1), 107&#x2013;115. 10.1111/j.1365-2648.2007.04569.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2648.2007.04569.x</ArticleId><ArticleId IdType="pubmed">18352969</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathi, R., Sheehan, O. C., Garrigues, S. K., Saliba, D., Leff, B., &amp; Ritchie, C. S. (2016). Development of an interdisciplinary team communication framework and quality metrics for home-based medical care practices. Journal of the American Medical Directors Association, 17(8), 725&#x2013;729. e710. 10.1016/j.jamda.2016.03.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2016.03.018</ArticleId><ArticleId IdType="pubmed">27217093</ArticleId></ArticleIdList></Reference><Reference><Citation>Finney Rutten, L. J., Agunwamba, A. A., Greene, S. M., Mazor, K. M., Ebbert, J. O., St Sauver, J. L., &amp; Dearing, J. W. (2014). Enabling patient-centered communication and care through health information technology. Journal of Communication in Healthcare, 7(4), 255&#x2013;261. 10.1179/1753807614Y.0000000067</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1753807614Y.0000000067</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleuren, M., Paulussen, T., Van Dommelen, P., &amp; Van Buuren, S. (2014). Measurement instrument for determinants of innovations (MIDI). TNO.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4195468</ArticleId><ArticleId IdType="pubmed">24951511</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh, T., Maylor, H., Shaw, S., Wherton, J., Papoutsi, C., Betton, V., Nelissen, N., Gremyr, A., Rushforth, A., Koshkouei, M., &amp; Taylor, J. (2020). The NASSS-CAT tools for understanding, guiding, monitoring, and researching technology implementation projects in health and social care: Protocol for an evaluation study in real-world settings. JMIR Research Protocols, 9(5), e16861. 10.2196/16861</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/16861</ArticleId><ArticleId IdType="pmc">PMC7254278</ArticleId><ArticleId IdType="pubmed">32401224</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaats, E., &amp; Opheij, W. (2013). Creating conditions for promising collaboration: Alliances, networks, chains, strategic partnerships. Springer Science &amp; Business Media.</Citation></Reference><Reference><Citation>Keith, R. E., Crosson, J. C., O&#x2019;Malley, A. S., Cromp, D., &amp; Taylor, E. F. (2017). Using the consolidated framework for implementation research (CFIR) to produce actionable findings: A rapid-cycle evaluation approach to improving implementation. Implementation Science, 12(1), 1&#x2013;12. 10.1186/s13012-017-0550-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13012-017-0550-7</ArticleId><ArticleId IdType="pmc">PMC5303301</ArticleId><ArticleId IdType="pubmed">28187747</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroneman, M., Boerma, W., van den Berg, M., Groenewegen, P., de Jong, J., &amp; van Ginneken, E. (2016). Netherlands: Health system review. Health Systems in Transition, 18(2), 1&#x2013;240. https://www.ncbi.nlm.nih.gov/pubmed/27467715</Citation><ArticleIdList><ArticleId IdType="pubmed">27467715</ArticleId></ArticleIdList></Reference><Reference><Citation>Maarse, J. A., &amp; Jeurissen, P. P. (2016). The policy and politics of the 2015 long-term care reform in the Netherlands. Health Policy, 120(3), 241&#x2013;245. 10.1016/j.healthpol.2016.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthpol.2016.01.014</ArticleId><ArticleId IdType="pubmed">26872702</ArticleId></ArticleIdList></Reference><Reference><Citation>Madara Marasinghe, K. (2016). Assistive technologies in reducing caregiver burden among informal caregivers of older adults: A systematic review. Disability and Rehabilitation. Assistive Technology, 11(5), 353&#x2013;360. 10.3109/17483107.2015.1087061</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17483107.2015.1087061</ArticleId><ArticleId IdType="pubmed">26371519</ArticleId></ArticleIdList></Reference><Reference><Citation>Makai, P., Perry, M., Robben, S. H., Schers, H. J., Heinen, M. M., Rikkert, M. G. O., &amp; Melis, R. F. (2014). Evaluation of an eHealth intervention in chronic care for frail older people: Why adherence is the first target. Journal of Medical Internet Research, 16(6), e3057. 10.2196/jmir.3057</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.3057</ArticleId><ArticleId IdType="pmc">PMC4090371</ArticleId><ArticleId IdType="pubmed">24966146</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthew-Maich, N., Harris, L., Ploeg, J., Markle-Reid, M., Valaitis, R., Ibrahim, S., Gafni, A., &amp; Isaacs, S. (2016). Designing, implementing, and evaluating mobile health technologies for managing chronic conditions in older adults: A scoping review. JMIR mHealth and uHealth, 4(2), e29&#x2013;e29. 10.2196/mhealth.5127</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/mhealth.5127</ArticleId><ArticleId IdType="pmc">PMC4919548</ArticleId><ArticleId IdType="pubmed">27282195</ArticleId></ArticleIdList></Reference><Reference><Citation>Melchiorre, M. G., Papa, R., Rijken, M., van Ginneken, E., Hujala, A., &amp; Barbabella, F. (2018). eHealth in integrated care programs for people with multimorbidity in Europe: Insights from the ICARE4EU project. Health Policy, 122(1), 53&#x2013;63. 10.1016/j.healthpol.2017.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthpol.2017.08.006</ArticleId><ArticleId IdType="pubmed">28899575</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore, G. F., Audrey, S., Barker, M., Bond, L., Bonell, C., Hardeman, W., Moore, L., O&#x2019;Cathain, A., Tinati, T., Wight, D., &amp; Baird, J. (2015). Process evaluation of complex interventions: Medical research council guidance. Bmj, 350(mar19 6), h1258. 10.1136/bmj.h1258</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h1258</ArticleId><ArticleId IdType="pmc">PMC4366184</ArticleId><ArticleId IdType="pubmed">25791983</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore, A., Frank, C., &amp; Chambers, L. W. (2018). Role of the family physician in dementia care. Canadian Family Physician, 64(10), 717&#x2013;719. https://www.ncbi.nlm.nih.gov/pubmed/30315013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6184977</ArticleId><ArticleId IdType="pubmed">30315013</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser, A., &amp; Korstjens, I. (2018). Series: Practical guidance to qualitative research. Part 3: Sampling, data collection and analysis. European Journal of General Practice, 24(1), 9&#x2013;18. 10.1080/13814788.2017.1375091</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13814788.2017.1375091</ArticleId><ArticleId IdType="pmc">PMC5774281</ArticleId><ArticleId IdType="pubmed">29199486</ArticleId></ArticleIdList></Reference><Reference><Citation>Munro, A. J., &amp; Swartzman, S. (2013). What is a virtual multidisciplinary team (vMDT)? British Journal of Cancer, 108(12), 2433&#x2013;2441. 10.1038/bjc.2013.231</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjc.2013.231</ArticleId><ArticleId IdType="pmc">PMC3694234</ArticleId><ArticleId IdType="pubmed">23756866</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieuwboer, M. S., Richters, A., &amp; van der Marck, M. A. (2017). Triple AIM improvement for individuals, services and society in dementia care: The DementiaNet collaborative care approach. Zeitschrift F&#xfc;r Gerontologie Und Geriatrie, 50(Suppl 2), 78&#x2013;83. 10.1007/s00391-017-1196-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00391-017-1196-4</ArticleId><ArticleId IdType="pmc">PMC5409810</ArticleId><ArticleId IdType="pubmed">28220251</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieuwboer, M. S., Perry, M., van der Sande, R., Maassen, I. T. H. M., Rikkert, M. G. M. O., &amp; van der Marck, M. A. (2018). Identification of influencing factors and strategies to improve communication between general practitioners and community nurses: A qualitative focus group study. Family Practice, 35(5), 619&#x2013;625. 10.1093/fampra/cmy009</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmy009</ArticleId><ArticleId IdType="pubmed">29529183</ArticleId></ArticleIdList></Reference><Reference><Citation>Oostra, D. L., Harmsen, A., Nieuwboer, M. S., Rikkert, M. G. O., &amp; Perry, M. (2021). Care integration in primary dementia care networks: A longitudinal mixed-methods study. International Journal of Integrated Care, 21(4), 29. 10.5334/ijic.5675</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/ijic.5675</ArticleId><ArticleId IdType="pmc">PMC8663750</ArticleId><ArticleId IdType="pubmed">34963758</ArticleId></ArticleIdList></Reference><Reference><Citation>OZOverbindzorg . (2021). Retrieved
June
9, 2021, from
https://www.ozoverbindzorg.nl</Citation></Reference><Reference><Citation>Peek, S. T. M., Wouters, E. J., Luijkx, K. G., &amp; Vrijhoef, H. J. (2016). What it takes to successfully implement technology for aging in place: Focus groups with stakeholders [Original Paper]. Journal of Medical Internet Research, 18(5), e98. 10.2196/jmir.5253</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.5253</ArticleId><ArticleId IdType="pmc">PMC4904824</ArticleId><ArticleId IdType="pubmed">27143097</ArticleId></ArticleIdList></Reference><Reference><Citation>Pope, C., Van Royen, P., &amp; Baker, R. (2002). Qualitative methods in research on healthcare quality. BMJ Quality &amp; Safety, 11(2), 148&#x2013;152. 10.1136/qhc.11.2.148</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/qhc.11.2.148</ArticleId><ArticleId IdType="pmc">PMC1743608</ArticleId><ArticleId IdType="pubmed">12448807</ArticleId></ArticleIdList></Reference><Reference><Citation>Radhakrishnan, K., Xie, B., &amp; Jacelon, C. S. (2015). Unsustainable home telehealth: A Texas qualitative study. The Gerontologist, 56(5), 830&#x2013;840. 10.1093/geront/gnv050</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnv050</ArticleId><ArticleId IdType="pubmed">26035878</ArticleId></ArticleIdList></Reference><Reference><Citation>Richters, A., Nieuwboer, M. S., Perry, M., Olde Rikkert, M. G. M., Melis, R. J. F., &amp; van der Marck, M. A. (2017). Evaluation of DementiaNet, a network-based primary care innovation for community-dwelling patients with dementia: Protocol for a longitudinal mixed methods multiple case study. BMJ Open, 7(8), e016433. 10.1136/bmjopen-2017-016433</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-016433</ArticleId><ArticleId IdType="pmc">PMC5629707</ArticleId><ArticleId IdType="pubmed">28780556</ArticleId></ArticleIdList></Reference><Reference><Citation>Richters, A., Nieuwboer, M. S., Olde Rikkert, M. G. M., Melis, R. J. F., Perry, M., van der Marck, M. A., &amp; Werner, P. (2018). Longitudinal multiple case study on effectiveness of network-based dementia care towards more integration, quality of care, and collaboration in primary care. PloS one, 13(6), e0198811. 10.1371/journal.pone.0198811</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198811</ArticleId><ArticleId IdType="pmc">PMC6021091</ArticleId><ArticleId IdType="pubmed">29949608</ArticleId></ArticleIdList></Reference><Reference><Citation>Robben, S. H., Perry, M., Huisjes, M., van Nieuwenhuijzen, L., Schers, H. J., van Weel, C., Rikkert, M. G. O., van Achterberg, T., Heinen, M. M., &amp; Melis, R. J. (2012). Implementation of an innovative web-based conference table for community-dwelling frail older people, their informal caregivers and professionals: A process evaluation. BMC Health Services Research, 12(1), 1&#x2013;12. 10.1186/1472-6963-12-251</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6963-12-251</ArticleId><ArticleId IdType="pmc">PMC3470954</ArticleId><ArticleId IdType="pubmed">22894654</ArticleId></ArticleIdList></Reference><Reference><Citation>Samal, L., Dykes, P. C., Greenberg, J. O., Hasan, O., Venkatesh, A. K., Volk, L. A., &amp; Bates, D. W. (2016). Care coordination gaps due to lack of interoperability in the United States: A qualitative study and literature review. BMC Health Services Research, 16(1), 143. 10.1186/s12913-016-1373-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-016-1373-y</ArticleId><ArticleId IdType="pmc">PMC4841960</ArticleId><ArticleId IdType="pubmed">27106509</ArticleId></ArticleIdList></Reference><Reference><Citation>Sligo, J., Gauld, R., Roberts, V., &amp; Villa, L. (2017). A literature review for large-scale health information system project planning, implementation and evaluation. International Journal of Medical Informatics, 97, 86&#x2013;97. 10.1016/j.ijmedinf.2016.09.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2016.09.007</ArticleId><ArticleId IdType="pubmed">27919399</ArticleId></ArticleIdList></Reference><Reference><Citation>Stange, K. C., &amp; Ferrer, R. L. (2009). The paradox of primary care. The Annals of Family Medicine, 7(4), 293&#x2013;299. 10.1370/afm.1023</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.1023</ArticleId><ArticleId IdType="pmc">PMC2713149</ArticleId><ArticleId IdType="pubmed">19597165</ArticleId></ArticleIdList></Reference><Reference><Citation>Stange, K. C. (2009). The problem of fragmentation and the need for integrative solutions. The Annals of Family Medicine, 7(2), 100&#x2013;103. 10.1370/afm.971</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.971</ArticleId><ArticleId IdType="pmc">PMC2653966</ArticleId><ArticleId IdType="pubmed">19273863</ArticleId></ArticleIdList></Reference><Reference><Citation>Steele Gray, C., Barnsley, J., Gagnon, D., Belzile, L., Kenealy, T., Shaw, J., Sheridan, N., Wankah Nji, P., &amp; Wodchis, W. P. (2018). Using information communication technology in models of integrated community-based primary health care: Learning from the iCOACH case studies. Implementation Science, 13(1), 87. 10.1186/s13012-018-0780-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13012-018-0780-3</ArticleId><ArticleId IdType="pmc">PMC6019521</ArticleId><ArticleId IdType="pubmed">29940992</ArticleId></ArticleIdList></Reference><Reference><Citation>Stille, C., Jerant, A., Bell, D., Meltzer, D., &amp; Elmore, J. G. (2005). Coordinating care across diseases, settings, and clinicians: A key role for the generalist in practice. Annals of Internal Medicine, 142(8), 700&#x2013;708. 10.7326/0003-4819-142-8-200504190-00038</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-142-8-200504190-00038</ArticleId><ArticleId IdType="pubmed">15838089</ArticleId></ArticleIdList></Reference><Reference><Citation>Svensson, A. (2019). Challenges in using IT systems for collaboration in healthcare services. International Journal of Environmental Research and Public Health, 16(10), 1773. 10.3390/ijerph16101773</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph16101773</ArticleId><ArticleId IdType="pmc">PMC6571855</ArticleId><ArticleId IdType="pubmed">31137472</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang, T., Heidebrecht, C., Coburn, A., Mansfield, E., Roberto, E., Lucez, E., Lim, M. E., Reid, R., &amp; Quan, S. D. (2019). Using an electronic tool to improve teamwork and interprofessional communication to meet the needs of complex hospitalized patients: A mixed methods study. International Journal of Medical Informatics, 127, 35&#x2013;42. 10.1016/j.ijmedinf.2019.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2019.04.010</ArticleId><ArticleId IdType="pubmed">31128830</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong, A., Sainsbury, P., &amp; Craig, J. (2007). Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care, 19(6), 349&#x2013;357. 10.1093/intqhc/mzm042</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intqhc/mzm042</ArticleId><ArticleId IdType="pubmed">17872937</ArticleId></ArticleIdList></Reference><Reference><Citation>Topicus . (2021). VIPLive verbindt de zorg. Retrieved June
9, 2021, from
https://viplive.nl</Citation></Reference><Reference><Citation>Valentijn, P. P., Schepman, S. M., Opheij, W., &amp; Bruijnzeels, M. A. (2013). Understanding integrated care: A comprehensive conceptual framework based on the integrative functions of primary care. International Journal of Integrated Care, 13(1), e010. 10.5334/ijic.886</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/ijic.886</ArticleId><ArticleId IdType="pmc">PMC3653278</ArticleId><ArticleId IdType="pubmed">23687482</ArticleId></ArticleIdList></Reference><Reference><Citation>Villars, H., Oustric, S., Andrieu, S., Baeyens, J.-P., Bernabei, R., Brodaty, H., Fitten, J., Chappell, N., Fitten, J., Frisoni, G., Froelich, L., Guerin, O., Gold, G., Holmerova, I., Iliffe, S., Lukas, A., Melis, R., Morley, J. E., Nies, H., &#x2026; Brummel-Smith, K. (2010). The primary care physician and Alzheimer&#x2019;s disease: An international position paper. The Journal of Nutrition, Health &amp; Aging, 14(2), 110&#x2013;120. 10.1007/s12603-010-0022-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-010-0022-0</ArticleId><ArticleId IdType="pubmed">20126959</ArticleId></ArticleIdList></Reference><Reference><Citation>Wherton, J., Sugarhood, P., Procter, R., Hinder, S., &amp; Greenhalgh, T. (2015). Co-production in practice: How people with assisted living needs can help design and evolve technologies and services. Implementation Science, 10(1), 75. 10.1186/s13012-015-0271-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13012-015-0271-8</ArticleId><ArticleId IdType="pmc">PMC4453050</ArticleId><ArticleId IdType="pubmed">26004047</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35855574</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-4048</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of gerontological social work</Title><ISOAbbreviation>J Gerontol Soc Work</ISOAbbreviation></Journal><ArticleTitle>Associates of Perceived Quality of Life in Chinese Older Adults Living with Cognitive Impairment.</ArticleTitle><Pagination><StartPage>368</StartPage><EndPage>380</EndPage><MedlinePgn>368-380</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/01634372.2022.2103865</ELocationID><Abstract><AbstractText>The aim of this study is to examine perceived quality of life in Chinese older adults living with cognitive impairment and explore its associations with caregivers' characteristics. Questionnaires were administered in person to 271 caregiver-care recipient dyads from urban communities in mainland China in 2019. We used the 40-item Alzheimer's Disease-related Quality of Life tool and asked caregiver respondents to indicate care recipients' life conditions. The questionnaire asked caregivers about their sociodemographic characteristics, levels of informal social support, caregiver burden, and depressive symptoms. Caregivers' higher levels of caregiver burden (&#x3b2;&#x2009;= &gt;&#x2009;-0.19, <i>p</i>&#x2009;&lt;&#x2009;.01) and depressive symptoms (&#x3b2;&#x2009;= &gt;&#x2009;-0.19, <i>p</i>&#x2009;&lt;&#x2009;.01) amongst caregivers were significantly associated with lower quality of life among care recipients. Informal support from relatives and friends to caregivers did not significantly affect quality of life of care recipients. The results suggested that reducing caregivers' burden and depressive symptoms are essential to promote quality of life of care recipients. Formal support from health professionals, service organizations, and communities are urgently called to promote the wellbeing of Chinese families affected by cognitive impairment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Sociology, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Kaipeng</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-2206-4318</Identifier><AffiliationInfo><Affiliation>Graduate School of Social Work, University of Denver, Denver, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Social Work, Michigan State University, East Lansing, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Fries</LastName><ForeName>Carson M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Graduate School of Social Work, University of Denver, Denver, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of internal medicine, Huazhong University of Science and Technology Hospital, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Peijun</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Sociology, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yali</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>University Library, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Gerontol Soc Work</MedlineTA><NlmUniqueID>7903311</NlmUniqueID><ISSNLinking>0163-4372</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095225" MajorTopicYN="N">East Asian People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Perceived quality of life</Keyword><Keyword MajorTopicYN="N">burden</Keyword><Keyword MajorTopicYN="N">cognitive impairment</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">social support</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>20</Day><Hour>2</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35855574</ArticleId><ArticleId IdType="doi">10.1080/01634372.2022.2103865</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35849106</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1758-5368</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>Suppl 1</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>13</Day></PubDate></JournalIssue><Title>The journals of gerontology. Series B, Psychological sciences and social sciences</Title><ISOAbbreviation>J Gerontol B Psychol Sci Soc Sci</ISOAbbreviation></Journal><ArticleTitle>COVID-19-Related Changes in Assistance Networks for U.S. Older Adults With and Without Dementia.</ArticleTitle><Pagination><StartPage>S81</StartPage><EndPage>S90</EndPage><MedlinePgn>S81-S90</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/geronb/gbac089</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Prepandemic research suggests assistance networks for older adults grow over time and are larger for those living with dementia. We examined how assistance networks of older adults changed in response to the onset of the coronavirus disease 2019 (COVID-19) pandemic and whether these changes differed for those with and without dementia.</AbstractText><AbstractText Label="METHODS">We used 3 rounds of the National Health and Aging Trends Study. We estimated multinomial logistic regression models to test whether changes in assistance networks during COVID-19 (2019-2020)-defined as expansion, contraction, and adaptation-differed from changes prior to COVID-19 (2018-2019). We also estimated ordinary least squares regression models to test differences in the numbers of helpers assisting with one (specialist) versus multiple (generalist) domains before and during COVID-19. For both sets of outcomes, we investigated whether pandemic-related changes differed for those with and without dementia.</AbstractText><AbstractText Label="RESULTS">Over all activity domains, a greater proportion of assistance networks adapted during COVID-19 compared to the pre-COVID-19 period (relative risk ratio = 1.19, p &lt; .05). Contractions in networks occurred for those without dementia. Transportation assistance contracted for those with and without dementia, and mobility/self-care assistance contracted for those with dementia. The average number of generalist helpers decreased during COVID-19 (&#x3b2; = -0.09, p &lt; .001).</AbstractText><AbstractText Label="DISCUSSION">Early in the pandemic, assistance networks of older adults adapted by substituting helpers, by contracting to reduce exposures with more intimate tasks for recipients with dementia, and by reducing transportation assistance. Future research should explore the impact of such changes on the well-being of older adults and their assistance networks.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Monique J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0001-9552-2440</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>South Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rural and Minority Health Research Center, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office for the Study of Aging, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Haowei</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-4409-6596</Identifier><AffiliationInfo><Affiliation>Population Research Institute, Pennsylvania State University, University Park, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>I-Fen</ForeName><Initials>IF</Initials><Identifier Source="ORCID">0000-0001-9070-990X</Identifier><AffiliationInfo><Affiliation>Department of Sociology, Bowling Green State University, Bowling Green, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gan</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-7920-9231</Identifier><AffiliationInfo><Affiliation>Gerontology Research Centre, Simon Fraser University, Burnaby, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oyeyemi</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manning</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychology, Oakland University, Rochester, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freedman</LastName><ForeName>Vicki A</ForeName><Initials>VA</Initials><Identifier Source="ORCID">0000-0002-4604-4207</Identifier><AffiliationInfo><Affiliation>Institute for Social Research, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K01 MH115794</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG032947</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01MH115794</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG059300</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30sAG059300</GrantID><Agency>Michigan Center for Contextual Factors in Alzheimer's Disease</Agency><Country/></Grant><Grant><GrantID>U01AG032947</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG060949</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Gerontol B Psychol Sci Soc Sci</MedlineTA><NlmUniqueID>9508483</NlmUniqueID><ISSNLinking>1079-5014</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012648" MajorTopicYN="N">Self Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Caregiving</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Network changes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>18</Day><Hour>11</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35849106</ArticleId><ArticleId IdType="pmc">PMC9384500</ArticleId><ArticleId IdType="doi">10.1093/geronb/gbac089</ArticleId><ArticleId IdType="pii">6645376</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Alzheimer&#x2019;s Association. (2022). 2022 Alzheimer&#x2019;s Disease Facts and Figures. https://www.alz.org/alzheimers-dementia/facts-figures</Citation></Reference><Reference><Citation>Cantor, M. H. (1979). Neighbors and friends: An overlooked resource in the informal support system. Research on Aging, 1(4), 434&#x2013;463. doi:10.1177/016402757914002</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/016402757914002</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang, Y., Connell, L. M., Rajpara, A. R., &amp; Hodgson, N. A. (2021). Impact of COVID-19 on dementia caregivers and factors associated with their anxiety symptoms. American Journal of Alzheimer's Diseases and Other Dementia, 36, 1&#x2013;8. doi:10.1177/15333175211008768</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15333175211008768</ArticleId><ArticleId IdType="pmc">PMC8573819</ArticleId><ArticleId IdType="pubmed">33853394</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper, J. D., &amp; Freedman, V. A. (2021). National Health and Aging Trends Study user guides: Rounds 1-10 beta release.Johns Hopkins University School of Public Health.</Citation></Reference><Reference><Citation>Kasper, J. D., Freedman, V. A., &amp; Spillman, B. C. (2013). Classification of persons by dementia status in the National Health and Aging Trends Study. Technical Paper No. 5. Johns Hopkins University School of Public Health.</Citation></Reference><Reference><Citation>Kasper, J. D., Freedman, V. A., Spillman, B. C., &amp; Wolff, J. L. (2015). The disproportionate impact of dementia on family and unpaid caregiving to older adults. Health Affairs, 34(10), 1642&#x2013;1649. doi:10.1377/hlthaff.2015.0536</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2015.0536</ArticleId><ArticleId IdType="pmc">PMC4635557</ArticleId><ArticleId IdType="pubmed">26438739</ArticleId></ArticleIdList></Reference><Reference><Citation>Litwak, E. (1985). Helping the elderly: The complementary roles of informal networks and formal systems. Guilford Press.</Citation></Reference><Reference><Citation>Messeri, P., Silverstein, M., &amp; Litwak, E. (1993). Choosing optimal support groups: A review and reformulation. Journal of Health and Social Behavior, 34(2), 122&#x2013;1 37. doi:10.2307/2137239</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2137239</ArticleId><ArticleId IdType="pubmed">8277125</ArticleId></ArticleIdList></Reference><Reference><Citation>Riffin, C., Van Ness, P. H., Wolff, J. L., &amp; Fried, T. (2017). Family and other unpaid caregivers and older adults with and without dementia and disability. Journal of the American Geriatrics Society, 65(8), 1821&#x2013;1828. doi:10.1111/jgs.14910</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.14910</ArticleId><ArticleId IdType="pmc">PMC5555780</ArticleId><ArticleId IdType="pubmed">28426910</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan, O. C., Haley, W. E., Howard, V. J., Huang, J., Rhodes, J. D., &amp; Roth, D. L. (2021). Stress, burden, and well-being in dementia and nondementia caregivers: Insights from the caregiving transitions study. The Gerontologist, 61(5), 670&#x2013;679. doi:10.1093/geront/gnaa108</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnaa108</ArticleId><ArticleId IdType="pmc">PMC8276607</ArticleId><ArticleId IdType="pubmed">32816014</ArticleId></ArticleIdList></Reference><Reference><Citation>Spillman, B. C., Freedman, V. A., Kasper, J. D., &amp; Wolff, J. L. (2020). Change over time in caregiving networks for older adults with and without dementia. The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 75(7), 1563&#x2013;1572. doi:10.1093/geronb/gbz065</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbz065</ArticleId><ArticleId IdType="pmc">PMC7424285</ArticleId><ArticleId IdType="pubmed">31102533</ArticleId></ArticleIdList></Reference><Reference><Citation>Tulloch, K., McCaul, T., &amp; Scott, T. L. (2022). Positive aspects of dementia caregiving during the COVID-19 pandemic. Clinical Gerontology, 45(1), 86&#x2013;96. doi:10.1080/07317115.2021.1929630</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07317115.2021.1929630</ArticleId><ArticleId IdType="pubmed">34080958</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35819579</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-501X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Molecular diversity</Title><ISOAbbreviation>Mol Divers</ISOAbbreviation></Journal><ArticleTitle>Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system.</ArticleTitle><Pagination><StartPage>959</StartPage><EndPage>985</EndPage><MedlinePgn>959-985</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11030-022-10489-3</ELocationID><Abstract><AbstractText>CNS disorders are indications with a very high unmet medical needs, relatively smaller number of available drugs, and a subpar satisfaction level among patients and caregiver. Discovery of CNS drugs is extremely expensive affair with its own unique challenges leading to extremely high attrition rates and low efficiency. With explosion of data in information age, there is hardly any aspect of life that has not been touched by data driven technologies such as artificial intelligence (AI) and machine learning (ML). Drug discovery is no exception, emergence of big data via genomic, proteomic, biological, and chemical technologies has driven pharmaceutical giants to collaborate with AI oriented companies to revolutionise drug discovery, with the goal of increasing the efficiency of the process. In recent years many examples of innovative applications of AI and ML techniques in CNS drug discovery has been reported. Research on therapeutics for diseases such as schizophrenia, Alzheimer's and Parkinsonism has been provided with a new direction and thrust from these developments. AI and ML has been applied to both ligand-based and structure-based drug discovery and design of CNS therapeutics. In this review, we have summarised the general aspects of AI and ML from the perspective of drug discovery followed by a comprehensive coverage of the recent developments in the applications of AI/ML techniques in CNS drug discovery.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gautam</LastName><ForeName>Vertika</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-4879-0681</Identifier><AffiliationInfo><Affiliation>Faculty of Science, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, 281406, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaurav</LastName><ForeName>Anand</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1039-064X</Identifier><AffiliationInfo><Affiliation>Faculty of Pharmaceutical Sciences, UCSI University, Jalan Menara Gading, Taman Connaught, Cheras, 56000, Kuala Lumpur, Malaysia. anand.pharma@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masand</LastName><ForeName>Neeraj</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Lala Lajpat Rai Memorial Medical College, Meerut, Uttar Pradesh, 250004, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Vannajan Sanghiran</ForeName><Initials>VS</Initials><Identifier Source="ORCID">0000-0002-2911-7726</Identifier><AffiliationInfo><Affiliation>Faculty of Science, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patil</LastName><ForeName>Vaishali M</ForeName><Initials>VM</Initials><Identifier Source="ORCID">0000-0002-5352-7872</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Chemistry, KIET Group of Institutions, KIET School of Pharmacy, Delhi-NCR, Ghaziabad, Uttar Pradesh, 201206, India. vaishuwise@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mol Divers</MedlineTA><NlmUniqueID>9516534</NlmUniqueID><ISSNLinking>1381-1991</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="Y">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">CNS</Keyword><Keyword MajorTopicYN="N">Deep learning</Keyword><Keyword MajorTopicYN="N">Drug discovery</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Neural networks</Keyword><Keyword MajorTopicYN="N">Neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">Neurological diseases</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>12</Day><Hour>11</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35819579</ArticleId><ArticleId IdType="doi">10.1007/s11030-022-10489-3</ArticleId><ArticleId IdType="pii">10.1007/s11030-022-10489-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DiMasi JA, Grabowski HG, Hansen RW (2015) The cost of drug development. N Engl J Med 372(20):1972. https://doi.org/10.1056/NEJMc1504317</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1504317</ArticleId><ArticleId IdType="pubmed">25970070</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S et al (2011) The cost of drug development: a systematic review. Health Policy 100(1):4&#x2013;17. https://doi.org/10.1016/j.healthpol.2010.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthpol.2010.12.002</ArticleId><ArticleId IdType="pubmed">21256615</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul SM et al (2010) How to improve R&amp;D productivity: the pharmaceutical industry&#x2019;s grand challenge. Nat Rev Drug Discov 9(3):203&#x2013;214. https://doi.org/10.1038/nrd3078</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd3078</ArticleId><ArticleId IdType="pubmed">20168317</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacace E, Kritikos G, Typas A (2017) Chemical genetics in drug discovery. Curr Opin Syst Biol 4:35&#x2013;42. https://doi.org/10.1016/j.coisb.2017.05.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coisb.2017.05.020</ArticleId><ArticleId IdType="pubmed">32715163</ArticleId><ArticleId IdType="pmc">7371212</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan CY et al (2013) Accelerating drug discovery via organs-on-chips. Lab Chip 13(24):4697&#x2013;4710. https://doi.org/10.1039/c3lc90115g</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c3lc90115g</ArticleId><ArticleId IdType="pubmed">24193241</ArticleId><ArticleId IdType="pmc">3998760</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews H, Hanison J, Nirmalan N (2016) &#x201c;Omics&#x201d;-informed drug and biomarker discovery: opportunities, challenges and future perspectives. Proteomes. https://doi.org/10.3390/proteomes4030028</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/proteomes4030028</ArticleId><ArticleId IdType="pubmed">28248238</ArticleId><ArticleId IdType="pmc">5217350</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenone M et al (2013) Target identification and mechanism of action in chemical biology and drug discovery. Nat Chem Biol 9(4):232&#x2013;240. https://doi.org/10.1038/nchembio.1199</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1199</ArticleId><ArticleId IdType="pubmed">23508189</ArticleId><ArticleId IdType="pmc">5543995</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos R et al (2017) A comprehensive map of molecular drug targets. Nat Rev Drug Discov 16(1):19&#x2013;34. https://doi.org/10.1038/nrd.2016.230</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2016.230</ArticleId><ArticleId IdType="pubmed">27910877</ArticleId></ArticleIdList></Reference><Reference><Citation>Rask-Andersen M, Alm&#xe9;n MS, Schi&#xf6;th HB (2011) Trends in the exploitation of novel drug targets. Nat Rev Drug Discov 10(8):579&#x2013;590. https://doi.org/10.1038/nrd3478</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd3478</ArticleId><ArticleId IdType="pubmed">21804595</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohs RC, Greig NH (2017) Drug discovery and development: role of basic biological research. Alzheimers Dement (N Y) 3(4):651&#x2013;657. https://doi.org/10.1016/j.trci.2017.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2017.10.005</ArticleId><ArticleId IdType="pubmed">29255791</ArticleId></ArticleIdList></Reference><Reference><Citation>Gribkoff VK, Kaczmarek LK (2017) The need for new approaches in CNS drug discovery: why drugs have failed, and what can be done to improve outcomes. Neuropharmacology 120:11&#x2013;19. https://doi.org/10.1016/j.neuropharm.2016.03.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2016.03.021</ArticleId><ArticleId IdType="pubmed">26979921</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott NJ (2013) Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis 36(3):437&#x2013;449. https://doi.org/10.1007/s10545-013-9608-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10545-013-9608-0</ArticleId><ArticleId IdType="pubmed">23609350</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankevich DE et al (2014) Improving and accelerating drug development for nervous system disorders. Neuron 84(3):546&#x2013;553. https://doi.org/10.1016/j.neuron.2014.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.10.007</ArticleId><ArticleId IdType="pubmed">25442933</ArticleId><ArticleId IdType="pmc">4254615</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lange ECM et al (2017) Novel CNS drug discovery and development approach: model-based integration to predict neuro-pharmacokinetics and pharmacodynamics. Expert Opin Drug Discov 12(12):1207&#x2013;1218. https://doi.org/10.1080/17460441.2017.1380623</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17460441.2017.1380623</ArticleId><ArticleId IdType="pubmed">28933618</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan HCS et al (2019) Advancing drug discovery via artificial intelligence. Trends Pharmacol Sci 40(8):592&#x2013;604. https://doi.org/10.1016/j.tips.2019.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2019.06.004</ArticleId><ArticleId IdType="pubmed">31320117</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith JS, Roitberg AE, Isayev O (2018) Transforming computational drug discovery with machine learning and AI. ACS Med Chem Lett 9(11):1065&#x2013;1069. https://doi.org/10.1021/acsmedchemlett.8b00437</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsmedchemlett.8b00437</ArticleId><ArticleId IdType="pubmed">30429945</ArticleId><ArticleId IdType="pmc">6231187</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhavoronkov A (2018) Artificial intelligence for drug discovery, biomarker development, and generation of novel chemistry. Mol Pharm 15(10):4311&#x2013;4313. https://doi.org/10.1021/acs.molpharmaceut.8b00930</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.molpharmaceut.8b00930</ArticleId><ArticleId IdType="pubmed">30269508</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak K-K, Pichika MR (2019) Artificial intelligence in drug development: present status and future prospects. Drug Discov Today 24(3):773&#x2013;780. https://doi.org/10.1016/j.drudis.2018.11.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2018.11.014</ArticleId><ArticleId IdType="pubmed">30472429</ArticleId></ArticleIdList></Reference><Reference><Citation>Smalley E (2017) AI-powered drug discovery captures pharma interest. Nat Biotechnol 35:604</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt0717-604</ArticleId><ArticleId IdType="pubmed">28700560</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbadawi M, Gaisford S, Basit AW (2021) Advanced machine-learning techniques in drug discovery. Drug Discov Today 26(3):769&#x2013;777. https://doi.org/10.1016/j.drudis.2020.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2020.12.003</ArticleId><ArticleId IdType="pubmed">33290820</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H (2020) Big data and artificial intelligence modeling for drug discovery. Annu Rev Pharmacol Toxicol 60(1):573&#x2013;589. https://doi.org/10.1146/annurev-pharmtox-010919-023324</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-010919-023324</ArticleId><ArticleId IdType="pubmed">31518513</ArticleId></ArticleIdList></Reference><Reference><Citation>Schadt EE et al (2011) Cloud and heterogeneous computing solutions exist today for the emerging big data problems in biology. Nat Rev Genet 12(3):224&#x2013;224. https://doi.org/10.1038/nrg2857-c2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2857-c2</ArticleId><ArticleId IdType="pubmed">21301474</ArticleId></ArticleIdList></Reference><Reference><Citation>Marx V (2013) The big challenges of big data. Nature 498(7453):255&#x2013;260. https://doi.org/10.1038/498255a</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/498255a</ArticleId><ArticleId IdType="pubmed">23765498</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown N et al (2018) Big data in drug discovery. In: Witty DR, Cox B (eds) Progress in medicinal chemistry. Elsevier, New York, pp 277&#x2013;356. https://doi.org/10.1016/bs.pmch.2017.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.pmch.2017.12.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R, Li X, Lam KS (2017) Combinatorial chemistry in drug discovery. Curr Opin Chem Biol 38:117&#x2013;126. https://doi.org/10.1016/j.cbpa.2017.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbpa.2017.03.017</ArticleId><ArticleId IdType="pubmed">28494316</ArticleId><ArticleId IdType="pmc">5645069</ArticleId></ArticleIdList></Reference><Reference><Citation>Benz M et al (2019) Marrying chemistry with biology by combining on-chip solution-based combinatorial synthesis and cellular screening. Nat Commun 10(1):2879. https://doi.org/10.1038/s41467-019-10685-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10685-0</ArticleId><ArticleId IdType="pubmed">31253767</ArticleId><ArticleId IdType="pmc">6599004</ArticleId></ArticleIdList></Reference><Reference><Citation>Borrel A et al (2020) High-throughput screening to predict chemical-assay interference. Sci Rep 10(1):3986&#x2013;3986. https://doi.org/10.1038/s41598-020-60747-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-60747-3</ArticleId><ArticleId IdType="pubmed">32132587</ArticleId><ArticleId IdType="pmc">7055224</ArticleId></ArticleIdList></Reference><Reference><Citation>Broach JR, Thorner J (1996) High-throughput screening for drug discovery. Nature 384(6604 Suppl):14&#x2013;16. https://doi.org/10.1038/384014a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/384014a0</ArticleId><ArticleId IdType="pubmed">8895594</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H et al (2014) Big data in chemical toxicity research: the use of high-throughput screening assays to identify potential toxicants. Chem Res Toxicol 27(10):1643&#x2013;1651. https://doi.org/10.1021/tx500145h</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/tx500145h</ArticleId><ArticleId IdType="pubmed">25195622</ArticleId><ArticleId IdType="pmc">4203392</ArticleId></ArticleIdList></Reference><Reference><Citation>Macarron R et al (2011) Impact of high-throughput screening in biomedical research. Nat Rev Drug Discov 10(3):188&#x2013;195. https://doi.org/10.1038/nrd3368</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd3368</ArticleId><ArticleId IdType="pubmed">21358738</ArticleId></ArticleIdList></Reference><Reference><Citation>Klekota J et al (2006) Using high-throughput screening data to discriminate compounds with single-target effects from those with side effects. J Chem Inf Model 46(4):1549&#x2013;1562. https://doi.org/10.1021/ci050495h</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci050495h</ArticleId><ArticleId IdType="pubmed">16859287</ArticleId></ArticleIdList></Reference><Reference><Citation>Favaretto M et al (2020) What is your definition of Big Data? Researchers&#x2019; understanding of the phenomenon of the decade. PLoS ONE 15(2):e0228987. https://doi.org/10.1371/journal.pone.0228987</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0228987</ArticleId><ArticleId IdType="pubmed">32097430</ArticleId><ArticleId IdType="pmc">7041862</ArticleId></ArticleIdList></Reference><Reference><Citation>Younas M (2019) Research challenges of big data. SOCA 13(2):105&#x2013;107. https://doi.org/10.1007/s11761-019-00265-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11761-019-00265-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishwarappa AJ (2015) A brief introduction on big data 5Vs characteristics and Hadoop technology. Procedia Comput Sci 48:319&#x2013;324. https://doi.org/10.1016/j.procs.2015.04.188</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.procs.2015.04.188</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonelli S (2019) The challenges of big data biology. Elife 8:e47381. https://doi.org/10.7554/eLife.47381</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.47381</ArticleId><ArticleId IdType="pubmed">30950793</ArticleId><ArticleId IdType="pmc">6450665</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CH, Yoon HJ (2017) Medical big data: promise and challenges. Kidney Res Clin Pract 36(1):3&#x2013;11. https://doi.org/10.23876/j.krcp.2017.36.1.3</Citation><ArticleIdList><ArticleId IdType="doi">10.23876/j.krcp.2017.36.1.3</ArticleId><ArticleId IdType="pubmed">28392994</ArticleId><ArticleId IdType="pmc">5331970</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheeder C, Heigwer F, Boutros M (2018) Machine learning and image-based profiling in drug discovery. Curr Opin Syst Biol 10:43&#x2013;52. https://doi.org/10.1016/j.coisb.2018.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coisb.2018.05.004</ArticleId><ArticleId IdType="pubmed">30159406</ArticleId><ArticleId IdType="pmc">6109111</ArticleId></ArticleIdList></Reference><Reference><Citation>Korotcov A et al (2017) Comparison of deep learning with multiple machine learning methods and metrics using diverse drug discovery data sets. Mol Pharm 14(12):4462&#x2013;4475. https://doi.org/10.1021/acs.molpharmaceut.7b00578</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.molpharmaceut.7b00578</ArticleId><ArticleId IdType="pubmed">29096442</ArticleId><ArticleId IdType="pmc">5741413</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing Y et al (2018) Deep learning for drug design: an artificial intelligence paradigm for drug discovery in the big data era. AAPS J 20(3):58. https://doi.org/10.1208/s12248-018-0210-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/s12248-018-0210-0</ArticleId><ArticleId IdType="pubmed">29603063</ArticleId></ArticleIdList></Reference><Reference><Citation>Wooller SK et al (2017) Bioinformatics in translational drug discovery. Biosci Rep. https://doi.org/10.1042/bsr20160180</Citation></Reference><Reference><Citation>Batool M, Ahmad B, Choi S (2019) A structure-based drug discovery paradigm. Int J Mol Sci. https://doi.org/10.3390/ijms20112783</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20112783</ArticleId><ArticleId IdType="pubmed">31461957</ArticleId><ArticleId IdType="pmc">6747277</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B et al (2019) Artificial intelligence and big data facilitated targeted drug discovery. Stroke Vasc Neurol 4(4):206&#x2013;213. https://doi.org/10.1136/svn-2019-000290</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/svn-2019-000290</ArticleId><ArticleId IdType="pubmed">32030204</ArticleId><ArticleId IdType="pmc">6979871</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L et al (2020) Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling. Drug Discov Today 25(9):1624&#x2013;1638. https://doi.org/10.1016/j.drudis.2020.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2020.07.005</ArticleId><ArticleId IdType="pubmed">32663517</ArticleId><ArticleId IdType="pmc">7572559</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel L et al (2020) Machine learning methods in drug discovery. Molecules. https://doi.org/10.3390/molecules25225277</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25225277</ArticleId><ArticleId IdType="pubmed">33396409</ArticleId><ArticleId IdType="pmc">7795772</ArticleId></ArticleIdList></Reference><Reference><Citation>Glicksberg BS et al (2019) Leveraging big data to transform drug discovery. Methods Mol Biol 1939:91&#x2013;118. https://doi.org/10.1007/978-1-4939-9089-4_6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-9089-4_6</ArticleId><ArticleId IdType="pubmed">30848458</ArticleId><ArticleId IdType="pmc">6657335</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X et al (2016) Drug-target interaction prediction: databases, web servers and computational models. Brief Bioinform 17(4):696&#x2013;712. https://doi.org/10.1093/bib/bbv066</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbv066</ArticleId><ArticleId IdType="pubmed">26283676</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier K et al (2020) The generated databases (GDBs) as a source of 3D-shaped building blocks for use in medicinal chemistry and drug discovery. Chimia (Aarau) 74(4):241&#x2013;246. https://doi.org/10.2533/chimia.2020.241</Citation><ArticleIdList><ArticleId IdType="doi">10.2533/chimia.2020.241</ArticleId><ArticleId IdType="pubmed">32331540</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie T et al (2015) Review of natural product databases. Cell Prolif 48(4):398&#x2013;404. https://doi.org/10.1111/cpr.12190</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cpr.12190</ArticleId><ArticleId IdType="pubmed">26009974</ArticleId><ArticleId IdType="pmc">6495245</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen-Vo TH et al (2020) Plant metabolite databases: from herbal medicines to modern drug discovery. J Chem Inf Model 60(3):1101&#x2013;1110. https://doi.org/10.1021/acs.jcim.9b00826</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.9b00826</ArticleId><ArticleId IdType="pubmed">31873010</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuentes G, Oyarzabal J, Rojas AM (2009) Databases of protein-protein interactions and their use in drug discovery. Curr Opin Drug Discov Devel 12(3):358&#x2013;366</Citation><ArticleIdList><ArticleId IdType="pubmed">19396737</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B et al (2019) Computer-assisted drug virtual screening based on the natural product databases. Curr Pharm Biotechnol 20(4):293&#x2013;301. https://doi.org/10.2174/1389201020666190328115411</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389201020666190328115411</ArticleId><ArticleId IdType="pubmed">30919773</ArticleId></ArticleIdList></Reference><Reference><Citation>Potemkin V, Potemkin A, Grishina M (2018) Internet resources for drug discovery and design. Curr Top Med Chem 18(22):1955&#x2013;1975. https://doi.org/10.2174/1568026619666181129142127</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026619666181129142127</ArticleId><ArticleId IdType="pubmed">30499394</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S (2016) Getting the most out of PubChem for virtual screening. Expert Opin Drug Discov 11(9):843&#x2013;855. https://doi.org/10.1080/17460441.2016.1216967</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17460441.2016.1216967</ArticleId><ArticleId IdType="pubmed">27454129</ArticleId><ArticleId IdType="pmc">5045798</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S et al (2018) Finding potential multitarget ligands using PubChem. Methods Mol Biol 1825:63&#x2013;91. https://doi.org/10.1007/978-1-4939-8639-2_2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-8639-2_2</ArticleId><ArticleId IdType="pubmed">30334203</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y et al (2012) PubChem&#x2019;s bioassay database. Nucleic Acids Res 40(Database issue):D400&#x2013;D412. https://doi.org/10.1093/nar/gkr1132</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr1132</ArticleId><ArticleId IdType="pubmed">22140110</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S et al (2021) PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res 49(D1):D1388-d1395. https://doi.org/10.1093/nar/gkaa971</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa971</ArticleId><ArticleId IdType="pubmed">33151290</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S et al (2016) Literature information in PubChem: associations between PubChem records and scientific articles. J Cheminform 8:32. https://doi.org/10.1186/s13321-016-0142-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13321-016-0142-6</ArticleId><ArticleId IdType="pubmed">27293485</ArticleId><ArticleId IdType="pmc">4901473</ArticleId></ArticleIdList></Reference><Reference><Citation>Umesh PK, Dubey VK (2021) Virtual screening and repurposing of FDA-approved drugs from ZINC database to identify potential autophagy inhibitors exploiting autophagy related 4A cysteine peptidase as a target: potential as novel anti-cancer molecule. J Biomol Struct Dyn 2021:1&#x2013;17. https://doi.org/10.1080/07391102.2020.1869100</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1869100</ArticleId></ArticleIdList></Reference><Reference><Citation>Boucherit H et al (2020) The research of new inhibitors of bacterial methionine aminopeptidase by structure based virtual screening approach of zinc database and in vitro validation. Curr Comput Aided Drug Des 16(4):389&#x2013;401. https://doi.org/10.2174/1573409915666190617165643</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573409915666190617165643</ArticleId><ArticleId IdType="pubmed">31244429</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdusalam AAA, Murugaiyah V (2020) Identification of potential inhibitors of 3CL protease of SARS-CoV-2 from zinc database by molecular docking-based virtual screening. Front Mol Biosci 7:603037. https://doi.org/10.3389/fmolb.2020.603037</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2020.603037</ArticleId><ArticleId IdType="pubmed">33392261</ArticleId><ArticleId IdType="pmc">7773842</ArticleId></ArticleIdList></Reference><Reference><Citation>Awale M, Jin X, Reymond JL (2015) Stereoselective virtual screening of the ZINC database using atom pair 3D-fingerprints. J Cheminform 7:3. https://doi.org/10.1186/s13321-014-0051-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13321-014-0051-5</ArticleId><ArticleId IdType="pubmed">25750664</ArticleId><ArticleId IdType="pmc">4352573</ArticleId></ArticleIdList></Reference><Reference><Citation>Monika KJ, Singh K (2013) Virtual screening using the ligand ZINC database for novel lipoxygenase-3 inhibitors. Bioinformation 9(11):583&#x2013;587. https://doi.org/10.6026/97320630009583</Citation><ArticleIdList><ArticleId IdType="doi">10.6026/97320630009583</ArticleId><ArticleId IdType="pubmed">23888100</ArticleId><ArticleId IdType="pmc">3717187</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogara PA et al (2015) Virtual screening of acetylcholinesterase inhibitors using the Lipinski&#x2019;s rule of five and ZINC databank. Biomed Res Int 2015:870389. https://doi.org/10.1155/2015/870389</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/870389</ArticleId><ArticleId IdType="pubmed">25685814</ArticleId><ArticleId IdType="pmc">4317581</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin JJ (2008) Using ZINC to acquire a virtual screening library. Curr Protoc Bioinformatics. https://doi.org/10.1002/0471250953.bi1406s22</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471250953.bi1406s22</ArticleId><ArticleId IdType="pubmed">18551414</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterling T, Irwin JJ (2015) ZINC 15&#x2014;ligand discovery for everyone. J Chem Inf Model 55(11):2324&#x2013;2337. https://doi.org/10.1021/acs.jcim.5b00559</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.5b00559</ArticleId><ArticleId IdType="pubmed">26479676</ArticleId><ArticleId IdType="pmc">4658288</ArticleId></ArticleIdList></Reference><Reference><Citation>Real Compound Libraries (2021) Enamine. https://enamine.net/library-synthesis/real-compounds/real-compound-libraries</Citation></Reference><Reference><Citation>Klingler F-M et al (2019) SAR by space: enriching hit sets from the chemical space. Molecules. https://doi.org/10.3390/molecules24173096</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24173096</ArticleId><ArticleId IdType="pubmed">31454992</ArticleId><ArticleId IdType="pmc">6749418</ArticleId></ArticleIdList></Reference><Reference><Citation>Grygorenko OO et al (2020) Generating multibillion chemical space of readily accessible screening compounds. iScience 23(11):101681. https://doi.org/10.1016/j.isci.2020.101681</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101681</ArticleId><ArticleId IdType="pubmed">33145486</ArticleId><ArticleId IdType="pmc">7593547</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorokina M et al (2021) COCONUT online: collection of open natural products database. J Cheminf 13(1):2. https://doi.org/10.1186/s13321-020-00478-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13321-020-00478-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies M et al (2015) ChEMBL web services: streamlining access to drug discovery data and utilities. Nucleic Acids Res 43(W1):W612&#x2013;W620. https://doi.org/10.1093/nar/gkv352</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv352</ArticleId><ArticleId IdType="pubmed">25883136</ArticleId><ArticleId IdType="pmc">4489243</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadatos G, Overington JP (2014) The ChEMBL database: a taster for medicinal chemists. Future Med Chem 6(4):361&#x2013;364. https://doi.org/10.4155/fmc.14.8</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/fmc.14.8</ArticleId><ArticleId IdType="pubmed">24635517</ArticleId></ArticleIdList></Reference><Reference><Citation>Capecchi A et al (2019) PubChem and ChEMBL beyond Lipinski. Mol Inform 38(5):e1900016. https://doi.org/10.1002/minf.201900016</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/minf.201900016</ArticleId><ArticleId IdType="pubmed">30844149</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez D et al (2019) ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res 47(D1):D930&#x2013;D940. https://doi.org/10.1093/nar/gky1075</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1075</ArticleId><ArticleId IdType="pubmed">30398643</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadatos G et al (2016) SureChEMBL: a large-scale, chemically annotated patent document database. Nucleic Acids Res 44(D1):D1220&#x2013;D1228. https://doi.org/10.1093/nar/gkv1253</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv1253</ArticleId><ArticleId IdType="pubmed">26582922</ArticleId></ArticleIdList></Reference><Reference><Citation>Falaguera MJ, Mestres J (2021) Identification of the core chemical structure in SureChEMBL patents. J Chem Inf Model 61(5):2241&#x2013;2247. https://doi.org/10.1021/acs.jcim.1c00151</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.1c00151</ArticleId><ArticleId IdType="pubmed">33929850</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth M et al (2013) SwissBioisostere: a database of molecular replacements for ligand design. Nucleic Acids Res 41(Database issue):D1137&#x2013;D1143. https://doi.org/10.1093/nar/gks1059</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks1059</ArticleId><ArticleId IdType="pubmed">23161688</ArticleId></ArticleIdList></Reference><Reference><Citation>Daina A, Zoete V (2019) Application of the SwissDrugDesign online resources in virtual screening. Int J Mol Sci. https://doi.org/10.3390/ijms20184612</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20184612</ArticleId><ArticleId IdType="pubmed">31540350</ArticleId><ArticleId IdType="pmc">6770839</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoete V et al (2016) SwissSimilarity: a web tool for low to ultra high throughput ligand-based virtual screening. J Chem Inf Model 56(8):1399&#x2013;1404. https://doi.org/10.1021/acs.jcim.6b00174</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.6b00174</ArticleId><ArticleId IdType="pubmed">27391578</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole JC et al (2018) Knowledge-based conformer generation using the Cambridge structural database. J Chem Inf Model 58(3):615&#x2013;629. https://doi.org/10.1021/acs.jcim.7b00697</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.7b00697</ArticleId><ArticleId IdType="pubmed">29425456</ArticleId></ArticleIdList></Reference><Reference><Citation>Groom CR et al (2016) The Cambridge structural database. Acta Crystallogr B Struct Sci Cryst Eng Mater 72(Pt 2):171&#x2013;179. https://doi.org/10.1107/s2052520616003954</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/s2052520616003954</ArticleId><ArticleId IdType="pubmed">27048719</ArticleId><ArticleId IdType="pmc">4822653</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart DS et al (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36(1):D901&#x2013;D906. https://doi.org/10.1093/nar/gkm958</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkm958</ArticleId><ArticleId IdType="pubmed">18048412</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart DS et al (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34(Database issue):D668&#x2013;D672. https://doi.org/10.1093/nar/gkj067</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkj067</ArticleId><ArticleId IdType="pubmed">16381955</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart DS et al (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46(D1):D1074&#x2013;D1082. https://doi.org/10.1093/nar/gkx1037</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1037</ArticleId><ArticleId IdType="pubmed">29126136</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart DS, Wu A (2016) Using DrugBank for in silico drug exploration and discovery. Curr Protoc Bioinformatics 54:14.4.1-14.4.31. https://doi.org/10.1002/cpbi.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpbi.1</ArticleId><ArticleId IdType="pubmed">27322405</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart DS (2008) DrugBank and its relevance to pharmacogenomics. Pharmacogenomics 9(8):1155&#x2013;1162. https://doi.org/10.2217/14622416.9.8.1155</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/14622416.9.8.1155</ArticleId><ArticleId IdType="pubmed">18681788</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman HM et al (2000) The protein data bank. Nucleic Acids Res 28(1):235&#x2013;242. https://doi.org/10.1093/nar/28.1.235</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/28.1.235</ArticleId><ArticleId IdType="pubmed">10592235</ArticleId><ArticleId IdType="pmc">102472</ArticleId></ArticleIdList></Reference><Reference><Citation>Burley SK et al (2017) Protein data bank (PDB): the single global macromolecular structure archive. Methods Mol Biol 1607:627&#x2013;641. https://doi.org/10.1007/978-1-4939-7000-1_26</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7000-1_26</ArticleId><ArticleId IdType="pubmed">28573592</ArticleId><ArticleId IdType="pmc">5823500</ArticleId></ArticleIdList></Reference><Reference><Citation>Prestegard JH (2021) A perspective on the PDB&#x2019;s impact on the field of glycobiology. J Biol Chem 296:100556. https://doi.org/10.1016/j.jbc.2021.100556</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100556</ArticleId><ArticleId IdType="pubmed">33744289</ArticleId><ArticleId IdType="pmc">8058564</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez J et al (2017) DeepSite: protein-binding site predictor using 3D-convolutional neural networks. Bioinformatics 33(19):3036&#x2013;3042. https://doi.org/10.1093/bioinformatics/btx350</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btx350</ArticleId><ArticleId IdType="pubmed">28575181</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez A (2019) Deep learning to therapeutically target unreported complexes. Trends Pharmacol Sci 40(8):551&#x2013;554. https://doi.org/10.1016/j.tips.2019.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2019.04.009</ArticleId><ArticleId IdType="pubmed">31126630</ArticleId></ArticleIdList></Reference><Reference><Citation>Li&#xf1;ares-Blanco J et al (2020) Molecular docking and machine learning analysis of Abemaciclib in colon cancer. BMC Mol Cell Biol 21(1):52. https://doi.org/10.1186/s12860-020-00295-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12860-020-00295-w</ArticleId><ArticleId IdType="pubmed">32640984</ArticleId><ArticleId IdType="pmc">7346626</ArticleId></ArticleIdList></Reference><Reference><Citation>The UniProt Consortium (2019) UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res 47(D1):D506&#x2013;D515. https://doi.org/10.1093/nar/gky1049</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1049</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarker IH (2021) Machine learning: algorithms, real-world applications and research directions. SN Comput Sci 2(3):160. https://doi.org/10.1007/s42979-021-00592-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42979-021-00592-x</ArticleId><ArticleId IdType="pubmed">33778771</ArticleId><ArticleId IdType="pmc">7983091</ArticleId></ArticleIdList></Reference><Reference><Citation>The UniProt Consortium (2017) UniProt: the universal protein knowledgebase. Nucleic Acids Res 45(D1):D158-d169. https://doi.org/10.1093/nar/gkw1099</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1099</ArticleId></ArticleIdList></Reference><Reference><Citation>Pundir S, Martin MJ, O&#x2019;Donovan C (2017) UniProt protein knowledgebase. Methods Mol Biol 1558:41&#x2013;55. https://doi.org/10.1007/978-1-4939-6783-4_2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-6783-4_2</ArticleId><ArticleId IdType="pubmed">28150232</ArticleId><ArticleId IdType="pmc">5565770</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y et al (2020) Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics. Nucleic Acids Res 48(D1):D1031&#x2013;D1041. https://doi.org/10.1093/nar/gkz981</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz981</ArticleId><ArticleId IdType="pubmed">31691823</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Ji ZL, Chen YZ (2002) TTD: therapeutic target database. Nucleic Acids Res 30(1):412&#x2013;415. https://doi.org/10.1093/nar/30.1.412</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/30.1.412</ArticleId><ArticleId IdType="pubmed">11752352</ArticleId><ArticleId IdType="pmc">99057</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamet P, Tremblay J (2017) Artificial intelligence in medicine. Metabolism 69:S36&#x2013;S40. https://doi.org/10.1016/j.metabol.2017.01.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2017.01.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Turing AM (1950) I&#x2014;Computing machinery and intelligence. Mind LIX(236):433&#x2013;460. https://doi.org/10.1093/mind/LIX.236.433</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/mind/LIX.236.433</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbonell JG, Michalski RS, Mitchell TM (1983) An overview of machine learning. In: Michalski RS, Carbonell JG, Mitchell TM (eds) Machine learning: an artificial intelligence approach. Springer, Berlin, pp 3&#x2013;23. https://doi.org/10.1007/978-3-662-12405-5_1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-662-12405-5_1</ArticleId></ArticleIdList></Reference><Reference><Citation>Todeschini R, Consonni V (2000) Frontmatter. In: Handbook of molecular descriptors. Wiley, Weinheim, pp i&#x2013;xxi. https://doi.org/10.1002/9783527613106.fmatter</Citation></Reference><Reference><Citation>Dong J et al (2015) ChemDes: an integrated web-based platform for molecular descriptor and fingerprint computation. J Cheminf 7(1):60. https://doi.org/10.1186/s13321-015-0109-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13321-015-0109-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukumar N et al (2011) Molecular descriptors for biological systems. In: Guha R, Bender A (eds) Computational approaches in cheminformatics and bioinformatics. Wiley-VCH, Weinheim, pp 107&#x2013;143. https://doi.org/10.1002/9781118131411.ch5</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9781118131411.ch5</ArticleId></ArticleIdList></Reference><Reference><Citation>Todeschini R, Consonni V, Gramatica P (2009) Chemometrics in QSAR. In: Brown SD, Tauler R, Walczak B (eds) Comprehensive chemometrics. Elsevier, Oxford, pp 129&#x2013;172. https://doi.org/10.1016/B978-044452701-1.00007-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-044452701-1.00007-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajorath J (2001) Selected concepts and investigations in compound classification, molecular descriptor analysis, and virtual screening. J Chem Inf Comput Sci 41(2):233&#x2013;245. https://doi.org/10.1021/ci0001482</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci0001482</ArticleId><ArticleId IdType="pubmed">11277704</ArticleId></ArticleIdList></Reference><Reference><Citation>Raymond JW, Willett P (2002) Effectiveness of graph-based and fingerprint-based similarity measures for virtual screening of 2D chemical structure databases. J Comput Aided Mol Des 16(1):59&#x2013;71. https://doi.org/10.1023/A:1016387816342</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1016387816342</ArticleId><ArticleId IdType="pubmed">12197666</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanciuc O (2013) Chemical graphs, molecular matrices and topological indices in chemoinformatics and quantitative structure-activity relationships. Curr Comput Aided Drug Des 9(2):153&#x2013;163. https://doi.org/10.2174/1573409911309020002</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573409911309020002</ArticleId><ArticleId IdType="pubmed">23701000</ArticleId></ArticleIdList></Reference><Reference><Citation>Kombo DC et al (2013) 3D molecular descriptors important for clinical success. J Chem Inf Model 53(2):327&#x2013;342. https://doi.org/10.1021/ci300445e</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci300445e</ArticleId><ArticleId IdType="pubmed">23244494</ArticleId></ArticleIdList></Reference><Reference><Citation>Orosz &#xc1;, H&#xe9;berger K, R&#xe1;cz A (2022) Comparison of descriptor-and fingerprint sets in machine learning models for ADME-Tox targets. Front Chem 10:852893. https://doi.org/10.3389/fchem.2022.852893</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2022.852893</ArticleId><ArticleId IdType="pubmed">35755260</ArticleId><ArticleId IdType="pmc">9214226</ArticleId></ArticleIdList></Reference><Reference><Citation>Senese CL et al (2004) 4D-fingerprints, universal QSAR and QSPR descriptors. J Chem Inf Comput Sci 44(5):1526&#x2013;1539. https://doi.org/10.1021/ci049898s</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci049898s</ArticleId><ArticleId IdType="pubmed">15446810</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaroslaw P (2009) Receptor dependent multidimensional QSAR for modeling drug&#x2013;receptor interactions. Curr Med Chem 16(25):3243&#x2013;3257. https://doi.org/10.2174/092986709788803286</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986709788803286</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayakawa D et al (2020) A molecular interaction field describing nonconventional intermolecular interactions and its application to protein&#x2013;ligand interaction prediction. J Mol Graph Model 96:107515. https://doi.org/10.1016/j.jmgm.2019.107515</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmgm.2019.107515</ArticleId><ArticleId IdType="pubmed">31896525</ArticleId></ArticleIdList></Reference><Reference><Citation>Chartier M, Najmanovich R (2015) Detection of binding site molecular interaction field similarities. J Chem Inf Model 55(8):1600&#x2013;1615. https://doi.org/10.1021/acs.jcim.5b00333</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.5b00333</ArticleId><ArticleId IdType="pubmed">26158641</ArticleId></ArticleIdList></Reference><Reference><Citation>Artese A et al (2013) Molecular interaction fields in drug discovery: recent advances and future perspectives. WIREs Comput Mol Sci 3(6):594&#x2013;613. https://doi.org/10.1002/wcms.1150</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wcms.1150</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranade V (2006) Molecular interaction fields. Am J Therapeutics 13(4):385&#x2013;386</Citation></Reference><Reference><Citation>Bertoni M et al (2021) Bioactivity descriptors for uncharacterized chemical compounds. Nat Commun 12(1):3932. https://doi.org/10.1038/s41467-021-24150-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24150-4</ArticleId><ArticleId IdType="pubmed">34168145</ArticleId><ArticleId IdType="pmc">8225676</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang KV, Gunsalus LM, Keiser MJ (2020) Learning molecular representations for medicinal chemistry. J Med Chem 63(16):8705&#x2013;8722. https://doi.org/10.1021/acs.jmedchem.0c00385</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.0c00385</ArticleId><ArticleId IdType="pubmed">32366098</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue L, Bajorath J (2000) Molecular descriptors in chemoinformatics, computational combinatorial chemistry, and virtual screening. Comb Chem High Throughput Screen 3(5):363&#x2013;372. https://doi.org/10.2174/1386207003331454</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1386207003331454</ArticleId><ArticleId IdType="pubmed">11032954</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers D, Hahn M (2010) Extended-connectivity fingerprints. J Chem Inf Model 50(5):742&#x2013;754. https://doi.org/10.1021/ci100050t</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci100050t</ArticleId><ArticleId IdType="pubmed">20426451</ArticleId></ArticleIdList></Reference><Reference><Citation>Glem RC et al (2006) Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME. IDrugs 9(3):199&#x2013;204</Citation><ArticleIdList><ArticleId IdType="pubmed">16523386</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearnes S et al (2016) Molecular graph convolutions: moving beyond fingerprints. J Comput Aided Mol Des 30(8):595&#x2013;608. https://doi.org/10.1007/s10822-016-9938-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10822-016-9938-8</ArticleId><ArticleId IdType="pubmed">27558503</ArticleId><ArticleId IdType="pmc">5028207</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X et al (2019) Molecule property prediction based on spatial graph embedding. J Chem Inf Model 59(9):3817&#x2013;3828. https://doi.org/10.1021/acs.jcim.9b00410</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.9b00410</ArticleId><ArticleId IdType="pubmed">31438677</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbeck C et al (2006) Recent developments of the chemistry development kit (CDK)&#x2014;an open-source java library for chemo- and bioinformatics. Curr Pharm Des 12(17):2111&#x2013;2120. https://doi.org/10.2174/138161206777585274</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161206777585274</ArticleId><ArticleId IdType="pubmed">16796559</ArticleId></ArticleIdList></Reference><Reference><Citation>Willighagen EL et al (2017) The Chemistry Development Kit (CDK) v2.0: atom typing, depiction, molecular formulas, and substructure searching. J Cheminform 9(1):33. https://doi.org/10.1186/s13321-017-0220-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13321-017-0220-4</ArticleId><ArticleId IdType="pubmed">29086040</ArticleId><ArticleId IdType="pmc">5461230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovri&#x107; M, Molero JM, Kern R (2019) PySpark and RDKit: moving towards big data in cheminformatics. Mol Inform 38(6):e1800082. https://doi.org/10.1002/minf.201800082</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/minf.201800082</ArticleId><ArticleId IdType="pubmed">30844132</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangadpalliwar SR et al (2019) ChemSuite: a package for chemoinformatics calculations and machine learning. Chem Biol Drug Des 93(5):960&#x2013;964. https://doi.org/10.1111/cbdd.13479</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cbdd.13479</ArticleId><ArticleId IdType="pubmed">30637953</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z et al (2018) iFeature: a Python package and web server for features extraction and selection from protein and peptide sequences. Bioinformatics 34(14):2499&#x2013;2502. https://doi.org/10.1093/bioinformatics/bty140</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty140</ArticleId><ArticleId IdType="pubmed">29528364</ArticleId><ArticleId IdType="pmc">6658705</ArticleId></ArticleIdList></Reference><Reference><Citation>Taguchi YH, Turki T (2020) A new advanced in silico drug discovery method for novel coronavirus (SARS-CoV-2) with tensor decomposition-based unsupervised feature extraction. PLoS ONE 15(9):e0238907. https://doi.org/10.1371/journal.pone.0238907</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0238907</ArticleId><ArticleId IdType="pubmed">32915876</ArticleId><ArticleId IdType="pmc">7485840</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma&#x2019;ayan A et al (2007) Network analysis of FDA approved drugs and their targets. Mt Sinai J Med N Y 74(1):27&#x2013;32. https://doi.org/10.1002/msj.20002</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/msj.20002</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkans U et al (2021) From ArrayExpress to BioStudies. Nucleic Acids Res 49(D1):D1502&#x2013;D1506. https://doi.org/10.1093/nar/gkaa1062</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1062</ArticleId><ArticleId IdType="pubmed">33211879</ArticleId></ArticleIdList></Reference><Reference><Citation>Clough E, Barrett T (2016) The gene expression omnibus database. Methods Mol Biol (Clifton, N.J.) 1418:93&#x2013;110. https://doi.org/10.1007/978-1-4939-3578-9_5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-3578-9_5</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinson H et al (2007) ArrayExpress&#x2014;a public database of microarray experiments and gene expression profiles. Nucleic Acids Res 35(Database issue):D747&#x2013;D750. https://doi.org/10.1093/nar/gkl995</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkl995</ArticleId><ArticleId IdType="pubmed">17132828</ArticleId></ArticleIdList></Reference><Reference><Citation>Athar A et al (2019) ArrayExpress update&#x2014;from bulk to single-cell expression data. Nucleic Acids Res 47(D1):D711&#x2013;D715. https://doi.org/10.1093/nar/gky964</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky964</ArticleId><ArticleId IdType="pubmed">30357387</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao C, Moult J (2014) GWAS and drug targets. BMC Genomics 15(Suppl 4):S5. https://doi.org/10.1186/1471-2164-15-S4-S5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-15-S4-S5</ArticleId><ArticleId IdType="pubmed">25057111</ArticleId><ArticleId IdType="pmc">4083410</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck T, Shorter T, Brookes AJ (2020) GWAS central: a comprehensive resource for the discovery and comparison of genotype and phenotype data from genome-wide association studies. Nucleic Acids Res 48(D1):D933&#x2013;D940. https://doi.org/10.1093/nar/gkz895</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz895</ArticleId><ArticleId IdType="pubmed">31612961</ArticleId></ArticleIdList></Reference><Reference><Citation>Buniello A et al (2019) The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res 47(D1):D1005&#x2013;D1012. https://doi.org/10.1093/nar/gky1120</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1120</ArticleId><ArticleId IdType="pubmed">30445434</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J et al (2021) Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection. Cell 184(1):76&#x2013;91. https://doi.org/10.1016/j.cell.2020.10.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.028</ArticleId><ArticleId IdType="pubmed">33147444</ArticleId></ArticleIdList></Reference><Reference><Citation>King EA, Davis JW, Degner JF (2019) Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS Genet 15(12):e1008489. https://doi.org/10.1371/journal.pgen.1008489</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1008489</ArticleId><ArticleId IdType="pubmed">31830040</ArticleId><ArticleId IdType="pmc">6907751</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodama Y et al (2012) The Sequence Read Archive: explosive growth of sequencing data. Nucleic Acids Res 40(Database issue):D54&#x2013;D56. https://doi.org/10.1093/nar/gkr854</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr854</ArticleId><ArticleId IdType="pubmed">22009675</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y et al (2019) DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies. Nucleic Acids Res 47(8):e45. https://doi.org/10.1093/nar/gkz096</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz096</ArticleId><ArticleId IdType="pubmed">30773592</ArticleId><ArticleId IdType="pmc">6486576</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y et al (2021) Corrigendum to article &#x201c;DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies.&#x201d; Nucleic Acids Res 49(7):4196. https://doi.org/10.1093/nar/gkab193</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab193</ArticleId><ArticleId IdType="pubmed">33744935</ArticleId><ArticleId IdType="pmc">8053120</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhasmana A et al (2020) Topological and system-level protein interaction network (PIN) analyses to deduce molecular mechanism of curcumin. Sci Rep 10(1):12045. https://doi.org/10.1038/s41598-020-69011-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-69011-0</ArticleId><ArticleId IdType="pubmed">32694520</ArticleId><ArticleId IdType="pmc">7374742</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z et al (2018) Resurrected protein interaction networks reveal the innovation potential of ancient whole-genome duplication. Plant Cell 30(11):2741&#x2013;2760. https://doi.org/10.1105/tpc.18.00409</Citation><ArticleIdList><ArticleId IdType="doi">10.1105/tpc.18.00409</ArticleId><ArticleId IdType="pubmed">30333148</ArticleId><ArticleId IdType="pmc">6305981</ArticleId></ArticleIdList></Reference><Reference><Citation>Farooq QUA et al (2020) A systems biology-driven approach to construct a comprehensive protein interaction network of influenza A virus with its host. BMC Infect Dis 20(1):480. https://doi.org/10.1186/s12879-020-05214-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05214-0</ArticleId><ArticleId IdType="pubmed">32631335</ArticleId><ArticleId IdType="pmc">7339526</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L et al (2017) Human enterovirus 71 protein interaction network prompts antiviral drug repositioning. Sci Rep 7:43143. https://doi.org/10.1038/srep43143</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep43143</ArticleId><ArticleId IdType="pubmed">28220872</ArticleId><ArticleId IdType="pmc">5318855</ArticleId></ArticleIdList></Reference><Reference><Citation>Farooq QUA et al (2020) Inferring Virus-Host relationship between HPV and its host Homo sapiens using protein interaction network. Sci Rep 10(1):8719. https://doi.org/10.1038/s41598-020-65837-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-65837-w</ArticleId><ArticleId IdType="pubmed">32457456</ArticleId><ArticleId IdType="pmc">7251128</ArticleId></ArticleIdList></Reference><Reference><Citation>Hase T et al (2009) Structure of protein interaction networks and their implications on drug design. PLOS Comput Biol 5(10):e1000550. https://doi.org/10.1371/journal.pcbi.1000550</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1000550</ArticleId><ArticleId IdType="pubmed">19876376</ArticleId><ArticleId IdType="pmc">2760708</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuji S et al (2021) Artificial intelligence-based computational framework for drug-target prioritization and inference of novel repositionable drugs for Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Res Therapy 13(1):92. https://doi.org/10.1186/s13195-021-00826-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00826-3</ArticleId></ArticleIdList></Reference><Reference><Citation>iCLUE&amp;ASK (2021) https://icluenask.standigm.com/about</Citation></Reference><Reference><Citation>White J (2020) PubMed. Med Ref Serv Q 39(4):382&#x2013;387. https://doi.org/10.1080/02763869.2020.1826228</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02763869.2020.1826228</ArticleId><ArticleId IdType="pubmed">33085945</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J et al (2013) DigSee: disease gene search engine with evidence sentences (version cancer). Nucleic Acids Res 41(Web Server Issue):W510&#x2013;W517. https://doi.org/10.1093/nar/gkt531</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt531</ArticleId><ArticleId IdType="pubmed">23761452</ArticleId><ArticleId IdType="pmc">3692119</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayal M, Honig B (2006) On the nature of cavities on protein surfaces: application to the identification of drug-binding sites. Proteins 63(4):892&#x2013;906. https://doi.org/10.1002/prot.20897</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.20897</ArticleId><ArticleId IdType="pubmed">16477622</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandoi G, Acencio ML, Lemke N (2015) Prediction of druggable proteins using machine learning and systems biology: A mini-review. Front Physiol 6:366. https://doi.org/10.3389/fphys.2015.00366</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2015.00366</ArticleId><ArticleId IdType="pubmed">26696900</ArticleId><ArticleId IdType="pmc">4672042</ArticleId></ArticleIdList></Reference><Reference><Citation>Rifaioglu AS et al (2021) MDeePred: novel multi-channel protein featurization for deep learning-based binding affinity prediction in drug discovery. Bioinformatics 37(5):693&#x2013;704. https://doi.org/10.1093/bioinformatics/btaa858</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btaa858</ArticleId><ArticleId IdType="pubmed">33067636</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandel J, Tayara H, Chong KT (2021) PUResNet: prediction of protein&#x2013;ligand binding sites using deep residual neural network. J Cheminf 13(1):65. https://doi.org/10.1186/s13321-021-00547-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13321-021-00547-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J-H et al (2020) Druggability assessment in TRAPP using machine learning approaches. J Chem Inf Model 60(3):1685&#x2013;1699. https://doi.org/10.1021/acs.jcim.9b01185</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.9b01185</ArticleId><ArticleId IdType="pubmed">32105476</ArticleId></ArticleIdList></Reference><Reference><Citation>Olah M et al (2005) WOMBAT: world of molecular bioactivity. Chemoinformatics Drug Discov 2005:221&#x2013;239. https://doi.org/10.1002/3527603743.ch9</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/3527603743.ch9</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K, Lee M, Kim D (2017) Utilizing random forest QSAR models with optimized parameters for target identification and its application to target-fishing server. BMC Bioinformatics 18(Suppl 16):567. https://doi.org/10.1186/s12859-017-1960-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-017-1960-x</ArticleId><ArticleId IdType="pubmed">29297315</ArticleId><ArticleId IdType="pmc">5751401</ArticleId></ArticleIdList></Reference><Reference><Citation>Senior AW et al (2020) Improved protein structure prediction using potentials from deep learning. Nature 577(7792):706&#x2013;710. https://doi.org/10.1038/s41586-019-1923-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1923-7</ArticleId><ArticleId IdType="pubmed">31942072</ArticleId></ArticleIdList></Reference><Reference><Citation>Cyclica Launches Ligand Express&#x2122;, a Disruptive Cloud-Based Platform to Revolutionize Drug Discovery (2017). https://www.cyclicarx.com/press-releases/cyclica-launches-ligand-express-a-disruptive-cloud-based-platform-to-revolutionize-drug-discovery</Citation></Reference><Reference><Citation>Korkmaz S, Zararsiz G, Goksuluk D (2015) MLViS: a web tool for machine learning-based virtual screening in early-phase of drug discovery and development. PLoS ONE 10(4):e0124600. https://doi.org/10.1371/journal.pone.0124600</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0124600</ArticleId><ArticleId IdType="pubmed">25928885</ArticleId><ArticleId IdType="pmc">4415797</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xf3;jcikowski M, Zielenkiewicz P, Siedlecki P (2015) Open Drug Discovery Toolkit (ODDT): a new open-source player in the drug discovery field. J Cheminf 7(1):26. https://doi.org/10.1186/s13321-015-0078-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13321-015-0078-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaschke T et al (2020) REINVENT 2.0: an AI tool for de novo drug design. J Chem Inf Model 60(12):5918&#x2013;5922. https://doi.org/10.1021/acs.jcim.0c00915</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.0c00915</ArticleId><ArticleId IdType="pubmed">33118816</ArticleId></ArticleIdList></Reference><Reference><Citation>Alley EC et al (2019) Unified rational protein engineering with sequence-based deep representation learning. Nat Methods 16(12):1315&#x2013;1322. https://doi.org/10.1038/s41592-019-0598-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0598-1</ArticleId><ArticleId IdType="pubmed">31636460</ArticleId><ArticleId IdType="pmc">7067682</ArticleId></ArticleIdList></Reference><Reference><Citation>Amendola G, Cosconati S (2021) PyRMD: a new fully automated AI-powered ligand-based virtual screening tool. J Chem Inf Model 61(8):3835&#x2013;3845. https://doi.org/10.1021/acs.jcim.1c00653</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.1c00653</ArticleId><ArticleId IdType="pubmed">34270903</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile F et al (2020) Deep docking: a deep learning platform for augmentation of structure based drug discovery. ACS Cent Sci 6(6):939&#x2013;949. https://doi.org/10.1021/acscentsci.0c00229</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.0c00229</ArticleId><ArticleId IdType="pubmed">32607441</ArticleId><ArticleId IdType="pmc">7318080</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Q et al (2020) MolAICal: a soft tool for 3D drug design of protein targets by artificial intelligence and classical algorithm. Brief Bioinformatics. https://doi.org/10.1093/bib/bbaa161</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbaa161</ArticleId><ArticleId IdType="pubmed">31392334</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y et al (2017) Protein&#x2013;ligand empirical interaction components for virtual screening. J Chem Inf Model 57(8):1793&#x2013;1806. https://doi.org/10.1021/acs.jcim.7b00017</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.7b00017</ArticleId><ArticleId IdType="pubmed">28678484</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherkasov A et al (2009) Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem Biol 4(1):65&#x2013;74. https://doi.org/10.1021/cb800240j</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cb800240j</ArticleId><ArticleId IdType="pubmed">19055425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinnings SL et al (2011) A machine learning-based method to improve docking scoring functions and its application to drug repurposing. J Chem Inf Model 51(2):408&#x2013;419. https://doi.org/10.1021/ci100369f</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci100369f</ArticleId><ArticleId IdType="pubmed">21291174</ArticleId><ArticleId IdType="pmc">3076728</ArticleId></ArticleIdList></Reference><Reference><Citation>Leong MK et al (2017) Prediction of N-methyl-D-aspartate receptor GluN1-ligand binding affinity by a novel SVM-pose/SVM-score combinatorial ensemble docking scheme. Sci Rep 7:40053. https://doi.org/10.1038/srep40053</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep40053</ArticleId><ArticleId IdType="pubmed">28059133</ArticleId><ArticleId IdType="pmc">5216401</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H et al (2015) Improving AutoDock Vina using random forest: the growing accuracy of binding affinity prediction by the effective exploitation of larger data sets. Mol Inf 34(2&#x2013;3):115&#x2013;126. https://doi.org/10.1002/minf.201400132</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/minf.201400132</ArticleId></ArticleIdList></Reference><Reference><Citation>Arciniega M, Lange OF (2014) Improvement of virtual screening results by docking data feature analysis. J Chem Inf Model 54(5):1401&#x2013;1411. https://doi.org/10.1021/ci500028u</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci500028u</ArticleId><ArticleId IdType="pubmed">24796936</ArticleId></ArticleIdList></Reference><Reference><Citation>Waszkowycz B (2008) Towards improving compound selection in structure-based virtual screening. Drug Discov Today 13(5&#x2013;6):219&#x2013;226. https://doi.org/10.1016/j.drudis.2007.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2007.12.002</ArticleId><ArticleId IdType="pubmed">18342797</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter KA et al (2018) Deep learning and virtual drug screening. Future Med Chem 10(21):2557&#x2013;2567. https://doi.org/10.4155/fmc-2018-0314</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/fmc-2018-0314</ArticleId><ArticleId IdType="pubmed">30288997</ArticleId><ArticleId IdType="pmc">6563286</ArticleId></ArticleIdList></Reference><Reference><Citation>Melville JL, Burke EK, Hirst JD (2009) Machine learning in virtual screening. Comb Chem High Throughput Screen 12(4):332&#x2013;343. https://doi.org/10.2174/138620709788167980</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138620709788167980</ArticleId><ArticleId IdType="pubmed">19442063</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira JC, Caffarena ER, dos Santos CN (2016) Boosting docking-based virtual screening with deep learning. J Chem Inf Model 56(12):2495&#x2013;2506. https://doi.org/10.1021/acs.jcim.6b00355</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.6b00355</ArticleId><ArticleId IdType="pubmed">28024405</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballester PJ, Mitchell JB (2010) A machine learning approach to predicting protein&#x2013;ligand binding affinity with applications to molecular docking. Bioinformatics 26(9):1169&#x2013;1175. https://doi.org/10.1093/bioinformatics/btq112</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq112</ArticleId><ArticleId IdType="pubmed">20236947</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilian D, Sotriffer CA (2013) SFCscore(RF): a random forest-based scoring function for improved affinity prediction of protein&#x2013;ligand complexes. J Chem Inf Model 53(8):1923&#x2013;1933. https://doi.org/10.1021/ci400120b</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci400120b</ArticleId><ArticleId IdType="pubmed">23705795</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Kwoh CK, Li J (2013) Binding affinity prediction for protein&#x2013;ligand complexes based on &#x3b2; contacts and B factor. J Chem Inf Model 53(11):3076&#x2013;3085. https://doi.org/10.1021/ci400450h</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci400450h</ArticleId><ArticleId IdType="pubmed">24191692</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H et al (2014) istar: a web platform for large-scale protein&#x2013;ligand docking. PLoS ONE 9(1):e85678. https://doi.org/10.1371/journal.pone.0085678</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0085678</ArticleId><ArticleId IdType="pubmed">24475049</ArticleId><ArticleId IdType="pmc">3901662</ArticleId></ArticleIdList></Reference><Reference><Citation>Li GB et al (2013) ID-Score: a new empirical scoring function based on a comprehensive set of descriptors related to protein&#x2013;ligand interactions. J Chem Inf Model 53(3):592&#x2013;600. https://doi.org/10.1021/ci300493w</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci300493w</ArticleId><ArticleId IdType="pubmed">23394072</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballester PJ (2012) Machine learning scoring functions based on random forest and support vector regression. In: Proceedings of the 6th international conference on pattern recognition in bioinformatics. Springer, Berlin</Citation></Reference><Reference><Citation>Durrant JD, McCammon JA (2010) NNScore: a neural-network-based scoring function for the characterization of protein&#x2013;ligand complexes. J Chem Inf Model 50(10):1865&#x2013;1871. https://doi.org/10.1021/ci100244v</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci100244v</ArticleId><ArticleId IdType="pubmed">20845954</ArticleId><ArticleId IdType="pmc">2964041</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang X, Handoko SD, Kwoh CK (2011) CScore: a simple yet effective scoring function for protein&#x2013;ligand binding affinity prediction using modified CMAC learning architecture. J Bioinform Comput Biol 9(Suppl 1):1&#x2013;14. https://doi.org/10.1142/s021972001100577x</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/s021972001100577x</ArticleId><ArticleId IdType="pubmed">22144250</ArticleId></ArticleIdList></Reference><Reference><Citation>Cang Z, Wei G-W (2017) TopologyNet: topology based deep convolutional and multi-task neural networks for biomolecular property predictions. PLOS Comput Biol 13(7):e1005690. https://doi.org/10.1371/journal.pcbi.1005690</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1005690</ArticleId><ArticleId IdType="pubmed">28749969</ArticleId><ArticleId IdType="pmc">5549771</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragoza M et al (2017) Protein&#x2013;ligand scoring with convolutional neural networks. J Chem Inf Model 57(4):942&#x2013;957. https://doi.org/10.1021/acs.jcim.6b00740</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.6b00740</ArticleId><ArticleId IdType="pubmed">28368587</ArticleId><ArticleId IdType="pmc">5479431</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepniewska-Dziubinska MM, Zielenkiewicz P, Siedlecki P (2018) Development and evaluation of a deep learning model for protein&#x2013;ligand binding affinity prediction. Bioinformatics 34(21):3666&#x2013;3674. https://doi.org/10.1093/bioinformatics/bty374</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty374</ArticleId><ArticleId IdType="pubmed">29757353</ArticleId><ArticleId IdType="pmc">6198856</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashtawy HM, Mahapatra NR (2015) BgN-Score and BsN-Score: Bagging and boosting based ensemble neural networks scoring functions for accurate binding affinity prediction of protein&#x2013;ligand complexes. BMC Bioinformatics 16(4):S8. https://doi.org/10.1186/1471-2105-16-S4-S8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-16-S4-S8</ArticleId><ArticleId IdType="pubmed">25734685</ArticleId><ArticleId IdType="pmc">4347622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ain QU et al (2015) Machine-learning scoring functions to improve structure-based binding affinity prediction and virtual screening. Wiley Interdiscip Rev Comput Mol Sci 5(6):405&#x2013;424. https://doi.org/10.1002/wcms.1225</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wcms.1225</ArticleId><ArticleId IdType="pubmed">27110292</ArticleId><ArticleId IdType="pmc">4832270</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X et al (2019) Concepts of artificial intelligence for computer-assisted drug discovery. Chem Rev 119(18):10520&#x2013;10594. https://doi.org/10.1021/acs.chemrev.8b00728</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.8b00728</ArticleId><ArticleId IdType="pubmed">31294972</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D et al (2019) Improving the virtual screening ability of target-specific scoring functions using deep learning methods. Front Pharmacol 10:924. https://doi.org/10.3389/fphar.2019.00924</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00924</ArticleId><ArticleId IdType="pubmed">31507420</ArticleId><ArticleId IdType="pmc">6713720</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L et al (2011) Target-specific support vector machine scoring in structure-based virtual screening: computational validation, in vitro testing in kinases, and effects on lung cancer cell proliferation. J Chem Inf Model 51(4):755&#x2013;759. https://doi.org/10.1021/ci100490w</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci100490w</ArticleId><ArticleId IdType="pubmed">21438548</ArticleId><ArticleId IdType="pmc">3092157</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan PF (2012) Puzzling over schizophrenia: schizophrenia as a pathway disease. Nat Med 18(2):210&#x2013;211. https://doi.org/10.1038/nm.2670</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2670</ArticleId><ArticleId IdType="pubmed">22310687</ArticleId><ArticleId IdType="pmc">4188922</ArticleId></ArticleIdList></Reference><Reference><Citation>Kottaram A et al (2019) Brain network dynamics in schizophrenia: reduced dynamism of the default mode network. Hum Brain Mapp 40(7):2212&#x2013;2228. https://doi.org/10.1002/hbm.24519</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.24519</ArticleId><ArticleId IdType="pubmed">30664285</ArticleId><ArticleId IdType="pmc">6917018</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermakov EA et al (2021) Oxidative stress-related mechanisms in schizophrenia pathogenesis and new treatment perspectives. Oxid Med Cell Longev 2021:8881770. https://doi.org/10.1155/2021/8881770</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8881770</ArticleId><ArticleId IdType="pubmed">33552387</ArticleId><ArticleId IdType="pmc">7847339</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKay M-AB et al (2018) Multidimensional connectomics and treatment-resistant schizophrenia: linking phenotypic circuits to targeted therapeutics. Front Psychiatry 9:537. https://doi.org/10.3389/fpsyt.2018.00537</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2018.00537</ArticleId><ArticleId IdType="pubmed">30425662</ArticleId><ArticleId IdType="pmc">6218602</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkovic MN et al (2017) Theranostic biomarkers for schizophrenia. Int J Mol Sci 18(4):733. https://doi.org/10.3390/ijms18040733</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18040733</ArticleId><ArticleId IdType="pubmed">28358316</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha S et al (2005) A systematic review of the prevalence of schizophrenia. PLoS Med 2(5):e141. https://doi.org/10.1371/journal.pmed.0020141</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0020141</ArticleId><ArticleId IdType="pubmed">15916472</ArticleId><ArticleId IdType="pmc">1140952</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (2008) The global burden of disease: 2004 update. World Health Organization, Geneva. https://apps.who.int/iris/handle/10665/43942</Citation></Reference><Reference><Citation>Hyman SE (2012) Revolution stalled. Sci Transl Med 4(155):155cm11. https://doi.org/10.1126/scitranslmed.3003142</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3003142</ArticleId><ArticleId IdType="pubmed">23052291</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang QX et al (2019) Identification of the gene signature reflecting schizophrenia&#x2019;s etiology by constructing artificial intelligence-based method of enhanced reproducibility. CNS Neurosci Ther 25(9):1054&#x2013;1063. https://doi.org/10.1111/cns.13196</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13196</ArticleId><ArticleId IdType="pubmed">31350824</ArticleId><ArticleId IdType="pmc">6698965</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao K, So HC (2019) Drug repositioning for schizophrenia and depression/anxiety disorders: a machine learning approach leveraging expression data. IEEE J Biomed Health Informatics 23(3):1304&#x2013;1315. https://doi.org/10.1109/JBHI.2018.2856535</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/JBHI.2018.2856535</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarty MM (2019) Guest editorial: special issue on machine learning in schizophrenia. Schizophr Res 214:1&#x2013;2. https://doi.org/10.1016/j.schres.2019.10.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.schres.2019.10.044</ArticleId><ArticleId IdType="pubmed">31711732</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M, Spillantini MG (2006) A century of Alzheimer&#x2019;s disease. Science 314(5800):777&#x2013;781. https://doi.org/10.1126/science.1132814</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1132814</ArticleId><ArticleId IdType="pubmed">17082447</ArticleId></ArticleIdList></Reference><Reference><Citation>2021 Alzheimer&#x2019;s disease facts and figures. Alzheimers Dement 17(3):327&#x2013;406. https://doi.org/10.1002/alz.12328</Citation></Reference><Reference><Citation>Misra S, Medhi B (2013) Drug development status for Alzheimer&#x2019;s disease: present scenario. Neurol Sci 34(6):831&#x2013;839. https://doi.org/10.1007/s10072-013-1316-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-013-1316-x</ArticleId><ArticleId IdType="pubmed">23392897</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL, Morstorf T, Zhong K (2014) Alzheimer&#x2019;s disease drug-development pipeline: few candidates, frequent failures. Alzheimer&#x2019;s Res Therapy 6(4):37. https://doi.org/10.1186/alzrt269</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt269</ArticleId></ArticleIdList></Reference><Reference><Citation>Louros N et al (2020) Structure-based machine-guided mapping of amyloid sequence space reveals uncharted sequence clusters with higher solubilities. Nat Commun 11(1):3314. https://doi.org/10.1038/s41467-020-17207-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17207-3</ArticleId><ArticleId IdType="pubmed">32620861</ArticleId><ArticleId IdType="pmc">7335209</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xfc;gis E et al (2019) HENA, heterogeneous network-based data set for Alzheimer&#x2019;s disease. Sci Data 6(1):151. https://doi.org/10.1038/s41597-019-0152-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41597-019-0152-0</ArticleId><ArticleId IdType="pubmed">31413325</ArticleId><ArticleId IdType="pmc">6694132</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung T-C et al (2014) In silico investigation of traditional Chinese medicine compounds to inhibit human histone deacetylase 2 for patients with Alzheimer&#x2019;s disease. BioMed Res Int 2014:769867. https://doi.org/10.1155/2014/769867</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/769867</ArticleId><ArticleId IdType="pubmed">25045700</ArticleId><ArticleId IdType="pmc">4090436</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J et al (2019) Development of predictive models for identifying potential S100A9 inhibitors based on machine learning methods. Front Chem 7:779. https://doi.org/10.3389/fchem.2019.00779</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2019.00779</ArticleId><ArticleId IdType="pubmed">31824919</ArticleId><ArticleId IdType="pmc">6886474</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavas L et al (2019) Neural network modeling of AChE inhibition by new carbazole-bearing oxazolones. Interdiscip Sci 11(1):95&#x2013;107. https://doi.org/10.1007/s12539-017-0245-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12539-017-0245-4</ArticleId><ArticleId IdType="pubmed">29236214</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal S, Grover A, Grover S (2019) Machine learning from molecular dynamics trajectories to predict caspase-8 inhibitors against Alzheimer&#x2019;s disease. Front Pharmacol 10:780. https://doi.org/10.3389/fphar.2019.00780</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00780</ArticleId><ArticleId IdType="pubmed">31354494</ArticleId><ArticleId IdType="pmc">6639425</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X-M et al (2021) Graph neural networks and their current applications in bioinformatics. Front Genet. https://doi.org/10.3389/fgene.2021.690049</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.690049</ArticleId><ArticleId IdType="pubmed">35548450</ArticleId><ArticleId IdType="pmc">8740130</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki Y et al (2020) Comprehensive exploration of target-specific ligands using a graph convolution neural network. Mol Inform 39(1&#x2013;2):e1900095. https://doi.org/10.1002/minf.201900095</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/minf.201900095</ArticleId><ArticleId IdType="pubmed">31815371</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleandrova VV, Speck-Planche A (2020) PTML modeling for Alzheimer&#x2019;s disease: design and prediction of virtual multi-target inhibitors of GSK3B, HDAC1, and HDAC6. Curr Top Med Chem 20(19):1661&#x2013;1676. https://doi.org/10.2174/1568026620666200607190951</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026620666200607190951</ArticleId><ArticleId IdType="pubmed">32515311</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R, Ambasta RK, Kumar P (2020) Identification of novel class I and class IIb histone deacetylase inhibitor for Alzheimer&#x2019;s disease therapeutics. Life Sci 256:117912. https://doi.org/10.1016/j.lfs.2020.117912</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.117912</ArticleId><ArticleId IdType="pubmed">32504755</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang J et al (2017) AlzhCPI: A knowledge base for predicting chemical&#x2013;protein interactions towards Alzheimer&#x2019;s disease. PLoS ONE 12(5):e0178347. https://doi.org/10.1371/journal.pone.0178347</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0178347</ArticleId><ArticleId IdType="pubmed">28542505</ArticleId><ArticleId IdType="pmc">5460905</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang J et al (2015) Discovery of multitarget-directed ligands against Alzheimer&#x2019;s disease through systematic prediction of chemical&#x2013;protein interactions. J Chem Inf Model 55(1):149&#x2013;164. https://doi.org/10.1021/ci500574n</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci500574n</ArticleId><ArticleId IdType="pubmed">25531792</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang XC et al (2018) Network pharmacology-based analysis of Chinese herbal Naodesheng formula for application to Alzheimer&#x2019;s disease. Chin J Nat Med 16(1):53&#x2013;62. https://doi.org/10.1016/s1875-5364(18)30029-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1875-5364(18)30029-3</ArticleId><ArticleId IdType="pubmed">29425590</ArticleId></ArticleIdList></Reference><Reference><Citation>Grisoni F et al (2019) Design of natural-product-inspired multitarget ligands by machine learning. ChemMedChem 14(12):1129&#x2013;1134. https://doi.org/10.1002/cmdc.201900097</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmdc.201900097</ArticleId><ArticleId IdType="pubmed">30973672</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson CA (2001) FDA approves galantamine for Alzheimer&#x2019;s disease. Am J Health Syst Pharm 58(8):649. https://doi.org/10.1093/ajhp/58.8.649a</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajhp/58.8.649a</ArticleId><ArticleId IdType="pubmed">11329755</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal S et al (2016) Integrating network, sequence and functional features using machine learning approaches towards identification of novel Alzheimer genes. BMC Genomics 17(1):807. https://doi.org/10.1186/s12864-016-3108-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-016-3108-1</ArticleId><ArticleId IdType="pubmed">27756223</ArticleId><ArticleId IdType="pmc">5070370</ArticleId></ArticleIdList></Reference><Reference><Citation>Exscientia announces second molecule created using AI from Sumitomo Dainippon Pharma collaboration to enter Phase 1 clinical trial. Cited 16 Sept 2021. https://www.exscientia.ai/news-insights/exscientia-second-ai-molecule-from-collaboration-in-phase1</Citation></Reference><Reference><Citation>Oh M, Ahn J, Yoon Y (2014) A network-based classification model for deriving novel drug-disease associations and assessing their molecular actions. PLoS ONE 9(10):e111668. https://doi.org/10.1371/journal.pone.0111668</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0111668</ArticleId><ArticleId IdType="pubmed">25356910</ArticleId><ArticleId IdType="pmc">4214731</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorsey ER et al (2018) The emerging evidence of the Parkinson pandemic. J Parkinsons Dis 8(s1):S3&#x2013;S8. https://doi.org/10.3233/jpd-181474</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jpd-181474</ArticleId><ArticleId IdType="pubmed">30584159</ArticleId><ArticleId IdType="pmc">6311367</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeve A, Simcox E, Turnbull D (2014) Ageing and Parkinson&#x2019;s disease: why is advancing age the biggest risk factor? Ageing Res Rev 14(100):19&#x2013;30. https://doi.org/10.1016/j.arr.2014.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2014.01.004</ArticleId><ArticleId IdType="pubmed">24503004</ArticleId><ArticleId IdType="pmc">3989046</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerri S, Mus L, Blandini F (2019) Parkinson&#x2019;s disease in women and men: what&#x2019;s the difference? J Parkinsons Dis 9(3):501&#x2013;515. https://doi.org/10.3233/jpd-191683</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jpd-191683</ArticleId><ArticleId IdType="pubmed">31282427</ArticleId><ArticleId IdType="pmc">6700650</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto M et al (2019) Boosting drug discovery for Parkinson&#x2019;s: enhancement of the delivery of a monoamine oxidase-b inhibitor by brain-targeted PEGylated polycaprolactone-based nanoparticles. Pharmaceutics. https://doi.org/10.3390/pharmaceutics11070331</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics11070331</ArticleId><ArticleId IdType="pubmed">31336891</ArticleId><ArticleId IdType="pmc">6681091</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Hardy J, Fischbeck KH (2002) Toxic proteins in neurodegenerative disease. Science 296(5575):1991&#x2013;1995. https://doi.org/10.1126/science.1067122</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1067122</ArticleId><ArticleId IdType="pubmed">12065827</ArticleId></ArticleIdList></Reference><Reference><Citation>Maclagan LC et al (2020) Identifying drugs with disease-modifying potential in Parkinson&#x2019;s disease using artificial intelligence and pharmacoepidemiology. Pharmacoepidemiol Drug Saf 29(8):864&#x2013;872. https://doi.org/10.1002/pds.5015</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.5015</ArticleId><ArticleId IdType="pubmed">32410265</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng J, Guan J, Shang X (2019) Predicting Parkinson&#x2019;s disease genes based on Node2vec and Autoencoder. Front Genet 10:226. https://doi.org/10.3389/fgene.2019.00226</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.00226</ArticleId><ArticleId IdType="pubmed">31001311</ArticleId><ArticleId IdType="pmc">6454041</ArticleId></ArticleIdList></Reference><Reference><Citation>Matarazzo M et al (2019) Remote monitoring of treatment response in Parkinson&#x2019;s disease: the habit of typing on a computer. Mov Disord 34(10):1488&#x2013;1495. https://doi.org/10.1002/mds.27772</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27772</ArticleId><ArticleId IdType="pubmed">31211469</ArticleId></ArticleIdList></Reference><Reference><Citation>Potashkin JA et al (2012) Biosignatures for Parkinson&#x2019;s disease and atypical parkinsonian disorders patients. PLoS ONE 7(8):e43595. https://doi.org/10.1371/journal.pone.0043595</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0043595</ArticleId><ArticleId IdType="pubmed">22952715</ArticleId><ArticleId IdType="pmc">3428307</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe1;radi C et al (2019) Serum N-glycosylation in Parkinson&#x2019;s disease: a novel approach for potential alterations. Molecules. https://doi.org/10.3390/molecules24122220</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24122220</ArticleId><ArticleId IdType="pubmed">31581746</ArticleId><ArticleId IdType="pmc">6804054</ArticleId></ArticleIdList></Reference><Reference><Citation>Verge genomics: employing AI to improve drug discovery (2018). Pharma Technology Focus, New York</Citation></Reference><Reference><Citation>Burik A (2018) AI is being put to work to treat Parkinson&#x2019;s disease in the UK. Labiotech.eu. https://www.labiotech.eu/trends-news/benevolent-ai-parkinsons-disease/</Citation></Reference><Reference><Citation>Yele V, Azam MA, Jupudi S (2020) Ligand-based pharmacophore modelling, in silico virtual screening, molecular docking and molecular dynamic simulation study to identify novel Francisella tularensis ParE inhibitors. Chem Pap 74(12):4567&#x2013;4580. https://doi.org/10.1007/s11696-020-01274-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11696-020-01274-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraz WR et al (2020) Ligand and structure-based virtual screening applied to the SARS-CoV-2 main protease: an in silico repurposing study. Future Med Chem 12(20):1815&#x2013;1828. https://doi.org/10.4155/fmc-2020-0165</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/fmc-2020-0165</ArticleId><ArticleId IdType="pubmed">32787684</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C et al (2020) Pharmacophore-based virtual screening toward the discovery of novel anti-echinococcal compounds. Front Cell Infect Microbiol. https://doi.org/10.3389/fcimb.2020.00118</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00118</ArticleId><ArticleId IdType="pubmed">33777826</ArticleId><ArticleId IdType="pmc">7785937</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng T et al (2012) Structure-based virtual screening for drug discovery: a problem-centric review. AAPS J 14(1):133&#x2013;141. https://doi.org/10.1208/s12248-012-9322-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/s12248-012-9322-0</ArticleId><ArticleId IdType="pubmed">22281989</ArticleId><ArticleId IdType="pmc">3282008</ArticleId></ArticleIdList></Reference><Reference><Citation>Maia EHB et al (2020) Structure-based virtual screening: from classical to artificial intelligence. Front Chem. https://doi.org/10.3389/fchem.2020.00343</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2020.00343</ArticleId><ArticleId IdType="pubmed">32411671</ArticleId><ArticleId IdType="pmc">7200080</ArticleId></ArticleIdList></Reference><Reference><Citation>Negi P, Prakash S, Patil VM (2021) Structure based drug design approach to identify potential SARS-CoV-2 polymerase inhibitors. Coronaviruses 2(4):507&#x2013;515. https://doi.org/10.2174/2666796701999201113114545</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/2666796701999201113114545</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe1;zquez J et al (2020) Merging ligand-based and structure-based methods in drug discovery: an overview of combined virtual screening approaches. Molecules 25(20):4723</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25204723</ArticleId><ArticleId IdType="pubmed">33076254</ArticleId><ArticleId IdType="pmc">7587536</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson GL, Lill MA (2011) Integrating structure-based and ligand-based approaches for computational drug design. Future Med Chem 3(6):735&#x2013;750. https://doi.org/10.4155/fmc.11.18</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/fmc.11.18</ArticleId><ArticleId IdType="pubmed">21554079</ArticleId></ArticleIdList></Reference><Reference><Citation>Sliwoski G et al (2014) Computational methods in drug discovery. Pharmacol Rev 66(1):334&#x2013;395. https://doi.org/10.1124/pr.112.007336</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.112.007336</ArticleId><ArticleId IdType="pubmed">24381236</ArticleId><ArticleId IdType="pmc">3880464</ArticleId></ArticleIdList></Reference><Reference><Citation>Klopmand G (1990) In: Johnson MA, Maggiora GM (eds) Concepts and applications of molecular similarity. Wiley, New York, p 393</Citation></Reference><Reference><Citation>Plewczynski D, Spieser SA, Koch U (2009) Performance of machine learning methods for ligand-based virtual screening. Comb Chem High Throughput Screen 12(4):358&#x2013;368. https://doi.org/10.2174/138620709788167962</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138620709788167962</ArticleId><ArticleId IdType="pubmed">19442065</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayaraj PB, Jain S (2019) Ligand based virtual screening using SVM on GPU. Comput Biol Chem 83:107143. https://doi.org/10.1016/j.compbiolchem.2019.107143</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiolchem.2019.107143</ArticleId><ArticleId IdType="pubmed">31743833</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma XH et al (2009) Comparative analysis of machine learning methods in ligand-based virtual screening of large compound libraries. Comb Chem High Throughput Screen 12(4):344&#x2013;357. https://doi.org/10.2174/138620709788167944</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138620709788167944</ArticleId><ArticleId IdType="pubmed">19442064</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukunishi Y (2009) Structure-based drug screening and ligand-based drug screening with machine learning. Comb Chem High Throughput Screen 12(4):397&#x2013;408. https://doi.org/10.2174/138620709788167890</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138620709788167890</ArticleId><ArticleId IdType="pubmed">19442067</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintus F et al (2009) Ligand scaffold hopping combining 3D maximal substructure search and molecular similarity. BMC Bioinformatics 10:245. https://doi.org/10.1186/1471-2105-10-245</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-10-245</ArticleId><ArticleId IdType="pubmed">19671127</ArticleId><ArticleId IdType="pmc">2739202</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain AN (2004) Ligand-based structural hypotheses for virtual screening. J Med Chem 47(4):947&#x2013;961. https://doi.org/10.1021/jm030520f</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm030520f</ArticleId><ArticleId IdType="pubmed">14761196</ArticleId></ArticleIdList></Reference><Reference><Citation>Briard JG et al (2016) QSAR accelerated discovery of potent ice recrystallization inhibitors. Sci Rep 6:26403. https://doi.org/10.1038/srep26403</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep26403</ArticleId><ArticleId IdType="pubmed">27216585</ArticleId><ArticleId IdType="pmc">4877635</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R et al (2015) An in silico platform for predicting, screening and designing of antihypertensive peptides. Sci Rep 5:12512. https://doi.org/10.1038/srep12512</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep12512</ArticleId><ArticleId IdType="pubmed">26213115</ArticleId><ArticleId IdType="pmc">4515604</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T et al (2015) Quantitative structure&#x2013;activity relationship: promising advances in drug discovery platforms. Expert Opin Drug Discov 10(12):1283&#x2013;1300. https://doi.org/10.1517/17460441.2015.1083006</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/17460441.2015.1083006</ArticleId><ArticleId IdType="pubmed">26358617</ArticleId></ArticleIdList></Reference><Reference><Citation>Geanes AR et al (2016) Ligand-based virtual screen for the discovery of novel M5 inhibitor chemotypes. Bioorg Med Chem Lett 26(18):4487&#x2013;4491. https://doi.org/10.1016/j.bmcl.2016.07.071</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2016.07.071</ArticleId><ArticleId IdType="pubmed">27503678</ArticleId><ArticleId IdType="pmc">4996684</ArticleId></ArticleIdList></Reference><Reference><Citation>Myint KZ et al (2012) Molecular fingerprint-based artificial neural networks QSAR for ligand biological activity predictions. Mol Pharm 9(10):2912&#x2013;2923. https://doi.org/10.1021/mp300237z</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/mp300237z</ArticleId><ArticleId IdType="pubmed">22937990</ArticleId><ArticleId IdType="pmc">3462244</ArticleId></ArticleIdList></Reference><Reference><Citation>Patra JC, Chua BH (2011) Artificial neural network-based drug design for diabetes mellitus using flavonoids. J Comput Chem 32(4):555&#x2013;567. https://doi.org/10.1002/jcc.21641</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.21641</ArticleId><ArticleId IdType="pubmed">20806262</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu L, Chen G, Chau RM (2006) A neural networks-based drug discovery approach and its application for designing aldose reductase inhibitors. J Mol Graph Model 24(4):244&#x2013;253. https://doi.org/10.1016/j.jmgm.2005.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmgm.2005.09.002</ArticleId><ArticleId IdType="pubmed">16226911</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatri N, Lather V, Madan AK (2014) Diverse classification models for anti-hepatitis C virus activity of thiourea derivatives. Chemom Intell Lab Syst. https://doi.org/10.1016/j.chemolab.2014.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chemolab.2014.10.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrent M et al (2011) Connecting peptide physicochemical and antimicrobial properties by a rational prediction model. PLoS ONE 6(2):e16968. https://doi.org/10.1371/journal.pone.0016968</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0016968</ArticleId><ArticleId IdType="pubmed">21347392</ArticleId><ArticleId IdType="pmc">3036733</ArticleId></ArticleIdList></Reference><Reference><Citation>Fjell CD et al (2009) Identification of novel antibacterial peptides by chemoinformatics and machine learning. J Med Chem 52(7):2006&#x2013;2015. https://doi.org/10.1021/jm8015365</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm8015365</ArticleId><ArticleId IdType="pubmed">19296598</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabet R et al (2012) Computer-aided design of novel antibacterial 3-hydroxypyridine-4-ones: application of QSAR methods based on the MOLMAP approach. J Comput Aided Mol Des 26(3):349&#x2013;361. https://doi.org/10.1007/s10822-012-9561-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10822-012-9561-2</ArticleId><ArticleId IdType="pubmed">22456859</ArticleId></ArticleIdList></Reference><Reference><Citation>Douali L, Villemin D, Cherqaoui D (2003) Neural networks: Accurate nonlinear QSAR model for HEPT derivatives. J Chem Inf Comput Sci 43(4):1200&#x2013;1207. https://doi.org/10.1021/ci034047q</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci034047q</ArticleId><ArticleId IdType="pubmed">12870912</ArticleId></ArticleIdList></Reference><Reference><Citation>Murcia-Soler M et al (2004) Artificial neural networks and linear discriminant analysis: a valuable combination in the selection of new antibacterial compounds. J Chem Inf Comput Sci 44(3):1031&#x2013;1041. https://doi.org/10.1021/ci030340e</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci030340e</ArticleId><ArticleId IdType="pubmed">15154772</ArticleId></ArticleIdList></Reference><Reference><Citation>AbdulHameed MD, Ippolito DL, Wallqvist A (2016) Predicting rat and human pregnane X receptor activators using Bayesian classification models. Chem Res Toxicol 29(10):1729&#x2013;1740. https://doi.org/10.1021/acs.chemrestox.6b00227</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrestox.6b00227</ArticleId><ArticleId IdType="pubmed">27603675</ArticleId></ArticleIdList></Reference><Reference><Citation>Renault N et al (2013) Virtual screening of CB(2) receptor agonists from Bayesian network and high-throughput docking: structural insights into agonist-modulated GPCR features. Chem Biol Drug Des 81(4):442&#x2013;454. https://doi.org/10.1111/cbdd.12095</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cbdd.12095</ArticleId><ArticleId IdType="pubmed">23217060</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh N et al (2012) QSAR classification model for antibacterial compounds and its use in virtual screening. J Chem Inf Model 52(10):2559&#x2013;2569. https://doi.org/10.1021/ci300336v</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci300336v</ArticleId><ArticleId IdType="pubmed">23013546</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L-l et al (2014) Novel Bayesian classification models for predicting compounds blocking hERG potassium channels. Acta Pharmacol Sin 35(8):1093&#x2013;1102. https://doi.org/10.1038/aps.2014.35</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2014.35</ArticleId><ArticleId IdType="pubmed">24976154</ArticleId><ArticleId IdType="pmc">4125710</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan RSK et al (2009) Combinatorial library enumeration and lead hopping using comparative interaction fingerprint analysis and classical 2D QSAR methods for seeking novel GABAA &#x3b1;3 modulators. J Chem Inf Model 49(11):2498&#x2013;2511. https://doi.org/10.1021/ci900309s</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci900309s</ArticleId><ArticleId IdType="pubmed">19891421</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekins S et al (2013) Bayesian models leveraging bioactivity and cytotoxicity information for drug discovery. Chem Biol 20(3):370&#x2013;378. https://doi.org/10.1016/j.chembiol.2013.01.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2013.01.011</ArticleId><ArticleId IdType="pubmed">23521795</ArticleId><ArticleId IdType="pmc">3607962</ArticleId></ArticleIdList></Reference><Reference><Citation>Prathipati P, Ma NL, Keller TH (2008) Global Bayesian models for the prioritization of antitubercular agents. J Chem Inf Model 48(12):2362&#x2013;2370. https://doi.org/10.1021/ci800143n</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci800143n</ArticleId><ArticleId IdType="pubmed">19053518</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender A, Mussa HY, Glen RC (2005) Screening for dihydrofolate reductase inhibitors using MOLPRINT 2D, a fast fragment-based method employing the na&#xef;ve Bayesian classifier: limitations of the descriptor and the importance of balanced chemistry in training and test sets. J Biomol Screen 10(7):658&#x2013;666. https://doi.org/10.1177/1087057105281048</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1087057105281048</ArticleId><ArticleId IdType="pubmed">16170051</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia X et al (2004) Classification of kinase inhibitors using a Bayesian model. J Med Chem 47(18):4463&#x2013;4470. https://doi.org/10.1021/jm0303195</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm0303195</ArticleId><ArticleId IdType="pubmed">15317458</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JJ, Visco DP (2017) Identifying novel factor XIIa inhibitors with PCA-GA-SVM developed vHTS models. Eur J Med Chem 140:31&#x2013;41</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2017.08.056</ArticleId><ArticleId IdType="pubmed">28918098</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JJ, Visco DP (2017) Developing an in silico pipeline for faster drug candidate discovery: virtual high throughput screening with the Signature molecular descriptor using support vector machine models. Chem Engg Sci 159:31&#x2013;42</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ces.2016.02.037</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, Bagui S, Bagui S (2017) Improving virtual screening predictive accuracy of Human kallikrein 5 inhibitors using machine learning models. Comput Biol Chem 69:110&#x2013;119. https://doi.org/10.1016/j.compbiolchem.2017.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiolchem.2017.05.007</ArticleId><ArticleId IdType="pubmed">28601761</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakharov AV et al (2016) QSAR Modeling and prediction of drug&#x2013;drug interactions. Mol Pharm 13(2):545&#x2013;556. https://doi.org/10.1021/acs.molpharmaceut.5b00762</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.molpharmaceut.5b00762</ArticleId><ArticleId IdType="pubmed">26669717</ArticleId></ArticleIdList></Reference><Reference><Citation>Svetnik V et al (2003) Random forest: a classification and regression tool for compound classification and QSAR modeling. J Chem Inf Comput Sci 43(6):1947&#x2013;1958. https://doi.org/10.1021/ci034160g</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci034160g</ArticleId><ArticleId IdType="pubmed">14632445</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J et al (2015) Deep neural nets as a method for quantitative structure&#x2013;activity relationships. J Chem Inf Model 55(2):263&#x2013;274. https://doi.org/10.1021/ci500747n</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci500747n</ArticleId><ArticleId IdType="pubmed">25635324</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin EJ et al (2017) Profile-QSAR 2.0: kinase virtual screening accuracy comparable to four-concentration IC(50)s for realistically novel compounds. J Chem Inf Model 57(8):2077&#x2013;2088. https://doi.org/10.1021/acs.jcim.7b00166</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.7b00166</ArticleId><ArticleId IdType="pubmed">28651433</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamsara J (2019) A random forest model to predict the activity of a large set of soluble epoxide hydrolase inhibitors solely based on a set of simple fragmental descriptors. Comb Chem High Throughput Screen 22(8):555&#x2013;569. https://doi.org/10.2174/1386207322666191016110232</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1386207322666191016110232</ArticleId><ArticleId IdType="pubmed">31622216</ArticleId></ArticleIdList></Reference><Reference><Citation>Simeon S, Jongkon N (2019) Construction of quantitative structure activity relationship (QSAR) models to predict potency of structurally diversed Janus kinase 2 inhibitors. Molecules. https://doi.org/10.3390/molecules24234393</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24234393</ArticleId><ArticleId IdType="pubmed">31805692</ArticleId><ArticleId IdType="pmc">6930640</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchese Robinson RL et al (2017) Comparison of the predictive performance and interpretability of random forest and linear models on benchmark data sets. J Chem Inf Model 57(8):1773&#x2013;1792. https://doi.org/10.1021/acs.jcim.6b00753</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.6b00753</ArticleId><ArticleId IdType="pubmed">28715209</ArticleId></ArticleIdList></Reference><Reference><Citation>Speck-Planche A, Kleandrova VV, Cordeiro MN (2013) New insights toward the discovery of antibacterial agents: multi-tasking QSBER model for the simultaneous prediction of anti-tuberculosis activity and toxicological profiles of drugs. Eur J Pharm Sci 48(4&#x2013;5):812&#x2013;818. https://doi.org/10.1016/j.ejps.2013.01.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejps.2013.01.011</ArticleId><ArticleId IdType="pubmed">23376211</ArticleId></ArticleIdList></Reference><Reference><Citation>Speck-Planche A, Cordeiro MN (2013) Simultaneous modeling of antimycobacterial activities and ADMET profiles: a chemoinformatic approach to medicinal chemistry. Curr Top Med Chem 13(14):1656&#x2013;1665. https://doi.org/10.2174/15680266113139990116</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/15680266113139990116</ArticleId><ArticleId IdType="pubmed">23889052</ArticleId></ArticleIdList></Reference><Reference><Citation>Speck-Planche A, Cordeiro MN (2014) Simultaneous virtual prediction of anti-Escherichia coli activities and ADMET profiles: a chemoinformatic complementary approach for high-throughput screening. ACS Comb Sci 16(2):78&#x2013;84. https://doi.org/10.1021/co400115s</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/co400115s</ArticleId><ArticleId IdType="pubmed">24383958</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleandrova VV et al (2016) Enabling the discovery and virtual screening of potent and safe antimicrobial peptides. Simultaneous prediction of antibacterial activity and cytotoxicity. ACS Comb Sci 18(8):490&#x2013;498. https://doi.org/10.1021/acscombsci.6b00063</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscombsci.6b00063</ArticleId><ArticleId IdType="pubmed">27280735</ArticleId></ArticleIdList></Reference><Reference><Citation>Speck-Planche A, Dias Soeiro Cordeiro MN (2017) Speeding up early drug discovery in antiviral research: a fragment-based in silico approach for the design of virtual anti-hepatitis C leads. ACS Comb Sci 19(8):501&#x2013;512. https://doi.org/10.1021/acscombsci.7b00039</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscombsci.7b00039</ArticleId><ArticleId IdType="pubmed">28437091</ArticleId></ArticleIdList></Reference><Reference><Citation>Vi&#xf1;a D et al (2009) Alignment-free prediction of a drug&#x2013;target complex network based on parameters of drug connectivity and protein sequence of receptors. Mol Pharm 6(3):825&#x2013;835. https://doi.org/10.1021/mp800102c</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/mp800102c</ArticleId><ArticleId IdType="pubmed">19281186</ArticleId></ArticleIdList></Reference><Reference><Citation>Speck-Planche A et al (2012) Chemoinformatics in multi-target drug discovery for anti-cancer therapy: in silico design of potent and versatile anti-brain tumor agents. Anticancer Agents Med Chem 12(6):678&#x2013;685. https://doi.org/10.2174/187152012800617722</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152012800617722</ArticleId><ArticleId IdType="pubmed">22043995</ArticleId></ArticleIdList></Reference><Reference><Citation>Speck-Planche A, Cordeiro M (2017) Fragment-based in silico modeling of multi-target inhibitors against breast cancer-related proteins. Mol Divers 21(3):511&#x2013;523. https://doi.org/10.1007/s11030-017-9731-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11030-017-9731-1</ArticleId><ArticleId IdType="pubmed">28194627</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahl GE et al (2021) Multi-task neural networks for QSAR predictions. arXiv:1406.1231</Citation></Reference><Reference><Citation>Zakharov AV et al (2019) Novel consensus architecture to improve performance of large-scale multitask deep learning QSAR models. J Chem Inf Model 59(11):4613&#x2013;4624. https://doi.org/10.1021/acs.jcim.9b00526</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.9b00526</ArticleId><ArticleId IdType="pubmed">31584270</ArticleId><ArticleId IdType="pmc">8381874</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon S et al (2019) Comprehensive ensemble in QSAR prediction for drug discovery. BMC Bioinformatics 20(1):521. https://doi.org/10.1186/s12859-019-3135-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-019-3135-4</ArticleId><ArticleId IdType="pubmed">31655545</ArticleId><ArticleId IdType="pmc">6815455</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu SH et al (2018) Bayesian varying coefficient kernel machine regression to assess neurodevelopmental trajectories associated with exposure to complex mixtures. Stat Med 37(30):4680&#x2013;4694. https://doi.org/10.1002/sim.7947</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.7947</ArticleId><ArticleId IdType="pubmed">30277584</ArticleId><ArticleId IdType="pmc">6522130</ArticleId></ArticleIdList></Reference><Reference><Citation>Maric NP et al (2016) Improving current treatments for schizophrenia. Drug Dev Res 77(7):357&#x2013;367. https://doi.org/10.1002/ddr.21337</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ddr.21337</ArticleId><ArticleId IdType="pubmed">27633376</ArticleId></ArticleIdList></Reference><Reference><Citation>Marunnan SM et al (2017) Development of MLR and SVM aided QSAR models to identify common SAR of GABA uptake herbal inhibitors used in the treatment of schizophrenia. Curr Neuropharmacol 15(8):1085&#x2013;1092. https://doi.org/10.2174/1567201814666161205131745</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567201814666161205131745</ArticleId><ArticleId IdType="pubmed">27919211</ArticleId><ArticleId IdType="pmc">5725540</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu KC, Wang FS (2017) Model-based optimization approaches for precision medicine: a case study in presynaptic dopamine overactivity. PLoS ONE 12(6):e0179575. https://doi.org/10.1371/journal.pone.0179575</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179575</ArticleId><ArticleId IdType="pubmed">28614410</ArticleId><ArticleId IdType="pmc">5470743</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo M et al (2014) Application of quantitative structure-activity relationship models of 5-HT1A receptor binding to virtual screening identifies novel and potent 5-HT1A ligands. J Chem Inf Model 54(2):634&#x2013;647. https://doi.org/10.1021/ci400460q</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci400460q</ArticleId><ArticleId IdType="pubmed">24410373</ArticleId><ArticleId IdType="pmc">3985444</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo M, Reid TE, Wang XS (2015) Discovery of natural product-derived 5-HT1A receptor binders by cheminfomatics modeling of known binders, high throughput screening and experimental validation. Comb Chem High Throughput Screen 18(7):685&#x2013;692. https://doi.org/10.2174/1386207318666150703113948</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1386207318666150703113948</ArticleId><ArticleId IdType="pubmed">26138565</ArticleId><ArticleId IdType="pmc">4667780</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan X et al (2020) Automated design and optimization of multitarget schizophrenia drug candidates by deep learning. Eur J Med Chem 204:112572. https://doi.org/10.1016/j.ejmech.2020.112572</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2020.112572</ArticleId><ArticleId IdType="pubmed">32711293</ArticleId></ArticleIdList></Reference><Reference><Citation>Jebapriya S et al (2019) Support vector machine for classification of autism spectrum disorder based on abnormal structure of corpus callosum. Int J Adv Comput Sci Appl. https://doi.org/10.14569/IJACSA.2019.0100965</Citation><ArticleIdList><ArticleId IdType="doi">10.14569/IJACSA.2019.0100965</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrielsen M et al (2014) Identification of novel serotonin transporter compounds by virtual screening. J Chem Inf Model 54(3):933&#x2013;943. https://doi.org/10.1021/ci400742s</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci400742s</ArticleId><ArticleId IdType="pubmed">24521202</ArticleId><ArticleId IdType="pmc">3982395</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;ber S et al (2011) Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates. Trends Pharmacol Sci 32(3):148&#x2013;157. https://doi.org/10.1016/j.tips.2010.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2010.12.003</ArticleId><ArticleId IdType="pubmed">21232805</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibley DR, Monsma FJ Jr (1992) Molecular biology of dopamine receptors. Trends Pharmacol Sci 13(2):61&#x2013;69. https://doi.org/10.1016/0165-6147(92)90025-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-6147(92)90025-2</ArticleId><ArticleId IdType="pubmed">1561715</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson MM et al (1999) Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments. Mol Pharmacol 56(6):1116&#x2013;1126. https://doi.org/10.1124/mol.56.6.1116</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.56.6.1116</ArticleId><ArticleId IdType="pubmed">10570038</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q et al (2010) Subtype selectivity of dopamine receptor ligands: insights from structure and ligand-based methods. J Chem Inf Model 50(11):1970&#x2013;1985. https://doi.org/10.1021/ci1002747</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci1002747</ArticleId><ArticleId IdType="pubmed">20936866</ArticleId><ArticleId IdType="pmc">4022043</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez L et al (2010) Synthesis, 3D-QSAR, and structural modeling of benzolactam derivatives with binding affinity for the D2 and D3 receptors. ChemMedChem 5(8):1300&#x2013;1317. https://doi.org/10.1002/cmdc.201000101</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmdc.201000101</ArticleId><ArticleId IdType="pubmed">20544783</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho DI, Zheng M, Kim KM (2010) Current perspectives on the selective regulation of dopamine D<sub>2</sub> and D<sub>3</sub> receptors. Arch Pharm Res 33(10):1521&#x2013;1538. https://doi.org/10.1007/s12272-010-1005-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12272-010-1005-8</ArticleId><ArticleId IdType="pubmed">21052931</ArticleId></ArticleIdList></Reference><Reference><Citation>Carro L et al (2009) Synthesis and binding affinity of potential atypical antipsychotics with the tetrahydroquinazolinone motif. Bioorg Med Chem Lett 19(21):6059&#x2013;6062. https://doi.org/10.1016/j.bmcl.2009.09.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2009.09.041</ArticleId><ArticleId IdType="pubmed">19796944</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber D, H&#xfc;bner H, Gmeiner P (2009) 1,1&#x2019;-Disubstituted ferrocenes as molecular hinges in mono- and bivalent dopamine receptor ligands. J Med Chem 52(21):6860&#x2013;6870. https://doi.org/10.1021/jm901120h</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm901120h</ArticleId><ArticleId IdType="pubmed">19807103</ArticleId></ArticleIdList></Reference><Reference><Citation>Han LY et al (2008) A support vector machines approach for virtual screening of active compounds of single and multiple mechanisms from large libraries at an improved hit-rate and enrichment factor. J Mol Graph Model 26(8):1276&#x2013;1286. https://doi.org/10.1016/j.jmgm.2007.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmgm.2007.12.002</ArticleId><ArticleId IdType="pubmed">18218332</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H et al (2007) Machine learning approaches for predicting compounds that interact with therapeutic and ADMET related proteins. J Pharm Sci 96(11):2838&#x2013;2860. https://doi.org/10.1002/jps.20985</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jps.20985</ArticleId><ArticleId IdType="pubmed">17786989</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahe P, Vert J-P (2009) Virtual screening with support vector machines and structure kernels. Comb Chem High Throughput Screen 12(4):409&#x2013;423. https://doi.org/10.2174/138620709788167926</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138620709788167926</ArticleId><ArticleId IdType="pubmed">19442068</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha MY et al (2003) QSAR studies on piperazinylalkylisoxazole analogues selectively acting on dopamine D3 receptor by HQSAR and CoMFA. Bioorg Med Chem Lett 11:1293&#x2013;1298. https://doi.org/10.1016/s0968-0896(02)00617-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0968-0896(02)00617-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Audouze K, Nielsen E, Peters D (2004) New series of morpholine and 1,4-oxazepane derivatives as dopamine D4 receptor ligands: synthesis and 3D-QSAR model. J Med Chem 47(12):3089&#x2013;3104. https://doi.org/10.1021/jm031111m</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm031111m</ArticleId><ArticleId IdType="pubmed">15163190</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark R, Abrahamian E (2008) Using a staged multi-objective optimization approach to find selective pharmacophore models. J Comp Aided Mol Design 23:765&#x2013;771. https://doi.org/10.1007/s10822-008-9227-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10822-008-9227-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Salama I et al (2007) Structure&#x2013;selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands. J Med Chem 50(3):489&#x2013;500. https://doi.org/10.1021/jm0611152</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm0611152</ArticleId><ArticleId IdType="pubmed">17266201</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J et al (2012) A two-step target binding and selectivity support vector machines approach for virtual screening of dopamine receptor subtype-selective ligands. PLoS ONE 7(6):e39076. https://doi.org/10.1371/journal.pone.0039076</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039076</ArticleId><ArticleId IdType="pubmed">22720033</ArticleId><ArticleId IdType="pmc">3376116</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsoumakas GK, Vlahavas I (2010) Mining multi-label data. In: Maimon O, Rokach L (eds) Data mining and knowledge discovery handbook. Springer, New York, pp 667&#x2013;685</Citation></Reference><Reference><Citation>Ma XH et al (2010) Virtual screening of selective multitarget kinase inhibitors by combinatorial support vector machines. Mol Pharm 7(5):1545&#x2013;1560. https://doi.org/10.1021/mp100179t</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/mp100179t</ArticleId><ArticleId IdType="pubmed">20712327</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsoumakas G, Katakis I (2007) Multi-label classification: an overview. Int J Data Warehousing Min (IJDWM) 3(3):1&#x2013;13</Citation><ArticleIdList><ArticleId IdType="doi">10.4018/jdwm.2007070101</ArticleId></ArticleIdList></Reference><Reference><Citation>Schietgat L et al (2010) Predicting gene function using hierarchical multi-label decision tree ensembles. BMC Bioinformatics 11(1):2. https://doi.org/10.1186/1471-2105-11-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-11-2</ArticleId><ArticleId IdType="pubmed">20044933</ArticleId><ArticleId IdType="pmc">2824675</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeckler F, Gmeiner P (2006) The structural evolution of dopamine D3 receptor ligands: structure&#x2013;activity relationships and selected neuropharmacological aspects. Pharmacol Ther 112(1):281&#x2013;333. https://doi.org/10.1016/j.pharmthera.2006.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2006.04.007</ArticleId><ArticleId IdType="pubmed">16905195</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J et al (2009) Dopamine D1 receptor ligands: where are we now and where are we going. Med Res Rev 29(2):272&#x2013;294. https://doi.org/10.1002/med.20130</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.20130</ArticleId><ArticleId IdType="pubmed">18642350</ArticleId></ArticleIdList></Reference><Reference><Citation>Herm L et al (2009) N-Substituted-2-alkyl- and 2-arylnorapomorphines: novel, highly active D-2 agonists. Bioorg Med Chem 17:4756&#x2013;4762. https://doi.org/10.1016/j.bmc.2009.04.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2009.04.047</ArticleId><ArticleId IdType="pubmed">19454369</ArticleId></ArticleIdList></Reference><Reference><Citation>Gueiffier C, Gueiffier A (2006) Recent progress in medicinal chemistry of D-4 Agonists. Curr Med Chem 13:2981&#x2013;2993. https://doi.org/10.2174/092986706778521841</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986706778521841</ArticleId><ArticleId IdType="pubmed">17073641</ArticleId></ArticleIdList></Reference><Reference><Citation>Overington J (2009) ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). Interview by Wendy A. Warr. J Comput Aided Mol Des 23(4):195&#x2013;198. https://doi.org/10.1007/s10822-009-9260-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10822-009-9260-9</ArticleId><ArticleId IdType="pubmed">19194660</ArticleId></ArticleIdList></Reference><Reference><Citation>Durrant JD, McCammon JA (2010) Computer-aided drug-discovery techniques that account for receptor flexibility. Curr Opin Pharmacol 10(6):770&#x2013;774. https://doi.org/10.1016/j.coph.2010.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2010.09.001</ArticleId><ArticleId IdType="pubmed">20888294</ArticleId><ArticleId IdType="pmc">3026641</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H (2008) Pharmacophore-based virtual screening. Curr Med Chem 15(10):1018&#x2013;1024. https://doi.org/10.2174/092986708784049630</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986708784049630</ArticleId><ArticleId IdType="pubmed">18393859</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprous DG et al (2010) QSAR in the pharmaceutical research setting: QSAR models for broad, large problems. Curr Top Med Chem 10(6):619&#x2013;637. https://doi.org/10.2174/156802610791111506</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156802610791111506</ArticleId><ArticleId IdType="pubmed">20337590</ArticleId></ArticleIdList></Reference><Reference><Citation>Willett P (2011) Similarity searching using 2D structural fingerprints. Methods Mol Biol 672:133&#x2013;158. https://doi.org/10.1007/978-1-60761-839-3_5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-60761-839-3_5</ArticleId><ArticleId IdType="pubmed">20838967</ArticleId></ArticleIdList></Reference><Reference><Citation>Talevi A et al (2009) Combined virtual screening strategies. Curr Comput Aided Drug Des 5(1):23&#x2013;37. https://doi.org/10.2174/157340909787580854</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157340909787580854</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulp J et al (2018) Structural insights of benzenesulfonamide analogues as NLRP3 inflammasome inhibitors: design, synthesis, and biological characterization. J Med Chem 61(12):5412&#x2013;5423. https://doi.org/10.1021/acs.jmedchem.8b00733</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.8b00733</ArticleId><ArticleId IdType="pubmed">29877709</ArticleId><ArticleId IdType="pmc">6225534</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z-D et al (2020) A novel artificial intelligence protocol to investigate potential leads for Parkinson&#x2019;s disease. RSC Adv 10(39):22939&#x2013;22958. https://doi.org/10.1039/D0RA04028B</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D0RA04028B</ArticleId><ArticleId IdType="pubmed">35520357</ArticleId><ArticleId IdType="pmc">9054719</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedaie A, Najafi AA (2018) Support vector machine with Dirichlet feature mapping. Neural Netw 98:87&#x2013;101. https://doi.org/10.1016/j.neunet.2017.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neunet.2017.11.006</ArticleId><ArticleId IdType="pubmed">29223012</ArticleId></ArticleIdList></Reference><Reference><Citation>Speybroeck N (2012) Classification and regression trees. Int J Public Health 57(1):243&#x2013;246. https://doi.org/10.1007/s00038-011-0315-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00038-011-0315-z</ArticleId><ArticleId IdType="pubmed">22015650</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter KA, Huang X (2018) Machine learning-based virtual screening and its applications to Alzheimer&#x2019;s drug discovery: a review. Curr Pharm Des 24(28):3347&#x2013;3358. https://doi.org/10.2174/1381612824666180607124038</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612824666180607124038</ArticleId><ArticleId IdType="pubmed">29879881</ArticleId><ArticleId IdType="pmc">6327115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Srivastava G, Sharma A (2017) A physicochemical descriptor based method for effective and rapid screening of dual inhibitors against BACE-1 and GSK-3&#x3b2; as targets for Alzheimer&#x2019;s disease. Comput Biol Chem 71:1&#x2013;9. https://doi.org/10.1016/j.compbiolchem.2017.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiolchem.2017.09.001</ArticleId><ArticleId IdType="pubmed">28950235</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y et al (2015) Discovery of new acetylcholinesterase inhibitors with small core structures through shape-based virtual screening. Bioorg Med Chem Lett 25(17):3442&#x2013;3446. https://doi.org/10.1016/j.bmcl.2015.07.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2015.07.026</ArticleId><ArticleId IdType="pubmed">26212777</ArticleId></ArticleIdList></Reference><Reference><Citation>Masand N et al (2015) Heterocyclic secretase inhibitors for the treatment of Alzheimer&#x2019;s disease: an overview. Cent Nerv Syst Agents Med Chem 17(1):3&#x2013;25. https://doi.org/10.2174/1570159X13666151029105752</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X13666151029105752</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta SP, Patil VM (2020) Recent studies on design and development of drugs against Alzheimer&#x2019;s disease (AD) based on inhibition of BACE-1 and other AD-causative agents. Curr Top Med Chem 20(13):1195&#x2013;1213. https://doi.org/10.2174/1568026620666200416091623</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026620666200416091623</ArticleId><ArticleId IdType="pubmed">32297584</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhardwaj M et al (2019) Anti-acetylcholinesterase derivatives: a privileged structural framework in drug discovery to treat Alzheimer&#x2019;s disease. Curr Enzyme Inhibition 15:8&#x2013;21. https://doi.org/10.2174/1573407215666190111150241</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573407215666190111150241</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambure P et al (2019) Identifying natural compounds as multi-target-directed ligands against Alzheimer&#x2019;s disease: an in silico approach. J Biomol Struct Dyn 37(5):1282&#x2013;1306. https://doi.org/10.1080/07391102.2018.1456975</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2018.1456975</ArticleId><ArticleId IdType="pubmed">29578387</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35797987</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1758-5341</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>24</Day></PubDate></JournalIssue><Title>The Gerontologist</Title><ISOAbbreviation>Gerontologist</ISOAbbreviation></Journal><ArticleTitle>"It's You": Caregiver and Clinician Perspectives on Lucidity in People Living With Dementia.</ArticleTitle><Pagination><StartPage>13</StartPage><EndPage>27</EndPage><MedlinePgn>13-27</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/geront/gnac095</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">Episodes of lucidity (ELs), or a transient return of abilities believed to be lost in people living with dementia, are a growing area of interest. These events hold important implications for care, caregiving, and our understanding of underlying etiologies. Research on ELs is largely limited to retrospective reports. The perspectives of professional and family caregivers on ELs and research approaches can inform efforts to define and study lucidity. The present study examined family caregiver and hospice clinician experiences with and perspectives on ELs in people living with dementia and observational approaches to studying these events.</AbstractText><AbstractText Label="RESEARCH DESIGN AND METHODS">This exploratory, descriptive qualitative study employed semistructured interviews (N = 20 caregivers, N = 6 clinicians). Data were analyzed using Rapid Identification of Themes and subsequent duplicate review of interview data to enhance trustworthiness.</AbstractText><AbstractText Label="RESULTS">Most participants readily recalled events they perceived as ELs, describing a transient return of abilities they felt was significant and/or meaningful. Defining features, interpretations, and the perceived impact of ELs varied, although ELs were commonly conceptualized as a manifestation of self. Caregivers described extensive efforts to detect patterns and supportive social conditions for ELs. Participants supported use of audiovisual observation to study ELs and provided recommendations for privacy, workflow, and caregiver engagement.</AbstractText><AbstractText Label="DISCUSSION AND IMPLICATIONS">Interpretations of ELs are heterogeneous, and recognition of these events may necessitate close familiarity with the person living with dementia. Participants endorse observational approaches and integration of caregivers in this research.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gilmore-Bykovskyi</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4930-3558</Identifier><AffiliationInfo><Affiliation>BerbeeWalsh, Department of Emergency Medicine, University of Wisconsin-Madison School of Medicine &amp; Public Health, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health Disparities Research, University of Wisconsin-Madison School of Medicine &amp; Public Health, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Block</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>BerbeeWalsh, Department of Emergency Medicine, University of Wisconsin-Madison School of Medicine &amp; Public Health, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benson</LastName><ForeName>Clark</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>BerbeeWalsh, Department of Emergency Medicine, University of Wisconsin-Madison School of Medicine &amp; Public Health, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fehland</LastName><ForeName>Jess</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>BerbeeWalsh, Department of Emergency Medicine, University of Wisconsin-Madison School of Medicine &amp; Public Health, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Botsch</LastName><ForeName>Meghan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>BerbeeWalsh, Department of Emergency Medicine, University of Wisconsin-Madison School of Medicine &amp; Public Health, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mueller</LastName><ForeName>Kimberly D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Department of Communication Sciences and Disorders, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Werner</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-2363-9491</Identifier><AffiliationInfo><Affiliation>Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Mindy J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Medicine Division of Geriatrics, University of Wisconsin-Madison School of Medicine &amp; Public Health, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 AG069827</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R33 AG069827</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gerontologist</MedlineTA><NlmUniqueID>0375327</NlmUniqueID><ISSNLinking>0016-9013</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Caregiving&#x2014;informal</Keyword><Keyword MajorTopicYN="N">Episodes of lucidity</Keyword><Keyword MajorTopicYN="N">Paradoxical lucidity</Keyword><Keyword MajorTopicYN="N">Qualitative research methods</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>7</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35797987</ArticleId><ArticleId IdType="pmc">PMC10091484</ArticleId><ArticleId IdType="doi">10.1093/geront/gnac095</ArticleId><ArticleId IdType="pii">6633668</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>D&#x2019;cruz, M. M. (2021). Does Alice live here anymore? Autonomy and identity in persons living and dying with dementia. Frontiers in Psychiatry, 12, 700567. doi:10.3389/fpsyt.2021.700567</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.700567</ArticleId><ArticleId IdType="pmc">PMC8339882</ArticleId><ArticleId IdType="pubmed">34366930</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilmore-Bykovskyi, A., Block, L., Benson, C., &amp; Griffin, J. M. (2021a). The importance of conceptualizing and defining episodes of lucidity. Journal of Gerontological Nursing, 47(4), 5. doi:10.3928/00989134-20210326-01</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/00989134-20210326-01</ArticleId><ArticleId IdType="pubmed">34038253</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilmore-Bykovskyi, A. L., Griffin, J. M., Mueller, K. D., Parnia, S., &amp; Kolanowski, A. (2022). Toward harmonization of strategies for investigating lucidity in AD/ADRD: A preliminary research framework. Alzheimers &amp; Dementia. Advance online publication. doi:10.1002/alz.12709</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12709</ArticleId><ArticleId IdType="pmc">PMC9792622</ArticleId><ArticleId IdType="pubmed">35757902</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilmore-Bykovskyi, A. L., Mueller, K., Werner, N., Block, L., Smith E., &amp; Benson, C. (2021b). Characterizing episodes of lucidity in dementia. Symposium presentation at the 2021 Gerontological Society of America Annual Meeting, Phoenix, AZ.</Citation></Reference><Reference><Citation>Gilmore-Bykovskyi, A. L., Roberts, T. J., Bowers, B. J., &amp; Brown, R. L. (2015). Caregiver person-centeredness and behavioral symptoms in nursing home residents with dementia: A timed-event sequential analysis. The Gerontologist, 55(Suppl. 1), S61&#x2013;S66. doi:10.1093/geront/gnu164</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnu164</ArticleId><ArticleId IdType="pmc">PMC4492066</ArticleId><ArticleId IdType="pubmed">26055782</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, D.E., Sagong, H., Kim, E., Jang, A.R., &amp; Yoon, J.Y. (2019). A systematic review of studies using video-recording to capture interactions between staff and persons with dementia in long-term care facilities. Journal of Korean Academy of Community Health Nursing, 30(4), 400&#x2013;413. 10.12799/jkachn.2019.30.4.400</Citation><ArticleIdList><ArticleId IdType="doi">10.12799/jkachn.2019.30.4.400</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, D. R., McKeith, I., Mosimann, U., Ghosh-Nodial, A., Grayson, L., Wilson, B., &amp; Thomas, A. J. (2014). The dementia cognitive fluctuation scale, a new psychometric test for clinicians to identify cognitive fluctuations in people with dementia. The American Journal of Geriatric Psychiatry, 22(9), 926&#x2013;935. doi:10.1016/j.jagp.2013.01.072</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2013.01.072</ArticleId><ArticleId IdType="pubmed">24332982</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, D. R., Taylor, J. P., &amp; Thomas, A. J. (2012). Assessment of cognitive fluctuation in dementia: A systematic review of the literature. The International Journal of Geriatric Psychiatry, 27(10), 989&#x2013;998. doi:10.1002/gps.2823</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.2823</ArticleId><ArticleId IdType="pubmed">22278997</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashour, G. A., Frank, L., Batthyany, A., Kolanowski, A. M., Nahm, M., Schulman-Green, D., Greyson, B., Pakhomov, S., Karlawish, J., &amp; Shah, R. C. (2019). Paradoxical lucidity: A potential paradigm shift for the neurobiology and treatment of severe dementias. Alzheimers &amp; Dementia, 15(8), 1107&#x2013;1114. doi:10.1016/j.jalz.2019.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.04.002</ArticleId><ArticleId IdType="pubmed">31229433</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann, G. M., Knopman, D. S., Chertkow, H.,Hyman, B.T., Jack, C.R., Jr., Kawas, C.H., Klunk, W.E., Koroshetz, W.J., Manly, J.J., Mayeux, R., Mohs, R.C., Morris, J.C.,Rossor, M.N.,Scheltens, P.,Carrillo, M.C., Thies, B., Weintraub, S., &amp; Phelps, C.H. (2011). The diagnosis of dementia due to Alzheimer&#x2019;s disease: Recommendations from the National Institute on Aging&#x2013;Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimers &amp; Dementia, 7(3), 263&#x2013;269. doi:10.1016/j.jalz.2011.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.03.005</ArticleId><ArticleId IdType="pmc">PMC3312024</ArticleId><ArticleId IdType="pubmed">21514250</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris, J. C. (1997). Clinical Dementia Rating: A reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. International Psychogeriatrics, 9(S1), 173&#x2013;176; discussion 177. doi:10.1017/s1041610297004870</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610297004870</ArticleId><ArticleId IdType="pubmed">9447441</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahm, M. (2022). Terminal lucidity versus paradoxical lucidity: A terminological clarification. Alzheimers &amp; Dementia, 18(3), 538&#x2013;539. doi:10.1002/alz.12574</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12574</ArticleId><ArticleId IdType="pubmed">35102690</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahm, M., Greyson, B., Kelly, E. W., &amp; Haraldsson, E. (2012). Terminal lucidity: A review and a case collection. Archives of Gerontology and Geriatrics, 55(1), 138&#x2013;142. doi:10.1016/j.archger.2011.06.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2011.06.031</ArticleId><ArticleId IdType="pubmed">21764150</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute on Aging. (2019). Lucidity in dementia (R21/R33 clinical trial optional) [Grant]. https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-017.html</Citation></Reference><Reference><Citation>Neal, J. W., Neal, Z. P., VanDyke, E., &amp; Kornbluh, M. (2014). Expediting the analysis of qualitative data in evaluation: A procedure for the Rapid Identification of Themes from Audio recordings (RITA). American Journal of Evaluation, 36(1), 118&#x2013;132. doi:10.1177/1098214014536601</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1098214014536601</ArticleId></ArticleIdList></Reference><Reference><Citation>Ney, D. B., Peterson, A., &amp; Karlawish, J. (2021). The ethical implications of paradoxical lucidity in persons with dementia. Journal of the American Geriatrics Society, 69(12), 3617&#x2013;3622. doi:10.1111/jgs.17484</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17484</ArticleId><ArticleId IdType="pmc">PMC9924090</ArticleId><ArticleId IdType="pubmed">34628640</ArticleId></ArticleIdList></Reference><Reference><Citation>Normann, H. K., Asplund, K., Karlsson, S., Sandman, P.-O., &amp; Norberg, A. (2006). People with severe dementia exhibit episodes of lucidity. A population-based study. Journal of Clinical Nursing, 15(11), 1413&#x2013;1417. doi:10.1111/j.1365-2702.2005.01505.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2702.2005.01505.x</ArticleId><ArticleId IdType="pubmed">17038102</ArticleId></ArticleIdList></Reference><Reference><Citation>Normann, H. K., Asplund, K., &amp; Norberg, A. (1998). Episodes of lucidity in people with severe dementia as narrated by formal carers. Journal of Advance Nursing, 28(6), 1295&#x2013;1300. doi:10.1046/j.1365-2648.1998.00845.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2648.1998.00845.x</ArticleId><ArticleId IdType="pubmed">9888375</ArticleId></ArticleIdList></Reference><Reference><Citation>Peacock, S. C., Hammond-Collins, K., &amp; Forbes, D. A. (2014). The journey with dementia from the perspective of bereaved family caregivers: A qualitative descriptive study. BMC Nursing, 13(1), 42. doi:10.1186/s12912-014-0042-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12912-014-0042-x</ArticleId><ArticleId IdType="pmc">PMC4247750</ArticleId><ArticleId IdType="pubmed">25435810</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson, A., Clapp, J., Largent, E. A., Harkins, K., Stites, S. D., &amp; Karlawish, J. (2022). What is paradoxical lucidity? The answer begins with its definition. Alzheimers &amp; Dementia, 18(3), 513&#x2013;521. doi:10.1002/alz.12424</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12424</ArticleId><ArticleId IdType="pmc">PMC8807788</ArticleId><ArticleId IdType="pubmed">34338400</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz, R., Boerner, K., Shear, K., Zhang, S., &amp; Gitlin, L. N. (2006). Predictors of complicated grief among dementia caregivers: A prospective study of bereavement. The American Journal of Geriatric Psychiatry, 14(8), 650&#x2013;658. doi:10.1097/01.JGP.0000203178.44894.db</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.JGP.0000203178.44894.db</ArticleId><ArticleId IdType="pubmed">16861369</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor, B., Henshall, C., Kenyon, S., Litchfield, I., &amp; Greenfield, S. (2018). Can rapid approaches to qualitative analysis deliver timely, valid findings to clinical leaders? A mixed methods study comparing rapid and thematic analysis. BMJ Open, 8(10), e019993. doi:10.1136/bmjopen-2017-019993</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-019993</ArticleId><ArticleId IdType="pmc">PMC6194404</ArticleId><ArticleId IdType="pubmed">30297341</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker, M. P., Ayre, G. A., Cummings, J. L., Wesnes, K., McKeith, I. G., O&#x2019;Brien, J. T., &amp; Ballard, C. G. (2000). Quantifying fluctuation in dementia with Lewy bodies, Alzheimer&#x2019;s disease, and vascular dementia. Neurology, 54(8), 1616&#x2013;1625. doi:10.1212/wnl.54.8.1616</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.54.8.1616</ArticleId><ArticleId IdType="pubmed">10762503</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35769020</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1465-3966</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Psychology, health &amp; medicine</Title><ISOAbbreviation>Psychol Health Med</ISOAbbreviation></Journal><ArticleTitle>Factors affecting the quality of life of family carers of people with dementia: the role of carer anxiety.</ArticleTitle><Pagination><StartPage>843</StartPage><EndPage>853</EndPage><MedlinePgn>843-853</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/13548506.2022.2093926</ELocationID><Abstract><AbstractText>The role of anxiety on the quality of life of family carers of people with dementia is somewhat neglected in the carer literature. The current study aimed to investigate the impact of common risk factors (i.e., care recipient's neuropsychiatric symptoms, carer depression, and burden) and anxiety on QoL. This cross-sectional study recruited 89 family carers. Most of the participants were looking after a spouse with Alzheimer's or mixed dementia. A multiple regression analysis was conducted with carer QoL as a dependent variable. All risk factors (i.e., people with dementia's neuropsychiatric symptoms, carer depression, anxiety, and burden) were entered into the model simultaneously as independent variables. The model's R2 was 33%. The results demonstrated that anxiety was the only significant independent variable predicting carer QoL (&#x3b2;&#xa0;= - 0.34, p =&#xa0;0.03, 95% CI: - 0.64 to - 0.04). These results indicated that having more symptoms of anxiety was associated with worse QoL as measured by the ICEpop CAPability measure for Older people (ICECAP-O). These findings suggested that improving carer's anxiety may be particularly important in promoting QoL among family carers of people with dementia. Future interventions should target this variable to achieve the desired result of improving carer QoL.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Milena</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5171-0534</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khondoker</LastName><ForeName>Mizanur</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1801-1635</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mioshi</LastName><ForeName>Eneida</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-0066-868X</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kishita</LastName><ForeName>Naoko</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-8453-2714</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychol Health Med</MedlineTA><NlmUniqueID>9604099</NlmUniqueID><ISSNLinking>1354-8506</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s</Keyword><Keyword MajorTopicYN="N">Informal caregivers</Keyword><Keyword MajorTopicYN="N">QoL</Keyword><Keyword MajorTopicYN="N">anxiety</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">neuropsychiatric symptoms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>30</Day><Hour>2</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35769020</ArticleId><ArticleId IdType="doi">10.1080/13548506.2022.2093926</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35762452</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-4657</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Season>May-Jun</Season></PubDate></JournalIssue><Title>Experimental aging research</Title><ISOAbbreviation>Exp Aging Res</ISOAbbreviation></Journal><ArticleTitle>Older Adult Health Condition as a Moderator of How Middle-Aged Adults' Ageist Attitudes and Aging Anxiety Relate to Their Compassion for and Emotional Distance from Older Adults.</ArticleTitle><Pagination><StartPage>252</StartPage><EndPage>270</EndPage><MedlinePgn>252-270</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/0361073X.2022.2091329</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Using Terror Management Theory and Social Identity Theory as frameworks, we examined whether the relationship of aging anxiety to compassion for and emotional distance from older adults was mediated by ageist attitudes and whether an older adult's health condition moderated these relationships.</AbstractText><AbstractText Label="METHOD">Using an experimental design, 292 middle-aged adults (40-55&#xa0;years) were assigned to read a description of an older adult with Alzheimer's Disease (AD), prostate cancer, or who was healthy.</AbstractText><AbstractText Label="RESULTS">The relationship of aging anxiety to compassion was mediated by ageist attitudes in both the AD and prostate cancer conditions. More ageist attitudes related to less compassion more strongly for unhealthy older adult conditions than for the healthy older adult condition as well as for the AD condition compared to the cancer condition. Ageist attitudes related to more emotional distance from the older adult with AD than the older adult with cancer.</AbstractText><AbstractText Label="DISCUSSION">Older adults with AD may evoke a stronger relationship of ageist attitudes with emotions toward older adults. These findings extend previous research by examining middle-aged participants, a population often serving as caregivers to their aging relatives.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bashian</LastName><ForeName>Hannah M</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0000-0002-8348-4228</Identifier><AffiliationInfo><Affiliation>Department of Education and Human Services, Lehigh University, Bethlehem, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caskie</LastName><ForeName>Grace I L</ForeName><Initials>GIL</Initials><Identifier Source="ORCID">0000-0003-2366-7695</Identifier><AffiliationInfo><Affiliation>Department of Education and Human Services, Lehigh University, Bethlehem, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Exp Aging Res</MedlineTA><NlmUniqueID>7603335</NlmUniqueID><ISSNLinking>0361-073X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004645" MajorTopicYN="N">Empathy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001290" MajorTopicYN="N">Attitude</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063506" MajorTopicYN="Y">Ageism</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="Y">Prostatic Neoplasms</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35762452</ArticleId><ArticleId IdType="doi">10.1080/0361073X.2022.2091329</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35751894</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1078-6791</ISSN><JournalIssue CitedMedium="Print"><Volume>29</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Alternative therapies in health and medicine</Title><ISOAbbreviation>Altern Ther Health Med</ISOAbbreviation></Journal><ArticleTitle>Effects of Assistive Technology Application in Dementia Intervention for People with Mild Cognitive Impairment &amp; Mild Alzheimer Type Dementia and Caregiver.</ArticleTitle><Pagination><StartPage>104</StartPage><EndPage>111</EndPage><MedlinePgn>104-111</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">AT7524</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Dementia, a degenerative disease, requires alternative treatment to maintain function, but previous studies suggest only the therapeutic effect of a temporary program.</AbstractText><AbstractText Label="PRIMARY STUDY OBJECTIVE" NlmCategory="UNASSIGNED">The current study aimed to examine the effects of assistive technologies on cognitive function, daily living ability, and psychosocial symptoms in elderlies with mild cognitive impairment, elderlies with mild dementia and their caregivers.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">The research team designed an experimental study that used application as the intervention.</AbstractText><AbstractText Label="SETTING" NlmCategory="UNASSIGNED">To recruit participants living in the local community, research participation was supported through local public health centers, welfare centers, and social welfare organizations. Evaluation and intervention were conducted by visiting the participant's home.</AbstractText><AbstractText Label="PARTICIPANT" NlmCategory="UNASSIGNED">The study participants were 29 Mild Cognitive Impairment (MCI) and 16 mild Alzheimer type dementia (AD) patients over the age of 75 with a total of 45 patients, 10 MCI caregivers and 11 AD caregivers with a total of 21 caregivers.</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="UNASSIGNED">The assistive technologies used for intervention are 3 area (8 daily living assistive devices, 7 safety assistive technologies, and 7 cognitive assistive technologies). Up to 5 assistive technologies were provided to one subject, and they were instructed to use them every day for 8 weeks.</AbstractText><AbstractText Label="OUTCOME MEASURE" NlmCategory="UNASSIGNED">Participants were evaluated at baseline and postintervention using specific scales appropriate to an area: cognitive function, activities of daily living, depression, anxiety, quality of life, satisfaction.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Cognitive function showed statistically significant changes in the MCI group. Basic activities of daily living, depression, anxiety, quality of life, satisfaction showed statistically significant positive effects in both MCI and AD groups. Instrumental activities of daily living did not show any statistically significant differences.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">As an alternative to dementia care in the future, the application and management of assistive technologies for each area should be provided at the government level.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hwan-Hee</ForeName><Initials>HH</Initials></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Nam-Hae</ForeName><Initials>NH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Altern Ther Health Med</MedlineTA><NlmUniqueID>9502013</NlmUniqueID><ISSNLinking>1078-6791</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012656" MajorTopicYN="Y">Self-Help Devices</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>25</Day><Hour>14</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35751894</ArticleId><ArticleId IdType="pii">AT7524</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35726809</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1874-6128</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Current aging science</Title><ISOAbbreviation>Curr Aging Sci</ISOAbbreviation></Journal><ArticleTitle>Muscle Strength Seems to be Related to The Functional Status and Severity of Dementia in Older Adults with Alzheimer's Disease.</ArticleTitle><Pagination><StartPage>75</StartPage><EndPage>83</EndPage><MedlinePgn>75-83</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2174/1573411018666220616114641</ELocationID><Abstract><AbstractText Label="AIM">This study aimed to determine the possible interrelationships between sarcopenia and Alzheimer's disease (AD).</AbstractText><AbstractText Label="BACKGROUND">Sarcopenia and AD are two common geriatric syndromes; however, the relationship between AD and sarcopenia has not been evaluated in detail so far.</AbstractText><AbstractText Label="OBJECTIVE">The objective is to evaluate the relationship between AD and sarcopenia.</AbstractText><AbstractText Label="METHODS">This cross-sectional study was performed retrospectively on 128 patients with probable AD, with a mean age of 76.56&#xb1;7.54 years. Comprehensive Geriatric Assessment, including the activities of daily living (ADLs), malnutrition, frailty, mini-mental state examination (MMSE), and orthostatic hypotension was performed. Sarcopenia was defined according to the revised EWGSOP-2 criteria.</AbstractText><AbstractText Label="RESULTS">The frequency of probable sarcopenia and definitive sarcopenia was 54.7% and 18.7%, respectively. AD patients with probable sarcopenia had lower MMSE and ADLs scores and were frailer. Clinical dementia rating (CDR) score, MMSE, and basic and instrumental ADLs were independently related to probable sarcopenia in the patients (p=0.003, p&lt;0.001, p=0.001, and p=0.001, respectively). The prevalence of probable sarcopenia in those with CDR 2 was higher than in those with CDR 0.5 and 1 (p=0.002).</AbstractText><AbstractText Label="CONCLUSION">Our findings suggest that probable sarcopenia seems to be related to worse MMSE and ADLs scores and frailty in patients with AD and seems to be related to the severity of AD. Considering adverse health outcomes and the burden of sarcopenia on the patients and their caregivers, optimal care and treatment of sarcopenia in patients with AD are of great importance.</AbstractText><CopyrightInformation>Copyright&#xa9; Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dost</LastName><ForeName>Fatma Sena</ForeName><Initials>FS</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erken</LastName><ForeName>Neziha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ontan</LastName><ForeName>Mehmet Selman</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ates Bulut</LastName><ForeName>Esra</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Adana State Hospital, Adana, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaya</LastName><ForeName>Derya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alzheimer Foundation, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kocyigit</LastName><ForeName>Suleyman Emre</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Tepecik Training and Research Hospital, Izmir, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dokuzlar</LastName><ForeName>Ozge</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aydin</LastName><ForeName>Ali Ekrem</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Sivas State Hospital, Sivas, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isik</LastName><ForeName>Ahmet Turan</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alzheimer Foundation, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Institute of Health Science, Dokuz Eylul University, Izmir, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Aging Sci</MedlineTA><NlmUniqueID>101473576</NlmUniqueID><ISSNLinking>1874-6098</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055948" MajorTopicYN="Y">Sarcopenia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="Y">Frailty</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085542" MajorTopicYN="N">Functional Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053580" MajorTopicYN="N">Muscle Strength</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">frailty</Keyword><Keyword MajorTopicYN="N">low muscle mass</Keyword><Keyword MajorTopicYN="N">low muscle strength</Keyword><Keyword MajorTopicYN="N">older adults</Keyword><Keyword MajorTopicYN="N">sarcopenia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>21</Day><Hour>7</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35726809</ArticleId><ArticleId IdType="doi">10.2174/1573411018666220616114641</ArticleId><ArticleId IdType="pii">CAS-EPUB-124537</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35656738</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1541-3535</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>International journal of aging &amp; human development</Title><ISOAbbreviation>Int J Aging Hum Dev</ISOAbbreviation></Journal><ArticleTitle>The DAS-6: A Short Form of the Dementia Attitudes Scale.</ArticleTitle><Pagination><StartPage>488</StartPage><EndPage>500</EndPage><MedlinePgn>488-500</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/00914150221106094</ELocationID><Abstract><AbstractText>Attitudes toward persons with dementia (PWD) are important predictors of emotional and behavioral outcomes for PWD and their caregivers. It is often desirable to have short, psychometrically-sound measures of such attitudes for inclusion in large community-based surveillance surveys and quick training assessments. The Dementia Attitudes Scale (DAS) is a 20-item scale that examines person-centered knowledge and perceptions of comfort working with PWD. Shorter versions of this scale have been used in various settings, although the psychometric properties of this abbreviated scale are unknown. This study used a principal components analysis to examine the properties associated with scales using a reduced number of items. Our final scale, the DAS-6 includes three items in each of the comfort and person-centered knowledge subscales.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Michaela S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Psychology, 5631West Virginia University, Morgantown, WV, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebert</LastName><ForeName>Alexandria R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Psychology, 5631West Virginia University, Morgantown, WV, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hicks Patrick</LastName><ForeName>Julie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8057-1732</Identifier><AffiliationInfo><Affiliation>Department of Psychology, 5631West Virginia University, Morgantown, WV, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Aging Hum Dev</MedlineTA><NlmUniqueID>0370033</NlmUniqueID><ISSNLinking>0091-4150</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004644" MajorTopicYN="N">Emotions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001290" MajorTopicYN="N">Attitude</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s</Keyword><Keyword MajorTopicYN="N">attitudes</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">methodology</Keyword><Keyword MajorTopicYN="N">psychometrics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>16</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>3</Day><Hour>3</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35656738</ArticleId><ArticleId IdType="doi">10.1177/00914150221106094</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35653168</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1929-0748</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>02</Day></PubDate></JournalIssue><Title>JMIR research protocols</Title><ISOAbbreviation>JMIR Res Protoc</ISOAbbreviation></Journal><ArticleTitle>Using Digital Media to Improve Dementia Care in India: Protocol for a Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>e38456</StartPage><MedlinePgn>e38456</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e38456</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/38456</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">India is undergoing a demographic transition characterized by population aging and is witnessing a high dementia rate. Although nearly 7 million people live with dementia in India, dementia awareness is poor, and current resources addressing dementia care are basic and often incomplete, duplicated, or conflicting. To address this gap, this study aims to use digital media, which has had a massive technological uptake in India, to improve dementia care in India.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of this paper is to describe an intervention study design that examines the feasibility and acceptability of Moving Pictures India, a digital media resource to improve dementia care in India.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study employs a mixed methods design and is divided into 4 phases: (1) video interviews with Indian caregivers and health professionals; (2) coproduction of resources; (3) pilot randomized controlled trial (RCT); and (4) dissemination and analytics. The pilot RCT will follow an experimental parallel group design with 2 arms aiming to assess the impact, feasibility, and acceptability of the developed resources. The primary outcome measures for the pilot RCT will be feasibility and acceptability, while the secondary outcome measures will be caregiver burden, mood, and quality of life.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This study received funding from the Alzheimer's Association in the United States in July 2021. In 2023, we will enroll 60 dementia caregivers (40 caregivers in the intervention arm and 20 in the control) for the pilot RCT. The study has been approved by the National Institute of Mental Health and Neuro Sciences Ethics Committee (26th IEC (BEH.SC.DIV.)/2020-21 dated November 11, 2020); the Health Ministry's Screening Committee, India (proposal ID 2020-10137); the Curtin University Human Research Ethics Committee (approval number HRE2020-0735); and the NARI Research Governance Office (site-specific approval dated March 17, 2021).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This protocol is designed to deliver unique, coproduced, and evidence-based media resources to support caregivers of persons with dementia in India and other countries aiming to utilize digital media for dementia care. If the intervention is found feasible and acceptable, postpiloting analytics and qualitative feedback will be used to develop an implementation trial to evaluate the effectiveness of the potential low-risk high-benefit intervention in practice.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Clinical Trials Registry-India CTRI/2021/01/030403; http://ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50794.</AbstractText><AbstractText Label="INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)" NlmCategory="UNASSIGNED">DERR1-10.2196/38456.</AbstractText><CopyrightInformation>&#xa9;Bianca Brijnath, Upasana Baruah, Josefine Antoniades, Mathew Varghese, Claudia Cooper, Briony Dow, Mike Kent, Santosh Loganathan. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 02.06.2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Brijnath</LastName><ForeName>Bianca</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-0536-6859</Identifier><AffiliationInfo><Affiliation>National Ageing Research Institute, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Baruah</LastName><ForeName>Upasana</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0002-5569-3970</Identifier><AffiliationInfo><Affiliation>Institute of Human Behaviour &amp; Allied Sciences, Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Antoniades</LastName><ForeName>Josefine</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4658-1405</Identifier><AffiliationInfo><Affiliation>National Ageing Research Institute, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Varghese</LastName><ForeName>Mathew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5670-5710</Identifier><AffiliationInfo><Affiliation>National Institute of Mental Health and Neuro Sciences, Bengaluru, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Cooper</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2777-7616</Identifier><AffiliationInfo><Affiliation>University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dow</LastName><ForeName>Briony</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-4186-314X</Identifier><AffiliationInfo><Affiliation>National Ageing Research Institute, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kent</LastName><ForeName>Mike</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3549-3808</Identifier><AffiliationInfo><Affiliation>Curtin University, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Loganathan</LastName><ForeName>Santosh</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9688-5058</Identifier><AffiliationInfo><Affiliation>National Institute of Mental Health and Neuro Sciences, Bengaluru, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Res Protoc</MedlineTA><NlmUniqueID>101599504</NlmUniqueID><ISSNLinking>1929-0748</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">India</Keyword><Keyword MajorTopicYN="N">care</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">digital health</Keyword><Keyword MajorTopicYN="N">film</Keyword></KeywordList><CoiStatement>Conflicts of Interest: BB is the lead principal investigator and JA is the principal investigator of the Moving Pictures Australia study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>2</Day><Hour>11</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35653168</ArticleId><ArticleId IdType="pmc">PMC9204579</ArticleId><ArticleId IdType="doi">10.2196/38456</ArticleId><ArticleId IdType="pii">v11i6e38456</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dias A, Patel V. Closing the treatment gap for dementia in India. Indian J Psychiatry. 2009 Jan;51 Suppl 1:S93&#x2013;7. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038542</ArticleId><ArticleId IdType="pubmed">21416026</ArticleId></ArticleIdList></Reference><Reference><Citation>Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013 Jan;9(1):63&#x2013;75.e2. doi: 10.1016/j.jalz.2012.11.007.S1552-5260(12)02531-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2012.11.007</ArticleId><ArticleId IdType="pubmed">23305823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh S. Care arrangements for persons with dementia: A review on formal care and its relevance to Indian context. J Geriatr Care Res. 2016;3(2):27&#x2013;34. 
 
</Citation></Reference><Reference><Citation>Brijnath B. Unforgotten: Love and the culture of dementia care in India. New York, NY: Berghahn Books; 2014.</Citation><ArticleIdList><ArticleId IdType="pubmed">27362272</ArticleId></ArticleIdList></Reference><Reference><Citation>Loganathan S, Iyengar Vijeth, Chowdappa Suresh Vedalaveni, Varghese Mathew. Population trends and public awareness of healthy and pathological ageing in India: A brief overview. Asian J Psychiatr. 2017 Oct;29:49&#x2013;53. doi: 10.1016/j.ajp.2017.04.012.S1876-2018(16)30517-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2017.04.012</ArticleId><ArticleId IdType="pubmed">29061427</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamech N, Raghuraman Shruti, Vaitheswaran Sridhar, Rangaswamy Thara. The support needs of family caregivers of persons with dementia in India: Implications for health services. Dementia (London) 2019 Aug;18(6):2230&#x2013;2243. doi: 10.1177/1471301217744613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301217744613</ArticleId><ArticleId IdType="pubmed">29199451</ArticleId></ArticleIdList></Reference><Reference><Citation>Brijnath B. Why does institutionalised care not appeal to Indian families? Legislative and social answers from urban India. Ageing and Society. 2011 Jun 09;32(4):697&#x2013;717. doi: 10.1017/S0144686X11000584. doi: 10.1017/s0144686x11000584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0144686X11000584</ArticleId><ArticleId IdType="doi">10.1017/s0144686x11000584</ArticleId></ArticleIdList></Reference><Reference><Citation>Danivas V, Bharmal Mufaddal, Keenan Paul, Jones Steven, Karat Samuel Christaprasad, Kalyanaraman Kumaran, Prince Martin, Fall Caroline H D, Krishna Murali. An interpretative phenomenological analysis (IPA) of coercion towards community dwelling older adults with dementia: findings from Mysore studies of natal effects on ageing and health (MYNAH) Soc Psychiatry Psychiatr Epidemiol. 2016 Dec;51(12):1659&#x2013;1664. doi: 10.1007/s00127-016-1286-4. 
 
10.1007/s00127-016-1286-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00127-016-1286-4</ArticleId><ArticleId IdType="pmc">PMC5131085</ArticleId><ArticleId IdType="pubmed">27689233</ArticleId></ArticleIdList></Reference><Reference><Citation>Prince M, Guerchet M, Prina M. The epidemiology and impact of dementia-current state and future trends. WHO Thematic Briefing. 2015.  [2022-05-23].  
 https://hal.archives-ouvertes.fr/hal-03517019/document
.</Citation></Reference><Reference><Citation>Caring for the caregiver: Why your mental health matters when you are caring for others. World Federation of Mental Health. 2009.  [2022-05-23].  
 https://wfmh.global/img/what-we-do/publications/Caring-for-the-Caregiver-11_04_09-FINAL-2edit2018.pdf
.</Citation></Reference><Reference><Citation>Mental health of older adults. World Health Organization. 2017.  [2022-05-23].  
 https://www.who.int/news-room/fact-sheets/detail/mental-health-of-older-adults
.</Citation></Reference><Reference><Citation>The challenging roles of informal carers. United Nations Economic Commission for Europe. 2019.  [2022-05-23].  
 https://unece.org/DAM/pau/age/Policy_briefs/ECE_WG1_31.pdf
.</Citation></Reference><Reference><Citation>Koo BM, Vizer LM. Examining mobile technologies to support older adults with dementia through the lens of personhood and human needs: scoping review. JMIR Mhealth Uhealth. 2019 Nov 11;7(11):e15122. doi: 10.2196/15122. 
 
v7i11e15122</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/15122</ArticleId><ArticleId IdType="pmc">PMC6878101</ArticleId><ArticleId IdType="pubmed">31710305</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown EL, Ruggiano N, Li J, Clarke PJ, Kay ES, Hristidis V. Smartphone-based health technologies for dementia care: opportunities, challenges, and current practices. J Appl Gerontol. 2019 Jan 04;38(1):73&#x2013;91. doi: 10.1177/0733464817723088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464817723088</ArticleId><ArticleId IdType="pubmed">28774215</ArticleId></ArticleIdList></Reference><Reference><Citation>ENS Economic Bureau  ICEA report: 83 crore smartphone users by 2022. The Indian Express. 2020. Jul 11,  [2022-05-23].  
 https://indianexpress.com/article/technology/tech-news-technology/icea-report-83-crore-smartphone-users-by-2022-6499952/
</Citation></Reference><Reference><Citation>Brijnath B, Antoniades J, Adams J, Browning C, Goeman D, Ellis K, Kent M. Moving Pictures: Raising awareness of dementia in CALD communities through multimedia. Innovation in Aging. 2019;3(Supplement 1):S452&#x2013;S452. doi: 10.1093/geroni/igz038.1693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geroni/igz038.1693</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, Medical Research Council Guidance  Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008 Sep 29;337(sep29 1):a1655&#x2013;a1655. doi: 10.1136/bmj.a1655. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.a1655</ArticleId><ArticleId IdType="pmc">PMC2769032</ArticleId><ArticleId IdType="pubmed">18824488</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006 Jan;3(2):77&#x2013;101. doi: 10.1191/1478088706qp063oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/1478088706qp063oa</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, Clarke V. Thematic analysis. In: Cooper H, editor. APA Handbook of Research Methods in Psychology. Washington DC: American Psychological Association; 2012.</Citation></Reference><Reference><Citation>Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qual Res Sport Exerc Health. 2019 Jun 13;11(4):589&#x2013;597. doi: 10.1080/2159676x.2019.1628806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/2159676x.2019.1628806</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan. Kelly F, Sav A, Kendall E, King Ma, Whitty Ja, Wheeler Aj. Using the Nominal Group Technique: how to analyse across multiple groups. Health Serv Outcomes Res Method. 2014 Jul 25;14(3):92&#x2013;108. doi: 10.1007/s10742-014-0121-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10742-014-0121-1</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolfe G. Validity, trustworthiness and rigour: quality and the idea of qualitative research. J Adv Nurs. 2006 Feb;53(3):304&#x2013;10. doi: 10.1111/j.1365-2648.2006.03727.x.JAN3727</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2648.2006.03727.x</ArticleId><ArticleId IdType="pubmed">16441535</ArticleId></ArticleIdList></Reference><Reference><Citation>TNN  Bengaluru's migrants cross 50% of the city's population. The Times of India. 2019. Aug 4,  [2022-05-23].  
 https://timesofindia.indiatimes.com/city/bengaluru/bengalurus-migrants-cross-50-of-the-citys-population/articleshow/70518536.cms
.</Citation></Reference><Reference><Citation>Ulla W. Bangalore city: A lot more than the silicon valley of India. Higher Education Review. 2015.  [2022-05-23].  
 https://www.thehighereducationreview.com/magazine/bangalore-city-a-lot-more-than-the-silicon-valley-of-india-TJJG311278607.html
.</Citation></Reference><Reference><Citation>Steinhubl SR, McGovern P, Dylan J, Topol EJ. The digitised clinical trial. The Lancet. 2017 Nov;390(10108):2135. doi: 10.1016/s0140-6736(17)32741-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(17)32741-1</ArticleId><ArticleId IdType="pubmed">29143747</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarit S, Orr N, Zarit JM. The Hidden Victims of Alzheimer's Disease: Families Under Stress. New York, NY: New York University Press; 1985.</Citation></Reference><Reference><Citation>Radloff LS. The CES-D Scale. Appl Psychol Meas. 2016 Jul 26;1(3):385&#x2013;401. doi: 10.1177/014662167700100306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/014662167700100306</ArticleId></ArticleIdList></Reference><Reference><Citation>The World Health Organization Quality Of Life (WHOQOL)-bref. World Health Organization. 1998.  [2022-05-23].  
 https://www.who.int/publications/i/item/WHO-HIS-HSI-Rev.2012.03
.</Citation></Reference><Reference><Citation>Dam AEH, van Boxtel MPJ, Rozendaal N, Verhey FRJ, de Vugt ME. Development and feasibility of Inlife: A pilot study of an online social support intervention for informal caregivers of people with dementia. PLoS One. 2017 Sep 8;12(9):e0183386. doi: 10.1371/journal.pone.0183386. 
 
PONE-D-16-50500</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0183386</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0183386</ArticleId><ArticleId IdType="pmc">PMC5590823</ArticleId><ArticleId IdType="pubmed">28886056</ArticleId></ArticleIdList></Reference><Reference><Citation>Modi D, Gopalan R, Shah S, Venkatraman S, Desai G, Desai S, Shah P. Development and formative evaluation of an innovative mHealth intervention for improving coverage of community-based maternal, newborn and child health services in rural areas of India. Glob Health Action. 2015 Feb 16;8(1):26769. doi: 10.3402/gha.v8.26769. 
 
26769</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/gha.v8.26769</ArticleId><ArticleId IdType="pmc">PMC4335194</ArticleId><ArticleId IdType="pubmed">25697233</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM, Murchie P, Devereux G, Johnston M, Lee AJ, Macleod U, Nicolson MC, Powell R, Ritchie LD, Wyke S, Campbell NC. Developing a complex intervention to reduce time to presentation with symptoms of lung cancer. Br J Gen Pract. 2012 Sep 01;62(602):e605&#x2013;e615. doi: 10.3399/bjgp12x654579.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp12x654579</ArticleId><ArticleId IdType="pmc">PMC3426599</ArticleId><ArticleId IdType="pubmed">22947581</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaji. Smitha K, Lal K Praveen, Prince M J. Caregivers of people with Alzheimer's disease: a qualitative study from the Indian 10/66 Dementia Research Network. Int J Geriatr Psychiatry. 2003 Jan;18(1):1&#x2013;6. doi: 10.1002/gps.649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.649</ArticleId><ArticleId IdType="pubmed">12497550</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong TV, Aringazina A, Baisunova G, Nurjanah. Pham TV, Pham KM, Truong TQ, Nguyen KT, Oo WM, Mohamad E, Su TT, Huang H, S&#xf8;rensen Kristine, Pelikan JM, Van den Broucke S, Chang PW. Measuring health literacy in Asia: Validation of the HLS-EU-Q47 survey tool in six Asian countries. J Epidemiol. 2017 Feb;27(2):80&#x2013;86. doi: 10.1016/j.je.2016.09.005. 
 
S0917-5040(16)30077-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.je.2016.09.005</ArticleId><ArticleId IdType="pmc">PMC5328731</ArticleId><ArticleId IdType="pubmed">28142016</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta. Gallagher-Thompson Dolores, Varghese Mathew, Loganathan Santosh, Baruah Upasana, Seeher Katrin, Zandi Diana, Dua Tarun, Pot Anne Margriet. iSupport, an online training and support program for caregivers of people with dementia: study protocol for a randomized controlled trial in India. Trials. 2018 May 08;19(1):271. doi: 10.1186/s13063-018-2604-9. 
 
10.1186/s13063-018-2604-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-018-2604-9</ArticleId><ArticleId IdType="doi">10.1186/s13063-018-2604-9</ArticleId><ArticleId IdType="pmc">PMC5941472</ArticleId><ArticleId IdType="pubmed">29739423</ArticleId></ArticleIdList></Reference><Reference><Citation>Purandare N, Luthra V, Swarbrick C, Burns A. Knowledge of dementia among South Asian (Indian) older people in Manchester, UK. Int J Geriatr Psychiatry. 2007 Aug;22(8):777&#x2013;81. doi: 10.1002/gps.1740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.1740</ArticleId><ArticleId IdType="pubmed">17192964</ArticleId></ArticleIdList></Reference><Reference><Citation>Shikimoto R, Sado M, Ninomiya A, Yoshimura K, Ikeda B, Baba T, Mimura M. Predictive factors associated with psychological distress of caregivers of people with dementia in Japan: a cross-sectional study. Int Psychogeriatr. 2017 Nov 10;30(8):1089&#x2013;1098. doi: 10.1017/s1041610217002289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610217002289</ArticleId><ArticleId IdType="pubmed">29122049</ArticleId></ArticleIdList></Reference><Reference><Citation>Baruah U, Varghese M, Loganathan S, Mehta KM, Gallagher-Thompson Dolores, Zandi D, Dua T, Pot AM. Feasibility and preliminary effectiveness of an online training and support program for caregivers of people with dementia in India: a randomized controlled trial. Int J Geriatr Psychiatry. 2021 Apr 08;36(4):606&#x2013;617. doi: 10.1002/gps.5502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5502</ArticleId><ArticleId IdType="pubmed">33491811</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett GG, Glasgow RE. The delivery of public health interventions via the Internet: actualizing their potential. Annu Rev Public Health. 2009 Apr;30:273&#x2013;92. doi: 10.1146/annurev.publhealth.031308.100235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.publhealth.031308.100235</ArticleId><ArticleId IdType="pubmed">19296777</ArticleId></ArticleIdList></Reference><Reference><Citation>Bero. Grilli R, Grimshaw J M, Harvey E, Oxman A D, Thomson M A. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ. 1998 Aug 15;317(7156):465&#x2013;8. doi: 10.1136/bmj.317.7156.465. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.317.7156.465</ArticleId><ArticleId IdType="pmc">PMC1113716</ArticleId><ArticleId IdType="pubmed">9703533</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasgow RE, Davidson KW, Dobkin PL, Ockene J, Spring B. Practical behavioral trials to advance evidence-based behavioral medicine. Ann Behav Med. 2006 Feb;31(1):5&#x2013;13. doi: 10.1207/s15324796abm3101_3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1207/s15324796abm3101_3</ArticleId><ArticleId IdType="pubmed">16472033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri. Jacob K S. Dementia in low-income and middle-income countries: Different realities mandate tailored solutions. PLoS Med. 2017 Mar;14(3):e1002271. doi: 10.1371/journal.pmed.1002271. 
 
PMEDICINE-D-17-00572</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002271</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1002271</ArticleId><ArticleId IdType="pmc">PMC5370095</ArticleId><ArticleId IdType="pubmed">28350797</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of External Affairs. New Delhi, India: Government of India; 2018.  [2022-05-23]. Population of overseas Indians. 
 https://mea.gov.in/images/attach/NRIs-and-PIOs_1.pdf
.</Citation></Reference><Reference><Citation>Giebel. Zubair Maria, Jolley David, Bhui Kamaldeep Singh, Purandare Nitin, Worden Angela, Challis David. South Asian older adults with memory impairment: improving assessment and access to dementia care. Int J Geriatr Psychiatry. 2015 Apr;30(4):345&#x2013;56. doi: 10.1002/gps.4242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4242</ArticleId><ArticleId IdType="pubmed">25503751</ArticleId></ArticleIdList></Reference><Reference><Citation>McCleary L, Persaud M, Hum S, Pimlott NJ, Cohen CA, Koehn S, Leung KK, Dalziel WB, Kozak J, Emerson VF, Silvius JL, Garcia L, Drummond N. Pathways to dementia diagnosis among South Asian Canadians. Dementia (London) 2013 Nov 26;12(6):769&#x2013;89. doi: 10.1177/1471301212444806.1471301212444806</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301212444806</ArticleId><ArticleId IdType="pubmed">24337639</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35574992</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-1788</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>International journal of psychiatry in clinical practice</Title><ISOAbbreviation>Int J Psychiatry Clin Pract</ISOAbbreviation></Journal><ArticleTitle>Unmet needs in the diagnosis and treatment of Parkinson's disease psychosis and dementia-related psychosis.</ArticleTitle><Pagination><StartPage>69</StartPage><EndPage>81</EndPage><MedlinePgn>69-81</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/13651501.2022.2058406</ELocationID><Abstract><AbstractText>Dementia due to Parkinson's disease and Alzheimer's disease are associated with behavioural and psychological symptoms, including psychosis. Long-term management presents a challenge for health care providers and caregivers. Symptoms of psychosis include hallucinations and delusions; if untreated, these can lead to institutionalisation, decreased quality of life, and significant patient and caregiver distress. A critical step in the effective management of dementia-related psychosis (DRP) is the identification and diagnosis of affected patients. The lack of a standardised diagnostic approach presents a barrier to treatment and there are no consensus guidelines for DRP. Furthermore, there are no approved therapies for the treatment of DRP. Antipsychotic medications are often prescribed off-label, even though some are associated with an increased risk of adverse events or mortality. We present currently available screening tools and guidelines for the diagnosis and treatment of Parkinson's disease psychosis and DRP in the context of what is needed for effective management of psychosis.KEY POINTSWe present currently available screening tools and guidelines for Parkinson's disease psychosis and dementia-related psychosis, and discuss the unmet need for simple clinical diagnostic tools and treatment guidelines.The identification of psychosis is variable across different settings and specialties, without a unified approach to screening, definition, or diagnosis.Currently used tools for defining and assessing psychosis in a research setting are usually too cumbersome for everyday clinical practice.The development of a standardised set of diagnostic criteria would provide clinicians the opportunity to improve the detection, treatment, and quality of life of patients and their caregivers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sabbagh</LastName><ForeName>Marwan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dignity Health/St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Small</LastName><ForeName>Gary W</ForeName><Initials>GW</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Hackensack University Medical Center, Behavioral Health Service, Hackensack Meridian Health, Hackensack, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isaacson</LastName><ForeName>Stuart H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Yaghi</LastName><ForeName>Yasar</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Parkinson's Foundation Center for Excellence, Translational Neurotherapeutics Program, Movement Disorders Program, MedStar Georgetown Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagan</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Parkinson's Foundation Center for Excellence, Translational Neurotherapeutics Program, Movement Disorders Program, MedStar Georgetown Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pahwa</LastName><ForeName>Rajesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Psychiatry Clin Pract</MedlineTA><NlmUniqueID>9709509</NlmUniqueID><ISSNLinking>1365-1501</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010880">Piperidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>8W8T17847W</RegistryNumber><NameOfSubstance UI="D014508">Urea</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010880" MajorTopicYN="N">Piperidines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014508" MajorTopicYN="N">Urea</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011618" MajorTopicYN="Y">Psychotic Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="Y">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Delusions</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease psychosis</Keyword><Keyword MajorTopicYN="N">dementia-related psychosis</Keyword><Keyword MajorTopicYN="N">hallucinations</Keyword><Keyword MajorTopicYN="N">pimavanserin</Keyword><Keyword MajorTopicYN="N">psychosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35574992</ArticleId><ArticleId IdType="doi">10.1080/13651501.2022.2058406</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35452376</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-7322</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Journal of women &amp; aging</Title><ISOAbbreviation>J Women Aging</ISOAbbreviation></Journal><ArticleTitle>"I'm still the queen and I'm still on my throne&#x2026;": Women's reflections on gender and living with dementia.</ArticleTitle><Pagination><StartPage>113</StartPage><EndPage>127</EndPage><MedlinePgn>113-127</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/08952841.2022.2054656</ELocationID><Abstract><AbstractText>People with dementia have long been defined by the label of dementia, rather than by other aspects of their identities including gender. As a result, little research has focused on gender and dementia, particularly through the perspectives of those living with dementia. The purpose of this study was to explore the experiences and perspectives of women living with dementia. Specifically, we sought to understand how gender structured their experiences of receiving and coping with a diagnosis, services, and important relationships and supports. Utilizing a qualitative research approach, twenty-one women living with dementia participated in individual or group interviews. Women discussed the following aspects of gender and dementia: caregiver roles, perceptions of gender differences, the impact of dementia on families, and women's strength and resilience. The findings of this study indicate a clear need for further research to explore diversity and gendered experiences for those diagnosed with dementia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wiersma</LastName><ForeName>Elaine C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Centre for Education and Research on Aging &amp; Health, Lakehead University, Thunder Bay, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harvey</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Alzheimer Society of Ontario, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dementia Dialogue, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caffery</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Alzheimer Society of Ontario, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Women Aging</MedlineTA><NlmUniqueID>8916635</NlmUniqueID><ISSNLinking>0895-2841</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000223" MajorTopicYN="Y">Adaptation, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">diversity</Keyword><Keyword MajorTopicYN="N">gender</Keyword><Keyword MajorTopicYN="N">lived experience</Keyword><Keyword MajorTopicYN="N">qualitative analysis</Keyword><Keyword MajorTopicYN="N">women</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>22</Day><Hour>17</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35452376</ArticleId><ArticleId IdType="doi">10.1080/08952841.2022.2054656</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35451921</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1545-3847</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Season>Apr-Jun</Season></PubDate></JournalIssue><Title>Gerontology &amp; geriatrics education</Title><ISOAbbreviation>Gerontol Geriatr Educ</ISOAbbreviation></Journal><ArticleTitle>Increased medical student understanding of dementia through virtual embodiment.</ArticleTitle><Pagination><StartPage>211</StartPage><EndPage>222</EndPage><MedlinePgn>211-222</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/02701960.2022.2067850</ELocationID><Abstract><AbstractText>Given the growing prevalence of Alzheimer's disease (AD), we assessed the impact of virtually embodying someone with progressive AD. This pilot explored students' understanding of individuals' needs with dementia, as well as, the efficacy of virtual reality (VR) as a curricular tool. Second-year medical students (n&#xa0;=&#xa0;150) completed a pre-survey, Embodied Labs, Inc. Beatriz Lab VR module, and a post-survey. Most students knew someone with dementia (72%), were a family member of someone with dementia (52%) or had worked with a patient (61%) with dementia. Using paired survey questions, students reported significant increases in understanding how their lives would be affected by dementia (71% vs. 94%) and the needs of a person with dementia (64% vs. 95%) after VR. They reported increased understanding of being a caregiver of someone with dementia (24% vs. 81%) and the impact it can have on the entire family (64% vs. 97%). Overall students agreed this simulation made them think about their approach to clinical skills (94%) and should be utilized more in the curriculum (76%). This pilot study indicated that this VR experience can be used to advance understanding of a person's experiences with dementia and that integrating VR into the medical curricula should be considered.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bard</LastName><ForeName>Jason T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Pathology and Anatomy, Eastern Virginia Medical School, Norfolk, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Hannah K</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department of Pathology and Anatomy, Eastern Virginia Medical School, Norfolk, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaia</LastName><ForeName>Jacqueline K</ForeName><Initials>JK</Initials><Identifier Source="ORCID">0000-0001-7873-669X</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Anatomy, Eastern Virginia Medical School, Norfolk, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wellman</LastName><ForeName>Laurie L</ForeName><Initials>LL</Initials><Identifier Source="ORCID">0000-0001-9195-2063</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Anatomy, Eastern Virginia Medical School, Norfolk, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elzie</LastName><ForeName>Carrie A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0001-5017-3936</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Anatomy, Eastern Virginia Medical School, Norfolk, Virginia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Gerontol Geriatr Educ</MedlineTA><NlmUniqueID>8101294</NlmUniqueID><ISSNLinking>0270-1960</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013337" MajorTopicYN="Y">Students, Medical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005853" MajorTopicYN="Y">Geriatrics</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076142" MajorTopicYN="Y">Virtual Reality</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">embodiment</Keyword><Keyword MajorTopicYN="N">empathy</Keyword><Keyword MajorTopicYN="N">simulation</Keyword><Keyword MajorTopicYN="N">virtual reality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>22</Day><Hour>12</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35451921</ArticleId><ArticleId IdType="doi">10.1080/02701960.2022.2067850</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35446750</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-7322</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Journal of women &amp; aging</Title><ISOAbbreviation>J Women Aging</ISOAbbreviation></Journal><ArticleTitle>A time for me: A virtual program to engage African American caregivers.</ArticleTitle><Pagination><StartPage>369</StartPage><EndPage>382</EndPage><MedlinePgn>369-382</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/08952841.2022.2064175</ELocationID><Abstract><AbstractText>To address the self-care needs of African American family caregivers, a community-engaged approach was used to develop and implement a half-day virtual self-care program. This study evaluates experiences of program attendees. All attendees were emailed an electronic survey containing Likert-type and open-ended questions. Responses were examined for patterns and key content-related categories using inductive content analysis. Eleven attendees responded to the survey. All 11 strongly agreed (64%) or agreed (36%) that the event met their expectations and/or needs. In addition to providing opportunity to take time to engage in self-care, the event created a virtual space for women to focus on themselves. Women spoke about three distinct ways the event met their needs: (1) learning and trying new things, (2) access to resources, and (3) having a shared experience. These findings suggest that virtual programs may be used as an additional resource to support the health of African American women caregivers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Keller</LastName><ForeName>Abiola O</ForeName><Initials>AO</Initials><Identifier Source="ORCID">0000-0003-2917-4410</Identifier><AffiliationInfo><Affiliation>College of Nursing, Marquette University, Milwaukee, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norris</LastName><ForeName>Nia C</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>Wisconsin Alzheimer's Institute Regional Milwaukee Office, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Easter</LastName><ForeName>Bashir</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garr</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Community Member, Milwaukee, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>Gail</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Wisconsin Alzheimer's Institute Regional Milwaukee Office, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dicks-Williams</LastName><ForeName>Ramona</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Community Member, Milwaukee, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galambos</LastName><ForeName>Colleen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Helen Bader School of Social Welfare, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Women Aging</MedlineTA><NlmUniqueID>8916635</NlmUniqueID><ISSNLinking>0895-2841</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001741" MajorTopicYN="Y">Black or African American</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003256" MajorTopicYN="Y">Community Participation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012648" MajorTopicYN="Y">Self Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073597" MajorTopicYN="N">Stakeholder Participation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">African American caregivers</Keyword><Keyword MajorTopicYN="N">community engagement</Keyword><Keyword MajorTopicYN="N">empowerment</Keyword><Keyword MajorTopicYN="N">self-care</Keyword><Keyword MajorTopicYN="N">tele-support</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>21</Day><Hour>17</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35446750</ArticleId><ArticleId IdType="doi">10.1080/08952841.2022.2064175</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35437043</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-5708</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of geriatric psychiatry and neurology</Title><ISOAbbreviation>J Geriatr Psychiatry Neurol</ISOAbbreviation></Journal><ArticleTitle>Examining the Impact of Different Components of Sleep Quality on Anxiety Among Family Carers of People with Dementia.</ArticleTitle><Pagination><StartPage>63</StartPage><EndPage>72</EndPage><MedlinePgn>63-72</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/08919887221093359</ELocationID><Abstract><AbstractText>Existing interventions for family carers of people with dementia tend to be less effective for anxiety than for depression. Therefore, identifying factors affecting carer anxiety is important to inform future interventions. This study conducted 2 multiple regression analyses using a sample of 91 family carers. The first regression model (<i>&#x2206;R</i><sup><i>2</i></sup> = .24), exploring the impact of demographic variables and carer stressors, demonstrated that hours of caring (<i>&#x3b2;</i> = .33) and overall sleep quality (<i>&#x3b2;</i> = .28) were significant predictors of anxiety. To further investigate the impact of sleep quality, the second model (<i>&#x2206;R</i><sup><i>2</i></sup> = .24) focussed on exploring the differential impact of various components of sleep quality on anxiety. Findings demonstrated that subjective sleep quality (<i>&#x3b2;</i> = .33) and sleep disturbances (<i>&#x3b2;</i> = .22) were significant predictors. Hours of caring per week, subjective sleep quality and sleep disturbances seem to be critical for treating anxiety in family carers. Future studies should investigate whether targeting these variables could improve carer anxiety.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Van Hout</LastName><ForeName>Elien</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-2956-7575</Identifier><AffiliationInfo><Affiliation>School of Health Sciences, 83726University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Milena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Health Sciences, 83726University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mioshi</LastName><ForeName>Eneida</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Health Sciences, 83726University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kishita</LastName><ForeName>Naoko</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-8453-2714</Identifier><AffiliationInfo><Affiliation>School of Health Sciences, 83726University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Geriatr Psychiatry Neurol</MedlineTA><NlmUniqueID>8805645</NlmUniqueID><ISSNLinking>0891-9887</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000089943" MajorTopicYN="N">Sleep Quality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001008" MajorTopicYN="N">Anxiety Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">care burden</Keyword><Keyword MajorTopicYN="N">caregivers</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">insomnia</Keyword><Keyword MajorTopicYN="N">mindfulness</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>19</Day><Hour>5</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35437043</ArticleId><ArticleId IdType="pmc">PMC9755697</ArticleId><ArticleId IdType="doi">10.1177/08919887221093359</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Frias CE, Garcia&#x2010;Pascual M, Montoro M, Ribas N, Risco E, Zabalegui A. Effectiveness of a psychoeducational intervention for caregivers of people with dementia with regard to burden, anxiety and depression: A systematic review. J Adv Nurs. 2020;76(3):787-802.</Citation><ArticleIdList><ArticleId IdType="pubmed">31808211</ArticleId></ArticleIdList></Reference><Reference><Citation>Stall NM, Kim SJ, Hardacre KA, et al. Association of informal caregiver distress with health outcomes of community&#x2010;dwelling dementia care recipients: A systematic review. J Am Geriatr Soc. 2019;67(3):609-617.</Citation><ArticleIdList><ArticleId IdType="pubmed">30536383</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu D, Hu M, Yu Y, Tang B, Xiao S. Acceptability of psychosocial interventions for dementia caregivers: A systematic review. BMC Psychiatry. 2019;19(1):23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6332684</ArticleId><ArticleId IdType="pubmed">30642300</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes CJ, Markham C. A pilot study to evaluate the effectiveness of an individualized and cognitive behavioural communication intervention for informal carers of people with dementia: The talking sense programme. Int J Lan Commun Disord. 2018;53(3):615-627.</Citation><ArticleIdList><ArticleId IdType="pubmed">29460337</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaddour L, Kishita N. Anxiety in informal dementia carers: A meta-analysis of prevalence. J Geriatr Psychiatry Neurol. 2020;33(3):161-172.</Citation><ArticleIdList><ArticleId IdType="pubmed">31409196</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney R, Regan C, Katona C, Livingston G. Anxiety and depression in family caregivers of people with Alzheimer disease: the LASER-AD study. Am J Geriatr Psychiatry. 2005;13(9):795-801.</Citation><ArticleIdList><ArticleId IdType="pubmed">16166409</ArticleId></ArticleIdList></Reference><Reference><Citation>Somers JM, Goldner EM, Waraich P, Hsu L. Prevalence and incidence studies of anxiety disorders: A systematic review of the literature. Can J Psychiatry. 2006;51(2):100-113.</Citation><ArticleIdList><ArticleId IdType="pubmed">16989109</ArticleId></ArticleIdList></Reference><Reference><Citation>Fri&#xf0;riksd&#xf3;ttir N, Saevarsd&#xf3;ttir T, Halfd&#xe1;nard&#xf3;ttir S, et al. Family members of cancer patients: Needs, quality of life and symptoms of anxiety and depression. Acta Oncol. 2011;50(2):252-258.</Citation><ArticleIdList><ArticleId IdType="pubmed">21231786</ArticleId></ArticleIdList></Reference><Reference><Citation>Loh AZ, Tan JS, Zhang MW, Ho RC. The global prevalence of anxiety and depressive symptoms among caregivers of stroke survivors. J Am Med Dir Assoc. 2017;18(2):111-116.</Citation><ArticleIdList><ArticleId IdType="pubmed">27742585</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishita N, Hammond L, Dietrich CM, Mioshi E. Which interventions work for dementia family carers?: An updated systematic review of randomized controlled trials of carer interventions. Int Psychogeriatr. 2018;30(11):1679-1696.</Citation><ArticleIdList><ArticleId IdType="pubmed">30017008</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson CA, Spilsbury K, Hall J, Birks Y, Barnes C, Adamson J. Systematic review of information and support interventions for caregivers of people with dementia. BMC Geriatr. 2007;7(1):18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1951962</ArticleId><ArticleId IdType="pubmed">17662119</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer L, Potterton R, Allen K, Musiat P, Schmidt U. Internet-based interventions for carers of individuals with psychiatric disorders, neurological disorders, or brain injuries: Systematic review. J Med Int Res. 2019;21(7):e10876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6647754</ArticleId><ArticleId IdType="pubmed">31290399</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper C, Balamurali TBS, Selwood A, Livingston G. A systematic review of intervention studies about anxiety in caregivers of people with dementia. Int J Geriatr Psychia. 2007;22(3):181-188.</Citation><ArticleIdList><ArticleId IdType="pubmed">17006872</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper C, Balamurali TB, Livingston G. A systematic review of the prevalence and covariates of anxiety in caregivers of people with dementia. Int psychogeriatr. 2007;19(2):175-195.</Citation><ArticleIdList><ArticleId IdType="pubmed">17005068</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong C, Biscardi M, Astell A, et al. Sex and gender differences in caregiving burden experienced by family caregivers of persons with dementia: A systematic review. PLoS ONE. 2020;15(4):1-22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7170244</ArticleId><ArticleId IdType="pubmed">32310969</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodaty H, Donkin M. Family caregivers of people with dementia. Dialo Clini Neuros. 2009;11(2):217-228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3181916</ArticleId><ArticleId IdType="pubmed">19585957</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenmakers B, Buntinx F, Delepeleire J. Factors determining the impact of care-giving on caregivers of elderly patients with dementia. A systematic literature review. Maturitas. 2010;66(2):191-200.</Citation><ArticleIdList><ArticleId IdType="pubmed">20307942</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams IC. Emotional health of black and white dementia caregivers: A contextual examination. j gerontol Ser B, Psycholo Sci Soc Sci. 2005;60(6):P287-295.</Citation><ArticleIdList><ArticleId IdType="pubmed">16260702</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishita N, Contreras ML, West J, Mioshi E. Exploring the impact of carer stressors and psychological inflexibility on depression and anxiety in family carers of people with dementia. J Contex Behav Sci. 2020;17:119-125.</Citation></Reference><Reference><Citation>Alvaro PK, Roberts RM, Harris JK. A systematic review assessing bidirectionality between sleep disturbances, anxiety, and depression. Sleep. 2013;36(7):1059-1068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3669059</ArticleId><ArticleId IdType="pubmed">23814343</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson B, Tatangelo G, McCabe M. Depression and anxiety among partner and offspring carers of people with dementia: A systematic review. Gerontol. 2019;59(5):e597-e610.</Citation><ArticleIdList><ArticleId IdType="pubmed">29878117</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun M, Knight BG, Youn G. Differences in stress and coping models of emotional distress among Korean, Korean-American and White-American caregivers. Aging &amp; Ment Heal. 2007;11(1):20-29.</Citation><ArticleIdList><ArticleId IdType="pubmed">17164154</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang BL, Brecht ML, Carter PA. Predictors of social support and caregiver outcomes. Women &amp; heal. 2001;33(1-2):39-61.</Citation><ArticleIdList><ArticleId IdType="pubmed">11523640</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth T, Jaeger S, Jin R, Kalsekar A, Stang PE, Kessler RC. Sleep problems, comorbid mental disorders, and role functioning in the national comorbidity survey replication. Biolo Psychiatry. 2006;60(12):1364-1371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1894656</ArticleId><ArticleId IdType="pubmed">16952333</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Li C, Shi Z, et al. Caregiver burden and prevalence of depression, anxiety and sleep disturbances in Alzheimer&#x2019;s disease caregivers in China. J clini nurs. 2017;26(9-10):1291-1300.</Citation><ArticleIdList><ArticleId IdType="pubmed">27681477</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaudreau SA, Spira AP, Gray HL, et al. The relationship between objectively measured sleep disturbance and dementia family caregiver distress and burden. J Geriatr Psychiatry Neuro. 2008;21(3):159-165.</Citation><ArticleIdList><ArticleId IdType="pubmed">18503035</ArticleId></ArticleIdList></Reference><Reference><Citation>Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193-213.</Citation><ArticleIdList><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Zhang H, Zhang M, et al. Prevalence and risk factors of anxiety, depression, and sleep problems among caregivers of people living with neurocognitive disorders during the COVID-19 pandemic. Front Psychiatry 2021;11:590343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820074</ArticleId><ArticleId IdType="pubmed">33488423</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali RM, Zolezzi M, Awaisu A. A systematic review of instruments for the assessment of insomnia in adults. Nat Sci Sleep 2020;12:377-409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7342485</ArticleId><ArticleId IdType="pubmed">32753991</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Rio Jo&#xe3;o KA, de Jesus SN, Carmo C, Pinto P. Sleep quality components and mental health: Study with a non-clinical population. Psychiatry res. 2018;269:244-250.</Citation><ArticleIdList><ArticleId IdType="pubmed">30153603</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsawh HJ, Stein MB, Belik S-L, Jacobi F, Sareen J. Relationship of anxiety disorders, sleep quality, and functional impairment in a community sample. J Psychiatric Res. 2009;43(10):926-933.</Citation><ArticleIdList><ArticleId IdType="pubmed">19269650</ArticleId></ArticleIdList></Reference><Reference><Citation>Argyriou AA, Karanasios P, Assimakopoulos K, et al. Assessing the quality of sleep in greek primary caregivers of patients with secondary progressive multiple sclerosis: A cross-sectional study. J Pain Symptom Manage. 2011;42(4):541-547.</Citation><ArticleIdList><ArticleId IdType="pubmed">21444179</ArticleId></ArticleIdList></Reference><Reference><Citation>Murawski B, Wade L, Plotnikoff RC, Lubans DR, Duncan MJ. A systematic review and meta-analysis of cognitive and behavioral interventions to improve sleep health in adults without sleep disorders. Sleep Med Rev. 2018;40:160-169.</Citation><ArticleIdList><ArticleId IdType="pubmed">29397329</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro CM, Lee KA, Bliwise DL, Urizar GG, Woodward SH, King AC. Sleep patterns and sleep-related factors between caregiving and non-caregiving women. Behav Sleep Med. 2009;7(3):164-179.</Citation><ArticleIdList><ArticleId IdType="pubmed">19568966</ArticleId></ArticleIdList></Reference><Reference><Citation>Pignatiello GA, Martin R, Kraus N, Gutierrez A, Cusick R, Hickman RL. Sleep interventions for informal caregivers of persons with dementia: A systematic review. West J Nurs Res 2021;43(6).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9887937</ArticleId><ArticleId IdType="pubmed">34085889</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer RL, Kroenke K, Williams JBW, L&#xf6;we B. A brief measure for assessing generalized anxiety disorder. Arc Int Med. 2006;166(10):1092-1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chr Dis. 1987;40(5):373-383.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676-682.</Citation><ArticleIdList><ArticleId IdType="pubmed">21330339</ArticleId></ArticleIdList></Reference><Reference><Citation>Degroot V, Beckerman H, Lankhorst G, Bouter L. How to measure comorbiditya critical review of available methods. J Clin Epidemiolo. 2003;56(3):221-229.</Citation><ArticleIdList><ArticleId IdType="pubmed">12725876</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollayeva T, Thurairajah P, Burton K, Mollayeva S, Shapiro CM, Colantonio A. The pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis. Sleep Med Rev 2016;25:52-73.</Citation><ArticleIdList><ArticleId IdType="pubmed">26163057</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E, Hsieh S, Savage S, Hornberger M, Hodges JR. Clinical staging and disease progression in frontotemporal dementia. Neurology. 2010;74(20):1591-1597.</Citation><ArticleIdList><ArticleId IdType="pubmed">20479357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail Z, Ag&#xfc;era-Ortiz L, Brodaty H, et al. The mild behavioral impairment checklist (MBI-C): A rating scale for neuropsychiatric symptoms in pre-dementia populations. J Alzheimer&#x2019;s Dis. 2017;56(3):929-938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5652315</ArticleId><ArticleId IdType="pubmed">28059789</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew TM. Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer&#x2019;s and non-Alzheimer&#x2019;s dementia. Alzheimer&#x2019;s Res Ther. 2020;12(1):35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110750</ArticleId><ArticleId IdType="pubmed">32234066</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallant J. PART FOUR: Statistical techniques to explore relationships among variables. In: Education M-H, eds. SPSS Survival Manual: A Step by Step Guide to Data Analysis Using SPSS. ProQuest Ebook Central; 2000:121-202.</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Society . Services, support and housing. In: Caring for a person with dementia: A practical guide. London: Alzheimer&#x2019;s Society; 2021:89-106.</Citation></Reference><Reference><Citation>Maayan N, Soares-Weiser K, Lee H. Respite care for people with dementia and their carers. Cochrane database syst rev. 2014;16(1):CD004396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11089513</ArticleId><ArticleId IdType="pubmed">24435941</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng S-T, Zhang F. A comprehensive meta-review of systematic reviews and meta-analyses on nonpharmacological interventions for informal dementia caregivers. BMC Geriatr. 2020;20(1):137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158025</ArticleId><ArticleId IdType="pubmed">32293325</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinson M, Carr SM, Rushmer R, Abley C. Investigating what works to support family carers of people with dementia: a rapid realist review. J pub heal (Oxford, England). 2016;39(4):e290-e301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5939885</ArticleId><ArticleId IdType="pubmed">27679663</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephan A, Bieber A, Bieber A, et al. Barriers and facilitators to the access to and use of formal dementia care: Findings of a focus group study with people with dementia, informal carers and health and social care professionals in eight European countries. BMC Geriatr. 2018;18(1):131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5987478</ArticleId><ArticleId IdType="pubmed">29866102</ArticleId></ArticleIdList></Reference><Reference><Citation>Southby K. Barriers to non-residential respite care for adults with moderate to complex needs: A UK perspective. J Int Disabili. 2017;21(4):366-386.</Citation><ArticleIdList><ArticleId IdType="pubmed">27440229</ArticleId></ArticleIdList></Reference><Reference><Citation>Boots LMM, Wolfs CAG, Verhey FRJ, Kempen GIJM, de Vugt ME. Qualitative study on needs and wishes of early-stage dementia caregivers: The paradox between needing and accepting help. Int Psychoger. 2015;27(6):927-936.</Citation><ArticleIdList><ArticleId IdType="pubmed">25566686</ArticleId></ArticleIdList></Reference><Reference><Citation>Neckelmann D, Mykletun A, Dahl AA. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep. 2007;30(7):873-880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1978360</ArticleId><ArticleId IdType="pubmed">17682658</ArticleId></ArticleIdList></Reference><Reference><Citation>Vedaa &#xd8;, Krossbakken E, Grimsrud ID, et al. Prospective study of predictors and consequences of insomnia: Personality, lifestyle, mental health, and work-related stressors. Sleep Med. 2016;20:51-58.</Citation><ArticleIdList><ArticleId IdType="pubmed">27318226</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao C, Chapagain NY, Scullin MK. Sleep duration and sleep quality in caregivers of patients with dementia. JAMA Net Open 2019;2(8):e199891.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6714015</ArticleId><ArticleId IdType="pubmed">31441938</ArticleId></ArticleIdList></Reference><Reference><Citation>Cupidi C, Realmuto S, Lo Coco G, et al. Sleep quality in caregivers of patients with Alzheimer&#x2019;s disease and Parkinson&#x2019;s disease and its relationship to quality of life. Int Psychogeriatr 2013;25(7):1.</Citation><ArticleIdList><ArticleId IdType="pubmed">22652066</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson EO, Roth T, Breslau N. The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. J Psychiatr Res. 2006;40(8):700-708.</Citation><ArticleIdList><ArticleId IdType="pubmed">16978649</ArticleId></ArticleIdList></Reference><Reference><Citation>Passarella S, Duong M-T. Diagnosis and treatment of insomnia. Am J Heal-Sys Phar. 2008;65(10):927-934.</Citation><ArticleIdList><ArticleId IdType="pubmed">18463341</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel D, Steinberg J, Patel P. Insomnia in the elderly: A review. J clin sleep med. 2018;14(6):1017-1024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5991956</ArticleId><ArticleId IdType="pubmed">29852897</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki R, Ayabe M, Kumahara H, Morimura K, Inukai Y. Effects of light-to-moderate intensity aerobic exercise on objectively measured sleep parameters among community-dwelling older people. Arc gerontolo geriatr 2021;94:104336.</Citation><ArticleIdList><ArticleId IdType="pubmed">33493954</ArticleId></ArticleIdList></Reference><Reference><Citation>Golshani G, Pirnia B. Comparison of mindfulness-based cognitive therapy (MBCT) with acceptance and commitment therapy (ACT) On the severity of fatigue, improvement of sleep quality and resilience in a patient with prostate cancer: A single-case experimental study. Int J Cancer Manag. 2019;12(2):e88416.</Citation></Reference><Reference><Citation>Salari N., Khazaie H, Hosseinian-Far A, et al. The effect of acceptance and commitment therapy on insomnia and sleep quality: A systematic review. BMC Neurolo. 2020;20(1):300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7425538</ArticleId><ArticleId IdType="pubmed">32791960</ArticleId></ArticleIdList></Reference><Reference><Citation>McCurry SM, Gibbons LE, Logsdon RG, Vitiello MV, Teri L. Insomnia in caregivers of persons with dementia: who is at risk and what can be done about it? Sleep Med Clin. 2009;4(4):519-526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2799891</ArticleId><ArticleId IdType="pubmed">20046806</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu Y-C, Lee Y-N, Wang P-C, et al. Family caregivers&#x2019; sleep disturbance and its associations with multilevel stressors when caring for patients with dementia. Aging &amp; Men Heal. 2014;18(1):92-101.</Citation><ArticleIdList><ArticleId IdType="pubmed">24053456</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth A, Whitehead L, Quigley E, Vafeas C, Emery L. Disrupted sleep and associated factors in Australian dementia caregivers: A cross-sectional study. BMC Geriatri. 2020;20(1):312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7453710</ArticleId><ArticleId IdType="pubmed">32854627</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson RH, Gander PH, Jones LM. Understanding the sleep problems of people with dementia and their family caregivers. Dementia. 2014;13(3):350-365.</Citation><ArticleIdList><ArticleId IdType="pubmed">24339061</ArticleId></ArticleIdList></Reference><Reference><Citation>McCurry SM, Logsdon RG, Teri L, Vitiello MV. Sleep disturbances in caregivers of persons with dementia: Contributing factors and treatment implications. Sleep Med Rev. 2007;11(2):143-153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1861844</ArticleId><ArticleId IdType="pubmed">17287134</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaffer KM, Carter P, Garland SN, Applebaum AJ. Cognitive behavioral therapy for insomnia for caregivers. In: Applebaum AJ, ed. Cancer Caregivers. Oxford University Press;2019: 201-218.</Citation></Reference><Reference><Citation>Jin JW, Nowakowski S, Taylor A, Medina LD, Kunik ME. Cognitive behavioral therapy for mood and insomnia in persons with dementia. Alzheimer Dis Assoc Disord. 2021;35(4):366-373.</Citation><ArticleIdList><ArticleId IdType="pubmed">33929370</ArticleId></ArticleIdList></Reference><Reference><Citation>van Ryn M, Sanders S, Kahn K, et al. Objective burden, resources, and other stressors among informal cancer caregivers: A hidden quality issue? Psycho-Oncolo. 2011;20(1):44-52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4479404</ArticleId><ArticleId IdType="pubmed">20201115</ArticleId></ArticleIdList></Reference><Reference><Citation>Mineka S, Anand D, Sumner JA. Important issues in understanding comorbidity between generalized anxiety disorder and major depressive disorder. In: Richards CS, O'Hara MW, eds. The Oxford Handbook of Depression and Comorbidity. Oxford University Press; 2014.</Citation></Reference><Reference><Citation>Grandner MA, Kripke DF, Yoon I-Y, Youngstedt SD. Criterion validity of the pittsburgh sleep quality index: Investigation in a non-clinical sample. Sleep Biolog Rhy. 2006;4(2):129-136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3399671</ArticleId><ArticleId IdType="pubmed">22822303</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35436334</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1758-5341</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>24</Day></PubDate></JournalIssue><Title>The Gerontologist</Title><ISOAbbreviation>Gerontologist</ISOAbbreviation></Journal><ArticleTitle>Reactions to Amyloid PET Scan Results and Levels of Anxious and Depressive Symptoms: CARE IDEAS Study.</ArticleTitle><Pagination><StartPage>71</StartPage><EndPage>81</EndPage><MedlinePgn>71-81</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/geront/gnac051</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">Few studies have examined care partners' reactions to their loved ones receiving amyloid-&#x3b2; positron emission tomography (PET) scan results, which can be indicative of Alzheimer's disease. We explored care partners' reactions qualitatively, and checked the association of scan results and diagnostic category (dementia vs mild cognitive impairment [MCI]) with care partner anxious and depressive symptoms through quantitative analysis.</AbstractText><AbstractText Label="RESEARCH DESIGN AND METHODS">Using data from 1,761 care partners in the Caregivers' Reactions and Experience, a supplemental study of the Imaging Dementia Evidence for Amyloid Scanning study, we applied an exploratory sequential mixed-methods design and examined the reactions of 196 care partners to receiving amyloid PET scan results through open-ended interview questions. Based on the qualitative content analysis, we hypothesized there would be an association of care partners' depressive (Patient Health Questionnaire-2) and anxious (6-item State-Trait Anxiety Inventory) symptoms with scan results and diagnostic category which we then tested with logistic regression models.</AbstractText><AbstractText Label="RESULTS">Content analysis of open-ended responses suggests that when scan results follow the care partner's expectations, for example, elevated amyloid in persons with dementia, care partners report relief and gratitude for the information, rather than distress. Adjusted logistic regression models of survey responses support this finding, with significantly higher odds of anxiety, but not depressive symptoms, among care partners of persons with MCI versus dementia and elevated amyloid.</AbstractText><AbstractText Label="DISCUSSION AND IMPLICATIONS">Care partners of persons with MCI reported distress and had higher odds of anxiety after receiving elevated amyloid PET scan results than care partners of persons with dementia. This has the potential to inform clinical practice through recommendations for mental health screening and referrals.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>B&#xe9;langer</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center for Gerontology and Healthcare Research, Brown University, School of Public Health, Providence, Rhode Island, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Services, Policy &amp; Practice, Brown University, School of Public Health, Providence, Rhode Island, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Silva</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Gerontology and Healthcare Research, Brown University, School of Public Health, Providence, Rhode Island, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>Michaela S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Center for Gerontology and Healthcare Research, Brown University, School of Public Health, Providence, Rhode Island, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Houtven</LastName><ForeName>Courtney H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Health Care System, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shepherd-Banigan</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Health Care System, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Valerie A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Health Care System, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wetle</LastName><ForeName>Terrie T</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Center for Gerontology and Healthcare Research, Brown University, School of Public Health, Providence, Rhode Island, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Services, Policy &amp; Practice, Brown University, School of Public Health, Providence, Rhode Island, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG053934</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gerontologist</MedlineTA><NlmUniqueID>0375327</NlmUniqueID><ISSNLinking>0016-9013</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000682">Amyloid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000682" MajorTopicYN="N">Amyloid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="Y">Anxiety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="Y">Depression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Anxiety</Keyword><Keyword MajorTopicYN="N">Caregiving</Keyword><Keyword MajorTopicYN="N">Mild cognitive impairment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>18</Day><Hour>17</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35436334</ArticleId><ArticleId IdType="pmc">PMC9872765</ArticleId><ArticleId IdType="doi">10.1093/geront/gnac051</ArticleId><ArticleId IdType="pii">6570000</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>2021 Alzheimer&#x2019;s disease facts and figures. (2021). Alzheimer&#x2019;s &amp; Dementia, 17(3), 327&#x2013;406. doi:10.1002/alz.12328</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12328</ArticleId><ArticleId IdType="pubmed">33756057</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., Snyder, P. J., Carrillo, M. C., Thies, B., &amp; Phelps, C. H. (2011). The diagnosis of mild cognitive impairment due to Alzheimer&#x2019;s disease: Recommendations from the National Institute on Aging&#x2013;Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimer&#x2019;s &amp; Dementia, 7(3), 270&#x2013;279. doi:10.1016/j.jalz.2011.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.03.008</ArticleId><ArticleId IdType="pmc">PMC3312027</ArticleId><ArticleId IdType="pubmed">21514249</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing, Inc. doi:10.1176/appi.books.9780890425596</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.books.9780890425596</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensa&#xef;dane, M. R., Beauregard, J.-M., Poulin, S., Buteau, F.-A., Guimond, J., Bergeron, D., Verret, L., Fortin, M.-P., Houde, M., Bouchard, R. W., Soucy, J.-P., &amp; Laforce, R. (2016). Clinical utility of amyloid PET imaging in the differential diagnosis of atypical dementias and its impact on caregivers. Journal of Alzheimer&#x2019;s Disease, 52(4), 1251&#x2013;1262. doi:10.3233/JAD-151180</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-151180</ArticleId><ArticleId IdType="pubmed">27104896</ArticleId></ArticleIdList></Reference><Reference><Citation>Black, B. S., Taylor, H. A., Rabins, P. V., &amp; Karlawish, J. (2018). Study partners perform essential tasks in dementia research and can experience burdens and benefits in this role. Dementia, 17(4), 494&#x2013;514. doi:10.1177/1471301216648796</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301216648796</ArticleId><ArticleId IdType="pmc">PMC5107353</ArticleId><ArticleId IdType="pubmed">27179001</ArticleId></ArticleIdList></Reference><Reference><Citation>Blennow, K., Mattsson, N., Sch&#xf6;ll, M., Hansson, O., &amp; Zetterberg, H. (2015). Amyloid biomarkers in Alzheimer&#x2019;s disease. Trends in Pharmacological Sciences, 36(5), 297&#x2013;309. doi:10.1016/j.tips.2015.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2015.03.002</ArticleId><ArticleId IdType="pubmed">25840462</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodaty, H., &amp; Donkin, M. (2009). Family caregivers of people with dementia. Dialogues in Clinical Neuroscience, 11(2), 217&#x2013;228. doi:10.31887/dcns.2009.11.2/hbrodaty</Citation><ArticleIdList><ArticleId IdType="doi">10.31887/dcns.2009.11.2/hbrodaty</ArticleId><ArticleId IdType="pmc">PMC3181916</ArticleId><ArticleId IdType="pubmed">19585957</ArticleId></ArticleIdList></Reference><Reference><Citation>Byszewski, A. M., Molnar, F. J., Aminzadeh, F., Eisner, M., Gardezi, F., &amp; Bassett, R. (2007). Dementia diagnosis disclosure: A study of patient and caregiver perspectives. Alzheimer Disease and Associated Disorders, 21(2), 107&#x2013;114. doi:10.1097/WAD.0b013e318065c481</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0b013e318065c481</ArticleId><ArticleId IdType="pubmed">17545735</ArticleId></ArticleIdList></Reference><Reference><Citation>Clipp, E. C., &amp; George, L. K. (1993). Dementia and cancer: A comparison of spouse caregivers. The Gerontologist, 33(4), 534&#x2013;541. doi:10.1093/geront/33.4.534</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/33.4.534</ArticleId><ArticleId IdType="pubmed">8375684</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper, C., Balamurali, T. B. S., &amp; Livingston, G. (2007). A systematic review of the prevalence and covariates of anxiety in caregivers of people with dementia. International Psychogeriatrics, 19(2), 175&#x2013;195. doi:10.1017/S1041610206004297</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610206004297</ArticleId><ArticleId IdType="pubmed">17005068</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuijpers, P. (2005). Depressive disorders in caregivers of dementia patients: A systematic review. Aging &amp; Mental Health, 9(4), 325&#x2013;330. doi:10.1080/13607860500090078</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607860500090078</ArticleId><ArticleId IdType="pubmed">16019288</ArticleId></ArticleIdList></Reference><Reference><Citation>Farias, S. T., Mungas, D., Reed, B. R., Cahn-Weiner, D., Jagust, W., Baynes, K., &amp; Decarli, C. (2008). The measurement of everyday cognition (ECog): Scale development and psychometric properties. Neuropsychology, 22(4), 531&#x2013;544. doi:10.1037/0894-4105.22.4.531</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0894-4105.22.4.531</ArticleId><ArticleId IdType="pmc">PMC2877034</ArticleId><ArticleId IdType="pubmed">18590364</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleisher, A. S., Chen, K., Liu, X., Roontiva, A., Thiyyagura, P., Ayutyanont, N., Joshi, A. D., Clark, C. M., Mintun, M. A., Pontecorvo, M. J., Doraiswamy, P. M., Johnson, K. A., Skovronsky, D. M., &amp; Reiman, E. M. (2011). Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer&#x2019;s disease. Archives of Neurology, 68(11), 1404&#x2013;1411. doi:10.1001/archneurol.2011.150</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21747008</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo, J. J., &amp; Lebowitz, B. D. (1999). The epidemiology of common late-life mental disorders in the community: Themes for the new century. Psychiatric Services, 50(9), 1158&#x2013;1166. doi:10.1176/ps.50.9.1158</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/ps.50.9.1158</ArticleId><ArticleId IdType="pubmed">10478901</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Alberca, J. M., Lara, J. P., &amp; Berthier, M. L. (2011). Anxiety and depression in caregivers are associated with patient and caregiver characteristics in Alzheimer&#x2019;s disease. International Journal of Psychiatry in Medicine, 41(1), 57&#x2013;69. doi:10.2190/PM.41.1.f</Citation><ArticleIdList><ArticleId IdType="doi">10.2190/PM.41.1.f</ArticleId><ArticleId IdType="pubmed">21495522</ArticleId></ArticleIdList></Reference><Reference><Citation>Green, R. C., Roberts, J. S., Cupples, L. A., Relkin, N. R., Whitehouse, P. J., Brown, T., Eckert, S. L., Butson, M., Sadovnick, A. D., Quaid, K. A., Chen, C., Cook-Deegan, R., Farrer, L. A., R. E., &amp; VEAL Study Group (2009). Disclosure of APOE genotype for risk of Alzheimer&#x2019;s disease. The New England Journal of Medicine, 361(3), 245&#x2013;254. doi:10.1056/NEJMoa0809578</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0809578</ArticleId><ArticleId IdType="pmc">PMC2778270</ArticleId><ArticleId IdType="pubmed">19605829</ArticleId></ArticleIdList></Reference><Reference><Citation>Grill, J. D., Cox, C. G., Kremen, S., Mendez, M. F., Teng, E., Shapira, J., Ringman, J. M., &amp; Apostolova, L. G. (2017). Patient and caregiver reactions to clinical amyloid imaging. Alzheimer&#x2019;s &amp; dementia: the journal of the Alzheimer&#x2019;s Association, 13(8), 924&#x2013;932. doi:10.1016/j.jalz.2017.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2017.01.001</ArticleId><ArticleId IdType="pmc">PMC5544590</ArticleId><ArticleId IdType="pubmed">28174068</ArticleId></ArticleIdList></Reference><Reference><Citation>Grundman, M., Pontecorvo, M. J., Salloway, S. P., Doraiswamy, P. M., Fleisher, A. S., Sadowsky, C. H., Nair, A. K., Siderowf, A., Lu, M., Arora, A. K., Agbulos, A., Flitter, M. L., Krautkramer, M. J., Sarsour, K., Skovronsky, D. M., Mintun, M. A., &amp; 45-A17 Study Group. (2013). Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline. Alzheimer Disease and Associated Disorders, 27(1), 4&#x2013;15. doi:10.1097/WAD.0b013e318279d02a</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0b013e318279d02a</ArticleId><ArticleId IdType="pubmed">23203162</ArticleId></ArticleIdList></Reference><Reference><Citation>Haley, W. E., Gitlin, L. N., Wisniewski, S. R., Mahoney, D. F., Coon, D. W., Winter, L., Corcoran, M., Schinfeld, S., &amp; Ory, M. (2004). Well-being, appraisal, and coping in African-American and Caucasian dementia caregivers: Findings from the REACH study. Aging &amp; Mental Health, 8(4), 316&#x2013;329. doi:10.1080/13607860410001728998</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607860410001728998</ArticleId><ArticleId IdType="pubmed">15370048</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh, H.-F., &amp; Shannon, S. E. (2005). Three approaches to qualitative content analysis. Qualitative Health Research, 15(9), 1277&#x2013;1288. doi:10.1177/1049732305276687</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1049732305276687</ArticleId><ArticleId IdType="pubmed">16204405</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., Liu, E., Molinuevo, J. L., Montine, T., Phelps, C., Rankin, K. P., Rowe, C. C., Scheltens, P., Siemers, E., Snyder, H. M., &#x2026; Silverberg, N. (2018). NIA-AA Research Framework: Toward a biological definition of Alzheimer&#x2019;s disease. Alzheimer&#x2019;s &amp; Dementia, 14(4), 535&#x2013;562. doi:10.1016/j.jalz.2018.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.02.018</ArticleId><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>James, H. J., Van Houtven, C. H., Lippmann, S., Burke, J. R., Shepherd-Banigan, M., Belanger, E., Wetle, T. F., &amp; Plassman, B. L. (2020). How accurately do patients and their care partners report results of amyloid-&#x3b2; PET scans for Alzheimer&#x2019;s disease assessment? Journal of Alzheimer&#x2019;s Disease, 74(2), 625&#x2013;636. doi:10.3233/JAD-190922</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-190922</ArticleId><ArticleId IdType="pmc">PMC7183243</ArticleId><ArticleId IdType="pubmed">32065790</ArticleId></ArticleIdList></Reference><Reference><Citation>Joling, K. J., van Marwijk, H. W. J., Veldhuijzen, A. E., van der Horst, H. E., Scheltens, P., Smit, F., &amp; van Hout, H. P. J. (2015). The two-year incidence of depression and anxiety disorders in spousal caregivers of persons with dementia: Who is at the greatest risk? The American Journal of Geriatric Psychiatry, 23(3), 293&#x2013;303. doi:10.1016/j.jagp.2014.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2014.05.005</ArticleId><ArticleId IdType="pubmed">24935785</ArticleId></ArticleIdList></Reference><Reference><Citation>Jutkowitz, E., Van Houtven, C. H., Plassman, B. L., &amp; Mor, V. (2020). Willingness to undergo a risky treatment to improve cognition among persons with cognitive impairment who received an amyloid PET scan. Alzheimer Disease and Associated Disorders, 34(1), 1&#x2013;9. doi:10.1097/WAD.0000000000000338</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0000000000000338</ArticleId><ArticleId IdType="pmc">PMC7015762</ArticleId><ArticleId IdType="pubmed">31414990</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke, K., Spitzer, R. L., &amp; Williams, J. B. W. (2003). The Patient Health Questionnaire-2: Validity of a two-item depression screener. Medical Care, 41(11), 1284&#x2013;1292. doi:10.1097/01.MLR.0000093487.78664.3C</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.MLR.0000093487.78664.3C</ArticleId><ArticleId IdType="pubmed">14583691</ArticleId></ArticleIdList></Reference><Reference><Citation>Largent, E. A., Abera, M., Harkins, K., Feldman, S. J., Uhlmann, W. R., Roberts, J. S., Karlawish, J., R. E., &amp; VEAL-SCAN Team (2021). Family members&#x2019; perspectives on learning cognitively unimpaired older adults&#x2019; amyloid-&#x3b2; PET scan results. Journal of the American Geriatrics Society, 69(11), 3203&#x2013;3211. doi:10.1111/jgs.17362</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17362</ArticleId><ArticleId IdType="pmc">PMC8595546</ArticleId><ArticleId IdType="pubmed">34252201</ArticleId></ArticleIdList></Reference><Reference><Citation>Largent, E. A., &amp; Karlawish, J. (2019). Preclinical Alzheimer disease and the dawn of the pre-caregiver. JAMA Neurology, 76(6), 631&#x2013;632. doi:10.1001/jamaneurol.2019.0165</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.0165</ArticleId><ArticleId IdType="pmc">PMC7171977</ArticleId><ArticleId IdType="pubmed">30855658</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim, Y. Y., Maruff, P., Getter, C., &amp; Snyder, P. J. (2016). Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability. Alzheimer&#x2019;s &amp; Dementia, 12(4), 454&#x2013;458. doi:10.1016/j.jalz.2015.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2015.09.005</ArticleId><ArticleId IdType="pubmed">26750717</ArticleId></ArticleIdList></Reference><Reference><Citation>Lingler, J. H., Sereika, S. M., Butters, M. A., Cohen, A. D., Klunk, W. E., Knox, M. L., McDade, E., Nadkarni, N. K., Roberts, J. S., Tamres, L. K., &amp; Lopez, O. L. (2020). A randomized controlled trial of amyloid positron emission tomography results disclosure in mild cognitive impairment. Alzheimer&#x2019;s &amp; Dementia, 16(9), 1330&#x2013;1337. doi:10.1002/alz.12129</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12129</ArticleId><ArticleId IdType="pmc">PMC7541680</ArticleId><ArticleId IdType="pubmed">32588971</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma, M., Dorstyn, D., Ward, L., &amp; Prentice, S. (2018). Alzheimers&#x2019; disease and caregiving: A meta-analytic review comparing the mental health of primary carers to controls. Aging &amp; Mental Health, 22(11), 1395&#x2013;1405. doi:10.1080/13607863.2017.1370689</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2017.1370689</ArticleId><ArticleId IdType="pubmed">28871796</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcus, C., Mena, E., &amp; Subramaniam, R. M. (2014). Brain PET in the diagnosis of Alzheimer&#x2019;s disease. Clinical Nuclear Medicine, 39(10), e413&#x2013;e422; quiz e423&#x2013;e426. doi:10.1097/RLU.0000000000000547</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RLU.0000000000000547</ArticleId><ArticleId IdType="pmc">PMC4332800</ArticleId><ArticleId IdType="pubmed">25199063</ArticleId></ArticleIdList></Reference><Reference><Citation>Marteau, T. M., &amp; Bekker, H. (1992). The development of a six-item short-form of the state scale of the Spielberger State&#x2013;Trait Anxiety Inventory (STAI). The British Journal of Clinical Psychology, 31(3), 301&#x2013;306. doi:10.1111/j.2044-8260.1992.tb00997.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2044-8260.1992.tb00997.x</ArticleId><ArticleId IdType="pubmed">1393159</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R.Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., Mohs, R. C., Morris, J. C., Rossor, M. N., Scheltens, P., Carrillo, M. C., Thies, B., Weintraub, S., &amp; Phelps, C. H. (2011). The diagnosis of dementia due to Alzheimer&#x2019;s disease: Recommendations from the National Institute on Aging&#x2013;Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimer&#x2019;s &amp; Dementia, 7(3), 263&#x2013;269. doi:10.1016/j.jalz.2011.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.03.005</ArticleId><ArticleId IdType="pmc">PMC3312024</ArticleId><ArticleId IdType="pubmed">21514250</ArticleId></ArticleIdList></Reference><Reference><Citation>Millar, K., Jelicic, M., Bonke, B., &amp; Asbury, A. J. (1995). Assessment of preoperative anxiety: Comparison of measures in patients awaiting surgery for breast cancer. British Journal of Anaesthesia, 74(2), 180&#x2013;183. doi:10.1093/bja/74.2.180</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/74.2.180</ArticleId><ArticleId IdType="pubmed">7696068</ArticleId></ArticleIdList></Reference><Reference><Citation>Milne, R., Bunnik, E., Diaz, A., Richard, E., Badger, S., Gove, D., Georges, J., Fauria, K., Molinuevo, J.-L., Wells, K., Ritchie, C., &amp; Brayne, C. (2018). Perspectives on communicating biomarker-based assessments of Alzheimer&#x2019;s disease to cognitively healthy individuals. Journal of Alzheimer&#x2019;s Disease, 62(2), 487&#x2013;498. doi:10.3233/JAD-170813</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170813</ArticleId><ArticleId IdType="pmc">PMC5836405</ArticleId><ArticleId IdType="pubmed">29480179</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke, N., Kupferschmidt, A. L., Claxton, A., Smith, J. Z., Chappell, N., &amp; Beattie, B. L. (2010). Psychological resilience predicts depressive symptoms among spouses of persons with Alzheimer disease over time. Aging &amp; Mental Health, 14(8), 984&#x2013;993. doi:10.1080/13607863.2010.501063</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2010.501063</ArticleId><ArticleId IdType="pubmed">21069604</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinquart, M., &amp; S&#xf6;rensen, S. (2003). Differences between caregivers and noncaregivers in psychological health and physical health: A meta-analysis. Psychology and Aging, 18(2), 250&#x2013;267. doi:10.1037/0882-7974.18.2.250</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0882-7974.18.2.250</ArticleId><ArticleId IdType="pubmed">12825775</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovici, G. D., Gatsonis, C., Apgar, C., Chaudhary, K., Gareen, I., Hanna, L., Hendrix, J., Hillner, B. E., Olson, C., Lesman-Segev, O. H., Romanoff, J., Siegel, B. A., Whitmer, R. A., &amp; Carrillo, M. C. (2019). Association of amyloid positron emission tomography with subsequent change in clinical management among Medicare beneficiaries with mild cognitive impairment or dementia. Journal of American Medical Association, 321(13), 1286&#x2013;1294. doi:10.1001/jama.2019.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.2000</ArticleId><ArticleId IdType="pmc">PMC6450276</ArticleId><ArticleId IdType="pubmed">30938796</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallim, A. B., Sayampanathan, A. A., Cuttilan, A., &amp; Ho, R. (2015). Prevalence of mental health disorders among caregivers of patients with Alzheimer disease. Journal of the American Medical Directors Association, 16(12), 1034&#x2013;1041. doi:10.1016/j.jamda.2015.09.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2015.09.007</ArticleId><ArticleId IdType="pubmed">26593303</ArticleId></ArticleIdList></Reference><Reference><Citation>Spielberger, C. D., Gorsuch, R. L., Lushene, R., Vagg, P. R., &amp; Jacobs, G. A. (1983). Manual for the State&#x2013;Trait Anxiety Inventory. Consulting Psychologists Press.</Citation></Reference><Reference><Citation>StataCorp. (2017). Stata statistical software (Version Release 15) [Computer software]. StataCorp LP.</Citation></Reference><Reference><Citation>Taswell, C., Donohue, C., Mastwyk, M., Louey, A. G., Giummarra, J., Robertson, J., Darby, D. G., Masters, C. L., &amp; Rowe, C. C. (2018). Safety of disclosing amyloid imaging results to MCI and AD patients. Mental Health in Family Medicine, 14, 748&#x2013;756. doi:10.1016/j.jagp.2017.01.147</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2017.01.147</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomaszewski Farias, S., Mungas, D., Harvey, D. J., Simmons, A., Reed, B. R., &amp; Decarli, C. (2011). The measurement of everyday cognition: Development and validation of a short form of the everyday cognition scales. Alzheimer&#x2019;s &amp; Dementia, 7(6), 593&#x2013;601. doi:10.1016/j.jalz.2011.02.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.02.007</ArticleId><ArticleId IdType="pmc">PMC3211103</ArticleId><ArticleId IdType="pubmed">22055976</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson, B., Tatangelo, G., &amp; McCabe, M. (2019). Depression and anxiety among partner and offspring carers of people with dementia: A systematic review. The Gerontologist, 59(5), e597&#x2013;e610. doi:10.1093/geront/gny049</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gny049</ArticleId><ArticleId IdType="pubmed">29878117</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35420258</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-5279</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</Title><ISOAbbreviation>Alzheimers Dement</ISOAbbreviation></Journal><ArticleTitle>The Collaborative Approach for Asian Americans and Pacific Islanders Research and Education (CARE): A recruitment registry for Alzheimer's disease and related dementias, aging, and caregiver-related research.</ArticleTitle><Pagination><StartPage>433</StartPage><EndPage>443</EndPage><MedlinePgn>433-443</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/alz.12667</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Clinical research focused on aging, Alzheimer's disease and related dementias (ADRD), and caregiving often does not recruit Asian Americans and Pacific Islanders (AAPIs).</AbstractText><AbstractText Label="METHODS">With funding from the National Institute on Aging, we designed and launched the Collaborative Approach for AAPIs Research and Education (CARE), a research recruitment registry to increase AAPIs' participation in ADRD, aging, and caregiving research. We present the design of this novel recruitment program.</AbstractText><AbstractText Label="RESULTS">CARE uses community-based participatory research methods that are culturally and linguistically appropriate. Since CARE's launch, it has enrolled &gt;7000 AAPIs in a 1-year period. The majority enrolled in CARE via community organizations and reported never having participated in any kind of research before. CARE also engages researchers by establishing a recruitment referral request protocol.</AbstractText><AbstractText Label="DISCUSSION">CARE provides a promising venue to foster meaningful inclusion of AAPIs who are under-represented in aging and dementia-related research.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Alzheimer's &amp; Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ta Park</LastName><ForeName>Van M</ForeName><Initials>VM</Initials><Identifier Source="ORCID">0000-0001-5020-0359</Identifier><AffiliationInfo><Affiliation>Department of Community Health Systems, School of Nursing, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Asian American Research Center on Health (ARCH), University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Oanh L</ForeName><Initials>OL</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, University of California Davis, Sacramento, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsoh</LastName><ForeName>Janice Y</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Asian American Research Center on Health (ARCH), University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanaya</LastName><ForeName>Alka M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Asian American Research Center on Health (ARCH), University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzuang</LastName><ForeName>Marian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Community Health Systems, School of Nursing, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nam</LastName><ForeName>Bora</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Community Health Systems, School of Nursing, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vuong</LastName><ForeName>Quyen</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>International Children Assistance Network, Milpitas, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bang</LastName><ForeName>Joon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Asian Pacific Center on Aging, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hinton</LastName><ForeName>Ladson</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, University of California Davis, Davis, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallagher-Thompson</LastName><ForeName>Dolores</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Stanford University School of Medicine, Stanford, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Optimal Aging Center, Los Altos, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grill</LastName><ForeName>Joshua D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Institute for Memory Impairments and Neurological Disorders, University of California Irvine, Irvine, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG066519</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG083926</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R24 AG063718</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Alzheimers Dement</MedlineTA><NlmUniqueID>101231978</NlmUniqueID><ISSNLinking>1552-5260</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001213" MajorTopicYN="N">Asian</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095188" MajorTopicYN="N">Pacific Island People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">Asian Americans</Keyword><Keyword MajorTopicYN="N">Pacific Islanders</Keyword><Keyword MajorTopicYN="N">aging</Keyword><Keyword MajorTopicYN="N">caregiving</Keyword><Keyword MajorTopicYN="N">recruitment registry</Keyword></KeywordList><CoiStatement>CONFLICTS OF INTEREST. The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>8</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35420258</ArticleId><ArticleId IdType="mid">NIHMS1838240</ArticleId><ArticleId IdType="pmc">PMC9562598</ArticleId><ArticleId IdType="doi">10.1002/alz.12667</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alzheimer&#x2019;s Association. Alzheimer&#x2019;s Disease Facts and Figures. Accessed
October 8, 2021. https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Impact Movement. Alzheimer&#x2019;s Research Funding at NIH Gets Important Boost in House Labor-HHS Appropriations Budget. Accessed
October 8, 2021. https://alzimpact.org/press/press_release/id/121</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Association International Conference. New National Strategy for Recruitment and Participation In Alzheimer&#x2019;s Disease Clinical Trials Takes Shape. Accessed
October 8, 2021. https://www.alz.org/aaic/downloads2018/Mon-pm-briefing-clinical-research-recruitment-strategy.pdf</Citation></Reference><Reference><Citation>Grill JD, Holbrook A, Pierce A, Hoang D, Gillen DL. Attitudes toward potential participant registries. J Alzheimers Dis. 2017;56(3):939&#x2013;946. 10.3233/JAD-160873</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160873</ArticleId><ArticleId IdType="pmc">PMC5533604</ArticleId><ArticleId IdType="pubmed">28106553</ArticleId></ArticleIdList></Reference><Reference><Citation>Grill JD, Karlawish J. Addressing the challenges to successful recruitment and retention in Alzheimer&#x2019;s disease clinical trials. Alzheimers Res Ther. 2010;2(6):34. 10.1186/alzrt58</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt58</ArticleId><ArticleId IdType="pmc">PMC3031880</ArticleId><ArticleId IdType="pubmed">21172069</ArticleId></ArticleIdList></Reference><Reference><Citation>Grill JD, Galvin JE. Facilitating Alzheimer disease research recruit ment. Alzheimer Dis Assoc Disord. 2014;28(1):1&#x2013;8. 10.1097/WAD.0000000000000016</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0000000000000016</ArticleId><ArticleId IdType="pmc">PMC3945167</ArticleId><ArticleId IdType="pubmed">24322484</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute on Aging. NIA and the National Plan to Address Alzheimer&#x2019;s Disease. Accessed
October 11, 2021. https://www.nia.nih.gov/about/nia-and-national-plan-address-alzheimers-disease</Citation></Reference><Reference><Citation>Pew Research Center. Key findings about U.S. immigrants. Pew Research Center. Accessed
October 11, 2021. http://www.pewresearch.org/fact-tank/2017/05/03/key-findings-about-us-immigrants/</Citation></Reference><Reference><Citation>National Asian Pacific Center on Aging. Asian Americans and Pacific Islanders in the United States Aged 65 Years and Older: Population, Nativity, and Language. Accessed
November 2, 2021. https://napca.org/wp-content/uploads/2017/10/65-population-report-FINAL.pdf</Citation></Reference><Reference><Citation>Vincent GK, Velkoff VA. The Next Four Decades: the Older Population in the United States: 2010 to 2050: Population Estimates and Projections. U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau. Accessed
October 11, 2021. https://www.census.gov/prod/2010pubs/p25-1138.pdf</Citation></Reference><Reference><Citation>Ross L, Beld M, Yeh J. Alzheimer&#x2019;s Disease and Related Dementias Facts and Figures in California: Current Status and Future Projections. University of California. Accessed
October 11, 2021. https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CDCB/CDPH%20Document%20Library/Alzheimers&#x2019;%20Disease%20Program/151764_Alzheimers_Disease_Facts_and_Figures_Reportv3_ADA.pdf</Citation></Reference><Reference><Citation>Woo BK. Knowledge of dementia among Chinese American immigrants. Asian J Psychiatr. 2013;6(4):351&#x2013;352. 10.1016/j.ajp.2013.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2013.03.010</ArticleId><ArticleId IdType="pubmed">23810148</ArticleId></ArticleIdList></Reference><Reference><Citation>Ta Park V, Nguyen K, Tran Y, et al. Perspectives and insights from Vietnamese American mental health professionals on how to cultureally tailor a Vietnamese dementia caregiving program. Clin Gerontol. 2018:41(3):184&#x2013;199. 10.1080/07317115.2018.1432734</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07317115.2018.1432734</ArticleId><ArticleId IdType="pubmed">29419364</ArticleId></ArticleIdList></Reference><Reference><Citation>National Alliance for Caregiving, AARP Public Policy Institute. Caregiving in the U.S. 2015: Focused look at caregivers of adults age 50+. Accessed
May 16, 2018. http://www.caregiving.org/wp-content/uploads/2015/05/2015_CaregivingintheUS_Care-Recipients-Over-50_WEB.pdf</Citation></Reference><Reference><Citation>Pinquart M, Sorensen S. Ethnic differences in stressors, resources, and psychological outcomes of family caregiving: a meta-analysis. Gerontologist. 2005;45(1):90&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">15695420</ArticleId></ArticleIdList></Reference><Reference><Citation>National Alzheimer&#x2019;s Coordinating Center (NACC). Web-Based Query System. Accessed
October 11, 2021. https://naccdata.org/requesting-data/web-query</Citation></Reference><Reference><Citation>Franzen S, Smith JE, van den Berg E, et al. Diversity in Alzheimer&#x2019;sdisease drug trials: the importance of eligibility criteria. Alzheimers Dement. 2021;10.1002/alz.12433</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12433</ArticleId><ArticleId IdType="pmc">PMC8964823</ArticleId><ArticleId IdType="pubmed">34590409</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman R, Quiroz YT, Langford O, et al. Disparities by race and ethnicity among adults recruited for a preclinical Alzheimer&#x2019;s disease trial. JAMA Network Open. 2021;4(7)10.1001/jamanetworkopen.2021.14364</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.14364</ArticleId><ArticleId IdType="pmc">PMC8261604</ArticleId><ArticleId IdType="pubmed">34228129</ArticleId></ArticleIdList></Reference><Reference><Citation>Doan LN, Takata Y, Sakuma KK, Irvin VL. Trends in clinical research including Asian American, Native Hawaiian, and Pacific Islander participants funded by the US National Institutes of Health, 1992 to 2018. JAMA Netw Open. 2019;2(7):e197432. 10.1001/jamanetworkopen.2019.7432</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.7432</ArticleId><ArticleId IdType="pmc">PMC6659145</ArticleId><ArticleId IdType="pubmed">31339543</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzuang M, Gallagher-Thompson D. Caring for Caregivers of a Person with Dementia. In: Pachana NA, Laidlaw K, eds. The Oxford Handbook of Clinical Geropsychology: International Perspectives. Oxford University Press; 2014:chap 39.</Citation></Reference><Reference><Citation>Watson JL, Ryan L, Silverberg N, Cahan V, Bernard MA. Obstacles and opportunities in Alzheimer&#x2019;s clinical trial recruitment. Health Aff (Mill-wood). 2014;33(4):574&#x2013;9. 10.1377/hlthaff.2013.1314</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2013.1314</ArticleId><ArticleId IdType="pmc">PMC4167360</ArticleId><ArticleId IdType="pubmed">24711317</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao SZ, Lai NB, Tse MM, et al. Recruitment of Chinese American elders into dementia research: the UCSF ADRC experience. Gerontologist. 2011;51 Suppl 1:S125&#x2013;S133. 10.1093/geront/gnr033</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnr033</ArticleId><ArticleId IdType="pmc">PMC3092979</ArticleId><ArticleId IdType="pubmed">21565814</ArticleId></ArticleIdList></Reference><Reference><Citation>Salazar CR, Hoang D, Gillen DL, Grill JD. Racial and ethnic differences in older adults&#x2019; willingness to be contacted about Alzheimer&#x2019;s disease research participation. Alzheimers Dement (N Y). 2020;6(1):e12023. 10.1002/trc2.12023</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12023</ArticleId><ArticleId IdType="pmc">PMC7207155</ArticleId><ArticleId IdType="pubmed">32399482</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Census Bureau. Facts for Features: Asian/Pacific American Heritage Month: May 2018. Accessed
October 12, 2021. https://www.census.gov/newsroom/facts-for-features/2018/asian-american.html</Citation></Reference><Reference><Citation>Kasenda B, von Elm E, You J, et al. Prevalence, characteristics, and publication of discontinued randomized trials. JAMA. 2014;311(10):1045&#x2013;1051. 10.1001/jama.2014.1361</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.1361</ArticleId><ArticleId IdType="pubmed">24618966</ArticleId></ArticleIdList></Reference><Reference><Citation>Vellas B, Pesce A, Robert PH, et al. AMPA workshop on challenges faced by investigators conducting Alzheimer&#x2019;s disease clinical trials. Alzheimers Dement. 2011;7(4):e109&#x2013;e117. 10.1016/j.jalz.2010.05.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2010.05.2020</ArticleId><ArticleId IdType="pubmed">21784343</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinowitz YG, Gallagher-Thompson D. Recruitment and retention of ethnic minority elders into clinical research. Alzheimer Dis Assoc Disord. 2010;24 Suppl:S35&#x2013;S41.</Citation><ArticleIdList><ArticleId IdType="pubmed">22720320</ArticleId></ArticleIdList></Reference><Reference><Citation>Aisen P, Touchon J, Andrieu S, et al. Registries and cohorts to accelerate early phase Alzheimer&#x2019;s trials. A report from the E.U./U.S. Clinical Trials in Alzheimer&#x2019;s Disease Task Force. J Prev Alzheimers Dis. 2016;3(2):68&#x2013;74. 10.14283/jpad.2016.97</Citation><ArticleIdList><ArticleId IdType="doi">10.14283/jpad.2016.97</ArticleId><ArticleId IdType="pubmed">29210442</ArticleId></ArticleIdList></Reference><Reference><Citation>Ta Park V, Grill JD, Zhu J, et al. Asian Americans and Pacific Islanders&#x2019;perspectives on participating in the CARE recruitment research registry for Alzheimer&#x2019;s disease and related dementias, aging, and caregiving research. Alzheimers Dement. 2021;7(1):e12195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8288079</ArticleId><ArticleId IdType="pubmed">34295961</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, aylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)&#x2013;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377&#x2013;381. 10.1016/j.jbi.2008.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Patridge EF, Bardyn TP. Research electronic data capture (REDCap). JMed Libr Assoc. 2018;106(1):142&#x2013;144.</Citation></Reference><Reference><Citation>Obeid JS, McGraw CA, Minor BL, et al. Procurement of shared data instruments for Research Electronic Data Capture (REDCap). J Biomed Inform. 2013;46(2):259&#x2013;65. 10.1016/j.jbi.2012.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2012.10.006</ArticleId><ArticleId IdType="pmc">PMC3600393</ArticleId><ArticleId IdType="pubmed">23149159</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Process of Translation and Adaptation of Instruments. Accessed
October 12, 2021. http://www.who.int/substance_abuse/research_tools/translation/en/</Citation></Reference><Reference><Citation>AAPI DATA. Infographic - Percentage of Asian Americans With LimitedEnglish Proficiency. Accessed
October 12, 2021. https://aapidata.com/infographic-limited-english-2-2/</Citation></Reference><Reference><Citation>Israel BA EE, Schulz AJ, Parker EA. Introduction to methods in community-based participatory research for health. In: Israel EE,Schulz AJ, Parker E, ed. Methods in Community-Based Participatory Research for Health. Jossey-Bass; 2005:3&#x2013;26.</Citation></Reference><Reference><Citation>Faridi Z, Grunbaum JA, Gray BS, Franks A, Simoes E. Community-based participatory research: necessary next steps. Prev Chronic Dis. 2007;4(3):A70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1955426</ArticleId><ArticleId IdType="pubmed">17572974</ArticleId></ArticleIdList></Reference><Reference><Citation>Minkler M, Blackwell AG, Thompson M, Tamir H. Community-based participatory research: implications for public health funding. Am J Public Health. 2003;93(8):1210&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1447939</ArticleId><ArticleId IdType="pubmed">12893597</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichtenberg PA. The generalizability of a participant registry for minority health research. Gerontologist. 2011;51 Suppl 1:S116&#x2013;S124. 10.1093/geront/gnr021</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnr021</ArticleId><ArticleId IdType="pmc">PMC3092975</ArticleId><ArticleId IdType="pubmed">21565813</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadiha LA, Washington OG, Lichtenberg PA, Green CR, Daniels KL,Jackson JS. Building a registry of research volunteers among older urban African Americans: recruitment processes and outcomes from a community-based partnership. Gerontologist. 2011;51 Suppl 1:S106&#x2013;S115. 10.1093/geront/gnr034</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnr034</ArticleId><ArticleId IdType="pmc">PMC3092980</ArticleId><ArticleId IdType="pubmed">21565812</ArticleId></ArticleIdList></Reference><Reference><Citation>Green-Harris G, Koscik RL, Houston S, et al. Using asset-based community involvement to address health disparities and increase African American Participation in ad research: experiences from the Wisconsin Alzheimer&#x2019;s Institute. Alzheimers Dement. 2017;13(7):P897&#x2013;P898. 10.1016/j.jalz.2017.07.308</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2017.07.308</ArticleId></ArticleIdList></Reference><Reference><Citation>Austrom MG, Bachman J, Altmeyer L, Gao S, Farlow M. A collaborative Alzheimer disease research exchange using a community-based Helpline as a recruitment tool. Alzheimer Dis Assoc Disord. 2010;24 Suppl:S49&#x2013;S53.</Citation><ArticleIdList><ArticleId IdType="pubmed">22720321</ArticleId></ArticleIdList></Reference><Reference><Citation>Katigbak C, Foley M, Robert L, Hutchinson MK. Experiences and lessons learned in using community-based participatory research to recruit Asian American immigrant research participants. J Nurs Scholarsh. 2016;48(2):210&#x2013;218. 10.1111/jnu.12194</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnu.12194</ArticleId><ArticleId IdType="pmc">PMC5296612</ArticleId><ArticleId IdType="pubmed">26836035</ArticleId></ArticleIdList></Reference><Reference><Citation>Langbaum JB, High N, Kettenhoven C, Reiman EM, Tariot PN. The Alzheimer&#x2019;s prevention registry: a large, internet-based participant recruitment registry to accelerate referrals to Alzheimer&#x2019;s-focused studies. J Prev Alzheimers Dis. 2020;7(4):242&#x2013;250. 10.14283/jpad.2020.31</Citation><ArticleIdList><ArticleId IdType="doi">10.14283/jpad.2020.31</ArticleId><ArticleId IdType="pmc">PMC7534299</ArticleId><ArticleId IdType="pubmed">32920626</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashford MT, Eichenbaum J, Williams T, et al. Effects of sex, race, ethnicity, and education on online aging research participation. Alzheimers Dement (N Y). 2020;6(1):e12028. 10.1002/trc2.12028</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12028</ArticleId><ArticleId IdType="pmc">PMC7249268</ArticleId><ArticleId IdType="pubmed">32478165</ArticleId></ArticleIdList></Reference><Reference><Citation>Grill JD, Hoang D, Gillen DL, et al. Constructing a local potential participant registry to improve Alzheimer&#x2019;s Disease Clinical Research recruitment. J Alzheimers Dis. 2018;63(3):1055&#x2013;1063. 10.3233/JAD-180069</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180069</ArticleId><ArticleId IdType="pubmed">29710723</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter S, Clanton TB, Langford OG, et al. Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a trial-ready cohort for preclinical and prodromal Alzheimer&#x2019;s Disease (TRC-PAD). JPrev Alzheimers Dis. 2020;7(4):219&#x2013;225. 10.14283/jpad.2020.46</Citation><ArticleIdList><ArticleId IdType="doi">10.14283/jpad.2020.46</ArticleId><ArticleId IdType="pmc">PMC7842199</ArticleId><ArticleId IdType="pubmed">32920623</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirza M, Siebert S, Pratt A, et al. Impact of the COVID-19 Pandemicon Recruitment to Clinical Research Studies in Rheumatology. Musculoskeletal Care. 2021;10.1002/msc.1561</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/msc.1561</ArticleId><ArticleId IdType="pmc">PMC8242596</ArticleId><ArticleId IdType="pubmed">33938621</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell EJ, Ahmed K, Breeman S, et al. It is unprecedented:trial management during the COVID-19 pandemic and beyond. Trials. 2020;21(1):784. 10.1186/s13063-020-04711-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-020-04711-6</ArticleId><ArticleId IdType="pmc">PMC7484918</ArticleId><ArticleId IdType="pubmed">32917258</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y, Chen R, Yang D. The relationship between filial piety and caregiver burden among adult children: a systematic review and meta-analysis. Geriatr Nurs. 2021;43:113&#x2013;123. 10.1016/j.gerinurse.2021.10.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gerinurse.2021.10.024</ArticleId><ArticleId IdType="pubmed">34864295</ArticleId></ArticleIdList></Reference><Reference><Citation>Krysinska K, Sachdev PS, Breitner J, Kivipelto M, Kukull W, Brodaty H. Dementia registries around the globe and their applications: a systematic review. Alzheimers Dement. 2017;13(9):1031&#x2013;1047. 10.1016/j.jalz.2017.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2017.04.005</ArticleId><ArticleId IdType="pmc">PMC6872163</ArticleId><ArticleId IdType="pubmed">28576507</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35393916</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1545-3847</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Season>Apr-Jun</Season></PubDate></JournalIssue><Title>Gerontology &amp; geriatrics education</Title><ISOAbbreviation>Gerontol Geriatr Educ</ISOAbbreviation></Journal><ArticleTitle>Preparing future health care workers for interactions with people with dementia: A mixed methods study.</ArticleTitle><Pagination><StartPage>223</StartPage><EndPage>242</EndPage><MedlinePgn>223-242</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/02701960.2022.2042805</ELocationID><Abstract><AbstractText>Strategies used in training future health professionals have expanded from traditional methods to a variety of approaches, including sensitivity training. Students who receive disease-specific sensitivity training are more compassionate to patients. Alzheimer's disease (AD) sensitivity training includes deficit-focused dementia tours that physically alter sensations. This embedded-experimental (between-subjects) variant mixed-methods study assessed the effectiveness of virtual reality as a delivery format for dementia tours compared to dementia tours that physically alter sensations. It also compared the effectiveness of deficit-focused dementia sensitivity training to reading strengths-focused case studies, a traditional instruction method. Forty-one university students were randomized into one of three conditions. All participants completed pre- and post-assessments and were interviewed. Quantitative results indicate that a dementia tour offered through virtual reality is as effective as a physical-based tour; however, compared to reading case studies, participants reported poorer attitudes about living with AD and feeling less prepared for caregiving. The qualitative results show an increase in empathy across all conditions. Integration of findings indicates that dementia tours in both formats are effective at encouraging empathy and that both strengths-based and deficit-based sensitivity training are important components of education for future health care workers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Torrence</LastName><ForeName>Caitlin</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7646-319X</Identifier><AffiliationInfo><Affiliation>Office of Research and Organizational Development &amp; Department of Public Health Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhanu</LastName><ForeName>Aasish</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Civil Engineering.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertrand</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Civil Engineering.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dye</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Engaged Aging.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Truong</LastName><ForeName>Khoa</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-8996-4126</Identifier><AffiliationInfo><Affiliation>Department of Public Health Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madathil</LastName><ForeName>Kapil Chalil</ForeName><Initials>KC</Initials><Identifier Source="ORCID">0000-0001-8938-9793</Identifier><AffiliationInfo><Affiliation>Department of Civil Engineering.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Gerontol Geriatr Educ</MedlineTA><NlmUniqueID>8101294</NlmUniqueID><ISSNLinking>0270-1960</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004645" MajorTopicYN="N">Empathy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005853" MajorTopicYN="Y">Geriatrics</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">empathy</Keyword><Keyword MajorTopicYN="N">health care</Keyword><Keyword MajorTopicYN="N">virtual reality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>8</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35393916</ArticleId><ArticleId IdType="doi">10.1080/02701960.2022.2042805</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35369803</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1364-6915</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Aging &amp; mental health</Title><ISOAbbreviation>Aging Ment Health</ISOAbbreviation></Journal><ArticleTitle>Informal antidepressant strategies for nursing home residents: two group concept mapping studies.</ArticleTitle><Pagination><StartPage>251</StartPage><EndPage>262</EndPage><MedlinePgn>251-262</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/13607863.2022.2057427</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To identify and structure potential informal antidepressant strategies that can be used in daily practice for nursing home residents alongside formal treatments.</AbstractText><AbstractText Label="METHODS">In a first Group Concept Mapping study, residents, relatives, and professional caregivers (<i>N</i>&#x2009;=&#x2009;124) brainstormed on strategies residents could use to prevent or alleviate depression. In a second study, the same participants (<i>N</i>&#x2009;=&#x2009;110) reported strategies for use by others. Furthermore, participants rated the expected effectiveness and feasibility of the suggested strategies. Simultaneously, all strategies were sorted by experts and clustered using multidimensional scaling and hierarchical cluster analysis.</AbstractText><AbstractText Label="RESULTS">Six clusters emerged for strategies by residents themselves and five clusters for strategies by others. For residents' strategies, the clusters <i>Being socially connected</i> and <i>Participating in activities</i> were perceived as most effective, as was the cluster <i>Offering personal attention</i> for strategies by others. Participants perceived <i>Creating a healthy living environment</i> as the most feasible cluster executed by residents. Within strategies by others, the clusters <i>Offering personal attention</i>, <i>Using positive treatment/approach</i>, and <i>Using or adapting the physical environment</i> were perceived as the most feasible.</AbstractText><AbstractText Label="CONCLUSION">The results indicated the importance of social connectedness, a personalized and positive approach by significant others, and tailored activity programs. The results also suggest that adaptations to the physical environment within nursing homes may be an easy applicable strategy to prevent or alleviate depression in residents. Although more research is needed, these findings may guide daily practice and the development of interventions that include informal strategies.</AbstractText><AbstractText Label="UNLABELLED">Supplemental data for this article can be accessed online at https://doi.org/10.1080/13607863.2022.2057427 .</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Knippenberg</LastName><ForeName>Inge A H</ForeName><Initials>IAH</Initials><Identifier Source="ORCID">0000-0003-2742-3057</Identifier><AffiliationInfo><Affiliation>Department of Primary and Community Care, Radboud University Medical Center, Radboud Institute for Health Sciences, Radboudumc Alzheimer Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Psychology, Open University of the Netherlands, Heerlen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leontjevas</LastName><ForeName>Ruslan</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9689-7611</Identifier><AffiliationInfo><Affiliation>Department of Primary and Community Care, Radboud University Medical Center, Radboud Institute for Health Sciences, Radboudumc Alzheimer Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Psychology, Open University of the Netherlands, Heerlen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stoyanov</LastName><ForeName>Slavi</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1190-5871</Identifier><AffiliationInfo><Affiliation>Faculty of Educational Sciences, Department of Technology Enhanced Learning and Innovation, Open University of the Netherlands, Heerlen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Persoon</LastName><ForeName>Anke</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4581-4748</Identifier><AffiliationInfo><Affiliation>Department of Primary and Community Care, Radboud University Medical Center, Radboud Institute for Health Sciences, Radboudumc Alzheimer Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verboon</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-8656-0890</Identifier><AffiliationInfo><Affiliation>Faculty of Psychology, Open University of the Netherlands, Heerlen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vermeulen</LastName><ForeName>Hester</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-0743-2979</Identifier><AffiliationInfo><Affiliation>IQ healthcare, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health and Social Studies, HAN University of Applied Sciences, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Lankveld</LastName><ForeName>Jacques J D M</ForeName><Initials>JJDM</Initials><Identifier Source="ORCID">0000-0003-0956-4067</Identifier><AffiliationInfo><Affiliation>Faculty of Psychology, Open University of the Netherlands, Heerlen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerritsen</LastName><ForeName>Debby L</ForeName><Initials>DL</Initials><Identifier Source="ORCID">0000-0002-3356-0237</Identifier><AffiliationInfo><Affiliation>Department of Primary and Community Care, Radboud University Medical Center, Radboud Institute for Health Sciences, Radboudumc Alzheimer Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Aging Ment Health</MedlineTA><NlmUniqueID>9705773</NlmUniqueID><ISSNLinking>1360-7863</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009735" MajorTopicYN="Y">Nursing Homes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="Y">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004777" MajorTopicYN="N">Environment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">group concept mapping</Keyword><Keyword MajorTopicYN="N">informal antidepressant strategies</Keyword><Keyword MajorTopicYN="N">mood</Keyword><Keyword MajorTopicYN="N">nursing home</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>4</Day><Hour>5</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35369803</ArticleId><ArticleId IdType="doi">10.1080/13607863.2022.2057427</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35356837</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1364-6915</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Aging &amp; mental health</Title><ISOAbbreviation>Aging Ment Health</ISOAbbreviation></Journal><ArticleTitle>Prevalence and type of unmet needs experienced by carers of people living with dementia.</ArticleTitle><Pagination><StartPage>904</StartPage><EndPage>910</EndPage><MedlinePgn>904-910</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/13607863.2022.2053833</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Carers of people with dementia experience significant physical, emotional, and social burdens. Needs assessment can provide important information to assist services in providing support to carers to reduce these burdens. However, few studies have examined the prevalence of unmet needs experienced by carers of people with dementia using a quantitative instrument. This study aimed to examine the prevalence and type of unmet needs experienced by carers of people with dementia in Australia.</AbstractText><AbstractText Label="METHODS">This was a cross-sectional survey of carers providing support to community-dwelling individuals living with dementia. Carers were recruited through geriatric clinics, aged care providers, support services and community organisations. Consenting carers completed a survey including an 80-item study-specific unmet needs instrument for carers (UNI-C) and sociodemographic characteristics. Descriptive statistics were used to identify the most prevalent unmet needs reported by carers.</AbstractText><AbstractText Label="RESULTS">A total of 169 carers (response rate 47%) completed the survey. Most (87%) carers reported at least one unmet need. Carers reported a median of 16.0 (IQR = 24.0; max = 58) out of a possible 80 unmet needs. The most frequently endorsed unmet needs spanned a range of areas including emotional wellbeing, accessing health and aged care services, managing apathy, and finding information.</AbstractText><AbstractText Label="CONCLUSION">This study highlighted that a large proportion of carers experience unmet needs associated with caring for someone with dementia. Developing and rigorously testing interventions to meet carers' commonly reported unmet needs are warranted.</AbstractText><AbstractText Label="UNLABELLED">Supplemental data for this article is available online at https://doi.org/10.1080/13607863.2022.2053833 .</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mansfield</LastName><ForeName>Elise</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7938-8401</Identifier><AffiliationInfo><Affiliation>Health Behaviour Research Collaborative, School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Priority Research Centre for Health Behaviour, University of Newcastle, Callaghan, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cameron</LastName><ForeName>Emilie C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Health Behaviour Research Collaborative, School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Priority Research Centre for Health Behaviour, University of Newcastle, Callaghan, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyes</LastName><ForeName>Allison W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Health Behaviour Research Collaborative, School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Priority Research Centre for Health Behaviour, University of Newcastle, Callaghan, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carey</LastName><ForeName>Mariko L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Health Behaviour Research Collaborative, School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Priority Research Centre for Health Behaviour, University of Newcastle, Callaghan, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>Balakrishnan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hunter New England Local Health District, New Lambton Heights, John Hunter Hospital, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Public Health (Medical Education and Professional Development), University of Newcastle, Callaghan, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Alix E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Hunter New England Local Health District, Hunter New England Population Health, Wallsend, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanson-Fisher</LastName><ForeName>Rob W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Health Behaviour Research Collaborative, School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Priority Research Centre for Health Behaviour, University of Newcastle, Callaghan, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Aging Ment Health</MedlineTA><NlmUniqueID>9705773</NlmUniqueID><ISSNLinking>1360-7863</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Support person</Keyword><Keyword MajorTopicYN="N">carer</Keyword><Keyword MajorTopicYN="N">measurement</Keyword><Keyword MajorTopicYN="N">unmet needs</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>31</Day><Hour>8</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35356837</ArticleId><ArticleId IdType="doi">10.1080/13607863.2022.2053833</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35346414</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1478-9523</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Palliative &amp; supportive care</Title><ISOAbbreviation>Palliat Support Care</ISOAbbreviation></Journal><ArticleTitle>Which has more influence on a family's assessment of the quality of dying of their long-term care resident with dementia: Frequency of symptoms or quality of communication with healthcare team?</ArticleTitle><Pagination><StartPage>438</StartPage><EndPage>444</EndPage><MedlinePgn>438-444</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S1478951522000323</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Symptoms present at the end of life and the quality of communication with the healthcare team have both been shown to impact family assessments of the quality of dying of their loved one with dementia. However, the relative contributions of these two factors to family assessments have not yet been investigated. To address this knowledge gap, we explored which of these two factors has more influence on family assessments of the quality of dying of long-term care (LTC) residents with dementia.</AbstractText><AbstractText Label="METHOD">This is a secondary analysis of a mortality follow-back study. Ninety-four family members of LTC residents who had died with dementia assessed the quality of dying (<i>very good</i> or <i>not very good</i>), the frequency of symptoms, and the quality of communication with the healthcare team using a self-administered questionnaire mailed 1 month after the resident's death. Logistic regression analyses were performed to determine the relative contributions of the two independent variables of primary interest (frequency of symptoms and quality of communication) to the families' assessments of the quality of dying.</AbstractText><AbstractText Label="RESULTS">Multivariate analyses revealed that the quality of communication with the healthcare team was closely linked to the quality of dying (<i>p</i> = 0.009, OR = 1.34, 95% CI = 1.09-1.65), whereas the frequency of symptoms was not (<i>p</i> = 0.142, OR = 1.05, 95% CI = 0.98-1.11) after controlling for potential confounders.</AbstractText><AbstractText Label="SIGNIFICANCE OF RESULTS">Our findings show that healthcare providers' ability to engage in the end-of-life conversations with families outweighs the frequency of symptoms in family assessments of the quality of dying of their relative with dementia. Enhancing healthcare providers' ability to communicate with families about the end-of-life care could improve families' perceptions of the quality of dying of their relative with dementia and, consequently, ease their grieving process.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Charest-Drapeau</LastName><ForeName>Olivia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Research Centre on Aging, CIUSSS de l'Estrie - CHUS, Sherbrooke, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Provencher</LastName><ForeName>V&#xe9;ronique</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-8211-7135</Identifier><AffiliationInfo><Affiliation>Research Centre on Aging, CIUSSS de l'Estrie - CHUS, Sherbrooke, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Rehabilitation, Faculty of Medicine and Health Sciences, Universit&#xe9; de Sherbrooke, Sherbrooke, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trottier</LastName><ForeName>Lise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Research Centre on Aging, CIUSSS de l'Estrie - CHUS, Sherbrooke, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xe9;onard</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Research Centre on Aging, CIUSSS de l'Estrie - CHUS, Sherbrooke, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Rehabilitation, Faculty of Medicine and Health Sciences, Universit&#xe9; de Sherbrooke, Sherbrooke, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilchesky</LastName><ForeName>Machelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Family Medicine and Division of Geriatric Medicine, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Donald Berman Maimonides Centre for Research in Aging, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bravo</LastName><ForeName>Gina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Research Centre on Aging, CIUSSS de l'Estrie - CHUS, Sherbrooke, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Community Health Sciences, Faculty of Medicine and Health Sciences, Universit&#xe9; de Sherbrooke, Sherbrooke, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>End-of-Life Care in Dementia Research Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Palliat Support Care</MedlineTA><NlmUniqueID>101232529</NlmUniqueID><ISSNLinking>1478-9515</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008134" MajorTopicYN="N">Long-Term Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009735" MajorTopicYN="N">Nursing Homes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013727" MajorTopicYN="Y">Terminal Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="N">Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010348" MajorTopicYN="N">Patient Care Team</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease and other dementias</Keyword><Keyword MajorTopicYN="N">End-of-life care</Keyword><Keyword MajorTopicYN="N">Family caregivers</Keyword><Keyword MajorTopicYN="N">Long-term care</Keyword><Keyword MajorTopicYN="N">Quality of dying</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>29</Day><Hour>5</Hour><Minute>40</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35346414</ArticleId><ArticleId IdType="doi">10.1017/S1478951522000323</ArticleId><ArticleId IdType="pii">S1478951522000323</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35321599</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1364-6915</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Aging &amp; mental health</Title><ISOAbbreviation>Aging Ment Health</ISOAbbreviation></Journal><ArticleTitle>The associations between unmet needs with protective factors, risk factors and outcomes among care partners of community-dwelling persons living with dementia.</ArticleTitle><Pagination><StartPage>334</StartPage><EndPage>342</EndPage><MedlinePgn>334-342</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/13607863.2022.2046698</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Describe the prevalence and types of unmet needs among community-dwelling dementia care partners (CPs) and determine associations between unmet needs with protective factors, risk factors and outcomes.</AbstractText><AbstractText Label="METHOD">A cross-sectional analysis of 638 racially and cognitively diverse community-dwelling persons living with dementia (PLWD) and their CPs participating in a comprehensive in-home assessment of dementia-related needs. Unmet CP needs (19 items, 6 domains) were rated by a clinician using the Johns Hopkins Dementia Care Needs Assessment (JHDCNA). Multivariate linear regression models were used to examine associations between total percent unmet CP needs with demographic, protective and risk factors.</AbstractText><AbstractText Label="RESULTS">Nearly all CPs had at least one unmet need (99.53%), with a mean of 5.7 (&#xb1;2.6). The most common domains with &#x2265;1 unmet need were memory disorder education, care skills and knowledge of resources (98%), legal issues/concerns (73.8%), CP mental health (44.6%) and access to informal support (42.7%). Adjusted multivariate models suggest the strongest consistent predictive factors relate to informal emotional support, CP physical health, use or difficulty getting formal services/supports (both for CPs and PLWD), and CP time spent with PLWD. Greater levels of unmet needs were associated with worse PLWD outcomes and CP outcomes, after adjusting for demographics.</AbstractText><AbstractText Label="CONCLUSIONS">CPs have high rates of diverse, but modifiable unmet needs. Data suggest optimal approaches to dementia care should take a family-centered home-based approach that includes routine CP needs assessment, offer targeted interventions that include both traditional medical supports as well as strategies to increase and leverage informal social networks, and ones that can bridge and coordinate medical with non-medical supports. These findings can be used to inform new approaches to support CPs, improve PLWD and CP outcomes, and target groups most at risk for inequities.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Antonsdottir</LastName><ForeName>Inga Margret</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Johns Hopkins School of Nursing, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leoutsakos</LastName><ForeName>Jeannie-Marie</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sloan</LastName><ForeName>Danetta</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Health Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spliedt</LastName><ForeName>Morgan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnston</LastName><ForeName>Deirdre</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reuland</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lyketsos</LastName><ForeName>Constantine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amjad</LastName><ForeName>Halima</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samus</LastName><ForeName>Quincy M</ForeName><Initials>QM</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 AG064036</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066507</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066587</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG046274</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Aging Ment Health</MedlineTA><NlmUniqueID>9705773</NlmUniqueID><ISSNLinking>1360-7863</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057187" MajorTopicYN="Y">Independent Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065840" MajorTopicYN="N">Protective Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006301" MajorTopicYN="N">Health Services Needs and Demand</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">care partners</Keyword><Keyword MajorTopicYN="N">caregiving</Keyword><Keyword MajorTopicYN="N">home and community-based support</Keyword><Keyword MajorTopicYN="N">intervention</Keyword><Keyword MajorTopicYN="N">unmet needs</Keyword></KeywordList><CoiStatement><b>Declaration of Interest:</b> The Johns Hopkins University, and several manuscript authors (Drs. Samus, Lyketsos, and Johnston) may have potential financial interest in the technology (MIND at Home dementia care coordination program) cited in this publication. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>24</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35321599</ArticleId><ArticleId IdType="mid">NIHMS1801252</ArticleId><ArticleId IdType="pmc">PMC9508284</ArticleId><ArticleId IdType="doi">10.1080/13607863.2022.2046698</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alzheimer&#x2019;s Association (2019). Alzheimer&#x2019;s Disease Facts and Figures. Alzheimer&#x2019;s &amp; dementia, 14, 367&#x2013;429.</Citation></Reference><Reference><Citation>Black BS, Johnston D, Rabins PV, Morrison A, Lyketsos C, Samus QM. Unmet needs of community-residing persons with dementia and their informal caregivers: findings from the maximizing independence at home study. Journal of American geriatric society. 2013;61(12):2087&#x2013;2095. http://www.ncbi.nlm.nih.gov/pubmed/24479141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4001885</ArticleId><ArticleId IdType="pubmed">24479141</ArticleId></ArticleIdList></Reference><Reference><Citation>Black CM, Ritchie CW, Khandker RK, et al. Non-professional caregiver burden is associated with the severity of patients&#x2019; cognitive impairment. Ginsberg SD, ed. PLoS One. 2018;13(12):e0204110. doi:10.1371/journal.pone.0204110</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0204110</ArticleId><ArticleId IdType="pmc">PMC6283568</ArticleId><ArticleId IdType="pubmed">30521532</ArticleId></ArticleIdList></Reference><Reference><Citation>Black et al. (2019) Unmet needs in community-living persons with dementia are common, often non-medical and related to patient and caregiver characteristics. International psychogeriatrics.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6679825</ArticleId><ArticleId IdType="pubmed">30714564</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodaty H, Donkin M. Family caregivers of people with dementia. Dialogues in clin neuroscience. 2009;11(2):217&#x2013;228. http://www.ncbi.nlm.nih.gov/pubmed/19585957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3181916</ArticleId><ArticleId IdType="pubmed">19585957</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng S-T. Dementia Caregiver Burden: a Research Update and Critical Analysis. Current psychiatry report. 2017;19(9):64. doi:10.1007/s11920-017-0818-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11920-017-0818-2</ArticleId><ArticleId IdType="pmc">PMC5550537</ArticleId><ArticleId IdType="pubmed">28795386</ArticleId></ArticleIdList></Reference><Reference><Citation>Covinsky KE, Newcomer R, Fox P, et al.
Patient and caregiver characteristics associated with depression in caregivers of patients with dementia. Journal of general internal medicine. 2003;18(12):1006&#x2013;1014. http://www.ncbi.nlm.nih.gov/pubmed/14687259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1494966</ArticleId><ArticleId IdType="pubmed">14687259</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins S. S.2076 &#x2013; 115th Congress (2017&#x2013;2018): BOLD Infrastructure for Alzheimer&#x2019;s Act. 2018. https://www.congress.gov/bill/115th-congress/senate-bill/2076.</Citation></Reference><Reference><Citation>Cummings JL, Medg M, Gray K, Rosenberg-Thompson S, Carusi DA, and Gornbein J (1994).The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308&#x2013;2314.</Citation><ArticleIdList><ArticleId IdType="pubmed">7991117</ArticleId></ArticleIdList></Reference><Reference><Citation>Dauphinot V, Delphin-Combe F, Mouchoux C, et al. Risk Factors of Caregiver Burden Among Patients with Alzheimer&#x2019;s Disease or Related Disorders: A Cross-Sectional Study. Journal of Alzheimer&#x2019;s disease. 2015;44(3):907&#x2013;916. doi:10.3233/JAD-142337</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-142337</ArticleId><ArticleId IdType="pubmed">25374109</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein MR, Folstein SE and McHugh PR (1975). &#x2018;Mini mental state&#x2019;. A practical method for grading the cognitive state of patients for the clinician. Journal of psychiatric research, 12, 189&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings LA, Reuben DB, Evertson LC, Serrano KS, Ercoli L, Grill J, ... &amp; Wenger NS (2015). Unmet needs of caregivers of individuals referred to a dementia care program. Journal of the American Geriatrics Society, 63(2), 282&#x2013;289.3s</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4332558</ArticleId><ArticleId IdType="pubmed">25688604</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston D et al. (2011). Identification of community residing individuals with dementia and their unmet needs for care. International journal of geriatric psychiatry, 26, 292&#x2013;298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3039061</ArticleId><ArticleId IdType="pubmed">20658473</ArticleId></ArticleIdList></Reference><Reference><Citation>Kales HC, Lyketsos CG, Miller EM, Ballard C (2018) Management of behavioral and psychological symptoms in people with Alzheimer&#x2019;s disease: An international Delphi consensus, Int Psychogeriatr 31, 83&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">30068400</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper JD, Freedman VA, Spillman BC, &amp; Wolff JL (2015). The disproportionate impact of dementia on family and unpaid caregiving to older adults. Health Affairs, 34(10), 1642&#x2013;1649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4635557</ArticleId><ArticleId IdType="pubmed">26438739</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer R and Williams JBW (2001). The PHQ-9: validity of a brief depression severity inventory. Journal of general internal medicine, 16, 606&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Logsdon RG, Gibbons LE, McCurry SM and Teri L (2002). Assessing quality of life in older adults with cognitive impairment. Psychosomatic medicine, 64, 510&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pubmed">12021425</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyketsos CG, et al. (1999).The General Medical Health Rating: a bedside global rating of medical comorbidity in patients with dementia. Journal of the American geriatrics society, 47, 487&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pubmed">10203127</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann GM et al. (2011). The diagnosis of dementia due to Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimer&#x2019;s &amp; dementia, 7, 263&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3312024</ArticleId><ArticleId IdType="pubmed">21514250</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrisby C, Joosten A, and Ciccarelli M (2018).Do services meet the needs of people with dementia and carers living in the community?A scoping review of the international literature.International pyschogeriatrics, 30, 5&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">28784193</ArticleId></ArticleIdList></Reference><Reference><Citation>Park M, Sung M, Kim SK, Kim S, Lee DY. Multidimensional determinants of family caregiver burden in Alzheimer&#x2019;s disease. International psychogeriatrics. 2015;27(08):1355&#x2013;1364. doi:10.1017/S1041610215000460</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610215000460</ArticleId><ArticleId IdType="pubmed">25853717</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyser CA, &amp; Tickle A (2019). Exploring the experience of the disclosure of a dementia diagnosis from a clinician, patient and carer perspective: a systematic review and Meta-ethnographic synthesis. Aging &amp; mental health, 23(12), 1605&#x2013;1615.</Citation><ArticleIdList><ArticleId IdType="pubmed">30430858</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuland M, Sloan D, Antonsdottir IM, Spliedt M, Deirdre Johnston MC, &amp; Samus Q (2021). Recruitment of a diverse research cohort in a large metropolitan area for dementia intervention studies. Contemporary Clinical Trials, 106622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8725208</ArticleId><ArticleId IdType="pubmed">34785304</ArticleId></ArticleIdList></Reference><Reference><Citation>Riffin C, Van Ness PH, Wolff JL, &amp; Fried T (2019). Multifactorial examination of caregiver burden in a national sample of family and unpaid caregivers. Journal of the American Geriatrics Society, 67(2), 277&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6367031</ArticleId><ArticleId IdType="pubmed">30452088</ArticleId></ArticleIdList></Reference><Reference><Citation>Samus QM et al. (2014). A multidimensional home-based care coordination intervention for elders with memory disorders: the maximizing independence at home (MIND) pilot randomized trial. The American journal of geriatric psychiatry, 22, 398&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4034346</ArticleId><ArticleId IdType="pubmed">24502822</ArticleId></ArticleIdList></Reference><Reference><Citation>Samus QM et al. (2017). Comprehensive home-based care coordination for vulnerable elders with dementia: Maximizing Independence at Home-Plus Study protocol. International journal of care coordination, 20, 123&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5870897</ArticleId><ArticleId IdType="pubmed">29607051</ArticleId></ArticleIdList></Reference><Reference><Citation>Samus QM et al. (2018). MIND at Home-Streamlined: study protocol for a randomized trial of home-based care coordination for persons with dementia and their caregivers. Contemporary clinical trials, 71, 103&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6415306</ArticleId><ArticleId IdType="pubmed">29783091</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;lzel-Dorenbos CJ, Meeuwsen EJ, &amp; Olde Rikkert MG (2010). Integrating unmet needs into dementia health-related quality of life research and care: Introduction of the Hierarchy Model of Needs in Dementia. Aging and Mental Health, 14(1), 113&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">20155528</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz R, Martire LM. Family caregiving of persons with dementia: prevalence, health effects, and support strategies. American journal of geriatric psychiatry. 12(3):240&#x2013;249. http://www.ncbi.nlm.nih.gov/pubmed/15126224.</Citation><ArticleIdList><ArticleId IdType="pubmed">15126224</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim SH, Kang HS, Kim JH, Kim DK. Factors Associated with Caregiver Burden in Dementia: 1-Year Follow-Up Study. Psychiatry investigations. 2016;13(1):43&#x2013;49. doi:10.4306/pi.2016.13.1.43</Citation><ArticleIdList><ArticleId IdType="doi">10.4306/pi.2016.13.1.43</ArticleId><ArticleId IdType="pmc">PMC4701684</ArticleId><ArticleId IdType="pubmed">26766945</ArticleId></ArticleIdList></Reference><Reference><Citation>StataCorp. Stata Statistical Software: Release 15. 2017.</Citation></Reference><Reference><Citation>Ware JE, Kosinski M and Keller SD (1996).A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity.Medical care, 34, 220&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">8628042</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson IM and Graham-White J (1980).Psychogeriatric Dependency Rating Scales (PGDRS): a method of assessment for use by nurses.The British journal of psychiatry, 137, 558&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">6452189</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarit SH, Reever KE and Bach-Peterson J (1980).Relatives of impaired elderly: correlates of feelings of burden. Gerontologist, 20, 649&#x2013;655.</Citation><ArticleIdList><ArticleId IdType="pubmed">7203086</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35229696</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1465-3419</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Ethnicity &amp; health</Title><ISOAbbreviation>Ethn Health</ISOAbbreviation></Journal><ArticleTitle>Alzheimer's disease (AD) knowledge in Korean Americans: identifying knowledge gaps and misconceptions and examining predictors of AD knowledge.</ArticleTitle><Pagination><StartPage>431</StartPage><EndPage>445</EndPage><MedlinePgn>431-445</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/13557858.2022.2045907</ELocationID><Abstract><AbstractText Label="OBJECTIVES">This study examined Alzheimer's disease (AD) knowledge and its predictors among Korean Americans (KAs).</AbstractText><AbstractText Label="DESIGN">Convenience sampling was used to recruit KAs in the Greater Washington metropolitan area. A total of 268 KAs participated in the study and completed a cross-sectional survey in 2014. Using the Alzheimer's Disease Knowledge Scale (ADKS), overall and domain knowledge was assessed. Multiple regression analyses were conducted for overall and domain knowledge with predictors including exposure to AD, social engagement, sources and frequency of health-related information, stigmatic beliefs (pity, antipathy, and social distance), English proficiency, and education.</AbstractText><AbstractText Label="RESULTS">KAs reported a 59% accuracy in the overall AD knowledge. At the domain level, KAs were most knowledgeable about assessment and diagnosis and least knowledgeable about caregiving. Our regression analyses showed that having a college degree or higher is associated with a greater overall AD knowledge. Three domain models of life impact, risk factors, and caregiving turned out to be significant: Having a college degree or higher is a predictor of greater knowledge in all three domains. Having more pity stigmatic beliefs is related to greater knowledge in both life impact and caregiving domains while having less pity stigmatic beliefs is associated with more risk factor knowledge; having less social distance stigmatic beliefs is associated with greater life impact knowledge; and having less antipathy stigmatic beliefs is related to better caregiving knowledge.</AbstractText><AbstractText Label="CONCLUSION">Our findings revealed areas of misconceptions and knowledge gaps in KAs which need to be addressed in educational interventions. Different knowledge status across the domains demonstrates a multi-dimensional nature of AD knowledge. Multivariate findings confirmed the robust role of education in overall and domain AD knowledge. The effect of different AD stigmatic beliefs on certain AD knowledge domains suggests ways of how stigma change can be efficient for the purpose of increasing AD domain knowledge in KAs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sang E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>School of Social Work, San Jose State University, San Jose, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Michin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Social Work, Indiana University, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casado</LastName><ForeName>Banghwa L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>YLC Consulting, Windsor, CO, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R03 HS022947</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ethn Health</MedlineTA><NlmUniqueID>9608374</NlmUniqueID><ISSNLinking>1355-7858</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001213" MajorTopicYN="N">Asian</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057545" MajorTopicYN="N">Social Stigma</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Asian American</Keyword><Keyword MajorTopicYN="N">Korean American</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">knowledge</Keyword><Keyword MajorTopicYN="N">stigma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>1</Day><Hour>8</Hour><Minute>41</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35229696</ArticleId><ArticleId IdType="doi">10.1080/13557858.2022.2045907</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35199931</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-5279</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</Title><ISOAbbreviation>Alzheimers Dement</ISOAbbreviation></Journal><ArticleTitle>Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos &amp; Alzheimer's Symposium.</ArticleTitle><Pagination><StartPage>1677</StartPage><EndPage>1686</EndPage><MedlinePgn>1677-1686</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/alz.12589</ELocationID><Abstract><AbstractText>The Alzheimer's Association hosted the second Latinos &amp; Alzheimer's Symposium in May 2021. Due to the COVID-19 pandemic, the meeting was held online over 2 days, with virtual presentations, discussions, mentoring sessions, and posters. The Latino population in the United States is projected to have the steepest increase in Alzheimer's disease (AD) in the next 40 years, compared to other ethnic groups. Latinos have increased risk for AD and other dementias, limited access to quality care, and are severely underrepresented in AD and dementia research and clinical trials. The symposium highlighted developments in AD research with Latino populations, including advances in AD biomarkers, and novel cognitive assessments for Spanish-speaking populations, as well as the need to effectively recruit and retain Latinos in clinical research, and how best to deliver health-care services and to aid caregivers of Latinos living with AD.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Alzheimer's &amp; Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Quiroz</LastName><ForeName>Yakeel T</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solis</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Freelance science writer, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aranda</LastName><ForeName>Mar&#xed;a P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>USC Roybal Institute on Aging, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arbaje</LastName><ForeName>Alicia I</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Division of Geriatric Medicine and Gerontology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arroyo-Miranda</LastName><ForeName>Mirna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Houston, Department of Psychology, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrera</LastName><ForeName>Laura Y</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>The Pennsylvania State University, Department of Engineering Science and Mechanics, University Park, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrasquillo</LastName><ForeName>Minerva Maria</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Mayo Clinic Florida, Jacksonville, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corrada</LastName><ForeName>Maria M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>University of California, Irvine, Irvine, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crivelli</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Fleni, Department of Cognitive Neurology, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diminich</LastName><ForeName>Erica D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Renaissance School of Medicine, Stony Brook, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorsman</LastName><ForeName>Karen A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>University of Texas Southwestern Medical Center, Dallas, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzales</LastName><ForeName>Mitzi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez</LastName><ForeName>H&#xe9;ctor M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of California, San Diego, San Diego, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Seda</LastName><ForeName>Ana L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Alzheimer's Association, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grinberg</LastName><ForeName>Lea T</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerrero</LastName><ForeName>Lourdes R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Carl V</ForeName><Initials>CV</Initials><AffiliationInfo><Affiliation>Alzheimer's Association, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimenez-Velazquez</LastName><ForeName>Ivonne Z</ForeName><Initials>IZ</Initials><AffiliationInfo><Affiliation>Medicine Department, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, Puerto Rico, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerra</LastName><ForeName>Jorge J Llibre</ForeName><Initials>JJL</Initials><AffiliationInfo><Affiliation>Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopera</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neuroscience Group of Antioquia, University of Antioquia, Medellin, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maestre</LastName><ForeName>Gladys</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Texas Rio Grande Valley, Edinburg, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medina</LastName><ForeName>Luis D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>University of Houston, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Bryant</LastName><ForeName>Sid</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of North Texas Health Science Center, Fort Worth, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pe&#xf1;aloza</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cognition, Development and Educational Psychology, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinzon</LastName><ForeName>Maria Mora</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Family Medicine and Community Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wisconsin Alzheimer's Institute, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mavarez</LastName><ForeName>Rosa V Pirela</ForeName><Initials>RVP</Initials><AffiliationInfo><Affiliation>University of Texas Rio Grande Valley, School of Medicine, Department of Human Genetics, Edinburg, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rio Grande Valley Alzheimer's Disease Resources Center for Minority Aging Research, University of Texas Rio Grande Valley, School of Medicine, Edinburg, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pluim</LastName><ForeName>Celina F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raman</LastName><ForeName>Rema</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rascovsky</LastName><ForeName>Katya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rentz</LastName><ForeName>Dorene M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes</LastName><ForeName>Yarissa</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Alzheimer's Association, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosselli</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychology, Florida Atlantic University, Boca Raton, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tansey</LastName><ForeName>Mal&#xfa; G&#xe1;mez</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>University of Florida, Gainesville, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vila-Castelar</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuelsdorff</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Wisconsin-Madison School of Nursing, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wisconsin Alzheimer's Disease Research Center, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrillo</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Alzheimer's Association, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sexton</LastName><ForeName>Claire</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-3846-2986</Identifier><AffiliationInfo><Affiliation>Alzheimer's Association, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R13 AG071167</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS017950</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG054076</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 AG053435</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG066823</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG059300</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066530</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG059305</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002373</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP1 AG069870</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG057247</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066546</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG044271</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG052409</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Alzheimers Dement</MedlineTA><NlmUniqueID>101231978</NlmUniqueID><ISSNLinking>1552-5260</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006630" MajorTopicYN="N">Hispanic or Latino</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Yakeel T. Quiroz, in the past 36 months, reports grants or contracts from the US National Institute on Aging (R01AG054671, R01AG066823), Alzheimer's Association, MGH ECOR; consulting fees from Biogen; payment or honoraria for seminars, academic rounds; has served as past chair of the ISTAART Diversity and Disparities PIA; and holds a role as chair of the International Neuropsychological Society Teleneuropsychology Special Interest Group. Maria P. Aranda, in the past 36 months, reports grants or contracts: Co&#x2010;Investigator and Director, Outreach, Recruitment and Engagement Core (ORE), USC Alzheimer's Disease Research Center; National Institute on Aging (5P 50AG005142); Co&#x2010;Investigator and Lead, Research Education Core (REC), USC Research Center on Alzheimer's Disease&#x2010;Minority Aging Research (AD&#x2010;RCMAR); National Institute on Aging (2P 30AG043073); Principal Investigator, SoCal Savvy, State of California, Department of Public Health, Alzheimer's Disease Program (19&#x2010;10538); Principal Investigator, Unidos en el Cuidado: The Savvy Caregiver: Translation, Transformation, and Feasibility of Evidenced&#x2010;Based Program for Dementia Caregivers (011069&#x2010;00001); Project Subaward: Alzheimer's Los Angeles; Principal Investigator, Interdisciplinary Aging Research to Address Health Disparities in Alzheimer's Disease and Related Dementias; National Institute on Aging(5R13AG063477); Co&#x2010;Investigator, NIA AD/ADRD Health Care Systems Research Collaboratory, IMPACT Collaboratory, National Institute on Aging (1U54AG063546&#x2010;01); 2019&#x2010;20 Consultant, Health Equity Team (HET); NIA AD/ADRD Health Care Systems Research Collaboratory, National Institute on Aging (1U54AG063546&#x2010;01); 2017 Principal Investigator, A Program for Families Caring for a Loved One with Dementia (Savvy Caregiver Program) (12&#x2010;2602&#x2010;3600); Research Council, USC Suzanne Dworak&#x2010;Peck School of Social Work, Los Angeles, CA; 2017 Principal Investigator, Establishing Rates of Caregiving to Adults with Physical and Cognitive Disabilities in Home&#x2010; and Community&#x2010;Based Services; St. Barnabas Senior Services &amp; AARP, Los Angeles, CA. MPA also received consulting fees for Avanir Pharmaceuticals, served as Chair, Caregiver Advisory Board&#x2014;one time and is a member of the External Advisory Board, San Diego Alzheimer's Disease Resource Center for Minority Aging Research. Alicia I. Arbaje, in the past 36 months, reports grants from AHRQ, NIA, JHAD&#x2010;RCMAR; received payment or honoraria for lecture from HealtheNetwork; participated on a DSMB or Advisory Board for a Vanderbilt University study. Mirna Arroyo&#x2010;Miranda received support for attending meetings and/or travel to ISTAART Diversity PIA Day at AAIC 2019, with a Travel Fellowship Award from the Alzheimer's Association. Laura Y. Cabrera, in the past 36 months, reports grants or contracts from NIH Bioethics supplement R21TW010896 &#x2010;12/2019&#x2010;11/2020, P30 AG059300&#x2010;01 Alzheimer's related Resource Centers for Minority Aging Research (ADRCMAR)&#x2014;Latinos Perceptions and Concerns about Alzheimer Disease (MCCFAD Pilot 2) &#x2010; 08/2018&#x2010;06/2020; received honoraria for lectures: 2018 Michigan Academy of Nutrition and Dietetics Annual Meeting and honoraria for presentations: 2018 OECD &#x201c;Minding Neurotechnology: Delivering Responsible Innovation for Health and Well&#x2010;being&#x201d;, 2019&#x2014;Keynote presentation at Markkula Center for Applied Ethics at Santa Clara University, 2019&#x2014;honoraria as panelist for the Michigan State University CommSciCom; received support for travel 2019&#x2014;attendance to GSA; and held role as board member for International Neuroethics Society and chair for IEEE Brain Neuroethics Subcommittee. Minerva Maria Carrasquillo received funding for research from NIH grants; received honoraria for serving as reviewer for NIH grants. Maria M. Corrada, in the past 36 months, reports grants from NIA; received payment or honoraria for grant reviews and for participation in a mentoring program; received support for attending meetings and/or travel from the Alzheimer's Association and NIA grants; participated on NIA organized DSB for a blood pressure lowering pragmatic trial; held a leadership or fiduciary role at <i>Alzheimer's and Dementia</i> journal editorial board; and is a member of the Alzheimer's Association International Conference Scientific Program Committee. Lucia Crivelli, in the past 36 months, reports grants or contracts from the Alzheimer's Association for the LatAm FINGERS project; and received support for a travel fellowship from the Alzheimer's Association for AAIC 2021. Erica D. Diminich, in the past 36 months, reports grants from Alzheimer's Association AACSF&#x2010;20&#x2010;682140; NIH/National Institute on Aging AG049953&#x2010;05 Diversity Supplement Award (under R01:AG049953). Karen A. Dorsman received a small scholarship as a student; received financial support (1 hotel night) to attend the Texas Alzheimer's Research and Care Consortium (TARCC) meeting in 2020; held or holds a leadership or fiduciary roles as a Student Representative&#x2010;Elect for the Hispanic Neuropsychological Society (unpaid, non&#x2010;voting Board member) 2021&#x2013; present, Ad Hoc Advisor to the Nicaraguan Alzheimer's Foundation (unpaid) 2019&#x2013;present, Latino Advisory Group member to the Alzheimer's Association, Northern California &amp; Northern Nevada chapter 2018&#x2013;2019. Mitzi Gonzales, in the past 36 months, reports grants or contracts from Alzheimer's Association Part of the Cloud Gates grant (PTCG&#x2010;20&#x2010;695184), NIA (R44 AG060855, U19 NS120384, U24 AG059624), the Alzheimer's Drug Discovery Foundation (GC&#x2010;201908&#x2010;2019443), Texas Alzheimer's Research and Care Consortium (2018&#x2010;28&#x2010;81&#x2010;J1); received support for attending Alzheimer's Association International Conference Travel Fellowship 2021. H&#xe9;ctor M. Gonz&#xe1;lez, in the past 36 months, reports grants or contracts from National Institute on Aging (R56 AG048642, RF1 AG054548, RF1 AG061022, P30 AG062429). Ana L. Gonzalez&#x2010;Seda held a leadership or fiduciary role at Office of Health Equity with the California Department of Public Health and City Heights Community Development Corporation. Lea T. Grinberg, in the past 36 months, reports grants or contracts from NIH several r01s, K24 and R01, Tau consortium, Weill Neurohub; received consulting fees from CuraSen Inc; received payment or honoraria from Zydus Pharmaceuticals 2021; received support for attending meetings and/or travel from Alzheimer Association, Tau Consortium, CONy. Lourdes Guerrero has nothing to disclose. Carl V. Hill, in the past 36 months, reports grants from National Institutes of Health; and held unpaid roles with advisory groups dedicated to Diversity, Equity and Inclusion at various academic and non&#x2010;profit institutions. Ivonne Z. Jimenez&#x2010;Velazquez has nothing to disclose. Jorge J. Llibre Guerra received research funding from the Alzheimer Association (SG&#x2010;20&#x2010;690363). Francisco Lopera, in the past 36 months, reports grants from NIA, Banner, and Roche, API Colombia grant, NIH: Colbos Grant; and received support for attending meetings and/or travel from Red Lat, San Francisco California. Gladys Maestre, in the past 36 months, reports grants from National Institute on Aging/National Institutes of Health and Texas Alzheimer's Research and Care Consortium; received payment or honoraria as a reviewer for NIH; held a leadership or fiduciary role at Funda conciencia and Appremed. Luis D. Medina, in the past 36 months, reports grants or contracts from National Institutes of Health R24AG065170 (Medina) Jan 2020&#x2013;Nov 2023, Alzheimer's Association 2019&#x2010;AARGD&#x2010;642445 (Medina) Feb 2020&#x2013;Jan 2023; received honoraria for lectures from UCSD, UMass Amherst; received support to attend AAIC 2021 as member of Alzheimer's Association International Research Grant Program Council. Sid O'Bryant, in the past 36 months, reports grants or contracts from NIH/NIA, Alzheimer's Association, MJFF, Cx Precision Medicine; and receives royalties from licensed patents. SO'B is the founding scientist from Cx Precision Medicine; holds multiple patents in precision medicine for neurodegenerative diseases; and is the founding scientist of Cx Precision Medicine and holds stocks. Claudia Pe&#xf1;aloza is supported by the Juan de la Cierva&#x2010;Incorporaci&#xf3;n Program (IJC2018&#x2010;037818) funded by Ministerio de Ciencia e Innovaci&#xf3;n, Agencia Estatal de Investigaci&#xf3;n MCIN/AEI 10.13039/501100011033. CP was employed by Boston University under NIH/NIDCD grant number U01DC014922 during the 24 previous months (January 2017&#x2013;August 2020) and is currently a research consultant for that institution. Maria Mora Pinzon, in the past 36 months, reports grants or contracts from Increasing Latinx participation in ADRD through a Community&#x2010;Based Approach. Wisconsin Alzheimer's Disease Research Center (ADRC) Research Education Component (&#x201c;REC&#x201d;) Scholar; Pisando Fuerte Online Adapting to COVID&#x2010;19, University of Wisconsin Institute for Clinical and Translational Research Dissemination and Implementation Launchpad; Leveraging social networks and trusted community influencers to disseminate an accurate and up&#x2010;to&#x2010;date understanding of COVID&#x2010;19 in Black, Latinx and American Indian Communities. Wisconsin Partnership Program (WPP); Beliefs and Attitudes about Dementia among Latinx Individuals Living in Dane County &#x2013; Validation of a Survey Instrument. Department of Medicine, University of Wisconsin &#x2013; Madison; Pisando Fuerte: a fall prevention program for Spanish speaking seniors, Retirement Research Foundation (RRF); Pisando Fuerte: a fall prevention program for Spanish speaking seniors. University of Wisconsin &#x2013; Institute for Clinical and Translational Research (UW &#x2013; ICTR). This project was supported in part by grant 1UL1TR002373 to UW ICTR from NIH/NCATS; was supported by the University of Wisconsin Department of Family Medicine and Community Health Primary Care Research Fellowship, funded by grant T32HP10010 from the Health Resources and Services Administration; received support for attending meetings and/or travel 2020 &#x2010; NIDDK/National Hispanic Medical Association Travel Award &#x2010; Cancelled due to COVID&#x2010;19; serves as President&#x2010;Elect Medical Organization for the Latino Advancement &#x2010; Wisconsin, Inc. (2021); was selected as an emerging scholar in the scientific training program, Interdisciplinary Aging Research to Address Health Disparities in Alzheimer's Disease and Related Dementias, USC Edward R. Roybal Institute on Aging, Los Angeles, CA. Funding for the scientific training program was made possible in part by 1 R13 AG 063477 &#x2010; 01 from the National Institute on Aging. Rosa V. Pirela Mavarez has nothing to disclose. Celina F. Pluim has nothing to disclose. Rema Raman received grant funding from the National Institutes of Health (R01AG063689; U24AG057437, 5R01AG061848, 5R01AG054029), Alzheimer's Association, Eli Lilly, and Eisai Inc.; she is the Vice&#x2010;Chair of the Board of the Alzheimer's Association's San Diego/Imperial chapter. Katya Rascovsky, in the past 36 months, reports grants or contracts from NIH. Dorene M. Rentz in the past 36 months, received consulting fees from Neurotrack and Digital Cognition Technologies; received payment or honoraria for ACTC IMPACT AD Course as faculty for presentations and group leadership activities and received support for attending ACTC Meeting in February 2020. Yarissa Reyes has nothing to disclose. Monica Rosselli, in the past 36 months, reports grants from the Alzheimer Disease Research Center. National Institutes of Health/National Institute of Aging, PI: T Golden &amp; R Duara; Co&#x2010;I: M. Rosselli (2015&#x2010;2020.; Cognitive Support Strategies to Improve Medication Adherence in Older Adults Undergoing Hemodialysis, Keryx Pharmaceitics, PI: D Hain. Co&#x2010;I: M. Rosselli. (2019&#x2010;2021); Neuro&#x2010;imaging, and Sensitive Novel Cognitive Measures in Detection of Early Alzheimer's Disease in Bilingual and Monolingual Hispanic Americans, Florida Department of Health&#x2010; Ed and Ethel Moore Alzheimer's Disease Research Program, PI: M Rosselli (2019&#x2010;2021); Fit2Drive: Development and Testing of a Driver Risk Predictor for Individuals with AD Florida Department of Health&#x2010; Ed and Ethel Moore Alzheimer's Disease Research Program, PI Tappen. Co&#x2010;I: M. Rosselli; Communication of Dementia Diagnoses: Investigating Patient, Family, and Physician Experiences and Developing Best Practices. Florida Department of Health&#x2010; Ed and Ethel Moore Alzheimer's Disease Research Program, PI: M. Amstrong (UF). Co&#x2010;I M. Rosselli (2020 &#x2013; 2023); In&#x2010;Vehicle Sensors to Detect Cognitive Change in Older Drivers. National Institutes of Health. National Institute of Aging, PI: R. Tappen. Co&#x2010;I: M. Rosselli; Florida Alzheimer's Disease Research Center. National Institutes of Health. National Institute of Aging, PI. T.Golde (UF). Co&#x2010;I: M. Rosselli (2020&#x2010;2025); Postdoctoral Research Fellowship in Neuropsychology and Brain Biomarkers of Abnormal Aging Florida Department of Health&#x2010; Ed and Ethel Moore Alzheimer's Disease Research Program, PI: M Rosselli. Mal&#xfa; G&#xe1;mez Tansey, in the past 36 months, reports grants or contracts from NIH, MJFF, Parkinson's Foundation; received consulting fees from INmune Bio, Cerebral Therapeutics; received multiple support for attending meetings and/or travel; participated on a DSMB or Advisory Board for MSAG, Weston Family Foundation; has held/holds stock or stock options at INmune bio. Clara Vila&#x2010;Castelar receives funding from the Alzheimer's Association (2019&#x2010;AARF&#x2010;644631); co&#x2010;chairs the Sex Differences Special Interest Group, Diversity and Disparities Professional Interest Area&#x2010;PIA of the International Society to Advance Alzheimer's Research and Treatment (ISTAART). Megan Zuelsdorff, in the past 36 months, reports grants AARF18562958 &#x2010; Psychosocial stressors, allostatic load, and cognitive aging; 1R03AG063303 (Zuelsdorff)&#x2010; Social&#x2010;biological dimensions of ADRD risk and resilience in a Native American cohort; held/holds a leadership or fiduciary role at Wisconsin Alzheimer's Institute Leadership Board and ISTAART Diversity &amp; Disparities Executive Committee. Maria Carrillo is a full&#x2010;time employee of the Alzheimer's Association and reports, in the past 36 months, participating on a Data Safety Monitoring Board or Advisory Board for US POINTER and holding a role for EASTERSEALS. Claire Sexton is a full&#x2010;time employee of the Alzheimer's Association and, in the past 36 months, reports consultation fees from Jazz Pharmaceuticals and support for attending meetings and/or travel to the AAIC Satellite Symposium Sydney (2019) and Society for the Study of Ingestive Behavior (SSIB) Annual Meeting (2019) and reports an unpaid role as a trustee of Dementia Adventure (2018&#x2013;2020).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>24</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35199931</ArticleId><ArticleId IdType="mid">NIHMS1829982</ArticleId><ArticleId IdType="pmc">PMC9399296</ArticleId><ArticleId IdType="doi">10.1002/alz.12589</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement J Alzheimers Assoc. 2013;9:63&#x2010;75.e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">23305823</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews KA, Xu W, Gaglioti AH, et&#xa0;al. Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015&#x2010;2060) in adults aged &#x2265;65 years. Alzheimers Dement J Alzheimers Assoc. 2019;15:17&#x2010;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6333531</ArticleId><ArticleId IdType="pubmed">30243772</ArticleId></ArticleIdList></Reference><Reference><Citation>2021 Alzheimer's disease facts and figures. Alzheimers Dement J Alzheimers Assoc 2021;17:327&#x2010;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">33756057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryc K, Velez C, Karafet T, et&#xa0;al. Colloquium paper: genome&#x2010;wide patterns of population structure and admixture among Hispanic/Latino populations. Proc Natl Acad Sci U S A. 2010;107:8954&#x2010;8961. Suppl 2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3024022</ArticleId><ArticleId IdType="pubmed">20445096</ArticleId></ArticleIdList></Reference><Reference><Citation>Haan MN, Mungas DM, Gonzalez HM, Ortiz TA, Acharya A, Jagust WJ. Prevalence of dementia in older Latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc. 2003;51:169&#x2010;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">12558712</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez HM, Tarraf W, Fornage M, et&#xa0;al. A research framework for cognitive aging and Alzheimer's disease among diverse US Latinos: design and implementation of the Hispanic Community Health Study/Study of Latinos&#x2010;Investigation of Neurocognitive Aging (SOL&#x2010;INCA). Alzheimers Dement J Alzheimers Assoc. 2019;15:1624&#x2010;1632.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6925624</ArticleId><ArticleId IdType="pubmed">31759880</ArticleId></ArticleIdList></Reference><Reference><Citation>Granot&#x2010;Hershkovitz E, Tarraf W, Kurniansyah N, et&#xa0;al. APOE alleles&#x2019; association with cognitive function differs across Hispanic/Latino groups and genetic ancestry in the study of Latinos&#x2010;investigation of neurocognitive aging (HCHS/SOL). Alzheimers Dement J Alzheimers Assoc. 2021;17:466&#x2010;474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8016734</ArticleId><ArticleId IdType="pubmed">33155766</ArticleId></ArticleIdList></Reference><Reference><Citation>
Krogstad JM, Gonzalez&#x2010;Barrera A, A majority of English&#x2010;speaking Hispanics in the U.S. are bilingual. Pew Res Cent n.d. https://www.pewresearch.org/fact&#x2010;tank/2015/03/24/a&#x2010;majority&#x2010;of&#x2010;english&#x2010;speaking&#x2010;hispanics&#x2010;in&#x2010;the&#x2010;u&#x2010;s&#x2010;are&#x2010;bilingual/ (accessed December 16, 2021)</Citation></Reference><Reference><Citation>Costumero V, Marin&#x2010;Marin L, Calabria M, et&#xa0;al. A cross&#x2010;sectional and longitudinal study on the protective effect of bilingualism against dementia using brain atrophy and cognitive measures. Alzheimers Res Ther. 2020;12:11. 10.1186/s13195-020-0581-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-0581-1</ArticleId><ArticleId IdType="pmc">PMC6954576</ArticleId><ArticleId IdType="pubmed">31924269</ArticleId></ArticleIdList></Reference><Reference><Citation>Bialystok E. Bilingualism: pathway to Cognitive Reserve. Trends Cogn Sci. 2021;25:355&#x2010;364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8035279</ArticleId><ArticleId IdType="pubmed">33771449</ArticleId></ArticleIdList></Reference><Reference><Citation>
Salvatierra JL, Rosselli M, The effect of bilingualism and age on inhibitory control, 2011 n.d. https://journals.sagepub.com/doi/10.1177/1367006910371021. Accessed September 17, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1367006910371021</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurado MB, Rosselli M. The elusive nature of executive functions: a review of our current understanding. Neuropsychol Rev. 2007;17:213&#x2010;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">17786559</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosselli M, Ardila A, Araujo K, et&#xa0;al. Verbal fluency and repetition skills in healthy older Spanish&#x2010;English bilinguals. Appl Neuropsychol. 2000;7:17&#x2010;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">10800624</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosselli M. In: Lantolf JP, Swain ME, eds. Neuropsychology of Bilingualism. Theory Second Lang. Dev. Routledge; 2018. Routledge Handb. Sociocult.</Citation></Reference><Reference><Citation>Rosselli M, Loewenstein DA, Curiel RE, et&#xa0;al. Effects of bilingualism on verbal and nonverbal memory measures in mild cognitive impairment. J Int Neuropsychol Soc JINS. 2019;25:15&#x2010;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6349543</ArticleId><ArticleId IdType="pubmed">30334507</ArticleId></ArticleIdList></Reference><Reference><Citation>Bialystok E. The bilingual adaptation: how minds accommodate experience. Psychol Bull. 2017;143:233&#x2010;262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5324728</ArticleId><ArticleId IdType="pubmed">28230411</ArticleId></ArticleIdList></Reference><Reference><Citation>Pliatsikas C. Understanding structural plasticity in the bilingual brain: the Dynamic Restructuring Model. Biling Lang Cogn. 2020;23:459&#x2010;471.</Citation></Reference><Reference><Citation>Torres VL, Rosselli M, Loewenstein DA, et&#xa0;al. The contribution of bilingualism to cognitive functioning and regional brain volume in normal and abnormal aging. Biling: Lang Cogn. 2021;1&#x2013;20. 10.1017/S1366728921000705</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1366728921000705</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Noort M, Vermeire K, Bosch P, et&#xa0;al. A systematic review on the possible relationship between bilingualism, cognitive decline, and the onset of dementia. Behav Sci. 2019;9:81. 10.3390/bs9070081</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/bs9070081</ArticleId><ArticleId IdType="pmc">PMC6680432</ArticleId><ArticleId IdType="pubmed">31340609</ArticleId></ArticleIdList></Reference><Reference><Citation>Brini S, Sohrabi HR, Hebert JJ, et&#xa0;al. Bilingualism is associated with a delayed onset of dementia but not with a lower risk of developing it: a systematic review with meta&#x2010;analyses. Neuropsychol Rev. 2020;30:1&#x2010;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7089902</ArticleId><ArticleId IdType="pubmed">32036490</ArticleId></ArticleIdList></Reference><Reference><Citation>Besser L, Kukull W, Knopman DS, et&#xa0;al. Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Dis Assoc Disord. 2018;32:351&#x2010;358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6249084</ArticleId><ArticleId IdType="pubmed">30376508</ArticleId></ArticleIdList></Reference><Reference><Citation>Magesh S, John D, Li WT, et&#xa0;al. Disparities in COVID&#x2010;19 outcomes by race, ethnicity, and socioeconomic status: a systematic&#x2010;review and meta&#x2010;analysis. JAMA Netw Open. 2021;4:e2134147. 10.1001/jamanetworkopen.2021.34147</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.34147</ArticleId><ArticleId IdType="pmc">PMC8586903</ArticleId><ArticleId IdType="pubmed">34762110</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et&#xa0;al. Post&#x2010;discharge persistent symptoms and health&#x2010;related quality of life after hospitalization for COVID&#x2010;19. J Infect. 2020;81:e4&#x2010;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Bryant SE, Johnson LA, Barber RC, et&#xa0;al. The Health &amp; Aging Brain among Latino Elders (HABLE) study methods and participant characteristics. Alzheimers Dement Amst Neth. 2021;13:e12202. 10.1002/dad2.12202</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dad2.12202</ArticleId><ArticleId IdType="pmc">PMC8215806</ArticleId><ArticleId IdType="pubmed">34189247</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Bryant SE, Zhang F, Petersen M, et&#xa0;al. A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community&#x2010;dwelling Mexican Americans and non&#x2010;Hispanic Whites: a method for increasing representation of diverse populations in clinical research. Alzheimers Dement J Alzheimers Assoc. 2022;18:77&#x2010;87. 10.1002/alz.12382</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12382</ArticleId><ArticleId IdType="pmc">PMC8936163</ArticleId><ArticleId IdType="pubmed">34057802</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Bryant S, Petersen M, Hall J, et&#xa0;al. Characterizing plasma NfL in a community&#x2010;dwelling multi&#x2010;ethnic cohort: results from the HABLE study. Alzheimers Dement J Alzheimers Assoc. 2021. 10.1002/alz.12404</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12404</ArticleId><ArticleId IdType="pmc">PMC9228481</ArticleId><ArticleId IdType="pubmed">34310015</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Bryant SE, Johnson L, Balldin V, et&#xa0;al. Characterization of Mexican Americans with mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis JAD. 2013;33:373&#x2010;379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3524411</ArticleId><ArticleId IdType="pubmed">22976076</ArticleId></ArticleIdList></Reference><Reference><Citation>Babulal GM, Quiroz YT, Albensi BC, et&#xa0;al. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: update and areas of immediate need. Alzheimers Dement J Alzheimers Assoc. 2019;15:292&#x2010;312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6368893</ArticleId><ArticleId IdType="pubmed">30555031</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Skike CE, Hussong SA, Hernandez SF, Banh AQ, DeRosa N, Galvan V. mTOR attenuation with rapamycin reverses neurovascular uncoupling and memory deficits in mice modeling Alzheimer's disease. J Neurosci Off J Soc Neurosci. 2021;41:4305&#x2010;4320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8143195</ArticleId><ArticleId IdType="pubmed">33888602</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark LT, Watkins L, Pi&#xf1;a IL, et&#xa0;al. Increasing diversity in clinical trials: overcoming critical barriers. Curr Probl Cardiol. 2019;44:148&#x2010;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">30545650</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngandu T, Lehtisalo J, Solomon A, et&#xa0;al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at&#x2010;risk elderly people (FINGER): a randomised controlled trial. Lancet Lond Engl. 2015;385:2255&#x2010;2263.</Citation><ArticleIdList><ArticleId IdType="pubmed">25771249</ArticleId></ArticleIdList></Reference><Reference><Citation>LatAm&#x2010;FINGERS (Latin America) &#x2010; Crivelli &#x2010; 2020 &#x2010; Alzheimer's &amp; Dementia &#x2010; Wiley Online Library n.d. https://alz&#x2010;journals.onlinelibrary.wiley.com/doi/10.1002/alz.046953. Accessed July 16, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.046953</ArticleId></ArticleIdList></Reference><Reference><Citation>Llibre&#x2010;Guerra JJ, Li Y, Allegri RFJ, et&#xa0;al. Dominantly inherited Alzheimer's disease in Latin America: genetic heterogeneity and clinical phenotypes. Alzheimers Dement J Alzheimers Assoc. 2021;17:653&#x2010;664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8140610</ArticleId><ArticleId IdType="pubmed">33226734</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott CL. Together we make the difference: national strategy for recruitment and participation in Alzheimer's and related dementias clinical research. Ethn Dis. 2020;30:705&#x2010;708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7683031</ArticleId><ArticleId IdType="pubmed">33250617</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S. Racial and ethnic disparities in subjective cognitive decline: a closer look, United States, 2015&#x2010;2018. BMC Public Health. 2021;21:1173. 10.1186/s12889-021-11068-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-11068-1</ArticleId><ArticleId IdType="pmc">PMC8223389</ArticleId><ArticleId IdType="pubmed">34162356</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz F, Fitten LJ. Barriers to healthcare access for cognitively impaired older Hispanics. Alzheimer Dis Assoc Disord. 2000;14:141&#x2010;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">10994655</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlawish J, Barg FK, Augsburger D, Beaver J, Ferguson A, Nunez J. What Latino Puerto Ricans and non&#x2010;Latinos say when they talk about Alzheimer's disease. Alzheimers Dement J Alzheimers Assoc. 2011;7:161&#x2010;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">21075061</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35171074</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1464-5165</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Disability and rehabilitation</Title><ISOAbbreviation>Disabil Rehabil</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of physical exercise at improving functional capacity in older adults living with Alzheimer's disease: a systematic review of randomized controlled trials.</ArticleTitle><Pagination><StartPage>391</StartPage><EndPage>402</EndPage><MedlinePgn>391-402</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/09638288.2022.2037744</ELocationID><Abstract><AbstractText Label="PURPOSE">To investigate the effects of physical exercise at improving functional capacity in older adults living with Alzheimer's disease (AD).</AbstractText><AbstractText Label="METHODS">Medline, Embase, Web of Science, The Cochrane Library, Lilacs, and PEDro were searched from inception until January 2021. Randomized controlled trials (RCTs) that reported functional capacity outcomes were included. The evidence was assessed using the GRADE approach.</AbstractText><AbstractText Label="RESULTS">Thirteen RCTs were included, involving 811 older adults living with AD. Multimodal exercise (ME), aerobic exercise (AE), and resistance exercise (RE) were used. The interventions were mainly supervised by caregivers. The evidence was low and with effect for activities of daily living (ADLs), moderate and with no effect for mobility and very low and with no effect for muscle strength, postural balance and flexibility after treatment with ME, moderate and with no effect for cardiorespiratory function and ADLs after treatment with AE. It was not possible to synthesize any type of evidence for RE.</AbstractText><AbstractText Label="CONCLUSIONS">Multimodal exercise promotes improvements in functional capacity (ADLs). Therefore, the practice of physical exercise can be recommended for older adults living with AD. The involvement of the caregiver in the physical exercises should also be considered, as it could enhance the benefits of exercise for these older adults.Implications for rehabilitationHealthcare providers with clinical knowledge regarding physical exercise should promote, prescribe and support the daily practice of physical exercises for older adults living with Alzheimer's disease (AD).The involvement of caregivers in home-based physical exercise programs should be considered, as it could enhance the benefits of such programs for these older adults.It is important to consider the degree of cognitive impairment in older adults living with AD when outlining goals for the improvement in functional capacity through physical exercise.Multimodal exercise involving aerobic training, postural balance, muscle strengthening, and flexibility is capable of promoting an improvement in functional capacity (activities of daily living) for these older adults.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Braz de Oliveira</LastName><ForeName>Marcos Paulo</ForeName><Initials>MP</Initials><Identifier Source="ORCID">0000-0003-4787-1113</Identifier><AffiliationInfo><Affiliation>Physical Therapy Department, Healthy Aging Research Laboratory, Federal University of S&#xe3;o Carlos, S&#xe3;o Carlos, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreira Padovez</LastName><ForeName>Roberta de F&#xe1;tima Carreira</ForeName><Initials>RFC</Initials><AffiliationInfo><Affiliation>Physical Therapy Department, Clinical and Occupational Kinesiology Laboratory, Federal University of S&#xe3;o Carlos, S&#xe3;o Carlos, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serr&#xe3;o</LastName><ForeName>Paula Regina Mendes da Silva</ForeName><Initials>PRMDS</Initials><AffiliationInfo><Affiliation>Physical Therapy Department, Rheumatology and Hand Rehabilitation Research Laboratory, Federal University of S&#xe3;o Carlos, S&#xe3;o Carlos, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Noronha</LastName><ForeName>Marcos Amaral</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Community and Allied Health Department, La Trobe University, Bendigo, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cezar</LastName><ForeName>Nat&#xe1;lia Oiring de Castro</ForeName><Initials>NOC</Initials><AffiliationInfo><Affiliation>Physical Therapy Department, Healthy Aging Research Laboratory, Federal University of S&#xe3;o Carlos, S&#xe3;o Carlos, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrade</LastName><ForeName>Larissa Pires de</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>Physical Therapy Department, Healthy Aging Research Laboratory, Federal University of S&#xe3;o Carlos, S&#xe3;o Carlos, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Disabil Rehabil</MedlineTA><NlmUniqueID>9207179</NlmUniqueID><ISSNLinking>0963-8288</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005081" MajorTopicYN="N">Exercise Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer disease</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">exercise</Keyword><Keyword MajorTopicYN="N">neurocognitive disorders</Keyword><Keyword MajorTopicYN="N">rehabilitation</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>16</Day><Hour>12</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35171074</ArticleId><ArticleId IdType="doi">10.1080/09638288.2022.2037744</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37124356</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2667-1743</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Biological psychiatry global open science</Title><ISOAbbreviation>Biol Psychiatry Glob Open Sci</ISOAbbreviation></Journal><ArticleTitle>Mapping Normative Trajectories of Cognitive Function and Its Relation to Psychopathology Symptoms and Genetic Risk in Youth.</ArticleTitle><Pagination><StartPage>255</StartPage><EndPage>263</EndPage><MedlinePgn>255-263</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpsgos.2022.01.007</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Adolescence hosts a sharp increase in the incidence of mental disorders. The prodromal phases are often characterized by cognitive deficits that predate disease onset by several years. Characterization of cognitive performance in relation to normative trajectories may have value for early risk assessment and monitoring.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Youth aged 8 to 21 years (<i>N</i> = 6481) from the Philadelphia Neurodevelopmental Cohort were included. Performance scores from a computerized neurocognitive battery were decomposed using principal component analysis, yielding a general cognitive score. Items reflecting various aspects of psychopathology from self-report questionnaires and collateral caregiver information were decomposed using independent component analysis, providing individual domain scores. Using normative modeling and Bayesian statistics, we estimated normative trajectories of cognitive function and tested for associations between cognitive deviance and psychopathological domain scores. In addition, we tested for associations with polygenic scores for mental and behavioral disorders often involving cognition, including schizophrenia, bipolar disorder, attention-deficit/hyperactivity disorder, and Alzheimer's disease.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">More negative normative cognitive deviations were associated with higher general psychopathology burden and domains reflecting positive and prodromal psychosis, attention problems, norm-violating behavior, and anxiety. In addition, better performance was associated with higher joint burden of depression, suicidal ideation, and negative psychosis symptoms. The analyses revealed no evidence for associations with polygenic scores.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Our results show that cognitive performance is associated with general and specific domains of psychopathology in youth. These findings support the close links between cognition and psychopathology in youth and highlight the potential of normative modeling for early risk assessment.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kjelkenes</LastName><ForeName>Rikka</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, University of Oslo, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolfers</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, University of Oslo, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Donders Centre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aln&#xe6;s</LastName><ForeName>Dag</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, University of Oslo, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oslo New University College, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Meer</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, University of Oslo, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Mental Health and Neuroscience Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedersen</LastName><ForeName>Mads Lund</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, University of Oslo, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahl</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, University of Oslo, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voldsbekk</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, University of Oslo, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moberget</LastName><ForeName>Torgeir</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, University of Oslo, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamnes</LastName><ForeName>Christian K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, University of Oslo, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreassen</LastName><ForeName>Ole A</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, University of Oslo, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marquand</LastName><ForeName>Andre F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Donders Centre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroimaging, Center for Neuroimaging Sciences, Institute of Psychiatry, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westlye</LastName><ForeName>Lars T</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, University of Oslo, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biol Psychiatry Glob Open Sci</MedlineTA><NlmUniqueID>9918227369306676</NlmUniqueID><ISSNLinking>2667-1743</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cognition</Keyword><Keyword MajorTopicYN="N">Development</Keyword><Keyword MajorTopicYN="N">Genetic risk</Keyword><Keyword MajorTopicYN="N">Normative modeling</Keyword><Keyword MajorTopicYN="N">PNC</Keyword><Keyword MajorTopicYN="N">Psychopathology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>3</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37124356</ArticleId><ArticleId IdType="pmc">PMC10140446</ArticleId><ArticleId IdType="doi">10.1016/j.bpsgos.2022.01.007</ArticleId><ArticleId IdType="pii">S2667-1743(22)00012-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hofmann W., Schmeichel B.J., Baddeley A.D. Executive functions and self-regulation. Trends Cogn Sci. 2012;16:174&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">22336729</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen B., Luna B. Adolescence as a neurobiological critical period for the development of higher-order cognition. Neurosci Biobehav Rev. 2018;94:179&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6526538</ArticleId><ArticleId IdType="pubmed">30201220</ArticleId></ArticleIdList></Reference><Reference><Citation>Sydnor V.J., Larsen B., Bassett D.S., Alexander-Bloch A., Fair D.A., Liston C., et al. Neurodevelopment of the association cortices: Patterns, mechanisms, and implications for psychopathology. Neuron. 2021;109:2820&#x2013;2846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8448958</ArticleId><ArticleId IdType="pubmed">34270921</ArticleId></ArticleIdList></Reference><Reference><Citation>Norbom L.B., Ferschmann L., Parker N., Agartz I., Andreassen O.A., Paus T., et al. New insights into the dynamic development of the cerebral cortex in childhood and adolescence: Integrating macro- and microstructural MRI findings. Prog Neurobiol. 2021;204:102109.</Citation><ArticleIdList><ArticleId IdType="pubmed">34147583</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication [published correction appears in Arch Gen Psychiatry 2005; 62:768] Arch Gen Psychiatry. 2005;62:593&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pubmed">15939837</ArticleId></ArticleIdList></Reference><Reference><Citation>Paus T., Keshavan M., Giedd J.N. Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci. 2008;9:947&#x2013;957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2762785</ArticleId><ArticleId IdType="pubmed">19002191</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnbaum R., Weinberger D.R. Genetic insights into the neurodevelopmental origins of schizophrenia. Nat Rev Neurosci. 2017;18:727&#x2013;740.</Citation><ArticleIdList><ArticleId IdType="pubmed">29070826</ArticleId></ArticleIdList></Reference><Reference><Citation>Insel T.R. Rethinking schizophrenia. Nature. 2010;468:187&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pubmed">21068826</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler R.C., Angermeyer M., Anthony J.C., de Graaf R., Demyttenaere K., Gasquet I., et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization&#x2019;s World Mental Health Survey Initiative. World Psychiatry. 2007;6:168&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2174588</ArticleId><ArticleId IdType="pubmed">18188442</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers S.P., Van Rheenen T.E., Gurvich C., Sumner P.J., Rossell S.L. Characterising the structure of cognitive heterogeneity in schizophrenia spectrum disorders. A systematic review and narrative synthesis. Neurosci Biobehav Rev. 2019;107:252&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">31505202</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce E.M., Roiser J.P. Cognitive heterogeneity in schizophrenia. Curr Opin Psychiatry. 2007;20:268&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2597188</ArticleId><ArticleId IdType="pubmed">17415081</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaskinn A., Haatveit B., Melle I., Andreassen O.A., Ueland T., Sundet K. Cognitive heterogeneity across schizophrenia and bipolar disorder: A cluster analysis of intellectual trajectories. J&#xa0;Int Neuropsychol Soc. 2020;26:860&#x2013;872.</Citation><ArticleIdList><ArticleId IdType="pubmed">32423506</ArticleId></ArticleIdList></Reference><Reference><Citation>Faraone S.V., Asherson P., Banaschewski T., Biederman J., Buitelaar J.K., Ramos-Quiroga J.A., et al. Attention-deficit/hyperactivity disorder. Nat Rev Dis Primers. 2015;1:15020.</Citation><ArticleIdList><ArticleId IdType="pubmed">27189265</ArticleId></ArticleIdList></Reference><Reference><Citation>Fusar-Poli P., Deste G., Smieskova R., Barlati S., Yung A.R., Howes O., et al. Cognitive functioning in prodromal psychosis: A meta-analysis. Arch Gen Psychiatry. 2012;69:562&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">22664547</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman R.J., Xiong C., Benzinger T.L.S., Fagan A.M., Goate A., Fox N.C., et al. Clinical and biomarker changes in dominantly inherited Alzheimer&#x2019;s disease [published correction appears in N Engl J Med 2012; 367:780] N&#xa0;Engl J Med. 2012;367:795&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3474597</ArticleId><ArticleId IdType="pubmed">22784036</ArticleId></ArticleIdList></Reference><Reference><Citation>Axelrud L.K., Santoro M.L., Pine D.S., Talarico F., Gadelha A., Manfro G.G., et al. Polygenic risk score for Alzheimer&#x2019;s disease: Implications for memory performance and hippocampal volumes in early life. Am J Psychiatry. 2018;175:555&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6372950</ArticleId><ArticleId IdType="pubmed">29495896</ArticleId></ArticleIdList></Reference><Reference><Citation>Korologou-Linden R., Anderson E.L., Jones H.J., Davey Smith G., Howe L.D., Stergiakouli E. Polygenic risk scores for Alzheimer&#x2019;s disease, and academic achievement, cognitive and behavioural measures in children from the general population. Int J Epidemiol. 2019;48:1972&#x2013;1980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6929531</ArticleId><ArticleId IdType="pubmed">31056667</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilker R., Helenius D., Fagerlund B., Skytthe A., Christensen K., Werge T.M., et al. Heritability of schizophrenia and schizophrenia spectrum based on the nationwide Danish Twin Register. Biol Psychiatry. 2018;83:492&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">28987712</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson V., Kuja-Halkola R., Cannon T.D., Hultman C.M., Hedman A.M. A&#xa0;population-based heritability estimate of bipolar disorder - In a Swedish twin sample. Psychiatry Res. 2019;278:180&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">31207455</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims R., Hill M., Williams J. The multiplex model of the genetics of Alzheimer&#x2019;s disease. Nat Neurosci. 2020;23:311&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pubmed">32112059</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophrenia Working Group of the Psychiatric Genomics Consortium Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4112379</ArticleId><ArticleId IdType="pubmed">25056061</ArticleId></ArticleIdList></Reference><Reference><Citation>Demontis D., Walters R.K., Martin J., Mattheisen M., Als T.D., Agerbo E., et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat Genet. 2019;51:63&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6481311</ArticleId><ArticleId IdType="pubmed">30478444</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullins N., Forstner A.J., O&#x2019;Connell K.S., Coombes B., Coleman J.R.I., Qiao Z., et al. Genome-wide association study of more than 40,000&#xa0;bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 2021;53:817&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8192451</ArticleId><ArticleId IdType="pubmed">34002096</ArticleId></ArticleIdList></Reference><Reference><Citation>Smeland O.B., Frei O., Dale A.M., Andreassen O.A. The polygenic architecture of schizophrenia&#x2014;Rethinking pathogenesis and nosology. Nat Rev Neurol. 2020;16:366&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">32528109</ArticleId></ArticleIdList></Reference><Reference><Citation>Foulkes L., Blakemore S.J. Studying individual differences in human adolescent brain development. Nat Neurosci. 2018;21:315&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pubmed">29403031</ArticleId></ArticleIdList></Reference><Reference><Citation>Marquand A.F., Kia S.M., Zabihi M., Wolfers T., Buitelaar J.K., Beckmann C.F. Conceptualizing mental disorders as deviations from normative functioning [published correction appears in Mol Psychiatry 2019; 24:1565] Mol Psychiatry. 2019;24:1415&#x2013;1424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6756106</ArticleId><ArticleId IdType="pubmed">31201374</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuthbert B.N., Insel T.R. Toward the future of psychiatric diagnosis: The seven pillars of RDoC. BMC Med. 2013;11:126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3653747</ArticleId><ArticleId IdType="pubmed">23672542</ArticleId></ArticleIdList></Reference><Reference><Citation>Aln&#xe6;s D., Kaufmann T., Doan N.T., C&#xf3;rdova-Palomera A., Wang Y., Bettella F., et al. Association of heritable cognitive ability and psychopathology with white matter properties in children and adolescents. JAMA Psychiatry. 2018;75:287&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5885956</ArticleId><ArticleId IdType="pubmed">29365026</ArticleId></ArticleIdList></Reference><Reference><Citation>Satterthwaite T.D., Connolly J.J., Ruparel K., Calkins M.E., Jackson C., Elliott M.A., et al. The Philadelphia Neurodevelopmental Cohort: A publicly available resource for the study of normal and abnormal brain development in youth. Neuroimage. 2016;124:1115&#x2013;1119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4591095</ArticleId><ArticleId IdType="pubmed">25840117</ArticleId></ArticleIdList></Reference><Reference><Citation>Satterthwaite T.D., Elliott M.A., Ruparel K., Loughead J., Prabhakaran K., Calkins M.E., et al. Neuroimaging of the Philadelphia Neurodevelopmental Cohort. Neuroimage. 2014;86:544&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3947233</ArticleId><ArticleId IdType="pubmed">23921101</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore T.M., Reise S.P., Gur R.E., Hakonarson H., Gur R.C. Psychometric properties of the Penn Computerized Neurocognitive Battery. Neuropsychology. 2015;29:235&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4345134</ArticleId><ArticleId IdType="pubmed">25180981</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen C.E., Williams C.K.I. the MIT Press; Cambridge, MA: 2006. Gaussian Processes for Machine Learning.</Citation></Reference><Reference><Citation>Marquand A.F., Rezek I., Buitelaar J., Beckmann C.F. Understanding heterogeneity in clinical cohorts using normative models: Beyond case-control studies. Biol Psychiatry. 2016;80:552&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5023321</ArticleId><ArticleId IdType="pubmed">26927419</ArticleId></ArticleIdList></Reference><Reference><Citation>Calkins M.E., Merikangas K.R., Moore T.M., Burstein M., Behr M.A., Satterthwaite T.D., et al. The Philadelphia Neurodevelopmental Cohort: Constructing a deep phenotyping collaborative. J&#xa0;Child Psychol Psychiatry. 2015;56:1356&#x2013;1369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4598260</ArticleId><ArticleId IdType="pubmed">25858255</ArticleId></ArticleIdList></Reference><Reference><Citation>Himberg J., Hyv&#xe4;rinen A., Esposito F. Validating the independent components of neuroimaging time series via clustering and visualization. Neuroimage. 2004;22:1214&#x2013;1222.</Citation><ArticleIdList><ArticleId IdType="pubmed">15219593</ArticleId></ArticleIdList></Reference><Reference><Citation>C&#xf3;rdova-Palomera A., Kaufmann T., Bettella F., Wang Y., Doan N.T., van der Meer D., et al. Effects of autozygosity and schizophrenia polygenic risk on cognitive and brain developmental trajectories. Eur J Hum Genet. 2018;26:1049&#x2013;1059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6018758</ArticleId><ArticleId IdType="pubmed">29700391</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S.W., O&#x2019;Reilly P.F. PRSice-2: Polygenic risk score software for biobank-scale data. Gigascience. 2019;8:giz082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6629542</ArticleId><ArticleId IdType="pubmed">31307061</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl E.A., Breen G., Forstner A.J., McQuillin A., Ripke S., Trubetskoy V., et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet. 2019;51:793&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6956732</ArticleId><ArticleId IdType="pubmed">31043756</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert J.C., Ibrahim-Verbaas C.A., Harold D., Naj A.C., Sims R., Bellenguez C., et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer&#x2019;s disease. Nat Genet. 2013;45:1452&#x2013;1458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3896259</ArticleId><ArticleId IdType="pubmed">24162737</ArticleId></ArticleIdList></Reference><Reference><Citation>Aln&#xe6;s D., Kaufmann T., van der Meer D., C&#xf3;rdova-Palomera A., Rokicki J., Moberget T., et al. Brain heterogeneity in schizophrenia and its association with polygenic risk [published correction appears in JAMA Psychiatry 2019; 76:986] JAMA Psychiatry. 2019;76:739&#x2013;748.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6583664</ArticleId><ArticleId IdType="pubmed">30969333</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;rkner P.C. Advanced Bayesian multilevel modeling with the R package brms. The R Journal. 2018;10:395&#x2013;411.</Citation></Reference><Reference><Citation>B&#xfc;rkner P.C. brms: An R package for Bayesian multilevel models using Stan. J&#xa0;Stat Soft. 2017;80:1&#x2013;28.</Citation></Reference><Reference><Citation>Wagenmakers E.J., Lodewyckx T., Kuriyal H., Grasman R. Bayesian hypothesis testing for psychologists: A tutorial on the Savage-Dickey method. Cogn Psychol. 2010;60:158&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">20064637</ArticleId></ArticleIdList></Reference><Reference><Citation>Gur R.C., Calkins M.E., Satterthwaite T.D., Ruparel K., Bilker W.B., Moore T.M., et al. Neurocognitive growth charting in psychosis spectrum youths. JAMA Psychiatry. 2014;71:366&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pubmed">24499990</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotov R., Chang S.W., Fochtmann L.J., Mojtabai R., Carlson G.A., Sedler M.J., Bromet E.J. Schizophrenia in the internalizing-externalizing framework: A third dimension? Schizophr Bull. 2011;37:1168&#x2013;1178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196945</ArticleId><ArticleId IdType="pubmed">20357134</ArticleId></ArticleIdList></Reference><Reference><Citation>Romer A.L., Pizzagalli D.A. Is executive dysfunction a risk marker or consequence of psychopathology? A test of executive function as a prospective predictor and outcome of general psychopathology in the adolescent brain cognitive development study&#xae;. Dev Cogn Neurosci. 2021;51:100994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8340137</ArticleId><ArticleId IdType="pubmed">34332330</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellanos-Ryan N., Bri&#xe8;re F.N., O&#x2019;Leary-Barrett M., Banaschewski T., Bokde A., Bromberg U., et al. The structure of psychopathology in adolescence and its common personality and cognitive correlates. J&#xa0;Abnorm Psychol. 2016;125:1039&#x2013;1052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5098414</ArticleId><ArticleId IdType="pubmed">27819466</ArticleId></ArticleIdList></Reference><Reference><Citation>Moberget T., Aln&#xe6;s D., Kaufmann T., Doan N.T., C&#xf3;rdova-Palomera A., Norbom L.B., et al. Cerebellar gray matter volume is associated with cognitive function and psychopathology in adolescence. Biol Psychiatry. 2019;86:65&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">30850129</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuckerman H., Pan Z., Park C., Brietzke E., Musial N., Shariq A.S., et al. Recognition and treatment of cognitive dysfunction in major depressive disorder. Front Psychiatry. 2018;9:655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6288549</ArticleId><ArticleId IdType="pubmed">30564155</ArticleId></ArticleIdList></Reference><Reference><Citation>Bethlehem R.A.I., Seidlitz J., Romero-Garcia R., Trakoshis S., Dumas G., Lombardo M.V. A normative modelling approach reveals age-atypical cortical thickness in a subgroup of males with autism spectrum disorder. Commun Biol. 2020;3:486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7474067</ArticleId><ArticleId IdType="pubmed">32887930</ArticleId></ArticleIdList></Reference><Reference><Citation>Tun&#xe7; B., Yankowitz L.D., Parker D., Alappatt J.A., Pandey J., Schultz R.T., Verma R. Deviation from normative brain development is associated with symptom severity in autism spectrum disorder. Mol Autism. 2019;10:46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6907209</ArticleId><ArticleId IdType="pubmed">31867092</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfers T., Beckmann C.F., Hoogman M., Buitelaar J.K., Franke B., Marquand A.F. Individual differences v. the average patient: Mapping the heterogeneity in ADHD using normative models. Psychol Med. 2020;50:314&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7083555</ArticleId><ArticleId IdType="pubmed">30782224</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfers T., Doan N.T., Kaufmann T., Aln&#xe6;s D., Moberget T., Agartz I., et al. Mapping the heterogeneous phenotype of schizophrenia and bipolar disorder using normative models. JAMA Psychiatry. 2018;75:1146&#x2013;1155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6248110</ArticleId><ArticleId IdType="pubmed">30304337</ArticleId></ArticleIdList></Reference><Reference><Citation>Zabihi M., Oldehinkel M., Wolfers T., Frouin V., Goyard D., Loth E., et al. Dissecting the heterogeneous cortical anatomy of autism spectrum disorder using normative models. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4:567&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6551348</ArticleId><ArticleId IdType="pubmed">30799285</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandaker G.M., Barnett J.H., White I.R., Jones P.B. A&#xa0;quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res. 2011;132:220&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3485562</ArticleId><ArticleId IdType="pubmed">21764562</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraza C.J., Dinga R., Beckmann C.F., Marquand A.F. Warped Bayesian linear regression for normative modelling of big data. Neuroimage. 2021;245:118715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7613680</ArticleId><ArticleId IdType="pubmed">34798518</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke T.K., Lupton M.K., Fernandez-Pujals A.M., Starr J., Davies G., Cox S., et al. Common polygenic risk for autism spectrum disorder (ASD) is associated with cognitive ability in the general population. Mol Psychiatry. 2016;21:419&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4759203</ArticleId><ArticleId IdType="pubmed">25754080</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebers D.T., Pirooznia M., Seiffudin F., Musliner K.L., Zandi P.P., Goes F.S. Polygenic risk of schizophrenia and cognition in a population-based survey of older adults. Schizophr Bull. 2016;42:984&#x2013;991.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4903061</ArticleId><ArticleId IdType="pubmed">26873889</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronald A., de Bode N., Polderman T.J.C. Systematic review: How the attention-deficit/hyperactivity disorder polygenic risk score adds to our understanding of ADHD and associated traits. J&#xa0;Am Acad Child Adolesc Psychiatry. 2021;60:1234&#x2013;1277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11164195</ArticleId><ArticleId IdType="pubmed">33548493</ArticleId></ArticleIdList></Reference><Reference><Citation>Axelrud L.K., Sato J.R., Santoro M.L., Talarico F., Pine D.S., Rohde L.A., et al. Genetic risk for Alzheimer&#x2019;s disease and functional brain connectivity in children and adolescents. Neurobiol Aging. 2019;82:10&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7658444</ArticleId><ArticleId IdType="pubmed">31376729</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y.Y., Zhang X.D., Schoepf U.J., Varga-Szemes A., Stubenrauch A., Liang X., et al. Lower functional connectivity of default mode network in cognitively normal young adults with mutation of APP, presenilins and APOE &#x3b5;4. Brain Imaging Behav. 2017;11:818&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pubmed">27189159</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntosh A.M., Gow A., Luciano M., Davies G., Liewald D.C., Harris S.E., et al. Polygenic risk for schizophrenia is associated with cognitive change between childhood and old age. Biol Psychiatry. 2013;73:938&#x2013;943.</Citation><ArticleIdList><ArticleId IdType="pubmed">23419543</ArticleId></ArticleIdList></Reference><Reference><Citation>Engen M.J., Lyngstad S.H., Ueland T., Simonsen C.E., Vaskinn A., Smeland O., et al. Polygenic scores for schizophrenia and general cognitive ability: Associations with six cognitive domains, premorbid intelligence, and cognitive composite score in individuals with a psychotic disorder and in healthy controls. Transl Psychiatry. 2020;10:416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7705731</ArticleId><ArticleId IdType="pubmed">33257657</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafee R., Nanda P., Padmanabhan J.L., Tandon N., Alliey-Rodriguez N., Kalapurakkel S., et al. Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. Transl Psychiatry. 2018;8:78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5895806</ArticleId><ArticleId IdType="pubmed">29643358</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubbard L., Tansey K.E., Rai D., Jones P., Ripke S., Chambert K.D., et al. Evidence of common genetic overlap between schizophrenia and cognition. Schizophr Bull. 2016;42:832&#x2013;842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4838093</ArticleId><ArticleId IdType="pubmed">26678674</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson B., McGorry P.D., Wichers M., Wigman J.T.W., Hartmann J.A. Moving from static to dynamic models of the onset of mental disorder: A review. JAMA Psychiatry. 2017;74:528&#x2013;534.</Citation><ArticleIdList><ArticleId IdType="pubmed">28355471</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35098811</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1364-6915</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Aging &amp; mental health</Title><ISOAbbreviation>Aging Ment Health</ISOAbbreviation></Journal><ArticleTitle>Diverse rural caregivers for individuals with Alzheimer's disease or related dementias: analysis of health factors at the individual, interpersonal, and community level.</ArticleTitle><Pagination><StartPage>94</StartPage><EndPage>100</EndPage><MedlinePgn>94-100</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/13607863.2022.2026880</ELocationID><Abstract><AbstractText><b>Objectives:</b> Approximately 6.2 million Americans aged 65 or older have Alzheimer's disease or related dementias (ADRD). Unpaid family members and friends provide the bulk of caregiving for these individuals. Caregiving in rural areas adds unique challenges, particularly for ethnically/racially diverse caregivers. This study provides a profile of diverse, rural ADRD caregivers with an emphasis on multi-level factors that influence physical and mental health.<b>Methods:</b> A cross-sectional survey was conducted with 156 diverse rural ADRD caregivers.<b>Results:</b> 65% of participants identified as White/Non-Hispanic (WNH; <i>n</i>&#x2009;=&#x2009;101) and 35% identified as ethnically/racially diverse (ERD; <i>n</i>&#x2009;=&#x2009;55). The majority of participants reported economic deprivation. More ERD caregivers were uninsured and had at least one chronic health condition. Higher proportions of ERD caregivers smoked cigarettes, consumed alcohol regularly, and had not seen or talked to a doctor in the previous year. There were no ethnic/racial group differences in stress, anxiety, depressive symptoms, subjective health, or sleep quality.<b>Conclusion:</b> Rural caregivers, regardless of ethnicity/race, may benefit from extra supports in order to maintain optimal health. Further research is needed to disentangle the complex relationship between culture, caregiving, and health.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McCarthy</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0001-9212-776X</Identifier><AffiliationInfo><Affiliation>Department of Social Work, Northern Arizona University, Flagstaff, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Y Evie</ForeName><Initials>YE</Initials><AffiliationInfo><Affiliation>Department of Educational Psychology, Northern Arizona University, Flagstaff, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Remiker</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Health Equity Research, Northern Arizona University, Flagstaff, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hustead</LastName><ForeName>Morgan Lee-Regalado</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Educational Psychology, Northern Arizona University, Flagstaff, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bacon</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Health Equity Research, Northern Arizona University, Flagstaff, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williamson</LastName><ForeName>Heather J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Center for Health Equity Research, Northern Arizona University, Flagstaff, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunn</LastName><ForeName>Dorothy J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>School of Nursing, Northern Arizona University, Flagstaff, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldwin</LastName><ForeName>Julie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1872-1925</Identifier><AffiliationInfo><Affiliation>Center for Health Equity Research, Northern Arizona University, Flagstaff, AZ, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 MD012388</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Aging Ment Health</MedlineTA><NlmUniqueID>9705773</NlmUniqueID><ISSNLinking>1360-7863</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005006" MajorTopicYN="N">Ethnicity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease and related dementias</Keyword><Keyword MajorTopicYN="N">caregivers</Keyword><Keyword MajorTopicYN="N">culture</Keyword><Keyword MajorTopicYN="N">diversity</Keyword><Keyword MajorTopicYN="N">rural</Keyword></KeywordList><CoiStatement>Disclosure statement. No potential conflict of interest was reported by the authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>31</Day><Hour>8</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35098811</ArticleId><ArticleId IdType="mid">NIHMS1778685</ArticleId><ArticleId IdType="pmc">PMC9339023</ArticleId><ArticleId IdType="doi">10.1080/13607863.2022.2026880</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>AARP and National Alliance for Caregiving. (2020). Caregiving in the United States 2020. AARP.</Citation></Reference><Reference><Citation>Accius J (2017). Breaking stereotypes: Spotlight on male family caregivers. AARP Public Policy Institute. https://nicheprogram.org/sites/niche/files/2017-12/Breaking-Stereotypes-Spotlight-on-Male-FamilyCaregivers.pdf</Citation></Reference><Reference><Citation>&#xc1;lvarez-Bueno C, Cavero-Redondo I, Mart&#xed;nez-Andr&#xe9;s M, Arias-Palencia N, Ramos-Blanes R, &amp; Salcedo-Aguilar F (2015). Effectiveness of multifactorial interventions in primary health care settings for primary prevention of cardiovascular disease: A systematic review of systematic reviews. Preventive Medicine, 76, S68&#x2013;S75. 10.1016/j.ypmed.2014.11.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ypmed.2014.11.028</ArticleId><ArticleId IdType="pubmed">25511466</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Disease Facts and Figures (ADFF). (2021). Alzheimer&#x2019;s &amp; dementia: The Journal of the Alzheimer&#x2019;s Association. Alzheimers Dement, 17(3), 327&#x2013;406. 10.1002/alz.12328</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12328</ArticleId><ArticleId IdType="pubmed">33756057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayly M, Morgan D, Chow AF, Kosteniuk J, &amp; Elliot V (2020). Dementiarelated education and support service availability, accessibility, and use in rural areas: Barriers and solutions. Canadian Journal on Aging=La Revue Canadienne du Vieillissement, 39(4), 545&#x2013;585. 10.1017/S0714980819000564</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0714980819000564</ArticleId><ArticleId IdType="pubmed">31975685</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;dard M, Molloy DW, Squire L, Dubois S, Lever JA, &amp; O&#x2019;Donnell M (2001). The Zarit Burden Interview: A new short version and screening version. The Gerontologist, 41(5), 652&#x2013;657. 10.1093/geront/41.5.652</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/41.5.652</ArticleId><ArticleId IdType="pubmed">11574710</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman DR (2019). Revisiting the urban-rural relationship on Arizona. ASU Morrison Institute for Public Policy. https://morrisoninstitute.asu.edu/sites/default/files/urban-rural_relationship.pdf.</Citation></Reference><Reference><Citation>Blewett LA, Smaida SA, Fuentes C, &amp; Zuehlke EU (2003). Health care needs of the growing Latino population in rural America: Focus group findings in one midwestern state. The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association, 19(1), 33&#x2013;41. 10.1111/j1748-0361.2003.tb00539.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j1748-0361.2003.tb00539.x</ArticleId><ArticleId IdType="pubmed">12585772</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouldin ED, Shaull L, Andresen EM, Edwards VJ, &amp; McGuire LC (2018). Financial and health barriers and caregiving-related difficulties among rural and urban caregivers: Barriers and difficulties among caregivers. The Journal of Rural Health, 34(3), 263&#x2013;274. 10.1111/jrh.12273</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jrh.12273</ArticleId><ArticleId IdType="pmc">PMC5866208</ArticleId><ArticleId IdType="pubmed">28940539</ArticleId></ArticleIdList></Reference><Reference><Citation>Breathett K, Spatz ES, Kramer DB, Essien UR, Wadhera RK, Peterson PN, Ho PM, &amp; Nallamothu BK (2021). The groundwater of racial and ethnic disparities research: A statement from. Circulation: Cardiovascular Quality and Outcomes, 14(2), 135&#x2013;139. 10.1161/CIRCOUTCOMES.121.007868</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.121.007868</ArticleId><ArticleId IdType="pmc">PMC7958971</ArticleId><ArticleId IdType="pubmed">33567860</ArticleId></ArticleIdList></Reference><Reference><Citation>Buysse DJ, Reynolds CF III, Monk TH, Berman SR, &amp; Kupfer DJ (1989). The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Research, 28(2), 193&#x2013;213. 10.1016/0165-1781(89)90047-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(89)90047-4</ArticleId><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>C. Ar&#xe9;valo-Flechas L, Acton G, I. Escamilla M, N. Bonner P, &amp; L. Lewis S (2014). Latino Alzheimer&#x2019;s caregivers: What is important to them? Journal of Managerial Psychology, 29(6), 661&#x2013;684. 10.1108/JMP-11-2012-0357</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/JMP-11-2012-0357</ArticleId></ArticleIdList></Reference><Reference><Citation>Center for Mental Health Services. (2005). Data manual: Phase IV of the CMHS national evaluation</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC). (2018). Healthy Days Measure. https://www.cdc.gov/hrqol/hrqol14_measure.htm</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC). (2020). Telehealth in Rural Communities.</Citation></Reference><Reference><Citation>Cheng S-T (2017). Dementia caregiver burden: A research update and critical analysis. Current Psychiatry Reports, 19(9), 1&#x2013;8. 10.1007/s11920-017-0818-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11920-017-0818-2</ArticleId><ArticleId IdType="pmc">PMC5550537</ArticleId><ArticleId IdType="pubmed">28795386</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng S-T, Mak EPM, Lau RW, Ng NSS, &amp; Lam LCW (2016). Voices of Alzheimer caregivers on positive aspects of caregiving. The Gerontologist, 56(3), 451&#x2013;460. 10.1093/geront/gnu118</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnu118</ArticleId><ArticleId IdType="pubmed">25614608</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen SA, Ahmed N, Brown MJ, Meucci MR, &amp; Greaney ML (2021). Rural-urban differences in informal caregiving and health-related quality of life. The Journal of Rural Health: official Journal of the American Rural Health Association and the National Rural Health Care Association, Advance Online Publication. 10.1111/jrh.12581</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jrh.12581</ArticleId><ArticleId IdType="pubmed">33956360</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S, Kamarck T, &amp; Mermelstein R (1983). A global measure of perceived stress. Journal of Health and Social Behavior, 24(4), 385&#x2013;396. 10.2307/2136404</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2136404</ArticleId><ArticleId IdType="pubmed">6668417</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham JK, Solomon TA, &amp; Muramoto ML (2016). Alcohol use among Native Americans compared to whites: Examining the veracity of the &#x2018;Native American elevated alcohol consumption&#x2019; belief. Drug and Alcohol Dependence, 160(1), 65&#x2013;75. 10.1016/j.drugalcdep.2015.12.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugalcdep.2015.12.015</ArticleId><ArticleId IdType="pubmed">26868862</ArticleId></ArticleIdList></Reference><Reference><Citation>Demirovic J, Prineas R, Loewenstein D, Bean J, Duara R, Sevush S, &amp; Szapocznik J (2003). Prevalence of dementia in three ethnic groups: The South Florida Program on Aging and Health. Annals of Epidemiology, 13(6), 472&#x2013;478. 10.1016/S1047-2797(02)00437-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1047-2797(02)00437-4</ArticleId><ArticleId IdType="pubmed">12875807</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez K, Penman-Aguilar A, Chang M-H, Moonesinghe R, Castellanos T, Rodriguez-Lainz A, &amp; Schieber R (2015). Vital signs: Leading causes of death, prevalence of diseases and risk factors, and use of health services among Hispanics in the United States&#x2014;2009&#x2013;2013. MMWR. Morbidity and Mortality Weekly Report, 64(17), 469&#x2013;478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4584552</ArticleId><ArticleId IdType="pubmed">25950254</ArticleId></ArticleIdList></Reference><Reference><Citation>Espey DK, Jim MA, Cobb N, Bartholomew M, Becker T, Haverkamp D, &amp; Plescia M (2014). Leading causes of death and all-cause mortality in American Indians and Alaska Natives. American Journal of Public Health, 104(S3), S303&#x2013;S311. 10.2105/AJPH.2013.301798</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2013.301798</ArticleId><ArticleId IdType="pmc">PMC4035872</ArticleId><ArticleId IdType="pubmed">24754554</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman SJ, Solway E, Kirch M, Malani P, Singer D, &amp; Roberts JS (2021). Correlates of formal support service use among dementia caregivers. Journal of Gerontological Social Work, 64(2), 135&#x2013;150. 10.1080/01634372.2020.1816589</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01634372.2020.1816589</ArticleId><ArticleId IdType="pmc">PMC9048125</ArticleId><ArticleId IdType="pubmed">32921273</ArticleId></ArticleIdList></Reference><Reference><Citation>Findling MTG, Blendon RJ, Benson JM, &amp; Miller C (2022). The unseen picture: Issues with health care, discrimination, police and safety, and housing experienced by Native American populations in rural America. The Journal of Rural Health, 38(1), 180&#x2013;186. 10.1111/jrh.12517</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jrh.12517</ArticleId><ArticleId IdType="pmc">PMC9290671</ArticleId><ArticleId IdType="pubmed">33022083</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleming P, &amp; Godwin M (2008). Lifestyle interventions in primary care: Systematic review of randomized controlled trials. Canadian Family Physician Medecin de Famille Canadien, 54(12), 1706&#x2013;1713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2602636</ArticleId><ArticleId IdType="pubmed">19074715</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao C, Chapagain NY, &amp; Scullin MK (2019). Sleep duration and sleep quality in caregivers of patients with dementia: A systematic review and meta-analysis. JAMA Network Open, 2(8), e199891&#x2013;e199891. 10.1001/jamanetworkopen.2019.9891</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.9891</ArticleId><ArticleId IdType="pmc">PMC6714015</ArticleId><ArticleId IdType="pubmed">31441938</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrett MD, Baldridge D, Benson W, Crowder J, &amp; Aldrich N (2015). Mental health disorders among an invisible minority: Depression and dementia among American Indian and Alaska Native elders. The Gerontologist, 55(2), 227&#x2013;236. 10.1093/geront/gnu181</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnu181</ArticleId><ArticleId IdType="pubmed">26035598</ArticleId></ArticleIdList></Reference><Reference><Citation>Goins RT, Spencer SM, McGuire LC, Goldberg J, Wen Y, &amp; Henderson JA (2011). Adult caregiving among American Indians: The role of cultural factors. The Gerontologist, 51(3), 310&#x2013;320. 10.1093/geront/gnq101</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnq101</ArticleId><ArticleId IdType="pmc">PMC3095652</ArticleId><ArticleId IdType="pubmed">21148253</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes AF, Coutts JJ (2020). Use Omega rather than Cronbach&#x2019;s Alpha for estimating reliability. But&#x2026;. Communication Methods and Measures, 14(1), 1&#x2013;24. 10.1080/19312458.2020.1718629</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19312458.2020.1718629</ArticleId></ArticleIdList></Reference><Reference><Citation>Henning-Smith C, Lahr M (2018, August). Perspectives on rural caregiving challenges and interventions. http://rhrc.umn.edu/wp-content/files_mf/1535129278UMNpolicybriefcaregivingchallenges.pdf</Citation></Reference><Reference><Citation>IBM Corp. (2019). IBM Corp. Released 2019. IBM SPSS Statistics for Windows, Version 26.0. IBM Corp. Google Search.</Citation></Reference><Reference><Citation>Jaramillo ET, &amp; Willging CE (2021). Producing insecurity: Healthcare access, health insurance, and wellbeing among American Indian elders. Social Science &amp; Medicine (1982), 268, 113384. 10.1016/j.socscimed.2020.113384</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113384</ArticleId><ArticleId IdType="pmc">PMC7755658</ArticleId><ArticleId IdType="pubmed">32998088</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz S, Ford AB, Moskowitz RW, Jackson BA, &amp; Jaffe MW (1963). Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA, 185, 914&#x2013;919. 10.1001/jama.1963.03060120024016</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1963.03060120024016</ArticleId><ArticleId IdType="pubmed">14044222</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, &amp; Williams JB (2003). The Patient Health Questionnaire-2: Validity of a two-item depression screener. Medical Care, 41(11), 1284&#x2013;1292. 10.1097/01.MLR.0000093487.78664.3C</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.MLR.0000093487.78664.3C</ArticleId><ArticleId IdType="pubmed">14583691</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton MP, &amp; Brody EM (1969). Assessment of older people: Selfmaintaining and instrumental activities of daily living. The Gerontologist, 9(3), 179&#x2013;186. 10.1093/geront/9.3_Part_1.179</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/9.3_Part_1.179</ArticleId><ArticleId IdType="pubmed">5349366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis JP, Manson SM, Jernigan VB, &amp; Noonan C (2021). &#x201c;Making sense of a disease that makes no sense&#x201d;: Understanding Alzheimer&#x2019;s disease and related disorders among caregivers and providers within alaska native communities. The Gerontologist, 61(3), 363&#x2013;373. 10.1093/geront/gnaa102</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnaa102</ArticleId><ArticleId IdType="pmc">PMC8023374</ArticleId><ArticleId IdType="pubmed">32789474</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Badana ANS, Burgdorf J, Fabius CD, Roth DL, &amp; Haley WE (2021). Systematic review and meta-analysis of racial and ethnic differences in dementia caregivers&#x2019; well-being. The Gerontologist, 61(5), e228&#x2013;e243. 10.1093/geront/gnaa028</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnaa028</ArticleId><ArticleId IdType="pmc">PMC8276619</ArticleId><ArticleId IdType="pubmed">32271380</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui PP, Tsong Y, Pham S, Ramadan B, Quezada L, Del Rio M, &amp; Zamboanga BL (2021). Explaining the alcohol immigrant paradox: Perspectives from Mexican American adults. Journal of Latinx Psychology, 9(2), 109&#x2013;124. 10.1037/lat0000176.supp</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/lat0000176.supp</ArticleId></ArticleIdList></Reference><Reference><Citation>Martell BN, Garrett BE, &amp; Caraballo RS (2016). Disparities in adult cigarette smoking &#x2013; United States, 2002-2005 and 2010-2013. MMWR. Morbidity and Mortality Weekly Report, 65(30), 753&#x2013;758. 10.15585/mmwr.mm6530a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6530a1</ArticleId><ArticleId IdType="pubmed">27491017</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrail MR, Humphreys JS, &amp; Ward B (2015). Accessing doctors at times of need&#x2013;measuring the distance tolerance of rural residents for health-related travel. BMC Health Services Research, 15(1), 1&#x2013;9. 10.1186/s12913-015-0880-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-015-0880-6</ArticleId><ArticleId IdType="pmc">PMC4446808</ArticleId><ArticleId IdType="pubmed">26022391</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy MJ, Lee-Regalado Hustead M, Bacon R, Garcia YE, Dunn D,Williamson H, &amp; Baldwin J (2021). Development and validation of a community assessment survey for diverse rural family caregivers of people with Alzheimer&#x2019;s Disease and related dementias. Family and Community Health, 44(3), 126&#x2013;135. 10.1097/FCH.0000000000000297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FCH.0000000000000297</ArticleId><ArticleId IdType="pmc">PMC8131205</ArticleId><ArticleId IdType="pubmed">33646980</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon HE, Haley WE, Rote SM, &amp; Sears JS (2020). Caregiver well-being and burden: Variations by race/ethnicity and care recipient nativity status. Innovation in Aging, 4(6), 1&#x2013;13. 10.1093/geroni/igaa045</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geroni/igaa045</ArticleId><ArticleId IdType="pmc">PMC7679974</ArticleId><ArticleId IdType="pubmed">33241124</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam I (2016). Financial difficulty effects on depressive symptoms among dementia patient caregivers. Community Mental Health Journal, 52(8), 1093&#x2013;1097. 10.1007/s10597-016-0033-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10597-016-0033-3</ArticleId><ArticleId IdType="pubmed">27289466</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute on Minority Health and Health Disparities (NIMHD). (2017). NIMHD research framework. https://www.nimhd.nih.gov/about/overview/research-framework.html.</Citation></Reference><Reference><Citation>O&#x2019;Connell ME, Germaine N, Burton R, Stewart N, &amp; Morgan DG (2013). Degree of rurality is not related to dementia caregiver distress, burden, and coping in a predominantly rural sample. Journal of Applied Gerontology, 32(8), 1015&#x2013;1029. https://doi.10.1177/0733464812450071
https://doi.org/10.1177/0733464812450071</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0733464812450071</ArticleId><ArticleId IdType="doi">10.1177/0733464812450071</ArticleId><ArticleId IdType="pubmed">25474826</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoli C, &amp; Pawlowski SD (2004). The Delphi method as a research tool: An example, design considerations and applications. Information &amp; Management, 42(1), 15&#x2013;29. 10.1016/j.im.2003.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.im.2003.11.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson TJ, Lee SJ, Berg-Weger M, &amp; Grossberg GT (2013). Caregiver health: Health of caregivers of Alzheimer&#x2019;s and other dementia patients. Current Psychiatry Reports, 15(7), 367 10.1007/s11920-013-0367-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11920-013-0367-2</ArticleId><ArticleId IdType="pubmed">23712718</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert Wood Johnson Foundation. (2021). The impact of coronavirus in households across America. https://www.rwjf.org/en/library/research/2020/09/the-impact-of-coronavirus-on-households-across-america.html</Citation></Reference><Reference><Citation>Robinson RL, Rentz DM, Andrews JS, Zagar A, Kim Y, Bruemmer V, Schwartz RL, Ye W, &amp; Fillit HM (2020). Costs of early stage Alzheimer&#x2019;s disease in the United States: Cross-sectional analysis of a prospective cohort study (GERAS-US). Journal of Alzheimer&#x2019;s Disease, 75(2), 437&#x2013;450. 10.3233/JAD-191212</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-191212</ArticleId><ArticleId IdType="pmc">PMC7306889</ArticleId><ArticleId IdType="pubmed">32250304</ArticleId></ArticleIdList></Reference><Reference><Citation>Rural Health Information Hub. (2019). Rural health disparities. https://www.ruralhealthinfo.org/topics/rural-health-disparities</Citation></Reference><Reference><Citation>Sheehan OC, Haley WE, Howard VJ, Huang J, Rhodes JD, &amp; Roth DL (2021). Stress, burden, and well-being in dementia and nondementia caregivers: Insights from the Caregiving Transitions Study. The Gerontologist, 61(5), 670&#x2013;679. 10.1093/geront/gnaa108</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnaa108</ArticleId><ArticleId IdType="pmc">PMC8276607</ArticleId><ArticleId IdType="pubmed">32816014</ArticleId></ArticleIdList></Reference><Reference><Citation>Smedley BD, Stith AY, &amp; Nelson AR (Eds.). (2003). Unequal treatment: Confronting racial and ethnic disparities in health care. Institute of Medicine (IOM), Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. National Academy Press.</Citation><ArticleIdList><ArticleId IdType="pubmed">25032386</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer RL, Kroenke K, Williams JB, &amp; L&#xf6;we B (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med, 166(10), 1092&#x2013;1097. 10.1001/archinte.166.10.1092</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.10.1092</ArticleId><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun F, Hilgeman MM, Durkin DW, Allen RS, &amp; Burgio LD (2009). Perceived income inadequacy as a predictor of psychological distress in Alzheimer&#x2019;s caregivers. Psychology and Aging, 24(1), 177&#x2013;183. 10.1037/a0014760</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0014760</ArticleId><ArticleId IdType="pmc">PMC2814818</ArticleId><ArticleId IdType="pubmed">19290749</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo S, Lakzadeh P, Cline S, Palma dos Reis R, &amp; Petrella R (2019). The clinical and economic burden among caregivers of patients with Alzheimer&#x2019;s disease in Canada. International Journal of Geriatric Psychiatry, 34(11), 1677&#x2013;1688. 10.1002/gps.5182</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5182</ArticleId><ArticleId IdType="pubmed">31353572</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabachnick BG, Fidell LS, &amp; Ullman JB (2007). Using multivariate statistics (Vol. 5). Pearson.</Citation></Reference><Reference><Citation>Tarlow BJ, Wisniewski SR, Belle SH, Rubert M, Ory MG, &amp; GallagherThompson D (2004). Positive aspects of caregiving: Contributions of the REACH project to the development of new measures for Alzheimer&#x2019;s caregiving. Research on Aging, 26(4), 429&#x2013;453. 10.1177/0164027504264493</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0164027504264493</ArticleId></ArticleIdList></Reference><Reference><Citation>US Census Bureau. (2010). Geographic Areas and Rural Data. Rural America. https://mtgis-portal.geo.census.gov/arcgis/apps/MapSeries/index.html?appid=49cd4bc9c8eb444ab51218c1d5001ef6</Citation></Reference><Reference><Citation>Vara-Garc&#xed;a C, Romero-Moreno R, M&#xe1;rquez-Gonz&#xe1;lez M, Mausbach BT, K&#xe4;nel R. v, G., Alberto L, Olmos R, &amp; Losada A (2019). Stress and blood pressure in dementia caregivers: The moderator role of mindfulness. Clinical Gerontologist, 42(5), 512&#x2013;520. 10.1080/07317115.2018.1554611</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07317115.2018.1554611</ArticleId><ArticleId IdType="pubmed">30560734</ArticleId></ArticleIdList></Reference><Reference><Citation>Weuve J, Hebert LE, Scherr PA, &amp; Evans DA (2015). Prevalence of Alzheimer disease in US States. Epidemiology (Cambridge, Mass.), 26(1), e4&#x2013;e6. 10.1097/EDE.0000000000000199</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000000199</ArticleId><ArticleId IdType="pubmed">25437325</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson HJ, McCarthy MJ, Garcia YE, Bacon R, Dunn DJ, &amp; Baldwin JA (2020). Addressing the needs of rural caregivers of individuals with Alzheimer&#x2019;s disease and related dementias during and beyond Coronavirus Disease 2019 (COVID-19). The Public Policy and Aging Report, 30(4), 178&#x2013;180. 10.1093/ppar/praa024</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ppar/praa024</ArticleId><ArticleId IdType="pmc">PMC7499747</ArticleId><ArticleId IdType="pubmed">33185627</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolters FJ, Segufa RA, Darweesh SKL, Bos D, Ikram MA, Sabayan B, Hofman A, &amp; Sedaghat S (2018). Coronary heart disease, heart failure, and the risk of dementia: A systematic review and meta-analysis. Alzheimer&#x2019;s &amp; Dementia : The Journal of the Alzheimer&#x2019;s Association, 14(11), 1493&#x2013;1504. 10.1016/j.jalz.2018.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.01.007</ArticleId><ArticleId IdType="pubmed">29494808</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Chen C, Hua S, Liao H, Wang M, Xiong Y, &amp; Cao F (2017). An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer&#x2019;s disease. Diabetes Research and Clinical Practice, 124, 41&#x2013;47. 10.1016/j.diabres.2016.10.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2016.10.024</ArticleId><ArticleId IdType="pubmed">28088029</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Yu J-T, Wang H-F, Meng X-F, Tan C-C, Wang J, Wang C, &amp; Tan L (2014). Association between stroke and Alzheimer&#x2019;s disease: Systematic review and meta-analysis. Journal of Alzheimer&#x2019;s Disease, 43(2), 479&#x2013;489. 10.3233/JAD-140666</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-140666</ArticleId><ArticleId IdType="pubmed">25096624</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34991360</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-3799</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Clinical nursing research</Title><ISOAbbreviation>Clin Nurs Res</ISOAbbreviation></Journal><ArticleTitle>Perceptions of Treatment Burden Among Caregivers of Elders With Diabetes and Co-morbid Alzheimer's Disease and Related Dementias: A Qualitative Study.</ArticleTitle><Pagination><StartPage>752</StartPage><EndPage>758</EndPage><MedlinePgn>752-758</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/10547738211067880</ELocationID><Abstract><AbstractText>Many older adults with diabetes (DM) have co-occurring Alzheimer's Disease (AD) and AD-Related Dementias (ADRD). Complex treatment plans may impose treatment burden for caregivers responsible for day-to-day self-management. The purpose of this qualitative study was to describe caregiver perceptions of treatment burden for people with DM-AD/ADRD. Caregivers (<i>n</i>&#x2009;=&#x2009;33) of patients with DM-AD/ADRD participated in semi-structured interviews about their caregiver role and perceptions of treatment burden of DM-AD/ADRD management. Qualitative data were analyzed using content analysis (ATLAS.ti). Caregivers reported high levels of burden related to complex treatment/self-management for patients with DM-AD/ADRD that varied day-to-day with the patient's cognitive status. Four themes were: (1) trajectory of treatment burden; (2) navigating multiple healthcare providers/systems of care; (3) caregiver role conflict; and (4) emotional burden. Interventions to reduce caregiver treatment burden should include activating supportive services, education, and care coordination especially, if patient treatment increases in complexity over time.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vaughan Dickson</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-6673-1960</Identifier><AffiliationInfo><Affiliation>NYU Rory Meyers College of Nursing, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melnyk</LastName><ForeName>Halia</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-0996-3746</Identifier><AffiliationInfo><Affiliation>NYU Rory Meyers College of Nursing, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferris</LastName><ForeName>Rosie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leon</LastName><ForeName>Alejandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Boston College Connell School of Nursing, Chestnut Hill, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arcila-Mesa</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rapozo</LastName><ForeName>Crystalinda</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chodosh</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blaum</LastName><ForeName>Caroline S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R33 AG057291</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Nurs Res</MedlineTA><NlmUniqueID>9208508</NlmUniqueID><ISSNLinking>1054-7738</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004644" MajorTopicYN="N">Emotions</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aging</Keyword><Keyword MajorTopicYN="N">caregiving</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">qualitative research</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>7</Day><Hour>5</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34991360</ArticleId><ArticleId IdType="doi">10.1177/10547738211067880</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34962993</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1758-5341</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>24</Day></PubDate></JournalIssue><Title>The Gerontologist</Title><ISOAbbreviation>Gerontologist</ISOAbbreviation></Journal><ArticleTitle>Clinimetric Evaluation of the Experienced Communication in Dementia Questionnaire.</ArticleTitle><Pagination><StartPage>40</StartPage><EndPage>51</EndPage><MedlinePgn>40-51</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/geront/gnab187</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">Tools to measure self-perceived communication between persons with early-stage dementia and their caregivers are lacking. Therefore, we developed a questionnaire for Experienced Communication in Dementia (ECD) with a patient version (ECD-P) and a caregiver version (ECD-C), which contains items on (a) caregiver competence, (b) social communication, (c) communication difficulties, and (d) experienced emotions. This article describes the feasibility and clinimetric evaluation of this instrument.</AbstractText><AbstractText Label="RESEARCH DESIGN AND METHODS">A prospective observational cohort study was conducted with 57 dyads (community-dwelling person with dementia and primary caregiver). ECD-P, ECD-C, and measures on quality of life, caregiver burden, cognitive functioning, physical functioning, and functional independence were administered. After 2 weeks, the dyads filled out the ECD again. Feasibility (completion time and missing values per item), internal consistency (Cronbach's &#x3b1;), test-retest reliability (intraclass correlation coefficients [ICCs]), and construct validity (hypotheses testing with Spearman's r) were evaluated.</AbstractText><AbstractText Label="RESULTS">Mean completion time was 10 min per questionnaire. ICCs for test-retest reliability ranged from 0.67 to 0.78, except for ECD-P2 (ICC = 0.31). Internal consistency ranged from &#x3b1; = 0.75 to 0.82 for ECD-P1 and all parts of ECD-C, except for ECD-P2 (&#x3b1; = 0.66). Correlation coefficients for convergent validity ranged from r = 0.31 to 0.69 and correlation coefficients for divergent validity were r &lt; 0.20 and statistically insignificant.</AbstractText><AbstractText Label="DISCUSSION AND IMPLICATIONS">Pending future research, the ECD, except part ECD-P2, seems to be a promising tool to measure experienced communication between persons with early-stage dementia and their caregivers.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of The Gerontological Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Olthof-Nefkens</LastName><ForeName>Maria W L J</ForeName><Initials>MWLJ</Initials><Identifier Source="ORCID">0000-0002-4377-1425</Identifier><AffiliationInfo><Affiliation>Zorggroep Maas &amp; Waal, Beneden-Leeuwen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rehabilitation, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Derksen</LastName><ForeName>Els W C</ForeName><Initials>EWC</Initials><AffiliationInfo><Affiliation>Department of Primary and Community Care, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboudumc Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambregts</LastName><ForeName>Britt</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Swart</LastName><ForeName>Bert J M</ForeName><Initials>BJM</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nijhuis-van der Sanden</LastName><ForeName>Maria W G</ForeName><Initials>MWG</Initials><AffiliationInfo><Affiliation>Radboudumc Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ Healthcare), Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalf</LastName><ForeName>Johanna G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboudumc Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gerontologist</MedlineTA><NlmUniqueID>0375327</NlmUniqueID><ISSNLinking>0016-9013</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="N">Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Caregiver</Keyword><Keyword MajorTopicYN="N">Cognitive communication disorders</Keyword><Keyword MajorTopicYN="N">Patient-reported outcome measures</Keyword><Keyword MajorTopicYN="N">Speech and language therapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>28</Day><Hour>17</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34962993</ArticleId><ArticleId IdType="pmc">PMC9872762</ArticleId><ArticleId IdType="doi">10.1093/geront/gnab187</ArticleId><ArticleId IdType="pii">6486461</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aday, L. A., &amp; Cornelius, L. J. (2006). Designing and conducting health surveys: A comprehensive guide. Wiley.</Citation></Reference><Reference><Citation>Banerjee, S., Willis, R., Graham, N., &amp; Gurland, B. J. (2010). The Stroud/ADI dementia quality framework: A cross-national population-level framework for assessing the quality of life impacts of services and policies for people with dementia and their family carers. International Journal of Geriatric Psychiatry, 25(3), 249&#x2013;257. doi:10.1002/gps.2330</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.2330</ArticleId><ArticleId IdType="pubmed">19697296</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes, C. J., &amp; Markham, C. (2018). A pilot study to evaluate the effectiveness of an individualized and cognitive behavioural communication intervention for informal carers of people with dementia: The talking sense programme. International Journal of Language &amp; Communication Disorders, 53(3), 615&#x2013;627. doi:10.1111/1460-6984.12375</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1460-6984.12375</ArticleId><ArticleId IdType="pubmed">29460337</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayles, K. A., &amp; Tomoeda, C. K. (1993). Arizona battery for communication disorders of dementia. Canyonlands Publishing.</Citation><ArticleIdList><ArticleId IdType="pubmed">8776438</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayles, K. A., &amp; Tomoeda, C. K. (1994). The functional linguistic communication inventory. Pro-ed.</Citation></Reference><Reference><Citation>Bayles, K. A., &amp; Tomoeda, C. K. (2014). Cognitive-communication disorders of dementia: Definition, diagnosis, and treatment (2nd ed.). Plural Publishing.</Citation></Reference><Reference><Citation>B&#xe9;dard, M., Molloy, D. W., Squire, L., Dubois, S., Lever, J. A., &amp; O&#x2019;Donnell, M. (2001). The Zarit Burden Interview: A new short version and screening version. The Gerontologist, 41(5), 652&#x2013;657. doi:10.1093/geront/41.5.652</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/41.5.652</ArticleId><ArticleId IdType="pubmed">11574710</ArticleId></ArticleIdList></Reference><Reference><Citation>Brod, M., Stewart, A. L., Sands, L., &amp; Walton, P. (1999). Conceptualization and measurement of quality of life in dementia: The dementia quality of life instrument (DQoL). The Gerontologist, 39(1), 25&#x2013;35. doi:10.1093/geront/39.1.25</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/39.1.25</ArticleId><ArticleId IdType="pubmed">10028768</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho, I. A., &amp; Mansur, L. L. (2008). Validation of ASHA FACS&#x2014;Functional assessment of communication skills for Alzheimer disease population. Alzheimer Disease and Associated Disorders, 22(4), 375&#x2013;381. doi:10.1097/wad.0b013e31818809b2</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/wad.0b013e31818809b2</ArticleId><ArticleId IdType="pubmed">19068501</ArticleId></ArticleIdList></Reference><Reference><Citation>Eadie, T. L., Yorkston, K. M., Klasner, E. R., Dudgeon, B. J., Deitz, J. C., Baylor, C. R., Miller, R. M., &amp; Amtmann, D. (2006). Measuring communicative participation: A review of self-report instruments in speech&#x2013;language pathology. American Journal of Speech-Language Pathology, 15(4), 307&#x2013;320. doi:10.1044/1058-0360(2006/030))</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/1058-0360(2006/030)</ArticleId><ArticleId IdType="pmc">PMC2649949</ArticleId><ArticleId IdType="pubmed">17102143</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferris, S., Ihl, R., Robert, P., Winblad, B., Gatz, G., Tennigkeit, F., &amp; Gauthier, S. (2009). Severe impairment battery language scale: A language-assessment tool for Alzheimer&#x2019;s disease patients. Alzheimer&#x2019;s &amp; Dementia, 5(5), 375&#x2013;379. doi:10.1016/j.jalz.2009.04.1236</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2009.04.1236</ArticleId><ArticleId IdType="pubmed">19751916</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauthier, S. (2001). Management of dementia (1st ed.). CRC Press. doi:10.3109/9780203213896</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/9780203213896</ArticleId></ArticleIdList></Reference><Reference><Citation>Graf, C. (2008). The Lawton instrumental activities of daily living (IADL) scale. Medsurg Nursing, 17(5), 343&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pubmed">19051984</ArticleId></ArticleIdList></Reference><Reference><Citation>Haberstroh, J., Wollstadt, P., Knebel, M., Oswald, F., Schr&#xf6;der, J., &amp; Pantel, J. (2013). Need for and challenges facing functional communication as outcome parameter in AD clinical trials. Alzheimer Disease and Associated Disorders, 27(4), 293&#x2013;301. doi:10.1097/wad.0b013e318299d28d</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/wad.0b013e318299d28d</ArticleId><ArticleId IdType="pubmed">23751370</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez, E., Spencer, B., Ingersoll-Dayton, B., Faber, A., &amp; Ewert, A. (2019). &#x201c;We are a team&#x201d;: Couple identity and memory loss. Dementia, 18(3), 1166&#x2013;1180. doi:10.1177/1471301217709604</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301217709604</ArticleId><ArticleId IdType="pubmed">28530123</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo, T. K., &amp; Li, M. Y. (2016). A guideline of selecting and reporting intraclass correlation coefficients for reliability research. Journal of Chiropractic Medicine, 15(2), 155&#x2013;163. doi:10.1016/j.jcm.2016.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcm.2016.02.012</ArticleId><ArticleId IdType="pmc">PMC4913118</ArticleId><ArticleId IdType="pubmed">27330520</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton, M.P. &amp; Brody, E.M. (1969). Assessment of older people: Self-maintaining and instrumental activities of daily living. The Gerontologist, 9(3), 179&#x2013;86. doi:10.1093/geront/9.3_part_1.179</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/9.3_part_1.179</ArticleId><ArticleId IdType="pubmed">5349366</ArticleId></ArticleIdList></Reference><Reference><Citation>Little, R. J. (1988). A test of missing completely at random for multivariate data with missing values. Journal of the American Statistical Association, 83(404), 1198&#x2013;1202. doi:10.1080/01621459.1988.10478722</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.1988.10478722</ArticleId></ArticleIdList></Reference><Reference><Citation>Logsdon, R. G., Gibbons, L. E., McCurry, S. M., &amp; Teri, L. (1999). Quality of life in Alzheimer&#x2019;s disease: Patient and caregiver reports. Journal of Mental Health and Aging, 5, 21&#x2013;32.</Citation></Reference><Reference><Citation>Mahoney, F. I., &amp; Barthel, D. W. (1965). Functional evaluation: The Barthel index. Maryland State Medical Journal, 14, 61&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">14258950</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin, M., Peter-Wight, M., Braun, M., Hornung, R., &amp; Scholz, U. (2009). The 3-phase-model of dyadic adaptation to dementia: Why it might sometimes be better to be worse. European Journal of Ageing, 6(4), 291. doi:10.1007/s10433-009-0129-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10433-009-0129-5</ArticleId><ArticleId IdType="pmc">PMC5547344</ArticleId><ArticleId IdType="pubmed">28798612</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokkink, L. B., Terwee, C. B., Patrick, D. L., Alonso, J., Stratford, P. W., Knol, D. L., Bouter, L. M., &amp; de Vet, H. C. (2010). The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. Journal of Clinical Epidemiology, 63(7), 737&#x2013;745. doi:10.1016/j.jclinepi.2010.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.02.006</ArticleId><ArticleId IdType="pubmed">20494804</ArticleId></ArticleIdList></Reference><Reference><Citation>Olthof-Nefkens, M. W. L. J., Derksen, E. W. C., de Swart, B. J. M., Nijhuis-van der Sanden, M. W. G., &amp; Kalf, J. G. (2021). Development of the experienced communication in dementia questionnaire: A qualitative study. Inquiry, 58, 1&#x2013;12. doi:10.1177/00469580211028181</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00469580211028181</ArticleId><ArticleId IdType="pmc">PMC8246470</ArticleId><ArticleId IdType="pubmed">34167366</ArticleId></ArticleIdList></Reference><Reference><Citation>Olthof-Nefkens, M. W. L. J., Kruse, H., Derksen, E., de Swart, B. J. M., Nijhuis-van der Sanden, M. W. G., &amp; Kalf, J. G. (2018). Improving communication between persons with mild dementia and their caregivers: Qualitative analysis of a practice-based logopaedic intervention. Folia phoniatrica et logopaedica, 70(3&#x2013;4), 124&#x2013;133. doi:10.1159/000491081</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000491081</ArticleId><ArticleId IdType="pubmed">30089312</ArticleId></ArticleIdList></Reference><Reference><Citation>Perfect, D., Griffiths, A. W., Vasconcelos Da Silva, M., Lemos Dekker, N., McDermid, J., &amp; Surr, C. A. (2021). Collecting self-report research data with people with dementia within care home clinical trials: Benefits, challenges and best practice. Dementia (London, England), 20(1), 148&#x2013;160. doi:10.1177/1471301219871168</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1471301219871168</ArticleId><ArticleId IdType="pubmed">31466468</ArticleId></ArticleIdList></Reference><Reference><Citation>Rikkert, M. G., Tona, K. D., Janssen, L., Burns, A., Lobo, A., Robert, P., Sartorius, N., Stoppe, G., &amp; Waldemar, G. (2011). Validity, reliability, and feasibility of clinical staging scales in dementia: A systematic review. American Journal of Alzheimer&#x2019;s Disease and Other Dementias, 26(5), 357&#x2013;365. doi:10.1177/1533317511418954</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317511418954</ArticleId><ArticleId IdType="pmc">PMC10845587</ArticleId><ArticleId IdType="pubmed">21914671</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;mhild, J., Fleischer, S., Meyer, G., Stephan, A., Zwakhalen, S., Leino-Kilpi, H., Zabalegui, A., Saks, K., Soto-Martin, M., Sutcliffe, C., Rahm Hallberg, I., &amp; Berg, A.; RightTimePlaceCare Consortium . (2018). Inter-rater agreement of the Quality of Life-Alzheimer&#x2019;s Disease (QoL-AD) self-rating and proxy rating scale: Secondary analysis of RightTimePlaceCare data. Health and Quality of Life Outcomes, 16(1), 131. doi:10.1186/s12955-018-0959-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-018-0959-y</ArticleId><ArticleId IdType="pmc">PMC6022444</ArticleId><ArticleId IdType="pubmed">29954384</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseaux, M., S&#xe8;ve, A., Vallet, M., Pasquier, F., &amp; Mackowiak-Cordoliani, M. A. (2010). An analysis of communication in conversation in patients with dementia. Neuropsychologia, 48(13), 3884&#x2013;3890. doi:10.1016/j.neuropsychologia.2010.09.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropsychologia.2010.09.026</ArticleId><ArticleId IdType="pubmed">20888846</ArticleId></ArticleIdList></Reference><Reference><Citation>Savundranayagam, M. Y., Hummert, M. L., &amp; Montgomery, R. J. (2005). Investigating the effects of communication problems on caregiver burden. The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 60(1), 48&#x2013;55. doi:10.1093/geronb/60.1.s48</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/60.1.s48</ArticleId><ArticleId IdType="pubmed">15643047</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenmakers, B., Buntinx, F., &amp; DeLepeleire, J. (2010). Supporting the dementia family caregiver: The effect of home care intervention on general well-being. Aging &amp; Mental Health, 14(1), 44&#x2013;56. doi:10.1080/13607860902845533</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607860902845533</ArticleId><ArticleId IdType="pubmed">20155520</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;lzel-Dorenbos, C. J., Arons, A. M., Wammes, J. J., Rikkert, M. G., &amp; Krabbe, P. F. (2012). Validation study of the prototype of a disease-specific index measure for health-related quality of life in dementia. Health and Quality of Life Outcomes, 10, 118. doi:10.1186/1477-7525-10-118</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-10-118</ArticleId><ArticleId IdType="pmc">PMC3503596</ArticleId><ArticleId IdType="pubmed">23009579</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiadle, J. M., Scholar, M., &amp; Zarit, S. H. (2014). Communication problems between caregivers and individuals with dementia: Implications for caregiver well-being. Pennsylvania State University State College.</Citation></Reference><Reference><Citation>Str&#xf8;m, B. S., Engedal, K., &amp; Grov, E. K. (2016). A psychometric evaluation of the Threadgold Communication Tool for persons with dementia. Dementia and Geriatric Cognitive Disorders Extra, 6(1), 150&#x2013;160. doi:10.1159/000444789</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000444789</ArticleId><ArticleId IdType="pmc">PMC4881245</ArticleId><ArticleId IdType="pubmed">27239188</ArticleId></ArticleIdList></Reference><Reference><Citation>Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., Bouter, L. M., &amp; de Vet, H. C. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34&#x2013;42. doi:10.1016/j.jclinepi.2006.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2006.03.012</ArticleId><ArticleId IdType="pubmed">17161752</ArticleId></ArticleIdList></Reference><Reference><Citation>Trigg, R., Jones, R. W., &amp; Skevington, S. M. (2007). Can people with mild to moderate dementia provide reliable answers about their quality of life? Age and Ageing, 36(6), 663&#x2013;669. doi:10.1093/ageing/afm077</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afm077</ArticleId><ArticleId IdType="pubmed">17586556</ArticleId></ArticleIdList></Reference><Reference><Citation>Vertesi, A., Lever, J. A., Molloy, D. W., Sanderson, B., Tuttle, I., Pokoradi, L., &amp; Principi, E. (2001). Standardized Mini-Mental State Examination. Use and interpretation. Canadian Family Physician Medecin de famille canadien, 47, 2018&#x2013;2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2018449</ArticleId><ArticleId IdType="pubmed">11723596</ArticleId></ArticleIdList></Reference><Reference><Citation>Volicer, L., &amp; Manzar, B. (2018). Communication assessment scale for advanced dementia: Psychometric properties. Geriatric Medicine and Care, 2, 1&#x2013;3. doi:10.15761/GMC.1000114</Citation><ArticleIdList><ArticleId IdType="doi">10.15761/GMC.1000114</ArticleId></ArticleIdList></Reference><Reference><Citation>Wade, D. T., &amp; Collin, C. (1988). The Barthel ADL Index: A standard measure of physical disability? International Disability Studies, 10(2), 64&#x2013;67. doi:10.3109/09638288809164105</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09638288809164105</ArticleId><ArticleId IdType="pubmed">3042746</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, C. L., &amp; Parker, C. (2012). Development of an observer rating scale for caregiver communication in persons with Alzheimer&#x2019;s disease. Issues in Mental Health Nursing, 33(4), 244&#x2013;250. doi:10.3109/01612840.2011.653040</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01612840.2011.653040</ArticleId><ArticleId IdType="pubmed">22468590</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, C. L., Newman, D., &amp; Hammar, L. M. (2017). Preliminary psychometric properties of the verbal and nonverbal interaction scale: An observational measure for communication in persons with dementia. Issues in Mental Health Nursing, 38(5), 381&#x2013;390. doi:10.1080/01612840.2017.1279248</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01612840.2017.1279248</ArticleId><ArticleId IdType="pubmed">28448228</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, C. L., Newman, D., &amp; Hammar, L. M. (2018). Preliminary study of a communication intervention for family caregivers and spouses with dementia. International Journal of Geriatric Psychiatry, 33(2), e343&#x2013;e349. doi:10.1002/gps.4816</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4816</ArticleId><ArticleId IdType="pubmed">29105129</ArticleId></ArticleIdList></Reference><Reference><Citation>Yorkston, K. M., Bourgeois, M. S., &amp; Baylor, C. R. (2010). Communication and aging. Physical Medicine and Rehabilitation Clinics of North America, 21(2), 309&#x2013;319. doi:10.1016/j.pmr.2009.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmr.2009.12.011</ArticleId><ArticleId IdType="pmc">PMC3074568</ArticleId><ArticleId IdType="pubmed">20494279</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34962459</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1545-2301</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Clinical gerontologist</Title><ISOAbbreviation>Clin Gerontol</ISOAbbreviation></Journal><ArticleTitle>Using a Multiple-Case Study Design to Explore the Worship Experiences of Black Families Affected by Dementia.</ArticleTitle><Pagination><StartPage>80</StartPage><EndPage>90</EndPage><MedlinePgn>80-90</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/07317115.2021.2017378</ELocationID><Abstract><AbstractText Label="OBJECTIVES">The purpose of this multiple-case study was to report on the worship experiences of Black families affected by dementia.</AbstractText><AbstractText Label="METHODS">Data were collected through participant observations of family caregivers (n&#xa0;=&#xa0;4) and persons living with dementia (n&#xa0;=&#xa0;4) during worship services and semi-structured interviews with the family caregivers over six months. Data were initially analyzed case-by-case, then across-cases.</AbstractText><AbstractText Label="RESULTS">Four overarching themes emerged: <i>Welcoming church culture, Community support from the church, Engagement during worship service</i>, and <i>Connectedness between the caregiver and their family member living with dementia</i>. Family caregivers reported that their family member with dementia was attentive and expressed moments of clarity during and immediately after worship services.</AbstractText><AbstractText Label="CONCLUSIONS">Worship services can be tailored to support families affected by dementia and can promote engagement of the person living with dementia with church activities and family members.</AbstractText><AbstractText Label="CLINICAL IMPLICATIONS">Health practitioners are encouraged to acknowledge the influence of religious practices within Black families affected by dementia and integrate them into interdisciplinary care plans and programs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gore</LastName><ForeName>Janelle E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0003-4506-0229</Identifier><AffiliationInfo><Affiliation>Nell Hodgson Woodruff School of Nursing, University, Emory University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brewster</LastName><ForeName>Glenna</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-7664-9381</Identifier><AffiliationInfo><Affiliation>Nell Hodgson Woodruff School of Nursing, University, Emory University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sainz</LastName><ForeName>Mayra</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nell Hodgson Woodruff School of Nursing, University, Emory University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Yiran</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Nell Hodgson Woodruff School of Nursing, University, Emory University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Jane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Nell Hodgson Woodruff School of Nursing, University, Emory University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Taylor</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Nell Hodgson Woodruff School of Nursing, University, Emory University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Epps</LastName><ForeName>Fayron</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-4332-4078</Identifier><AffiliationInfo><Affiliation>Nell Hodgson Woodruff School of Nursing, University, Emory University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 AG065452</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AG070378</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Gerontol</MedlineTA><NlmUniqueID>8300869</NlmUniqueID><ISSNLinking>0731-7115</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001741" MajorTopicYN="N">Black or African American</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">African American</Keyword><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">engagement</Keyword><Keyword MajorTopicYN="N">faith communities</Keyword><Keyword MajorTopicYN="N">religion</Keyword><Keyword MajorTopicYN="N">religious practices</Keyword></KeywordList><CoiStatement>Disclosure statement. No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>28</Day><Hour>12</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34962459</ArticleId><ArticleId IdType="mid">NIHMS1767989</ArticleId><ArticleId IdType="pmc">PMC9237185</ArticleId><ArticleId IdType="doi">10.1080/07317115.2021.2017378</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Agli O, Bailly N, &amp; Ferrand C (2014). Spirituality and religion in older adults with dementia: A systematic review. International Psychogeriatrics, 27(5), 715&#x2013;725.</Citation><ArticleIdList><ArticleId IdType="pubmed">25155440</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Association. (2021). 2021 Alzheimer&#x2019;s disease facts and figures. Alzheimer&#x2019;s &amp; Dementia, 17(3), 391&#x2013;460.</Citation><ArticleIdList><ArticleId IdType="pubmed">33756057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco A, Schneider J, Coleston-Shields DM, &amp; Orrell M (2019). Dementia care model: Promoting personhood through co-production. Archives of Gerontology and Geriatrics, 81, 59&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">30517898</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, &amp; Clarke V (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77&#x2013;101.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. (2018, September
20). U.S. burden of Alzheimer&#x2019;s disease, related dementias to double by 2060
Centers for Disease Control and Prevention. https://www.cdc.gov/media/releases/2018/p0920-alzheimers-burden-double-2060.html.</Citation></Reference><Reference><Citation>Choy LT (2014). The strengths and weaknesses of research methodology: Comparison and complimentary between qualitative and quantitative approaches. IOSR Journal of Humanities and Social Science, 19(4), 99&#x2013;104.</Citation></Reference><Reference><Citation>Creswell JW, &amp; Miller DL (2000). Determining validity in qualitative inquiry. Theory into Practice, 39(3), 124&#x2013;130.</Citation></Reference><Reference><Citation>Dilworth-Anderson P, Brummett BH, Goodwin P, Williams S. Wallace, Williams RB and Siegler IC (2005). Effect of race on cultural justifications for caregiving. The Journals of Gerontology: Series B, 60(5), S257&#x2013;S262.</Citation><ArticleIdList><ArticleId IdType="pubmed">16131626</ArticleId></ArticleIdList></Reference><Reference><Citation>Epps F, Brewster G, Alexander K, Choe J, Heidbreder V, &amp; Hepburn K (2019). Dementia-friendly faith village worship services to support African American families: Research protocol. Research in Nursing &amp; Health, 42(3), 189&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">30892713</ArticleId></ArticleIdList></Reference><Reference><Citation>Epps F, Heidbreder V, Alexander K, Tomlinson A, Freeman V, &amp; Williams N (2020a). A dementia-friendly church: How can the African American church support families affected by dementia? Dementia, 20(2), 556&#x2013;569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11203389</ArticleId><ArticleId IdType="pubmed">31958978</ArticleId></ArticleIdList></Reference><Reference><Citation>Epps F, Skipper A, &amp; Williams IC (2020b). Broadening research and practice approaches to assessing religiosity in African American older adults. Research in Gerontological Nursing, 13(4), 170&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">33912322</ArticleId></ArticleIdList></Reference><Reference><Citation>Epps F, &amp; Williams IC (2018). The importance of religiosity to the well-being of African American older adults living with dementia. Journal of Applied Gerontology, 39(5), 509&#x2013;518.</Citation><ArticleIdList><ArticleId IdType="pubmed">30584790</ArticleId></ArticleIdList></Reference><Reference><Citation>Epps F (2014). The relationship between family obligation and religiosity on caregiving. Geriatric Nursing, 35(2), 126&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">24314743</ArticleId></ArticleIdList></Reference><Reference><Citation>Foronda C, Baptiste D-L, Reinholdt MM, &amp; Ousman K (2016). Cultural humility: A concept analysis. Journal ofTranscultural Nursing, 27(3), 210&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">26122618</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge Y, Sainz M, Gore J, &amp; Epps F (2021). &#x201c;Everything is either sent by God or used by God&#x201d;: An exploratory study on the impact of Covid-19 upon the religious lives of Black families living with dementia. Journal of Religion and Health, 60(5), 3193&#x2013;3208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8262582</ArticleId><ArticleId IdType="pubmed">34235606</ArticleId></ArticleIdList></Reference><Reference><Citation>Haley WE, Gitlin LN, Wisniewski SR, Mahoney DF, Coon DW, Winter L, &#x2026; Ory M (2004). Well-being, appraisal, and coping in African-American and Caucasian dementia caregivers: Findings from the REACH study. Aging &amp; Mental Health, 8(4), 316&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pubmed">15370048</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo G. Jeongim &amp; Koeske G. (2013). The role of religious coping and race in Alzheimer&#x2019;s disease caregiving. J ApplGerontol, 32(5), 582&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">25474763</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill PC &amp; Pargament KI (2003). Advances in the conceptualization and measurement of religion and spirituality: Implications for physical and mental health research. American Psychologist, 58(1), 64&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">12674819</ArticleId></ArticleIdList></Reference><Reference><Citation>Innes A, Smith SK, &amp; Bushell S (2021). Dementia friendly care: Methods to improve stakeholder engagement and decision making. Journal of Healthcare Leadership, 13, 183&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8379145</ArticleId><ArticleId IdType="pubmed">34429678</ArticleId></ArticleIdList></Reference><Reference><Citation>Isaac KS, Hay JL, &amp; Lubetkin EI (2016). Incorporating spirituality in primary care. Journal of Religion and Health, 55(3), 1065&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4814294</ArticleId><ArticleId IdType="pubmed">26832335</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing W, Willis R, &amp; Feng Z (2016). Factors influencing quality of life of elderly people with dementia and care implications: A systematic review. Archives of Gerontology and Geriatrics, 66, 23&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">27176488</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno T (2003). Personal spirituality of persons with early-stage dementia. Dementia, 2(3), 315&#x2013;335.</Citation></Reference><Reference><Citation>Levin J, Chatters LM, &amp; Taylor RJ (2005). Religion, health and medicine in African Americans: Implications for physicians. Journal of the National Medical Association, 97(2), 237&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2568750</ArticleId><ArticleId IdType="pubmed">15712787</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Badana AN, Burgdorf J, Fabius CD, Roth DL, &amp; Haley WE (2020). Systematic review and meta-analysis of racial and ethnic differences in dementia caregivers&#x2019; well-being. The Gerontologist.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8276619</ArticleId><ArticleId IdType="pubmed">32271380</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews KA, Xu W, Gaglioti AH, Holt JB, Croft JB, Mack D, &amp; McGuire LC (2018). Racial and ethnic estimates of Alzheimer&#x2019;s disease and related dementias in the United States (2015&#x2013;2060) in adults aged &#x2265;65 years. Alzheimer&#x2019;s &amp; Dementia: The Journal of the Alzheimer&#x2019;s Association, 15(1), 17&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6333531</ArticleId><ArticleId IdType="pubmed">30243772</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed B
2021. Most Black Protestants say denominational affiliation is less important than inspiring sermons. Pew Research Center. Retrieved
April 29, September 22, 2021
from https://www.pewresearch.org/fact-tank/2021/04/29/most-black-protestants-say-denominational-affiliation-is-less-important-than-inspiring-sermons/</Citation></Reference><Reference><Citation>Morrow SL (2007). Qualitative research in counseling psychology. The Counseling Psychologist, 35(2), 209&#x2013;235.</Citation></Reference><Reference><Citation>Musselman C (2021). New evaluation guide for dfa communities. Dementia Friendly America
https://www.dfamerica.org/spotlight/2021/5/26/new-evaluation-guide-for-dfa-communities.</Citation></Reference><Reference><Citation>Price PC, Jhangiani R, Chiang I, Leighton D, &amp; Cuttler C (2017). Research methods in psychology: Core skills and concepts
3rd. North America: Creative Commons Attribution NonCommercial ShareAlike. https://opentext.wsu.edu/carriecuttler/</Citation></Reference><Reference><Citation>Regan JL (2013). Redefining dementia care barriers for ethnic minorities: The religion&#x2013;culture distinction. Mental Health, Religion &amp; Culture, 17(4), 345&#x2013;353.</Citation></Reference><Reference><Citation>Robinson-Lane SG, Dredger M, &amp; Patel A (2019). Towards a novel intervention for Black family caregivers of persons with dementia. Alzheimer&#x2019;s &amp; Dementia, 15.</Citation></Reference><Reference><Citation>Saguil A, &amp; Phelps K (2012). The spiritual assessment. American Family Physician, 86(6), 546&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pubmed">23062046</ArticleId></ArticleIdList></Reference><Reference><Citation>Samson ZB, Parker M, Dye C, &amp; Hepburn K (2016). Experiences and learning needs of African American family dementia caregivers. American Journal of Alzheimer&#x2019;s Disease &amp; Other Dementias, 31(6), 492&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10852808</ArticleId><ArticleId IdType="pubmed">26953236</ArticleId></ArticleIdList></Reference><Reference><Citation>Steensland B, Park JZ, Regnerus MD, Robinson LD, Wilcox WB, &amp; Woodberry RD (2000). The measure of American Religion: Toward improving the state of the art. Social Forces, 79(1), 291.</Citation></Reference><Reference><Citation>Yin RK (2017). Case study research and applications: Design and methods. North America: Sage publications.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34865577</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1364-6915</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Aging &amp; mental health</Title><ISOAbbreviation>Aging Ment Health</ISOAbbreviation></Journal><ArticleTitle>Well-being in long-term care: an ode to vulnerability.</ArticleTitle><Pagination><StartPage>230</StartPage><EndPage>235</EndPage><MedlinePgn>230-235</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/13607863.2021.2008869</ELocationID><Abstract><AbstractText>In health care, well-being is considered to be composed of multiple interacting dimensions and to regard the subjective (affective and cognitive) evaluation of these dimensions. These dimensions are often referred to as physical, psychological, and social domains of life. Although there are various disease-specific and group-specific conceptual approaches, starting from a universal perspective provides a more inclusive approach to well-being. Indeed, universal approaches to well-being have striking overlaps with dementia-specific approaches. Although many initiatives have been launched to promote person-centered care and attention for well-being in recent decades, the current COVID pandemic showed that the primary focus in (Dutch) long-term care was still on physical health. However, a well-being perspective can be a central base of care: it is a means to include positive aspects, and it can be applied when addressing problems such as challenging behavior in the sense that both are about needs. Furthermore, providing care from this perspective is not only about the well-being of frail people and their loved ones but also about the well-being and needs of the involved professionals. Increasingly, research shows the importance of the quality of the resident-carer relationship, the carer's behavior, and their well-being for improving the well-being of residents. Applying the care approaches 'attentiveness in care' and relationship-centered care can contribute to the well-being of all involved stakeholders as these uphold the reciprocity of care relationships and take the values and attitudes, but also the vulnerability of those involved, into account.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gerritsen</LastName><ForeName>Debby L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Radboud Institute for Health Sciences, Radboudumc Alzheimer Center, Department of Primary and Community care, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Aging Ment Health</MedlineTA><NlmUniqueID>9705773</NlmUniqueID><ISSNLinking>1360-7863</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008134" MajorTopicYN="Y">Long-Term Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018802" MajorTopicYN="N">Patient-Centered Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Nursing homes</Keyword><Keyword MajorTopicYN="N">challenging behavior</Keyword><Keyword MajorTopicYN="N">relationship-centered care</Keyword><Keyword MajorTopicYN="N">well-being</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>6</Day><Hour>5</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34865577</ArticleId><ArticleId IdType="doi">10.1080/13607863.2021.2008869</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34864998</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1758-5341</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>24</Day></PubDate></JournalIssue><Title>The Gerontologist</Title><ISOAbbreviation>Gerontologist</ISOAbbreviation></Journal><ArticleTitle>Psychometric Properties of Instruments Measuring Dyadic Communication and Environment in Dementia Care: A Systematic Review.</ArticleTitle><Pagination><StartPage>52</StartPage><EndPage>70</EndPage><MedlinePgn>52-70</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/geront/gnab178</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">A valid and reliable assessment of dementia dyadic communication and environment is essential to understand and facilitate social interaction and quality care. This review described the characteristics and evaluated psychometric properties of instruments that assess dyadic communication and environment between persons living with dementia and their caregivers.</AbstractText><AbstractText Label="RESEARCH DESIGN AND METHODS">A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Literature published until June 30, 2021, was searched. Ten psychometric properties and the ratio of sample size to the number of items were evaluated using the Psychometric Assessment for Self-report and Observational Tool.</AbstractText><AbstractText Label="RESULTS">A total of 3,708 scholarly records was identified, and 24 eligible instruments from 48 scholarly records were evaluated. Twenty-two instruments assessed dyadic communication, and 2 assessed both dyadic communication and environment. Eighteen instruments were developed to assess task-related communication and 15 for paid (professional) caregivers. All instruments were scored as low psychometric quality (score range = 0-7). Behavioral Observation Scoring System was scored the highest (total score = 7), followed by Dyadic Dementia Coding System, Grid for observation of physical and verbal behaviors of caregiver and resident, and Trouble-Indicating Behaviors and Repair (total score = 6). These instruments had low psychometric evidence for internal consistency, content validity, and structural validity.</AbstractText><AbstractText Label="DISCUSSION AND IMPLICATIONS">Existing instruments are in the early stages of development and validation in dementia population. Further testing is needed in diverse communication types in paid and unpaid dementia caregiver populations.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sohyun</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7043-7345</Identifier><AffiliationInfo><Affiliation>College of Nursing, The University of Iowa, Iowa City, Iowa, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wen</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-1491-7384</Identifier><AffiliationInfo><Affiliation>College of Nursing, The University of Iowa, Iowa City, Iowa, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gerontologist</MedlineTA><NlmUniqueID>0375327</NlmUniqueID><ISSNLinking>0016-9013</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="N">Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Analysis&#x2014;systematic review</Keyword><Keyword MajorTopicYN="N">Caregiving&#x2014;formal</Keyword><Keyword MajorTopicYN="N">Caregiving&#x2014;informal</Keyword><Keyword MajorTopicYN="N">Measurement</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>5</Day><Hour>21</Hour><Minute>41</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34864998</ArticleId><ArticleId IdType="doi">10.1093/geront/gnab178</ArticleId><ArticleId IdType="pii">6453393</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33245000</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1748-3115</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Disability and rehabilitation. Assistive technology</Title><ISOAbbreviation>Disabil Rehabil Assist Technol</ISOAbbreviation></Journal><ArticleTitle>Impact of the FindMyApps program on people with mild cognitive impairment or dementia and their caregivers; an exploratory pilot randomised controlled trial.</ArticleTitle><Pagination><StartPage>253</StartPage><EndPage>265</EndPage><MedlinePgn>253-265</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/17483107.2020.1842918</ELocationID><Abstract><AbstractText Label="PURPOSE">FindMyApps is a web-based selection-tool and errorless learning training program to help people with mild dementia/Mild Cognitive Impairment (MCI) and caregivers find user-friendly apps. In preparation of a definitive trial, the impact and feasibility of the FindMyApps intervention on self-management and engagement in meaningful activities, including social participation, was explored.</AbstractText><AbstractText Label="MATERIALS AND METHODS">An exploratory pilot randomised controlled trial (trial registration approval number: NL7210) with pre/post measurements was conducted with community-dwelling people with mild dementia/MCI and their caregivers (<i>n</i>&#x2009;=&#x2009;59) in the Netherlands. Dyads in the experimental group (<i>n</i>&#x2009;=&#x2009;28) received training to use the tablet and FindMyApps, and the errorless learning method was taught to their caregivers. Control group dyads (<i>n</i>&#x2009;=&#x2009;31) received a tablet (without FindMyApps), instructions on tablet-use and links to dementia-friendly apps. Validated instruments were used to assess person with dementia's self-management, meaningful activities and social participation, caregiver's sense of competence and both their quality of life.</AbstractText><AbstractText Label="RESULTS AND CONCLUSIONS">No statistical significant group differences on the outcomes were found. Small to moderate effect-sizes in favour of the FindMyApps group were found for self-management and social participation. Caregivers tended to have more positive care experiences. Subgroup analyses showed that people older than 70 benefitted more from FindMyApps regarding self-management and higher educated people benefitted more regarding social participation. FindMyApps is feasible for the target group and may have potential to improve self-management and social participation. For a future definitive effectiveness trial a larger sample size is recommended, as well as taking into account the possible impact of education and age.IMPLICATIONS FOR REHABILITATIONThe FindMyApps program is feasible for people with dementia/MCI and may have potential to improve their self-management and social participation.Informal caregivers may develop a more positive care experience when utilizing FindMyApps to find suitable apps for self-management and social participation for the person with dementia/MCI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beentjes</LastName><ForeName>Kim M</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0001-5160-5569</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Amsterdam University Medical Centers, location VUmc, Amsterdam Public Health research institute, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neal</LastName><ForeName>David P</ForeName><Initials>DP</Initials><Identifier Source="ORCID">0000-0001-7916-3299</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Amsterdam University Medical Centers, location VUmc, Amsterdam Public Health research institute, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerkhof</LastName><ForeName>Yvonne J F</ForeName><Initials>YJF</Initials><Identifier Source="ORCID">0000-0002-0396-3414</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Amsterdam University Medical Centers, location VUmc, Amsterdam Public Health research institute, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Nursing Research, Sector Health Care, Saxion University of Applied Sciences, Deventer/Enschede, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Broeder</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Amsterdam University Medical Centers, location VUmc, Amsterdam Public Health research institute, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Science, Universiteit van Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moeridjan</LastName><ForeName>Za&#xef;nah D J</ForeName><Initials>ZDJ</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Amsterdam University Medical Centers, location VUmc, Amsterdam Public Health research institute, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Behavior and Movement Sciences, Department of Clinical Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ettema</LastName><ForeName>Teake P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Amsterdam University Medical Centers, location VUmc, Amsterdam Public Health research institute, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelkmans</LastName><ForeName>Wiesje</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-6708-5374</Identifier><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muller</LastName><ForeName>Majon M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-7127-6413</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Section Geriatric Medicine, Center of Geriatric Medicine (COGA), Amsterdam University Medical Centers, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graff</LastName><ForeName>Maud J L</ForeName><Initials>MJL</Initials><Identifier Source="ORCID">0000-0003-4361-4291</Identifier><AffiliationInfo><Affiliation>Department of Rehabilitation and Scientific Institute for Quality of Healthcare, Radboud University Medical Centre, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dr&#xf6;es</LastName><ForeName>Rose-Marie</ForeName><Initials>RM</Initials><Identifier Source="ORCID">0000-0002-4812-1229</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Amsterdam University Medical Centers, location VUmc, Amsterdam Public Health research institute, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Disabil Rehabil Assist Technol</MedlineTA><NlmUniqueID>101255937</NlmUniqueID><ISSNLinking>1748-3107</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">mild cognitive impairment</Keyword><Keyword MajorTopicYN="N">psychosocial interventions</Keyword><Keyword MajorTopicYN="N">self-management</Keyword><Keyword MajorTopicYN="N">social participation</Keyword><Keyword MajorTopicYN="N">touch screen technology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>27</Day><Hour>8</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33245000</ArticleId><ArticleId IdType="doi">10.1080/17483107.2020.1842918</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32737755</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0303-4240</ISSN><JournalIssue CitedMedium="Print"><Volume>185</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Reviews of physiology, biochemistry and pharmacology</Title><ISOAbbreviation>Rev Physiol Biochem Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Endosomal Acid-Base Homeostasis in Neurodegenerative Diseases.</ArticleTitle><Pagination><StartPage>195</StartPage><EndPage>231</EndPage><MedlinePgn>195-231</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/112_2020_25</ELocationID><Abstract><AbstractText>Neurodegenerative disorders are debilitating and largely untreatable conditions that pose a significant burden to affected individuals and caregivers. Overwhelming evidence supports a crucial preclinical role for endosomal dysfunction as an upstream pathogenic hub and driver in Alzheimer's disease (AD) and related neurodegenerative disorders. We present recent advances on the role of endosomal acid-base homeostasis in neurodegeneration and discuss evidence for converging mechanisms. The strongest genetic risk factor in sporadic AD is the &#x3b5;4 allele of Apolipoprotein E (ApoE4), which potentiates pre-symptomatic endosomal dysfunction and prominent amyloid beta (A&#x3b2;) pathology, although how these pathways are linked mechanistically has remained unclear. There is emerging evidence that the Christianson syndrome protein NHE6 is a prominent ApoE4 effector linking endosomal function to A&#x3b2; pathologies. By functioning as a dominant leak pathway for protons, the Na<sup>+</sup>/H<sup>+</sup> exchanger activity of NHE6 limits endosomal acidification and regulates &#x3b2;-secretase (BACE)-mediated A&#x3b2; production and LRP1 receptor-mediated A&#x3b2; clearance. Pathological endosomal acidification may impact both A&#x3b2; generation and clearance mechanisms and emerges as a promising therapeutic target in AD. We also offer our perspective on the complex role of endosomal acid-base homeostasis in the pathogenesis of neurodegeneration and its therapeutic implications for neuronal rescue and repair strategies.</AbstractText><CopyrightInformation>&#xa9; 2020. The Author(s), under exclusive license to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prasad</LastName><ForeName>Hari</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Physiology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Rajini</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Physiology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. rrao@jhmi.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>IA/E/17/1/503665</GrantID><Acronym>WTDBT_</Acronym><Agency>DBT-Wellcome Trust India Alliance</Agency><Country>India</Country></Grant><Grant><GrantID>R01 DK108304</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Rev Physiol Biochem Pharmacol</MedlineTA><NlmUniqueID>0434624</NlmUniqueID><ISSNLinking>0303-4240</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053327">Apolipoprotein E4</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053327" MajorTopicYN="N">Apolipoprotein E4</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Amyloid</Keyword><Keyword MajorTopicYN="N">ApoE4</Keyword><Keyword MajorTopicYN="N">Endosomal pH</Keyword><Keyword MajorTopicYN="N">NHE6</Keyword><Keyword MajorTopicYN="N">Na+/H+ exchanger</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32737755</ArticleId><ArticleId IdType="mid">EMS130379</ArticleId><ArticleId IdType="pmc">PMC7614123</ArticleId><ArticleId IdType="doi">10.1007/112_2020_25</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Afghah Z, Chen X, Geiger JD. Role of endolysosomes and inter-organellar signaling in brain disease. Neurobiol Dis. 2019;134:104670. doi: 10.1016/j.nbd.2019.104670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104670</ArticleId><ArticleId IdType="pmc">PMC7184921</ArticleId><ArticleId IdType="pubmed">31707116</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam MS, Getz M, Haldar K. Chronic administration of an HDAC inhibitor treats both neurological and systemic Niemann-pick type C disease in a mouse model. Sci Transl Med. 2016;8(326):326ra323. doi: 10.1126/scitranslmed.aad9407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aad9407</ArticleId><ArticleId IdType="pubmed">26888431</ArticleId></ArticleIdList></Reference><Reference><Citation>Barkla BJ, Blumwald E. Identification of a 170-kDa protein associated with the vacuolar Na +/H+ antiport of Beta vulgaris. Proc Natl Acad Sci U S A. 1991;88(24):11177&#x2013;11181. doi: 10.1073/pnas.88.24.11177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.88.24.11177</ArticleId><ArticleId IdType="pmc">PMC53097</ArticleId><ArticleId IdType="pubmed">1662387</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement. 2015;11(6):718&#x2013;726. doi: 10.1016/j.jalz.2015.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2015.05.016</ArticleId><ArticleId IdType="pubmed">26045020</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben Halima S, Mishra S, Raja KMP, Willem M, Baici A, Simons K, Brustle O, Koch P, Haass C, Caflisch A, Rajendran L. Specific inhibition of beta-secretase processing of the Alzheimer disease amyloid precursor protein. Cell Rep. 2016;14(9):2127&#x2013;2141. doi: 10.1016/j.celrep.2016.01.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.01.076</ArticleId><ArticleId IdType="pubmed">26923602</ArticleId></ArticleIdList></Reference><Reference><Citation>Blumwald E, Poole RJ. Na/H antiport in isolated tonoplast vesicles from storage tissue of Beta vulgaris. Plant Physiol. 1985;78(1):163&#x2013;167. doi: 10.1104/pp.78.1.163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1104/pp.78.1.163</ArticleId><ArticleId IdType="pmc">PMC1064695</ArticleId><ArticleId IdType="pubmed">16664191</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowers K, Levi BP, Patel FI, Stevens TH. The sodium/proton exchanger Nhx1p is required for endosomal protein trafficking in the yeast Saccharomyces cerevisiae. Mol Biol Cell. 2000;11(12):4277&#x2013;4294. doi: 10.1091/mbc.11.12.4277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.11.12.4277</ArticleId><ArticleId IdType="pmc">PMC15072</ArticleId><ArticleId IdType="pubmed">11102523</ArticleId></ArticleIdList></Reference><Reference><Citation>Brett CL, Wei Y, Donowitz M, Rao R. Human Na(+)/H(+) exchanger isoform 6 is found in recycling endosomes of cells, not in mitochondria. Am J Physiol Cell Physiol. 2002;282(5):C1031&#x2013;C1041. doi: 10.1152/ajpcell.00420.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00420.2001</ArticleId><ArticleId IdType="pubmed">11940519</ArticleId></ArticleIdList></Reference><Reference><Citation>Brett CL, Donowitz M, Rao R. Evolutionary origins of eukaryotic sodium/proton exchangers. Am J Physiol Cell Physiol. 2005a;288(2):C223&#x2013;C239. doi: 10.1152/ajpcell.00360.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00360.2004</ArticleId><ArticleId IdType="pubmed">15643048</ArticleId></ArticleIdList></Reference><Reference><Citation>Brett CL, Tukaye DN, Mukherjee S, Rao R. The yeast endosomal Na+K+/H+ exchanger Nhx1 regulates cellular pH to control vesicle trafficking. Mol Biol Cell. 2005b;16(3):1396&#x2013;1405. doi: 10.1091/mbc.e04-11-0999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e04-11-0999</ArticleId><ArticleId IdType="pmc">PMC551501</ArticleId><ArticleId IdType="pubmed">15635088</ArticleId></ArticleIdList></Reference><Reference><Citation>Brett CL, Kallay L, Hua Z, Green R, Chyou A, Zhang Y, Graham TR, Donowitz M, Rao R. Genome-wide analysis reveals the vacuolar pH-stat of Saccharomyces cerevisiae. PLoS One. 2011;6(3):e17619. doi: 10.1371/journal.pone.0017619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017619</ArticleId><ArticleId IdType="pmc">PMC3056714</ArticleId><ArticleId IdType="pubmed">21423800</ArticleId></ArticleIdList></Reference><Reference><Citation>Caglayan S, Takagi-Niidome S, Liao F, Carlo AS, Schmidt V, Burgert T, Kitago Y, Fuchtbauer EM, Fuchtbauer A, Holtzman DM, Takagi J, et al. Lysosomal sorting of amyloidbeta by the SORLA receptor is impaired by a familial Alzheimer&#x2019;s disease mutation. Sci Transl Med. 2014;6(223):223ra220. doi: 10.1126/scitranslmed.3007747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3007747</ArticleId><ArticleId IdType="pubmed">24523320</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, Wong PC. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci. 2001;4(3):233&#x2013;234. doi: 10.1038/85064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/85064</ArticleId><ArticleId IdType="pubmed">11224536</ArticleId></ArticleIdList></Reference><Reference><Citation>Caporaso GL, Gandy SE, Buxbaum JD, Greengard P. Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein. Proc Natl Acad Sci U S A. 1992;89(6):2252&#x2013;2256. doi: 10.1073/pnas.89.6.2252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.89.6.2252</ArticleId><ArticleId IdType="pmc">PMC48635</ArticleId><ArticleId IdType="pubmed">1549591</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey JR, Grinstein S, Orlowski J. Sensors and regulators of intracellular pH. Nat Rev Mol Cell Biol. 2010;11(1):50&#x2013;61. doi: 10.1038/nrm2820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2820</ArticleId><ArticleId IdType="pubmed">19997129</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, Fagan AM, Morris JC, Mawuenyega KG, Cruchaga C, Goate AM, et al. Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med. 2011;3(89):89ra57. doi: 10.1126/scitranslmed.3002156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3002156</ArticleId><ArticleId IdType="pmc">PMC3192364</ArticleId><ArticleId IdType="pubmed">21715678</ArticleId></ArticleIdList></Reference><Reference><Citation>Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer&#x2019;s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol. 2000;157(1):277&#x2013;286. doi: 10.1016/s0002-9440(10)64538-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-9440(10)64538-5</ArticleId><ArticleId IdType="pmc">PMC1850219</ArticleId><ArticleId IdType="pubmed">10880397</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan CY, Prudom C, Raines SM, Charkhzarrin S, Melman SD, De Haro LP, Allen C, Lee SA, Sklar LA, Parra KJ. Inhibitors of V-ATPase proton transport reveal uncoupling functions of tether linking cytosolic and membrane domains of V0 subunit a (Vph1p) J Biol Chem. 2012;287(13):10236&#x2013;10250. doi: 10.1074/jbc.M111.321133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.321133</ArticleId><ArticleId IdType="pmc">PMC3323027</ArticleId><ArticleId IdType="pubmed">22215674</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Durakoglugil MS, Xian X, Herz J. ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling. Proc Natl Acad Sci U S A. 2010;107(26):12011&#x2013;12016. doi: 10.1073/pnas.0914984107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0914984107</ArticleId><ArticleId IdType="pmc">PMC2900641</ArticleId><ArticleId IdType="pubmed">20547867</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Schoepp DD, Paul SM, Mennerick S, Holtzman DM. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron. 2005;48(6):913&#x2013;922. doi: 10.1016/j.neuron.2005.10.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2005.10.028</ArticleId><ArticleId IdType="pubmed">16364896</ArticleId></ArticleIdList></Reference><Reference><Citation>Colacurcio DJ, Nixon RA. Disorders of lysosomal acidification-the emerging role of v-ATPase in aging and neurodegenerative disease. Ageing Res Rev. 2016;32:75&#x2013;88. doi: 10.1016/j.arr.2016.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2016.05.004</ArticleId><ArticleId IdType="pmc">PMC5112157</ArticleId><ArticleId IdType="pubmed">27197071</ArticleId></ArticleIdList></Reference><Reference><Citation>Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the riskof Alzheimer&#x2019;s disease in late onset families. Science. 1993;261(5123):921&#x2013;923. doi: 10.1126/science.8346443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8346443</ArticleId><ArticleId IdType="pubmed">8346443</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL, Morstorf T, Zhong K. Alzheimer&#x2019;s disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res Ther. 2014;6(4):37. doi: 10.1186/alzrt269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt269</ArticleId><ArticleId IdType="pmc">PMC4095696</ArticleId><ArticleId IdType="pubmed">25024750</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang DK, Makena MR, Llongueras JP, Prasad H, Ko M, Bandral M, Rao R. A Ca(2+)- ATPase regulates e-cadherin biogenesis and epithelial-mesenchymal transition in breast cancer cells. Mol Cancer Res. 2019;17(8):1735&#x2013;1747. doi: 10.1158/1541-7786.MCR-19-0070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1541-7786.MCR-19-0070</ArticleId><ArticleId IdType="pmc">PMC6679749</ArticleId><ArticleId IdType="pubmed">31076498</ArticleId></ArticleIdList></Reference><Reference><Citation>Das U, Scott DA, Ganguly A, Koo EH, Tang Y, Roy S. Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway. Neuron. 2013;79(3):447&#x2013;460. doi: 10.1016/j.neuron.2013.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.05.035</ArticleId><ArticleId IdType="pmc">PMC3741682</ArticleId><ArticleId IdType="pubmed">23931995</ArticleId></ArticleIdList></Reference><Reference><Citation>Deane EC, Ilie AE, Sizdahkhani S, Das Gupta M, Orlowski J, McKinney RA. Enhanced recruitment of endosomal Na+/H+ exchanger NHE6 into Dendritic spines of hippocampal pyramidal neurons during NMDA receptor-dependent long-term potentiation. J Neurosci. 2013;33(2):595&#x2013;610. doi: 10.1523/JNEUROSCI.2583-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2583-12.2013</ArticleId><ArticleId IdType="pmc">PMC6704919</ArticleId><ArticleId IdType="pubmed">23303939</ArticleId></ArticleIdList></Reference><Reference><Citation>Diering GH, Numata Y, Fan S, Church J, Numata M. Endosomal acidification by Na+/H+ exchanger NHE5 regulates TrkA cell-surface targeting and NGF-induced PI3K signaling. Mol Biol Cell. 2013;24(21):3435&#x2013;3448. doi: 10.1091/mbc.E12-06-0445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E12-06-0445</ArticleId><ArticleId IdType="pmc">PMC3814139</ArticleId><ArticleId IdType="pubmed">24006492</ArticleId></ArticleIdList></Reference><Reference><Citation>Donowitz M, Ming Tse C, Fuster D. SLC9/NHE gene family, a plasma membrane and organellar family of Na(+)/H(+) exchangers. Mol Asp Med. 2013;34(2-3):236&#x2013;251. doi: 10.1016/j.mam.2012.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2012.05.001</ArticleId><ArticleId IdType="pmc">PMC3724465</ArticleId><ArticleId IdType="pubmed">23506868</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito F, Sorosina M, Ottoboni L, Lim ET, Replogle JM, Raj T, Brambilla P, Liberatore G, Guaschino C, Romeo M, Pertel T, et al. A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity. Ann Neurol. 2015;78(1):115&#x2013;127. doi: 10.1002/ana.24429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24429</ArticleId><ArticleId IdType="pubmed">25914168</ArticleId></ArticleIdList></Reference><Reference><Citation>Flavell SW, Kim TK, Gray JM, Harmin DA, Hemberg M, Hong EJ, Markenscoff-Papadimitriou E, Bear DM, Greenberg ME. Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection. Neuron. 2008;60(6):1022&#x2013;1038. doi: 10.1016/j.neuron.2008.11.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2008.11.029</ArticleId><ArticleId IdType="pmc">PMC2630178</ArticleId><ArticleId IdType="pubmed">19109909</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuster DG, Alexander RT. Traditional and emerging roles for the SLC9 Na+/H+ exchangers. Pflugers Arch. 2014;466(1):61&#x2013;76. doi: 10.1007/s00424-013-1408-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-013-1408-8</ArticleId><ArticleId IdType="pubmed">24337822</ArticleId></ArticleIdList></Reference><Reference><Citation>Garai K, Baban B, Frieden C. Self-association and stability of the ApoE isoforms at low pH: implications for ApoE-lipid interactions. Biochemistry. 2011;50(29):6356&#x2013;6364. doi: 10.1021/bi2006702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi2006702</ArticleId><ArticleId IdType="pubmed">21699199</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbern JY, Neumann M, Trojanowski JQ, Lee VM, Feldman G, Norris JW, Friez MJ, Schwartz CE, Stevenson R, Sima AA. A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition. Brain. 2010;133(Pt 5):1391&#x2013;1402. doi: 10.1093/brain/awq071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq071</ArticleId><ArticleId IdType="pmc">PMC2859154</ArticleId><ArticleId IdType="pubmed">20395263</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaxiola RA, Rao R, Sherman A, Grisafi P, Alper SL, Fink GR. The Arabidopsis thaliana proton transporters, AtNhx1 and Avp1, can function in cation detoxification in yeast. Proc Natl Acad Sci U S A. 1999;96(4):1480&#x2013;1485. doi: 10.1073/pnas.96.4.1480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.4.1480</ArticleId><ArticleId IdType="pmc">PMC15488</ArticleId><ArticleId IdType="pubmed">9990049</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilfillan GD, Selmer KK, Roxrud I, Smith R, Kyllerman M, Eiklid K, Kroken M, Mattingsdal M, Egeland T, Stenmark H, Sjoholm H, et al. SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome. Am J Hum Genet. 2008;82(4):1003&#x2013;1010. doi: 10.1016/j.ajhg.2008.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2008.01.013</ArticleId><ArticleId IdType="pmc">PMC2427207</ArticleId><ArticleId IdType="pubmed">18342287</ArticleId></ArticleIdList></Reference><Reference><Citation>Haass C, Capell A, Citron M, Teplow DB, Selkoe DJ. The vacuolar H(+)-ATPase inhibitor bafilomycin A1 differentially affects proteolytic processing of mutant and wild-type betaamyloid precursor protein. J Biol Chem. 1995;270(11):6186&#x2013;6192. doi: 10.1074/jbc.270.11.6186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.11.6186</ArticleId><ArticleId IdType="pubmed">7890753</ArticleId></ArticleIdList></Reference><Reference><Citation>Haure-Mirande JV, Audrain M, Fanutza T, Kim SH, Klein WL, Glabe C, Readhead B, Dudley JT, Blitzer RD, Wang M, Zhang B, et al. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer&#x2019;s pathology. Acta Neuropathol. 2017;134(5):769&#x2013;788. doi: 10.1007/s00401-017-1737-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1737-3</ArticleId><ArticleId IdType="pmc">PMC5645450</ArticleId><ArticleId IdType="pubmed">28612290</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauser MA, Li YJ, Xu H, Noureddine MA, Shao YS, Gullans SR, Scherzer CR, Jensen RV, McLaurin AC, Gibson JR, Scott BL, et al. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism. Arch Neurol. 2005;62(6):917&#x2013;921. doi: 10.1001/archneur.62.6.917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.62.6.917</ArticleId><ArticleId IdType="pubmed">15956162</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibaoui Y, Grad I, Letourneau A, Santoni FA, Antonarakis SE, Feki A. Data in brief: Transcriptome analysis of induced pluripotent stem cells from monozygotic twins discordant for trisomy 21. Genom Data. 2014;2:226&#x2013;229. doi: 10.1016/j.gdata.2014.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gdata.2014.07.006</ArticleId><ArticleId IdType="pmc">PMC4535757</ArticleId><ArticleId IdType="pubmed">26484098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoefgen S, Dahms SO, Oertwig K, Than ME. The amyloid precursor protein shows a pH-dependent conformational switch in its E1 domain. J Mol Biol. 2015;427(2):433&#x2013;442. doi: 10.1016/j.jmb.2014.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2014.12.005</ArticleId><ArticleId IdType="pubmed">25528641</ArticleId></ArticleIdList></Reference><Reference><Citation>Huffman JE, Knezevic A, Vitart V, Kattla J, Adamczyk B, Novokmet M, Igl W, Pucic M, Zgaga L, Johannson A, Redzic I, et al. Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults. Hum Mol Genet. 2011;20(24):5000&#x2013;5011. doi: 10.1093/hmg/ddr414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr414</ArticleId><ArticleId IdType="pubmed">21908519</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilie A, Gao AY, Reid J, Boucher A, McEwan C, Barriere H, Lukacs GL, McKinney RA, Orlowski J. A Christianson syndrome-linked deletion mutation ((287)ES(288)) in SLC9A6 disrupts recycling endosomal function and elicits neurodegeneration and cell death. Mol Neurodegener. 2016;11(1):63. doi: 10.1186/s13024-016-0129-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0129-9</ArticleId><ArticleId IdType="pmc">PMC5010692</ArticleId><ArticleId IdType="pubmed">27590723</ArticleId></ArticleIdList></Reference><Reference><Citation>Itoh N, Okochi M, Tagami S, Nishitomi K, Nakayama T, Yanagida K, Fukumori A, Jiang J, Mori K, Hosono M, Kikuchi J, et al. Destruxin E decreases Beta-amyloid generation by reducing colocalization of beta-amyloid-cleaving enzyme 1 and beta-amyloid protein precursor. Neurodegener Dis. 2009;6(5-6):230&#x2013;239. doi: 10.1159/000236902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000236902</ArticleId><ArticleId IdType="pubmed">19738368</ArticleId></ArticleIdList></Reference><Reference><Citation>Jentsch TJ, Pusch M. CLC chloride channels and transporters: structure, function, physiology, and disease. Physiol Rev. 2018;98(3):1493&#x2013;1590. doi: 10.1152/physrev.00047.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00047.2017</ArticleId><ArticleId IdType="pubmed">29845874</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji ZS, Miranda RD, Newhouse YM, Weisgraber KH, Huang Y, Mahley RW. Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells. J Biol Chem. 2002;277(24):21821&#x2013;21828. doi: 10.1074/jbc.M112109200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112109200</ArticleId><ArticleId IdType="pubmed">11912196</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, Mullaney KA, Peterhoff CM, Che S, Schmidt SD, Boyer-Boiteau A, Ginsberg SD, Cataldo AM, Mathews PM, Nixon RA. Alzheimer&#x2019;s-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition. Proc Natl Acad Sci U S A. 2010;107(4):1630&#x2013;1635. doi: 10.1073/pnas.0908953107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908953107</ArticleId><ArticleId IdType="pmc">PMC2824382</ArticleId><ArticleId IdType="pubmed">20080541</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, Rigoglioso A, Peterhoff CM, Pawlik M, Sato Y, Bleiwas C, Stavrides P, Smiley JF, Ginsberg SD, Mathews PM, Levy E, et al. Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF. Neurobiol Aging. 2016;39:90&#x2013;98. doi: 10.1016/j.neurobiolaging.2015.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.11.013</ArticleId><ArticleId IdType="pmc">PMC4773919</ArticleId><ArticleId IdType="pubmed">26923405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kagami T, Chen S, Memar P, Choi M, Foster LJ, Numata M. Identification and biochemical characterization of the SLC9A7 interactome. Mol Membr Biol. 2008;25(5):436&#x2013;447. doi: 10.1080/09687680802263046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09687680802263046</ArticleId><ArticleId IdType="pubmed">18654930</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanatsu K, Morohashi Y, Suzuki M, Kuroda H, Watanabe T, Tomita T, Iwatsubo T. Decreased CALM expression reduces Abeta42 to total Abeta ratio through clathrin-mediated endocytosis of gamma-secretase. Nat Commun. 2014;5:3386. doi: 10.1038/ncomms4386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4386</ArticleId><ArticleId IdType="pubmed">24577224</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, Fujiki N, Nishino S, Holtzman DM. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science. 2009;326(5955):1005&#x2013;1007. doi: 10.1126/science.1180962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1180962</ArticleId><ArticleId IdType="pmc">PMC2789838</ArticleId><ArticleId IdType="pubmed">19779148</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, Goate AM. Alzheimer&#x2019;s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry. 2015;77(1):43&#x2013;51. doi: 10.1016/j.biopsych.2014.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2014.05.006</ArticleId><ArticleId IdType="pmc">PMC4234692</ArticleId><ArticleId IdType="pubmed">24951455</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerner-Rossi M, Gulinello M, Walkley S, Dobrenis K. Pathobiology of Christianson syndrome: linking disrupted endosomal-lysosomal function with intellectual disability and sensory impairments. Neurobiol Learn Mem. 2019;165:106867. doi: 10.1016/j.nlm.2018.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nlm.2018.05.004</ArticleId><ArticleId IdType="pmc">PMC6235725</ArticleId><ArticleId IdType="pubmed">29772390</ArticleId></ArticleIdList></Reference><Reference><Citation>Kett LR, Dauer WT. Endolysosomal dysfunction in Parkinson&#x2019;s disease: recent developments and future challenges. Mov Disord. 2016;31(10):1433&#x2013;1443. doi: 10.1002/mds.26797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26797</ArticleId><ArticleId IdType="pmc">PMC5061051</ArticleId><ArticleId IdType="pubmed">27619535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Sato Y, Mohan PS, Peterhoff C, Pensalfini A, Rigoglioso A, Jiang Y, Nixon RA. Evidence that the rab5 effector APPL1 mediates APP-betaCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer&#x2019;s disease. Mol Psychiatry. 2016;21(5):707&#x2013;716. doi: 10.1038/mp.2015.97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2015.97</ArticleId><ArticleId IdType="pmc">PMC4721948</ArticleId><ArticleId IdType="pubmed">26194181</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko M, Qui&#xf1;ones-Hinojosa A, Rao R. Emerging links between endosomal pH and cancer. Cancer Metastasis Rev. 2020;39(2):519&#x2013;534. doi: 10.1007/s10555-020-09870-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10555-020-09870-1</ArticleId><ArticleId IdType="pmc">PMC7316587</ArticleId><ArticleId IdType="pubmed">32253638</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondapalli KC, Hack A, Schushan M, Landau M, Ben-Tal N, Rao R. Functional evaluation of autism-associated mutations in NHE9. Nat Commun. 2013;4:2510. doi: 10.1038/ncomms3510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms3510</ArticleId><ArticleId IdType="pmc">PMC3815575</ArticleId><ArticleId IdType="pubmed">24065030</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondapalli KC, Prasad H, Rao R. An inside job: how endosomal Na(+)/H(+) exchangers link to autism and neurological disease. Front Cell Neurosci. 2014;8:172. doi: 10.3389/fncel.2014.00172.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00172</ArticleId><ArticleId IdType="pmc">PMC4066934</ArticleId><ArticleId IdType="pubmed">25002837</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondapalli KC, Llongueras JP, Capilla-Gonzalez V, Prasad H, Hack A, Smith C, Guerrero-Cazares H, Quinones-Hinojosa A, Rao R. A leak pathway for luminal protons in endosomes drives oncogenic signalling in glioblastoma. Nat Commun. 2015;6:6289. doi: 10.1038/ncomms7289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7289</ArticleId><ArticleId IdType="pmc">PMC4354686</ArticleId><ArticleId IdType="pubmed">25662504</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundra R, Ciryam P, Morimoto RI, Dobson CM, Vendruscolo M. Protein homeostasis of a metastable subproteome associated with Alzheimer&#x2019;s disease. Proc Natl Acad Sci U S A. 2017;114(28):E5703&#x2013;E5711. doi: 10.1073/pnas.1618417114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1618417114</ArticleId><ArticleId IdType="pmc">PMC5514703</ArticleId><ArticleId IdType="pubmed">28652376</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahiri DK. Effect of ionophores on the processing of the beta-amyloid precursor protein in different cell lines. Cell Mol Neurobiol. 1994;14(4):297&#x2013;313. doi: 10.1007/BF02088713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02088713</ArticleId><ArticleId IdType="pubmed">7788640</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, Wolfe DM, Martinez-Vicente M, Massey AC, Sovak G, Uchiyama Y, et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell. 2010;141(7):1146&#x2013;1158. doi: 10.1016/j.cell.2010.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.05.008</ArticleId><ArticleId IdType="pmc">PMC3647462</ArticleId><ArticleId IdType="pubmed">20541250</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C, Kang HJ, von Ballmoos C, Newstead S, Uzdavinys P, Dotson DL, Iwata S, Beckstein O, Cameron AD, Drew D. A two-domain elevator mechanism for sodium/proton antiport. Nature. 2013;501(7468):573&#x2013;577. doi: 10.1038/nature12484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12484</ArticleId><ArticleId IdType="pmc">PMC3914025</ArticleId><ArticleId IdType="pubmed">23995679</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Chen J, Ricupero CL, Hart RP, Schwartz MS, Kusnecov A, Herrup K. Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. Nat Med. 2012;18(5):783&#x2013;790. doi: 10.1038/nm.2709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2709</ArticleId><ArticleId IdType="pmc">PMC3378917</ArticleId><ArticleId IdType="pubmed">22466704</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Zhang F, Hu Y, Jiang Y, Gong Z, Liu S, Chen X, Jiang Q, Hao J. Genetic variants and multiple sclerosis risk gene SLC9A9 expression in distinct human brain regions. Mol Neurobiol. 2017;54(9):6820&#x2013;6826. doi: 10.1007/s12035-016-0208-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0208-5</ArticleId><ArticleId IdType="pubmed">27766536</ArticleId></ArticleIdList></Reference><Reference><Citation>Martina JA, Lelouvier B, Puertollano R. The calcium channel mucolipin-3 is a novel regulator of trafficking along the endosomal pathway. Traffic. 2009;10(8):1143&#x2013;1156. doi: 10.1111/j.1600-0854.2009.00935.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0854.2009.00935.x</ArticleId><ArticleId IdType="pmc">PMC2955859</ArticleId><ArticleId IdType="pubmed">19497048</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinelli-Boneschi F, Giacalone G, Magnani G, Biella G, Coppi E, Santangelo R, Brambilla P, Esposito F, Lupoli S, Clerici F, Benussi L, et al. Pharmacogenomics in Alzheimer&#x2019;s disease: a genome-wide association study of response to cholinesterase inhibitors. Neurobiol Aging. 2013;34(6):1711.e1717&#x2013;1711.e1713. doi: 10.1016/j.neurobiolaging.2012.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.12.008</ArticleId><ArticleId IdType="pubmed">23374588</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah E, Mallory M, Alford M, DeTeresa R, Hansen LA, McKeel DW, Jr, Morris JC. Altered expression of synaptic proteins occurs early during progression of Alzheimer&#x2019;s disease. Neurology. 2001;56(1):127&#x2013;129. doi: 10.1212/wnl.56.1.127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.56.1.127</ArticleId><ArticleId IdType="pubmed">11148253</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauvezin C, Neufeld TP. Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion. Autophagy. 2015;11(8):1437&#x2013;1438. doi: 10.1080/15548627.2015.1066957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1066957</ArticleId><ArticleId IdType="pmc">PMC4590655</ArticleId><ArticleId IdType="pubmed">26156798</ArticleId></ArticleIdList></Reference><Reference><Citation>Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ. Decreased clearance of CNS beta-amyloid in Alzheimer&#x2019;s disease. Science. 2010;330(6012):1774. doi: 10.1126/science.1197623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1197623</ArticleId><ArticleId IdType="pmc">PMC3073454</ArticleId><ArticleId IdType="pubmed">21148344</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxfield FR. Role of endosomes and lysosomes in human disease. Cold Spring Harb Perspect Biol. 2014;6(5):a016931. doi: 10.1101/cshperspect.a016931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a016931</ArticleId><ArticleId IdType="pmc">PMC3996470</ArticleId><ArticleId IdType="pubmed">24789821</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayburd A, Baranova A. Knowledge-based compact disease models identify new molecular players contributing to early-stage Alzheimer&#x2019;s disease. BMC Syst Biol. 2013;7:121. doi: 10.1186/1752-0509-7-121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1752-0509-7-121</ArticleId><ArticleId IdType="pmc">PMC3827844</ArticleId><ArticleId IdType="pubmed">24196233</ArticleId></ArticleIdList></Reference><Reference><Citation>Meda SA, Narayanan B, Liu J, Perrone-Bizzozero NI, Stevens MC, Calhoun VD, Glahn DC, Shen L, Risacher SL, Saykin AJ, Pearlson GD. A large scale multivariate parallel ICA method reveals novel imaging-genetic relationships for Alzheimer &#x2018;s disease in the ADNI cohort. NeuroImage. 2012;60(3):1608&#x2013;1621. doi: 10.1016/j.neuroimage.2011.12.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2011.12.076</ArticleId><ArticleId IdType="pmc">PMC3312985</ArticleId><ArticleId IdType="pubmed">22245343</ArticleId></ArticleIdList></Reference><Reference><Citation>Mignot C, Heron D, Bursztyn J, Momtchilova M, Mayer M, Whalen S, Legall A, Billette de Villemeur T, Burglen L. Novel mutation in SLC9A6 gene in a patient with Christianson syndrome and retinitis pigmentosum. Brain and Development. 2013;35(2):172&#x2013;176. doi: 10.1016/j.braindev.2012.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.braindev.2012.03.010</ArticleId><ArticleId IdType="pubmed">22541666</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller JA, Ding SL, Sunkin SM, Smith KA, Ng L, Szafer A, Ebbert A, Riley ZL, Royall JJ, Aiona K, Arnold JM, et al. Transcriptional landscape of the prenatal human brain. Nature. 2014;508(7495):199&#x2013;206. doi: 10.1038/nature13185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13185</ArticleId><ArticleId IdType="pmc">PMC4105188</ArticleId><ArticleId IdType="pubmed">24695229</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitterreiter S, Page RM, Kamp F, Hopson J, Winkler E, Ha HR, Hamid R, Herms J, Mayer TU, Nelson DJ, Steiner H, et al. Bepridil and amiodarone simultaneously target the Alzheimer&#x2019;s disease beta-and gamma-secretase via distinct mechanisms. J Neurosci. 2010;30(26):8974&#x2013;8983. doi: 10.1523/JNEUROSCI.1199-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1199-10.2010</ArticleId><ArticleId IdType="pmc">PMC6632893</ArticleId><ArticleId IdType="pubmed">20592218</ArticleId></ArticleIdList></Reference><Reference><Citation>Mkhikian H, Grigorian A, Li CF, Chen HL, Newton B, Zhou RW, Beeton C, Torossian S, Tatarian GG, Lee SU, Lau K, et al. Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis. Nat Commun. 2011;2:334. doi: 10.1038/ncomms1333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms1333</ArticleId><ArticleId IdType="pmc">PMC3133923</ArticleId><ArticleId IdType="pubmed">21629267</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan AJ, Galione A. NAADP induces pH changes in the lumen of acidic Ca2+ stores. Biochem J. 2007;402(2):301&#x2013;310. doi: 10.1042/BJ20060759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20060759</ArticleId><ArticleId IdType="pmc">PMC1798430</ArticleId><ArticleId IdType="pubmed">17117921</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow EM, Yoo SY, Flavell SW, Kim TK, Lin Y, Hill RS, Mukaddes NM, Balkhy S, Gascon G, Hashmi A, Al-Saad S, et al. Identifying autism loci and genes by tracing recent shared ancestry. Science. 2008;321(5886):218&#x2013;223. doi: 10.1126/science.1157657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1157657</ArticleId><ArticleId IdType="pmc">PMC2586171</ArticleId><ArticleId IdType="pubmed">18621663</ArticleId></ArticleIdList></Reference><Reference><Citation>Muro S, Mateescu M, Gajewski C, Robinson M, Muzykantov VR, Koval M. Control of intracellular trafficking of ICAM-1-targeted nanocarriers by endothelial Na+/H+ exchanger proteins. Am J Physiol Lung Cell Mol Physiol. 2006;290(5):L809&#x2013;L817. doi: 10.1152/ajplung.00311.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00311.2005</ArticleId><ArticleId IdType="pubmed">16299052</ArticleId></ArticleIdList></Reference><Reference><Citation>Musgrove E, Seaman M, Hedley D. Relationship between cytoplasmic pH and proliferation during exponential growth and cellular quiescence. Exp Cell Res. 1987;172(1):65&#x2013;75. doi: 10.1016/0014-4827(87)90093-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-4827(87)90093-0</ArticleId><ArticleId IdType="pubmed">3653258</ArticleId></ArticleIdList></Reference><Reference><Citation>Nass R, Rao R. Novel localization of a Na+/H+ exchanger in a late endosomal compartment of yeast. Implications for vacuole biogenesis. J Biol Chem. 1998;273(33):21054&#x2013;21060. doi: 10.1074/jbc.273.33.21054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.33.21054</ArticleId><ArticleId IdType="pubmed">9694857</ArticleId></ArticleIdList></Reference><Reference><Citation>Nass R, Cunningham KW, Rao R. Intracellular sequestration of sodium by a novel Na+/H+ exchanger in yeast is enhanced by mutations in the plasma membrane H+-ATPase. Insights into mechanisms of sodium tolerance. J Biol Chem. 1997;272(42):26145&#x2013;26152. doi: 10.1074/jbc.272.42.26145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.42.26145</ArticleId><ArticleId IdType="pubmed">9334180</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumova OY, Palejev D, Vlasova NV, Lee M, Rychkov SY, Babich ON, Vaccarino FM, Grigorenko EL. Age-related changes of gene expression in the neocortex: preliminary data on RNA-Seq of the transcriptome in three functionally distinct cortical areas. Dev Psychopathol. 2012;24(4):1427&#x2013;1442. doi: 10.1017/S0954579412000818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0954579412000818</ArticleId><ArticleId IdType="pmc">PMC3539811</ArticleId><ArticleId IdType="pubmed">23062308</ArticleId></ArticleIdList></Reference><Reference><Citation>Nixon RA. Endosome function and dysfunction in Alzheimer&#x2019;s disease and other neurode-generative diseases. Neurobiol Aging. 2005;26(3):373&#x2013;382. doi: 10.1016/j.neurobiolaging.2004.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2004.09.018</ArticleId><ArticleId IdType="pubmed">15639316</ArticleId></ArticleIdList></Reference><Reference><Citation>Nixon RA. Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer&#x2019;s disease: inseparable partners in a multifactorial disease. FASEB J. 2017;31(7):2729&#x2013;2743. doi: 10.1096/fj.201700359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201700359</ArticleId><ArticleId IdType="pmc">PMC6137496</ArticleId><ArticleId IdType="pubmed">28663518</ArticleId></ArticleIdList></Reference><Reference><Citation>Olubiyi OO, Strodel B. Structures of the amyloid beta-peptides Abeta1-40 and Abeta1-42 as influenced by pH and a D-peptide. J Phys Chem B. 2012;116(10):3280&#x2013;3291. doi: 10.1021/jp2076337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jp2076337</ArticleId><ArticleId IdType="pubmed">22300010</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang Q, Lizarraga SB, Schmidt M, Yang U, Gong J, Ellisor D, Kauer JA, Morrow EM. Christianson syndrome protein NHE6 modulates TrkB endosomal signaling required for neuronal circuit development. Neuron. 2013;80(1):97&#x2013;112. doi: 10.1016/j.neuron.2013.07.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.043</ArticleId><ArticleId IdType="pmc">PMC3830955</ArticleId><ArticleId IdType="pubmed">24035762</ArticleId></ArticleIdList></Reference><Reference><Citation>Park M, Penick EC, Edwards JG, Kauer JA, Ehlers MD. Recycling endosomes supply AMPA receptors for LTP. Science. 2004;305(5692):1972&#x2013;1975. doi: 10.1126/science.1102026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1102026</ArticleId><ArticleId IdType="pubmed">15448273</ArticleId></ArticleIdList></Reference><Reference><Citation>Park C, Ha J, Park S. Prediction of Alzheimer&#x2019;s disease based on deep neural network by integrating gene expression and DNA methylation dataset. Expert Syst Appl. 2019;140:112873</Citation></Reference><Reference><Citation>Pedersen SF, Counillon L. The SLC9A-C mammalian Na(+)/H(+) exchanger family: molecules, mechanisms, and physiology. Physiol Rev. 2019;99(4):2015&#x2013;2113. doi: 10.1152/physrev.00028.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00028.2018</ArticleId><ArticleId IdType="pubmed">31507243</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereda AE. Electrical synapses and their functional interactions with chemical synapses. Nat Rev Neurosci. 2014;15(4):250&#x2013;263. doi: 10.1038/nrn3708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3708</ArticleId><ArticleId IdType="pmc">PMC4091911</ArticleId><ArticleId IdType="pubmed">24619342</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Palma E, Bustos BI, Villaman CF, Alarcon MA, Avila ME, Ugarte GD, Reyes AE, Opazo C, De Ferrari GV Alzheimer&#x2019;s Disease Neuroimaging I Group N-LNFS. Overrepresentation of glutamate signaling in Alzheimer&#x2019;s disease: network-based pathway enrichment using meta-analysis of genome-wide association studies. PLoS One. 2014;9(4):e95413. doi: 10.1371/journal.pone.0095413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095413</ArticleId><ArticleId IdType="pmc">PMC3995778</ArticleId><ArticleId IdType="pubmed">24755620</ArticleId></ArticleIdList></Reference><Reference><Citation>Persson T, Lattanzio F, Calvo-Garrido J, Rimondini R, Rubio-Rodrigo M, Sundstrom E, Maioli S, Sandebring-Matton A, Cedazo-Minguez A. Apolipoprotein E4 elicits lysosomal cathepsin D release, decreased thioredoxin-1 levels, and apoptosis. J Alzheimers Dis. 2017;56(2):601&#x2013;617. doi: 10.3233/JAD-150738.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-150738</ArticleId><ArticleId IdType="pmc">PMC5271484</ArticleId><ArticleId IdType="pubmed">28035917</ArticleId></ArticleIdList></Reference><Reference><Citation>Pessetto ZY, Chen B, Alturkmani H, Hyter S, Flynn CA, Baltezor M, Ma Y, Rosenthal HG, Neville KA, Weir SJ, Butte AJ, et al. In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma. Oncotarget. 2017;8(3):4079&#x2013;4095. doi: 10.18632/oncotarget.13385.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.13385</ArticleId><ArticleId IdType="pmc">PMC5354814</ArticleId><ArticleId IdType="pubmed">27863422</ArticleId></ArticleIdList></Reference><Reference><Citation>Phatnani H, Maniatis T. Astrocytes in neurodegenerative disease. Cold Spring Harb Perspect Biol. 2015;7(6):a020628. doi: 10.1101/cshperspect.a020628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a020628</ArticleId><ArticleId IdType="pmc">PMC4448607</ArticleId><ArticleId IdType="pubmed">25877220</ArticleId></ArticleIdList></Reference><Reference><Citation>Poroca DR, Pelis RM, Chappe VM. ClC channels and transporters: structure, physiological functions, and implications in human chloride channelopathies. Front Pharmacol. 2017;8:151. doi: 10.3389/fphar.2017.00151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2017.00151</ArticleId><ArticleId IdType="pmc">PMC5362633</ArticleId><ArticleId IdType="pubmed">28386229</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad H, Rao R. Applying knowledge of autism to brain cancer management: what do we know? Future Oncol. 2015a;11(13):1847&#x2013;1850. doi: 10.2217/fon.15.93.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fon.15.93</ArticleId><ArticleId IdType="pubmed">26161920</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad H, Rao R. The Na+/H+ exchanger NHE6 modulates endosomal pH to control processing of amyloid precursor protein in a cell culture model of Alzheimer disease. J Biol Chem. 2015b;290(9):5311&#x2013;5327. doi: 10.1074/jbc.M114.602219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.602219</ArticleId><ArticleId IdType="pmc">PMC4342450</ArticleId><ArticleId IdType="pubmed">25561733</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad H, Rao R. Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH. Proc Natl Acad Sci U S A. 2018a;115(28):E6640&#x2013;E6649. doi: 10.1073/pnas.1801612115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1801612115</ArticleId><ArticleId IdType="pmc">PMC6048470</ArticleId><ArticleId IdType="pubmed">29946028</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad H, Rao R. Histone deacetylase-mediated regulation of endolysosomal pH. J Biol Chem. 2018b;293(18):6721&#x2013;6735. doi: 10.1074/jbc.RA118.002025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.002025</ArticleId><ArticleId IdType="pmc">PMC5936830</ArticleId><ArticleId IdType="pubmed">29567836</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad H, Osei-Owusu J, Rao R. Functional analysis of Na(+)/H(+) exchanger 9 variants identified in patients with autism and epilepsy. Matters (Zur) 2017. 2017 doi: 10.19185/matters.201704000009.</Citation><ArticleIdList><ArticleId IdType="doi">10.19185/matters.201704000009</ArticleId><ArticleId IdType="pmc">PMC5555647</ArticleId><ArticleId IdType="pubmed">28815171</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad H, Dang DK, Kondapalli KC, Natarajan N, Cebotaru V, Rao R. NHA2 promotes cyst development in an in vitro model of polycystic kidney disease. J Physiol. 2019;597(2):499&#x2013;519. doi: 10.1113/JP276796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP276796</ArticleId><ArticleId IdType="pmc">PMC6332743</ArticleId><ArticleId IdType="pubmed">30242840</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugach EK, Feltes M, Kaufman RJ, Ory DS, Bang AG. High-content screen for modifiers of Niemann-pick type C disease in patient cells. Hum Mol Genet. 2018;27(12):2101&#x2013;2112. doi: 10.1093/hmg/ddy117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy117</ArticleId><ArticleId IdType="pmc">PMC5985738</ArticleId><ArticleId IdType="pubmed">29659804</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, Simons K. Alzheimer&#x2019;s disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A. 2006;103(30):11172&#x2013;11177. doi: 10.1073/pnas.0603838103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0603838103</ArticleId><ArticleId IdType="pmc">PMC1544060</ArticleId><ArticleId IdType="pubmed">16837572</ArticleId></ArticleIdList></Reference><Reference><Citation>Riess A, Rossier E, Kruger R, Dufke A, Beck-Woedl S, Horber V, Alber M, Glaser D, Riess O, Tzschach A. Novel SLC9A6 mutations in two families with Christianson syndrome. Clin Genet. 2013;83(6):596&#x2013;597. doi: 10.1111/j.1399-0004.2012.01948.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2012.01948.x</ArticleId><ArticleId IdType="pubmed">22931061</ArticleId></ArticleIdList></Reference><Reference><Citation>Savina A, Furlan M, Vidal M, Colombo MI. Exosome release is regulated by a calciumdependent mechanism in K562 cells. J Biol Chem. 2003;278(22):20083&#x2013;20090. doi: 10.1074/jbc.M301642200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M301642200</ArticleId><ArticleId IdType="pubmed">12639953</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt MR, Haucke V. Recycling endosomes in neuronal membrane traffic. Biol Cell. 2007;99(6):333&#x2013;342. doi: 10.1042/BC20070007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BC20070007</ArticleId><ArticleId IdType="pubmed">17504239</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrader-Fischer G, Paganetti PA. Effect of alkalizing agents on the processing of the betaamyloid precursor protein. Brain Res. 1996;716(1-2):91&#x2013;100. doi: 10.1016/0006-8993(96)00002-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(96)00002-9</ArticleId><ArticleId IdType="pubmed">8738224</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwede M, Garbett K, Mirnics K, Geschwind DH, Morrow EM. Genes for endosomal NHE6 and NHE9 are misregulated in autism brains. Mol Psychiatry. 2014;19(3):277&#x2013;279. doi: 10.1038/mp.2013.28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2013.28</ArticleId><ArticleId IdType="pmc">PMC3932404</ArticleId><ArticleId IdType="pubmed">23508127</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott CC, Gruenberg J. Ion flux and the function of endosomes and lysosomes: pH is just the start: the flux of ions across endosomal membranes influences endosome function not only through regulation of the luminal pH. Bioessays. 2011;33(2):103&#x2013;110. doi: 10.1002/bies.201000108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.201000108</ArticleId><ArticleId IdType="pubmed">21140470</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng M, Sabatini BL, Sudhof TC. Synapses and Alzheimer &#x2018;s disease. Cold Spring Harb Perspect Biol. 2012;4(5):a005777. doi: 10.1101/cshperspect.a005777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a005777</ArticleId><ArticleId IdType="pmc">PMC3331702</ArticleId><ArticleId IdType="pubmed">22491782</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman JM, Imboywa S, Giagtzoglou N, Powers MP, Hu Y, Devenport D, Chipendo P, Chibnik LB, Diamond A, Perrimon N, Brown NH, et al. Functional screening in Drosophila identifies Alzheimer&#x2019;s disease susceptibility genes and implicates Tau-mediated mechanisms. Hum Mol Genet. 2014;23(4):870&#x2013;877. doi: 10.1093/hmg/ddt478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt478</ArticleId><ArticleId IdType="pmc">PMC3900103</ArticleId><ArticleId IdType="pubmed">24067533</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinajon P, Verbaan D, So J. The expanding phenotypic spectrum of female SLC9A6 mutation carriers: a case series and review of the literature. Hum Genet. 2016;135(8):841&#x2013;850. doi: 10.1007/s00439-016-1675-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-016-1675-5</ArticleId><ArticleId IdType="pubmed">27142213</ArticleId></ArticleIdList></Reference><Reference><Citation>Small SA, Simoes-Spassov S, Mayeux R, Petsko GA. Endosomal traffic jams represent a pathogenic hub and therapeutic target in Alzheimer&#x2019;s disease. Trends Neurosci. 2017;40(10):592&#x2013;602. doi: 10.1016/j.tins.2017.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2017.08.003</ArticleId><ArticleId IdType="pmc">PMC5654621</ArticleId><ArticleId IdType="pubmed">28962801</ArticleId></ArticleIdList></Reference><Reference><Citation>Stromme P, Dobrenis K, Sillitoe RV, Gulinello M, Ali NF, Davidson C, Micsenyi MC, Stephney G, Ellevog L, Klungland A, Walkley SU. X-linked Angelman-like syndrome caused by Slc9a6 knockout in mice exhibits evidence of endosomal-lysosomal dysfunction. Brain. 2011;134(Pt 11):3369&#x2013;3383. doi: 10.1093/brain/awr250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr250</ArticleId><ArticleId IdType="pmc">PMC3212719</ArticleId><ArticleId IdType="pubmed">21964919</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarawneh R, Holtzman DM. The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harb Perspect Med. 2012;2(5):a006148. doi: 10.1101/cshperspect.a006148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a006148</ArticleId><ArticleId IdType="pmc">PMC3331682</ArticleId><ArticleId IdType="pubmed">22553492</ArticleId></ArticleIdList></Reference><Reference><Citation>Theendakara V, Patent A, Peters Libeu CA, Philpot B, Flores S, Descamps O, Poksay KS, Zhang Q, Cailing G, Hart M, John V, et al. Neuroprotective Sirtuin ratio reversed by ApoE4. Proc Natl Acad Sci U S A. 2013;110(45):18303&#x2013;18308. doi: 10.1073/pnas.1314145110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1314145110</ArticleId><ArticleId IdType="pmc">PMC3831497</ArticleId><ArticleId IdType="pubmed">24145446</ArticleId></ArticleIdList></Reference><Reference><Citation>Thome R, Moraes AS, Bombeiro AL, Farias Ados S, Francelin C, da Costa TA, Di Gangi R, dos Santos LM, de Oliveira AL, Verinaud L. Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis. PLoS One. 2013;8(6):e65913. doi: 10.1371/journal.pone.0065913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0065913</ArticleId><ArticleId IdType="pmc">PMC3683039</ArticleId><ArticleId IdType="pubmed">23799062</ArticleId></ArticleIdList></Reference><Reference><Citation>Treusch S, Hamamichi S, Goodman JL, Matlack KE, Chung CY, Baru V, Shulman JM, Parrado A, Bevis BJ, Valastyan JS, Han H, et al. Functional links between Abeta toxicity, endocytic trafficking, and Alzheimer&#x2019;s disease risk factors in yeast. Science. 2011;334(6060):1241&#x2013;1245. doi: 10.1126/science.1213210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1213210</ArticleId><ArticleId IdType="pmc">PMC3281757</ArticleId><ArticleId IdType="pubmed">22033521</ArticleId></ArticleIdList></Reference><Reference><Citation>Troncoso JC, Cataldo AM, Nixon RA, Barnett JL, Lee MK, Checler F, Fowler DR, Smialek JE, Crain B, Martin LJ, Kawas CH. Neuropathology of preclinical and clinical late-onset Alzheimer&#x2019;s disease. Ann Neurol. 1998;43(5):673&#x2013;676. doi: 10.1002/ana.410430519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410430519</ArticleId><ArticleId IdType="pubmed">9585365</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullman JC, Yang J, Sullivan M, Bendor J, Levy J, Pham E, Silm K, Seifikar H, Sohal VS, Nicoll RA, Edwards RH. A mouse model of autism implicates endosome pH in the regulation of presynaptic calcium entry. Nat Commun. 2018;9(1):330. doi: 10.1038/s41467-017-02716-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02716-5</ArticleId><ArticleId IdType="pmc">PMC5780507</ArticleId><ArticleId IdType="pubmed">29362376</ArticleId></ArticleIdList></Reference><Reference><Citation>Urmoneit B, Turner J, Dyrks T. Pulse-chase experiments revealed beta-secretase cleavage from immature full-length amyloid precursor protein harboring the Swedish mutation. Implications for distinct pathways. J Mol Neurosci. 1998;11(2):141&#x2013;150. doi: 10.1385/JMN:11:2:141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/JMN:11:2:141</ArticleId><ArticleId IdType="pubmed">10096041</ArticleId></ArticleIdList></Reference><Reference><Citation>Vagnozzi AN, Li JG, Chiu J, Razmpour R, Warfield R, Ramirez SH, Pratico D. VPS35 regulates tau phosphorylation and neuropathology in tauopathy. Mol Psychiatry. 2019 doi: 10.1038/s41380-019-0453-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-019-0453-x</ArticleId><ArticleId IdType="pmc">PMC6949432</ArticleId><ArticleId IdType="pubmed">31289348</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassar R, Kandalepas PC. The beta-secretase enzyme BACE1 as a therapeutic target for Alzheimer&#x2019;s disease. Alzheimers Res Ther. 2011;3(3):20. doi: 10.1186/alzrt82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt82</ArticleId><ArticleId IdType="pmc">PMC3226309</ArticleId><ArticleId IdType="pubmed">21639952</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, et al. Beta-secretase cleavage of Alzheimer&#x2019;s amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286(5440):735&#x2013;741. doi: 10.1126/science.286.5440.735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.286.5440.735</ArticleId><ArticleId IdType="pubmed">10531052</ArticleId></ArticleIdList></Reference><Reference><Citation>Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, Bu G, Frieden C, Holtzman DM. ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions. Proc Natl Acad Sci U S A. 2013;110(19):E1807&#x2013;E1816. doi: 10.1073/pnas.1220484110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1220484110</ArticleId><ArticleId IdType="pmc">PMC3651443</ArticleId><ArticleId IdType="pubmed">23620513</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster JA, Gibbs JR, Clarke J, Ray M, Zhang W, Holmans P, Rohrer K, Zhao A, Marlowe L, Kaleem M, McCorquodale DS, 3rd, Cuello C, et al. Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet. 2009;84(4):445&#x2013;458. doi: 10.1016/j.ajhg.2009.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2009.03.011</ArticleId><ArticleId IdType="pmc">PMC2667989</ArticleId><ArticleId IdType="pubmed">19361613</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegiel J, Frackowiak J, Mazur-Kolecka B, Schanen NC, Cook EH, Jr, Sigman M, Brown WT, Kuchna I, Wegiel J, Nowicki K, Imaki H, et al. Abnormal intracellular accumulation and extracellular Abeta deposition in idiopathic and Dup15q11.2-q13 autism spectrum disorders. PLoS One. 2012;7(5):e35414. doi: 10.1371/journal.pone.0035414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035414</ArticleId><ArticleId IdType="pmc">PMC3342283</ArticleId><ArticleId IdType="pubmed">22567102</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff G, Reyna SM, Dunlap M, Van Der Kant R, Callender JA, Young JE, Roberts EA, Goldstein LS. Defective transcytosis of APP and lipoproteins in human iPSC-derived neurons with familial Alzheimer&#x2019;s disease mutations. Cell Rep. 2016;17(3):759&#x2013;773. doi: 10.1016/j.celrep.2016.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.09.034</ArticleId><ArticleId IdType="pmc">PMC5796664</ArticleId><ArticleId IdType="pubmed">27732852</ArticleId></ArticleIdList></Reference><Reference><Citation>Xian X, Pohlkamp T, Durakoglugil MS, Wong CH, Beck JK, Lane-Donovan C, Plattner F, Herz J. Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer&#x2019;s disease. Elife. 2018;7:e40048. doi: 10.7554/eLife.40048.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.40048</ArticleId><ArticleId IdType="pmc">PMC6261251</ArticleId><ArticleId IdType="pubmed">30375977</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu PT, Li YJ, Qin XJ, Scherzer CR, Xu H, Schmechel DE, Hulette CM, Ervin J, Gullans SR, Haines J, Pericak-Vance MA, et al. Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Neurobiol Dis. 2006;21(2):256&#x2013;275. doi: 10.1016/j.nbd.2005.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2005.07.004</ArticleId><ArticleId IdType="pubmed">16198584</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M, Ouyang Q, Gong J, Pescosolido MF, Pruett BS, Mishra S, Schmidt M, Jones RN, Gamsiz Uzun ED, Lizarraga SB, Morrow EM. Mixed neurodevelopmental and neurodegenera-tive pathology in Nhe6-null mouse model of Christianson syndrome. eNeuro. 2017;4(6):0388. doi: 10.1523/ENEURO.0388-17.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0388-17.2017</ArticleId><ArticleId IdType="pmc">PMC5771691</ArticleId><ArticleId IdType="pubmed">29349289</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki Y, Painter MM, Bu G, Kanekiyo T. Apolipoprotein E as a therapeutic target in Alzheimer&#x2019;s disease: a review of basic research and clinical evidence. CNS Drugs. 2016;30(9):773&#x2013;789. doi: 10.1007/s40263-016-0361-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-016-0361-4</ArticleId><ArticleId IdType="pmc">PMC5526196</ArticleId><ArticleId IdType="pubmed">27328687</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Gaiteri C, Bodea LG, Wang Z, McElwee J, Podtelezhnikov AA, Zhang C, Xie T, Tran L, Dobrin R, Fluder E, et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer&#x2019;s disease. Cell. 2013;153(3):707&#x2013;720. doi: 10.1016/j.cell.2013.03.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.03.030</ArticleId><ArticleId IdType="pmc">PMC3677161</ArticleId><ArticleId IdType="pubmed">23622250</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Carney KE, Falgoust L, Pan JW, Sun D, Zhang Z. Emerging roles of Na(+)/H(+) exchangers in epilepsy and developmental brain disorders. Prog Neurobiol. 2016;138-140:19&#x2013;35. doi: 10.1016/j.pneurobio.2016.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2016.02.002</ArticleId><ArticleId IdType="pmc">PMC4852136</ArticleId><ArticleId IdType="pubmed">26965387</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao N, Liu CC, Van Ingelgom AJ, Martens YA, Linares C, Knight JA, Painter MM, Sullivan PM, Bu G. Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes. Neuron. 2017;96(1):115&#x2013;129.:e115. doi: 10.1016/j.neuron.2017.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.09.003</ArticleId><ArticleId IdType="pmc">PMC5621659</ArticleId><ArticleId IdType="pubmed">28957663</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Hayashi I, Wong J, Tugusheva K, Renger JJ, Zerbinatti C. Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer&#x2019;s disease. PLoS One. 2014;9(7):e103187. doi: 10.1371/journal.pone.0103187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0103187</ArticleId><ArticleId IdType="pmc">PMC4106906</ArticleId><ArticleId IdType="pubmed">25051234</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoncu R, Bar-Peled L, Efeyan A, Wang S, Sancak Y, Sabatini DM. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science. 2011;334(6056):678&#x2013;683. doi: 10.1126/science.1207056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1207056</ArticleId><ArticleId IdType="pmc">PMC3211112</ArticleId><ArticleId IdType="pubmed">22053050</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32684177</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-203X</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>International psychogeriatrics</Title><ISOAbbreviation>Int Psychogeriatr</ISOAbbreviation></Journal><ArticleTitle>A systematic review of the prevalence of depression, anxiety, and apathy in frontotemporal dementia, atypical and young-onset Alzheimer's disease, and inherited dementia.</ArticleTitle><Pagination><StartPage>457</StartPage><EndPage>476</EndPage><MedlinePgn>457-476</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S1041610220001118</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Depression, anxiety, and apathy are the most commonly reported neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD). Understanding their prevalence in rarer dementias such as frontotemporal dementia (FTD), primary progressive aphasia (PPA), posterior cortical atrophy (PCA), young-onset AD (YOAD), and inherited dementias has implications for both clinical practice and research. In this study, we aimed to examine the current state of knowledge of the prevalence of these three NPS in less prevalent dementias.</AbstractText><AbstractText Label="DESIGN">We conducted a systematic review based on searches of EMBASE, PsycINFO, and PubMed up to September 2019.</AbstractText><AbstractText Label="RESULTS">47 articles meeting inclusion criteria were identified. Depression, anxiety, and apathy were commonly reported across the phenotypes studied but their prevalence showed large variation between studies. Apathy showed the highest reported frequency in FTD (50-100% across studies), behavioral variant frontotemporal dementia (bvFTD) (73-100%), and YOAD (44-100%). Anxiety was frequently reported in FTD (0-100%) and bvFTD (19-63%). Depression showed the highest prevalence in FTD (7-69%) and YOAD (11-55%). Among the three variants of PPA, sv-PPA is the one most investigated (seven articles). Three or fewer articles were identified examining NPS in the remaining PPA variants, PCA, familial AD, and familial FTD. Inconsistency in the tools used to measure symptoms and small sample sizes were common methodological limitations.</AbstractText><AbstractText Label="CONCLUSIONS">Future studies should consider the inclusion of larger sample sizes (e.g. through multicenter collaborations) and the use of harmonized protocols that include the combination of caregiver and patient-derived measures and symptom-specific questionnaires. More research is needed on the phenotype-specific barriers and facilitators for people living with dementia to successfully engage in self-reports of NPS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Jessica D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henley</LastName><ForeName>Susie M D</ForeName><Initials>SMD</Initials><AffiliationInfo><Affiliation>Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su&#xe1;rez-Gonz&#xe1;lez</LastName><ForeName>Aida</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int Psychogeriatr</MedlineTA><NlmUniqueID>9007918</NlmUniqueID><ISSNLinking>1041-6102</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Int Psychogeriatr. 2023 Sep;35(9):449-452. doi: 10.1017/S1041610223000637</RefSource><PMID Version="1">37643743</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057565" MajorTopicYN="Y">Apathy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anxiety</Keyword><Keyword MajorTopicYN="N">apathy</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">early onset dementia</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32684177</ArticleId><ArticleId IdType="doi">10.1017/S1041610220001118</ArticleId><ArticleId IdType="pii">S1041610220001118</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32497369</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2702</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>15-16</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of clinical nursing</Title><ISOAbbreviation>J Clin Nurs</ISOAbbreviation></Journal><ArticleTitle>Aggressive behaviour of persons with dementia towards professional caregivers in the home care setting-A scoping review.</ArticleTitle><Pagination><StartPage>4541</StartPage><EndPage>4558</EndPage><MedlinePgn>4541-4558</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jocn.15363</ELocationID><Abstract><AbstractText Label="AIMS AND OBJECTIVES" NlmCategory="OBJECTIVE">To outline and to examine the current research and grey literature on aggressive incidents of persons with dementia towards professional caregivers in the home care setting. We intended to identify evidence and research gaps in this field.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Worldwide, around fifty million people are living with dementia. Current research indicates that aggressive behaviour of persons with dementia towards professional caregivers occurs frequently in inpatient settings. However, there has been little research on this phenomenon in the home care setting.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">The design entails a scoping review using the methodological framework of Arksey and O'Malley and PRISMA-ScR.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic literature search in five databases and a web search in Google Scholar was conducted. Title and abstract screening and a full-text screening were conducted by two independent authors. A free web search for grey literature was conducted in Google.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The search yielded 1,376 hits. A total of seven journal articles met the inclusion criteria. In the free web search, six references were identified for inclusion, resulting in a total of 13 references. We identified the following four themes: (1) aggressive behaviour in the context of dementia, (2) triggering factors of aggressive behaviour in persons with dementia, (3) skills and educational needs and (4) hindrances to solving the problem of aggressive behaviour.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is a lack of literature on aggressive behaviour of persons with dementia in the home care setting, and various hindrances to solving this problematic behaviour have been identified.</AbstractText><AbstractText Label="RELEVANCE TO CLINICAL PRACTICE" NlmCategory="CONCLUSIONS">For home caregivers, specific education concerning communication skills and responding to aggressive behaviour may help to deal with the situation. A further approach may involve specific training aimed to improve caregivers' confidence.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Journal of Clinical Nursing published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schnelli</LastName><ForeName>Angela</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0805-6247</Identifier><AffiliationInfo><Affiliation>Department of Nursing Science, University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health, Center for Dementia Care, Institute of Applied Nursing Sciences, St. Gallen University of Applied Sciences, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karrer</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nursing Science, University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health, Center for Dementia Care, Institute of Applied Nursing Sciences, St. Gallen University of Applied Sciences, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Nursing Science, University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeller</LastName><ForeName>Adelheid</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Health, Center for Dementia Care, Institute of Applied Nursing Sciences, St. Gallen University of Applied Sciences, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Foundation for Nursing Science Switzerland</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Clin Nurs</MedlineTA><NlmUniqueID>9207302</NlmUniqueID><ISSNLinking>0962-1067</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006699" MajorTopicYN="Y">Home Care Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000374" MajorTopicYN="N">Aggression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="N">Communication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aggression</Keyword><Keyword MajorTopicYN="N">Alzheimer's Disease</Keyword><Keyword MajorTopicYN="N">Community health nursing</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Home care services</Keyword><Keyword MajorTopicYN="N">Workplace violence</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32497369</ArticleId><ArticleId IdType="doi">10.1111/jocn.15363</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Algase, D. L., Beck, C., Kolanowski, A., Whall, A., Berent, S., Richards, K., &amp; Beattie, E. (1996). Need-driven dementia-compromised behavior: An alternative view of disruptive behavior. American Journal of Alzheimer's Disease and Other Dementias, 11(6), 10-19. https://doi.org/10.1177/153331759601100603</Citation></Reference><Reference><Citation>American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders: Dsm-5, 5th ed. Washington, DC: American Psychiatric Publ.</Citation></Reference><Reference><Citation>Arksey, H., &amp; O'Malley, L. (2005). Scoping studies: Towards a methodological framework. International Journal of Social Research Methodology, 8(1), 19-32. https://doi.org/10.1080/1364557032000119616</Citation></Reference><Reference><Citation>Barrick, Ann Louise (2008) Bathing without a battle. Person-directed care of individuals with dementia. 2nd ed. New York: Springer Pub (Springer series on geriatric nursing). Retrieved from http://site.ebrary.com/lib/academiccompletetitles/home.action.</Citation></Reference><Reference><Citation>Bundesamt f&#xfc;r Gesundheit (2018). Zahlen &amp; Fakten zu Demenz. Retrieved from https://www.bag.admin.ch/bag/de/home/zahlen-und-statistiken/zahlen-fakten-demenz.html.</Citation></Reference><Reference><Citation>Carter, D. (2016). Fix dementia care: Home Care. Alzheimer&#x2019;s Society. Retrieved from alzheimers.org.uk/fixdementiacare.</Citation></Reference><Reference><Citation>Choi, S. S. W., Budhathoki, C., &amp; Gitlin, L. N. (2017). Co-Occurrence and predictors of three commonly occurring behavioral symptoms in dementia: Agitation, aggression, and rejection of care. American Journal of Geriatric Psychiatry, 25(5), 459-468. https://doi.org/10.1016/j.jagp.2016.10.013</Citation></Reference><Reference><Citation>Cohen-Mansfield, J. (2013). Nonpharmacologic treatment of behavioral disorders in dementia. Current Treatment Options in Neurology, 15(6), 765-785. https://doi.org/10.1007/s11940-013-0257-2</Citation></Reference><Reference><Citation>Cohen-Mansfield, J., Marx, M. S., &amp; Rosenthal, A. S. (1989). A description of agitation in a nursing home. Journal of Gerontology, 44(3), M77-84. https://doi.org/10.1093/geronj/44.3.M77</Citation></Reference><Reference><Citation>Cooper, C., Selwood, A., Blanchard, M., &amp; Livingston, G. (2010). Abusive behaviour experienced by family carers from people with dementia: The CARD (caring for relatives with dementia) study. Journal of Neurology, Neurosurgery &amp; Psychiatry, 81(6), 592-596. https://doi.org/10.1136/jnnp.2009.190934</Citation></Reference><Reference><Citation>Edward, K.-L., Ousey, K., Warelow, P., &amp; Lui, S. (2014). Nursing and aggression in the workplace: A systematic review. British Journal of Nursing, 23(12), 653-654, 656-9 https://doi.org/10.12968/bjon.2014.23.12.653.</Citation></Reference><Reference><Citation>Fauth, E. B., &amp; Gibbons, A. (2014). Which behavioral and psychological symptoms of dementia are the most problematic? Variability by prevalence, intensity, distress ratings, and associations with caregiver depressive symptoms. International Journal of Geriatric Psychiatry, 29(3), 263-271. https://doi.org/10.1002/gps.4002</Citation></Reference><Reference><Citation>Fitzwater, E., &amp; Gates, D. (2000). Violence and home care. A focus group study. Home Healthcare Nurse, 18(9), 596-605. https://doi.org/10.1097/00004045-200010000-00012</Citation></Reference><Reference><Citation>Galinsky, T., Feng, H. A., Streit, J., Brightwell, W., Pierson, K., Parsons, K., &amp; Proctor, C. (2010). Risk factors associated with patient assaults of home healthcare workers. Rehabilitation Nursing, 35(5), 206-215. https://doi.org/10.1002/j.2048-7940.2010.tb00049.x</Citation></Reference><Reference><Citation>Hadjistavropoulos, T., Herr, K., Prkachin, K. M., Craig, K. D., Gibson, S. J., Lukas, A., &amp; Smith, J. H. (2014). Pain assessment in elderly adults with dementia. The Lancet Neurology, 13(12), 1216-1227. https://doi.org/10.1016/S1474-4422(14)70103-6</Citation></Reference><Reference><Citation>Hamel, M., Gold, D. P., Andres, D., Reis, M., Dastoor, D., Grauer, H., &amp; Bergman, H. (1990). Predictors and consequences of aggressive behavior by community-based dementia patients. The Gerontologist, 30(2), 206-211. https://doi.org/10.1093/geront/30.2.206</Citation></Reference><Reference><Citation>Heckemann, B., Zeller, A., Hahn, S., Dassen, T., Schols, J., &amp; Halfens, R. (2015). The effect of aggression management training programmes for nursing staff and students working in an acute hospital setting. A narrative review of current literature. Nurse Education Today, 35(1), 212-219. https://doi.org/10.1016/j.nedt.2014.08.003</Citation></Reference><Reference><Citation>Hedinger, B. (2015). Konzept Demenz: Pflege und Betreuung von Menschen mit Demenz und von Angeh&#xf6;rigen im h&#xe4;uslichen. Luzern: Umfeld.</Citation></Reference><Reference><Citation>James, I. A., Jackman, L., Reichelt, K., Howarth, A., Crooks, M., Sells, D., &amp; Hughes, J. (2017). Understanding behaviour in dementia that challenges, 2nd ed. London: Jessica Kingsley Publishers.</Citation></Reference><Reference><Citation>Kim, J., de Bellis, A. M., &amp; Xiao, L. D. (2018). The experience of paid family-care workers of people with dementia in South Korea. Asian Nursing Research, 12(1), 34-41. https://doi.org/10.1016/j.anr.2018.01.002</Citation></Reference><Reference><Citation>Magnavita, N. (2014). Workplace violence and occupational stress in healthcare workers: A chicken-and-egg situation-results of a 6-year follow-up study. Journal of Nursing Scholarship, 46(5), 366-376. https://doi.org/10.1111/jnu.12088</Citation></Reference><Reference><Citation>McGowan, J., Sampson, M., Salzwedel, D. M., Cogo, E., Foerster, V., &amp; Lefebvre, C. (2016). Press peer review of electronic search strategies: 2015 guideline statement. Journal of Clinical Epidemiology, 75, 40-46. https://doi.org/10.1016/j.jclinepi.2016.01.021</Citation></Reference><Reference><Citation>Meier, K. (2016). Mit Bedrohungen Aktiv Umgehen. Spitex Magazin, 3, 12-15.</Citation></Reference><Reference><Citation>M&#xfc;ller, S. (2017). Hochprofessionelle Mitarbeitende sind unverzichtbar, aber nicht kostenlos zu haben. Spitex Magazin, 1, 18-20.</Citation></Reference><Reference><Citation>Nakaishi, L., Moss, H., Weinstein, M., Perrin, N., Rose, L., Anger, W. K., &#x2026; Glass, N. (2013). Exploring workplace violence among home care workers in a consumer-driven Home Health Care Program. Workplace Health and Safety, 61(10), 441-450. https://doi.org/10.3928/21650799-20130916-17</Citation></Reference><Reference><Citation>Nakanishi, M., Endo, K., Hirooka, K., Granvik, E., Minthon, L., N&#xe4;gga, K., &amp; Nishida, A. (2018). Psychosocial behaviour management programme for home-dwelling people with dementia: A cluster-randomized controlled trial. International Journal of Geriatric Psychiatry, 33(3), 495-503. https://doi.org/10.1002/gps.4784</Citation></Reference><Reference><Citation>Nakanishi, M., Endo, K., Hirooka, K., Nakashima, T., Morimoto, Y., Granvik, E., &#x2026; Nishida, A. (2018). Dementia behaviour management programme at home: Impact of a palliative care approach on care managers and professional caregivers of home care services. Aging &amp; Mental Health, 22(8), 1057-1062. https://doi.org/10.1080/13607863.2017.1332160</Citation></Reference><Reference><Citation>Nakanishi, M., Hirooka, K., Imai, Y., Inoue, S., Yukari, Y., Katayama, C., &#x2026; Nishida, A. (2018). Dementia care competence among care professionals and reduced challenging behavior of home-dwelling persons with dementia: A pre- and post-intervention data analysis. Journal of Alzheimer&#x2019;s Disease, 64(2), 515-523. https://doi.org/10.3233/JAD-171077</Citation></Reference><Reference><Citation>Needham, I., Abderhalden, C., Halfens, R. J. G., Fischer, J. E., &amp; Dassen, T. (2005). Non-somatic effects of patient aggression on nurses: A systematic review. Journal of Advanced Nursing, 49(3), 283-296. https://doi.org/10.1111/j.1365-2648.2004.03286.x</Citation></Reference><Reference><Citation>Patterson, C. (2018). World Alzheimer Report 2018: The state of the art of dementia research: New frontiers. London: Retrieved from. https://www.alz.co.uk/research/WorldAlzheimerReport2018.pdf.</Citation></Reference><Reference><Citation>Pool, J. (2015). Alzheimer's Society guide to the dementia care environment. London: Alzheimer's Society.</Citation></Reference><Reference><Citation>Rabold, S., &amp; Goergen, T. (2007). Abuse and neglect of older care recipients in domestic settings - a survey among nurses of in-home care services. Zeitschrift F&#xfc;r Gerontologie Und Geriatrie, 40(5), 366-374. https://doi.org/10.1007/s00391-007-0447-1</Citation></Reference><Reference><Citation>Richter, D., &amp; Berger, K. (2001). Patienten&#xfc;bergriffe auf Mitarbeiter. Eine prospektive Untersuchung der H&#xe4;ufigkeit, Situationen und Folgen. Der Nervenarzt, 72(9), 693-699. https://doi.org/10.1007/s001150170048</Citation></Reference><Reference><Citation>Roberts, J. (2012). Dementia and challenging behaviour guidance for home care staff. Retrieved from https://www.communitycare.co.uk/2012/08/29/dementia-and-challenging-behaviour-guidance-for-home-care-staff/.</Citation></Reference><Reference><Citation>Schneider, F. (2017). Facharztwissen Psychiatrie, Psychosomatik und Psychotherapie. Berlin, Heidelberg: Springer, Berlin Heidelberg. https://doi.org/10.1007/978-3-662-50345-4</Citation></Reference><Reference><Citation>State of Minnesota, Office of the Revisor of Statutes (2018). Minnesota Legislature. Orientation and annual training requirements.</Citation></Reference><Reference><Citation>Steinert, T. (1995). Aggression bei psychisch Kranken: 5 Tabellen. Stuttgart: Enke.</Citation></Reference><Reference><Citation>Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., &#x2026; Straus, S. E. (2018). Prisma extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169(7), 467-473. https://doi.org/10.7326/M18-0850</Citation></Reference><Reference><Citation>Zeh, A., Schablon, A., Wohlert, C., Richter, D., &amp; Nienhaus, A. (2009). Gewalt und Aggression in Pflege- und Betreuungsberufen. Ein Literatur&#xfc;berblick [Violence and aggression in care-related jobs - a literature overview]. Gesundheitswesen (Bundesverband Der &#xc4;rzte Des &#xd6;ffentlichen Gesundheitsdienstes [Germany]), 71(8-9), 449-459. https://doi.org/10.1055/s-0029-1192027</Citation></Reference><Reference><Citation>Zeller, A., Needham, I., Dassen, T., Kok, G., &amp; Halfens, R. J. G. (2013). Erfahrungen und Umgang der Pflegenden mit aggressivem Verhalten von Bewohner(inne)n: Eine deskriptive Querschnittstudie in Schweizer Pflegeheimen [Nurses' experiences with aggressive behaviour of nursing home residents: A cross sectional study in Swiss nursing homes]. Pflege, 26(5), 321-335. https://doi.org/10.1024/1012-5302/a000316</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32434925</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2045-4368</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>BMJ supportive &amp; palliative care</Title><ISOAbbreviation>BMJ Support Palliat Care</ISOAbbreviation></Journal><ArticleTitle>Integrated palliative homecare in advanced dementia: reduced healthcare utilisation and costs.</ArticleTitle><Pagination><StartPage>77</StartPage><EndPage>85</EndPage><MedlinePgn>77-85</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjspcare-2019-002145</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine the economic benefit of an integrated home-based palliative care programme for advanced dementia (Programme Dignity), evaluation is required. This study aimed to estimate Programme Dignity's average monthly cost from a provider's perspective; and compare healthcare utilisation and costs of programme patients with controls, accounting for enrolment duration.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a retrospective cohort study. Home-dwelling patients with advanced dementia (stage 7 on the functional assessment staging in Alzheimer's disease) with a history of pneumonia, albumin &lt;35&#x2009;g/L or tube-feeding and known to be deceased were analysed (Programme Dignity=184, controls=139). One-year programme operational costs were apportioned on a per patient-month basis. Cumulative healthcare utilisation and costs were examined at 1, 3 and 6&#x2009;months look-back from death. Between-group comparisons used Poisson, zero-inflated Poisson regressions and generalised linear models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The average monthly programme cost was SGD$1311 (SGD-Pounds exchange rate: 0.481) per patient. Fully enrolled programme patients were less likely to visit the emergency department (incidence rate ratios (IRRs): 1 month=0.56; 3 months=0.19; 6 months=0.10; all p&lt;0.001), be admitted to hospital (IRRs: 1 month=0.60; 3 months=0.19; 6 months=0.15; all p&lt;0.001), had a lower cumulative length of stay (IRRs: 1 month=0.78; 3 months=0.49; 6 months=0.24; all p&lt;0.001) and incurred lesser healthcare utilisation costs (&#x3b2;-coefficients: 1 month=0.70; 3 months=0.40; 6 months=0.43; all p&lt;0.01) at all time-points examined.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Programme Dignity for advanced dementia reduces healthcare utilisation and costs. If scalable, it may benefit more patients wishing to remain at home at the end-of-life, allowing for a potentially sustainable care model to cope with rapid population ageing. It contributes to the evidence base of advanced dementia palliative care and informs healthcare policy making. Future studies should estimate informal caregiving costs for comprehensive economic evaluation.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Michelle Jessica</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Health Services and Outcomes Research, National Healthcare Group, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tay</LastName><ForeName>Ri Yin</ForeName><Initials>RY</Initials><Identifier Source="ORCID">0000-0002-2180-2489</Identifier><AffiliationInfo><Affiliation>Research, Dover Park Hospice, Singapore riyin_tay@doverpark.sg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Palliative Care Centre for Excellence in Research and Education, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Woan Shin</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Health Services and Outcomes Research, National Healthcare Group, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Palliative Care Centre for Excellence in Research and Education, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molina</LastName><ForeName>Joseph Antonio De Castro</ForeName><Initials>JAC</Initials><AffiliationInfo><Affiliation>Health Services and Outcomes Research, National Healthcare Group, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Noorhazlina Binte</ForeName><Initials>NB</Initials><AffiliationInfo><Affiliation>Geriatric Medicine, Tan Tock Seng Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leong</LastName><ForeName>Ian Yi Onn</ForeName><Initials>IYO</Initials><AffiliationInfo><Affiliation>Integrative and Community Care, Tan Tock Seng Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Huei Yaw</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Palliative Care Centre for Excellence in Research and Education, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Palliative Medicine, Tan Tock Seng Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chin</LastName><ForeName>Jing Jih</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Geriatric Medicine, Tan Tock Seng Hospital, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Integrative and Community Care, Tan Tock Seng Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Angel Onn Kei</ForeName><Initials>AOK</Initials><AffiliationInfo><Affiliation>Palliative Medicine, St. Andrew's Community Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koh</LastName><ForeName>Mervyn Yong Hwang</ForeName><Initials>MYH</Initials><AffiliationInfo><Affiliation>Palliative Care Centre for Excellence in Research and Education, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Palliative Medicine, Tan Tock Seng Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hum</LastName><ForeName>Allyn Y M</ForeName><Initials>AYM</Initials><AffiliationInfo><Affiliation>Palliative Care Centre for Excellence in Research and Education, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Palliative Medicine, Tan Tock Seng Hospital, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Support Palliat Care</MedlineTA><NlmUniqueID>101565123</NlmUniqueID><ISSNLinking>2045-435X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006699" MajorTopicYN="Y">Home Care Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010166" MajorTopicYN="N">Palliative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">home care</Keyword><Keyword MajorTopicYN="N">neurological conditions</Keyword><Keyword MajorTopicYN="N">service evaluation</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32434925</ArticleId><ArticleId IdType="doi">10.1136/bmjspcare-2019-002145</ArticleId><ArticleId IdType="pii">bmjspcare-2019-002145</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32405541</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2399-5300</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Innovation in aging</Title><ISOAbbreviation>Innov Aging</ISOAbbreviation></Journal><ArticleTitle>The Public Health Road Map to Respond to the Growing Dementia Crisis.</ArticleTitle><Pagination><StartPage>igz043</StartPage><MedlinePgn>igz043</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">igz043</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/geroni/igz043</ELocationID><Abstract><AbstractText>As the proportion of older adults in the United States is projected to increase dramatically in the coming decades, it is imperative that public health address and maintain the cognitive health of this growing population. More than 5 million Americans live with Alzheimer's disease and related dementias (ADRD) today, and this number is projected to more than double by 2050. The public health community must be proactive in outlining the response to this growing crisis. Promoting cognitive decline risk reduction, early detection and diagnosis, and increasing the use and availability of timely data are critical components of this response. To prepare state, local, and tribal organizations, CDC and the Alzheimer's Association have developed a series of Road Maps that chart the public health response to dementia. Since the initial Healthy Brain Initiative (HBI) Road Map release in 2007, the Road Map has undergone two new iterations, with the most recent version, The HBI's <i>State and Local Public Health Partnerships to Address Dementia: The 2018-2023 Road Map</i>, released in late 2018. Over the past several years, significant advances were made in the science of risk reduction and early detection of ADRD. As a result, the public health response requires a life-course approach that focuses on reducing risk and identifying memory issues earlier to improve health outcomes. The most recent Road Map was revised to accommodate these strides in the science and to effect change at the policy, systems, and environment levels. The 2018-2023 Road Map identifies 25 actions that state and local public health agencies and their partners can implement to promote cognitive health and address cognitive impairment and the needs of caregivers. The actions are categorized into four traditional domains of public health, and the Road Map can help public health and its partners chart a course for a dementia-prepared future.</AbstractText><CopyrightInformation>Published by Oxford University Press on behalf of The Gerontological Society of America 2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Olivari</LastName><ForeName>Benjamin S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>French</LastName><ForeName>Molly E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Alzheimer's Association, Washington, DC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGuire</LastName><ForeName>Lisa C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Innov Aging</MedlineTA><NlmUniqueID>101703706</NlmUniqueID><ISSNLinking>2399-5300</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aging</Keyword><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Brain health</Keyword><Keyword MajorTopicYN="N">Caregiving</Keyword><Keyword MajorTopicYN="N">Chronic conditions</Keyword><Keyword MajorTopicYN="N">Cognitive decline</Keyword><Keyword MajorTopicYN="N">Comorbidities</Keyword><Keyword MajorTopicYN="N">Health policy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32405541</ArticleId><ArticleId IdType="pmc">PMC7207259</ArticleId><ArticleId IdType="doi">10.1093/geroni/igz043</ArticleId><ArticleId IdType="pii">igz043</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anderson LA, Egge R. Expanding efforts to address Alzheimer's disease: the Healthy Brain Initiative. Alzheimers Dement. 2014;10(suppl 5):S453&#x2013;S456. doi:10.1016/j.jalz.2014.05.1748</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2014.05.1748</ArticleId><ArticleId IdType="pmc">PMC4443789</ArticleId><ArticleId IdType="pubmed">25088658</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson LA, McConnell SR. Cognitive health: an emerging public health issue. Alzheimers Dement. 2007;3(S2):3&#x2013;4. doi:10.1016/j.jalz.2007.01.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2007.01.018</ArticleId><ArticleId IdType="pubmed">19595979</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ortman JM, Velkoff VA, Hogan H; US Department of Commerce, Census Bureau 
An aging nation: the older population in the United States, population estimates and projections
https://www.census.gov/prod/2014pubs/p25-1140.pdf. 2014.  Accessed February 4, 2019.</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Association. 2019 Alzheimer's disease facts and figures. Alzheimers Dement. 2019;15(3):321&#x2013;387. doi:10.1016/j.jalz.2019.01.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.01.010</ArticleId><ArticleId IdType="pubmed">19426951</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute on Aging. Alzheimer&#x2019;s and related dementias
NIA Web site; 
https://www.nia.nih.gov/health/alzheimers/related-dementias. Accessed August 14, 2019.</Citation></Reference><Reference><Citation>
Heron M.
Deaths: Leading causes for 2016. Natl Vital Stat Rep. 2018;67(6):1&#x2013;77. https://www.cdc.gov/nchs/data/nvsr/nvsr67/nvsr67_06.pdf. Accessed June 4, 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">30248017</ArticleId></ArticleIdList></Reference><Reference><Citation>
Kramarow EA, Tejada-Vera B. 
Dementia mortality in the United States, 2000&#x2013;2017. Natl Vital Stat Rep. 2019;68(2):1&#x2013;29. https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_02-508.pdf. Accessed April 30, 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">31112120</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor CA, Greenlund SF, McGuire LC, Lu H, Croft JB. Deaths from Alzheimer&#x2019;s disease&#x2014;United States, 1999&#x2013;2014. MMWR Morb Mortal Wkly Rep. 2017;66:521&#x2013;526. doi:10.15585/mmwr.mm6620a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6620a1.</ArticleId><ArticleId IdType="pmc">PMC5657871</ArticleId><ArticleId IdType="pubmed">28542120</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010&#x2013;2050) estimated using the 2010 census. Neurology. 2013;80(19):1778&#x2013;1783. doi:10.1212/WNL.0b013e31828726f5</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31828726f5</ArticleId><ArticleId IdType="pmc">PMC3719424</ArticleId><ArticleId IdType="pubmed">23390181</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews KA, Xu W, Gaglioti AH, et al. . Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015&#x2013;2060) in adults aged &#x2265;65 years. Alzheimers Dement. 2019;15(1):17&#x2013;24. doi:10.1016/j.jalz.2018.06.3063</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.06.3063</ArticleId><ArticleId IdType="pmc">PMC6333531</ArticleId><ArticleId IdType="pubmed">30243772</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivari BS, Baumgart M, Lock SL, et al. . CDC Grand Rounds: promoting well-being and independence in older adults. MMWR Morb Mortal Wkly Rep. 2018;67:1036&#x2013;1039. doi:10.15585/mmwr.mm6737a4</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6737a4</ArticleId><ArticleId IdType="pmc">PMC6147419</ArticleId><ArticleId IdType="pubmed">30235185</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Alliance for Caregiving; AARP Public Policy Institute. Caregiving in the U.S.https://www.caregiving.org/caregiving2015. 2015.  Accessed March 15, 2019.</Citation></Reference><Reference><Citation>Taylor CA, Bouldin ED, McGuire LC. Subjective cognitive decline among adults aged &#x2265;45 years&#x2014;United States, 2015&#x2013;2016. MMWR Morb Mortal Wkly Rep. 2018;67:753&#x2013;757. doi:10.15585/mmwr.mm6727a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6727a1</ArticleId><ArticleId IdType="pmc">PMC6047468</ArticleId><ArticleId IdType="pubmed">30001562</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessen F, Amariglio RE, van Boxtel M, et al. . A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer&#x2019;s disease. Alzheimers Dement. 2014;10(6):844&#x2013;852. doi:10.1016/j.jalz.2014.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2014.01.001</ArticleId><ArticleId IdType="pmc">PMC4317324</ArticleId><ArticleId IdType="pubmed">24798886</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine. Cognitive Aging: Progress in Understanding and Opportunities for Action. Washington, DC: National Academies Press; 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">25879131</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement. 2015;11:718&#x2013;726. doi:10.1016/j.jalz.2015.05.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2015.05.016</ArticleId><ArticleId IdType="pubmed">26045020</ArticleId></ArticleIdList></Reference><Reference><Citation>The SPRINT MIND Investigators for the SPRINT Research Group. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA. 2019;321(6):553&#x2013;561. doi:10.1001/jama.2018.21442</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.21442</ArticleId><ArticleId IdType="pmc">PMC6439590</ArticleId><ArticleId IdType="pubmed">30688979</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston G, Sommerlad A, Orgeta V, et al. . Dementia prevention, intervention and care. Lancet. 2017;390(10113):2673&#x2013;2734. doi:10.1016/S0140-6736(17)31363&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">28735855</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford A, Kunik ME, Schulz P, Williams SP, Singh H. Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors. Alzheimer Dis Assoc Disord. 2009;23(4):306&#x2013;314. doi:10.1097/WAD.0b013e3181a6bebc</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0b013e3181a6bebc</ArticleId><ArticleId IdType="pmc">PMC2787842</ArticleId><ArticleId IdType="pubmed">19568149</ArticleId></ArticleIdList></Reference><Reference><Citation>Chodosh J, Petitti DB, Elliott M, et al. . Physician recognition of cognitive impairment: evaluating the need for improvement. J Am Geriatr Soc. 2004;52(7):1051&#x2013;1059. doi:10.1111/j.1532-5415.2004.52301.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2004.52301.x</ArticleId><ArticleId IdType="pubmed">15209641</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner P, Karnieli-Miller O, Eidelman C. Current knowledge and future directions about the disclosure of dementia: a systematic review of the first decade of the 21st Century. Alzheimers Dement. 2013;9(2):e74&#x2013;88. doi:10.1016/j.jalz.2012.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2012.02.006</ArticleId><ArticleId IdType="pubmed">23098912</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Association and Centers for Disease Control and Prevention (CDC). Healthy Brain Initiative, State and Local Public Health Partnerships to Address Dementia: The 2018&#x2013;2023 Road Map. Chicago, IL: Alzheimer&#x2019;s Association; 2018.</Citation></Reference><Reference><Citation>Institute of Medicine. The Future of Public Health. Washington DC: National Academies Press; 1988.</Citation></Reference><Reference><Citation>Institute of Medicine. The Future of the Public's Health in the 21st Century. Washington, DC: National Academies Press; 2003.</Citation></Reference><Reference><Citation>Harrell JA, Baker EL. The essential services of public health. Leadership Public Health. 1994;3(3):27&#x2013;30.</Citation></Reference><Reference><Citation>
Centers for Disease Control and Prevention (CDC). National Public Health Performance Standards Program (NPHPSP): 10 essential public health services
CDC Web site; 
https://www.cdc.gov/nphpsp/essentialservices.html. 2018..  Accessed May 6, 2019.</Citation></Reference><Reference><Citation>Baker EL, Melton RJ, Stange PV, et al. . Health reform and the health of the public: forging community health partnerships. JAMA. 1994;272(16):1276&#x2013;1282. doi:10.1001/jama.1994.03520160060044</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1994.03520160060044</ArticleId><ArticleId IdType="pubmed">7772104</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Prevention Council; Office of the Surgeon General. Elimination of health disparities
https://www.improvingpopulationhealth.org/Action%20Plan.pdf. 2012.  Accessed August 14, 2019.</Citation></Reference><Reference><Citation>
Lavizzo-Mourey R; Robert Wood Johnson Foundation 
In it together-building a culture of health.https://www.rwjf.org/en/library/annual-reports/presidents-message-2015.html. 2015.  Accessed May 10, 2019.</Citation></Reference><Reference><Citation>
Alzheimer&#x2019;s Association. Public health &#x2013; state overview
Alzheimer&#x2019;s Association Web site; 
https://www.alz.org/professionals/public-health/state-overview. Accessed August 5, 2019.</Citation></Reference><Reference><Citation>Institute of Medicine. Retooling for an Aging America: Building the Health Care Workforce. Washington, DC: National Academies Press; 2008.</Citation><ArticleIdList><ArticleId IdType="pubmed">25009893</ArticleId></ArticleIdList></Reference><Reference><Citation>
Moore MJ, Moir P, Patrick MM; The Merck Institute of Aging and Health 
The state of aging and health in America: 2004
https://www.cdc.gov/aging/pdf/State_of_Aging_and_Health_in_America_2004.pdf. 2004.  Accessed March 2019.</Citation></Reference><Reference><Citation>
Alzheimer&#x2019;s Association. Public health curriculum
Alzheimer&#x2019;s Association Web site; 
https://www.alz.org/professionals/public-health/core-areas/educate-train-professionals/public-health-curriculum-on-alzheimer-s. Accessed December 6, 2019.</Citation></Reference><Reference><Citation>Odenheimer G, Borson S, Sanders AE, et al. . Quality improvement in neurology: dementia management quality measures. Neurology. 2013;81(17):1545&#x2013;1549. doi:10.1212/WNL.0b013e3182a956bf</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182a956bf</ArticleId><ArticleId IdType="pmc">PMC3888169</ArticleId><ArticleId IdType="pubmed">24068786</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordell CB, Borson S, Boustani M, et al. . Medicare Detection of Cognitive Impairment Workgroup. Alzheimer&#x2019;s Association recommendations for operationalizing the detection of cognitive impairment during the Medicare annual wellness visit in a primary care setting. Alzheimers Dement. 2013;9(2):141&#x2013;150. doi:10.1016/j.jalz.2012.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2012.09.011</ArticleId><ArticleId IdType="pubmed">23265826</ArticleId></ArticleIdList></Reference><Reference><Citation>
Alzheimer&#x2019;s Association Expert Task Force. Cognitive assessment and care planning services: Alzheimer&#x2019;s Association Expert Task Force recommendations and tools for implementation.Alzheimer&#x2019;s Association Web site; 
https://www.alz.org/careplanning/downloads/cms-consensus.pdf. 2018.  Accessed April 8, 2019.</Citation></Reference><Reference><Citation>
Agency for Healthcare Research and Quality (AHRQ). Physician practices use software-facilitated system to complete Medicare Annual Wellness Visit, improving preventive care and generating high satisfaction
AHRQ Web site; 
https://innovations.ahrq.gov/profiles/physician-practices-use-software-facilitated-system-complete-medicare-annual-wellness-visitExternal. 2014.  Accessed May 6, 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">18677259</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganguli I, Souza J, McWilliams JM, Mehrotra A. Trends in use of the US Medicare Annual Wellness Visit, 2011&#x2013;2014. JAMA. 2017;317:2233&#x2013;5. doi:10.1001/jama.2017.4342</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.4342</ArticleId><ArticleId IdType="pmc">PMC5815054</ArticleId><ArticleId IdType="pubmed">28423397</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitwood T. Dementia Reconsidered: The Person Comes First. Buckingham, UK: Open University Press; 1997.</Citation></Reference><Reference><Citation>Fazio S, Pace D, Maslow K, Zimmerman S, Kallmyer B. Alzheimer's Association dementia care practice recommendations. Gerontologist. 2018;58(suppl 1):S1&#x2013;S9. doi:10.1093/geront/gny003</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gny003</ArticleId><ArticleId IdType="pubmed">29361074</ArticleId></ArticleIdList></Reference><Reference><Citation>
American College of Preventive Medicine (ACPM). Brain health course
ACPM Web site; 
https://www.acpm.org/page/brainhealthcourse. 2019.  Accessed January 7, 2019.</Citation></Reference><Reference><Citation>
US Department of Health and Human Services. Healthy people 2030
Healthy People Web site; 
https://www.healthypeople.gov/sites/default/files/ObjectivesPublicComment508_1.17.19.pdf. 2018.  Accessed May 7, 2019.</Citation></Reference><Reference><Citation>
Gerontological Society of America (GSA). Cognitive impairment detection and earlier diagnosis
GSA Web site; 
https://www.geron.org/programs-services/alliances-and-multi-stakeholder-collaborations/cognitive-impairment-detection-and-earlier-diagnosisExternal. 2014..  Accessed April 13, 2019.</Citation></Reference><Reference><Citation>
BRFSS Web site
http://www.cdc.gov/brfss. Accessed August 14, 2019.</Citation></Reference><Reference><Citation>
Centers for Disease Control and Prevention (CDC) and National Association of Chronic Disease Directors (NACDD). The State of Aging in America: data briefs
CDC Web site; 
https://www.cdc.gov/aging/agingdata/data-portal/state-aging-health.html. 2019.  Accessed August 14, 2019.</Citation></Reference><Reference><Citation>
Centers for Disease Control and Prevention (CDC). Alzheimer&#x2019;s Disease and Healthy Aging Data Portal
CDC Web site; 
https://www.cdc.gov/aging/agingdata/index.html. 2019..  Accessed August 2, 2019.</Citation></Reference><Reference><Citation>Mayeda E, Glymour M, Quesenberry C, Whitmer R. Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Alzheimers Dement. 2016;12(3):216&#x2013;224. doi:10.1016/j.jalz.2015.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2015.12.007</ArticleId><ArticleId IdType="pmc">PMC4969071</ArticleId><ArticleId IdType="pubmed">26874595</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Association and Centers for Disease Control and Prevention (CDC). Healthy Brain Initiative, Road Map for Indian Country. Chicago, IL: Alzheimer&#x2019;s Association; 2019.</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Association. 2018 Alzheimer&#x2019;s disease facts and figures. Alzheimers Dement. 2018;14:367&#x2013;429. doi:10.1016/j.jalz.2018.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.02.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlawish J, Jack CR Jr, Rocca WA, Snyder HM, Carrillo MC. Alzheimer&#x2019;s disease: the next frontier-Special Report 2017. Alzheimers Dement. 2017;13(4):374&#x2013;380. doi:10.1016/j.jalz.2017.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2017.02.006</ArticleId><ArticleId IdType="pubmed">28314660</ArticleId></ArticleIdList></Reference><Reference><Citation>
United States Congress. The Building Our Largest Dementia Infrastructure (BOLD) Act
https://www.congress.gov/bill/115th-congress/senate-bill/2076. 2018.  Accessed April 23, 2019.</Citation></Reference><Reference><Citation>Meyer H. A new paradigm slashes hospital use and nursing home stays for the elderly and the physically and mentally disabled. Health Aff. 2011;30(3):412&#x2013;415. doi:10.1377/hlthaff.2011.0113</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2011.0113</ArticleId><ArticleId IdType="pubmed">21383354</ArticleId></ArticleIdList></Reference><Reference><Citation>
Meyers D, Peikes D, Genevro J, et al. . 
The roles of patient-centered medical homes and accountable care organizations in coordinating patient care
Agency for Healthcare Research and Quality (AHRQ) white paper 11-M005-EF; 
https://pcmh.ahrq.gov/sites/default/files/attachments/Roles%20of%20PCMHs%20And%20ACOs%20in%20Coordinating%20Patient%20Care.pdf. 2010.  Accessed August 14, 2019.</Citation></Reference><Reference><Citation>
Rich E, Lipson D, Libersky J, Parchman M. 
Coordinating care for adults with complex care needs in the patient-centered medical home: challenges and solutions
Agency for Healthcare Research and Quality (AHRQ) white paper 12-0010-EF; 
https://pcmh.ahrq.gov/sites/default/files/attachments/coordinating-care-for-adults-with-complex-care-needs-white-paper.pdf. 2012.  Accessed August 14, 2019</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32274979</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1545-2301</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Clinical gerontologist</Title><ISOAbbreviation>Clin Gerontol</ISOAbbreviation></Journal><ArticleTitle>Race and Personal Exposure to AD Influence Projected Memory Failure Attributions and Help-Seeking Behaviors.</ArticleTitle><Pagination><StartPage>53</StartPage><EndPage>65</EndPage><MedlinePgn>53-65</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/07317115.2020.1751765</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Examine race and personal exposure to Alzheimer's Disease (AD) on projected memory failure attributions and medical help-seeking thresholds of pre-morbid adults. The goal is to better understand race discrepancies in help-seeking for those potentially at risk for early-onset AD.</AbstractText><AbstractText Label="METHODS">498 adults aged 40 to 65 (<i>M&#xa0;</i>=&#xa0;52.27), screened for current memory failure, completed an online questionnaire exploring their help-seeking intentions and threshold, attributions of hypothetical memory failures, and level of AD concern.</AbstractText><AbstractText Label="RESULTS">Non-Hispanic Whites (<i>n&#xa0;</i>=&#xa0;248) were significantly more concerned about AD than African Americans (<i>n&#xa0;</i>=&#xa0;250) (<i>p&#xa0;</i>=.027). Personal exposure to AD moderated the impact of race on memory failure attributions (<i>p&#xa0;</i>=.036), so that personal exposure was more influential for African Americans. Those who were more likely to attribute hypothetical memory failures to AD had lower projected thresholds for seeking a medical evaluation (<i>p&#xa0;</i>=.010). Memory failure attribution emerged as a potential mediator of the impact of race on projected help-seeking behaviors (<i>p&#xa0;</i>=.057).</AbstractText><AbstractText Label="CONCLUSIONS">African Americans were more influenced by personal experience when considering the causes of hypothetical memory failures.</AbstractText><AbstractText Label="CLINICAL IMPLICATIONS">Healthcare providers should emphasize to African American families the value of early AD detection and treatment in terms of quality of life for both patient and caregiver.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>Marisa S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-4732-2192</Identifier><AffiliationInfo><Affiliation>Department of Behavioral Sciences, University of Michigan-Dearborn, Dearborn, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitehead</LastName><ForeName>Brenda R</ForeName><Initials>BR</Initials><Identifier Source="ORCID">0000-0002-8383-6537</Identifier><AffiliationInfo><Affiliation>Department of Behavioral Sciences, University of Michigan-Dearborn, Dearborn, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howells Wrobel</LastName><ForeName>Nancy</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Behavioral Sciences, University of Michigan-Dearborn, Dearborn, Michigan, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Gerontol</MedlineTA><NlmUniqueID>8300869</NlmUniqueID><ISSNLinking>0731-7115</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000066505" MajorTopicYN="Y">Help-Seeking Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044465" MajorTopicYN="N">White People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001741" MajorTopicYN="N">Black or African American</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">aging</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">help-seeking behavior</Keyword><Keyword MajorTopicYN="N">memory failure attribution</Keyword><Keyword MajorTopicYN="N">older adults</Keyword><Keyword MajorTopicYN="N">racial disparities</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32274979</ArticleId><ArticleId IdType="doi">10.1080/07317115.2020.1751765</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31945246</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2702</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>11-12</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of clinical nursing</Title><ISOAbbreviation>J Clin Nurs</ISOAbbreviation></Journal><ArticleTitle>Oral care practices of long-term care home residents and caregivers: Secondary analysis of observational video recordings.</ArticleTitle><Pagination><StartPage>2023</StartPage><EndPage>2030</EndPage><MedlinePgn>2023-2030</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jocn.15187</ELocationID><Abstract><AbstractText Label="AIMS AND OBJECTIVES" NlmCategory="OBJECTIVE">To describe the proportion of toothbrushing task steps, long-term care residents had an opportunity to complete; the duration and quality of toothbrushing by both residents and caregivers; and the feedback caregivers provided.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Poor oral health is widespread among older adults in long-term care homes; however, little is known about their actual oral health practices.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Secondary analysis of video recordings.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 58 video-recorded sessions were analysed from two long-term care homes in Canada. Eligible residents had at least one natural tooth, required oral care assistance, had Alzheimer's disease and understood English. Eligible caregivers spoke English and had worked for at least 1&#xa0;year with people with dementia. Toothbrushing success was identified by the resident's participation in, and completion of, nine toothbrushing steps. Total time spent brushing teeth was calculated by summing the duration of time spent brushing teeth. Quality was described by time spent brushing the facial versus the lingual or occlusal surfaces. Caregiver verbal feedback was pulled from transcripts and analysed using content analysis. STROBE guidelines were used in reporting this study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The two step residents most frequently completed or attempted were brushing their teeth (77% complete, 7% attempt) and rinsing their mouth (86% complete, 2% attempt). The average time spent brushing teeth was 60.33&#xa0;s (SD&#xa0;=&#xa0;35.15). In 66% of observed videos, toothbrushing occurred only on the facial tooth surfaces, with no time spent brushing the lingual or occlusal surfaces.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Caregivers are supporting residents to independently complete toothbrushing; however, the duration and quality of toothbrushing are not sufficient to ensure optimal oral health.</AbstractText><AbstractText Label="RELEVANCE TO CLINICAL PRACTICE" NlmCategory="CONCLUSIONS">Clear, detailed guidelines are required to ensure adequate oral care for long-term care residents. Staff need to be aware that all surfaces should be brushed to ensure proper oral health.</AbstractText><CopyrightInformation>&#xa9; 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Minn N</ForeName><Initials>MN</Initials><Identifier Source="ORCID">0000-0002-1949-793X</Identifier><AffiliationInfo><Affiliation>School of Dentistry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ickert</LastName><ForeName>Carla</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-1238-094X</Identifier><AffiliationInfo><Affiliation>School of Dentistry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Rozanne</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7845-0704</Identifier><AffiliationInfo><Affiliation>Department of Speech-Language Pathology, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mihailidis</LastName><ForeName>Alex</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2233-0919</Identifier><AffiliationInfo><Affiliation>Department of Occupational Science &amp; Occupational Therapy, Institute of Biomaterials &amp; Biomedical Engineering, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rochon</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-5521-0513</Identifier><AffiliationInfo><Affiliation>Department of Speech-Language Pathology, Rehabilitation Sciences Institute, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Doctoral Research Training Award</GrantID><Agency>Alzheimer Society</Agency><Country/></Grant><Grant><GrantID>Everyday Technologies for Alzheimer Care (ETAC) Gr</GrantID><Agency>American Alzheimer Association</Agency><Country/></Grant><Grant><GrantID>STIHR Fellowship in Health Care, Technology, and P</GrantID><Acronym>CAPMC</Acronym><Agency> CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>STIHR Fellowship in Health Care, Technology, and P</GrantID><Acronym>CAPMC</Acronym><Agency> CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Clin Nurs</MedlineTA><NlmUniqueID>9207302</NlmUniqueID><ISSNLinking>0962-1067</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008134" MajorTopicYN="N">Long-Term Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009909" MajorTopicYN="N">Oral Health</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014099" MajorTopicYN="N">Toothbrushing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014741" MajorTopicYN="N">Video Recording</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">care activities</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">long-term care</Keyword><Keyword MajorTopicYN="N">oral care</Keyword><Keyword MajorTopicYN="N">toothbrushing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31945246</ArticleId><ArticleId IdType="doi">10.1111/jocn.15187</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Alzheimer&#x2019;s Disease International. (2015). World Alzheimer report 2015: The global impact of dementia. An analysis of prevalence, incidence, cost and trends. Retrieved from: https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf.</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Society of Canada (2010). Rising tide: The impact of dementia on Canadian society. Retrieved from: http://www.alzheimer.ca/~/media/Files/national/Advocacy/ASC_Rising_Tide_Full_Report_e.pdf.</Citation></Reference><Reference><Citation>Asadoorian, J. (2006). Canadian Dental Hygienists Association position paper on tooth brushing. Canadian Journal of Dental Hygiene, 40(5), 232-248.</Citation></Reference><Reference><Citation>Castle, N., Engberg, J., &amp; Anderson, R. (2007). Job satisfaction of nurse aides in nursing homes: Intent to leave and turnover. The Gerontologist, 47, 193-204. https://doi.org/10.1177/1077558706298291</Citation></Reference><Reference><Citation>Coleman, P., &amp; Watson, N. (2006). Oral care provided by certified nursing assistants in nursing homes. Journal of the American Geriatrics Society, 54, 138-143. https://doi.org/10.1111/j.1532-5415.2005.00565</Citation></Reference><Reference><Citation>Daly, B., Thompsell, A., Sharpling, J., Rooney, Y. M., Hillman, L., Wanyonyi, K., &#x2026; Gallagher, J. E. (2017). Evidence summary: The relationship between oral health and dementia. British Dental Journal, 223(11), 846-853. https://doi.org/10.1038/sj.bdj.2017.992</Citation></Reference><Reference><Citation>Dietrich, T., Sharma, P., Walter, C., Weston, P., &amp; Beck, J. (2013). The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. Journal of Clinical Periodontology, 40, S70-S84. https://doi.org/10.1111/jcpe.12062</Citation></Reference><Reference><Citation>Folstein, M. F., Folsein, S. E., &amp; McHugh, P. R. (1975). &#x201c;Mini-mental-state&#x201d;: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198. https://doi.org/10.1016/0022-3956(75)90026-6</Citation></Reference><Reference><Citation>Fox, C. (2010). Evidence summary: Why is access to dental care for frail elderly people worse than for other groups? British Dental Journal, 208, 119-122. https://doi.org/10.1038/sj.bdj.2010.103</Citation></Reference><Reference><Citation>Galik, E. (2012). Function-focused care in the nursing home. In B. Resnick, E. Galik, M. Boltz, &amp; I. Pretzer-Aboff (Eds.), Restorative care nursing for older adults: A guide for all care settings, 2nd ed. (pp. 41-66). New York, NY: Springer Publishing Company.</Citation></Reference><Reference><Citation>Gallagher, A., Sowinski, J., Bowman, J., Barrett, K., Lowe, S., Patel, K., &#x2026; Creeth, J. (2009). The effect of brushing time and dentifrice on dental plaque removal in vivo. Journal of Dental Hygiene, 83, 111-116.</Citation></Reference><Reference><Citation>Gaszynska, E., Szatko, F., Godala, M., &amp; Gaszynski, T. (2014). Oral health status, dental treatment needs, and barriers to dental care of elderly care home residents in Lodz, Poland. Clinical Interventions in Aging, 9, 1637-1644.</Citation></Reference><Reference><Citation>Guralnik, J., Alecxih, L., Branch, L., &amp; Wiener, M. (2002). Medical and long-term care costs when older persons become more dependent. American Journal of Public Health, 92, 1244-1245. https://doi.org/10.2105/AJPH.92.8.1244</Citation></Reference><Reference><Citation>Han, P., Suarez-Durall, P., &amp; Mulligan, R. (2015). Dry mouth: A critical topic for older adult patients. Journal of Prosthodontic Research, 59, 6-19. https://doi.org/10.1016/j.jpor.2014.11.001</Citation></Reference><Reference><Citation>Hoben, M., Clarke, A., Huynh, K. T., Kobagi, N., Kent, A., Hu, H., &#x2026; Yoon, M. N. (2017). Barriers and facilitators in providing oral care to nursing home residents, from the perspective of care aides: A systematic review and meta-analysis. International Journal of Nursing Studies, 73, 34-51. https://doi.org/10.1016/j.ijnurstu.2017.05.003</Citation></Reference><Reference><Citation>Hoben, M., Poss, J., Norton, P., &amp; Estabrooks, C. (2016). Oral/dental items in the resident assessment instrument - minimum Data Set 2.0 lack validity: Results of a retrospective, longitudinal validation study. Population Health Metrics, 21, 36.</Citation></Reference><Reference><Citation>Hsieh, H., &amp; Shannon, S. (2005). Three approaches to qualitative content analysis. Qualitative Health Research, 15, 1277-1288. https://doi.org/10.1177/1049732305276687</Citation></Reference><Reference><Citation>Islam, N., Bhattacharyya, I., &amp; Cohen, D. (2011). Common oral manifestations of systemic disease. Otolaryngologic Clinics of North America, 44, 161-182. https://doi.org/10.1016/j.otc.2010.09.006</Citation></Reference><Reference><Citation>Janssens, B., Vanobbergen, J., Petrovic, M., Jacquet, W., Schols, J., &amp; De Visschere, L. (2017). The oral health condition and treatment needs assessment of nursing home residents in Flanders (Belgium). Community Dental Health, 34(3), 143-151.</Citation></Reference><Reference><Citation>Kelsey, J., &amp; Lamster, I. (2008). Influence of musculoskeletal conditions on oral health among older adults. American Journal of Public Health, 98, 1177-1183. https://doi.org/10.2105/AJPH.2007.129429</Citation></Reference><Reference><Citation>Kogan, A., Wilber, K., &amp; Mosqueda, L. (2016). Person-centered care for older adults with chronic conditions and functional impairment: A systematic literature review. Journal of the American Geriatric Society, 64, e1-e7. https://doi.org/10.1111/jgs.13873</Citation></Reference><Reference><Citation>Komulainen, K., Yl&#xf6;stalo, P., Syrj&#xe4;l&#xe4;, A. M., Ruoppi, P., Knuuttila, M., Sulkava, R., &amp; Hartikainen, S. (2012). Associations of instrumental activities of daily living and handgrip strength with oral self-care among home-dwelling elderly 75+. Gerodontology, 29(2), e135-e142. https://doi.org/10.1111/j.1741-2358.2010.00427.x</Citation></Reference><Reference><Citation>Kshetrimayum, N., Reddy, C. V. K., Siddhana, S., Manjunath, M., Rudraswamy, S., &amp; Sulavai, S. (2013). Oral health-related quality of life and nutritional status of institutionalized elderly population aged 60 years and above in Mysore City, India. Gerondontology, 30(2), 119-125. https://doi.org/10.1111/j.1741-2358.2012.00651.x</Citation></Reference><Reference><Citation>MacEntee, M. I., Thorne, S., &amp; Kazanjian, A. (1999). Conflicting priorities: Oral health in long-term care. Special Care in Dentistry, 19, 164-172. https://doi.org/10.1111/j.1754-4505.1999.tb01380</Citation></Reference><Reference><Citation>Matthews, D., Clovis, J., Brillant, M., Filiaggi, M., McNally, M., Kotzer, R., &amp; Lawrence, H. (2012). Oral health status of long-term care residents: A vulnerable population. Journal of the Canadian Dental Association, 78, c3.</Citation></Reference><Reference><Citation>Perry, M., Carpenter, I., Challis, D., &amp; Hope, K. (2003). Understanding the roles of registered general nurses and care assistants in UK nursing homes. Journal of Advanced Nursing, 42, 497-505. https://doi.org/10.1046/j.1365-2648.2003.02649</Citation></Reference><Reference><Citation>Petelin, M., Coti&#x10d;, J., Perki&#x10d;, K., &amp; Pavli&#x10d;, A. (2012). Oral health of the elderly living in residential homes in Slovenia. Gerodontology, 29, e447-e457. https://doi.org/10.1111/j.1741-2358.2007.00136</Citation></Reference><Reference><Citation>R&#xe4;ikk&#xf6;nen, O., Per&#xe4;l&#xe4;, M., &amp; Kahanp&#xe4;&#xe4;, A. (2007). Staffing adequacy, supervisory support and quality of care in long-term care settings: Staff perceptions. Journal of Advanced Nursing, 60, 615-626. https://doi.org/10.1111/j.1365-2648.2007.04443</Citation></Reference><Reference><Citation>Resnick, B. (2012). Focusing on function in all care interactions: A new philosophy of nursing care. In B. Resnick, E. Galik, M. Boltz, &amp; I. Pretzer-Aboff (Eds.), Restorative care nursing for older adults: A guide for all care settings, 2nd ed. (pp. 1-14). New York, NY: Springer Publishing Company.</Citation></Reference><Reference><Citation>Resnick, B., Galik, E., &amp; Boltz, M. (2013). Function focused care approaches: Literature review of progress and future possibilities. Journal of the American Medical Directors Association, 14, 313-318. https://doi.org/10.1016/j.jamda.2012.10.019</Citation></Reference><Reference><Citation>Squires, J. E., Hoben, M., Linklater, S., Carleton, H. L., Graham, N., &amp; Estabrooks, C. A. (2015). Job satisfaction among care aides in residential long-term care: A systematic review of contributing factors, both individual and organizational. Nursing Research and Practice, 2015, 1-24. https://doi.org/10.1155/2015/157924</Citation></Reference><Reference><Citation>Stein, P., &amp; Henry, R. (2009). Poor oral hygiene in long-term care. American Journal of Nursing, 109(6), 44-50. https://doi.org/10.1097/01.NAJ.0000352472.70993.3b</Citation></Reference><Reference><Citation>Tappen, R. M. (1994). Development of the refined ADL assessment scale for patients with Alzheimer&#x2019;s and related disorders. Journal of Gerontological Nursing, 20, 36-42. https://doi.org/10.3928/0098-9134-19940601-09</Citation></Reference><Reference><Citation>Van der Weijden, F. A., &amp; Slot, D. E. (2015). Efficacy of homecare regimens for mechanical plaque removal in managing gingivitis a meta review. Journal of Clinical Periodontology, 42, S77-S91. https://doi.org/10.1111/jcpe.12359</Citation></Reference><Reference><Citation>Van Lancker, A., Verhaeghe, S., Van Hecke, A., Vanderwee, K., Goossens, J., &amp; Beeckman, D. (2012). The association between malnutrition and oral health status in elderly in long-term care facilities: A systematic review. International Journal of Nursing Studies, 49, 1568-1581. https://doi.org/10.1016/j.ijnurstu.2012.04.001</Citation></Reference><Reference><Citation>Wainwright, J., &amp; Sheiham, A. (2014). An analysis of methods of toothbrushing recommended by dental associations, toothpaste and toothbrush companies and in dental texts. British Dental Journal, 217(3), E5. https://doi.org/10.1038/sj.bdj.2014.651</Citation></Reference><Reference><Citation>Wardh, I., Hallberg, L., Berggren, U., Andersson, L., &amp; Sorensen, S. (2000). Oral health care - a low priority in nursing: In-depth interviews with nursing staff. Scandinavian Journal of Caring Sciences, 14, 137-142. https://doi.org/10.1111/j.1471-6712.2000.tb00574</Citation></Reference><Reference><Citation>Wilson, R., Rochon, E., Mihailidis, A., &amp; Leonard, C. (2013). Quantitative analysis of formal caregivers&#x2019; use of communication strategies while assisting individuals with moderate and severe Alzheimer&#x2019;s disease during oral care. Journal of Communication Disorders, 46, 249-263. https://doi.org/10.1016/j.jcomdis.2013.01.004</Citation></Reference><Reference><Citation>World Health Organization (2015). Tokyo declaration on dental care and oral health for healthy longevity. Retrieved from: http://www.who.int/oral_health/tokyodeclaration_final.pdf?ua=1.</Citation></Reference><Reference><Citation>Wu, B., Fillenbaum, G., Plassman, B., &amp; Guo, L. (2016). Association between oral health and cognitive status: A systematic review. Journal of the American Geriatric Society, 64(4), 739-751. https://doi.org/10.1111/jgs.14036</Citation></Reference><Reference><Citation>Wyatt, C., Papas, A. S., &amp; MacEntee, M. I. (2010). Caries and Frail Elders. In M. I. MacEntee (Ed.), Oral Healthcare and the Frail Elder: A Clinical Perspective (pp. 147-160). Ames, IA: Wiley-Blackwell.</Citation></Reference><Reference><Citation>Yoon, M. N., Ickert, C., Slaughter, S., Lengyel, C., Carrier, N., &amp; Keller, H. (2018). Oral health status of long-term care residents in Canada: Results of a national cross-sectional study. Gerondontology, 35(4), 359-364. https://doi.org/10.1111/ger.12356</Citation></Reference><Reference><Citation>Yoon, M. N., &amp; Steele, C. M. (2012). Health-care professionals' perspectives on oral care for LTC residents: Nursing staff, speech-language pathologists and dental hygienists. Gerodontology, 29, e525-535. https://doi.org/10.1111/j.1741-2358.2011.00513</Citation></Reference><Reference><Citation>Zander, A., &amp; Boniface, D. (2017). Directly observed daily mouth care provided to care home residents in one area of Kent, UK. Community Dental Health Journal, 34, 32-36. https://doi.org/10.1922/CDH_3956Zander05</Citation></Reference><Reference><Citation>Zenthofer, A., Rammelsberg, R., Cabrera, T., &amp; Hassel, A. (2014). Increasing dependency of older people in nursing homes is associated with need for dental treatments. Neuropsychiatric Disease and Treatment, 10, 2285-2290. https://doi.org/10.2147/NDT.S71184</Citation></Reference><Reference><Citation>Zuanazzi, D., Souto, R., Mattos, M., Zuanazzi, M., Tura, B., Sansone, C., &amp; Colombo, A. (2010). Prevalence of potential bacterial respiratory pathogens in the oral cavity of hospitalised individuals. Archives of Oral Biology, 55, 21-28. https://doi.org/10.1016/j.archoralbio.2009.10.005</Citation></Reference><Reference><Citation>Zuluaga, D., Ferreira, J., Montoya, J., &amp; Willumsen, T. (2012). Oral health in institutionalised elderly people in Oslo, Norway and its relationship with dependence and cognitive impairment. Gerodontology, 29, e420-426. https://doi.org/10.1111/j.1741-2358.2011.00490</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">31647053</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-203X</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>International psychogeriatrics</Title><ISOAbbreviation>Int Psychogeriatr</ISOAbbreviation></Journal><ArticleTitle>Modelling the impact of functionality, cognition, and mood state on awareness in people with Alzheimer's disease.</ArticleTitle><Pagination><StartPage>361</StartPage><EndPage>371</EndPage><MedlinePgn>361-371</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S1041610219001467</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To investigate the nature of the relationship between cognitive function, mood state, and functionality in predicting awareness in a non-clinically depressed sample of participants with mild to moderate Alzheimer's disease (AD) in Brazil.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">People with AD (PwAD) aged 60 years or older were recruited from an outpatient unit at the Center of AD of the Federal University of Rio de Janeiro, Brazil. Measures of awareness of condition (Assessment Scale of the Psychosocial Impact of the Diagnosis of Dementia), cognitive function (Mini-Mental State Examination), mood state (Cornell Scale for Depression in Dementia), and functionality (Pfeffer Functional Activities Questionnaire) were applied to 264 people with mild to moderate AD and their caregivers. Hypotheses were tested statistically using SEM approach. Three competing models were compared.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The first model, in which the influence of mood state and cognitive function on awareness was mediated by functionality, showed a very good fit to the data and a medium effect size. The competing models, in which the mediating variables were mood state and cognitive function, respectively, only showed poor model fit.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our model supports the notion that the relationship between different factors and awareness in AD is mediated by functionality and not by depressive mood state or cognitive level. The proposed direct and indirect effects on awareness are discussed, as well as the missing direct influence of mood state on awareness. The understanding of awareness in dementia is crucial and our model gives one possible explanation of its underlying structure in AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0902-9286</Identifier><AffiliationInfo><Affiliation>Department of Psychology, Pontifical Catholic University of Rio de Janeiro, Rua Marqu&#xea;s de S&#xe3;o Vicente, 225, G&#xe1;vea, Rio de Janeiro, RJ, 22451-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dourado</LastName><ForeName>Marcia Cristina Nascimento</ForeName><Initials>MCN</Initials><Identifier Source="ORCID">0000-0001-6267-8202</Identifier><AffiliationInfo><Affiliation>Institute of Psychiatry, Federal University of Rio de Janeiro, Avenida Venceslau Br&#xe1;s, 71, Botafogo, Rio de Janeiro, RJ, 22290-140, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laks</LastName><ForeName>Jerson</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, Federal University of Rio de Janeiro, Avenida Venceslau Br&#xe1;s, 71, Botafogo, Rio de Janeiro, RJ, 22290-140, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landeira-Fernandez</LastName><ForeName>Jesus</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Psychology, Pontifical Catholic University of Rio de Janeiro, Rua Marqu&#xea;s de S&#xe3;o Vicente, 225, G&#xe1;vea, Rio de Janeiro, RJ, 22451-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Robin G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, Camberwell, London SE5 8AF, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mograbi</LastName><ForeName>Daniel C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, Camberwell, London SE5 8AF, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int Psychogeriatr</MedlineTA><NlmUniqueID>9007918</NlmUniqueID><ISSNLinking>1041-6102</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000339" MajorTopicYN="N">Affect</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anosognosia</Keyword><Keyword MajorTopicYN="N">awareness</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">functionality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31647053</ArticleId><ArticleId IdType="doi">10.1017/S1041610219001467</ArticleId><ArticleId IdType="pii">S1041610219001467</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21482915</PMID><DateCompleted><Year>2011</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-3687</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>8</Issue><PubDate><Year>2011</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Archives of neurology</Title><ISOAbbreviation>Arch Neurol</ISOAbbreviation></Journal><ArticleTitle>Lack of evidence for the efficacy of memantine in mild Alzheimer disease.</ArticleTitle><Pagination><StartPage>991</StartPage><EndPage>998</EndPage><MedlinePgn>991-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/archneurol.2011.69</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We directly assessed the clinical trials' evidence for memantine's efficacy in mild Alzheimer disease (AD). Memantine is indicated in the United States and Europe for moderate to severe AD, which is diagnosed if a patient has a Mini-Mental State Examination (MMSE) score of less than 15 or less than 20, respectively. Yet memantine is very frequently prescribed for mild AD and mild cognitive impairment, and a manufacturer-sponsored meta-analysis claimed its efficacy in mild AD.</AbstractText><AbstractText Label="DATA SOURCES, STUDY SELECTION, AND DATA EXTRACTION" NlmCategory="METHODS">Manufacturer-sponsored meta-analyses, registries, presentations, and publications were systematically searched for randomized placebo-controlled, parallel-group clinical trials of memantine in patients with mild to moderate AD. The trials' characteristics and outcomes were extracted by one reviewer and checked by another. Meta-analyses were performed as inverse variance-weighted averages of mean differences using fixed-effects models. Summary results for patients with mild AD were obtained by contrasting the summary results for patients with mild or moderate AD with the summary results for the subset of patients with moderate AD.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">Three trials were identified that included 431 patients with mild AD (ie, with MMSE scores of 20-23) and 697 patients with moderate AD (ie, with MMSE scores of 10-19). There were no significant differences between memantine and placebo on any outcome for patients with mild AD, either within any trial or when data were combined: mean differences (95% confidence intervals [CIs]) on the Alzheimer Disease Assessment Scale-cognitive subscale (ADAS-cog), the Clinician's Interview-Based Impression of Change plus caregiver's input (CIBIC-plus), the Alzheimer Disease Cooperative Study-activities of daily living (ADCS-ADL) scale, and the Neuropsychiatric Inventory (NPI) were -0.17 (95% CI, -1.60 to 1.26), -0.09 (95% CI, -0.30 to 0.12), 0.62 (95% CI, -1.64 to 2.71), and 0.09 (95% CI, -2.11 to 2.29), respectively. For patients with moderate AD, there were small differences on the ADAS-cog and the CIBIC-plus, -1.33 (95% CI, -2.28 to -0.38) and -0.16 (95% CI, -0.32 to 0.00), respectively, but no differences on the ADCS-ADL scale (-0.57 [95% CI, -1.75 to 0.60]) or the NPI (0.25 [95% CI, -1.48 to 1.99]).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Despite its frequent off-label use, evidence is lacking for a benefit of memantine in mild AD, and there is meager evidence for its efficacy in moderate AD. Prospective trials are needed to further assess the potential for efficacy of memantine either alone or added to cholinesterase inhibitors in mild and moderate AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Lon S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA. lschneid@usc.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dagerman</LastName><ForeName>Karen S</ForeName><Initials>KS</Initials></Author><Author ValidYN="Y"><LastName>Higgins</LastName><ForeName>Julian P T</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>McShane</LastName><ForeName>Rupert</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_U105285807</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>P50 AG05142</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arch Neurol</MedlineTA><NlmUniqueID>0372436</NlmUniqueID><ISSNLinking>0003-9942</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018691">Excitatory Amino Acid Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>W8O17SJF3T</RegistryNumber><NameOfSubstance UI="D008559">Memantine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018691" MajorTopicYN="N">Excitatory Amino Acid Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008559" MajorTopicYN="N">Memantine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21482915</ArticleId><ArticleId IdType="doi">10.1001/archneurol.2011.69</ArticleId><ArticleId IdType="pii">archneurol.2011.69</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12486898</PMID><DateCompleted><Year>2003</Year><Month>02</Month><Day>05</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0035-3787</ISSN><JournalIssue CitedMedium="Print"><Volume>158</Volume><Issue>6-7</Issue><PubDate><Year>2002</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Revue neurologique</Title><ISOAbbreviation>Rev Neurol (Paris)</ISOAbbreviation></Journal><ArticleTitle>[Perturbations of activities of daily living in Alzheimer's disease. A study of 172 patients with the using a questionnaire completed by caregivers].</ArticleTitle><Pagination><StartPage>684</StartPage><EndPage>700</EndPage><MedlinePgn>684-700</MedlinePgn></Pagination><Abstract><AbstractText>Functional decline was studied retrospectively in 172 patients with Alzheimer's disease, AD, using a questionnaire completed by the caregiver. Ninety-nine of these patients had a second assessment after a follow-up of 22.1 +/- 13.8 months. The questionnaire included French versions of the Physical Self-Maintenance Activities, ADL, and of the Instrumental Activities of Daily Living, IADL (Lawton and Brody, 1969). A third part assessing social activities, SADL, was derived from Katz and Lyerly (1963). The earliest and most frequent perturbations in early AD involved SADL, mainly a reduction in social and leisure activities, appearing in subjects with a MMSE score &gt; 26. The earliest decline in IADL involved the ability for handling finances, odd jobs-sewing, and shopping, which were more frequently perturbed than ability to use telephone, traveling or handling medication. The most interesting results of our study were as follows. Functional decline did not allow to distinguish patients with early AD (MMSE score &gt; or = 24) from those with mild dementia (MMSE score 20-23). Mild perturbations of ADL, mainly dressing and walking, were observed in early AD. There was a good correlation, but no parallelism, between functional decline and cognitive decline. Disturbances in ADL and SADL significantly differed only between patients with severe dementia (MMSE &lt; 10) and those of the three other groups. Apathy appeared to be a stronger predictor of functional decline than the score on the MMSE in the early stages of AD. There was a great variability among the patients regarding the type of functional decline as well as the rate of decline. Functional decline is very useful for detecting early AD. However, its specificity seems to be low and the diagnosis should be supported by cognitive assessment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Derouesn&#xe9;</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Service de Neurologie, Pavillon Paul Castaigne, H&#xf4;pital de la Salp&#xea;tri&#xe8;re, 47 Boulevard de l'H&#xf4;pital, 75651 Paris. chderou@noos.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thibault</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Lozeron</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Baudouin-Madec</LastName><ForeName>V</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Piquard</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Lacomblez</LastName><ForeName>L</ForeName><Initials>L</Initials></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Perturbations des activit&#xe9;s quotidiennes au cours de la maladie d'Alzheimer. Etude chez 172 patients &#xe0; l'aide d'un questionnaire rempli par le conjoint.</VernacularTitle></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Rev Neurol (Paris)</MedlineTA><NlmUniqueID>2984779R</NlmUniqueID><ISSNLinking>0035-3787</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="N">Dementia</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012727" MajorTopicYN="N">Sex Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012919" MajorTopicYN="N">Social Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>12</Month><Day>19</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>2</Month><Day>6</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>12</Month><Day>19</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12486898</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>